PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bonetta, L				Bonetta, Laura			Interactome under construction	NATURE			English	Editorial Material							INTERACTION NETWORK; SYSTEM; CELLS											Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; BENNETT EJ, CELL IN PRESS; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Nomura DK, 2010, NAT REV CANCER, V10, P630, DOI 10.1038/nrc2901; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Yu YH, 2009, P NATL ACAD SCI USA, V106, P11606, DOI 10.1073/pnas.0905165106	13	160	164	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					851	854		10.1038/468851a	http://dx.doi.org/10.1038/468851a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21150998				2022-12-28	WOS:000285093700051
J	Rada-Iglesias, A; Bajpai, R; Swigut, T; Brugmann, SA; Flynn, RA; Wysocka, J				Rada-Iglesias, Alvaro; Bajpai, Ruchi; Swigut, Tomek; Brugmann, Samantha A.; Flynn, Ryan A.; Wysocka, Joanna			A unique chromatin signature uncovers early developmental enhancers in humans	NATURE			English	Article							EMBRYONIC STEM-CELLS; EXPRESSION ANALYSIS; GENE-EXPRESSION; TRANSCRIPTION; IDENTIFICATION; ZEBRAFISH; PROMOTERS; GENOME; EOMESODERMIN; DATABASE	Cell-fate transitions involve the integration of genomic information encoded by regulatory elements, such as enhancers, with the cellular environment(1,2). However, identification of genomic sequences that control human embryonic development represents a formidable challenge(3). Here we show that in human embryonic stem cells (hESCs), unique chromatin signatures identify two distinct classes of genomic elements, both of which are marked by the presence of chromatin regulators p300 and BRG1, monomethylation of histone H3 at lysine 4 (H3K4me1), and low nucleosomal density. In addition, elements of the first class are distinguished by the acetylation of histone H3 at lysine 27 (H3K27ac), overlap with previously characterized hESC enhancers, and are located proximally to genes expressed in hESCs and the epiblast. In contrast, elements of the second class, which we term 'poised enhancers', are distinguished by the absence of H3K27ac, enrichment of histone H3 lysine 27 trimethylation (H3K27me3), and are linked to genes inactive in hESCs and instead are involved in orchestrating early steps in embryogenesis, such as gastrulation, mesoderm formation and neurulation. Consistent with the poised identity, during differentiation of hESCs to neuroepithelium, a neuroectoderm-specific subset of poised enhancers acquires a chromatin signature associated with active enhancers. When assayed in zebrafish embryos, poised enhancers are able to direct cell-type and stage-specific expression characteristic of their proximal developmental gene, even in the absence of sequence conservation in the fish genome. Our data demonstrate that early developmental enhancers are epigenetically pre-marked in hESCs and indicate an unappreciated role of H3K27me3 at distal regulatory elements. Moreover, the wealth of new regulatory sequences identified here provides an invaluable resource for studies and isolation of transient, rare cell populations representing early stages of human embryogenesis.	[Rada-Iglesias, Alvaro; Bajpai, Ruchi; Swigut, Tomek; Brugmann, Samantha A.; Flynn, Ryan A.; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Wysocka, J (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	wysocka@stanford.edu	Li, Yapeng/N-1042-2017	Li, Yapeng/0000-0002-5042-6881; Swigut, Tomek/0000-0002-7649-6781; Bajpai, Ruchi/0000-0001-7737-3567; Rada-Iglesias, Alvaro/0000-0001-7137-1341	WM Keck Foundation; CIRM [RN1 00579-1]; EMBO; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K99DE019853] Funding Source: NIH RePORTER	WM Keck Foundation(W.M. Keck Foundation); CIRM(California Institute for Regenerative Medicine); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Wysocka laboratory members for ideas and manuscript comments; I. A. Shestopalov and J. K. Chen for sharing zebrafish resources, equipment and knowledge; T. Howes and D. M. Kingsley for the pT2HE vector; Z. Weng and A. Sidow for Illumina sequencing; and A. Valouev for discussion on ChIP-seq data analysis. This work was supported by WM Keck Foundation Distinguished Young Scholar in Biomedical Research Award and CIRM RN1 00579-1 grant to J.W.A.R.-I. was supported by an EMBO long-term fellowship.	Bajpai R, 2009, CELL DEATH DIFFER, V16, P807, DOI 10.1038/cdd.2009.18; Blechinger SR, 2002, MECH DEVELOP, V112, P213, DOI 10.1016/S0925-4773(01)00652-9; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; COCKERILL PN, 1995, MOL CELL BIOL, V15, P2071; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hancock SN, 1999, MECH DEVELOP, V81, P205, DOI 10.1016/S0925-4773(98)00244-5; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Itani HA, 2007, ENDOCRINOLOGY, V148, P1424, DOI 10.1210/en.2006-1381; Kerppola TK, 2009, TRENDS CELL BIOL, V19, P692, DOI 10.1016/j.tcb.2009.10.001; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Marin O, 2002, DEVELOPMENT, V129, P761; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Nakabayashi H, 2004, BIOCHEM BIOPH RES CO, V318, P773, DOI 10.1016/j.bbrc.2004.04.096; Navratilova P, 2009, DEV BIOL, V327, P526, DOI 10.1016/j.ydbio.2008.10.044; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Robb L, 2000, DEV DYNAM, V219, P497, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1070>3.0.CO;2-O; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Segawa K, 2009, J ENDOCRINOL, V200, P107, DOI 10.1677/JOE-08-0376; Sprague J, 2006, NUCLEIC ACIDS RES, V34, pD581, DOI 10.1093/nar/gkj086; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Yeom YI, 1996, DEVELOPMENT, V122, P881	39	1470	1502	4	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					279	+		10.1038/nature09692	http://dx.doi.org/10.1038/nature09692			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21160473	Green Accepted			2022-12-28	WOS:000287144200048
J	Doherty, RB				Doherty, Robert B.			Universal Health Care Coverage in the United States: Is It "Slip Slidin' Away"?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								With passage of the Affordable Care Act, affordable health insurance for all Americans is in sight, yet politics could cause it to slip away. A resurgent Republican Party will mount a sustained challenge at the federal and state levels, but the new Congress will not bring about the Affordable Care Act's repeal. More likely, the law's effectiveness could be undermined by congressional restrictions on its implementation, underfunding of programs to improve public health and train more primary care physicians, and resistance by many states to its mandates. Congress could instead seek a bipartisan accord on improving the law, such as by giving the states more options, but this is unlikely in the current polarized environment. This debate is occurring even as the United States faces an unprecedented crisis in access to health insurance coverage, affecting nearly every demographic group, yet the uninsured have largely become an afterthought. Medical professionalism requires a commitment to improving access to care, and physicians could play a crucial role in informing lawmakers that providing all Americans with affordable health care coverage is a moral and medical imperative to prevent needless suffering and death, and must not be allowed to slip away. Ann Intern Med. 2011;154:118-120.	Amer Coll Physicians, Washington, DC 20001 USA	American College of Physicians	Doherty, RB (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.							[Anonymous], 2008, ANN INTERN MED, V148, P55, DOI 10.7326/0003-4819-148-1-200801010-00196; Blendon Robert J, 2010, N Engl J Med, V363, pe30, DOI 10.1056/NEJMp1011714; Carroll AE, 2008, ANN INTERN MED, V148, P566, DOI 10.7326/0003-4819-148-7-200804010-00026; Cass C, 2010, EXIT POLL BAD EC ECL; Commonwealth Fund, UNM NEEDS MED CAR WO; Congressional Budget Office, 2009, COMMUNICATION   1104; Congressional Budget Office, 2010, LETT SEN CRAP BUDG I; Congressional Research Service, 2010, REQ IND OBT HLTH INS; DeNavas-Walt C., 2009, INCOME POVERTY HLTH; Fox J. B., 2010, Morbidity and Mortality Weekly Report, V59, P1448; Gould E, 2010, DECLINE EMPLOYER SPO; Herndon Alliance, 2010, PRES AUG 2010 RES; House Republicans Congress, PLEDG AM NEW GOV AG; Institute of Medicine Committee on Health Insurance Status and Its Consequences, 2009, AM UN CRIS CONS HLTH; Klein E, 2010, HAVE BROWN S WYDEN R; Levey N, 2010, LOS ANGELES TIM 0915; Ramshaw E, KAISER HLTH NEWS; Sack K, 2010, REPUBLICANS RISE POW; Senkeeto N, 2008, ACHIEVING AFFORDABLE; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Volsky I, 2010, FORMER OBAMA HLTH PO; 1990, ANN INTERN MED, V112, P641	22	3	3	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2					118	+		10.7326/0003-4819-154-2-201101180-00302	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-00302			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706MW	21135288				2022-12-28	WOS:000286223500006
J	Cao, C; Elliott, E; Joseph, J; Wu, H; Petricka, J; Schafer, T; Thomas, JE				Cao, C.; Elliott, E.; Joseph, J.; Wu, H.; Petricka, J.; Schaefer, T.; Thomas, J. E.			Universal Quantum Viscosity in a Unitary Fermi Gas	SCIENCE			English	Article							THERMODYNAMICS	A Fermi gas of atoms with resonant interactions is predicted to obey universal hydrodynamics, in which the shear viscosity and other transport coefficients are universal functions of the density and temperature. At low temperatures, the viscosity has a universal quantum scale (h) over bar n, where n is the density and (h) over bar is Planck's constant h divided by 2 pi, whereas at high temperatures the natural scale is p(T)(3)/(h) over bar (2), where p(T) is the thermal momentum. We used breathing mode damping to measure the shear viscosity at low temperature. At high temperature T, we used anisotropic expansion of the cloud to find the viscosity, which exhibits precise T-3/2 scaling. In both experiments, universal hydrodynamic equations including friction and heating were used to extract the viscosity. We estimate the ratio of the shear viscosity to the entropy density and compare it with that of a perfect fluid.	[Cao, C.; Elliott, E.; Joseph, J.; Wu, H.; Thomas, J. E.] Duke Univ, Dept Phys, Durham, NC 27708 USA; [Petricka, J.] Gustavus Adolphus Coll, Dept Phys, St Peter, MN 56082 USA; [Schaefer, T.] N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA	Duke University; Gustavus Adolphus College; University of North Carolina; North Carolina State University	Thomas, JE (corresponding author), Duke Univ, Dept Phys, Durham, NC 27708 USA.	jet@phy.duke.edu	Cao, Chenglin/G-4631-2011; Thomas, John/Q-9759-2018	Thomas, John/0000-0002-0018-2831; Schaefer, Thomas/0000-0002-2297-782X	Direct For Mathematical & Physical Scien [0751177] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Bruun GM, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.043612; Csernai LP, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.152303; Escobedo M. A., PHYS REV A; Gelman BA, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.043601; Giorgini S, 2008, REV MOD PHYS, V80, P1215, DOI 10.1103/RevModPhys.80.1215; Ho TL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.090402; Horikoshi M, 2010, SCIENCE, V327, P442, DOI 10.1126/science.1183012; Hu H, 2007, NAT PHYS, V3, P469, DOI 10.1038/nphys598; Ketterle W., 2008, ULTRACOLD FERMI GASE; Kinast J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.170404; Kinast J, 2005, SCIENCE, V307, P1296, DOI 10.1126/science.1109220; Kovtun PK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.111601; Luo L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.080402; Luo L, 2009, J LOW TEMP PHYS, V154, P1, DOI 10.1007/s10909-008-9850-2; Massignan P, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.033607; Menotti C, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.250402; Nascimbene S, 2010, NATURE, V463, P1057, DOI 10.1038/nature08814; O'Hara KM, 2002, SCIENCE, V298, P2179, DOI 10.1126/science.1079107; Schafer T, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.063618; Son DT, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.020604; Stewart JT, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.220406; Taylor E, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.053610; Thomas JE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.120402; Turlapov A, 2008, J LOW TEMP PHYS, V150, P567, DOI 10.1007/s10909-007-9589-1	25	234	235	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					58	61		10.1126/science.1195219	http://dx.doi.org/10.1126/science.1195219			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21148347	Green Submitted			2022-12-28	WOS:000285974000033
J	Porter, ME				Porter, Michael E.			What Is Value in Health Care?.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Business, Boston, MA 02163 USA	Harvard University	Porter, ME (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.							Institute of Medicine, 2006, PERF MEAS ACC IMPR; National Committee for Quality Assurance (NCQA), HEDIS QUAL MEAS TECH; Porter M.E., 2006, REDEFINING HLTH CARE; Porter ME, 2010, UCLA MED CTR KIDN TR; Porter ME, 2008, 2007 IOM ANN M SUMM, P161	5	2891	2913	7	179	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2010	363	26					2477	2481		10.1056/NEJMp1011024	http://dx.doi.org/10.1056/NEJMp1011024			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697YL	21142528				2022-12-28	WOS:000285555600001
J	Sacco, A; Mourkioti, F; Tran, R; Choi, J; Llewellyn, M; Kraft, P; Shkreli, M; Delp, S; Pomerantz, JH; Artandi, SE; Blau, HM				Sacco, Alessandra; Mourkioti, Foteini; Tran, Rose; Choi, Jinkuk; Llewellyn, Michael; Kraft, Peggy; Shkreli, Marina; Delp, Scott; Pomerantz, Jason H.; Artandi, Steven E.; Blau, Helen M.			Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice	CELL			English	Article							MEDIATED GENE-THERAPY; SKELETAL-MUSCLE REGENERATION; REPLICATIVE LIFE-SPAN; SELF-RENEWAL; HUMAN LIVER; SPINAL DEFORMITY; SATELLITE CELLS; MITOTIC CLOCK; MOUSE; MDX	In Duchenne muscular dystrophy (DMD), dystrophin mutation leads to progressive lethal skeletal muscle degeneration. For unknown reasons, dystrophin deficiency does not recapitulate DMD in mice (mdx), which have mild skeletal muscle defects and potent regenerative capacity. We postulated that human DMD progression is a consequence of loss of functional muscle stem cells (MuSC), and the mild mouse mdx phenotype results from greater MuSC reserve fueled by longer telomeres. We report that mdx mice lacking the RNA component of telomerase (mdx/mTR) have shortened telomeres in muscle cells and severe muscular dystrophy that progressively worsens with age. Muscle wasting severity parallels a decline in MuSC regenerative capacity and is ameliorated histologically by transplantation of wild-type MuSC. These data show that DMD progression results, in part, from a cell-autonomous failure of MuSC to maintain the damage-repair cycle initiated by dystrophin deficiency. The essential role of MuSC function has therapeutic implications for DMD.	[Sacco, Alessandra; Mourkioti, Foteini; Tran, Rose; Kraft, Peggy; Pomerantz, Jason H.; Blau, Helen M.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Inst Stem Cell Biol & Regenerat Med,Sch Med, Stanford, CA 94305 USA; [Choi, Jinkuk; Shkreli, Marina; Artandi, Steven E.] Stanford Univ, Sch Med, Dept Med, Canc Biol Program, Stanford, CA 94305 USA; [Llewellyn, Michael; Delp, Scott] Stanford Univ, James H Clark Ctr Biomed Engn & Sci, BioX Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Pomerantz, JH (corresponding author), Univ Calif San Francisco, Div Plast & Reconstruct Surg, Craniofacial & Mesenchymal Biol Program, Eli & Edythe Broad Ctr Regenerat Med,Dept Surg, San Francisco, CA 94143 USA.	jason.pomerantz@ucsfmedctr.org; hblau2@stanford.edu		Choi, Jinkuk/0000-0002-2449-8291; Delp, Scott/0000-0002-9643-7551; Mourkioti, Foteini/0000-0002-7119-6640	American Heart Association [10SDG3510024]; NIH [AG009521, AG020961]; Muscular Dystrophy Association [4320]; Baxter Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397, R01HL096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020961, R01AG009521, R37AG009521] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Baxter Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Kassie Koleckar for excellent technical support; Fabio Rossi for providing the alpha 7-integrin-PE-conjugated antibody; Jackie Kustan for help with the scheme; and Frezghi Habte at the Stanford Small Imaging Facility for help with the CT-Scan. This work was supported by American Heart Association Scientist Development Grant 10SDG3510024 to F. M.; NIH grants AG009521 and AG020961; Muscular Dystrophy Association grant 4320; and the Baxter Foundation to H.M.B.	Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Artandi SE, 2006, NEW ENGL J MED, V355, P1195, DOI 10.1056/NEJMp068187; Blaauw B, 2008, HUM MOL GENET, V17, P3686, DOI 10.1093/hmg/ddn264; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BLAU HM, 1983, P NATL ACAD SCI-BIOL, V80, P4856, DOI 10.1073/pnas.80.15.4856; Bockhold KJ, 1998, MUSCLE NERVE, V21, P173, DOI 10.1002/(SICI)1097-4598(199802)21:2<173::AID-MUS4>3.0.CO;2-8; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Decary S, 2000, NEUROMUSCULAR DISORD, V10, P113, DOI 10.1016/S0960-8966(99)00093-0; Decary S, 1997, HUM GENE THER, V8, P1429, DOI 10.1089/hum.1997.8.12-1429; DIMARIO JX, 1991, DEV BIOL, V148, P314, DOI 10.1016/0012-1606(91)90340-9; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; GUSSONI E, 1992, NATURE, V356, P435, DOI 10.1038/356435a0; HARRIS JB, 1981, TOXICON, V19, P419, DOI 10.1016/0041-0101(81)90046-5; Hemann MT, 2001, MOL BIOL CELL, V12, P2023, DOI 10.1091/mbc.12.7.2023; Herrera E, 1999, EMBO J, V18, P1172, DOI 10.1093/emboj/18.5.1172; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; LINDSEY J, 1991, MUTAT RES, V256, P45, DOI 10.1016/0921-8734(91)90032-7; Liu Y, 2000, CURR BIOL, V10, P1459, DOI 10.1016/S0960-9822(00)00805-8; MCDONALD CM, 1995, AM J PHYS MED REHAB, V74, pS70, DOI 10.1097/00002060-199509001-00003; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Mouly V, 2005, ACTA PHYSIOL SCAND, V184, P3, DOI 10.1111/j.1365-201X.2005.01417.x; ODA T, 1993, J PEDIATR ORTHOPED, V13, P478, DOI 10.1097/01241398-199307000-00012; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Renault V, 2002, EXP GERONTOL, V37, P1513, DOI 10.1016/S0531-5565(02)00095-5; Rodier F, 2005, INT J BIOCHEM CELL B, V37, P977, DOI 10.1016/j.biocel.2004.10.012; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; RYDERCOOK AS, 1988, EMBO J, V7, P3017, DOI 10.1002/j.1460-2075.1988.tb03165.x; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Takubo K, 2000, J GERONTOL A-BIOL, V55, pB533, DOI 10.1093/gerona/55.11.B533; VAZIRI H, 1993, AM J HUM GENET, V52, P661; WEBSTER C, 1986, HUM GENET, V74, P74; WEBSTER C, 1990, SOMAT CELL MOLEC GEN, V16, P557, DOI 10.1007/BF01233096; Westerman KA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-96; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; WILKINS KE, 1976, J BONE JOINT SURG AM, V58, P24, DOI 10.2106/00004623-197658010-00004; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; ZATZ M, 1991, J NEUROL SCI, V102, P190, DOI 10.1016/0022-510X(91)90068-I	57	339	349	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1059	1071		10.1016/j.cell.2010.11.039	http://dx.doi.org/10.1016/j.cell.2010.11.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21145579	Green Accepted, Bronze			2022-12-28	WOS:000285625400005
J	Gharbi-Ayachi, A; Labbe, JC; Burgess, A; Vigneron, S; Strub, JM; Brioudes, E; Van-Dorsselaer, A; Castro, A; Lorca, T				Gharbi-Ayachi, Aicha; Labbe, Jean-Claude; Burgess, Andrew; Vigneron, Suzanne; Strub, Jean-Marc; Brioudes, Estelle; Van-Dorsselaer, Alain; Castro, Anna; Lorca, Thierry			The Substrate of Greatwall Kinase, Arpp19, Controls Mitosis by Inhibiting Protein Phosphatase 2A	SCIENCE			English	Article							ALPHA-ENDOSULFINE; ARREST; ENTRY; EXIT	Initiation and maintenance of mitosis require the activation of protein kinase cyclin B-Cdc2 and the inhibition of protein phosphatase 2A (PP2A), which, respectively, phosphorylate and dephosphorylate mitotic substrates. The protein kinase Greatwall (Gwl) is required to maintain mitosis through PP2A inhibition. We describe how Gwl activation results in PP2A inhibition. We identified cyclic adenosine monophosphate-regulated phosphoprotein 19 (Arpp19) and alpha-Endosulfine as two substrates of Gwl that, when phosphorylated by this kinase, associate with and inhibit PP2A, thus promoting mitotic entry. Conversely, in the absence of Gwl activity, Arpp19 and alpha-Endosulfine are dephosphorylated and lose their capacity to bind and inhibit PP2A. Although both proteins can inhibit PP2A, endogenous Arpp19, but not alpha-Endosulfine, is responsible for PP2A inhibition at mitotic entry in Xenopus egg extracts.	[Gharbi-Ayachi, Aicha; Labbe, Jean-Claude; Burgess, Andrew; Vigneron, Suzanne; Brioudes, Estelle; Castro, Anna; Lorca, Thierry] Univ Montpellier 2, Ctr Rech Biochim Macromol, IFR 122, CNRS,UMR 5237, F-34293 Montpellier 5, France; [Gharbi-Ayachi, Aicha; Labbe, Jean-Claude; Burgess, Andrew; Vigneron, Suzanne; Brioudes, Estelle; Castro, Anna; Lorca, Thierry] Univ Montpellier 1, Ctr Rech Biochim Macromol, IFR 122, CNRS,UMR 5237, F-34293 Montpellier 5, France; [Strub, Jean-Marc; Van-Dorsselaer, Alain] Inst Pluridisciplinaire Hubert Curien, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Castro, A (corresponding author), Univ Montpellier 2, Ctr Rech Biochim Macromol, IFR 122, CNRS,UMR 5237, 1919 Route Mende, F-34293 Montpellier 5, France.	anna.castro@crbm.cnrs.fr; thierry.lorca@crbm.cnrs.fr	Gharbi, Aicha/C-5521-2011; labbe, jean-claude/B-2277-2009; Burgess, Andrew/H-3339-2019; CASTRO, ANNA/F-4350-2010; Burgess, Andrew/C-7952-2009	Burgess, Andrew/0000-0003-4536-9226; CASTRO, ANNA/0000-0002-3655-1352; Burgess, Andrew/0000-0003-4536-9226; Strub, Jean-Marc/0000-0001-6224-3428; Lorca, Thierry/0000-0003-2007-8924	Ligue Regionale Contre le Cancer (Comite du Gard); Association pour la Recherche sur le Cancer	Ligue Regionale Contre le Cancer (Comite du Gard); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank L. Gros and A. Virsolvy for providing the pBKS-Arpp19, pBKS-alpha-Endosulfine constructs, and antibodies to human alpha-Endosulfine and T. Hunt and S. Mochida for the antibody to phosphoS67/62 Endo-Arp. This work was supported by the Ligue Regionale Contre le Cancer (Comite du Gard) and the "Association pour la Recherche sur le Cancer". A. B. and E. B. are "Fondation pour la Recherche Medicale" and "Ligue Nationale Contre le Cancer" fellows, respectively. There is a patent pending that pertains to results presented in this paper.	Archambault V, 2007, PLOS GENET, V3, P2163, DOI 10.1371/journal.pgen.0030200; Bataille D, 1999, CELL MOL LIFE SCI, V56, P78, DOI 10.1007/s000180050008; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; Gros L, 2002, DIABETOLOGIA, V45, P703, DOI 10.1007/s00125-002-0794-9; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Lorca T, 2010, J CELL SCI, V123, P2281, DOI 10.1242/jcs.064527; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Vigneron S, 2009, EMBO J, V28, P2786, DOI 10.1038/emboj.2009.228; Von Stetina JR, 2008, DEVELOPMENT, V135, P3697, DOI 10.1242/dev.025114; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871	11	299	308	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1673	1677		10.1126/science.1197048	http://dx.doi.org/10.1126/science.1197048			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164014	Green Published			2022-12-28	WOS:000285390500066
J	Halpern, SD; Barnes, B; Hasz, RD; Abt, PL				Halpern, Scott D.; Barnes, Barbara; Hasz, Richard D.; Abt, Peter L.			Estimated Supply of Organ Donors After Circulatory Determination of Death: A Population-Based Cohort Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CARDIAC DEATH; TRANSPLANTATION; DONATION		[Halpern, Scott D.] Univ Penn, Sch Med, Div Pulm & Crit Care Med, Philadelphia, PA 19104 USA; [Barnes, Barbara; Hasz, Richard D.] Gift Life Donor Program, Philadelphia, PA USA; [Abt, Peter L.] Univ Penn, Sch Med, Div Transplant Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Halpern, SD (corresponding author), Univ Penn, Sch Med, Div Pulm & Crit Care Med, Philadelphia, PA 19104 USA.	shalpern@exchange.upenn.edu	Abt, Peter/AAD-6856-2019		AHRQ HHS [K08 HS018406, K08HS018406] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018406] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Campbell GMD, 1999, CAN MED ASSOC J, V160, P1573; Durall AL, 2007, PEDIATRICS, V119, pE219, DOI 10.1542/peds.2006-0375; Childress James F., 2006, ORG DON OPP ACT; Koogler T, 1998, PEDIATRICS, V101, P1049, DOI 10.1542/peds.101.6.1049; Lacroix JD, 2004, CAN J SURG, V47, P10; Reich DJ, 2009, AM J TRANSPLANT, V9, P2004, DOI 10.1111/j.1600-6143.2009.02739.x	6	18	18	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2010	304	23					2592	2594		10.1001/jama.2010.1824	http://dx.doi.org/10.1001/jama.2010.1824			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694MX	21156947	Bronze			2022-12-28	WOS:000285303400021
J	Charlier, P; Huynh-Charlier, I; Poupon, J; Keyser, C; Lancelot, E; Favier, D; Vignal, JN; Sorel, P; Chaillot, PF; Boano, R; Grilletto, R; Delacourte, S; Duriez, JM; Loublier, Y; Campos, P; Willerslev, E; Gilbert, MTP; Eisenberg, L; Ludes, B; de la Grandmaison, GL				Charlier, Philippe; Huynh-Charlier, Isabelle; Poupon, Joel; Keyser, Christine; Lancelot, Eloise; Favier, Dominique; Vignal, Jean-Noel; Sorel, Philippe; Chaillot, Pierre F.; Boano, Rosa; Grilletto, Renato; Delacourte, Sylvaine; Duriez, Jean-Michel; Loublier, Yves; Campos, Paola; Willerslev, Eske; Gilbert, M. T. P.; Eisenberg, Leslie; Ludes, Bertrand; de la Grandmaison, Geoffroy Lorin			Christmas 2010: History Multidisciplinary medical identification of a French king's head (Henri IV)	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Charlier, Philippe; Chaillot, Pierre F.; de la Grandmaison, Geoffroy Lorin] Univ Hosp, Dept Forens Med & Pathol, F-92380 Garches, France; [Charlier, Philippe] Fac Med, Lab Med Eth, Paris, France; [Huynh-Charlier, Isabelle] Univ Hosp Pitie Salpetriere, Dept Radiol, Paris, France; [Poupon, Joel] Lariboisiere Hosp, Dept Biol Toxicol, Paris, France; [Keyser, Christine; Ludes, Bertrand] Univ Strasbourg, Inst Med Legale, Fac Med, F-67085 Strasbourg, France; [Lancelot, Eloise] Horiba Jobin Yvon, Applications Lab, F-59650 Villeneuve Dascq, France; [Favier, Dominique] Int Flavors & Fragrances Inc, F-92200 Neuilly Sur Seine, France; [Vignal, Jean-Noel] Inst Rech Criminelle Gendarmerie Natl, Forens Anthropol, Rosny Sous Bois, France; [Sorel, Philippe] Carnavalet Museum, Paris, France; [Boano, Rosa; Grilletto, Renato] Univ Turin, Dept Anim & Human Biol, I-10123 Turin, Italy; [Delacourte, Sylvaine] Guerlain, Perfumes Dev, Paris, France; [Duriez, Jean-Michel] Jean Patou Rochas, Perfumes Dev, Paris, France; [Loublier, Yves] CNRS, Gif Sur Yvette, France; [Campos, Paola; Willerslev, Eske; Gilbert, M. T. P.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenetics, DK-1307 Copenhagen, Denmark; [Eisenberg, Leslie] Wisconsin Hist Soc, Madison, WI 53706 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Horiba Ltd.; International Flavors & Fragrances; University of Turin; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Copenhagen	Charlier, P (corresponding author), Univ Hosp, Dept Forens Med & Pathol, 104 R Poincare Blvd, F-92380 Garches, France.	ph_charlier@yahoo.fr	Gilbert, Marcus TP/A-8936-2013; Campos, Paula F/B-1634-2010; Campos, Paula/ABF-9898-2021; Willerslev, Eske/AAA-5686-2019; Willerslev, Eske/A-9619-2011; Eisenberg, Leslie/AAH-9893-2020; LUDES, Bertrand/AAB-6309-2022	Gilbert, Marcus TP/0000-0002-5805-7195; Campos, Paula F/0000-0003-1285-4671; Willerslev, Eske/0000-0002-7081-6748; 				BABELON JP, 2009, FAYARD; Charlier Philippe, 2006, Med Secoli, V18, P777; DELAMARTINE A, 1865, HIST GIRONDINS; GUILLEMEAU J, 1649, OEUVRES CHIRURG; Lever DE, 2008, HISTOPATHOLOGY SKIN; PIGRAY P, 1625, EPITOME PRECEPTES ME, P398; Ruhli FJ, 2004, CAN ASSOC RADIOL J, V55, P218	7	13	13	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 14	2010	341								c6805	10.1136/bmj.c6805	http://dx.doi.org/10.1136/bmj.c6805			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XD	21156748	Green Submitted			2022-12-28	WOS:000285552200010
J	Harris, JB; LaRocque, RC; Charles, RC; Mazumder, RN; Khan, AI; Bardhan, PK				Harris, Jason B.; LaRocque, Regina C.; Charles, Richelle C.; Mazumder, Ramendra N.; Khan, Azharul I.; Bardhan, Pradip K.			Cholera's western front	LANCET			English	Editorial Material							TETRACYCLINE; VACCINES		[Harris, Jason B.; LaRocque, Regina C.; Charles, Richelle C.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Harris, Jason B.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [LaRocque, Regina C.; Charles, Richelle C.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Mazumder, Ramendra N.; Khan, Azharul I.; Bardhan, Pradip K.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; International Centre for Diarrhoeal Disease Research (ICDDR)	Harris, JB (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	jbharris@partners.org	Harris, Jason/ABF-2684-2020; Charles, Richelle/W-4342-2019	Harris, Jason/0000-0003-3642-5126; Charles, Richelle/0000-0002-8881-1849	FOGARTY INTERNATIONAL CENTER [K01TW007409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI089721] Funding Source: NIH RePORTER; FIC NIH HHS [K01 TW007409] Funding Source: Medline; NIAID NIH HHS [K08 AI089721] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1473; [Anonymous], 2010, WORLD HLTH STAT 2010; Hossain MS, 2002, J HEALTH POPUL NUTR, V20, P18; Jeuland M, 2009, VALUE HEALTH, V12, P899, DOI 10.1111/j.1524-4733.2009.00562.x; *PAN AM HLTH ORG, 2010, EP AL UPD SIT HAIT; RABBANI GH, 1989, ANTIMICROB AGENTS CH, V33, P1447, DOI 10.1128/AAC.33.9.1447; Ryan ET, 2000, AM J TROP MED HYG, V63, P12, DOI 10.4269/ajtmh.2000.63.12; Sack DA, 2006, NEW ENGL J MED, V355, P649, DOI 10.1056/NEJMp068144; Saha D, 2006, NEW ENGL J MED, V354, P2452, DOI 10.1056/NEJMoa054493; *VACC RES LIB, 2010, CHOL OUTBR TRAIN SHI; *WHO, 2004, 1 STEPS MAN OUTBR AC; WHO/UNICEF Joint Water Supply and Sanitation Monitoring Programme, 2015, PROGR SAN DRINK WAT; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P117; World Health Organization, 2005, TREATM DIARRH MAN PH	15	36	39	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2010	376	9757					1961	1965		10.1016/S0140-6736(10)62172-1	http://dx.doi.org/10.1016/S0140-6736(10)62172-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	701GZ	21112083	Green Accepted			2022-12-28	WOS:000285807700004
J	Rohn, J				Rohn, Jennifer			Women scientists must speak out	NATURE			English	Editorial Material									UCL, London WC1E 6BT, England	University of London; University College London	Rohn, J (corresponding author), UCL, London WC1E 6BT, England.	jenny@lablit.com		Rohn, Jennifer/0000-0001-8766-6056					0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2010	468	7325					733	733		10.1038/468733a	http://dx.doi.org/10.1038/468733a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21150949	Bronze			2022-12-28	WOS:000285093700006
J	Passarani, I				Passarani, Ilaria			What do patients want of performance information?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Passarani, Ilaria] European Consumers Org, Brussels, Belgium; [Passarani, Ilaria] Univ Maastricht, Fac Hlth Med & Life Sci, Dept Hlth Org Policy & Econ, Maastricht, Netherlands	Maastricht University	Passarani, I (corresponding author), European Consumers Org, Brussels, Belgium.	ilaria.passarani@beuc.eu						Hibbard JH, 2005, HEALTH AFFAIR, V24, P1150, DOI 10.1377/hlthaff.24.4.1150; 2010, WHICH RESPONSE PUBLI	2	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2010	341								c6955	10.1136/bmj.c6955	http://dx.doi.org/10.1136/bmj.c6955			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	694ZL	21147733				2022-12-28	WOS:000285340300017
J	Fahy, JV; Dickey, BF				Fahy, John V.; Dickey, Burton F.			MEDICAL PROGRESS Airway Mucus Function and Dysfunction	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MUCOUS CELL METAPLASIA; GROWTH-FACTOR RECEPTOR; FIBROSIS PULMONARY GUIDELINES; INHALED AZTREONAM LYSINE; CYSTIC-FIBROSIS; MOUSE MODEL; BRONCHIAL EPITHELIUM; PROTEIN EXPRESSION; HYPERTONIC SALINE; OLIGOMERIC MUCINS		[Dickey, Burton F.] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Fahy, John V.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Fahy, John V.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Dickey, BF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, POB 301402,1515 Holcombe Blvd, Houston, TX 77030 USA.	bdickey@mdanderson.org		Dickey, Burton/0000-0002-4780-1847	BioMarcks Pharmaceuticals; Five Prime Therapeutics; Amira; Oxagen; Gilead; GlaxoSmithKline; Amgen; Genentech; Boehringer Ingelheim; Aerovance; Merck; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202, P50HL107191] Funding Source: NIH RePORTER	BioMarcks Pharmaceuticals; Five Prime Therapeutics; Amira; Oxagen; Gilead(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Amgen(Amgen); Genentech(Roche HoldingGenentech); Boehringer Ingelheim(Boehringer Ingelheim); Aerovance; Merck(Merck & Company); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Dickey reports receiving consulting fees from BioMarcks Pharmaceuticals; Dr. Fahy, serving on a scientific advisory board for Cytokinetics and receiving consulting fees from Five Prime Therapeutics, Amira, Oxagen, Gilead, GlaxoSmithKline, and Amgen, grant support to the University of California, San Francisco, from Genentech, Boehringer Ingelheim, and Aerovance, and travel fees from GlaxoSmithKline, Merck, Amira, and Amgen. Dr. Fahy reports being named on a provisional patent application submitted for a gene signature for type 2 helper T cell-high asthma (with Genentech). No other potential conflict of interest relevant to this article was reported.	Adler KB, 2001, AM J RESP CELL MOL, V25, P397, DOI 10.1165/ajrcmb.25.4.f214; Alimam MZ, 2000, AM J RESP CELL MOL, V22, P253, DOI 10.1165/ajrcmb.22.3.3768; Anwar GA, 2008, RESP MED, V102, P1494, DOI 10.1016/j.rmed.2008.06.005; Bateman ED, 2009, PULM PHARMACOL THER, V22, P533, DOI 10.1016/j.pupt.2009.06.002; Bergeron Celine, 2009, Proc Am Thorac Soc, V6, P301, DOI 10.1513/pats.200808-089RM; Boogaard R, 2007, PEDIATR PULM, V42, P989, DOI 10.1002/ppul.20693; Bosse Y, 2010, ANNU REV PHYSIOL, V72, P437, DOI 10.1146/annurev-physiol-021909-135851; Boucher RC, 2007, TRENDS MOL MED, V13, P231, DOI 10.1016/j.molmed.2007.05.001; Burgel PR, 2008, EUR RESPIR J, V32, P1068, DOI 10.1183/09031936.00172007; Canning BJ, 2006, CHEST, V129, p33S, DOI 10.1378/chest.129.1_suppl.33S; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Casalino-Matsuda SM, 2009, AM J RESP CELL MOL, V40, P277, DOI 10.1165/rcmb.2008-0073OC; Chen EYT, 2010, AM J PHYSIOL-LUNG C, V299, pL542, DOI 10.1152/ajplung.00180.2010; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Chen S, 2009, P NATL ACAD SCI USA, V106, P9180, DOI 10.1073/pnas.0903111106; Chen Y, 2001, AM J RESP CELL MOL, V25, P542, DOI 10.1165/ajrcmb.25.5.4298; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Curran DR, 2010, AM J RESP CELL MOL, V42, P268, DOI 10.1165/rcmb.2009-0151TR; Daniels JMA, 2010, AM J RESP CRIT CARE, V181, P150, DOI 10.1164/rccm.200906-0837OC; Davies JR, 2007, INT J BIOCHEM CELL B, V39, P1943, DOI 10.1016/j.biocel.2007.05.013; Davis CW, 2008, RESP PHYSIOL NEUROBI, V163, P208, DOI 10.1016/j.resp.2008.05.015; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; Davis PB, 2006, AM J RESP CRIT CARE, V173, P475, DOI 10.1164/rccm.200505-840OE; Decramer M, 2010, EUR RESPIR REV, V19, P134, DOI 10.1183/09059180.00003610; Deshmukh HS, 2008, AM J RESP CELL MOL, V38, P446, DOI 10.1165/rcmb.2006-0339OC; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; Drouin SM, 2002, J IMMUNOL, V169, P5926, DOI 10.4049/jimmunol.169.10.5926; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Evans CM, 2004, AM J RESP CELL MOL, V31, P382, DOI 10.1165/rcmb.2004-0060OC; Evans SE, 2010, ANNU REV PHYSIOL, V72, P413, DOI 10.1146/annurev-physiol-021909-135909; FAHY JV, 1993, AM REV RESPIR DIS, V147, pA551; FAHY JV, 1995, J ALLERGY CLIN IMMUN, V95, P843, DOI 10.1016/S0091-6749(95)70128-1; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Flume PA, 2009, AM J RESP CRIT CARE, V180, P802, DOI 10.1164/rccm.200812-1845PP; Flume PA, 2009, RESP CARE, V54, P522; Foster KA, 2006, NEUROTOX RES, V9, P101, DOI 10.1007/BF03354881; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hayashi T, 2004, VIRCHOWS ARCH, V444, P66, DOI 10.1007/s00428-003-0926-8; Hays SR, 2003, AM J MED, V115, P68, DOI 10.1016/S0002-9343(03)00260-2; Hays SR, 2006, AM J RESP CRIT CARE, V174, P1018, DOI 10.1164/rccm.200603-310OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hogg JC, 1997, APMIS, V105, P735, DOI 10.1111/j.1699-0463.1997.tb05079.x; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Holtzman MJ, 2009, ADV IMMUNOL, V102, P245, DOI 10.1016/S0065-2776(09)01205-X; Humbles AA, 2000, NATURE, V406, P998, DOI 10.1038/35023175; Hung LY, 2008, CRIT REV IMMUNOL, V28, P269, DOI 10.1615/CritRevImmunol.v28.i4.10; Imberty A, 2008, CURR OPIN STRUC BIOL, V18, P567, DOI 10.1016/j.sbi.2008.08.001; Innes AL, 2006, CHEST, V130, P1102, DOI 10.1378/chest.130.4.1102; Innes AL, 2009, AM J RESP CRIT CARE, V180, P203, DOI 10.1164/rccm.200807-1056OC; Kamio K, 2005, AM J RESP CRIT CARE, V171, P949, DOI 10.1164/rccm.200409-1168OC; Kapur N, 2009, COCHRANE DB SYST REV, V1; Kesimer M, 2010, AM J PHYSIOL-LUNG C, V298, pL15, DOI 10.1152/ajplung.00194.2009; Kesimer M, 2009, AM J PHYSIOL-LUNG C, V296, pL92, DOI 10.1152/ajplung.90388.2008; Kettle R, 2010, AM J RESP CELL MOL, V42, P472, DOI 10.1165/rcmb.2009-0018OC; Kim KC, 2008, AM J RESP CELL MOL, V39, P644, DOI 10.1165/rcmb.2008-0169TR; Kim KC, 2003, J PHARMACOL SCI, V92, P301; Kim S, 2002, AM J PHYSIOL-LUNG C, V283, pL67, DOI 10.1152/ajplung.00404.2001; Kirkham S, 2002, BIOCHEM J, V361, P537, DOI 10.1042/0264-6021:3610537; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kummer W, 2008, HISTOCHEM CELL BIOL, V130, P219, DOI 10.1007/s00418-008-0455-2; Kuperman DA, 2005, J IMMUNOL, V175, P3746, DOI 10.4049/jimmunol.175.6.3746; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; Lazarowski ER, 2009, CURR OPIN PHARMACOL, V9, P262, DOI 10.1016/j.coph.2009.02.004; Leopold PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008157; Levin MH, 2006, J BIOL CHEM, V281, P25803, DOI 10.1074/jbc.M604332200; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; MACKLEM PT, 1970, RESP PHYSIOL, V8, P191, DOI 10.1016/0034-5687(70)90015-0; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Marsh DG, 1997, NAT GENET, V15, P389; Martinez S, 2008, RADIOGRAPHICS, V28, P1369, DOI 10.1148/rg.285075212; Mccoy KS, 2008, AM J RESP CRIT CARE, V178, P921, DOI 10.1164/rccm.200712-1804OC; Minasian C, 2010, THORAX, V65, P51, DOI 10.1136/thx.2009.116970; Moghaddam SJ, 2008, AM J RESP CELL MOL, V38, P629, DOI 10.1165/rcmb.2007-0366OC; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; National Heart Lung and Blood Institute. National Asthma Education and Prevention Program, 2007, 3 NAT HEART LUNG BLO; Neveu WA, 2009, J IMMUNOL, V183, P1732, DOI 10.4049/jimmunol.0802923; Nguyen LP, 2008, AM J RESP CELL MOL, V38, P256, DOI 10.1165/rcmb.2007-0279RC; Nguyen LP, 2009, P NATL ACAD SCI USA, V106, P2435, DOI 10.1073/pnas.0810902106; O'Donnell AE, 1998, CHEST, V113, P1329, DOI 10.1378/chest.113.5.1329; Ordonez CL, 2000, AM J RESP CRIT CARE, V161, P1185, DOI 10.1164/ajrccm.161.4.9812061; Peng J, 2010, CELL RES, V20, P62, DOI 10.1038/cr.2009.128; PLOPPER CG, 1989, AM J ANAT, V184, P31, DOI 10.1002/aja.1001840104; POTTER JL, 1969, AM REV RESPIR DIS, V99, P909; Ransford GA, 2009, AM J RESP CELL MOL, V41, P525, DOI 10.1165/rcmb.2008-0367OC; RAO S, 1970, AM REV RESPIR DIS, V102, P17; Reader JR, 2003, AM J PATHOL, V162, P2069, DOI 10.1016/S0002-9440(10)64338-6; Retsch-Bogart GZ, 2009, CHEST, V135, P1223, DOI 10.1378/chest.08-1421; Rogers CS, 2008, AM J PHYSIOL-LUNG C, V295, pL240, DOI 10.1152/ajplung.90203.2008; Rogers DF, 2007, RESP CARE, V52, P1176; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Rubin BK, 2010, OTOLARYNG CLIN N AM, V43, P27, DOI 10.1016/j.otc.2009.11.002; Rubin BK, 2010, LUNG, V188, pS69, DOI 10.1007/s00408-009-9198-7; Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253; Seemungal TAR, 2008, AM J RESP CRIT CARE, V178, P1139, DOI 10.1164/rccm.200801-145OC; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; SHEEHAN JK, 1995, AM J RESP CELL MOL, V13, P748, DOI 10.1165/ajrcmb.13.6.7576713; SHRIDHARANI M, 1982, ANN ALLERGY, V49, P156; Singer M, 2004, NAT MED, V10, P193, DOI 10.1038/nm983; Siroux V, 2009, J ALLERGY CLIN IMMUN, V124, P681, DOI 10.1016/j.jaci.2009.06.010; Smart JD, 2005, ADV DRUG DELIVER REV, V57, P1556, DOI 10.1016/j.addr.2005.07.001; Smyth AR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002009.pub3; Southam DS, 2008, AM J RESP CRIT CARE, V178, P1115, DOI 10.1164/rccm.200801-084OC; Takeyama K, 2001, AM J PHYSIOL-LUNG C, V280, pL165, DOI 10.1152/ajplung.2001.280.1.L165; Tamashiro E, 2009, AM J RHINOL ALLERGY, V23, P117, DOI 10.2500/ajra.2009.23.3280; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tesfaigzi Y, 2008, CURR MOL MED, V8, P408, DOI 10.2174/156652408785160961; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Thornton David J, 2004, Proc Am Thorac Soc, V1, P54, DOI 10.1513/pats.2306016; Tuvim MJ, 2009, J BIOL CHEM, V284, P9781, DOI 10.1074/jbc.M807849200; VASCONCELLOS CA, 1994, SCIENCE, V263, P969, DOI 10.1126/science.8310295; VERDUGO P, 1990, ANNU REV PHYSIOL, V52, P157, DOI 10.1146/annurev.ph.52.030190.001105; VERRA F, 1995, AM J RESP CRIT CARE, V151, P630; Wan HJ, 2004, DEVELOPMENT, V131, P953, DOI 10.1242/dev.00966; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Woodruff PG, 2010, AM J RESP CRIT CARE, V181, P438, DOI 10.1164/rccm.200909-1415OC; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P796; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Young HWJ, 2007, AM J RESP CELL MOL, V37, P273, DOI 10.1165/rcmb.2005-0460OC; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	126	943	984	3	110	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2233	2247		10.1056/NEJMra0910061	http://dx.doi.org/10.1056/NEJMra0910061			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EP	21121836	Green Accepted			2022-12-28	WOS:000284832900011
J	Goldman, DP; Vaiana, M; Romley, JA				Goldman, Dana P.; Vaiana, Mary; Romley, John A.			The Emerging Importance of Patient Amenities in Hospital Care.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goldman, Dana P.; Romley, John A.] Univ So Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA 90089 USA; [Vaiana, Mary] RAND Corp, Santa Monica, CA USA	University of Southern California; RAND Corporation	Goldman, DP (corresponding author), Univ So Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA 90089 USA.		Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396	NIA NIH HHS [R03 AG031990] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R03AG031990] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Cutler DM, 1998, Q J ECON, V113, P991, DOI 10.1162/003355398555801; Gawande A., 2009, NEW YORKER; Goldman D., 2008, HOSP HOTELS ROLE PAT HOSP HOTELS ROLE PAT; Grote K.D., 2007, MCKINSEY Q; Sofaer S, 2005, HEALTH SERV RES, V40, P2018, DOI 10.1111/j.1475-6773.2005.00473.x	5	32	32	2	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2185	2187		10.1056/NEJMp1009501	http://dx.doi.org/10.1056/NEJMp1009501			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	688EP	21121830	Green Accepted			2022-12-28	WOS:000284832900003
J	Raveh, A; Cooper, A; Guy-David, L; Reuveny, E				Raveh, Adi; Cooper, Ayelet; Guy-David, Liora; Reuveny, Eitan			Nonenzymatic Rapid Control of GIRK Channel Function by a G Protein-Coupled Receptor Kinase	CELL			English	Article							G-BETA-GAMMA; PLECKSTRIN HOMOLOGY DOMAIN; SHORT-TERM DESENSITIZATION; K+-CURRENT; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CONFORMATIONAL REARRANGEMENTS; MUTATIONAL ANALYSIS; POTASSIUM CHANNEL; ACTIVATION; MEMBRANE	G protein-coupled receptors (GPCRs) respond to agonists to activate downstream enzymatic pathways or to gate ion channel function. Turning off GPCR signaling is known to involve phosphorylation of the GPCR by GPCR kinases (GRKs) to initiate their internalization. The process, however, is relatively slow and cannot account for the faster desensitization responses required to regulate channel gating. Here, we show that GRKs enable rapid desensitization of the G protein-coupled potassium channel (GIRK/Kir3.x) through a mechanism independent of their kinase activity. On GPCR activation, GRKs translocate to the membrane and quench channel activation by competitively binding and titrating G protein beta gamma subunits away from the channel. Of interest, the ability of GRKs to effect this rapid desensitization depends on the receptor type. The findings thus reveal a stimulus-specific, phosphorylation-independent mechanism for rapidly downregulating GPCR activity at the effector level.	[Raveh, Adi; Cooper, Ayelet; Guy-David, Liora; Reuveny, Eitan] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Reuveny, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.reuveny@weizmann.ac.il			Josef Cohn Center for Biomembrane Research; Israeli Science Foundation (ISF) [207/09]; Minerva Foundation; Human Frontier Science Program	Josef Cohn Center for Biomembrane Research; Israeli Science Foundation (ISF)(Israel Science Foundation); Minerva Foundation; Human Frontier Science Program(Human Frontier Science Program)	The authors like to thank Ruth Meller and Elisha Shalgi for technical help, and the Reuveny laboratory for helpful comments. We are grateful to Drs. J.L. Benovic for GRK2 and GRK6, W.C. Claycomb for HL-1 cells, D.E. Logothetis for PtdIns(4,5)P2 GIRK mutants, C. Barlot for G alpha<INF>s</INF> mutant, S. Nakanishi for the mGluR2, Z. Vogel for mu OR, and R. Tsien for mCherry cDNAs. The work was supported in part by the Josef Cohn Center for Biomembrane Research, The Israeli Science Foundation (ISF grant 207/09), The Minerva Foundation, and the Human Frontier Science Program.	Aragay AM, 1998, FEBS LETT, V430, P37, DOI 10.1016/S0014-5793(98)00495-5; Bender K, 2001, J BIOL CHEM, V276, P28873, DOI 10.1074/jbc.M102328200; Berlot CH, 2002, J BIOL CHEM, V277, P21080, DOI 10.1074/jbc.M201330200; Blanchet C, 2002, P NATL ACAD SCI USA, V99, P4674, DOI 10.1073/pnas.072075399; Bunemann M, 1999, ANNU REV PHYSIOL, V61, P169, DOI 10.1146/annurev.physiol.61.1.169; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cordeaux Y, 2004, BRIT J PHARMACOL, V143, P705, DOI 10.1038/sj.bjp.0705925; Dang VC, 2009, J NEUROSCI, V29, P3322, DOI 10.1523/JNEUROSCI.4749-08.2009; Day PW, 2004, J BIOL CHEM, V279, P53643, DOI 10.1074/jbc.M401438200; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Doupnik CA, 2008, J RECEPT SIG TRANSD, V28, P83, DOI [10.1080/10799890801941970, 10.1080/10799890801941970 ]; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; GARCIAHIGUERA I, 1994, J BIOL CHEM, V269, P1348; Goedhart J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001011; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Keselman I, 2007, CHANNELS, V1, P113, DOI 10.4161/chan.4321; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Koike-Tani M, 2005, J PHYSIOL-LONDON, V564, P489, DOI 10.1113/jphysiol.2004.079285; KONG GH, 1994, J BIOL CHEM, V269, P13084; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Li JL, 2003, J BIOL CHEM, V278, P30219, DOI 10.1074/jbc.M302385200; Lleres David, 2007, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1210s42; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Meyer T, 2001, J BIOL CHEM, V276, P5650, DOI 10.1074/jbc.M009179200; Murga C, 1998, NEUROSCIENCE, V87, P631, DOI 10.1016/S0306-4522(98)00145-6; Nikolov EN, 2004, J BIOL CHEM, V279, P23630, DOI 10.1074/jbc.M312861200; Nobles M, 2010, PFLUG ARCH EUR J PHY, V460, P99, DOI 10.1007/s00424-010-0799-z; Palczewski K, 1997, EUR J BIOCHEM, V248, P261, DOI 10.1111/j.1432-1033.1997.00261.x; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Raveh Adi, 2008, V491, P199, DOI 10.1007/978-1-59745-526-8_16; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rishal I, 2005, J BIOL CHEM, V280, P16685, DOI 10.1074/jbc.M412196200; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Sadja R, 2002, P NATL ACAD SCI USA, V99, P10783, DOI 10.1073/pnas.162346199; Sadja R, 2001, NEURON, V29, P669, DOI 10.1016/S0896-6273(01)00242-2; Sadja R, 2009, CHANNELS, V3, P205, DOI 10.4161/chan.3.3.9136; Shui Z, 1998, J PHYSIOL-LONDON, V507, P325, DOI 10.1111/j.1469-7793.1998.325bt.x; Sickmann T, 2003, J NEUROPHYSIOL, V90, P2494, DOI 10.1152/jn.00112.2003; Sickmann T, 2008, NEUROSCI LETT, V436, P102, DOI 10.1016/j.neulet.2008.02.067; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; TOUHARA K, 1995, J BIOL CHEM, V270, P17000, DOI 10.1074/jbc.270.28.17000; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wu GY, 1998, J BIOL CHEM, V273, P7197, DOI 10.1074/jbc.273.13.7197; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	63	46	47	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					750	760		10.1016/j.cell.2010.10.018	http://dx.doi.org/10.1016/j.cell.2010.10.018			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111235	Bronze			2022-12-28	WOS:000284583500017
J	Einterz, EM				Einterz, Ellen M.			Health district development and the need to dig deeper	LANCET			English	Editorial Material									Kolofata Dist Hosp, Mora, Extreme Nord, Cameroon		Einterz, EM (corresponding author), Kolofata Dist Hosp, BP 111, Mora, Extreme Nord, Cameroon.	emeinterz@yahoo.com		Einterz, Ellen/0000-0002-0818-847X					0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2011	377	9771					1122	1123		10.1016/S0140-6736(10)62191-5	http://dx.doi.org/10.1016/S0140-6736(10)62191-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	743QY	21167588				2022-12-28	WOS:000289035000034
J	Zha, S; Guo, CG; Boboila, C; Oksenych, V; Cheng, HL; Zhang, Y; Wesemann, DR; Yuen, G; Patel, H; Goff, PH; Dubois, RL; Alt, FW				Zha, Shan; Guo, Chunguang; Boboila, Cristian; Oksenych, Valentyn; Cheng, Hwei-Ling; Zhang, Yu; Wesemann, Duane R.; Yuen, Grace; Patel, Harin; Goff, Peter H.; Dubois, Richard L.; Alt, Frederick W.			ATM damage response and XLF repair factor are functionally redundant in joining DNA breaks	NATURE			English	Article							DOUBLE-STRAND BREAKS; GENOMIC INSTABILITY; V(D)J RECOMBINATION; HISTONE H2AX; TRANSLOCATIONS; LYMPHOCYTES; CERNUNNOS; MECHANISM; PATHWAY; MICE	Classical non-homologous DNA end-joining (NHEJ) is a major mammalian DNA double-strand-break (DSB) repair pathway. Deficiencies for classical NHEJ factors, such as XRCC4, abrogate lymphocyte development, owing to a strict requirement for classical NHEJ to join V(D) J recombination DSB intermediates(1,2). The XRCC4-like factor (XLF; also called NHEJ1) is mutated in certain immunodeficient human patients and has been implicated in classical NHEJ(3-6); however, XLF-deficient mice have relatively normal lymphocyte development and their lymphocytes support normal V(D) J recombination(5). The ataxia telangiectasia-mutated protein (ATM) detects DSBs and activates DSB responses by phosphorylating substrates including histone H2AX(7). However, ATM deficiency causes only modest V(D) J recombination and lymphocyte developmental defects, and H2AX deficiency does not have a measurable impact on these processes(7-9). Here we show that XLF, ATM and H2AX all have fundamental roles in processing and joining DNA ends during V(D) J recombination, but that these roles have been masked by unanticipated functional redundancies. Thus, combined deficiency of ATM and XLF nearly blocks mouse lymphocyte development due to an inability to process and join chromosomal V(D) J recombination DSB intermediates. Combined XLF and ATM deficiency also severely impairs classical NHEJ, but not alternative end-joining, during IgH class switch recombination. Redundant ATM and XLF functions in classical NHEJ are mediated by ATM kinase activity and are not required for extra-chromosomal V(D) J recombination, indicating a role for chromatin-associated ATM substrates. Correspondingly, conditional H2AX inactivation in XLF-deficient pro-B lines leads to V(D) J recombination defects associated with marked degradation of unjoined V(D) J ends, revealing that H2AX has a role in this process.	[Zha, Shan; Guo, Chunguang; Boboila, Cristian; Oksenych, Valentyn; Cheng, Hwei-Ling; Zhang, Yu; Wesemann, Duane R.; Yuen, Grace; Patel, Harin; Goff, Peter H.; Alt, Frederick W.] Childrens Hosp, Howard Hughes Med Inst, Immune Dis Inst, Boston, MA 02115 USA; [Zha, Shan; Guo, Chunguang; Boboila, Cristian; Oksenych, Valentyn; Cheng, Hwei-Ling; Zhang, Yu; Wesemann, Duane R.; Yuen, Grace; Patel, Harin; Goff, Peter H.; Alt, Frederick W.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Dubois, Richard L.] Columbia Univ, Inst Canc Genet, Dept Pediat, Dept Pathol & Cell Biol, New York, NY 10032 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Columbia University	Alt, FW (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Immune Dis Inst, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu	Oksenych, Valentyn/J-6216-2019; Yuen, Grace/M-9383-2019	Oksenych, Valentyn/0000-0002-5088-3791; Yuen, Grace/0000-0002-3253-9575; Zha, Shan/0000-0002-6568-1818; Wesemann, Duane/0000-0002-6690-944X; Goff, Peter/0000-0002-3488-4997	NIH [AI076210, AI020047, AI007376]; Cancer Research Institute; AAAI/GlaxoSmithKline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007376, P01AI076210, R01AI020047, R37AI020047, K08AI089972] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; AAAI/GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. Fujiwara and P. Huang for technical support. We thank B. Sleckman for advice, reagents and for critical review of this manuscript. This work is supported by NIH grant AI076210 and AI020047 to F. W. A. F. W. A. is an investigator of the Howard Hughes Medical Institute. S.Z. was a fellow, then senior fellow of Leukemia and Lymphomas Society of America and a St Baldrick Scholar. C. G. and Y.Z. are fellows of Cancer Research Institute. C. B. receives support from the pre-doctoral training program of Cancer Research Institute. D. R. W. is supported by a career development award from AAAI/GlaxoSmithKline and by NIH training grant AI007376.	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Callen E, 2009, MOL CELL, V34, P285, DOI 10.1016/j.molcel.2009.04.025; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; GELLERT M, 1992, ANNU REV GENET, V26, P425, DOI 10.1146/annurev.ge.26.120192.002233; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lumsden JM, 2004, J EXP MED, V200, P1111, DOI 10.1084/jem.20041074; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Sekiguchi J, 2001, P NATL ACAD SCI USA, V98, P3243, DOI 10.1073/pnas.051632098; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Yin B, 2009, J EXP MED, V206, P2625, DOI 10.1084/jem.20091320; Zha S, 2008, P NATL ACAD SCI USA, V105, P9302, DOI 10.1073/pnas.0803520105; Zha S, 2007, P NATL ACAD SCI USA, V104, P4518, DOI 10.1073/pnas.0611734104	26	151	152	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					250	254		10.1038/nature09604	http://dx.doi.org/10.1038/nature09604			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21160472	Green Accepted			2022-12-28	WOS:000286143400046
J	Nijhout, HF; Grunert, LW				Nijhout, H. Frederik; Grunert, Laura W.			The Cellular and Physiological Mechanism of Wing-Body Scaling in Manduca sexta	SCIENCE			English	Article							PROTHORACIC GLAND; TOBACCO HORNWORM; CRITICAL WEIGHT; IMAGINAL DISKS; SIZE; DROSOPHILA; GROWTH; ECDYSONE; INSECTS; NUTRITION	In animals, appendages develop in proportion to overall body size; when individual size varies, appendages covary proportionally. In insects with complete metamorphosis, adult appendages develop from precursor tissues called imaginal disks that grow after somatic growth has ceased. It is unclear, however, how the growth of these appendages is matched to the already established body size. We studied the pattern of cell division in the tobacco hornworm Manduca sexta and found that both the rate of cell division and the duration of growth of the wing imaginal disks depend on the size of the body in which they develop. Moreover, we found that both of these processes are controlled by the level and duration of secretion of the steroid hormone ecdysone. Thus, proportional growth is under hormonal control and indirectly regulated by the central nervous system.	[Nijhout, H. Frederik; Grunert, Laura W.] Duke Univ, Dept Biol, Durham, NC 27705 USA	Duke University	Nijhout, HF (corresponding author), Duke Univ, Dept Biol, Durham, NC 27705 USA.	hfn@duke.edu			NSF [IOS-0641144, IOS-0744952]	NSF(National Science Foundation (NSF))	We thank C. Shreve, V. Callier, R. Dilling, K. Preuss, and I. Jalli for assistance and helpful discussions. Supported by NSF grants IOS-0641144 and IOS-0744952.	ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Champlin DT, 1998, DEVELOPMENT, V125, P2009; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; D'Amico LJ, 2001, P ROY SOC B-BIOL SCI, V268, P1589, DOI 10.1098/rspb.2001.1698; Davidowitz G, 2004, INTEGR COMP BIOL, V44, P443, DOI 10.1093/icb/44.6.443; Davidowitz G, 2004, EVOL ECOL RES, V6, P49; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Emlen DJ, 2003, INTEGR COMP BIOL, V43, P617, DOI 10.1093/icb/43.5.617; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; KATO Y, 1987, DEVELOPMENT, V100, P227; Kingan TG, 2000, J EXP BIOL, V203, P3011; LABARBERA M, 1989, ANNU REV ECOL SYST, V20, P97, DOI 10.1146/annurev.es.20.110189.000525; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Leopold P, 2006, SCIENCE, V312, P1317, DOI 10.1126/science.1128343; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Mirth CK, 2009, DEVELOPMENT, V136, P2345, DOI 10.1242/dev.032672; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; Nijhout H F, 2006, J Biol, V5, P16, DOI 10.1186/jbiol43; Nijhout H.F., 1994, INSECT HORMONES; Nijhout HF, 2007, DEV BIOL, V302, P569, DOI 10.1016/j.ydbio.2006.10.023; NIJHOUT HF, 1979, J INSECT PHYSIOL, V25, P277, DOI 10.1016/0022-1910(79)90055-6; NIJHOUT HF, 1984, J INSECT PHYSIOL, V30, P629, DOI 10.1016/0022-1910(84)90047-7; Nijhout HF, 2002, P NATL ACAD SCI USA, V99, P15446, DOI 10.1073/pnas.242548399; Orme MH, 2005, CELL METAB, V2, P277, DOI 10.1016/j.cmet.2005.10.005; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SCHWARTZ LM, 1983, DEV BIOL, V99, P103, DOI 10.1016/0012-1606(83)90257-9; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Stern DL, 1999, DEVELOPMENT, V126, P1091; TRUMAN JW, 1981, AM ZOOL, V21, P655; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122	34	55	55	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2010	330	6011					1693	1695		10.1126/science.1197292	http://dx.doi.org/10.1126/science.1197292			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21109634				2022-12-28	WOS:000285390500071
J	Ricci-Tersenghi, F				Ricci-Tersenghi, Federico			Being Glassy Without Being Hard to Solve	SCIENCE			English	Editorial Material							TRANSITION		Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy	Sapienza University Rome	Ricci-Tersenghi, F (corresponding author), Univ Roma La Sapienza, Dipartimento Fis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	federico.ricci@uniroma1.it		Ricci-Tersenghi, Federico/0000-0003-4970-7376				Barthel W, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.188701; Cavagna A, 2009, PHYS REP, V476, P51, DOI 10.1016/j.physrep.2009.03.003; Creignou N, 1999, DISCRETE APPL MATH, V97, P41, DOI 10.1016/S0166-218X(99)00032-3; Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704; DUBOIS O, 2002, P 43 ANN IEEE S FDN; Franz S, 2001, EUROPHYS LETT, V55, P465, DOI 10.1209/epl/i2001-00438-4; Garey M.R., 1979, COMPUTERS INTRACTABI; Krzakala F, 2007, P NATL ACAD SCI USA, V104, P10318, DOI 10.1073/pnas.0703685104; Mezard M, 2003, J STAT PHYS, V111, P505, DOI 10.1023/A:1022886412117; Mezard M, 2002, SCIENCE, V297, P812, DOI 10.1126/science.1073287; Mezard M., 2009, INFORM PHYS COMPUTAT, pp 584, DOI [10.1093/acprof:oso/9780198570837.001.0001, DOI 10.1093/ACPROF:OSO/9780198570837.001, DOI 10.1093/ACPROF:OSO/9780198570837.001.0001]; Montanari A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.134406	13	21	21	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2010	330	6011					1639	1640		10.1126/science.1189804	http://dx.doi.org/10.1126/science.1189804			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164007				2022-12-28	WOS:000285390500055
J	Solomon, AW; Kirwan, CJ; Alexander, NDE; Nimako, K; Jurukov, A; Forth, RJ; Rahman, TM				Solomon, Anthony W.; Kirwan, Christopher J.; Alexander, Neal D. E.; Nimako, Kofi; Jurukov, Angela; Forth, Rebecca J.; Rahman, Tony M.		Prospective Anal Renal Compensatio	CHRISTMAS 2010: THE LIVES OF DOCTORS Urine output on an intensive care unit: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE KIDNEY INJURY; HYDRATION; CAFFEINE; THERAPY; FLUID	Objective To compare urine output between junior doctors in an intensive care unit and the patients for whom they are responsible. Design Case-control study. Setting General intensive care unit in a tertiary referral hospital. Participants 18 junior doctors responsible for clerking patients on weekday day shifts in the unit from 23 March to 23 April 2009 volunteered as "cases." Controls were the patients in the unit clerked by those doctors. Exclusion criteria (for both groups) were pregnancy, baseline estimated glomerular filtration rate <15 ml/min/1.73 m(2), and renal replacement therapy. Main outcome measures Oliguria (defined as mean urine output <0.5 ml/kg/hour over six or more hours of measurement) and urine output (in ml/kg/hour) as a continuous variable. Results Doctors were classed as oliguric and "at risk" of acute kidney injury on 19 (22%) of 87 shifts in which urine output was measured, and oliguric to the point of being "in injury" on one (1%) further shift. Data were available for 208 of 209 controls matched to cases in the data collection period; 13 of these were excluded because the control was receiving renal replacement therapy. Doctors were more likely to be oliguric than their patients (odds ratio 1.99, 95% confidence interval 1.08 to 3.68, P=0.03). For each additional 1 ml/kg/hour mean urine output, the odds ratio for being a case rather than a control was 0.27 (0.12 to 0.58, P=0.001). Mortality among doctors was astonishingly low, at 0% (0% to 18%). Conclusions Managing our own fluid balance is more difficult than managing it in our patients. We should drink more water. Modifications to the criteria for acute kidney injury could be needed for the assessment of junior doctors in an intensive care unit.	[Solomon, Anthony W.] Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England; [Solomon, Anthony W.; Kirwan, Christopher J.; Nimako, Kofi; Jurukov, Angela; Rahman, Tony M.] Univ London St Georges Hosp, Gen Intens Care Unit, London, England; [Solomon, Anthony W.] Univ London St Georges Hosp, Clin Infect Unit, London, England; [Kirwan, Christopher J.] Univ London St Georges Hosp, Dept Renal Med, London, England; [Alexander, Neal D. E.] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Nimako, Kofi] Univ London St Georges Hosp, Dept Chest Med, London, England; [Forth, Rebecca J.] Inst Child Hlth, Portex Anaesthesia Intens Therapy & Resp Unit, London, England; [Rahman, Tony M.] Univ London St Georges Hosp, Dept Gastroenterol & Hepatol, London, England	University of London; London School of Hygiene & Tropical Medicine; St Georges University London; St Georges University London; St Georges University London; University of London; London School of Hygiene & Tropical Medicine; St Georges University London; University of London; University College London; St Georges University London	Solomon, AW (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Clin Res, Keppel St, London WC1E 7HT, England.	anthony.solomon@lshtm.ac.uk	Dodds, Richard Matthew/D-7772-2016; Rahman, Tony M/E-4468-2013; Philips, Barbara/H-1670-2011; Cecconi, Maurizio/A-6241-2012	Dodds, Richard Matthew/0000-0003-4968-7678; Rahman, Tony M/0000-0002-5551-4688; Philips, Barbara/0000-0002-1124-0988; Cecconi, Maurizio/0000-0002-4376-6538; Solomon, Anthony/0000-0001-7101-6649; Gatheral, Timothy/0000-0003-2677-8729	National Institute for Health Research [CL-2009-20-001] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Armitage P, 2001, STAT METHODS MED RES, V4th; Armstrong LE, 2005, INT J SPORT NUTR EXE, V15, P252, DOI 10.1123/ijsnem.15.3.252; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Collett D., 1991, MODELLING BINARY DAT; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Mathew D, 2009, CRITICAL CARE S2, V13, P460; Millard-Stafford ML, 2007, INT J SPORT NUTR EXE, V17, P163, DOI 10.1123/ijsnem.17.2.163; National Centre for Social Research/Medical Research Council, 2008, ASS DIET SOD LEV AD; NHS Employers, 2008, NAT HLTH SERV HOSP M; Ostermann M, 2010, QJM; Ostermann M, 2007, CRIT CARE MED, V35, P1837, DOI 10.1097/01.CCM.0000277041.13090.0A; Pearse R, 2005, CRIT CARE, V9, pR687, DOI 10.1186/cc3887; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Rogozov V., 2009, BMJ-BRIT MED J, V339, P1420, DOI [10.1136/bmj.b4965, DOI 10.1136/BMJ.B4965]; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Royal College of Nurses, 2005, WORK WELL IMPR WORK; THURAU K, 1976, AM J MED, V61, P308, DOI 10.1016/0002-9343(76)90365-X; Wemple RD, 1997, INT J SPORTS MED, V18, P40, DOI 10.1055/s-2007-972593	18	24	24	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2010	341								c6761	10.1136/bmj.c6761	http://dx.doi.org/10.1136/bmj.c6761			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XD	21156738	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000285552200017
J	Bockle, BC; Auer, H; Mikuz, G; Sepp, NT				Boeckle, Barbara C.; Auer, Herbert; Mikuz, Gregor; Sepp, Norbert T.			Danger lurks in the Mediterranean	LANCET			English	Editorial Material									[Boeckle, Barbara C.; Sepp, Norbert T.] Innsbruck Med Univ, Dept Dermatol, A-6020 Innsbruck, Austria; [Mikuz, Gregor] Innsbruck Med Univ, Inst Pathol, A-6020 Innsbruck, Austria; [Auer, Herbert] Innsbruck Med Univ, Inst Specif Prophylaxis & Trop Med, Dept Med Parasitol, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Bockle, BC (corresponding author), Innsbruck Med Univ, Dept Dermatol, Anichstr 35, A-6020 Innsbruck, Austria.	Barbara.Boeckle@i-med.ac.at						Auer H, 2008, WIEN KLIN WOCHENSCHR, V120, P250; Genchi C, 2009, VET PARASITOL, V163, P286, DOI 10.1016/j.vetpar.2009.03.026; Pampiglione S, 2001, HISTOPATHOLOGY, V38, P344, DOI 10.1046/j.1365-2559.2001.01099.x; Tzanetou K, 2009, TRAVEL MED INFECT DI, V7, P318, DOI 10.1016/j.tmaid.2009.05.001	4	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2010	376	9757					2040	2040		10.1016/S0140-6736(10)61258-5	http://dx.doi.org/10.1016/S0140-6736(10)61258-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701GZ	21146105				2022-12-28	WOS:000285807700033
J	Moravcevic, K; Mendrola, JM; Schmitz, KR; Wang, YH; Slochower, D; Janmey, PA; Lemmon, MA				Moravcevic, Katarina; Mendrola, Jeannine M.; Schmitz, Karl R.; Wang, Yu-Hsiu; Slochower, David; Janmey, Paul A.; Lemmon, Mark A.			Kinase Associated-1 Domains Drive MARK/PAR1 Kinases to Membrane Targets by Binding Acidic Phospholipids	CELL			English	Article							PROTEIN-KINASE; MOLECULAR DISSECTION; PLASMA-MEMBRANE; SEPTIN; CHECKPOINT; ORGANIZATION; MORPHOGENESIS; LOCALIZATION; RECOGNITION; ACTIVATION	Phospholipid-binding modules such as PH, C1, and C2 domains play crucial roles in location-dependent regulation of many protein kinases. Here, we identify the KA1 domain (kinase associated-1 domain), found at the C terminus of yeast septin-associated kinases (Kcc4p, Gin4p, and Hsl1p) and human MARK/PAR1 kinases, as a membrane association domain that binds acidic phospholipids. Membrane localization of isolated KA1 domains depends on phosphatidylserine. Using X-ray crystallography, we identified a structurally conserved binding site for anionic phospholipids in KA1 domains from Kcc4p and MARK1. Mutating this site impairs membrane association of both KA1 domains and intact proteins and reveals the importance of phosphatidylserine for bud neck localization of yeast Kcc4p. Our data suggest that KA1 domains contribute to "coincidence detection," allowing kinases to bind other regulators (such as septins) only at the membrane surface. These findings have important implications for understanding MARK/PAR1 kinases, which are implicated in Alzheimer's disease, cancer, and autism.	[Moravcevic, Katarina; Mendrola, Jeannine M.; Lemmon, Mark A.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Moravcevic, Katarina; Schmitz, Karl R.; Slochower, David; Janmey, Paul A.; Lemmon, Mark A.] Univ Penn, Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA; [Janmey, Paul A.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Wang, Yu-Hsiu] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Wang, Yu-Hsiu; Slochower, David; Janmey, Paul A.] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Lemmon, MA (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	mlemmon@mail.med.upenn.edu	Wang, Yu-Hsiu/N-8094-2013	Wang, Yu-Hsiu/0000-0001-9753-5535; Lemmon, Mark/0000-0002-3379-5319; Schmitz, Karl/0000-0003-1411-7624	NCI [Y1-CO-1020]; NIGMS [Y1-GM-1104]; U.S. Department of Energy [DE-AC02-06CH11357]; NIGMS; NSF [DMR-0936384]; NIH [RR-01646, R01-GM056846]; American Heart Association Great Rivers Affiliate; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275, R01GM056846] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy(United States Department of Energy (DOE)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Great Rivers Affiliate(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Lemmon, Ferguson, and Bi laboratories and Ben Black, Jim Shorter, and Greg Van Duyne for constructive comments. Erfei Bi, Scott Emr, and Daryll DeWald provided yeast strains used in this study. Crystallographic data were collected in part at the GM/CA Collaborative Access Team at the Advanced Photon Source (APS), funded by NCI (Y1-CO-1020) and NIGMS (Y1-GM-1104). Use of APS was supported by the U.S. Department of Energy, under contract No. DE-AC02-06CH11357. Additional crystallographic data were collected at beamline F2 at the Cornell High Energy Synchrotron Source (CHESS), supported by NIGMS and the NSF (under award DMR-0936384), using the Macromolecular Diffraction at CHESS (MacCHESS) facility, supported by the NIH (award RR-01646). This work was funded in part by NIH grant R01-GM056846 (to M. A. L.) and a predoctoral fellowship from the American Heart Association Great Rivers Affiliate (K.M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Casamayor A, 2003, MOL CELL BIOL, V23, P2762, DOI 10.1128/MCB.23.8.2762-2777.2003; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Crutchley J, 2009, MOL BIOL CELL, V20, P1926, DOI 10.1091/mbc.E08-08-0848; DeLano W.L, PYMOL MOL GRAPHICS S; Demel R A, 1994, Subcell Biochem, V23, P83; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Elbert M, 2005, MOL BIOL CELL, V16, P532, DOI 10.1091/mbc.E04-07-0549; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goransson O, 2006, J CELL SCI, V119, P4059, DOI 10.1242/jcs.03097; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Halstead JR, 2005, TRENDS PHARMACOL SCI, V26, P654, DOI 10.1016/j.tips.2005.10.004; Hanrahan J, 2003, MOL CELL, V12, P663, DOI 10.1016/j.molcel.2003.08.006; HIKIJI T, 1988, J BIOCHEM-TOKYO, V104, P894, DOI 10.1093/oxfordjournals.jbchem.a122579; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Hurov JB, 2007, P NATL ACAD SCI USA, V104, P5680, DOI 10.1073/pnas.0701179104; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; Longtine MS, 1998, J CELL BIOL, V143, P719, DOI 10.1083/jcb.143.3.719; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Marx A, 2010, FASEB J, V24, P1637, DOI 10.1096/fj.09-148064; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Maussion G, 2008, HUM MOL GENET, V17, P2541, DOI 10.1093/hmg/ddn154; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Okuzaki D, 2001, FEBS LETT, V489, P197, DOI 10.1016/S0014-5793(01)02104-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sakchaisri K, 2004, P NATL ACAD SCI USA, V101, P4124, DOI 10.1073/pnas.0400641101; Sanchez-Barrena MJ, 2007, MOL CELL, V26, P427, DOI 10.1016/j.molcel.2007.04.013; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shulewitz MJ, 1999, MOL CELL BIOL, V19, P7123; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Stahelin RV, 2007, J BIOL CHEM, V282, P25737, DOI 10.1074/jbc.M702861200; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Szkotnicki L, 2008, MOL BIOL CELL, V19, P4675, DOI 10.1091/mbc.E08-06-0663; Tassan JP, 2004, BIOL CELL, V96, P193, DOI 10.1016/j.biolcel.2003.10.009; Timm T, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S9; Tochio N, 2006, PROTEIN SCI, V15, P2534, DOI 10.1110/ps.062391106; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	61	120	125	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					966	977		10.1016/j.cell.2010.11.028	http://dx.doi.org/10.1016/j.cell.2010.11.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145462	Green Accepted, Bronze			2022-12-28	WOS:000285182600013
J	Beasley, M				Beasley, Malcolm			Michael Tinkham (1928-2010) OBITUARY	NATURE			English	Biographical-Item									Stanford Univ, Stanford, CA 94305 USA	Stanford University	Beasley, M (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	beasley@stanford.edu						TINKHAM M, PUBLICATION LIST, DOI DOI 10.1126/SCIENCE.1120014	1	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2010	468	7325					766	766		10.1038/468766a	http://dx.doi.org/10.1038/468766a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21150984	Bronze			2022-12-28	WOS:000285093700028
J	Bowman, JD; Rogers, AEE				Bowman, Judd D.; Rogers, Alan E. E.			A lower limit of Delta z > 0.06 for the duration of the reionization epoch	NATURE			English	Article							HIGH REDSHIFTS; FLUCTUATIONS	Observations of the 21-centimetre line of atomic hydrogen in the early Universe directly probe the history of the reionization of the gas between galaxies(1). The observations are challenging, though, because of the low expected signal strength (similar to 10 mK), and contamination by strong (>100 K) foreground synchrotron emission in the Milky Way and extragalactic continuum sources(2). If reionization happened rapidly, there should be a characteristic signature(2-4) visible against the smooth foreground in an all-sky spectrum. Here we report an all-sky spectrum between 100 and 200 MHz, corresponding to the redshift range 6 < z < 13 for the 21-centimetre line. The data exclude a rapid reionization timescale of Delta z<0.06 at the 95% confidence level.	[Bowman, Judd D.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Rogers, Alan E. E.] MIT, Haystack Observ, Westford, MA 01886 USA	Arizona State University; Arizona State University-Tempe; Massachusetts Institute of Technology (MIT)	Bowman, JD (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	judd.bowman@asu.edu			NSF; NASA; Space Telescope Science Institute	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Space Telescope Science Institute(Space Telescope Science Institute)	This work was supported by the NSF. J.D.B was supported during part of this work at the California Institute of Technology by NASA through a Hubble Fellowship awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy for NASA. This scientific work uses data obtained from the Murchison Radio-astronomy Observatory. We acknowledge the Wajarri Yamatji people as the traditional owners of the Observatory site. We thank CSIRO and Curtin University for logistical support and D. DeBoer, D. Herne, D. Emrich, M. Halleen and C. Halleen for on-site support.	Bowman JD, 2008, ASTROPHYS J, V676, P1, DOI 10.1086/528675; Furlanetto SR, 2006, PHYS REP, V433, P181, DOI 10.1016/j.physrep.2006.08.002; Furlanetto SR, 2006, MON NOT R ASTRON SOC, V371, P867, DOI 10.1111/j.1365-2966.2006.10725.x; Gnedin NY, 2004, ASTROPHYS J, V608, P611, DOI 10.1086/420735; Komatsu E., 2010, 7 YEAR WILKINSON MIC; LARSON D, 2010, 7 YEAR WILKINSON MIC; Madau P, 1997, ASTROPHYS J, V475, P429, DOI 10.1086/303549; Pritchard JR, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.065009; Pritchard JR, 2010, MON NOT R ASTRON SOC, V408, P57, DOI 10.1111/j.1365-2966.2010.17150.x; Pritchard JR, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.023006; Rogers AEE, 2008, ASTRON J, V136, P641, DOI 10.1088/0004-6256/136/2/641; Shaver PA, 1999, ASTRON ASTROPHYS, V345, P380	13	170	172	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2010	468	7325					796	798		10.1038/nature09601	http://dx.doi.org/10.1038/nature09601			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21150993	Green Submitted			2022-12-28	WOS:000285093700039
J	Jentink, J; Dolk, H; Loane, MA; Morris, JK; Wellesley, D; Garne, E; de Jong-van den Berg, L				Jentink, Janneke; Dolk, Helen; Loane, Maria A.; Morris, Joan K.; Wellesley, Diana; Garne, Ester; de Jong-van den Berg, Lolkje		EUROCAT Antiepileptic Study Workin	Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTIEPILEPTIC DRUGS; MAJOR MALFORMATIONS; VALPROIC ACID; IN-UTERO; PREGNANCY; EPILEPSY; FETAL; RISK; TERATOGENESIS; LAMOTRIGINE	Objective To identify specific major congenital malformations associated with use of carbamazepine in the first trimester of pregnancy. Design A review of all published cohort studies to identify key indications and a population based case-control study to test these indications. Setting Review of PubMed, Web of Science, and Embase for papers about carbamazepine exposure in the first trimester of pregnancy and specific malformations, and the EUROCAT Antiepileptic Study Database, including data from 19 European population based congenital anomaly registries, 1995-2005. Participants The literature review covered eight cohort studies of 2680 pregnancies with carbamazepine monotherapy exposure, and the EUROCAT dataset included 98 075 registrations of malformations covering over 3.8 million births. Main outcome measures Overall prevalence for a major congenital malformation after exposure to carbamazepine monotherapy in the first trimester. Odds ratios for malformations with exposure to carbamazepine among cases (five types of malformation identified in the literature review) compared with two groups of controls: other non-chromosomal registrations of malformations and chromosomal syndromes. Results The literature review yielded an overall prevalence for a major congenital malformation of 3.3% (95% confidence interval 2.7 to 4.2) after exposure to carbamazepine monotherapy in the first trimester. In 131 registrations of malformations, the fetus had been exposed to carbamazepine monotherapy. Spina bifida was the only specific major congenital malformation significantly associated with exposure to carbamazepine monotherapy (odds ratio 2.6 (95% confidence interval 1.2 to 5.3) compared with no antiepileptic drug), but the risk was smaller for carbamazepine than for valproic acid (0.2, 0.1 to 0.6). There was no evidence for an association with total anomalous pulmonary venous return (no cases with carbamazepine exposure), cleft lip (with or without palate) (0.2, 0.0 to 1.3), diaphragmatic hernia (0.9, 0.1 to 6.6), or hypospadias (0.7, 0.3 to 1.6) compared with no exposure to antiepileptic drugs. Further exploratory analysis suggested a higher risk of single ventricle and atrioventricular septal defect. Conclusion Carbamazepine teratogenicity is relatively specific to spina bifida, though the risk is less than with valproic acid. Despite the large dataset, there was not enough power to detect moderate risks for some rare major congenital malformations.	[Jentink, Janneke; de Jong-van den Berg, Lolkje] Univ Groningen, Dept PharmacoEpidemiol & PharmacoEcon, Div Pharm, NL-9700 AB Groningen, Netherlands; [Morris, Joan K.] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England; [Wellesley, Diana] Southampton Univ Hosp Trust, Wessex Clin Genet Serv, Southampton, Hants, England; [de Jong-van den Berg, Lolkje] Lillebaelt Hosp, Kolding, Denmark	University of Groningen; University of London; Queen Mary University London; University of Southampton; University Hospital Southampton NHS Foundation Trust	de Jong-van den Berg, L (corresponding author), Univ Groningen, Dept PharmacoEpidemiol & PharmacoEcon, Div Pharm, NL-9700 AB Groningen, Netherlands.	l.t.w.de.jong-van.den.berg@rug.nl	Barisic, Ingeborg/A-7314-2016; Khoshnood, Babak/N-9096-2017; Pierini, Anna/A-9622-2013; Morris, Joan/AAT-9211-2020	Pierini, Anna/0000-0003-3321-9343; Morris, Joan/0000-0002-7164-612X; Loane, Maria/0000-0002-1206-3637; Portillo, Isabel/0000-0002-3871-3423	European Public Health Programme; GlaxoSmithKline	European Public Health Programme; GlaxoSmithKline(GlaxoSmithKline)	The EUROCAT Central Database is supported in part by the European Public Health Programme, with various sources of public funding for individual registries. Additional funding was obtained from GlaxoSmithKline for a study of lamotrigine, during which the antiepileptic study database was constructed (all authors were involved in this study). GlaxoSmithKline was not involved in the present study.	Diav-Citrin O, 2001, NEUROLOGY, V57, P321, DOI 10.1212/WNL.57.2.321; Dolk H, 2008, NEUROLOGY, V71, P714, DOI 10.1212/01.wnl.0000316194.98475.d8; *EUROCAT, 2005, EUROCAT GUID 1 3 REF; Harden CL, 2009, EPILEPSIA, V50, P1237, DOI 10.1111/j.1528-1167.2009.02129.x; Hernandez-Diaz S, 2007, BIRTH DEFECTS RES A, V79, P357; Jentink J, 2010, NEW ENGL J MED, V362, P2185, DOI 10.1056/NEJMoa0907328; Kaaja E, 2003, NEUROLOGY, V60, P575, DOI 10.1212/01.WNL.0000044157.28073.DC; Kini U, 2006, ARCH DIS CHILD-FETAL, V91, pF90, DOI 10.1136/adc.2004.067421; Marson AG, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001030; Matalon S, 2002, REPROD TOXICOL, V16, P9, DOI 10.1016/S0890-6238(01)00199-X; Meador KJ, 2006, NEUROLOGY, V67, P407, DOI 10.1212/01.wnl.0000227919.81208.b2; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; Ornoy A, 2006, REPROD TOXICOL, V22, P214, DOI 10.1016/j.reprotox.2006.03.014; Perucca E, 2005, LANCET NEUROL, V4, P781, DOI 10.1016/S1474-4422(05)70224-6; Sabers A, 2004, ACTA NEUROL SCAND, V109, P9, DOI 10.1034/j.1600-0404.2003.00200.x; Samren EB, 1997, EPILEPSIA, V38, P981, DOI 10.1111/j.1528-1157.1997.tb01480.x; Tomson T, 2004, EPILEPSIA, V45, P1171, DOI 10.1111/j.0013-9580.2004.15104.x; Vajda FJE, 2007, J CLIN NEUROSCI, V14, P611, DOI 10.1016/j.jocn.2006.04.025; Wide K, 2004, ACTA PAEDIATR, V93, P174, DOI 10.1080/08035250310021118; World Health Organization, 2003, ATC IND DDDS 2003 GU	20	110	113	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2010	341								c6581	10.1136/bmj.c6581	http://dx.doi.org/10.1136/bmj.c6581			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691OW	21127116	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000285091700002
J	Schindler, D				Schindler, David			Tar sands need solid science	NATURE			English	Editorial Material							EARLY-LIFE STAGES; CYP1A INDUCTION; ATHABASCA RIVER; OIL		Univ Alberta, Edmonton, AB T6G 2E9, Canada	University of Alberta	Schindler, D (corresponding author), Univ Alberta, Edmonton, AB T6G 2E9, Canada.	d.schindler@ualberta.ca						Chen, 2009, CANC INCIDENCE FORT; Colavecchia MV, 2007, J TOXICOL ENV HEAL A, V70, P1542, DOI 10.1080/15287390701384726; Colavecchia MV, 2006, J TOXICOL ENV HEAL A, V69, P967, DOI 10.1080/15287390500362154; Kelly EN, 2010, P NATL ACAD SCI USA, V107, P16178, DOI 10.1073/pnas.1008754107; Kelly EN, 2009, P NATL ACAD SCI USA, V106, P22346, DOI 10.1073/pnas.0912050106; *LIB PART CAN, 2010, HIDD DIM WAT OIL SAN; *NEW DEM PART CAN, 2010, MISS ACT FED GOV PRO; Rosenberg, 2004, OIL SANDS REGIONAL A; Squires Allison J., 2010, Integrated Environmental Assessment and Management, V6, P119, DOI 10.1897/IEAM_2008-081.1; Timoney Kevin P., 2009, Open Conservation Biology Journal, V3, P65, DOI 10.2174/1874839200903010065	10	96	96	0	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					499	501		10.1038/468499a	http://dx.doi.org/10.1038/468499a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	684WA	21107404	Bronze			2022-12-28	WOS:000284584200016
J	da Fonseca, PCA; Kong, EH; Zhang, ZG; Schreiber, A; Williams, MA; Morris, EP; Barford, D				da Fonseca, Paula C. A.; Kong, Eric H.; Zhang, Ziguo; Schreiber, Anne; Williams, Mark. A.; Morris, Edward P.; Barford, David			Structures of APC/C-Cdh1 with substrates identify Cdh1 and Apc10 as the D-box co-receptor	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; DESTRUCTION BOX; CRYSTAL-STRUCTURE; CYCLIN-B; KEN BOX; RECOGNITION; SUBUNIT; BINDING; YEAST; COMPLEX/CYCLOSOME	The ubiquitylation of cell-cycle regulatory proteins by the large multimeric anaphase-promoting complex (APC/C) controls sister chromatid segregation and the exit from mitosis(1,2). Selection of APC/C targets is achieved through recognition of destruction motifs, predominantly the destruction (D)-box(3) and KEN (Lys-Glu-Asn)-box(4). Although this process is known to involve a coactivator protein (either Cdc20 or Cdh1) together with core APC/C subunits(1,2), the structural basis for substrate recognition and ubiquitylation is not understood. Here we investigate budding yeast APC/C using single-particle electron microscopy and determine a cryo-electron microscopy map of APC/C in complex with the Cdh1 co-activator protein (APC/C-Cdh1) bound to a D-box peptide at similar to 10 angstrom resolution. We find that a combined catalytic and substrate-recognition module is located within the central cavity of the APC/C assembled from Cdh1, Apc10-a core APC/C subunit previously implicated in substrate recognition(5-7)-and the cullin domain of Apc2. Cdh1 and Apc10, identified from difference maps, create a co-receptor for the D-box following repositioning of Cdh1 towards Apc10. Using NMR spectroscopy we demonstrate specific D-box-Apc10 interactions, consistent with a role for Apc10 in directly contributing towards D-box recognition by the APC/C-Cdh1 complex. Our results rationalize the contribution of both co-activator and core APC/C subunits to D-box recognition(8,9) and provide a structural framework for understanding mechanisms of substrate recognition and catalysis by the APC/C.	[da Fonseca, Paula C. A.; Kong, Eric H.; Zhang, Ziguo; Schreiber, Anne; Morris, Edward P.; Barford, David] Chester Beatty Labs, Inst Canc Res, Sect Struct Biol, London SW3 6JB, England; [Williams, Mark. A.] Univ London, Dept Biol Sci, Inst Struct & Mol Biol, London WC1E 7HX, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Birkbeck University London	Barford, D (corresponding author), Chester Beatty Labs, Inst Canc Res, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	david.barford@icr.ac.uk		Morris, Edward/0000-0003-3544-0041; da Fonseca, Paula/0000-0001-8656-5747; Williams, Mark/0000-0002-1645-2189	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was funded by a Cancer Research UK grant to D. B. We thank F. Beuron for help with the early stages of this project and for EM support. We are grateful to J. Kirkpatrick for the use of the facilities of the UCL/Birkbeck Institute of Structural Molecular Biology (ISMB) Biomolecular NMR Centre.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Au SWN, 2002, J MOL BIOL, V316, P955, DOI 10.1006/jmbi.2002.5399; Baryshnikova OK, 2008, J BIOMOL NMR, V41, P5, DOI 10.1007/s10858-008-9234-6; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Passmore LA, 2005, MOL CELL, V20, P855, DOI 10.1016/j.molcel.2005.11.003; Passmore LA, 2005, METHOD ENZYMOL, V398, P195, DOI 10.1016/S0076-6879(05)98017-8; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wendt KS, 2001, NAT STRUCT BIOL, V8, P784, DOI 10.1038/nsb0901-784; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Yamano H, 1998, EMBO J, V17, P5670, DOI 10.1093/emboj/17.19.5670; Zhang ZG, 2010, J MOL BIOL, V397, P1316, DOI 10.1016/j.jmb.2010.02.045; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	38	147	149	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2011	470	7333					274	+		10.1038/nature09625	http://dx.doi.org/10.1038/nature09625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21107322	Green Accepted			2022-12-28	WOS:000287144200047
J	Anderson, K; Lutz, C; van Delft, FW; Bateman, CM; Guo, YP; Colman, SM; Kempski, H; Moorman, AV; Titley, I; Swansbury, J; Kearney, L; Enver, T; Greaves, M				Anderson, Kristina; Lutz, Christoph; van Delft, Frederik W.; Bateman, Caroline M.; Guo, Yanping; Colman, Susan M.; Kempski, Helena; Moorman, Anthony V.; Titley, Ian; Swansbury, John; Kearney, Lyndal; Enver, Tariq; Greaves, Mel			Genetic variegation of clonal architecture and propagating cells in leukaemia	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CANCER STEM-CELLS; BREAST-CANCER; CHILDHOOD LEUKEMIA; INTRATUMORAL HETEROGENEITY; PROSTATE-CANCER; TUMOR-CELLS; PROGRESSION; EVOLUTION; DIVERSITY	Little is known of the genetic architecture of cancer at the subclonal and single-cell level or in the cells responsible for cancer clonemaintenance and propagation. Here we have examined this issue in childhood acute lymphoblastic leukaemia in which the ETV6-RUNX1 gene fusion is an early or initiating genetic lesion followed by a modest number of recurrent or 'driver' copy number alterations. By multiplexing fluorescence in situ hybridization probes for these mutations, up to eight genetic abnormalities can be detected in single cells, a genetic signature of subclones identified and a composite picture of subclonal architecture and putative ancestral trees assembled. Subclones in acute lymphoblastic leukaemia have variegated genetics and complex, nonlinear or branching evolutionary histories. Copy number alterations are independently and reiteratively acquired in subclones of individual patients, and in no preferential order. Clonal architecture is dynamic and is subject to change in the lead-upto a diagnosis and in relapse. Leukaemia propagating cells, assayed by serial transplantation in NOD/SCID IL2R gamma(null) mice, are also genetically variegated, mirroring subclonal patterns, and vary in competitive regenerative capacity in vivo. These data have implications for cancer genomics and for the targeted therapy of cancer.	[Anderson, Kristina; van Delft, Frederik W.; Bateman, Caroline M.; Colman, Susan M.; Titley, Ian; Swansbury, John; Kearney, Lyndal; Greaves, Mel] Inst Canc Res, Sect Haematooncol, Sutton SM2 5NG, Surrey, England; [Lutz, Christoph; Guo, Yanping; Enver, Tariq] John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England; [Kempski, Helena] Great Ormond St Hosp Sick Children, Paediat Malignancy Unit, London WC1N 3JH, England; [Kempski, Helena] UCL Inst Child Hlth, London WC1N 3JH, England; [Moorman, Anthony V.] Newcastle Univ, No Inst Canc Res, Leukaemia Res Cytogenet Grp, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	University of London; Institute of Cancer Research - UK; University of Oxford; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Newcastle University - UK	Greaves, M (corresponding author), Inst Canc Res, Sect Haematooncol, Sutton SM2 5NG, Surrey, England.	mel.greaves@icr.ac.uk	Moorman, Anthony/F-5518-2010; Moorman, Anthony/G-1468-2014; Bateman, Caroline/AAE-6007-2022	Moorman, Anthony/0000-0002-9781-6107; Greaves, Melvyn/0000-0002-7239-1384; van Delft, Frederik Willem/0000-0002-3704-3720	Kay Kendall Leukaemia Fund; Leukaemia & Lymphoma Research; Deutsche Forschungsgemeinschaft [LU 1474/1-1]; Oxford BRC; Medical Research Council [MC_U137973817] Funding Source: researchfish; MRC [MC_U137973817] Funding Source: UKRI	Kay Kendall Leukaemia Fund; Leukaemia & Lymphoma Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Oxford BRC; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is supported by specialist programme grants from The Kay Kendall Leukaemia Fund (M.G.) and Leukaemia & Lymphoma Research (M.G., T.E.) and a Deutsche Forschungsgemeinschaft fellowship LU 1474/1-1 (to C.L.). T. E. and C.L. acknowledge support from the Oxford BRC.	Adams JM, 2008, CANCER RES, V68, P4018, DOI 10.1158/0008-5472.CAN-07-6334; Attard G, 2009, CANCER RES, V69, P2912, DOI 10.1158/0008-5472.CAN-08-3667; Aubele M, 1999, CANCER GENET CYTOGEN, V110, P94, DOI 10.1016/S0165-4608(98)00205-2; Barrett Paul H., 1987, C DARWINS NOTEBOOKS; Bateman CM, 2010, BLOOD, V115, P3553, DOI 10.1182/blood-2009-10-251413; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BOLAND CR, 1995, NAT MED, V1, P902, DOI 10.1038/nm0995-902; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Castor A, 2005, NAT MED, V11, P630, DOI 10.1038/nm1253; Clark J, 2008, ONCOGENE, V27, P1993, DOI 10.1038/sj.onc.1210843; Cottu PH, 2008, ANN ONCOL, V19, P596, DOI 10.1093/annonc/mdn021; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Feldhahn N, 2007, J EXP MED, V204, P1157, DOI 10.1084/jem.20062662; Fox EJ, 2009, CANCER RES, V69, P4948, DOI 10.1158/0008-5472.CAN-09-1231; Gatenby RA, 2003, CANCER RES, V63, P6212; Geyer FC, 2010, J PATHOL, V220, P562, DOI 10.1002/path.2675; Greaves M, 2010, SEMIN CANCER BIOL, V20, P65, DOI 10.1016/j.semcancer.2010.03.002; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Horsley SW, 2008, GENE CHROMOSOME CANC, V47, P333, DOI 10.1002/gcc.20537; Kearney Lyndal, 2009, V538, P57, DOI 10.1007/978-1-59745-418-6_4; Kitagawa Y, 2002, J BIOL CHEM, V277, P46289, DOI 10.1074/jbc.M208353200; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Klein CA, 2009, CANCER RES, V69, P5285, DOI 10.1158/0008-5472.CAN-08-4586; Kuukasjarvi T, 1997, CANCER RES, V57, P1597; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Loncarevic IF, 1999, GENE CHROMOSOME CANC, V24, P272, DOI 10.1002/(SICI)1098-2264(199903)24:3<272::AID-GCC13>3.3.CO;2-L; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; Maenhaut C, 2010, CARCINOGENESIS, V31, P149, DOI 10.1093/carcin/bgp259; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Takahashi T, 1998, CANCER RES, V58, P5835; Teixeira MR, 1996, CANCER RES, V56, P855; Tsao JL, 1999, AM J PATHOL, V154, P1815, DOI 10.1016/S0002-9440(10)65437-5; van Dongen J. J. M, 2002, LEUKEMIA, P85; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Zuna J, 2004, CLIN CANCER RES, V10, P5355, DOI 10.1158/1078-0432.CCR-04-0584	53	594	615	3	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					356	+		10.1038/nature09650	http://dx.doi.org/10.1038/nature09650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21160474				2022-12-28	WOS:000286385600043
J	Regot, S; Macia, J; Conde, N; Furukawa, K; Kjellen, J; Peeters, T; Hohmann, S; de Nadal, E; Posas, F; Sole, R				Regot, Sergi; Macia, Javier; Conde, Nuria; Furukawa, Kentaro; Kjellen, Jimmy; Peeters, Tom; Hohmann, Stefan; de Nadal, Eulalia; Posas, Francesc; Sole, Ricard			Distributed biological computation with multicellular engineered networks	NATURE			English	Article							SYNTHETIC BIOLOGY; COMMUNICATION; PARTS	Ongoing efforts within synthetic and systems biology have been directed towards the building of artificial computational devices(1) using engineered biological units as basic building blocks(2,3). Such efforts, inspired in the standard design of electronic circuits(4-7), are limited by the difficulties arising from wiring the basic computational units (logic gates) through the appropriate connections, each one to be implemented by a different molecule. Here, we show that there is a logically different form of implementing complex Boolean logic computations that reduces wiring constraints thanks to a redundant distribution of the desired output among engineered cells. A practical implementation is presented using a library of engineered yeast cells, which can be combined in multiple ways. Each construct defines a logic function and combining cells and their connections allow building more complex synthetic devices. As a proof of principle, we have implemented many logic functions by using just a few engineered cells. Of note, small modifications and combination of those cells allowed for implementing more complex circuits such as a multiplexer or a 1-bit adder with carry, showing the great potential for re-utilization of small parts of the circuit. Our results support the approach of using cellular consortia as an efficient way of engineering complex tasks not easily solvable using single-cell implementations.	[Macia, Javier; Conde, Nuria; Sole, Ricard] UPF, ICREA Complex Syst Lab, E-08003 Barcelona, Spain; [Regot, Sergi; Conde, Nuria; Peeters, Tom; de Nadal, Eulalia; Posas, Francesc] UPF, Dept Ciencies Expt & Salut, Cell Signaling Unit, E-08003 Barcelona, Spain; [Furukawa, Kentaro; Kjellen, Jimmy; Hohmann, Stefan] Univ Gothenburg, Dept Cell & Mol Biol Microbiol, S-40530 Gothenburg, Sweden; [Sole, Ricard] Santa Fe Inst, Santa Fe, NM 87501 USA; [Sole, Ricard] UPF, CSIC, Inst Biol Evolut, E-08003 Barcelona, Spain	ICREA; Pompeu Fabra University; Pompeu Fabra University; University of Gothenburg; The Santa Fe Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University	Sole, R (corresponding author), UPF, ICREA Complex Syst Lab, E-08003 Barcelona, Spain.	francesc.posas@upf.edu; ricard.sole@upf.edu	Posas, Francesc/K-1364-2013; Conde, Núria/ABC-5973-2021; Hohmann, Stefan/K-9895-2013; de Nadal, Eulalia/J-8178-2014	Posas, Francesc/0000-0002-4164-7076; Conde, Nuria/0000-0001-5766-309X; Hohmann, Stefan/0000-0002-0809-1985; de Nadal, Eulalia/0000-0003-0039-5607; Sole, Ricard/0000-0001-6974-1008; Peeters, Tom/0000-0003-3929-9559; Furukawa, Kentaro/0000-0002-1551-1538; Regot, Sergi/0000-0001-9786-3897	FPU (Spanish Government); James McDonnell Foundation; MICINN [BIO2009-07762, FIS2009-12365]; Consolider Ingenio 2010 programme [CSD2007-0015]; ESF [ERAS-CT-2003-980409]; CELLCOMPUT (FP6) project; FP7 UNICELLSYS [201142]; Santa Fe Institute; Fundacion Marcelino Botin (FMB); ICREA Academia (Generalitat de Catalunya); ICREA Funding Source: Custom	FPU (Spanish Government)(Spanish Government); James McDonnell Foundation; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Consolider Ingenio 2010 programme(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ESF(European Commission); CELLCOMPUT (FP6) project(European Commission); FP7 UNICELLSYS; Santa Fe Institute; Fundacion Marcelino Botin (FMB); ICREA Academia (Generalitat de Catalunya)(ICREAGeneralitat de Catalunya); ICREA(ICREA)	We thank L. Subirana and S. Ovejas for technical support and S. Pellet and M. Peter for their help in setting up the microfluidics platform, and K. Kuchler for the FUS1-mCherry construct. S. R. is recipient of a FPU fellowship (Spanish Government). This work was supported by grants from the James McDonnell Foundation to R. S., the MICINN (BIO2009-07762 and FIS2009-12365); Consolider Ingenio 2010 programme (grant CSD2007-0015), from the ESF (ERAS-CT-2003-980409) FP6 as part of a EURYI scheme award (www.esf.org/euryi) to F. P. and the CELLCOMPUT (FP6) project to F. P., R. S. and S. H., and FP7 UNICELLSYS grant (#201142) to F. P. and S. H., and The Santa Fe Institute to R. S.; F. P. and R. S. laboratories are also supported by the Fundacion Marcelino Botin (FMB). F. P. is recipient of an ICREA Academia (Generalitat de Catalunya).	Amos M, 2004, SER SYST BIOL, P3; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; ARKIN A, 1994, BIOPHYS J, V67, P560, DOI 10.1016/S0006-3495(94)80516-8; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Bashor CJ, 2010, ANNU REV BIOPHYS, V39, P515, DOI 10.1146/annurev.biophys.050708.133652; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Chin JW, 2006, CURR OPIN STRUC BIOL, V16, P551, DOI 10.1016/j.sbi.2006.06.011; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Greber D, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq671; HJELMFELT A, 1991, P NATL ACAD SCI USA, V88, P10983, DOI 10.1073/pnas.88.24.10983; Kramer BP, 2004, BIOTECHNOL BIOENG, V87, P478, DOI 10.1002/bit.20142; Lucks JB, 2008, CURR OPIN MICROBIOL, V11, P567, DOI 10.1016/j.mib.2008.10.002; MCADAMS HH, 1995, SCIENCE, V269, P650, DOI 10.1126/science.7624793; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; Weber W, 2008, P NATL ACAD SCI USA, V105, P9994, DOI 10.1073/pnas.0800663105; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	27	211	219	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					207	211		10.1038/nature09679	http://dx.doi.org/10.1038/nature09679			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21150900				2022-12-28	WOS:000286143400037
J	Zhou, RB; Yazdi, AS; Menu, P; Tschopp, J				Zhou, Rongbin; Yazdi, Amir S.; Menu, Philippe; Tschopp, Juerg			A role for mitochondria in NLRP3 inflammasome activation	NATURE			English	Article							THIOREDOXIN-INTERACTING PROTEIN; OXYGEN SPECIES PRODUCTION; NALP3 INFLAMMASOME; DISEASE; CELLS; PATHOGENESIS; DYSFUNCTION; APOPTOSIS; AUTOPHAGY; CHANNEL	An inflammatory response initiated by the NLRP3 inflammasome is triggered by a variety of situations of host 'danger', including infection and metabolic dysregulation(1,2). Previous studies suggested that NLRP3 inflammasome activity is negatively regulated by autophagy and positively regulated by reactive oxygen species (ROS) derived from an uncharacterized organelle. Here we show that mitophagy/autophagy blockade leads to the accumulation of damaged, ROS-generating mitochondria, and this in turn activates the NLRP3 inflammasome. Resting NLRP3 localizes to endoplasmic reticulum structures, whereas on inflammasome activation both NLRP3 and its adaptor ASC redistribute to the perinuclear space where they co-localize with endoplasmic reticulum and mitochondria organelle clusters. Notably, both ROS generation and inflammasome activation are suppressed when mitochondrial activity is dysregulated by inhibition of the voltage-dependent anion channel. This indicates that NLRP3 inflammasome senses mitochondrial dysfunction and may explain the frequent association of mitochondrial damage with inflammatory diseases.	[Zhou, Rongbin; Yazdi, Amir S.; Menu, Philippe; Tschopp, Juerg] Univ Lausanne, Ctr Immun & Infect, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Lausanne	Tschopp, J (corresponding author), Univ Lausanne, Ctr Immun & Infect, Dept Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Zhou, Rongbin/B-1430-2013		Swiss National Science Foundation; Institute for Arthritis Research; DFG	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Institute for Arthritis Research; DFG(German Research Foundation (DFG))	This study was supported by grants of the Swiss National Science Foundation and by the Institute for Arthritis Research. A.S.Y. is a recipient of a stipend of the DFG. We would like to thank K. Schroder, C. Thomas and J. Vince for critical reading of the manuscript and G. W. Knott, EPFL, Lausanne, for help in collecting electron micrographs.	Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Franchi L, 2010, EUR J IMMUNOL, V40, P611, DOI 10.1002/eji.200940180; Goldman SJ, 2010, MITOCHONDRION, V10, P309, DOI 10.1016/j.mito.2010.01.005; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Latz E, 2010, BLOOD, V116, P1393, DOI 10.1182/blood-2010-06-287342; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Oliveira JMA, 2010, J NEUROCHEM, V114, P1, DOI 10.1111/j.1471-4159.2010.06741.x; Papin S, 2007, CELL DEATH DIFFER, V14, P1457, DOI 10.1038/sj.cdd.4402142; Restivo NL, 2004, J PEDIATR GASTR NUTR, V38, P534, DOI 10.1097/00005176-200405000-00014; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sato T, 2004, J IMMUNOL, V173, P285, DOI 10.4049/jimmunol.173.1.285; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Yamagata H, 2009, ONCOGENE, V28, P3563, DOI 10.1038/onc.2009.213; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	28	3304	3444	20	686	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					221	225		10.1038/nature09663	http://dx.doi.org/10.1038/nature09663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21124315				2022-12-28	WOS:000286143400040
J	Madhusudhan, N; Harrington, J; Stevenson, KB; Nymeyer, S; Campo, CJ; Wheatley, PJ; Deming, D; Blecic, J; Hardy, RA; Lust, NB; Anderson, DR; Collier-Cameron, A; Britt, CBT; Bowman, WC; Hebb, L; Hellier, C; Maxted, PFL; Pollacco, D; West, RG				Madhusudhan, Nikku; Harrington, Joseph; Stevenson, Kevin B.; Nymeyer, Sarah; Campo, Christopher J.; Wheatley, Peter J.; Deming, Drake; Blecic, Jasmina; Hardy, Ryan A.; Lust, Nate B.; Anderson, David R.; Collier-Cameron, Andrew; Britt, Christopher B. T.; Bowman, William C.; Hebb, Leslie; Hellier, Coel; Maxted, Pierre F. L.; Pollacco, Don; West, Richard G.			A high C/O ratio and weak thermal inversion in the atmosphere of exoplanet WASP-12b	NATURE			English	Article							GIANT PLANETS; HOT JUPITERS; HD 189733B; TEMPERATURE; EMISSION; PHOTOCHEMISTRY; CHEMISTRY; SPECTRA; DWARFS; STARS	The carbon-to-oxygen ratio (C/O) in a planet provides critical information about its primordial origins and subsequent evolution. A primordial C/O greater than 0.8 causes a carbide-dominated interior, as opposed to the silicate-dominated composition found on Earth(1); the atmosphere can also differ from those in the Solar System(1,2). The solar C/O is 0.54 (ref. 3). Here we report an analysis of dayside multi-wavelength photometry(4,5) of the transiting hot Jupiter WASP-12b (ref. 6) that reveals C/O >= 1 in its atmosphere. The atmosphere is abundant in CO. It is depleted in water vapour and enhanced in methane, each by more than two orders of magnitude compared to a solar-abundance chemical-equilibrium model at the expected temperatures. We also find that the extremely irradiated atmosphere (T > 2,500 K) of WASP-12b lacks a prominent thermal inversion (or stratosphere) and has very efficient day-night energy circulation. The absence of a strong thermal inversion is in stark contrast to theoretical predictions for the most highly irradiated hot-Jupiter atmospheres(7-9).	[Madhusudhan, Nikku] MIT, Cambridge, MA 02139 USA; [Harrington, Joseph; Stevenson, Kevin B.; Nymeyer, Sarah; Campo, Christopher J.; Blecic, Jasmina; Hardy, Ryan A.; Lust, Nate B.; Britt, Christopher B. T.; Bowman, William C.] Univ Cent Florida, Dept Phys, Planetary Sci Grp, Orlando, FL 32816 USA; [Wheatley, Peter J.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Deming, Drake] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Anderson, David R.; Hellier, Coel; Maxted, Pierre F. L.] Univ Keele, Astrophys Grp, Keele ST5 5BG, Staffs, England; [Collier-Cameron, Andrew] Univ St Andrews, Sch Phys & Astron, Haugh KY16 9SS, Fife, Scotland; [Hebb, Leslie] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Pollacco, Don] Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland; [West, Richard G.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England	Massachusetts Institute of Technology (MIT); State University System of Florida; University of Central Florida; University of Warwick; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Keele University; University of St Andrews; Vanderbilt University; Queens University Belfast; University of Leicester	Madhusudhan, N (corresponding author), Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA.	nmadhu@mit.edu	Anderson, David/ADM-7446-2022; Harrington, Joseph/E-6250-2011; Stevenson, Kevin/AAC-8222-2019	Anderson, David/0000-0001-7416-7522; Stevenson, Kevin/0000-0002-7352-7941; Cameron, Andrew/0000-0002-8863-7828; Blecic, Jasmina/0000-0002-0769-9614; Wheatley, Peter/0000-0003-1452-2240; Hardy, Ryan/0000-0002-3849-9551; Harrington, Joseph/0000-0002-8955-8531; West, Richard/0000-0001-6604-5533	NASA; JPL/Caltech; STFC [PP/F000073/1, PP/F000065/1, PP/D000955/1, ST/G002355/1, ST/F002599/1, ST/I002308/1, PP/F000057/1, PP/F000081/1, ST/J000035/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J000035/1, PP/D000955/1, ST/I002308/1, PP/F000073/1, PP/F000065/1, ST/F002599/1, PP/F000081/1, ST/G002355/1, PP/F000057/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); JPL/Caltech; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the authors of ref. 5 for sharing their ground-based observations before publication, and Thomas J. Loredo for discussions. N.M. thanks S. Seager for financial support during his stay at MIT, where most of the modelling work was carried out. This work is based on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. Support for this work was provided by NASA through an award issued by JPL/Caltech.	Asplund M, 2005, ASTR SOC P, V336, P25; Atreya SK, 2005, SPACE SCI REV, V116, P121, DOI 10.1007/s11214-005-1951-5; Bond JC, 2010, ASTROPHYS J, V715, P1050, DOI 10.1088/0004-637X/715/2/1050; Burrows A, 2008, ASTROPHYS J, V678, P1436, DOI 10.1086/533518; Burrows A, 1999, ASTROPHYS J, V512, P843, DOI 10.1086/306811; Campo CJ, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/2/125; Castelli F., 2004, NEW GRIDS ATLAS9 MOD; Croll B., 2010, ASTROPHYS J IN PRESS; Cushing MC, 2005, ASTROPHYS J, V623, P1115, DOI 10.1086/428040; Fortney JJ, 2008, ASTROPHYS J, V678, P1419, DOI 10.1086/528370; Fossati L, 2010, ASTROPHYS J, V720, P872, DOI 10.1088/0004-637X/720/1/872; Gilks W. R., 1996, MARKOV CHAIN MONTE C; Hebb L, 2009, ASTROPHYS J, V693, P1920, DOI 10.1088/0004-637X/693/2/1920; Hubeny I, 2003, ASTROPHYS J, V594, P1011, DOI 10.1086/377080; Knutson HA, 2010, ASTROPHYS J, V720, P1569, DOI 10.1088/0004-637X/720/2/1569; Kuchner MJ, 2005, EXTRASOLAR CARBON PL; Line MR, 2010, ASTROPHYS J, V717, P496, DOI 10.1088/0004-637X/717/1/496; Lodders K, 2002, ICARUS, V155, P393, DOI 10.1006/icar.2001.6740; Lopez-Morales M, 2010, ASTROPHYS J LETT, V716, pL36, DOI 10.1088/2041-8205/716/1/L36; Madhusudhan N, 2009, ASTROPHYS J, V707, P24, DOI 10.1088/0004-637X/707/1/24; Owen T, 1999, NATURE, V402, P269, DOI 10.1038/46232; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; Seager S, 2005, ASTROPHYS J, V632, P1122, DOI 10.1086/444411; Spiegel DS, 2009, ASTROPHYS J, V699, P1487, DOI 10.1088/0004-637X/699/2/1487; Swain MR, 2009, ASTROPHYS J LETT, V690, pL114, DOI 10.1088/0004-637X/690/2/L114; Yung Y.L., 1999, PHOTOCHEMISTRY PLANE; Zahnle K, 2009, ASTROPHYS J LETT, V701, pL20, DOI 10.1088/0004-637X/701/1/L20	30	221	225	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					64	67		10.1038/nature09602	http://dx.doi.org/10.1038/nature09602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21150901	Green Accepted			2022-12-28	WOS:000285921600031
J	Premaor, MO; Compston, JE				Premaor, Melissa O.; Compston, Juliet E.			Rational Testing Testing for secondary causes of osteoporosis	BRITISH MEDICAL JOURNAL			English	Editorial Material							CELIAC-DISEASE; FRACTURE RISK; WOMEN		[Compston, Juliet E.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England; [Premaor, Melissa O.] Univ Fed Santa Maria, Dept Clin Med, BR-97105900 Santa Maria, RS, Brazil	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Universidade Federal de Santa Maria (UFSM)	Compston, JE (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Box 157, Cambridge CB2 0QQ, England.	jec1001@cam.ac.uk	Premaor, Melissa/K-7401-2016	Premaor, Melissa/0000-0002-0770-9202				ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1; CAPLAN GA, 1994, J ROY SOC MED, V87, P200; Francis RM, 2004, QJM-INT J MED, V97, P63, DOI 10.1093/qjmed/hch012; Jafri MR, 2008, DIGEST DIS SCI, V53, P964, DOI 10.1007/s10620-007-9976-0; Kanis JA, 2010, OSTEOPOROSIS INT, V21, P407, DOI 10.1007/s00198-010-1253-y; Kristinsson SY, 2010, BLOOD, V116, P2651, DOI 10.1182/blood-2010-04-282848; Nolla JM, 2001, J RHEUMATOL, V28, P2289; Siris ES, 2001, JAMA-J AM MED ASSOC, V286, P2815, DOI 10.1001/jama.286.22.2815; Tannenbaum C, 2002, J CLIN ENDOCR METAB, V87, P4431, DOI 10.1210/jc.2002-020275; van der Windt DAWM, 2010, JAMA-J AM MED ASSOC, V303, P1738, DOI 10.1001/jama.2010.549	10	3	3	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 16	2010	341								c6959	10.1136/bmj.c6959	http://dx.doi.org/10.1136/bmj.c6959			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XM	21163836				2022-12-28	WOS:000285553100009
J	Song, Y; Altarejos, J; Goodarzi, MO; Inoue, H; Guo, XQ; Berdeaux, R; Kim, JH; Goode, J; Igata, M; Paz, JC; Hogan, MF; Singh, PK; Goebel, N; Vera, L; Miller, N; Cui, JR; Jones, MR; Chen, YDI; Taylor, KD; Hsueh, WA; Rotter, JI; Montminy, M				Song, Youngsup; Altarejos, Judith; Goodarzi, Mark O.; Inoue, Hiroshi; Guo, Xiuqing; Berdeaux, Rebecca; Kim, Jeong-Ho; Goode, Jason; Igata, Motoyuki; Paz, Jose C.; Hogan, Meghan F.; Singh, Pankaj K.; Goebel, Naomi; Vera, Lili; Miller, Nina; Cui, Jinrui; Jones, Michelle R.; Chen, Yii-Der I.; Taylor, Kent D.; Hsueh, Willa A.; Rotter, Jerome I.; Montminy, Marc		CHARGE Consortium; GIANT Consortium	CRTC3 links catecholamine signalling to energy balance	NATURE			English	Article							CREB COACTIVATOR CRTC2; BROWN ADIPOSE-TISSUE; ADENYLYL-CYCLASE; INSULIN-RESISTANCE; LIPOPROTEIN-LIPASE; MEXICAN-AMERICANS; OBESITY; GENE; TRANSCRIPTION; CELLS	The adipose-derived hormone leptin maintains energy balance in part through central nervous system-mediated increases in sympathetic outflow that enhance fat burning. Triggering of beta-adrenergic receptors in adipocytes stimulates energy expenditure by cyclic AMP (cAMP)-dependent increases in lipolysis and fatty-acid oxidation. Although the mechanism is unclear, catecholamine signalling is thought to be disrupted in obesity, leading to the development of insulin resistance. Here we show that the cAMP response element binding (CREB) coactivator Crtc3 promotes obesity by attenuating beta-adrenergic receptor signalling in adipose tissue. Crtc3 was activated in response to catecholamine signals, when it reduced adenyl cyclase activity by upregulating the expression of Rgs2, a GTPase-activating protein that also inhibits adenyl cyclase activity. As a common human CRTC3 variant with increased transcriptional activity is associated with adiposity in two distinct Mexican-American cohorts, these results suggest that adipocyte CRTC3 may play a role in the development of obesity in humans.	[Song, Youngsup; Altarejos, Judith; Inoue, Hiroshi; Berdeaux, Rebecca; Kim, Jeong-Ho; Goode, Jason; Igata, Motoyuki; Paz, Jose C.; Hogan, Meghan F.; Singh, Pankaj K.; Goebel, Naomi; Vera, Lili; Miller, Nina; Montminy, Marc] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Goodarzi, Mark O.; Jones, Michelle R.] Cedars Sinai Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA; [Guo, Xiuqing; Cui, Jinrui; Chen, Yii-Der I.; Taylor, Kent D.; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Hsueh, Willa A.] Methodist Hosp, Res Inst, Diabet Res Ctr, Div Diabet Obes & Lipids, Houston, TX 77030 USA	Salk Institute; Cedars Sinai Medical Center; Cedars Sinai Medical Center; The Methodist Hospital System; The Methodist Hospital - Houston	Montminy, M (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu	Goodarzi, Mark/AAH-7106-2021; Paz, Jose Carlos/I-5783-2015; Hogan, Meghan/AAD-4425-2020; Rotter, Jerome/AAY-6598-2021	Goodarzi, Mark/0000-0001-6364-5103; Paz, Jose Carlos/0000-0001-9684-9735; Hogan, Meghan/0000-0002-5767-1599; Singh, Pankaj/0000-0001-8903-0131; Inoue, Hiroshi/0000-0002-7724-6637; Berdeaux, Rebecca/0000-0002-9929-1711; Song, Youngsup/0000-0002-6268-5223	National Institutes of Health [R01-DK049777, R01-DK083834, P30-DK063491, R01-HL088457, R01-DK79888, R01-HL071205, N01-HC95159, N02-HL64278, M01-RR00425]; Cedars-Sinai Board of Governor's Chair in Medical Genetics; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071205, R01HL088457, R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK083834, R01DK079888, P30DK063491, R01DK033651, R01DK083834, R01DK049777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cedars-Sinai Board of Governor's Chair in Medical Genetics; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by National Institutes of Health grants R01-DK049777, R01-DK083834, P30-DK063491, R01-HL088457, R01-DK79888, R01-HL071205, N01-HC95159, N02-HL64278 and M01-RR00425 (General Clinical Research Center Grant from the National Center for Research Resources, The J.W. Kieckhefer Foundation, The Clayton Medical Research Foundation, Inc., The Helmsley Foundation, the Cedars-Sinai Winnick Clinical Scholars Award (to M.O.G.) and the Cedars-Sinai Board of Governor's Chair in Medical Genetics (J.I.R.). We thank B. Beutler and O. Siggs (The Scripps Research Institute) for help with macrophage studies.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Freson K, 2007, J HYPERTENS, V25, P117, DOI 10.1097/HJH.0b013e3280109c6c; Fu A, 2008, CELL CYCLE, V7, P3823, DOI 10.4161/cc.7.24.7241; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Goodarzi MO, 2004, DIABETES, V53, P214, DOI 10.2337/diabetes.53.1.214; Goodarzi MO, 2003, GENET MED, V5, P322, DOI 10.1097/01.GIM.0000076971.55421.AD; GRANNEMAN JG, 1995, ENDOCRINOLOGY, V136, P2007, DOI 10.1210/en.136.5.2007; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Landsberg L, 2006, CELL MOL NEUROBIOL, V26, P497, DOI 10.1007/s10571-006-9010-7; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; ROHLFS EM, 1995, J BIOL CHEM, V270, P10723, DOI 10.1074/jbc.270.18.10723; Roy AA, 2006, CELL SIGNAL, V18, P336, DOI 10.1016/j.cellsig.2005.05.004; Saberi M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1137, DOI 10.1152/ajpendo.00158.2009; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Soloveva V, 1997, MOL ENDOCRINOL, V11, P27, DOI 10.1210/me.11.1.27; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	48	112	122	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					933	U329		10.1038/nature09564	http://dx.doi.org/10.1038/nature09564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164481	Green Accepted			2022-12-28	WOS:000285344600040
J	Yonezawa, T; Hasegawa, M				Yonezawa, Takahiro; Hasegawa, Masami			Was the universal common ancestry proved?	NATURE			English	Letter							ECHOLOCATING BATS; EVOLUTION		[Yonezawa, Takahiro; Hasegawa, Masami] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Hasegawa, Masami] Inst Stat Math, Tokyo 1908562, Japan	Fudan University; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan	Yonezawa, T (corresponding author), Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China.	masamihase@gmail.com		Yonezawa, Takahiro/0000-0002-0012-1887	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094468] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM094468] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akaike H, 1973, P 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Christin PA, 2007, CURR BIOL, V17, P1241, DOI 10.1016/j.cub.2007.06.036; Darwin C., 1859, ORIGIN SPECIES BYMEA, V1st; Dawkins R., 1986, BLIND WATCHMAKER WHY; Li Y, 2010, CURR BIOL, V20, pR55, DOI 10.1016/j.cub.2009.11.042; Liu Y, 2010, CURR BIOL, V20, pR53, DOI 10.1016/j.cub.2009.11.058; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; Theobald DL, 2010, NATURE, V465, P219, DOI 10.1038/nature09014; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhong BJ, 2010, MOL BIOL EVOL, V27, P2855, DOI 10.1093/molbev/msq170	10	14	14	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 16	2010	468	7326					E9	E9		10.1038/nature09482	http://dx.doi.org/10.1038/nature09482			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164432	Bronze			2022-12-28	WOS:000285344600001
J	Klein, AM; Dioum, EM; Cobb, MH				Klein, Aileen M.; Dioum, Elhadji M.; Cobb, Melanie H.			Exposing Contingency Plans for Kinase Networks	CELL			English	Editorial Material							SACCHAROMYCES-CEREVISIAE; SIGNALING PATHWAYS; PHOSPHORYLATION; YEAST	Understanding how signaling pathways are interconnected is vital for characterizing mechanisms of normal development and disease pathogenesis. In this issue, Van Wageningen et al. (2010) examine phosphorylation networks in Sacharromyces cerevisiae with genome-wide expression profiling to identify recurring themes in signaling redundancy.	[Klein, Aileen M.; Dioum, Elhadji M.; Cobb, Melanie H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	melanie.cobb@utsouthwestern.edu		Cobb, Melanie/0000-0003-0833-5473				Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Hall JP, 1996, MOL CELL BIOL, V16, P6715; Old WM, 2009, MOL CELL, V34, P115, DOI 10.1016/j.molcel.2009.03.007; van Wageningen S, 2010, CELL, V143, P991, DOI 10.1016/j.cell.2010.11.021; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000	10	2	2	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 10	2010	143	6					867	869		10.1016/j.cell.2010.11.046	http://dx.doi.org/10.1016/j.cell.2010.11.046			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145453	Bronze			2022-12-28	WOS:000285182600004
J	Mackowiak, PA				Mackowiak, Philip A.			Christmas 2010: Primary Care A modest proposal	BRITISH MEDICAL JOURNAL			English	Editorial Material	Annual Meeting of the American-College-of-Physicians	APR 24, 2010	Toronto, CANADA	Amer Coll Physicians					[Mackowiak, Philip A.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Mackowiak, Philip A.] VA Maryland Hlth Care Syst, Med Care Clin Ctr, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore	Mackowiak, PA (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.	philip.mackowiak@va.gov						American Medical Association, 2006, PHYS CHAR DISTR US; Nurnberg HG, 2008, JAMA-J AM MED ASSOC, V300, P395, DOI 10.1001/jama.300.4.395; RAWLINS MD, 2008, HARVEIAN ORATION 200; Russell LB., 2007, PREVENTIONS POTENTIA; SWIFT J, MODEST PROPOSAL PREV, V1729; 2009, SCIENCE, V374, P357	6	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 9	2010	341								c6605	10.1136/bmj.c6605	http://dx.doi.org/10.1136/bmj.c6605			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	694ZU	21148211				2022-12-28	WOS:000285341200001
J	Suzuki, J; Umeda, M; Sims, PJ; Nagata, S				Suzuki, Jun; Umeda, Masato; Sims, Peter J.; Nagata, Shigekazu			Calcium-dependent phospholipid scrambling by TMEM16F	NATURE			English	Article							SCOTT-SYNDROME; BLOOD-COAGULATION; APOPTOTIC CELLS; EXPRESSION CLONING; PHOSPHATIDYLSERINE; FAMILY; PHOSPHATIDYLETHANOLAMINE; LYMPHOCYTES; DISORDER; EXPOSURE	In all animal cells, phospholipids are asymmetrically distributed between the outer and inner leaflets of the plasma membrane(1). This asymmetrical phospholipid distribution is disrupted in various biological systems. For example, when blood platelets are activated, they expose phosphatidylserine (PtdSer) to trigger the clotting system(2,3). The PtdSer exposure is believed to be mediated by Ca2+-dependent phospholipid scramblases that transport phospholipids bidirectionally(1,4), but its molecular mechanism is still unknown. Here we show that TMEM16F (transmembrane protein 16F) is an essential component for the Ca2+-dependent exposure of PtdSer on the cell surface. When a mouse B-cell line, Ba/F3, was treated with a Ca2+ ionophore under low-Ca2+ conditions, it reversibly exposed PtdSer. Using this property, we established a Ba/F3 subline that strongly exposed PtdSer by repetitive fluorescence-activated cell sorting. A complementary DNA library was constructed from the subline, and a cDNA that caused Ba/F3 to expose PtdSer spontaneously was identified by expression cloning. The cDNA encoded a constitutively active mutant of TMEM16F, a protein with eight transmembrane segments(5). Wild-type TMEM16F was localized on the plasma membrane and conferred Ca2+-dependent scrambling of phospholipids. A patient with Scott syndrome(6,7), which results from a defect in phospholipid scrambling activity(8,9), was found to carry a mutation at a splice-acceptor site of the gene encoding TMEM16F, causing the premature termination of the protein.	[Suzuki, Jun; Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; [Suzuki, Jun; Nagata, Shigekazu] Japan Sci & Technology Corp, Core Res Evolut Sci & Technol, Kyoto 6068501, Japan; [Umeda, Masato] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Sims, Peter J.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; University of Rochester	Nagata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.	snagata@mfour.med.kyoto-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426	Japan Society for the Promotion of Science; National Institutes of Health, USA	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank T. Wiedmer for critical reading of our manuscript, and M. Fujii and M. Harayama for secretarial assistance. This work was supported in part by Grants-in-Aid for Specially Promoted Research (to S.N.) and for Young Scientists Start-up (to J.S.) from the Japan Society for the Promotion of Science. J.S. is supported by a research fellowship from the Japan Society for the Promotion of Science. P.J.S. was supported by grants from the National Institutes of Health, USA.	AOKI Y, 1994, J BIOCHEM-TOKYO, V116, P291, DOI 10.1093/oxfordjournals.jbchem.a124522; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Emoto K, 1997, EXP CELL RES, V232, P430, DOI 10.1006/excr.1997.3521; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; FUKUNAGA R, 1990, J BIOL CHEM, V265, P14008; Galietta LJV, 2009, BIOPHYS J, V97, P3047, DOI 10.1016/j.bpj.2009.09.024; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, J IMMUNOL, V172, P3876, DOI 10.4049/jimmunol.172.6.3876; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Huppertz B, 2006, MICRON, V37, P509, DOI 10.1016/j.micron.2005.12.011; KAVATHAS P, 1983, NATURE, V306, P385, DOI 10.1038/306385a0; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KOJIMA H, 1994, J CLIN INVEST, V94, P2237, DOI 10.1172/JCI117586; Lentz BR, 2003, PROG LIPID RES, V42, P423, DOI 10.1016/S0163-7827(03)00025-0; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shi JL, 2003, BLOOD, V101, P2628, DOI 10.1182/blood-2002-07-1951; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Toti F, 1996, BLOOD, V87, P1409, DOI 10.1182/blood.V87.4.1409.bloodjournal8741409; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; Weiss HJ, 1997, BLOOD, V90, P475, DOI 10.1182/blood.V90.1.475; Wielders SJH, 2009, THROMB HAEMOSTASIS, V102, P76, DOI 10.1160/TH08-11-0719; Williamson P, 2001, BIOCHEMISTRY-US, V40, P8065, DOI 10.1021/bi001929z; Williamson P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000729; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003; Zwaal RFA, 1998, BBA-REV BIOMEMBRANES, V1376, P433, DOI 10.1016/S0304-4157(98)00018-5	36	591	611	0	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					834	U135		10.1038/nature09583	http://dx.doi.org/10.1038/nature09583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21107324	Green Submitted			2022-12-28	WOS:000285093700048
J	Pipeling, MR; Fan, E				Pipeling, Matthew R.; Fan, Eddy			Therapies for Refractory Hypoxemia in Acute Respiratory Distress Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ACUTE LUNG INJURY; FREQUENCY OSCILLATORY VENTILATION; INHALED NITRIC-OXIDE; EXTRACORPOREAL MEMBRANE-OXYGENATION; END-EXPIRATORY PRESSURE; MECHANICAL VENTILATION; RECRUITMENT MANEUVERS; CLINICAL-TRIAL; TIDAL VOLUME; OUTCOMES	Acute respiratory distress syndrome (ARDS) is a common and severe form of acute lung injury, resulting from both direct (eg, pneumonia) and indirect (eg, sepsis) pulmonary insults. It is a common cause of admission to the intensive care unit due to hypoxemic respiratory failure requiring mechanical ventilation, and is associated with significant morbidity and mortality. In some patients, ARDS leads to the development of life-threatening refractory hypoxemia. In these patients, physicians may consider a number of therapies (eg, recruitment maneuvers, prone positioning, inhaled nitric oxide, high-frequency oscillatory ventilation, extracorporeal membrane oxygenation) to alleviate hypoxemia in patients unable to maintain reasonable oxygenation while being supported with conventional mechanical ventilation. Although these strategies have demonstrated improved oxygenation with their use, their impact on patient-important outcomes (eg, mortality) remains unproven. However, in the minority of patients with ARDS and refractory hypoxemia, institution of these therapies may be considered on a case-by-case basis. Future studies are needed to elucidate the efficacy of these therapies on outcomes in patients with severe ARDS and refractory hypoxemia. JAMA. 2010; 304(22): 2521-2527	[Pipeling, Matthew R.; Fan, Eddy] Johns Hopkins Univ, Johns Hopkins Med Inst, Div Pulm & Crit Care Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Fan, E (corresponding author), Toronto Western Hosp, 399 Bathurst St,2MCL-411H, Toronto, ON M5T 2S8, Canada.	eddy.fan@uhn.on.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Dr Fan is supported by a fellowship award from the Canadian Institutes of Health Research.	Adhikari NKJ, 2007, BMJ-BRIT MED J, V334, P779, DOI 10.1136/bmj.39139.716794.55; ARDS Clinical Trials Network, 2003, CRIT CARE MED, V31, P2592, DOI 10.1097/01.CCM.0000090001.91640.45; ASHBAUGH DG, 1967, LANCET, V2, P319; Bartlett RH, 2000, JAMA-J AM MED ASSOC, V283, P904, DOI 10.1001/jama.283.7.904; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bollen CW, 2005, CRIT CARE, V9, pR430, DOI 10.1186/cc3737; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; Broome M, 2008, ANN THORAC SURG, V86, P1357, DOI 10.1016/j.athoracsur.2008.03.053; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Christie JD, 2009, J HEART LUNG TRANSPL, V28, P1031, DOI 10.1016/j.healun.2009.08.004; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Dellinger RP, 1998, CRIT CARE MED, V26, P15, DOI 10.1097/00003246-199801000-00011; Derdak S, 2002, AM J RESP CRIT CARE, V166, P801, DOI 10.1164/rccm.2108052; Diaz JV, 2010, CRIT CARE MED, V38, P1644, DOI 10.1097/CCM.0b013e3181e795ee; DRAZEN JM, 1984, PHYSIOL REV, V64, P505, DOI 10.1152/physrev.1984.64.2.505; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Fan E, 2005, JAMA-J AM MED ASSOC, V294, P2889, DOI 10.1001/jama.294.22.2889; Fan E, 2006, CLIN CHEST MED, V27, P615, DOI 10.1016/j.ccm.2006.06.008; Fan E, 2008, AM J RESP CRIT CARE, V178, P1156, DOI 10.1164/rccm.200802-335OC; Ferguson ND, 2005, CRIT CARE MED, V33, P479, DOI 10.1097/01.CCM.0000155785.23200.9E; Fischer S, 2006, J THORAC CARDIOV SUR, V131, P719, DOI 10.1016/j.jtcvs.2005.10.050; Fort P, 1997, CRIT CARE MED, V25, P937, DOI 10.1097/00003246-199706000-00008; Gattinoni L, 2001, NEW ENGL J MED, V345, P568, DOI 10.1056/NEJMoa010043; Gerlach H, 2003, AM J RESP CRIT CARE, V167, P1008, DOI 10.1164/rccm.2108121; Griffiths MJD, 2005, NEW ENGL J MED, V353, P2683, DOI 10.1056/NEJMra051884; Guerin C, 2004, JAMA-J AM MED ASSOC, V292, P2379, DOI 10.1001/jama.292.19.2379; Hager DN, 2007, CRIT CARE MED, V35, P1522, DOI 10.1097/01.CCM.0000266586.04676.55; Jackson A, 2008, J HEART LUNG TRANSPL, V27, P348, DOI 10.1016/j.healun.2007.12.006; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Lundin S, 1999, INTENS CARE MED, V25, P911, DOI 10.1007/s001340050982; Mancebo J, 2006, AM J RESP CRIT CARE, V173, P1233, DOI 10.1164/rccm.200503-353OC; Meade MO, 2008, RESP CARE, V53, P1441; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Mehta S, 2001, CRIT CARE MED, V29, P1360, DOI 10.1097/00003246-200107000-00011; Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646; Michael JR, 1998, AM J RESP CRIT CARE, V157, P1372, DOI 10.1164/ajrccm.157.5.96-10089; MORRIS AH, 1994, AM J RESP CRIT CARE, V149, P295, DOI 10.1164/ajrccm.149.2.8306022; MUSCEDERE JG, 1994, AM J RESP CRIT CARE, V149, P1327, DOI 10.1164/ajrccm.149.5.8173774; Oczenski W, 2004, ANESTHESIOLOGY, V101, P620, DOI 10.1097/00000542-200409000-00010; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Richard JC, 2001, AM J RESP CRIT CARE, V163, P1609, DOI 10.1164/ajrccm.163.7.2004215; Richman PS, 2006, CRIT CARE MED, V34, P1395, DOI 10.1097/01.CCM.0000215454.50964.F8; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; Slutsky AS, 1999, CHEST, V116, p9S, DOI 10.1378/chest.116.suppl_1.9S-a; Stapleton RD, 2005, CHEST, V128, P525, DOI 10.1378/chest.128.2.525; Sud S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2327; Sud S, 2010, INTENS CARE MED, V36, P585, DOI 10.1007/s00134-009-1748-1; Taccone P, 2009, JAMA-J AM MED ASSOC, V302, P1977, DOI 10.1001/jama.2009.1614; Taylor RW, 2004, JAMA-J AM MED ASSOC, V291, P1603, DOI 10.1001/jama.291.13.1603; Thompson BT, 2001, CHEST, V120, P1622, DOI 10.1378/chest.120.5.1622; Troncy E, 1998, AM J RESP CRIT CARE, V157, P1483, DOI 10.1164/ajrccm.157.5.9707090; Ware Lorraine B, 2005, Crit Care Med, V33, pS217, DOI 10.1097/01.CCM.0000155788.39101.7E; White DB, 2009, JAMA-J AM MED ASSOC, V302, P1905, DOI 10.1001/jama.2009.1539; ZAPOL WM, 1979, JAMA-J AM MED ASSOC, V242, P2193, DOI 10.1001/jama.242.20.2193	57	85	94	2	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2010	304	22					2521	2527		10.1001/jama.2010.1752	http://dx.doi.org/10.1001/jama.2010.1752			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691AS	21139113				2022-12-28	WOS:000285053300026
J	Lam, LL; Cameron, PA; Schneider, HG; Abramson, MJ; Muller, C; Krum, H				Lam, Louisa L.; Cameron, Peter A.; Schneider, Hans G.; Abramson, Michael J.; Mueller, Christian; Krum, Henry			Meta-analysis: Effect of B-Type Natriuretic Peptide Testing on Clinical Outcomes in Patients With Acute Dyspnea in the Emergency Setting	ANNALS OF INTERNAL MEDICINE			English	Review							CONGESTIVE-HEART-FAILURE; RENAL-FUNCTION; DEPARTMENT PATIENTS; NT-PROBNP; DIAGNOSIS; UTILITY; CARE; MANAGEMENT; ACCURACY; DISEASE	Background: Although the accuracy of B-type natriuretic peptide (BNP) testing for diagnosing acute decompensated heart failure has been extensively evaluated, the effect of this test on clinical outcomes remains unclear. Purpose: To investigate whether BNP testing of patients presenting with acute dyspnea in the emergency department leads to fewer admissions, shorter length of stay, and improved short-term survival compared with usual care without BNP testing. Data Sources: Two reviewers searched Ovid MEDLINE and EMBASE, without language restrictions, to identify pertinent studies published from January 1996 to July 2010. Study Selection: Randomized, controlled trials that compared BNP testing to diagnose heart failure with routine care in patients presenting with acute dyspnea and information about 1 or more of the following outcomes: mortality, admission, or length of hospital stay. Data Extraction: Two authors independently reviewed articles, extracted data, and assessed quality and risk for bias of studies. Data Synthesis: Five trials conducted in 5 countries and involving 2513 patients met inclusion criteria. Study settings had differing emergency department staffing models and used various BNP testing protocols. The pooled estimate of effect of BNP testing on all-cause mortality had wide confidence bounds and was inconclusive (odds ratio, 0.96 [95% CI, 0.65 to 1.41]). Admission rates decreased in the tested group compared with the control group (odds ratio, 0.82 [CI, 0.67 to 1.01]), although this finding was not statistically significant. Length of hospital and critical care unit stay were both modestly reduced in the tested group compared with the control group, with a mean difference of -1.22 days (CI, -2.31 to -0.14 day) and -0.56 day (CI, -1.06 to -0.05 day), respectively. Limitation: Few relevant trials were studied. Patients included in the trials and the settings in which trials were conducted were heterogeneous. Conclusion: B-type natriuretic peptide testing in the emergency department for patients presenting with acute dyspnea decreased length hospital of stay by about 1 day and possibly reduced admission rates but did not conclusively affect hospital mortality rates.	[Lam, Louisa L.] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med,Alfred Ctr, Melbourne, Vic 3004, Australia; [Cameron, Peter A.] Monash Univ, Melbourne, Vic 3004, Australia; Univ Basel Hosp, CH-4031 Basel, Switzerland; Alfred Hlth, Prahran, Vic, Australia	Monash University; Monash University; University of Basel	Lam, LL (corresponding author), Monash Univ, Australian & New Zealand Intens Care Res Ctr, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med,Alfred Ctr, Level 6,99 Commercial Rd, Melbourne, Vic 3004, Australia.	louisa.lam@mo-nash.edu	Lam, Louisa Lok Yi/R-7147-2018; Abramson, Michael/AAQ-2671-2020; Lam, Louisa/ADA-7185-2022	Lam, Louisa Lok Yi/0000-0002-1439-0893; Abramson, Michael/0000-0002-9954-0538; Cameron, Peter/0000-0002-1443-557X; Schneider, Hans Gerhard/0000-0002-6048-8744	Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia; GlaxoSmithKline; Reckitts-Benckiser; Boehringer Ingelheim; Alere; Brahms; Siemens; Abbott	Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia(Monash University); GlaxoSmithKline(GlaxoSmithKline); Reckitts-Benckiser; Boehringer Ingelheim(Boehringer Ingelheim); Alere; Brahms; Siemens(Siemens AG); Abbott(Abbott Laboratories)	Primary Funding Source: Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; Dr. Abramson: Board membership (money to institution): GlaxoSmithKline. Grants received (money to institution): Reckitts-Benckiser. Payment for lectures including service on speakers bureaus: Boehringer Ingelheim. Dr. Muller: Grants received (money to institution): Alere, Brahms, Siemens, and Abbott. Payment for lectures including service on speakers bureaus: Roche, Alere, Brahms, Siemens, and Abbott. Dr. Schneider: Payment for lectures including service on speakers bureaus: Amgen. Travel/accommodations/meeting expenses unrelated to activities listed: Australasian Association of Clinical Biochemists. Brahms, Siemens, and Abbott. Dr. Schneider: Payment for lectures including service on speakers bureaus: Amgen. Travel/accommodations/meeting expenses unrelated to activities listed: Australasian Association of Clinical Biochemists. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum = M10-1390.	Anwaruddin S, 2006, J AM COLL CARDIOL, V47, P91, DOI 10.1016/j.jacc.2005.08.051; Bayes-Genis A, 2004, EUR J HEART FAIL, V6, P301, DOI 10.1016/j.ejheart.2003.12.013; Chenevier-Gobeaux C, 2005, CLIN CHIM ACTA, V361, P167, DOI 10.1016/j.cccn.2005.05.021; Chung T, 2006, AM HEART J, V152, P949, DOI 10.1016/j.ahj.2006.05.020; Dao Q, 2001, J AM COLL CARDIOL, V37, P379, DOI 10.1016/S0735-1097(00)01156-6; Doust JA, 2004, ARCH INTERN MED, V164, P1978, DOI 10.1001/archinte.164.18.1978; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; Harrison A, 2002, ANN EMERG MED, V39, P131, DOI 10.1067/mem.2002.121483; Hawkridge AM, 2005, P NATL ACAD SCI USA, V102, P17442, DOI 10.1073/pnas.0508782102; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Januzzi JL, 2005, AM J CARDIOL, V95, P948, DOI 10.1016/j.amjcard.2004.12.032; Januzzi JL, 2006, ARCH INTERN MED, V166, P315, DOI 10.1001/archinte.166.3.315; Knudsen CW, 2005, ANN EMERG MED, V45, P573, DOI 10.1016/j.annemergmed.2005.01.027; Kosowsky JM, 2006, J EMERG MED, V31, P147, DOI 10.1016/j.jemermed.2005.10.001; Lainchbury JG, 2003, J AM COLL CARDIOL, V42, P728, DOI 10.1016/S0735-1097(03)00787-3; Lam CSP, 2007, J AM COLL CARDIOL, V49, P1193, DOI 10.1016/j.jacc.2006.12.024; Mair J, 2008, CLIN CHEM LAB MED, V46, P1507, DOI 10.1515/CCLM.2008.295; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; MANTEL N, 1959, J NATL CANCER I, V22, P719; McCullough PA, 2003, AM J KIDNEY DIS, V41, P571, DOI 10.1053/ajkd.2003.50118; Moe GW, 2007, CIRCULATION, V115, P3103, DOI 10.1161/CIRCULATIONAHA.106.666255; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Morrison LK, 2002, J AM COLL CARDIOL, V39, P202, DOI 10.1016/S0735-1097(01)01744-2; Mueller C, 2004, NEW ENGL J MED, V350, P647, DOI 10.1056/NEJMoa031681; Parshall MB, 2001, HEART LUNG, V30, P47; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Rutten JHW, 2008, AM HEART J, V156, P71, DOI 10.1016/j.ahj.2008.02.021; Schneider HG, 2009, ANN INTERN MED, V150, P365, DOI 10.7326/0003-4819-150-6-200903170-00004; Singer AJ, 2009, CIRC-HEART FAIL, V2, P287, DOI 10.1161/CIRCHEARTFAILURE.108.826685; Wright SP, 2003, J AM COLL CARDIOL, V42, P1793, DOI 10.1016/j.jacc.2003.05.011; Wu AHB, 2004, EUR J HEART FAIL, V6, P309, DOI 10.1016/j.ejheart.2003.12.014; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195	33	44	46	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 7	2010	153	11					728	735		10.7326/0003-4819-153-11-201012070-00006	http://dx.doi.org/10.7326/0003-4819-153-11-201012070-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	690KN	21135296				2022-12-28	WOS:000285003800005
J	Lin, JS; O'Connor, E; Whitlock, EP; Beil, TL				Lin, Jennifer S.; O'Connor, Elizabeth; Whitlock, Evelyn P.; Beil, Tracy L.			Behavioral Counseling to Promote Physical Activity and a Healthful Diet to Prevent Cardiovascular Disease in Adults: A Systematic Review for the U.S. Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; LIFE-STYLE INTERVENTION; CORONARY-HEART-DISEASE; IMPAIRED GLUCOSE-TOLERANCE; PRIMARY-CARE; OLDER-ADULTS; LOW-FAT; BLOOD-PRESSURE; HYPERTENSION PREVENTION; RISK-FACTORS	Background: Poor diet and lack of physical activity can worsen cardiovascular health, yet most Americans do not meet diet and physical activity recommendations. Purpose: To assist the U.S. Preventive Services Task Force in updating its previous recommendations by systematically reviewing trials of physical activity or dietary counseling to prevent cardiovascular disease. Data Sources: MEDLINE, PsycINFO, Cochrane Central Register of Controlled Trials (2001 to January 2010), experts, and existing systematic reviews. Study Selection: Two investigators independently reviewed 13 562 abstracts and 481 articles against a set of a priori inclusion criteria and critically appraised each study by using design-specific quality criteria. Data Extraction and Analysis: Data from 73 studies (109 articles) were abstracted by one reviewer and checked by a second reviewer. Random-effects meta-analyses were conducted for multiple intermediate health and behavioral outcomes. Data Synthesis: Long-term observational follow-up of intensive sodium reduction counseling showed a decrease in the incidence of cardiovascular disease; however, other direct evidence for reduction in disease morbidity is lacking. High-intensity dietary counseling, with or without physical activity counseling, resulted in changes of -0.3 to -0.7 kg/m(2) in body mass index (adiposity), -1.5 mm Hg (95% CI, -0.9 to -2.1 mm Hg) in systolic blood pressure, -0.7 mm Hg (CI, -0.6 to -0.9 mm Hg) in diastolic pressure, -0.17 mmol/L (CI, -0.09 to -0.25 mmol/L) (-6.56 mg/dL [CI, -3.47 to -9.65 mg/dL]) in total cholesterol level, and -0.13 mmol/L (CI, -0.06 to -0.21 mmol/L) (-5.02 mg/dL [CI, -2.32 to -8.11 mg/dL]) in low-density lipoprotein cholesterol level. Medium-and high-intensity counseling resulted in moderate to large changes in self-reported dietary and physical activity behaviors. Limitations: Meta-analyses for some outcomes had large statistical heterogeneity or evidence for publication bias. Only 11 trials followed outcomes beyond 12 months. Conclusion: Counseling to improve diet or increase physical activity changed health behaviors and was associated with small improvements in adiposity, blood pressure, and lipid levels.	[Lin, Jennifer S.; O'Connor, Elizabeth; Whitlock, Evelyn P.; Beil, Tracy L.] Kaiser Permanente NW, Ctr Hlth Res, Portland, OR 97227 USA	Kaiser Permanente	Lin, JS (corresponding author), Kaiser Permanente NW, Ctr Hlth Res, 3800 N Interstate Ave, Portland, OR 97227 USA.				Agency for Healthcare Research and Quality, Rockville, Maryland [HHS-290-2007-10057-I]; Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality, Rockville, Maryland(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Grant Support: By the Agency for Healthcare Research and Quality, Rockville, Maryland (contract HHS-290-2007-10057-I, task order 3).; Primary Funding Source: Agency for Healthcare Research and Quality.	Aittasalo M, 2006, PREV MED, V42, P40, DOI 10.1016/j.ypmed.2005.10.003; Albert CM, 2000, NEW ENGL J MED, V343, P1355, DOI 10.1056/NEJM200011093431902; Aldana SG, 2005, J AM DIET ASSOC, V105, P371, DOI 10.1016/j.jada.2004.12.007; Aldana Steven G, 2006, Prev Chronic Dis, V3, pA05; Allen Peg, 2008, Prev Chronic Dis, V5, pA76; AMMERMAN A, 2003, COUNSELING PROMOTE H, P145; Ammerman AS, 2002, PREV MED, V35, P25, DOI 10.1006/pmed.2002.1028; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; ANDERSON JW, 1992, AM J CLIN NUTR, V56, P887, DOI 10.1093/ajcn/56.5.887; [Anonymous], 1990, Arch Intern Med, V150, P153, DOI 10.1001/archinte.150.1.153; Babazono A, 2007, DIS MANAG HEALTH OUT, V15, P119, DOI 10.2165/00115677-200715020-00007; BARON JA, 1990, BRIT J GEN PRACT, V40, P137; Beresford SAA, 1997, AM J PUBLIC HEALTH, V87, P610, DOI 10.2105/AJPH.87.4.610; Bernstein MA, 2002, J AM DIET ASSOC, V102, P1421, DOI 10.1016/S0002-8223(02)90315-9; Bowen D, 1996, ANN EPIDEMIOL, V6, P507, DOI 10.1016/S1047-2797(96)00072-5; Brekke HK, 2005, DIABETES RES CLIN PR, V70, P225, DOI 10.1016/j.diabres.2005.03.027; Brekke HK, 2004, J HUM NUTR DIET, V17, P513, DOI 10.1111/j.1365-277X.2004.00566.x; Carpenter RA, 2004, J NUTR EDUC BEHAV, V36, P20, DOI 10.1016/S1499-4046(06)60124-3; Castro CM, 2002, PSYCHOSOM MED, V64, P458, DOI 10.1097/00006842-200205000-00010; *CDCP PRES COUNC P, 2006, MIDC REV HLTH PEOPL; Coates RJ, 1999, AM J EPIDEMIOL, V149, P1104, DOI 10.1093/oxfordjournals.aje.a009764; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Connell CM, 2009, J APPL GERONTOL, V28, P171, DOI 10.1177/0733464808326951; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; De Vet E, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-11; Delichatsios HK, 2001, AM J HEALTH PROMOT, V15, P215, DOI 10.4278/0890-1171-15.4.215; Dutton GR, 2008, PREV MED, V46, P216, DOI 10.1016/j.ypmed.2007.12.012; Eakin EG, 2007, HEALTH PSYCHOL, V26, P392, DOI 10.1037/0278-6133.26.4.392; Eakin EG, 2007, AM J PREV MED, V32, P419, DOI 10.1016/j.amepre.2007.01.004; Edelman D, 2006, J GEN INTERN MED, V21, P728, DOI 10.1111/j.1525-1497.2006.00495.x; EDEN KB, 2002, CLIN COUNSELING PROM, P34; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elley CR, 2003, BRIT MED J, V326, P793, DOI 10.1136/bmj.326.7393.793; Fowles ER, 2007, CAN J NURS RES, V39, P146; Franko DL, 2008, PREV MED, V47, P369, DOI 10.1016/j.ypmed.2008.06.013; Fries E, 2005, AM J PREV MED, V28, P162, DOI 10.1016/j.amepre.2004.10.017; Giri S, 1999, JAMA-J AM MED ASSOC, V282, P1731, DOI 10.1001/jama.282.18.1731; Goldstein MG, 1999, ANN BEHAV MED, V21, P40, DOI 10.1007/BF02895032; Grandes G, 2009, ARCH INTERN MED, V169, P694, DOI 10.1001/archinternmed.2009.23; Greaney ML, 2008, GERONTOLOGIST, V48, P358, DOI 10.1093/geront/48.3.358; Green BB, 2002, AM J PREV MED, V22, P177, DOI 10.1016/S0749-3797(01)00428-7; Greene GW, 2008, GERONTOLOGIST, V48, P378, DOI 10.1093/geront/48.3.378; Halbert JA, 2000, MED J AUSTRALIA, V173, P84, DOI 10.5694/j.1326-5377.2000.tb139250.x; Halbert JA, 1999, J AM GERIATR SOC, V47, P477, DOI 10.1111/j.1532-5415.1999.tb07242.x; Hall WD, 2003, ETHNIC DIS, V13, P337; Hallqvist J, 2000, AM J EPIDEMIOL, V151, P459, DOI 10.1093/oxfordjournals.aje.a010231; Hardcastle S, 2008, PATIENT EDUC COUNS, V70, P31, DOI 10.1016/j.pec.2007.09.014; Harland J, 1999, BRIT MED J, V319, P828, DOI 10.1136/bmj.319.7213.828; Hebert Patricia R., 1995, Annals of Epidemiology, V5, P130, DOI 10.1016/1047-2797(94)00057-Z; HELLENIUS ML, 1995, QUAL LIFE RES, V4, P13, DOI 10.1007/BF00434378; HELLENIUS ML, 1993, ATHEROSCLEROSIS, V103, P81, DOI 10.1016/0021-9150(93)90042-S; HERMAN C, 2006, AM PUBL HLTH ASS 134; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hillsdon M, 2005, Cochrane Database Syst Rev, pCD003180; Hivert MF, 2007, INT J OBESITY, V31, P1262, DOI 10.1038/sj.ijo.0803572; HOLTZMAN J, 2004, EFFECTIVENESS BEHAV, P336; Hooper L, 2004, Cochrane Database Syst Rev, pCD003656; Howard BV, 2010, AM J CLIN NUTR, V91, P860, DOI 10.3945/ajcn.2009.28034; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Institute of Medicine, 2006, DRI DIET REF INT ESS; Jeffery RW, 1999, AM J PUBLIC HEALTH, V89, P747, DOI 10.2105/AJPH.89.5.747; John JH, 2002, LANCET, V359, P1969, DOI 10.1016/S0140-6736(02)98858-6; Joint WHO/FAO Expert Consultation, 2003, WHO TECHN REP SER; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; Kallings LV, 2009, EUR J CARDIOV PREV R, V16, P80, DOI 10.1097/HJR.0b013e32831e953a; Kallings LV, 2008, PHYS ACTIVITY PRESCR; Katz DL, 2008, J EVAL CLIN PRACT, V14, P294, DOI 10.1111/j.1365-2753.2007.00853.x; Kerse N, 2005, J AM GERIATR SOC, V53, P1951, DOI 10.1111/j.1532-5415.2005.00466.x; Keyserling TC, 2008, PREV MED, V46, P499, DOI 10.1016/j.ypmed.2008.02.011; King AC, 2007, HEALTH PSYCHOL, V26, P718, DOI 10.1037/0278-6133.26.6.718; King AC, 2002, J GERONTOL A-BIOL, V57, pM26, DOI 10.1093/gerona/57.1.M26; Kinmonth AL, 2008, LANCET, V371, P41, DOI 10.1016/S0140-6736(08)60070-7; Kolt GS, 2007, J AM GERIATR SOC, V55, P986, DOI 10.1111/j.1532-5415.2007.01203.x; Kristal AR, 2000, PREV MED, V31, P380, DOI 10.1006/pmed.2000.0711; Kumanyika SK, 2005, J HUM HYPERTENS, V19, P33, DOI 10.1038/sj.jhh.1001774; KUMANYIKA SK, 1993, HYPERTENSION, V22, P502, DOI 10.1161/01.HYP.22.4.502; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Lawton BA, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2509; Lemmens VEPP, 2008, OBES REV, V9, P446, DOI 10.1111/j.1467-789X.2008.00468.x; Lin JS, 2010, BEHAV COUNSELING PRO; Lutz SF, 1999, J AM DIET ASSOC, V99, P705, DOI 10.1016/S0002-8223(99)00169-8; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Marcus BH, 2007, HEALTH PSYCHOL, V26, P401, DOI 10.1037/0278-6133.26.4.401; Marshall AL, 2003, ANN BEHAV MED, V25, P194, DOI 10.1207/S15324796ABM2503_05; Martinson BC, 2008, PREV MED, V46, P111, DOI 10.1016/j.ypmed.2007.08.007; Martinson BC, 2010, PREV MED, V51, P37, DOI 10.1016/j.ypmed.2010.04.002; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; MEINERT CL, 1989, CONTROL CLIN TRIALS, V10, pS1, DOI 10.1016/0197-2456(89)90040-8; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Moore TJ, 1999, HYPERTENSION, V34, P472, DOI 10.1161/01.HYP.34.3.472; Morey MC, 2008, J REHABIL RES DEV, V45, P31, DOI 10.1682/JRRD.2007.03.0044; Morey MC, 2009, J AM GERIATR SOC, V57, P1166, DOI 10.1111/j.1532-5415.2009.02301.x; Mosca L, 2008, CIRC-CARDIOVASC QUAL, V1, P98, DOI 10.1161/CIRCOUTCOMES.108.825786; Napolitano MA, 2006, PREV MED, V43, P447, DOI 10.1016/j.ypmed.2006.06.011; Naslund GK, 1996, J EPIDEMIOL COMMUN H, V50, P131, DOI 10.1136/jech.50.2.131; Norris SL, 2000, PREV MED, V30, P513, DOI 10.1006/pmed.2000.0673; Oldroyd JC, 2006, DIABETES RES CLIN PR, V72, P117, DOI 10.1016/j.diabres.2005.09.018; Oldroyd JC, 2001, DIABETES RES CLIN PR, V52, P29, DOI 10.1016/S0168-8227(00)00244-8; Pekmezi DW, 2009, AM J PREV MED, V37, P495, DOI 10.1016/j.amepre.2009.08.023; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Pinto BM, 2002, AM J PREV MED, V23, P113, DOI 10.1016/S0749-3797(02)00441-5; Pinto BM, 1998, AM J PREV MED, V15, P95, DOI 10.1016/S0749-3797(98)00043-9; Pinto BM, 2005, AM J PREV MED, V29, P247, DOI 10.1016/j.amepre.2005.06.016; Prentice RL, 2006, JAMA-J AM MED ASSOC, V295, P629, DOI 10.1001/jama.295.6.629; Prochaska JO, 2005, PREV MED, V41, P406, DOI 10.1016/j.ypmed.2004.09.050; Roderick P, 1997, BRIT J GEN PRACT, V47, P7; Sacerdote C, 2006, INT J EPIDEMIOL, V35, P409, DOI 10.1093/ije/dyi170; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Satterfield S, 1991, Ann Epidemiol, V1, P455; SHAH M, 1990, J AM DIET ASSOC, V90, P69; Sherwood Nancy E, 2008, BMC Geriatr, V8, P17, DOI 10.1186/1471-2318-8-17; Simkin-Silverman L R, 1998, Womens Health, V4, P255; Simkin-Silverman LR, 2003, ANN BEHAV MED, V26, P212, DOI 10.1207/S15324796ABM2603_06; SIMKINSILVERMAN L, 1995, PREV MED, V24, P509, DOI 10.1006/pmed.1995.1081; SISCOVICK DS, 1984, NEW ENGL J MED, V311, P874, DOI 10.1056/NEJM198410043111402; Stefanick ML, 1998, NEW ENGL J MED, V339, P12, DOI 10.1056/NEJM199807023390103; STENSEL DJ, 1994, EUR J APPL PHYSIOL O, V68, P531, DOI 10.1007/BF00599525; Stevens VJ, 2003, PREV MED, V36, P594, DOI 10.1016/S0091-7435(03)00019-7; Stewart AL, 2001, J GERONTOL A-BIOL, V56, pM465, DOI 10.1093/gerona/56.8.M465; Terrin N, 2005, J CLIN EPIDEMIOL, V58, P894, DOI 10.1016/j.jclinepi.2005.01.006; Thompson JL, 2008, AM J PREV MED, V34, P192, DOI 10.1016/j.amepre.2007.11.014; Thompson RL., 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001366, 10.1002/14651858.CD001366]; Tinker LF, 2008, ARCH INTERN MED, V168, P1500, DOI 10.1001/archinte.168.14.1500; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; US Department of Health and Human Services and US Department of Agriculture, 2005, DIET GUID AM; US Preventive Services Task Force, 2008, AHRQ PUBL; van der Bij AK, 2002, AM J PREV MED, V22, P120, DOI 10.1016/S0749-3797(01)00413-5; Vandelanotte C, 2005, ANN BEHAV MED, V29, P138, DOI 10.1207/s15324796abm2902_8; von Klot S, 2008, EUR HEART J, V29, P1881, DOI 10.1093/eurheartj/ehn235; Watanabe M, 2003, DIABETES CARE, V26, P3209, DOI 10.2337/diacare.26.12.3209; Wells H. F., 2008, Economic Information Bulletin - USDA Economic Research Service; WHELTON PK, 1992, JAMA-J AM MED ASSOC, V267, P1213, DOI 10.1001/jama.1992.03480090061028; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657; Williams K, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-48; WILLICH SN, 1993, NEW ENGL J MED, V329, P1684, DOI 10.1056/NEJM199312023292302; Wister A, 2007, CAN MED ASSOC J, V177, P859, DOI 10.1503/cmaj.061059; YATES T, 2009, DIABETIC MED, V26, P17; Yates T, 2008, PATIENT EDUC COUNS, V73, P264, DOI 10.1016/j.pec.2008.06.010; Yates T, 2009, DIABETES CARE, V32, P1404, DOI 10.2337/dc09-0130; Zaza S, 2000, AM J PREV MED, V18, P27, DOI 10.1016/S0749-3797(99)00123-3	141	150	153	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 7	2010	153	11					736	750		10.7326/0003-4819-153-11-201012070-00007	http://dx.doi.org/10.7326/0003-4819-153-11-201012070-00007			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	690KN	21135297				2022-12-28	WOS:000285003800006
J	Harris, KM; Maurer, J; Kellermann, AL				Harris, Katherine M.; Maurer, Juergen; Kellermann, Arthur L.			Influenza Vaccine -- Safe, Effective, and Mistrusted.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Harris, Katherine M.; Maurer, Juergen; Kellermann, Arthur L.] RAND Corp, Arlington, VA USA	RAND Corporation	Harris, KM (corresponding author), RAND Corp, Arlington, VA USA.			/0000-0002-3923-677X				Harris K. M., 2010, Morbidity and Mortality Weekly Report, V59, P357; Maurer J, 2010, PREV MED, V51, P185, DOI 10.1016/j.ypmed.2010.05.008; Maurer J, 2009, VACCINE, V27, P5732, DOI 10.1016/j.vaccine.2009.07.080; MOYER CS, 2010, AM MED NEWS     0719; SteelFisher GK, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1005102	5	40	40	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2183	2185		10.1056/NEJMp1012333	http://dx.doi.org/10.1056/NEJMp1012333			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	688EP	21105831				2022-12-28	WOS:000284832900002
J	Culjkovic-Kraljacic, B; Borden, KLB				Culjkovic-Kraljacic, Bijana; Borden, Katherine L. B.			Puzzled by PML	SCIENCE			English	Editorial Material							LEUKEMIA PROTEIN PML; BODIES		[Culjkovic-Kraljacic, Bijana; Borden, Katherine L. B.] Univ Montreal, Dept Pathol & Cell Biol, Inst Res Immunol & Canc, Montreal, PQ, Canada	Universite de Montreal	Culjkovic-Kraljacic, B (corresponding author), Univ Montreal, Dept Pathol & Cell Biol, Inst Res Immunol & Canc, Chemin Polytech, Montreal, PQ, Canada.	katherine.borden@umontreal.ca			NATIONAL CANCER INSTITUTE [R01CA098571, R01CA080728] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Borden KLB, 2009, FRONT BIOSCI-LANDMRK, V14, P497, DOI 10.2741/3258; Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; Dellaire G, 2006, J CELL SCI, V119, P1034, DOI 10.1242/jcs.02817; Duprez E, 1999, J CELL SCI, V112, P381; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Maul GG, 2000, J STRUCT BIOL, V129, P278, DOI 10.1006/jsbi.2000.4239; Nichol JN, 2009, FRONT BIOSCI-LANDMRK, V14, P2293, DOI 10.2741/3380; Quignon F, 1998, NAT GENET, V20, P259, DOI 10.1038/3068; Salomoni P, 2008, CELL RES, V18, P620, DOI 10.1038/cr.2008.58; Volpon L, 2010, P NATL ACAD SCI USA, V107, P5441, DOI 10.1073/pnas.0909877107	13	0	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1183	1184		10.1126/science.1199405	http://dx.doi.org/10.1126/science.1199405			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109655				2022-12-28	WOS:000284613700022
J	Gaziano, JM				Gaziano, J. Michael			The Evolution of Population Science Advent of the Mega Cohort	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gaziano, J. Michael] VA Boston Healthcare Syst, MAVERIC, Boston, MA 02130 USA; [Gaziano, J. Michael] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Aging, Boston, MA 02115 USA; [Gaziano, J. Michael] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Cardiovasc Med, Boston, MA 02115 USA; [Gaziano, J. Michael] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Prevent Med, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gaziano, JM (corresponding author), VA Boston Healthcare Syst, MAVERIC MAV 151, 150 S Huntington Ave, Boston, MA 02130 USA.	jmgaziano@partners.org						AUERBACH O, 1957, NEW ENGL J MED, V256, P97, DOI 10.1056/NEJM195701172560301; DAWBER TR, 1962, CIRC RES, V11, P587; Doll R, 2001, SOZ PRAVENTIV MED, V46, P75, DOI 10.1007/BF01299724; DOLL R, 1954, BMJ-BRIT MED J, V1, P1451, DOI 10.1136/bmj.1.4877.1451; GAZIANO JM, 2008, WILEY ENCY CLIN TRIA; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Manolio TA, 2010, JAMA-J AM MED ASSOC, V304, P2290, DOI 10.1001/jama.2010.1686; Paneth N, 2002, SOZ PRAVENTIV MED, V47, P282, DOI 10.1007/PL00012638; Rothman KJ, 1996, LANCET, V347, P37, DOI 10.1016/S0140-6736(96)91562-7; Yoshioka A, 1998, BRIT MED J, V317, P1220, DOI 10.1136/bmj.317.7167.1220	10	15	18	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2010	304	20					2288	2289		10.1001/jama.2010.1691	http://dx.doi.org/10.1001/jama.2010.1691			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KI	21098773				2022-12-28	WOS:000284548400028
J	Matsuki, T; Matthews, RT; Cooper, JA; van der Brug, MP; Cookson, MR; Hardy, JA; Olson, EC; Howell, BW				Matsuki, Tohru; Matthews, Russell T.; Cooper, Jonathan A.; van der Brug, Marcel P.; Cookson, Mark R.; Hardy, John A.; Olson, Eric C.; Howell, Brian W.			Reelin and Stk25 Have Opposing Roles in Neuronal Polarization and Dendritic Golgi Deployment	CELL			English	Article							MATRIX PROTEIN GM130; APOE RECEPTOR 2; TYROSINE PHOSPHORYLATION; TAU PHOSPHORYLATION; BRAIN-DEVELOPMENT; CORTICAL-NEURONS; VLDL RECEPTOR; SAD KINASES; POLARITY; MOUSE	The Reelin ligand regulates a Dab1-dependent signaling pathway required for brain lamination and normal dendritogenesis, but the specific mechanisms underlying these actions remain unclear. We find that Stk25, a modifier of Reelin-Dab1 signaling, regulates Golgi morphology and neuronal polarization as part of an LKB1-Stk25-Golgi matrix protein 130 (GM130) signaling pathway. Overexpression of Stk25 induces Golgi condensation and multiple axons, both of which are rescued by Reelin treatment. Reelin stimulation of cultured neurons induces the extension of the Golgi into dendrites, which is suppressed by Stk25 overexpression. In vivo, Reelin and Dab1 are required for the normal extension of the Golgi apparatus into the apical dendrites of hippocampal and neocortical pyramidal neurons. This demonstrates that the balance between Reelin-Dab1 signaling and LKB1-Stk25-GM130 regulates Golgi dispersion, axon specification, and dendrite growth and provides insights into the importance of the Golgi apparatus for cell polarization.	[Matsuki, Tohru; Matthews, Russell T.; Olson, Eric C.; Howell, Brian W.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [van der Brug, Marcel P.; Cookson, Mark R.; Hardy, John A.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Cooper, Jonathan A.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Fred Hutchinson Cancer Center	Howell, BW (corresponding author), SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA.	howellb@upstate.edu	Hardy, John/C-2451-2009; Cookson, Mark/AAW-2516-2021	Hardy, John/0000-0002-3122-0423; Cookson, Mark/0000-0002-1058-3831; Matsuki, Tohru/0000-0003-1832-2406; Howell, Brian/0000-0002-0204-0773	NINDS; SUNY Upstate Medical University; NIH [NS066071, NS069660, CA41072]; NIA; NATIONAL CANCER INSTITUTE [R37CA041072, R01CA041072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066071, R01NS069660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000947] Funding Source: NIH RePORTER; Medical Research Council [G0701075] Funding Source: researchfish; MRC [G0701075] Funding Source: UKRI	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); SUNY Upstate Medical University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank Zainab Mansaray and Kristin Giamanco for experimental assistance, Michael Zuber for comments on the manuscript, Hans Clevers for cell lines, Louis Cantley and Jun-ichi Miyazaki for DNA vectors, Arvydas Matiukas and Melissa Pepling for assistance with confocal microscopy, and Bonnie Lee Howell for editing. This work was supported by funds from the NINDS intramural program and SUNY Upstate Medical University to B.W.H.; NIH grants NS066071 to E.C.O., NS069660 to R.T.M., and CA41072 to J.A.C.; and NIA intramural funds for M.R.C.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Asada N, 2007, J NEUROSCI, V27, P11769, DOI 10.1523/JNEUROSCI.1938-07.2007; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Barnes AP, 2008, CURR OPIN NEUROBIOL, V18, P44, DOI 10.1016/j.conb.2008.05.003; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Bisbal M, 2008, J NEUROSCI, V28, P9297, DOI 10.1523/JNEUROSCI.1879-08.2008; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Brich J, 2003, J NEUROSCI, V23, P187; CAVINESS VS, 1973, J COMP NEUROL, V147, P235, DOI 10.1002/cne.901470206; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; de Anda FC, 2010, J NEUROSCI, V30, P10391, DOI 10.1523/JNEUROSCI.0381-10.2010; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Forster E, 2010, EUR J NEUROSCI, V31, P1511, DOI 10.1111/j.1460-9568.2010.07222.x; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Jacobs T, 2007, J NEUROSCI, V27, P8604, DOI 10.1523/JNEUROSCI.0765-07.2007; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Matsuki T, 2008, J CELL SCI, V121, P1869, DOI 10.1242/jcs.027334; Nichols AJ, 2010, CEREB CORTEX, V20, P2213, DOI 10.1093/cercor/bhp303; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Olson EC, 2006, J NEUROSCI, V26, P1767, DOI 10.1523/JNEUROSCI.3000-05.2006; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Rice DS, 2001, NEURON, V31, P929, DOI 10.1016/S0896-6273(01)00436-6; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sanada K, 2004, NEURON, V42, P197, DOI 10.1016/S0896-6273(04)00222-3; Sanchez-Ponce D, 2008, MOL CELL NEUROSCI, V37, P832, DOI 10.1016/j.mcn.2008.01.010; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Sutterlin C, 2010, J CELL BIOL, V188, P621, DOI 10.1083/jcb.200910001; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Yin DM, 2008, J NEUROSCI, V28, P8832, DOI 10.1523/JNEUROSCI.1291-08.2008; Zmuda JF, 1998, CELL MOTIL CYTOSKEL, V41, P18, DOI 10.1002/(SICI)1097-0169(1998)41:1<18::AID-CM2>3.0.CO;2-B	57	113	117	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					826	836		10.1016/j.cell.2010.10.029	http://dx.doi.org/10.1016/j.cell.2010.10.029			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111240	Green Accepted, Bronze			2022-12-28	WOS:000284583500023
J	Heo, JB; Sung, S				Heo, Jae Bok; Sung, Sibum			Vernalization-Mediated Epigenetic Silencing by a Long Intronic Noncoding RNA	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; X-CHROMOSOME; POLYCOMB; REQUIRES; FLC; TRANSCRIPTION; COMPLEX; GENES	Vernalization is an environmentally-induced epigenetic switch in which winter cold triggers epigenetic silencing of floral repressors and thus provides competence to flower in spring. In Arabidopsis, winter cold triggers enrichment of tri-methylated histone H3 Lys(27) at chromatin of the floral repressor, FLOWERING LOCUS C (FLC), and results in epigenetically stable repression of FLC. This epigenetic change is mediated by an evolutionarily conserved repressive complex, polycomb repressive complex 2 (PRC2). Here, we show that a long intronic noncoding RNA [termed COLD ASSISTED INTRONIC NONCODING RNA (COLDAIR)] is required for the vernalization-mediated epigenetic repression of FLC. COLDAIR physically associates with a component of PRC2 and targets PRC2 to FLC. Our results show that COLDAIR is required for establishing stable repressive chromatin at FLC through its interaction with PRC2.	[Heo, Jae Bok; Sung, Sibum] Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Heo, Jae Bok; Sung, Sibum] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Sung, S (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA.	sbsung@mail.utexas.edu	Sung, Sibum/AAM-6500-2020		University of Texas at Austin; NSF	University of Texas at Austin; NSF(National Science Foundation (NSF))	We thank the members of Sung lab and E. Huq for helpful discussions, C. Pikaard for RNAPIV and RNAPV mutant seeds, and J. Goodrich for GFP::CLF seeds. S.S. thanks R. Amasino for encouragement and mentoring on the vernalization study. This work was supported by the start-up funds from the University of Texas at Austin and in part by the NSF to S.S.	De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Doyle MR, 2009, PLANT PHYSIOL, V151, P1688, DOI 10.1104/pp.109.145581; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Greb T, 2007, CURR BIOL, V17, P73, DOI 10.1016/j.cub.2006.11.052; Hsieh TF, 2003, TRENDS PLANT SCI, V8, P439, DOI 10.1016/S1360-1385(03)00189-4; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Khaitovich P, 2006, PLOS GENET, V2, P1590, DOI 10.1371/journal.pgen.0020171; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Krajewski WA, 2005, MOL CELL BIOL, V25, P1891, DOI 10.1128/MCB.25.5.1891-1899.2005; Lang A., 1965, PHYSL FLOWE INITIATI, P1371; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Sheldon CC, 2009, PLANT J, V59, P488, DOI 10.1111/j.1365-313X.2009.03883.x; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; Sung SB, 2006, NAT GENET, V38, P706, DOI 10.1038/ng1795; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	27	742	800	16	292	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					76	79		10.1126/science.1197349	http://dx.doi.org/10.1126/science.1197349			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21127216				2022-12-28	WOS:000285974000039
J	Huismans, Y; Rouzee, A; Gijsbertsen, A; Jungmann, JH; Smolkowska, AS; Logman, PSWM; Lepine, F; Cauchy, C; Zamith, S; Marchenko, T; Bakker, JM; Berden, G; Redlich, B; van der Meer, AFG; Muller, HG; Vermin, W; Schafer, KJ; Spanner, M; Ivanov, MY; Smirnova, O; Bauer, D; Popruzhenko, SV; Vrakking, MJJ				Huismans, Y.; Rouzee, A.; Gijsbertsen, A.; Jungmann, J. H.; Smolkowska, A. S.; Logman, P. S. W. M.; Lepine, F.; Cauchy, C.; Zamith, S.; Marchenko, T.; Bakker, J. M.; Berden, G.; Redlich, B.; van der Meer, A. F. G.; Muller, H. G.; Vermin, W.; Schafer, K. J.; Spanner, M.; Ivanov, M. Yu.; Smirnova, O.; Bauer, D.; Popruzhenko, S. V.; Vrakking, M. J. J.			Time-Resolved Holography with Photoelectrons	SCIENCE			English	Article							ABOVE-THRESHOLD IONIZATION; FIELD; DYNAMICS; MOLECULES; RESCATTERING; DIFFRACTION; PHYSICS; RINGS	Ionization is the dominant response of atoms and molecules to intense laser fields and is at the basis of several important techniques, such as the generation of attosecond pulses that allow the measurement of electron motion in real time. We present experiments in which metastable xenon atoms were ionized with intense 7-micrometer laser pulses from a free-electron laser. Holographic structures were observed that record underlying electron dynamics on a sublaser-cycle time scale, enabling photoelectron spectroscopy with a time resolution of almost two orders of magnitude higher than the duration of the ionizing pulse.	[Huismans, Y.; Rouzee, A.; Gijsbertsen, A.; Jungmann, J. H.; Smolkowska, A. S.; Logman, P. S. W. M.; Muller, H. G.; Vrakking, M. J. J.] FOM Inst AMOLF, NL-1098 XG Amsterdam, Netherlands; [Rouzee, A.; Smirnova, O.; Vrakking, M. J. J.] Max Born Inst, D-12489 Berlin, Germany; [Lepine, F.; Cauchy, C.] Univ Lyon 1, CNRS, UMR 5579, Spectrometrie Ion & Mol Lab, F-69622 Villeurbanne, France; [Zamith, S.] Univ Toulouse, UPS, Inst Rech Syst Atom & Mol Complexes, Lab Collis, F-31062 Toulouse, France; [Zamith, S.] CNRS, UMR 5589, F-31062 Toulouse, France; [Marchenko, T.] Univ Paris 06, CNRS, UMR 7614, Lab Chim Phys Mat & Rayonnement, F-75005 Paris, France; [Bakker, J. M.; Berden, G.; Redlich, B.; van der Meer, A. F. G.] FOM Inst Plasma Phys Rijnhuizen, NL-3439 MN Nieuwegein, Netherlands; [Vermin, W.] SARA Comp & Networking Serv, NL-1098 XG Amsterdam, Netherlands; [Schafer, K. J.] Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA; [Spanner, M.] Natl Res Council Canada, Ottawa, ON K1A 0R6, Canada; [Ivanov, M. Yu.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2BW, England; [Bauer, D.] Univ Rostock, Inst Phys, D-18051 Rostock, Germany; [Popruzhenko, S. V.] Natl Res Nucl Univ, Moscow Engn Phys Inst, Moscow 115409, Russia	AMOLF; Max Born Institute for Nonlinear Optics & Short Term Spectroscopy; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Louisiana State University System; Louisiana State University; National Research Council Canada; Imperial College London; University of Rostock; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)	Huismans, Y (corresponding author), FOM Inst AMOLF, Sci Pk 113, NL-1098 XG Amsterdam, Netherlands.	marc.vrakking@mbi.berlin.de	Bakker, Joost/E-8058-2011; Bakker, Joost/X-6612-2019; Zamith, Sebastien/AAH-3269-2021; Bakker, Joost M/L-1704-2015; Ivanov, Mikhail/AAG-1727-2021; Berden, Giel/F-9690-2015; Marchenko, Tatiana/AAB-2225-2019; Jungmann, Julia H/I-6706-2013; Redlich, Britta/F-9689-2015; Vrakking, Marc JJ/F-6770-2014; Bauer, Dieter/A-5158-2009; Schafer, Kenneth/R-3729-2019; Popruzhenko, S V/A-6807-2017	Bakker, Joost/0000-0002-1394-7661; Bakker, Joost M/0000-0002-1394-7661; Marchenko, Tatiana/0000-0002-9015-3339; Jungmann, Julia H/0000-0002-7194-7985; Vrakking, Marc JJ/0000-0002-3249-1663; Bauer, Dieter/0000-0003-4680-5560; Popruzhenko, S V/0000-0001-6676-7974; Zamith, Sebastien/0000-0001-6493-4548	Nederlandse organisatie voor Wetenschappelijk Onderzoek (NWO); NSF [PHY-0701372]; Engineering and Physical Sciences Research Council [EP/E036112/1]; Leibniz SAW award; EPSRC [EP/E036112/1] Funding Source: UKRI	Nederlandse organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); NSF(National Science Foundation (NSF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leibniz SAW award; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge R. Kemper, H. Schoenmaker, A. de Snaijer, I. Cerjak, and the staff at the FELIX facility for their great technical assistance. This work is part of the research program of FOM, which is financially supported by the Nederlandse organisatie voor Wetenschappelijk Onderzoek (NWO). K.J.S. is supported by NSF grant PHY-0701372 and the Ball Professorship at LSU. M.Y.I. is supported by Science and Innovation grant EP/E036112/1 of the Engineering and Physical Sciences Research Council. O.S. acknowledges a Leibniz SAW award.	Baker S, 2006, SCIENCE, V312, P424, DOI 10.1126/science.1123904; Bakker JM, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3313926; BECKER W, 1994, J PHYS B-AT MOL OPT, V27, pL325, DOI 10.1088/0953-4075/27/14/005; Brabec T, 1996, PHYS REV A, V54, pR2551, DOI 10.1103/PhysRevA.54.R2551; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Eppink ATJB, 1997, REV SCI INSTRUM, V68, P3477, DOI 10.1063/1.1148310; Gabor D., 1992, NOBEL LECT PHYS 1971; Gopal R, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.053001; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Kling MF, 2008, ANNU REV PHYS CHEM, V59, P463, DOI 10.1146/annurev.physchem.59.032607.093532; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; LEWENSTEIN M, 1995, PHYS REV A, V51, P1495, DOI 10.1103/PhysRevA.51.1495; Mairesse Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.213601; Mauritsson J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.073003; Meckel M, 2008, SCIENCE, V320, P1478, DOI 10.1126/science.1157980; Muller HG, 1999, LASER PHYS, V9, P138; Niikura H, 2002, NATURE, V417, P917, DOI 10.1038/nature00787; Paulus GG, 2000, PHYS REV LETT, V84, P3791, DOI 10.1103/PhysRevLett.84.3791; PAULUS GG, 1994, J PHYS B-AT MOL OPT, V27, pL703, DOI 10.1088/0953-4075/27/21/003; Popruzhenko SV, 2008, J MOD OPTIC, V55, P2573, DOI 10.1080/09500340802161881; Shafir D, 2009, NAT PHYS, V5, P412, DOI 10.1038/NPHYS1251; Smirnova O, 2009, NATURE, V460, P972, DOI 10.1038/nature08253; Spanner M, 2004, J PHYS B-AT MOL OPT, V37, pL243, DOI 10.1088/0953-4075/37/12/L02; YANG BR, 1993, PHYS REV LETT, V71, P3770, DOI 10.1103/PhysRevLett.71.3770; Yudin GL, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.033404	25	434	437	8	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					61	64		10.1126/science.1198450	http://dx.doi.org/10.1126/science.1198450			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21163963	Green Submitted			2022-12-28	WOS:000285974000034
J	Cafaro, J; Rieke, F				Cafaro, Jon; Rieke, Fred			Noise correlations improve response fidelity and stimulus encoding	NATURE			English	Article							RETINAL GANGLION-CELLS; FEEDFORWARD INHIBITION; FIRING RATE; CORTEX; VARIABILITY; SELECTIVITY; EXCITATION; NEURONS; INFORMATION; INTEGRATION	Computation in the nervous system often relies on the integration of signals from parallel circuits with different functional properties. Correlated noise in these inputs can, in principle, have diverse and dramatic effects on the reliability of the resulting computations(1-8). Such theoretical predictions have rarely been tested experimentally because of a scarcity of preparations that permit measurement of both the covariation of a neuron's input signals and the effect on a cell's output of manipulating such covariation. Here we introduce a method to measure covariation of the excitatory and inhibitory inputs a cell receives. This method revealed strong correlated noise in the inputs to two types of retinal ganglion cell. Eliminating correlated noise without changing other input properties substantially decreased the accuracy with which a cell's spike outputs encoded light inputs. Thus, covariation of excitatory and inhibitory inputs can be a critical determinant of the reliability of neural coding and computation.	[Rieke, Fred] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Cafaro, Jon; Rieke, Fred] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rieke, F (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	rieke@u.washington.edu			HHMI; NIH [EY-11850]; NATIONAL EYE INSTITUTE [R01EY011850] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Dacey, O. Packer, J. Crook, B. Peterson and T. Haun for providing primate tissue; P. Newman and E. Martinson for technical assistance; T. Azevedo, E. J. Chichilnisky, F. Dunn, G. Murphy, S. Kuo, E. Shea-Brown, M. Shadlen and W. Spain for comments on the manuscript and discussions. Support was provided by HHMI and NIH (EY-11850).	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; Calkins DJ, 1996, NATURE, V381, P613, DOI 10.1038/381613a0; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; DACEY DM, 1992, P NATL ACAD SCI USA, V89, P9666, DOI 10.1073/pnas.89.20.9666; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Leary CJ, 2008, J NEUROSCI, V28, P5481, DOI 10.1523/JNEUROSCI.5041-07.2008; Luna VM, 2008, J NEUROSCI, V28, P8851, DOI 10.1523/JNEUROSCI.2385-08.2008; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; POLYAK S., 1949, DOCUMENTA OPHTHALMOL, V3, P24, DOI 10.1007/BF00162597; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Taylor WR, 2002, J NEUROSCI, V22, P7712; Trong PK, 2008, NAT NEUROSCI, V11, P1343, DOI 10.1038/nn.2199; van Hateren JH, 2001, VISION RES, V41, P1851, DOI 10.1016/S0042-6989(01)00052-9; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545	32	96	97	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					964	U363		10.1038/nature09570	http://dx.doi.org/10.1038/nature09570			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21131948	Green Accepted			2022-12-28	WOS:000285344600047
J	FitzGerald, G				FitzGerald, Garret			Drug development needs a new brand of science	NATURE			English	Editorial Material									Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania	FitzGerald, G (corresponding author), Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.	garret@exchange.upenn.edu	FitzGerald, Garret A/A-4222-2010						0	10	10	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 16	2010	468	7326					869	869		10.1038/468869a	http://dx.doi.org/10.1038/468869a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	695BC	21164436	Bronze			2022-12-28	WOS:000285344600006
J	Kump, LR				Kump, Lee R.			Earth's Second Wind	SCIENCE			English	Editorial Material							OXYGEN; RISE; PGE		Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kump, LR (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	lkump@psu.edu	Kump, Lee/H-8287-2012					Butterfield NJ, 2009, GEOBIOLOGY, V7, P1, DOI 10.1111/j.1472-4669.2009.00188.x; Dahl TW, 2010, P NATL ACAD SCI USA, V107, P17911, DOI 10.1073/pnas.1011287107; DERRY LA, 2010, ANN M GEOL SOC AM DE; Glasspool IJ, 2010, NAT GEOSCI, V3, P627, DOI 10.1038/NGEO923; Hayes JM, 2006, PHILOS T R SOC B, V361, P931, DOI 10.1098/rstb.2006.1840; Payne JL, 2009, P NATL ACAD SCI USA, V106, P24, DOI 10.1073/pnas.0806314106; RUNNEGAR B, 1982, ALCHERINGA, V6, P223, DOI 10.1080/03115518208565415; Schwartzman D., 1999, LIFE TEMPERATURE EAR; Shields G.A., 2007, EEARTH DISCUSSIONS, V2, P69, DOI DOI 10.5194/eed-2-69-2007; Siebert C, 2005, GEOCHIM COSMOCHIM AC, V69, P1787, DOI 10.1016/j.gca.2004.10.006; Wille M, 2007, GEOCHIM COSMOCHIM AC, V71, P2417, DOI 10.1016/j.gca.2007.02.019	11	7	7	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1490	1491		10.1126/science.1199919	http://dx.doi.org/10.1126/science.1199919			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148381				2022-12-28	WOS:000285153500050
J	Schoof, C				Schoof, Christian			Ice-sheet acceleration driven by melt supply variability	NATURE			English	Article							GLACIER SURGE MECHANISM; SUBGLACIAL DRAINAGE; WEST GREENLAND; SURFACE MELT; WATER-LEVEL; FAST-FLOW; VELOCITY; SYSTEM; TEMPERATURE; SWITZERLAND	Increased ice velocities in Greenland(1) are contributing significantly to eustatic sea level rise. Faster ice flow has been associated with ice-ocean interactions in water-terminating outlet glaciers(2) and with increased surface meltwater supply to the ice-sheet bed inland. Observed correlations between surface melt and ice acceleration(2-6) have raised the possibility of a positive feedback in which surface melting and accelerated dynamic thinning reinforce one another(7), suggesting that overall warming could lead to accelerated mass loss. Here I show that it is not simply mean surface melt(4) but an increase in water input variability(8) that drives faster ice flow. Glacier sliding responds to melt indirectly through changes in basal water pressure(9-11), with observations showing that water under glaciers drains through channels at low pressure or through interconnected cavities at high pressure(12-15). Using a model that captures the dynamic switching(12) between channel and cavity drainage modes, I show that channelization and glacier deceleration rather than acceleration occur above a critical rate of water flow. Higher rates of steady water supply can therefore suppress rather than enhance dynamic thinning(16), indicating that the melt/dynamic thinning feedback is not universally operational. Shortterm increases in water input are, however, accommodated by the drainage system through temporary spikes in water pressure. It is these spikes that lead to ice acceleration, which is therefore driven by strong diurnal melt cycles(4,14) and an increase in rain and surface lake drainage events(8,17,18) rather than an increase in mean melt supply(3,4).	Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Schoof, C (corresponding author), Univ British Columbia, Dept Earth & Ocean Sci, 6339 Stores Rd, Vancouver, BC V6T 1Z4, Canada.	cschoof@eos.ubc.ca	Schoof, Christian/A-8587-2013		Canada Research Chairs; NSERC [357193-08]; Canadian Foundation for Climate and Atmospheric Science through the Polar Climate Stability Network	Canada Research Chairs(Canada Research ChairsCGIAR); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Climate and Atmospheric Science through the Polar Climate Stability Network	Thanks to G. Clarke, T. Creyts, G. Flowers, I. Hewitt, R. Hindmarsh, M. Jellinek and V. Radic for comments on the manuscript, and to C. Koziol and M. Jaffrey for discussions. Financial support was provided by the Canada Research Chairs Program, NSERC Discovery Grant 357193-08 and the Canadian Foundation for Climate and Atmospheric Science through the Polar Climate Stability Network.	Bartholomaus TC, 2008, NAT GEOSCI, V1, P33, DOI 10.1038/ngeo.2007.52; Bartholomew I, 2010, NAT GEOSCI, V3, P408, DOI 10.1038/NGEO863; Clarke GKC, 1996, J GEOPHYS RES-SOL EA, V101, P17547, DOI 10.1029/96JB01508; Das SB, 2008, SCIENCE, V320, P778, DOI 10.1126/science.1153360; FOWLER AC, 1987, J GLACIOL, V33, P255, DOI 10.3189/S0022143000008820; Hewitt IJ, 2008, HYDROL PROCESS, V22, P3919, DOI 10.1002/hyp.7029; Hewitt IJ, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006185; Howat IM, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000925; HUBBARD BP, 1995, J GLACIOL, V41, P572, DOI 10.3189/S0022143000034894; IKEN A, 1986, J GLACIOL, V32, P101, DOI 10.3189/S0022143000006936; IKEN A, 1993, J GLACIOL, V39, P15, DOI 10.3189/S0022143000015689; Iverson NR, 1999, J GLACIOL, V45, P31, DOI 10.3189/S0022143000003014; Joughin I, 2008, SCIENCE, V320, P781, DOI 10.1126/science.1153288; KAMB B, 1985, SCIENCE, V227, P469, DOI 10.1126/science.227.4686.469; KAMB B, 1987, J GEOPHYS RES-SOLID, V92, P9083, DOI 10.1029/JB092iB09p09083; Lappegard G, 2006, J GLACIOL, V52, P137, DOI 10.3189/172756506781828908; Luthi M, 2002, J GLACIOL, V48, P369, DOI 10.3189/172756502781831322; Magnusson E, 2010, CRYOSPHERE, V4, P13, DOI 10.5194/tc-4-13-2010; Nye J.F., 1976, J GLACIOL, V17, P181, DOI [10.3189/S002214300001354X, DOI 10.3189/S002214300001354X]; Parizek BR, 2004, QUATERNARY SCI REV, V23, P1013, DOI 10.1016/j.quascirev.2003.12.024; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Ru┬thlisberger H., 1972, J GLACIOL, V11, P177, DOI [10.3189/S0022143000022188, DOI 10.1017/S0022143000022188]; Schoof C, 2005, P ROY SOC A-MATH PHY, V461, P609, DOI 10.1098/rspa.2004.1350; Schuenemann KC, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD011706; Shepherd A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035758; Tarasov L, 1997, J GEOPHYS RES-ATMOS, V102, P21665, DOI 10.1029/97JD01766; Tsai VC, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001474; van de Wal RSW, 2008, SCIENCE, V321, P111, DOI 10.1126/science.1158540; WALDER JS, 1986, J GLACIOL, V32, P439, DOI 10.3189/S0022143000012156; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	30	438	442	3	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2010	468	7325					803	806		10.1038/nature09618	http://dx.doi.org/10.1038/nature09618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21150994				2022-12-28	WOS:000285093700041
J	Sibinga, EMS; Wu, AW				Sibinga, Erica M. S.; Wu, Albert W.			Clinician Mindfulness and Patient Safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROGRAM; ERRORS		[Sibinga, Erica M. S.] Johns Hopkins Sch Med, Dept Pediat, Ctr Child & Community Hlth Res, Div Gen Pediat & Adolescent Med, Baltimore, MD USA; [Wu, Albert W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Wu, Albert W.] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Sibinga, EMS (corresponding author), Ste 4200,Mason F Lord Bldg,Ctr Tower,5200 Eastern, Baltimore, MD 21224 USA.	esibinga@jhmi.edu	Wu, Albert/AAJ-4780-2021					Baer RA, 2003, CLIN PSYCHOL-SCI PR, V10, P125, DOI 10.1093/clipsy/bpg015; Carmody J, 2008, J BEHAV MED, V31, P23, DOI 10.1007/s10865-007-9130-7; Croskerry P, 2003, ACAD MED, V78, P775, DOI 10.1097/00001888-200308000-00003; Croskerry P, 2008, LANCET, V372, P1205, DOI 10.1016/S0140-6736(08)61500-7; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; Groopman J, 2007, DOCTORS THINK; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Krasner MS, 2009, JAMA-J AM MED ASSOC, V302, P1284, DOI 10.1001/jama.2009.1384; Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1350, DOI 10.1001/jama.300.11.1350; Newman-Toker DE, 2009, JAMA-J AM MED ASSOC, V301, P1060, DOI 10.1001/jama.2009.249	10	49	51	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2010	304	22					2532	2533		10.1001/jama.2010.1817	http://dx.doi.org/10.1001/jama.2010.1817			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	691AS	21139116				2022-12-28	WOS:000285053300029
J	McKnight, SL				McKnight, Steven L.			On Getting There from Here	SCIENCE			English	Editorial Material							FAMILY; HIF; PROTEIN; CANCER; DOMAIN	Studies on a variety of interesting biological problems, ranging from circadian rhythm to cancer cell growth to longevity, have begun to give evidence that the physiological state of cells and tissues reflects both the cell's regulatory systems and its state of intermediary metabolism. It is appreciated that the regulatory state of a cell or tissue, as driven by transcription factors and signaling pathways, can impose itself upon the dynamics of metabolic state. It follows that the reciprocal must also be the case, that metabolic state will feed back to impose itself on regulatory state. An appreciation and understanding of this reciprocity may be required to crack open problems in biological research that have heretofore been insoluble.	Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu						Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P319; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	16	80	81	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1338	1339		10.1126/science.1199908	http://dx.doi.org/10.1126/science.1199908			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127243				2022-12-28	WOS:000284902100032
J	Galan, P; Kesse-Guyot, E; Czernichow, S; Briancon, S; Blacher, J; Hercberg, S				Galan, Pilar; Kesse-Guyot, Emmanuelle; Czernichow, Sebastien; Briancon, Serge; Blacher, Jacques; Hercberg, Serge		SU FOL OM3 Collaborative Grp	Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; POLYUNSATURATED FATTY-ACIDS; FOLIC-ACID; FISH-OIL; MYOCARDIAL-INFARCTION; PLASMA HOMOCYSTEINE; STROKE PREVENTION; VASCULAR-DISEASE; RISK-FACTOR; EVENTS	Objective To investigate whether dietary supplementation with B vitamins or omega 3 fatty acids, or both, could prevent major cardiovascular events in patients with a history of ischaemic heart disease or stroke. Design Double blind, randomised, placebo controlled trial; factorial design. Setting Recruitment throughout France via a network of 417 cardiologists, neurologists, and other physicians. Participants 2501 patients with a history of myocardial infarction, unstable angina, or ischaemic stroke. Intervention Daily dietary supplement containing 5-methyltetrahydrofolate (560 mu g), vitamin B-6 (3 mg), and vitamin B-12 (20 mu g) or placebo; and containing omega 3 fatty acids (600 mg of eicosapentanoic acid and docosahexaenoic acid at a ratio of 2: 1) or placebo. Median duration of supplementation was 4.7 years. Main outcome measures Major cardiovascular events, defined as a composite of non-fatal myocardial infarction, stroke, or death from cardiovascular disease. Results Allocation to B vitamins lowered plasma homocysteine concentrations by 19% compared with placebo, but had no significant effects on major vascular events (75 v 82 patients, hazard ratio, 0.90 (95% confidence interval 0.66 to 1.23, P=0.50)). Allocation to omega 3 fatty acids increased plasma concentrations of omega 3 fatty acids by 37% compared with placebo, but also had no significant effect on major vascular events (81 v 76 patients, hazard ratio 1.08 (0.79 to 1.47, P=0.64)). Conclusion This study does not support the routine use of dietary supplements containing B vitamins or omega 3 fatty acids for prevention of cardiovascular disease in people with a history of ischaemic heart disease or ischaemic stroke, at least when supplementation is introduced after the acute phase of the initial event.	[Galan, Pilar; Kesse-Guyot, Emmanuelle; Czernichow, Sebastien; Blacher, Jacques; Hercberg, Serge] Inserm, UMR U557, F-93017 Bobigny, France; [Galan, Pilar; Kesse-Guyot, Emmanuelle; Czernichow, Sebastien; Blacher, Jacques; Hercberg, Serge] Inra, U1125, F-93017 Bobigny, France; [Galan, Pilar; Kesse-Guyot, Emmanuelle; Czernichow, Sebastien; Blacher, Jacques; Hercberg, Serge] Cnam, F-93017 Bobigny, France; [Galan, Pilar; Kesse-Guyot, Emmanuelle; Czernichow, Sebastien; Blacher, Jacques; Hercberg, Serge] Univ Paris 13, CR NH IdF, F-93017 Bobigny, France; [Czernichow, Sebastien; Hercberg, Serge] Hop Avicenne, Dept Sante Publ, F-93017 Bobigny, France; [Briancon, Serge] CHU Nancy, Fac Med, Epidemiol Clin, Ecole Sante Publ,EA 4003, Nancy, France; [Blacher, Jacques] Univ Paris 05, Fac Med, Paris, France; [Blacher, Jacques] AP HP, Paris, France; [Blacher, Jacques] Hop Hotel Dieu, Ctr Diagnost & Therapeut, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; CHU de Nancy; Universite de Lorraine; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Galan, P (corresponding author), SMBH, INSERM INRA CNAM UP13 U557, 74 Rue Marcel Cachin, F-93017 Bobigny, France.	p.galan@uren.smbh.univ-paris13.fr	Pilar, Galan/F-2908-2017; Kesse-Guyot, Emmanuelle/ABH-7347-2020; Blacher, Jacques/F-2685-2017; HERCBERG, Serge/B-4429-2008; Kesse-Guyot, Emmanuelle/F-2692-2017; Kesse-Guyot, Emmanuelle/K-4689-2012; Serge, Hercberg/F-3038-2017	Pilar, Galan/0000-0003-1706-3107; Blacher, Jacques/0000-0003-4860-4279; HERCBERG, Serge/0000-0002-3168-1350; Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Serge, Hercberg/0000-0002-3168-1350	French Ministry of Research [R02010JJ]; Ministry of Health (DGS); Sodexo; Candia; Unilever; Danone; Roche Laboratory; Merck EPROVA GS; Pierre Fabre Laboratory	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Ministry of Health (DGS); Sodexo; Candia; Unilever(Unilever); Danone(Danone Nutricia); Roche Laboratory(Roche Holding); Merck EPROVA GS; Pierre Fabre Laboratory	The SU.FOL.OM3 trial was supported by the French Ministry of Research (R02010JJ), Ministry of Health (DGS), Sodexo, Candia, Unilever, Danone, Roche Laboratory, Merck EPROVA GS, and Pierre Fabre Laboratory.	Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Baker F, 2002, CIRCULATION, V106, P741; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; Brouwer IA, 2009, EUR HEART J, V30, P820, DOI 10.1093/eurheartj/ehp003; Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7; BURR ML, 1989, LANCET, V2, P757; Burr ML, 2003, EUR J CLIN NUTR, V57, P193, DOI 10.1038/sj.ejcn.1601539; Clarke R, 2006, AM HEART J, V151, P282, DOI 10.1016/j.ahj.2005.04.025; Clarke R, 2005, AM J CLIN NUTR, V82, P806, DOI 10.1093/ajcn/82.4.806; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; Clarke R, ARCH INTERN IN PRESS; Danesh J, 1998, J Cardiovasc Risk, V5, P229, DOI 10.1097/00043798-199808000-00004; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Erkkila AT, 2003, AM J CLIN NUTR, V78, P65, DOI 10.1093/ajcn/78.1.65; Ford ES, 2002, INT J EPIDEMIOL, V31, P59, DOI 10.1093/ije/31.1.59; Galan P, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-35; Hankey GJ, 2010, LANCET NEUROL, V9, P855, DOI 10.1016/S1474-4422(10)70187-3; He K, 2004, STROKE, V35, P169, DOI 10.1161/01.STR.0000106762.55994.86; He K, 2004, CIRCULATION, V109, P2705, DOI 10.1161/01.CIR.0000132503.19410.6B; Hooper L, 2004, Cochrane Database Syst Rev, pCD003177; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Jamison RL, 2007, JAMA-J AM MED ASSOC, V298, P1163, DOI 10.1001/jama.298.10.1163; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Lange H, 2004, NEW ENGL J MED, V350, P2673, DOI 10.1056/NEJMoa032845; London B, 2007, CIRCULATION, V116, pE320, DOI 10.1161/CIRCULATIONAHA.107.712984; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; MCCULLY KS, 1969, AM J PATHOL, V56, P111; Morrison HI, 1996, JAMA-J AM MED ASSOC, V275, P1893, DOI 10.1001/jama.275.24.1893; Pentieva K, 2004, J NUTR, V134, P580, DOI 10.1093/jn/134.3.580; Raitt MH, 2005, JAMA-J AM MED ASSOC, V293, P2884, DOI 10.1001/jama.293.23.2884; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; Schnyder G, 2001, NEW ENGL J MED, V345, P1593, DOI 10.1056/NEJMoa011364; Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, 2010, JAMA-J AM MED ASSOC, V24, P2485; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Wald DS, 2006, BMJ-BRIT MED J, V333, P1114, DOI 10.1136/bmj.39000.486701.68; Wang CC, 2006, AM J CLIN NUTR, V84, P5, DOI 10.1093/ajcn/84.1.5; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Yusuf S, 2000, NEW ENGL J MED, V342, P145	48	323	363	2	38	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2010	341								c6273	10.1136/bmj.c6273	http://dx.doi.org/10.1136/bmj.c6273			25	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845KC	21115589	Green Published, hybrid			2022-12-28	WOS:000296820600001
J	DeFelipe, J				DeFelipe, Javier			From the Connectome to the Synaptome: An Epic Love Story	SCIENCE			English	Review							HUMAN BRAIN; TRANSMISSION; SYNAPSE; NEURONS; CAJAL	A major challenge in neuroscience is to decipher the structural layout of the brain. The term "connectome" has recently been proposed to refer to the highly organized connection matrix of the human brain. However, defining how information flows through such a complex system represents so difficult a task that it seems unlikely it could be achieved in the near future or, for the most pessimistic, perhaps ever. Circuit diagrams of the nervous system can be considered at different levels, although they are surely impossible to complete at the synaptic level. Nevertheless, advances in our capacity to marry macro-and microscopic data may help establish a realistic statistical model that could describe connectivity at the ultrastructural level, the "synaptome," giving us cause for optimism.	[DeFelipe, Javier] CSIC, Inst Cajal, Madrid, Spain; [DeFelipe, Javier] Univ Politecn Madrid, Ctr Tecnol Biomed, Lab Circuitos Corticales, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB)	DeFelipe, J (corresponding author), CSIC, Inst Cajal, Madrid, Spain.	defelipe@cajal.csic.es	DEFELIPE, JAVIER/D-1195-2014	DEFELIPE, JAVIER/0000-0001-5484-0660	Spanish Ministry of Science and Innovation	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been supported by the Spanish Ministry of Science and Innovation (Cajal Blue Brain Project).	Alonso-Nanclares L, 2008, P NATL ACAD SCI USA, V105, P14615, DOI 10.1073/pnas.0803652105; Bartelmez GW, 1933, J COMP NEUROL, V57, P401, DOI 10.1002/cne.900570303; Benavides-Piccione R, 2005, CEREB CORTEX, V15, P1584, DOI 10.1093/cercor/bhi036; Bennett MVL, 2000, BRAIN RES REV, V32, P16, DOI 10.1016/S0165-0173(99)00065-X; Binzegger T, 2009, NEURAL NETWORKS, V22, P1071, DOI 10.1016/j.neunet.2009.07.011; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bodian D, 1940, J COMP NEUROL, V73, P323, DOI 10.1002/cne.900730205; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; DeFelipe J., 2010, CAJALS BUTTERFLIES S, DOI [10.1093/acprof:oso/9780195392708.001.0001, DOI 10.1093/ACPROF:OSO/9780195392708.001.0001]; Descarries L, 2000, PROG BRAIN RES, V125, P27; Fuxe K, 2007, BRAIN RES REV, V55, P17, DOI 10.1016/j.brainresrev.2007.02.009; Jones EG, 2007, BRAIN RES REV, V55, P248, DOI 10.1016/j.brainresrev.2007.06.001; Koch C, 2000, NAT NEUROSCI, V3, P1171, DOI 10.1038/81444; LI A, 2010, SCIENCE         1104, DOI DOI 10.1126/SCIENCE.1191776; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Merchan-Perez A, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.018.2009; Nikolenko V, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.005.2008; PALADE GE, 1954, ANAT REC, V118, P335; Perea G, 2010, BRAIN RES REV, V63, P93, DOI 10.1016/j.brainresrev.2009.10.005; Ramon y Cajal S, 1917, RECUERDOS MI VIDA; Ramon y Cajal S S, 1888, REV TRIM HISTOL NORM, V1, P1; ROBERTSON JD, 1953, P SOC EXP BIOL MED, V82, P219; SHEPHERD GM, 2004, ENCY NEUROSCIENCE; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Toga AW, 2006, NAT REV NEUROSCI, V7, P952, DOI 10.1038/nrn2012	27	111	115	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2010	330	6008					1198	1201		10.1126/science.1193378	http://dx.doi.org/10.1126/science.1193378			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109663				2022-12-28	WOS:000284613700030
J	Logothetis, NK				Logothetis, Nikos K.			Bold claims for optogenetics	NATURE			English	Letter							SYNAPTIC ORGANIZATION; NEURONS; CORTEX; FMRI; EXCITATION; RESPONSES; CELLS; CAT		[Logothetis, Nikos K.] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Logothetis, Nikos K.] Univ Manchester, Manchester, Lancs, England	Max Planck Society; University of Manchester	Logothetis, NK (corresponding author), Max Planck Inst Biol Cybernet, Tubingen, Germany.	nikos.logothetis@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019					Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P659, DOI 10.1113/jphysiol.1991.sp018730; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; FERSTER D, 1985, J PHYSIOL-LONDON, V367, P233, DOI 10.1113/jphysiol.1985.sp015822; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; JUEPTNER M, 1995, NEUROIMAGE, V2, P148, DOI 10.1006/nimg.1995.1017; KELLER A, 1993, CEREB CORTEX, V3, P430, DOI 10.1093/cercor/3.5.430; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; PHILLIPS C. G., 1959, QUART JOUR EXPTL PHYSIOL, V44, P1; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1	15	32	32	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 25	2010	468	7323					E3	E4		10.1038/nature09532	http://dx.doi.org/10.1038/nature09532			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107378				2022-12-28	WOS:000284584200001
J	Church, TS; Blair, SN; Cocreham, S; Johannsen, N; Johnson, W; Kramer, K; Mikus, CR; Myers, V; Nauta, M; Rodarte, RQ; Sparks, L; Thompson, A; Earnest, CP				Church, Timothy S.; Blair, Steven N.; Cocreham, Shannon; Johannsen, Neil; Johnson, William; Kramer, Kimberly; Mikus, Catherine R.; Myers, Valerie; Nauta, Melissa; Rodarte, Ruben Q.; Sparks, Lauren; Thompson, Angela; Earnest, Conrad P.			Effects of Aerobic and Resistance Training on Hemoglobin A(1c) Levels in Patients With Type 2 Diabetes A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIORESPIRATORY FITNESS; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; GLYCEMIC CONTROL; BODY-MASS; EXERCISE; MORTALITY; RISK; MEN; COMPLICATIONS	Context Exercise guidelines for individuals with diabetes include both aerobic and resistance training although few studies have directly examined this exercise combination. Objective To examine the benefits of aerobic training alone, resistance training alone, and a combination of both on hemoglobin A(1c) (HbA(1c)) in individuals with type 2 diabetes. Design, Setting, and Participants A randomized controlled trial in which 262 sedentary men and women in Louisiana with type 2 diabetes and HbA(1c) levels of 6.5% or higher were enrolled in the 9-month exercise program between April 2007 and August 2009. Intervention Forty-one participants were assigned to the nonexercise control group, 73 to resistance training 3 days a week, 72 to aerobic exercise in which they expended 12 kcal/kg per week; and 76 to combined aerobic and resistance training in which they expended 10 kcal/kg per week and engaged in resistance training twice a week. Main Outcome Change in HbA(1c) level. Secondary outcomes included measures of anthropometry and fitness. Results The study included 63.0% women and 47.3% nonwhite participants who were a mean (SD) age of 55.8 years (8.7 years) with a baseline HbA(1c) level of 7.7% (1.0%). Compared with the control group, the absolute mean change in HbA(1c) in the combination training exercise group was -0.34% (95% confidence interval [CI], -0.64% to -0.03%; P=.03). The mean changes in HbA(1c) were not statistically significant in either the resistance training (-0.16%; 95% CI, -0.46% to 0.15%; P=.32) or the aerobic (-0.24%; 95% CI, -0.55% to 0.07%; P=.14) groups compared with the control group. Only the combination exercise group improved maximum oxygen consumption (mean, 1.0 mL/kg per min; 95% CI, 0.5-1.5, P<.05) compared with the control group. All exercise groups reduced waist circumference from -1.9 to -2.8 cm compared with the control group. The resistance training group lost a mean of -1.4 kg fat mass (95% CI, -2.0 to -0.7 kg; P<.05) and combination training group lost a mean of -1.7 (-2.3 to -1.1 kg; P<.05) compared with the control group. Conclusions Among patients with type 2 diabetes mellitus, a combination of aerobic and resistance training compared with the nonexercise control group improved HbA(1c) levels. This was not achieved by aerobic or resistance training alone.	[Church, Timothy S.; Cocreham, Shannon; Johannsen, Neil; Johnson, William; Kramer, Kimberly; Myers, Valerie; Nauta, Melissa; Rodarte, Ruben Q.; Thompson, Angela; Earnest, Conrad P.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Blair, Steven N.] Univ S Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Mikus, Catherine R.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA; [Sparks, Lauren] Maastricht Univ, Med Ctr, Dept Human Biol, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Missouri System; University of Missouri Columbia; Maastricht University; Maastricht University Medical Centre (MUMC)	Church, TS (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	tim.church@pbrc.edu	Hug, Balthasar L./G-1568-2010; Thompson-Paul, Angela/N-7067-2016; Earnest, Conrad P./M-6849-2017; Earnest, Conrad P/A-7860-2009	Thompson-Paul, Angela/0000-0003-1186-9150; Earnest, Conrad P./0000-0002-6546-1268; 	American Heart Association; National Institutes of Health [DK068298]; Sanofi Aventis; Orexigen; Arena; Amylin; Human Kinetics; Department of Defense; Body Media; Coca-Cola; HART-D grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068298] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanofi Aventis(Sanofi-Aventis); Orexigen; Arena(Australian Renewable Energy Agency (ARENA)); Amylin; Human Kinetics; Department of Defense(United States Department of Defense); Body Media; Coca-Cola; HART-D grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr Church reported that he receives honoraria for lectures from scientific, educational, and lay groups; has received research funding from the American Heart Association and the National Institutes of Health, oversaw study sites for large pharmaceutical trials funded by Sanofi Aventis, Orexigen, Arena, and Amylin; is a member of the Jenny Craig medical advisory board; has served as a consultant to Technogym, Trestle Tree, Neuliven Health, and Coca-Cola; and serves as a paid expert for EverydayHealth.com. Dr Blair reported that he receives book royalties (<$5000 annually) from publisher Human Kinetics; honoraria for service on the scientific/medical advisory Boards for Alere, Technogym, Santech, and Jenny Craig; and honoraria for lectures and consultations from scientific, educational, and lay groups. During the past 5-year period he reported that he has received research grants from the National Institutes of Health, Department of Defense, Body Media, and Coca-Cola. Dr Earnest reported that he receives honoraria for lectures from scientific, educational, and lay groups. No other disclosures were reported.; This work was supported by grant DK068298 from the National Institutes of Health.; Contributions: We thank all HART-D participants and the Pennington Biomedical Research Center staff members Gina Billiot, Sheletta Donatto, RD, and Ronald Monce, PA-C, for their hard work and commitment. In addition we thank the HART-D data and safety monitoring board and Scientific Advisory Board, and Pennington Biomedical Research Center faculty members William Cefalu, MD, Steve Smith, MD (now at Burnham Institute in Orlando, Florida), and Jennifer Rood, PhD, for their scientific guidance both in planning and conducting the study. Part of Ms Donatto and Mr Monce's salaries were supported through the HART-D grant, and Dr. Rood's laboratory was reimbursed for clinical laboratory measures. Members of the data and safety monitoring board were provided modest honorariums for their time. Drs Cefalu and Dr Smith and the Scientific Advisory Board received no compensation for their contributions.	Agel J, 2005, AM J SPORT MED, V33, P524, DOI 10.1177/0363546504269937; American College., 2006, ACSMS GUID EX TEST P; [Anonymous], 2007, DIABETES CARE, V30, pS4, DOI [10.2337/dc07-S004, DOI 10.2337/DC07-S004]; BLOCK G, 1992, J AM DIET ASSOC, V92, P686; Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218; Church TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004515; Church TS, 2005, ARCH INTERN MED, V165, P2114, DOI 10.1001/archinte.165.18.2114; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; Goldberg PA, 2004, DIABETES CARE, V27, P461, DOI 10.2337/diacare.27.2.461; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; King NA, 2008, INT J OBESITY, V32, P177, DOI 10.1038/sj.ijo.0803712; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Marwick TH, 2009, CIRCULATION, V119, P3244, DOI 10.1161/CIRCULATIONAHA.109.192521; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Ross R, 2001, MED SCI SPORT EXER, V33, pS521, DOI 10.1097/00005768-200106001-00023; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; Snowling NJ, 2006, DIABETES CARE, V29, P2518, DOI 10.2337/dc06-1317; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A	20	541	564	1	101	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2010	304	20					2253	2262		10.1001/jama.2010.1710	http://dx.doi.org/10.1001/jama.2010.1710			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KI	21098771	Bronze, Green Accepted			2022-12-28	WOS:000284548400024
J	Quinn, TC; Serwadda, D				Quinn, Thomas C.; Serwadda, David			The future of HIV/AIDS in Africa: a shared responsibility	LANCET			English	Editorial Material									[Quinn, Thomas C.] NIAID, Bethesda, MD 20892 USA; [Quinn, Thomas C.] Johns Hopkins Univ, Ctr Global Hlth, Baltimore, MD 21205 USA; [Serwadda, David] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Makerere University	Quinn, TC (corresponding author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.	tquinn@jhmi.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001040, ZIAAI000361] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Institute of Medicine (US) Committee on Envisioning a Strategy for the Long-Term Burden of HIV/AIDS: African Needs and U.S. Interests, 2011, PREP FUT HIV AIDS AF; *UNAIDS, 2009, AIDS EP UPD	2	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1133	1134		10.1016/S0140-6736(10)62183-6	http://dx.doi.org/10.1016/S0140-6736(10)62183-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	750IH	21126758				2022-12-28	WOS:000289539300008
J	Ginsburg, PB				Ginsburg, Paul B.			Rapidly Evolving Physician-Payment Policy - More Than the SGR	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Studying Hlth Syst Change, Washington, DC USA		Ginsburg, PB (corresponding author), Ctr Studying Hlth Syst Change, Washington, DC USA.							*CBO, CBO EST CHANG NET FE; *FED HOSP INS BOAR, 2010, 2010 ANN REP BOARDS; Ginsburg PB, 2007, NEW ENGL J MED, V356, P1201, DOI 10.1056/NEJMp068272; GINSBURG PB, 2008, BITTER MED PRESCRIPT; *MED PAYM ADV COMM, 2006, MED PAYM POL C; Zuckerman S, 2009, HEALTH AFFAIR, V28, pW335, DOI 10.1377/hlthaff.28.2.w335	6	19	19	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					172	176		10.1056/NEJMhpr1004028	http://dx.doi.org/10.1056/NEJMhpr1004028			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	705NJ	21142529				2022-12-28	WOS:000286142900014
J	Bozin, ES; Malliakas, CD; Souvatzis, P; Proffen, T; Spaldin, NA; Kanatzidis, MG; Billinge, SJL				Bozin, Emil S.; Malliakas, Christos D.; Souvatzis, Petros; Proffen, Thomas; Spaldin, Nicola A.; Kanatzidis, Mercouri G.; Billinge, Simon J. L.			Entropically Stabilized Local Dipole Formation in Lead Chalcogenides	SCIENCE			English	Article								We report the observation of local structural dipoles that emerge from an undistorted ground state on warming, in contrast to conventional structural phase transitions in which distortions emerge on cooling. Using experimental and theoretical probes of the local structure, we demonstrate this behavior in binary lead chalcogenides, which were believed to adopt the ideal, undistorted rock-salt structure at all temperatures. The behavior is consistent with a simple thermodynamic model in which the emerging dipoles are stabilized in the disordered state at high temperature due to the extra configurational entropy despite the fact that the undistorted structure has lower internal energy. Our findings shed light on the anomalous electronic and thermoelectric properties of the lead chalcogenides. Similar searches may show that the phenomenon is more widespread.	[Bozin, Emil S.; Billinge, Simon J. L.] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA; [Malliakas, Christos D.; Kanatzidis, Mercouri G.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Souvatzis, Petros] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Proffen, Thomas] Los Alamos Natl Lab, Lujan Neutron Scattering Ctr, Los Alamos, NM 87545 USA; [Spaldin, Nicola A.] ETH, Dept Mat, Zurich, Switzerland; [Kanatzidis, Mercouri G.] Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA; [Billinge, Simon J. L.] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Northwestern University; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Swiss Federal Institutes of Technology Domain; ETH Zurich; United States Department of Energy (DOE); Argonne National Laboratory; Columbia University	Billinge, SJL (corresponding author), Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA.	sb2896@columbia.edu	Bozin, Emil/E-4679-2011; Bozin, Emil/AAB-4551-2020; Spaldin, Nicola A/A-1017-2010; Proffen, Thomas/B-3585-2009	Spaldin, Nicola A/0000-0003-0709-9499; Proffen, Thomas/0000-0002-1408-6031; Billinge, Simon/0000-0002-9734-4998	U.S. Department of Energy, Office of Basic Energy Sciences (DOE-BES) [DE-AC02-98CH10886]; Office of Naval Research; NSF [DMR-0940420]	U.S. Department of Energy, Office of Basic Energy Sciences (DOE-BES)(United States Department of Energy (DOE)); Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF))	S.J.B. and E. B. thank J. Richardson for his early support and enthusiasm for the project and dedicate the paper to him. We acknowledge useful discussions with A. Millis, P. Allen, R. Cohen, C. Farrow, and J. Hill. Work in the Billinge group was supported by the U.S. Department of Energy, Office of Basic Energy Sciences (DOE-BES), under contract DE-AC02-98CH10886. Work in the Kanatzidis group was supported by the Office of Naval Research. Work in the Spaldin group was supported by the NSF under award DMR-0940420. The neutron diffraction measurements were carried out at the Lujan Center at Los Alamos National Laboratory, and the x-ray experiments were carried out at the Advanced Photon Source, Argonne National Laboratory, both of which are supported by DOE-BES, and the calculations were performed at the San Diego Supercomputer Center, which is supported by NSF.	An JM, 2008, SOLID STATE COMMUN, V148, P417, DOI 10.1016/j.ssc.2008.09.027; Billinge SJL, 2007, SCIENCE, V316, P561, DOI 10.1126/science.1135080; Debye P, 1912, ANN PHYS-BERLIN, V39, P789; Egami T, 2003, PERGAMON MATER SER, V7, pVII; Jeong IK, 1999, J PHYS CHEM A, V103, P921, DOI 10.1021/jp9836978; JOFFE AF, 1956, CAN J PHYS, V34, P1342, DOI 10.1139/p56-150; Jona F., 1993, FERROELECTRIC CRYSTA; Kwei G.-H., 1995, Ferroelectrics, V164, P57, DOI 10.1080/00150199508221830; KWEI GH, 1993, J PHYS CHEM-US, V97, P2368, DOI 10.1021/j100112a043; Lin H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.174113; Rosenfeld H. D., 1995, Ferroelectrics, V164, P133, DOI 10.1080/00150199508221835; Sootsman JR, 2008, ANGEW CHEM INT EDIT, V47, P8618, DOI 10.1002/anie.200803934; Souvatzis P, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.095901; TAUBER RN, 1966, J APPL PHYS, V37, P4855, DOI 10.1063/1.1708150; Waghmare UV, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.125111; Walter P, 2006, NANO LETT, V6, P2215, DOI 10.1021/nl061493u; Warren B, 1990, XRAY DIFFRACTION, P253; Yu B. A. E., 1970, SEMICONDUCTING LEAD, V5	19	268	272	8	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1660	1663		10.1126/science.1192759	http://dx.doi.org/10.1126/science.1192759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164012				2022-12-28	WOS:000285390500062
J	Prentice, IC				Prentice, Iain Colin			The Burning Issue	SCIENCE			English	Editorial Material							FIRE; CLIMATE; EMISSIONS; MODEL; AREA		Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia	Macquarie University	Prentice, IC (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia.	colin.prentice@mq.edu.au						Archibald S, 2009, GLOBAL CHANGE BIOL, V15, P613, DOI 10.1111/j.1365-2486.2008.01754.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Ferretti DF, 2005, SCIENCE, V309, P1714, DOI 10.1126/science.1115193; Giglio L, 2010, BIOGEOSCIENCES, V7, P1171, DOI 10.5194/bg-7-1171-2010; Harrison SP, 2010, INT YEAR PLANET EART, P21, DOI 10.1007/978-90-481-8716-4_3; Kloster S, 2010, BIOGEOSCIENCES, V7, P1877, DOI 10.5194/bg-7-1877-2010; Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102; Marlon JR, 2008, NAT GEOSCI, V1, P697, DOI 10.1038/ngeo313; Pechony O, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011927; Scholze M, 2006, P NATL ACAD SCI USA, V103, P13116, DOI 10.1073/pnas.0601816103; Thonicke K, 2010, BIOGEOSCIENCES, V7, P1991, DOI 10.5194/bg-7-1991-2010; van der Werf GR, 2008, P NATL ACAD SCI USA, V105, P20350, DOI 10.1073/pnas.0803375105; Wang Z, 2010, SCIENCE, V330, P1663, DOI 10.1126/science.1197257	13	18	19	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2010	330	6011					1636	1637		10.1126/science.1199809	http://dx.doi.org/10.1126/science.1199809			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164005				2022-12-28	WOS:000285390500053
J	Tagami, S; Sekine, S; Kumarevel, T; Hino, N; Murayama, Y; Kamegamori, S; Yamamoto, M; Sakamoto, K; Yokoyama, S				Tagami, Shunsuke; Sekine, Shun-ichi; Kumarevel, Thirumananseri; Hino, Nobumasa; Murayama, Yuko; Kamegamori, Syunsuke; Yamamoto, Masaki; Sakamoto, Kensaku; Yokoyama, Shigeyuki			Crystal structure of bacterial RNA polymerase bound with a transcription inhibitor protein	NATURE			English	Article							3.3 ANGSTROM RESOLUTION; II ELONGATION COMPLEX; THERMUS-THERMOPHILUS; ESCHERICHIA-COLI; CRYSTALLOGRAPHIC ANALYSIS; ACTIVE-CENTER; COILED-COIL; GRE FACTORS; AMINO-ACID; NMR SYSTEM	The multi-subunit DNA-dependent RNA polymerase (RNAP) is the principal enzyme of transcription for gene expression. Transcription is regulated by various transcription factors. Gre factor homologue 1 (Gfh1), found in the Thermus genus, is a close homologue of the well-conserved bacterial transcription factor GreA, and inhibits transcription initiation and elongation by binding directly to RNAP(1-8). The structural basis of transcription inhibition by Gfh1 has remained elusive, although the crystal structures of RNAP and Gfh1 have been determined separately(6-9). Here we report the crystal structure of Thermus thermophilus RNAP complexed with Gfh1. The amino-terminal coiled-coil domain of Gfh1 fully occludes the channel formed between the two central modules of RNAP; this channel would normally be used for nucleotide triphosphate (NTP) entry into the catalytic site. Furthermore, the tip of the coiled-coil domain occupies the NTP beta-gamma phosphate-binding site. The NTP-entry channel is expanded, because the central modules are 'ratcheted' relative to each other by similar to 7 degrees, as compared with the previously reported elongation complexes. This 'ratcheted state' is an alternative structural state, defined by a newly acquired contact between the central modules. Therefore, the shape of Gfh1 is appropriate to maintain RNAP in the ratcheted state. Simultaneously, the ratcheting expands the nucleic-acid-binding channel, and kinks the bridge helix, which connects the central modules. Taken together, the present results reveal that Gfh1 inhibits transcription by preventing NTP binding and freezing RNAP in the alternative structural state. The ratcheted state might also be associated with other aspects of transcription, such as RNAP translocation and transcription termination.	[Tagami, Shunsuke; Sekine, Shun-ichi; Murayama, Yuko; Kamegamori, Syunsuke; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Tagami, Shunsuke; Sekine, Shun-ichi; Hino, Nobumasa; Murayama, Yuko; Kamegamori, Syunsuke; Sakamoto, Kensaku; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Sekine, Shun-ichi; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Struct Biol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Kumarevel, Thirumananseri] RIKEN SPring 8 Ctr, Harima Inst, Struct & Mol Biol Lab, Sayo, Hyogo 6795148, Japan; [Yamamoto, Masaki] RIKEN SPring 8 Ctr, Harima Inst, SR Life Sci Instrumentat Unit, Sayo, Hyogo 6795148, Japan	University of Tokyo; RIKEN; University of Tokyo; RIKEN; RIKEN	Sekine, S (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	sekine@biochem.s.u-tokyo.ac.jp; yokoyama@biochem.s.u-tokyo.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Sekine, Shun-ichi/N-5450-2015; Kumarevel, Thirumananseri/C-6275-2012; Yamamoto, Masaki/B-7844-2015; Sakamoto, Kensaku/N-7496-2015; Tagami, Shunsuke/N-5057-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338; Sekine, Shun-ichi/0000-0001-8174-8704; Kumarevel, Thirumananseri/0000-0001-9326-6585; Yamamoto, Masaki/0000-0002-1311-1768; Sakamoto, Kensaku/0000-0003-2866-5031; Tagami, Shunsuke/0000-0002-1720-3627; Hino, Nobumasa/0000-0002-7072-1183	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; JSPS Global Centers of Excellence; Grants-in-Aid for Scientific Research [22570175] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS Global Centers of Excellence; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is based on experiments performed at SPring-8 (with the approval of the Japan Synchrotron Radiation Research Institute) and at the Swiss Light Source (SLS). We thank N. Shimizu for supporting our data collection at SPring-8 beamline BL41XU; T. Tomizaki and C. Schulze-Briese for supporting our data collection at SLS beamline X06SA; and Y. Fujii for assisting with our data collection and for comments. We thank T. Tanaka and K. Sakamoto for assistance in protein preparation. This work was supported in part by a Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Young Scientists (to S.-i.S.), a JSPS Grant-in-Aid for Scientific Research (to S.i.-S. and S. Y.), and the Targeted Proteins Research Program (TPRP), the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. S. T. was supported by the JSPS Global Centers of Excellence Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms).	Abyzov A, 2010, PROTEINS, V78, P309, DOI 10.1002/prot.22544; BORUKHOV S, 1992, P NATL ACAD SCI USA, V89, P8899, DOI 10.1073/pnas.89.19.8899; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chumpolkulwong Namthip, 2006, Journal of Structural and Functional Genomics, V7, P31, DOI 10.1007/s10969-006-9007-y; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Darst SA, 2002, P NATL ACAD SCI USA, V99, P4296, DOI 10.1073/pnas.052054099; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Hogan BP, 2002, J BIOL CHEM, V277, P967, DOI 10.1074/jbc.M108737200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kashkina E, 2006, NUCLEIC ACIDS RES, V34, P4036, DOI 10.1093/nar/gkl559; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Lamour V, 2006, J MOL BIOL, V356, P179, DOI 10.1016/j.jmb.2005.10.083; Laptenko O, 2003, METHOD ENZYMOL, V371, P219; Laptenko O, 2006, EMBO J, V25, P2131, DOI 10.1038/sj.emboj.7601094; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukhopadhyay J, 2008, CELL, V135, P295, DOI 10.1016/j.cell.2008.09.033; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Sakamoto K, 2009, STRUCTURE, V17, P335, DOI 10.1016/j.str.2009.01.008; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Symersky J, 2006, J BIOL CHEM, V281, P1309, DOI 10.1074/jbc.C500405200; Tagami S, 2010, ACTA CRYSTALLOGR F, V66, P64, DOI 10.1107/S1744309109049215; Tan Lin, 2008, J Biol, V7, P40, DOI 10.1186/jbiol98; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Vassylyeva MN, 2007, EMBO REP, V8, P1038, DOI 10.1038/sj.embor.7401079; Vassylyeva MN, 2002, ACTA CRYSTALLOGR D, V58, P1497, DOI 10.1107/S0907444902011770; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	41	119	123	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					978	U282		10.1038/nature09573	http://dx.doi.org/10.1038/nature09573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21124318				2022-12-28	WOS:000285344600050
J	Hankinson, AL; Daviglus, ML; Bouchard, C; Carnethon, M; Lewis, CE; Schreiner, PJ; Liu, KA; Sidney, S				Hankinson, Arlene L.; Daviglus, Martha L.; Bouchard, Claude; Carnethon, Mercedes; Lewis, Cora E.; Schreiner, Pamela J.; Liu, Kiang; Sidney, Stephen			Maintaining a High Physical Activity Level Over 20 Years and Weight Gain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; ENERGY-BALANCE; PUBLIC-HEALTH; UNITED-STATES; FOLLOW-UP; EXERCISE; MEN; OBESITY; ADULTS; ASSOCIATIONS	Context Data supporting physical activity guidelines to prevent long-term weight gain are sparse, particularly during the period when the highest risk of weight gain occurs. Objective To evaluate the relationship between habitual activity levels and changes in body mass index (BMI) and waist circumference over 20 years. Design, Setting, and Participants The Coronary Artery Risk Development in Young Adults (CARDIA) study is a prospective longitudinal study with 20 years of follow-up, 1985-1986 to 2005-2006. Habitual activity was defined as maintaining high, moderate, and low activity levels based on sex-specific tertiles of activity scores at baseline. Participants comprised a population-based multicenter cohort (Chicago, Illinois; Birmingham, Alabama; Minneapolis, Minnesota; and Oakland, California) of 3554 men and women aged 18 to 30 years at baseline. Main Outcome Measures Average annual changes in BMI and waist circumference. Results Over 20 years, maintaining high levels of activity was associated with smaller gains in BMI and waist circumference compared with low activity levels after adjustment for race, baseline BMI, age, education, cigarette smoking status, alcohol use, and energy intake. Men maintaining high activity gained 2.6 fewer kilograms per year (+0.15 BMI units; 95% confidence interval [CI], 0.11-0.18 vs +0.20 in the lower activity group; 95% CI, 0.17-0.23), and women maintaining higher activity gained 6.1 fewer kilograms per year (+0.17 BMI units; 95% CI, 0.12-0.21 vs +0.30 in the lower activity group; 95% CI, 0.25-0.34). Men maintaining high activity gained 3.1 fewer centimeters in waist circumference per year (+0.52 cm; 95% CI, 0.43-0.61 cm vs 0.67 cm in the lower activity group; 95% CI, 0.60-0.75 cm) and women maintaining higher activity gained 3.8 fewer centimeters per year (+0.49 cm; 95% CI, 0.39-0.58 cm vs 0.67 cm in the lower activity group; 95% CI, 0.60-0.75 cm). Conclusion Maintaining high activity levels through young adulthood may lessen weight gain as young adults transition to middle age, particularly in women. JAMA. 2010;304(23):2603-2610 www.jama.com	[Hankinson, Arlene L.; Daviglus, Martha L.; Carnethon, Mercedes; Liu, Kiang] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Bouchard, Claude] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Lewis, Cora E.] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Schreiner, Pamela J.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Sidney, Stephen] Kaiser Permanente, Div Res, Oakland, CA USA	Northwestern University; Feinberg School of Medicine; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities; Kaiser Permanente	Hankinson, AL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA.	alhankinson@northwestern.edu	s, s/GYR-2278-2022; Bouchard, Claude/A-7637-2009; Bouchard, Claude/AAE-2035-2019; s, s/HHD-0404-2022; s, s/HIK-1178-2022	Bouchard, Claude/0000-0002-0048-491X; Schreiner, Pamela/0000-0002-9920-6257; Carnethon, Mercedes/0000-0001-7035-0848	National Heart, Lung, and Blood Institute [N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, R01 HL078972]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048048, N01HC048049, N01HC048050, N01HC048047, N01HC095095] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048050, R29HL048048, R01HL078972, R01HL048048, R01HL048049] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the following contracts and grants from the National Heart, Lung, and Blood Institute: N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, and R01 HL078972.	Ball K, 2001, INT J OBESITY, V25, P914, DOI 10.1038/sj.ijo.0801622; Daviglus ML, 2004, JAMA-J AM MED ASSOC, V292, P2743, DOI 10.1001/jama.292.22.2743; Di Pietro L, 2004, INT J OBESITY, V28, P1541, DOI 10.1038/sj.ijo.0802821; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Droyvold WB, 2004, INT J OBESITY, V28, P410, DOI 10.1038/sj.ijo.0802569; Erlichman J, 2002, Obes Rev, V3, P273, DOI 10.1046/j.1467-789X.2002.00078.x; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fogelholm M, 2000, Obes Rev, V1, P95, DOI 10.1046/j.1467-789x.2000.00016.x; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Gordon-Larsen P, 2009, AM J CLIN NUTR, V89, P19, DOI 10.3945/ajcn.2008.26147; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Jacobs David R Jr, 1989, J Cardiopulm Rehabil, V9, P448, DOI 10.1097/00008483-198911000-00003; Jakicic JM, 2003, JAMA-J AM MED ASSOC, V290, P1323, DOI 10.1001/jama.290.10.1323; Jakicic JM, 2008, ARCH INTERN MED, V168, P1550, DOI 10.1001/archinte.168.14.1550; Kimm SYS, 2005, LANCET, V366, P301, DOI 10.1016/S0140-6736(05)66837-7; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Lee IM, 2010, JAMA-J AM MED ASSOC, V303, P1173, DOI 10.1001/jama.2010.312; Littman AJ, 2005, INT J OBESITY, V29, P524, DOI 10.1038/sj.ijo.0802886; Liu Kiang, 1994, Ethnicity and Disease, V4, P15; McTiernan A, 2007, OBESITY, V15, P1496, DOI 10.1038/oby.2007.178; Parker ED, 2007, AM J PUBLIC HEALTH, V97, P703, DOI 10.2105/AJPH.2004.055889; Physical Activity Guidelines Committee, 2008, PHYS ACT GUID ADV CO; Pratt M, 1999, MED SCI SPORT EXER, V31, pS526, DOI 10.1097/00005768-199911001-00007; Ross R, 2001, MED SCI SPORT EXER, V33, pS521, DOI 10.1097/00005768-200106001-00023; Saris W H M, 2003, Obes Rev, V4, P101, DOI 10.1046/j.1467-789X.2003.00101.x; Schmitz KH, 2000, INT J OBESITY, V24, P1475, DOI 10.1038/sj.ijo.0801415; Sheehan TJ, 2003, INT J OBESITY, V27, P498, DOI 10.1038/sj.ijo.0802263; Sherwood NE, 2000, INT J OBESITY, V24, P395, DOI 10.1038/sj.ijo.0801169; Slentz CA, 2004, ARCH INTERN MED, V164, P31, DOI 10.1001/archinte.164.1.31; Sternfeld B, 2004, AM J EPIDEMIOL, V160, P912, DOI 10.1093/aje/kwh299; VAUGHAN L, 1991, AM J CLIN NUTR, V53, P821, DOI 10.1093/ajcn/53.4.821; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; Wenche Droyvold B, 2004, J Womens Health (Larchmt), V13, P55; Westerterp KR, 1997, INT J OBESITY, V21, P184, DOI 10.1038/sj.ijo.0800385; Westerterp KR, 1998, AM J CLIN NUTR, V68, p970S, DOI 10.1093/ajcn/68.4.970S; Williams PT, 2006, INT J OBESITY, V30, P543, DOI 10.1038/sj.ijo.0803172; WILLIAMSON DF, 1993, INT J OBESITY, V17, P279; World Health Organization, 1999, OB PREV MAN GLOB EP; 2002, CARBOHYDRATE FIBER F	39	186	192	3	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2010	304	23					2603	2610		10.1001/jama.2010.1843	http://dx.doi.org/10.1001/jama.2010.1843			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694MX	21156948	Green Accepted			2022-12-28	WOS:000285303400023
J	Schirawski, J; Mannhaupt, G; Munch, K; Brefort, T; Schipper, K; Doehlemann, G; Di Stasio, M; Rossel, N; Mendoza-Mendoza, A; Pester, D; Muller, O; Winterberg, B; Meyer, E; Ghareeb, H; Wollenberg, T; Munsterkotter, M; Wong, P; Walter, M; Stukenbrock, E; Guldener, U; Kahmann, R				Schirawski, Jan; Mannhaupt, Gertrud; Muench, Karin; Brefort, Thomas; Schipper, Kerstin; Doehlemann, Gunther; Di Stasio, Maurizio; Roessel, Nicole; Mendoza-Mendoza, Artemio; Pester, Doris; Mueller, Olaf; Winterberg, Britta; Meyer, Elmar; Ghareeb, Hassan; Wollenberg, Theresa; Muensterkoetter, Martin; Wong, Philip; Walter, Mathias; Stukenbrock, Eva; Gueldener, Ulrich; Kahmann, Regine			Pathogenicity Determinants in Smut Fungi Revealed by Genome Comparison	SCIENCE			English	Article							USTILAGO-MAYDIS; SPORISORIUM; MAIZE	Biotrophic pathogens, such as the related maize pathogenic fungi Ustilago maydis and Sporisorium reilianum, establish an intimate relationship with their hosts by secreting protein effectors. Because secreted effectors interacting with plant proteins should rapidly evolve, we identified variable genomic regions by sequencing the genome of S. reilianum and comparing it with the U. maydis genome. We detected 43 regions of low sequence conservation in otherwise well-conserved syntenic genomes. These regions primarily encode secreted effectors and include previously identified virulence clusters. By deletion analysis in U. maydis, we demonstrate a role in virulence for four previously unknown diversity regions. This highlights the power of comparative genomics of closely related species for identification of virulence determinants.	[Schirawski, Jan; Mannhaupt, Gertrud; Muench, Karin; Brefort, Thomas; Schipper, Kerstin; Doehlemann, Gunther; Di Stasio, Maurizio; Roessel, Nicole; Mendoza-Mendoza, Artemio; Pester, Doris; Mueller, Olaf; Winterberg, Britta; Meyer, Elmar; Ghareeb, Hassan; Wollenberg, Theresa; Stukenbrock, Eva; Kahmann, Regine] Max Planck Inst Terr Microbiol, Dept Organism Interact, D-35043 Marburg, Germany; [Schirawski, Jan] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Mol Biol Plant Microbe Interact, D-37073 Gottingen, Germany; [Mannhaupt, Gertrud; Muensterkoetter, Martin; Wong, Philip; Walter, Mathias; Gueldener, Ulrich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, D-85764 Neuherberg, Germany	Max Planck Society; University of Gottingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kahmann, R (corresponding author), Max Planck Inst Terr Microbiol, Dept Organism Interact, Karl von Frisch Str 10, D-35043 Marburg, Germany.	Kahmann@mpi-marburg.mpg.de	Münsterkötter, Martin/L-3436-2019; Walter, Mathias/AGP-4944-2022; Kahmann, Regine/AAS-1230-2021; Mendoza, Artemio Mendoza/P-7540-2019; Güldener, Ulrich/G-5227-2012; Doehlemann, Gunther/C-1777-2008; Schipper, Kerstin/H-4656-2011; Walter, Mathias/B-8837-2013; Münsterkötter, Martin/C-5288-2017; Mendoza, Artemio Mendoza/F-3519-2013; Schirawski, Jan/Q-9393-2019; Holtgrewe Stukenbrock, Eva/I-4333-2016	Münsterkötter, Martin/0000-0002-0044-2381; Walter, Mathias/0000-0003-3012-2626; Mendoza, Artemio Mendoza/0000-0002-1532-3406; Güldener, Ulrich/0000-0001-5052-8610; Walter, Mathias/0000-0003-3012-2626; Münsterkötter, Martin/0000-0002-0044-2381; Mendoza, Artemio Mendoza/0000-0002-1532-3406; Schirawski, Jan/0000-0003-1615-1201; Holtgrewe Stukenbrock, Eva/0000-0001-8590-3345; Doehlemann, Gunther/0000-0002-7353-8456; Ghareeb, Hassan/0000-0001-5694-3225	Max Planck Society; Deutsche Forschungsgemeinschaft [SFB593]; Humboldt fellowship; International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology; State of Hesse	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Humboldt fellowship(Alexander von Humboldt Foundation); International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology; State of Hesse	We are grateful to the Max Planck Society for funding genome sequencing and annotation. T. B. was supported through the Deutsche Forschungsgemeinschaft via SFB593. A. M. M. received a Humboldt fellowship. H. G. was funded by the International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology. R. K. acknowledges support through the LOEWE program of the State of Hesse. We thank U. Bonas and G. Gottschalk for critical comments on the manuscript. The sequence was submitted to European Molecular Biology Laboratory database under accession numbers FQ311430 to FQ311474.	Basse CW, 2000, MOL CELL BIOL, V20, P329, DOI 10.1128/MCB.20.1.329-339.2000; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brefort T, 2009, ANNU REV PHYTOPATHOL, V47, P423, DOI 10.1146/annurev-phyto-080508-081923; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Doehlemann G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000290; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Martinez C, 1999, PHYTOPATHOLOGY, V89, P247, DOI 10.1094/PHYTO.1999.89.3.247; Skibbe DS, 2010, SCIENCE, V328, P89, DOI 10.1126/science.1185775; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Stoll M, 2005, MYCOL RES, V109, P342, DOI 10.1017/S0953756204002229	11	226	238	8	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2010	330	6010					1546	1548		10.1126/science.1195330	http://dx.doi.org/10.1126/science.1195330			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148393				2022-12-28	WOS:000285153500067
J	Sampat, BN				Sampat, Bhaven N.			Lessons from Bayh-Dole	NATURE			English	Editorial Material									Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10032 USA	Columbia University	Sampat, BN (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10032 USA.	bns3@columbia.edu						Cohen WM, 2002, MANAGE SCI, V48, P1, DOI 10.1287/mnsc.48.1.1.14273; *FED COUNC SCI TEC, 1976, ANN REP GOV PAT POL; HUGHES SS, 1997, STANFORDS OFFICE TEC; NRC (National Research Council), 2010, MAN U INT PROP PUBL; NSF, 2010, SCI ENG IND 2010; ROSENBERG N, 1994, RES POLICY, V23, P323, DOI 10.1016/0048-7333(94)90042-6; Sampat BN, 2009, AM J PUBLIC HEALTH, V99, P9, DOI 10.2105/AJPH.2007.128769; UNNIKRISHNAN CH, 2010, MINT            0810	8	8	8	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2010	468	7325					755	756		10.1038/468755a	http://dx.doi.org/10.1038/468755a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21150971				2022-12-28	WOS:000285093700016
J	Horton, R				Horton, Richard			A new epoch for health professionals' education	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							[Anonymous], 1999, WORLD HLTH REPORT 19; Bateman C, 2001, LANCET, V358, P1539, DOI 10.1016/S0140-6736(01)06586-2; Bhutta ZA, 2010, LANCET, V375, P1137, DOI 10.1016/S0140-6736(10)60450-3; Boelen C, 2009, MED EDUC, V43, P887, DOI 10.1111/j.1365-2923.2009.03413.x; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Cole Jonathan R., 2009, GREAT AM U ITS RISE; Dzau VJ, 2010, LANCET, V375, P949, DOI 10.1016/S0140-6736(09)61082-5; Flexner A., 1910, MEDICAL ED US CANADA; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Menand Louis, 2010, MARKETPLACE IDEAS RE; Mullan F, 2010, ANN INTERN MED, V152, P804, DOI 10.7326/0003-4819-152-12-201006150-00009; NEWMAN JH, 1939, SCOPE NATURE U ED; Royal College of Physicians, 2005, DOCT SOC MED PROF CH; WILDAUSKY B, 2010, GREAT BRAIN RACE GLO	14	47	49	2	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 4	2010	376	9756					1875	1877		10.1016/S0140-6736(10)62008-9	http://dx.doi.org/10.1016/S0140-6736(10)62008-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	696KH	21112621				2022-12-28	WOS:000285439800004
J	Eichenbaum, H				Eichenbaum, Howard			Dedicated to Memory?	SCIENCE			English	Editorial Material							RECOGNITION MEMORY; RECOLLECTION		Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA	Boston University	Eichenbaum, H (corresponding author), Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA.	hbe@bu.edu						Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Farovik A, 2008, J NEUROSCI, V28, P13428, DOI 10.1523/JNEUROSCI.3662-08.2008; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; Griffiths S, 2008, NEURON, V58, P186, DOI 10.1016/j.neuron.2008.02.022; McTighe SM, 2010, SCIENCE, V330, P1408, DOI 10.1126/science.1194780; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; UNDERLIDE LG, 1982, 2 CORTICAL VISUAL SY, P549	8	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1331	1332		10.1126/science.1199462	http://dx.doi.org/10.1126/science.1199462			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127238				2022-12-28	WOS:000284902100028
J	Ren, DC; Tu, HC; Kim, H; Wang, GX; Bean, GR; Takeuchi, O; Jeffers, JR; Zambetti, GP; Hsieh, JJD; Cheng, EHY				Ren, Decheng; Tu, Ho-Chou; Kim, Hyungjin; Wang, Gary X.; Bean, Gregory R.; Takeuchi, Osamu; Jeffers, John R.; Zambetti, Gerard P.; Hsieh, James J. -D.; Cheng, Emily H. -Y.			BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death Program	SCIENCE			English	Article							BCL-2 FAMILY-MEMBERS; MITOCHONDRIAL APOPTOSIS; MEMBRANE PERMEABILIZATION; NEURONAL APOPTOSIS; CYTOCHROME-C; JNK PATHWAY; BH3 DOMAINS; PROTEINS; MECHANISM; RELEASE	Although the proteins BAX and BAK are required for initiation of apoptosis at the mitochondria, how BAX and BAK are activated remains unsettled. We provide in vivo evidence demonstrating an essential role of the proteins BID, BIM, and PUMA in activating BAX and BAK. Bid, Bim, and Puma triple-knockout mice showed the same developmental defects that are associated with deficiency of Bax and Bak, including persistent interdigital webs and imperforate vaginas. Genetic deletion of Bid, Bim, and Puma prevented the homo-oligomerization of BAX and BAK, and thereby cytochrome c-mediated activation of caspases in response to diverse death signals in neurons and T lymphocytes, despite the presence of other BH3-only molecules. Thus, many forms of apoptosis require direct activation of BAX and BAK at the mitochondria by a member of the BID, BIM, or PUMA family of proteins.	[Ren, Decheng; Tu, Ho-Chou; Kim, Hyungjin; Wang, Gary X.; Bean, Gregory R.; Hsieh, James J. -D.; Cheng, Emily H. -Y.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Takeuchi, Osamu] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Jeffers, John R.; Zambetti, Gerard P.] St Jude Childrens Hosp, Memphis, TN 38105 USA; [Cheng, Emily H. -Y.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Osaka University; St Jude Children's Research Hospital; Washington University (WUSTL)	Cheng, EHY (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.	chenge1@mskcc.org	Zambetti, Gerard/N-8093-2018; Takeuchi, Osamu/D-6007-2011; Ren, decheng/B-8310-2011; Takeuchi, Osamu/AAG-9359-2019	Zambetti, Gerard/0000-0002-0929-5007; Takeuchi, Osamu/0000-0002-1260-6232; Wang, Gary/0000-0002-8013-0766	NIH [R01CA125562, R01GM083159, P30CA21765]; Searle Scholars Program; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA125562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083159] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We apologize to all the investigators whose research could not be appropriately cited owing to space limitation. We thank T. D. Westergard and H.-F. Chen for technical assistance. This work was supported by grants to E.H.-Y.C. from NIH (R01CA125562) and the Searle Scholars Program, and to G.P.Z. from NIH (R01GM083159 and P30CA21765)	Besirli CG, 2005, J CELL BIOL, V170, P401, DOI 10.1083/jcb.200501138; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Fu NY, 2009, MOL CELL, V33, P15, DOI 10.1016/j.molcel.2008.11.025; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gross A., 1999, Genes Dev, V13, P1899; Harris CA, 2001, J BIOL CHEM, V276, P37754; Kim HA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1972; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; Miller TM, 1997, J CELL BIOL, V139, P205, DOI 10.1083/jcb.139.1.205; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Putcha GV, 2002, J CELL BIOL, V157, P441, DOI 10.1083/jcb.200110108; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	30	344	372	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1390	1393		10.1126/science.1190217	http://dx.doi.org/10.1126/science.1190217			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127253	Green Accepted			2022-12-28	WOS:000284902100045
J	Alexander, P				Alexander, Philip			Flail Chest.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Lady Willingdon Hosp, Manali, Himachal Prades, India		Alexander, P (corresponding author), Lady Willingdon Hosp, Manali, Himachal Prades, India.	philalex1@gmail.com	Alexander, Philip/AAL-2150-2021						0	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					E35	E35		10.1056/NEJMicm0904437	http://dx.doi.org/10.1056/NEJMicm0904437			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EP	21121828				2022-12-28	WOS:000284832900013
J	Keesing, F; Belden, LK; Daszak, P; Dobson, A; Harvell, CD; Holt, RD; Hudson, P; Jolles, A; Jones, KE; Mitchell, CE; Myers, SS; Bogich, T; Ostfeld, RS				Keesing, Felicia; Belden, Lisa K.; Daszak, Peter; Dobson, Andrew; Harvell, C. Drew; Holt, Robert D.; Hudson, Peter; Jolles, Anna; Jones, Kate E.; Mitchell, Charles E.; Myers, Samuel S.; Bogich, Tiffany; Ostfeld, Richard S.			Impacts of biodiversity on the emergence and transmission of infectious diseases	NATURE			English	Review							WEST-NILE-VIRUS; SPECIES-DIVERSITY; ANTIBIOTIC-TREATMENT; BACTERIAL VAGINOSIS; COMMUNITY DIVERSITY; IMMUNE DEFENSE; HOST; PREVALENCE; POPULATION; PATHOGENS	Current unprecedented declines in biodiversity reduce the ability of ecological communities to provide many fundamental ecosystem services. Here we evaluate evidence that reduced biodiversity affects the transmission of infectious diseases of humans, other animals and plants. In principle, loss of biodiversity could either increase or decrease disease transmission. However, mounting evidence indicates that biodiversity loss frequently increases disease transmission. In contrast, areas of naturally high biodiversity may serve as a source pool for new pathogens. Overall, despite many remaining questions, current evidence indicates that preserving intact ecosystems and their endemic biodiversity should generally reduce the prevalence of infectious diseases.	[Keesing, Felicia] Bard Coll, Dept Biol, Annandale On Hudson, NY 12504 USA; [Belden, Lisa K.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Daszak, Peter; Bogich, Tiffany] EcoHlth Alliance, New York, NY 10001 USA; [Dobson, Andrew] Princeton Univ, EEB, Princeton, NJ 08544 USA; [Harvell, C. Drew] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Holt, Robert D.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Hudson, Peter] Penn State Univ, Ctr Infect Dis Dynam, College Stn, TX USA; [Jolles, Anna] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA; [Jones, Kate E.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Mitchell, Charles E.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Myers, Samuel S.] Harvard Univ, Harvard Med Sch, Cambridge, MA 02138 USA; [Ostfeld, Richard S.] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA	Virginia Polytechnic Institute & State University; EcoHealth Alliance; Princeton University; Cornell University; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Oregon State University; Zoological Society of London; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Cary Institute of Ecosystem Studies	Keesing, F (corresponding author), Bard Coll, Dept Biol, Annandale On Hudson, NY 12504 USA.	keesing@bard.edu	Mitchell, Charles E/I-3709-2014; daszak, peter/U-4588-2017; Jones, Kate E/G-4768-2010; Jones, Kate/Y-3317-2019; Hudson, Peter/AAB-8080-2020	Mitchell, Charles E/0000-0002-1633-1993; daszak, peter/0000-0002-2046-5695; Jones, Kate E/0000-0001-5231-3293; Jones, Kate/0000-0001-5231-3293; Hudson, Peter/0000-0003-0468-3403; Belden, Lisa/0000-0002-3514-3920; Bogich, Tiffany/0000-0002-8143-5289; Ostfeld, Richard/0000-0002-3707-9301; Jolles, Anna/0000-0003-3074-9912	NSF-NIH; EPA	NSF-NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPA(United States Environmental Protection Agency)	We acknowledge the support of the joint NSF-NIH Ecology of Infectious Disease programme and the EPA Biodiversity and Human Health programme. M. Gillespie provided help in the preparation of the manuscript.	Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Begon Michael, 2008, P12; BOUMA M, 1995, T ROY SOC TROP MED H, V89, P351, DOI 10.1016/0035-9203(95)90004-7; Brunner JL, 2008, ECOLOGY, V89, P2259, DOI 10.1890/07-0665.1; Bunker D.E., 2009, BIODIVERSITY ECOSYST; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Carlson JC, 2009, J MED ENTOMOL, V46, P460, DOI 10.1603/033.046.0307; *CDC, 2009, MMWR-MORBID MORTAL W, V58, P1409; Cecere MC, 1997, MED VET ENTOMOL, V11, P383, DOI 10.1111/j.1365-2915.1997.tb00426.x; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Clay CA, 2009, ECOHEALTH, V6, P250, DOI 10.1007/s10393-009-0240-2; Clay CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006467; Cronin JP, 2010, ECOL LETT, V13, P1221, DOI 10.1111/j.1461-0248.2010.01513.x; Dennehy JJ, 2007, ECOL LETT, V10, P230, DOI 10.1111/j.1461-0248.2006.01013.x; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dizney LJ, 2009, EMERG INFECT DIS, V15, P1012, DOI [10.3201/eid1507.081621, 10.3201/eid1507.081083]; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; Efrony R, 2009, CURR MICROBIOL, V58, P139, DOI 10.1007/s00284-008-9290-x; Epstein Jonathan H, 2006, Curr Infect Dis Rep, V8, P59, DOI 10.1007/s11908-006-0036-2; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Flanagan JL, 2007, J CLIN MICROBIOL, V45, P1954, DOI 10.1128/JCM.02187-06; Hall SR, 2009, ECOLOGY, V90, P791, DOI 10.1890/08-0838.1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Holzman C, 2001, AM J PUBLIC HEALTH, V91, P1664, DOI 10.2105/AJPH.91.10.1664; Hudson P. J., 2008, INFECT DIS EC EFF, P347; IUCN, IUCN RED LIST THREAT; Johnson PTJ, 2010, J EXP BIOL, V213, P961, DOI 10.1242/jeb.037721; Johnson PTJ, 2009, P ROY SOC B-BIOL SCI, V276, P1657, DOI 10.1098/rspb.2008.1718; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2009, P ROY SOC B-BIOL SCI, V276, P3911, DOI 10.1098/rspb.2009.1159; Kelly DW, 2009, FRESHWATER BIOL, V54, P1805, DOI 10.1111/j.1365-2427.2009.02228.x; Koenig WD, 2010, OECOLOGIA, V163, P903, DOI 10.1007/s00442-010-1627-z; Kopp K, 2007, OIKOS, V116, P295, DOI [10.1111/j.2006.0030-1299.15290.x, 10.1111/j.0030-1299.2007.15290.x]; Kosoy MY, 1997, AM J TROP MED HYG, V57, P578, DOI 10.4269/ajtmh.1997.57.578; LARACUENTE A, 1979, AM J TROP MED HYG, V28, P99, DOI 10.4269/ajtmh.1979.28.99; Laurenson MK, 2003, J ANIM ECOL, V72, P177, DOI 10.1046/j.1365-2656.2003.00688.x; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Lee KA, 2008, J ANIM ECOL, V77, P356, DOI 10.1111/j.1365-2656.2007.01347.x; Logiudice K, 2008, ECOLOGY, V89, P2841, DOI 10.1890/07-1047.1; Loh J, 2008, 2010 RISING BIODIVER; MACE GM, 2005, MILLENNIUM ECOSYSTEM, V1, pCH4; Margules CR, 2007, ECOL BIODIVERS CONS, P1; MARRIS E, 2010, NATURE, DOI DOI 10.1038/NEWS.2010.297; Martin II LB, 2006, OECOLOGIA, V147, P565, DOI 10.1007/s00442-005-0314-y; Martin LB, 2007, ECOLOGY, V88, P2516, DOI 10.1890/07-0060.1; Matos A, 2005, MICROB ECOL, V49, P257, DOI 10.1007/s00248-004-0179-3; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; Mundt CC, 2002, ANNU REV PHYTOPATHOL, V40, P381, DOI 10.1146/annurev.phyto.40.011402.113723; Ostfeld RS, 2003, ECOLOGY, V84, P1421, DOI 10.1890/02-3125; Pilgrim ES, 2004, BIOL CONSERV, V120, P161, DOI 10.1016/j.biocon.2004.02.008; Raymundo LJ, 2009, P NATL ACAD SCI USA, V106, P17067, DOI 10.1073/pnas.0900365106; Roos K, 2001, BRIT MED J, V322, P1, DOI DOI 10.1136/bmj.322.7280.210; Roscher C, 2007, OECOLOGIA, V153, P173, DOI 10.1007/s00442-007-0713-3; Rudolf VHW, 2005, AM NAT, V166, P112, DOI 10.1086/430674; Saul A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-32; Sleator RD, 2008, LETT APPL MICROBIOL, V46, P143, DOI 10.1111/j.1472-765X.2007.02293.x; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Suzan G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005461; Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488; Tersago K, 2008, VECTOR-BORNE ZOONOT, V8, P235, DOI 10.1089/vbz.2007.0160; Thieltges DW, 2008, PARASITOLOGY, V135, P1111, DOI 10.1017/S0031182008004526; Thieltges DW, 2009, BIOL INVASIONS, V11, P1421, DOI 10.1007/s10530-008-9350-y; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; Yates TL, 2002, BIOSCIENCE, V52, P989, DOI 10.1641/0006-3568(2002)052[0989:TEAEHO]2.0.CO;2; Zhu YY, 2005, PHYTOPATHOLOGY, V95, P433, DOI 10.1094/PHYTO-95-0433	72	1044	1079	16	826	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					647	652		10.1038/nature09575	http://dx.doi.org/10.1038/nature09575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124449	Green Published			2022-12-28	WOS:000284836700031
J	Giulivi, C; Zhang, YF; Omanska-Klusek, A; Ross-Inta, C; Wong, S; Hertz-Picciotto, I; Tassone, F; Pessah, IN				Giulivi, Cecilia; Zhang, Yi-Fan; Omanska-Klusek, Alicja; Ross-Inta, Catherine; Wong, Sarah; Hertz-Picciotto, Irva; Tassone, Flora; Pessah, Isaac N.			Mitochondrial Dysfunction in Autism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-CHAIN DISORDERS; COPY NUMBER; SPECTRUM; DNA; DEFICIENCY; METABOLISM; CHILDREN; MUSCLE; CELLS	Context Impaired mitochondrial function may influence processes highly dependent on energy, such as neurodevelopment, and contribute to autism. No studies have evaluated mitochondrial dysfunction and mitochondrial DNA (mtDNA) abnormalities in a well-defined population of children with autism. Objective To evaluate mitochondrial defects in children with autism. Design, Setting, and Patients Observational study using data collected from patients aged 2 to 5 years who were a subset of children participating in the Childhood Autism Risk From Genes and Environment study in California, which is a population-based, case-control investigation with confirmed autism cases and age-matched, genetically unrelated, typically developing controls, that was launched in 2003 and is still ongoing. Mitochondrial dysfunction and mtDNA abnormalities were evaluated in lymphocytes from 10 children with autism and 10 controls. Main Outcome Measures Oxidative phosphorylation capacity, mtDNA copy number and deletions, mitochondrial rate of hydrogen peroxide production, and plasma lactate and pyruvate. Results The reduced nicotinamide adenine dinucleotide (NADH) oxidase activity (normalized to citrate synthase activity) in lymphocytic mitochondria from children with autism was significantly lower compared with controls (mean, 4.4 [95% confidence interval {CI}, 2.8-6.0] vs 12 [95% CI, 8-16], respectively; P=.001). The majority of children with autism (6 of 10) had complex I activity below control range values. Higher plasma pyruvate levels were found in children with autism compared with controls (0.23 mM [95% CI, 0.15-0.31 mM] vs 0.08 mM [95% CI, 0.04-0.12 mM], respectively; P=.02). Eight of 10 cases had higher pyruvate levels but only 2 cases had higher lactate levels compared with controls. These results were consistent with the lower pyruvate dehydrogenase activity observed in children with autism compared with controls (1.0 [95% CI, 0.6-1.4] nmol x [min x mg protein](-1) vs 2.3 [95% CI, 1.7-2.9] nmol x [min x mg protein](-1), respectively; P=.01). Children with autism had higher mitochondrial rates of hydrogen peroxide production compared with controls (0.34 [95% CI, 0.26-0.42] nmol x [min x mg of protein](-1) vs 0.16 [95% CI, 0.12-0.20] nmol x [min x mg protein](-1) by complex III; P=.02). Mitochondrial DNA overreplication was found in 5 cases (mean ratio of mtDNA to nuclear DNA: 239 [95% CI, 217239] vs 179 [95% CI, 165-193] in controls; P=10(-4)). Deletions at the segment of cytochrome b were observed in 2 cases (ratio of cytochrome b to ND1: 0.80 [95% CI, 0.68-0.92] vs 0.99 [95% CI, 0.93-1.05] for controls; P=.01). Conclusion In this exploratory study, children with autism were more likely to have mitochondrial dysfunction, mtDNA overreplication, and mtDNA deletions than typically developing children. JAMA. 2010;304(21):2389-2396 www.jama.com	[Giulivi, Cecilia; Zhang, Yi-Fan; Omanska-Klusek, Alicja; Ross-Inta, Catherine; Wong, Sarah; Pessah, Isaac N.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Hertz-Picciotto, Irva] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Tassone, Flora] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Hertz-Picciotto, Irva; Tassone, Flora] Univ Calif Davis, Sch Med, Davis, CA 95616 USA; [Hertz-Picciotto, Irva; Pessah, Isaac N.] Univ Calif Davis, Ctr Childrens Environm Hlth & Dis Prevent, Davis, CA 95616 USA; [Hertz-Picciotto, Irva; Tassone, Flora; Pessah, Isaac N.] Univ Calif Davis, Med Invest Neurodev Disorders Inst, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Giulivi, C (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, 1 Shields Ave,1120 Haring Hall, Davis, CA 95616 USA.	cgiulivi@ucdavis.edu	Giulivi, Cecilia/ABB-7809-2020; Pessah, Isaac N/K-7985-2017; Giulivi, Cecilia/AAV-6774-2021	Giulivi, Cecilia/0000-0003-1033-7435; Pessah, Isaac N/0000-0002-8149-588X; Hertz-Picciotto, Irva/0000-0001-6952-2390	University of California, Davis; MIND Institute [FT19900]; National Institute of Environmental Health Sciences [P01 ES11269, R01 ES015359]; Autism Speaks; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015359, P01ES011269, R01ES012691] Funding Source: NIH RePORTER	University of California, Davis(University of California System); MIND Institute; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Autism Speaks; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study received funding from the 2008 Medical Investigations of Neurodevelopmental Disorders Institute Pilot Research Grant, University of California, Davis, and support from Autism Speaks awarded to Dr Giulivi. Additional funding was provided by the MIND Institute Gift Funds FT19900 to Dr Tassone. Additional support was provided by grants P01 ES11269 and R01 ES015359 from the National Institute of Environmental Health Sciences. Additional funding was received by Dr Pessah through an Environmental Innovator Award from Autism Speaks.	Aldred S, 2003, J AUTISM DEV DISORD, V33, P93, DOI 10.1023/A:1022238706604; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; DEMEIRLEIR L, 1993, PEDIATR NEUROL, V9, P216, DOI 10.1016/0887-8994(93)90088-T; Erecinska M, 1996, BBA-BIOENERGETICS, V1277, P13, DOI 10.1016/S0005-2728(96)00103-X; Filiano JJ, 2002, J CHILD NEUROL, V17, P435, DOI 10.1177/088307380201700607; Filipek PA, 2004, J AUTISM DEV DISORD, V34, P615, DOI 10.1007/s10803-004-5283-1; Filipek PA, 2003, ANN NEUROL, V53, P801, DOI 10.1002/ana.10596; FISCHER JC, 1985, CLIN CHIM ACTA, V145, P89, DOI 10.1016/0009-8981(85)90022-1; GIULIVI C, 1995, ARCH BIOCHEM BIOPHYS, V316, P909, DOI 10.1006/abbi.1995.1122; GIULIVI C, 2003, SIGNAL TRANSDUCTION, P311; Hao HL, 1999, HUM MOL GENET, V8, P1117, DOI 10.1093/hmg/8.6.1117; Haynes V, 2010, AM J PHYSIOL-ENDOC M, V298, pE978, DOI 10.1152/ajpendo.00739.2009; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; Hertz-Picciotto I, 2006, ENVIRON HEALTH PERSP, V114, P1119, DOI 10.1289/ehp.8483; James SJ, 2009, FASEB J, V23, P2374, DOI 10.1096/fj.08-128926; Krebs H A, 1973, Symp Soc Exp Biol, V27, P299; Lissens W, 2000, HUM MUTAT, V15, P209, DOI 10.1002/(SICI)1098-1004(200003)15:3<209::AID-HUMU1>3.0.CO;2-K; Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Meng XM, 2005, NEUROLOGY, V64, P1644, DOI 10.1212/01.WNL.0000160391.58004.D4; Ming X, 2010, BRAIN DEV-JPN, V32, P105, DOI 10.1016/j.braindev.2008.12.017; Mullen E.M., 1995, MULLEN SCALES EARLY; National Institute of Neurological Disorders and Stroke, AUT FACT SHEET; Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rice Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P1; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718; Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2; SHAY JW, 1990, J BIOL CHEM, V265, P14802; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; SPARROW SS, 1985, J PEDIATR PSYCHOL, V10, P215, DOI 10.1093/jpepsy/10.2.215; STJERNHOLM RL, 1967, J BACTERIOL, V93, P1657, DOI 10.1128/JB.93.5.1657-1661.1967; WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390; World Medical Association, DECL HELS ETH PRINC; Zecavati N, 2009, CURR NEUROL NEUROSCI, V9, P129, DOI 10.1007/s11910-009-0021-x; Zeviani M, 2003, CURR OPIN GENET DEV, V13, P262, DOI 10.1016/S0959-437X(03)00052-2	43	281	287	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2010	304	21					2389	2396		10.1001/jama.2010.1706	http://dx.doi.org/10.1001/jama.2010.1706			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687FH	21119085	Green Accepted, Bronze			2022-12-28	WOS:000284763900020
J	McBride, D; Hardoon, S; Walters, K; Gilmour, S; Raine, R				McBride, Dulcie; Hardoon, Sarah; Walters, Kate; Gilmour, Stuart; Raine, Rosalind			Explaining variation in referral from primary to secondary care: cohort study	BRITISH MEDICAL JOURNAL			English	Article							PRACTICE RESEARCH DATABASE; JOINT ARTHROPLASTY; HEALTH; HIP; OSTEOARTHRITIS; EXPLORATION; PEOPLE; EQUITY; SCORES; WOMEN	Objectives To determine the extent to which referral for defined symptoms from primary care varies by age, sex, and social deprivation and whether any sociodemographic variations in referral differ according to the presence of national referral guidance and the potential of the symptoms to be life threatening. Design Cohort study using individual patient data from the health improvement network database in primary care. Setting United Kingdom. Participants 5492 patients with postmenopausal bleeding, 23 121 with hip pain, and 101 212 with dyspepsia from 326 general practices, 2001-7. Main outcome measures Multivariable associations between odds of immediate referral for postmenopausal bleeding and age and social deprivation; hazard rates of referral for hip pain or dyspepsia and age, sex, and social deprivation. Analyses for dyspepsia were stratified for people aged less than and more than 55 years because referral guidance differs by age. Results 61.4% (3374/5492) of patients with postmenopausal bleeding, 17.4% (4019/23 121) with hip pain, and 13.8% (13 944/101 212) with dyspepsia were referred. The likelihood of referral for postmenopausal bleeding declined with increasing age: the adjusted odds ratio for patients aged 85 or more compared with those aged 55-64 was 0.39 (95% confidence interval 0.31 to 0.49). Patients aged 85 or more with hip pain were also less likely to be referred than those aged 55-64 (0.68, 0.57 to 0.81). Women were less likely than men to be referred for hip pain (hazard ratio 0.90, 95% confidence interval 0.84 to 0.96). More deprived patients with hip pain or dyspepsia (if aged <55) were less likely to be referred. Adjusted hazard ratios for those in the most deprived Townsend fifth compared with the least deprived were 0.72 (95% confidence interval 0.62 to 0.82) and 0.76 (0.68 to 0.85), respectively. No socioeconomic gradient was evident in referral for postmenopausal bleeding. Conclusions Inequalities in referral associated with socioeconomic circumstances were more likely to occur in the absence of both explicit guidance and potentially life threatening conditions, whereas inequalities with age were evident for all conditions.	[McBride, Dulcie; Raine, Rosalind] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Hardoon, Sarah; Walters, Kate] UCL, Royal Free & Univ Med Sch, Dept Primary Care & Populat Hlth, London WC1E 6BT, England; [Gilmour, Stuart] Kings Fund, London, England	University of London; University College London; University of London; University College London	McBride, D (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	dulciemcbride@googlemail.com		Walters, Kate/0000-0003-2173-2430; Raine, Rosalind/0000-0003-0904-749X	King's Fund; National Institute for Health Research; National Institute for Health Research University College London Hospitals/University College London Comprehensive Biomedical Research Centre	King's Fund; National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research University College London Hospitals/University College London Comprehensive Biomedical Research Centre	The King's Fund provided support for access to the data. RR is partly funded by a National Institute for Health Research public health career scientist award and by the National Institute for Health Research University College London Hospitals/University College London Comprehensive Biomedical Research Centre. The opinions stated in this paper are those of the authors as individuals, independent from the funding sources. The funding sources had no role in the study design, analysis, interpretation, writing the report or decision to submit the paper for publication.	Adams J, 2005, J PUBLIC HEALTH, V27, P101, DOI 10.1093/pubmed/fdh193; Bowling A, 1999, BRIT MED J, V319, P1353, DOI 10.1136/bmj.319.7221.1353; *BRIT SOC GASTR, 2002, DYSP MAN GUID; Campbell S., 2000, GYNAECOLOGY 10 TEACH; Campbell SM, 1996, FAM PRACT, V13, P75, DOI 10.1093/fampra/13.1.75; COULTHARD M, 2004, FOCUS SOCIAL INEQUAL; D'Ambrosia RD, 2005, ORTHOPEDICS, V28, pS201; *DEP HLTH, 2008, NEW GMS CONTR QOF IM; *DEP HLTH, 2000, REF GUID SUSP CANC; Department of Health, 2001, NAT SERV FRAM OLD PE; Department of Health, 2000, NHS CANC PLAN; DIEPPE P, 1995, BRIT MED J, V311, P853, DOI 10.1136/bmj.311.7009.853; Dixon Anna, 2007, J Health Serv Res Policy, V12, P104, DOI 10.1258/135581907780279549; Goddard M, 2001, SOC SCI MED, V53, P1149, DOI 10.1016/S0277-9536(00)00415-9; GREDMARK T, 1995, BRIT J OBSTET GYNAEC, V102, P133, DOI 10.1111/j.1471-0528.1995.tb09066.x; Grundy E, 2001, J EPIDEMIOL COMMUN H, V55, P895, DOI 10.1136/jech.55.12.895; Hawker GA, 2000, NEW ENGL J MED, V342, P1016, DOI 10.1056/NEJM200004063421405; Hawker GA, 2002, ARTHRITIS RHEUM-US, V46, P3331, DOI 10.1002/art.10682; Karlsen E., 1997, AM J MED, V102, P534; Katz JN, 2001, JAMA-J AM MED ASSOC, V286, P1506, DOI 10.1001/jama.286.12.1506; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; MAJEED A, 2001, AC HLTH SERV RES HLT, V18, P89; Mercer SW, 2007, ANN FAM MED, V5, P503, DOI 10.1370/afm.778; Miller P, 1999, BRIT J GEN PRACT, V49, P541; Moller AM, 2003, J BONE JOINT SURG BR, V85B, P178, DOI 10.1302/0301-620X.85B2.13717; MORRIS S, 2003, INEQUITY INEQUALITY; North of England Dyspepsia Guideline Development G. National Institute for Health and Clinical Excellence: Guidance, 2004, DYSP MAN DYSP AD PRI; O'Donnell CA, 2000, FAM PRACT, V17, P462, DOI 10.1093/fampra/17.6.462; Parker C, 2007, BRIT J GEN PRACT, V57, P371; Raine R, 2000, J Health Serv Res Policy, V5, P237; Raine R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1279; Santaguida PL, 2008, CAN J SURG, V51, P428; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; STEWARD A, 2005, CANC ATLAS UK IRELAN; SURENDER R, 1995, BRIT MED J, V311, P1205, DOI 10.1136/bmj.311.7014.1205; Tate AR, 2010, BRIT J CANCER, V102, P947, DOI 10.1038/sj.bjc.6605593; Townsend P., 1986, INEQUALITIES HLTH NO; Walters K, 2001, FAM PRACT, V18, P277, DOI 10.1093/fampra/18.3.277; Walters K, 2008, EUR HEART J, V29, P2981, DOI 10.1093/eurheartj/ehn477; Williams A, 1997, HEALTH ECON, V6, P117, DOI 10.1002/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-B; 2008, HLTH EPISODE STAT	42	60	60	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 30	2010	341								c6267	10.1136/bmj.c6267	http://dx.doi.org/10.1136/bmj.c6267			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	691OG	21118873	Green Published, hybrid			2022-12-28	WOS:000285090100004
J	Liu, CC; Arkin, AP				Liu, Chang C.; Arkin, Adam P.			The Case for RNA	SCIENCE			English	Editorial Material							SYNTHETIC BIOLOGY; PARTS; RIBOSWITCHES; DEVICES		[Liu, Chang C.; Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Liu, Chang C.] Miller Inst Basic Res Sci, Berkeley, CA 94720 USA; [Arkin, Adam P.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Arkin, Adam P.] Univ Calif Berkeley, QB3 Calif Inst Quantitat Biol Res, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Liu, CC (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	ccliu@berkeley.edu; aparkin@lbl.gov	Arkin, Adam P/A-6751-2008; Arkin, Adam/M-9941-2019	Arkin, Adam P/0000-0002-4999-2931; Arkin, Adam/0000-0002-4999-2931; Liu, Chang/0000-0002-3290-2880				Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Ellington AD, 2007, ACS CHEM BIOL, V2, P445, DOI 10.1021/cb700139t; Gesnel MC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/104853; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; Joyce GF, 2007, ANGEW CHEM INT EDIT, V46, P6420, DOI 10.1002/anie.200701369; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Link KH, 2009, GENE THER, V16, P1189, DOI 10.1038/gt.2009.81; Lucks JB, 2008, CURR OPIN MICROBIOL, V11, P567, DOI 10.1016/j.mib.2008.10.002; Topp S, 2010, ACS CHEM BIOL, V5, P139, DOI 10.1021/cb900278x; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; Wang Y, 2009, NAT METHODS, V6, P825, DOI [10.1038/nmeth.1379, 10.1038/NMETH.1379]; Werstuck G, 1998, SCIENCE, V282, P296, DOI 10.1126/science.282.5387.296; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Win MN, 2009, CHEM BIOL, V16, P298, DOI 10.1016/j.chembiol.2009.02.011	15	13	13	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2010	330	6008					1185	1186		10.1126/science.1199495	http://dx.doi.org/10.1126/science.1199495			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109657				2022-12-28	WOS:000284613700024
J	Mitton-Fry, RM; DeGregorio, SJ; Wang, JM; Steitz, TA; Steitz, JA				Mitton-Fry, Rachel M.; DeGregorio, Suzanne J.; Wang, Jimin; Steitz, Thomas A.; Steitz, Joan A.			Poly(A) Tail Recognition by a Viral RNA Element Through Assembly of a Triple Helix	SCIENCE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; HUMAN TELOMERASE RNA; TERTIARY INTERACTIONS; KAPOSIS-SARCOMA; NUCLEAR-RNA; PSEUDOKNOT; BINDING; DECAY	Kaposi's sarcoma-associated herpesvirus produces a highly abundant, nuclear noncoding RNA, polyadenylated nuclear (PAN) RNA, which contains an element that prevents its decay. The 79-nucleotide expression and nuclear retention element (ENE) was proposed to adopt a secondary structure like that of a box H/ACA small nucleolar RNA (snoRNA), with a U-rich internal loop that hybridizes to and protects the PAN RNA poly(A) tail. The crystal structure of a complex between the 40-nucleotide ENE core and oligo(A)(9) RNA at 2.5 angstrom resolution reveals that unlike snoRNAs, the U-rich loop of the ENE engages its target through formation of a major-groove triple helix. A-minor interactions extend the binding interface. Deadenylation assays confirm the functional importance of the triple helix. Thus, the ENE acts as an intramolecular RNA clamp, sequestering the PAN poly(A) tail and preventing the initiation of RNA decay.	[Mitton-Fry, Rachel M.; DeGregorio, Suzanne J.; Steitz, Joan A.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, Howard Hughes Med Inst,Boyer Ctr Mol Med, New Haven, CT 06536 USA; [Wang, Jimin; Steitz, Thomas A.] Yale Univ, Bass Ctr Mol & Struct Biol, Dept MB&B, New Haven, CT 06536 USA; [Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Bass Ctr Mol & Struct Biol, HHMI, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, JA (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, Howard Hughes Med Inst,Boyer Ctr Mol Med, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu	Steitz, Thomas A./C-6559-2009		NIH [CA16038, GM022778]; Jane Coffin Childs Memorial Fund; NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026154, P01GM022778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Borah, K. Tycowski, K. Herbert, and K. Riley for critical reading of the manuscript and the entire Steitz laboratories for helpful discussion. We thank S. Strobel and G. Conn for the generous gifts of iridium(III) hexamine and 3'-hepatitis delta virus (HDV) plasmid, respectively. Special thanks to Y. Zuo and G. Blaha for crystallography assistance, P. Moore and E. Paulson for NMR assistance, and M.-D. Shu, D. Mishler, and K. Durniak for technical assistance. X-ray data were collected at the National Synchrotron Light Source (X29A) at Brookhaven National Laboratory (13). Financial support for this research was provided by NIH grant CA16038 to J.A.S. and NIH grant GM022778 to T. A. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH. R.M.M.-F. is supported by a Jane Coffin Childs Memorial Fund Postdoctoral fellowship. J.A.S. and T. A. S. are investigators of the Howard Hughes Medical Institute. Coordinates and structure factors have been deposited in the Protein Data Bank under accession code 3P22.	Conrad NK, 2007, P NATL ACAD SCI USA, V104, P10412, DOI 10.1073/pnas.0704187104; Conrad NK, 2006, MOL CELL, V24, P943, DOI 10.1016/j.molcel.2006.10.029; Conrad NK, 2005, EMBO J, V24, P1831, DOI 10.1038/sj.emboj.7600662; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doherty EA, 2001, NAT STRUCT BIOL, V8, P339, DOI 10.1038/86221; DSOUZA DJ, 1992, J BIOMOL STRUCT DYN, V10, P141, DOI 10.1080/07391102.1992.10508634; FELSENFELD G, 1957, BIOCHIM BIOPHYS ACTA, V26, P457, DOI 10.1016/0006-3002(57)90091-4; FELSENFELD G, 1957, J AM CHEM SOC, V79, P2023, DOI 10.1021/ja01565a074; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Jin H, 2007, MOL CELL, V26, P205, DOI 10.1016/j.molcel.2007.03.014; Kim NK, 2008, J MOL BIOL, V384, P1249, DOI 10.1016/j.jmb.2008.10.005; Kiss T, 2010, MOL CELL, V37, P597, DOI 10.1016/j.molcel.2010.01.032; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X; Song MJ, 2001, J VIROL, V75, P3129, DOI 10.1128/JVI.75.7.3129-3140.2001; Sun R, 1996, P NATL ACAD SCI USA, V93, P11883, DOI 10.1073/pnas.93.21.11883; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Viejo-Borbolla Abel, 2004, Curr HIV/AIDS Rep, V1, P5, DOI 10.1007/s11904-004-0001-3; Wu HH, 2007, P NATL ACAD SCI USA, V104, P6655, DOI 10.1073/pnas.0701534104; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641	25	123	127	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1244	1247		10.1126/science.1195858	http://dx.doi.org/10.1126/science.1195858			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109672	Green Accepted			2022-12-28	WOS:000284613700042
J	Rothman, DJ; Chimonas, S				Rothman, David J.; Chimonas, Susan			Academic Medical Centers' Conflict of Interest Policies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rothman, David J.; Chimonas, Susan] Columbia Univ Coll Phys & Surg, Ctr Med Profess, New York, NY 10032 USA	Columbia University	Rothman, DJ (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Med Profess, 630 W 168th St, New York, NY 10032 USA.	djr5@columbia.edu		Chimonas, Susan/0000-0002-7742-5950				Institute of Medicine, 2009, CONFL INT MED RES ED; KOWALCZYK L, 2009, BOSTON GLOBE    0321, pB1; Stanford School of Medicine, POL GUID INT STANF U; Tanne JH, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1075; *U PA, HOSP U PENNS CLIN PR; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; WILSON D, 2010, NY TIMES        0111, pB4	7	19	20	1	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2010	304	20					2294	2295		10.1001/jama.2010.1714	http://dx.doi.org/10.1001/jama.2010.1714			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KI	21098775				2022-12-28	WOS:000284548400031
J	Sebastian, C; Mostoslavsky, R				Sebastian, Carlos; Mostoslavsky, Raul			SIRT3 in Calorie Restriction: Can You Hear Me Now?	CELL			English	Editorial Material							SIRTUINS; PHYSIOLOGY		[Sebastian, Carlos; Mostoslavsky, Raul] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Mostoslavsky, R (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA.	rmostoslavsky@mgh.harvard.edu	Sebastian, Carlos/H-8014-2018; Sebastian, Carlos/CAG-6271-2022	Sebastian, Carlos/0000-0001-6623-8028; 	NIDDK NIH HHS [R01 DK088190] Funding Source: Medline; NIGMS NIH HHS [R01 GM093072] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093072] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Liu XZ, 2007, J PATHOL, V211, P188, DOI 10.1002/path.2102; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Someya S, 2007, NEUROBIOL AGING, V28, P1613, DOI 10.1016/j.neurobiolaging.2006.06.024; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; SWEET RJ, 1988, AUDIOLOGY, V27, P305	10	27	29	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					667	668		10.1016/j.cell.2010.11.009	http://dx.doi.org/10.1016/j.cell.2010.11.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111225	Bronze			2022-12-28	WOS:000284583500006
J	Tursun, B; Patel, T; Kratsios, P; Hobert, O				Tursun, Baris; Patel, Tulsi; Kratsios, Paschalis; Hobert, Oliver			Direct Conversion of C. elegans Germ Cells into Specific Neuron Types	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; HISTONE CHAPERONES; STEM-CELLS; GENE; EXPRESSION; DIFFERENTIATION; TOTIPOTENCY; INDUCTION; ENCODES; PATHWAY	The ability of transcription factors to directly reprogram the identity of cell types is usually restricted and is defined by cellular context. Through the ectopic expression of single Caenorhabditis elegans transcription factors, we found that the identity of mitotic germ cells can be directly converted into that of specific neuron types: glutamatergic, cholinergic, or GABAergic. This reprogramming event requires the removal of the histone chaperone LIN-53 (RbAp46/48 in humans), a component of several histone remodeling and modifying complexes, and this removal can be mimicked by chemical inhibition of histone deacetylases. Our findings illustrate the ability of germ cells to be directly converted into individual, terminally differentiated neuron types and demonstrate that a specific chromatin factor provides a barrier for cellular reprogramming.	[Tursun, Baris; Patel, Tulsi; Kratsios, Paschalis; Hobert, Oliver] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Tursun, B (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA.	bt2189@columbia.edu; or38@columbia.edu		Hobert, Oliver/0000-0002-7634-2854; Tursun, Baris/0000-0001-7293-8629; Kratsios, Paschalis/0000-0002-1363-9271	NIH [R01NS039996-05, R01NS050266-03]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050266, R01NS039996] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grants R01NS039996-05 and R01NS050266-03. O.H. is an Investigator of the HHMI and B.T. is a Francis Goelet Research Scientist. We thank T. Schedl, M. Krause, J. McGhee, P. Sengupta, Y. B. Qi, Y. Jin, M. Nonet, S. Strome, and members of the Hobert lab for reagents; I. Greenwald and members of the Hobert lab for comments on the manuscript; and Q. Chen for expert assistance in strain generation.	AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; BARTON MK, 1987, GENETICS, V115, P107; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Cinar H, 2005, CURR BIOL, V15, P340, DOI 10.1016/j.cub.2005.02.025; Ciosk R, 2006, SCIENCE, V311, P851, DOI 10.1126/science.1122491; CUI M, 2007, WORMBOOK, DOI DOI 10.1895/W0RMB00K.1.139.1; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Fukushige T, 2005, DEVELOPMENT, V132, P1795, DOI 10.1242/dev.01774; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Prasad B, 2008, DEV BIOL, V323, P207, DOI 10.1016/j.ydbio.2008.08.029; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Shi Y, 1998, GENE DEV, V12, P943, DOI 10.1101/gad.12.7.943; Uchida O, 2003, DEVELOPMENT, V130, P1215, DOI 10.1242/dev.00341; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	28	153	153	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2011	331	6015					304	308		10.1126/science.1199082	http://dx.doi.org/10.1126/science.1199082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21148348	Green Accepted			2022-12-28	WOS:000286636300029
J	Wei, W; Hamby, AM; Zhou, KL; Feller, MB				Wei, Wei; Hamby, Aaron M.; Zhou, Kaili; Feller, Marla B.			Development of asymmetric inhibition underlying direction selectivity in the retina	NATURE			English	Article							STARBURST AMACRINE CELLS; GANGLION-CELLS; RABBIT RETINA; MOUSE RETINA; VISUAL EXPERIENCE; IDENTIFICATION; ORGANIZATION; CONNECTIONS; MECHANISMS; DENDRITES	Establishing precise synaptic connections is crucial to the development of functional neural circuits. The direction-selective circuit in the retina relies upon highly selective wiring of inhibitory inputs from starburst amacrine cells(1) (SACs) onto four subtypes of ON-OFF direction-selective ganglion cells (DSGCs), each preferring motion in one of four cardinal directions(2). It has been reported in rabbit that the SACs on the 'null' sides of DSGCs form functional GABA (c-aminobutyric acid)-mediated synapses, whereas those on the preferred sides do not(3). However, it is not known how the asymmetric wiring between SACs and DSGCs is established during development. Here we report that in transgenic mice with cell-type-specific labelling, the synaptic connections from SACs to DSGCs were of equal strength during the first postnatal week, regardless of whether the SAC was located on the preferred or null side of the DSGC. However, by the end of the second postnatal week, the strength of the synapses made from SACs on the null side of a DSGC significantly increased whereas those made from SACs located on the preferred side remained constant. Blocking retinal activity by intraocular injections of muscimol or gabazine during this period did not alter the development of direction selectivity. Hence, the asymmetric inhibition between the SACs and DSGCs is achieved by a developmental program that specifically strengthens the GABA-mediated inputs from SACs located on the null side, in a manner not dependent on neural activity.	[Wei, Wei; Hamby, Aaron M.; Zhou, Kaili; Feller, Marla B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Feller, Marla B.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Feller, MB (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mfeller@berkeley.edu			National Institutes of Health [RO1EY013528, ARRA EY019498]; NATIONAL EYE INSTITUTE [R01EY013528, R01EY019498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank S. Nakanishi for mGluR2-GFP mice, A. Huberman for Drd4-GFP mice, J. Elstrott for help with MATLAB software, X. Han for mouse genotyping, J. Ledue for imaging assistance and A. Blankenship for reading the manuscript. This work was supported by grants RO1EY013528 and ARRA EY019498 from the National Institutes of Health.	Amthor FR, 2002, VISUAL NEUROSCI, V19, P495, DOI 10.1017/S0952523802194119; ARIEL M, 1982, J PHYSIOL-LONDON, V324, P161, DOI 10.1113/jphysiol.1982.sp014105; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Chan YC, 2008, VISION RES, V48, P2466, DOI 10.1016/j.visres.2008.08.010; Chen MG, 2009, J PHYSIOL-LONDON, V587, P819, DOI 10.1113/jphysiol.2008.161240; Chen YC, 2008, J COMP NEUROL, V508, P175, DOI 10.1002/cne.21677; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Dong W, 2004, J PHYSIOL-LONDON, V556, P11, DOI 10.1113/jphysiol.2004.060715; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; Elstrott J, 2010, J NEUROSCI, V30, P11197, DOI 10.1523/JNEUROSCI.2302-10.2010; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Famiglietti EV, 2002, VISUAL NEUROSCI, V19, P145, DOI 10.1017/S0952523802191139; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Huang ZJ, 2009, J PHYSIOL-LONDON, V587, P1881, DOI 10.1113/jphysiol.2008.168211; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jeon CJ, 2002, J COMP NEUROL, V449, P195, DOI 10.1002/cne.10288; KITTILA CA, 1995, J NEUROPHYSIOL, V73, P703, DOI 10.1152/jn.1995.73.2.703; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; OYSTER CW, 1968, J PHYSIOL-LONDON, V199, P613, DOI 10.1113/jphysiol.1968.sp008671; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; VANEY DI, 1989, NEUROBIOLOGY INNER R, P157; Wang CT, 2007, J NEUROSCI, V27, P9130, DOI 10.1523/JNEUROSCI.1293-07.2007; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Wei W, 2010, NAT PROTOC, V5, P1347, DOI 10.1038/nprot.2010.106; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	30	131	133	4	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					402	+		10.1038/nature09600	http://dx.doi.org/10.1038/nature09600			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21131947	Green Accepted			2022-12-28	WOS:000286385600053
J	Allegranzi, B; Nejad, SB; Combescure, C; Graafmans, W; Attar, H; Donaldson, L; Pittet, D				Allegranzi, Benedetta; Nejad, Sepideh Bagheri; Combescure, Christophe; Graafmans, Wilco; Attar, Homo; Donaldson, Liam; Pittet, Didier			Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis	LANCET			English	Article							SURGICAL-SITE INFECTIONS; VENTILATOR-ASSOCIATED PNEUMONIA; HOSPITAL-ACQUIRED INFECTIONS; BLOOD-STREAM INFECTIONS; HAND HYGIENE COMPLIANCE; NOSOCOMIAL INFECTIONS; RISK-FACTORS; WOUND-INFECTION; SURVEILLANCE SYSTEM; PREVALENCE SURVEY	Background Health-care-associated infection is the most frequent result of unsafe patient care worldwide, but few data are available from the developing world. We aimed to assess the epidemiology of endemic health-care-associated infection in developing countries. Methods We searched electronic databases and reference lists of relevant papers for articles published 1995-2008. Studies containing full or partial data from developing countries related to infection prevalence or incidence including overall health-care-associated infection and major infection sites, and their microbiological cause were selected. We classified studies as low-quality or high-quality according to predefined criteria. Data were pooled for analysis. Findings Of 271 selected articles, 220 were induded in the final analysis. Limited data were retrieved from some regions and many countries were not represented. 118 (54%) studies were low quality. In general, infection frequencies reported in high-quality studies were greater than those from low-quality studies. Prevalence of health-care-associated infection (pooled prevalence in high-quality studies, 15.5 per 100 patients [95% CI 12.6-18.9]) was much higher than proportions reported from Europe and the USA. Pooled overall health-care-associated infection density in adult intensive-care units was 47.9 per 1000 patient-days (95% CI 36.7-59.1), at least three times as high as densities reported from the USA. Surgical-site infection was the leading infection in hospitals (pooled cumulative incidence 5.6 per 100 surgical procedures), strikingly higher than proportions recorded in developed countries. Gram-negative bacilli represented the most common nosocomial isolates. Apart from meticillin resistance, noted in 158 of 290 (54%) Staphylococcus aureus isolates (in eight studies), very few articles reported antimicrobial resistance. Interpretation The burden of health-care-associated infection in developing countries is high. Our findings indicate a need to improve surveillance and infection-control practices.	[Pittet, Didier] Univ Hosp Geneva, Infect Control Programme, CH-1211 Geneva 14, Switzerland; [Pittet, Didier] Univ Hosp Geneva, WHO Collaborating Ctr Patient Safety Infect Contr, CH-1211 Geneva 14, Switzerland; [Allegranzi, Benedetta; Nejad, Sepideh Bagheri; Graafmans, Wilco; Attar, Homo; Donaldson, Liam; Pittet, Didier] WHO Patient Safety, Global Patient Safety Challenge 1, Geneva, Switzerland; [Combescure, Christophe] Univ Hosp Geneva, Div Clin Epidemiol, CH-1211 Geneva 14, Switzerland; [Combescure, Christophe; Pittet, Didier] Fac Med, CH-1211 Geneva 14, Switzerland; [Donaldson, Liam] Natl Patient Safety Agcy, London, England	University of Geneva; University of Geneva; World Health Organization; University of Geneva; University of Geneva	Pittet, D (corresponding author), Univ Hosp Geneva, Infect Control Programme, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	didier.pittet@hcuge.ch			World Health Organization	World Health Organization(World Health Organization)	World Health Organization.	Abramczyk Marcelo L., 2003, Braz J Infect Dis, V7, P375, DOI 10.1590/S1413-86702003000600004; Abu Shady M. R., 1999, Egyptian Journal of Microbiology, V34, P629; Agarwal R, 2006, J INFECTION, V53, P98, DOI 10.1016/j.jinf.2005.10.021; Allegranzi B, 2008, LANCET, V372, P1719, DOI 10.1016/S0140-6736(08)61715-8; Allegranzi B, 2007, INFECT CONT HOSP EP, V28, P1323, DOI 10.1086/521656; Allegranzi B, 2010, INFECT CONT HOSP EP, V31, P133, DOI 10.1086/649796; Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; [Anonymous], 2008, 2 M INF NETW INF PRE; Anvikar A.R., 1999, INDIAN J MED MICROBI, V17, P129; Arabi Y, 2008, INT J INFECT DIS, V12, P505, DOI 10.1016/j.ijid.2008.02.010; Arabshahi Kamran Soltani, 2006, Int Wound J, V3, P59, DOI 10.1111/j.1742-4801.2006.00176.x; Arias CA, 2003, WORLD J SURG, V27, P529, DOI 10.1007/s00268-003-6786-1; Asare A, 2009, J INFECT DEV COUNTR, V3, P352; Askarian M, 2006, INT J INFECT DIS, V10, P185, DOI 10.1016/j.ijid.2005.04.004; Askarian M, 2004, AM J INFECT CONTROL, V32, P23, DOI 10.1016/j.ajic.2003.03.004; Avila-Figueroa C, 1999, SALUD PUBLICA MEXICO, V41, pS18; Azzam R, 2001, J HOSP INFECT, V49, P74, DOI 10.1053/jhin.2001.1043; Bates DW, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1775; Ben Jaballah N, 2006, MED MALADIES INFECT, V36, P379, DOI 10.1016/j.medmal.2006.05.004; Bhatia J Y, 2003, Indian J Med Microbiol, V21, P246; Boas PJFV, 2004, REV SAUDE PUBL, V38, P372, DOI 10.1590/S0034-89102004000300006; Brown S, 2007, J HOSP INFECT, V66, P160, DOI 10.1016/j.jhin.2007.03.007; Brown SM, 2007, INFECT CONT HOSP EP, V28, P319, DOI 10.1086/509849; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; Cavalcante SS, 2006, PEDIATR INFECT DIS J, V25, P438, DOI 10.1097/01.inf.0000217377.54597.92; Cevik MA, 2005, J HOSP INFECT, V59, P324, DOI 10.1016/j.jhin.2004.10.012; Chadli A, 2005, MED MALADIES INFECT, V35, P218, DOI 10.1016/j.medmal.2005.03.007; Contreras-Cuellar Germán A., 2007, Rev. salud pública, V9, P439, DOI 10.1590/S0124-00642007000300012; Couto RC, 2007, AM J INFECT CONTROL, V35, P183, DOI 10.1016/j.ajic.2006.06.013; Cuellar LE, 2008, REV PANAM SALUD PUBL, V24, P16, DOI 10.1590/S1020-49892008000700002; CULVER DH, 1991, AM J MED, V91, pS152, DOI 10.1016/0002-9343(91)90361-Z; da Rocha LD, 2008, BRAZ J INFECT DIS, V12, P80, DOI 10.1590/S1413-86702008000100017; Damani N, 2007, J HOSP INFECT, V65, P151, DOI 10.1016/S0195-6701(07)60034-6; Danchaivijitr S, 1996, J HOSP INFECT, V32, P147, DOI 10.1016/S0195-6701(96)90056-0; Danchaivijitr Somwang, 2005, J Med Assoc Thai, V88 Suppl 10, pS36; Danchaivijitr Somwang, 1995, Journal of the Medical Association of Thailand, V78, pS67; Danchaivijitr Somwang, 1995, Journal of the Medical Association of Thailand, V78, pS73; Danchaivijitr Somwang, 2007, Journal of the Medical Association of Thailand, V90, P1524; Danchaivijitrmd Somwang, 2005, J Med Assoc Thai, V88 Suppl 10, pS1; Dantas SRPE, 2006, J HOSP INFECT, V63, P117, DOI 10.1016/j.jhin.2005.10.018; de Gentile A, 2001, INFECT CONT HOSP EP, V22, P762, DOI 10.1086/501859; de Leon-Rosales SP, 2000, CRIT CARE MED, V28, P1316, DOI 10.1097/00003246-200005000-00010; de Macedo JLS, 2006, BURNS, V32, P477, DOI 10.1016/j.burns.2005.11.012; De Oliveira AC, 2006, AM J INFECT CONTROL, V34, P201, DOI 10.1016/j.ajic.2005.12.011; Deep Akash, 2004, Indian Pediatr, V41, P1238; Dia NM, 2008, MED MALADIES INFECT, V38, P270, DOI 10.1016/j.medmal.2007.11.001; Diaz-Ramos RD, 1999, SALUD PUBLICA MEXICO, V41, pS12; Dridi E, 2006, Sante Publique, V18, P187; Duerink DO, 2006, J HOSP INFECT, V62, P219, DOI 10.1016/j.jhin.2005.08.004; Dumpis U, 2003, Euro Surveill, V8, P73; Durmaz B, 2000, INFECT CONT HOSP EP, V21, P534, DOI 10.1086/501803; ECDC, 2008, ANN EP REP COMM DIS; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; El Rhazi K., 2007, Eastern Mediterranean Health Journal, V13, P56; El Sayed NM, 2000, J INFECT DIS, V181, P91, DOI 10.1086/315167; El-Nawawy AA, 2006, J TROP PEDIATRICS, V52, P185, DOI 10.1093/tropej/fmi091; Elatrous S, 1996, CLIN INTENSIVE CARE, V7, P276, DOI DOI 10.3109/TCIC.7.6.276.281; Ellidokuz H, 2003, ARCH GERONTOL GERIAT, V37, P259, DOI 10.1016/S0167-4943(03)00062-1; Erbay H, 2003, INTENS CARE MED, V29, P1482, DOI 10.1007/s00134-003-1788-x; Erdem I, 2008, JPN J INFECT DIS, V61, P339; Erdinc FS, 2006, J HOSP INFECT, V64, P391, DOI 10.1016/j.jhin.2006.06.020; Eriksen HM, 2003, J HOSP INFECT, V55, P14, DOI 10.1016/S0195-6701(03)00225-1; Erman T, 2005, SURG NEUROL, V63, P107, DOI 10.1016/j.surneu.2004.04.024; Ertugrul BM, 2006, SAUDI MED J, V27, P52; Esen S, 2004, SCAND J INFECT DIS, V36, P144, DOI 10.1080/00365540410019156; Fajardo Rodriguez Hugo A, 2005, Rev Salud Publica (Bogota), V7, P89, DOI 10.1590/S0124-00642005000100007; Faria S, 2008, J HOSP INFECT, V69, P95, DOI 10.1016/j.jhin.2008.01.029; Faria S, 2007, J HOSP INFECT, V65, P244, DOI 10.1016/j.jhin.2006.11.007; Fehr J, 2006, INFECT CONT HOSP EP, V27, P1401, DOI 10.1086/509855; Garcia-Garcia MD, 2001, INFECT CONT HOSP EP, V22, P386, DOI 10.1086/501920; Gastmeier P, 2006, J HOSP INFECT, V64, P16, DOI 10.1016/j.jhin.2006.04.017; Gaynes RP, 2001, CLIN INFECT DIS, V33, pS69, DOI 10.1086/321860; Giri Bishnu Rath, 2008, J Pak Med Assoc, V58, P148; Gosling R, 2003, ANN TROP MED PARASIT, V97, P69, DOI 10.1179/000349803125002724; Habibi S, 2008, TROP DOCT, V38, P233, DOI 10.1258/td.2008.070395; Hajdu A, 2007, J HOSP INFECT, V66, P378, DOI 10.1016/j.jhin.2007.04.018; HALEY RW, 1985, AM J EPIDEMIOL, V121, P182, DOI 10.1093/oxfordjournals.aje.a113990; Hauri AM, 2004, INT J STD AIDS, V15, P7, DOI 10.1258/095646204322637182; Haynes Alex B, 2009, N Engl J Med, V360, P491, DOI 10.1056/NEJMsa0810119; HELICS, 2006, SURV SURG SIT INF SS; Hernandez K, 2005, INFECT CONT HOSP EP, V26, P473, DOI 10.1086/502570; Higuera F, 2005, CRIT CARE MED, V33, P2022, DOI 10.1097/01.CCM.0000178190.89663.E5; Hodges AM, 1997, TROP DOCT, V27, P174, DOI 10.1177/004947559702700321; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hughes AJ, 2005, INFECT CONT HOSP EP, V26, P100, DOI 10.1086/502494; Inan D, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-5; Inan D, 2006, INFECT CONT HOSP EP, V27, P343, DOI 10.1086/503344; International Nosocomial Infection Control Consortium, PROGR SERV; Izquierdo-Cubas F, 2008, J HOSP INFECT, V68, P234, DOI 10.1016/j.jhin.2007.12.006; Jaballah NB, 2007, AM J INFECT CONTROL, V35, P613, DOI 10.1016/j.ajic.2006.09.007; Jaimes F, 2007, RESP MED, V101, P762, DOI 10.1016/j.rmed.2006.08.008; Jroundi I, 2007, AM J INFECT CONTROL, V35, P412, DOI 10.1016/j.ajic.2006.06.010; Kallel H, 2005, J HOSP INFECT, V59, P343, DOI 10.1016/j.jhin.2004.09.015; Kanafani ZA, 2003, INFECT CONT HOSP EP, V24, P864, DOI 10.1086/502151; Kanafani ZA, 2006, SCAND J INFECT DIS, V38, P589, DOI 10.1080/00365540600606440; Kasatpibal N, 2006, J HOSP INFECT, V63, P148, DOI 10.1016/j.jhin.2006.01.023; Kasatpibal N, 2005, AM J INFECT CONTROL, V33, P587, DOI 10.1016/j.ajic.2004.11.012; Kasatpibal N, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-111; Kasatpibal Nongyao, 2005, Journal of the Medical Association of Thailand, V88, P1083; Kawagoe JY, 2001, AM J INFECT CONTROL, V29, P109, DOI 10.1067/mic.2001.114162; Kaya Ekrem, 2006, Surg Infect (Larchmt), V7, P519, DOI 10.1089/sur.2006.7.519; Kehachindawat Pranee, 2007, Journal of the Medical Association of Thailand, V90, P1356; Kesah C N F, 2004, Niger Postgrad Med J, V11, P4; Khuri-Bulos NA, 1999, AM J INFECT CONTROL, V27, P547, DOI 10.1016/S0196-6553(99)70035-0; KISS Krankenhaus-Infektions-Surveillance-System, 2010, MOD ITS KISS MRE KIS; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Koigi-Kamau R, 2005, East Afr Med J, V82, P357; Kotisso B, 1998, E AFR MED J, V75, P402; Lahsaeizadeh S, 2008, J HOSP INFECT, V69, P283, DOI 10.1016/j.jhin.2008.05.006; Thu LTA, 2006, INFECT CONT HOSP EP, V27, P855, DOI 10.1086/506400; Leblebicioglu H, 2007, J HOSP INFECT, V65, P251, DOI 10.1016/j.jhin.2006.10.012; Leblebicioglu H, 2003, J HOSP INFECT, V53, P207, DOI 10.1053/jhin.2002.1362; Longtin Y, 2010, MAYO CLIN PROC, V85, P53, DOI 10.4065/mcp.2009.0248; Lopes JMM, 2002, AM J INFECT CONTROL, V30, P1, DOI 10.1067/mic.2002.117039; Luksamijarulkul Pipat, 2006, Journal of the Medical Association of Thailand, V89, P81; Maksimovic J, 2008, CROAT MED J, V49, P58, DOI 10.3325/cmj.2008.1.58; Malik A, 2001, Indian Pediatr, V38, P68; Martinez-Aguilar G, 2001, SALUD PUBLICA MEXICO, V43, P515, DOI 10.1590/S0036-36342001000600001; Medeiros Aldo Cunha, 2005, Braz J Infect Dis, V9, P310, DOI 10.1590/S1413-86702005000400007; Mehta A, 2007, J HOSP INFECT, V67, P168, DOI 10.1016/j.jhin.2007.07.008; Meric M, 2005, JPN J INFECT DIS, V58, P297; Metintas S, 2004, AM J INFECT CONTROL, V32, P409, DOI 10.1016/j.ajic.2004.05.001; Moreno CA, 2006, INFECT CONT HOSP EP, V27, P349, DOI 10.1086/503341; Murthy R, 1998, Indian J Med Sci, V52, P553; Nagata E, 2002, AM J INFECT CONTROL, V30, P26, DOI 10.1067/mic.2002.119823; Nguyen D, 2001, INFECT CONT HOSP EP, V22, P485, DOI 10.1086/501938; Noor Ahmed, 2005, J Coll Physicians Surg Pak, V15, P92; Nthumba PM, 2010, BRIT J SURG, V97, P1621, DOI 10.1002/bjs.7213; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Oliveira AC, 2004, AM J INFECT CONTROL, V32, P358, DOI 10.1016/j.ajic.2004.02.009; Oncul O, 2002, BURNS, V28, P738, DOI 10.1016/S0305-4179(02)00106-7; Onen A, 2002, J HOSP INFECT, V52, P166, DOI 10.1053/jhin.2002.1285; Pawar M, 2004, J CARDIOTHOR VASC AN, V18, P304, DOI 10.1053/j.jvca.2004.03.009; Pessoa-Silva CL, 2004, INFECT CONT HOSP EP, V25, P772, DOI 10.1086/502475; Petdachai Witaya, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P724; Petdachai Witaya, 2000, Journal of the Medical Association of Thailand, V83, P392; Picheansathian W, 2008, INT J NURS PRACT, V14, P315, DOI 10.1111/j.1440-172X.2008.00699.x; Pishori T, 2003, AM J INFECT CONTROL, V31, P296, DOI 10.1067/mic.2003.7; Pitaksiripan Sukanya, 1995, Journal of the Medical Association of Thailand, V78, pS53; Pittet D, 2005, LANCET, V366, P1246, DOI 10.1016/S0140-6736(05)67506-X; Porras-Hernandez JD, 2003, AM J INFECT CONTROL, V31, P302, DOI 10.1067/mic.2003.85; Raka L, 2006, INFECT CONT HOSP EP, V27, P421, DOI 10.1086/503387; Raka L, 2007, J INFECT DEV COUNTR, V1, P337, DOI 10.3855/jidc.375; Rakshit P, 2005, INDIAN J CRIT CARE M, V9, P211, DOI 10.4103/0972-5229.19761; Barba EJR, 2006, AM J INFECT CONTROL, V34, P244, DOI 10.1016/j.ajic.2005.05/024; Razavi Seyd Mansour, 2005, BMC Surg, V5, P2; Rezende EM, 1998, INFECT CONT HOSP EP, V19, P872, DOI 10.1086/647751; Ribas Rosineide M., 2003, Braz J Infect Dis, V7, P210, DOI 10.1590/S1413-86702003000300006; Rosenthal VD, 2006, AM J INFECT CONTROL, V34, P58, DOI 10.1016/j.ajic.2005.11.002; Rosenthal VD, 2005, AM J INFECT CONTROL, V33, P392, DOI 10.1016/j.ajic.2004.08.009; Rosenthal VD, 2004, INFECT CONT HOSP EP, V25, P251, DOI 10.1086/502386; Rosenthal VD, 2004, INFECT CONT HOSP EP, V25, P47, DOI 10.1086/502291; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P291, DOI 10.1067/mic.2003.1; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P85, DOI 10.1067/mic.2003.63; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P405, DOI 10.1067/mic.2003.52; Rosenthal VD, 2008, AM J INFECT CONTROL, V36, P627, DOI [10.1016/j.ajic.2008.10.009, 10.1016/j.ajic.2008.06.003]; Rosenthal VD, 2006, ANN INTERN MED, V145, P582, DOI 10.7326/0003-4819-145-8-200610170-00007; Rozaidi S W, 2001, Med J Malaysia, V56, P207; Saba R, 2005, ACTA HAEMATOL-BASEL, V113, P190, DOI 10.1159/000084449; Salahuddin N, 2004, J HOSP INFECT, V57, P223, DOI 10.1016/j.jhin.2004.03.002; Salamati Payman, 2006, Indian Journal of Pediatrics, V73, P197, DOI 10.1007/BF02825479; Sallam S A, 2005, East Mediterr Health J, V11, P52; Salomao R, 2008, REV PANAM SALUD PUBL, V24, P195, DOI 10.1590/S1020-49892008000900006; Sangrasi AK, 2008, INT WOUND J, V5, P74, DOI 10.1111/j.1742-481X.2007.00365.x; Santos KRN, 1997, J HOSP INFECT, V36, P229, DOI 10.1016/S0195-6701(97)90198-5; Santos KRN, 1997, INFECTION, V25, P217, DOI 10.1007/BF01713147; Shears P, 2007, J HOSP INFECT, V67, P217, DOI 10.1016/j.jhin.2007.08.016; Simsek S, 2001, J HOSP INFECT, V47, P321, DOI 10.1053/jhin.2000.0932; Sohn AH, 2002, INFECT CONT HOSP EP, V23, P382, DOI 10.1086/502070; Soleto L, 2003, INFECT CONT HOSP EP, V24, P26, DOI 10.1086/502111; Solomon S, 2003, AM J INFECT CONTROL, V31, P481; Starling CEF, 1997, AM J INFECT CONTROL, V25, P303, DOI 10.1016/S0196-6553(97)90022-5; Taye M, 2005, ETHIOPIAN MED J, V43, P167; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Thongpiyapoom Somchit, 2004, Journal of the Medical Association of Thailand, V87, P819; Thu LTA, 2007, INFECT CONT HOSP EP, V28, P583, DOI 10.1086/516661; Thu LTA, 2005, J HOSP INFECT, V60, P360, DOI 10.1016/j.jhin.2005.02.006; Tinoco JC, 1997, SALUD PUBLICA MEXICO, V39, P25, DOI 10.1590/S0036-36341997000100005; Tran TS, 1998, J HOSP INFECT, V40, P141, DOI 10.1016/S0195-6701(98)90093-7; Turgut H, 2008, INFECTION, V36, P262, DOI 10.1007/s15010-008-6346-6; Uckay I, 2008, CLIN INFECT DIS, V46, P557, DOI 10.1086/526534; Valenzuela-Flores Adriana A, 2004, Cir Cir, V72, P41; Valinteliene R, 1996, J HOSP INFECT, V34, P321, DOI 10.1016/S0195-6701(96)90112-7; Velasco E, 1997, AM J INFECT CONTROL, V25, P458, DOI 10.1016/S0196-6553(97)90067-5; Vilar-Compte D, 2001, AM J INFECT CONTROL, V29, P99, DOI 10.1067/mic.2001.112241; Vilar-Compte D, 1999, SALUD PUBLICA MEXICO, V41, pS44; Vosylius S, 2003, ACTA ANAESTH SCAND, V47, P1132, DOI 10.1034/j.1399-6576.2003.00230.x; Wagner MB, 1997, J HOSP INFECT, V35, P277, DOI 10.1016/S0195-6701(97)90221-8; WHO, 2008, SAF SURG SAV LIV SEC; Wojkowska-Mach J, 2006, INFECT CONT HOSP EP, V27, P784, DOI 10.1086/504447; World Bank, 2008, WORLD BANK COUNTRY, P1, DOI 10.1596/978-0-8213-7462-7; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2009, WHO GUID HAND HYG HL; World Health Organization, CLEAN CAR IS SAF CAR; World Health Organization, 2009, WHO PAT SAF CURR GUI; World Health Organization, 2010, BURD HLTH CAR ASS IN; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; YALCIN AN, 1995, J HOSP INFECT, V29, P305, DOI 10.1016/0195-6701(95)90278-3; Yalcin AN, 2003, INFECT CONT HOSP EP, V24, P235, DOI 10.1086/503477; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	200	1192	1280	6	168	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2011	377	9761					228	241		10.1016/S0140-6736(10)61458-4	http://dx.doi.org/10.1016/S0140-6736(10)61458-4			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	712WG	21146207				2022-12-28	WOS:000286696400030
J	Bauersachs, R; Berkowitz, SD; Brenner, B; Buller, HR; Decousus, H; Gallus, AS; Lensing, AW; Misselwitz, F; Prins, MH; Raskob, GE; Segers, A; Verhamme, P; Wells, P; Agnelli, G; Bounameaux, H; Cohen, A; Davidson, BL; Piovella, F; Schellong, S				Bauersachs, Rupert; Berkowitz, Scott D.; Brenner, Benjamin; Buller, Harry R.; Decousus, Herve; Gallus, Alex S.; Lensing, Anthonie W.; Misselwitz, Frank; Prins, Martin H.; Raskob, Gary E.; Segers, Annelise; Verhamme, Peter; Wells, Phil; Agnelli, Giancarlo; Bounameaux, Henri; Cohen, Alexander; Davidson, Bruce L.; Piovella, Franco; Schellong, Sebastian		EINSTEIN Investigators	Oral Rivaroxaban for Symptomatic Venous Thromboembolism.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FACTOR-XA INHIBITOR; DEEP-VEIN THROMBOSIS; THERAPY; IDRAPARINUX; PREVENTION; DISEASE	Background: Rivaroxaban, an oral factor Xa inhibitor, may provide a simple, fixed-dose regimen for treating acute deep-vein thrombosis (DVT) and for continued treatment, without the need for laboratory monitoring. Methods: We conducted an open-label, randomized, event-driven, noninferiority study that compared oral rivaroxaban alone (15 mg twice daily for 3 weeks, followed by 20 mg once daily) with subcutaneous enoxaparin followed by a vitamin K antagonist (either warfarin or acenocoumarol) for 3, 6, or 12 months in patients with acute, symptomatic DVT. In parallel, we carried out a double-blind, randomized, event-driven superiority study that compared rivaroxaban alone (20 mg once daily) with placebo for an additional 6 or 12 months in patients who had completed 6 to 12 months of treatment for venous thromboembolism. The primary efficacy outcome for both studies was recurrent venous thromboembolism. The principal safety outcome was major bleeding or clinically relevant nonmajor bleeding in the initial-treatment study and major bleeding in the continued-treatment study. Results: The study of rivaroxaban for acute DVT included 3449 patients: 1731 given rivaroxaban and 1718 given enoxaparin plus a vitamin K antagonist. Rivaroxaban had noninferior efficacy with respect to the primary outcome (36 events [2.1%], vs. 51 events with enoxaparin-vitamin K antagonist [3.0%]; hazard ratio, 0.68; 95% confidence interval [CI], 0.44 to 1.04; P<0.001). The principal safety outcome occurred in 8.1% of the patients in each group. In the continued-treatment study, which included 602 patients in the rivaroxaban group and 594 in the placebo group, rivaroxaban had superior efficacy (8 events [1.3%], vs. 42 with placebo [7.1%]; hazard ratio, 0.18; 95% CI, 0.09 to 0.39; P<0.001). Four patients in the rivaroxaban group had nonfatal major bleeding (0.7%), versus none in the placebo group (P=0.11). Conclusions: Rivaroxaban offers a simple, single-drug approach to the short-term and continued treatment of venous thrombosis that may improve the benefit-to-risk profile of anticoagulation. (Funded by Bayer Schering Pharma and Ortho-McNeil; ClinicalTrials.gov numbers, NCT00440193 and NCT00439725.) N Engl J Med 2010;363:2499-510.	[Buller, Harry R.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Bauersachs, Rupert] Klinikum Darmstadt, Max Ratschow Klin Angiol, Darmstadt, Germany; [Berkowitz, Scott D.] Bayer HealthCare Pharmaceut, Montville, NJ USA; [Brenner, Benjamin] Technion Israel Inst Technol, Dept Hematol, Haifa, Israel; [Decousus, Herve] Univ St Etienne, INSERM, CIE3, Ctr Hosp Univ,EA3065, St Etienne, France; [Gallus, Alex S.] Flinders Med Ctr, Adelaide, SA, Australia; [Gallus, Alex S.] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Lensing, Anthonie W.; Misselwitz, Frank] Bayer HealthCare, Wuppertal, Germany; [Prins, Martin H.] Maastricht Univ, Med Ctr, Dept Epidemiol, Care Hlth Res Inst, Maastricht, Netherlands; [Prins, Martin H.] Maastricht Univ, Med Ctr, Dept Epidemiol, Publ Hlth Res Inst, Maastricht, Netherlands; [Raskob, Gary E.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Segers, Annelise] Int Clin Trial Org, Amsterdam, Netherlands; [Segers, Annelise] Management Acad Res Org, Amsterdam, Netherlands; [Verhamme, Peter] Univ Hosp Leuven, Dept Vasc Med & Hemostasis, Louvain, Belgium; [Wells, Phil] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Wells, Phil] Ottawa Hosp, Ottawa, ON, Canada; [Agnelli, Giancarlo] Univ Perugia, Osped Santa Maria della Misericordia, Sez Med Interna & Cardiovasc, I-06100 Perugia, Italy; [Bounameaux, Henri] Univ Hosp Geneva, Div Angiol & Hemostasis, Geneva, Switzerland; [Cohen, Alexander] Kings Coll Hosp London, London, England; [Davidson, Bruce L.] Univ Washington, Sch Med, Seattle, WA USA; [Piovella, Franco] Fdn IRCCS Policlin San Matteo, Pavia, Italy; [Schellong, Sebastian] Municipal Hosp Friedrichstadt, Dresden, Germany	University of Amsterdam; Academic Medical Center Amsterdam; Klinikum Darmstadt; Bayer AG; Bayer Healthcare Pharmaceuticals; Technion Israel Institute of Technology; CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Flinders Medical Centre; Flinders University South Australia; Bayer AG; Bayer Healthcare Pharmaceuticals; Maastricht University; Maastricht University; University of Oklahoma System; University of Oklahoma Health Sciences Center; KU Leuven; University Hospital Leuven; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Hospital Santa Maria della Misericordia; University of Perugia; University of Geneva; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Washington; University of Washington Seattle; IRCCS Fondazione San Matteo	Buller, HR (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, F4-275,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.r.buller@amc.uva.nl	Berkowitz, Scott Darrell/AAS-9397-2021; Quere, Isabelle/AAB-8519-2020; Gallus, Alexander/AAH-6204-2020; Piovella, Franco/AAM-8305-2020; Kovacs, Michael/G-3315-2011; Martinelli, ida/J-2287-2015; Schulman, Sam/I-7559-2019; Beyer-Westendorf, Jan/K-7569-2019	Berkowitz, Scott Darrell/0000-0002-9428-4408; Quere, Isabelle/0000-0002-1492-9764; Martinelli, ida/0000-0001-9218-3622; Schulman, Sam/0000-0002-8512-9043; Beyer-Westendorf, Jan/0000-0002-6983-9993; Harenberg, Job/0000-0003-4590-4225; Borris, Lars/0000-0002-0527-1518; Sekhar, Mallika/0000-0002-5783-1855; Farkas, Katalin/0000-0001-5577-6808; Marschang, Peter/0000-0002-8239-3447; Gallus, Alexander/0000-0001-7347-9989; Meijer, Karina/0000-0001-9447-0465	Bayer Schering Pharma; Ortho-McNeil	Bayer Schering Pharma(Bayer AG); Ortho-McNeil	Supported by Bayer Schering Pharma and Ortho-McNeil.	Agnelli G, 2007, CIRCULATION, V116, P180, DOI 10.1161/CIRCULATIONAHA.106.668020; Buller HR, 2008, BLOOD, V112, P2242, DOI 10.1182/blood-2008-05-160143; Buller HR, 2007, NEW ENGL J MED, V357, P1105; Buller HR, 2007, NEW ENGL J MED, V357, P1094; Eriksson BI, 2009, J BONE JOINT SURG BR, V91B, P1120; Eriksson BI, 2009, J BONE JOINT SURG BR, V91B, P636, DOI 10.1302/0301-620X.91B5.21691; Hutten BA, 2006, COCHRANE DB SYST REV, V1; Kearon C, 2008, CHEST, V134, P892, DOI DOI 10.1378/CHEST.08-0658; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Keisu M, 2010, Handb Exp Pharmacol, P407, DOI 10.1007/978-3-642-00663-0_13; Kubitza D, 2005, CLIN PHARMACOL THER, V78, P412, DOI 10.1016/j.clpt.2005.06.011; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; Schulman S, 2003, NEW ENGL J MED, V349, P1713, DOI 10.1056/NEJMoa030104; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Spencer FA, 2006, J GEN INTERN MED, V21, P722, DOI 10.1111/j.1525-1497.2006.00458.x; Turpie AGG, 2009, LANCET, V373, P1673, DOI 10.1016/S0140-6736(09)60734-0; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003	19	2201	2313	1	137	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2010	363	26					2499	2510		10.1056/NEJMoa1007903	http://dx.doi.org/10.1056/NEJMoa1007903			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697YL	21128814				2022-12-28	WOS:000285555600005
J	Amstrup, SC; DeWeaver, ET; Douglas, DC; Marcot, BG; Durner, GM; Bitz, CM; Bailey, DA				Amstrup, Steven C.; DeWeaver, Eric T.; Douglas, David C.; Marcot, Bruce G.; Durner, George M.; Bitz, Cecilia M.; Bailey, David A.			Greenhouse gas mitigation can reduce sea-ice loss and increase polar bear persistence	NATURE			English	Article							CLIMATE-CHANGE; 21ST-CENTURY; SYSTEM; POLICY	On the basis of projected losses of their essential sea-ice habitats, a United States Geological Survey research team concluded in 2007 that two-thirds of the world's polar bears (Ursus maritimus) could disappear by mid-century if business-as-usual greenhouse gas emissions continue(1-3). That projection, however, did not consider the possible benefits of greenhouse gas mitigation. A key question is whether temperature increases lead to proportional losses of sea-ice habitat, or whether sea-ice cover crosses a tipping point and irreversibly collapses when temperature reaches a critical threshold(4-6). Such a tipping point would mean future greenhouse gas mitigation would confer no conservation benefits to polar bears. Here we show, using a general circulation model(7), that substantially more sea-ice habitat would be retained if greenhouse gas rise is mitigated. We also show, with Bayesian network model outcomes, that increased habitat retention under greenhouse gas mitigation means that polar bears could persist throughout the century in greater numbers and more areas than in the business-as-usual case(3). Our general circulation model outcomes did not reveal thresholds leading to irreversible loss of ice(6); instead, a linear relationship between global mean surface air temperature and sea-ice habitat substantiated the hypothesis that sea-ice thermodynamics can overcome albedo feedbacks proposed to cause sea-ice tipping points(5,6,8). Our outcomes indicate that rapid summer ice losses in models(9) and observations(6,10) represent increased volatility of a thinning sea-ice cover, rather than tipping-point behaviour. Mitigation-driven Bayesian network outcomes show that previously predicted declines in polar bear distribution and numbers(3) are not unavoidable. Because polar bears are sentinels of the Arctic marine ecosystem(11) and trends in their sea-ice habitats foreshadow future global changes, mitigating greenhouse gas emissions to improve polar bear status would have conservation benefits throughout and beyond the Arctic(12).	[Amstrup, Steven C.; Durner, George M.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [DeWeaver, Eric T.] Natl Sci Fdn, Arlington, VA 22230 USA; [Douglas, David C.] US Geol Survey, Alaska Sci Ctr, Juneau, AK 99801 USA; [Marcot, Bruce G.] US Forest Serv, USDA, PNW Res Stn, Portland, OR 97205 USA; [Bitz, Cecilia M.] Univ Washington, Seattle, WA 98195 USA; [Bailey, David A.] Natl Ctr Atmospher Res, Boulder, CO 80305 USA	United States Department of the Interior; United States Geological Survey; National Science Foundation (NSF); United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); United States Forest Service; University of Washington; University of Washington Seattle; National Center Atmospheric Research (NCAR) - USA	Amstrup, SC (corresponding author), Polar Bears Int, 810 N Wallace,Suite E,POB 3008, Bozeman, MT 59772 USA.	samstrup@pbears.org	Bitz, Cecilia M/S-8423-2016; Douglas, David C./AAU-1087-2021; Daniel, Emily M/A-7387-2012	Bitz, Cecilia M/0000-0002-9477-7499; Douglas, David C./0000-0003-0186-1104; Bailey, David/0000-0002-6584-0663	USGS; USDA Forest Service, Pacific Northwest Research Station; Office of Science (BER), US Department of Energy [ER64735]; National Science Foundation (NSF); NSF Office of Polar Programs [0908675]; Directorate For Geosciences [0908675] Funding Source: National Science Foundation	USGS(United States Geological Survey); USDA Forest Service, Pacific Northwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); Office of Science (BER), US Department of Energy(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Office of Polar Programs(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Principal funding for this project was provided by the USGS. B. G. M. acknowledges support from the USDA Forest Service, Pacific Northwest Research Station. E. T. D. acknowledges the support of the Office of Science (BER), US Department of Energy, under grant ER64735 to the University of Maryland. E.D.'s work also was supported by the National Science Foundation (NSF) during his employment there. The findings reported here, however, are not endorsed by and do not necessarily reflect the views of the NSF. CCSM3 simulations were performed using computing resources provided by the National Center for Atmospheric Research and the Earth Simulator in Japan. D. A. B. was supported under a grant from the NSF Office of Polar Programs, award number 0908675. M. Holland provided comments regarding model design and analysis. We acknowledge the Program for Climate Model Diagnosis and Intercomparison and the World Climate Research Programme's Working Group on Coupled Modeling for their roles in making available the Coupled Model Intercomparison Project phase 3 multi-model data set (support of this data set is provided by the Office of Science, US Department of Energy). We thank W. Washington and L. Buja for running the AS and providing us with the output from the CCSP integrations. We thank D. Vongraven and S. Vavrus for comments on earlier versions of this manuscript, and we thank N. Lunn and L. Peacock for providing the peer reviews necessary for the beta version of our Bayesian network model. Any use of trade names is for descriptive purposes only and does not represent endorsement by the US government.	Aars J., 2006, POL BEARS P 14 WORK, P189; Amstrup SC, 2008, GEOPHYS MONOGR SER, V180, P213, DOI 10.1029/180GM14; Amstrup SC, 2009, INTERFACES, V39, P353, DOI 10.1287/inte.1090.0444; [Anonymous], 2000, SPECIAL REPORT EMISS; Cavalieri D.J., 1996, SEA ICE CONCENTRATIO; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Deser C, 2008, GEOPHYS MONOGR SER, V180, P7, DOI 10.1029/180GM03; Durner GM, 2009, ECOL MONOGR, V79, P25, DOI 10.1890/07-2089.1; Eisenman I, 2009, P NATL ACAD SCI USA, V106, P28, DOI 10.1073/pnas.0806887106; Grosell M., 2006, OCEANOGRAPHY WASH DC, V19, P127; Hansen J, 2000, P NATL ACAD SCI USA, V97, P9875, DOI 10.1073/pnas.170278997; Holland MM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028024; Holland MM, 2008, GEOPHYS MONOGR SER, V180, P133, DOI 10.1029/180GM10; Hunter CM, 2010, ECOLOGY, V91, P2883, DOI 10.1890/09-1641.1; Kerr RA, 2007, SCIENCE, V318, P33, DOI 10.1126/science.318.5847.33a; Kizzia T., 2007, ANCHORAGE DAILY 0908, pA1; Lawrence DM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033985; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lindsay RW, 2005, J CLIMATE, V18, P4879, DOI 10.1175/JCLI3587.1; Manly B.F.J., 2002, RESOURCE SELECTION A; Marcot BG, 2006, CAN J FOREST RES, V36, P3063, DOI 10.1139/X06-135; Meehl GA, 2004, J CLIMATE, V17, P3721, DOI 10.1175/1520-0442(2004)017<3721:CONAAF>2.0.CO;2; Meehl GA, 2006, J CLIMATE, V19, P2597, DOI 10.1175/JCLI3746.1; Molnar PK, 2010, BIOL CONSERV, V143, P1612, DOI 10.1016/j.biocon.2010.04.004; National Snow and Ice Data Center, 2009, 69 NSIDC, V69; Notz D, 2009, P NATL ACAD SCI USA, V106, P20590, DOI 10.1073/pnas.0902356106; Ramanathan V, 2008, P NATL ACAD SCI USA, V105, P14245, DOI 10.1073/pnas.0803838105; Regehr EV, 2010, J ANIM ECOL, V79, P117, DOI 10.1111/j.1365-2656.2009.01603.x; Rode KD, 2010, ECOL APPL, V20, P768, DOI 10.1890/08-1036.1; Sokolov AP, 2009, J CLIMATE, V22, P5175, DOI 10.1175/2009JCLI2863.1; Stirling I, 1999, ARCTIC, V52, P294; Stroeve J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029703; Thiemann GW, 2008, ORYX, V42, P504, DOI 10.1017/S0030605308001877; U.S. Climate Change Science Program, 2007, SCEN GREENH GAS EM A; Washington WM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037074; Wigley TML, 2005, SCIENCE, V307, P1766, DOI 10.1126/science.1103934; Winton M, 2008, GEOPHYS MONOGR SER, V180, P111, DOI 10.1029/180GM09	37	96	100	7	302	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					955	958		10.1038/nature09653	http://dx.doi.org/10.1038/nature09653			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164484				2022-12-28	WOS:000285344600045
J	Booth, LN; Tuch, BB; Johnson, AD				Booth, Lauren N.; Tuch, Brian B.; Johnson, Alexander D.			Intercalation of a new tier of transcription regulation into an ancient circuit	NATURE			English	Article							HETEROTRIMERIC G-PROTEIN; YEAST CANDIDA-ALBICANS; CELL-CYCLE ARREST; SACCHAROMYCES-CEREVISIAE; KLUYVEROMYCES-LACTIS; GENE-EXPRESSION; EVOLUTION; PHEROMONE; IDENTIFICATION; MEIOSIS	Changes in gene regulatory networks are a major source of evolutionary novelty(1-3). Here we describe a specific type of network rewiring event, one that intercalates a new level of transcriptional control into an ancient circuit. We deduce that, over evolutionary time, the direct ancestral connections between a regulator and its target genes were broken and replaced by indirect connections, preserving the overall logic of the ancestral circuit but producing a new behaviour. The example was uncovered through a series of experiments in three ascomycete yeasts: the bakers' yeast Saccharomyces cerevisiae, the dairy yeast Kluyveromyces lactis and the human pathogen Candida albicans. All three species have three cell types: two mating-competent cell forms (a and alpha) and the product of their mating (a/alpha), which is mating-incompetent. In the ancestral mating circuit, two homeodomain proteins, Mata1 and Mat alpha 2, form a heterodimer that directly represses four genes that are expressed only in a and alpha cells and are required for mating(4-6). In a relatively recent ancestor of K. lactis, a reorganization occurred. The Mata1-Mat alpha 2 heterodimer represses the same four genes (known as the core haploid-specific genes) but now does so indirectly through an intermediate regulatory protein, Rme1. The overall logic of the ancestral circuit is preserved (haploid-specific genes ON in a and alpha cells and OFF in a/alpha cells), but a new phenotype was produced by the rewiring: unlike S. cerevisiae and C. albicans, K. lactis integrates nutritional signals, by means of Rme1, into the decision of whether or not to mate.	[Booth, Lauren N.; Tuch, Brian B.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Booth, Lauren N.; Tuch, Brian B.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA.	ajohnson@cgl.ucsf.edu			National Institutes of Health [RO1 GM037049]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Q. Mitrovich, O. Homann, A. Hernday, M. Miller, C. Cain, T. Sorrells and H. Madhani for helpful discussions and technical contributions; and S. Astrom for generously providing the K. lactis strains used in this study. The S. cerevisiae strains were a gift from the H. Madhani and J. Li laboratories. The work was funded by grant RO1 GM037049 from the National Institutes of Health. L.N.B. is a National Science Foundation Graduate Research Fellow.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barsoum E, 2010, GENETICS, V184, P999, DOI 10.1534/genetics.110.114678; Barsoum E, 2010, GENE DEV, V24, P33, DOI 10.1101/gad.557310; Bennett RJ, 2003, MOL CELL BIOL, V23, P8189, DOI 10.1128/MCB.23.22.8189-8201.2003; Butty AC, 1998, SCIENCE, V282, P1511, DOI 10.1126/science.282.5393.1511; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Coria R, 2006, FEMS YEAST RES, V6, P336, DOI 10.1111/j.1567-1364.2005.00022.x; Cote P, 2008, MOL MICROBIOL, V68, P392, DOI 10.1111/j.1365-2958.2008.06158.x; COVITZ PA, 1993, GENE DEV, V7, P1598, DOI 10.1101/gad.7.8.1598; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dignard D, 2008, EUKARYOT CELL, V7, P1591, DOI 10.1128/EC.00077-08; Ezov TK, 2006, GENETICS, V174, P1455, DOI 10.1534/genetics.106.062745; Falcone C., 2003, SPRINGER LAB MANUAL, P195; Galgoczy DJ, 2004, P NATL ACAD SCI USA, V101, P18069, DOI 10.1073/pnas.0407611102; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Gojkovic Z, 2000, J MOL BIOL, V295, P1073, DOI 10.1006/jmbi.1999.3393; GOUTTE C, 1994, EMBO J, V13, P1434, DOI 10.1002/j.1460-2075.1994.tb06397.x; HERMAN AI, 1970, ANTON VAN LEE J M S, V36, P421, DOI 10.1007/BF02069042; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Hickman MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000710; Homann OR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-49; Hull CM, 1999, SCIENCE, V285, P1271, DOI 10.1126/science.285.5431.1271; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; KASSIR Y, 1976, GENETICS, V82, P187; KURTZMAN CP, 2000, YEASTS TAXONOMIC STU; Lemoine S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-467; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MITCHELL AP, 1986, NATURE, V319, P738, DOI 10.1038/319738a0; Mitrovich QM, 2007, GENOME RES, V17, P492, DOI 10.1101/gr.6111907; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Srikantha T, 2006, EUKARYOT CELL, V5, P1674, DOI 10.1128/EC.00252-06; TOONE WM, 1995, EMBO J, V14, P5824, DOI 10.1002/j.1460-2075.1995.tb00270.x; Tsong AE, 2003, CELL, V115, P389, DOI 10.1016/S0092-8674(03)00885-7; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	43	57	65	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					959	U358		10.1038/nature09560	http://dx.doi.org/10.1038/nature09560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164485	Green Accepted			2022-12-28	WOS:000285344600046
J	Elowitz, M; Lim, WA				Elowitz, Michael; Lim, Wendell A.			Build life to understand it	NATURE			English	Editorial Material							SYNTHETIC BIOLOGY		[Elowitz, Michael] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	California Institute of Technology; University of California System; University of California San Francisco	Elowitz, M (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	melowitz@caltech.edu; lim@cmp.ucsf.edu			NEI NIH HHS [PN2 EY016546] Funding Source: Medline; NIGMS NIH HHS [R01 GM055040-11, R01 GM055040, P50 GM081879] Funding Source: Medline; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040, P50GM081879] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bar-Even A, 2010, P NATL ACAD SCI USA, V107, P8889, DOI 10.1073/pnas.0907176107; Bashor CJ, 2010, ANNU REV BIOPHYS, V39, P515, DOI 10.1146/annurev.biophys.050708.133652; Carothers JM, 2009, CURR OPIN BIOTECH, V20, P498, DOI 10.1016/j.copbio.2009.08.001; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Noor E, 2010, MOL CELL, V39, P809, DOI 10.1016/j.molcel.2010.08.031; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yeh BJ, 2007, NAT CHEM BIOL, V3, P521, DOI 10.1038/nchembio0907-521	9	140	147	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 16	2010	468	7326					889	890		10.1038/468889a	http://dx.doi.org/10.1038/468889a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164460	Green Accepted			2022-12-28	WOS:000285344600018
J	Linsel-Nitschke, P; Samani, NJ; Schunkert, H				Linsel-Nitschke, Patrick; Samani, Nilesh J.; Schunkert, Heribert			Sorting Out Cholesterol and Coronary Artery Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LOCUS		[Linsel-Nitschke, Patrick; Schunkert, Heribert] Univ Lubeck, Med Klin 2, Lubeck, Germany; [Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Samani, Nilesh J.] Univ Leicester, Leicester Natl Inst Hlth Res, Biomed Res Unit Cardiovasc Dis, Leicester, Leics, England	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Leicester; University of Leicester	Linsel-Nitschke, P (corresponding author), Univ Lubeck, Med Klin 2, Lubeck, Germany.							Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006; Linsel-Nitschke P, 2010, ATHEROSCLEROSIS, V208, P183, DOI 10.1016/j.atherosclerosis.2009.06.034; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366	5	26	28	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2010	363	25					2462	2463		10.1056/NEJMcibr1010765	http://dx.doi.org/10.1056/NEJMcibr1010765			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZK	21158662	Green Published			2022-12-28	WOS:000285340200016
J	Rothberg, MB; Arora, A; Hermann, J; Kleppel, R; St Marie, P; Visintainer, P				Rothberg, Michael B.; Arora, Ashish; Hermann, Jodie; Kleppel, Reva; St Marie, Peter; Visintainer, Paul			CHRISTMAS 2010: THE LIVES OF DOCTORS Phantom vibration syndrome among medical staff: a cross sectional survey	BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To describe the prevalence of and risk factors for experiencing "phantom vibrations," the sensory hallucination sometimes experienced by people carrying pagers or cell phones when the device is not vibrating. Design Cross sectional survey. Setting Academic medical centre. Participants 176 medical staff who responded to questionnaire (76% of the 232 people invited). Measurements Electronic survey consisting of 17 questions about demographics, device use, phantom vibrations experienced, and attempts to stop them. Results Of the 169 participants who answered the question, 115 (68%, 95% confidence interval 61% to 75%) reported having experienced phantom vibrations. Most (68/112) who experienced phantom vibrations did so after carrying the device between 1 month and 1 year, and 13% experienced them daily. Four factors were independently associated with phantom vibrations: occupation (resident v attending physician, prevalence ratio 1.47, 95% confidence interval 1.10 to 1.97), device location (breast pocket v belt, prevalence ratio 1.66, 1.29 to 2.14), hours carried (per 6 hour increment, prevalence ratio 1.30, 1.07 to 1.58), and more frequent use in vibrate mode (per frequency category, prevalence ratio 1.18, 1.03 to 1.34). Of those who experienced phantom vibrations, 43 (39%, 30% to 48%) were able to stop them. Strategies for stopping phantom vibrations included taking the device off vibrate mode, changing the location of the device, and using a different device (success rates 75% v 63% v 50%, respectively, P=0.217). However, 39% (30% to 49%) of respondents did not attempt any strategies. Conclusions Phantom vibration syndrome is common among those who use electronic devices.	[Rothberg, Michael B.; Arora, Ashish; Hermann, Jodie; Kleppel, Reva; St Marie, Peter; Visintainer, Paul] Baystate Med Ctr, Div Gen Med, Springfield, MA 01199 USA; [Rothberg, Michael B.; Arora, Ashish; Hermann, Jodie; Kleppel, Reva; St Marie, Peter; Visintainer, Paul] Tufts Univ, Sch Med, Boston, MA 02111 USA	Baystate Medical Center; Tufts University	Rothberg, MB (corresponding author), Baystate Med Ctr, Div Gen Med & Geriatr, 759 Chestnut St, Springfield, MA 01199 USA.	Michael.Rothberg@bhs.org	ARORA, ASHISH/ABE-6212-2021	Visintainer, Paul/0000-0002-2491-1242; St. Marie, Peter/0000-0002-3567-2582				Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Goodman B, 2006, NY TIMES        0504; Haupt A., 2007, US TODAY        0612; Laramie D., 2007, THESIS ALLIANT INT U; Market Information and Statistics Division TDB International Telecommunication Union, 2009, WORLD 2009 ICT FACTS; PENNEBAKER JW, 1981, J PERS SOC PSYCHOL, V41, P213, DOI 10.1037/0022-3514.41.2.213	7	35	35	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 15	2010	341								c6914	10.1136/bmj.c6914	http://dx.doi.org/10.1136/bmj.c6914			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XJ	21159761	hybrid			2022-12-28	WOS:000285552800008
J	McKee, M; Diethelm, P				McKee, Martin; Diethelm, Pascal			Christmas 2010: Reading between the Lines How the growth of denialism undermines public health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BELIEFS; SCIENCE		[McKee, Martin] London Sch Hyg & Trop Med, London WC1H 9SH, England; [Diethelm, Pascal] OxyRomandie, Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine	McKee, M (corresponding author), London Sch Hyg & Trop Med, London WC1H 9SH, England.	martin.mckee@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683				[Anonymous], 2008, GUARDIAN        0731; [Anonymous], 2010, BBC NEWS        0819; Bates S, 2008, GUARDIAN        0401; BEGG N, 1994, BRIT MED J, V309, P1073, DOI 10.1136/bmj.309.6961.1073; Chigwedere P, 2010, AIDS BEHAV, V14, P237, DOI 10.1007/s10461-009-9654-7; Diethelm PA, 2005, LANCET, V366, P86, DOI 10.1016/S0140-6736(05)66474-4; Diethelm P, 2009, EUR J PUBLIC HEALTH, V19, P2, DOI 10.1093/eurpub/ckn139; Elliott L, 2010, GUARDIAN        0901; Festinger L., 1956, PROPHECY FAILS SOCIA; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Feygina I, 2010, PERS SOC PSYCHOL B, V36, P326, DOI 10.1177/0146167209351435; Goldacre Ben, 2009, BAD SCI; Gollust SE, 2009, AM J PUBLIC HEALTH, V99, P2160, DOI 10.2105/AJPH.2009.161414; Guillaume Louise, 2008, Health Informatics J, V14, P323, DOI 10.1177/1460458208096654; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hoofnagle C, DENIALISM BLOG; Kamerow D., 2008, BMJ-BRIT MED J, V337, pa2093; McKee M, 2003, EUR J PUBLIC HEALTH, V13, P289, DOI 10.1093/eurpub/13.4.289; McKee M, 2006, BRIT MED J, V333, P871, DOI 10.1136/bmj.39003.629606.BE; Monbiot G, 2010, GUARDIAN        0624; Munro GD, 2010, J APPL SOC PSYCHOL, V40, P579, DOI 10.1111/j.1559-1816.2010.00588.x; NICOLL A, 1993, AIDS CARE, V5, P231, DOI 10.1080/09540129308258604; Nyhan B, 2010, POLIT BEHAV, V32, P303, DOI 10.1007/s11109-010-9112-2; Ong EK, 2001, AM J PUBLIC HEALTH, V91, P1749, DOI 10.2105/AJPH.91.11.1749; Seal J, 2005, SANTA LIFE; Swami V, 2010, APPL COGNITIVE PSYCH, V24, P749, DOI 10.1002/acp.1583; Taleb N.N., 2010, BLACK SWAN IMPACT HI, DOI DOI 10.1176/PS.2009.60.11.1564; Westen D, 2006, J COGNITIVE NEUROSCI, V18, P1947, DOI 10.1162/jocn.2006.18.11.1947; Woodward B, 2004, PLAN ATTACK BUSH W 2	29	19	20	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2010	341								c6950	10.1136/bmj.c6950	http://dx.doi.org/10.1136/bmj.c6950			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XD	21156741	Green Accepted			2022-12-28	WOS:000285552200006
J	Malik, I				Malik, Iqbal			Is coronary artery bypass grafting the treatment of choice for diabetic patients with multivessel disease? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR OUTCOMES; REVASCULARIZATION; MELLITUS; INTERVENTION; MANAGEMENT; HEART		[Malik, Iqbal] Imperial Coll Healthcare NHS Trust, Int Ctr Circ Hlth Cardiovascular Sci & Renal Inst, London W2 1NY, England	Imperial College London	Malik, I (corresponding author), Imperial Coll Healthcare NHS Trust, Int Ctr Circ Hlth Cardiovascular Sci & Renal Inst, London W2 1NY, England.	Iqbal.malik@imperial.nhs.uk						Anselmino M, 2008, EUR J CARDIOV PREV R, V15, P216, DOI 10.1097/HJR.0b013e3282f335d0; Banning AP, 2010, J AM COLL CARDIOL, V55, P1067, DOI 10.1016/j.jacc.2009.09.057; Bari D Study Grp, 2009, NEW ENGL J MED, V360, P2503, DOI 10.1056/NEJMoa0805796; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048; Carson JL, 2002, J AM COLL CARDIOL, V40, P418, DOI 10.1016/S0735-1097(02)01969-1; Cooper-DeHoff RM, 2010, JAMA-J AM MED ASSOC, V304, P61, DOI 10.1001/jama.2010.884; Detre KM, 1999, CIRCULATION, V99, P633, DOI 10.1161/01.CIR.99.5.633; Farkouh ME, 2008, AM HEART J, V155, P215, DOI 10.1016/j.ahj.2007.10.012; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014; Kim LJ, 2009, JACC-CARDIOVASC INTE, V2, P384, DOI 10.1016/j.jcin.2009.01.009; Lee MS, 2010, AM J CARDIOL, V105, P1540, DOI 10.1016/j.amjcard.2010.01.009; Mak KH, 1997, J AM COLL CARDIOL, V30, P171, DOI 10.1016/S0735-1097(97)00118-6; Malmberg K, 2000, CIRCULATION, V102, P1014, DOI 10.1161/01.CIR.102.9.1014; *NAT CLIN GUID CTR, CLIN GUID, V94; Pignone M, 2010, J AM COLL CARDIOL, V55, P2878, DOI 10.1016/j.jacc.2010.04.003; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626	19	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2010	341								c6975	10.1136/bmj.c6975	http://dx.doi.org/10.1136/bmj.c6975			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XA	21149467				2022-12-28	WOS:000285551900006
J	Chakraborty, A; Koldobskiy, MA; Bello, NT; Maxwell, M; Potter, JJ; Juluri, KR; Maag, D; Kim, S; Huang, AS; Dailey, MJ; Saleh, M; Snowman, AM; Moran, TH; Mezey, E; Snyder, SH				Chakraborty, Anutosh; Koldobskiy, Michael A.; Bello, Nicholas T.; Maxwell, Micah; Potter, James J.; Juluri, Krishna R.; Maag, David; Kim, Seyun; Huang, Alex S.; Dailey, Megan J.; Saleh, Masoumeh; Snowman, Adele M.; Moran, Timothy H.; Mezey, Esteban; Snyder, Solomon H.			Inositol Pyrophosphates Inhibit Akt Signaling, Thereby Regulating Insulin Sensitivity and Weight Gain	CELL			English	Article							PROTEIN-KINASE-B; MICE LACKING; PPAR-GAMMA; FAT MASS; PHOSPHORYLATION; ACTIVATION; MTOR; PHOSPHOINOSITIDES; RESISTANCE; MEMBRANE	The inositol pyrophosphate IP7 (5-diphosphoinositolpentakisphosphate), formed by a family of three inositol hexakisphosphate kinases (IP6Ks), modulates diverse cellular activities. We now report that IP7 is a physiologic inhibitor of Akt, a serine/threonine kinase that regulates glucose homeostasis and protein translation, respectively, via the GSK3 beta and mTOR pathways. Thus, Akt and mTOR signaling are dramatically augmented and GSK3b signaling reduced in skeletal muscle, white adipose tissue, and liver of mice with targeted deletion of IP6K1. IP7 affects this pathway by potently inhibiting the PDK1 phosphorylation of Akt, preventing its activation and thereby affecting insulin signaling. IP6K1 knockout mice manifest insulin sensitivity and are resistant to obesity elicited by high-fat diet or aging. Inhibition of IP6K1 may afford a therapeutic approach to obesity and diabetes.	[Chakraborty, Anutosh; Koldobskiy, Michael A.; Maxwell, Micah; Juluri, Krishna R.; Maag, David; Kim, Seyun; Huang, Alex S.; Saleh, Masoumeh; Snowman, Adele M.; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Bello, Nicholas T.; Dailey, Megan J.; Moran, Timothy H.; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Potter, James J.; Mezey, Esteban] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu	Kim, Seyun/B-3387-2012	Bello, Nicholas/0000-0001-5300-5604	U.S. Public Health Service [MH18501, DA-000266]; Research Scientist Award [DA00074]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018501, R01MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266, K05DA000074] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Research Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Robert Luo for providing the pCDNA-TOPO-V5/His full-length and Delta PH Akt constructs; Susan Aja for the Oxymax experiments; Cory Brayton for histological analysis; Molee Chakraborty, Nadine Forbes, Kent Werner, and Gary Ho for technical support; and Asif Mustafa for helpful discussions. This work was supported by U.S. Public Health Service Grants MH18501 and DA-000266 and Research Scientist Award DA00074 (to S.H.S.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Barker CJ, 2009, CELL MOL LIFE SCI, V66, P3851, DOI 10.1007/s00018-009-0115-2; BENNETT M, 2000, NAT REV MOL CELL BIO, V1, P11; Bhandari R, 2008, P NATL ACAD SCI USA, V105, P2349, DOI 10.1073/pnas.0712227105; Bhandari R, 2007, P NATL ACAD SCI USA, V104, P15305, DOI 10.1073/pnas.0707338104; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Chakraborty A, 2008, P NATL ACAD SCI USA, V105, P1134, DOI 10.1073/pnas.0711168105; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; CURRIE RA, 2001, BIOCHEM J, V337, P575; DEPINTO FL, 2010, LIVER INT, V30, P603; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Downes CP, 2005, BIOCHEM SOC T, V33, P1303, DOI 10.1042/BST0331303; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; FRUMAN DA, 1985, BIOCHEM SOC T, V27, P624; Funai K, 2006, AM J PHYSIOL-REG I, V290, pR1080, DOI 10.1152/ajpregu.00277.2005; Hand CE, 2007, BIOORG MED CHEM LETT, V17, P183, DOI 10.1016/j.bmcl.2006.09.066; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hoffler U, 2009, ENDOCRINE, V36, P311, DOI 10.1007/s12020-009-9224-9; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Ito M, 2008, J ENDOCRINOL, V198, P309, DOI 10.1677/JOE-08-0087; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kaidanovich Oksana, 2002, Expert Opin Ther Targets, V6, P555; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Koldobskiy MA, 2010, P NATL ACAD SCI USA, V107, P20947, DOI 10.1073/pnas.1015671107; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lin HY, 2009, J BIOL CHEM, V284, P1863, DOI 10.1074/jbc.M805686200; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Padmanabhan U, 2009, J BIOL CHEM, V284, P10571, DOI 10.1074/jbc.M900752200; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Ruggero D, 2005, ONCOGENE, V24, P7426, DOI 10.1038/sj.onc.1209098; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shao J, 2000, J ENDOCRINOL, V167, P107, DOI 10.1677/joe.0.1670107; Shay KP, 2009, BIOGERONTOLOGY, V10, P443, DOI 10.1007/s10522-008-9187-x; Shears SB, 2007, BIOCHEM SOC SYMP, V74, P211, DOI 10.1042/BSS2007c18; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tou JCL, 2002, EXP BIOL MED, V227, P587, DOI 10.1177/153537020222700806; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Welsh GL, 2005, BIOCHEM SOC T, V33, P346, DOI 10.1042/BST0330346; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	65	240	255	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					897	910		10.1016/j.cell.2010.11.032	http://dx.doi.org/10.1016/j.cell.2010.11.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145457	Bronze, Green Accepted			2022-12-28	WOS:000285182600008
J	Karhausen, LR				Karhausen, Lucien R.			Christmas 2010: History Mozart's 140 causes of death and 27 mental disorders	BRITISH MEDICAL JOURNAL			English	Editorial Material												lucienkarhausen@gmail.com						AUTEXIER PA, 1982, OEUVRES TEMOINS MOZA; BITTNER G, 1992, WA MOZART, P27; BONE JM, 1992, B LIVERPOOL MED HIST, V5, P20; DAVIES PJ, 1989, MOZART PERSON HIS CH; Ferenczi S., 1955, FINAL CONTRIBUTIONS, P197; GELBER GS, 1993, MENT HEAL LIB MONOGR, P67; GERBER PH, 1898, DEUT MED WOCHENSCHR, V22, P351; HEINE EW, 1984, ERMORDETE MOZART ENT; Karhausen L R, 2001, J Med Biogr, V9, P109; Karhausen L R, 2001, J Med Biogr, V9, P34; Karhausen L R, 2002, J Med Biogr, V10, P109; Karhausen L R, 1999, J Med Biogr, V7, P111; KARHAUSEN LR, 1993, BRIT MED J, V306, P522, DOI 10.1136/bmj.306.6876.522; Karhausen LR, 1998, J ROY SOC MED, V91, P546, DOI 10.1177/014107689809101019; KARHAUSEN LR, 1995, PERSPECT BIOL MED, V39, P152; KARHAUSEN LR, 1990, TLS-TIMES LIT SUPPL, P1375; KARHAUSEN LR, 2009, ANN INTERN MED  1013; KARHAUSEN LR, 1996, MITTEILUNGEN INT STI, V44, P60; KERNER D, 1961, Z Laryngol Rhinol Otol, V40, P475; LANGEEICHBAUM W, 1935, IRRSINN RHUM; Mackowiak P, 2007, POST MORTEM SOLVING; MILLS JL, 1993, NEW ENGL J MED, V329, P1196, DOI 10.1056/NEJM199310143291613; NISSEN GN, 1991, BIOGRAPHIE WA MOZART; RIVERE J, 1956, MUSICA PARIS, V27, P23; Scheidt W, 1965, Med Klin, V60, P1789; SLATER E, 1960, CONFIN PSYCHIAT, V2, P129	26	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 10	2010	341								c6789	10.1136/bmj.c6789	http://dx.doi.org/10.1136/bmj.c6789			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	695AE	21148619				2022-12-28	WOS:000285342200003
J	Binder, WD; Traum, AZ; Makar, RS; Colvin, RB				Binder, William D.; Traum, Avram Z.; Makar, Robert S.; Colvin, Robert B.			Case 37-2010: A 16-Year-Old Girl with Confusion, Anemia, and Thrombocytopenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; HEMOLYTIC-UREMIC SYNDROME; VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; THROMBOTIC MICROANGIOPATHIES; NEUROLOGIC MANIFESTATIONS; CLINICAL-OUTCOMES; PLASMA-EXCHANGE; PURPURA; ADAMTS13		[Binder, William D.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Traum, Avram Z.] Massachusetts Gen Hosp, Pediat Nephrol Serv, Boston, MA 02114 USA; [Makar, Robert S.] Massachusetts Gen Hosp, Blood Transfus Serv, Boston, MA 02114 USA; [Colvin, Robert B.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Binder, William D.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Traum, Avram Z.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Makar, Robert S.; Colvin, Robert B.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Binder, WD (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA.							Allford SL, 2003, BRIT J HAEMATOL, V120, P556, DOI 10.1046/j.1365-2141.2003.04049.x; BELL WR, 1991, NEW ENGL J MED, V325, P398, DOI 10.1056/NEJM199108083250605; Bennett CL, 2007, J AM COLL CARDIOL, V50, P1138, DOI 10.1016/j.jacc.2007.04.093; Benseler SM, 2007, RHEUM DIS CLIN N AM, V33, P471, DOI 10.1016/j.rdc.2007.07.008; Chavez-Bueno S, 2005, PEDIATR CLIN N AM, V52, P795, DOI 10.1016/j.pcl.2005.02.011; Chemnitz J, 2002, AM J HEMATOL, V71, P105, DOI 10.1002/ajh.10204; Coppo P, 2004, MEDICINE, V83, P233, DOI 10.1097/01.md.0000133622.03370.07; Cuchacovich R, 2009, RHEUM DIS CLIN N AM, V35, P75, DOI 10.1016/j.rdc.2009.03.003; Furlan M, 1997, BLOOD, V89, P3097, DOI 10.1182/blood.V89.9.3097; Furlan M, 1998, BLOOD, V91, P2839, DOI 10.1182/blood.V91.8.2839.2839_2839_2846; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Galbusera M, 2005, BLOOD, V106, P925, DOI 10.1182/blood-2004-12-4885; George JN, 2000, BLOOD, V96, P1223, DOI 10.1182/blood.V96.4.1223.h8001223_1223_1229; George JN, 2006, NEW ENGL J MED, V354, P1927, DOI 10.1056/NEJMcp053024; Glassock RJ, 2007, J AM SOC NEPHROL, V18, P2221, DOI 10.1681/ASN.2006111300; Goldstein JN, 2009, EMERG MED CLIN N AM, V27, P1, DOI 10.1016/j.emc.2008.07.002; Greenberg BM, 2009, NEUROLOGIST, V15, P115, DOI 10.1097/NRL.0b013e31818ff9aa; HARKNESS DR, 1981, JAMA-J AM MED ASSOC, V246, P1931, DOI 10.1001/jama.246.17.1931; JAFFEY PB, 2005, EMERGEN MED, V37, P36; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Lehman RK, 2008, CLIN PEDIATR EMERG M, V9, P68, DOI 10.1016/j.cpem.2008.02.003; Marcus N, 2008, ISR MED ASSOC J, V10, P395; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Muscal E, 2010, NEUROL CLIN, V28, P61, DOI 10.1016/j.ncl.2009.09.004; RIDOLFI RL, 1981, MEDICINE, V60, P413, DOI 10.1097/00005792-198111000-00003; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; Sadler JE, 2008, BLOOD, V112, P11, DOI 10.1182/blood-2008-02-078170; Schmugge M, 2003, J PEDIATR-US, V143, P666, DOI 10.1067/S0022-3476(03)00389-5; Swisher KK, 2009, TRANSFUSION, V49, P873, DOI 10.1111/j.1537-2995.2008.02082.x; Terrell DR, 2005, J THROMB HAEMOST, V3, P1432, DOI 10.1111/j.1538-7836.2005.01436.x; Tsai H M, 2001, Clin Lab, V47, P387; Tsai HM, 2006, KIDNEY INT, V70, P16, DOI 10.1038/sj.ki.5001535; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Vesely SK, 2003, BLOOD, V102, P60, DOI 10.1182/blood-2003-01-0193; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Zheng XL, 2004, BLOOD, V103, P4043, DOI 10.1182/blood-2003-11-4035; Zheng XL, 2003, ANN INTERN MED, V138, P105, DOI 10.7326/0003-4819-138-2-200301210-00011; Ziakas PD, 2005, ANN RHEUM DIS, V64, P1366, DOI 10.1136/ard.2004.033100	38	7	10	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2010	363	24					2352	2361		10.1056/NEJMcpc0910929	http://dx.doi.org/10.1056/NEJMcpc0910929			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691PA	21142538				2022-12-28	WOS:000285092100012
J	Furman, JL; Murray, F; Stern, S				Furman, Jeffrey L.; Murray, Fiona; Stern, Scott			More for the research dollar	NATURE			English	Editorial Material									[Furman, Jeffrey L.] Boston Univ, Sch Management, Boston, MA 02215 USA; [Murray, Fiona; Stern, Scott] MIT Sloan Sch Management, Cambridge, MA 02142 USA	Boston University; Massachusetts Institute of Technology (MIT)	Furman, JL (corresponding author), Boston Univ, Sch Management, Boston, MA 02215 USA.	fmurray@mit.edu	Furman, Jeffrey L/A-9771-2008	Furman, Jeffrey L/0000-0002-6273-8380				Chandrasekharan S, 2009, NAT BIOTECHNOL, V27, P140, DOI 10.1038/nbt0209-140; FURMAN J, AM EC REV IN PRESS; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; LEMLEY MA, 2007, HOFSTRA L REV, V36, P257; MURRAY F, AM J SOCIOL IN PRESS; Murray Fiona, 2009, 14819 NBER; Shane S, 2007, J ECON BEHAV ORGAN, V63, P739, DOI 10.1016/j.jebo.2006.05.012; Smaglik P, 2000, NATURE, V403, P350, DOI 10.1038/35000368; Williams Heidi L., 2010, 16213 NBER	9	7	7	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					757	758		10.1038/468757a	http://dx.doi.org/10.1038/468757a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21150972	Bronze			2022-12-28	WOS:000285093700017
J	Teske, A				Teske, Andreas			Cryptic Links in the Ocean	SCIENCE			English	Editorial Material							OXYGEN MINIMUM ZONE; CHILE; THIOPLOCA; SULFUR		Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Teske, A (corresponding author), Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27599 USA.	teske@email.unc.edu	Teske, Andreas/AAQ-9577-2021					Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; FOSSING H, 1995, NATURE, V374, P713, DOI 10.1038/374713a0; Gallardo V.A., 1992, GAYANA OCEANOL, V1, P27; GALLARDO VA, 1977, NATURE, V268, P331, DOI 10.1038/268331a0; German CR, 2010, P NATL ACAD SCI USA, V107, P14020, DOI 10.1073/pnas.1009205107; Molina V, 2005, MAR ECOL PROG SER, V288, P35, DOI 10.3354/meps288035; Morales CE, 1999, J MAR RES, V57, P909, DOI 10.1357/002224099321514097; Otte S, 1999, APPL ENVIRON MICROB, V65, P3148; Schulz HN, 2000, MAR ECOL PROG SER, V200, P117, DOI 10.3354/meps200117; Stevens H, 2008, ENVIRON MICROBIOL, V10, P1244, DOI 10.1111/j.1462-2920.2007.01539.x; Sunamura M, 2004, APPL ENVIRON MICROB, V70, P1190, DOI 10.1128/AEM.70.2.1190-1198.2004; Walsh DA, 2009, SCIENCE, V326, P578, DOI 10.1126/science.1175309; Zopfi J, 2008, GEOCHIM COSMOCHIM AC, V72, P827, DOI 10.1016/j.gca.2007.11.031	13	11	11	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1326	1327		10.1126/science.1198400	http://dx.doi.org/10.1126/science.1198400			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127234				2022-12-28	WOS:000284902100024
J	Feldser, DM; Kostova, KK; Winslow, MM; Taylor, SE; Cashman, C; Whittaker, CA; Sanchez-Rivera, FJ; Resnick, R; Bronson, R; Hemann, MT; Jacks, T				Feldser, David M.; Kostova, Kamena K.; Winslow, Monte M.; Taylor, Sarah E.; Cashman, Chris; Whittaker, Charles A.; Sanchez-Rivera, Francisco J.; Resnick, Rebecca; Bronson, Roderick; Hemann, Michael T.; Jacks, Tyler			Stage-specific sensitivity to p53 restoration during lung cancer progression	NATURE			English	Article							ONCOGENIC K-RAS; TUMOR PROGRESSION; IN-VIVO; SENESCENCE; PROLIFERATION; AMPLIFICATION; EXPRESSION; MICE	Tumorigenesis is a multistep process that results from the sequential accumulation of mutations in key oncogene and tumour suppressor pathways. Personalized cancer therapy that is based on targeting these underlying genetic abnormalities presupposes that sustained inactivation of tumour suppressors and activation of oncogenes is essential in advanced cancers. Mutations in the p53 tumour-suppressor pathway are common in human cancer and significant efforts towards pharmaceutical reactivation of defective p53 pathways are underway(1-3). Here we show that restoration of p53 in established murine lung tumours leads to significant but incomplete tumour cell loss specifically in malignant adenocarcinomas, but not in adenomas. We define amplification of MAPK signalling as a critical determinant of malignant progression and also a stimulator of Arf tumour-suppressor expression. The response to p53 restoration in this context is critically dependent on the expression of Arf. We propose that p53 not only limits malignant progression by suppressing the acquisition of alterations that lead to tumour progression, but also, in the context of p53 restoration, responds to increased oncogenic signalling to mediate tumour regression. Our observations also underscore that the p53 pathway is not engaged by low levels of oncogene activity that are sufficient for early stages of lung tumour development. These data suggest that restoration of pathways important in tumour progression, as opposed to initiation, may lead to incomplete tumour regression due to the stage-heterogeneity of tumour cell populations.	[Feldser, David M.; Kostova, Kamena K.; Winslow, Monte M.; Taylor, Sarah E.; Cashman, Chris; Whittaker, Charles A.; Sanchez-Rivera, Francisco J.; Resnick, Rebecca; Hemann, Michael T.; Jacks, Tyler] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Feldser, David M.; Kostova, Kamena K.; Winslow, Monte M.; Taylor, Sarah E.; Cashman, Chris; Whittaker, Charles A.; Sanchez-Rivera, Francisco J.; Resnick, Rebecca; Hemann, Michael T.; Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Bronson, Roderick] Tufts Univ, Boston, MA 02115 USA; [Bronson, Roderick] Harvard Univ, Sch Med, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Tufts University; Harvard University; Harvard Medical School	Jacks, T (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu	Kostova, Kamena/AAK-9431-2020; Sánchez-Rivera, Francisco J./AAV-6985-2020	Kostova, Kamena/0000-0001-9973-401X; Sánchez-Rivera, Francisco J./0000-0002-8466-8563; Resnick, Rebecca/0000-0001-5804-4418; Whittaker, Charles/0000-0002-2400-0094; Feldser, David/0000-0001-5975-864X	National Cancer Institute [P30-CA14051]; American Cancer Society; MIT; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); MIT; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank M. DuPage and C. Kim for critical reading of the manuscript. We are indebted to D. Crowley, E. Vasile and M. Griffin at the Koch Institute Core facilities (supported by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute). We are grateful to M. Luo for microarray support. We thank M. Leversha at MSKCC for FISH. D. M. F. has been supported by the American Cancer Society (New England Area Fellow), and is a current Fellow of the Leukemia and Lymphoma Society. K. K. K. is supported by the John Reed Fund of the MIT undergraduate research program. M.M.W. was a Merck Fellow of the Damon Runyon Cancer Research Foundation and a Genentech postdoctoral fellow. T.J. is the David H. Koch Professor of Biology and a Daniel K. Ludwig Scholar. The Howard Hughes Medical Institute supported this work.	Bolstad BM, 2004, INT REV NEUROBIOL, V60, P25; Bolstad BM, 2005, STAT BIOL HEALTH, P13; BREMNER R, 1990, CELL, V61, P407, DOI 10.1016/0092-8674(90)90523-H; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Liu ML, 1998, ONCOGENE, V17, P2403, DOI 10.1038/sj.onc.1202456; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Selivanova G, 2007, ONCOGENE, V26, P2243, DOI 10.1038/sj.onc.1210295; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Young NP, 2010, P NATL ACAD SCI USA, V107, P10184, DOI 10.1073/pnas.1004796107	25	208	214	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					572	U249		10.1038/nature09535	http://dx.doi.org/10.1038/nature09535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107428	Green Accepted, Green Submitted			2022-12-28	WOS:000284584200044
J	Gooley, TA; Chien, JW; Pergam, SA; Hingorani, S; Sorror, ML; Boeckh, M; Martin, PJ; Sandmaier, BM; Marr, KA; Appelbaum, FR; Storb, R; McDonald, GB				Gooley, Ted A.; Chien, Jason W.; Pergam, Steven A.; Hingorani, Sangeeta; Sorror, Mohamed L.; Boeckh, Michael; Martin, Paul J.; Sandmaier, Brenda M.; Marr, Kieren A.; Appelbaum, Frederick R.; Storb, Rainer; McDonald, George B.			Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; INVASIVE FUNGAL-INFECTIONS; RISK-FACTORS; IMMUNE RECONSTITUTION; CONDITIONING REGIMEN; URSODEOXYCHOLIC ACID; RECIPIENTS; CYTOMEGALOVIRUS; COMPLICATIONS	Background: Over the past decade, advances have been made in the care of patients undergoing transplantation. We conducted a study to determine whether these advances have improved the outcomes of transplantation. Methods: We analyzed overall mortality, mortality not preceded by relapse, recurrent malignant conditions, and the frequency and severity of major complications of transplantation, including graft-versus-host disease (GVHD) and hepatic, renal, pulmonary, and infectious complications, among 1418 patients who received their first allogeneic transplants at our center in Seattle in the period from 1993 through 1997 and among 1148 patients who received their first allogeneic transplants in the period from 2003 through 2007. Components of the Pretransplant Assessment of Mortality (PAM) score were used in regression models to adjust for the severity of illness at the time of transplantation. Results: In the 2003-2007 period, as compared with the 1993-1997 period, we observed significant decreases in mortality not preceded by relapse, both at day 200 (by 60%) and overall (by 52%), the rate of relapse or progression of a malignant condition (by 21%), and overall mortality (by 41%), after adjustment for components of the PAM score. The results were similar when the analyses were limited to patients who received myeloablative conditioning therapy. We also found significant decreases in the risk of severe GVHD; disease caused by viral, bacterial, and fungal infections; and damage to the liver, kidneys, and lungs. Conclusions: We found a substantial reduction in the hazard of death related to allogeneic hematopoietic-cell transplantation, as well as increased long-term survival, over the past decade. Improved outcomes appear to be related to reductions in organ damage, infection, and severe acute GVHD. (Funded by the National Institutes of Health.) N Engl J Med 2010;363:2091-101.	[McDonald, George B.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Gastroenterol Hepatol Sect D2 190, Seattle, WA 98109 USA; [Pergam, Steven A.; Boeckh, Michael] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98109 USA; [Chien, Jason W.; Pergam, Steven A.; Sorror, Mohamed L.; Boeckh, Michael; Martin, Paul J.; Sandmaier, Brenda M.; Marr, Kieren A.; Appelbaum, Frederick R.; Storb, Rainer; McDonald, George B.] Univ Washington, Dept Med, Seattle, WA USA; [Hingorani, Sangeeta] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Gooley, Ted A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	McDonald, GB (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, Gastroenterol Hepatol Sect D2 190, 1100 Fairview Ave N, Seattle, WA 98109 USA.		Boeckh, Michael/AAA-1607-2022; Pergam, Steven A/C-2286-2008	Pergam, Steven A/0000-0002-6333-5196	National Institutes of Health [CA 18029, CA 15704, CA78902, HL36444, HL088201, HL088021, HL096831, DK063038]; American Society for Blood and Marrow Transplantation; ViroPharma; Roche/Genentech; Astellas; Pfizer; Merck; Vical; Chimerix; AiCuris; Boehringer Ingelheim; Theraclone Sciences; Soligenix; Basilea; Evolva; Gentium; NATIONAL CANCER INSTITUTE [P01CA018029, P01CA078902, P30CA015704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL088021, K23HL096831, R01HL088201, K99HL088021, P01HL036444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK063038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society for Blood and Marrow Transplantation; ViroPharma; Roche/Genentech(Roche HoldingGenentech); Astellas(Astellas Pharmaceuticals); Pfizer(Pfizer); Merck(Merck & Company); Vical; Chimerix; AiCuris; Boehringer Ingelheim(Boehringer Ingelheim); Theraclone Sciences; Soligenix; Basilea; Evolva; Gentium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants (CA 18029, CA 15704, CA78902, HL36444, HL088201, HL088021, HL096831, and DK063038) from the National Institutes of Health.; Dr. Gooley reports serving as a statistical consultant to DOR BioPharma; Dr. Pergam, receiving research funding from Chimerix and ViroPharma (through a sponsored American Society for Blood and Marrow Transplantation New Investigator Award), and consulting fees from ViroPharma; Dr. Boeckh, receiving grant support, consulting fees, or both from Roche/Genentech, ViroPharma, Astellas, Pfizer, Merck, Vical, Chimerix, AiCuris, Boehringer Ingelheim, and Theraclone Sciences; Dr. Martin, receiving grant support from Roche and Soligenix and payments for serving on data and safety monitoring boards for Pfizer; Dr. Marr, receiving grant support from Astellas and Merck and consulting fees from Astellas, Basilea, Evolva, Merck, and Pfizer; and Dr. McDonald, being a consultant to and holding an equity position with Soligenix and receiving consulting fees from Gentium. No other potential conflict of interest relevant to this article was reported.	al-Jurf M, 2005, J CLIN ONCOL, V23, P5074, DOI 10.1200/JCO.2005.09.020; Appelbaum F, 2009, THOMAS HEMATOPOIETIC; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Boeckh M, 2004, J CLIN MICROBIOL, V42, P1142, DOI 10.1128/JCM.42.3.1142-1148.2004; Boeckh M, 1999, BLOOD, V93, P1781, DOI 10.1182/blood.V93.5.1781; Chien JW, 2010, BONE MARROW TRANSPL, V45, P317, DOI 10.1038/bmt.2009.129; Chien JW, 2008, BLOOD, V111, P2462, DOI 10.1182/blood-2007-09-101709; Clark JG, 1999, CRIT CARE MED, V27, P1800, DOI 10.1097/00003246-199909000-00016; de Lima M, 2004, BLOOD, V104, P857, DOI 10.1182/blood-2004-02-0414; Freudenberger TD, 2003, BLOOD, V102, P3822, DOI 10.1182/blood-2002-06-1813; FRIED RH, 1992, ANN INTERN MED, V116, P624, DOI 10.7326/0003-4819-116-8-624; Fukuda T, 2003, BLOOD, V102, P827, DOI 10.1182/blood-2003-02-0456; Gooley TA, 2005, HEPATOLOGY, V41, P345, DOI 10.1002/hep.20529; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Hakki M, 2003, BLOOD, V102, P3060, DOI 10.1182/blood-2002-11-3472; Hingorani SR, 2008, BIOL BLOOD MARROW TR, V14, P1365, DOI 10.1016/j.bbmt.2008.09.015; Hingorani SR, 2005, KIDNEY INT, V67, P272, DOI 10.1111/j.1523-1755.2005.00078.x; Hockenbery DM, 2007, BLOOD, V109, P4557, DOI 10.1182/blood-2006-05-021139; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Martin PJ, 2004, BIOL BLOOD MARROW TR, V10, P320, DOI 10.1016/j.bbmt.2003.12.304; McCune JS, 2009, CLIN PHARMACOL THER, V85, P615, DOI 10.1038/clpt.2009.27; McDonald GB, 2003, BLOOD, V101, P2043, DOI 10.1182/blood-2002-06-1860; McDonald GB, 2010, HEPATOLOGY, V51, P1450, DOI 10.1002/hep.23533; Mielcarek M, 2009, BLOOD, V113, P2888, DOI 10.1182/blood-2008-07-168401; Nakamae H, 2009, BIOL BLOOD MARROW TR, V15, P694, DOI 10.1016/j.bbmt.2009.02.009; Narimatsu H, 2005, BIOL BLOOD MARROW TR, V11, P429, DOI 10.1016/j.bbmt.2005.01.010; Parimon T, 2006, ANN INTERN MED, V144, P407, DOI 10.7326/0003-4819-144-6-200603210-00007; Parimon T, 2005, AM J RESP CRIT CARE, V172, P384, DOI 10.1164/rccm.200502-212OC; Patriarca F, 2004, BONE MARROW TRANSPL, V33, P751, DOI 10.1038/sj.bmt.1704426; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Ruutu T, 2002, BLOOD, V100, P1977, DOI 10.1182/blood-2001-12-0159; Sandmaier BM, 2009, THOMAS HEMATOPOIETIC, P1043; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Storek J, 2001, BLOOD, V97, P3380, DOI 10.1182/blood.V97.11.3380; Strasser SI, 2009, THOMAS HEMATOPOIETIC; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; Yokoe D, 2009, BONE MARROW TRANSPL, V44, P495, DOI 10.1038/bmt.2009.261	40	1039	1060	0	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2010	363	22					2091	2101		10.1056/NEJMoa1004383	http://dx.doi.org/10.1056/NEJMoa1004383			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684XE	21105791	Green Accepted			2022-12-28	WOS:000284587800004
J	Sommers, BD; Epstein, AM				Sommers, Benjamin D.; Epstein, Arnold M.			Medicaid Expansion - The Soft Underbelly of Health Care Reform?.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sommers, Benjamin D.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Sommers, BD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.		Sommers, Benjamin/D-2871-2011					Call KT, 2008, HEALTH SERV RES, V43, P901, DOI 10.1111/j.1475-6773.2007.00808.x; Cohen Ross D., 2008, HLTH COVERAGE CHILDR; Cohen Ross D., 2007, RESUMING PATH HLTH C; Kaiser, 2009, AR STAT TOD MED STAT; Kaiser Family Foundation, 2010, MED FIN EL PRIM PATH	5	57	57	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2010	363	22					2085	2087		10.1056/NEJMp1010866	http://dx.doi.org/10.1056/NEJMp1010866			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	684XE	21105788	Green Published, Green Submitted			2022-12-28	WOS:000284587800002
J	Duran-Cantolla, J; Aizpuru, F; Montserrat, JM; Ballester, E; Teran-Santos, J; Aguirregomoscorta, JI; Gonzalez, M; Lloberes, P; Masa, JF; De la Pena, M; Carrizo, S; Mayos, M; Barbe, F				Duran-Cantolla, Joaquin; Aizpuru, Felipe; Montserrat, Jose Maria; Ballester, Eugeni; Teran-Santos, Joaquin; Aguirregomoscorta, Jose Ignacio; Gonzalez, Monica; Lloberes, Patricia; Masa, Juan Fernando; De la Pena, Monica; Carrizo, Santiago; Mayos, Mercedes; Barbe, Ferran		Spanish Sleep Breathing Grp	Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE; RISK-FACTOR; PLACEBO; HYPOPNEA; ASSOCIATION; STROKE; CPAP; METAANALYSIS; MORTALITY; OXYGEN	Objective To assess the effect of continuous positive airway pressure (CPAP) on 24 hour ambulatory blood pressure monitoring values in a large number of patients with untreated systemic hypertension of new onset and obstructive sleep apnoea. Design Multicentre, double blind, randomised, placebo controlled trial. Setting Eleven general hospitals in Spain between 2004 and 2007. Participants 340 patients recently diagnosed as having systemic hypertension by a general practitioner (systolic blood pressure >= 140 mm Hg, diastolic blood pressure >= 90 mm Hg, or both) and an apnoea-hypopnoea index per hour of sleep of >15 events/hour. Intervention Patients were assigned to CPAP (n=169) or sham CPAP (n=171) for three months. Main outcome measurements Net changes in the different 24 hour ambulatory blood pressure monitoring values from baseline to three months of optimal or sham CPAP. Results 277 (81%) of the 340 patients randomised were men; the patients had a mean age of 52.4 (SD 10.5) years, a body mass index of 31.9 (5.7), an Epworth sleepiness scale score of 10.1 (4.3), an apnoea-hypopnoea index of 43.5 (24.5). No differences between groups were seen at baseline. Compared with placebo and analysed by intention to treat, the mean 24 hour ambulatory blood pressure of the CPAP group decreased by 1.5 (95% confidence interval: 0.4 to 2.7) mm Hg (P=0.01). The mean 24 hour ambulatory blood pressure monitoring measures decreased by 2.1 mm Hg (0.4 to 3.7) mm Hg (P=0.01) for systolic pressure and 1.3 (0.2 to 2.3) mm Hg (P=0.02) for diastolic blood pressure. Mean nocturnal blood pressure decreased by 2.1 (0.5 to 3.6) mm Hg (P=0.01). Conclusions CPAP produced a statistically significant reduction in blood pressure in patients with systemic hypertension and obstructive sleep apnoea. This reduction is small and did not achieve the 3 mm Hg drop in mean 24 hour ambulatory blood pressure that the trial was powered to detect. Consequently, these results may have uncertain clinical relevance. However, taking into account the prevalence of hypertension and the likelihood of comorbidities, the decrease in blood pressure, although minimal, may be beneficial.	[Duran-Cantolla, Joaquin] Univ Basque Country, Fac Med, Hosp Univ Txagorritxu, Sleep Unit, Vitoria 01009, Spain; [Duran-Cantolla, Joaquin; Barbe, Ferran] IRBlleida, Dept Resp Med, Lleida 25198, Spain; [Aizpuru, Felipe] Hosp Univ Txagorritxu, Araba Res Unit, Vitoria, Spain; [Aizpuru, Felipe; Montserrat, Jose Maria; Ballester, Eugeni; Teran-Santos, Joaquin; Lloberes, Patricia; Masa, Juan Fernando; De la Pena, Monica; Carrizo, Santiago; Barbe, Ferran] Inst Salud Carlos III, Madrid, Spain; [Montserrat, Jose Maria; Ballester, Eugeni] Hosp Clin Barcelona, Dept Resp Med, Sleep Unit, E-08036 Barcelona, Spain; [Teran-Santos, Joaquin] Hosp Gen Yague, Dept Resp & Sleep Med, Burgos 09005, Spain; [Aguirregomoscorta, Jose Ignacio] Hosp Galdakano, Dept Resp Med, Sleep Unit, Vizcaya 48960, Spain; [Gonzalez, Monica] Hosp Univ Marques Valdecilla, Dept Resp & Sleep Med, Santander 39008, Spain; [Lloberes, Patricia] Hosp Valle De Hebron, Dept Resp Med, Sleep Unit, Barcelona 08035, Spain; [Masa, Juan Fernando] Hosp San Pedro de Alcantara, Dept Resp Med, Sleep Unit, Caceres 10003, Spain; [De la Pena, Monica] Hosp Son Dureta, Dept Resp Med, Sleep Unit, Palma de Mallorca 07014, Spain; [Carrizo, Santiago] Hosp Univ Miguel Server, Dept Resp Med, Sleep Unit, Zaragoza 50009, Spain; [Mayos, Mercedes] Hosp San Pablo, Dept Resp Med, Sleep Unit, Barcelona 08030, Spain	University Hospital of Araba; University of Basque Country; Institut de Recerca Biomedica - IRB Lleida; University Hospital of Araba; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; Hospital General Yague; Galdakao Hospital; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitari Vall d'Hebron; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Miguel Servet University Hospital	Duran-Cantolla, J (corresponding author), Univ Basque Country, Fac Med, Hosp Univ Txagorritxu, Sleep Unit, Vitoria 01009, Spain.	joaquin.durancantolla@gmail.com	GONZALEZ, MONICA/AAM-4033-2021; Cantolla, Joaquin Duran/B-6996-2015; Barbé, Ferran/A-5988-2010; Garin, Intza/J-4500-2012; LOPEZ-PICADO, AMANDA/AAF-3948-2019; CARRIZO SIERRA, SANTIAGO/AAO-1780-2021; Lloberes Canadell, Patricia/F-9707-2014	GONZALEZ, MONICA/0000-0003-1516-0181; Barbé, Ferran/0000-0002-2340-8928; LOPEZ-PICADO, AMANDA/0000-0002-5649-296X; Lloberes Canadell, Patricia/0000-0002-1595-8225; de la Pena, Monica/0000-0003-3276-776X; MONTSERRAT, Josep Maria/0000-0003-3098-4605	Spanish Ministry of Health [PI041110]; Basque Government's Department of Health [20031103]; Spanish Respiratory Society	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Basque Government's Department of Health; Spanish Respiratory Society	The study was sponsored by the Spanish Ministry of Health (PI041110), the Basque Government's Department of Health (20031103), and the Spanish Respiratory Society (SEPAR 2005). The sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, and approval of the manuscript. The opinions, results, and conclusions are those of the authors.	Alajmi M, 2007, LUNG, V185, P67, DOI 10.1007/s00408-006-0117-x; Arias MA, 2006, EUR HEART J, V27, P1106, DOI 10.1093/eurheartj/ehi807; Arias MA, 2005, CIRCULATION, V112, P375, DOI 10.1161/CIRCULATIONAHA.104.501841; Barbe F, 2001, ANN INTERN MED, V134, P1015, DOI 10.7326/0003-4819-134-11-200106050-00007; Barbe F, 2010, AM J RESP CRIT CARE, V181, P718, DOI 10.1164/rccm.200901-0050OC; Barnes M, 2004, AM J RESP CRIT CARE, V170, P656, DOI 10.1164/rccm.200311-1571OC; Bazzano LA, 2007, HYPERTENSION, V50, P417, DOI 10.1161/HYPERTENSIONAHA.106.085175; Becker HF, 2003, CIRCULATION, V107, P68, DOI 10.1161/01.CIR.0000042706.47107.7A; Campos-Rodriguez F, 2006, CHEST, V129, P1459, DOI 10.1378/chest.129.6.1459; *CHMP, 2009, GUID MISS DAT CONF C; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Ellen RLB, 2006, J CLIN SLEEP MED, V2, P193; Faccenda JF, 2001, AM J RESP CRIT CARE, V163, P344, DOI 10.1164/ajrccm.163.2.2005037; Farre R, 1999, LANCET, V353, P1154, DOI 10.1016/S0140-6736(99)01056-9; Fox KM, 2003, LANCET, V362, P782; Giles TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001106.pub3; Haentjens P, 2007, ARCH INTERN MED, V167, P757, DOI 10.1001/archinte.167.8.757; Hui DS, 2006, THORAX, V61, P1083, DOI 10.1136/thx.2006.064063; Johnson KG, 2010, J CLIN SLEEP MED, V6, P131; Kaneko Y, 2003, NEW ENGL J MED, V348, P1233, DOI 10.1056/NEJMoa022479; Kohler M, 2008, EUR RESPIR J, V32, P1488, DOI 10.1183/09031936.00026608; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Mansfield DR, 2004, AM J RESP CRIT CARE, V169, P361, DOI 10.1164/rccm.200306-752OC; Mar J, 2003, EUR RESPIR J, V21, P515, DOI 10.1183/09031936.03.00040903; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marshall NS, 2008, SLEEP, V31, pA145; Marshall NS, 2005, THORAX, V60, P427, DOI 10.1136/thx.2004.032078; Masa JF, 2004, AM J RESP CRIT CARE, V170, P1218, DOI 10.1164/rccm.200312-1787OC; McDaid C, 2009, SLEEP MED REV, V13, P427, DOI 10.1016/j.smrv.2009.02.004; Mills PJ, 2006, J APPL PHYSIOL, V100, P343, DOI 10.1152/japplphysiol.00494.2005; Mo Li, 2007, Zhonghua Yi Xue Za Zhi, V87, P1177; Monasterio C, 2001, AM J RESP CRIT CARE, V164, P939, DOI 10.1164/ajrccm.164.6.2008010; Munoz R, 2006, STROKE, V37, P2317, DOI 10.1161/01.STR.0000236560.15735.0f; Newman AB, 2001, AM J EPIDEMIOL, V154, P50, DOI 10.1093/aje/154.1.50; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Norman D, 2006, HYPERTENSION, V47, P840, DOI 10.1161/01.HYP.0000217128.41284.78; O'Connor GT, 2009, AM J RESP CRIT CARE, V179, P1159, DOI 10.1164/rccm.200712-1809OC; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Peppard PE, 2006, ARCH INTERN MED, V166, P1709, DOI 10.1001/archinte.166.16.1709; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Pepperell JCT, 2002, LANCET, V359, P204, DOI 10.1016/S0140-6736(02)07445-7; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Robinson GV, 2006, EUR RESPIR J, V27, P1229, DOI 10.1183/09031936.06.00062805; Rodway GW, 2010, SLEEP, V33, P260, DOI 10.1093/sleep/33.2.260; Tregear S, 2009, J CLIN SLEEP MED, V5, P573; Turnbull F, 2003, LANCET, V362, P1527; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young T, 2008, SLEEP, V31, P1071	52	166	176	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2010	341								c5991	10.1136/bmj.c5991	http://dx.doi.org/10.1136/bmj.c5991			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EA	21106625	Green Published, hybrid			2022-12-28	WOS:000284831400003
J	[Anonymous]				[Anonymous]			An essay on a topic of international health importance	LANCET			English	Editorial Material																			0	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 22	2011	377	9762					350	351						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	714ZO	21167589				2022-12-28	WOS:000286850400031
J	Cavo, M; Tacchetti, P; Patriarca, F; Petrucci, MT; Pantani, L; Galli, M; Di Raimondo, F; Crippa, C; Zamagni, E; Palumbo, A; Offidani, M; Corradini, P; Narni, F; Spadano, A; Pescosta, N; Deliliers, GL; Ledda, A; Cellini, C; Caravita, T; Tosi, P; Baccarani, M				Cavo, Michele; Tacchetti, Paola; Patriarca, Francesca; Petrucci, Maria Teresa; Pantani, Lucia; Galli, Monica; Di Raimondo, Francesco; Crippa, Claudia; Zamagni, Elena; Palumbo, Antonio; Offidani, Massimo; Corradini, Paolo; Narni, Franco; Spadano, Antonio; Pescosta, Norbert; Deliliers, Giorgio Lambertenghi; Ledda, Antonio; Cellini, Claudia; Caravita, Tommaso; Tosi, Patrizia; Baccarani, Michele		GIMEMA Italian Myeloma Network	Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study	LANCET			English	Article							HIGH-DOSE MELPHALAN; COMBINATION THERAPY; ELDERLY-PATIENTS; HERPES-ZOSTER; PREDNISONE; VTD; TRIAL; CHEMOTHERAPY; MAINTENANCE; RELEVANT	Background Thalidomide plus dexamethasone (TD) is a standard induction therapy for myeloma. We aimed to assess the efficacy and safety of addition of bortezomib to TD (VTD) versus TD alone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma. Methods Patients (aged 18-65 years) with previously untreated symptomatic myeloma were enrolled from 73 sites in Italy between May, 2006, and April, 2008, and data collection continued until June 30, 2010. Patients were randomly allocated (1:1 ratio) by a web-based system to receive three 21-day cycles of thalidomide (100 mg daily for the first 14 days and 200 mg daily thereafter) plus dexamethasone (40 mg daily on 8 of the first 12 days, but not consecutively; total of 320 mg per cycle), either alone or with bortezomib (1.3 mg/m(2) on days 1, 4, 8, and 11). The randomisation sequence was computer generated by the study coordinating team and was stratified by disease stage. After double autologous stem-cell transplantation, patients received two 35-day cycles of their assigned drug regimen, VTD or TD, as consolidation therapy. The primary endpoint was the rate of complete or near complete response to induction therapy. Analysis was by intention to treat. Patients and treating physicians were not masked to treatment allocation. This study is still underway but is not recruiting participants, and is registered with ClinicalTrials.gov, number NCT01134484, and with EudraCT, number 2005-003723-39. Findings 480 patients were enrolled and randomly assigned to receive VTD (n=241 patients) or TD (n=239). Six patients withdrew consent before start of treatment, and 236 on VTD and 238 on TD were included in the intention-to-treat analysis. After induction therapy, complete or near complete response was achieved in 73 patients (31%, 95% CI 25.0-36.8) receiving VTD, and 27 (11%, 7.3-15.4) on TD (p<0.0001). Grade 3 or 4 adverse events were recorded in a significantly higher number of patients on VTD (n=132, 56%) than in those on TD (n=79, 33%; p<0.0001), with a higher occurrence of peripheral neuropathy in patients on VTD (n=23, 10%) than in those on TD (n=5, 2%; p=0.0004). Resolution or improvement of severe peripheral neuropathy was recorded in 18 of 23 patients on VTD, and in three of five patients on TD. Interpretation VTD induction therapy before double autologous stem-cell transplantation significantly improves rate of complete or near complete response, and represents a new standard of care for patients with multiple myeloma who are eligible for transplant.	[Cavo, Michele] Univ Bologna, Ist Ematol Seragnoli, Policlin St Orsola Malpighi, I-40138 Bologna, Italy; [Baccarani, Michele] Univ Bologna, Dipartimento Ematol & Sci Oncol Seragnoli, I-40138 Bologna, Italy; [Patriarca, Francesca] Policlin Univ, Clin Ematol, Udine, Italy; [Petrucci, Maria Teresa] Univ Roma La Sapienza, Cattedra Ematol, Rome, Italy; [Galli, Monica] Osped Riuniti Bergamo, Div Ematol, I-24100 Bergamo, Italy; [Di Raimondo, Francesco] Osped Ferrarotto, Cattedra Ematol, Catania, Italy; [Crippa, Claudia] Spedali Civil Brescia, Div Ematol, I-25125 Brescia, Italy; [Palumbo, Antonio] Azienda Osped Univ San Giovanni Battista, Osped Molinette, Dipartimento Ematol, Turin, Italy; [Offidani, Massimo] Osped Nuovo Torrette, Clin Ematol, Ancona, Italy; [Corradini, Paolo] Univ Milan, Ist Nazl Cura Tumori, Div Ematol & Trapianto, Milan, Italy; [Narni, Franco] Azienda Osped Univ Policlin, Unita Trapianto Midollo Ematol, Modena, Italy; [Spadano, Antonio] Osped Civile Spirito Santo, Div Ematol, Pescara, Italy; [Pescosta, Norbert] Osped Gen Reg, Div Ematol, Bolzano, Italy; [Pescosta, Norbert] Osped Gen Reg, Ctr Trapianto Midollo Osseo, Bolzano, Italy; [Deliliers, Giorgio Lambertenghi] Carattere Sci Osped Maggiore, Ist Ricovero & Cura, Ctr Trapianti Midollo Osseo, Unita Operat Ematol 1, Milan, Italy; [Ledda, Antonio] Osped Binaghi, Ctr Trapianti Midollo Osseo, Cagliari, Italy; [Cellini, Claudia] Osped Santa Maria Croci, Unita Operat Ematol, Ravenna, Italy; [Caravita, Tommaso] Osped St Eugenio, Div Ematol, Rome, Italy; [Tosi, Patrizia] Osped Civile Infermi, Div Ematol, Rimini, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; Hospital Santa Maria della Misericordia; Sapienza University Rome; Ospedali Riuniti di Bergamo; Hospital Spedali Civili Brescia; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Sant'Eugenio Hospital	Cavo, M (corresponding author), Univ Bologna, Ist Ematol Seragnoli, Policlin St Orsola Malpighi, Via Massarenti 9, I-40138 Bologna, Italy.	michele.cavo@unibo.it	Patriarca, Francesca/ABH-9856-2020; Morabito, Fortunato/I-7819-2012; Corradini, Paolo/N-7584-2017; Montefusco, Vittorio/D-1133-2017; Pisani, Francesco/ABH-8545-2020; Caravita, Tommaso/O-8929-2019; gozzetti, alessandro/D-9055-2014; CAVO, MICHELE/AAK-8274-2020; tacchetti, paola/L-9608-2013; Roccaro, Aldo/AAA-8957-2022; Di Raimondo, Francesco/K-7965-2016	Corradini, Paolo/0000-0002-9186-1353; Montefusco, Vittorio/0000-0001-7842-3386; Pisani, Francesco/0000-0002-6853-5605; gozzetti, alessandro/0000-0003-0769-6891; CAVO, MICHELE/0000-0003-4514-3227; Roccaro, Aldo/0000-0002-1872-5128; Zamagni, Elena/0000-0003-1422-7305; NARNI, Franco/0000-0003-3994-9101; Baldini, Luca/0000-0003-2964-9981; Offidani, Massimo/0000-0003-2749-7347; Di Raimondo, Francesco/0000-0002-7749-0293; Perosa, Federico/0000-0002-4072-4244; TIRINDELLI, MARIA CRISTINA/0000-0003-4645-4465; Capalbo, Silvana/0000-0002-6247-5007; Onida, Francesco/0000-0002-2991-3474; La Nasa, Giorgio/0000-0002-8247-583X; Ledda, Antonio/0000-0002-0218-6203	Seragnoli Institute of Haematology at the University of Bologna, Bologna, Italy; Janssen-Cilag; University of Bologna	Seragnoli Institute of Haematology at the University of Bologna, Bologna, Italy; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); University of Bologna	This study was funded and sponsored by Seragnoli Institute of Haematology at the University of Bologna, Bologna, Italy. The study was partly supported by Janssen-Cilag providing bortezomib free of charge, by the University of Bologna through a grant to MC (Ricerca Fondamentale Orientata) for substudies within the main study, and by BolognAIL through a grant to MC for substudies within the main study. We thank Nicoletta Testoni, Carolina Terragna, and Giulia Marzocchi for doing cytogenetic analyses; Mauro Fiacchini and Antonio de Vivo for their valuable support in statistical analysis of the data; Katia Vitali for supporting data analysis; Valeria Andreani for help in data collection; and Stephen Hill of FireKite for editorial assistance in the development of this report, which was supported by Millennium Pharmaceuticals, and Johnson & Johnson Pharmaceutical Research and Development.	Anderson KC, 2008, LEUKEMIA, V22, P231, DOI 10.1038/sj.leu.2405016; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Avet-Loiseau H, 2010, J CLIN ONCOL, V28, P4630, DOI 10.1200/JCO.2010.28.3945; Barlogie B, 2008, BLOOD, V112, P3115, DOI 10.1182/blood-2008-03-145235; Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x; Blade J, 2010, BLOOD, V115, P3655, DOI 10.1182/blood-2009-08-238196; Cavo M, 2005, BLOOD, V106, P35, DOI 10.1182/blood-2005-02-0522; Cavo M, 2007, J CLIN ONCOL, V25, P2434, DOI 10.1200/JCO.2006.10.2509; Cavo Michele, 2006, J Clin Oncol, V24, pe4, DOI 10.1200/JCO.2005.04.7506; Cavo M, 2009, J CLIN ONCOL, V27, P5001, DOI 10.1200/JCO.2009.22.7389; Chanan-Khan A, 2008, J CLIN ONCOL, V26, P4784, DOI 10.1200/JCO.2007.14.9641; Chanan-Khan AA, 2010, J CLIN ONCOL, V28, P2612, DOI 10.1200/JCO.2009.25.4250; Child JA, 2003, NEW ENGL J MED, V348, P1875, DOI 10.1056/NEJMoa022340; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Facon T, 2007, LANCET, V370, P1209, DOI 10.1016/S0140-6736(07)61537-2; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Harousseau JL, 2010, J CLIN ONCOL, V28, P4621, DOI 10.1200/JCO.2009.27.9158; Harousseau JL, 2009, BLOOD, V114, P150; Hulin C, 2009, J CLIN ONCOL, V27, P3664, DOI 10.1200/JCO.2008.21.0948; Kristinsson SY, 2008, BLOOD, V112, P3582, DOI 10.1182/blood-2008-04-151076; Lokhorst HM, 2010, BLOOD, V115, P1113, DOI 10.1182/blood-2009-05-222539; Palumbo A, 2008, BLOOD, V112, P3107, DOI 10.1182/blood-2008-04-149427; Pineda-Roman M, 2008, LEUKEMIA, V22, P1419, DOI 10.1038/leu.2008.99; Rajkumar SV, 2006, J CLIN ONCOL, V24, P431, DOI 10.1200/JCO.2005.03.0221; Reeder CB, 2009, LEUKEMIA, V23, P1337, DOI 10.1038/leu.2009.26; Richardson PG, 2006, J CLIN ONCOL, V24, P3113, DOI 10.1200/JCO.2005.04.7779; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-268862; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Rosinol L, 2009, BLOOD, V114, P59; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Sonneveld P, 2009, HAEMATOL-HEMATOL J, V94, P191; Stewart AK, 2009, BLOOD, V114, P5436, DOI 10.1182/blood-2009-07-204651; van de Velde HJK, 2007, HAEMATOLOGICA, V92, P1399, DOI 10.3324/haematol.11534; van Rhee F, 2010, BLOOD, V116, P1220, DOI 10.1182/blood-2010-01-264333; Vickrey E, 2009, CANCER-AM CANCER SOC, V115, P229, DOI 10.1002/cncr.24006; Wang M, 2007, HEMATOLOGY, V12, P235, DOI 10.1080/10245330701214236	36	649	680	1	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2010	376	9758					2075	2085		10.1016/S0140-6736(10)61424-9	http://dx.doi.org/10.1016/S0140-6736(10)61424-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702LA	21146205				2022-12-28	WOS:000285895000025
J	Witten, IB; Lin, SC; Brodsky, M; Prakash, R; Diester, I; Anikeeva, P; Gradinaru, V; Ramakrishnan, C; Deisseroth, K				Witten, Ilana B.; Lin, Shih-Chun; Brodsky, Matthew; Prakash, Rohit; Diester, Ilka; Anikeeva, Polina; Gradinaru, Viviana; Ramakrishnan, Charu; Deisseroth, Karl			Cholinergic Interneurons Control Local Circuit Activity and Cocaine Conditioning	SCIENCE			English	Article							NUCLEUS-ACCUMBENS CORE; ACETYLCHOLINE-RECEPTORS; RAT NEOSTRIATUM; FIRING PATTERNS; NEURONS; ADDICTION; STRIATUM; NICOTINE; SYSTEMS; REINFORCEMENT	Cholinergic neurons are widespread, and pharmacological modulation of acetylcholine receptors affects numerous brain processes, but such modulation entails side effects due to limitations in specificity for receptor type and target cell. As a result, causal roles of cholinergic neurons in circuits have been unclear. We integrated optogenetics, freely moving mammalian behavior, in vivo electrophysiology, and slice physiology to probe the cholinergic interneurons of the nucleus accumbens by direct excitation or inhibition. Despite representing less than 1% of local neurons, these cholinergic cells have dominant control roles, exerting powerful modulation of circuit activity. Furthermore, these neurons could be activated by cocaine, and silencing this drug-induced activity during cocaine exposure (despite the fact that the manipulation of the cholinergic interneurons was not aversive by itself) blocked cocaine conditioning in freely moving mammals.	[Witten, Ilana B.; Lin, Shih-Chun; Brodsky, Matthew; Prakash, Rohit; Diester, Ilka; Anikeeva, Polina; Gradinaru, Viviana; Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Lin, Shih-Chun] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Diester, Ilka/D-4473-2011		Deisseroth lab; Helen Hay Whitney Foundation; National Institute of Neurological Disorders and Stroke; DAAD; Human Frontier Science Program; Stanford Dean's fellowship; Bio-X SIGF; Keck Foundation; Snyder Foundation; Woo Foundation; Yu Foundation; McKnight Foundation; CIRM; National Institute of Mental Health; National Institute on Drug Abuse; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957, R01MH086373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020794] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000616] Funding Source: NIH RePORTER	Deisseroth lab; Helen Hay Whitney Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Human Frontier Science Program(Human Frontier Science Program); Stanford Dean's fellowship; Bio-X SIGF; Keck Foundation(W.M. Keck Foundation); Snyder Foundation; Woo Foundation; Yu Foundation; McKnight Foundation; CIRM(California Institute for Regenerative Medicine); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the entire Deisseroth lab for their support. I. B. W. is supported by the Helen Hay Whitney Foundation; S.-C. L. is supported by the National Institute of Neurological Disorders and Stroke; I. D. is supported by DAAD and the Human Frontier Science Program; P. A. is supported by the Stanford Dean's fellowship; V. G. is supported by Bio-X SIGF; K. D. is supported by the Keck, Snyder, Woo, Yu, and McKnight Foundations, as well as by CIRM, the National Institute of Mental Health, and the National Institute on Drug Abuse.	Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; AOSAKI T, 1994, J NEUROSCI, V14, P3969; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; CARELLI RM, 1994, J NEUROSCI, V14, P7735; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Changeux JP, 2009, CR BIOL, V332, P421, DOI 10.1016/j.crvi.2009.02.005; Chen BT, 2010, ANN NY ACAD SCI, V1187, P129, DOI 10.1111/j.1749-6632.2009.05154.x; Crespo JA, 2006, J NEUROSCI, V26, P6004, DOI 10.1523/JNEUROSCI.4494-05.2006; de Rover M, 2002, EUR J NEUROSCI, V16, P2279, DOI 10.1046/j.1460-9568.2002.02289.x; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Hikida T, 2001, P NATL ACAD SCI USA, V98, P13351, DOI 10.1073/pnas.231488998; Hoebel BG, 2007, CURR OPIN PHARMACOL, V7, P617, DOI 10.1016/j.coph.2007.10.014; Hrabovska A, 2010, CHEM-BIOL INTERACT, V183, P194, DOI 10.1016/j.cbi.2009.09.025; Ikemoto S, 1998, PHYSIOL BEHAV, V63, P811, DOI 10.1016/S0031-9384(98)00007-9; Inokawa H, 2010, NEUROSCIENCE, V168, P395, DOI 10.1016/j.neuroscience.2010.03.062; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; Krause M, 2010, J NEUROSCI, V30, P4746, DOI 10.1523/JNEUROSCI.0197-10.2010; Maskos U, 2008, BRIT J PHARMACOL, V153, pS438, DOI 10.1038/bjp.2008.5; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Nisell M, 1997, J NEURAL TRANSM, V104, P1, DOI 10.1007/BF01271290; Peoples LL, 1996, J NEUROSCI, V16, P3459; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Pratt WE, 2007, BEHAV NEUROSCI, V121, P1215, DOI 10.1037/0735-7044.121.6.1215; Pratt WE, 2004, BEHAV NEUROSCI, V118, P730, DOI 10.1037/0735-7044.118.4.730; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Williams MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1779, DOI 10.1038/sj.npp.1301585; WILSON CJ, 1990, J NEUROSCI, V10, P508; Wise R A, 1984, NIDA Res Monogr, V50, P15; Zhou FM, 2003, NEUROSCIENTIST, V9, P23, DOI 10.1177/1073858402239588; Zhou FM, 2002, J NEUROBIOL, V53, P590, DOI 10.1002/neu.10150	39	329	372	0	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1677	1681		10.1126/science.1193771	http://dx.doi.org/10.1126/science.1193771			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164015	Green Accepted			2022-12-28	WOS:000285390500067
J	Neuman, MD				Neuman, Mark D.			Surgeons' Decisions and the Financial and Human Costs of Medical Care.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Neuman, Mark D.] Univ Penn, Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Neuman, Mark D.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Neuman, MD (corresponding author), Univ Penn, Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.							LAUFMAN H, 1960, CHRISTOPHERS TXB SUR, P1492; LEONHART D, 2009, NY TIMES MAGAZI 0428; SABISTON DC, 1972, DAVISCHRISTOPHER TXB; Townsend CM, 2008, SABISTON TXB SURG	4	10	10	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2010	363	25					2382	2383		10.1056/NEJMp1009621	http://dx.doi.org/10.1056/NEJMp1009621			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	694ZK	21158656				2022-12-28	WOS:000285340200003
J	[Anonymous]				[Anonymous]			Christmas 2010: Primary Care Liberating the NHS acronym	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2010	341								c6615	10.1136/bmj.c6615	http://dx.doi.org/10.1136/bmj.c6615			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XA	21149465				2022-12-28	WOS:000285551900008
J	Morgan, GJ; Davies, FE; Gregory, WM; Cocks, K; Bell, SE; Szubert, AJ; Navarro-Coy, N; Drayson, MT; Owen, RG; Feyler, S; Ashcroft, AJ; Ross, F; Byrne, J; Roddie, H; Rudin, C; Cook, G; Jackson, GH; Child, JA				Morgan, Gareth J.; Davies, Faith E.; Gregory, Walter M.; Cocks, Kim; Bell, Sue E.; Szubert, Alex J.; Navarro-Coy, Nuria; Drayson, Mark T.; Owen, Roger G.; Feyler, Sylvia; Ashcroft, A. John; Ross, Fiona; Byrne, Jennifer; Roddie, Huw; Rudin, Claudius; Cook, Gordon; Jackson, Graham H.; Child, J. Anthony		Natl Canc Res Inst Haematological	First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial	LANCET			English	Article							EARLY BREAST-CANCER; LONG-TERM; DOUBLE-BLIND; PREVENTIVE MEASURES; BISPHOSPHONATES; OSTEONECROSIS; JAW; PAMIDRONATE; SURVIVAL; THERAPY	Background Bisphosphonates reduce the risk of skeletal events in patients with malignant bone disease, and zoledronic acid has shown potential anticancer effects in preclinical and clinical studies. We aimed to establish whether bisphosphonates can affect clinical outcomes in patients with multiple myeloma. Methods Patients of age 18 years or older with newly diagnosed multiple myeloma were enrolled from 120 centres in the UK. Computer-generated randomisation sequence was used to allocate patients equally, via an automated telephone service, to receive 4 mg zoledronic acid as an infusion every 3-4 weeks or 1600 mg oral clodronic acid daily. Patients also received intensive or non-intensive induction chemotherapy. No investigators, staff, or patients were masked to treatment allocation, and bisphosphonate and maintenance therapy continued at least until disease progression. The primary endpoints were overall survival, progression-free survival, and overall response rate. We assessed between-group differences with Cox proportional hazards models for progression-free survival and overall survival, and with logistic regression models for overall response rate. Analysis was by intention to treat. This trial is registered, number ISRCTN68454111. Findings 1970 patients were enrolled between May, 2003, and November, 2007, of whom 1960 were eligible for intention-to-treat analysis: 981 in the zoledronic acid group (555 on intensive chemotherapy, 426 on non-intensive chemotherapy); and 979 on clodronic acid (556 on intensive chemotherapy, 423 on non-intensive chemotherapy). The treatment cutoff was Oct 5,2009, with patients receiving bisphosphonates for a median of 350 days (IQR 137-632) before disease progression, with a median of 3.7 years' follow-up (IQR 2.9-4.7). Zoledronic acid reduced mortality by 16% (95% CI 4-26) versus clodronic acid (hazard ratio [HR] 0.84, 95% CI 0.74-0.96; p=0.0118), and extended median overall survival by 5.5 months (50.0 months, IQR 21.0 to not reached vs 44.5 months, IQR 16.5 to not reached; p=0.04). Zoledronic acid also significantly improved progression-free survival by 12% (95% CI 2-20) versus clodronic acid (HR 0.88, 95% CI 0.80-0.98; p=0.0179), and increased median progression-free survival by 2.0 months (19.5 months, IQR 9.0-33.0 vs 17.5 months, IQR 8.5-34.0; p=0.07). Rates of complete, very good partial, or partial response did not differ significantly between the zoledronic acid and clodronic acid groups for patients receiving intensive induction chemotherapy (432 patients [78%] vs 422 [76%]; p=0.43) or non-intensive induction chemotherapy (215 [50%] vs 195 [46%]; p=0.18). Both bisphosphonates were generally well tolerated, with similar occurrence of acute renal failure and treatment-emergent serious adverse events, but zoledronic acid was associated with higher rates of confirmed osteonecrosis of the jaw (35 [4%]) than was clodronic acid (3 [<1%]). Interpretation Consistent with the potential anticancer activity of zoledronic acid, overall survival improved independently of prevention of skeletal-related events, showing that zoledronic acid has treatment benefits beyond bone health. These findings support immediate treatment with zoledronic acid in patients with newly diagnosed multiple myeloma, not only for prevention of skeletal-related events, but also for potential antimyeloma benefits.	[Morgan, Gareth J.] Royal Marsden NHS Fdn Trust, Inst Canc Res, Sect Haematooncol, London SM2 5NG, England; [Gregory, Walter M.; Cocks, Kim; Bell, Sue E.; Szubert, Alex J.; Navarro-Coy, Nuria; Child, J. Anthony] Univ Leeds, Clin Trials Res Unit, Leeds, W Yorkshire, England; [Drayson, Mark T.] Univ Birmingham, Birmingham, W Midlands, England; [Owen, Roger G.; Cook, Gordon] St James Univ Hosp, Leeds, W Yorkshire, England; [Feyler, Sylvia] Calderdale & Huddersfield NHS Trust, Huddersfield, W Yorkshire, England; [Ashcroft, A. John] Mid Yorkshire Hosp NHS Trust, Wakefield, England; [Ross, Fiona] Univ Southampton, Wessex Reg Genet Lab, Salisbury, Wilts, England; [Byrne, Jennifer] Univ Nottingham Hosp, Nottingham NG7 2UH, England; [Roddie, Huw] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [Rudin, Claudius] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England; [Jackson, Graham H.] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Leeds; University of Birmingham; Saint James's University Hospital; University of Southampton; University of Nottingham; University of Edinburgh; University of Exeter; Newcastle University - UK	Morgan, GJ (corresponding author), Royal Marsden NHS Fdn Trust, Inst Canc Res, Sect Haematooncol, Brookes Lawley Bldg,15 Cotswold Rd, London SM2 5NG, England.	gareth.morgan@icr.ac.uk	Jackson, Graham/GMW-7638-2022; Cocks, Kim/AGG-7843-2022	Jackson, Graham/0000-0003-0756-969X; Cocks, Kim/0000-0003-2595-708X; Drayson, Mark/0000-0002-1528-7564; Byrne, Jenny/0000-0002-9381-1851; morgan, gareth/0000-0002-4271-6360; Davies, Faith/0000-0002-3971-2393	Celgene; Ortho Biotech; UK MRC; Novartis; Schering Health Care; Chugai; Pharmion; Novartis Pharmaceuticals; Medical Research Council [G0100132] Funding Source: researchfish; MRC [G0100132] Funding Source: UKRI	Celgene(Bristol-Myers SquibbCelgene Corporation); Ortho Biotech; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novartis(Novartis); Schering Health Care; Chugai; Pharmion; Novartis Pharmaceuticals(Novartis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	GJM has participated in advisory boards for, received payment for lectures and development of educational presentations from, and received travel support from Celgene, Novartis, Merck, and Johnson and Johnson. FED has participated in advisory boards and spoken at meetings for Celgene, Ortho Biotech, and Novartis; and has received travel support to attend meetings from Celgene and Ortho Biotech. KC and SEB's institutions have received support for travel to meetings for this study from Celgene and OrthoBiotech. RGO has received speakers fees and travel support to attend scientific meetings from Celgene and Ortho Biotech. JB has received an honorarium for membership of an advisory board for Novartis. GHJ has received honoraria from Celgene and Janssen-Cilag for speaking at educational meetings. JAC has received honoraria and travel support from SAN GmbH (Science Agency and Network) for presentations which included aspects of results from the MRC Myeloma IX trial. All other authors declare that they have no conflicts of interest.; Financial support for the MRC Myeloma IX trial was obtained from the UK MRC, with additional funding in the form of unrestricted educational grants from Novartis, Schering Health Care, Chugai, Pharmion, Celgene, and Ortho Biotech, mainly to support trial coordination and the laboratory studies. Financial support for medical editorial assistance was provided by Novartis Pharmaceuticals. We thank all the patients, investigators, and staff who participated in the MRC Myeloma IX Trial; staff at the Clinical Trials Research Unit, University of Leeds, Leeds, UK, for trial coordination and data management; staff at the Department of Immunology, University of Birmingham, Birmingham, UK; staff at Wessex Regional Genetics Laboratory, University of Southampton, Southampton, UK; staff at Haematological Malignancy Diagnostic Service, Leeds Teaching Hospitals NHS Trust, Leeds, UK; staff at Institute of Cancer Research, London, UK, for central laboratory investigations; David Bowen for independent safety oversight; the MRC Leukaemia Data Monitoring and Ethics Committee; the MRC Leukaemia Trial Steering Committee; the National Cancer Research Institute Haematological Oncology Clinical Studies Group; Myeloma UK; the support of the National Institute for Health Research, through the National Cancer Research Network; and Catherine Browning (ProEd Communications, Beachwood, OH, USA) for her medical editorial assistance with this report. Lead investigators in the 20 centres with the highest trial enrolment were N H Russell (Nottingham University Hospitals, Nottingham, UK), Gordon Cook (Leeds Teaching Hospitals NHS Trust, Leeds, UK), Huw Roddie (Western General Hospital, Edinburgh, UK), Claudius Rudin (Royal Devon and Exeter Hospital, Exeter, UK), D W Milligan (Birmingham Heartlands Hospital, Birmingham, UK), John Snowden (Royal Hallamshire Hospital, Sheffield, UK), Haz Sayala (Hull and East Yorkshire Hospitals NHS Trust, Hull, UK), Patrick Chu (Royal Liverpool University Hospital, Liverpool, UK), David Wright (Mid Yorkshire NHS Trust, Wakefield, UK), K Gelly (Ninewells Hospital, Dundee, UK), Deborah Turner (Torbay Hospital, Torquay, UK), Helen Jackson (University Hospital of Wales. Cardiff, UK), Jenny Craig (Addenbrooke's Hospital, Cambridge, UK), Jane Tighe (Aberdeen Royal Infimary, Aberdeen, UK), Salim Shafeek (Worcestershire Royal Hospital, Worcester, UK), Jeffrey Neilson (Russells Hall Hospital, Dudley, UK), James Covet (Christie Hospital, Manchester, UK), A McKernan (Royal Derby Hospital, Derby, UK), Anton Kruger (Royal Cornwall Hospital, Truro, UK), M P Macheta (Blackpool Victoria Hospital, Blackpool, UK), Angela Wood (James Cook University Hospital, Middlesbrough, UK), and Alastair Smith (Southampton General Hospital, Southampton, UK). The findings of this study have been previously published in 2010 as abstracts for the American Society of Clinical Oncology, European Hematology Association, Cancer Induced Bore Disease conference of the Cancer and Bone Society European Society for Medical Oncology, and American Society of Hematology	Attal M, 2006, BLOOD, V108, P3289, DOI 10.1182/blood-2006-05-022962; Aviles A, 2007, MED ONCOL, V24, P227, DOI 10.1007/BF02698044; Berenson JR, 2006, CANCER BIOL THER, V5, P1082, DOI 10.4161/cbt.5.9.3307; Berenson JR, 1998, J CLIN ONCOL, V16, P593, DOI 10.1200/JCO.1998.16.2.593; Child JA, 2003, NEW ENGL J MED, V348, P1875, DOI 10.1056/NEJMoa022340; Corso A, 2005, HEMATOLOGY, V10, P215, DOI 10.1080/10245330500094714; Croucher PI, 2003, J BONE MINER RES, V18, P482, DOI 10.1359/jbmr.2003.18.3.482; Dearnaley DP, 2009, LANCET ONCOL, V10, P872, DOI 10.1016/S1470-2045(09)70201-3; Dimopoulos MA, 2009, ANN ONCOL, V20, P117, DOI 10.1093/annonc/mdn554; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Eidtmann H, 2010, ANN ONCOL, V21, P2188, DOI 10.1093/annonc/mdq217; Fonseca R, 2009, LEUKEMIA, V23, P2210, DOI 10.1038/leu.2009.174; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Green JR, 2004, ONCOLOGIST, V9, P3, DOI 10.1634/theoncologist.9-90004-3; Guenther A, 2010, INT J CANCER, V126, P239, DOI 10.1002/ijc.24758; Kyle RA, 2007, J CLIN ONCOL, V25, P2464, DOI 10.1200/JCO.2007.12.1269; Kyle RA, 2009, CLIN LYMPHOMA MYELOM, V9, P278, DOI 10.3816/CLM.2009.n.056; Lipton A, 2007, EXPERT OPIN DRUG SAF, V6, P305, DOI 10.1517/14740338.6.3.305; Lipton A, 2007, CLIN LYMPHOMA MYELOM, V7, P346, DOI 10.3816/CLM.2007.n.011; McCloskey EV, 2001, BRIT J HAEMATOL, V113, P1035, DOI 10.1046/j.1365-2141.2001.02851.x; Montefusco V, 2008, LEUKEMIA LYMPHOMA, V49, P2156, DOI 10.1080/10428190802483778; Musto P, 2008, CANCER-AM CANCER SOC, V113, P1588, DOI 10.1002/cncr.23783; Palumbo Antonio, 2009, Hematology Am Soc Hematol Educ Program, P566, DOI 10.1182/asheducation-2009.1.566; Ripamonti CI, 2009, ANN ONCOL, V20, P137, DOI 10.1093/annonc/mdn526; Rosen LS, 2001, CANCER J, V7, P377; Rosen LS, 2003, CANCER-AM CANCER SOC, V98, P1735, DOI 10.1002/cncr.11701; San-Miguel Jesus F, 2009, Hematology Am Soc Hematol Educ Program, P555, DOI 10.1182/asheducation-2009.1.555; Sanders J, 2007, INT J LAB HEMATOL, V29, P395, DOI 10.1111/j.1365-2257.2006.00860.x; SEZER O, 2010, 15 C EUR HEM ASS BAR; Spencer Andrew, 2008, BMC Clin Pharmacol, V8, P2, DOI 10.1186/1472-6904-8-2; Terpos E, 2009, ANN ONCOL, V20, P1303, DOI 10.1093/annonc/mdn796; Weitzman R, 2007, CRIT REV ONCOL HEMAT, V62, P148, DOI 10.1016/j.critrevonc.2006.12.005; Winter MC, 2008, CANCER TREAT REV, V34, P453, DOI 10.1016/j.ctrv.2008.02.004	33	397	411	0	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2010	376	9757					1989	1999		10.1016/S0140-6736(10)62051-X	http://dx.doi.org/10.1016/S0140-6736(10)62051-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701GZ	21131037	Green Published, Bronze			2022-12-28	WOS:000285807700028
J	Bennett, EJ; Rush, J; Gygi, SP; Harper, JW				Bennett, Eric J.; Rush, John; Gygi, Steven P.; Harper, J. Wade			Dynamics of Cullin-RING Ubiquitin Ligase Network Revealed by Systematic Quantitative Proteomics	CELL			English	Article							NEDD8; ACTIVATION; JAB1/CSN5; INHIBITOR; CSN; SCF	Dynamic reorganization of signaling systems frequently accompanies pathway perturbations, yet quantitative studies of network remodeling by pathway stimuli are lacking. Here, we report the development of a quantitative proteomics platform centered on multiplex absolute quantification (AQUA) technology to elucidate the architecture of the cullin-RING ubiquitin ligase (CRL) network and to evaluate current models of dynamic CRL remodeling. Current models suggest that CRL complexes are controlled by cycles of CRL deneddylation and CAND1 binding. Contrary to expectations, acute CRL inhibition with MLN4924, an inhibitor of the NEDD8-activating enzyme, does not result in a global reorganization of the CRL network. Examination of CRL complex stoichiometry reveals that, independent of cullin neddylation, a large fraction of cullins are assembled with adaptor modules, whereas only a small fraction are associated with CAND1. These studies suggest an alternative model of CRL dynamicity where the abundance of adaptor modules, rather than cycles of neddylation and CAND1 binding, drives CRL network organization.	[Bennett, Eric J.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Bennett, Eric J.; Gygi, Steven P.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Rush, John] Cell Signaling Technol, Danvers, MA 01923 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu		Harper, Jeffrey/0000-0002-6944-7236	Millennium Pharmaceuticals; National Institutes of Health; Stewart Trust; Damon Runyon Cancer Research Foundation [DRG 1974-08]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070565, R01GM054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stewart Trust; Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Woong Kim, Ryan Kunz, and Fiona McAllister from the Gygi laboratory (Harvard Medical School) for assistance with the AQUA analysis, Harper lab members John Lydeard for reagents, Mat Sowa for bioinformatics assistance, and Brenda O'Connell for a critical reading of the manuscript. This work was supported by grants to J.W.H. from Millennium Pharmaceuticals, the National Institutes of Health, and the Stewart Trust. E.J.B. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG 1974-08). J.W.H. is a consultant for Millennium Pharmaceuticals. J.R. is an employee of Cell Signaling Technologies.	Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Bosu DR, 2010, DEV BIOL, V346, P113, DOI 10.1016/j.ydbio.2010.07.020; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Olma MH, 2009, J CELL SCI, V122, P1035, DOI 10.1242/jcs.043539; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Przytycka TM, 2010, BRIEF BIOINFORM, V11, P15, DOI 10.1093/bib/bbp057; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Schmidt MW, 2009, MOL CELL, V35, P586, DOI 10.1016/j.molcel.2009.07.024; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Siergiejuk E, 2009, EMBO J, V28, P3845, DOI 10.1038/emboj.2009.354; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Zhang WJ, 2008, P NATL ACAD SCI USA, V105, P8470, DOI 10.1073/pnas.0804144105; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0	29	263	265	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					951	965		10.1016/j.cell.2010.11.017	http://dx.doi.org/10.1016/j.cell.2010.11.017			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145461	Green Accepted, Bronze			2022-12-28	WOS:000285182600012
J	Chiang, YM				Chiang, Yet-Ming			Building a Better Battery	SCIENCE			English	Editorial Material							LITHIUM-ION BATTERIES; ELECTRODE MATERIALS; STORAGE; TRANSITION; CATHODES		MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Chiang, YM (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	ychiang@mit.edu		Chiang, Yet-Ming/0000-0002-0833-7674				Amatucci GG, 2007, J FLUORINE CHEM, V128, P243, DOI 10.1016/j.jfluchem.2006.11.016; Chan CK, 2008, NAT NANOTECHNOL, V3, P31, DOI 10.1038/nnano.2007.411; Chen GY, 2006, ELECTROCHEM SOLID ST, V9, pA295, DOI 10.1149/1.2192695; Huang JY, 2010, SCIENCE, V330, P1515, DOI 10.1126/science.1195628; Idota Y, 1997, SCIENCE, V276, P1395, DOI 10.1126/science.276.5317.1395; Kao YH, 2010, CHEM MATER, V22, P5845, DOI 10.1021/cm101698b; Li H, 2004, J ELECTROCHEM SOC, V151, pA1878, DOI 10.1149/1.1801451; Limthongkul P, 2003, ACTA MATER, V51, P1103, DOI 10.1016/S1359-6454(02)00514-1; Meethong N, 2007, ADV FUNCT MATER, V17, P1115, DOI 10.1002/adfm.200600938; Meethong N, 2010, CHEM MATER, V22, P1088, DOI 10.1021/cm902118m; Obrovac MN, 2007, J ELECTROCHEM SOC, V154, pA103, DOI 10.1149/1.2402112; Poizot P, 2000, NATURE, V407, P496, DOI 10.1038/35035045; Tang M, 2010, ANNU REV MATER RES, V40, P501, DOI 10.1146/annurev-matsci-070909-104435	13	356	372	76	912	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1485	1486		10.1126/science.1198591	http://dx.doi.org/10.1126/science.1198591			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148377				2022-12-28	WOS:000285153500046
J	Manning, BD				Manning, Brendan D.			Insulin Signaling: Inositol Phosphates Get into the Akt	CELL			English	Editorial Material							PYROPHOSPHATES; SENSITIVITY; OBESITY	An acute but transient response to insulin is essential for glucose homeostasis in mammals. Chakraborty et al. (2010) uncover a new feedback mechanism regulating insulin signaling. They show that the inositol pyrophosphate IP7, which is produced in response to insulin, inhibits the Akt kinase, a primary effector of insulin signaling.	Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Manning, BD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	bmanning@hsph.harvard.edu	Manning, Brendan/ABD-6528-2021	Manning, Brendan/0000-0003-3895-5956	NCI NIH HHS [R01 CA122617] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA122617] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bhandari R, 2008, P NATL ACAD SCI USA, V105, P2349, DOI 10.1073/pnas.0712227105; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8	10	17	18	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 10	2010	143	6					861	863		10.1016/j.cell.2010.11.040	http://dx.doi.org/10.1016/j.cell.2010.11.040			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145450	Bronze, Green Accepted			2022-12-28	WOS:000285182600001
J	Simiyu, K; Daar, AS; Singer, PA				Simiyu, Ken; Daar, Abdallah S.; Singer, Peter A.			Stagnant Health Technologies in Africa	SCIENCE			English	Editorial Material							BIOTECH; MARKET		[Singer, Peter A.] Univ Hlth Network, McLaughlin Rotman Ctr Global Hlth, Toronto, ON M5G 1L7, Canada; Univ Toronto, Toronto, ON M5G 1L7, Canada	University of Toronto; University Health Network Toronto; University of Toronto	Singer, PA (corresponding author), Univ Hlth Network, McLaughlin Rotman Ctr Global Hlth, Toronto, ON M5G 1L7, Canada.	peter.singer@mrcglobal.org			Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		*AFR UN, AFR UN COMM SCI ADD; Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x; Aubert J.-E., 2005, PROMOTING INNOVATION; Bosompem KM, 2004, TROP MED INT HEALTH, V9, P991, DOI 10.1111/j.1365-3156.2004.01289.x; CHEGE K, 2007, SCIDEVNET NEWS  0620; DAAR AS, 2000, OXFORD TXB SURG, P3278; Frew SE, 2008, NAT BIOTECHNOL, V26, P37, DOI 10.1038/nbt0108-37; Frew SE, 2007, NAT BIOTECHNOL, V25, P403, DOI 10.1038/nbt0407-403; Gans JS, 2003, RES POLICY, V32, P333, DOI 10.1016/S0048-7333(02)00103-8; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000485; Hotez PJ, 2009, BIOLOGICALS, V37, P160, DOI 10.1016/j.biologicals.2009.02.008; Masum H., 2007, Innovations: Technology / Governance / Globalisation, V2, P129, DOI 10.1162/itgg.2007.2.4.129; Mills-Robertson FC, 2009, AFR J PHARM PHARMACO, V3, P476; Nwaka S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000293; OYELARANOYEYINK.B, 2007, INN AFR CONT FOR POL; Rezaie R, 2008, NAT BIOTECHNOL, V26, P627, DOI 10.1038/nbt0608-627; Scott C, 2007, NAT MED, V13, P228, DOI 10.1038/nm0307-228a; SINGER P, 2008, GLOBAL FORUM UPDATE, V5, P143; Singer PA, 2007, NATURE, V449, P160, DOI 10.1038/449160a; WAMBOGAMUGIRYA P, 2006, SCIDEVNET NEWS  0601; *WEF, 2007, ASS AFR COMP GLOB CO, P3	21	11	11	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2010	330	6010					1483	1484		10.1126/science.1195401	http://dx.doi.org/10.1126/science.1195401			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	692LE	21148376				2022-12-28	WOS:000285153500045
J	van Wageningen, S; Kemmeren, P; Lijnzaad, P; Margaritis, T; Benschop, JJ; de Castro, IJ; van Leenen, D; Koerkamp, MJAG; Ko, CW; Miles, AJ; Brabers, N; Brok, MO; Lenstra, TL; Fiedler, D; Fokkens, L; Aldecoa, R; Apweiler, E; Taliadouros, V; Sameith, K; van de Pasch, LAL; van Hooff, SR; Bakker, LV; Krogan, NJ; Snel, B; Holstege, FCP				van Wageningen, Sake; Kemmeren, Patrick; Lijnzaad, Philip; Margaritis, Thanasis; Benschop, Joris J.; de Castro, Ines J.; van Leenen, Dik; Koerkamp, Marian J. A. Groot; Ko, Cheuk W.; Miles, Antony J.; Brabers, Nathalie; Brok, Mariel O.; Lenstra, Tineke L.; Fiedler, Dorothea; Fokkens, Like; Aldecoa, Rodrigo; Apweiler, Eva; Taliadouros, Virginia; Sameith, Katrin; van de Pasch, Loes A. L.; van Hooff, Sander R.; Bakker, Linda V.; Krogan, Nevan J.; Snel, Berend; Holstege, Frank C. P.			Functional Overlap and Regulatory Links Shape Genetic Interactions between Signaling Pathways	CELL			English	Article							ACTIVATED PROTEIN-KINASE; 2C SER/THR PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; TYROSINE PHOSPHATASES; ACTIN CYTOSKELETON; DUPLICATED GENES; BACKUP CIRCUITS; YEAST; NETWORK; CELL	To understand relationships between phosphorylation-based signaling pathways, we analyzed 150 deletion mutants of protein kinases and phosphatases in S. cerevisiae using DNA microarrays. Downstream changes in gene expression were treated as a phenotypic readout. Double mutants with synthetic genetic interactions were included to investigate genetic buffering relationships such as redundancy. Three types of genetic buffering relationships are identified: mixed epistasis, complete redundancy, and quantitative redundancy. In mixed epistasis, the most common buffering relationship, different gene sets respond in different epistatic ways. Mixed epistasis arises from pairs of regulators that have only partial overlap in function and that are coupled by additional regulatory links such as repression of one by the other. Such regulatory modules confer the ability to control different combinations of processes depending on condition or context. These properties likely contribute to the evolutionary maintenance of paralogs and indicate a way in which signaling pathways connect for multiprocess control.	[van Wageningen, Sake; Kemmeren, Patrick; Lijnzaad, Philip; Margaritis, Thanasis; Benschop, Joris J.; de Castro, Ines J.; van Leenen, Dik; Koerkamp, Marian J. A. Groot; Ko, Cheuk W.; Miles, Antony J.; Brabers, Nathalie; Brok, Mariel O.; Lenstra, Tineke L.; Aldecoa, Rodrigo; Apweiler, Eva; Taliadouros, Virginia; Sameith, Katrin; van de Pasch, Loes A. L.; van Hooff, Sander R.; Bakker, Linda V.; Holstege, Frank C. P.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Fiedler, Dorothea; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Fokkens, Like; Snel, Berend] Univ Utrecht, Fac Sci, Dept Biol, NL-3584 CH Utrecht, Netherlands; [Lijnzaad, Philip; Bakker, Linda V.] Netherlands Bioinformat Ctr, NL-6525 GA Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; University of California System; University of California San Francisco; Utrecht University	Holstege, FCP (corresponding author), Univ Med Ctr Utrecht, Univ Weg 100, Utrecht, Netherlands.	f.c.p.holstege@umcutrecht.nl	Aldecoa, Rodrigo/I-3569-2012; Holstege, Frank/AAM-9944-2021; Lenstra, Tineke/E-9429-2013; Snel, Berend/B-8886-2011; Lijnzaad, Philip/ABE-4205-2021; Lenstra, Tineke/L-3958-2016; Benschop, Joris j/C-7809-2012	Snel, Berend/0000-0002-5804-8547; Lijnzaad, Philip/0000-0002-7535-583X; Lenstra, Tineke/0000-0002-4440-9962; Sameith, Katrin/0000-0003-4306-930X; Kemmeren, Patrick/0000-0003-2237-7354; Aldecoa, Rodrigo/0000-0002-8041-3416; Groot Koerkamp, Marian JA/0000-0002-0867-0821; Fokkens, Like/0000-0001-6696-4409; de Castro, Ines/0000-0001-8710-3667	Netherlands Bioinformatics Centre (NBIC); Netherlands Organization of Scientific Research (NWO) [016.108.607, 817.02.015, 050.71.057, 911.06.009, 021.002.035, 863.07.007, 700.57.407]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084448] Funding Source: NIH RePORTER	Netherlands Bioinformatics Centre (NBIC); Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Netherlands Bioinformatics Centre (NBIC) and the Netherlands Organization of Scientific Research (NWO), grants 016.108.607, 817.02.015, 050.71.057, 911.06.009, 021.002.035 (T. L. L.), 863.07.007 (P. K.), 700.57.407 (J.J.B.).	Albert I, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-16; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dean EJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000113; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; DeLuna A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000347; ELION EA, 1991, P NATL ACAD SCI USA, V88, P9392, DOI 10.1073/pnas.88.21.9392; Erdman S, 2001, GENETICS, V159, P919; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; INNAN H, 1997, J BIOL CHEM, V1, P17749; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kiel C, 2010, CELL, V140, P33, DOI 10.1016/j.cell.2009.12.028; MA D, 1995, MOL BIOL CELL, V6, P889, DOI 10.1091/mbc.6.7.889; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; Musso G, 2008, GENOME RES, V18, P1092, DOI 10.1101/gr.076174.108; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Rodriguez-Pena JM, 2005, MICROBIOL-SGM, V151, P2241, DOI 10.1099/mic.0.27989-0; ROTH FP, 2009, EMBO REP, V4, P246; van Bakel H, 2004, EMBO REP, V5, P964, DOI 10.1038/sj.embor.7400253; Vavouri T, 2008, TRENDS GENET, V24, P485, DOI 10.1016/j.tig.2008.08.005; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Warmka J, 2001, MOL CELL BIOL, V21, P51, DOI 10.1128/MCB.21.1.51-60.2001; Winkler A, 2002, EUKARYOT CELL, V1, P163, DOI 10.1128/EC.1.2.163-173.2002; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Young C, 2002, EUKARYOT CELL, V1, P1032, DOI 10.1128/EC.1.6.1032-1040.2002; Zeng GH, 2001, MOL BIOL CELL, V12, P3759, DOI 10.1091/mbc.12.12.3759	44	98	101	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 10	2010	143	6					991	1004		10.1016/j.cell.2010.11.021	http://dx.doi.org/10.1016/j.cell.2010.11.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145464	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000285182600015
J	Bass, J; Takahashi, JS				Bass, Joseph; Takahashi, Joseph S.			Circadian Integration of Metabolism and Energetics	SCIENCE			English	Review							DIET-INDUCED OBESITY; REV-ERB-ALPHA; HIGH-FAT DIET; GENE-EXPRESSION; TRANSCRIPTION FACTOR; GLUCOSE-HOMEOSTASIS; NUCLEAR RECEPTORS; MAMMALIAN CLOCK; BLOOD-PRESSURE; MOUSE-LIVER	Circadian clocks align behavioral and biochemical processes with the day/night cycle. Nearly all vertebrate cells possess self-sustained clocks that couple endogenous rhythms with changes in cellular environment. Genetic disruption of clock genes in mice perturbs metabolic functions of specific tissues at distinct phases of the sleep/wake cycle. Circadian desynchrony, a characteristic of shift work and sleep disruption in humans, also leads to metabolic pathologies. Here, we review advances in understanding the interrelationship among circadian disruption, sleep deprivation, obesity, and diabetes and implications for rational therapeutics for these conditions.	[Bass, Joseph] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Bass, Joseph] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Bass, Joseph] Northwestern Univ, Weinberg Coll Arts & Sci, Evanston, IL 60208 USA; [Bass, Joseph] Northwestern Univ, Ctr Sleep & Circadian Biol, Evanston, IL 60208 USA; [Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Northwestern University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bass, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA.	bass@northwestern.edu	Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878	NIH [PO1 AG011412, R01HL097817, P50 MH074924, R01 MH078024]; Chicago Biomedical Consortium; Islet Biology Core University of Chicago Diabetes Research and Training Center; American Diabetes Association; Amylin Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078024, P50MH074924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; Islet Biology Core University of Chicago Diabetes Research and Training Center; American Diabetes Association(American Diabetes Association); Amylin Pharmaceuticals(Bristol-Myers Squibb); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Allada, F. Turek, B. Chung and K.-M. Ramsey for helpful suggestions and B. Marcheva for figures. This work was supported by NIH (PO1 AG011412 and R01HL097817), Chicago Biomedical Consortium Searle Funds, Islet Biology Core of the University of Chicago Diabetes Research and Training Center, American Diabetes Association, and Juvenile Diabetes Research Foundation to J.B., and NIH P50 MH074924 and R01 MH078024 to J.S.T. J.S.T. is an investigator in the Howard Hughes Medical Institute. J.S.T. is a cofounder of ReSet Therapeutics, Inc., and J.S.T. and J.B. are members of its scientific advisory board. J.B. is also an advisor and receives support from Amylin Pharmaceuticals. Patents have been applied for related to J.B.'s work on therapeutic applications of NAD and melatonin.	Adamantidis A, 2008, TRENDS ENDOCRIN MET, V19, P362, DOI 10.1016/j.tem.2008.08.007; Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Allaman-Pillet N, 2004, MOL CELL ENDOCRINOL, V226, P59, DOI 10.1016/j.mce.2004.06.001; Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Ayala DE, 2009, CHRONOBIOL INT, V26, P1189, DOI 10.1080/07420520903206294; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Boden G, 1999, DIABETES, V48, pA69; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Cretenet G, 2010, CELL METAB, V11, P47, DOI 10.1016/j.cmet.2009.11.002; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Duez H, 2008, DIABETES VASC DIS RE, V5, P82, DOI 10.3132/dvdr.2008.0014; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Durgan DJ, 2010, CIRC RES, V106, P647, DOI 10.1161/CIRCRESAHA.109.209957; Funato H, 2009, CELL METAB, V9, P64, DOI 10.1016/j.cmet.2008.10.010; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Kalsbeek A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003194; Kawai M, 2010, ENDOCRINOLOGY, V151, P4861, DOI 10.1210/en.2010-0407; Kawai M, 2010, P NATL ACAD SCI USA, V107, P10508, DOI 10.1073/pnas.1000788107; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; Ko CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000513; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kudo T, 2007, J BIOL RHYTHM, V22, P312, DOI 10.1177/0748730407302625; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Laposky AD, 2008, AM J PHYSIOL-REG I, V295, pR2059, DOI 10.1152/ajpregu.00026.2008; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Mulder H, 2009, DIABETOLOGIA, V52, P1240, DOI 10.1007/s00125-009-1359-y; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Peschke E, 1998, DIABETOLOGIA, V41, P1085, DOI 10.1007/s001250051034; POLONSKY KS, 1988, NEW ENGL J MED, V318, P1231, DOI 10.1056/NEJM198805123181903; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; ROESLER WJ, 1992, J BIOL CHEM, V267, P21235; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Schoenhard JA, 2003, J MOL CELL CARDIOL, V35, P473, DOI 10.1016/S0022-2828(03)00051-8; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; Taheri S, 2002, ANNU REV NEUROSCI, V25, P283, DOI 10.1146/annurev.neuro.25.112701.142826; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tasali E, 2008, P NATL ACAD SCI USA, V105, P1044, DOI 10.1073/pnas.0706446105; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Westgate EJ, 2008, CIRCULATION, V117, P2087, DOI 10.1161/CIRCULATIONAHA.107.739227; Wu X, 2009, INT J OBESITY, V33, P971, DOI 10.1038/ijo.2009.137; Wu XY, 2007, OBESITY, V15, P2560, DOI 10.1038/oby.2007.308; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	68	1168	1220	18	357	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1349	1354		10.1126/science.1195027	http://dx.doi.org/10.1126/science.1195027			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127246	Green Accepted			2022-12-28	WOS:000284902100035
J	Collins, FS; Glass, RI; Whitescarver, J; Wakefield, M; Goosby, EP				Collins, Francis S.; Glass, Roger I.; Whitescarver, Jack; Wakefield, Mary; Goosby, Eric P.			Developing Health Workforce Capacity in Africa	SCIENCE			English	Editorial Material									[Glass, Roger I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Whitescarver, Jack] NIH, Off AIDS Res, Bethesda, MD 20892 USA; [Wakefield, Mary] US Hlth Resources & Serv Adm, Rockville, MD 20857 USA; [Goosby, Eric P.] Off Global AIDS Coordinator, Washington, DC 20522 USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); National Institutes of Health (NIH) - USA; United States Health Resources & Service Administration (HRSA)	Glass, RI (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.	glassr@mail.nih.gov						[Anonymous], 2009, US PRESIDENTS EMERGE; *GLOB HLTH WORKF A, 2008, SCAL UP SAV LIV; *I MED, 2007, PEPFAR IMPL PROGR PR; *INT ORG MIGR, 2005, WORLD MIGR 2005; Mullan F, 2010, SUBSAHARAN AFRICAN M; National Institutes of Health, 2010, DIR AW COLL PARTN ME; WHO, 2009, WHO PEPFAR PLANN M S; World Health Organization, 2008, 2008 2013 ACT PLAN G	8	61	61	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1324	1325		10.1126/science.1199930	http://dx.doi.org/10.1126/science.1199930			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	689BK	21127233	Green Published			2022-12-28	WOS:000284902100023
J	Prince, FHM; Otten, MH; van Suijlekom-Smit, LWA				Prince, Femke H. M.; Otten, Marieke H.; van Suijlekom-Smit, Lisette W. A.			Diagnosis and management of juvenile idiopathic arthritis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; CHILDREN; METHOTREXATE; TRIAL; SULFASALAZINE; DISEASE		[Prince, Femke H. M.; Otten, Marieke H.; van Suijlekom-Smit, Lisette W. A.] Erasmus MC, Sophia Childrens Hosp, Dept Paediat Paediat Rheumatol, Rotterdam, Netherlands; [Prince, Femke H. M.] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA USA	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Prince, FHM (corresponding author), Erasmus MC, Sophia Childrens Hosp, Dept Paediat Paediat Rheumatol, Rotterdam, Netherlands.	f.prince@erasmusmc.nl			Niels Stensen Foundation; Bristol-Myers Squibb; Wyeth Pharmaceuticals; Abbott; Novartis Pharma; Teva Pharma; Roche; Pfizer; Schering-Plough	Niels Stensen Foundation; Bristol-Myers Squibb(Bristol-Myers Squibb); Wyeth Pharmaceuticals(Wyeth); Abbott(Abbott Laboratories); Novartis Pharma; Teva Pharma(Teva Pharmaceutical Industries); Roche(Roche Holding); Pfizer(Pfizer); Schering-Plough(Merck & CompanySchering Plough Corporation)	FHMP is funded by the Niels Stensen Foundation.; The authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: FHMP had support from the Niels Stensen Foundation for the submitted work; FHMP received consulting fees from Bristol-Myers Squibb, a travel grant from Wyeth Pharmaceuticals, and financial support for educational purposes from Abbott, Bristol-Myers Squib, Novartis Pharma, Teva Pharma, and Wyeth Pharmaceuticals, MHO received consulting fees from Roche and a travel grant from Wyeth Pharmaceuticals, LWAS received research grants from Abbott, Pfizer, and Wyeth Pharmaceuticals and consulting fees from Bristol-Myers Squibb, Roche and Schering-Plough in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Albers HM, 2009, ARTHRIT RHEUM-ARTHR, V61, P46, DOI 10.1002/art.24087; *AUSTR GOV, CLIN GUID DIAGN MAN; Berkun Y, 2010, AUTOIMMUN REV, V9, pA319, DOI 10.1016/j.autrev.2009.11.018; Davidson J, 2000, EUR J RADIOL, V33, P128, DOI 10.1016/S0720-048X(99)00161-8; Davies K, 2010, RHEUMATOLOGY, V49, P1406, DOI 10.1093/rheumatology/kep460; Flato B, 2003, J RHEUMATOL, V30, P386; Foster C Stephen, 2003, Curr Opin Ophthalmol, V14, P395; Giannini EH, 1997, ARTHRITIS RHEUM, V40, P1202; Hashkes PJ, 2010, NAT REV RHEUMATOL, V6, P561, DOI 10.1038/nrrheum.2010.142; Hashkes PJ, 2005, JAMA-J AM MED ASSOC, V294, P1671, DOI 10.1001/jama.294.13.1671; Hull RG, 2001, RHEUMATOLOGY, V40, P1308, DOI 10.1093/rheumatology/40.11.1308; Lovell DJ, 2008, NEW ENGL J MED, V359, P810, DOI 10.1056/NEJMoa0706290; Lovell DJ, 2000, NEW ENGL J MED, V342, P763, DOI 10.1056/NEJM200003163421103; Minden K, 2009, HORM RES, V72, P20, DOI 10.1159/000229759; NIGROVIC PA, 2010, ARTHRITIS RHEUM 0411; Ostile IL, 2009, CLIN EXP RHEUMATOL, V27, P1039; Petty RE, 2004, J RHEUMATOL, V31, P390; Prakken BJ, 2009, BEST PRACT RES CL RH, V23, P599, DOI 10.1016/j.berh.2009.07.003; Prince FHM, 2010, ANN RHEUM DIS, V69, P138, DOI 10.1136/ard.2009.111260; Ringold S, 2009, J RHEUMATOL, V36, P1330, DOI 10.3899/jrheum.081028; Ruperto N, 2008, LANCET, V372, P383, DOI 10.1016/S0140-6736(08)60998-8; Saurenmann RK, 2007, ARTHRITIS RHEUM, V56, P1974, DOI 10.1002/art.22709; Shenoi Susan, 2010, Curr Rheumatol Rep, V12, P80, DOI 10.1007/s11926-010-0085-2; Sherry DD, 1999, ARTHRITIS RHEUM, V42, P2330, DOI 10.1002/1529-0131(199911)42:11<2330::AID-ANR11>3.0.CO;2-B; Silverman E, 2005, NEW ENGL J MED, V352, P1655, DOI 10.1056/NEJMoa041810; van Rossum MAJ, 1998, ARTHRITIS RHEUM, V41, P808, DOI 10.1002/1529-0131(199805)41:5<808::AID-ART6>3.0.CO;2-T; van Rossum MAJ, 2007, ANN RHEUM DIS, V66, P1518, DOI 10.1136/ard.2006.064717; Wallace CA, 2006, BEST PRACT RES CL RH, V20, P279, DOI 10.1016/j.berh.2005.11.008; Wallace CA, 2004, J RHEUMATOL, V31, P2290; Woo P, 2006, NAT CLIN PRACT RHEUM, V2, P28, DOI 10.1038/ncprheum0084; Woo P, 2000, ARTHRITIS RHEUM-US, V43, P1849, DOI 10.1002/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F; Zulian F, 2004, RHEUMATOLOGY, V43, P1288, DOI 10.1093/rheumatology/keh313	32	41	41	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2010	341								c6434	10.1136/bmj.c6434	http://dx.doi.org/10.1136/bmj.c6434			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691PC	21131338				2022-12-28	WOS:000285092300001
J	Lee, CTA; Luffi, P; Le Roux, V; Dasgupta, R; Albarede, F; Leeman, WP				Lee, Cin-Ty A.; Luffi, Peter; Le Roux, Veronique; Dasgupta, Rajdeep; Albarede, Francis; Leeman, William P.			The redox state of arc mantle using Zn/Fe systematics	NATURE			English	Article							OXIDATION-STATE; OXYGEN FUGACITY; SOURCE REGIONS; EARTHS MANTLE; DIFFERENTIATION; PERIDOTITES; INSIGHTS; BASALTS; MAGMAS; METASOMATISM	Many arc lavas are more oxidized than mid-ocean-ridge basalts and subduction introduces oxidized components into the mantle(1-4). As a consequence, the sub-arc mantle wedge is widely believed to be oxidized(3,5). The Fe oxidation state of sub-arc mantle is, however, difficult to determine directly, and debate persists as to whether this oxidation is intrinsic to the mantle source(6,7). Here we show that Zn/Fe(T) (where Fe(T) = Fe(2+) + Fe(3+)) is redox-sensitive and retains a memory of the valence state of Fe in primary arc basalts and their mantle sources. During melting of mantle peridotite, Fe(2+) and Zn behave similarly, but because Fe(3+) is more incompatible than Fe(2+), melts generated in oxidized environments have low Zn/Fe(T). Primitive arc magmas have identical Zn/Fe(T) to mid-ocean-ridge basalts, suggesting that primary mantle melts in arcs and ridges have similar Fe oxidation states. The constancy of Zn/Fe(T) during early differentiation involving olivine requires that Fe(3+)/Fe(T) remains low in the magma. Only after progressive fractionation does Fe(3+)/Fe(T) increase and stabilize magnetite as a fractionating phase. These results suggest that subduction of oxidized crustal material may not significantly alter the redox state of the mantle wedge. Thus, the higher oxidation states of arc lavas must be in part a consequence of shallow-level differentiation processes, though such processes remain poorly understood.	[Lee, Cin-Ty A.; Luffi, Peter; Le Roux, Veronique; Dasgupta, Rajdeep; Albarede, Francis; Leeman, William P.] Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; [Albarede, Francis] Univ Lyon 1, Ecole Normale Super Lyon, F-69007 Lyon, France; [Albarede, Francis] CNRS, F-69007 Lyon, France; [Leeman, William P.] Natl Sci Fdn, Div Earth Sci, Arlington, VA 22230 USA	Rice University; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); National Science Foundation (NSF); NSF - Directorate for Geosciences (GEO); NSF - Division of Earth Sciences (EAR)	Lee, CTA (corresponding author), Rice Univ, Dept Earth Sci, Houston, TX 77005 USA.	ctlee@rice.edu	Luffi, Peter I/C-1229-2013; Lee, Cin-Ty/A-5469-2008; Lee, Cin-Ty/AAV-8155-2021; Albarede, Francis/A-8871-2011; Le Roux, Veronique/C-4633-2011; Dasgupta, Rajdeep/C-7252-2009	Luffi, Peter I/0000-0001-9536-5405; Lee, Cin-Ty/0000-0002-3586-0110; Albarede, Francis/0000-0003-1994-1428; Dasgupta, Rajdeep/0000-0001-5392-415X; Le Roux, Veronique/0000-0002-5855-4888	Geological Society of America	Geological Society of America	Discussions and debates with D. Canil, R. Lange, E. Cottrell and K. Kelley are appreciated. We especially thank H. O'Neill for insights. This work was facilitated by a Geological Society of America award (to C.-T.A.L.) F.A. was supported by the Keith-Weiss Visiting Professorship at Rice University.	ALT JC, 1986, J GEOPHYS RES-SOLID, V91, P309, DOI 10.1029/JB091iB10p10309; Arculus RJ, 2003, J PETROL, V44, P929, DOI 10.1093/petrology/44.5.929; Bezos A, 2005, GEOCHIM COSMOCHIM AC, V69, P711, DOI 10.1016/j.gca.2004.07.026; Canil D, 1997, NATURE, V389, P842, DOI 10.1038/39860; CANIL D, 1994, EARTH PLANET SC LETT, V123, P205, DOI 10.1016/0012-821X(94)90268-2; CARMICHAEL ISE, 1991, CONTRIB MINERAL PETR, V106, P129, DOI 10.1007/BF00306429; CHRISTIE DM, 1986, EARTH PLANET SC LETT, V79, P397, DOI 10.1016/0012-821X(86)90195-0; Dauphas N, 2009, EARTH PLANET SC LETT, V288, P255, DOI 10.1016/j.epsl.2009.09.029; FROST BR, 1991, MINERAL SOC AM REV M, V25, P1; Frost DJ, 2008, ANNU REV EARTH PL SC, V36, P389, DOI 10.1146/annurev.earth.36.031207.124322; Gill J., 1981, OROGENIC ANDESITES P; Holloway JR, 2004, CHEM GEOL, V210, P225, DOI 10.1016/j.chemgeo.2004.06.009; Ishimaru S, 2009, EARTH PLANET SC LETT, V284, P352, DOI 10.1016/j.epsl.2009.04.042; Kelley KA, 2009, SCIENCE, V325, P605, DOI 10.1126/science.1174156; KRESS VC, 1991, CONTRIB MINERAL PETR, V108, P82, DOI 10.1007/BF00307328; Lange RA, 1996, CONTRIB MINERAL PETR, V125, P167, DOI 10.1007/s004100050214; Le Roux V, 2010, GEOCHIM COSMOCHIM AC, V74, P2779, DOI 10.1016/j.gca.2010.02.004; Lee CTA, 2005, J PETROL, V46, P2313, DOI 10.1093/petrology/egi056; Malaspina N, 2009, J PETROL, V50, P1533, DOI 10.1093/petrology/egp040; Mallmann G, 2009, J PETROL, V50, P1765, DOI 10.1093/petrology/egp053; McInnes BIA, 2001, EARTH PLANET SC LETT, V188, P169, DOI 10.1016/S0012-821X(01)00306-5; Mungall JE, 2002, GEOLOGY, V30, P915, DOI 10.1130/0091-7613(2002)030<0915:RTMSMA>2.0.CO;2; OSBORN EF, 1959, AM J SCI, V257, P609, DOI 10.2475/ajs.257.9.609; Parkinson IJ, 1999, CHEM GEOL, V160, P409, DOI 10.1016/S0009-2541(99)00110-2; Patino LC, 2000, CONTRIB MINERAL PETR, V138, P265, DOI 10.1007/s004100050562; ROEDER PL, 1970, CONTRIB MINERAL PETR, V29, P275, DOI 10.1007/BF00371276; Rowe MC, 2009, J PETROL, V50, P61, DOI 10.1093/petrology/egn072; SISSON TW, 1993, CONTRIB MINERAL PETR, V113, P143, DOI 10.1007/BF00283225; Teng FZ, 2008, SCIENCE, V320, P1620, DOI 10.1126/science.1157166; Wang J, 2007, CONTRIB MINERAL PETR, V153, P607, DOI 10.1007/s00410-006-0166-4; WOOD BJ, 1990, SCIENCE, V248, P337, DOI 10.1126/science.248.4953.337	31	200	214	2	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 2	2010	468	7324					681	685		10.1038/nature09617	http://dx.doi.org/10.1038/nature09617			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124454				2022-12-28	WOS:000284836700038
J	Klaers, J; Schmitt, J; Vewinger, F; Weitz, M				Klaers, Jan; Schmitt, Julian; Vewinger, Frank; Weitz, Martin			Bose-Einstein condensation of photons in an optical microcavity	NATURE			English	Article							EXCITON POLARITONS; PHASE-TRANSITION; CAVITY; GAS; LASERS	Bose-Einstein condensation (BEC)-the macroscopic ground-state accumulation of particles with integer spin (bosons) at low temperature and high density-has been observed in several physical systems(1-9), including cold atomic gases and solid-state quasiparticles. However, the most omnipresent Bose gas, blackbody radiation (radiation in thermal equilibrium with the cavity walls) does not show this phase transition. In such systems photons have a vanishing chemical potential, meaning that their number is not conserved when the temperature of the photon gas is varied(10); at low temperatures, photons disappear in the cavity walls instead of occupying the cavity ground state. Theoretical works have considered thermalization processes that conserve photon number (a prerequisite for BEC), involving Compton scattering with a gas of thermal electrons(11) or photon-photon scattering in a nonlinear resonator configuration(12,13). Number-conserving thermalization was experimentally observed(14) for a two-dimensional photon gas in a dye-filled optical microcavity, which acts as a 'white-wall' box. Here we report the observation of a Bose-Einstein condensate of photons in this system. The cavity mirrors provide both a confining potential and a nonvanishing effective photon mass, making the system formally equivalent to a two-dimensional gas of trapped, massive bosons. The photons thermalize to the temperature of the dye solution (room temperature) by multiple scattering with the dye molecules. Upon increasing the photon density, we observe the following BEC signatures: the photon energies have a Bose-Einstein distribution with a massively populated ground-state mode on top of a broad thermal wing; the phase transition occurs at the expected photon density and exhibits the predicted dependence on cavity geometry; and the ground-state mode emerges even for a spatially displaced pump spot. The prospects of the observed effects include studies of extremely weakly interacting low-dimensional Bose gases(9) and new coherent ultraviolet sources(15).	[Klaers, Jan; Schmitt, Julian; Vewinger, Frank; Weitz, Martin] Univ Bonn, Inst Angew Phys, D-53115 Bonn, Germany	University of Bonn	Weitz, M (corresponding author), Univ Bonn, Inst Angew Phys, Wegelerstr 8, D-53115 Bonn, Germany.	martin.weitz@uni-bonn.de	Klaers, Jan/N-9793-2016	Klaers, Jan/0000-0001-5939-7477; Vewinger, Frank/0000-0001-7818-2981; Schmitt, Julian/0000-0002-0002-3777; Weitz, Martin/0000-0002-4236-318X	Deutsche Forschungsgemeinschaft within the focused research unit [FOR557]; IFRAF at LKB Paris	Deutsche Forschungsgemeinschaft within the focused research unit; IFRAF at LKB Paris	We thank J. Dalibard and Y. Castin for discussions. Financial support from the Deutsche Forschungsgemeinschaft within the focused research unit FOR557 is acknowledged. M.W. thanks the IFRAF for support of a guest stay at LKB Paris, where part of the discussion on interacting two-dimensional photon gases was developed.	ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; BAGNATO V, 1991, PHYS REV A, V44, P7439, DOI 10.1103/PhysRevA.44.7439; Balili R, 2007, SCIENCE, V316, P1007, DOI 10.1126/science.1140990; Bolda EL, 2001, PHYS REV LETT, V86, P416, DOI 10.1103/PhysRevLett.86.416; Bradley CC, 1997, PHYS REV LETT, V78, P985, DOI 10.1103/PhysRevLett.78.985; Chiao RY, 2000, OPT COMMUN, V179, P157, DOI 10.1016/S0030-4018(99)00615-X; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; De Angelis E, 2000, J OPT B-QUANTUM S O, V2, P149, DOI 10.1088/1464-4266/2/2/315; DEMARTINI F, 1988, PHYS REV LETT, V60, P1711, DOI 10.1103/PhysRevLett.60.1711; Demokritov SO, 2006, NATURE, V443, P430, DOI 10.1038/nature05117; Deng H, 2002, SCIENCE, V298, P199, DOI 10.1126/science.1074464; Einstein A, 1917, PHYS Z, V18, P121; Einstein A, 1925, SITZUNGSBERICHTE PRE, V1, P3; GRIFFIN A, 1995, BOSEEINSTEIN CONDENS; HADZIBABIC Z, 2009, 2 DIMENSIONAL BOSE F; Hadzibabic Z, 2006, NATURE, V441, P1118, DOI 10.1038/nature04851; HUANG K, 1987, STAT MECH, V2nd, P293; Jonkers J, 2006, PLASMA SOURCES SCI T, V15, pS8, DOI 10.1088/0963-0252/15/2/S02; Kasprzak J, 2006, NATURE, V443, P409, DOI 10.1038/nature05131; Ketterle W, 1999, P INT SCH PHYS, V140, P67; Klaers J, 2010, NAT PHYS, V6, P512, DOI 10.1038/NPHYS1680; Kocharovsky VV, 2006, ADV ATOM MOL OPT PHY, V53, P291, DOI 10.1016/S1049-250X(06)53010-1; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P6; Mullin WJ, 1997, J LOW TEMP PHYS, V106, P615, DOI 10.1007/BF02395928; Siegman A. E., 1986, LASER; YAMAMOTO Y, 1992, OPT QUANT ELECTRON, V24, pS215, DOI 10.1007/BF00625826; YOKOYAMA H, 1989, J APPL PHYS, V66, P4801, DOI 10.1063/1.343793; YOKOYAMA H, 1992, QUANTUM ELECTRON, V24, pS245; ZELDOVIC.YB, 1969, SOV PHYS JETP-USSR, V28, P1287; [No title captured]	30	464	469	7	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 25	2010	468	7323					545	548		10.1038/nature09567	http://dx.doi.org/10.1038/nature09567			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107426	Green Submitted			2022-12-28	WOS:000284584200038
J	Stankovic, KM; Juliano, AF; Hasserjian, RP				Stankovic, Konstantina M.; Juliano, Amy F.; Hasserjian, Robert P.			Case 36-2010: A 50-Year-Old Woman with Pain and Loss of Hearing in the Left Ear	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; OTOLOGIC MANIFESTATIONS; GRANULOCYTIC-SARCOMA; TEMPORAL BONE; POLYCYTHEMIA-VERA; INVOLVEMENT; HYDROXYUREA		[Stankovic, Konstantina M.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA; [Juliano, Amy F.] Massachusetts Eye & Ear Infirm, Dept Radiol, Boston, MA 02114 USA; [Hasserjian, Robert P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Stankovic, Konstantina M.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Juliano, Amy F.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Hasserjian, Robert P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Stankovic, KM (corresponding author), Massachusetts Eye & Ear Infirm, Dept Otolaryngol, 243 Charles St, Boston, MA 02114 USA.							Arber DA, 2008, WHO CLASSIFICATION T, P124; Byrd JC, 1997, J CLIN ONCOL, V15, P466, DOI 10.1200/JCO.1997.15.2.466; CLAIRMONT AA, 1977, ANN OTO RHINOL LARYN, V86, P306, DOI 10.1177/000348947708600305; CUNNINGHAM MJ, 1989, ARCH OTOLARYNGOL, V115, P807; Falini B, 2007, LEUKEMIA, V21, P1566, DOI 10.1038/sj.leu.2404699; Finazzi G, 2000, BRIT J HAEMATOL, V110, P577, DOI 10.1046/j.1365-2141.2000.02188.x; Finazzi G, 2005, BLOOD, V105, P2664, DOI 10.1182/blood-2004-09-3426; FINAZZI G, 2005, CANCER, V104, P1032; Hamilton TK, 1999, ARCH DERMATOL, V135, P464; HAZELL JWP, 1976, J LARYNGOL OTOL, V90, P877, DOI 10.1017/S0022215100082840; Kimura T., 1948, T SOC PATH JAP, V37, P179; Lee B, 2002, AM J NEURORADIOL, V23, P1497; Nadol JB, 2006, OTOLARYNG CLIN N AM, V39, P723, DOI 10.1016/j.otc.2006.05.003; NEIMAN RS, 1981, CANCER-AM CANCER SOC, V48, P1426, DOI 10.1002/1097-0142(19810915)48:6<1426::AID-CNCR2820480626>3.0.CO;2-G; Ogawa S, 2006, INTERNAL MED, V45, P733, DOI 10.2169/internalmedicine.45.1671; Passamonti F, 2005, CANCER, V104, P1032, DOI 10.1002/cncr.21297; Passamonti F, 2008, HAEMATOL-HEMATOL J, V93, P1645, DOI 10.3324/haematol.13346; Pileri SA, 2007, LEUKEMIA, V21, P340, DOI 10.1038/sj.leu.2404491; SHEIKHA A, 1992, J LARYNGOL OTOL, V106, P316, DOI 10.1017/S0022215100119383; Sterkers Y, 1998, BLOOD, V91, P616, DOI 10.1182/blood.V91.2.616.616_616_622; Sugimoto Y, 2004, HEMATOL J, V5, P84, DOI 10.1038/sj.thj.6200336; Takagi D, 2002, LARYNGOSCOPE, V112, P1684, DOI 10.1097/00005537-200209000-00029; Tam CS, 2008, BLOOD, V112, P1628, DOI 10.1182/blood-2008-02-138230; Tefferi A, 2000, NEW ENGL J MED, V342, P1255, DOI 10.1056/NEJM200004273421706; TODD NW, 1984, INT J PEDIATR OTORHI, V7, P173, DOI 10.1016/S0165-5876(84)80041-5; TUERLINGS J, 1990, CANCER GENET CYTOGEN, V50, P103, DOI 10.1016/0165-4608(90)90243-4; Yamauchi K, 2002, CANCER-AM CANCER SOC, V94, P1739, DOI 10.1002/cncr.10399; YANIV E, 1987, AM J OTOLARYNG, V8, P356, DOI 10.1016/S0196-0709(87)80020-0; ZAPPIA JJ, 1990, INT J PEDIATR OTORHI, V19, P259, DOI 10.1016/0165-5876(90)90005-C	29	2	2	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2010	363	22					2146	2156		10.1056/NEJMcpc1000967	http://dx.doi.org/10.1056/NEJMcpc1000967			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684XE	21105797				2022-12-28	WOS:000284587800011
J	Fairman, JA; Rowe, JW; Hassmiller, S; Shalala, DE				Fairman, Julie A.; Rowe, John W.; Hassmiller, Susan; Shalala, Donna E.			Broadening the Scope of Nursing Practice.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fairman, Julie A.] Univ Penn, Sch Nursing, Barbara Bates Ctr Study Hist Nursing, Philadelphia, PA 19104 USA; [Fairman, Julie A.; Rowe, John W.; Hassmiller, Susan; Shalala, Donna E.] Robert Wood Johnson Fdn, Initiat Future Nursing, Inst Med, Washington, DC USA; [Rowe, John W.] Columbia Univ, Dept Hlth Policy & Management, Mailman Sch Publ Hlth, New York, NY USA; [Shalala, Donna E.] Univ Miami, Miami, FL USA	University of Pennsylvania; Robert Wood Johnson Foundation (RWJF); Columbia University; University of Miami	Fairman, JA (corresponding author), Univ Penn, Sch Nursing, Barbara Bates Ctr Study Hist Nursing, Philadelphia, PA 19104 USA.							Eibner C, 2009, CONTROLLING HLTH CAR; Institute of Medicine, 2010, FUT NURS LEAD CHANG; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Starck PL, 2005, J PROF NURS, V21, P183, DOI 10.1016/j.profnurs.2005.04.007	4	138	139	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2011	364	3					193	196		10.1056/NEJMp1012121	http://dx.doi.org/10.1056/NEJMp1012121			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	708SF	21158652				2022-12-28	WOS:000286383900001
J	Mawuenyega, KG; Sigurdson, W; Ovod, V; Munsell, L; Kasten, T; Morris, JC; Yarasheski, KE; Bateman, RJ				Mawuenyega, Kwasi G.; Sigurdson, Wendy; Ovod, Vitaliy; Munsell, Ling; Kasten, Tom; Morris, John C.; Yarasheski, Kevin E.; Bateman, Randall J.			Decreased Clearance of CNS beta-Amyloid in Alzheimer's Disease	SCIENCE			English	Article							IN-VIVO		[Mawuenyega, Kwasi G.; Sigurdson, Wendy; Ovod, Vitaliy; Munsell, Ling; Kasten, Tom; Morris, John C.; Bateman, Randall J.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Sigurdson, Wendy; Morris, John C.; Bateman, Randall J.] Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Morris, John C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Yarasheski, Kevin E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Bateman, Randall J.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bateman, RJ (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	batemanr@wustl.edu	Yarasheski, Kevin E/A-3025-2008; Yarasheski, Kevin/AAC-7450-2021; Morris, John C/A-1686-2012	Yarasheski, Kevin/0000-0001-5436-2451; Bateman, Randall/0000-0002-7729-1702	NIH [K08 AG027091, K23 AG030946, R01 NS065667, P50 AG05681, P01 AG03991, UL1 RR024992, P41 RR000954, P60 DK020579, P30 DK056341]; Eli Lilly research; Knight Initiative for Alzheimer's Research; James and Elizabeth McDonnell Fund for Alzheimer's Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954, UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG030946, P50AG005681, K08AG027091, P01AG003991] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly research; Knight Initiative for Alzheimer's Research; James and Elizabeth McDonnell Fund for Alzheimer's Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to the participants for their time and effort. The authors thank J. X. Wang for gas chromatography-mass spectrometry (MS) analysis and R. Connors and R. Potter for immunoprecipitation-MS analysis. Special thanks to D. M. Holtzman for mentoring, support, and review of the manuscript. This work was supported by grants from NIH (nos. K08 AG027091, K23 AG030946, R01 NS065667, P50 AG05681, P01 AG03991, UL1 RR024992, P41 RR000954, P60 DK020579, and P30 DK056341), an anonymous foundation, Eli Lilly research, the Knight Initiative for Alzheimer's Research, and the James and Elizabeth McDonnell Fund for Alzheimer's Research. R.J.B. and D. M. Holtzman are cofounders of a company (C2N Diagnostics) that has licensed a pending Washington University patent on the technology described in this article.	Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Ellis RJ, 1996, NEUROLOGY, V46, P1592, DOI 10.1212/WNL.46.6.1592; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864	7	1417	1497	6	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1774	1774		10.1126/science.1197623	http://dx.doi.org/10.1126/science.1197623			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21148344	Green Accepted			2022-12-28	WOS:000285603700030
J	Jonietz, F; Muhlbauer, S; Pfleiderer, C; Neubauer, A; Munzer, W; Bauer, A; Adams, T; Georgii, R; Boni, P; Duine, RA; Everschor, K; Garst, M; Rosch, A				Jonietz, F.; Muehlbauer, S.; Pfleiderer, C.; Neubauer, A.; Muenzer, W.; Bauer, A.; Adams, T.; Georgii, R.; Boeni, P.; Duine, R. A.; Everschor, K.; Garst, M.; Rosch, A.			Spin Transfer Torques in MnSi at Ultralow Current Densities	SCIENCE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; DOMAIN-WALL MOTION; MAGNETIC MULTILAYER; ELECTRIC-CURRENT; DRIVEN; EXCITATION; STATE	Spin manipulation using electric currents is one of the most promising directions in the field of spintronics. We used neutron scattering to observe the influence of an electric current on the magnetic structure in a bulk material. In the skyrmion lattice of manganese silicon, where the spins form a lattice of magnetic vortices similar to the vortex lattice in type II superconductors, we observe the rotation of the diffraction pattern in response to currents that are over five orders of magnitude smaller than those typically applied in experimental studies on current-driven magnetization dynamics in nanostructures. We attribute our observations to an extremely efficient coupling of inhomogeneous spin currents to topologically stable knots in spin structures.	[Jonietz, F.; Muehlbauer, S.; Pfleiderer, C.; Neubauer, A.; Muenzer, W.; Bauer, A.; Adams, T.; Georgii, R.; Boeni, P.] Tech Univ Munich, Phys Dept E21, D-85748 Garching, Germany; [Muehlbauer, S.; Georgii, R.] Tech Univ Munich, Forsch Neutronenquelle Heinz Maier Leibnitz FRM 2, D-85748 Garching, Germany; [Duine, R. A.] Univ Utrecht, Inst Theoret Phys, NL-3584 CE Utrecht, Netherlands; [Everschor, K.; Garst, M.; Rosch, A.] Univ Cologne, Inst Theoret Phys, D-50937 Cologne, Germany	Technical University of Munich; Technical University of Munich; Utrecht University; University of Cologne	Pfleiderer, C (corresponding author), Tech Univ Munich, Phys Dept E21, D-85748 Garching, Germany.	christian.pfleiderer@frm2.tum.de	Georgii, Robert Heinrich/N-8891-2019; Garst, Markus/B-6740-2012; Everschor-Sitte, Karin/O-3759-2016; Duine, Rembert A/F-3559-2016; Rosch, Achim/AAY-7730-2020; Rosch, Achim/A-2962-2009; Pfleiderer, Christian/P-3575-2014	Georgii, Robert Heinrich/0000-0002-9366-4935; Garst, Markus/0000-0001-5390-3316; Everschor-Sitte, Karin/0000-0001-8767-6633; Rosch, Achim/0000-0002-6586-5721; Rosch, Achim/0000-0002-6586-5721; Pfleiderer, Christian/0000-0001-7749-7965; Bauer, Andreas/0000-0002-1070-9748	German Science Foundation (Deutsche Forschungsgemeinschaft) [SFB608, TRR80, SFB/TR12]; Deutsche Telekom Stiftung; NSF [PHY05-51164]; Stichting voor Fundamenteel Onderzoek der Materie; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; European Research Council	German Science Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Deutsche Telekom Stiftung; NSF(National Science Foundation (NSF)); Stichting voor Fundamenteel Onderzoek der Materie(FOM (The Netherlands)); Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); European Research Council(European Research Council (ERC)European Commission)	We thank B. Binz, S. Dunsiger, E. M. Forgan, C. Franz, E. Hering, M. Janoschek, H. Kolb, M. Laver, S. Legl, T. Lorenz, A. H. MacDonald, T. Nattermann, J. Peters, S. M. Ramos da Silva, B. Russ, T. Schulz, R. Schwikowski, B. Spivak, A. Vishwanath, M. Vojta, M. Wagner, W. Zwerger, and the team of FRM II for discussions and support. We gratefully acknowledge financial support through SFB608 and TRR80, SFB/TR12 of the German Science Foundation (Deutsche Forschungsgemeinschaft), the Deutsche Telekom Stiftung (K. E.), NSF grant PHY05-51164 (A. R.), and by Stichting voor Fundamenteel Onderzoek der Materie, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, and the European Research Council (R.A.D.).	Belitz D, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.054431; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Binz B, 2008, PHYSICA B, V403, P1336, DOI 10.1016/j.physb.2007.10.136; BLATTER G, 1994, REV MOD PHYS, V66, P1125, DOI 10.1103/RevModPhys.66.1125; Bode M, 2007, NATURE, V447, P190, DOI 10.1038/nature05802; Goto K., 2008, CURRENT INDUCED DYNA; Grollier J, 2003, APPL PHYS LETT, V83, P509, DOI 10.1063/1.1594841; He J, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.184408; Kiselev SI, 2003, NATURE, V425, P380, DOI 10.1038/nature01967; Lee M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.186601; Lopez D, 1999, PHYS REV LETT, V82, P1277, DOI 10.1103/PhysRevLett.82.1277; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Munzer W, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041203; Myers EB, 1999, SCIENCE, V285, P867, DOI 10.1126/science.285.5429.867; Neubauer A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.186602; Pfleiderer C, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/16/164207; Pfleiderer C, 2010, NATURE, V465, P880, DOI 10.1038/465880a; Schieback C, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.214403; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Tatara G, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.054707; THIELE AA, 1973, PHYS REV LETT, V30, P230, DOI 10.1103/PhysRevLett.30.230; Tsoi M, 2003, APPL PHYS LETT, V83, P2617, DOI 10.1063/1.1578165; Tsoi M, 1998, PHYS REV LETT, V80, P4281, DOI 10.1103/PhysRevLett.80.4281; Wessely O, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.256601; Yamanouchi M, 2004, NATURE, V428, P539, DOI 10.1038/nature02441; Ye JW, 1999, PHYS REV LETT, V83, P3737, DOI 10.1103/PhysRevLett.83.3737; Yu XZ, 2010, NATURE, V465, P901, DOI 10.1038/nature09124	27	868	874	14	385	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1648	1651		10.1126/science.1195709	http://dx.doi.org/10.1126/science.1195709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164010	Green Submitted			2022-12-28	WOS:000285390500059
J	Tammann, GA				Tammann, Gustav A.			Allan Sandage (1926-2010) OBITUARY	NATURE			English	Biographical-Item									Univ Basel, CH-4003 Basel, Switzerland	University of Basel	Tammann, GA (corresponding author), Univ Basel, CH-4003 Basel, Switzerland.	g-a.tammann@unibas.ch							0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 16	2010	468	7326					898	898		10.1038/468898a	http://dx.doi.org/10.1038/468898a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164471	Bronze			2022-12-28	WOS:000285344600028
J	Axelsson, J; Sundelin, T; Ingre, M; Van Someren, EJW; Olsson, A; Lekander, M				Axelsson, John; Sundelin, Tina; Ingre, Michael; Van Someren, Eus J. W.; Olsson, Andreas; Lekander, Mats			CHRISTMAS 2010: RESEARCH Beauty sleep: experimental study on the perceived health and attractiveness of sleep deprived people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEPRIVATION; DURATION; SYSTEM; IMPACT; BRAIN; HEART; FACE	Objective To investigate whether sleep deprived people are perceived as less healthy, less attractive, and more tired than after a normal night's sleep. Design Experimental study. Setting Sleep laboratory in Stockholm, Sweden. Participants 23 healthy, sleep deprived adults (age 1831) who were photographed and 65 untrained observers (age 18-61) who rated the photographs. Intervention Participants were photographed after a normal night's sleep (eight hours) and after sleep deprivation (31 hours of wakefulness after a night of reduced sleep). The photographs were presented in a randomised order and rated by untrained observers. Main outcome measure Difference in observer ratings of perceived health, attractiveness, and tiredness between sleep deprived and well rested participants using a visual analogue scale (100 mm). Results Sleep deprived people were rated as less healthy (visual analogue scale scores, mean 63 (SE 2) v 68 (SE 2), P<0.001), more tired (53 (SE 3) v 44 (SE 3), P<0.001), and less attractive (38 (SE 2) v 40 (SE 2), P<0.001) than after a normal night's sleep. The decrease in rated health was associated with ratings of increased tiredness and decreased attractiveness. Conclusion Our findings show that sleep deprived people appear less healthy, less attractive, and more tired compared with when they are well rested. This suggests that humans are sensitive to sleep related facial cues, with potential implications for social and clinical judgments and behaviour. Studies are warranted for understanding how these effects may affect clinical decision making and can add knowledge with direct implications in a medical context.	[Axelsson, John; Lekander, Mats] Karolinska Inst, Dept Clin Neurosci, Osher Ctr Integrat Med, S-17177 Stockholm, Sweden; [Axelsson, John; Sundelin, Tina; Olsson, Andreas] Karolinska Inst, Dept Clin Neurosci, Div Psychol, S-17177 Stockholm, Sweden; [Ingre, Michael; Lekander, Mats] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Van Someren, Eus J. W.] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Van Someren, Eus J. W.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands	Karolinska Institutet; Karolinska Institutet; Stockholm University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Axelsson, J (corresponding author), Karolinska Inst, Dept Clin Neurosci, Osher Ctr Integrat Med, S-17177 Stockholm, Sweden.	john.axelsson@ki.se	Van Someren, Eus/AAA-6789-2020; Axelsson, John/AAH-5998-2019	Axelsson, John/0000-0003-3932-7310; Sundelin, Tina/0000-0002-7590-0826; Ingre, Michael/0000-0003-0678-4494	Swedish Society for Medical Research; Rut and Arvid Wolff's Memory Fund; Osher Center for Integrative Medicine	Swedish Society for Medical Research; Rut and Arvid Wolff's Memory Fund; Osher Center for Integrative Medicine	This study was funded by the Swedish Society for Medical Research, Rut and Arvid Wolff's Memory Fund, and the Osher Center for Integrative Medicine.	Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Bryant PA, 2004, NAT REV IMMUNOL, V4, P457, DOI 10.1038/nri1369; Cirelli C, 2006, SLEEP MED REV, V10, P307, DOI 10.1016/j.smrv.2006.04.001; Deten A, 2005, CARDIOVASC RES, V65, P52, DOI 10.1016/j.cardiores.2004.11.009; Doyle AC, 1993, CASE BOOK S HOLMES S; Drummond SPA, 2000, NATURE, V403, P655, DOI 10.1038/35001068; Harrison Y, 2000, J EXP PSYCHOL-APPL, V6, P236, DOI 10.1037//1076-898X.6.3.236; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Horne J., 1989, WHY WE SLEEP; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Irwin MR, 2006, ARCH INTERN MED, V166, P1756, DOI 10.1001/archinte.166.16.1756; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Krull JL, 2001, MULTIVAR BEHAV RES, V36, P249, DOI 10.1207/S15327906MBR3602_06; Lieberman MD, 2002, ADV EXP SOC PSYCHOL, V34, P199, DOI 10.1016/S0065-2601(02)80006-5; Olson LG, 2006, BRIT J HOSP MED, V67, P118, DOI 10.12968/hmed.2006.67.3.20610; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Ranjbaran Z, 2007, INFLAMM RES, V56, P51, DOI 10.1007/s00011-006-6067-1; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Schleicher R, 2008, ERGONOMICS, V51, P982, DOI 10.1080/00140130701817062; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; WIERWILLE WW, 1994, ACCIDENT ANAL PREV, V26, P571, DOI 10.1016/0001-4575(94)90019-1; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x	23	65	65	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2010	341								c6614	10.1136/bmj.c6614	http://dx.doi.org/10.1136/bmj.c6614			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XD	21156746	Green Published, hybrid			2022-12-28	WOS:000285552200004
J	Scott, CJ				Scott, C. John			Christmas 2010: History A shopping list of doctors	BRITISH MEDICAL JOURNAL			English	Editorial Material											Scott, CJ (corresponding author), 35 Ashgrove Rd W, Aberdeen AB16 5BB, Scotland.	cjohnscott@aol.com						[Anonymous], 1943, NY TIMES; Borsay A, 2004, OXFORD DICT NATL BIO, V41, P764; Jacyna LS, 2004, OXFORD DICT NATL BIO, V1, P99; Lock SP, 2001, OXFORD ILLUSTRATED C, P827; McDonald DI, 1974, AUSTR DICT BIOGRAPHY, V5, P429; Mosley J, 2004, OXFORD DICT NATL BIO, V21, P99; Moynihan BGA, 1936, TRUANTS STORY SOME W; Scott C J, 1999, Proc R Coll Physicians Edinb, V29, P258; Woodhouse FL, 1974, AUSTR DICT BIOGRAPHY, V5, P89	9	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 14	2010	341								c5727	10.1136/bmj.c5727	http://dx.doi.org/10.1136/bmj.c5727			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XD	21156734				2022-12-28	WOS:000285552200001
J	McCartney, M; Ewart, P; Scott, C				McCartney, Margaret; Ewart, Philip; Scott, Christine			Christmas 2010: Primary Care Are there too many referral forms?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[McCartney, Margaret; Ewart, Philip; Scott, Christine] Fulton St Med Ctr, Glasgow, Lanark, Scotland		McCartney, M (corresponding author), Fulton St Med Ctr, Glasgow, Lanark, Scotland.	margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2010	341								c6576	10.1136/bmj.c6576	http://dx.doi.org/10.1136/bmj.c6576			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XA	21149464				2022-12-28	WOS:000285551900003
J	Ratje, AH; Loerke, J; Mikolajka, A; Brunner, M; Hildebrand, PW; Starosta, AL; Donhofer, A; Connell, SR; Fucini, P; Mielke, T; Whitford, PC; Onuchic, JN; Yu, YN; Sanbonmatsu, KY; Hartmann, RK; Penczek, PA; Wilson, DN; Spahn, CMT				Ratje, Andreas H.; Loerke, Justus; Mikolajka, Aleksandra; Bruenner, Matthias; Hildebrand, Peter W.; Starosta, Agata L.; Doenhoefer, Alexandra; Connell, Sean R.; Fucini, Paola; Mielke, Thorsten; Whitford, Paul C.; Onuchic, Jose N.; Yu, Yanan; Sanbonmatsu, Karissa Y.; Hartmann, Roland K.; Penczek, Pawel A.; Wilson, Daniel N.; Spahn, Christian M. T.			Head swivel on the ribosome facilitates translocation by means of intra-subunit tRNA hybrid sites	NATURE			English	Article							ELECTRON-MICROSCOPY; MOLECULAR-DYNAMICS; CONFORMATIONAL-CHANGES; INTERMEDIATE STATES; MESSENGER-RNA; 70S RIBOSOME; TRANSLATION; MECHANISM; MOVEMENT; GTP	The elongation cycle of protein synthesis involves the delivery of aminoacyl-transfer RNAs to the aminoacyl-tRNA-binding site (A site) of the ribosome, followed by peptide-bond formation and translocation of the tRNAs through the ribosome to reopen the A site(1,2). The translocation reaction is catalysed by elongation factor G (EF-G) in a GTP-dependent manner(3). Despite the availability of structures of various EF-G-ribosome complexes, the precise mechanism by which tRNAs move through the ribosome still remains unclear. Here we use multiparticle cryoelectron microscopy analysis to resolve two previously unseen subpopulations within Thermus thermophilus EF-G-ribosome complexes at subnanometre resolution, one of them with a partly translocated tRNA. Comparison of these substates reveals that translocation of tRNA on the 30S subunit parallels the swivelling of the 30S head and is coupled to unratcheting of the 30S body. Because the tRNA maintains contact with the peptidyl-tRNA-binding site (P site) on the 30S head and simultaneously establishes interaction with the exit site (E site) on the 30S platform, a novel intra-subunit 'pe/E' hybrid state is formed. This state is stabilized by domain IV of EF-G, which interacts with the swivelled 30S-head conformation. These findings provide direct structural and mechanistic insight into the 'missing link' in terms of tRNA intermediates involved in the universally conserved translocation process.	[Ratje, Andreas H.; Loerke, Justus; Bruenner, Matthias; Hildebrand, Peter W.; Mielke, Thorsten; Spahn, Christian M. T.] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Ratje, Andreas H.; Hartmann, Roland K.] Univ Marburg, Inst Pharmazeut Chem, D-35037 Marburg, Germany; [Mikolajka, Aleksandra; Starosta, Agata L.; Doenhoefer, Alexandra; Wilson, Daniel N.] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Mikolajka, Aleksandra; Starosta, Agata L.; Doenhoefer, Alexandra; Wilson, Daniel N.] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Mikolajka, Aleksandra; Wilson, Daniel N.] Univ Munich, Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Connell, Sean R.; Fucini, Paola] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Frankfurt Inst Mol Life Sci, D-60438 Frankfurt, Germany; [Mielke, Thorsten] Max Planck Inst Mol Genet, UltraStrukturNetzwerk, D-14195 Berlin, Germany; [Whitford, Paul C.; Sanbonmatsu, Karissa Y.] Los Alamos Natl Lab, Div Theoret, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA; [Onuchic, Jose N.] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Onuchic, Jose N.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Yu, Yanan] Florida State Univ, Dept Comp Sci, Tallahassee, FL 32306 USA; [Penczek, Pawel A.] Univ Texas Houston, Sch Med, Houston, TX 77030 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Philipps University Marburg; University of Munich; University of Munich; University of Munich; Goethe University Frankfurt; Max Planck Society; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California San Diego; University of California System; University of California San Diego; State University System of Florida; Florida State University; University of Texas System; University of Texas Health Science Center Houston	Spahn, CMT (corresponding author), Charite, Inst Med Phys & Biophys, Ziegelstr 5-9, D-10117 Berlin, Germany.	wilson@lmb.uni-muenchen.de; christian.spahn@charite.de	Fucini, Paola/M-1118-2014; Starosta, Agata/D-9535-2017; Yu, Yan/GYV-4514-2022; Connell, Sean/ABF-6090-2021; Wilson, Daniel/AAE-8504-2019; Connell, Sean R/K-6725-2013; connell, sean/B-2305-2012	Fucini, Paola/0000-0003-1724-8507; Starosta, Agata/0000-0003-3915-5723; Connell, Sean/0000-0001-7807-7049; Wilson, Daniel/0000-0003-3816-3828; Connell, Sean R/0000-0001-7807-7049; connell, sean/0000-0001-7807-7049; Loerke, Justus/0000-0002-3424-8536	Deutsche Forschungsgemeinschaft (DFG) [SFB 740 TP A3, TP Z1, SP 1130/2-1, FU579 1-3, HA 1672/7-5, WI3285/1-1]; European Union 3D-EM Network of Excellence; European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum); US National Institutes of Health (NIH) [GM 60635]; Goethe University Frankfurt (DFG) [EXC 115]; Human Frontiers of Science Program [HFSP67/07]; LANL; National Science Foundation (NSF) [PHY-0822283]; NIH [R01-GM072686]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060635, R01GM072686] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union 3D-EM Network of Excellence(European Commission); European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Goethe University Frankfurt (DFG)(German Research Foundation (DFG)); Human Frontiers of Science Program(Human Frontier Science Program); LANL(United States Department of Energy (DOE)Los Alamos National Laboratory); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The present work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG; SFB 740 TP A3 and TP Z1, SP 1130/2-1 to C.M.T.S., FU579 1-3 to P.F., HA 1672/7-5 to R.K.H. and WI3285/1-1 to D.N.W.), the European Union 3D-EM Network of Excellence (to C.M.T.S.), the European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum) and US National Institutes of Health (NIH; grant GM 60635 to P.A.P.), the Cluster of Excellence 'Macromolecular complexes' at the Goethe University Frankfurt (DFG Project EXC 115 to P.F. and S.C.), and the Human Frontiers of Science Program Young Investigators Award HFSP67/07 (to P.F.). We thank the New Mexico Computing Application Center for generous time on the Encanto Supercomputer. P.C.W. is currently funded by a LANL Director's Fellowship. This work was also supported by the Center for Theoretical Biological Physics sponsored by the National Science Foundation (NSF; grant PHY-0822283) with additional support from NSF-MCB-0543906, the LANL LDRD program and NIH grant R01-GM072686.	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Bocharov EV, 2004, J BIOL CHEM, V279, P17697, DOI 10.1074/jbc.M313384200; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Connell SR, 2008, NAT STRUCT MOL BIOL, V15, P910, DOI 10.1038/nsmb.1469; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frank J, 2006, REP PROG PHYS, V69, P1383, DOI 10.1088/0034-4885/69/5/R03; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Matassova NB, 2001, RNA, V7, P1879; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Munro JB, 2009, TRENDS BIOCHEM SCI, V34, P390, DOI 10.1016/j.tibs.2009.04.004; Orzechowski M, 2008, BIOPHYS J, V95, P5692, DOI 10.1529/biophysj.108.139451; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; Shoji S, 2009, ACS CHEM BIOL, V4, P93, DOI 10.1021/cb8002946; Spahn CMT, 2009, CURR OPIN STRUC BIOL, V19, P623, DOI 10.1016/j.sbi.2009.08.001; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Spirin AS, 2009, J BIOL CHEM, V284, P21103, DOI 10.1074/jbc.X109.001552; Ticu C, 2009, EMBO J, V28, P2053, DOI 10.1038/emboj.2009.169; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Whitford PC, 2010, RNA, V16, P1196, DOI 10.1261/rna.2035410; Whitford PC, 2009, BIOPHYS J, V96, pL7, DOI 10.1016/j.bpj.2008.10.033; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	42	268	270	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					713	U143		10.1038/nature09547	http://dx.doi.org/10.1038/nature09547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124459	Green Accepted			2022-12-28	WOS:000284836700045
J	Hayes, JH; Ollendorf, DA; Pearson, SD; Barry, MJ; Kantoff, PW; Stewart, ST; Bhatnagar, V; Sweeney, CJ; Stahl, JE; McMahon, PM				Hayes, Julia H.; Ollendorf, Daniel A.; Pearson, Steven D.; Barry, Michael J.; Kantoff, Philip W.; Stewart, Susan T.; Bhatnagar, Vibha; Sweeney, Christopher J.; Stahl, James E.; McMahon, Pamela M.			Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate Cancer A Decision Analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXTERNAL-BEAM RADIATION; QUALITY-OF-LIFE; RADICAL PROSTATECTOMY; PROTON RADIOTHERAPY; SECONDARY-CANCER; SCREENING TRIAL; HEALTH STATES; PATIENT AGE; THERAPY; MANAGEMENT	Context In the United States, 192 000 men were diagnosed as having prostate cancer in 2009, the majority with low-risk, clinically localized disease. Treatment of these cancers is associated with substantial morbidity. Active surveillance is an alternative to initial treatment, but long-term outcomes and effect on quality of life have not been well characterized. Objective To examine the quality-of-life benefits and risks of active surveillance compared with initial treatment for men with low-risk, clinically localized prostate cancer. Design and Setting Decision analysis using a simulation model was performed: men were treated at diagnosis with brachytherapy, intensity-modulated radiation therapy (IMRT), or radical prostatectomy or followed up by active surveillance (a strategy of close monitoring of newly diagnosed patients with serial prostate-specific antigen measurements, digital rectal examinations, and biopsies, with treatment at disease progression or patient choice). Probabilities and utilities were derived from previous studies and literature review. In the base case, the relative risk of prostate cancer-specific death for initial treatment vs active surveillance was assumed to be 0.83. Men incurred short-and long-term adverse effects of treatment. Patients Hypothetical cohorts of 65-year-old men newly diagnosed as having clinically localized, low-risk prostate cancer (prostate-specific antigen level <10 ng/mL, stage <= T2a disease, and Gleason score <= 6). Main Outcome Measure Quality-adjusted life expectancy (QALE). Results Active surveillance was associated with the greatest QALE (11.07 quality-adjusted life-years [QALYs]), followed by brachytherapy (10.57 QALYs), IMRT (10.51 QALYs), and radical prostatectomy (10.23 QALYs). Active surveillance remained associated with the highest QALE even if the relative risk of prostate cancer-specific death for initial treatment vs active surveillance was as low as 0.6. However, the QALE gains and the optimal strategy were highly dependent on individual preferences for living under active surveillance and for having been treated. Conclusions Under a wide range of assumptions, for a 65-year-old man, active surveillance is a reasonable approach to low-risk prostate cancer based on QALE compared with initial treatment. However, individual preferences play a central role in the decision whether to treat or to pursue active surveillance. JAMA. 2010;304(21):2373-2380 www.jama.com	[Hayes, Julia H.; Kantoff, Philip W.; Sweeney, Christopher J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA; [Hayes, Julia H.; Stahl, James E.; McMahon, Pamela M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02115 USA; [Ollendorf, Daniel A.; Pearson, Steven D.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Inst Clin & Econ Review, Boston, MA 02115 USA; [Barry, Michael J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Med Practices Evaluat Ctr, Boston, MA 02115 USA; [Stewart, Susan T.] Harvard Univ, Interfac Program Hlth Syst Improvement, Cambridge, MA 02138 USA; [Stewart, Susan T.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Bhatnagar, Vibha] Vet Affairs San Diego Hlth Care Syst, Ctr Patient Oriented Care, Hlth Serv Res & Dev, San Diego, CA USA; [Bhatnagar, Vibha] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; National Bureau of Economic Research; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Hayes, JH (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Dana 1230,44 Binney St, Boston, MA 02115 USA.	julia_hayes@dfci.harvard.edu		Kantoff, Philip/0000-0001-7275-0597	Foundation for Informed Medical Decision Making; National Cancer Institute at the National Institutes of Health [R25 CA92203-08]; Department of Defense [W81XWH-09-1-0512]; Prostate Cancer Foundation; Blue Shield of California Foundation; NATIONAL CANCER INSTITUTE [R25CA092203] Funding Source: NIH RePORTER	Foundation for Informed Medical Decision Making; National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Prostate Cancer Foundation; Blue Shield of California Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Barry receives salary support as president of the Foundation for Informed Medical Decision Making, a not-for-profit private foundation. The foundation develops content for patient education programs, including a program on prostate cancer treatment. The foundation has an arrangement with a for-profit company, Health Dialog, to coproduce these programs. The programs are used as part of the decision support and disease management services Health Dialog provides to consumers through health care organizations and employers.; This work was supported in part by grant R25 CA92203-08 from the National Cancer Institute at the National Institutes of Health, by grant W81XWH-09-1-0512 from the Department of Defense, by a Young Investigators Award to Dr Hayes from the Prostate Cancer Foundation, and in part by funding to the Institute for Clinical and Economic Review from the Blue Shield of California Foundation.	Abdel-Wahab M, 2008, INT J RADIAT ONCOL, V72, P58, DOI 10.1016/j.ijrobp.2007.12.043; Alibhai SMH, 2003, J CLIN ONCOL, V21, P3318, DOI 10.1200/JCO.2003.09.034; Andersson SO, 2004, BJU INT, V94, P327, DOI 10.1111/j.1464-410X.2004.04930.x; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; [Anonymous], AC RAD MORB SCOR CRI; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Bacon CG, 2003, ANN INTERN MED, V139, P161, DOI 10.7326/0003-4819-139-3-200308050-00005; Barocas DA, 2008, J UROLOGY, V180, P1330, DOI 10.1016/j.juro.2008.06.019; BECK JR, 1994, J UROLOGY, V152, P1894, DOI 10.1016/S0022-5347(17)32409-6; Bhatnagar V, 2004, UROLOGY, V63, P103, DOI 10.1016/j.urology.2003.08.011; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; Bostrom PJ, 2007, EUR UROL, V52, P973, DOI 10.1016/j.eururo.2007.07.002; Brenner DJ, 2000, CANCER, V88, P398, DOI 10.1002/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO;2-V; Burnet KL, 2007, BJU INT, V100, P540, DOI 10.1111/j.1464-410X.2007.07009.x; Carter HB, 2002, J UROLOGY, V167, P1231, DOI 10.1016/S0022-5347(05)65271-8; CHUNG CS, 2008, AM SOC THER RAD ONC; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; Cooperberg MR, 2010, J CLIN ONCOL, V28, P1117, DOI 10.1200/JCO.2009.26.0133; Cooperberg MR, 2005, J CLIN ONCOL, V23, P8146, DOI 10.1200/JCO.2005.02.9751; D'Amico AV, 2009, INT J RADIAT ONCOL, V75, P10, DOI 10.1016/j.ijrobp.2008.10.082; D'Amico AV, 1999, J CLIN ONCOL, V17, P168, DOI 10.1200/JCO.1999.17.1.168; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; Dale W, 2008, MED DECIS MAKING, V28, P102, DOI 10.1177/0272989X07309639; Dall'Era MA, 2008, CANCER-AM CANCER SOC, V112, P2664, DOI 10.1002/cncr.23502; Djavan B, 2001, J UROLOGY, V166, P856, DOI 10.1016/S0022-5347(05)65851-X; FLEMING C, 1993, JAMA-J AM MED ASSOC, V269, P2650, DOI 10.1001/jama.269.20.2650; Griffin CR, 2007, J UROLOGY, V178, P860, DOI 10.1016/j.juro.2007.05.016; Grossfeld GD, 1998, J UROLOGY, V159, P1437, DOI 10.1097/00005392-199805000-00004; Hardie C, 2005, BJU INT, V95, P956, DOI 10.1111/j.1464-410X.2005.05446.x; Horwitz EM, 2005, J UROLOGY, V173, P797, DOI 10.1097/01.ju.0000152556.53602.64; *I CLIN EC REV, IMRT FIN APPR FULL R; *I CLIN EC REV, ACT SURV RAD PROST F; Institute for Clinical and Economic Review, FIN APPR DOC BRACH P; Jang TL, 2007, UROL ONCOL-SEMIN ORI, V25, P510, DOI 10.1016/j.urolonc.2007.05.025; Kattan MW, 1997, J GEN INTERN MED, V12, P299, DOI 10.1046/j.1525-1497.1997.012005299.x; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Kry SF, 2005, INT J RADIAT ONCOL, V62, P1195, DOI 10.1016/j.ijrobp.2005.03.053; Litwin MS, 2002, CANCER, V95, P54, DOI 10.1002/cncr.10651; Louie-Johnsun M, 2009, BJU INT, V104, P1501, DOI 10.1111/j.1464-410X.2009.08597.x; LuYao GL, 1996, J NATL CANCER I, V88, P166, DOI 10.1093/jnci/88.3-4.166; Magheli A, 2007, J UROLOGY, V178, P1933, DOI 10.1016/j.juro.2007.07.016; *NAT CANC I CANC T, 1999, COMM TOX CRIT; Nguyen TD, 2005, RADIOTHER ONCOL, V77, P286, DOI 10.1016/j.radonc.2005.10.015; Pickles T, 2007, BJU INT, V100, P544, DOI 10.1111/j.1464-410X.2007.06981.x; Roemeling S, 2007, EUR UROL, V51, P1244, DOI 10.1016/j.eururo.2006.11.053; Rosser CJ, 2006, UROLOGY, V67, P769, DOI 10.1016/j.urology.2005.10.027; Rossi CJ, 2004, UROLOGY, V64, P729, DOI 10.1016/j.urology.2004.04.043; Schneider U, 2006, STRAHLENTHER ONKOL, V182, P647, DOI 10.1007/s00066-006-1534-8; Schneider U, 2008, RADIOTHER ONCOL, V89, P135, DOI 10.1016/j.radonc.2008.07.017; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Shapiro EY, 2009, J UROLOGY, V181, P1665, DOI 10.1016/j.juro.2008.11.122; Sommers BD, 2007, CANCER-AM CANCER SOC, V110, P2210, DOI 10.1002/cncr.23028; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; Stewart ST, 2005, MED CARE, V43, P347, DOI 10.1097/01.mlr.0000156862.33341.45; Sullivan PW, 2006, MED DECIS MAKING, V26, P410, DOI 10.1177/0272989X06290495; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; TreeAge Pro, 2009, TREEAGE PRO 2009 SUI; van As NJ, 2008, EUR UROL, V54, P1297, DOI 10.1016/j.eururo.2008.02.039; van den Bergh RCN, 2010, BJU INT, V105, P956, DOI 10.1111/j.1464-410X.2009.08887.x; van den Bergh RCN, 2009, CANCER-AM CANCER SOC, V115, P3868, DOI 10.1002/cncr.24446; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099	62	194	202	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2010	304	21					2373	2380		10.1001/jama.2010.1720	http://dx.doi.org/10.1001/jama.2010.1720			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687FH	21119084	Green Accepted, Bronze			2022-12-28	WOS:000284763900018
J	Mountford, J; Davie, C				Mountford, James; Davie, Charlie			Toward an Outcomes-Based Health Care System A View From the United Kingdom	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mountford, James; Davie, Charlie] UCLPartners Acad Hlth Sci Partnership, London, England	University of London; University College London	Mountford, J (corresponding author), 149 Tottenham Court Rd,Ste 1A,Maple House, London W1T 7NF, England.	james.mountford@uclpartners.com						Black N, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2066; Chantler C, 2009, JAMA-J AM MED ASSOC, V302, P2032, DOI 10.1001/jama.2009.1644; Dzau VJ, 2010, LANCET, V375, P949, DOI 10.1016/S0140-6736(09)61082-5; General Medical Council, 2009, TOMORROWS DOCTORS; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Porter ME, 2007, JAMA-J AM MED ASSOC, V297, P1103, DOI 10.1001/jama.297.10.1103; Secretary of State for Health, 2010, EQ EXC LIB NHS; Swensen SJ, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp0911199	8	13	13	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2010	304	21					2407	2408		10.1001/jama.2010.1751	http://dx.doi.org/10.1001/jama.2010.1751			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687FH	21119088				2022-12-28	WOS:000284763900023
J	Zuccotti, G; Pogliani, L; Pariani, E; Amendola, A; Zanetti, A				Zuccotti, GianVincenzo; Pogliani, Laura; Pariani, Elena; Amendola, Antonella; Zanetti, Alessandro			Transplacental Antibody Transfer Following Maternal Immunization With a Pandemic 2009 Influenza A(H1N1) MF59-Adjuvanted Vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MOTHERS		[Zuccotti, GianVincenzo; Pogliani, Laura] Univ Milan, Dept Pediat, Milan, Italy; [Pariani, Elena; Amendola, Antonella; Zanetti, Alessandro] Univ Milan, Dept Publ Hlth Microbiol & Virol, Milan, Italy	University of Milan; University of Milan	Zuccotti, G (corresponding author), Univ Milan, Dept Pediat, Milan, Italy.	gianvincenzo.zuccotti@unimi.it	Amendola, Antonella/M-8980-2016; Pariani, Elena/M-3491-2016; Zuccotti, Gianvincenzo/H-8572-2017	Amendola, Antonella/0000-0002-0499-8977; Pariani, Elena/0000-0001-5681-3455; Zuccotti, Gianvincenzo/0000-0002-2795-9874				Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Steinhoff MC, 2010, NEW ENGL J MED, V362, P1644, DOI 10.1056/NEJMc0912599; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	6	53	54	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2010	304	21					2360	2361		10.1001/jama.2010.1729	http://dx.doi.org/10.1001/jama.2010.1729			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687FH	21119083				2022-12-28	WOS:000284763900016
J	Milburn, GJ				Milburn, Gerard J.			Quantum Measurement and Control of Single Spins in Diamond	SCIENCE			English	Editorial Material									Univ Queensland, Sch Math & Phys, Ctr Quantum Comp Technol, St Lucia, Qld 4067, Australia	University of Queensland	Milburn, GJ (corresponding author), Univ Queensland, Sch Math & Phys, Ctr Quantum Comp Technol, St Lucia, Qld 4067, Australia.	milburn@physics.uq.edu.au	MIlburn, Gerard J/B-6381-2008	MIlburn, Gerard J/0000-0002-5404-9681				Bradac C, 2010, NAT NANOTECHNOL, V5, P345, DOI [10.1038/NNANO.2010.56, 10.1038/nnano.2010.56]; BRUNE M, 1990, PHYS REV LETT, V65, P976, DOI 10.1103/PhysRevLett.65.976; Buckley BB, 2010, SCIENCE, V330, P1212, DOI 10.1126/science.1196436; McDermott R, 2005, SCIENCE, V307, P1299, DOI 10.1126/science.1107572; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; SAUTER T, 1986, PHYS REV LETT, V57, P1696, DOI 10.1103/PhysRevLett.57.1696; Schrodinger E., 1995, INTERPRETATION QUANT	7	10	11	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2010	330	6008					1188	1189		10.1126/science.1198299	http://dx.doi.org/10.1126/science.1198299			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109659				2022-12-28	WOS:000284613700026
J	Junttila, MR; Karnezis, AN; Garcia, D; Madriles, F; Kortlever, RM; Rostker, F; Swigart, LB; Pham, DM; Seo, Y; Evan, GI; Martins, CP				Junttila, Melissa R.; Karnezis, Anthony N.; Garcia, Daniel; Madriles, Francesc; Kortlever, Roderik M.; Rostker, Fanya; Swigart, Lamorna Brown; Pham, David M.; Seo, Youngho; Evan, Gerard I.; Martins, Carla P.			Selective activation of p53-mediated tumour suppression in high-grade tumours	NATURE			English	Article							P53 RESTORATION; MOUSE MODELS; LUNG-CANCER; IN-VIVO; K-RAS; SENESCENCE; EXPRESSION; ONCOGENE; KRAS2	Non-small cell lung carcinoma (NSCLC) is the leading cause of cancer-related death worldwide, with an overall 5-year survival rate of only 10-15%(1). Deregulation of the Ras pathway is a frequent hallmark of NSCLC, often through mutations that directly activate Kras(2). p53 is also frequently inactivated in NSCLC and, because oncogenic Ras can be a potent trigger of p53 (ref. 3), it seems likely that oncogenic Ras signalling has a major and persistent role in driving the selection against p53. Hence, pharmacological restoration of p53 is an appealing therapeutic strategy for treating this disease(4). Here we model the probable therapeutic impact of p53 restoration in a spontaneously evolving mouse model of NSCLC initiated by sporadic oncogenic activation of endogenous Kras(5). Surprisingly, p53 restoration failed to induce significant regression of established tumours, although it did result in a significant decrease in the relative proportion of high-grade tumours. This is due to selective activation of p53 only in the more aggressive tumour cells within each tumour. Such selective activation of p53 correlates with marked upregulation in Ras signal intensity and induction of the oncogenic signalling sensor p19(ARF) (ref. 6). Our data indicate that p53-mediated tumour suppression is triggered only when oncogenic Ras signal flux exceeds a critical threshold. Importantly, the failure of low-level oncogenic Kras to engage p53 reveals inherent limits in the capacity of p53 to restrain early tumour evolution and in the efficacy of therapeutic p53 restoration to eradicate cancers.	[Junttila, Melissa R.; Karnezis, Anthony N.; Garcia, Daniel; Kortlever, Roderik M.; Rostker, Fanya; Swigart, Lamorna Brown; Evan, Gerard I.; Martins, Carla P.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Junttila, Melissa R.; Karnezis, Anthony N.; Garcia, Daniel; Kortlever, Roderik M.; Rostker, Fanya; Swigart, Lamorna Brown; Pham, David M.; Seo, Youngho; Evan, Gerard I.; Martins, Carla P.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Madriles, Francesc] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge CB2 0RE, England; [Pham, David M.; Seo, Youngho] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Cancer Research UK; CRUK Cambridge Institute; University of California System; University of California San Francisco	Evan, GI (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England.	gie20@cam.ac.uk	Seo, Youngho/D-5705-2013; Kortlever, Roderik/AAY-9220-2020	Seo, Youngho/0000-0001-5908-6636; Kortlever, Roderik/0000-0001-5558-2851	NCI [CA98018, CA100193]; AICR [09-0649]; Ellison Medical Foundation; Samuel R. Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA098018, R01CA100193] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AICR; Ellison Medical Foundation(Lawrence Ellison Foundation); Samuel R. Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are indebted to T. Jacks for the KR mice, C. Sherr and M. Roussel for the p19<SUP>ARF</SUP> antibody, M. Dail and A.-T. Maia for advice on Kras copy number analysis and V. Weinberg for guidance on statistical analysis. We also thank D. Tuveson and all the members of the Evan laboratory for their comments. This work was supported by grants NCI CA98018, NCI CA100193, AICR 09-0649, the Ellison Medical Foundation and from the Samuel R. Waxman Cancer Research Foundation (all to G.I.E.). M.R.J. is the Enrique Cepero, PhD Fellow of the Damon Runyon Cancer Research Foundation.	Bertwistle D, 2004, HYBRIDOMA HYBRIDOM, V23, P293, DOI 10.1089/hyb.2004.23.293; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELDEIRY WS, 1994, CANCER RES, V54, P1169; FELDSER D, 1953, NATURE IN PRESS, DOI DOI 10.1038/NATURE09535; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Lawlor ER, 2006, CANCER RES, V66, P4591, DOI 10.1158/0008-5472.CAN-05-3826; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; Wagner PL, 2009, AM J CLIN PATHOL, V132, P500, DOI 10.1309/AJCPF10ZUNSOLIFG; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	30	192	194	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					567	U244		10.1038/nature09526	http://dx.doi.org/10.1038/nature09526			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107427	Green Submitted, Green Accepted			2022-12-28	WOS:000284584200043
J	Lawlor, DA; Benfield, L; Logue, J; Tilling, K; Howe, LD; Fraser, A; Cherry, L; Watt, P; Ness, AR; Smith, GD; Sattar, N				Lawlor, Debbie A.; Benfield, Li; Logue, Jennifer; Tilling, Kate; Howe, Laura D.; Fraser, Abigail; Cherry, Lynne; Watt, Pauline; Ness, Andrew R.; Smith, George Davey; Sattar, Naveed			Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; CORONARY-HEART-DISEASE; CAUSE-SPECIFIC MORTALITY; BLOOD-PRESSURE; CONTEMPORARY COHORT; CHILDREN; OVERWEIGHT; ADULTHOOD; FAT; PREVALENCE	Objectives To examine the prospective associations between body mass index (BMI), waist circumference, and fat mass in childhood and cardiovascular risk factors at age 15-16. Design Prospective cohort study. Setting Avon Longitudinal Study of Parents and Children. Participants 5235 children aged 9-12 at start of study. Main exposures BMI, waist circumference, and fat mass determined by dual energy x ray absorptiometry, assessed at age 9-12 and at age 15-16. Main outcome measures Systolic and diastolic blood pressure and concentrations of fasting glucose, insulin, triglycerides, low density lipoprotein cholesterol, and high density lipoprotein cholesterol assessed at age 15-16. Results In girls a 1 SD greater BMI at age 9-12 was associated with cardiovascular risk factors at age 15-16 in fully adjusted models: odds ratio 1.23 (95% confidence interval 1.10 to 1.38) for high systolic blood pressure (>= 130 mm Hg); 1.19 (1.03 to 1.38) for high concentration of low density lipoprotein cholesterol (>= 2.79 mmol/l); 1.43 (1.06 to 1.92) for high concentration of triglycerides (>= 1.7 mmol/l); 1.25 (1.08 to 1.46) for low concentration of high density lipoprotein cholesterol (<1.03 mmol/l); and 1.45 (1.22 to 1.73) for high concentration of insulin (>= 16.95 IU/l). Equivalent results in boys were 1.24 (1.13 to 1.37) for systolic blood pressure; 1.30 (1.07 to 1.59) for low density lipoprotein cholesterol; 1.96 (1.51 to 2.55) for triglycerides; 1.39 (1.22 to 1.57) for high density lipoprotein cholesterol, and 1.84 (1.56 to 2.17) for insulin. BMI was associated with high fasting glucose (>= 5.6 mmol/l) only in boys (1.18, 1.03 to 1.36). With these binary outcomes there was statistical evidence that associations differed between girls and boys for fasting glucose (P=0.03) and insulin (P<0.001). When risk factors were examined as continuous outcomes there was evidence for stronger associations of BMI with more adverse levels in boys than girls for fasting insulin, glucose, and triglyceride concentrations (all interaction P <= 0.03). BMI, waist circumference, and fat mass were all strongly correlated with each other (r=0.89-0.94), and associations of the three with cardiovascular outcomes were of similar magnitude with statistical evidence of consistency in associations (all P>0.2 for heterogeneity). When waist circumference or fat mass or both were added to models including BMI they did not increase the variation in cardiovascular risk factors already explained by BMI and confounders alone. Girls who were overweight/obese at age 9-12 but were normal weight by 15-16 had similar odds of adverse levels of risk factors to those who were normal weight at both ages. In boys odds of high systolic blood pressure, high concentrations of triglycerides and insulin, and low concentrations of high density lipoprotein cholesterol remained higher in this group compared with those who were normal weight at both ages but were lower than in those who remained overweight/obese at both ages. Conclusions Measurements of waist circumference or directly assessed fat mass in childhood do not seem to be associated with cardiovascular risk factors in adolescence any more strongly than BMI. Girls who favourably alter their overweight status between childhood and adolescence have cardiovascular risk profiles broadly similar to those who were normal weight at both time points, but boys who change from overweight to normal show risk factor profiles intermediate between those seen in boys who are normal weight at both ages or overweight at both ages.	[Lawlor, Debbie A.; Benfield, Li; Howe, Laura D.; Fraser, Abigail; Smith, George Davey] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol BS8 2BN, Avon, England; [Lawlor, Debbie A.; Benfield, Li; Tilling, Kate; Howe, Laura D.; Fraser, Abigail; Smith, George Davey] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Logue, Jennifer; Cherry, Lynne; Watt, Pauline; Sattar, Naveed] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Ness, Andrew R.] Univ Bristol, Dept Oral & Dent Sci, Bristol BS8 2BN, Avon, England	University of Bristol; University of Bristol; University of Glasgow; University of Bristol	Lawlor, DA (corresponding author), Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol BS8 2BN, Avon, England.	d.a.lawlor@bristol.ac.uk	Ness, Andy R/M-7612-2013; Tilling, Kate/AAY-1578-2021; Davey Smith, George/A-7407-2013; Logue, Jennifer/O-5076-2019; Berryman, Katie/J-4236-2014	Ness, Andy R/0000-0003-3548-9523; Davey Smith, George/0000-0002-1407-8314; Logue, Jennifer/0000-0001-9549-2738; Lawlor, Debbie A/0000-0002-6793-2262; Fraser, Abigail/0000-0002-7741-9470; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Tilling, Kate/0000-0002-1010-8926; Howe, Laura/0000-0003-3357-2796	US National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK077659]; Medical Research Council (MRC) [G0600705]; Wellcome Trust; University of Bristol; UK Medical Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077659] Funding Source: NIH RePORTER; MRC [G0600705, G0701594] Funding Source: UKRI; Medical Research Council [G0701594, G9815508, G0600705] Funding Source: researchfish	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by a grant from US National Institutes of Health (NIH) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK077659). The Medical Research Council (MRC), the Wellcome Trust, and the University of Bristol provide core funding support for ALSPAC. The MRC (G0600705) and the University of Bristol provide core funding for the MRC Centre of Causal Analyses in Translational Epidemiology. AF is funded by a UK Medical Research Council research fellowship. The views expressed in this paper are those of the authors and not necessarily those of any funding body or others whose support is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage P., 2001, STAT METHODS MED RES; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; Brion MA, 2007, J HUM HYPERTENS, V21, P283, DOI 10.1038/sj.jhh.1002152; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Efron B., 1994, MONOGRAPHS STAT APPL; FALASCHETTI E, 2010, EUR HEART J     1023; Fraser A, 2007, GASTROENTEROLOGY, V133, P1814, DOI 10.1053/j.gastro.2007.08.077; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freedman DS, 2009, AM J CLIN NUTR, V90, P210, DOI 10.3945/ajcn.2009.27525; Freedman DS, 2005, INT J OBESITY, V29, P1, DOI 10.1038/sj.ijo.0802735; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Johnson ST, 2010, J PEDIATR-US, V156, P247, DOI 10.1016/j.jpeds.2009.08.010; Lawlor DA, 2005, CURR OPIN NEPHROL HY, V14, P259, DOI 10.1097/01.mnh.0000165893.13620.2b; Lawlor DA, 2008, PLOS MED, V5, P484, DOI 10.1371/journal.pmed.0050033; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; Li XR, 2004, CIRCULATION, V110, P3488, DOI 10.1161/01.CIR.0000149713.48317.27; Mamun AA, 2005, HYPERTENSION, V45, P1083, DOI 10.1161/01.HYP.0000166720.18319.51; Maynard LM, 2001, PEDIATRICS, V107, P344, DOI 10.1542/peds.107.2.344; McCarthy HD, 2001, EUR J CLIN NUTR, V55, P902, DOI 10.1038/sj.ejcn.1601240; Moran A, 2008, CIRCULATION, V117, P2361, DOI 10.1161/CIRCULATIONAHA.107.704569; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; Ness AR, 2006, INT J PEDIATR OBES, V1, P59, DOI 10.1080/17477160600569339; Owen CG, 2009, INT J OBESITY, V33, P866, DOI 10.1038/ijo.2009.102; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Sinaiko AR, 1999, CIRCULATION, V99, P1471, DOI 10.1161/01.CIR.99.11.1471; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Srinivasan SR, 1996, METABOLISM, V45, P235, DOI 10.1016/S0026-0495(96)90060-8; Taylor AE, 2010, AM J CLIN NUTR, V91, P547, DOI 10.3945/ajcn.2009.28757; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	32	199	203	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2010	341								c6224	10.1136/bmj.c6224	http://dx.doi.org/10.1136/bmj.c6224			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688ED	21109577	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000284831700001
J	Nguyen, ML; Patel, AS				Nguyen, My-Linh; Patel, Anand S.			Plasmacytoma of the Skull.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nguyen, My-Linh] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Patel, Anand S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Nguyen, ML (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2010	363	22					E33	E33		10.1056/NEJMicm1003790	http://dx.doi.org/10.1056/NEJMicm1003790			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	684XE	21105787				2022-12-28	WOS:000284587800010
J	Annema, JT; van Meerbeeck, JP; Rintoul, RC; Dooms, C; Deschepper, E; Dekkers, OM; De Leyn, P; Braun, J; Carroll, NR; Praet, M; de Ryck, F; Vansteenkiste, J; Vermassen, F; Versteegh, MI; Veselic, M; Nicholson, AG; Rabe, KF; Tournoy, KG				Annema, Jouke T.; van Meerbeeck, Jan P.; Rintoul, Robert C.; Dooms, Christophe; Deschepper, Ellen; Dekkers, Olaf M.; De Leyn, Paul; Braun, Jerry; Carroll, Nicholas R.; Praet, Marleen; de Ryck, Frederick; Vansteenkiste, Johan; Vermassen, Frank; Versteegh, Michel I.; Veselic, Maud; Nicholson, Andrew G.; Rabe, Klaus F.; Tournoy, Kurt G.			Mediastinoscopy vs Endosonography for Mediastinal Nodal Staging of Lung Cancer A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FINE-NEEDLE-ASPIRATION; ENDOSCOPIC ULTRASOUND; ENDOBRONCHIAL ULTRASOUND; ESTS GUIDELINES; EBUS-TBNA; DIAGNOSIS; CLASSIFICATION; SURGERY; EUS	Context Mediastinal nodal staging is recommended for patients with resectable non-small cell lung cancer (NSCLC). Surgical staging has limitations, which results in the performance of unnecessary thoracotomies. Current guidelines acknowledge minimally invasive endosonography followed by surgical staging (if no nodal metastases are found by endosonography) as an alternative to immediate surgical staging. Objective To compare the 2 recommended lung cancer staging strategies. Design, Setting, and Patients Randomized controlled multicenter trial (Ghent, Leiden, Leuven, Papworth) conducted between February 2007 and April 2009 in 241 patients with resectable (suspected) NSCLC in whom mediastinal staging was indicated based on computed or positron emission tomography. Intervention Either surgical staging or endosonography (combined transesophageal and endobronchial ultrasound [EUS-FNA and EBUS-TBNA]) followed by surgical staging in case no nodal metastases were found at endosonography. Thoracotomy with lymph node dissection was performed when there was no evidence of mediastinal tumor spread. Main Outcome Measures The primary outcome was sensitivity for mediastinal nodal (N2/N3) metastases. The reference standard was surgical pathological staging. Secondary outcomes were rates of unnecessary thoracotomy and complications. Results Two hundred forty-one patients were randomized, 118 to surgical staging and 123 to endosonography, of whom 65 also underwent surgical staging. Nodal metastases were found in 41 patients (35%; 95% confidence interval [CI], 27%-44%) by surgical staging vs 56 patients (46%; 95% CI, 37%-54%) by endosonography (P=.11) and in 62 patients (50%; 95% CI, 42%-59%) by endosonography followed by surgical staging (P=.02). This corresponded to sensitivities of 79% (41/52; 95% CI, 66%-88%) vs 85% (56/66; 95% CI, 74%-92%) (P=.47) and 94% (62/66; 95% CI, 85%-98%) (P=.02). Thoracotomy was unnecessary in 21 patients (18%; 95% CI, 12%-26%) in the mediastinoscopy group vs 9 (7%; 95% CI, 4%-13%) in the endosonography group (P=.02). The complication rate was similar in both groups. Conclusions Among patients with (suspected) NSCLC, a staging strategy combining endosonography and surgical staging compared with surgical staging alone resulted in greater sensitivity for mediastinal nodal metastases and fewer unnecessary thoracotomies. Trial Registration clinicaltrials.gov Identifier: NCT00432640 JAMA. 2010;304(20):2245-2252 www.jama.com	[Annema, Jouke T.; Rabe, Klaus F.] Leiden Univ, Med Ctr, Dept Pulmonol, NL-2333 ZA Leiden, Netherlands; [Dekkers, Olaf M.] Leiden Univ, Med Ctr, Dept Clin Epidemiol Endocrinol & Metab Dis, NL-2333 ZA Leiden, Netherlands; [Braun, Jerry; Versteegh, Michel I.] Leiden Univ, Med Ctr, Dept Cardiothorac Surg, NL-2333 ZA Leiden, Netherlands; [Veselic, Maud] Leiden Univ, Med Ctr, Dept Pathol, NL-2333 ZA Leiden, Netherlands; [van Meerbeeck, Jan P.; Praet, Marleen; de Ryck, Frederick; Vermassen, Frank; Tournoy, Kurt G.] Ghent Univ Hosp, Lung Oncol Network, B-9000 Ghent, Belgium; [Deschepper, Ellen] Ghent Univ Hosp, Dept Biostat, B-9000 Ghent, Belgium; [Rintoul, Robert C.; Carroll, Nicholas R.] Papworth Hosp, Dept Thorac Oncol, Cambridge CB3 8RE, England; [Dooms, Christophe; Vansteenkiste, Johan] Katholieke Univ Leuven Hosp, Dept Pulmonol, Leuven, Belgium; [De Leyn, Paul] Katholieke Univ Leuven Hosp, Dept Surg, Leuven, Belgium; [Nicholson, Andrew G.] Harefield Hosp, Royal Brompton Hosp, Dept Histopathol, London, England; [Nicholson, Andrew G.] Imperial Coll Sch Med, Natl Heart & Lung Div, London, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Papworth Hospital; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton Hospital; Imperial College London	Annema, JT (corresponding author), Leiden Univ, Med Ctr, Dept Pulmonol, C3-P,Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	j.t.annema@lumc.nl	Braun, Jerry/K-6145-2017; De Ryck, Frederic/AFQ-6312-2022; Vansteenkiste, Johan F/B-8191-2014; van Meerbeeck, Jan/ABA-5109-2020; Rintoul, Robert Campbell/Q-1727-2015; Rabe, Klaus F./AAW-6296-2021	Braun, Jerry/0000-0002-4504-6235; De Ryck, Frederic/0000-0002-1984-9536; Vansteenkiste, Johan F/0000-0002-6721-2775; Rintoul, Robert Campbell/0000-0003-3875-3780; Rabe, Klaus F./0000-0002-7020-1401; Tournoy, Kurt/0000-0003-4943-3782; Dekkers, Olaf/0000-0002-1333-7580; van Meerbeeck, Jan/0000-0001-7872-8622	Hitachi Medical Systems (the Netherlands/Germany); COOK (Ireland); UK National Health Service [06/302/216]; National Institute for Health Research Cambridge Biomedical Research Centre; National Institute for Health Research [06/302/216] Funding Source: researchfish	Hitachi Medical Systems (the Netherlands/Germany)(Netherlands Government); COOK (Ireland); UK National Health Service; National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Drs Annema and Rabe reported that the Department of Pulmonology at Leiden University Medical Center received support for endosonography training courses from Hitachi Medical Systems (the Netherlands/Germany) and COOK (Ireland). Dr Rintoul reported that Papworth Hospital, Cambridge, received loan EBUS equipment and support for educational endosonography courses from Olympus UK. No other disclosures were reported.; Local support for data collection at Ghent University Hospital was provided by the Zorgprogramma Oncologie Gent (ZOG) (Carla Vandenabeele, Ghent University Hospital). Data collection in Papworth Hospital was supported by the UK National Health Service R&D Health Technology Assessment Program (project No. 06/302/216). Drs Rintoul and Rassl were supported in part by the National Institute for Health Research Cambridge Biomedical Research Centre.	Annema JT, 2008, JAMA-J AM MED ASSOC, V299, P2510, DOI 10.1001/jama.299.21.2510-a; Annema JT, 2010, GASTROINTEST ENDOSC, V71, P64, DOI 10.1016/j.gie.2009.07.027; Annema JT, 2005, JAMA-J AM MED ASSOC, V294, P931, DOI 10.1001/jama.294.8.931; Annema JT, 2005, J CLIN ONCOL, V23, P8357, DOI 10.1200/JCO.2005.01.1965; Bhutani MS, 1997, GASTROINTEST ENDOSC, V45, P474, DOI 10.1016/S0016-5107(97)70176-7; Bossuyt PMM, 2000, LANCET, V356, P1844, DOI 10.1016/S0140-6736(00)03246-3; De Leyn P, 2007, EUR J CARDIO-THORAC, V32, P1, DOI 10.1016/j.ejcts.2007.01.075; Detterbeck FC, 2007, CHEST, V132, p202S, DOI 10.1378/chest.07-1362; Ernst A, 2008, J THORAC ONCOL, V3, P577, DOI 10.1097/JTO.0b013e3181753b5e; Fischer B, 2009, NEW ENGL J MED, V361, P32, DOI 10.1056/NEJMoa0900043; Garcia-Olive I, 2010, EUR RESPIR J, V35, P391, DOI 10.1183/09031936.00028109; Gu P, 2009, EUR J CANCER, V45, P1389, DOI 10.1016/j.ejca.2008.11.043; Handy JR, 2002, CHEST, V122, P21, DOI 10.1378/chest.122.1.21; Harewood GC, 2010, LUNG CANCER, V67, P366, DOI 10.1016/j.lungcan.2009.04.019; Hetth FJF, 2008, CHEST, V133, P887, DOI 10.1378/chest.07-2535; Lardinois D, 2006, EUR J CARDIO-THORAC, V30, P787, DOI 10.1016/j.ejcts.2006.08.008; Micames CG, 2007, CHEST, V131, P539, DOI 10.1378/chest.06-1437; Mountain CF, 1997, CHEST, V111, P1718, DOI 10.1378/chest.111.6.1718; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rami-Porta R, 2005, LUNG CANCER, V49, P25, DOI 10.1016/j.lungcan.2005.01.001; Rintoul RC, 2005, EUR RESPIR J, V25, P416, DOI 10.1183/09031936.05.00095404; Rintoul RC, 2009, J THORAC ONCOL, V4, P44, DOI 10.1097/JTO.0b013e3181914357; Robinson LA, 2007, CHEST, V132, p243S, DOI 10.1378/chest.07-1379; Scott WJ, 2007, CHEST, V132, p234S, DOI 10.1378/chest.07-1378; Tournoy KG, 2008, AM J RESP CRIT CARE, V177, P531, DOI 10.1164/rccm.200708-1241OC; Tournoy KG, 2009, J THORAC ONCOL, V4, P1576, DOI 10.1097/JTO.0b013e3181c1274f; Vilmann P, 2005, ENDOSCOPY, V37, P833, DOI 10.1055/s-2005-870276; Wallace MB, 2008, JAMA-J AM MED ASSOC, V299, P540, DOI 10.1001/jama.299.5.540	28	399	418	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2010	304	20					2245	2252		10.1001/jama.2010.1705	http://dx.doi.org/10.1001/jama.2010.1705			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KI	21098770				2022-12-28	WOS:000284548400023
J	Doitsh, G; Cavrois, M; Lassen, KG; Zepeda, O; Yang, ZY; Santiago, ML; Hebbeler, AM; Greene, WC				Doitsh, Gilad; Cavrois, Marielle; Lassen, Kara G.; Zepeda, Orlando; Yang, Zhiyuan; Santiago, Mario L.; Hebbeler, Andrew M.; Greene, Warner C.			Abortive HIV Infection Mediates CD4 T Cell Depletion and Inflammation in Human Lymphoid Tissue	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE TRANSCRIPTION; BYSTANDER APOPTOSIS; LYMPHOCYTES; FUSION; ACTIVATION; MECHANISM; THERAPY; ENTRY; DEATH	The mechanism by which CD4 T cells are depleted in HIV-infected hosts remains poorly understood. In ex vivo cultures of human tonsil tissue, CD4 T cells undergo a pronounced cytopathic response following HIV infection. Strikingly, >95% of these dying cells are not productively infected but instead correspond to bystander cells. We now show that the death of these "bystander'' cells involves abortive HIV infection. Inhibitors blocking HIV entry or early steps of reverse transcription prevent CD4 T cell death while inhibition of later events in the viral life cycle does not. We demonstrate that the nonpermissive state exhibited by the majority of resting CD4 tonsil T cells leads to accumulation of incomplete reverse transcripts. These cytoplasmic nucleic acids activate a host defense program that elicits a coordinated proapoptotic and proinflammatory response involving caspase-3 and caspase-1 activation. While this response likely evolved to protect the host, it centrally contributes to the immunopathogenic effects of HIV.	[Doitsh, Gilad; Cavrois, Marielle; Lassen, Kara G.; Zepeda, Orlando; Yang, Zhiyuan; Santiago, Mario L.; Hebbeler, Andrew M.; Greene, Warner C.] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Greene, WC (corresponding author), Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	wgreene@gladstone.ucsf.edu	Yang, Zhiyuan/C-9543-2012	Yang, Zhiyuan/0000-0002-1175-4188; Santiago, Mario L./0000-0001-7792-2706	Universitywide AIDS Research Program [F04-GIVI-210]; UCSF-GIVI Center for AIDS Research, NIH/NIAID [P30 AI027763]; Francis Goelet Fellowship; UCSF, NIH/NIGMS [T32 GM007618-32]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA036502] Funding Source: NIH RePORTER	Universitywide AIDS Research Program; UCSF-GIVI Center for AIDS Research, NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Francis Goelet Fellowship; UCSF, NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank David N. Levy for the NLENG1 plasmid; David Fenard for the NL4-3 variant plasmids SIM, GIA, GIA-SKY, and SKY; George M. Shaw for the WEAU 16-8 env clone; and Suraj J. Patel, Kevin R. King, and Martin L. Yarmush for the H35 ISRE-GFP reporter cell line. The following reagents were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: AMD3100, T-20, Saquinavir, Amprenavir, Indinavir, Nevirapine, Efavirenz, and AZT-resistant HIV-1 clones #629 and #964. Special thanks to Dr. Eva Herker for assistance with fluorescence microscopy; to Dr. Stefanie Sowinski for help with assessing inflammatory responses in primary immune cells; and to Jason Neidleman for stimulating discussions and technical advice. We also thank Marty Bigos for assistance with the flow cytometry; Stephen Ordway and Gary Howard for editorial assistance; John C.W. Carroll and Alisha Wilson for graphics; and Robin Givens and Sue Cammack for administrative assistance. Funding for this project was provided by the Universitywide AIDS Research Program, F04-GIVI-210 (G.D.); the UCSF-GIVI Center for AIDS Research, NIH/NIAID P30 AI027763 (M.C.); the Francis Goelet Fellowship (K.G.L.); and the UCSF Medical Scientist Training Program, NIH/NIGMS T32 GM007618-32 (O.Z.).	ARTS EJ, 1994, ANTIMICROB AGENTS CH, V38, P1008, DOI 10.1128/AAC.38.5.1008; Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; de Sio FRS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006571; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Gandhi RT, 1998, J EXP MED, V187, P1113, DOI 10.1084/jem.187.7.1113; Garg H, 2007, J BIOL CHEM, V282, P16899, DOI 10.1074/jbc.M701701200; GLUSHAKOVA S, 1995, NAT MED, V1, P1320, DOI 10.1038/nm1295-1320; Grivel JC, 2003, AIDS RES HUM RETROV, V19, P211, DOI 10.1089/088922203763315713; Hayden MS, 2003, AIDS, V17, P629, DOI 10.1097/00002030-200303070-00021; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Holm GH, 2005, J VIROL, V79, P6299, DOI 10.1128/JVI.79.10.6299-6311.2005; Holm GH, 2004, J VIROL, V78, P4541, DOI 10.1128/JVI.78.9.4541-4551.2004; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jekle A, 2003, J VIROL, V77, P5846, DOI 10.1128/JVI.77.10.5846-5854.2003; Kamata M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000342; Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856; Labonte JA, 2000, J VIROL, V74, P10690, DOI 10.1128/JVI.74.22.10690-10698.2000; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Li XY, 2007, J BIOL CHEM, V282, P32065, DOI 10.1074/jbc.M703423200; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; MARGOLIS LB, 1995, AIDS RES HUM RETROV, V11, P697, DOI 10.1089/aid.1995.11.697; Patel SJ, 2009, P NATL ACAD SCI USA, V106, P12867, DOI 10.1073/pnas.0809292106; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; SCHRODER K, 2010, NAT CELL BIOL, V9, P310; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Swiggard WJ, 2004, AIDS RES HUM RETROV, V20, P285, DOI 10.1089/088922204322996527; Thomas C, 2009, NAT MED, V15, P855, DOI 10.1038/nm0809-855; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Vlahakis SR, 2001, J CLIN INVEST, V107, P207, DOI 10.1172/JCI11109; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005	41	310	318	2	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 24	2010	143	5					789	801		10.1016/j.cell.2010.11.001	http://dx.doi.org/10.1016/j.cell.2010.11.001			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111238	Bronze, Green Accepted			2022-12-28	WOS:000284583500020
J	Shibata, Y; Shemesh, T; Prinz, WA; Palazzo, AF; Kozlov, MM; Rapoport, TA				Shibata, Yoko; Shemesh, Tom; Prinz, William A.; Palazzo, Alexander F.; Kozlov, Michael M.; Rapoport, Tom A.			Mechanisms Determining the Morphology of the Peripheral ER	CELL			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; RIBOSOME RECEPTOR; ROUGH; BINDING; IDENTIFICATION; BIOSYNTHESIS; MICROTUBULES; ORGANIZATION; GTPASES	The endoplasmic reticulum (ER) consists of the nuclear envelope and a peripheral network of tubules and membrane sheets. The tubules are shaped by the curvature-stabilizing proteins reticulons and DP1/Yop1p, but how the sheets are formed is unclear. Here, we identify several sheet-enriched membrane proteins in the mammalian ER, including proteins that translocate and modify newly synthesized polypeptides, as well as coiled-coil membrane proteins that are highly upregulated in cells with proliferated ER sheets, all of which are localized by membrane-bound polysomes. These results indicate that sheets and tubules correspond to rough and smooth ER, respectively. One of the coiled-coil proteins, Climp63, serves as a "luminal ER spacer'' and forms sheets when overexpressed. More universally, however, sheet formation appears to involve the reticulons and DP1/Yop1p, which localize to sheet edges and whose abundance determines the ratio of sheets to tubules. These proteins may generate sheets by stabilizing the high curvature of edges.	[Shemesh, Tom; Kozlov, Michael M.] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Shibata, Yoko; Palazzo, Alexander F.; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Shibata, Yoko] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Prinz, William A.] NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA; [Palazzo, Alexander F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Toronto	Kozlov, MM (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	michk@post.tau.ac.il; tom_rapoport@hms.harvard.edu	Shemesh, Tom/J-5060-2013; Palazzo, Alexander/B-1270-2013	Palazzo, Alexander/0000-0002-9700-1995	American Heart Association; National Institute of Diabetes and Digestive and Kidney Diseases; Israel Science Foundation (ISF); Marie Curie network "Virus Entry"; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060105] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Israel Science Foundation (ISF)(Israel Science Foundation); Marie Curie network "Virus Entry"; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Denison, J. Minsteris, and S. Gygi for mass spectrometry analysis; J. Baughman for microarray analysis; A. Condon and A. Boye-Doe for technical assistance; J. Iwasa for help with illustrations; G. Kreibich, K. Ogawa-Goto, L. Lu, and R. Yan for materials; the Nikon Imaging Center and the Electron Microscopy facility at HMS for microscopy assistance; and R. Klemm and A. Osborne for critical reading of the manuscript. Y.S. was supported by the American Heart Association and is a Howard Hughes Medical Institute postdoctoral fellow. W.A.P. is supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. T.A.R. is a Howard Hughes Medical Institute Investigator. M.M.K. is supported by the Israel Science Foundation (ISF) and the Marie Curie network "Virus Entry.''	AMBROZIAK J, 1994, J BIOL CHEM, V269, P15344; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Becker F, 1999, J CELL BIOL, V146, P273, DOI 10.1083/jcb.146.2.273; Benyamini P, 2009, MOL BIOL CELL, V20, P732, DOI 10.1091/mbc.E08-07-0682; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Christensen AK, 1999, ANAT REC, V255, P116, DOI 10.1002/(SICI)1097-0185(19990601)255:2<116::AID-AR2>3.0.CO;2-O; Dawson TR, 2009, J CELL BIOL, V184, P659, DOI 10.1083/jcb.200806174; Fawcett D.W., 1981, CELL; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; HINMAN ND, 1970, SCIENCE, V170, P1222, DOI 10.1126/science.170.3963.1222; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Klopfenstein DR, 2001, J CELL BIOL, V153, P1287, DOI 10.1083/jcb.153.6.1287; Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168; KREIBICH G, 1978, J CELL BIOL, V77, P464, DOI 10.1083/jcb.77.2.464; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Nikonov AV, 2007, J CELL SCI, V120, P2248, DOI 10.1242/jcs.008979; Nikonov AV, 2002, J CELL BIOL, V158, P497, DOI 10.1083/jcb.200201116; Ogawa-Goto K, 2007, MOL BIOL CELL, V18, P3741, DOI 10.1091/mbc.E06-12-1125; Puhka M, 2007, J CELL BIOL, V179, P895, DOI 10.1083/jcb.200705112; SAVITZ AJ, 1990, NATURE, V346, P540, DOI 10.1038/346540a0; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Senda T, 1998, ANAT REC, V251, P339; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Sparkes I, 2010, PLANT CELL, V22, P1333, DOI 10.1105/tpc.110.074385; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; Ueno T, 2010, J BIOL CHEM, V285, P29941, DOI 10.1074/jbc.M109.094607; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; VOGEL F, 1990, EUR J CELL BIOL, V53, P197; [No title captured]	38	324	331	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					774	788		10.1016/j.cell.2010.11.007	http://dx.doi.org/10.1016/j.cell.2010.11.007			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111237	Green Accepted, Bronze			2022-12-28	WOS:000284583500019
J	Flagel, SB; Clark, JJ; Robinson, TE; Mayo, L; Czuj, A; Willuhn, I; Akers, CA; Clinton, SM; Phillips, PEM; Akil, H				Flagel, Shelly B.; Clark, Jeremy J.; Robinson, Terry E.; Mayo, Leah; Czuj, Alayna; Willuhn, Ingo; Akers, Christina A.; Clinton, Sarah M.; Phillips, Paul E. M.; Akil, Huda			A selective role for dopamine in stimulus-reward learning	NATURE			English	Article							PAVLOVIAN APPROACH BEHAVIOR; NUCLEUS-ACCUMBENS CORE; INCENTIVE SALIENCE; NOVELTY-SEEKING; ACQUISITION; SENSITIZATION; PERFORMANCE; RECEPTORS; SYSTEMS; NMDA	Individuals make choices and prioritize goals using complex processes that assign value to rewards and associated stimuli. During Pavlovian learning, previously neutral stimuli that predict rewards can acquire motivational properties, becoming attractive and desirable incentive stimuli. However, whether a cue acts solely as a predictor of reward, or also serves as an incentive stimulus, differs between individuals. Thus, individuals vary in the degree to which cues bias choice and potentially promote maladaptive behaviour. Here we use rats that differ in the incentive motivational properties they attribute to food cues to probe the role of the neurotransmitter dopamine in stimulus-reward learning. We show that intact dopamine transmission is not required for all forms of learning in which reward cues become effective predictors. Rather, dopamine acts selectively in a form of stimulus-reward learning in which incentive salience is assigned to reward cues. In individuals with a propensity for this form of learning, reward cues come to powerfully motivate and control behaviour. This work provides insight into the neurobiology of a form of stimulus-reward learning that confers increased susceptibility to disorders of impulse control.	[Clark, Jeremy J.; Willuhn, Ingo; Akers, Christina A.; Phillips, Paul E. M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Clark, Jeremy J.; Willuhn, Ingo; Akers, Christina A.; Phillips, Paul E. M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Flagel, Shelly B.; Mayo, Leah; Clinton, Sarah M.; Akil, Huda] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Robinson, Terry E.; Czuj, Alayna] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Phillips, PEM (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	pemp@uw.edu; akil@umich.edu	Flagel, Shelly B/G-5561-2012; Clark, Jeremy/J-9552-2015; Phillips, Paul/E-7813-2013; Clinton, Sarah M/N-3953-2017; Willuhn, Ingo/AAP-4276-2021; Mayo, Leah/AAX-5320-2020; Phillips, Paul E. M./A-4463-2008	Flagel, Shelly B/0000-0002-7309-9908; Phillips, Paul/0000-0002-8749-7026; Clinton, Sarah M/0000-0001-7158-411X; Willuhn, Ingo/0000-0001-6540-6894; Mayo, Leah/0000-0002-0645-4869; Phillips, Paul E. M./0000-0002-8749-7026	National Institutes of Health [R01-MH079292, R01-DA027858, T32-DA07278, F32-DA24540, R37-DA04294, 5P01-DA021633-02]; Office of Naval Research [N00014-02-1-0879]; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH085859, R01MH079292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA021633, T32DA007278, R37DA004294, F32DA024540, R01DA027858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants: R01-MH079292 (to P.E.M.P.), R01-DA027858 (to P.E.M.P.), T32-DA07278 (to J.J.C.), F32-DA24540 (to J.J.C.), R37-DA04294 (to T.E.R.), and 5P01-DA021633-02 (to T.E.R. and H.A.). The selective breeding colony was supported by a grant from the Office of Naval Research to H.A. (N00014-02-1-0879). We thank K. Berridge and J. Morrow for comments on earlier versions of the manuscript, and S. Ng-Evans for technical support.	Balleine BW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P367, DOI 10.1016/B978-0-12-374176-9.00024-5; Beckmann JS, 2011, BEHAV BRAIN RES, V216, P159, DOI 10.1016/j.bbr.2010.07.022; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2001, PSYCHOL LEARN MOTIV, V40, P223, DOI 10.1016/s0079-7421(00)80022-5; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Boakes RA, 1977, OPERANT PAVLOVIAN IN, V1st, P35; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; Clinton SM, 2007, HORM BEHAV, V51, P655, DOI 10.1016/j.yhbeh.2007.03.009; Dalley JW, 2005, P NATL ACAD SCI USA, V102, P6189, DOI 10.1073/pnas.0502080102; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Hearst E, 1974, HEARSTSIGN TRACKING; Heien MLAV, 2004, ANAL CHEM, V76, P5697, DOI 10.1021/ac0491509; Kelley AE, 1999, ANN NY ACAD SCI, V877, P71, DOI 10.1111/j.1749-6632.1999.tb09262.x; Kuo WJ, 2009, SCIENCE, V324, P519, DOI 10.1126/science.1165598; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Panksepp J, 2005, CONSCIOUS COGN, V14, P30, DOI 10.1016/j.concog.2004.10.004; Parkinson JA, 2002, BEHAV BRAIN RES, V137, P149, DOI 10.1016/S0166-4328(02)00291-7; Parkinson JA, 1999, J NEUROSCI, V19, P2401; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Robinson TE, 2009, BIOL PSYCHIAT, V65, P869, DOI 10.1016/j.biopsych.2008.09.006; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Stead JDH, 2006, BEHAV GENET, V36, P697, DOI 10.1007/s10519-006-9058-7; Tindell AJ, 2009, J NEUROSCI, V29, P12220, DOI 10.1523/JNEUROSCI.2499-09.2009; Tomie A, 1998, PSYCHOPHARMACOLOGY, V139, P376, DOI 10.1007/s002130050728; Verbeke G, 2000, LINEAR MIXED MODELS; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wyvell CL, 2001, J NEUROSCI, V21, P7831, DOI 10.1523/JNEUROSCI.21-19-07831.2001; Wyvell CL, 2000, J NEUROSCI, V20, P8122; Zhang J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000437	35	633	637	3	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					53	U63		10.1038/nature09588	http://dx.doi.org/10.1038/nature09588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21150898	Green Accepted			2022-12-28	WOS:000285921600029
J	Zumla, A				Zumla, Alimuddin			The white plague returns to London-with a vengeance	LANCET			English	Editorial Material							TUBERCULOSIS		UCL, Sch Med, Windeyer Inst Med Sci, Dept Infect, London W1T 4JF, England	University of London; University College London; UCL Medical School	Zumla, A (corresponding author), UCL, Sch Med, Windeyer Inst Med Sci, Dept Infect, London W1T 4JF, England.	a.zumla@ucl.ac.uk	ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735				Anderson C, 2010, J EPIDEMIOL COMMUN H, V64, P373, DOI 10.1136/jech.2009.094375; Crofts JP, 2008, PUBLIC HEALTH, V122, P1302, DOI 10.1016/j.puhe.2008.04.011; DROBNIEWSKI F, 1995, LANCET, V346, P948, DOI 10.1016/S0140-6736(95)91562-1; Gilbert RL, 2009, INT J TUBERC LUNG D, V13, P645; Griffiths C, 2007, LANCET, V369, P1528, DOI 10.1016/S0140-6736(07)60707-7; Hayward J, 2010, LONDON TB SERVICE RE; Health Protection Agency (UK), TUB UK ANN REP TUB S; Hollo V, 2009, EUROSURVEILLANCE, V14; Mitchell SL, 2011, THORAX, V66, P630, DOI 10.1136/thx.2010.148866; *NEW YORK CIT DEP, 2008, CLIN POL PROT; World Health Organization, GLOB TUB CONTR EP ST; Zumla, 2009, TUBERCULOSIS COMPREH, P1	12	23	23	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 1	2011	377	9759					10	11		10.1016/S0140-6736(10)62176-9	http://dx.doi.org/10.1016/S0140-6736(10)62176-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	709MQ	21168203				2022-12-28	WOS:000286445200008
J	Reynolds, CF; Albert, SM				Reynolds, Charles F., III; Albert, Steven M.			Management of mental disorders: lessons from India	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE; COLLABORATIVE CARE; OLDER-ADULTS; COST-EFFECTIVENESS; DEPRESSION; INTERVENTION; EFFICACY; OUTCOMES; ANXIETY		[Reynolds, Charles F., III] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA; [Reynolds, Charles F., III; Albert, Steven M.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Reynolds, CF (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA.	reynoldscf@upmc.edu		Albert, Steven/0000-0001-6786-9956				Bruce ML, 2004, JAMA-J AM MED ASSOC, V291, P1081, DOI 10.1001/jama.291.9.1081; Cohen A, 2006, ARCH GEN PSYCHIAT, V63, P50, DOI 10.1001/archpsyc.63.1.50; Dew MA, 2007, AM J PSYCHIAT, V164, P892, DOI 10.1176/appi.ajp.164.6.892; Gallo JJ, 2007, ANN INTERN MED, V146, P689, DOI 10.7326/0003-4819-146-10-200705150-00002; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Lyness JM, 2006, ANN INTERN MED, V144, P496, DOI 10.7326/0003-4819-144-7-200604040-00008; Patel V, 2003, LANCET, V361, P33, DOI 10.1016/S0140-6736(03)12119-8; Patel V, 2010, LANCET, V376, P2086, DOI 10.1016/S0140-6736(10)61508-5; Proudfoot J, 2004, BRIT J PSYCHIAT, V185, P46, DOI 10.1192/bjp.185.1.46; Reynolds CF, 2009, DEPRESS ANXIETY, V26, P1062, DOI 10.1002/da.20644; Rollman BL, 2009, JAMA-J AM MED ASSOC, V302, P2095, DOI 10.1001/jama.2009.1670; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; van't Veer-Tazelaar P, 2010, BRIT J PSYCHIAT, V196, P319, DOI 10.1192/bjp.bp.109.069617	13	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 18	2010	376	9758					2045	2046		10.1016/S0140-6736(10)61886-7	http://dx.doi.org/10.1016/S0140-6736(10)61886-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702LA	21159376				2022-12-28	WOS:000285895000005
J	Fraser, AG; Dunstan, FD				Fraser, Alan G.; Dunstan, Frank D.			Christmas 2010: Reading between the Lines On the impossibility of being expert	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Fraser, Alan G.] Cardiff Univ, Sch Med, Wales Heart Res Inst, Cardiff CF14 4XN, S Glam, Wales; [Dunstan, Frank D.] Cardiff Univ, Sch Med, Dept Primary Care & Public Hlth, Cardiff, S Glam, Wales	Cardiff University; Cardiff University	Fraser, AG (corresponding author), Cardiff Univ, Sch Med, Wales Heart Res Inst, Cardiff CF14 4XN, S Glam, Wales.	fraserag@cf.ac.uk						Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Cullis J, 2010, NEPHROLOGY, V15, P269, DOI 10.1111/j.1440-1797.2010.01282.x; Domain Tools Inc, 2010, TOT LIST 12 SEPT 201; Fraser AG, 2006, EUR HEART J, V27, P1750, DOI 10.1093/eurheartj/ehl031; Garritty C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009914; Greenberg SA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2680; Hall Amanda, 2004, Health Info Libr J, V21, P102, DOI 10.1111/j.1471-1842.2004.00506.x; Ioannidis JPA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000005; Porrino JA, 2008, J HAND SURG-AM, V33A, P2, DOI 10.1016/j.jhsa.2007.10.007; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Shortliffe EH, 2010, JAMA-J AM MED ASSOC, V304, P1227, DOI 10.1001/jama.2010.1262; Straus S, 2009, CAN MED ASSOC J, V180, P942, DOI 10.1503/cmaj.081697; Tatsioni A, 2007, JAMA-J AM MED ASSOC, V298, P2517, DOI 10.1001/jama.298.21.2517; Tenopir C, 2004, J MED LIBR ASSOC, V92, P233; Toffler A., 1980, 3 WAVE; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Wager Elizabeth, 2008, COCHRANE DB SYST REV, V4; Ware M., 2009, STM REPORT OVERVIEW	19	53	54	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2010	341								c6815	10.1136/bmj.c6815	http://dx.doi.org/10.1136/bmj.c6815			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XD	21156739	Green Accepted			2022-12-28	WOS:000285552200012
J	Kyrle, PA; Rosendaal, FR; Eichinger, S				Kyrle, Paul Alexander; Rosendaal, Frits R.; Eichinger, Sabine			Risk assessment for recurrent venous thrombosis	LANCET			English	Review							DEEP-VEIN-THROMBOSIS; ORAL ANTICOAGULANT-THERAPY; FACTOR-V-LEIDEN; D-DIMER LEVELS; LOW-INTENSITY WARFARIN; HIGH PLASMA-LEVELS; 1ST EPISODE; FACTOR-VIII; PULMONARY-EMBOLISM; LONG-TERM	Venous thrombosis is a common disease that frequently recurs. Recurrence can be prevented by anticoagulants, albeit at the cost of bleeding. Thus, assessment of the risk of recurrence is important to balance the risks and benefits of anticoagulation treatment. Many clinical and laboratory risk factors for recurrent venous thrombosis have been established. Nevertheless, prediction of recurrence in an individual patient remains a challenge. Detection of some laboratory markers is associated with only a moderate risk of recurrence, and the relevance of others is not known. Many patients have several risk factors and the effect of combined defects is obscure. Routine screening for these laboratory markers should therefore be abandoned. Risk assessment can be improved by measurement of global markers that encompass the effects of clotting and fibrinolytic disorders. Analysis of preliminary data suggests that risk assessment can also be refined through integration of prothrombotic coagulation changes and clinical risk factors.	[Kyrle, Paul Alexander; Eichinger, Sabine] Med Univ Vienna, Dept Med 1, A-1090 Vienna, Austria; [Kyrle, Paul Alexander; Eichinger, Sabine] Karl Landsteiner Inst Thrombosis Res, Vienna, Austria; [Rosendaal, Frits R.] Leiden Univ, Med Ctr, Leiden, Netherlands	Medical University of Vienna; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kyrle, PA (corresponding author), Med Univ Vienna, Dept Med 1, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	paul.kyrle@meduniwien.ac.at	Rosendaal, Frits/Q-3842-2017	Rosendaal, Frits/0000-0003-2558-7496				Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Aujesky D, 2006, ARCH INTERN MED, V166, P169, DOI 10.1001/archinte.166.2.169; Baglin T, 2003, LANCET, V362, P523, DOI 10.1016/S0140-6736(03)14111-6; Baglin T, 2010, BRIT J HAEMATOL, V149, P209, DOI 10.1111/j.1365-2141.2009.08022.x; Besser M, 2008, J THROMB HAEMOST, V6, P1720, DOI 10.1111/j.1538-7836.2008.03117.x; BEYTH RJ, 1995, ARCH INTERN MED, V155, P1031, DOI 10.1001/archinte.155.10.1031; Beyth RJ, 2000, ANN INTERN MED, V133, P687, DOI 10.7326/0003-4819-133-9-200011070-00010; Brouwer JLP, 2009, THROMB HAEMOSTASIS, V101, P93, DOI 10.1160/TH08-06-0364; Bruinstroop E, 2009, J THROMB HAEMOST, V7, P611, DOI 10.1111/j.1538-7836.2009.03293.x; Carrier M, 2010, ANN INTERN MED, V152, P578, DOI 10.7326/0003-4819-152-9-201005040-00008; Chandler WL, 2003, AM J CLIN PATHOL, V120, P34, DOI 10.1309/C8T8YNB4G3W45PRF; Christiansen SC, 2005, JAMA-J AM MED ASSOC, V293, P2352, DOI 10.1001/jama.293.19.2352; Cohn D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007069.pub2; Coppens M, 2008, J THROMB HAEMOST, V6, P1474, DOI 10.1111/j.1538-7836.2008.03055.x; Cosmi B, 2010, BLOOD, V115, P481, DOI 10.1182/blood-2009-08-237354; Crowther MA, 2001, THROMB HAEMOSTASIS, V85, P390; De Stefano V, 2006, HAEMATOLOGICA, V91, P695; Decousus H, 2005, CIRCULATION, V112, P416, DOI 10.1161/CIRCULATIONHA.104.512834; den Heijer M, 2007, BLOOD, V109, P139, DOI 10.1182/blood-2006-04-014654; Douketis JD, 2007, ANN INTERN MED, V147, P766, DOI 10.7326/0003-4819-147-11-200712040-00007; Eichinger S, 2004, BLOOD, V103, P3773, DOI 10.1182/blood-2003-10-3422; Eichinger S, 2004, ARCH INTERN MED, V164, P92, DOI 10.1001/archinte.164.1.92; Eichinger S, 1997, THROMB HAEMOSTASIS, V77, P624; Eichinger S, 2003, JAMA-J AM MED ASSOC, V290, P1071, DOI 10.1001/jama.290.8.1071; Eichinger S, 1999, THROMB HAEMOSTASIS, V81, P14; Eichinger S, 1998, THROMB HAEMOSTASIS, V80, P566; Eichinger S, 2008, ARCH INTERN MED, V168, P1678, DOI 10.1001/archinte.168.15.1678; Eichinger S, 2007, THROMB HAEMOSTASIS, V98, P1232, DOI 10.1160/TH07-05-0376; Eichinger S, 2007, CIRCULATION, V115, P1609, DOI 10.1161/CIRCULATIONAHA.106.649954; Eichinger S, 2010, CIRCULATION, V121, P1630, DOI 10.1161/CIRCULATIONAHA.109.925214; Eichinger S, 2008, CLIN CHEM, V54, P2042, DOI 10.1373/clinchem.2008.112243; Eischer L, 2009, MEDICINE, V88, P366, DOI 10.1097/MD.0b013e3181c29e31; Galanaud JP, 2009, J THROMB HAEMOST, V7, P2028, DOI 10.1111/j.1538-7836.2009.03629.x; Goldenberg NA, 2004, NEW ENGL J MED, V351, P1081, DOI 10.1056/NEJMoa040161; Goldhaber SZ, 2004, LANCET, V363, P1295, DOI 10.1016/S0140-6736(04)16004-2; Hansson PO, 2000, ARCH INTERN MED, V160, P769, DOI 10.1001/archinte.160.6.769; Heit JA, 2001, THROMB HAEMOSTASIS, V86, P452, DOI 10.1161/ATVBAHA.108.162545; Ho WK, 2006, ARCH INTERN MED, V166, P729, DOI 10.1001/archinte.166.7.729; Hoibraaten E, 2000, THROMB HAEMOSTASIS, V84, P961; Hoke M, 2005, THROMB HAEMOSTASIS, V94, P787, DOI 10.1160/TH05-06-0412; Hron G, 2006, J THROMB HAEMOST, V4, P752, DOI 10.1111/j.1538-7836.2006.01868.x; Hron G, 2006, AM J MED, V119, P50, DOI 10.1016/j.amjmed.2005.04.043; Hron G, 2006, JAMA-J AM MED ASSOC, V296, P397, DOI 10.1001/jama.296.4.397; HULL R, 1979, NEW ENGL J MED, V301, P855, DOI 10.1056/NEJM197910183011602; Hyers TM, 2001, CHEST, V119, p176S, DOI 10.1378/chest.119.1_suppl.176S; Jilma B, 2006, ARCH INTERN MED, V166, P1655, DOI 10.1001/archinte.166.15.1655; Jimenez D, 2006, THROMB HAEMOSTASIS, V95, P562, DOI 10.1160/TH05-10-0677; Kearon C, 2004, J THROMB HAEMOST, V2, P743, DOI 10.1046/j.1538-7836.2004.00698.x; Kearon C, 2008, BLOOD, V112, P4432, DOI 10.1182/blood-2008-06-163279; KHAMASHTA MA, 1995, NEW ENGL J MED, V332, P993, DOI 10.1056/NEJM199504133321504; Kraaijenhagen RA, 2000, THROMB HAEMOSTASIS, V83, P5; Kyrle PA, 2005, LANCET, V365, P1163, DOI 10.1016/S0140-6736(05)71880-8; Kyrle PA, 2000, NEW ENGL J MED, V343, P457, DOI 10.1056/NEJM200008173430702; Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959; Kyrle PA, 2008, LANCET, V371, P1312, DOI 10.1016/S0140-6736(08)60572-3; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Legnani C, 2004, BRIT J HAEMATOL, V124, P504, DOI 10.1046/j.1365-2141.2003.04795.x; Lijfering WM, 2010, CIRCULATION, V121, P1706, DOI 10.1161/CIRCULATIONAHA.109.906347; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; Marchiori A, 2007, HAEMATOLOGICA, V92, P1107, DOI 10.3324/haematol.10234; Marcucci R, 2003, AM J MED, V115, P601, DOI 10.1016/j.amjmed.2003.06.005; McMahan DA, 1998, J GEN INTERN MED, V13, P311, DOI 10.1046/j.1525-1497.1998.00096.x; Mcrae S, 2006, LANCET, V368, P371, DOI 10.1016/S0140-6736(06)69110-1; Murin S, 2002, THROMB HAEMOSTASIS, V88, P407; Mustafa S, 2008, J VASC SURG, V47, P566, DOI 10.1016/j.jvs.2007.09.060; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; Palareti G, 2003, CIRCULATION, V108, P313, DOI 10.1161/01.CIR.0000079162.69615.0F; Palareti G, 2002, THROMB HAEMOSTASIS, V87, P7; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Piovella F, 2002, HAEMATOLOGICA, V87, P515; Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108; Prandoni P, 2002, ANN INTERN MED, V137, P955, DOI 10.7326/0003-4819-137-12-200212170-00008; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516; Prandoni P, 2009, ANN INTERN MED, V150, P577, DOI 10.7326/0003-4819-150-9-200905050-00003; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; Ruiz-Irastorza G, 2007, ARTHRIT RHEUM-ARTHR, V57, P1487, DOI 10.1002/art.23109; Schulman S, 2006, J THROMB HAEMOST, V4, P734, DOI 10.1111/j.1538-7836.2006.01795.x; Schulman S, 1998, AM J MED, V104, P332, DOI 10.1016/S0002-9343(98)00060-6; Schulman S, 1996, THROMB HAEMOSTASIS, V75, P607; Schulman S, 2003, NEW ENGL J MED, V349, P1713, DOI 10.1056/NEJMoa030104; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Segal JB, 2009, JAMA-J AM MED ASSOC, V301, P2472, DOI 10.1001/jama.2009.853; Seligsohn U, 2001, NEW ENGL J MED, V344, P1222, DOI 10.1056/NEJM200104193441607; Shrivastava S, 2006, J THROMB HAEMOST, V4, P1208, DOI 10.1111/j.1538-7836.2006.01935.x; Simioni P, 1997, NEW ENGL J MED, V336, P399, DOI 10.1056/NEJM199702063360602; Simioni P, 2000, BLOOD, V96, P3329; Siragusa S, 2008, BLOOD, V112, P511, DOI 10.1182/blood-2008-01-131656; Stain M, 2005, J THROMB HAEMOST, V3, P2671, DOI 10.1111/j.1538-7836.2005.01648.x; Tripodi A, 2008, J THROMB HAEMOST, V6, P1327, DOI 10.1111/j.1538-7836.2008.03018.x; vandenBelt AGM, 1997, ARCH INTERN MED, V157, P2227, DOI 10.1001/archinte.157.19.2227; Verhovsek M, 2008, ANN INTERN MED, V149, P481, DOI 10.7326/0003-4819-149-7-200810070-00008; Vossen CY, 2005, ARTERIOSCL THROM VAS, V25, P1992, DOI 10.1161/01.ATV.0000174806.76629.7b; Weltermann A, 2003, J THROMB HAEMOST, V1, P28, DOI 10.1046/j.1538-7836.2003.00038.x; White RH, 2000, ARCH INTERN MED, V160, P2033, DOI 10.1001/archinte.160.13.2033; White RH, 1998, ARCH INTERN MED, V158, P1005, DOI 10.1001/archinte.158.9.1005	97	186	198	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2010	376	9757					2032	2039		10.1016/S0140-6736(10)60962-2	http://dx.doi.org/10.1016/S0140-6736(10)60962-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701GZ	21131039				2022-12-28	WOS:000285807700032
J	Rees, DC; Williams, TN; Gladwin, MT				Rees, David C.; Williams, Thomas N.; Gladwin, Mark T.			Sickle-cell disease	LANCET			English	Article							ACUTE CHEST SYNDROME; PLASMODIUM-FALCIPARUM MALARIA; ACUTE VASOOCCLUSIVE CRISIS; FETAL-HEMOGLOBIN LEVELS; PULMONARY-HYPERTENSION; NITRIC-OXIDE; RISK-FACTORS; HYDROXYUREA THERAPY; HOSPITAL ADMISSIONS; ADHESION MOLECULES	Sickle-cell disease is one of the most common severe monogenic disorders in the world. Haemoglobin polymerisation, leading to erythrocyte rigidity and vaso-occlusion, is central to the pathophysiology of this disease, although the importance of chronic anaemia, haemolysis, and vasculopathy has been established. Clinical management is basic and few treatments have a robust evidence base. One of the main problems of sickle-cell disease in children is the development of cerebrovascular disease and cognitive impairment, and the role of blood transfusion and hydroxycarbamide for prevention of these complications is starting to be understood. Recurrent episodes of vaso-occlusion and inflammation result in progressive damage to most organs, including the brain, kidneys, lungs, bones, and cardiovascular system, which becomes apparent with increasing age. Most people with sickle-cell disease live in Africa, where little is known about this disease; however, we do know that the disorder follows a more severe clinical course in Africa than for the rest of the world and that infectious diseases have a role in causing this increased severity of sickle-cell disease. More work is needed to develop effective treatments that specifically target pathophysiological changes and clinical complications of sickle-cell disease.	[Rees, David C.] Kings Coll London, Kings Coll Hosp NHS Fdn Trust, Dept Paediat Haematol, London SE5 9RS, England; [Williams, Thomas N.] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Williams, Thomas N.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Gladwin, Mark T.] Univ Pittsburgh, Pulm Allergy & Crit Care Med & Vasc Med Inst, Pittsburgh, PA USA	King's College Hospital NHS Foundation Trust; University of London; King's College London; Kenya Medical Research Institute; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rees, DC (corresponding author), Kings Coll London, Kings Coll Hosp NHS Fdn Trust, Dept Paediat Haematol, Denmark Hill, London SE5 9RS, England.	david.rees@kcl.ac.uk	Rees, David/B-6789-2011	Rees, David/0000-0003-3647-1050	Sangart; Novartis; Wyeth; UK Medical Research Council; Wellcome Trust, UK [076934]; European Virtual Institute for Malaria Research; Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania, PA, USA; National Heart, Lung and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01HL098032, RC1DK085852, P30AR058910]; US Government; National Institutes of Health; INO Therapeutics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR058910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK085852] Funding Source: NIH RePORTER	Sangart; Novartis(Novartis); Wyeth(Wyeth); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust, UK(Wellcome Trust); European Virtual Institute for Malaria Research; Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania, PA, USA; National Heart, Lung and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)NIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); US Government; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INO Therapeutics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	DCR has received consultancy fees from Sangart and speaker's fees and travel expenses from Novartis; he is chief investigator for the UK for a clinical trial of conjugated pneumococcal vaccine sponsored by Wyeth, and receives research funding from the UK Medical Research Council. TNW is supported by the Wellcome Trust, UK (grant 076934) and the European Virtual Institute for Malaria Research. MTG receives grant support from the Institute for Transfusion Medicine, the Hemophilia Center of Western Pennsylvania, PA, USA; and federal funding from the National Heart, Lung and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, and National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (grants R01HL098032, RC1DK085852, and P30AR058910). He has received money for grants or grants pending from the US Government. His institution has received money grants or grants pending from the National Institutes of Health, the US Government, and INO Therapeutics.	Adamkiewicz TV, 2003, J PEDIATR-US, V143, P438, DOI 10.1067/S0022-3476(03)00331-7; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Ataga KI, 2007, HAEMATOLOGICA, V93, P20, DOI 10.3324/haematol.11763; Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x; Bachir D, 2009, BLOOD, V114, P238, DOI 10.1182/blood.V114.22.572.572; Bain BJ, 2009, J CLIN PATHOL, V62, P53, DOI 10.1136/jcp.2008.060624; Ballas SK, 2009, J NATL MED ASSOC, V101, P1046, DOI 10.1016/S0027-9684(15)31072-5; Bartolucci P, 2009, BLOOD, V114, P3742, DOI 10.1182/blood-2009-06-227330; Belcher JD, 2005, AM J PHYSIOL-HEART C, V288, pH2715, DOI 10.1152/ajpheart.00986.2004; Belcher JD, 2003, BLOOD, V101, P3953, DOI 10.1182/blood-2002-10-3313; Bernaudin F, 2009, BLOOD, V114, P743, DOI 10.1182/blood-2009-05-217778; Bernini JC, 1998, BLOOD, V92, P3082, DOI 10.1182/blood.V92.9.3082.421k15_3082_3089; Berthaut I, 2008, HAEMATOL-HEMATOL J, V93, P988, DOI 10.3324/haematol.11515; Bhatia M, 2008, BONE MARROW TRANSPL, V41, P109, DOI 10.1038/sj.bmt.1705943; Brawley OW, 2008, ANN INTERN MED, V148, P932, DOI 10.7326/0003-4819-148-12-200806170-00220; BRITTENHAM GM, 1985, BLOOD, V65, P183; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; Cartron JP, 2008, TRANSFUS CLIN BIOL, V15, P39, DOI 10.1016/j.tracli.2008.05.001; Cavalli-Sforza L, 1994, HIST GEOGRAPHY HUMAN, P1088; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; De Castro LM, 2008, AM J HEMATOL, V83, P19, DOI 10.1002/ajh.21058; Deane CR, 2010, HAEMATOL-HEMATOL J, V95, P1287, DOI 10.3324/haematol.2010.022624; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Dessap AM, 2008, AM J RESP CRIT CARE, V177, P646, DOI 10.1164/rccm.200710-1606OC; Dham N, 2009, AM J CARDIOL, V104, P713, DOI 10.1016/j.amjcard.2009.04.034; Erkman JR, 2001, SEMIN HEMATOL, V38, P23, DOI 10.1053/shem.2001.20141; Field JJ, 2008, AM J HEMATOL, V83, P855, DOI 10.1002/ajh.21275; Fitzhugh CD, 2005, PEDIATR BLOOD CANCER, V45, P982, DOI 10.1002/pbc.20296; Flint J, 1998, BAILLIERE CLIN HAEM, V11, P1, DOI 10.1016/S0950-3536(98)80069-3; Frenette PS, 2002, CURR OPIN HEMATOL, V9, P101, DOI 10.1097/00062752-200203000-00003; Fullerton HJ, 2004, BLOOD, V104, P336, DOI 10.1182/blood-2004-02-0636; Garenne M, 2006, B WORLD HEALTH ORGAN, V84, P470, DOI 10.2471/BLT.05.029231; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; Geva A, 2004, NEW ENGL J MED, V351, P1532, DOI 10.1056/NEJMoa040771; GILL FM, 1995, BLOOD, V86, P776, DOI 10.1182/blood.V86.2.776.bloodjournal862776; GILMAN JG, 1985, BLOOD, V66, P783; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; Gladwin MT, 2006, J CLIN INVEST, V116, P2330, DOI 10.1172/JCI29807; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Graham GS, 1924, ARCH INTERN MED, V34, P778, DOI 10.1001/archinte.1924.00120060041003; GRIFFIN TC, 1994, NEW ENGL J MED, V330, P733, DOI 10.1056/NEJM199403173301101; Hagar W, 2008, BRIT J HAEMATOL, V141, P346, DOI 10.1111/j.1365-2141.2008.07097.x; Halasa NB, 2007, CLIN INFECT DIS, V44, P1428, DOI 10.1086/516781; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hargrave DR, 2003, BLOOD, V101, P846, DOI 10.1182/blood-2002-05-1392; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hernigou Philippe, 2008, Open Orthop J, V2, P62, DOI 10.2174/1874325000802010062; Herrick J.B., 1910, ARCH INTERN MED, V6, P517; HIGGS DR, 1982, NEW ENGL J MED, V306, P1441, DOI 10.1056/NEJM198206173062402; Hogan AM, 2006, DEVELOPMENTAL SCI, V9, P379, DOI 10.1111/j.1467-7687.2006.00503.x; Hoppe C, 2004, BLOOD, V103, P2391, DOI 10.1182/blood-2003-09-3015; Hoppe C, 2007, STROKE, V38, P2241, DOI 10.1161/STROKEAHA.107.483115; Hsieh MM, 2009, NEW ENGL J MED, V361, P2309, DOI 10.1056/NEJMoa0904971; Jacobson SJ, 1997, LANCET, V350, P1358, DOI 10.1016/S0140-6736(97)08462-6; JOHN AB, 1984, BRIT MED J, V288, P1567, DOI 10.1136/bmj.288.6430.1567; JOHNSON FL, 1984, NEW ENGL J MED, V311, P780, DOI 10.1056/NEJM198409203111207; Jones S, 2005, BRIT J HAEMATOL, V131, P530, DOI 10.1111/j.1365-2141.2005.05799.x; KAR BC, 1986, LANCET, V2, P1198; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Kato GJ, 2006, AM J HEMATOL, V81, P503, DOI 10.1002/ajh.20642; KOSHY M, 1989, BLOOD, V74, P1403; Kwiatkowski JL, 2009, BRIT J HAEMATOL, V146, P300, DOI 10.1111/j.1365-2141.2009.07753.x; Lanzkron S, 2008, ANN INTERN MED, V148, P939, DOI 10.7326/0003-4819-148-12-200806170-00221; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Lou TF, 2009, EXP BIOL MED, V234, P1374, DOI 10.3181/0811-RM-339; Lysenko A.J., 1968, MEDICINSKAJA GEOGRAF, P25; Machado RF, 2005, BRIT J HAEMATOL, V130, P445, DOI 10.1111/j.1365-2141.2005.05625.x; MACHADO RF, 2010, MURRAY NADELS TXB RE, P1999; Makani J, 2007, ANN TROP MED PARASIT, V101, P3, DOI 10.1179/136485907X154638; Makani J, 2010, BLOOD, V115, P215, DOI 10.1182/blood-2009-07-233528; Masiello D, 2007, AM J HEMATOL, V82, P643, DOI 10.1002/ajh.20847; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; McAuley CF, 2010, BLOOD, V116, P1663, DOI 10.1182/blood-2010-01-265249; Mekeel KL, 2007, LIVER TRANSPLANT, V13, P505, DOI 10.1002/lt.20999; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Minniti CR, 2009, HAEMATOL-HEMATOL J, V94, P340, DOI 10.3324/haematol.13812; Mittal H, 2009, ANN HEMATOL, V88, P529, DOI 10.1007/s00277-008-0598-1; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; MONPLAISIR N, 1986, P NATL ACAD SCI USA, V83, P9363, DOI 10.1073/pnas.83.24.9363; MOOPENN W, 1975, BLOOD, V46, P363; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Nagel RL, 2003, BLOOD REV, V17, P167, DOI 10.1016/S0268-960X(03)00003-1; Nagel RL, 1998, BLOOD, V92, P4375, DOI 10.1182/blood.V92.11.4375.423k30_4375_4382; *NAT CONF ENQ PAT, 2008, SICKL CRIS REP NAT C; Neumayr LD, 2006, J BONE JOINT SURG AM, V88A, P2573, DOI 10.2106/JBJS.E.01454; NOGUCHI CT, 1988, NEW ENGL J MED, V318, P96, DOI 10.1056/NEJM198801143180207; Nolan VG, 2005, BLOOD, V106, P3264, DOI 10.1182/blood-2005-04-1594; O'Driscoll S, 2008, BRIT J HAEMATOL, V140, P206, DOI 10.1111/j.1365-2141.2007.06894.x; Ohene-Frempong K, 1998, BLOOD, V91, P288; Oniyangi O, 2006, COCHRANE DB SYST REV, V4; Orringer EP, 2001, JAMA-J AM MED ASSOC, V286, P2099, DOI 10.1001/jama.286.17.2099; Osarogiagbon UR, 2000, BLOOD, V96, P314, DOI 10.1182/blood.V96.1.314.013k39_314_320; PADMOS MA, 1991, BRIT J HAEMATOL, V79, P93, DOI 10.1111/j.1365-2141.1991.tb08013.x; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806; Pegelow CH, 1997, AM J MED, V102, P171; Persons Derek A, 2009, Hematology Am Soc Hematol Educ Program, P690, DOI 10.1182/asheducation-2009.1.690; PERUTZ MF, 1951, NATURE, V167, P929, DOI 10.1038/167929a0; PLATT OS, 1984, J CLIN INVEST, V74, P652, DOI 10.1172/JCI111464; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Prohovnik I, 2009, J CEREBR BLOOD F MET, V29, P803, DOI 10.1038/jcbfm.2009.6; Rachid D, 2009, UROLOGY, V74, P1054, DOI 10.1016/j.urology.2009.04.071; Rahimy MC, 2003, BLOOD, V102, P834, DOI 10.1182/blood-2002-05-1453; REDWOOD AM, 1976, BRIT MED J, V1, P66, DOI 10.1136/bmj.1.6001.66; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; REPKA T, 1991, BLOOD, V78, P2753; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Ryan K, 2010, BRIT J HAEMATOL, V149, P35, DOI 10.1111/j.1365-2141.2009.08054.x; Sachdev V, 2007, J AM COLL CARDIOL, V49, P472, DOI 10.1016/j.jacc.2006.09.038; Sayag D, 2008, EUR J OPHTHALMOL, V18, P248, DOI 10.1177/112067210801800213; Scheinman JI, 2009, NAT CLIN PRACT NEPHR, V5, P78, DOI 10.1038/ncpneph1008; Sebastiani P, 2005, NAT GENET, V37, P435, DOI 10.1038/ng1533; Serjeant GR, 2005, BRIT MED J, V330, P432, DOI 10.1136/bmj.330.7489.432; Serjeant GR, 2001, SICKLE CELL DIS; Singh SA, 2008, PEDIATR BLOOD CANCER, V50, P1258, DOI 10.1002/pbc.21480; Siqueira RC, 2006, ACTA OPHTHALMOL SCAN, V84, P834, DOI 10.1111/j.1600-0420.2006.00779.x; Smith ER, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.01.FOCUS08307; Steinberg MH, 2006, CURR OPIN HEMATOL, V13, P131, DOI 10.1097/01.moh.0000219656.50291.73; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Strouse JJ, 2008, PEDIATRICS, V122, P1332, DOI 10.1542/peds.2008-0441; Switzer JA, 2006, LANCET NEUROL, V5, P501, DOI 10.1016/S1474-4422(06)70469-0; Sydenstricker VP, 1924, J AMER MED ASSOC, V83, P12, DOI 10.1001/jama.1924.02660010016004; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Turhan A, 2002, P NATL ACAD SCI USA, V99, P3047, DOI 10.1073/pnas.052522799; Vasavda N, 2007, BRIT J HAEMATOL, V138, P263, DOI 10.1111/j.1365-2141.2007.06643.x; Verduzco LA, 2009, BLOOD, V114, P5117, DOI 10.1182/blood-2009-05-220921; VICHINSKY E, 1988, PEDIATRICS, V81, P749; Vichinsky E, 2007, BRIT J HAEMATOL, V136, P501, DOI 10.1111/j.1365-2141.2006.06455.x; Vichinsky EP, 2000, NEW ENGL J MED, V342, P1855, DOI 10.1056/NEJM200006223422502; VICHINSKY EP, 1990, NEW ENGL J MED, V322, P1617, DOI 10.1056/NEJM199006073222301; Voskaridou E, 2010, BLOOD, V115, P2354, DOI 10.1182/blood-2009-05-221333; Ware RE, 2010, J PEDIATR-US, V156, P66, DOI 10.1016/j.jpeds.2009.06.060; WATSON J, 1948, AM J MED SCI, V215, P419, DOI 10.1097/00000441-194804000-00008; Weatherall D, 2005, BLOOD, V105, P921, DOI 10.1182/blood-2004-06-2404; Weiner DL, 2003, JAMA-J AM MED ASSOC, V289, P1136, DOI 10.1001/jama.289.9.1136; Wellems TE, 2009, J CLIN INVEST, V119, P2496, DOI 10.1172/JCI38307; Westerman M, 2008, BRIT J HAEMATOL, V142, P126, DOI 10.1111/j.1365-2141.2008.07155.x; Williams TN, 2009, LANCET, V374, P1364, DOI 10.1016/S0140-6736(09)61374-X; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; WITKOWSKA HE, 1991, NEW ENGL J MED, V325, P1150, DOI 10.1056/NEJM199110173251607; Wood JC, 2004, BLOOD, V103, P1934, DOI 10.1182/blood-2003-06-1919; Wood KC, 2005, FASEB J, V19, pA702; Yallop D, 2007, BRIT J HAEMATOL, V136, P844, DOI 10.1111/j.1365-2141.2007.06493.x; Zimmerman SA, 2007, BLOOD, V110, P1043, DOI 10.1182/blood-2006-11-057893; 2010, STROKE TRANSFUSIONS; 2010, SILENT CEREBRAL INFA; 2009, INHALED NITRIC OXIDE	150	1133	1178	9	308	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2010	376	9757					2018	2031		10.1016/S0140-6736(10)61029-X	http://dx.doi.org/10.1016/S0140-6736(10)61029-X			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701GZ	21131035				2022-12-28	WOS:000285807700031
J	Baxter, L; Tripathy, S; Ishaque, N; Boot, N; Cabral, A; Kemen, E; Thines, M; Ah-Fong, A; Anderson, R; Badejoko, W; Bittner-Eddy, P; Boore, JL; Chibucos, MC; Coates, M; Dehal, P; Delehaunty, K; Dong, SM; Downton, P; Dumas, B; Fabro, G; Fronick, C; Fuerstenberg, SI; Fulton, L; Gaulin, E; Govers, F; Hughes, L; Humphray, S; Jiang, RHY; Judelson, H; Kamoun, S; Kyung, K; Meijer, H; Minx, P; Morris, P; Nelson, J; Phuntumart, V; Qutob, D; Rehmany, A; Rougon-Cardoso, A; Ryden, P; Torto-Alalibo, T; Studholme, D; Wang, YC; Win, J; Wood, J; Clifton, SW; Rogers, J; Van den Ackerveken, G; Jones, JDG; McDowell, JM; Beynon, J; Tyler, BM				Baxter, Laura; Tripathy, Sucheta; Ishaque, Naveed; Boot, Nico; Cabral, Adriana; Kemen, Eric; Thines, Marco; Ah-Fong, Audrey; Anderson, Ryan; Badejoko, Wole; Bittner-Eddy, Peter; Boore, Jeffrey L.; Chibucos, Marcus C.; Coates, Mary; Dehal, Paramvir; Delehaunty, Kim; Dong, Suomeng; Downton, Polly; Dumas, Bernard; Fabro, Georgina; Fronick, Catrina; Fuerstenberg, Susan I.; Fulton, Lucinda; Gaulin, Elodie; Govers, Francine; Hughes, Linda; Humphray, Sean; Jiang, Rays H. Y.; Judelson, Howard; Kamoun, Sophien; Kyung, Kim; Meijer, Harold; Minx, Patrick; Morris, Paul; Nelson, Joanne; Phuntumart, Vipa; Qutob, Dinah; Rehmany, Anne; Rougon-Cardoso, Alejandra; Ryden, Peter; Torto-Alalibo, Trudy; Studholme, David; Wang, Yuanchao; Win, Joe; Wood, Jo; Clifton, Sandra W.; Rogers, Jane; Van den Ackerveken, Guido; Jones, Jonathan D. G.; McDowell, John M.; Beynon, Jim; Tyler, Brett M.			Signatures of Adaptation to Obligate Biotrophy in the Hyaloperonospora arabidopsidis Genome	SCIENCE			English	Article							SOJAE-EFFECTOR AVR1B; DOWNY MILDEW; PHYTOPHTHORA; PLANT; THALIANA; CELLS; SUPPRESSION; PARASITES; PROTEINS; DELIVERY	Many oomycete and fungal plant pathogens are obligate biotrophs, which extract nutrients only from living plant tissue and cannot grow apart from their hosts. Although these pathogens cause substantial crop losses, little is known about the molecular basis or evolution of obligate biotrophy. Here, we report the genome sequence of the oomycete Hyaloperonospora arabidopsidis (Hpa), an obligate biotroph and natural pathogen of Arabidopsis thaliana. In comparison with genomes of related, hemibiotrophic Phytophthora species, the Hpa genome exhibits dramatic reductions in genes encoding (i) RXLR effectors and other secreted pathogenicity proteins, (ii) enzymes for assimilation of inorganic nitrogen and sulfur, and (iii) proteins associated with zoospore formation and motility. These attributes comprise a genomic signature of evolution toward obligate biotrophy.	[Anderson, Ryan; McDowell, John M.; Tyler, Brett M.] Virginia Polytech Inst & State Univ, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [Baxter, Laura; Badejoko, Wole; Bittner-Eddy, Peter; Coates, Mary; Downton, Polly; Hughes, Linda; Rehmany, Anne; Ryden, Peter; Beynon, Jim] Univ Warwick, Sch Life Sci, Wellesbourne CV35 9EF, Warwick, England; [Tripathy, Sucheta; Chibucos, Marcus C.; Torto-Alalibo, Trudy; Tyler, Brett M.] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Ishaque, Naveed; Kemen, Eric; Thines, Marco; Fabro, Georgina; Kamoun, Sophien; Rougon-Cardoso, Alejandra; Studholme, David; Win, Joe; Jones, Jonathan D. G.] John Innes Ctr, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Boot, Nico; Cabral, Adriana; Van den Ackerveken, Guido] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands; [Thines, Marco] Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Thines, Marco] Goethe Univ Frankfurt, Dept Biol Sci, Inst Ecol Evolut & Divers, D-60323 Frankfurt, Germany; [Ah-Fong, Audrey; Judelson, Howard] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Boore, Jeffrey L.; Fuerstenberg, Susan I.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Dehal, Paramvir] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Delehaunty, Kim; Fronick, Catrina; Fulton, Lucinda; Kyung, Kim; Minx, Patrick; Nelson, Joanne; Clifton, Sandra W.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63110 USA; [Dong, Suomeng; Qutob, Dinah] Agr & Agri Food Canada, London, ON N5V 4T3, Canada; [Dong, Suomeng; Wang, Yuanchao] Nanjing Agr Univ, Dept Plant Pathol, Nanjing 210095, Peoples R China; [Dumas, Bernard; Gaulin, Elodie] Univ Toulouse, UPS, F-31326 Castanet Tolosan, France; [Dumas, Bernard; Gaulin, Elodie] CNRS, F-31326 Castanet Tolosan, France; [Govers, Francine; Jiang, Rays H. Y.; Meijer, Harold] Wageningen Univ, Phytopathol Lab, NL-16708 PB Wageningen, Netherlands; [Govers, Francine; Jiang, Rays H. Y.; Meijer, Harold] Ctr BioSyst Genom, NL-16708 PB Wageningen, Netherlands; [Humphray, Sean; Wood, Jo; Rogers, Jane] Sanger, Cambridge CB10 1SA, England; [Jiang, Rays H. Y.] MIT & Harvard, Broad Inst, Cambridge, MA 02141 USA; [Morris, Paul; Phuntumart, Vipa] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA	Virginia Polytechnic Institute & State University; University of Warwick; Virginia Polytechnic Institute & State University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Utrecht University; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; University of California System; University of California Riverside; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Washington University (WUSTL); Agriculture & Agri Food Canada; Nanjing Agricultural University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Wageningen University & Research; Centre for BioSystems Genomics; Wellcome Trust Sanger Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Ohio; Bowling Green State University	McDowell, JM (corresponding author), Virginia Polytech Inst & State Univ, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA.	johnmcd@vt.edu	Studholme, David/H-6790-2019; Fabro, Georgina/ABA-7275-2020; Downton, Polly/HCI-9878-2022; Baxter, laura/GWD-1304-2022; Govers, Francine/A-5616-2009; Chibucos, Marcus/B-1506-2015; Kamoun, Sophien/B-3529-2009; Meijer, Harold/S-3891-2019; Thines, Marco/H-1685-2011; Rougon-Cardoso, Alejandra/GLS-1544-2022; Dumas, Bernard/D-1751-2009; Van den Ackerveken, Guido/B-8568-2011; Jones, Jonathan DG/J-5129-2012; Win, Joe/H-2557-2014; Cabral, Adriana/AAX-3284-2021; wang, yuanchao/G-9667-2011; Tripathy, Sucheta/N-3097-2019; Meijer, HJG/AFN-5216-2022; Ishaque, Naveed/AAF-3454-2020	Studholme, David/0000-0002-3010-6637; Govers, Francine/0000-0001-5311-929X; Chibucos, Marcus/0000-0001-9586-0780; Kamoun, Sophien/0000-0002-0290-0315; Meijer, Harold/0000-0002-0883-219X; Rougon-Cardoso, Alejandra/0000-0002-5273-5709; Dumas, Bernard/0000-0002-4138-3533; Van den Ackerveken, Guido/0000-0002-0183-8978; Jones, Jonathan DG/0000-0002-4953-261X; Win, Joe/0000-0002-9851-2404; wang, yuanchao/0000-0001-5803-5343; Tripathy, Sucheta/0000-0003-0611-8088; Meijer, HJG/0000-0002-0883-219X; Ishaque, Naveed/0000-0002-8426-901X; McDowell, John/0000-0002-9070-4874; Gaulin, Elodie/0000-0003-0572-8749; Kemen, Eric/0000-0002-7924-116X; Wood, Jonathan/0000-0002-7545-2162; Morris, Paul/0000-0002-2989-041X; Downton, Polly/0000-0002-1617-6153	U.S. NSF [EF-0412213, IOS-0744875, IOS-0924861, MCB-0639226]; U.S. Department of Agriculture National Institute of Food and Agriculture [2004-35600-15055, 2007-35319-18100]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/C509123/1, BB/E024815/1, BB/F0161901, T12144]; Engineering and Physical Sciences Research Council/BBSRC [EP/F500025/1]; Gatsby [GAT2545]; Biotechnology and Biological Sciences Research Council [BB/E007120/1, BB/C509123/1, BB/E024882/1, BB/E024815/1, BB/G015244/1] Funding Source: researchfish; BBSRC [BB/E024882/1, BB/E024815/1, BB/G015244/1, BB/E007120/1] Funding Source: UKRI	U.S. NSF(National Science Foundation (NSF)); U.S. Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council/BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Engineering & Physical Sciences Research Council (EPSRC)); Gatsby; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank E. Holub for providing the Emoy2 isolate, D. Greenshields and N. Bruce for technical assistance, A. Heck and M. Slijper for analysis of secreted Hpa proteins, R. Hubley for creating repeat modeller libraries, and participants in the 2007 Annotation Jamboree and in the 2008 and 2009 Oomycete Bioinformatics Training Workshops for sequence annotations. This research was supported by grants EF-0412213, IOS-0744875, IOS-0924861, and MCB-0639226 from the U.S. NSF and 2004-35600-15055 and 2007-35319-18100 from the U.S. Department of Agriculture National Institute of Food and Agriculture to B. M. T. and J.M.M.; Biotechnology and Biological Sciences Research Council (BBSRC) BB/C509123/1, BB/E024815/1, and Engineering and Physical Sciences Research Council/BBSRC Systems Biology DTC student EP/F500025/1 to J.B.; Gatsby GAT2545 and BBSRC BB/F0161901, BB/E024882/1, and BBSRC CASE studentship T12144 to J.D.G.J. Other support is detailed in the supporting online material. Genome browsers are maintained at the Virginia Bioinformatics Institute (vmd.vbi.vt.edu) and the Sainsbury Laboratories (gbrowse2.tsl.ac.uk/cgi-bin/gb2/gbrowse/hpa_emoy2_publication).	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Bittner-Eddy PD, 2003, MOL PLANT PATHOL, V4, P501, DOI 10.1046/J.1364-3703.2003.00194.X; CLARK J, 2000, ENCY MICROBIOLOGY, V2, P117; Coates ME, 2010, ANNU REV PHYTOPATHOL, V48, P329, DOI 10.1146/annurev-phyto-080508-094422; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Gaulin E, 2006, PLANT CELL, V18, P1766, DOI 10.1105/tpc.105.038687; Giresse X, 2010, J PHYTOPATHOL, V158, P321, DOI 10.1111/j.1439-0434.2009.01619.x; Goker M, 2007, FUNGAL GENET BIOL, V44, P105, DOI 10.1016/j.fgb.2006.07.005; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hardham AR, 1997, ADV BOT RES, V24, P353; Holub EB, 2008, EUR J PLANT PATHOL, V122, P91, DOI 10.1007/s10658-008-9286-1; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; MILBRATH D. G., 1923, Journal of Agricultural Research, V23, P989; Panstruga R, 2009, SCIENCE, V324, P748, DOI 10.1126/science.1171652; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Skalicky V., 1966, PRESLIA, V38, P117; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Thines M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004790; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037	27	315	329	6	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2010	330	6010					1549	1551		10.1126/science.1195203	http://dx.doi.org/10.1126/science.1195203			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148394	Green Accepted			2022-12-28	WOS:000285153500068
J	Chen, JH; Stoltz, DA; Karp, PH; Ernst, SE; Pezzulo, AA; Moninger, TO; Rector, MV; Reznikov, LR; Launspach, JL; Chaloner, K; Zabner, J; Welsh, MJ				Chen, Jeng-Haur; Stoltz, David A.; Karp, Philip H.; Ernst, Sarah E.; Pezzulo, Alejandro A.; Moninger, Thomas O.; Rector, Michael V.; Reznikov, Leah R.; Launspach, Janice L.; Chaloner, Kathryn; Zabner, Joseph; Welsh, Michael J.			Loss of Anion Transport without Increased Sodium Absorption Characterizes Newborn Porcine Cystic Fibrosis Airway Epithelia	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NASAL POTENTIAL DIFFERENCE; PSEUDOMONAS-AERUGINOSA; RESPIRATORY EPITHELIA; HYPERTONIC SALINE; SURFACE LIQUID; NA+ TRANSPORT; CHANNEL; DISEASE; ENAC	Defective transepithelial electrolyte transport is thought to initiate cystic fibrosis (CF) lung disease. Yet, how loss of CFTR affects electrolyte transport remains uncertain. CFTR-/- pigs spontaneously develop lung disease resembling human CF. At birth, their airways exhibit a bacterial host defense defect, but are not inflamed. Therefore, we studied ion transport in newborn nasal and tracheal/bronchial epithelia in tissues, cultures, and in vivo. CFTR-/- epithelia showed markedly reduced Cl- and HCO3- transport. However, in contrast to a widely held view, lack of CFTR did not increase transepithelial Na+ or liquid absorption or reduce periciliary liquid depth. Like human CF, CFTR-/- pigs showed increased amiloride-sensitive voltage and current, but lack of apical Cl- conductance caused the change, not increased Na+ transport. These results indicate that CFTR provides the predominant transcellular pathway for Cl- and HCO3- in porcine airway epithelia, and reduced anion permeability may initiate CF airway disease.	[Chen, Jeng-Haur; Stoltz, David A.; Karp, Philip H.; Ernst, Sarah E.; Pezzulo, Alejandro A.; Moninger, Thomas O.; Rector, Michael V.; Reznikov, Leah R.; Launspach, Janice L.; Zabner, Joseph; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Chaloner, Kathryn] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Biostat, Iowa City, IA 52242 USA; [Chen, Jeng-Haur; Karp, Philip H.; Reznikov, Leah R.; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu	Reznikov, Leah R./J-4314-2019; Chaloner, Kathryn/B-5090-2013; Chen, Jeng-Haur/E-1483-2011	Reznikov, Leah R./0000-0002-4074-9070; Chen, Jeng-Haur/0000-0001-6756-6939; Pezzulo, Alejandro/0000-0001-7544-5109; Zabner, Joseph/0000-0002-9606-1339; Stoltz, David/0000-0003-0893-9015; Welsh, Michael/0000-0002-1646-6206	National Heart Lung and Blood Institute [HL51670, HL091842, HL097622]; National Institute of Diabetes and Digestive and Kidney Diseases [DK54759]; Cystic Fibrosis Foundation; National Institute of Allergy and Infectious Diseases [AI076671]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051670, T15HL097622, P01HL091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI076671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Lisaurie Lopez Rivera, Paula Ludwig, Theresa Mayhew, Peter Taft, Jingyang Zhang, and Yuping Zhang for excellent assistance. We thank Drs. John B Stokes and Peter M Snyder for helpful discussions. GlyH-101 was a generous gift from the Cystic Fibrosis Foundation Therapeutics and R. Bridges. This work was supported by the National Heart Lung and Blood Institute (grants HL51670, HL091842, and HL097622), the National Institute of Diabetes and Digestive and Kidney Diseases (grant DK54759), and the Cystic Fibrosis Foundation. D.A.S. is a Parker B. Francis Fellow and was supported by the National Institute of Allergy and Infectious Diseases (grant AI076671). M.J.W. is an Investigator of the HHMI. M.J.W. was a cofounder of Exemplar Genetics, a company that is licensing materials and technology related to this work.	[Anonymous], 2009, LANG ENV STAT COMP; Azad AK, 2009, HUM MUTAT, V30, P1093, DOI 10.1002/humu.21011; Baker E, 1998, J CLIN INVEST, V102, P10, DOI 10.1172/JCI1795; Bates D., 2009, IME4 LINEAR MIXED EF; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; BOUCHER RC, 1988, J PHYSIOL-LONDON, V405, P77, DOI 10.1113/jphysiol.1988.sp017322; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; CULLEN JJ, 1987, J CLIN INVEST, V79, P73, DOI 10.1172/JCI112811; Davies JC, 2005, AM J RESP CRIT CARE, V171, P1015, DOI 10.1164/rccm.200408-1116OC; Davis PB, 2006, AM J RESP CRIT CARE, V173, P475, DOI 10.1164/rccm.200505-840OE; Donaldson SH, 2007, CHEST, V132, P1631, DOI 10.1378/chest.07-0288; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; DUSZYK M, 1991, J THEOR BIOL, V151, P231, DOI 10.1016/S0022-5193(05)80362-5; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Flynn AN, 2009, P NATL ACAD SCI USA, V106, P3591, DOI 10.1073/pnas.0813393106; Fu Z, 2007, AM J PHYSIOL-LUNG C, V292, pL353, DOI 10.1152/ajplung.00042.2006; Gray T., 2004, AM J PHYSIOL-LUNG C, V286, pL320; Griesenbach U., 2010, AM J RESP CELL MOL B, DOI [10.1165/rcmb.2009-0265OC, DOI 10.1165/RCMB.2009-02650C]; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; HELMAN SI, 1973, AM J PHYSIOL, V225, P972, DOI 10.1152/ajplegacy.1973.225.4.972; Horisberger JD, 2003, PFLUG ARCH EUR J PHY, V445, P522, DOI 10.1007/s00424-002-0956-0; Huber R, 2010, CELL PHYSIOL BIOCHEM, V25, P145, DOI 10.1159/000272059; Joo NS, 2006, J BIOL CHEM, V281, P7392, DOI 10.1074/jbc.M512766200; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kerem E, 1999, NEW ENGL J MED, V341, P156, DOI 10.1056/NEJM199907153410304; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; Kunzelmann K, 2006, FASEB J, V20, P545, DOI 10.1096/fj.05-4454fje; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Meyerholz D.K., 2010, AM J RESP C IN PRESS; Meyerholz DK, 2010, AM J PATHOL, V176, P1377, DOI 10.2353/ajpath.2010.090849; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Quinton PM, 2007, PHYSIOLOGY, V22, P212, DOI 10.1152/physiol.00041.2006; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; Robinson M, 1997, THORAX, V52, P900, DOI 10.1136/thx.52.10.900; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; SATIR P, 1963, J CELL BIOL, V18, P345, DOI 10.1083/jcb.18.2.345; Schaedel C, 1999, J PEDIATR-US, V135, P739, DOI 10.1016/S0022-3476(99)70094-6; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Sheridan MB, 2005, HUM MOL GENET, V14, P3493, DOI 10.1093/hmg/ddi374; Sims DE, 1997, AM J PHYSIOL-LUNG C, V273, pL1036; SMITH JJ, 1992, J CLIN INVEST, V89, P1148, DOI 10.1172/JCI115696; Standaert TA, 2004, PEDIATR PULM, V37, P385, DOI 10.1002/ppul.10448; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; WIDDICOMBE JH, 1985, P NATL ACAD SCI USA, V82, P6167, DOI 10.1073/pnas.82.18.6167; WILLUMSEN NJ, 1991, AM J PHYSIOL, V261, pC319, DOI 10.1152/ajpcell.1991.261.2.C319; WILLUMSEN NJ, 1991, AM J PHYSIOL, V261, pC332, DOI 10.1152/ajpcell.1991.261.2.C332; Wine JJ, 1999, J CLIN INVEST, V103, P309, DOI 10.1172/JCI6222; Zabner J, 1998, MOL CELL, V2, P397, DOI 10.1016/S1097-2765(00)80284-1	60	185	188	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					911	923		10.1016/j.cell.2010.11.029	http://dx.doi.org/10.1016/j.cell.2010.11.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145458	Green Accepted, Bronze			2022-12-28	WOS:000285182600009
J	Brook, RH				Brook, Robert H.			A Physician = Emotion plus Passion plus Science	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									RAND Corp, Santa Monica, CA 90407 USA	RAND Corporation	Brook, RH (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90407 USA.	robert_brook@rand.org						BROOK RH, 1983, NEW ENGL J MED, V309, P1426, DOI 10.1056/NEJM198312083092305; Shermer MB, 2002, SOC STUD SCI, V32, P489, DOI 10.1177/030631202128967244	2	7	7	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2010	304	22					2528	2529		10.1001/jama.2010.1807	http://dx.doi.org/10.1001/jama.2010.1807			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691AS	21139114				2022-12-28	WOS:000285053300027
J	Halonen, J; Loponen, P; Jarvinen, O; Karjalainen, J; Parviainen, I; Halonen, P; Magga, J; Turpeinen, A; Hippelainen, M; Hartikainen, J; Hakala, T				Halonen, Jari; Loponen, Pertti; Jarvinen, Otso; Karjalainen, Jari; Parviainen, Ilkka; Halonen, Pirjo; Magga, Jarkko; Turpeinen, Anu; Hippelainen, Mikko; Hartikainen, Juha; Hakala, Tapio			Metoprolol Versus Amiodarone in the Prevention of Atrial Fibrillation After Cardiac Surgery A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							ARTERY-BYPASS-SURGERY; OPEN-HEART-SURGERY; INTRAVENOUS AMIODARONE; ORAL AMIODARONE; GRAFT-SURGERY; PROPHYLAXIS; METAANALYSIS; PREDICTORS; INTERVENTIONS; ARRHYTHMIAS	Background: Current guidelines recommend beta-blockers as the first-line preventive treatment of atrial fibrillation (AF) after cardiac surgery. Despite this, 19% of physicians report using amiodarone as first-line prophylaxis of postoperative AF. Data directly comparing the efficacy of these agents in preventing postoperative AF are lacking. Objective: To determine whether intravenous metoprolol and amiodarone are equally effective in preventing postoperative AF after cardiac surgery. Design: Randomized, prospective, equivalence, open-label, multicenter study. (ClinicalTrials.gov registration number: NCT00784316) Setting: 3 cardiac care referral centers in Finland. Patients: 316 consecutive patients who were hemodynamically stable and free of mechanical ventilation and AF within 24 hours after cardiac surgery. Intervention: Patients were randomly assigned to receive 48-hour infusion of metoprolol, 1 to 3 mg/h, according to heart rate, or amiodarone, 15 mg/kg of body weight daily, with a maximum daily dose of 1000 mg, starting 15 to 21 hours after cardiac surgery. Measurements: The primary end point was the occurrence of the first AF episode or completion of the 48-hour infusion. Results: Atrial fibrillation occurred in 38 of 159 (23.9%) patients in the metoprolol group and 39 of 157 (24.8%) patients in the amiodarone group (P = 0.85). However, the difference (-0.9 percentage point [90% CI, -8.9 to 7.0 percentage points]) does not meet the prespecified equivalence margin of 5 percentage points. The adjusted hazard ratio of the metoprolol group compared with the amiodarone group was 1.09 (95% CI, 0.67 to 1.76). Limitations: Caregivers were not blinded to treatment allocation, and the trial evaluated only stable patients who were not at particularly elevated risk for AF. The withdrawal of preoperative beta-blocker therapy may have increased the risk for AF in the amiodarone group. Conclusion: The occurrence of AF was similar in the metoprolol and amiodarone groups. However, because of the wide range of the CIs, the authors cannot conclude that the 2 treatments were equally effective.	[Halonen, Jari; Karjalainen, Jari; Parviainen, Ilkka; Magga, Jarkko; Turpeinen, Anu; Hippelainen, Mikko; Hartikainen, Juha] Kuopio Univ Hosp, Kuopio 70211, Finland; [Loponen, Pertti] Vaasa Cent Hosp, Vaasa 65100, Finland; [Jarvinen, Otso] Tampere Heart Ctr, Tampere 33521, Finland; [Halonen, Pirjo] Univ Jyvaskyla, Jyvaskyla 40014, Finland; [Hakala, Tapio] N Karelia Cent Hosp, Joensuu 80210, Finland	Kuopio University Hospital; University of Eastern Finland; Vaasa Central Hospital; University of Jyvaskyla	Halonen, J (corresponding author), Kuopio Univ Hosp, POB 1777, Kuopio 70211, Finland.	jari.halonen@kuh.fi	Halonen, Jari/K-9329-2018		Finnish Foundation for Cardiovascular Research; Kuopio University EVO Foundation	Finnish Foundation for Cardiovascular Research; Kuopio University EVO Foundation	By the Finnish Foundation for Cardiovascular Research and the Kuopio University EVO Foundation.	Aasbo JD, 2005, ANN INTERN MED, V143, P327, DOI 10.7326/0003-4819-143-5-200509060-00008; Almassi GH, 1997, ANN SURG, V226, P501, DOI 10.1097/00000658-199710000-00011; ANDREWS TC, 1991, CIRCULATION, V84, P236; Aranki SF, 1996, CIRCULATION, V94, P390, DOI 10.1161/01.CIR.94.3.390; Auer J, 2004, AM HEART J, V147, P636, DOI 10.1016/j.ahj.2003.10.041; Buckley MS, 2007, PHARMACOTHERAPY, V27, P360, DOI 10.1592/phco.27.3.360; Burgess DC, 2006, EUR HEART J, V27, P2846, DOI 10.1093/eurheartj/ehl272; CRESWELL LL, 1993, ANN THORAC SURG, V56, P539, DOI 10.1016/0003-4975(93)90894-N; Crystal E, 2002, CIRCULATION, V106, P75, DOI 10.1161/01.CIR.0000021113.44111.3E; Daoud EG, 1997, NEW ENGL J MED, V337, P1785, DOI 10.1056/NEJM199712183372501; Dunning J, 2006, EUR J CARDIO-THORAC, V30, P852, DOI 10.1016/j.ejcts.2006.09.003; Gillespie EL, 2005, ANN PHARMACOTHER, V39, P1409, DOI 10.1345/aph.1E592; Giri S, 2001, LANCET, V357, P830, DOI 10.1016/S0140-6736(00)04196-9; Guarnieri T, 1999, J AM COLL CARDIOL, V34, P343, DOI 10.1016/S0735-1097(99)00212-0; Hakala T, 2002, Scand J Surg, V91, P339; Halonen J, 2006, CIRCULATION, V114, pI1, DOI 10.1161/CIRCULATIONAHA.105.000851; Halonen J, 2007, JAMA-J AM MED ASSOC, V297, P1562, DOI 10.1001/jama.297.14.1562; HOHNLOSER SH, 1991, AM HEART J, V121, P89, DOI 10.1016/0002-8703(91)90960-P; Jafari-Fesharaki M, 1998, PACE, V21, P108, DOI 10.1111/j.1540-8159.1998.tb01068.x; KOWEY PR, 1992, AM J CARDIOL, V69, P963, DOI 10.1016/0002-9149(92)90802-6; Lahtinen J, 2004, ANN THORAC SURG, V77, P1241, DOI 10.1016/j.athoracsur.2003.09.077; Lee SH, 2000, ANN THORAC SURG, V70, P157, DOI 10.1016/S0003-4975(00)01308-4; Mahoney EM, 2002, J AM COLL CARDIOL, V40, P737, DOI 10.1016/S0735-1097(02)02003-X; Majahalme S, 2002, INT J CARDIOL, V82, P209, DOI 10.1016/S0167-5273(01)00622-2; Mathew JP, 1996, JAMA-J AM MED ASSOC, V276, P300, DOI 10.1001/jama.276.4.300; Mitchell LB, 2005, JAMA-J AM MED ASSOC, V294, P3093, DOI 10.1001/jama.294.24.3093; POCOCK SJ, 1983, CLIN TRIALS PRACTICA, P129; Price J, 2009, ANN THORAC SURG, V88, P106, DOI 10.1016/j.athoracsur.2009.03.059; Singh BN, 2008, J CARDIOVASC PHARM, V52, P300, DOI 10.1097/FJC.0b013e31818914b6; Sleilaty G, 2009, INT J CARDIOL, V137, P116, DOI 10.1016/j.ijcard.2008.06.034; Solomon AJ, 2001, AM HEART J, V142, P811, DOI 10.1067/mhj.2001.118738; Svedjeholm R, 2000, SCAND CARDIOVASC J, V34, P516; Valtola A, 2007, EUR J CLIN PHARMACOL, V63, P471, DOI 10.1007/s00228-007-0276-6; Zaman AG, 2000, CIRCULATION, V101, P1403, DOI 10.1161/01.CIR.101.12.1403	34	22	24	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 7	2010	153	11					703	709		10.7326/0003-4819-153-11-201012070-00003	http://dx.doi.org/10.7326/0003-4819-153-11-201012070-00003			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	690KN	21135293				2022-12-28	WOS:000285003800002
J	Keoghane, SR; Sullivan, ME				Keoghane, S. R.; Sullivan, M. E.			Investigating and managing chronic scrotal pain	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CHRONIC PELVIC PAIN; CHRONIC TESTICULAR PAIN; MANAGEMENT; VASECTOMY; MEN; COMPLICATIONS; ORCHIALGIA; THERAPY		[Keoghane, S. R.] Portsmouth NHS Trust, Dept Urol, Portsmouth PO6 3LY, Hants, England; [Sullivan, M. E.] Churchill Hosp, Dept Urol, Oxford OX3 7LJ, England	Portsmouth Hospitals NHS Trust; University of Oxford	Keoghane, SR (corresponding author), Portsmouth NHS Trust, Dept Urol, Portsmouth PO6 3LY, Hants, England.	srkeo@hotmail.com						Abrams P, 2002, AM J OBSTET GYNECOL, V187, P116, DOI 10.1067/mob.2002.125704; Akinci E, 2006, INT J INFECT DIS, V10, P171, DOI 10.1016/j.ijid.2005.02.006; Alves Leonardo S., 2004, Int. braz j urol., V30, P413, DOI 10.1590/S1677-55382004000500012; Anderson RU, 2009, J UROLOGY, V182, P2753, DOI 10.1016/j.juro.2009.08.033; Anderson RU, 2005, J UROLOGY, V174, P155, DOI 10.1097/01.ju.0000161609.31185.d5; Awsare NS, 2005, ANN ROY COLL SURG, V87, P406, DOI 10.1308/003588405X71054; Cayan S, 2009, J ANDROL, V30, P33, DOI 10.2164/jandrol.108.005967; Cornel EB, 2005, EUR UROL, V47, P607, DOI 10.1016/j.eururo.2004.12.014; DAVIS BE, 1990, J UROLOGY, V143, P936, DOI 10.1016/S0022-5347(17)40143-1; Dohle G R, 2005, Ned Tijdschr Geneeskd, V149, P2728; Fall M, 2004, EUR UROL, V46, P681, DOI 10.1016/j.eururo.2004.07.030; Fall M, 2010, EUR UROL, V57, P35, DOI 10.1016/j.eururo.2009.08.020; Gjertson CK, 2008, J UROLOGY, V180, P2037, DOI 10.1016/j.juro.2008.07.045; Granitsiotis P, 2004, EUR UROL, V45, P430, DOI 10.1016/j.eururo.2003.11.004; Heidenreich A, 2002, EUR UROL, V41, P392, DOI 10.1016/S0302-2838(02)00023-4; Hetrick DC, 2006, NEUROUROL URODYNAM, V25, P46, DOI 10.1002/nau.20162; Jara Rascon Jose, 1998, Archivos Espanoles de Urologia, V51, P82; Kiddoo DA, 2004, J UROLOGY, V171, P746, DOI 10.1097/01.ju.0000103636.61790.43; Kim FJ, 2003, J ENDOUROL, V17, P405, DOI 10.1089/089277903767923209; Leslie TA, 2007, BJU INT, V100, P1330, DOI 10.1111/j.1464-410X.2007.07128.x; Manikandan R, 2004, BJU INT, V93, P571, DOI 10.1111/j.1464-410X.2003.04663.x; Menke JJ, 2000, ANN PHARMACOTHER, V34, P479, DOI 10.1345/aph.19212; Morris C, 2002, J FAM PLAN REPROD H, V28, P142, DOI 10.1783/147118902101196298; Nickel JC, 2008, J UROLOGY, V180, P1572; OKADOME A, 2002, JPN J UROL, V93, P580; Peng PWH, 2008, PAIN PHYSICIAN, V11, P215; Romero Perez P, 2004, Actas Urol Esp, V28, P175; Rowe E, 2005, J UROLOGY, V173, P2044, DOI 10.1097/01.ju.0000158445.68149.38; Shoskes DA, 2009, UROLOGY, V73, P538, DOI 10.1016/j.urology.2008.09.074; Srinivasan Arun K, 2007, Curr Pain Headache Rep, V11, P359, DOI 10.1007/s11916-007-0218-0; Strebel RT, 2005, EUR UROL, V47, P812, DOI 10.1016/j.eururo.2005.01.003; Strom KH, 2008, J UROLOGY, V180, P949, DOI 10.1016/j.juro.2008.05.018; Sweeney CA, 2008, UROLOGY, V71, P1099, DOI 10.1016/j.urology.2008.02.036	33	7	9	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 6	2010	341								c6716	10.1136/bmj.c6716	http://dx.doi.org/10.1136/bmj.c6716			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694YC	21135012				2022-12-28	WOS:000285336800006
J	Bitton, S; Roth, J				Bitton, Samuel; Roth, Jesse			Addressing Food Insecurity Freedom From Want, Freedom From Fear	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bitton, Samuel] N Shore Long Isl Jewish Hlth Syst, Cohen Childrens Med Ctr New York, New Hyde Pk, NY USA; [Roth, Jesse] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Roth, Jesse] Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA	Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Northwell Health; Yeshiva University; Albert Einstein College of Medicine	Roth, J (corresponding author), 149-37 Powells Cove Blvd, Whitestone, NY 11357 USA.	jesserothmd@hotmail.com						Alaimo K, 2001, PEDIATRICS, V108, P44; [Anonymous], 2010, J AM DIET ASSOC, V110, P1368, DOI 10.1016/j.jada.2010.07.015; Casey PH, 2006, PEDIATRICS, V118, pE1406, DOI 10.1542/peds.2006-0097; Food Research and Action Center, 2010, FOOD HARDSH CLOS LOO; Laraia BA, 2010, J AM DIET ASSOC, V110, P692, DOI 10.1016/j.jada.2010.02.014; Lee JS, 2001, J NUTR, V131, P1503, DOI 10.1093/jn/131.5.1503; Nord M, 2009, EC RES SERVICE PUBLI; Seligman HK, 2010, NEW ENGL J MED, V363, P6, DOI 10.1056/NEJMp1000072; Young J, 2009, PUBLIC HEALTH NUTR, V12, P2129, DOI 10.1017/S1368980009005795; SNAP FOOD STAMP MONT	10	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2010	304	21					2405	2406		10.1001/jama.2010.1747	http://dx.doi.org/10.1001/jama.2010.1747			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687FH	21119087				2022-12-28	WOS:000284763900022
J	Buckingham, S				Buckingham, Susan			Call in the women	NATURE			English	Editorial Material									[Buckingham, Susan] Brunel Univ, Ctr Human Geog, Uxbridge UB8 3PH, Middx, England; [Buckingham, Susan] Brunel Univ, Inst Environm, Uxbridge UB8 3PH, Middx, England	Brunel University; Brunel University	Buckingham, S (corresponding author), Brunel Univ, Ctr Human Geog, Uxbridge UB8 3PH, Middx, England.	susan.buckingham@brunel.ac.uk		Buckingham, Susan/0000-0002-3632-2592				BUCKINGHAM S, 2010, LOCAL ENV, V10, P427; McKinsey, 2007, WOMEN MATTER; Stevens C., 2010, ARE WOMEN KEY SUSTAI; *UNDP, 2007, FIGHT CLIM CHANG UND; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147	5	29	29	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 25	2010	468	7323					502	502		10.1038/468502a	http://dx.doi.org/10.1038/468502a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	684WA	21107405	Bronze			2022-12-28	WOS:000284584200017
J	Cohen, P; Tcherpakov, M				Cohen, Philip; Tcherpakov, Marianna			Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases?	CELL			English	Article							SMALL-MOLECULE INHIBITOR; UNANCHORED POLYUBIQUITIN CHAINS; KAPPA-B ACTIVATION; DEUBIQUITINATING ENZYME; DNA-DAMAGE; LIGASE; PROTEASOME; MDM2; P53; IDENTIFICATION	Protein phosphorylation and protein ubiquitination regulate most aspects of cell life, and defects in these control mechanisms cause cancer and many other diseases. In the past decade, protein kinases have become one of the most important classes of drug targets for the pharmaceutical industry. In contrast, drug discovery programs that target components of the ubiquitin system have lagged behind. In this Perspective, we discuss the reasons for the delay in this pipeline, the drugs targeting the ubiquitin system that have been developed, and new approaches that may popularize this area of drug discovery in the future.	[Cohen, Philip] MRC Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Cohen, Philip] Scottish Inst Cell Signalling, Sir James Black Ctr, Dundee DD1 5EH, Scotland; [Tcherpakov, Marianna] BCC Res, Wellesley, MA 02481 USA	University of Dundee; University of Dundee	Cohen, P (corresponding author), MRC Prot Phosphorylat Unit, Dow St, Dundee DD1 5EH, Scotland.	p.cohen@dundee.ac.uk	高, 雨莉/HGU-8187-2022		Medical Research Council Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams J, 2002, ONCOLOGIST, V7, P9, DOI 10.1634/theoncologist.7-1-9; Aghajan M, 2010, NAT BIOTECHNOL, V28, P738, DOI 10.1038/nbt.1645; Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bennett EJ, 2008, NAT STRUCT MOL BIOL, V15, P20, DOI 10.1038/nsmb0108-20; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bianchi G, 2009, BLOOD, V113, P3040, DOI 10.1182/blood-2008-08-172734; Cardozo T, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S9; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Everly MJ, 2008, TRANSPLANTATION, V86, P1754, DOI 10.1097/TP.0b013e318190af83; FISCHER EH, 1955, J BIOL CHEM, V216, P121; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; LAWLER B, 2009, BIO53B GLOB MARK BCC; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Li ZB, 2005, EMBO REP, V6, P373, DOI 10.1038/sj.embor.7400377; Lierman E, 2006, BLOOD, V108, P1374, DOI 10.1182/blood-2006-02-004457; Lin G, 2009, NATURE, V461, P621, DOI 10.1038/nature08357; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Maguire M, 2008, CANCER RES, V68, P3232, DOI 10.1158/0008-5472.CAN-07-5271; Merlet J, 2009, CELL MOL LIFE SCI, V66, P1924, DOI 10.1007/s00018-009-8712-7; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nakajima H, 2008, BIOCHEM BIOPH RES CO, V368, P1007, DOI 10.1016/j.bbrc.2008.01.166; Oliveira AM, 2006, J CLIN ONCOL, V24, pe2; Oliveira Andre M, 2006, J Clin Oncol, V24, pe2, DOI 10.1200/JCO.2005.04.4818; Orlicky S, 2010, NAT BIOTECHNOL, V28, P733, DOI 10.1038/nbt.1646; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; TCHERPAKOV M, 2010, PHM066A BCC; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Wu H, 2007, CELL, V131, P655, DOI 10.1016/j.cell.2007.10.042; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	55	220	227	0	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 24	2010	143	5					686	693		10.1016/j.cell.2010.11.016	http://dx.doi.org/10.1016/j.cell.2010.11.016			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111230	Bronze			2022-12-28	WOS:000284583500011
J	Paynter, S; Ware, RS; Weinstein, P; Williams, G; Sly, PD				Paynter, Stuart; Ware, Robert S.; Weinstein, Philip; Williams, Gail; Sly, Peter D.			Childhood pneumonia: a neglected, climate-sensitive disease?	LANCET			English	Editorial Material									[Ware, Robert S.; Sly, Peter D.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld 4029, Australia; [Paynter, Stuart; Ware, Robert S.; Williams, Gail] Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4029, Australia; [Weinstein, Philip] Univ S Australia, Grad Res Ctr, Adelaide, SA 5001, Australia	University of Queensland; University of Queensland; University of South Australia	Sly, PD (corresponding author), Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld 4029, Australia.	p.sly@uq.edu.au	Weinstein, Phil/C-9805-2011; Sly, Peter D/F-1486-2010; Ware, Robert S./B-2024-2014; Williams, Gail/S-8833-2019	Sly, Peter D/0000-0001-6305-2201; Ware, Robert S./0000-0002-6129-6736; Williams, Gail/0000-0002-4822-5263; Weinstein, Philip/0000-0001-9860-7166				[Anonymous], 2009, PROT HLTH CLIM CHANG; Chan PWK, 2002, PEDIATR PULM, V34, P47, DOI 10.1002/ppul.10095; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Confalonieri U, 2007, CLIMATE CHANGE 2007; Dowell SF, 2003, EMERG INFECT DIS, V9, P573, DOI 10.3201/eid0905.020556; Enwere G, 2007, TROP MED INT HEALTH, V12, P1377, DOI 10.1111/j.1365-3156.2007.01922.x; Moura FEA, 2006, AM J TROP MED HYG, V74, P165, DOI 10.4269/ajtmh.2006.74.165; Naylor RL, 2007, P NATL ACAD SCI USA, V104, P7752, DOI 10.1073/pnas.0701825104; Omer SB, 2008, EPIDEMIOL INFECT, V136, P1319, DOI 10.1017/S0950268807000015; Organization WH, 2009, GLOB HLTH RISKS MORT; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; World Health Organization, 2008, GLOB BURD DIS 2004 U; Ye Y, 2009, AM J TROP MED HYG, V81, P770, DOI 10.4269/ajtmh.2009.09-0070; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X	14	34	35	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2010	376	9755					1804	1805		10.1016/S0140-6736(10)62141-1	http://dx.doi.org/10.1016/S0140-6736(10)62141-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696KG	21111894				2022-12-28	WOS:000285439700006
J	Gravel, D; Bell, T; Barbera, C; Bouvier, T; Pommier, T; Venail, P; Mouquet, N				Gravel, Dominique; Bell, Thomas; Barbera, Claire; Bouvier, Thierry; Pommier, Thomas; Venail, Patrick; Mouquet, Nicolas			Experimental niche evolution alters the strength of the diversity-productivity relationship	NATURE			English	Article							PSEUDOMONAS-FLUORESCENS; ECOSYSTEM PRODUCTIVITY; PLANT DIVERSITY; BIODIVERSITY; GENERALISTS; ASSEMBLAGES; SPECIALISTS; RESOURCE; SERVICES; MODEL	The relationship between biodiversity and ecosystem functioning (BEF) has become a cornerstone of community and ecosystem ecology(1-3) and an essential criterion for making decisions in conservation biology and policy planning(4,5). It has recently been proposed that evolutionary history should influence the BEF relationship because it determines species traits and, thus, species' ability to exploit resources(6,7). Here we test this hypothesis by combining experimental evolution with a BEF experiment. We isolated 20 bacterial strains from a marine environment and evolved each to be generalists or specialists(8). We then tested the effect of evolutionary history on the strength of the BEF relationship with assemblages of 1 to 20 species constructed from the specialists, generalists and ancestors(9). Assemblages of generalists were more productive on average because of their superior ability to exploit the environmental heterogeneity(10). The slope of the BEF relationship was, however, stronger for the specialist assemblages because of enhanced niche complementarity. These results show how the BEF relationship depends critically on the legacy of past evolutionary events.	[Gravel, Dominique] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [Gravel, Dominique; Barbera, Claire; Venail, Patrick; Mouquet, Nicolas] Univ Montpellier 2, CNRS, Inst Sci Evolut UMR 5554, F-34095 Montpellier 05, France; [Bell, Thomas] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Bouvier, Thierry; Pommier, Thomas] Univ Montpellier 2, CNRS, Ecosyst Langunaires UMR 5119, F-34095 Montpellier 05, France; [Pommier, Thomas] Univ Lyon 1, CNRS, INRA, UMR 5557,USC 1193,Lab Ecol Microbienne, F-69622 Villeurbanne, France	University of Quebec; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Oxford; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup	Gravel, D (corresponding author), Univ Quebec, Dept Biol Chim & Geog, 300 Alee Ursulines, Rimouski, PQ G5L 3A1, Canada.	dominique_gravel@uqar.qc.ca; nmouquet@univ-montp2.fr	Bouvier, Thierry/A-1895-2013; MOUQUET, Nicolas/AAL-1440-2021; Pommier, Thomas/AAR-1115-2021; Venail, Patrick/D-2968-2018	Pommier, Thomas/0000-0003-2986-5326; Venail, Patrick/0000-0003-1126-280X; Mouquet, Nicolas/0000-0003-1840-6984; Bell, Thomas/0000-0002-2615-3932; bouvier, thierry/0000-0002-7151-5680	Natural Sciences and Engineering Research Council of Canada; Canada Research Chair Program;  [ANR-09-JCJC-0110-01]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair Program(Canada Research Chairs); 	We thank T. Barraclough, G. Bell, M. Loreau, R. C. MacLean and A. Paquette for comments on earlier versions of the manuscript. This work was supported by a fellowship from the Natural Sciences and Engineering Research Council of Canada and a research grant from the Canada Research Chair Program, to D.G., and research grant ANR-09-JCJC-0110-01, to N.M.	Abrams PA, 2006, EVOLUTION, V60, P427; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barrett RDH, 2005, AM NAT, V166, P470, DOI 10.1086/444440; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bell T., 2009, BIODIVERSITY ECOSYST, P121, DOI DOI 10.1093/ACPROF:OSO/9780199547951.003.0009; Bell T, 2009, AM NAT, V174, P836, DOI 10.1086/647931; BOCHNER BR, 1989, NATURE, V339, P157, DOI 10.1038/339157a0; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P2050, DOI 10.1111/j.1462-2920.2007.01321.x; Buckling A, 2009, NATURE, V457, P824, DOI 10.1038/nature07892; Bunker D.E., 2009, BIODIVERSITY ECOSYST; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kinzig A. P., 2002, FUNCTIONAL CONSEQUEN; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; LEVINS RICHARD, 1968; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2001, P ROY SOC B-BIOL SCI, V268, P303, DOI 10.1098/rspb.2000.1366; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; MacLean RC, 2005, J EVOLUTION BIOL, V18, P1376, DOI 10.1111/j.1420-9101.2005.00931.x; MacLean RC, 2004, P NATL ACAD SCI USA, V101, P8072, DOI 10.1073/pnas.0307195101; Maidak BL, 1999, NUCLEIC ACIDS RES, V27, P171, DOI 10.1093/nar/27.1.171; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Salles JF, 2009, ECOLOGY, V90, P3324, DOI 10.1890/09-0188.1; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Venail PA, 2008, NATURE, V452, P210, DOI 10.1038/nature06554; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	38	137	139	8	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					89	U1601		10.1038/nature09592	http://dx.doi.org/10.1038/nature09592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21131946				2022-12-28	WOS:000285921600037
J	van Dokkum, PG; Conroy, C				van Dokkum, Pieter G.; Conroy, Charlie			A substantial population of low-mass stars in luminous elliptical galaxies	NATURE			English	Article							M-DWARF; STELLAR; EVOLUTION; FRAGMENTATION; CONSTRAINTS; SPECTRA; GROWTH	The stellar initial mass function (IMF) describes the mass distribution of stars at the time of their formation and is of fundamental importance for many areas of astrophysics. The IMF is reasonably well constrained in the disk of the Milky Way(1) but we have very little direct information on the form of the IMF in other galaxies and at earlier cosmic epochs. Here we report observations of the Na I doublet(2,3) and the Wing-Ford molecular FeH band(4,5) in the spectra of elliptical galaxies. These lines are strong in stars with masses less than 0.3 M-circle dot (where M-circle dot is the mass of the Sun) and are weak or absent in all other types of stars(5-7). We unambiguously detect both signatures, consistent with previous studies(8) that were based on data of lower signal-to-noise ratio. The direct detection of the light of low-mass stars implies that they are very abundant in elliptical galaxies, making up over 80% of the total number of stars and contributing more than 60% of the total stellar mass. We infer that the IMF in massive star-forming galaxies in the early Universe produced many more low-mass stars than the IMF in the Milky Way disk, and was probably slightly steeper than the Salpeter form(9) in the mass range 0.1 M-circle dot to 1 M-circle dot.	[van Dokkum, Pieter G.] Yale Univ, Dept Astron, New Haven, CT 06511 USA; [Conroy, Charlie] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Conroy, Charlie] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Yale University; Princeton University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	van Dokkum, PG (corresponding author), Yale Univ, Dept Astron, New Haven, CT 06511 USA.	pieter.vandokkum@yale.edu						Banerji M, 2009, ASTROPHYS J, V692, P283, DOI 10.1088/0004-637X/692/1/283; Bate MR, 2005, MON NOT R ASTRON SOC, V356, P1201, DOI 10.1111/j.1365-2966.2004.08593.x; Baugh CM, 2005, MON NOT R ASTRON SOC, V356, P1191, DOI 10.1111/j.1365-2966.2004.08553.x; Bonnell IA, 2008, MON NOT R ASTRON SOC, V389, P1556, DOI 10.1111/j.1365-2966.2008.13679.x; BOROSON TA, 1991, ASTRON J, V101, P111, DOI 10.1086/115672; CARTER D, 1986, ASTROPHYS J, V311, P637, DOI 10.1086/164804; Cenarro AJ, 2003, MON NOT R ASTRON SOC, V339, pL12, DOI 10.1046/j.1365-8711.2003.06360.x; Conroy C, 2009, ASTROPHYS J, V699, P486, DOI 10.1088/0004-637X/699/1/486; COUTURE J, 1993, ASTROPHYS J, V406, P142, DOI 10.1086/172426; Cushing MC, 2003, ASTROPHYS J, V582, P1066, DOI 10.1086/344525; Dave R, 2008, MON NOT R ASTRON SOC, V385, P147, DOI 10.1111/j.1365-2966.2008.12866.x; FABER SM, 1980, ASTROPHYS J, V235, P405, DOI 10.1086/157644; Fardal MA, 2007, MON NOT R ASTRON SOC, V379, P985, DOI 10.1111/j.1365-2966.2007.11522.x; Kroupa P, 2001, MON NOT R ASTRON SOC, V322, P231, DOI 10.1046/j.1365-8711.2001.04022.x; Labbe I, 2010, ASTROPHYS J LETT, V716, pL103, DOI 10.1088/2041-8205/716/2/L103; Naab T, 2007, ASTROPHYS J, V658, P710, DOI 10.1086/510841; Novati SC, 2008, ASTRON ASTROPHYS, V480, P723, DOI 10.1051/0004-6361:20078439; OKE JB, 1995, PUBL ASTRON SOC PAC, V107, P375, DOI 10.1086/133562; Rayner JT, 2009, ASTROPHYS J SUPPL S, V185, P289, DOI 10.1088/0067-0049/185/2/289; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Schiavon RP, 1997, ASTROPHYS J, V484, P499, DOI 10.1086/304332; Schiavon RP, 1997, ASTROPHYS J, V479, P902, DOI 10.1086/303907; Schiavon RP, 2000, ASTROPHYS J, V532, P453, DOI 10.1086/308533; Treu T, 2010, ASTROPHYS J, V709, P1195, DOI 10.1088/0004-637X/709/2/1195; Van Der Wel A, 2008, ASTROPHYS J, V688, P48, DOI 10.1086/592267; van Dokkum PG, 2008, ASTROPHYS J, V674, P29, DOI 10.1086/525014; van Dokkum PG, 2010, ASTROPHYS J, V709, P1018, DOI 10.1088/0004-637X/709/2/1018; WING RF, 1969, PUBL ASTRON SOC PAC, V81, P527, DOI 10.1086/128814	30	369	369	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					940	942		10.1038/nature09578	http://dx.doi.org/10.1038/nature09578			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21124316	Green Submitted			2022-12-28	WOS:000285344600041
J	McCain, RS; Harris, AR; McCallion, K; Campbell, WJ; Kirk, SJ				McCain, R. Scott; Harris, Andrew R.; McCallion, Kevin; Campbell, W. Jeffrey; Kirk, Stephen J.			CHRISTMAS 2010: THE LIVES OF DOCTORS The barrier method as a new tool to assist in career selection: covert observational study	BRITISH MEDICAL JOURNAL			English	Editorial Material							PERSONALITY	Objective To determine if senior doctors' parking habits and skills are associated with clinical specialty and, if so, whether observation of junior doctors' parking could provide guidance in choice of specialty. Design Covert observational study. Setting Pass-card controlled consultants' car park (parking lot), December 2009. Participants 103 consultants entering the car park on three consecutive mornings. Main outcome measures The outcomes were specialty and sex of the consultants, manner of approaching the barrier (pass-card ready or not), and time taken to park, exit the vehicle, and walk to a designated point. Results Approaches to the barrier and parking were recorded for 103 consultants (79 men, 24 women): 28 anaesthetists (22 men, six women), 29 physicians (internists, 18 men, 11 women), 14 radiologists (nine men, five women), and 32 surgeons (30 men, two women). The manner of approaching the barrier (card ready) differed by specialty but not by sex. The total time taken to park (seconds) differed significantly between specialties: surgery (median 68, interquartile range 61-71 seconds), anaesthesia (82, 76-91), radiology (86, 70-103), and general medicine (112, 96-136). The time taken to park was overall longer among women, but this was explained by their specialty (men and women matched by specialty did not differ). Conclusions The total time taken to park and manner of approaching the barrier to gain entry to the car park differed across specialties. Surgical consultants were fastest, followed by consultant anaesthetists and consultant radiologists, with physicians slowest. Sex was not an influencing factor. If reproducible in studies of a similar nature the "barrier method" could allow for a low cost means of guiding junior doctors in career selection.	[McCain, R. Scott; Harris, Andrew R.; McCallion, Kevin; Campbell, W. Jeffrey; Kirk, Stephen J.] Ulster Hosp, Dept Gen Surg, Belfast BT16 1RH, Antrim, North Ireland		McCain, RS (corresponding author), Ulster Hosp, Dept Gen Surg, Belfast BT16 1RH, Antrim, North Ireland.	smccain01@qub.ac.uk		McCain, Scott/0000-0002-9045-7279				CALDICOTT L, 2009, BRIT MED J, V339, pB4948; Department of Health, 2004, MOD MED CAR NEXT STE; GREENBURG AG, 1982, SURGERY, V92, P368; Jefferis Tony, 2007, BMJ, V334, P1302, DOI 10.1136/bmj.39238.447338.AD; Nabi H, 2005, AM J EPIDEMIOL, V161, P864, DOI 10.1093/aje/kwi110; Thomas JH, 1997, AM J SURG, V174, P573, DOI 10.1016/S0002-9610(97)00208-0; Tooke JE., 2008, ASPIRING EXCELLENCE	7	1	1	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2010	341								c6968	10.1136/bmj.c6968	http://dx.doi.org/10.1136/bmj.c6968			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XJ	21159762	Green Published, hybrid			2022-12-28	WOS:000285552800012
J	Yin, HS; Wolf, MS; Dreyer, BP; Sanders, LM; Parker, RM				Yin, H. Shonna; Wolf, Michael S.; Dreyer, Benard P.; Sanders, Lee M.; Parker, Ruth M.			Evaluation of Consistency in Dosing Directions and Measuring Devices for Pediatric Nonprescription Liquid Medications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH LITERACY; ACETAMINOPHEN; PARENTS; ERRORS; VARIABILITY; ASSOCIATION; INSTRUMENTS; ACCURACY; LABELS	Context In response to reports of unintentional drug overdoses among children given over-the-counter (OTC) liquid medications, in November 2009 the US Food and Drug Administration (FDA) released new voluntary industry guidelines that recommend greater consistency and clarity in OTC medication dosing directions and their accompanying measuring devices. Objective To determine the prevalence of inconsistent dosing directions and measuring devices among popular pediatric OTC medications at the time the FDA's guidance was released. Design and Setting Descriptive study of 200 top-selling pediatric oral liquid OTC medications during the 52 weeks ending October 30, 2009. Sample represents 99% of the US market of analgesic, cough/cold, allergy, and gastrointestinal OTC oral liquid products with dosing information for children younger than 12 years. Main Outcome Measures Inclusion of measuring device, within-product inconsistency between dosing directions on the bottle's label and dose markings on enclosed measuring device, across-product use of nonstandard units and abbreviations, and presence of abbreviation definitions. Results Measuring devices were packaged with 148 of 200 products (74.0%). Within this subset of 148 products, inconsistencies between the medication's dosing directions and markings on the device were found in 146 cases (98.6%). These included missing markings (n=36, 24.3%) and superfluous markings (n=120, 81.1%). Across all products, 11 (5.5%) used atypical units of measurement (eg, drams, cc) for doses listed. Milliliter, teaspoon, and tablespoon units were used for doses in 143 (71.5%), 155 (77.5%), and 37 (18.5%) products, respectively. A nonstandard abbreviation for milliliter (not mL) was used by 97 products. Of the products that included an abbreviation, 163 did not define at least 1 abbreviation. Conclusion At the time the FDA released its new guidance, top-selling pediatric OTC liquid medications contained highly variable and inconsistent dosing directions and measuring devices. JAMA. 2010;304(23):2595-2602 www.jama.com	[Yin, H. Shonna; Dreyer, Benard P.] NYU, Sch Med, Dept Pediat, New York, NY 10016 USA; [Yin, H. Shonna; Dreyer, Benard P.] Bellevue Hosp Ctr, New York, NY 10016 USA; [Wolf, Michael S.] Northwestern Univ, Feinberg Sch Med, Hlth Literacy & Learning Program, Ctr Commun Healthcare,Div Gen Internal Med, Chicago, IL 60611 USA; [Wolf, Michael S.] Northwestern Univ, Feinberg Sch Med, Inst Healthcare Studies, Chicago, IL 60611 USA; [Sanders, Lee M.] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA; [Parker, Ruth M.] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA	New York University; Bellevue Hospital Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Miami; Emory University	Yin, HS (corresponding author), NYU, Sch Med, Dept Pediat, 550 1st Ave,NBV 8S4-11, New York, NY 10016 USA.	yinh02@med.nyu.edu	Parker, Ruth M/S-4583-2017; Wolf, Michael/V-3351-2018	Parker, Ruth M/0000-0001-9685-6396; Wolf, Michael/0000-0002-4342-6517; Yin, Hsiang Shonna/0000-0003-3287-0011; Dreyer, Benard/0000-0001-5299-5634	Pfizer; McNeil Consumer Healthcare; Abbott Foundation; McNeil ConsumerHealth	Pfizer(Pfizer); McNeil Consumer Healthcare; Abbott Foundation; McNeil ConsumerHealth	Dr Yin reported receiving funds from Pfizer as part of its Fellowship in Health Literacy/Clear Health Communication and having served as a paid consultant to McKing Consulting Corporation. Dr Wolf reported receiving unrestricted research grant funding from McNeil Consumer Healthcare and Abbott Foundation and having served as a paid consultant to McNeil Consumer Healthcare and Abbott Laboratories. Dr Sanders reported receiving unrestricted research grant funding from Pfizer as part of its Fellowship in Health Literacy/Clear Health Communication and having served as a paid consultant to Pfizer's Clear Health Communication program. Dr Parker reported receiving unrestricted research grant funding from McNeil ConsumerHealth and Abbott Foundation and having served as a paid consultant to Johnson & Johnson and McKing Consulting Corporation. No other disclosures were reported.	*AM AC PED, PAR COM Q A MED; *AM COLL PHYS FDN, IMPR PRESCR DRUG CON; [Anonymous], 2002, FDA Consum, V36, P35; BACIU A, 2007, FUTURE DRUG SAFETY P; Brunetti L, 2007, JT COMM J QUAL PATIE, V33, P576, DOI 10.1016/S1553-7250(07)33062-6; Budnitz DS, 2007, PHARMACOEPIDEM DR S, V16, P160, DOI 10.1002/pds.1242; *CHAIN DRUG REV, TOP 100 CHAINS PHARM; *CONS HEALTHC PROD, VOL MEAS DOS OV THE; Dart RC, 2009, ANN EMERG MED, V53, P411, DOI 10.1016/j.annemergmed.2008.09.015; Davis TC, 2006, J GEN INTERN MED, V21, P847, DOI 10.1111/j.1525-1497.2006.00529.x; Davis TC, 2006, ANN INTERN MED, V145, P887, DOI 10.7326/0003-4819-145-12-200612190-00144; Frush KS, 2004, ARCH PEDIAT ADOL MED, V158, P620, DOI 10.1001/archpedi.158.7.620; GRIBETZ B, 1987, PEDIATRICS, V80, P630; Hahn Robert, 2007, MMWR Recomm Rep, V56, P1; HERNANDEZ LM, 2007, STANDARDIZING MEDICA; HYAM E, 1989, FAM PRACT, V6, P221, DOI 10.1093/fampra/6.3.221; *I MED, 2010, SAF US IN HLTH LIT W; Institute of Medicine, 2007, PREV MED ERR QUAL CH; *JOINT COMM, OFF DO NOT US LIST; Kutner M, HLTH LITERACY AM ADU; Li SF, 2000, PEDIATR EMERG CARE, V16, P394, DOI 10.1097/00006565-200012000-00003; LITOVITZ T, 1992, ANN PHARMACOTHER, V26, P917, DOI 10.1177/106002809202600710; Madlon-Kay DJ, 2000, J FAM PRACTICE, V49, P741; MCKENZIE MW, 1981, US PHARM, V6, P55; McMahon SR, 1997, PEDIATRICS, V100, P330, DOI 10.1542/peds.100.3.330; Nielson-Bohlman L, 2004, HLTH LITERACY PRESCR; Persell SD, 2007, J GEN INTERN MED, V22, P1523, DOI 10.1007/s11606-007-0334-x; Schillie SF, 2009, AM J PREV MED, V37, P181, DOI 10.1016/j.amepre.2009.05.018; Sharif I, 2010, PEDIATRICS, V125, P960, DOI 10.1542/peds.2009-2530; Shrank W, 2007, ANN PHARMACOTHER, V41, P783, DOI 10.1345/aph.1H582; Shrank WH, 2007, ARCH INTERN MED, V167, P1760, DOI 10.1001/archinte.167.16.1760; Simon HK, 1997, ARCH PEDIAT ADOL MED, V151, P654, DOI 10.1001/archpedi.1997.02170440016003; Sobhani P, 2008, ANN PHARMACOTHER, V42, P46, DOI 10.1345/aph.1K420; *US DEP HHS, GUID IND DOS DEL DEV; *US PHARM, 32 USP; *USP CTR ADV PAT S, ABB CAN LEAD MED ERR; Vernacchio L, 2009, PEDIATRICS, V124, P446, DOI 10.1542/peds.2008-2869; Wolf MS, 2007, PATIENT EDUC COUNS, V67, P293, DOI 10.1016/j.pec.2007.03.024; Wolf MS, 2006, AM J HEALTH-SYST PH, V63, P1048, DOI 10.2146/ajhp050469; Wolf MS, 2006, PATIENT EDUC COUNS, V62, P316, DOI 10.1016/j.pec.2006.06.010; Wolf MS, 2009, MED CARE, V47, P370, DOI 10.1097/MLR.0b013e31818af91a; YAFFE SJ, 1975, PEDIATRICS, V56, P327; Yin HS, 2008, ARCH PEDIAT ADOL MED, V162, P814, DOI 10.1001/archpedi.162.9.814; Yin HS, 2007, AMBUL PEDIATR, V7, P292, DOI 10.1016/j.ambp.2007.04.004; Yin H Shonna, 2009, Pediatrics, V124 Suppl 3, pS289, DOI 10.1542/peds.2009-1162E; Yin HS, 2010, ARCH PEDIAT ADOL MED, V164, P181, DOI 10.1001/archpediatrics.2009.269; 2009, DRUG STORE NEWS, V31	47	50	52	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2010	304	23					2595	2602		10.1001/jama.2010.1797	http://dx.doi.org/10.1001/jama.2010.1797			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694MX	21119074	Bronze			2022-12-28	WOS:000285303400022
J	Kinnell, HG				Kinnell, Herbert G.			Christmas 2010: Whodunit Agatha Christie's doctors	BRITISH MEDICAL JOURNAL			English	Editorial Material											Kinnell, HG (corresponding author), 3 Welwick Close,Lower Earley, Reading, Berkshire, England.	anne@perfectpages.freeserve.co.uk							0	0	0	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 14	2010	341								c6438	10.1136/bmj.c6438	http://dx.doi.org/10.1136/bmj.c6438			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XD	21156735				2022-12-28	WOS:000285552200003
J	Phillips, JS; Mason, MJ; Dixon, H				Phillips, John S.; Mason, Matthew J.; Dixon, Heather			Christmas 2010: Surgery Middle ear instrument nomenclature: a taxonomic approach	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Phillips, John S.] Univ British Columbia, Rotary Hearing Clin, Vancouver, BC V6Z 1Y6, Canada; [Mason, Matthew J.; Dixon, Heather] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	University of British Columbia; University of Cambridge	Phillips, JS (corresponding author), Univ British Columbia, Rotary Hearing Clin, Vancouver, BC V6Z 1Y6, Canada.	john.phillips@mac.com	Mason, Matthew James/AAX-9783-2021	Mason, Matthew James/0000-0001-7845-0720				Bill J.H., 1882, INT ENCY SURG SYSTEM, V2, P101; Brochu CA, 2001, AM ZOOL, V41, P564, DOI 10.1668/0003-1569(2001)041[0564:CSISAT]2.0.CO;2; Bryson Bill, 1990, MOTHER TONGUE ENGLIS; GOULEY JWS, 1877, MED REC, V12, P529; HELMUTH WT, 1875, DOCUMENTS ASSEMBLY S, V8, P195; JONES HM, 1881, TREATISE AURAL SURG; JONES HM, 1889, LANCET, V134, P159; JONES HM, 1889, LANCET, V134, P209; KEYES EL, 1875, MED REC, V10, P163; KINLOCH RA, 1877, AM J MED SCI, V74, P125; Knight Edward Henry, 1884, KNIGHTS NEW MECH DIC; PEMBERTON O, 1884, LANCET, V123, P927; RYERSON T, 1876, T MED SOC NEW JERSEY, P302; Salisbury SW, 2006, P ROY SOC B-BIOL SCI, V273, P2439, DOI 10.1098/rspb.2006.3613; STEARN WT, 1959, SYST ZOOL, V8, P4, DOI 10.2307/2411603; Wilkinson DM, 2001, NATURE, V412, P485, DOI 10.1038/35087676	16	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 13	2010	341								c5137	10.1136/bmj.c5137	http://dx.doi.org/10.1136/bmj.c5137			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XA	21149463				2022-12-28	WOS:000285551900009
J	Bloomfield, G; Skelton, J; Ivens, A; Tanaka, Y; Kay, RR				Bloomfield, Gareth; Skelton, Jason; Ivens, Alasdair; Tanaka, Yoshimasa; Kay, Robert R.			Sex Determination in the Social Amoeba Dictyostelium discoideum	SCIENCE			English	Article							CELLULAR SLIME-MOLD; UNIPARENTAL INHERITANCE; MACROCYST FORMATION; MITOCHONDRIAL-DNA; POLYMORPHISM	The genetics of sex determination remain mysterious in many organisms, including some that are otherwise well studied. Here we report the discovery and analysis of the mating-type locus of the model organism Dictyostelium discoideum. Three forms of a single genetic locus specify this species' three mating types: two versions of the locus are entirely different in sequence, and the third resembles a composite of the other two. Single, unrelated genes are sufficient to determine two of the mating types, whereas homologs of both these genes are required in the composite type. The key genes encode polypeptides that possess no recognizable similarity to established protein families. Sex determination in the social amoebae thus appears to use regulators that are unrelated to any others currently known.	[Bloomfield, Gareth; Tanaka, Yoshimasa; Kay, Robert R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Bloomfield, Gareth; Skelton, Jason; Ivens, Alasdair] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Tanaka, Yoshimasa] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	MRC Laboratory Molecular Biology; Wellcome Trust Sanger Institute; University of Tsukuba	Bloomfield, G (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	garethb@mrc-lmb.cam.ac.uk		Ivens, Al/0000-0002-0112-3876; Kay, Robert R/0000-0001-9836-7967; Bloomfield, Gareth/0000-0003-4269-8059	Wellcome Trust [06724]; Medical Research Council; MRC [MC_U105115237] Funding Source: UKRI; Medical Research Council [MC_U105115237] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust grant number 06724 and core funding from the Medical Research Council. We thank the Dicty Stock Center (www.dictybase.org/StockCenter/StockCenter.html), D. Francis, H. Hagiwara, and P. Schaap for providing strains; T. Feltwell, N. Nikolaidou-Katsaridou, and K. Jagels for technical assistance; and M. Fookes, C. Carret, K. Brooks, C. Pears, N. Barry, and the members and associate members of the Dictyostelium group at the Laboratory of Molecular Biology for valuable advice and discussions. A. I. is now at Fios Genomics, ETTC, King's Buildings, Edinburgh EH9 3JL, UK. We are grateful to the U.S. Department of Energy Joint Genome Institute (www.jgi.doe.gov/) and co-workers, and to the Actyostelium Genome Consortium for making the Dictyostelium purpureum and Acytostelium subglobosum genome data available before publication. Microarray data are available under accession no. E-TABM-394 and the array design under A-SGRP-3 at www.ebi.ac.uk/arrayexpress/, and DNA sequences have been deposited in EMBL-Bank under accessions nos. FN543120 to FN543124, FN994780, FR666792, and FR666793.	BLASKOVICS JC, 1957, BIOL BULL-US, V113, P58, DOI 10.2307/1538802; Bloomfield G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r75; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; ERDOS GW, 1973, P NATL ACAD SCI USA, V70, P1828, DOI 10.1073/pnas.70.6.1828; FILOSA MF, 1972, DEV BIOL, V29, P1, DOI 10.1016/0012-1606(72)90038-3; Flowers JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001013; Hurst LD, 1996, P ROY SOC B-BIOL SCI, V263, P415, DOI 10.1098/rspb.1996.0063; KAWANO S, 1987, J GEN MICROBIOL, V133, P3175; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; MIRFAKHRAI M, 1990, GENETICS, V124, P607; Muramoto T, 2003, MECH DEVELOP, V120, P965, DOI 10.1016/S0925-4773(03)00136-9; ODAY DH, 1979, CAN J MICROBIOL, V25, P1416, DOI 10.1139/m79-221; RAPER KB, 1984, DICTYOSTELIDS, pCH9; ROBSON GE, 1979, GENETICS, V93, P861; ROBSON GE, 1980, CURR GENET, V1, P229, DOI 10.1007/BF00390948; SAGA Y, 1983, J CELL SCI, V60, P157; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Tanurdzic M, 2004, PLANT CELL, V16, pS61, DOI 10.1105/tpc.016667; Urushihara H, 2006, EUR J CELL BIOL, V85, P961, DOI 10.1016/j.ejcb.2006.05.012; WALLACE MA, 1979, J GEN MICROBIOL, V113, P327, DOI 10.1099/00221287-113-2-327; Wong JL, 2010, TRENDS CELL BIOL, V20, P134, DOI 10.1016/j.tcb.2009.12.007	23	65	66	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1533	1536		10.1126/science.1197423	http://dx.doi.org/10.1126/science.1197423			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148389	Green Accepted			2022-12-28	WOS:000285153500063
J	Dessler, AE				Dessler, A. E.			A Determination of the Cloud Feedback from Climate Variations over the Past Decade	SCIENCE			English	Article							GENERAL-CIRCULATION MODELS; WATER-VAPOR FEEDBACK; SENSITIVITY; SYSTEM	Estimates of Earth's climate sensitivity are uncertain, largely because of uncertainty in the long-term cloud feedback. I estimated the magnitude of the cloud feedback in response to short-term climate variations by analyzing the top-of-atmosphere radiation budget from March 2000 to February 2010. Over this period, the short-term cloud feedback had a magnitude of 0.54 +/- 0.74 (2 sigma) watts per square meter per kelvin, meaning that it is likely positive. A small negative feedback is possible, but one large enough to cancel the climate's positive feedbacks is not supported by these observations. Both long-and short-wave components of short-term cloud feedback are also likely positive. Calculations of short-term cloud feedback in climate models yield a similar feedback. I find no correlation in the models between the short- and long-term cloud feedbacks.	Texas A&M Univ, Dept Atmospher Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Dessler, AE (corresponding author), Texas A&M Univ, Dept Atmospher Sci, College Stn, TX 77843 USA.	adessler@tamu.edu	Dessler, Andrew E/G-8852-2012; Keyes, Dennis/AAZ-9285-2021	Dessler, Andrew E/0000-0003-3939-4820; 	NASA [NNX08AR27G]	NASA(National Aeronautics & Space Administration (NASA))	I thank the CERES, MERRA, and ECMWF groups for producing the data used in this paper. Support for this work came from NASA grant NNX08AR27G to Texas A&M University. I also acknowledge useful contributions from N. Loeb, M. Bosilovich, J.-J. Morcrette, M. Zelinka, P. Stackhouse, T. Wong, J. Fasullo, P. Yang, and G. North. Finally, I acknowledge the modeling groups, the Program for Climate Model Diagnosis and Intercomparison, and the WCRP's Working Group on Coupled Modeling for their roles in making available the WCRP CMIP3 multimodel data set. Support of this data set is provided by the U.S. Department of Energy Office of Science.	Chung ES, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042698; Clement AC, 2009, SCIENCE, V325, P460, DOI 10.1126/science.1171255; Colman R, 2003, CLIM DYNAM, V20, P865, DOI 10.1007/s00382-003-0310-z; Dessler AE, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010137; Dessler AE, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035333; Dessler AE, 2009, SCIENCE, V323, P1020, DOI 10.1126/science.1171264; Dufresne JL, 2008, J CLIMATE, V21, P5135, DOI 10.1175/2008JCLI2239.1; Held IM, 2000, ANNU REV ENERG ENV, V25, P441, DOI 10.1146/annurev.energy.25.1.441; Huybers P, 2010, J CLIMATE, V23, P3009, DOI 10.1175/2010JCLI3380.1; Lindzen RS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039628; Loeb NG, 2007, J CLIMATE, V20, P575, DOI 10.1175/JCLI4018.1; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Minschwaner K, 2004, J CLIMATE, V17, P1272, DOI 10.1175/1520-0442(2004)017<1272:WVFITT>2.0.CO;2; Moy LA, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012758; Murphy DM, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042911; Randall DA., 2007, CLIMATE CHANGE 2007; Shell KM, 2008, J CLIMATE, V21, P2269, DOI [10.1175/2007JCLI2044.1, 10.1175/2007JCL12044.1]; Simmons A, 2006, ECMWF NEWSLETTER, P110; Smith CA, 2000, INT J CLIMATOL, V20, P1543, DOI 10.1002/1097-0088(20001115)20:13&lt;1543::AID-JOC579&gt;3.0.CO;2-A; Soden BJ, 2008, J CLIMATE, V21, P3504, DOI 10.1175/2007JCLI2110.1; Soden BJ, 2006, J CLIMATE, V19, P3354, DOI 10.1175/JCLI3799.1; Sohn BJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010053; Spencer RW, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029698; Spencer RW, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013371; Stephens GL, 2005, J CLIMATE, V18, P237, DOI 10.1175/JCLI-3243.1; Suarez M. J., 2008, NASATM2008104606, V27; Trenberth KE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042314; Webb MJ, 2006, CLIM DYNAM, V27, P17, DOI 10.1007/s00382-006-0111-2; Wielicki BA, 1996, B AM METEOROL SOC, V77, P853, DOI 10.1175/1520-0477(1996)077<0853:CATERE>2.0.CO;2; Zelinka MD, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD013817; Zhang MH, 1994, J GEOPHYS RES-ATMOS, V99, P5525, DOI 10.1029/93JD03523	31	152	155	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1523	1527		10.1126/science.1192546	http://dx.doi.org/10.1126/science.1192546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148386				2022-12-28	WOS:000285153500060
J	Hatch, AJ; York, JD				Hatch, Ace J.; York, John D.			SnapShot: Inositol Phosphates	CELL			English	Editorial Material									[Hatch, Ace J.; York, John D.] Duke Univ, HHMI, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute	Hatch, AJ (corresponding author), Duke Univ, HHMI, Durham, NC 27710 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL055672] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alcazar-Roman AR, 2008, CHROMOSOMA, V117, P1, DOI 10.1007/s00412-007-0126-4; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Burton A, 2009, J CELL PHYSIOL, V220, P8, DOI 10.1002/jcp.21763; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; Michell RH, 2009, CELL CALCIUM, V45, P521, DOI 10.1016/j.ceca.2009.03.007; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Monserrate JP, 2010, CURR OPIN CELL BIOL, V22, P365, DOI 10.1016/j.ceb.2010.03.006; Sauer K, 2010, NAT REV IMMUNOL, V10, P257, DOI 10.1038/nri2745; Shears SB, 2009, ADV ENZYME REGUL, V49, P87, DOI 10.1016/j.advenzreg.2008.12.008	10	61	67	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					1030	U183	1030.e1	10.1016/j.cell.2010.11.045	http://dx.doi.org/10.1016/j.cell.2010.11.045			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145466	Bronze, Green Accepted			2022-12-28	WOS:000285182600018
J	Wilusz, CJ; Wilusz, J				Wilusz, Carol J.; Wilusz, Jeffrey			Consequences of mRNA Wardrobe Malfunctions	CELL			English	Editorial Material							COMPLEX; EXPORT; CAP	As mRNAs are generated, they are clothed with proteins to form messenger ribonucleoprotein particles (mRNPs), which are then actively remodeled during various steps of gene expression. Franks et al. (2010) now show that mRNP remodeling is required even for the death of an mRNA.	[Wilusz, Carol J.; Wilusz, Jeffrey] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Wilusz, J (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	jeffrey.wilusz@colostate.edu	Wilusz, Carol/AAC-2901-2021; Wilusz, Carol/F-7241-2017		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059247] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR059247] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Franks TM, 2010, CELL, V143, P938, DOI 10.1016/j.cell.2010.11.043; Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042; Granneman S, 2010, EMBO J, V29, P2026, DOI 10.1038/emboj.2010.86; Hosoda N, 2006, MOL CELL BIOL, V26, P3085, DOI 10.1128/MCB.26.8.3085-3097.2006; Iglesias N, 2010, GENE DEV, V24, P1927, DOI 10.1101/gad.583310; Otsuka Y, 2009, MOL CELL BIOL, V29, P2155, DOI 10.1128/MCB.01325-08; Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019	9	6	6	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 10	2010	143	6					863	865		10.1016/j.cell.2010.11.041	http://dx.doi.org/10.1016/j.cell.2010.11.041			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145451	Bronze			2022-12-28	WOS:000285182600002
J	Hippisley-Cox, J; Coupland, C; Robson, J; Brindle, P				Hippisley-Cox, Julia; Coupland, Carol; Robson, John; Brindle, Peter			Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY PREVENTION; ENGLAND; PREDICTION; WALES; WOMEN; MEN; STATINS; SCORE; AGE	Objective To develop, validate, and evaluate a new QRISK model to estimate lifetime risk of cardiovascular disease. Design Prospective cohort study with routinely collected data from general practice. Cox proportional hazards models in the derivation cohort to derive risk equations accounting for competing risks. Measures of calibration and discrimination in the validation cohort. Setting 563 general practices in England and Wales contributing to the QResearch database. Subjects Patients aged 30-84 years who were free of cardiovascular disease and not taking statins between 1 January 1994 and 30 April 2010: 2 343 759 in the derivation dataset, and 1 267 159 in the validation dataset. Main outcomes measures Individualised estimate of lifetime risk of cardiovascular disease accounting for smoking status, ethnic group, systolic blood pressure, ratio of total cholesterol: high density lipoprotein cholesterol, body mass index, family history of coronary heart disease in first degree relative aged <60 years, Townsend deprivation score, treated hypertension, rheumatoid arthritis, chronic renal disease, type 2 diabetes, and atrial fibrillation. Age-sex centile values for lifetime cardiovascular risk compared with 10 year risk estimated using QRISK2 (2010). Results Across all the 1 267 159 patients in the validation dataset, the 50th, 75th, 90th, and 95th centile values for lifetime risk were 31%, 39%, 50%, and 57% respectively. Of the 10% of patients in the validation cohort classified at highest risk with either the lifetime risk model or the 10 year risk model, only 18 385(14.5%) were at high risk on both measures. Patients identified as high risk with the lifetime risk approach were more likely to be younger, male, from ethnic minority groups, and have a positive family history of premature coronary heart disease than those identified with the 10 year QRISK2 score. The lifetime risk calculator is available at www.qrisk.org/lifetime/. Conclusions Compared with using a 10 year QRISK2 score, a lifetime risk score will tend to identify patients for intervention at a younger age. Although lifestyle interventions at an earlier age could be advantageous, there would be small gains under the age of 65, and medical interventions carry risks as soon as they are initiated. Research is needed to examine closely the cost effectiveness and acceptability of such an approach.	[Hippisley-Cox, Julia; Coupland, Carol] Div Primary Care, Univ Pk, Nottingham NG2 7RD, England; [Robson, John] Barts & London Queen Marys Sch Med & Dent, Ctr Hlth Sci, London E1 2AT, England; [Brindle, Peter] NHS Bristol, Res & Evaluat Programme, Bristol BS1 3NX, Avon, England	University of Nottingham; University of London; Queen Mary University London	Hippisley-Cox, J (corresponding author), Div Primary Care, Univ Pk, Nottingham NG2 7RD, England.	juliahippisleycox@gmail.com	Hippisley-Cox, Julia/AAY-2788-2020; Robson, John/H-3904-2014	Hippisley-Cox, Julia/0000-0002-2479-7283; Robson, John/0000-0001-6889-0415; Coupland, Carol/0000-0002-2327-3306				[Anonymous], 2008, NICE CLIN GUID, V64; Berger JS, 2010, J AM COLL CARDIOL, V55, P1169, DOI 10.1016/j.jacc.2009.09.066; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; *BRIT HEART FDN, 2007, COR HEART DIS STAT; Collins GS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2442; Collins GS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2584; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; Daviglus ML, 2003, ARCH INTERN MED, V163, P2460, DOI 10.1001/archinte.163.20.2460; DENT THS, ATHEROSCLER IN PRESS; *DEP HLTH, 2008, PUTT PREV 1 VASC CHE, P15; Ebrahim S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001561.pub3; Elward KS, 2010, POSTGRAD MED, V122, P192, DOI 10.3810/pgm.2010.07.2186; GOTTO AM, 1997, TRIAL, V277, P595; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Gray A, 2002, BRIT MED J, V325, P860, DOI 10.1136/bmj.325.7369.860; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, pb880, DOI DOI 10.1136/bmj.b880; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hippisley-Cox J, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-49; Hippisley-Cox J, 2010, HEART, V96, P939, DOI 10.1136/hrt.2010.199034; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; HIPPISLEYCOX J, 2010, QRISK2 2010 ANN UPDA, P4; HIPPISLEYCOX J, 2010, QRISK SEARCH DEFINIT; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Lloyd-Jones DM, 2004, AM J CARDIOL, V94, P20, DOI 10.1016/j.amjcard.2004.03.023; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; NAVEED S, 2010, LANCET, V375, P735; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Royston P, 1998, J R STAT SOC A STAT, V161, P79, DOI 10.1111/1467-985X.00091; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Wells S, 2010, HEART, V96, P708, DOI 10.1136/hrt.2009.191320; Wolbers M, 2009, EPIDEMIOLOGY, V20, P555, DOI 10.1097/EDE.0b013e3181a39056	39	190	199	1	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2010	341								c6624	10.1136/bmj.c6624	http://dx.doi.org/10.1136/bmj.c6624			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZU	21148212	Green Published, hybrid			2022-12-28	WOS:000285341200002
J	Ibrahimi, OA; Anderson, RR				Ibrahimi, Omar A.; Anderson, R. Rox			Bleomycin-Induced Flagellate Hyperpigmentation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ibrahimi, Omar A.; Anderson, R. Rox] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Ibrahimi, OA (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	omar.ibrahimi@gmail.com							0	11	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2010	363	24					E36	E36		10.1056/NEJMicm1002334	http://dx.doi.org/10.1056/NEJMicm1002334			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691PA	21142531				2022-12-28	WOS:000285092100011
J	Gogotsi, Y				Gogotsi, Yury			High-Temperature Rubber Made from Carbon Nanotubes	SCIENCE			English	Editorial Material							VISCOELASTICITY		Drexel Univ, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA	Drexel University	Gogotsi, Y (corresponding author), Drexel Univ, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.	gogotsi@drexel.edu	Gogotsi, Yury/B-2167-2008	Gogotsi, Yury/0000-0001-9423-4032				Asaka K, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/38/385705; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Cao AY, 2005, SCIENCE, V310, P1307, DOI 10.1126/science.1118957; Gogotsi Y., 2006, CARBON NANOMATERIALS; Hutchens SB, 2010, ADV FUNCT MATER, V20, P2338, DOI 10.1002/adfm.201000305; Lakes R, 2009, VISCOELASTIC MATERIALS, P1, DOI 10.1017/CBO9780511626722; Pathak S, 2009, CARBON, V47, P1969, DOI 10.1016/j.carbon.2009.03.042; Rotkin SV, 2002, MATER RES INNOV, V5, P191, DOI 10.1007/s10019-001-0152-4; Xu M, 2010, SCIENCE, V330, P1364, DOI 10.1126/science.1194865; Zhang Q, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/31/315401	10	53	56	1	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1332	1333		10.1126/science.1198982	http://dx.doi.org/10.1126/science.1198982			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127239				2022-12-28	WOS:000284902100029
J	Wise, J; Coombes, R				Wise, Jacqui; Coombes, Rebecca			Professional Values Responsibilities beyond the patient	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Coombes, Rebecca] BMJ, London WC1H 9JR, England										0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 30	2010	341								c6832	10.1136/bmj.c6832	http://dx.doi.org/10.1136/bmj.c6832			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	691OG	21118879				2022-12-28	WOS:000285090100019
J	Miyake, A; Kost-Smith, LE; Finkelstein, ND; Pollock, SJ; Cohen, GL; Ito, TA				Miyake, Akira; Kost-Smith, Lauren E.; Finkelstein, Noah D.; Pollock, Steven J.; Cohen, Geoffrey L.; Ito, Tiffany A.			Reducing the Gender Achievement Gap in College Science: A Classroom Study of Values Affirmation	SCIENCE			English	Article							STEREOTYPE THREAT; SELF-AFFIRMATION; PERFORMANCE; INTERVENTION; RESPONSES; MODEL	In many science, technology, engineering, and mathematics disciplines, women are outperformed by men in test scores, jeopardizing their success in science-oriented courses and careers. The current study tested the effectiveness of a psychological intervention, called values affirmation, in reducing the gender achievement gap in a college-level introductory physics class. In this randomized double-blind study, 399 students either wrote about their most important values or not, twice at the beginning of the 15-week course. Values affirmation reduced the male-female performance and learning difference substantially and elevated women's modal grades from the C to B range. Benefits were strongest for women who tended to endorse the stereotype that men do better than women in physics. A brief psychological intervention may be a promising way to address the gender gap in science performance and learning.	[Miyake, Akira; Ito, Tiffany A.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Kost-Smith, Lauren E.; Finkelstein, Noah D.; Pollock, Steven J.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Cohen, Geoffrey L.] Stanford Univ, Dept Psychol, Sch Educ, Palo Alto, CA 94304 USA; [Cohen, Geoffrey L.] Stanford Univ, Grad Sch Business, Palo Alto, CA 94304 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Stanford University; Stanford University	Miyake, A (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.	akira.miyake@colorado.edu	Miyake, Akira/A-8694-2008	MIYAKE, AKIRA/0000-0003-4671-7843	NSF [DRL0910373]	NSF(National Science Foundation (NSF))	We are grateful to course instructor M. Dubson, the course teaching assistants, and the student participants. We also thank L. Newnes and N. Golaszewski for invaluable assistance with data collection and C. Judd and B. Park for their statistical advice. This research was supported by NSF grant DRL0910373.	Anita Borg Institute for Women and Technology,, STAT WOM TECHN FIELD; [Anonymous], 2008, 08321 NSF DIV SCI RE; Aronson J, 2004, PSYCHOL SCI, V15, P829, DOI 10.1111/j.0956-7976.2004.00763.x; Beilock SL, 2007, J EXP PSYCHOL GEN, V136, P256, DOI 10.1037/0096-3445.136.2.256; Brahmia S., 2001, J COLL SCI TEACH, V31, P183; Brewe E, 2010, PHYS REV SPEC TOP-PH, V6, DOI 10.1103/PhysRevSTPER.6.010106; Cohen GL, 2006, SCIENCE, V313, P1307, DOI 10.1126/science.1128317; Cohen GL, 2008, CURR DIR PSYCHOL SCI, V17, P365, DOI 10.1111/j.1467-8721.2008.00607.x; Cohen GL, 2009, SCIENCE, V324, P400, DOI 10.1126/science.1170769; Creswell JD, 2005, PSYCHOL SCI, V16, P846, DOI 10.1111/j.1467-9280.2005.01624.x; Good C, 2003, J APPL DEV PSYCHOL, V24, P645, DOI 10.1016/j.appdev.2003.09.002; Hazari Z, 2007, SCI EDUC, V91, P847, DOI 10.1002/sce.20223; HELLER P, 1992, AM J PHYS, V60, P627, DOI 10.1119/1.17117; Kost LE, 2009, PHYS REV SPEC TOP-PH, V5, DOI 10.1103/PhysRevSTPER.5.010101; Laws PW, 1999, AM J PHYS, V67, pS32, DOI 10.1119/1.19077; Lorenzo M, 2006, AM J PHYS, V74, P118, DOI 10.1119/1.2162549; Martens A, 2006, J EXP SOC PSYCHOL, V42, P236, DOI 10.1016/j.jesp.2005.04.010; Mazur E., 1997, PEER INSTRUCTION USE; McDermott L., 2002, TUTORIALS INTRO PHYS, V2nd; National Academy of Sciences, 2005, RIS GATH STORM EN EM; National Science Board, 2003, NSF0369; Pollock SJ, 2007, PHYS REV SPEC TOP-PH, V3, DOI 10.1103/PhysRevSTPER.3.010107; Schiebinger L, 2001, HAS FEMINISM CHANGED; Schmader T, 2004, SEX ROLES, V50, P835, DOI 10.1023/B:SERS.0000029101.74557.a0; Schmader T, 2008, PSYCHOL REV, V115, P336, DOI 10.1037/0033-295X.115.2.336; Schneider M. B., 2001, PHYS TEACH, V39, P280, DOI DOI 10.1119/1.1375465; Sherman DK, 2006, ADV EXP SOC PSYCHOL, V38, P183, DOI 10.1016/S0065-2601(06)38004-5; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Steele C.M., 1988, ADV EXP SOC PSYCHOL, P261, DOI DOI 10.1016/S0065-2601(08)60229-4; Steele C. M., 2002, ADV EXPT SOCIAL PSYC, P183; Thornton RK, 1998, AM J PHYS, V66, P338, DOI 10.1119/1.18863	31	391	396	6	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2010	330	6008					1234	1237		10.1126/science.1195996	http://dx.doi.org/10.1126/science.1195996			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	685FE	21109670				2022-12-28	WOS:000284613700039
J	Barrowclough, C; Haddock, G; Wykes, T; Beardmore, R; Conrod, P; Craig, T; Davies, L; Dunn, G; Eisner, E; Lewis, S; Moring, J; Steel, C; Tarrier, N				Barrowclough, Christine; Haddock, Gillian; Wykes, Til; Beardmore, Ruth; Conrod, Patricia; Craig, Tom; Davies, Linda; Dunn, Graham; Eisner, Emily; Lewis, Shon; Moring, Jan; Steel, Craig; Tarrier, Nicholas			Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DRUG-ABUSE; USE DISORDERS; ALCOHOL; SCHIZOPHRENIA; INTERVENTIONS; RELIABILITY; INVENTORY; VALIDITY	Objectives To evaluate the effectiveness of integrated motivational interviewing and cognitive behavioural therapy in addition to standard care for patients with psychosis and a comorbid substance use problem. Design Two centre, open, rater blind randomised controlled trial. Setting Secondary care in the United Kingdom. Participants 327 patients with a clinical diagnosis of schizophrenia, schizophreniform disorder, or schizoaffective disorder and a diagnosis of dependence on or misuse of drugs, alcohol, or both according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition. Intervention The intervention was integrated motivational interviewing and cognitive behavioural therapy plus standard care, which was compared with standard care alone. Phase one of therapy-"motivation building"-concerns engaging the patient, then exploring and resolving ambivalence for change in substance use. Phase two-"action"-supports and facilitates change using cognitive behavioural approaches. Up to 26 therapy sessions were delivered over one year. Main outcome measures The primary outcome was death from any cause or admission to hospital in the 12 months after completion of therapy. Secondary outcomes were frequency and amount of substance use (assessed using the timeline followback method), readiness to change, perceived negative consequences of use, psychotic symptom ratings, number and duration of relapses, and global assessment of functioning and deliberate self harm at 12 and 24 months, with additional timeline followback assessments at 6 and 18 months. Analysis was by intention to treat and robust treatment effect estimates were produced. Results 327 participants were randomly allocated to either the intervention (n=164) or treatment as usual (n=163). At 24 months, 326 (99.7%) were assessed on the primary outcome and 246 (75.2%) on the main secondary outcomes. Treatment had no beneficial effect on hospital admissions or death during follow-up, with 23.3% (38/163) of the therapy group and 20.2% (33/163) of controls deceased or admitted (adjusted odds ratio 1.16, 95% confidence interval 0.68 to 1.99; P=0.579). Therapy had no effect on the frequency of substance use or the perceived negative consequences of misuse, but did have a statistically significant effect on amount used per substance using day (adjusted ORs for main substance 1.50, 95% CI 1.08 to 2.09; P=0.016; and all substances 1.48, 95% CI 1.07 to 2.05; P=0.017). Treatment had a statistically significant effect on readiness to change use at 12 months (adjusted OR 2.05, 95% CI 1.26 to 3.31; P=0.004) that was not maintained at 24 months (0.78, 95% CI 0.48 to 1.28; P=0.320). There were no effects of treatment on clinical outcomes such as relapses, psychotic symptoms, functioning, and self harm. Conclusions Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and substance misuse do not improve outcome in terms of hospitalisation, symptom outcomes, or functioning. This approach does reduce the amount of substance used for at least one year after completion of therapy.	[Barrowclough, Christine; Haddock, Gillian; Beardmore, Ruth; Eisner, Emily; Tarrier, Nicholas] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Wykes, Til; Conrod, Patricia; Craig, Tom] Kings Coll London, London WC2R 2LS, England; [Davies, Linda; Dunn, Graham; Lewis, Shon] Univ Manchester, Sch Community Based Med, Manchester, Lancs, England; [Moring, Jan] Greater Manchester W Mental Hlth NHS Fdn Trust, Substance Misuse Directorate, Prestwich, England; [Steel, Craig] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England	University of Manchester; University of London; King's College London; University of Manchester; University of Reading	Barrowclough, C (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.	christine.barrowclough@manchester.ac.uk	Wykes, Til/AAE-9718-2022; Conrod, Patricia J/P-4187-2018; Craig, Tom K J/A-9083-2011; Steel, Craig/F-1460-2013; Wykes, Til/B-3812-2011; Wykes, Til/AFE-8438-2022	Wykes, Til/0000-0002-5881-8003; Wykes, Til/0000-0002-5881-8003; Wykes, Til/0000-0002-5881-8003; Lewis, Shon/0000-0003-1861-4652; Eisner, Emily/0000-0001-5164-2407; Haddock, Professor Gillian/0000-0001-6234-5774; Davies, Linda/0000-0001-8801-3559	National Institute for Health Research (NIHR); Biomedical Research Centre for Mental Health at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; NIHR Mental Health Research Network; UK Medical Research Council [GO200471]; Department of Health; National Institute for Health Research [NF-SI-0509-10023] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Biomedical Research Centre for Mental Health at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London(General Electric); NIHR Mental Health Research Network; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the patients who participated in the study and all the staff who facilitated recruitment. We are also grateful to all the collaborating NHS trusts and to all the research assistants. TW acknowledges some additional funding provided by National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, Kings College London. All authors acknowledge the support of the NIHR Mental Health Research Network.; The study was sponsored by the University of Manchester and funded by the UK Medical Research Council (grant no: GO200471) and the Department of Health. The sponsor and the funder of the study had no role in the study design, the data collection, analysis, and interpretation, or the reporting of this work, or the decision to submit the work for publication. All authors are independent of the funding source. All authors had full access to all study data.	Alexander D, 2006, AM J DRUG ALCOHOL AB, V32, P351, DOI 10.1080/00952990600753594; Babor T.F., 2001, AUDIT ALCOHOL USE DI, P1; Baker A, 2002, ADDICTION, V97, P1329, DOI 10.1046/j.1360-0443.2002.00178.x; Baker A, 2006, BRIT J PSYCHIAT, V188, P439, DOI 10.1192/bjp.188.5.439; Barrowclough C, 2001, AM J PSYCHIAT, V158, P1706, DOI 10.1176/appi.ajp.158.10.1706; Barrowclough C, 2009, ADDICT BEHAV, V34, P859, DOI 10.1016/j.addbeh.2009.03.007; Bellack AS, 2006, ARCH GEN PSYCHIAT, V63, P426, DOI 10.1001/archpsyc.63.4.426; Blanchard KA, 2003, PSYCHOL ADDICT BEHAV, V17, P328, DOI 10.1037/0893-164X.17.4.328; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Carey KB, 2004, J STUD ALCOHOL, V65, P774, DOI 10.15288/jsa.2004.65.774; Carey KB, 1997, PSYCHOL ADDICT BEHAV, V11, P26, DOI 10.1037/0893-164X.11.1.26; Cicchetti D.V., 1994, PSYCHOL ASSESSMENT, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cleary M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001088.pub2; Denis C., 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD005336.PUB2; DIXON L, 1991, AM J PSYCHIAT, V148, P224; Drake R., 1996, OUTCOMES ASSESSMENT, P113; Dutra L, 2008, AM J PSYCHIAT, V165, P179, DOI 10.1176/appi.ajp.2007.06111851; Edwards J, 2006, ACTA PSYCHIAT SCAND, V114, P109, DOI 10.1111/j.1600-0447.2006.00783.x; First M. B., 1997, STRUCTURED CLIN INTE; Graham H., 2003, SUBSTANCE MISUSE PSY, P106; Haddock G, 2003, BRIT J PSYCHIAT, V183, P418, DOI 10.1192/bjp.183.5.418; HADDOCK G, 2010, J MENT HLTH UNPUB; Hettema J, 2005, ANNU REV CLIN PSYCHO, V1, P91, DOI 10.1146/annurev.clinpsy.1.102803.143833; HOGAN TP, 1983, PSYCHOL MED, V13, P177, DOI 10.1017/S0033291700050182; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Martins RK, 2009, CLIN PSYCHOL REV, V29, P283, DOI 10.1016/j.cpr.2009.02.001; MASLIN J, 2003, SUBSTANCE MISUSE PSY, P3; Miller W, 2002, MOTIVATIONAL INTERVI, V2<feminine; Miller WR, 2002, ADDICTION, V97, P265, DOI 10.1046/j.1360-0443.2002.00019.x; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; National Association of Psychiatric Intensive Care & Low Secure Units, 2018, CAPACITY DEV RESOURC; National Institute for Health and Clinical Excellence, 2009, SCH COR INT TREATM M; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; ROLLNICK S, 1992, BRIT J ADDICT, V87, P743; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Stasiewicz PR, 2008, PSYCHOL ADDICT BEHAV, V22, P78, DOI 10.1037/0893-164X.22.1.78; Stewart SH, 2005, J COGN PSYCHOTHER, V19, P195, DOI 10.1891/jcop.2005.19.3.195; Weaver T, 2001, SOC PSYCH PSYCH EPID, V36, P399, DOI 10.1007/s001270170030; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; Wykes T, 2008, SCHIZOPHRENIA BULL, V34, P523, DOI 10.1093/schbul/sbm114; Ziedonis Douglas M, 2005, J Psychiatr Pract, V11, P315, DOI 10.1097/00131746-200509000-00005	46	131	132	0	43	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2010	341								c6325	10.1136/bmj.c6325	http://dx.doi.org/10.1136/bmj.c6325			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	688EA	21106618	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000284831400006
J	Nishiyama, T; Ladurner, R; Schmitz, J; Kreidl, E; Schleiffer, A; Bhaskara, V; Bando, M; Shirahige, K; Hyman, AA; Mechtler, K; Peters, JM				Nishiyama, Tomoko; Ladurner, Rene; Schmitz, Julia; Kreidl, Emanuel; Schleiffer, Alexander; Bhaskara, Venugopal; Bando, Masashige; Shirahige, Katsuhiko; Hyman, Anthony A.; Mechtler, Karl; Peters, Jan-Michael			Sororin Mediates Sister Chromatid Cohesion by Antagonizing Wapl	CELL			English	Article							DNA-REPLICATION; COMPLEX; ESTABLISHMENT; ACETYLATION; DROSOPHILA; ANAPHASE; PROTEIN; ROLES; PROPHASE; BINDING	Sister chromatid cohesion is essential for chromosome segregation and is mediated by cohesin bound to DNA. Cohesin-DNA interactions can be reversed by the cohesion-associated protein Wapl, whereas a stably DNA-bound form of cohesin is thought to mediate cohesion. In vertebrates, Sororin is essential for cohesion and stable cohesin-DNA interactions, but how Sororin performs these functions is unknown. We show that DNA replication and cohesin acetylation promote binding of Sororin to cohesin, and that Sororin displaces Wapl from its binding partner Pds5. In the absence of Wapl, Sororin becomes dispensable for cohesion. We propose that Sororin maintains cohesion by inhibiting Wapl's ability to dissociate cohesin from DNA. Sororin has only been identified in vertebrates, but we show that many invertebrate species contain Sororin-related proteins, and that one of these, Dalmatian, is essential for cohesion in Drosophila. The mechanism we describe here may therefore be widely conserved among different species.	[Nishiyama, Tomoko; Ladurner, Rene; Schmitz, Julia; Kreidl, Emanuel; Schleiffer, Alexander; Bhaskara, Venugopal; Mechtler, Karl; Peters, Jan-Michael] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Bando, Masashige; Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Tokyo; Max Planck Society	Peters, JM (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	peters@imp.univie.ac.at	Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017; Mechtler, Karl/AAF-2717-2019	Hyman, Anthony A/0000-0003-3664-154X; Mechtler, Karl/0000-0002-3392-9946; Kreidl, Emanuel/0000-0002-4037-5881; Ladurner, Rene/0000-0001-9261-7304; Schleiffer, Alexander/0000-0001-6251-2747; Shirahige, Katsuhiko/0000-0002-7862-1144; Bhaskara, Venugopal/0000-0002-8807-3292; /0000-0002-8002-9967	European Molecular Biology Organization (EMBO); Japanese Society for the Promotion of Science (JSPS); Boehringer Ingelheim; Austrian Science Fund [F34-B03]; EC	European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Boehringer Ingelheim(Boehringer Ingelheim); Austrian Science Fund(Austrian Science Fund (FWF)); EC(European CommissionEuropean Commission Joint Research Centre)	We are grateful to O. Hudecz, P. Huis in't Veld, I. Poser, and M. Sykora for assistance and reagents; to G. Karpen, J. Knoblich, C. Lehner, and C. Sunkel for reagents and advice on Drosophila experiments; and to N. Kraut for BI 2536. T.N. is supported by the European Molecular Biology Organization (EMBO) and the Japanese Society for the Promotion of Science (JSPS). K.S. is supported by Grant-in-Aid for Scientific Research (S). Research in the groups of J.-M.P. and K.M. is supported by Boehringer Ingelheim and the Austrian Science Fund via the special research program "Chromosome Dynamics'' (F34-B03). Work in the groups of J.-M.P., K.M., and A.A.H. was also supported by the EC via the Integrated Project "MitoCheck.''	Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Diaz-Martinez LA, 2007, CELL CYCLE, V6, P714, DOI 10.4161/cc.6.6.3935; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Perez-Mongiovi D, 2005, DEVELOPMENT, V132, P4509, DOI 10.1242/dev.02028; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Prokopenko SN, 2000, GENETICS, V156, P1691; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Sakuno T, 2009, CHROMOSOME RES, V17, P239, DOI 10.1007/s10577-008-9013-y; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Somma MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000126; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	29	246	259	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					737	749		10.1016/j.cell.2010.10.031	http://dx.doi.org/10.1016/j.cell.2010.10.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111234	Bronze			2022-12-28	WOS:000284583500016
J	Betz, AG				Betz, Alexander G.			Have You Seen Your Mother, Baby ...	SCIENCE			English	Editorial Material							REGULATORY T-CELLS; TOLERANCE; BLOOD		Univ Cambridge, MRC, Mol Biol Lab, Prot & Nucle Acid Chem Facil, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology; University of Cambridge	Betz, AG (corresponding author), Univ Cambridge, MRC, Mol Biol Lab, Prot & Nucle Acid Chem Facil, Cambridge CB2 0QH, England.	betz@mrc-lmb.cam.ac.uk	Betz, Alexander/GQQ-2221-2022		Medical Research Council [MC_U105184296] Funding Source: Medline; MRC [MC_U105184296] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; CHAOUAT G, 1979, J IMMUNOL, V122, P1383; Flanagan KL, 2010, EUR J IMMUNOL, V40, P1062, DOI 10.1002/eji.200939638; HAYNES BF, 1988, J EXP MED, V168, P1061, DOI 10.1084/jem.168.3.1061; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Ochs HD, 2005, IMMUNOL REV, V203, P156, DOI 10.1111/j.0105-2896.2005.00231.x; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Wegienka G, 2009, J REPROD IMMUNOL, V81, P74, DOI 10.1016/j.jri.2009.03.001; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537	14	13	13	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2010	330	6011					1635	1636		10.1126/science.1200406	http://dx.doi.org/10.1126/science.1200406			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164004				2022-12-28	WOS:000285390500052
J	Stepney, R				Stepney, Rob			Christmas 2010: Reading Between the Lines A dose by any other name would not sell as sweet	BRITISH MEDICAL JOURNAL			English	Editorial Material												walcot2@freenetname.co.uk						*GLAXOSMITHKLINE, 2010, OUR HIST; HERPER M, 2004, FORBES          0316; Mills JG, 1997, ALIMENT PHARM THER, V11, P129, DOI 10.1046/j.1365-2036.1997.136312000.x; *WELLC TRUST, INV HIST; 2010, FASTEST CARS WORLD T	5	6	6	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2010	341								c6895	10.1136/bmj.c6895	http://dx.doi.org/10.1136/bmj.c6895			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XJ	21159760				2022-12-28	WOS:000285552800001
J	Franks, TM; Singh, G; Lykke-Andersen, J				Franks, Tobias M.; Singh, Guramrit; Lykke-Andersen, Jens			Upf1 ATPase-Dependent mRNP Disassembly Is Required for Completion of Nonsense-Mediated mRNA Decay	CELL			English	Article							EXON-JUNCTION COMPLEX; ENDONUCLEOLYTIC CLEAVAGE; SACCHAROMYCES-CEREVISIAE; SURVEILLANCE COMPLEX; BINDING-PROTEIN; QUALITY-CONTROL; CAENORHABDITIS-ELEGANS; PROCESSING BODIES; BOX PROTEIN; P-BODIES	Cellular mRNAs exist in messenger ribonucleoprotein (mRNP) complexes, which undergo transitions during the lifetime of the mRNAs and direct posttranscriptional gene regulation. A final posttranscriptional step in gene expression is the turnover of the mRNP, which involves degradation of the mRNA and recycling of associated proteins. How tightly associated protein components are released from degrading mRNPs is unknown. Here, we demonstrate that the ATPase activity of the RNA helicase Upf1 allows disassembly of mRNPs undergoing nonsense-mediated mRNA decay (NMD). In the absence of Upf1 ATPase activity, partially degraded NMD mRNA intermediates accumulate in complex with NMD factors and concentrate in processing bodies. Thus, disassembly and completion of turnover of mRNPs undergoing NMD requires ATP hydrolysis by Upf1. This uncovers a previously unappreciated and potentially regulated step in mRNA decay and raises the question of how other mRNA decay pathways release protein components of substrate mRNPs.	[Franks, Tobias M.; Singh, Guramrit; Lykke-Andersen, Jens] Univ Colorado, Boulder, CO 80309 USA; [Franks, Tobias M.; Lykke-Andersen, Jens] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California San Diego	Lykke-Andersen, J (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	jlykkeandersen@ucsd.edu		Lykke-Andersen, Jens/0000-0003-1821-0754	National Institutes of Health [R01 GM077243]; National Institute of General Medical Sciences [GM-07135]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007135, R01GM077243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Tom Blumenthal (University of Colorado), Melissa Moore (University of Massachusetts Medical Center), and Sebastien Durand (UCSD) for comments on the manuscript. Alex Choe and Claire Egan are thanked for technical support and Joachim Weischenfeldt for production of the antigen for anti-Smg1 antibodies. Drs. Marv Fritzler, Ed Chan, and Donald Bloch are thanked for human IC-6 serum. Dr. Oliver Muhlemann is thanked for the HA-Smg6 construct. Work on P bodies in our laboratory is supported by funding from grant R01 GM077243 from the National Institutes of Health to J.L.-A. T.M.F. has been supported by National Institutes of Health NRSA Institutional Training grant number GM-07135 from the National Institute of General Medical Sciences.	Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; BEELMAN CA, 1994, J BIOL CHEM, V269, P9687; Behm-Ansmant I, 2007, FEBS LETT, V581, P2845, DOI 10.1016/j.febslet.2007.05.027; Bhattacharya A, 2000, RNA, V6, P1226, DOI 10.1017/S1355838200000546; Buhler M, 2006, NAT STRUCT MOL BIOL, V13, P462, DOI 10.1038/nsmb1081; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; CEREGHINO GP, 1995, MOL BIOL CELL, V6, P1125, DOI 10.1091/mbc.6.9.1125; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cheng ZH, 2007, EMBO J, V26, P253, DOI 10.1038/sj.emboj.7601464; Cho H, 2009, MOL CELL, V33, P75, DOI 10.1016/j.molcel.2008.11.022; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; CZAPLINSKI K, 1995, RNA, V1, P610; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Fischer N, 2002, EMBO J, V21, P2788, DOI 10.1093/emboj/21.11.2788; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Fukuhara N, 2005, MOL CELL, V17, P537, DOI 10.1016/j.molcel.2005.01.010; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gatfield D, 2004, NATURE, V429, P575, DOI 10.1038/nature02559; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Huntzinger E, 2008, RNA, V14, P2609, DOI 10.1261/rna.1386208; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Jankowsky E, 2006, NUCLEIC ACIDS RES, V34, P4181, DOI 10.1093/nar/gkl410; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Liu YM, 2003, RNA, V9, P677, DOI 10.1261/rna.2128903; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Muhlemann O, 2010, RNA BIOL, V7, P28; Muhlemann O, 2008, BIOCHEM SOC T, V36, P497, DOI 10.1042/BST0360497; Muhlemann O, 2008, BBA-GENE REGUL MECH, V1779, P538, DOI 10.1016/j.bbagrm.2008.06.012; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Page MF, 1999, MOL CELL BIOL, V19, P5943; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schwartz DC, 2000, MOL CELL BIOL, V20, P7933, DOI 10.1128/MCB.20.21.7933-7942.2000; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Singh G, 2007, MOL CELL, V27, P780, DOI 10.1016/j.molcel.2007.06.030; Stalder L, 2009, RNA, V15, P1265, DOI 10.1261/rna.1672509; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; VREKEN P, 1992, MOL CELL BIOL, V12, P2986, DOI 10.1128/MCB.12.7.2986; Weng YM, 1998, RNA, V4, P205; Weng YM, 1996, MOL CELL BIOL, V16, P5491, DOI 10.1128/mcb.16.10.5491; Weng YM, 1996, MOL CELL BIOL, V16, P5477; Wilusz J, 2009, NAT STRUCT MOL BIOL, V16, P9, DOI 10.1038/nsmb0109-9; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001	71	165	168	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					938	950		10.1016/j.cell.2010.11.043	http://dx.doi.org/10.1016/j.cell.2010.11.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145460	Green Accepted, Bronze			2022-12-28	WOS:000285182600011
J	Jones, HE; Kaltenbach, K; Heil, SH; Stine, SM; Coyle, MG; Arria, AM; O'Grady, KE; Selby, P; Martin, PR; Fischer, G				Jones, Hendree E.; Kaltenbach, Karol; Heil, Sarah H.; Stine, Susan M.; Coyle, Mara G.; Arria, Amelia M.; O'Grady, Kevin E.; Selby, Peter; Martin, Peter R.; Fischer, Gabriele			Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEPENDENT PREGNANT-WOMEN; OPIOID DEPENDENCE; DOUBLE-BLIND; MAINTENANCE; OPIATE; INFANTS; HEROIN; TRIAL; MANAGEMENT; VARIANTS	BACKGROUND Methadone, a full mu-opioid agonist, is the recommended treatment for opioid dependence during pregnancy. However, prenatal exposure to methadone is associated with a neonatal abstinence syndrome (NAS) characterized by central nervous system hyperirritability and autonomic nervous system dysfunction, which often requires medication and extended hospitalization. Buprenorphine, a partial mu-opioid agonist, is an alternative treatment for opioid dependence but has not been extensively studied in pregnancy. METHODS We conducted a double-blind, double-dummy, flexible-dosing, randomized, controlled study in which buprenorphine and methadone were compared for use in the comprehensive care of 175 pregnant women with opioid dependency at eight international sites. Primary outcomes were the number of neonates requiring treatment for NAS, the peak NAS score, the total amount of morphine needed to treat NAS, the length of the hospital stay for neonates, and neonatal head circumference. RESULTS Treatment was discontinued by 16 of the 89 women in the methadone group (18%) and 28 of the 86 women in the buprenorphine group (33%). A comparison of the 131 neonates whose mothers were followed to the end of pregnancy according to treatment group (with 58 exposed to buprenorphine and 73 exposed to methadone) showed that the former group required significantly less morphine (mean dose, 1.1 mg vs. 10.4 mg; P<0.0091), had a significantly shorter hospital stay (10.0 days vs. 17.5 days, P<0.0091), and had a significantly shorter duration of treatment for the neonatal abstinence syndrome (4.1 days vs. 9.9 days, P<0.003125) (P values calculated in accordance with prespecified thresholds for significance). There were no significant differences between groups in other primary or secondary outcomes or in the rates of maternal or neonatal adverse events. CONCLUSIONS These results are consistent with the use of buprenorphine as an acceptable treatment for opioid dependence in pregnant women.	[Jones, Hendree E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Jones, Hendree E.] Johns Hopkins Univ, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21205 USA; [Kaltenbach, Karol] Thomas Jefferson Univ, Jefferson Med Coll, Dept Pediat, Philadelphia, PA 19107 USA; [Kaltenbach, Karol] Thomas Jefferson Univ, Jefferson Med Coll, Dept Psychiat, Philadelphia, PA 19107 USA; [Kaltenbach, Karol] Thomas Jefferson Univ, Jefferson Med Coll, Dept Human Behav, Philadelphia, PA 19107 USA; [Heil, Sarah H.] Univ Vermont, Dept Psychiat, Burlington, VT USA; [Heil, Sarah H.] Univ Vermont, Dept Psychol, Burlington, VT 05405 USA; [Stine, Susan M.] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI USA; [Coyle, Mara G.] Brown Univ, Warren Alpert Med Sch, Dept Pediat, Providence, RI 02912 USA; [Arria, Amelia M.] Univ Maryland, Ctr Young Adult Hlth & Dev, College Pk, MD 20742 USA; [O'Grady, Kevin E.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Selby, Peter] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Selby, Peter] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Martin, Peter R.] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Martin, Peter R.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Martin, Peter R.] Vanderbilt Univ, Sch Med, Addict Ctr, Nashville, TN 37212 USA; [Fischer, Gabriele] Med Univ Vienna, Addict Clin, Dept Psychiat & Psychotherapy, Vienna, Austria	Johns Hopkins University; Johns Hopkins University; Jefferson University; Jefferson University; Jefferson University; University of Vermont; University of Vermont; Wayne State University; Brown University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Toronto; University of Toronto; Vanderbilt University; Vanderbilt University; Vanderbilt University; Medical University of Vienna	Jones, HE (corresponding author), Johns Hopkins Bayview Med Ctr, Ctr Addict & Pregnancy, D-3 E,4940 Eastern Ave, Baltimore, MD 21224 USA.	hjones18@jhmi.edu	Fischer, Gabriele/B-3048-2013; Martin, Peter R/A-7738-2008	Arria, Amelia/0000-0002-6360-9265; Stine, Susan/0000-0001-5426-4448	National Institute on Drug Abuse [R01 DA015778, R01 DA015764, R01 DA018417, R01DA015738, R01 DA015741, R01 DA 018410, M01 RR109, R01 DA 017513, M01 RR00095, R01DA15832]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015741, R01DA018410, R01DA018417, R01DA015738, R01DA015832, R01DA015778, R01DA015764] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by grants from the National Institute on Drug Abuse (R01 DA015778, to Brown University; R01 DA015764, to Johns Hopkins University; R01 DA018417, to the Medical University of Vienna; R01DA015738, to Thomas Jefferson University; R01 DA015741, to the University of Toronto; R01 DA 018410 and M01 RR109, to the University of Vermont; R01 DA 017513 and M01 RR00095, to Vanderbilt University; and R01DA15832, to Wayne State University).	Bakstad B, 2009, EUR ADDICT RES, V15, P128, DOI 10.1159/000210042; Bell J, 2009, ADDICTION, V104, P1193, DOI 10.1111/j.1360-0443.2009.02627.x; D'Apolito K., 1994, SCORING SYSTEM ASSES; Ebner N, 2007, DRUG ALCOHOL DEPEN, V87, P131, DOI 10.1016/j.drugalcdep.2006.08.024; Finnegan LP., 1992, PRIMARY PEDIAT CARE, P1367; Fischer G, 2006, ADDICTION, V101, P275, DOI 10.1111/j.1360-0443.2006.01321.x; Fischer G, 2000, ADDICTION, V95, P239, DOI 10.1046/j.1360-0443.2000.95223910.x; Fischer G, 1999, ADDICTION, V94, P1337, DOI 10.1046/j.1360-0443.1999.94913376.x; Goldkind SF, 2010, NEW ENGL J MED, V362, P2241, DOI 10.1056/NEJMp1003462; Hemauer SJ, 2009, BIOCHEM PHARMACOL, V78, P1272, DOI 10.1016/j.bcp.2009.07.002; Hulse GK, 1997, ADDICTION, V92, P1571; Hytinantti T, 2008, ACTA PAEDIATR, V97, P1040, DOI 10.1111/j.1651-2227.2008.00838.x; Jansson Lauren M, 2009, J Opioid Manag, V5, P47; JASINSKI DR, 1978, ARCH GEN PSYCHIAT, V35, P501; Johnson RE, 2003, DRUG ALCOHOL DEPEN, V70, pS87, DOI 10.1016/S0376-8716(03)00062-0; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; Johnson RE, 2001, DRUG ALCOHOL DEPEN, V63, P97, DOI 10.1016/S0376-8716(00)00194-0; Jones HE, 2005, DRUG ALCOHOL DEPEN, V79, P1, DOI 10.1016/j.drugalcdep.2004.11.013; Jones HE, 2005, DRUG ALCOHOL DEPEN, V78, P33, DOI 10.1016/j.drugalcdep.2004.08.027; Jones HE, 2008, J SUBST ABUSE TREAT, V35, P245, DOI 10.1016/j.jsat.2007.10.007; Jones HE, 2008, AM J ADDICTION, V17, P372, DOI 10.1080/10550490802266276; Kakko J, 2008, DRUG ALCOHOL DEPEN, V96, P69, DOI 10.1016/j.drugalcdep.2008.01.025; Kaltenbach K, 1998, OBSTET GYN CLIN N AM, V25, P139, DOI 10.1016/S0889-8545(05)70362-4; KANDALL S, 1993, IMPROVING TREATMENT; KANDALL SR, 1977, EARLY HUM DEV, V1, P159, DOI 10.1016/0378-3782(77)90017-2; Lejeune C, 2006, DRUG ALCOHOL DEPEN, V82, P250, DOI 10.1016/j.drugalcdep.2005.10.001; Lester Barry M, 2004, Harm Reduct J, V1, P5, DOI 10.1186/1477-7517-1-5; Levran O, 2008, HUM MOL GENET, V17, P2219, DOI 10.1093/hmg/ddn122; LIFSCHITZ MH, 1985, PEDIATRICS, V75, P269; Ling W, 1996, ARCH GEN PSYCHIAT, V53, P401; Ling W, 2003, DRUG ALCOHOL DEPEN, V70, pS49, DOI 10.1016/S0376-8716(03)00059-0; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Mattick RP, 2003, ADDICTION, V98, P441, DOI 10.1046/j.1360-0443.2003.00335.x; Mattick RP, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002209; MELLO NK, 1980, SCIENCE, V207, P657, DOI 10.1126/science.7352279; Messinger DS, 2004, PEDIATRICS, V113, P1677, DOI 10.1542/peds.113.6.1677; Rosado J, 2007, DRUG ALCOHOL DEPEN, V90, P261, DOI 10.1016/j.drugalcdep.2007.04.006; Schindler SD, 2003, ADDICTION, V98, P103, DOI 10.1046/j.1360-0443.2003.00245.x; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Stine SM, 2009, AM J DRUG ALCOHOL AB, V35, P429, DOI 10.3109/00952990903374080; Unger AS, 2010, EUR ADDICT RES, V16, P99, DOI 10.1159/000284683; WALSH SL, 1995, J PHARMACOL EXP THER, V274, P361; Winklbaur B, 2008, ADDICTION, V103, P1429, DOI 10.1111/j.1360-0443.2008.02283.x; Yuferov V, 2010, ANN NY ACAD SCI, V1187, P184, DOI 10.1111/j.1749-6632.2009.05275.x	44	607	609	0	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2010	363	24					2320	2331		10.1056/NEJMoa1005359	http://dx.doi.org/10.1056/NEJMoa1005359			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691PA	21142534	Bronze, Green Accepted			2022-12-28	WOS:000285092100007
J	McLachlan, JC				McLachlan, John C.			Christmas 2010: Reading between the Lines Integrative medicine and the point of credulity	BRITISH MEDICAL JOURNAL			English	Editorial Material									[McLachlan, John C.] Univ Durham, Sch Med & Hlth, Stockton On Tees TS17 6BH, England	Durham University	McLachlan, JC (corresponding author), Univ Durham, Sch Med & Hlth, Stockton On Tees TS17 6BH, England.	j.c.mclachlan@durham.ac.uk	McLachlan, John/AAF-4203-2021	McLachlan, John/0000-0001-5493-2645				DIXON M, 2009, SCI BASED MED; *HOUS COMM SCI TEC, 4 HOUS COMM SCI TECH; Sokal A., 1998, INTELLECTUAL IMPOSTU; Sokal A., 1996, SOCIAL TEXT, V46/47, P217, DOI [10.2307/466856, DOI 10.2307/466856]; Strauss S, 2005, EVIDENCE BASED MED P, V3rd; 2009, DCS IMPROBABLE SCI	6	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 8	2010	341								c6979	10.1136/bmj.c6979	http://dx.doi.org/10.1136/bmj.c6979			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	694ZL	21147748				2022-12-28	WOS:000285340300006
J	Stigler, FL; Duvivier, RJ; Weggemans, M; Salzer, HJF				Stigler, Florian L.; Duvivier, Robbert J.; Weggemans, Margot; Salzer, Helmut J. F.			Health professionals for the 21st century: a students' view	LANCET			English	Editorial Material									[Duvivier, Robbert J.] Maastricht Univ, NL-6200 MD Maastricht, Netherlands; [Stigler, Florian L.; Salzer, Helmut J. F.] Med Univ Graz, Graz, Austria; [Weggemans, Margot] Univ Utrecht, Utrecht, Netherlands	Maastricht University; Medical University of Graz; Utrecht University	Duvivier, RJ (corresponding author), Maastricht Univ, NL-6200 MD Maastricht, Netherlands.	dobbertduvivier@gmail.com	Salzer, Helmut J.F./E-8808-2010; Duvivier, Robbert J/G-7479-2011	Duvivier, Robbert J/0000-0001-8282-1715; Salzer, Helmut J.F./0000-0003-0146-8310; Weggemans, Margot/0000-0001-9475-0731				[Anonymous], 2007, WORLD HEALTHC STUD S; Duvivier R, 2010, MED EDUC, V44, P528, DOI 10.1111/j.1365-2923.2009.03583.x; Duvivier R, 2010, LANCET, V375, P376, DOI 10.1016/S0140-6736(10)60164-X; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Hilgers J, 2007, MED TEACH, V29, P270, DOI 10.1080/01421590701268731	5	17	18	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2010	376	9756					1877	1878		10.1016/S0140-6736(10)61968-X	http://dx.doi.org/10.1016/S0140-6736(10)61968-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	696KH	21112622				2022-12-28	WOS:000285439800005
J	Friedman, N; Schuldiner, M				Friedman, Nir; Schuldiner, Maya			The DNA Damage Road Map	SCIENCE			English	Editorial Material							INTERACTION NETWORKS; MODULARITY		[Friedman, Nir] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, Jerusalem, Israel; [Friedman, Nir] Hebrew Univ Jerusalem, Inst Life Sci, Jerusalem, Israel; [Schuldiner, Maya] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Weizmann Institute of Science	Friedman, N (corresponding author), Hebrew Univ Jerusalem, Sch Comp Sci & Engn, Jerusalem, Israel.	nir@cs.huji.ac.il; maya.schuldiner@weizmann.ac.il	Friedman, Nir/H-9692-2012; Schuldiner, Maya/C-9488-2009	Friedman, Nir/0000-0002-9678-3550; Schuldiner, Maya/0000-0001-9947-115X				Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Battle A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.27; Beltrao P, 2010, CELL, V141, P739, DOI 10.1016/j.cell.2010.05.019; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Breker M, 2009, MOL BIOSYST, V5, P1473, DOI 10.1039/b907076c; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Jaimovich A, 2010, BIOINFORMATICS, V26, pi228, DOI 10.1093/bioinformatics/btq197; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Ulitsky I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.42	11	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1327	1328		10.1126/science.1199862	http://dx.doi.org/10.1126/science.1199862			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127235				2022-12-28	WOS:000284902100025
J	Pin, PA; Benlloch, R; Bonnet, D; Wremerth-Weich, E; Kraft, T; Gielen, JJL; Nilsson, O				Pin, Pierre A.; Benlloch, Reyes; Bonnet, Dominique; Wremerth-Weich, Elisabeth; Kraft, Thomas; Gielen, Jan J. L.; Nilsson, Ove			An Antagonistic Pair of FT Homologs Mediates the Control of Flowering Time in Sugar Beet	SCIENCE			English	Article							ANNUAL HABIT; LOCUS-T; VERNALIZATION; REPRESSOR; GENE; ARABIDOPSIS	Cultivated beets (Beta vulgaris ssp. vulgaris) are unable to form reproductive shoots during the first year of their life cycle. Flowering only occurs if plants get vernalized, that is, pass through the winter, and are subsequently exposed to an increasing day length (photoperiod) in spring. Here, we show that the regulation of flowering time in beets is controlled by the interplay of two paralogs of the FLOWERING LOCUS T (FT) gene in Arabidopsis that have evolved antagonistic functions. BvFT2 is functionally conserved with FT and essential for flowering. In contrast, BvFT1 represses flowering and its down-regulation is crucial for the vernalization response in beets. These data suggest that the beet has evolved a different strategy relative to Arabidopsis and cereals to regulate vernalization.	[Pin, Pierre A.; Benlloch, Reyes; Nilsson, Ove] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Pin, Pierre A.; Wremerth-Weich, Elisabeth; Kraft, Thomas] Syngenta Seeds AB, S-26123 Landskrona, Sweden; [Bonnet, Dominique; Gielen, Jan J. L.] Syngenta Seeds SAS, F-31790 St Sauveur, France	Swedish University of Agricultural Sciences; Umea University; Syngenta; Syngenta	Nilsson, O (corresponding author), Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden.	Ove.Nilsson@genfys.slu.se	Benlloch, Reyes/K-1110-2019; Benlloch, Reyes/L-7526-2014	Benlloch, Reyes/0000-0002-0364-1589; PIN, Pierre A./0000-0001-8933-1452; Nilsson, Ove/0000-0002-1033-1909	Swedish Research Council; Swedish Governmental Agency for Innovation Systems; Sudzucker	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Governmental Agency for Innovation Systems(Vinnova); Sudzucker	We thank F. Domene, J. Bensefelt, A. Karlsson, R. Sant, P. van Roggen, and A.-M. Nilsson for technical assistance, and Y. Fischer for help in preparing the manuscript. We also thank C. Bellini for critical reading of the manuscript. This work was supported by the Swedish Research Council and the Swedish Governmental Agency for Innovation Systems to O.N. and T. K., as well as by Sudzucker. Phylogenetic data have been deposited with Dryad Digital Repository (DOI: 10.5061/dryad.4930). Nucleotide sequences have been deposited with GenBank under accession numbers HM448909 to HM448918 and HQ148107 to HQ148132. The use of BvFT1 and BvFT2 in control of sugar beet flowering is the subject of the patent application WO2010/025888.	Abegg F. A., 1936, J AGR RES, V53, P493; Abegg FA, 1936, J AGRIC RES, V53, P0493; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; [Anonymous], 2010, The use of BvFT1 and BvFT2 in control of sugar beet flowering is the subject of the patent application, Patent No. [WO2010/025888, 2010025888]; Bell GDH, 1942, J AGR SCI, V32, P112, DOI 10.1017/S0021859600047584; Blackman BK, 2010, CURR BIOL, V20, P629, DOI 10.1016/j.cub.2010.01.059; BOUDRY P, 1994, THEOR APPL GENET, V88, P852, DOI 10.1007/BF01253996; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; Gyllenstrand N, 2007, PLANT PHYSIOL, V144, P248, DOI 10.1104/pp.107.095802; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; JUNG C, 1993, THEOR APPL GENET, V86, P449, DOI 10.1007/BF00838560; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Letschert JPW, 1993, WAGENINGEN AGR U PAP, V93-1; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Ohno S., 1970, EVOLUTION GENE DUPLI; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Sung SB, 2004, CURR OPIN PLANT BIOL, V7, P4, DOI 10.1016/j.pbi.2003.11.010; Tadege M, 2001, PLANT J, V28, P545, DOI 10.1046/j.1365-313X.2001.01182.x; Van Dijk H, 2009, J EXP BOT, V60, P3143, DOI 10.1093/jxb/erp142; Wang RH, 2009, NATURE, V459, P423, DOI 10.1038/nature07988; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305	24	302	324	7	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1397	1400		10.1126/science.1197004	http://dx.doi.org/10.1126/science.1197004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127254				2022-12-28	WOS:000284902100047
J	Saar, BG; Freudiger, CW; Reichman, J; Stanley, CM; Holtom, GR; Xie, XS				Saar, Brian G.; Freudiger, Christian W.; Reichman, Jay; Stanley, C. Michael; Holtom, Gary R.; Xie, X. Sunney			Video-Rate Molecular Imaging in Vivo with Stimulated Raman Scattering	SCIENCE			English	Article							HIGH-SENSITIVITY; LABEL-FREE; MICROSCOPY; STORAGE	Optical imaging in vivo with molecular specificity is important in biomedicine because of its high spatial resolution and sensitivity compared with magnetic resonance imaging. Stimulated Raman scattering (SRS) microscopy allows highly sensitive optical imaging based on vibrational spectroscopy without adding toxic or perturbative labels. However, SRS imaging in living animals and humans has not been feasible because light cannot be collected through thick tissues, and motion-blur arises from slow imaging based on backscattered light. In this work, we enable in vivo SRS imaging by substantially enhancing the collection of the backscattered signal and increasing the imaging speed by three orders of magnitude to video rate. This approach allows label-free in vivo imaging of water, lipid, and protein in skin and mapping of penetration pathways of topically applied drugs in mice and humans.	[Saar, Brian G.; Freudiger, Christian W.; Holtom, Gary R.; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Freudiger, Christian W.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Reichman, Jay; Stanley, C. Michael] Chroma Technol, Bellows Falls, VT 05101 USA	Harvard University; Harvard University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu			Boehringer Ingelheim Fonds; Bill and Melinda Gates Foundation; NIH [1R01EB010244-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010244] Funding Source: NIH RePORTER	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank J. MacArthur for advice on electronics and K. Sherwood, W. Faustino, and X. Zhang for helpful discussions. C. W. F. was supported by a Boehringer Ingelheim Fonds Ph.D. fellowship. This work was supported by the Bill and Melinda Gates Foundation and an NIH T-R01 award (1R01EB010244-01) to X. S. X. Patent applications based on this work have been filed by Harvard Univ. Imaging was performed in accordance with Harvard Univ. Faculty of Arts and Sciences Institutional Animal Care and Use Committee protocol number 29-01.	[Anonymous], 2010, ZEM US GUID; Cheng JX, 2002, J OPT SOC AM B, V19, P1363, DOI 10.1364/JOSAB.19.001363; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Combs CA, 2007, J MICROSC-OXFORD, V228, P330, DOI 10.1111/j.1365-2818.2007.01851.x; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Fu D, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2780173; Ganikhanov F, 2006, OPT LETT, V31, P1872, DOI 10.1364/OL.31.001872; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Huff TB, 2007, J MICROSC-OXFORD, V225, P175, DOI 10.1111/j.1365-2818.2007.01729.x; Jacques S. L., 1987, Lasers in the Life Sciences, V1, P309; Konig K, 2007, MICROSC RES TECHNIQ, V70, P398, DOI 10.1002/jemt.20445; Lademann J, 2008, SKIN PHARMACOL PHYS, V21, P150, DOI 10.1159/000131079; Levenson M. D., 1988, INTRO NONLINEAR LASE; Li L, 2005, BIOPHYS J, V89, P3480, DOI 10.1529/biophysj.105.065607; Llewellyn ME, 2008, NATURE, V454, P784, DOI 10.1038/nature07104; Min W, 2009, NATURE, V461, P1105, DOI 10.1038/nature08438; Nandakumar P, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033026; Ozeki Y, 2009, OPT EXPRESS, V17, P3651, DOI 10.1364/OE.17.003651; Ploetz E, 2007, APPL PHYS B-LASERS O, V87, P389, DOI 10.1007/s00340-007-2630-x; Prausnitz MR, 2004, NAT REV DRUG DISCOV, V3, P115, DOI 10.1038/nrd1304; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; Rinia HA, 2006, J PHYS CHEM B, V110, P4472, DOI 10.1021/jp0564849; Saar BG, 2010, ANGEW CHEM INT EDIT, V49, P5476, DOI 10.1002/anie.201000900; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Slipchenko MN, 2010, ANALYST, V135, P2613, DOI 10.1039/c0an00252f; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142	28	587	614	11	297	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1368	1370		10.1126/science.1197236	http://dx.doi.org/10.1126/science.1197236			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127249	Green Accepted, Green Submitted			2022-12-28	WOS:000284902100039
J	Bean, JL; Kempton, EMR; Homeier, D				Bean, Jacob L.; Kempton, Eliza Miller-Ricci; Homeier, Derek			A ground-based transmission spectrum of the super-Earth exoplanet GJ 1214b	NATURE			English	Article							OCEAN-PLANETS; MASS; ATMOSPHERES; SEARCH; RICH	In contrast to planets with masses similar to that of Jupiter and higher, the bulk compositions of planets in the so-called super-Earth regime (masses 2-10 times that of the Earth) cannot be uniquely determined from a measurement of mass and radius alone. For these planets, there is a degeneracy between the mass and composition of both the interior and a possible atmosphere in theoretical models(1,2). The recently discovered transiting super-Earth exoplanet GJ 1214b is one example of this problem(3). Three distinct models for the planet that are consistent with its mass and radius have been suggested(4). Breaking the degeneracy between these models requires obtaining constraints on the planet's atmospheric composition(5,6). Here we report a ground-based measurement of the transmission spectrum of GJ 1214b between wavelengths of 780 and 1,000 nm. The lack of features in this spectrum rules out (at 4.9 sigma confidence) cloud-free atmospheres composed primarily of hydrogen. If the planet's atmosphere is hydrogen-dominated, then it must contain clouds or hazes that are optically thick at the observed wavelengths at pressures less than 200 mbar. Alternatively, the featureless transmission spectrum is also consistent with the presence of a dense, water vapour atmosphere.	[Bean, Jacob L.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Bean, Jacob L.; Homeier, Derek] Univ Gottingen, Inst Astrophys, D-37077 Gottingen, Germany; [Kempton, Eliza Miller-Ricci] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Gottingen; University of California System; University of California Santa Cruz	Bean, JL (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	jbean@cfa.harvard.edu		Bean, Jacob/0000-0003-4733-6532; Homeier, Derek/0000-0002-8546-9128; Kempton, Eliza/0000-0002-1337-9051	European Commissions; NASA	European Commissions(European CommissionEuropean Commission Joint Research Centre); NASA(National Aeronautics & Space Administration (NASA))	We thank D. Charbonneau, J.-M. Desert, J. Fortney, S. Seager, L. Rogers and D. Sasselov for discussions about this work. J.L.B. received funding from the European Commissions Seventh Framework Program as a Marie Curie International Incoming Fellow. J.L.B. and E.M.-R.K. acknowledge funding from NASA through the Sagan Fellowship Program. The results presented are based on observations made with ESO telescopes at the Paranal Observatories under programs 284.C-5042 and 285.C-5019.	Adams ER, 2008, ASTROPHYS J, V673, P1160, DOI 10.1086/524925; Bean JL, 2010, ASTROPHYS J, V713, P410, DOI 10.1088/0004-637X/713/1/410; Charbonneau D, 2009, NATURE, V462, P891, DOI 10.1038/nature08679; Deming D, 2009, PUBL ASTRON SOC PAC, V121, P952, DOI 10.1086/605913; Elkins-Tanton LT, 2008, ASTROPHYS J, V685, P1237, DOI 10.1086/591433; Kaltenegger L, 2009, ASTROPHYS J, V698, P519, DOI 10.1088/0004-637X/698/1/519; Knutson HA, 2007, PUBL ASTRON SOC PAC, V119, P616, DOI 10.1086/520098; Leger A, 2004, ICARUS, V169, P499, DOI 10.1016/j.icarus.2004.01.001; Leger A, 2009, ASTRON ASTROPHYS, V506, P287, DOI 10.1051/0004-6361/200911933; LODDERS K, 2006, CHEM LOW MASS SUBSTE, P1; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Miller-Ricci E, 2010, ASTROPHYS J LETT, V716, pL74, DOI 10.1088/2041-8205/716/1/L74; Miller-Ricci E, 2009, ASTROPHYS J, V690, P1056, DOI 10.1088/0004-637X/690/2/1056; NETTELMANN N, 2010, THERMAL EVOLUTION IN; Nutzman P, 2008, PUBL ASTRON SOC PAC, V120, P317, DOI 10.1086/533420; Queloz D, 2009, ASTRON ASTROPHYS, V506, P303, DOI 10.1051/0004-6361/200913096; Rogers LA, 2010, ASTROPHYS J, V716, P1208, DOI 10.1088/0004-637X/716/2/1208; Rogers LA, 2010, ASTROPHYS J, V712, P974, DOI 10.1088/0004-637X/712/2/974; Selsis F, 2007, ICARUS, V191, P453, DOI 10.1016/j.icarus.2007.04.010; Valencia D, 2010, ASTRON ASTROPHYS, V516, DOI 10.1051/0004-6361/200912839	22	260	263	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 2	2010	468	7324					669	672		10.1038/nature09596	http://dx.doi.org/10.1038/nature09596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124452	Green Submitted			2022-12-28	WOS:000284836700035
J	Chen, LQ; Hou, BH; Lalonde, S; Takanaga, H; Hartung, ML; Qu, XQ; Guo, WJ; Kim, JG; Underwood, W; Chaudhuri, B; Chermak, D; Antony, G; White, FF; Somerville, SC; Mudgett, MB; Frommer, WB				Chen, Li-Qing; Hou, Bi-Huei; Lalonde, Sylvie; Takanaga, Hitomi; Hartung, Mara L.; Qu, Xiao-Qing; Guo, Woei-Jiun; Kim, Jung-Gun; Underwood, William; Chaudhuri, Bhavna; Chermak, Diane; Antony, Ginny; White, Frank F.; Somerville, Shauna C.; Mudgett, Mary Beth; Frommer, Wolf B.			Sugar transporters for intercellular exchange and nutrition of pathogens	NATURE			English	Article							FANCONI-BICKEL-SYNDROME; POWDERY MILDEW; ENDOPLASMIC-RETICULUM; GLUCOSE-TRANSPORTER; BACTERIAL-BLIGHT; PETUNIA-HYBRIDA; GENE; ARABIDOPSIS; SUCROSE; RESISTANCE	Sugar efflux transporters are essential for the maintenance of animal blood glucose levels, plant nectar production, and plant seed and pollen development. Despite broad biological importance, the identity of sugar efflux transporters has remained elusive. Using optical glucose sensors, we identified a new class of sugar transporters, named SWEETs, and show that at least six out of seventeen Arabidopsis, two out of over twenty rice and two out of seven homologues in Caenorhabditis elegans, and the single copy human protein, mediate glucose transport. Arabidopsis SWEET8 is essential for pollen viability, and the rice homologues SWEET11 and SWEET14 are specifically exploited by bacterial pathogens for virulence by means of direct binding of a bacterial effector to the SWEET promoter. Bacterial symbionts and fungal and bacterial pathogens induce the expression of different SWEET genes, indicating that the sugar efflux function of SWEET transporters is probably targeted by pathogens and symbionts for nutritional gain. The metazoan homologues may be involved in sugar efflux from intestinal, liver, epididymis and mammary cells.	[Chen, Li-Qing; Hou, Bi-Huei; Lalonde, Sylvie; Takanaga, Hitomi; Hartung, Mara L.; Qu, Xiao-Qing; Guo, Woei-Jiun; Chaudhuri, Bhavna; Chermak, Diane; Frommer, Wolf B.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Kim, Jung-Gun; Mudgett, Mary Beth] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Antony, Ginny; White, Frank F.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Underwood, William; Somerville, Shauna C.] Energy Biosci Inst, Berkeley, CA 94720 USA	Carnegie Institution for Science; Stanford University; Kansas State University	Frommer, WB (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	wfrommer@carnegiescience.edu	Antony, Ginny/ABC-9539-2021; Frommer, Wolf B/A-8256-2008; Frommer, Wolf B/K-5042-2017; GUO, WOEI-JIUN/F-8487-2012	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; Underwood, William/0000-0002-9920-8228; Antony, Ginny/0000-0003-0619-3176	Department of Energy [DE-FG02-04ER15542]; NIH (NIDDK) [1RO1DK079109]; Carnegie Institution; National Natural Science Foundation of China (NSFC) [30771288]; NSF [IOS-0821801]; NIH [ZRO1GM06886-06A1, F32GM083439-02]; NSF; USDA NIFA [2007-35319-18103]; NSF Plant Genome [DBI-0820831]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM083439, R01GM068886] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); NIH (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Carnegie Institution; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); USDA NIFA(United States Department of Agriculture (USDA)); NSF Plant Genome(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was made possible by grants from the Department of Energy (DE-FG02-04ER15542) and NIH (NIDDK; 1RO1DK079109) to W.B.F., X.-Q.Q. was supported by The Carnegie Institution and the National Natural Science Foundation of China (NSFC; 30771288). NSF (IOS-0821801) and NIH (ZRO1GM06886-06A1) to M.B.M. and J.-G.K. was supported 50% by NIH and 50% by NSF. W.U. was supported in part by an NIH postdoctoral fellowship (F32GM083439-02). G.A. and F.F.W. were supported by grants from USDA NIFA (2007-35319-18103) and NSF Plant Genome (DBI-0820831).	AKED J, 1993, NEW PHYTOL, V123, P271, DOI 10.1111/j.1469-8137.1993.tb03735.x; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; ANTONY G, 2003, PLANT CELL IN PRESS; *AR, 2010, PLANT MEMBR PROT DAT; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Ballatori N, 1996, AM J PHYSIOL-REG I, V270, pR1156, DOI 10.1152/ajpregu.1996.270.5.R1156; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bermejo C, 2010, BIOCHEM J, V432, P399, DOI 10.1042/BJ20100946; *BIOP, 2010, SLC TABL; Bisseling T, 2009, SCIENCE, V324, P691, DOI 10.1126/science.1174404; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Chaudhuri B, 2008, PLANT J, V56, P948, DOI 10.1111/j.1365-313X.2008.03652.x; Chernova MN, 1997, J GEN PHYSIOL, V109, P345, DOI 10.1085/jgp.109.3.345; Chu ZH, 2006, THEOR APPL GENET, V112, P455, DOI 10.1007/s00122-005-0145-6; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Detaille D, 1999, EUR J PHARMACOL, V377, P127, DOI 10.1016/S0014-2999(99)00413-6; Engel ML, 2005, PLANT PHYSIOL, V138, P2124, DOI 10.1104/pp.104.054213; Fehr M, 2005, MOL CELL BIOL, V25, P11102, DOI 10.1128/MCB.25.24.11102-11112.2005; Ferrari S, 2007, PLANT PHYSIOL, V144, P367, DOI 10.1104/pp.107.095596; Ge YX, 2001, MOL GENET GENOMICS, V265, P414, DOI 10.1007/s004380100449; Ge YX, 2000, PLANT J, V24, P725, DOI 10.1046/j.1365-313x.2000.00926.x; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Guan YF, 2008, PLANT PHYSIOL, V147, P852, DOI 10.1104/pp.108.118026; Hamada M, 2005, DIFFERENTIATION, V73, P364, DOI 10.1111/j.1432-0436.2005.00037.x; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HESSE M, 2004, TAPETUM CYTOLOGY FUN, P1; Hosokawa M, 2002, AM J PHYSIOL-ENDOC M, V282, pE794, DOI 10.1152/ajpendo.00374.2001; Hou BH, 2009, CELL CALCIUM, V46, P130, DOI 10.1016/j.ceca.2009.06.003; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; *HUM PROT ATL, 2010, RAG1AP1 HUM PROT ATL; Ibberson M, 2000, J BIOL CHEM, V275, P4607, DOI 10.1074/jbc.275.7.4607; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; Lalonde S, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00024; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Mansfield JW, 2009, MOL PLANT PATHOL, V10, P721, DOI 10.1111/j.1364-3703.2009.00576.x; MANZ F, 1987, PEDIATR NEPHROL, V1, P509, DOI 10.1007/BF00849262; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; PATRICK JW, 1989, AUST J PLANT PHYSIOL, V16, P53, DOI 10.1071/PP9890053; Quirino BF, 1999, PLANT MOL BIOL, V40, P267, DOI 10.1023/A:1006199932265; Quirino BF, 2001, PLANT MOL BIOL, V46, P447, DOI 10.1023/A:1010639015959; RIESMEIER JW, 1992, EMBO J, V11, P4705, DOI 10.1002/j.1460-2075.1992.tb05575.x; Santer R, 1997, NAT GENET, V17, P324, DOI 10.1038/ng1197-324; Song LF, 2009, PLANT SIGNAL BEHAV, V4, P1193, DOI 10.4161/psb.4.12.10063; Stumpel F, 2001, P NATL ACAD SCI USA, V98, P11330, DOI 10.1073/pnas.211357698; Sutton PN, 2007, PHYSIOL PLANTARUM, V129, P787, DOI 10.1111/j.1399-3054.2007.00863.x; Sutton PN, 1999, PLANTA, V208, P426, DOI 10.1007/s004250050578; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Takanaga H, 2010, FASEB J, V24, P2849, DOI 10.1096/fj.09-146472; Tang DJ, 2005, J BACTERIOL, V187, P6231, DOI 10.1128/JB.187.17.6231-6237.2005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorens B, 2000, J BIOL CHEM, V275, P23751, DOI 10.1074/jbc.M002908200; UDVARDI MK, 1990, MOL PLANT MICROBE IN, V3, P334, DOI 10.1094/MPMI-3-334; Voegele RT, 2001, P NATL ACAD SCI USA, V98, P8133, DOI 10.1073/pnas.131186798; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Yuan M, 2009, PLANT CELL PHYSIOL, V50, P947, DOI 10.1093/pcp/pcp046; Zhou YC, 2007, PLANT J, V49, P750, DOI 10.1111/j.1365-313X.2006.03000.x	61	859	980	30	469	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					527	U199		10.1038/nature09606	http://dx.doi.org/10.1038/nature09606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107422	Green Accepted			2022-12-28	WOS:000284584200034
J	Correia-Pinto, J; Henriques-Coelho, T				Correia-Pinto, Jorge; Henriques-Coelho, Tiago			Neonatal Pneumomediastinum and the Spinnaker-Sail Sign.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Correia-Pinto, Jorge; Henriques-Coelho, Tiago] Hosp Sao Joao, Oporto, Portugal	Sao Joao Hospital	Correia-Pinto, J (corresponding author), Hosp Sao Joao, Oporto, Portugal.	jcp@ecsaude.uminho.pt	Correia-Pinto, Jorge/B-3344-2012	Correia-Pinto, Jorge/0000-0002-9265-6896; Henriques-Coelho, Tiago/0000-0003-0193-1467					0	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2010	363	22					2145	2145		10.1056/NEJMicm1002462	http://dx.doi.org/10.1056/NEJMicm1002462			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	684XE	21105796	Green Published, Green Submitted			2022-12-28	WOS:000284587800009
J	Ribet, D; Cossart, P				Ribet, David; Cossart, Pascale			Pathogen-Mediated Posttranslational Modifications: A Re-emerging Field	CELL			English	Review							NF-KAPPA-B; PHOSPHOTHREONINE LYASE ACTIVITY; INNATE IMMUNE-RESPONSES; MAMMALIAN-CELLS; NS1 PROTEIN; UBIQUITIN; EFFECTOR; ISG15; TARGETS; DEGRADATION	Posttranslational modifications are increasingly recognized as key strategies used by bacterial and viral pathogens to modulate host factors critical for infection. A number of recent studies illustrate how pathogens use these posttranslational modifications to target central signaling pathways in the host cell, such as the NF-kB and MAP kinase pathways, which are essential for pathogens' replication, propagation, and evasion from host immune responses. These discoveries open new avenues for investigating the fundamental mechanisms of pathogen infection and the development of new therapeutics.	[Ribet, David; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, Dept Biol Cellulaire & Infect, F-75015 Paris, France; [Ribet, David; Cossart, Pascale] INSERM, U604, F-75015 Paris, France; [Ribet, David; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, Dept Biol Cellulaire & Infect, F-75015 Paris, France.	pascale.cossart@pasteur.fr	Ribet, David/AAA-6659-2020	Ribet, David/0000-0003-1175-6471	Institut Pasteur; Inserm; INRA; ERC [233348]; Fondation le Roch Les Mousquetaires; Fondation Louis-Jeantet; Association pour la Recherche sur le Cancer	Institut Pasteur(European Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INRA; ERC(European Research Council (ERC)European Commission); Fondation le Roch Les Mousquetaires; Fondation Louis-Jeantet; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We apologize to authors whose work could not be included because of space constraints. Work in P.C.'s laboratory receives financial support from Institut Pasteur, Inserm, INRA, ERC (advanced grant 233348), the Fondation le Roch Les Mousquetaires, and the Fondation Louis-Jeantet. D.R. is supported by a fellowship from the Association pour la Recherche sur le Cancer. P.C. is an international research scholar of the Howard Hughes Medical Institute.	Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008; Boname JM, 2010, TRAFFIC, V11, P210, DOI 10.1111/j.1600-0854.2009.01011.x; Bonazzi M, 2008, CELL MICROBIOL, V10, P2208, DOI 10.1111/j.1462-5822.2008.01200.x; Bour S, 2001, J BIOL CHEM, V276, P15920, DOI 10.1074/jbc.M010533200; Brennan DF, 2009, TRENDS BIOCHEM SCI, V34, P108, DOI 10.1016/j.tibs.2008.11.005; Chang PC, 2010, J BIOL CHEM, V285, P5266, DOI 10.1074/jbc.M109.088088; Chang TH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000493; COLLIER RJ, 1969, SCIENCE, V164, P1179, DOI 10.1126/science.164.3884.1179; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Gastaldello S, 2010, NAT CELL BIOL, V12, P351, DOI 10.1038/ncb2035; Gouin E, 2010, P NATL ACAD SCI USA, V107, P17333, DOI 10.1073/pnas.1007765107; Hicks SW, 2010, CURR OPIN MICROBIOL, V13, P41, DOI 10.1016/j.mib.2009.11.008; Hotson A, 2003, MOL MICROBIOL, V50, P377, DOI 10.1046/j.1365-2958.2003.03730.x; Jeon YJ, 2010, BBA-MOL BASIS DIS, V1802, P485, DOI 10.1016/j.bbadis.2010.02.006; Jubelin G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001128; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Kim JG, 2008, PLANT CELL, V20, P1915, DOI 10.1105/tpc.108.058529; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Knodler LA, 2009, CELL MICROBIOL, V11, P1652, DOI 10.1111/j.1462-5822.2009.01356.x; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; Kumar A, 2009, J IMMUNOL, V182, P538, DOI 10.4049/jimmunol.182.1.538; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lapaque N, 2009, P NATL ACAD SCI USA, V106, P14052, DOI 10.1073/pnas.0906735106; Le Negrate G, 2008, J IMMUNOL, V180, P5045, DOI 10.4049/jimmunol.180.7.5045; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Mazurkiewicz P, 2008, MOL MICROBIOL, V67, P1371, DOI 10.1111/j.1365-2958.2008.06134.x; Misaghi S, 2006, MOL MICROBIOL, V61, P142, DOI 10.1111/j.1365-2958.2006.05199.x; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Patel JC, 2009, CELL, V137, P283, DOI 10.1016/j.cell.2009.01.056; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527; Ribet D, 2010, FEBS LETT, V584, P2748, DOI 10.1016/j.febslet.2010.05.012; Ribet D, 2010, NATURE, V464, P1192, DOI 10.1038/nature08963; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Skaug B, 2010, CELL, V143, P187, DOI 10.1016/j.cell.2010.09.033; Tang YJ, 2010, J IMMUNOL, V184, P5777, DOI 10.4049/jimmunol.0903588; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zhao C, 2010, P NATL ACAD SCI USA, V107, P2253, DOI 10.1073/pnas.0909144107	63	126	131	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					694	702		10.1016/j.cell.2010.11.019	http://dx.doi.org/10.1016/j.cell.2010.11.019			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111231	Green Published, Bronze			2022-12-28	WOS:000284583500012
J	Chin, CS; Sorenson, J; Harris, JB; Robins, WP; Charles, RC; Jean-Charles, RR; Bullard, J; Webster, DR; Kasarskis, A; Peluso, P; Paxinos, EE; Yamaichi, Y; Calderwood, SB; Mekalanos, JJ; Schadt, EE; Waldor, MK				Chin, Chen-Shan; Sorenson, Jon; Harris, Jason B.; Robins, William P.; Charles, Richelle C.; Jean-Charles, Roger R.; Bullard, James; Webster, Dale R.; Kasarskis, Andrew; Peluso, Paul; Paxinos, Ellen E.; Yamaichi, Yoshiharu; Calderwood, Stephen B.; Mekalanos, John J.; Schadt, Eric E.; Waldor, Matthew K.			The Origin of the Haitian Cholera Outbreak Strain.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPARATIVE GENOMICS; VIBRIO; TIME; EPIDEMIOLOGY; VACCINES; SEQUENCE; VARIANT	Background: Although cholera has been present in Latin America since 1991, it had not been epidemic in Haiti for at least 100 years. Recently, however, there has been a severe outbreak of cholera in Haiti. Methods: We used third-generation single-molecule real-time DNA sequencing to determine the genome sequences of 2 clinical Vibrio cholerae isolates from the current outbreak in Haiti, 1 strain that caused cholera in Latin America in 1991, and 2 strains isolated in South Asia in 2002 and 2008. Using primary sequence data, we compared the genomes of these 5 strains and a set of previously obtained partial genomic sequences of 23 diverse strains of V. cholerae to assess the likely origin of the cholera outbreak in Haiti. Results: Both single-nucleotide variations and the presence and structure of hypervariable chromosomal elements indicate that there is a close relationship between the Haitian isolates and variant V. cholerae El Tor O1 strains isolated in Bangladesh in 2002 and 2008. In contrast, analysis of genomic variation of the Haitian isolates reveals a more distant relationship with circulating South American isolates. Conclusions: The Haitian epidemic is probably the result of the introduction, through human activity, of a V. cholerae strain from a distant geographic source. (Funded by the National Institute of Allergy and Infectious Diseases and the Howard Hughes Medical Institute.) N Engl J Med 2011;364:33-42.	[Chin, Chen-Shan; Sorenson, Jon; Harris, Jason B.; Webster, Dale R.; Kasarskis, Andrew; Peluso, Paul; Paxinos, Ellen E.; Schadt, Eric E.] Pacific Biosci, Menlo Pk, CA USA; [Harris, Jason B.; Charles, Richelle C.; Calderwood, Stephen B.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Yamaichi, Yoshiharu; Waldor, Matthew K.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Harris, Jason B.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Charles, Richelle C.; Yamaichi, Yoshiharu; Calderwood, Stephen B.; Waldor, Matthew K.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Robins, William P.; Calderwood, Stephen B.; Mekalanos, John J.; Waldor, Matthew K.] Harvard Univ, Sch Med, Dept Microbiol, Boston, MA 02115 USA; [Robins, William P.; Calderwood, Stephen B.; Mekalanos, John J.; Waldor, Matthew K.] Harvard Univ, Sch Med, Dept Mol Genet, Boston, MA 02115 USA; [Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Jean-Charles, Roger R.] Fdn Dev Univ & Rech Haiti, Port Au Prince, Haiti	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Schadt, EE (corresponding author), Pacific Biosci, Menlo Pk, CA USA.	eschadt@pacificbiosciences.com	Paxinos, Ellen/AAG-2907-2019; Yamaichi, Yoshiharu/E-1776-2019; Charles, Richelle/W-4342-2019; Harris, Jason/ABF-2684-2020	Paxinos, Ellen/0000-0002-1710-8064; Yamaichi, Yoshiharu/0000-0003-0835-5407; Charles, Richelle/0000-0002-8881-1849; Harris, Jason/0000-0003-3642-5126; Sorenson, Jon/0000-0002-5301-8306; Waldor, Matthew/0000-0003-1843-7000	National Institute of Allergy and Infectious Diseases [AI-018045, AI R37-042347, AI058935]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007061, R37AI042347, K08AI089721, R01AI042347, R37AI018045, R01AI026289, R01AI018045, R22AI018045, U01AI058935] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work at Harvard Medical School and Brigham and Women's Hospital was supported by grants from the National Institute of Allergy and Infectious Diseases (AI-018045, to Dr. Mekalanos; and AI R37-042347) and by a grant from the Howard Hughes Medical Institute to Dr. Waldor. Work at Massachusetts General Hospital was supported by a grant from the National Institute of Allergy and Infectious Diseases (AI058935, to Dr. Calderwood).	Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1473; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; [Anonymous], 2010, CIRCLE BLUE WAT 1111; Burrus V, 2006, PLASMID, V55, P173, DOI 10.1016/j.plasmid.2006.01.001; C Reed, 2010, DISCOVERY NEWS  1124; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; Constantin de Magny Guillaume, 2009, Trans Am Clin Climatol Assoc, V120, P119; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Enserink M, 2010, SCIENCE, V330, P738, DOI 10.1126/science.330.6005.738; Enserink M, 2010, SCIENCE, V329, P1462, DOI 10.1126/science.329.5998.1462; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; GLASS RI, 1991, LANCET, V338, P791, DOI 10.1016/0140-6736(91)90673-D; Goel AK, 2008, J INFECTION, V57, P280, DOI 10.1016/j.jinf.2008.06.015; Grim CJ, 2010, J BACTERIOL, V192, P3524, DOI 10.1128/JB.00040-10; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Lam C, 2010, EMERG INFECT DIS, V16, P1130, DOI 10.3201/eid1607.100131; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Nusrin S, 2009, J MED MICROBIOL, V58, P342, DOI 10.1099/jmm.0.005397-0; Quilici ML, 2010, EMERG INFECT DIS, V16, P1804, DOI 10.3201/eid1611.100568; Ryan ET, 2006, EXPERT REV VACCINES, V5, P483, DOI 10.1586/14760584.5.4.483; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Schadt EE, 2010, HUM MOL GENET, V19, pR227, DOI 10.1093/hmg/ddq416; Schadt EE, 2010, NAT REV GENET, V11, P647, DOI 10.1038/nrg2857; Siddique AK, 2010, EPIDEMIOL INFECT, V138, P347, DOI 10.1017/S0950268809990550; Sur D, 2010, INDIAN J MED RES, V131, P1; Taviani E, 2010, FEMS MICROBIOL LETT, V308, P130, DOI 10.1111/j.1574-6968.2010.02008.x; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; WACHSMUTH IK, 1993, J INFECT DIS, V167, P621, DOI 10.1093/infdis/167.3.621; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000786	31	489	517	2	102	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2011	364	1					33	42		10.1056/NEJMoa1012928	http://dx.doi.org/10.1056/NEJMoa1012928			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702UY	21142692	Green Accepted			2022-12-28	WOS:000285922600008
J	Schmitz, KH; Ahmed, RL; Troxel, AB; Cheville, A; Lewis-Grant, L; Smith, R; Bryan, CJ; Williams-Smith, CT; Chittams, J				Schmitz, Kathryn H.; Ahmed, Rehana L.; Troxel, Andrea B.; Cheville, Andrea; Lewis-Grant, Lorita; Smith, Rebecca; Bryan, Cathy J.; Williams-Smith, Catherine T.; Chittams, Jesse			Weight Lifting for Women at Risk for Breast Cancer-Related Lymphedema A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL-ACTIVITY; NODE BIOPSY; RESISTANCE EXERCISE; ARM LYMPHEDEMA; FOLLOW-UP; SURVIVORS; COMPLICATIONS; QUESTIONNAIRE; VALIDATION; DISSECTION	Context Clinical guidelines for breast cancer survivors without lymphedema advise against upper body exercise, preventing them from obtaining established health benefits of weight lifting. Objective To evaluate lymphedema onset after a 1-year weight lifting intervention vs no exercise (control) among survivors at risk for breast cancer-related lymphedema (BCRL). Design, Setting, and Participants A randomized controlled equivalence trial (Physical Activity and Lymphedematrial) in the Philadelphia metropolitan area of 154 breast cancer survivors 1 to 5 years postunilateral breast cancer, with at least 2 lymph nodes removed and without clinical signs of BCRL at study entry. Participants were recruited between October 1, 2005, and February 2007, with data collection ending in August 2008. Intervention Weight lifting intervention included a gym membership and 13 weeks of supervised instruction, with the remaining 9 months unsupervised, vs no exercise. Main Outcome Measures Incident BCRL determined by increased arm swelling during 12 months (>= 5% increase in interlimb difference). Clinician-defined BCRL onset was also evaluated. Equivalence margin was defined as doubling of lyphedema incidence. Results A total of 134 participants completed follow-up measures at 1 year. The proportion of women who experienced incident BCRL onset was 11% (8 of 72) in the weight lifting intervention group and 17% (13 of 75) in the control group (cumulative incidence difference [CID], -6.0%; 95% confidence interval [CI], -17.2% to 5.2%; P for equivalence=.04). Among women with 5 or more lymph nodes removed, the proportion who experienced incident BCRL onset was 7% (3 of 45) in the weight lifting intervention group and 22% (11 of 49) in the control group (CID, -15.0%; 95% CI, -18.6% to -11.4%; P for equivalence=.003). Clinician-defined BCRL onset occurred in 1 woman in the weight lifting intervention group and 3 women in the control group (1.5% vs 4.4%, P for equivalence=.12). Conclusion In breast cancer survivors at risk for lymphedema, a program of slowly progressive weight lifting compared with no exercise did not result in increased incidence of lymphedema.	[Schmitz, Kathryn H.; Troxel, Andrea B.; Lewis-Grant, Lorita; Bryan, Cathy J.; Williams-Smith, Catherine T.; Chittams, Jesse] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Schmitz, Kathryn H.; Troxel, Andrea B.; Lewis-Grant, Lorita; Bryan, Cathy J.; Williams-Smith, Catherine T.; Chittams, Jesse] Abramson Canc Ctr, Philadelphia, PA USA; [Ahmed, Rehana L.] Univ Minnesota, Sch Med, Dept Dermatol, Minneapolis, MN 55455 USA; [Cheville, Andrea] Mayo Clin, Rochester, MN USA; [Cheville, Andrea; Smith, Rebecca] Univ Penn, Sch Med, Dept Phys Med & Rehabil, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; University of Pennsylvania	Schmitz, KH (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, 903 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	schmitz@mail.med.upenn.edu	Schmitz, Kathryn H/F-3516-2012; Schmitz, Kathryn/B-7154-2011	Troxel, Andrea/0000-0002-1393-3075; Schmitz, Kathryn/0000-0003-2400-2935	National Cancer Institute [R01-CA106851]; National Institutes of Health [RR024134]; NATIONAL CANCER INSTITUTE [R01CA106851] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grant R01-CA106851 from the National Cancer Institute (Dr Schmitz) and by the Public Health Services Research grant RR024134 from the National Institutes of Health to the University of Pennsylvania. In addition, BSN Medical provided in-kind support in the form of custom-fitted compression garments and the fitness centers where the weight lifting intervention was delivered discounted membership fees for study participants (YMCA of Philadelphia and Vicinity, Sisters in Shape, the Family YMCA of Burlington County, New Jersey, and the Community YMCA of Eastern Delaware County).	Ahmed RL, 2006, J CLIN ONCOL, V24, P2765, DOI 10.1200/JCO.2005.03.6749; Ahmed RL, 2008, J CLIN ONCOL, V26, P5689, DOI 10.1200/JCO.2008.16.4731; *AM CANC SOC, LYMPH WHAT EV WOM BR; Barnard K L, 1999, J Cardiopulm Rehabil, V19, P52, DOI 10.1097/00008483-199901000-00007; Cheville AL, 2003, SEMIN RADIAT ONCOL, V13, P214, DOI 10.1016/S1053-4296(03)00038-9; Cormier JN, 2009, LYMPHOLOGY, V42, P161; Courneya KS, 2007, J CLIN ONCOL, V25, P4396, DOI 10.1200/JCO.2006.08.2024; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dodds Rachel L, 2004, Work, V22, P107; Evans S. J. W., 1990, MINIM MINIMISATION P; Francis WP, 2006, AM J SURG, V192, P636, DOI 10.1016/j.amjsurg.2006.08.018; Holmes MD, 2005, JAMA-J AM MED ASSOC, V293, P2479, DOI 10.1001/jama.293.20.2479; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johansson K, 2005, LYMPHOLOGY, V38, P167; King T I 2nd, 1993, J Hand Ther, V6, P202; Kraemer WJ., 1997, DESIGNING RESISTANCE; Lacomba MT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5396; McKenzie DC, 2003, J CLIN ONCOL, V21, P463, DOI 10.1200/JCO.2003.04.069; *NAT LYMPH NETW, 2006, POS STAT NAT LYMPH N; *NAT LYMPH NETW, 2005, POS STAT NAT LYMPH N; *NAT LYMPH NETW, 2008, POS STAT NAT LYMPH N; Norman SA, 2001, PHYS THER, V81, P1192, DOI 10.1093/ptj/81.6.1192; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Radak Z, 2008, AGEING RES REV, V7, P34, DOI 10.1016/j.arr.2007.04.004; Ries L, SEER CANC STAT REV; Sagen A, 2009, ACTA ONCOL, V48, P1102, DOI 10.3109/02841860903061683; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; Schmitz KH, 2010, EXERC SPORT SCI REV, V38, P17, DOI 10.1097/JES.0b013e3181c5cd5a; Schmitz KH, 2009, NEW ENGL J MED, V361, P664, DOI 10.1056/NEJMoa0810118; Schmitz KH, 2009, CONTEMP CLIN TRIALS, V30, P233, DOI 10.1016/j.cct.2009.01.001; Schrenk P, 2000, CANCER, V88, P608, DOI 10.1002/(SICI)1097-0142(20000201)88:3<608::AID-CNCR17>3.0.CO;2-K; *SG KOM CUR, LYMPH; Shaw C E, 1995, J Cardiopulm Rehabil, V15, P283, DOI 10.1097/00008483-199507000-00005; Shih YCT, 2009, J CLIN ONCOL, V27, P2007, DOI 10.1200/JCO.2008.18.3517; Sternfeld B, 2009, CANCER EPIDEM BIOMAR, V18, P87, DOI 10.1158/1055-9965.EPI-08-0595; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Wilke LG, 2006, ANN SURG ONCOL, V13, P491, DOI 10.1245/ASO.2006.05.013	37	262	268	1	28	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2010	304	24					2699	2705		10.1001/jama.2010.1837	http://dx.doi.org/10.1001/jama.2010.1837			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697MP	21148134	Bronze			2022-12-28	WOS:000285518000014
J	Chen, SD; Zhang, YE; Long, MY				Chen, Sidi; Zhang, Yong E.; Long, Manyuan			New Genes in Drosophila Quickly Become Essential	SCIENCE			English	Article							EVOLUTION; MELANOGASTER; GENOME; MOUSE; DIVERGENCE; PHYLOGENY; DUPLICATE; INSIGHTS; ORIGIN	To investigate the origin and evolution of essential genes, we identified and phenotyped 195 young protein-coding genes, which originated 3 to 35 million years ago in Drosophila. Knocking down expression with RNA interference showed that 30% of newly arisen genes are essential for viability. The proportion of genes that are essential is similar in every evolutionary age group that we examined. Under constitutive silencing of these young essential genes, lethality was high in the pupal stage and also found in the larval stages. Lethality was attributed to diverse cellular and developmental defects, such as organ formation and patterning defects. These data suggest that new genes frequently and rapidly evolve essential functions and participate in development.	[Chen, Sidi; Zhang, Yong E.; Long, Manyuan] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Long, MY (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	mlong@uchicago.edu	Zhang, Yong E./AAC-8610-2019; Zhang, Yong/A-7855-2011; CHEN, SIDI/D-8284-2016	Zhang, Yong E./0000-0003-3770-2383; CHEN, SIDI/0000-0002-3819-5005	University of Chicago Biological Sciences Division; National Institutes of Health [R01GM065429-01A1, R01GM078070-01A1]; National Science Foundation [MCB 0238168]; Chicago Biomedical Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078070, R01GM065429] Funding Source: NIH RePORTER	University of Chicago Biological Sciences Division(University of Chicago); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Chicago Biomedical Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. H. Langley and D. Begun for providing polymorphism data; W. Du, J. Gavin-Smyth, Q. Guo, and M. Guffey for technical assistance and discussion; J. Coyne, M. Kreitman, and X. Ni for critically reading and/or revising the manuscript; and the members of the Manyuan Long laboratory, C. Ferguson, R. Hudson, C. I. Wu, and T. Nagylaki, for valuable discussion. S. C. was supported by University of Chicago Biological Sciences Division Fellowships. This research was supported by National Institutes of Health (R01GM065429-01A1 and R01GM078070-01A1) and National Science Foundation (CAREER Award MCB 0238168) to M. L. Y.E.Z. was also supported by the Searle Funds from Chicago Biomedical Consortium (2009, Spark).	Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Gauhar Z., 2008, COMMUNICATION; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Ida H, 2009, NUCLEIC ACIDS RES, V37, P1423, DOI 10.1093/nar/gkn1068; Jones CD, 2005, P NATL ACAD SCI USA, V102, P11373, DOI 10.1073/pnas.0503528102; Joppich C, 2009, CHROMOSOME RES, V17, P19, DOI 10.1007/s10577-008-9002-1; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Keleman K, 2009, COMMUNICATION; Kilpatrick S. T., 2009, LEWINS ESSENTIAL GEN; Kreitman M, 1999, CURR OPIN GENET DEV, V9, P637, DOI 10.1016/S0959-437X(99)00034-9; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Liang H, 2007, TRENDS GENET, V23, P375, DOI 10.1016/j.tig.2007.04.005; Liao BY, 2007, TRENDS GENET, V23, P378, DOI 10.1016/j.tig.2007.05.006; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Loppin B, 2005, CURR BIOL, V15, P87, DOI 10.1016/j.cub.2004.12.071; Lynch M, 2001, GENETICS, V159, P1789; Makino T, 2009, TRENDS GENET, V25, P152, DOI 10.1016/j.tig.2009.03.001; Miklos GLG, 1996, CELL, V86, P521, DOI 10.1016/S0092-8674(00)80126-9; Mueller JL, 2007, GENETICS, V175, P777, DOI 10.1534/genetics.106.065318; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Perrimon N, 1996, GENETICS, V144, P1681; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Su ZX, 2008, J MOL EVOL, V67, P705, DOI 10.1007/s00239-008-9170-9; WALSH JB, 1995, GENETICS, V139, P421; WILLIAMS JA, 1993, DEVELOPMENT, V117, P571; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041	28	204	214	2	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1682	1685		10.1126/science.1196380	http://dx.doi.org/10.1126/science.1196380			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164016	Green Accepted			2022-12-28	WOS:000285390500068
J	Davidson, EH				Davidson, Eric H.			Emerging properties of animal gene regulatory networks	NATURE			English	Review							FEEDFORWARD LOOP; DORSAL GRADIENT; FOLD-CHANGE; EXPRESSION; CELLS; DIFFERENTIATION; PATTERN; SYSTEM; FATE; PROLIFERATION	Gene regulatory networks (GRNs) provide system level explanations of developmental and physiological functions in the terms of the genomic regulatory code. Depending on their developmental functions, GRNs differ in their degree of hierarchy, and also in the types of modular sub-circuit of which they are composed, although there is a commonly employed sub-circuit repertoire. Mathematical modelling of some types of GRN sub-circuit has deepened biological understanding of the functions they mediate. The structural organization of various kinds of GRN reflects their roles in the life process, and causally illuminates both developmental and evolutionary process.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	California Institute of Technology	Davidson, EH (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.	Davidson@caltech.edu			NIH [HD-37105, GM-61005]; Lucille P. Markey Charitable Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061005] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lucille P. Markey Charitable Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I am grateful for the reviews of the manuscript by E. V. Rothenberg and I. S. Peter. This work was supported by NIH grants HD-37105 and GM-61005 and by the Lucille P. Markey Charitable Trust.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bessa J, 2008, DEVELOPMENT, V135, P799, DOI 10.1242/dev.011932; Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; Bolouri H, 2008, COMPUTATIONAL MODELI; Bolouri H, 2010, DEV BIOL, V340, P170, DOI 10.1016/j.ydbio.2009.06.007; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brohl D, 2008, DEV BIOL, V322, P381, DOI 10.1016/j.ydbio.2008.08.002; Chan TM, 2009, BBA-GENE REGUL MECH, V1789, P279, DOI 10.1016/j.bbagrm.2008.09.005; Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Christiaen L, 2008, SCIENCE, V320, P1349, DOI 10.1126/science.1158170; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Cvekl A, 2007, PROG RETIN EYE RES, V26, P555, DOI 10.1016/j.preteyeres.2007.07.002; Davidson EH, 2009, COLD SH Q B, V74, P65, DOI 10.1101/sqb.2009.74.042; Davidson E. H., 2001, DEV EVOLUTION; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davidson EH, 2006, REG GEN GEN REG; Davidson EH, 2009, CURR OPIN GENET DEV, V19, P535, DOI 10.1016/j.gde.2009.10.007; Dessaud E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000382; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Gao F, 2008, P NATL ACAD SCI USA, V105, P6091, DOI 10.1073/pnas.0801201105; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hinman VF, 2007, P NATL ACAD SCI USA, V104, P19404, DOI 10.1073/pnas.0709994104; Hinman VF, 2009, BBA-GENE REGUL MECH, V1789, P326, DOI 10.1016/j.bbagrm.2009.01.004; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Hong JW, 2008, P NATL ACAD SCI USA, V105, P20072, DOI 10.1073/pnas.0806476105; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang AM, 1997, GENE DEV, V11, P1963, DOI 10.1101/gad.11.15.1963; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Koide T, 2005, P NATL ACAD SCI USA, V102, P4943, DOI 10.1073/pnas.0408125102; KRAUT R, 1991, DEVELOPMENT, V111, P611; Kumar JP, 2009, BBA-GENE REGUL MECH, V1789, P306, DOI 10.1016/j.bbagrm.2008.10.001; Lagha M, 2009, DEV CELL, V17, P892, DOI 10.1016/j.devcel.2009.10.021; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lembong J, 2009, P NATL ACAD SCI USA, V106, P3213, DOI 10.1073/pnas.0810728106; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Liberman LM, 2009, P NATL ACAD SCI USA, V106, P22317, DOI 10.1073/pnas.0906227106; Liberman LM, 2009, DEV BIOL, V327, P578, DOI 10.1016/j.ydbio.2008.12.020; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Maduro MF, 2009, BBA-GENE REGUL MECH, V1789, P250, DOI 10.1016/j.bbagrm.2008.07.013; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Materna SC, 2010, GENE EXPR PATTERNS, V10, P177, DOI 10.1016/j.gep.2010.04.002; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Morley RH, 2009, P NATL ACAD SCI USA, V106, P3829, DOI 10.1073/pnas.0808382106; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Narula J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000771; Nikitina N, 2008, P NATL ACAD SCI USA, V105, P20083, DOI 10.1073/pnas.0806009105; Nishi Y, 2009, BBA-GENE REGUL MECH, V1789, P299, DOI 10.1016/j.bbagrm.2009.01.002; Ochoa-Espinosa A, 2009, P NATL ACAD SCI USA, V106, P3823, DOI 10.1073/pnas.0807878105; Oliveri P, 2008, P NATL ACAD SCI USA, V105, P5955, DOI 10.1073/pnas.0711220105; Oliveri P, 2007, SCIENCE, V315, P1510, DOI 10.1126/science.1140979; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Perkins TJ, 2006, PLOS COMPUT BIOL, V2, P417, DOI 10.1371/journal.pcbi.0020051; Peter IS, 2010, DEV BIOL, V340, P188, DOI 10.1016/j.ydbio.2009.10.037; Peter IS, 2009, FEBS LETT, V583, P3948, DOI 10.1016/j.febslet.2009.11.060; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Reim I, 2005, MECH DEVELOP, V122, P1056, DOI 10.1016/j.mod.2005.04.006; Ribes V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002014; Ririe TO, 2008, P NATL ACAD SCI USA, V105, P20095, DOI 10.1073/pnas.0806377105; RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5; Rosenfeld N, 2003, J MOL BIOL, V329, P645, DOI 10.1016/S0022-2836(03)00506-0; Rothenberg EV, 2009, IMMUNOL CELL BIOL, V87, P109, DOI 10.1038/icb.2008.100; Saka Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-47; Sanchez L, 2001, J THEOR BIOL, V211, P115, DOI 10.1006/jtbi.2001.2335; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Smith J, 2008, P NATL ACAD SCI USA, V105, P20089, DOI 10.1073/pnas.0806442105; Smith PA, 2007, DEV BIOL, V302, P25, DOI 10.1016/j.ydbio.2006.08.023; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Starck J, 2003, MOL CELL BIOL, V23, P1390, DOI 10.1128/MCB.23.4.1390-1402.2003; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Su YH, 2009, DEV BIOL, V329, P410, DOI 10.1016/j.ydbio.2009.02.029; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Wang L, 2009, J IMMUNOL, V183, P2903, DOI 10.4049/jimmunol.0901041; Woodland HR, 2008, BIOESSAYS, V30, P757, DOI 10.1002/bies.20785; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104; Zhu XY, 2004, CURR OPIN GENET DEV, V14, P567, DOI 10.1016/j.gde.2004.08.006	92	392	397	4	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					911	920		10.1038/nature09645	http://dx.doi.org/10.1038/nature09645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164479	Green Accepted			2022-12-28	WOS:000285344600037
J	Khoramnia, R; Wegner, A				Khoramnia, Ramin; Wegner, Aharon			Subconjunctival Dirofilaria repens.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Khoramnia, Ramin; Wegner, Aharon] Tech Univ Munich, Klinikum Rechts Isar, D-8000 Munich, Germany	Technical University of Munich	Khoramnia, R (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, D-8000 Munich, Germany.		Wegner, Aharon/H-8448-2019; Khoramnia, Ramin/AAR-8358-2020	Wegner, Aharon/0000-0002-1969-3076; Khoramnia, Ramin/0000-0002-6237-7773					0	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2010	363	25					E37	E37		10.1056/NEJMicm1003006	http://dx.doi.org/10.1056/NEJMicm1003006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZK	21158653				2022-12-28	WOS:000285340200011
J	Mascia, L; Pasero, D; Slutsky, AS; Arguis, MJ; Berardino, M; Grasso, S; Munari, M; Boifava, S; Cornara, G; Della Corte, F; Vivaldi, N; Malacarne, P; Del Gaudio, P; Livigni, S; Zavala, E; Filippini, C; Martin, EL; Donadio, PP; Mastromauro, I; Ranieri, VM				Mascia, Luciana; Pasero, Daniela; Slutsky, Arthur S.; Jose Arguis, M.; Berardino, Maurizio; Grasso, Salvatore; Munari, Marina; Boifava, Silvia; Cornara, Giuseppe; Della Corte, Francesco; Vivaldi, Nicoletta; Malacarne, Paolo; Del Gaudio, Paolo; Livigni, Sergio; Zavala, Elisabeth; Filippini, Claudia; Martin, Erica L.; Donadio, Pier Paolo; Mastromauro, Ilaria; Ranieri, V. Marco			Effect of a Lung Protective Strategy for Organ Donors on Eligibility and Availability of Lungs for Transplantation A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-DISTRESS-SYNDROME; BRAIN-INJURY; MANAGEMENT; VENTILATION; SELECTION; MODEL	Context Many potential donor lungs deteriorate between the time of brain death and evaluation for transplantation suitability, possibly because of the ventilatory strategy used after brain death. Objective To test whether a lung protective strategy increases the number of lungs available for transplantation. Design, Setting, and Patients Multicenter randomized controlled trial of patients with beating hearts who were potential organ donors conducted at 12 European intensive care units from September 2004 to May 2009 in the Protective Ventilatory Strategy in Potential Lung Donors Study. Interventions Potential donors were randomized to the conventional ventilatory strategy (with tidal volumes of 10-12 mL/kg of predicted body weight, positive endexpiratory pressure [PEEP] of 3-5 cm H2O, apnea tests performed by disconnecting the ventilator, and open circuit for airway suction) or the protective ventilatory strategy (with tidal volumes of 6-8 mL/kg of predicted body weight, PEEP of 8-10 cm H2O, apnea tests performed by using continuous positive airway pressure, and closed circuit for airway suction). Main Outcome Measures The number of organ donors meeting eligibility criteria for harvesting, number of lungs harvested, and 6-month survival of lung transplant recipients. Results The trial was stopped after enrolling 118 patients (59 in the conventional ventilatory strategy and 59 in the protective ventilatory strategy) because of termination of funding. The number of patients who met lung donor eligibility criteria after the 6-hour observation period was 32 (54%) in the conventional strategy vs 56 (95%) in the protective strategy (difference of 41% [95% confidence interval {CI}, 26.5% to 54.8%]; P<.001). The number of patients in whom lungs were harvested was 16 (27%) in the conventional strategy vs 32 (54%) in the protective strategy (difference of 27% [95% CI, 10.0% to 44.5%]; P=.004). Six-month survival rates did not differ between recipients who received lungs from donors ventilated with the conventional strategy compared with the protective strategy (11/16 [69%] vs 24/32 [75%], respectively; difference of 6% [95% CI, -22% to 32%]). Conclusion Use of a lung protective strategy in potential organ donors with brain death increased the number of eligible and harvested lungs compared with a conventional strategy.	[Mascia, Luciana; Pasero, Daniela; Filippini, Claudia; Martin, Erica L.; Donadio, Pier Paolo; Mastromauro, Ilaria; Ranieri, V. Marco] Univ Turin, San Giovanni Battista Molinette Hosp, Dept Anesthesia & Intens Care Med, I-10126 Turin, Italy; [Del Gaudio, Paolo] Univ Turin, San Giovanni Battista Molinette Hosp, Dept Emergency Med, I-10126 Turin, Italy; [Berardino, Maurizio] Univ Turin, San Giovanni Battista Molinette Hosp, Dept Neurol, I-10126 Turin, Italy; [Slutsky, Arthur S.] Univ Toronto, Dept Med, Div Crit Care Med, Toronto, ON, Canada; [Jose Arguis, M.; Zavala, Elisabeth] Univ Barcelona, Hosp Clin, Dept Anesthesia & Intens Care Med, Barcelona, Spain; [Grasso, Salvatore] Univ Bari, Consorziale Policlin Hosp, Dept Anesthesia & Intens Care Med, Bari, Italy; [Munari, Marina] Univ Padua, Azienda Hosp Padova, Dept Anesthesia & Intens Care Med, Padua, Italy; [Boifava, Silvia] Azienda CTO Hosp, Dept Anesthesia & Intens Care Med, Turin, Italy; [Cornara, Giuseppe] Azienda Santa Croce & Carle Hosp, Dept Anesthesia & Intens Care Med, Cuneo, Italy; [Della Corte, Francesco] Univ Novara, Maggiore della Carita Hosp, Dept Anesthesia & Intens Care Med, Novara, Italy; [Vivaldi, Nicoletta] SS Antonio Biagio & Cesare Arrigo Hosp, Dept Anesthesia & Intens Care Med, Alessandria, Italy; [Malacarne, Paolo] Santa Chiara Hosp, Dept Anesthesia & Intens Care Med, Pisa, Italy; [Livigni, Sergio] Giovanni Bosco Hosp, Dept Anesthesia & Intens Care Med, Turin, Italy	A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; University of Toronto; University of Barcelona; Hospital Clinic de Barcelona; Universita degli Studi di Bari Aldo Moro; University of Padua; Azienda Ospedaliera - Universita di Padova; A.O.U. Citta della Salute e della Scienza di Torino; University of Eastern Piedmont Amedeo Avogadro; Azienda Ospedaliera SS Antonio Biagio Cesare Arrigo; Santa Chiara Hospital	Ranieri, VM (corresponding author), Univ Turin, San Giovanni Battista Molinette Hosp, Dept Anesthesia, Corso Dogliotti 14, I-10126 Turin, Italy.	marco.ranieri@unito.it	Ranieri, Marco/AFX-8152-2022; Conte, Erica L/L-7494-2013; Della Corte, Francesco/ABI-7646-2020; Grasso, Salvatore/AAF-3696-2020; mascia, Luciana/L-3039-2018; livigni, sergio/AGN-7187-2022; Slutsky, Arthur/M-3325-2019; pasero, daniela cristina/ABF-4731-2021; Grasso, Salvatore/K-8801-2019	Della Corte, Francesco/0000-0003-1736-2318; Grasso, Salvatore/0000-0002-0287-0232; Filippini, Claudia/0000-0003-0194-142X; Conte, Erica/0000-0002-2699-9591	Ministero della Salute [VMR23a]; Regione Piemonte [CIPE LM002]; Ministero dell'Universita [VMRLM98]	Ministero della Salute(Ministry of Health, Italy); Regione Piemonte(Regione Piemonte); Ministero dell'Universita(Ministry of Education, Universities and Research (MIUR))	The study was supported by grant VMR23a (2004-2006) from the Ministero della Salute, Programma Ricerca Finalizzata, grant CIPE LM002 (2005-2007) from the Regione Piemonte, Programma Ricerca Finalizzata, and grant VMRLM98 (2007-2010) from the Ministero dell'Universita, Programmi di Ricerca di Interesse Nazionale.	Angel LF, 2006, AM J RESP CRIT CARE, V174, P710, DOI 10.1164/rccm.200603-432OC; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; *CAN COUNC DON TRA, ORG DON MAN SURV GUI; de Perrot M, 2002, J THORAC CARDIOV SUR, V124, P1137, DOI 10.1067/mtc.2002.125056; Determann RM, 2010, CRIT CARE, V14, DOI 10.1186/cc8230; Fisher AJ, 2001, AM J RESP CRIT CARE, V163, P259, DOI 10.1164/ajrccm.163.1.2005093; Frost AE, 1997, CLIN CHEST MED, V18, P231, DOI 10.1016/S0272-5231(05)70374-9; Gabbay E, 1999, AM J RESP CRIT CARE, V160, P265, DOI 10.1164/ajrccm.160.1.9811017; Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; KEEGAN MT, 2010, YB INTENSIVE CARE EM; Lopez-Aguilar J, 2005, CRIT CARE MED, V33, P1077, DOI 10.1097/01.CCM.0000162913.72479.F7; Maggiore SM, 2003, AM J RESP CRIT CARE, V167, P1215, DOI 10.1164/rccm.200203-195OC; Marini JJ, 2008, CRIT CARE, V12, DOI 10.1186/cc6910; Mascia L, 2006, CRIT CARE MED, V34, P321, DOI 10.1097/01.CCM.0000196828.87358.6E; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Matuschak GM, 2006, CRIT CARE MED, V34, P548, DOI 10.1097/01.CCM.0000199980.48324.FA; POCOCK SJ, 1977, BIOMETRIKA, V64, P191, DOI 10.1093/biomet/64.2.191; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Rosengard BR, 2002, AM J TRANSPLANT, V2, P701, DOI 10.1034/j.1600-6143.2002.20804.x; Squadrone V, 2005, JAMA-J AM MED ASSOC, V293, P589, DOI 10.1001/jama.293.5.589; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Trulock EP, 1997, AM J RESP CRIT CARE, V155, P789, DOI 10.1164/ajrccm.155.3.9117010; *UN NETW ORG SHAR, 2010, CRIT PATHW ORG DON; Van Raemdonck Dirk, 2009, Proc Am Thorac Soc, V6, P28, DOI 10.1513/pats.200808-098GO; Ware LB, 2002, LANCET, V360, P619, DOI 10.1016/S0140-6736(02)09774-X; Wood KE, 2004, NEW ENGL J MED, V351, P2730, DOI 10.1056/NEJMra013103	29	211	233	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2010	304	23					2620	2627		10.1001/jama.2010.1796	http://dx.doi.org/10.1001/jama.2010.1796			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694MX	21156950	Bronze, Green Submitted			2022-12-28	WOS:000285303400025
J	Buddingh, KT; van Dam, GM; Crane, LMA				Buddingh, K. T.; van Dam, G. M.; Crane, L. M. A.			Christmas 2010: Reading between the Lines Pie sharing in complex clinical collaborations: a piece of cake?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Buddingh, K. T.; van Dam, G. M.; Crane, L. M. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, NL-9700 RB Groningen, Netherlands	University of Groningen	Buddingh, KT (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Post Box 30-001, NL-9700 RB Groningen, Netherlands.	k.t.buddingh@chir.umcg.nl							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 10	2010	341								c6641	10.1136/bmj.c6641	http://dx.doi.org/10.1136/bmj.c6641			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	695AE	21148620				2022-12-28	WOS:000285342200004
J	Morewedge, CK; Huh, YE; Vosgerau, J				Morewedge, Carey K.; Huh, Young Eun; Vosgerau, Joachim			Thought for Food: Imagined Consumption Reduces Actual Consumption	SCIENCE			English	Article							SENSORY-SPECIFIC SATIETY; ELABORATED INTRUSION THEORY; MENTAL PRACTICE; IMAGERY; HABITUATION; BEHAVIOR; CHILDREN; LIKING; HUMANS; MEMORY	The consumption of a food typically leads to a decrease in its subsequent intake through habituation-a decrease in one's responsiveness to the food and motivation to obtain it. We demonstrated that habituation to a food item can occur even when its consumption is merely imagined. Five experiments showed that people who repeatedly imagined eating a food (such as cheese) many times subsequently consumed less of the imagined food than did people who repeatedly imagined eating that food fewer times, imagined eating a different food (such as candy), or did not imagine eating a food. They did so because they desired to eat it less, not because they considered it less palatable. These results suggest that mental representation alone can engender habituation to a stimulus.	[Morewedge, Carey K.] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Huh, Young Eun; Vosgerau, Joachim] Carnegie Mellon Univ, Tepper Sch Business, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Morewedge, CK (corresponding author), Carnegie Mellon Univ, Dept Social & Decis Sci, Porter Hall 208, Pittsburgh, PA 15213 USA.	morewedge@cmu.edu	Huh, Young Eun/O-9359-2017	Huh, Young Eun/0000-0002-3069-319X	Carnegie Mellon University	Carnegie Mellon University	This work benefited from financial support from a grant to C. K. M. from the Berkman Faculty Development Fund at Carnegie Mellon University. We thank A. Kim, K. Khanna, M. Fei, L. Mosca, M. Christian, and Center for Behavioral Decision Research summer interns in 2008 and 2009 for help with the data collection. We thank C. Janiszewski, D. Kahneman, G. Loewenstein, B. Rolls, and L. Williams for helpful comments.	Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; BRICKMAN P, 1978, J PERS SOC PSYCHOL, V36, P917, DOI 10.1037/0022-3514.36.8.917; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Dadds MR, 1997, PSYCHOL BULL, V122, P89, DOI 10.1037/0033-2909.122.1.89; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; DEGRANDPRE RJ, 1993, J EXP ANAL BEHAV, V60, P641, DOI 10.1901/jeab.1993.60-641; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; Epstein LH, 2009, PSYCHOL REV, V116, P384, DOI 10.1037/a0015074; Epstein LH, 2003, APPETITE, V41, P283, DOI 10.1016/S0195-6663(03)00106-5; Ernst MM, 2002, APPETITE, V38, P224, DOI 10.1006/appe.2001.0484; Frederick S., 1999, WELL BEING FDN HEDON, P302; Havermans RC, 2009, APPETITE, V52, P222, DOI 10.1016/j.appet.2008.09.020; Higgs S, 2008, PSYCHOL SCI, V19, P623, DOI 10.1111/j.1467-9280.2008.02132.x; Huber DE, 2008, J EXP PSYCHOL LEARN, V34, P1305, DOI 10.1037/a0013370; Kavanagh DJ, 2005, PSYCHOL REV, V112, P446, DOI 10.1037/0033-295X.112.2.446; Kemps E, 2007, J EXP PSYCHOL-APPL, V13, P95, DOI 10.1037/1076-898X.13.2.95; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; LANG PJ, 1977, BEHAV THER, V8, P862, DOI 10.1016/S0005-7894(77)80157-3; McSweeney FK, 2000, J EXP ANAL BEHAV, V74, P347, DOI 10.1901/jeab.2000.74-347; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; ROLLS BJ, 1982, PHYSIOL BEHAV, V29, P409, DOI 10.1016/0031-9384(82)90259-1; ROLLS BJ, 1981, PHYSIOL BEHAV, V27, P137, DOI 10.1016/0031-9384(81)90310-3; Rozin P, 1998, PSYCHOL SCI, V9, P392, DOI 10.1111/1467-9280.00073; Soetens B, 2006, J HEALTH PSYCHOL, V11, P655, DOI 10.1177/1359105306066615; TIFFANY ST, 1990, ADDICT BEHAV, V15, P531, DOI 10.1016/0306-4603(90)90053-Z; Williams LE, 2008, PSYCHOL SCI, V19, P302, DOI 10.1111/j.1467-9280.2008.02084.x; Wohldmann EL, 2007, J EXP PSYCHOL LEARN, V33, P254, DOI 10.1037/0278-7393.33.1.254; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	28	193	196	5	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1530	1533		10.1126/science.1195701	http://dx.doi.org/10.1126/science.1195701			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	692LE	21148388				2022-12-28	WOS:000285153500062
J	Takano, K; Watanabe-Takano, H; Suetsugu, S; Kurita, S; Tsujita, K; Kimura, S; Karatsu, T; Takenawa, T; Endo, T				Takano, Kazunori; Watanabe-Takano, Haruko; Suetsugu, Shiro; Kurita, Souichi; Tsujita, Kazuya; Kimura, Sumiko; Karatsu, Takashi; Takenawa, Tadaomi; Endo, Takeshi			Nebulin and N-WASP Cooperate to Cause IGF-1-Induced Sarcomeric Actin Filament Formation	SCIENCE			English	Article							SKELETAL-MUSCLE; ELONGATION-FACTORS; NUCLEATION	Insulin-like growth factor 1 (IGF-1) induces skeletal muscle maturation and enlargement (hypertrophy). These responses require protein synthesis and myofibril formation (myofibrillogenesis). However, the signaling mechanisms of myofibrillogenesis remain obscure. We found that IGF-1-induced phosphatidylinositol 3-kinase-Akt signaling formed a complex of nebulin and N-WASP at the Z bands of myofibrils by interfering with glycogen synthase kinase-3 beta in mice. Although N-WASP is known to be an activator of the Arp2/3 complex to form branched actin filaments, the nebulin-N-WASP complex caused actin nucleation for unbranched actin filament formation from the Z bands without the Arp2/3 complex. Furthermore, N-WASP was required for IGF-1-induced muscle hypertrophy. These findings present the mechanisms of IGF-1-induced actin filament formation in myofibrillogenesis required for muscle maturation and hypertrophy and a mechanism of actin nucleation.	[Takano, Kazunori; Watanabe-Takano, Haruko; Kurita, Souichi; Kimura, Sumiko; Endo, Takeshi] Chiba Univ, Grad Sch Sci, Dept Biol, Inage Ku, Chiba 2638522, Japan; [Takano, Kazunori; Watanabe-Takano, Haruko; Suetsugu, Shiro; Takenawa, Tadaomi; Endo, Takeshi] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Suetsugu, Shiro] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Suetsugu, Shiro] Japan Sci & Technol Agcy, PRESTO, Chiyoda Ku, Tokyo 1020075, Japan; [Tsujita, Kazuya; Takenawa, Tadaomi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Lipid Biochem, Kobe, Hyogo 6500017, Japan; [Karatsu, Takashi] Chiba Univ, Grad Sch Engn, Dept Appl Chem & Biotechnol, Inage Ku, Chiba 2638522, Japan	Chiba University; Japan Science & Technology Agency (JST); University of Tokyo; Japan Science & Technology Agency (JST); Kobe University; Chiba University	Endo, T (corresponding author), Chiba Univ, Grad Sch Sci, Dept Biol, Inage Ku, 1-33 Yayoicho, Chiba 2638522, Japan.	t.endo@faculty.chiba-u.jp	Suetsugu, Shiro/B-3300-2010; Suetsugu, Shiro/AAF-4427-2019; Suetsugu, Shiro/ABB-6033-2020; Karatsu, Takashi/M-6937-2017	Suetsugu, Shiro/0000-0002-4612-0628; Suetsugu, Shiro/0000-0002-4612-0628; Karatsu, Takashi/0000-0002-8515-9584	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan [17A-10, 20B-13]; Grants-in-Aid for Scientific Research [22570153, 22770185] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Watanabe and T. Itoh for comments. This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Research Grants (17A-10 and 20B-13) for Nervous and Mental Disorders from the Ministry of Health, Labor, and Welfare of Japan.	Bang ML, 2006, J CELL BIOL, V173, P905, DOI 10.1083/jcb.200603119; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; LABEIT S, 1995, J MOL BIOL, V248, P308, DOI 10.1016/S0022-2836(95)80052-2; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McElhinny AS, 2003, TRENDS CARDIOVAS MED, V13, P195, DOI 10.1016/S1050-1738(03)00076-8; Mourkioti F, 2005, TRENDS IMMUNOL, V26, P535, DOI 10.1016/j.it.2005.08.002; Ojima K, 2000, J CELL BIOL, V150, P553, DOI 10.1083/jcb.150.3.553; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Pfuhl M, 1996, J MOL BIOL, V257, P367, DOI 10.1006/jmbi.1996.0169; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Qualmann B, 2009, TRENDS CELL BIOL, V19, P276, DOI 10.1016/j.tcb.2009.03.004; Sanoudou D, 2001, TRENDS MOL MED, V7, P362, DOI 10.1016/S1471-4914(01)02089-5; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Witt CC, 2006, EMBO J, V25, P3843, DOI 10.1038/sj.emboj.7601242	17	64	68	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2010	330	6010					1536	1540		10.1126/science.1197767	http://dx.doi.org/10.1126/science.1197767			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148390				2022-12-28	WOS:000285153500064
J	Cunningham, AL; Jones, CP; Ansell, J; Barry, JD				Cunningham, Andrew L.; Jones, Christopher P.; Ansell, James; Barry, Jonathan D.			Christmas 2010: Surgery Red for danger: the effects of red hair in surgical practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BRITTLE CORNEA SYNDROME; RECEPTOR GENE; VARIANTS; REDHEADS; HUMANS; COLOR; PAIN		[Cunningham, Andrew L.; Jones, Christopher P.; Barry, Jonathan D.] Abertawe Bro Morgannwg NHS Trust, Morriston Hosp, Dept Gen Surg, Welsh Inst Metab & Obes Surg,Fdn Programme, Swansea SA6 6NL, W Glam, Wales	Morriston Hospital	Barry, JD (corresponding author), Abertawe Bro Morgannwg NHS Trust, Morriston Hosp, Dept Gen Surg, Welsh Inst Metab & Obes Surg,Fdn Programme, Swansea SA6 6NL, W Glam, Wales.	jbarry@doctors.org.uk						Abu A, 2008, AM J HUM GENET, V82, P1217, DOI 10.1016/j.ajhg.2008.04.001; Abu A, 2006, INVEST OPHTH VIS SCI, V47, P5283, DOI 10.1167/iovs.06-0206; [Anonymous], 2007, NATL GEOGRAPHIC  SEP; EIBERG H, 1987, CLIN GENET, V32, P125; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Klinge U, 2006, Hernia, V10, P472, DOI 10.1007/s10029-006-0145-8; Kumar VV, 2004, LARYNGOSCOPE, V114, P2031, DOI 10.1097/01.mlg.0000147942.82626.1c; Liem EB, 2006, ANESTH ANALG, V102, P313, DOI 10.1213/01.ANE.0000180769.51576.CD; Liem EB, 2005, ANESTHESIOLOGY, V102, P509, DOI 10.1097/00000542-200503000-00006; Liem EB, 2004, ANESTHESIOLOGY, V101, P279, DOI 10.1097/00000542-200408000-00006; Missmer SA, 2006, FERTIL STERIL, V85, P866, DOI 10.1016/j.fertnstert.2005.12.008; Mogil JS, 2005, J MED GENET, V42, P583, DOI 10.1136/jmg.2004.027698; ROYCE PM, 1990, EUR J PEDIATR, V149, P465, DOI 10.1007/BF01959396; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; *WIK, 2010, KISS JUD; 2010, HARMAN SAYS SORRY GI	16	6	6	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2010	341								c6931	10.1136/bmj.c6931	http://dx.doi.org/10.1136/bmj.c6931			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZU	21148222				2022-12-28	WOS:000285341200011
J	Bonnett, LJ; Tudur-Smith, C; Williamson, PR; Marson, AG				Bonnett, L. J.; Tudur-Smith, C.; Williamson, P. R.; Marson, A. G.			Risk of recurrence after a first seizure and implications for driving: further analysis of the Multicentre study of early Epilepsy and Single Seizures	BRITISH MEDICAL JOURNAL			English	Article							SURVIVAL; TRIAL	Objective To determine for how long after a first unprovoked seizure a driver must be seizure-free before the risk of recurrence in the next 12 months falls below 20%, enabling them to regain their driving licence. Design Randomised controlled trial: Multicentre study of early Epilepsy and Single Seizures (MESS). Setting UK hospital outpatient clinics from 1 January 1993 to 31 December 2000. Participants People entered MESS if they had had one or more unprovoked seizures and both the participant and the clinician were uncertain about the need to start antiepileptic drug treatment. The subset of people used for this analysis comprised participants aged at least 16 years with a single unprovoked seizure. Main outcome measure Risk of seizure recurrence in the 12 months after a seizure-free period of 6, 12, 18, or 24 months from the date of the first (index) seizure. Regression modelling was used to investigate how antiepileptic treatment and several clinical factors influence the risk of seizure recurrence. Results At six months after the index seizure the risk of recurrence in the next 12 months for those who start antiepileptic drugs was significantly below 20% (unadjusted risk 14%, 95% confidence interval 10% to 18%). For patients who did not start treatment the risk estimate was less than 20% but the upper limit of the confidence interval was greater than 20% (18%, 13% to 23%). Multivariable analyses identified subgroups with a significantly greater than 20% risk of seizure recurrence in the 12 months after a six month seizure-free period, such as those with a remote symptomatic seizure with abnormal electroencephalogram results. Conclusion After a single unprovoked seizure this reanalysis of MESS provides estimates of seizure recurrence risks that will inform policy and guidance about regaining an ordinary driving licence. Further guidance is needed as to how such data should be utilised; in particular, whether a population approach should be taken with a focus on the unadjusted results or whether attempts should be made to individualise risk. Guidance is also required as to whether the focus should be on risk estimates only or on the confidence interval as well. If the focus is on the estimate only our unadjusted estimates suggest that treated and untreated patients are eligible to drive after being seizure-free for six months. If the focus is also on confidence intervals, direction is needed as to whether a conservative or liberal approach should be taken.	[Bonnett, L. J.; Tudur-Smith, C.; Williamson, P. R.; Marson, A. G.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Marson, AG (corresponding author), Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England.	A.G.Marson@liverpool.ac.uk	Marson, Anthony/AAW-9776-2020; Bonnett, Laura/A-2159-2015; Williamson, Paula R/B-6425-2016	Marson, Anthony/0000-0002-6861-8806; Bonnett, Laura/0000-0002-6981-9212; Williamson, Paula R/0000-0001-9802-6636	National Institute for Health [RP-PG-0606-1062]; Medical Research Council; National Institute for Health Research [RP-PG-0606-1062] Funding Source: researchfish	National Institute for Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study (RP-PG-0606-1062) was supported by the National Institute for Health Research programme grants for applied research funding scheme. The original trial was funded by the Medical Research Council. The views and opinions expressed within this paper do not necessarily reflect those of the National Health Service, the National Institute for Health Research, or the Department of Health. The researchers are independent from the funders.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Collett, 2003, MODELLING SURVIVAL D; Cox D. R., 1984, ANAL SURVIVAL DATA; Davis FG, 1999, CANCER, V85, P485, DOI 10.1002/(SICI)1097-0142(19990115)85:2<485::AID-CNCR29>3.3.CO;2-C; Driver and Vehicle Licensing Agency, 2010, GLANC GUID CURR MED; FISHER RS, 1994, EPILEPSIA, V35, P675, DOI 10.1111/j.1528-1157.1994.tb02491.x; HART YM, 1990, LANCET, V336, P1271, DOI 10.1016/0140-6736(90)92960-P; Kim LG, 2006, LANCET NEUROL, V5, P317, DOI 10.1016/S1474-4422(06)70383-0; Krauss GL, 2001, NEUROLOGY, V57, P1780, DOI 10.1212/WNL.57.10.1780; Lin CL, 2003, SURG NEUROL, V60, P402, DOI 10.1016/S0090-3019(03)00322-7; Marson A, 2005, LANCET, V365, P2007, DOI 10.1016/S0140-6736(05)66694-9; Schmedding E, 2004, ACTA NEUROL BELG, V104, P68; *SEC EUR WORK GROU, 2005, EP DRIV EUR; 1992, EPILEPSIA, V33, P45	14	35	36	1	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 7	2010	341								c6477	10.1136/bmj.c6477	http://dx.doi.org/10.1136/bmj.c6477			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694YK	21147743	Green Published, hybrid			2022-12-28	WOS:000285337600006
J	Woodhead, C; Wessely, S				Woodhead, Charlotte; Wessely, Simon			Commentary: what interventions work for victims of conflict related rape?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WAR		[Woodhead, Charlotte; Wessely, Simon] Kings Coll London, Inst Psychiat, Kings Ctr Mil Hlth Res, London WC2R 2LS, England	University of London; King's College London	Wessely, S (corresponding author), Kings Coll London, Inst Psychiat, Kings Ctr Mil Hlth Res, London WC2R 2LS, England.	simon.wessely@kcl.ac.uk	Wessely, Simon C/A-8713-2008	Wessely, Simon Charles/0000-0002-6743-9929				BBC News, 2010, BBC NEWS        0908; Bracken P J, 1992, Med War, V8, P155, DOI 10.1080/07488009208409041; BURNAM MA, 1988, J CONSULT CLIN PSYCH, V56, P843, DOI 10.1037/0022-006X.56.6.843; Farwell N, 2004, AFFILIA J WOM SOC WO, V19, P389, DOI 10.1177/0886109904268868; Gingerich T., 2004, USE RAPE WEAPON WAR; IASC, 2015, GUID INT GEND BAS VI; KOZARICKOVACIC D, 1993, CROAT MED J, V34, P86; Loncar M, 2006, CROAT MED J, V47, P67; MAWATHE A, 2010, BBC NEWS        0515; Moszynski P, 2004, BRIT MED J, V329, P251, DOI 10.1136/bmj.329.7460.251-b; Mukwege DM, 2010, INT HEALTH, V2, P163, DOI 10.1016/j.inhe.2010.06.003; Ojiambo-Ochieng R., 2008, J INT WOMENS STUDIES, V9, P174; Papineni P, 2003, LANCET, V362, P825, DOI 10.1016/S0140-6736(03)14277-8; Pupavac V., 2004, EUR J SOC THEORY, V7, P149, DOI [DOI 10.1177/1368431004041749, 10.1177/1368431004041749]; Shanks L, 2000, CAN MED ASSOC J, V163, P1152; Stein DJ, 2007, LANCET, V369, P139, DOI 10.1016/S0140-6736(07)60075-0; STIGLMAYER A, 1993, MASS RAPE WAR WOMEN, P1; Summerfield D, 2008, BMJ-BRIT MED J, V336, P992, DOI 10.1136/bmj.39513.441030.AD; TWAGIRAMARIYA C, 1998, WHAT WOMEN DO WARTIM, P101; *UN COMM HUM RIGHT, 1995, SEX VIOL REG GUID PR; *UN SUBCOMM PROM P, 2002, SYST RAP SEX SLAV SL; UNFPA, 2010, STAT WORLD POP 2010; UNICEF, 2006, STAT WORLDS CHILDR 2; WARD J, 2006, INT S SEX VIOL CONFL	24	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2010	341								c7038	10.1136/bmj.c7038	http://dx.doi.org/10.1136/bmj.c7038			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	694YK	21139010				2022-12-28	WOS:000285337600009
J	Levine, AJ; Puzio-Kuter, AM				Levine, Arnold J.; Puzio-Kuter, Anna M.			The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes	SCIENCE			English	Review							CELL-GROWTH; P53-INDUCIBLE REGULATOR; GLUTAMINE-METABOLISM; DIABETIC-PATIENTS; P53; METFORMIN; PROTEIN; GLYCOLYSIS; APOPTOSIS; PATHWAYS	Cells from some tumors use an altered metabolic pattern compared with that of normal differentiated adult cells in the body. Tumor cells take up much more glucose and mainly process it through aerobic glycolysis, producing large quantities of secreted lactate with a lower use of oxidative phosphorylation that would generate more adenosine triphosphate (ATP), water, and carbon dioxide. This is the Warburg effect, which provides substrates for cell growth and division and free energy (ATP) from enhanced glucose use. This metabolic switch places the emphasis on producing intermediates for cell growth and division, and it is regulated by both oncogenes and tumor suppressor genes in a number of key cancer-producing pathways. Blocking these metabolic pathways or restoring these altered pathways could lead to a new approach in cancer treatments.	[Levine, Arnold J.] Inst Adv Study, Princeton, NJ 08540 USA; [Levine, Arnold J.; Puzio-Kuter, Anna M.] Canc Inst New Jersey, New Brunswick, NJ 08903 USA	Institute for Advanced Study - USA; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Levine, AJ (corresponding author), Inst Adv Study, Olden Lane, Princeton, NJ 08540 USA.	alevine@ias.edu						Ak P, 2010, FASEB J, V24, P3643, DOI 10.1096/fj.10-160549; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Dang CV, 1999, MOL CELL BIOL, V19, P1; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Feng Z., 2010, P53 FAMILY, P199; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Gottlieb E., 2010, P5O FAMILY, P187; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hewitson KS, 2003, BIOCHEM SOC T, V31, P510, DOI 10.1042/BST0310510; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hu W., 2010, P NATL ACAD SCI USA, V107, P7455; Hunt TK, 2007, ANTIOXID REDOX SIGN, V9, P1115, DOI 10.1089/ars.2007.1674; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kranendijk M, 2010, SCIENCE, V330, P336, DOI 10.1126/science.1192632; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Locasale JW, 2009, NAT BIOTECHNOL, V27, P916, DOI 10.1038/nbt1009-916; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Tennant DA, 2009, CARCINOGENESIS, V30, P1269, DOI 10.1093/carcin/bgp070; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P309; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	39	880	912	8	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1340	1344		10.1126/science.1193494	http://dx.doi.org/10.1126/science.1193494			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127244				2022-12-28	WOS:000284902100033
J	Gan, BY; Hu, JA; Jiang, S; Liu, YC; Sahin, E; Zhuang, L; Fletcher-Sananikone, E; Colla, S; Wang, YA; Chin, L; DePinho, RA				Gan, Boyi; Hu, Jian; Jiang, Shan; Liu, Yingchun; Sahin, Erguen; Zhuang, Li; Fletcher-Sananikone, Eliot; Colla, Simona; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.			Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells	NATURE			English	Article							MITOCHONDRIAL BIOGENESIS; ENERGY; RESISTANCE; PATHWAY; BIOLOGY; STRESS; KINASE; FOXOS	The capacity to fine-tune cellular bioenergetics with the demands of stem-cell maintenance and regeneration is central to normal development and ageing, and to organismal survival during periods of acute stress. How energy metabolism and stem-cell homeostatic processes are coordinated is not well understood. Lkb1 acts as an evolutionarily conserved regulator of cellular energy metabolism in eukaryotic cells and functions as the major upstream kinase to phosphorylate AMP-activated protein kinase (AMPK) and 12 other AMPK-related kinases(1-3). Whether Lkb1 regulates stem-cell maintenance remains unknown. Here we show that Lkb1 has an essential role in haematopoietic stem cell (HSC) homeostasis. We demonstrate that ablation of Lkb1 in adult mice results in severe pancytopenia and subsequent lethality. Loss of Lkb1 leads to impaired survival and escape from quiescence of HSCs, resulting in exhaustion of the HSC pool and a marked reduction of HSC repopulating potential in vivo. Lkb1 deletion has an impact on cell proliferation in HSCs, but not on more committed compartments, pointing to context-specific functions for Lkb1 in haematopoiesis. The adverse impact of Lkb1 deletion on haematopoiesis was predominantly cell-autonomous and mTOR complex 1 (mTORC1)-independent, and involves multiple mechanisms converging on mitochondrial apoptosis and possibly downregulation of PGC-1 coactivators and their transcriptional network, which have critical roles in mitochondrial biogenesis and function. Thus, Lkb1 serves as an essential regulator of HSCs and haematopoiesis, and more generally, points to the critical importance of coupling energy metabolism and stem-cell homeostasis.	[Gan, Boyi; Hu, Jian; Jiang, Shan; Liu, Yingchun; Sahin, Erguen; Zhuang, Li; Fletcher-Sananikone, Eliot; Colla, Simona; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Gan, Boyi; Hu, Jian; Jiang, Shan; Liu, Yingchun; Sahin, Erguen; Zhuang, Li; Fletcher-Sananikone, Eliot; Colla, Simona; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Gan, Boyi; Hu, Jian; Jiang, Shan; Liu, Yingchun; Sahin, Erguen; Zhuang, Li; Fletcher-Sananikone, Eliot; Colla, Simona; Wang, Y. Alan; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med & Genet, Boston, MA 02115 USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	DePinho, RA (corresponding author), Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu	Gan, Boyi/HDM-4206-2022	DePinho, Ronald/0000-0002-5625-577X; Colla, Simona/0000-0001-6583-8910	DOD [TS093049]; Multiple Myeloma Research Foundation; Robert A. and Renee E. Belfer Foundation;  [U01CA141508];  [R21CA135057]; NATIONAL CANCER INSTITUTE [R21CA135057, U01CA141508] Funding Source: NIH RePORTER	DOD(United States Department of Defense); Multiple Myeloma Research Foundation; Robert A. and Renee E. Belfer Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to A. Berns for providing the Rosa26-creERt2 mouse strain. We are also grateful to S. Zhou for assistance in the animal facility and C. Lim for assistance with genotyping. We thank S. Lazo-Kallanian, J. Daley and P. Schow for assistance with flow cytometry. We also thank N. Bardeesy and S. Morrison for communicating unpublished information; A. Stegh for comments on apoptosis; and D. Nakada for western blotting protocol from sorted HSCs. This research was supported by U01CA141508 (R.A.D. and L.C.), R21CA135057 (R.A.D. and B.G.) and DOD TSCRP Career Transition Award (TS093049) (B.G.). B.G. and J.H. are the Research Fellows of the Leukemia and Lymphoma Society. Y.A.W. is supported by Multiple Myeloma Research Foundation. R.A.D. was supported by an American Cancer Society Research Professorship and the Robert A. and Renee E. Belfer Foundation.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Gan B, 2009, CELL CYCLE, V8, P1003, DOI 10.4161/cc.8.7.8045; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Ito K, 2009, CURR OPIN GENET DEV, V19, P51, DOI 10.1016/j.gde.2009.01.004; Ji HK, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl803; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Li C., 2003, ANAL GENE EXPRESSION; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	24	318	332	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 2	2010	468	7324					701	U125		10.1038/nature09595	http://dx.doi.org/10.1038/nature09595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124456	Green Accepted			2022-12-28	WOS:000284836700042
J	Casillas, CE; Kammen, DM				Casillas, Christian E.; Kammen, Daniel M.			The Energy-Poverty-Climate Nexus	SCIENCE			English	Editorial Material									[Casillas, Christian E.; Kammen, Daniel M.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Kammen, Daniel M.] Univ Calif Berkeley, Goldman Sch Publ Policy, Berkeley, CA 94720 USA; [Casillas, Christian E.; Kammen, Daniel M.] Univ Calif Berkeley, Renewable & Appropriate Energy Lab, Berkeley, CA 94720 USA; [Kammen, Daniel M.] World Bank, Washington, DC 20443 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; The World Bank	Kammen, DM (corresponding author), Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA.	dkammen@worldbank.org						Alteri MA, 2002, AGR ECOSYST ENVIRON, V93, P1, DOI 10.1016/S0167-8809(02)00085-3; [Anonymous], EN SUST FUT SECR GEN; [Anonymous], 2005, ENERGY SERVICES MILL; Bierbaum R.M., 2010, WORLD DEV REPORT 201; Cabraal RA, 2005, ANNU REV ENV RESOUR, V30, P117, DOI 10.1146/annurev.energy.30.050504.144228; Cecelski E., 2000, ENABBING EQUITABLE A; Energy Sector Management Assistance Programme, 2007, TECHN EC ASS OFF GRI; Ezzati M, 2001, LANCET, V358, P619, DOI 10.1016/S0140-6736(01)05777-4; Flavin C., 2005, ENERGY DEV POTENTIAL; Independent Evaluation Group, 2008, WELF IMP RUR EL REAS; Intergovernmental Panel on Climate Change, 2007, CLIM CHANG 2007 IMP; Jacobson A, 2005, ENERG POLICY, V33, P1825, DOI 10.1016/j.enpol.2004.02.017; JAFFE AB, 1994, ENERG POLICY, V22, P804, DOI 10.1016/0301-4215(94)90138-4; Johnson T., 2009, LOW CARBON DEV MEXIC; Kirubi C, 2009, WORLD DEV, V37, P1208, DOI 10.1016/j.worlddev.2008.11.005; McKinsey & Company, 2009, PATHW LOW CARB EC; Mills E, 2005, SCIENCE, V308, P1263, DOI 10.1126/science.1113090; Mostert W., 2007, UNLOCKING POTENTIAL; Romijn H, 2010, ENVIRON SCI POLICY, V13, P326, DOI 10.1016/j.envsci.2010.03.006; Smith KR, 2010, J EXPO SCI ENV EPID, V20, P406, DOI 10.1038/jes.2009.30; Stern PC, 2010, ENVIRON SCI TECHNOL, V44, P4847, DOI 10.1021/es100896p; [No title captured]	22	133	136	9	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1181	1182		10.1126/science.1197412	http://dx.doi.org/10.1126/science.1197412			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	685FE	21109654				2022-12-28	WOS:000284613700021
J	Rossky, PJ; Walker, GC				Rossky, Peter J.; Walker, Gilbert C.			Paul F. Barbara (1953-2010)	SCIENCE			English	Biographical-Item									[Rossky, Peter J.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Walker, Gilbert C.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada	University of Texas System; University of Texas Austin; University of Toronto	Rossky, PJ (corresponding author), Univ Texas Austin, Dept Chem & Biochem, 1 Univ Stn,A5300, Austin, TX 78712 USA.	rossky@mail.utexas.edu; gwalker@chem.utoronto.ca						BARBARA PF, PUBLICATION LIST, DOI DOI 10.1146/ANNUREV.NEURO.27.070203.144327	1	0	0	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2010	330	6008					1191	1191		10.1126/science.1199894	http://dx.doi.org/10.1126/science.1199894			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109661				2022-12-28	WOS:000284613700028
J	Ma, I; Tierney, LM				Ma, Iris; Tierney, Lawrence M., Jr.			Name That Murmur - Eponyms for the Astute Auscultician.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AUSTIN FLINT MURMUR		[Ma, Iris] Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ma, I (corresponding author), Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94143 USA.							BARLOW JB, 1983, CC/CLIN PRACTICE, P18; BARLOW JB, 1968, BRIT HEART J, V30, P203; Berry D, 2006, CIRCULATION, V114, pF172; BESTERMAN EMM, 1955, BRIT HEART J, V17, P360; Bramwell C., 1942, BRIT HEART JOUR, V4, P115; Cabot RC, 1903, B JOHNS HOPKINS HOSP, V14, P115; CABOT RC, 1912, PHYS DIAGNOSIS; CANDY D, 2001, CLIN PAEDIAT CHILD H, P173; Chaterjee K., 2007, TXB CARDIOVASCULAR M, P193; Cheng TO, 2000, CLIN CARDIOL, V23, P66, DOI 10.1002/clc.4960230123; Chizner MA, 2008, CURR PROB CARDIOLOGY, V33, P326, DOI 10.1016/j.cpcardiol.2008.03.003; Coombs C., 1924, RHEUMATIC HEART DIS; DOCK W, 1967, AM J MED, V42, P617, DOI 10.1016/0002-9343(67)90060-5; DODDS TA, 1993, ANN INTERN MED, V119, P417, DOI 10.7326/0003-4819-119-5-199309010-00011; Dunn PM, 2006, ARCH DIS CHILD-FETAL, V91, pF75, DOI 10.1136/adc.2005.074534; FLINT A, 1862, AM J MED SCI, V44, P29; FORTUIN NJ, 1972, CIRCULATION, V45, P558, DOI 10.1161/01.CIR.45.3.558; FOWLER G, 1990, NY TIMES        1023; FRASER AG, 1991, J ROY COLL PHYS LOND, V25, P66; Gibson GA, 1906, MED PRESS CIRCULAR, V132, P572; GILCHRIST AR, 1945, BRIT HEART J, V7, P1; HAMILTON EBD, 1986, ANN RHEUM DIS, V45, P1, DOI 10.1136/ard.45.1.1; HODGKIN T, 1928, LONDON MEDICAL GAZET, V3, P433; LANDZBERG JS, 1992, J AM COLL CARDIOL, V20, P408, DOI 10.1016/0735-1097(92)90110-9; Mehta NJ, 2000, TEX HEART I J, V27, P386; MULCAHY R, 1962, BRIT HEART J, V24, P633; O'Rourke RA, 2004, HEART, P1695; O'Rourke RA, 2004, HURSTS HEART, P217; Oshinski J, 1998, CIRCULATION, V98, P2782, DOI 10.1161/01.CIR.98.24.2782; Ramaswamy P, VENTRICULAR SEPTAL D; Roger H., 1879, B ACAD MED PARIS, V8, P1074; Ruschhaupt D. G, 2004, ESSENTIAL PEDIAT CAR, P9; Steel G., 1888, MED CHRONICLE, V9, P182; Steell G, 1942, BMJ-BRIT MED J, V1, P129; Still G F, 1897, Med Chir Trans, V80, P47; STILL GF, 1909, COMMON DISORDERS DIS; Treves F, 1900, J AMER MED ASSOC, V35, P293; Tynan M, 2003, CARDIOL YOUNG, V13, P559, DOI 10.1017/S1047951103001161; *WHONAMEDIT COM, BARL SYNDR; WIGLE ED, 1976, ANNU REV MED, V27, P165, DOI 10.1146/annurev.me.27.020176.001121; WOOD P, 1958, BRIT MED J, V2, P755, DOI 10.1136/bmj.2.5099.755; WOOD P, 1950, P ROY SOC MED, V43, P195, DOI 10.1177/003591575004300316; 1970, JAMA, V213, P456; 1924, BMJ, V2, P70	44	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2010	363	22					2164	2168		10.1056/NEJMon1006947	http://dx.doi.org/10.1056/NEJMon1006947			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	684XE	21105801				2022-12-28	WOS:000284587800015
J	Israelsen, WJ; Vander Heiden, MG				Israelsen, William J.; Vander Heiden, Matthew G.			ATP Consumption Promotes Cancer Metabolism	CELL			English	Editorial Material							ENDOPLASMIC-RETICULUM; SULFATE		[Israelsen, William J.; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Vander Heiden, MG (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mvh@mit.edu		Israelsen, William/0000-0002-3653-9353				DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DUNAWAY GA, 1983, MOL CELL BIOCHEM, V52, P75; Fang M, 2010, CELL, V143, P711, DOI 10.1016/j.cell.2010.10.010; Hartsough MT, 2000, J BIOENERG BIOMEMBR, V32, P301, DOI 10.1023/A:1005597231776; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; SCHOLNICK P, 1973, J BIOL CHEM, V248, P5175; Trombetta ES, 1999, EMBO J, V18, P3282, DOI 10.1093/emboj/18.12.3282; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546	10	39	40	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					669	671		10.1016/j.cell.2010.11.010	http://dx.doi.org/10.1016/j.cell.2010.11.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111226	Green Published, Bronze			2022-12-28	WOS:000284583500007
J	Decramer, M; Sibille, Y				Decramer, Marc; Sibille, Yves			European conference on chronic respiratory disease	LANCET			English	Editorial Material							PULMONARY REHABILITATION; COPD; CHILDHOOD; IMPACT		[Decramer, Marc] Katholieke Univ Leuven, Div Resp, B-3000 Louvain, Belgium; [Sibille, Yves] Univ Louvain, Louvain, Belgium	KU Leuven	Decramer, M (corresponding author), Katholieke Univ Leuven, Div Resp, B-3000 Louvain, Belgium.	marc.decramer@uzleuven.be						Bourbeau J, 2003, ARCH INTERN MED, V163, P585, DOI 10.1001/archinte.163.5.585; Brooks D, 2007, CAN RESPIR J, V14, P87, DOI 10.1155/2007/951498; Bush A, 2008, COPD, V5, P53, DOI 10.1080/15412550701815965; Casas A, 2006, EUR RESPIR J, V28, P123, DOI 10.1183/09031936.06.00063205; Chronic Disease Alliance, UN PREV APPR; Decramer M, 2008, COPD, V5, P235, DOI 10.1080/15412550802237531; *EUR COMM, 2009, SURV TOB AN REP; Gibson J, 2013, EUROPEAN LUNG WHITE BOOK: RESPIRATORY HEALTH AND DISEASE IN EUROPE, P16; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Laurent GJ, 2004, THORAX, V59, P1010, DOI 10.1136/thx.2004.024182; Li YF, 2005, CHEST, V127, P1232, DOI 10.1378/chest.127.4.1232; Munthe-Kaas MC, 2010, J ALLERGY CLIN IMMUN, V125, P1361, DOI 10.1016/j.jaci.2010.02.010; Rennard S, 2002, EUR RESPIR J, V20, P799, DOI 10.1183/09031936.02.03242002; Soriano JB, 2009, LANCET, V374, P721, DOI 10.1016/S0140-6736(09)61290-3; Svanes C, 2010, THORAX, V65, P14, DOI 10.1136/thx.2008.112136; The Forum of International Respiratory Societies (FIRS), YEAR LUNG; Troosters T, 2005, AM J RESP CRIT CARE, V172, P19, DOI 10.1164/rccm.200408-1109SO; WHO, 2008, WORLD HLTH STAT	18	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					104	106		10.1016/S0140-6736(10)62239-8	http://dx.doi.org/10.1016/S0140-6736(10)62239-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707NH	21168909				2022-12-28	WOS:000286292800007
J	Katz, KA				Katz, Kenneth A.			Health Hazards of "Don't Ask, Don't Tell"	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Katz, Kenneth A.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Katz, Kenneth A.] Univ Calif San Diego, Div Dermatol, La Jolla, CA 92093 USA	California State University System; San Diego State University; University of California System; University of California San Diego	Katz, KA (corresponding author), San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA.							Gates GJ., 2010, LESBIAN GAY BISEXUAL; Nagel Frederick, 2010, Virtual Mentor, V12, P663, DOI 10.1001/virtualmentor.2010.12.8.pfor1-1008; *OFF SECR DEF, SUMM CHANG REV DONT; OREILLY KB, 2009, AM MED NEWS     1123; Smith DM, 2008, J HOMOSEXUAL, V54, P277, DOI 10.1080/00918360801982173	5	15	15	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2010	363	25					2380	2381		10.1056/NEJMp1012496	http://dx.doi.org/10.1056/NEJMp1012496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	694ZK	21121826				2022-12-28	WOS:000285340200002
J	Hurley, JH; Boura, E; Carlson, LA; Rozycki, B				Hurley, James H.; Boura, Evzen; Carlson, Lars-Anders; Rozycki, Bartosz			Membrane Budding	CELL			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; ESCRT-III PROTEIN; VESICULAR-STOMATITIS-VIRUS; PLASMA-MEMBRANE; MATRIX PROTEIN; PHASE-SEPARATION; STRUCTURAL BASIS; LIPID RAFTS; INTRALUMENAL VESICLES; COAT PROTEINS	Membrane budding is a key step in vesicular transport, multivesicular body biogenesis, and enveloped virus release. These events range from those that are primarily protein driven, such as the formation of coated vesicles, to those that are primarily lipid driven, such as microdomain-dependent biogenesis of multivesicular bodies. Other types of budding reside in the middle of this spectrum, including caveolae biogenesis, HIV-1 budding, and ESCRT-catalyzed multivesicular body formation. Some of these latter events involve budding away from cytosol, and this unusual topology involves unique mechanisms. This Review discusses progress toward understanding the structural and energetic bases of these different membrane-budding paradigms.	[Hurley, James H.; Boura, Evzen; Carlson, Lars-Anders] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Rozycki, Bartosz] NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Rozycki, Bartosz/B-7005-2009; Boura, Evzen/G-5275-2014; Boura, Evzen/I-2626-2012	Rozycki, Bartosz/0000-0001-5938-7308; Carlson, Lars-Anders/0000-0003-2342-6488; Boura, Evzen/0000-0002-9652-4065	National Institutes of Health; NIDDK; IATAP; European Community; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); IATAP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Freed, G. Raposo, W. Prinz, M. Marks, J. Gruenberg, and J. Bonifacino for comments on drafts of the manuscript, J. Heuser for providing the image used in Figure 1F, and many colleagues for stimulating discussions. Research in the Hurley laboratory is supported the Intramural program of the National Institutes of Health, NIDDK, and IATAP. B.R. was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme.	ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Barman S, 2004, J VIROL, V78, P5258, DOI 10.1128/JVI.78.10.5258-5269.2004; Bassereau P, 2010, NAT CELL BIOL, V12, P422, DOI 10.1038/ncb0510-422; Bauer M, 2006, FEBS LETT, V580, P5559, DOI 10.1016/j.febslet.2006.08.077; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; BLOOM M, 1991, Q REV BIOPHYS, V24, P293, DOI 10.1017/S0033583500003735; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Bruce EA, 2009, VIROLOGY, V390, P268, DOI 10.1016/j.virol.2009.05.016; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Campbell S, 2001, P NATL ACAD SCI USA, V98, P10875, DOI 10.1073/pnas.191224698; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Chen BJ, 2008, VIROLOGY, V372, P221, DOI 10.1016/j.virol.2007.11.008; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Chiantia S, 2006, BIOPHYS J, V90, P4500, DOI 10.1529/biophysj.106.081026; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Elson EL, 2010, ANNU REV BIOPHYS, V39, P207, DOI 10.1146/annurev.biophys.093008.131238; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Falguieres T, 2008, MOL BIOL CELL, V19, P4942, DOI 10.1091/mbc.E08-03-0239; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Freed EO, 2002, J VIROL, V76, P4679, DOI 10.1128/JVI.76.10.4679-4687.2002; Fujii K, 2009, VIROLOGY, V391, P284, DOI 10.1016/j.virol.2009.06.016; Garcia-Saez AJ, 2010, FEBS LETT, V584, P1653, DOI 10.1016/j.febslet.2009.12.036; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; HELLER H, 1993, J PHYS CHEM-US, V97, P8343, DOI 10.1021/j100133a034; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Hinrichsen L, 2006, P NATL ACAD SCI USA, V103, P8715, DOI 10.1073/pnas.0600312103; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Im YJ, 2008, DEV CELL, V14, P902, DOI 10.1016/j.devcel.2008.04.004; Im YJ, 2009, DEV CELL, V17, P234, DOI 10.1016/j.devcel.2009.07.008; Irie T, 2004, J VIROL, V78, P7823, DOI 10.1128/JVI.78.14.7823-7827.2004; Ivanchenko S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000652; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Jadwin JA, 2010, J VIROL, V84, P704, DOI 10.1128/JVI.01319-09; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Koga Y, 2005, BIOSCI BIOTECH BIOCH, V69, P2019, DOI 10.1271/bbb.69.2019; Koivusalo M, 2007, MOL BIOL CELL, V18, P5113, DOI 10.1091/mbc.E07-04-0330; Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lenz M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038101; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Lineberry N, 2008, J BIOL CHEM, V283, P28497, DOI 10.1074/jbc.M805092200; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; LIPOWSKY R, 1992, J PHYS II, V2, P1825, DOI 10.1051/jp2:1992238; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; Lorizate M, 2009, J BIOL CHEM, V284, P22238, DOI 10.1074/jbc.M109.029256; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; MERRITT EA, 1994, PROTEIN SCI, V3, P166; Misra S, 2001, CELL, V107, P559, DOI 10.1016/S0092-8674(01)00594-3; Mobius W, 2003, TRAFFIC, V4, P222; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Murk JLAN, 2003, P NATL ACAD SCI USA, V100, P13332, DOI 10.1073/pnas.2232379100; Neu U, 2008, P NATL ACAD SCI USA, V105, P5219, DOI 10.1073/pnas.0710301105; Nossal R, 2001, TRAFFIC, V2, P138, DOI 10.1034/j.1600-0854.2001.020208.x; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Ono A, 2007, VIROLOGY, V360, P27, DOI 10.1016/j.virol.2006.10.011; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Peck J.W., 2004, BIOCHEM J, V377, P693; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Polozov IV, 2008, NAT CHEM BIOL, V4, P248, DOI 10.1038/nchembio.77; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Popova E, 2010, J VIROL, V84, P6590, DOI 10.1128/JVI.00035-10; Pucadyil TJ, 2009, SCIENCE, V325, P1217, DOI 10.1126/science.1171004; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Reider A, 2009, EMBO J, V28, P3103, DOI 10.1038/emboj.2009.248; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; Saad JS, 2008, J MOL BIOL, V382, P434, DOI 10.1016/j.jmb.2008.07.027; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Sandvig K, 2008, HISTOCHEM CELL BIOL, V129, P267, DOI 10.1007/s00418-007-0376-5; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Schmitt AP, 2005, J VIROL, V79, P2988, DOI 10.1128/JVI.79.5.2988-2997.2005; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Shnyrova AV, 2007, J CELL BIOL, V179, P627, DOI 10.1083/jcb.200705062; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Solon J, 2005, J GEN VIROL, V86, P3357, DOI 10.1099/vir.0.81129-0; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Stimpson HEM, 2009, MOL BIOL CELL, V20, P4640, DOI 10.1091/mbc.E09-05-0429; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Traub LM, 2010, NATURE, V465, P556, DOI 10.1038/465556a; Usami Y, 2008, J VIROL, V82, P4898, DOI 10.1128/JVI.02675-07; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; Veatch SL, 2007, P NATL ACAD SCI USA, V104, P17650, DOI 10.1073/pnas.0703513104; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Voeltz GK, 2007, NAT REV MOL CELL BIO, V8, P258, DOI 10.1038/nrm2119; Welsch S, 2007, FEBS LETT, V581, P2089, DOI 10.1016/j.febslet.2007.03.060; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Yorikawa C, 2005, BIOCHEM J, V387, P17, DOI 10.1042/BJ20041227; Zhang YQ, 1998, J VIROL, V72, P1782, DOI 10.1128/JVI.72.3.1782-1789.1998; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	154	201	204	0	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					875	887		10.1016/j.cell.2010.11.030	http://dx.doi.org/10.1016/j.cell.2010.11.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145455	Green Accepted, Bronze			2022-12-28	WOS:000285182600006
J	Wenk, MR				Wenk, Markus R.			Lipidomics: New Tools and Applications	CELL			English	Article							RAMAN SCATTERING MICROSCOPY; MASS-SPECTROMETRY; ELECTROSPRAY-IONIZATION; CRYSTAL-STRUCTURE; LIPIDS; PHOSPHOLIPIDS; IDENTIFICATION; MEDIATORS; CHEMISTRY; CELLS	Once viewed simply as a reservoir for carbon storage, lipids are no longer cast as bystanders in the drama of biological systems. The emerging field of lipidomics is driven by technology, most notably mass spectrometry, but also by complementary approaches for the detection and characterization of lipids and their biosynthetic enzymes in living cells. The development of these integrated tools promises to greatly advance our understanding of the diverse biological roles of lipids.	[Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117456, Singapore; [Wenk, Markus R.] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Ctr Life Sci CeLS, Singapore 117456, Singapore; [Wenk, Markus R.] Univ Basel, CH-4003 Basel, Switzerland	National University of Singapore; National University of Singapore; University of Basel	Wenk, MR (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, 28 Med Dr, Singapore 117456, Singapore.	markus_wenk@nuhs.edu.sg	Wenk, Markus Rene/D-1441-2014					Alving CR, 2006, J LIPOSOME RES, V16, P157, DOI 10.1080/08982100600848553; Andreyev AY, 2010, MOL CELL PROTEOMICS, V9, P388, DOI 10.1074/mcp.M900432-MCP200; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Baker CJO, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S5; Becker JS, 2009, CHEM SOC REV, V38, P1969, DOI 10.1039/b618635c; Berry KAZ, 2010, EUR J MASS SPECTROM, V16, P463, DOI 10.1255/ejms.1083; Blanksby SJ, 2010, ANNU REV ANAL CHEM, V3, P433, DOI 10.1146/annurev.anchem.111808.073705; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Deigner HP, 2008, CURR OPIN LIPIDOL, V19, P289, DOI 10.1097/MOL.0b013e3282fe1d0e; Durrett TP, 2010, P NATL ACAD SCI USA, V107, P9464, DOI 10.1073/pnas.1001707107; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ernst AM, 2010, FEBS LETT, V584, P1713, DOI 10.1016/j.febslet.2009.12.060; Fahmi S, 2008, HUM MOL GENET, V17, P2101, DOI 10.1093/hmg/ddn108; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fahy E, 2007, METHOD ENZYMOL, V432, P247, DOI 10.1016/S0076-6879(07)32011-9; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Gubbens J, 2010, MOL BIOSYST, V6, P1751, DOI 10.1039/c003064n; Hakomori S, 1997, CHEM BIOL, V4, P97, DOI 10.1016/S1074-5521(97)90253-2; Hamasur B, 2004, CLIN EXP IMMUNOL, V138, P30, DOI 10.1111/j.1365-2249.2004.02593.x; HAN XL, 1994, P NATL ACAD SCI USA, V91, P10635, DOI 10.1073/pnas.91.22.10635; Hicks AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000672; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Kanter JL, 2006, NAT MED, V12, P138, DOI 10.1038/nm1344; KIM HY, 1994, ANAL CHEM, V66, P3977, DOI 10.1021/ac00094a020; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; Manford A, 2010, EMBO J, V29, P1489, DOI 10.1038/emboj.2010.57; Marshall AG, 2008, P NATL ACAD SCI USA, V105, P18090, DOI 10.1073/pnas.0805069105; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Martin DDO, 2008, FASEB J, V22, P797, DOI 10.1096/fj.07-9198com; Milne SB, 2010, NAT CHEM BIOL, V6, P205, DOI 10.1038/NCHEMBIO.311; Minami Y, 2009, P NATL ACAD SCI USA, V106, P9890, DOI 10.1073/pnas.0900617106; Miskovic L, 2010, TRENDS BIOTECHNOL, V28, P391, DOI 10.1016/j.tibtech.2010.05.003; Muller M, 2007, CHEMPHYSCHEM, V8, P2156, DOI 10.1002/cphc.200700202; Murphy RC, 2009, J LIPID RES, V50, pS317, DOI 10.1194/jlr.R800051-JLR200; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Patwardhan AM, 2010, J CLIN INVEST, V120, P1617, DOI 10.1172/JCI41678; Pemble CW, 2007, NAT STRUCT MOL BIOL, V14, P704, DOI 10.1038/nsmb1265; Postle AD, 2009, J CHROMATOGR B, V877, P2716, DOI 10.1016/j.jchromb.2009.03.046; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Ridenour WB, 2010, ANAL CHEM, V82, P1881, DOI 10.1021/ac9026115; Rinaldi S, 2010, PROG LIPID RES, V49, P87, DOI 10.1016/j.plipres.2009.09.001; Serhan CN, 2009, J THROMB HAEMOST, V7, P44, DOI 10.1111/j.1538-7836.2009.03396.x; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; SWARTZ GM, 1988, P NATL ACAD SCI USA, V85, P1902, DOI 10.1073/pnas.85.6.1902; SYED SA, 1992, LANCET, V339, P496, DOI 10.1016/0140-6736(92)91106-I; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Thomas MC, 2009, METHODS MOL BIOL, V579, P413, DOI 10.1007/978-1-60761-322-0_21; Tully SE, 2010, J AM CHEM SOC, V132, P3264, DOI 10.1021/ja1000505; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Volkmer A, 2005, J PHYS D APPL PHYS, V38, pR59, DOI 10.1088/0022-3727/38/5/R01; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Wheelock CE, 2009, METHODS MOL BIOL, V580, P339, DOI 10.1007/978-1-60761-325-1_19; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yang K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001368; Yang PY, 2010, J AM CHEM SOC, V132, P656, DOI 10.1021/ja907716f; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]	65	412	419	3	138	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					888	895		10.1016/j.cell.2010.11.033	http://dx.doi.org/10.1016/j.cell.2010.11.033			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145456	Green Accepted, Bronze			2022-12-28	WOS:000285182600007
J	Eichberger, M; Schafer, H; Krumova, M; Beyer, M; Demsar, J; Berger, H; Moriena, G; Sciaini, G; Miller, RJD				Eichberger, Maximilian; Schaefer, Hanjo; Krumova, Marina; Beyer, Markus; Demsar, Jure; Berger, Helmuth; Moriena, Gustavo; Sciaini, German; Miller, R. J. Dwayne			Snapshots of cooperative atomic motions in the optical suppression of charge density waves	NATURE			English	Article							1T TAS2; 1T-TAS2; DIFFRACTION; ELECTRON; BISMUTH	Macroscopic quantum phenomena such as high-temperature superconductivity, colossal magnetoresistance, ferrimagnetism and ferromagnetism arise from a delicate balance of different interactions among electrons, phonons and spins on the nanoscale(1). The study of the interplay among these various degrees of freedom in strongly coupled electron-lattice systems is thus crucial to their understanding and for optimizing their properties. Charge-density-wave (CDW) materials(2), with their inherent modulation of the electron density and associated periodic lattice distortion, represent ideal model systems for the study of such highly cooperative phenomena. With femtosecond time-resolved techniques, it is possible to observe these interactions directly by abruptly perturbing the electronic distribution while keeping track of energy relaxation pathways and coupling strengths among the different subsystems(3-7). Numerous time-resolved experiments have been performed on CDWs(8-13), probing the dynamics of the electronic subsystem. However, the dynamics of the periodic lattice distortion have been only indirectly inferred(14). Here we provide direct atomic-level information on the structural dynamics by using femtosecond electron diffraction(15) to study the quasi two-dimensional CDW system 1T-TaS2. Effectively, we have directly observed the atomic motions that result from the optically induced change in the electronic spatial distribution. The periodic lattice distortion, which has an amplitude of similar to 0.1 angstrom, is suppressed by about 20% on a timescale (similar to 250 femtoseconds) comparable to half the period of the corresponding collective mode. These highly cooperative, electronically driven atomic motions are accompanied by a rapid electron-phonon energy transfer (similar to 350 femtoseconds) and are followed by fast recovery of the CDW (similar to 4 picoseconds). The degree of cooperativity in the observed structural dynamics is remarkable and illustrates the importance of obtaining atomic-level perspectives of the processes directing the physics of strongly correlated systems.	[Moriena, Gustavo; Sciaini, German; Miller, R. J. Dwayne] Univ Toronto, Inst Opt Sci, Toronto, ON M5S 3H6, Canada; [Moriena, Gustavo; Sciaini, German; Miller, R. J. Dwayne] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Moriena, Gustavo; Sciaini, German; Miller, R. J. Dwayne] Univ Toronto, Dept Phys, Toronto, ON M5S 3H6, Canada; [Eichberger, Maximilian; Schaefer, Hanjo; Beyer, Markus; Demsar, Jure] Univ Konstanz, Dept Phys, D-78457 Constance, Germany; Univ Konstanz, Ctr Appl Photon, D-78457 Constance, Germany; [Eichberger, Maximilian; Schaefer, Hanjo; Beyer, Markus; Demsar, Jure] Univ Konstanz, Zukunftskolleg, D-78457 Constance, Germany; [Krumova, Marina] Univ Konstanz, Dept Chem, D-78457 Constance, Germany; [Demsar, Jure] Jozef Stefan Inst, Complex Matter Dept, SI-1000 Ljubljana, Slovenia; [Berger, Helmuth] Ecole Polytech Fed Lausanne, Dept Phys, CH-1015 Lausanne, Switzerland; [Moriena, Gustavo; Sciaini, German; Miller, R. J. Dwayne] Univ Hamburg, Dept Phys, Max Planck Res Dept Struct Dynam, Ctr Free Electron Laser Sci,DESY, D-22607 Hamburg, Germany	University of Toronto; University of Toronto; University of Toronto; University of Konstanz; University of Konstanz; University of Konstanz; University of Konstanz; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; University of Hamburg	Miller, RJD (corresponding author), Univ Toronto, Inst Opt Sci, Toronto, ON M5S 3H6, Canada.	jure.demsar@uni-konstanz.de; dmiller@lphys.chem.utoronto.ca	Demsar, Jure/B-5578-2008; Demsar, Jure/F-7243-2016	Demsar, Jure/0000-0003-4551-7444; Schaefer, Hanjo/0000-0002-0015-1656; Moriena, Gustavo/0000-0001-9249-1764; Sciaini, German/0000-0002-2120-3996	Alexander von Humboldt Foundation; Center for Applied Photonics and Zukunftskolleg at the University of Konstanz; Natural Science and Engineering Research Council of Canada; Canada Foundation for Innovation; Stiftung der Deutschen Wirtschaft; Swiss NSF; NCCR MaNEP	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Center for Applied Photonics and Zukunftskolleg at the University of Konstanz; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Stiftung der Deutschen Wirtschaft; Swiss NSF(Swiss National Science Foundation (SNSF)); NCCR MaNEP(Swiss National Science Foundation (SNSF))	We would like to acknowledge discussions with V. V. Kabanov, T. Dekorsy, D. Mihailovic, U. Bovensiepen and M. Wolf, and thank A. Nagy for help in preparing the video in Supplementary Material. This research was supported by the Sofja Kovalevskaja Award of the Alexander von Humboldt Foundation, the Center for Applied Photonics and Zukunftskolleg at the University of Konstanz, the Natural Science and Engineering Research Council of Canada and the Canada Foundation for Innovation. M.E. acknowledges financial support through the Stiftung der Deutschen Wirtschaft. H.B. acknowledges financial support from the Swiss NSF and the NCCR MaNEP.	Als-Nielsen J., 2001, ELEMENTS MODERN XRAY; Averitt RD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.017401; Beaud P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.155702; Chergui M, 2009, CHEMPHYSCHEM, V10, P28, DOI 10.1002/cphc.200800667; Clerc F, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.155114; Demsar J, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.041101; Demsar J, 1999, PHYS REV LETT, V83, P800, DOI 10.1103/PhysRevLett.83.800; DUFFEY JR, 1976, SOLID STATE COMMUN, V20, P617, DOI 10.1016/0038-1098(76)91073-5; FAZEKAS P, 1979, PHILOS MAG B, V39, P229, DOI 10.1080/13642817908245359; Fritz DM, 2007, SCIENCE, V315, P633, DOI 10.1126/science.1135009; Gruner G., 1994, DENSITY WAVES SOLIDS; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Johnson SL, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.175503; Kubler C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.116401; Kusar P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.227001; Miller RJD, 2010, ACTA CRYSTALLOGR A, V66, P137, DOI 10.1107/S0108767309053926; Ogasawara T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.087202; Perfetti L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.067402; Rini M, 2007, NATURE, V449, P72, DOI 10.1038/nature06119; Schafer H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.066402; Schmitt F, 2008, SCIENCE, V321, P1649, DOI 10.1126/science.1160778; Sciaini G, 2009, NATURE, V458, P56, DOI 10.1038/nature07788; SCRUBY CB, 1975, PHILOS MAG, V31, P255, DOI 10.1080/14786437508228930; Sipos B, 2008, NAT MATER, V7, P960, DOI 10.1038/nmat2318; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; Sokolowski-Tinten K, 2003, NATURE, V422, P287, DOI 10.1038/nature01490; Tomeljak A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.066404; WILLIAMS PM, 1974, PHILOS MAG, V29, P695, DOI 10.1080/14786437408213248; WILSON JA, 1975, ADV PHYS, V24, P117, DOI 10.1080/00018737500101391; Yusupov RV, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.246402	30	315	316	7	277	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					799	802		10.1038/nature09539	http://dx.doi.org/10.1038/nature09539			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21107321	Green Submitted			2022-12-28	WOS:000285093700040
J	Philpot, CR				Philpot, C. Ross			Christmas 2010: Whodunit Dr Watson: a regular reader of the British Medical Journal	BRITISH MEDICAL JOURNAL			English	Editorial Material												rsphilpot@bigpond.com						BARINGGOULD W, 1962, S HOLMES BIOGRAPHY W; BARKER AE, 1886, BRIT MED J, V1, P618; Conan Doyle Arthur, 1989, ORIGINAL ILLUSTRATED; Delamothe T, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1744; GOODENOUGH S, 1984, HOUND BASKERVILLES B; GUNN RI, 1934, BRIT MED J, V2, P278; *HARV SOC LOND, 1900, BRIT MED J, V1, P197; Klinger Leslie S., 2005, NEW ANNOTATED S HOLM, V1; Klinger Leslie S., 2005, NEW ANNOTATED S HOLM, V3; KLINGER LS, 2005, NEW ANNOTATED S HOLM, V2; Rugman F, 2007, BMJ-BRIT MED J, V335, P1315, DOI 10.1136/bmj.39416.469595.AD; 1893, BMJ, V2, P866; 1893, BMJ, V2, P1442; 1899, BMJ, V2, P1120; 1899, BMJ, V2, P25; 1895, BMJ, V1, P1225; 1899, BMJ, V2, P1808; 1894, BMJ, V2, P1320; 2009, BMJ, V339, pB2861	19	0	0	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 9	2010	341								c6898	10.1136/bmj.c6898	http://dx.doi.org/10.1136/bmj.c6898			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZU	21148221				2022-12-28	WOS:000285341200005
J	Tozan, Y; Klein, EY; Darley, S; Panicker, R; Laxminarayan, R; Breman, JG				Tozan, Yesim; Klein, Eili Y.; Darley, Sarah; Panicker, Rajashree; Laxminarayan, Ramanan; Breman, Joel G.			Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis	LANCET			English	Article							FALCIPARUM-MALARIA; CHILDREN; PRIORITIES; TANZANIA; HEALTH	Background Severely ill patients with malaria with vomiting, prostration, and altered consciousness cannot be treated orally and need injections. In rural areas, access to health facilities that provide parenteral antimalarial treatment is poor. Safe and effective treatment of most severe malaria cases is delayed or not achieved. Rectal artesunate interrupts disease progression by rapidly reducing parasite density, but should be followed by further antimalarial treatment. We estimated the cost-effectiveness of community-based prereferral artesunate treatment of children suspected to have severe malaria in areas with poor access to formal health care. Methods We assessed the cost-effectiveness (in international dollars) of the intervention from the provider perspective. We studied a cohort of 1000 newborn babies until 5 years of age. The analysis assessed how the cost-effectiveness results changed with low (25%), moderate (50%), high (75%), and full (100%) referral compliance and intervention uptake. Findings At low intervention uptake and referral compliance (25%), the intervention was estimated to avert 19 disability-adjusted life-years (DALYs; 95% CI 16-21) and to cost I$1173 (95% CI 1050-1297) per DALY averted. Under the full uptake and compliance scenario (100%), the intervention could avert 967 DALYs (884-1050) at a cost of I$77 (73-81) per DALY averted. Interpretation Prereferral artesunate treatment is a cost-effective, life-saving intervention, which can substantially improve the management of severe childhood malaria in rural African settings in which programmes for community health workers are in place.	[Tozan, Yesim] Boston Univ, Sch Publ Hlth, Dept Int Hlth, Boston, MA 02118 USA; [Klein, Eili Y.; Darley, Sarah; Panicker, Rajashree; Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC USA; [Klein, Eili Y.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Laxminarayan, Ramanan] Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA; [Tozan, Yesim; Breman, Joel G.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Boston University; Princeton University; Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Tozan, Y (corresponding author), Boston Univ, Sch Publ Hlth, Dept Int Hlth, 801 Massachusetts Ave, Boston, MA 02118 USA.	tozan@bu.edu	Klein, Eili/C-3745-2012; Laxminarayan, Ramanan/ABD-5050-2021	Klein, Eili/0000-0002-1304-5289	Disease Control Priorities Project; Fogarty International Center; US National Institutes of Health; Boston University	Disease Control Priorities Project; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University	Funding The Disease Control Priorities Project; Fogarty International Center; US National Institutes of Health; and the Peter Paul Career Development Professorship, Boston University.	[Anonymous], 11 NIH FOG INT CTR; [Anonymous], 1996, GLOBAL BURDEN DIS CO; [Anonymous], 2010, GUID TREATM MAL; [Anonymous], COST EFF RESOUR ALLO, DOI DOI 10.1186/1478-7547-7-3; Beiersmann C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-106; de Savigny D, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-27; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Font Fidel, 2002, BMC Int Health Hum Rights, V2, P4, DOI 10.1186/1472-698X-2-4; Gomes MF, 2009, LANCET, V373, P557, DOI 10.1016/S0140-6736(08)61734-1; Goodman C, 2000, EC ANAL MALARIA CONT; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hopkins H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-134; Idro R, 2006, ANN TROP MED PARASIT, V100, P95, DOI 10.1179/136485906X91459; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Montanari RM, 2001, B WORLD HEALTH ORGAN, V79, P648; Najera JA, 1996, WHOCTDMAL9610; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Onwujekwe O, 2007, ACTA TROP, V101, P95, DOI 10.1016/j.actatropica.2006.07.013; Roca-Feltrer A, 2008, TROP MED INT HEALTH, V13, P771, DOI 10.1111/j.1365-3156.2008.02076.x; Roll Back Malaria, 2007, ROLL BACK MAL; Simba DO, 2009, TROP MED INT HEALTH, V14, P775, DOI 10.1111/j.1365-3156.2009.02299.x; TEKLEHAIMANOT A, 2005, COMING GRIPS MALARIA; U.S. Department of State Bureau of Democracy, 2010, 2009 HUM RIGHTS REP; Warsame M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000149; *WHO, 2009, WORLD MAL REP; World Bank, 1993, WORLD DEV REP INV HL; World Health Organization (WHO), 2005, METH ASS US EST COST	30	25	26	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2010	376	9756					1910	1915		10.1016/S0140-6736(10)61460-2	http://dx.doi.org/10.1016/S0140-6736(10)61460-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696KH	21122910				2022-12-28	WOS:000285439800032
J	Becerra, MC; Appleton, SC; Franke, MF; Chalco, K; Arteaga, F; Bayona, J; Murray, M; Atwood, SS; Mitnick, CD				Becerra, Mercedes C.; Appleton, Sasha C.; Franke, Molly F.; Chalco, Katiuska; Arteaga, Fernando; Bayona, Jaime; Murray, Megan; Atwood, Sidney S.; Mitnick, Carole D.			Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study	LANCET			English	Article							CLOSE CONTACTS	Background Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis have emerged as major global health threats. WHO recommends contact investigation in close contacts of patients with MDR and XDR tuberculosis. We aimed to assess the burden of tuberculosis disease in household contacts of such patients. Methods We undertook a retrospective cohort study of household contacts of patients treated for MDR or XDR tuberculosis in Lima, Peru, in 1996-2003. The primary outcome was active tuberculosis in household contacts at the time the index patient began MDR tuberculosis treatment and during the 4-year follow-up. We examined whether the occurrence of active tuberculosis in the household contacts differed by resistance pattern of the index patient: either MDR or XDR tuberculosis. Findings 693 households of index patients with MDR tuberculosis were enrolled in the study. In 48 households, the Mycobacterium tuberculosis isolate from the index patient was XDR. Of the 4503 household contacts, 117 (2.60%) had active tuberculosis at the time the index patient began MDR tuberculosis treatment there was no difference in prevalence between XDR and MDR tuberculosis households. During the 4-year follow-up, 242 contacts developed active tuberculosis the frequency of active tuberculosis was nearly two times higher in contacts of patients with XDR tuberculosis than it was in contacts of patients with MDR tuberculosis (hazard ratio 1.88, 95% CI 1.10-3.21). In the 359 contacts with active tuberculosis, 142 (40%) had had isolates tested for resistance against first-line drugs, of whom 129 (90.9%, 95% CI 85.0-94.6) had MDR tuberculosis. Interpretation In view of the high risk of disease recorded in household contacts of patients with MDR or XDR tuberculosis, tuberculosis programmes should implement systematic household contact investigations for all patients identified as having MDR or XDR tuberculosis. If shown to have active tuberculosis, these household contacts should be suspected as having MDR tuberculosis until proven otherwise.	[Becerra, Mercedes C.; Appleton, Sasha C.; Franke, Molly F.; Bayona, Jaime; Mitnick, Carole D.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Becerra, Mercedes C.; Appleton, Sasha C.; Franke, Molly F.; Chalco, Katiuska; Arteaga, Fernando; Bayona, Jaime; Murray, Megan; Mitnick, Carole D.] Socios Salud Sucursal Peru, Lima, Peru; [Becerra, Mercedes C.; Appleton, Sasha C.; Franke, Molly F.; Chalco, Katiuska; Arteaga, Fernando; Bayona, Jaime; Murray, Megan; Mitnick, Carole D.] Partners Hlth, Boston, MA USA; [Becerra, Mercedes C.; Murray, Megan; Atwood, Sidney S.; Mitnick, Carole D.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Brigham & Women's Hospital	Becerra, MC (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA.	mbecerra@post.harvard.edu	Mitnick, Carole/GRO-1991-2022; Franke, Molly/AAK-7559-2020	Mitnick, Carole/0000-0002-3455-658X; Franke, Molly/0000-0002-4890-5728; Atwood, Sidney/0000-0001-8865-6300	Charles H Hood Foundation; David Rockefeller Center for Latin American Studies at Harvard University; Bill & Melinda Gates Foundation; National Heart, Lung, and Blood Institute [K01 HL080939]; National Institute of Allergy and Infectious Diseases [K01 A1065836]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL080939] Funding Source: NIH RePORTER	Charles H Hood Foundation; David Rockefeller Center for Latin American Studies at Harvard University; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Charles H Hood Foundation, the David Rockefeller Center for Latin American Studies at Harvard University, and the Bill & Melinda Gates Foundation funded this study. The authors also acknowledge the support of career development awards from the National Heart, Lung, and Blood Institute (K01 HL080939, to MCB) and the National Institute of Allergy and Infectious Diseases (K01 A1065836, to CDM).	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Attamna A, 2009, THORAX, V64, P271, DOI 10.1136/thx.2008.100974; Bayona J, 2003, INT J TUBERC LUNG D, V7, pS501; Cobelens FGJ, 2008, PLOS MED, V5, P1037, DOI 10.1371/journal.pmed.0050150; Fraser A, 2006, Cochrane Database Syst Rev, pCD005435; Furin JJ, 2000, EUR J CLIN MICROBIOL, V19, P132, DOI 10.1007/s100960050445; Keshavjee S, 2008, ANN NY ACAD SCI, V1136, P1, DOI 10.1196/annals.1425.009; Kritski AL, 1996, AM J RESP CRIT CARE, V153, P331, DOI 10.1164/ajrccm.153.1.8542139; Medical Research Council, 1974, B WORLD HEALTH ORGAN, V51, P473; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Mohammadi A., 2008, Eastern Mediterranean Health Journal, V14, P1238; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schaaf HS, 2002, PEDIATRICS, V109, P765, DOI 10.1542/peds.109.5.765; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Teixeira L, 2001, INT J TUBERC LUNG D, V5, P321; Tuberculosis Coalition for Technical Assistance, INT STAND TUB CAR IS; *UNAIDS WHO, UNAIDS WHO EP FACT S; [World Health Organization International Union Against Tuberculosis and Lung Disease Global Project on Anti-tuberculosis Drug Resistance Surveillance], 1997, WHOCDSTB1997229 INT; World Health Organization, 2009, GLOB TUB CONTR EP ST; World Health Organization (WHO), GUID PROGR MAN DRUG	21	97	98	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					147	152		10.1016/S0140-6736(10)61972-1	http://dx.doi.org/10.1016/S0140-6736(10)61972-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707NH	21145581				2022-12-28	WOS:000286292800027
J	Richardson, PG				Richardson, Paul G.			A new standard of care in newly diagnosed multiple myeloma	LANCET			English	Editorial Material							STEM-CELL TRANSPLANTATION; PLUS DEXAMETHASONE; ELDERLY-PATIENTS; CLINICAL-TRIAL; THALIDOMIDE; BORTEZOMIB; PREDNISONE; MELPHALAN; INDUCTION; THERAPY		[Richardson, Paul G.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Richardson, Paul G.] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Richardson, PG (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	paul_richardson@dfci.harvard.edu						[Anonymous], ASH ANN M; ATTAL M, 2010, P SOC AM CLIN ONCO S, V28, P8018; Cavo M, 2005, BLOOD, V106, P35, DOI 10.1182/blood-2005-02-0522; CAVO M, 2010, LANCET          1210, DOI DOI 10.1016/S0140-6736(10)61424-9; Facon T, 2007, LANCET, V370, P1209, DOI 10.1016/S0140-6736(07)61537-2; Harousseau JL, 2010, J CLIN ONCOL, V28, P4621, DOI 10.1200/JCO.2009.27.9158; HAROUSSEAU JL, 2009, 51 AM SOC HEM ANN M, P354; JAKUBOWIAK AJ, 2009, 51 AM SOC HEM ANN M, P132; KUMAR S, 2009, 51 AM SOC HEM ANN M, P127; MCCARTHY PL, 2010, P SOC AM CLIN ONCO S, V28, P8017; Palumbo A, 2008, BLOOD, V112, P3107, DOI 10.1182/blood-2008-04-149427; Rajkumar SV, 2010, LANCET ONCOL, V11, P29, DOI 10.1016/S1470-2045(09)70284-0; Rajkumar SV, 2006, J CLIN ONCOL, V24, P431, DOI 10.1200/JCO.2005.03.0221; Reeder CB, 2009, LEUKEMIA, V23, P1337, DOI 10.1038/leu.2009.26; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-268862; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479	16	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 18	2010	376	9758					2043	2044		10.1016/S0140-6736(10)62177-0	http://dx.doi.org/10.1016/S0140-6736(10)62177-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702LA	21146204				2022-12-28	WOS:000285895000004
J	Mold, JE; Venkatasubrahmanyam, S; Burt, TD; Michaelsson, J; Rivera, JM; Galkina, SA; Weinberg, K; Stoddart, CA; McCune, JM				Mold, Jeff E.; Venkatasubrahmanyam, Shivkumar; Burt, Trevor D.; Michaelsson, Jakob; Rivera, Jose M.; Galkina, Sofiya A.; Weinberg, Kenneth; Stoddart, Cheryl A.; McCune, Joseph M.			Fetal and Adult Hematopoietic Stem Cells Give Rise to Distinct T Cell Lineages in Humans	SCIENCE			English	Article							MATERNAL HLA ANTIGENS; EARLY EVENTS; HUMAN FETUS; LONG-TERM; IN-UTERO; IDENTIFICATION; EXPRESSION; TOLERANCE; RESPONSES; ONTOGENY	Although the mammalian immune system is generally thought to develop in a linear fashion, findings in avian and murine species argue instead for the developmentally ordered appearance (or "layering") of distinct hematopoietic stem cells (HSCs) that give rise to distinct lymphocyte lineages at different stages of development. Here we provide evidence of an analogous layered immune system in humans. Our results suggest that fetal and adult T cells are distinct populations that arise from different populations of HSCs that are present at different stages of development. We also provide evidence that the fetal T cell lineage is biased toward immune tolerance. These observations offer a mechanistic explanation for the tolerogenic properties of the developing fetus and for variable degrees of immune responsiveness at birth.	[Mold, Jeff E.; Burt, Trevor D.; Rivera, Jose M.; Galkina, Sofiya A.; Stoddart, Cheryl A.; McCune, Joseph M.] Univ Calif San Francisco, Div Expt Med, Dept Med, San Francisco, CA 94143 USA; [Venkatasubrahmanyam, Shivkumar] Stanford Univ, Sch Med, Ctr Biomed Informat Res, Stanford, CA 94305 USA; [Burt, Trevor D.] Univ Calif San Francisco, Dept Pediat, Div Neonatol, San Francisco, CA 94143 USA; [Michaelsson, Jakob] Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden; [Weinberg, Kenneth] Stanford Univ, Sch Med, Dept Pediat, Div Hematol Oncol & Stem Cell Transplantat, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; Karolinska Institutet; Stanford University	McCune, JM (corresponding author), Univ Calif San Francisco, Div Expt Med, Dept Med, UCSF Box 1234,SFGH Bldg 3, San Francisco, CA 94143 USA.	mike.mccune@ucsf.edu		Mold, Jeffrey/0000-0003-2195-2978; Burt, Trevor/0000-0001-7933-529X	NIH [OD000329, AI40312, CA049605, AG033314]; Harvey V. Berneking Living Trust; National Institute of Allergy and Infectious Diseases, NIH [N01-AI-70002]; Deborah Addicott Fellowship for Bioinformatics and Stem Cell Biology; Swedish Research Council; American Pediatric Society; American Academy of Pediatrics; March of Dimes; NIH, NIH Roadmap for Medical Research [DPI OD00329]; NATIONAL CANCER INSTITUTE [P01CA049605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040312, P30AI027763, R01AI040312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033314] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvey V. Berneking Living Trust; National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Deborah Addicott Fellowship for Bioinformatics and Stem Cell Biology; Swedish Research Council(Swedish Research CouncilEuropean Commission); American Pediatric Society; American Academy of Pediatrics; March of Dimes(March of Dimes); NIH, NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank all of the patients who generously donated tissue that was used in these studies. We also thank S. J. Fisher and D. F. Nixon for valuable discussions; A. J. Butte, M. E. Moreno, and G. Kosikova for technical support; and the Gladstone Genomics Core for microarray analysis. Support for this work was provided by grants from NIH to J. M. M. (OD000329 and AI40312) and to K. W. and A. J. Butte (CA049605 and AG033314) and from the Harvey V. Berneking Living Trust. This project has been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, NIH, under contract no. N01-AI-70002. S. V. is supported by the Deborah Addicott Fellowship for Bioinformatics and Stem Cell Biology. J. M. is supported by the Swedish Research Council. T. D. B. received funding from American Pediatric Society, the American Academy of Pediatrics, and the March of Dimes as a fellow of the Pediatric Scientist Development Program. J. M. M. is a recipient of the NIH Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research, through grant DPI OD00329. The microarray data have been deposited in the Gene Expression Omnibus with accession code GSE25119.	BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BRENT L, 1989, IMMUNOL LETT, V21, P55, DOI 10.1016/0165-2478(89)90012-6; Burlingham WJ, 1998, NEW ENGL J MED, V339, P1657, DOI 10.1056/NEJM199812033392302; BYRNE JA, 1994, J IMMUNOL, V152, P3098; CLAAS FHJ, 1988, SCIENCE, V241, P1815, DOI 10.1126/science.3051377; COLTEY M, 1989, J EXP MED, V170, P543, DOI 10.1084/jem.170.2.543; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Harrison DE, 1997, EXP HEMATOL, V25, P293; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; HAYNES BF, 1988, J EXP MED, V168, P1061, DOI 10.1084/jem.168.3.1061; HERZENBERG LA, 1989, CELL, V59, P953, DOI 10.1016/0092-8674(89)90748-4; LUCIVERO G, 1991, Fetal Diagnosis and Therapy, V6, P101; Martin MA, 2005, STEM CELLS DEV, V14, P493, DOI 10.1089/scd.2005.14.493; Michaelsson J, 2006, J IMMUNOL, V176, P5741, DOI 10.4049/jimmunol.176.10.5741; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Muench MO, 2003, DEV COMP IMMUNOL, V27, P899, DOI 10.1016/S0145-305X(03)00081-8; NAMIKAWA R, 1990, J EXP MED, V172, P1055, DOI 10.1084/jem.172.4.1055; Pennington DJ, 2006, NATURE, V444, P1073, DOI 10.1038/nature06051; Schallenberg S, 2010, J EXP MED, V207, P1393, DOI 10.1084/jem.20100045; SILVERSTEIN AM, 1964, SCIENCE, V144, P1423, DOI 10.1126/science.144.3625.1423; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Takahata Y, 2004, EXP HEMATOL, V32, P622, DOI 10.1016/j.exphem.2004.03.012; Tavian M, 2005, EXP HEMATOL, V33, P1062, DOI 10.1016/j.exphem.2005.06.025; ZANJANI ED, 1993, BLOOD, V81, P399	26	282	285	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1695	1699		10.1126/science.1196509	http://dx.doi.org/10.1126/science.1196509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164017	Green Accepted			2022-12-28	WOS:000285390500072
J	Moon, JC; Flett, AS; Godman, BB; Grosso, AM; Wierzbicki, AS				Moon, James C.; Flett, Andrew S.; Godman, Brian B.; Grosso, Anthony M.; Wierzbicki, Anthony S.			Getting better value from the NHS drug budget	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SWITCHING STATINS; INITIATIVES; SIMVASTATIN; EFFICIENCY; REFORMS; ENHANCE; IMPACT; COST		[Moon, James C.; Flett, Andrew S.] Univ Coll London Hosp, Heart Hosp, London W1M 8PH, England; [Godman, Brian B.] Mario Negri Inst Pharmacol Res, Milan, Italy; [Godman, Brian B.] Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden; [Grosso, Anthony M.] Univ Coll London Hosp, Dept Pharm, London NW1 2PG, England; [Wierzbicki, Anthony S.] Guys & St Thomas NHS Trust, St Thomas Hosp, London SE1 7EH, England	University College London Hospitals NHS Foundation Trust; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Karolinska Institutet; University College London Hospitals NHS Foundation Trust; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust	Moon, JC (corresponding author), Univ Coll London Hosp, Heart Hosp, London W1M 8PH, England.	james.moon@uclh.nhs.uk	Wierzbicki, Anthony/AAP-1735-2020; Godman, Brian/R-8897-2019; Moon, James/AAA-9905-2020; Moon, James C/F-1031-2014	Wierzbicki, Anthony/0000-0003-2756-372X; Moon, James/0000-0001-8071-1491; Moon, James C/0000-0001-8071-1491				British Hypertension Society, 2010, GUID MAN HYP; Erhardt LR, 2005, INT J CLIN PRACT, V59, P571, DOI 10.1111/j.1368-5031.2005.00513.x; Godman B, 2008, PHARMACOECONOMICS, V26, P91, DOI 10.2165/00019053-200826020-00001; Godman B, 2010, PHARMACEUTICALS, V3, P2470, DOI 10.3390/ph3082470; Godman B, 2010, EXPERT REV PHARM OUT, V10, P199, DOI [10.1586/erp.10.6, 10.1586/ERP.10.6]; Godman Brian, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P475, DOI 10.1586/erp.09.43; Gumbs PD, 2007, BRIT J CLIN PHARMACO, V64, P680, DOI 10.1111/j.1365-2125.2007.02958.x; Kjeldsen SE, 2010, J HUM HYPERTENS, V24, P263, DOI 10.1038/jhh.2009.77; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Light D., 2010, RISKS PRESCRIPTION D; McGinn D, 2010, EXPERT REV PHARM OUT, V10, P73, DOI [10.1586/erp.09.73, 10.1586/ERP.09.73]; Meredith PA, 2010, J HUM HYPERTENS, V24, P525, DOI 10.1038/jhh.2009.99; Moon JC, 2006, BMJ-BRIT MED J, V332, P1344, DOI 10.1136/bmj.332.7554.1344; NHS Information Centre, 2010, PRESCR COST AN 2009; Prosser H, 2005, SOC SCI MED, V60, P1335, DOI 10.1016/j.socscimed.2004.07.013; Sakshaug S, 2007, BRIT J CLIN PHARMACO, V64, P476, DOI 10.1111/j.1365-2125.2007.02907.x; Sermet C, 2010, APPL HEALTH ECON HEA, V8, P7, DOI 10.2165/11313900-000000000-00000; Universtiy College London Hospital NHS Trust, 2010, UCLH GUID ANG 2 REC; Usher-Smith J, 2008, INT J CLIN PRACT, V62, P480, DOI 10.1111/j.1742-1241.2007.01690.x; Wettermark B, 2008, PHARMACOECONOMICS, V26, P537, DOI 10.2165/00019053-200826070-00001; Wright J.M, 2008, COCHRANE DB SYST REV, V2008, DOI [10.1002/14651858.CD003822.pub2., DOI 10.1002/14651858.CD003822.PUB2]	21	14	15	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2010	341								c6449	10.1136/bmj.c6449	http://dx.doi.org/10.1136/bmj.c6449			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XO	21169320				2022-12-28	WOS:000285553300006
J	Naik, JD; Sathiyaseelan, SRK; Vasudev, NS				Naik, Jay D.; Sathiyaseelan, Suren R. K.; Vasudev, Naveen S.			Easily Missed? Febrile neutropenia	BRITISH MEDICAL JOURNAL			English	Editorial Material							COLONY-STIMULATING FACTOR; CANCER-PATIENTS; CHEMOTHERAPY; GUIDELINES		[Naik, Jay D.; Vasudev, Naveen S.] St James Univ Hosp, St Jamess Inst Med Oncol, Leeds LS9 7TF, W Yorkshire, England; [Sathiyaseelan, Suren R. K.] Surg Nursery Lane & Adel, Leeds LS17 7AQ, W Yorkshire, England	Saint James's University Hospital	Vasudev, NS (corresponding author), St James Univ Hosp, St Jamess Inst Med Oncol, Leeds LS9 7TF, W Yorkshire, England.	n.vasudev@leeds.ac.uk		Vasudev, Naveen/0000-0001-8470-7481				Aapro MS, 2006, EUR J CANCER, V42, P2433, DOI 10.1016/j.ejca.2006.05.002; de Naurois J, 2010, ANN ONCOL, V21, pv252, DOI 10.1093/annonc/mdq196; Klastersky J, 2000, J CLIN ONCOL, V18, P3038, DOI 10.1200/JCO.2000.18.16.3038; Kuderer NM, 2007, J CLIN ONCOL, V25, P3158, DOI 10.1200/JCO.2006.08.8823; Malik I, 2001, J INFECTION, V42, P120, DOI 10.1053/jinf.2001.0798; *MED PROT SOC, 2010, CASEBOOK, V18, P19; *MED PROT SOC, 2003, CASEBOOK, V11, P20; National Chemotherapy Advisory Group, 2009, CHEM SERV ENGL ENS Q; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; 2008, NATL CONFIDENTIONAL	10	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2010	341								c6981	10.1136/bmj.c6981	http://dx.doi.org/10.1136/bmj.c6981			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XO	21169321				2022-12-28	WOS:000285553300005
J	Hyde, Z; Flicker, L; Hankey, GJ; Almeida, OP; McCaul, KA; Chubb, SAP; Yeap, BB				Hyde, Zoe; Flicker, Leon; Hankey, Graeme J.; Almeida, Osvaldo P.; McCaul, Kieran A.; Chubb, S. A. Paul; Yeap, Bu B.			Prevalence of Sexual Activity and Associated Factors in Men Aged 75 to 95 Years A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							FREE TESTOSTERONE; OLDER-ADULTS; HEALTH; DEPRESSION; ATTITUDES; PERCEPTIONS; VALIDITY; THERAPY; LIFE	Background: Knowledge about sexuality in elderly persons is limited, and normative data are lacking. Objective: To determine the proportion of older men who are sexually active and to explore factors predictive of sexual activity. Design: Population-based cohort study. Setting: Community-dwelling men from Perth, Western Australia, Australia. Participants: 3274 men aged 75 to 95 years. Measurements: Questionnaires from 1996 to 1999, 2001 to 2004, and 2008 to 2009 assessed social and medical factors. Sex hormones were measured from 2001 to 2004. Sexual activity was assessed by questionnaire from 2008 to 2009. Results: A total of 2783 men (85.0%) provided data on sexual activity. Sex was considered at least somewhat important by 48.8% (95% CI, 47.0% to 50.6%), and 30.8% (CI, 29.1% to 32.5%) had had at least 1 sexual encounter in the past 12 months. Of the latter, 56.5% were satisfied with the frequency of activity, whereas 43.0% had sex less often than preferred. In cross-sectional analyses, increasing age, partner's lack of interest, partner's physical limitations, osteoporosis, prostate cancer, diabetes, antidepressant use, and beta-blocker use were independently associated with reduced odds of sexual activity. Living with a partner and having a non-English-speaking background were associated with increased odds. In longitudinal analyses, higher testosterone levels were associated with increased odds of being sexually active. Other factors were similar to the cross-sectional model. Limitations: Response bias may have influenced findings because sexuality can be a sensitive topic. Attrition may have resulted in a healthier-than-average sample of older men. Conclusion: One half of elderly men consider sex important, and one third report being sexually active. Men's health problems were associated with lack of sexual activity. Key modifiable risk factors include diabetes, depression, and medication use. Endogenous testosterone levels predict sexual activity, but the role of testosterone therapy remains uncertain.	[Hankey, Graeme J.] Royal Perth Hosp, Perth, WA 6001, Australia; [Chubb, S. A. Paul; Yeap, Bu B.] Fremantle Hosp, Fremantle, WA 6959, Australia; Univ Western Australia, Western Australian Ctr Hlth & Ageing, Ctr Med Res,Western Australian Inst Med Res, Sch Med & Pharmacol,Sch Psychiat & Clin Neurosci, Crawley, WA 6009, Australia	Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia	Hyde, Z (corresponding author), Univ Western Australia, Western Australian Ctr Hlth & Ageing M570, 35 Stirling Highway, Crawley, WA 6009, Australia.	zoe@sexologyresearch.org	McCaul, Kieran A/B-8751-2008; Almeida, Osvaldo P./A-4925-2008; Flicker, Leon/AAE-1530-2022; Hyde, Zoë/B-6411-2009; Flicker, Leon/A-9039-2008; Hankey, Graeme J/H-4968-2014	Almeida, Osvaldo P./0000-0002-8689-6199; Flicker, Leon/0000-0002-3650-0475; Hyde, Zoë/0000-0002-5985-1729; Hankey, Graeme J/0000-0002-6044-7328	National Health and Medical Research Council of Australia [279408, 379600, 403963, 513823, 634492]; MBF Foundation of Australia [DS 080608]; National Health and Medical Research Council; Sylvia and Charles Viertel Charitable Foundation, New South Wales, Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); MBF Foundation of Australia; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Charitable Foundation, New South Wales, Australia	By grants 279408, 379600, 403963, 513823, and 634492 from the National Health and Medical Research Council of Australia and grant DS 080608 from the MBF Foundation of Australia. Ms. Hyde is supported by a National Health and Medical Research Council Biomedical Postgraduate Scholarship. Hormone assays were funded by a Clinical Investigator Award to Dr. Yeap from the Sylvia and Charles Viertel Charitable Foundation, New South Wales, Australia.	Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8; Andrews CN, 2007, AUST FAM PHYSICIAN, V36, P867; Araujo AB, 2004, J AM GERIATR SOC, V52, P1502, DOI 10.1111/j.0002-8614.2004.52413.x; Australian Institute of Health and Welfare, 2007, OLD AUSTR GLANC; Beckman N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a279; Bolona ER, 2007, MAYO CLIN PROC, V82, P20, DOI 10.4065/82.1.20; Clayton AH, 2006, J CLIN PSYCHIAT, V67, P33; Comfort A, 1991, Clin Geriatr Med, V7, P1; COVEY HC, 1989, GERONTOLOGIST, V29, P93, DOI 10.1093/geront/29.1.93; Fenton KA, 2001, SEX TRANSM INFECT, V77, P84, DOI 10.1136/sti.77.2.84; Ginsberg TB, 2005, AGE AGEING, V34, P475, DOI 10.1093/ageing/afi143; Gott M, 2004, SOC SCI MED, V58, P2093, DOI 10.1016/j.socscimed.2003.08.025; Gott M, 2003, SOC SCI MED, V56, P1617, DOI 10.1016/S0277-9536(02)00180-6; Harman SM, 2003, J ANDROL, V24, pS42; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P381, DOI 10.1111/j.1365-2265.2005.02350.x; Jung A, 2004, EUR J OBSTET GYN R B, V113, P123, DOI 10.1016/j.ejogrb.2003.10.007; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Ko DT, 2002, JAMA-J AM MED ASSOC, V288, P351, DOI 10.1001/jama.288.3.351; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Norman PE, 2009, INT J EPIDEMIOL, V38, P48, DOI 10.1093/ije/dyn041; Schwandt A, 2009, CURR OPIN UROL, V19, P322, DOI 10.1097/MOU.0b013e32832a082c; Smith AM, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-139; Smith LJ, 2007, J SEX MED, V4, P1247, DOI 10.1111/j.1743-6109.2007.00568.x; VERMEULEN A, 1992, J CLIN ENDOCR METAB, V74, P939, DOI 10.1210/jc.74.4.939; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Waite LJ, 2009, J GERONTOL B-PSYCHOL, V64, pI56, DOI 10.1093/geronb/gbp038; Wylie K, 2010, MATURITAS, V65, P23, DOI 10.1016/j.maturitas.2009.10.018; Yeap BB, 2009, INT J IMPOT RES, V21, P24, DOI 10.1038/ijir.2008.60; Yeap BB, 2007, EUR J ENDOCRINOL, V156, P585, DOI 10.1530/EJE-06-0714	33	63	63	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 7	2010	153	11					693	702		10.7326/0003-4819-153-11-201012070-00002	http://dx.doi.org/10.7326/0003-4819-153-11-201012070-00002			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	690KN	21135292				2022-12-28	WOS:000285003800001
J	Moller, BL				Moller, Birger Lindberg			Dynamic Metabolons	SCIENCE			English	Editorial Material							CYANOGENIC GLUCOSIDE DHURRIN; SORGHUM-BICOLOR; BIOSYNTHESIS; CONVERSION; EXPRESSION; CATALYZES; CLONING; COMPLEX		Univ Copenhagen, Dept Plant Biol & Biotechnol, Plant Biochem Lab, DK-1871 Frederiksberg C, Denmark	University of Copenhagen	Moller, BL (corresponding author), Univ Copenhagen, Dept Plant Biol & Biotechnol, Plant Biochem Lab, DK-1871 Frederiksberg C, Denmark.	blm@life.ku.dk	Møller, Birger Lindberg/H-2657-2014; Møller, Birger Lindberg/GQI-1792-2022	Møller, Birger Lindberg/0000-0002-3252-3119; Møller, Birger Lindberg/0000-0002-3252-3119				An S, 2010, J BIOL CHEM, V285, P11093, DOI 10.1074/jbc.M110.101139; Bak S, 1998, PLANT MOL BIOL, V36, P393, DOI 10.1023/A:1005915507497; Bartosova L, 2006, NEUROTOX RES, V9, P291, DOI 10.1007/BF03033319; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Brandina I, 2006, BBA-BIOENERGETICS, V1757, P1217, DOI 10.1016/j.bbabio.2006.07.001; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Conrado RJ, 2008, CURR OPIN BIOTECH, V19, P492, DOI 10.1016/j.copbio.2008.07.006; DRUMM JE, 1995, ACS SYM SER, V584, P396; Jones PR, 1999, J BIOL CHEM, V274, P35483, DOI 10.1074/jbc.274.50.35483; Jorgensen K, 2005, CURR OPIN PLANT BIOL, V8, P280, DOI 10.1016/j.pbi.2005.03.014; Moller BL, 2010, CURR OPIN PLANT BIOL, V13, P338, DOI 10.1016/j.pbi.2010.01.009; MOLLER BL, 1980, J BIOL CHEM, V255, P3049; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Rusch GM, 2009, DRUG CHEM TOXICOL, V32, P381, DOI 10.1080/01480540903154187; Sakurada K, 2009, TOXICOL LETT, V189, P110, DOI 10.1016/j.toxlet.2009.05.007; SIBBESEN O, 1995, J BIOL CHEM, V270, P3506, DOI 10.1074/jbc.270.8.3506; Thellier M, 2006, FEBS J, V273, P4287, DOI 10.1111/j.1742-4658.2006.05425.x; Wittstock U, 2000, J BIOL CHEM, V275, P14659, DOI 10.1074/jbc.275.19.14659	18	97	98	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1328	1329		10.1126/science.1194971	http://dx.doi.org/10.1126/science.1194971			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127236				2022-12-28	WOS:000284902100026
J	Claridge, LC; Eksteen, B; Smith, A; Shah, T; Holt, AP				Claridge, Lee C.; Eksteen, Bertus; Smith, Amanda; Shah, Tahir; Holt, Andrew P.			Lesson of the Week Acute liver failure after administration of paracetamol at the maximum recommended daily dose in adults	BRITISH MEDICAL JOURNAL			English	Article							INDUCED HEPATIC NECROSIS; HEPATOTOXICITY; ACETAMINOPHEN; GLUTATHIONE		[Eksteen, Bertus] MRC, London W1N 4AL, England			l.c.claridge@bham.ac.uk			Medical Research Council [G0601816] Funding Source: Medline; MRC [G0601816] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ERIKSSON LS, 1992, J INTERN MED, V231, P567, DOI 10.1111/j.1365-2796.1992.tb00976.x; Forget P, 2009, BRIT J ANAESTH, V103, P899, DOI 10.1093/bja/aep322; FORREST JAH, 1982, CLIN PHARMACOKINET, V7, P93, DOI 10.2165/00003088-198207020-00001; JOLLOW DJ, 1973, J PHARMACOL EXP THER, V187, P195; Kurtovic J, 2003, J INTERN MED, V253, P240, DOI 10.1046/j.1365-2796.2003.01097.x; LAUTERBURG BH, 1988, GUT, V29, P1153, DOI 10.1136/gut.29.9.1153; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MILNER DJ, 1979, BIOCHEM PHARMACOL, V28, P3285; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211; Moling O, 2006, CLIN THER, V28, P755, DOI 10.1016/j.clinthera.2006.05.002; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Pearce B, 2008, ANAESTHESIA, V63, P89, DOI 10.1111/j.1365-2044.2007.05340.x; 2010, BRIT NATL FORMULARY, P60	13	29	32	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 2	2010	341								c6764	10.1136/bmj.c6764	http://dx.doi.org/10.1136/bmj.c6764			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691OW	21127120				2022-12-28	WOS:000285091700001
J	Ezra, DG; Pavesio, CE				Ezra, Daniel G.; Pavesio, Carlos E.			Chorioretinal Granuloma in Tuberculosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ezra, Daniel G.; Pavesio, Carlos E.] Natl Inst Hlth Res, Biomed Res Ctr Ophthalmol, London, England	University of London; University College London	Ezra, DG (corresponding author), Natl Inst Hlth Res, Biomed Res Ctr Ophthalmol, London, England.	d.ezra@ucl.ac.uk							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2248	2248		10.1056/NEJMicm0912935	http://dx.doi.org/10.1056/NEJMicm0912935			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EP	21121837				2022-12-28	WOS:000284832900012
J	Roselle, HA; Herman, M				Roselle, Harry A.; Herman, Marc			A hearty sneeze	LANCET			English	Editorial Material							ORBITAL EMPHYSEMA		[Roselle, Harry A.] Englewood Hosp & Med Ctr, Dept Med, Englewood, NJ 07631 USA; [Herman, Marc] Englewood Hosp & Med Ctr, Dept Radiol, Englewood, NJ 07631 USA	Englewood Hospital & Medical Center; Englewood Hospital & Medical Center	Roselle, HA (corresponding author), Englewood Hosp & Med Ctr, Dept Med, 309 Engle St, Englewood, NJ 07631 USA.	rosellesrhj@aol.com						Benharbit M, 2003, J FR OPHTALMOL, V26, P957; Bolognini A, 2008, UNDERSEA HYPERBAR M, V35, P163; Chiu WC, 2008, AM J EMERG MED, V26, DOI 10.1016/j.ajem.2007.05.021; Upadhyay Daya, 2007, Int J Chron Obstruct Pulmon Dis, V2, P187; Wright J, 2008, MED LEGAL J, V14, P157	5	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2010	376	9755					1872	1872		10.1016/S0140-6736(10)61161-0	http://dx.doi.org/10.1016/S0140-6736(10)61161-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696KG	21111910				2022-12-28	WOS:000285439700037
J	Jaskelioff, M; Muller, FL; Paik, JH; Thomas, E; Jiang, S; Adams, AC; Sahin, E; Kost-Alimova, M; Protopopov, A; Cadinanos, J; Horner, JW; Maratos-Flier, E; DePinho, RA				Jaskelioff, Mariela; Muller, Florian L.; Paik, Ji-Hye; Thomas, Emily; Jiang, Shan; Adams, Andrew C.; Sahin, Ergun; Kost-Alimova, Maria; Protopopov, Alexei; Cadinanos, Juan; Horner, James W.; Maratos-Flier, Eleftheria; DePinho, Ronald A.			Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice	NATURE			English	Article							NEURAL STEM-CELLS; OLFACTORY-BULB; DNA-DAMAGE; CHROMOSOMAL INSTABILITY; LIFE-SPAN; CANCER; NEUROGENESIS; ADULT; MOUSE; RECOMBINATION	An ageing world population has fuelled interest in regenerative remedies that may stem declining organ function and maintain fitness. Unanswered is whether elimination of intrinsic instigators driving age-associated degeneration can reverse, as opposed to simply arrest, various afflictions of the aged. Such instigators include progressively damaged genomes. Telomerase-deficient mice have served as a model system to study the adverse cellular and organismal consequences of wide-spread endogenous DNA damage signalling activation in vivo(1). Telomere loss and uncapping provokes progressive tissue atrophy, stem cell depletion, organ system failure and impaired tissue injury responses(1). Here, we sought to determine whether entrenched multi-system degeneration in adult mice with severe telomere dysfunction can be halted or possibly reversed by reactivation of endogenous telomerase activity. To this end, we engineered a knock-in allele encoding a 4-hydroxytamoxifen (4-OHT)-inducible telomerase reverse transcriptase-oestrogen receptor (TERT-ER) under transcriptional control of the endogenous TERT promoter. Homozygous TERT-ER mice have short dysfunctional telomeres and sustain increased DNA damage signalling and classical degenerative phenotypes upon successive generational matings and advancing age. Telomerase reactivation in such late generation TERT-ER mice extends telomeres, reduces DNA damage signalling and associated cellular checkpoint responses, allows resumption of proliferation in quiescent cultures, and eliminates degenerative phenotypes across multiple organs including testes, spleens and intestines. Notably, somatic telomerase reactivation reversed neurodegeneration with restoration of proliferating Sox2(+) neural progenitors, Dcx(+) newborn neurons, and Olig2(+) oligodendrocyte populations. Consistent with the integral role of subventricular zone neural progenitors in generation and maintenance of olfactory bulb interneurons(2), this wave of telomerase-dependent neurogenesis resulted in alleviation of hyposmia and recovery of innate olfactory avoidance responses. Accumulating evidence implicating telomere damage as a driver of age-associated organ decline and disease risk(1,3) and the marked reversal of systemic degenerative phenotypes in adult mice observed here support the development of regenerative strategies designed to restore telomere integrity.	[Jaskelioff, Mariela; Muller, Florian L.; Paik, Ji-Hye; Thomas, Emily; Jiang, Shan; Sahin, Ergun; Kost-Alimova, Maria; Protopopov, Alexei; Cadinanos, Juan; Horner, James W.; DePinho, Ronald A.] Harvard Univ, Sch Med, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Jaskelioff, Mariela; Muller, Florian L.; Paik, Ji-Hye; Thomas, Emily; Jiang, Shan; Sahin, Ergun; Kost-Alimova, Maria; Protopopov, Alexei; Cadinanos, Juan; Horner, James W.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Jaskelioff, Mariela; Muller, Florian L.; Paik, Ji-Hye; Thomas, Emily; Jiang, Shan; Sahin, Ergun; Kost-Alimova, Maria; Protopopov, Alexei; Cadinanos, Juan; Horner, James W.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; [Jaskelioff, Mariela; Muller, Florian L.; Paik, Ji-Hye; Thomas, Emily; Jiang, Shan; Sahin, Ergun; Kost-Alimova, Maria; Protopopov, Alexei; Cadinanos, Juan; Horner, James W.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Genet, Boston, MA 02115 USA; [Adams, Andrew C.; Maratos-Flier, Eleftheria] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	DePinho, RA (corresponding author), Harvard Univ, Sch Med, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu		DePinho, Ronald/0000-0002-5625-577X; Cadinanos, Juan/0000-0001-7561-7759; Muller, Florian/0000-0001-7568-2948	Susan G. Komen for the Cure fellowship [PDF060881]; NIH National Cancer Institute [R01CA84628, U01CA141508]; Belfer Foundation; American Cancer Society (ACS) [PF-08-261-01-TBE]; NATIONAL CANCER INSTITUTE [R01CA084628, U01CA141508] Funding Source: NIH RePORTER	Susan G. Komen for the Cure fellowship(Susan G. Komen Breast Cancer Foundation); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Belfer Foundation; American Cancer Society (ACS)(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank R. Segal for critical comments, R. Bronson, K. Ligon and C. Maire for histological advice, S. S. Chae for assistance with neurosphere measurement studies and L. Cameron for time-lapse microscopy studies. M.J. was supported in part by a Susan G. Komen for the Cure fellowship (PDF060881). F.L.M. was supported by ACS fellowship PF-08-261-01-TBE. This work and R.A.D. was supported by R01CA84628 and U01CA141508 grants from the NIH National Cancer Institute and the Belfer Foundation. R.A.D. was supported by an American Cancer Society Research Professorship.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Best BP, 2009, REJUV RES, V12, P199, DOI 10.1089/rej.2009.0847; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Caporaso GL, 2003, MOL CELL NEUROSCI, V23, P693, DOI 10.1016/S1044-7431(03)00103-9; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Drapeau E, 2008, AGING CELL, V7, P569, DOI 10.1111/j.1474-9726.2008.00369.x; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Ferron S, 2004, DEVELOPMENT, V131, P4059, DOI 10.1242/dev.01215; Ferron SR, 2009, J NEUROSCI, V29, P14394, DOI 10.1523/JNEUROSCI.3836-09.2009; Gorczyca W, 2001, METHOD CELL BIOL, V64, P421; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Ju ZY, 2008, BIOCHIMIE, V90, P24, DOI 10.1016/j.biochi.2007.09.006; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Lafreniere D, 2009, OTOLARYNG CLIN N AM, V42, P123, DOI 10.1016/j.otc.2008.09.001; Lee J, 2010, NEUROCHEM RES, V35, P211, DOI 10.1007/s11064-009-0044-3; Ma DKK, 2009, ANN NY ACAD SCI, V1170, P664, DOI 10.1111/j.1749-6632.2009.04373.x; Mahoney JE, 2008, PROC SPIE, V6859, DOI 10.1117/12.763858; Maser RS, 2007, MOL CELL BIOL, V27, P2253, DOI 10.1128/MCB.01354-06; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Potzner MR, 2007, MOL CELL BIOL, V27, P5316, DOI 10.1128/MCB.00339-07; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Shao CS, 1999, P NATL ACAD SCI USA, V96, P9230, DOI 10.1073/pnas.96.16.9230; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Spink AJ, 2001, PHYSIOL BEHAV, V73, P731, DOI 10.1016/S0031-9384(01)00530-3; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Zhang P, 2007, NEUROSCIENCE, V145, P1439, DOI 10.1016/j.neuroscience.2006.11.052	35	508	537	3	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					102	U1700		10.1038/nature09603	http://dx.doi.org/10.1038/nature09603			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21113150	Green Accepted			2022-12-28	WOS:000285921600040
J	Marois, C; Zuckerman, B; Konopacky, QM; Macintosh, B; Barman, T				Marois, Christian; Zuckerman, B.; Konopacky, Quinn M.; Macintosh, Bruce; Barman, Travis			Images of a fourth planet orbiting HR 8799	NATURE			English	Article							EXTRASOLAR GIANT PLANETS; DEBRIS DISK; BROWN DWARFS; SYSTEM; SPECTROSCOPY; STARS; LUMINOSITY	High-contrast near-infrared imaging of the nearby star HR 8799 has shown three giant planets(1). Such images were possible because of the wide orbits (>25 astronomical units, where 1 AU is the Earth-Sun distance) and youth (<100 Myr) of the imaged planets, which are still hot and bright as they radiate away gravitational energy acquired during their formation. An important area of contention in the exoplanet community is whether outer planets (>10 AU) more massive than Jupiter form by way of one-step gravitational instabilities(2) or, rather, through a two-step process involving accretion of a core followed by accumulation of a massive outer envelope composed primarily of hydrogen and helium(3). Here we report the presence of a fourth planet, interior to and of about the same mass as the other three. The system, with this additional planet, represents a challenge for current planet formation models as none of them can explain the in situ formation of all four planets. With its four young giant planets and known cold/warm debris belts(4), the HR 8799 planetary system is a unique laboratory in which to study the formation and evolution of giant planets at wide (>10 AU) separations.	[Marois, Christian] Natl Res Council Canada, Herzberg Inst Astrophys, Victoria, BC V9E 2E7, Canada; [Zuckerman, B.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Konopacky, Quinn M.; Macintosh, Bruce] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Barman, Travis] Lowell Observ, Flagstaff, AZ 86001 USA	National Research Council Canada; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Marois, C (corresponding author), Natl Res Council Canada, Herzberg Inst Astrophys, 5071 W Saanich Rd, Victoria, BC V9E 2E7, Canada.	christian.marois@nrc-cnrc.gc.ca		Konopacky, Quinn/0000-0002-9936-6285; Macintosh, Bruce/0000-0003-1212-7538	US Department of Energy by LLNL; NSF Center for Adaptive Optics; NASA	US Department of Energy by LLNL(United States Department of Energy (DOE)); NSF Center for Adaptive Optics; NASA(National Aeronautics & Space Administration (NASA))	We thank the Keck staff, particularly H. Lewis, B. Goodrich and J. Lyke, for support with the follow-up observations. We thank G. Laughlin and D. C. Fabrycky for discussions. Portions of this research were performed under the auspices of the US Department of Energy by LLNL and also supported in part by the NSF Center for Adaptive Optics. We acknowledge support by NASA grants to UCLA, LLNL and Lowell Observatory. The data were obtained at the W. M. Keck Observatory. This publication makes use of data products from the Two Micron All Sky Survey and the SIMBAD database.	Baraffe I, 2003, ASTRON ASTROPHYS, V402, P701, DOI 10.1051/0004-6361:20030252; Bowler BP, 2010, ASTROPHYS J, V723, P850, DOI 10.1088/0004-637X/723/1/850; Chambers JE, 1999, MON NOT R ASTRON SOC, V304, P793, DOI 10.1046/j.1365-8711.1999.02379.x; Chauvin G, 2010, ASTRON ASTROPHYS, V509, DOI 10.1051/0004-6361/200911716; Dodson-Robinson SE, 2009, ASTROPHYS J, V707, P79, DOI 10.1088/0004-637X/707/1/79; Eggenberger A, 2010, EAS PUBLICATIONS, V41, P27, DOI 10.1051/eas/1041002; Gaspar A, 2009, ASTROPHYS J, V697, P1578, DOI 10.1088/0004-637X/697/2/1578; Golimowski DA, 2004, ASTRON J, V127, P3516, DOI 10.1086/420709; Gozdziewski K, 2009, MON NOT R ASTRON SOC, V397, pL16, DOI 10.1111/j.1745-3933.2009.00674.x; Hinz PM, 2010, ASTROPHYS J, V716, P417, DOI 10.1088/0004-637X/716/1/417; Janson M, 2010, ASTROPHYS J LETT, V710, pL35, DOI 10.1088/2041-8205/710/1/L35; Kratter KM, 2010, ASTROPHYS J, V710, P1375, DOI 10.1088/0004-637X/710/2/1375; Lafreniere D, 2007, ASTROPHYS J, V670, P1367, DOI 10.1086/522826; Lafreniere D, 2007, ASTROPHYS J, V660, P770, DOI 10.1086/513180; Malhotra R, 1998, ASTR SOC P, V149, P37; Marley MS, 2007, ASTROPHYS J, V655, P541, DOI 10.1086/509759; Marois C, 2006, ASTROPHYS J, V641, P556, DOI 10.1086/500401; MAROIS C, 2010, P SOC PHOTO-OPT INS, V7736; MIZUNO H, 1980, PROG THEOR PHYS, V64, P544, DOI 10.1143/PTP.64.544; Moor A, 2006, ASTROPHYS J, V644, P525, DOI 10.1086/503381; Moya A, 2010, MON NOT R ASTRON SOC, V405, pL81, DOI 10.1111/j.1745-3933.2010.00863.x; Nielsen EL, 2010, ASTROPHYS J, V717, P878, DOI 10.1088/0004-637X/717/2/878; Rhee JH, 2007, ASTROPHYS J, V660, P1556, DOI 10.1086/509912; Stamatellos D, 2009, MON NOT R ASTRON SOC, V392, P413, DOI 10.1111/j.1365-2966.2008.14069.x; Su KYL, 2009, ASTROPHYS J, V705, P314, DOI 10.1088/0004-637X/705/1/314; Torres C. A. O., 2008, HDB STAR FORMING REG, V5, P757	30	632	634	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1080	1083		10.1038/nature09684	http://dx.doi.org/10.1038/nature09684			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21150902	Green Submitted			2022-12-28	WOS:000285553800053
J	White, NJ				White, Nicholas J.			Artemisinin resistance-the clock is ticking	LANCET			English	Editorial Material							MALARIA; AFRICA		Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand	Mahidol University	White, NJ (corresponding author), Mahidol Univ, Fac Trop Med, 420-6 Rajvithi Rd, Bangkok 10400, Thailand.	nickw@tropmedres.ac	White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019	White, Nick/0000-0002-1897-1978	Wellcome Trust [093956] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 2010, SCIENCE, V328, P846, DOI 10.1126/science.328.5980.846; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Henderson D A, 1998, Bull World Health Organ, V76 Suppl 2, P17; Korenromp EL, 2003, LANCET INFECT DIS, V3, P349, DOI 10.1016/S1473-3099(03)00657-1; Marsh K, 1998, LANCET, V352, P924, DOI 10.1016/S0140-6736(05)61510-3; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; WHO, ART RES CONT PROJ	9	77	81	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2010	376	9758					2051	2052		10.1016/S0140-6736(10)61963-0	http://dx.doi.org/10.1016/S0140-6736(10)61963-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702LA	21168039				2022-12-28	WOS:000285895000008
J	Hino, T; Matsumoto, Y; Nagano, S; Sugimoto, H; Fukumori, Y; Murata, T; Iwata, S; Shiro, Y				Hino, Tomoya; Matsumoto, Yushi; Nagano, Shingo; Sugimoto, Hiroshi; Fukumori, Yoshihiro; Murata, Takeshi; Iwata, So; Shiro, Yoshitsugu			Structural Basis of Biological N2O Generation by Bacterial Nitric Oxide Reductase	SCIENCE			English	Article							CYTOCHROME-C-OXIDASE; PARACOCCUS-DENITRIFICANS; SPECTROSCOPIC CHARACTERIZATION; PSEUDOMONAS-AERUGINOSA; NO REDUCTASE; BC COMPLEX; HEME; PATHWAY; GLUTAMATES; STUTZERI	Nitric oxide reductase (NOR) is an iron-containing enzyme that catalyzes the reduction of nitric oxide (NO) to generate a major greenhouse gas, nitrous oxide (N2O). Here, we report the crystal structure of NOR from Pseudomonas aeruginosa at 2.7 angstrom resolution. The structure reveals details of the catalytic binuclear center. The non-heme iron (Fe-B) is coordinated by three His and one Glu ligands, but a His-Tyr covalent linkage common in cytochrome oxidases (COX) is absent. This structural characteristic is crucial for NOR reaction. Although the overall structure of NOR is closely related to COX, neither the D-nor K-proton pathway, which connect the COX active center to the intracellular space, was observed. Protons required for the NOR reaction are probably provided from the extracellular side.	[Hino, Tomoya; Matsumoto, Yushi; Nagano, Shingo; Sugimoto, Hiroshi; Shiro, Yoshitsugu] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Hino, Tomoya; Murata, Takeshi; Iwata, So] Japan Sci & Technol Agcy, Human Receptor Crystallog Project, Sakyo Ku, Kyoto 6068501, Japan; [Hino, Tomoya; Murata, Takeshi; Iwata, So] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Matsumoto, Yushi] Kyushu Univ, Med Inst Bioregulat, Postgenome Sci Ctr, Div Prot Chem, Fukuoka 8128552, Japan; [Nagano, Shingo] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan; [Fukumori, Yoshihiro] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Iwata, So] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Membrane Prot Crystallog Grp, London SW7 2AZ, England	RIKEN; Japan Science & Technology Agency (JST); Kyoto University; Kyushu University; Tottori University; Kanazawa University; Imperial College London	Hino, T (corresponding author), RIKEN SPring 8 Ctr, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.		Shiro, Yoshitsugu Y/J-3757-2014; Murata, Takeshi/J-6181-2017; Murata, Takeshi/F-6114-2011; Sugimoto, Hiroshi/AAR-5442-2021; Sugimoto, Hiroshi/K-4041-2017; Fukumori, Yoshihiro/J-2483-2014	Shiro, Yoshitsugu Y/0000-0003-0695-8327; Murata, Takeshi/0000-0002-5748-4670; Sugimoto, Hiroshi/0000-0002-3140-8362; 	Ministry of Education, Culture, Sports, Science and Technology (MEXT); RIKEN; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	Atomic coordinates and structure factors have been deposited to the Protein Data Bank (PDB) with code 3O0R. We thank T. Tosha for measurements of the enzymatic activity of cNOR under various conditions and the staff of the SPring-8 beamlines for their help with diffraction measurements. S.N., H. S., and Y.S. are supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and Y.S. also acknowledges financial support from the Structural Biology and Molecular Ensemble projects of RIKEN. A part of this work was also supported by a grant from the ERATO IWATA Human Receptor Crystallography Project from the Japan Science and Technology Agency.	BELL LC, 1992, J GEN MICROBIOL, V138, P437, DOI 10.1099/00221287-138-3-437; Blomberg LM, 2006, BBA-BIOENERGETICS, V1757, P240, DOI 10.1016/j.bbabio.2006.04.008; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Butland G, 2001, J BACTERIOL, V183, P189, DOI 10.1128/JB.183.1.189-199.2001; Butler CS, 1997, BIOCHEMISTRY-US, V36, P16259, DOI 10.1021/bi971481a; Collman JP, 2008, P NATL ACAD SCI USA, V105, P15660, DOI 10.1073/pnas.0808606105; DeBoer APN, 1996, EUR J BIOCHEM, V242, P592, DOI 10.1111/j.1432-1033.1996.0592r.x; Flock U, 2008, J BIOL CHEM, V283, P3839, DOI 10.1074/jbc.M704615200; Flock U, 2009, J INORG BIOCHEM, V103, P845, DOI 10.1016/j.jinorgbio.2009.02.008; Girsch P, 1997, BBA-BIOENERGETICS, V1318, P202, DOI 10.1016/S0005-2728(96)00138-7; Gronberg KLC, 1999, BIOCHEMISTRY-US, V38, P13780, DOI 10.1021/bi9916426; HEISS B, 1989, J BACTERIOL, V171, P3288, DOI 10.1128/jb.171.6.3288-3297.1989; Hemp J, 2007, BIOCHEMISTRY-US, V46, P9963, DOI 10.1021/bi700659y; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kakishima K, 2007, BIOCHEM BIOPH RES CO, V355, P587, DOI 10.1016/j.bbrc.2007.02.017; Kumita H, 2004, J BIOL CHEM, V279, P55247, DOI 10.1074/jbc.M409996200; Lin YW, 2010, P NATL ACAD SCI USA, V107, P8581, DOI 10.1073/pnas.1000526107; Moenne-Loccoz P, 2000, J AM CHEM SOC, V122, P9344, DOI 10.1021/ja0016295; Moenne-Loccoz P, 1998, J AM CHEM SOC, V120, P5147, DOI 10.1021/ja973671e; Moenne-Loccoz P, 2007, NAT PROD REP, V24, P610, DOI 10.1039/B604194A; Regan JJ, 1998, J BIOENERG BIOMEMBR, V30, P35, DOI 10.1023/A:1020551326307; Reimann J, 2007, BBA-BIOENERGETICS, V1767, P362, DOI 10.1016/j.bbabio.2007.03.006; SARASTE M, 1994, FEBS LETT, V341, P1, DOI 10.1016/0014-5793(94)80228-9; SHAPLEIGH JP, 1985, J BACTERIOL, V163, P837, DOI 10.1128/JB.163.3.837-840.1985; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; VANDEROOST J, 1994, FEMS MICROBIOL LETT, V121, P1, DOI 10.1016/0378-1097(94)90137-6; Wuebbles DJ, 2009, SCIENCE, V326, P56, DOI 10.1126/science.1179571; YE RW, 1994, APPL ENVIRON MICROB, V60, P1053, DOI 10.1128/AEM.60.4.1053-1058.1994; Yeung N, 2009, NATURE, V462, P1079, DOI 10.1038/nature08620; ZUMFT WG, 1994, EUR J BIOCHEM, V219, P481, DOI 10.1111/j.1432-1033.1994.tb19962.x	31	245	249	1	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1666	1670		10.1126/science.1195591	http://dx.doi.org/10.1126/science.1195591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21109633				2022-12-28	WOS:000285390500064
J	Soukoulis, CM; Wegener, M				Soukoulis, Costas M.; Wegener, Martin			Optical Metamaterials-More Bulky and Less Lossy	SCIENCE			English	Editorial Material							NEGATIVE REFRACTIVE-INDEX; PHOTONIC METAMATERIAL		[Soukoulis, Costas M.] Iowa State Univ, Ames Lab, Ames, IA 50011 USA; [Soukoulis, Costas M.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Soukoulis, Costas M.] Univ Crete, Fdn Res & Technol Hellas, Inst Elect Struct & Laser, Iraklion, Crete, Greece; [Wegener, Martin] Karlsruhe Inst Technol, Inst Nanotechnol, Inst Appl Phys, Karlsruhe, Germany; [Wegener, Martin] Karlsruhe Inst Technol, Ctr Funct Nanostruct, Karlsruhe, Germany	Iowa State University; United States Department of Energy (DOE); Ames National Laboratory; Iowa State University; Foundation for Research & Technology - Hellas (FORTH); University of Crete; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Soukoulis, CM (corresponding author), Iowa State Univ, Ames Lab, Ames, IA 50011 USA.	soukoulis@ameslab.gov	Soukoulis, Costas M./A-5295-2008; Wegener, Martin/S-5456-2016; Wegener, Martin/ABD-5353-2021	Wegener, Martin/0000-0002-9770-2441; Wegener, Martin/0000-0002-9770-2441				Burckel DB, 2010, ADV MATER, V22, P3171, DOI 10.1002/adma.200904153; Fang A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.121102; Gansel JK, 2009, SCIENCE, V325, P1513, DOI 10.1126/science.1177031; Guney DO, 2010, OPT EXPRESS, V18, P12348, DOI 10.1364/OE.18.012348; Kinsler P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.167401; Liu N, 2008, NAT MATER, V7, P31, DOI 10.1038/nmat2072; Meinzer N, 2010, OPT EXPRESS, V18, P24140, DOI 10.1364/OE.18.024140; Plum E, 2009, OPT EXPRESS, V17, P8548, DOI 10.1364/OE.17.008548; Rockstuhl C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.017401; Soukoulis CM, 2007, SCIENCE, V315, P47, DOI 10.1126/science.1136481; Stockman MI, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.177404; Valentine J, 2008, NATURE, V455, P376, DOI 10.1038/nature07247; Wuestner S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.127401; Xiao SM, 2010, NATURE, V466, P735, DOI 10.1038/nature09278	14	187	194	4	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2010	330	6011					1633	1634		10.1126/science.1198858	http://dx.doi.org/10.1126/science.1198858			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164003				2022-12-28	WOS:000285390500051
J	Yao, L; Schiavi, F; Cascon, A; Qin, YJ; Inglada-Perez, L; King, EE; Toledo, RA; Ercolino, T; Rapizzi, E; Ricketts, CJ; Mori, L; Giacche, M; Mendola, A; Taschin, E; Boaretto, F; Loli, P; Iacobone, M; Rossi, GP; Biondi, B; Lima, JV; Kater, CE; Bex, M; Vikkula, M; Grossman, AB; Gruber, SB; Barontini, M; Persu, A; Castellano, M; Toledo, SPA; Maher, ER; Mannelli, M; Opocher, G; Robledo, M; Dahia, PLM				Yao, Li; Schiavi, Francesca; Cascon, Alberto; Qin, Yuejuan; Inglada-Perez, Lucia; King, Elizabeth E.; Toledo, Rodrigo A.; Ercolino, Tonino; Rapizzi, Elena; Ricketts, Christopher J.; Mori, Luigi; Giacche, Mara; Mendola, Antonella; Taschin, Elisa; Boaretto, Francesca; Loli, Paola; Iacobone, Maurizio; Rossi, Gian-Paolo; Biondi, Bernadette; Lima-Junior, Jose Viana; Kater, Claudio E.; Bex, Marie; Vikkula, Miikka; Grossman, Ashley B.; Gruber, Stephen B.; Barontini, Marta; Persu, Alexandre; Castellano, Maurizio; Toledo, Sergio P. A.; Maher, Eamonn R.; Mannelli, Massimo; Opocher, Giuseppe; Robledo, Mercedes; Dahia, Patricia L. M.			Spectrum and Prevalence of FP/TMEM127 Gene Mutations in Pheochromocytomas and Paragangliomas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TUMOR-SUPPRESSOR; SUSCEPTIBILITY; 1P36	Context Pheochromocytomas and paragangliomas are genetically heterogeneous neural crest-derived neoplasms. We recently identified germline mutations of the novel transmembrane-encoding gene FP/TMEM127 in familial and sporadic pheochromocytomas consistent with a tumor suppressor effect. Objectives To examine the prevalence and spectrum of FP/TMEM127 mutations in pheochromocytomas and paragangliomas and to test the effect of mutations in vitro. Design, Setting, and Participants We sequenced the FP/TMEM127 gene in 990 individuals with pheochromocytomas and/or paragangliomas, including 898 previously unreported cases without mutations in other susceptibility genes from 8 independent worldwide referral centers between January 2009 and June 2010. A multiplex polymerase chain reaction-based method was developed to screen for large gene deletions in 545 of these samples. Confocal microscopy of 5 transfected mutant proteins was used to determine their subcellular localization. Main Outcome Measures The frequency and type of FP/TMEM127 mutation or deletion was assessed and correlated with clinical variables; the subcellular localization of 5 overexpressed mutants was compared with wild-type FP/TMEM127 protein. Results We identified 19 potentially pathogenic FP/TMEM127 germline mutations in 20 independent families, but no large deletions were detected. All mutation carriers had adrenal tumors, including 7 bilateral (P=2.7 x 10(-4)) and/or with familial disease (5 of 20 samples; P=.005). The median age at disease onset in the FP/TMEM127 mutation group was similar to that of patients without a mutation (41.5 vs 45 years, respectively; P=.54). The most common presentation was that of a single benign adrenal tumor in patients older than 40 years. Malignancy was seen in 1 mutation carrier (5%). Expression of 5 novel FP/TMEM127 mutations in cell lines revealed diffuse localization of the mutant proteins in contrast with the discrete multiorganelle distribution of wild-type TMEM127. Conclusions Germline mutations of FP/TMEM127 were associated with pheochromocytoma but not paraganglioma and occured in an age group frequently excluded from genetic screening algorithms. Disease-associated mutations disrupt intracellular distribution of the FP/TMEM127 protein. JAMA. 2010;304(23):2611-2619 www.jama.com	[Dahia, Patricia L. M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Yao, Li; Qin, Yuejuan; King, Elizabeth E.; Dahia, Patricia L. M.] Univ Texas Hlth Sci Ctr San Antonio, Div Hematol & Med Oncol, San Antonio, TX 78229 USA; [King, Elizabeth E.] Univ Texas Hlth Sci Ctr San Antonio, Div Endocrinol, San Antonio, TX 78229 USA; [Yao, Li; Qin, Yuejuan; Dahia, Patricia L. M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Schiavi, Francesca; Taschin, Elisa; Boaretto, Francesca; Opocher, Giuseppe] Univ Padua, Veneto Inst Oncol, Familial Canc Clin, Padua, Italy; [Iacobone, Maurizio] Univ Padua, Dept Surg & Gastroenterol Sci, Padua, Italy; [Rossi, Gian-Paolo] Univ Padua, Dept Internal Med 4, Padua, Italy; [Opocher, Giuseppe] Univ Padua, Dept Med & Surg Sci, Padua, Italy; [Cascon, Alberto; Inglada-Perez, Lucia; Robledo, Mercedes] Spanish Natl Canc Res Ctr, Hereditary Endocrine Canc Grp, Madrid, Spain; [Cascon, Alberto; Inglada-Perez, Lucia; Robledo, Mercedes] Inst Salud Carlos III, Ctr Biomed Res Rare Dis, Madrid, Spain; [Toledo, Rodrigo A.; Toledo, Sergio P. A.] Univ Sao Paulo, Sch Med, Dept Med, Div Endocrinol,Endocrine Genet Unit LIM 25, Sao Paulo, Brazil; [Lima-Junior, Jose Viana; Kater, Claudio E.] Univ Fed Sao Paulo, Dept Med, Div Endocrinol, Sao Paulo, Brazil; [Ercolino, Tonino; Rapizzi, Elena; Mannelli, Massimo] Univ Florence, Dept Clin Pathophysiol, Florence, Italy; [Mannelli, Massimo] Ist Toscano Tumori, Florence, Italy; [Ricketts, Christopher J.; Maher, Eamonn R.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Ricketts, Christopher J.; Maher, Eamonn R.] Univ Birmingham, Ctr Rare Dis & Personalised Med, Birmingham, W Midlands, England; [Mori, Luigi; Giacche, Mara; Castellano, Maurizio] Univ Brescia, Endocrine & Metab Unit, Med Clin, Brescia, Italy; [Mendola, Antonella; Vikkula, Miikka] Catholic Univ Louvain, Clin Univ St Luc, Lab Human Mol Genet, de Duve Inst, B-1200 Brussels, Belgium; [Persu, Alexandre] Catholic Univ Louvain, Clin Univ St Luc, Div Cardiol, B-1200 Brussels, Belgium; [Loli, Paola] Osped Niguarda Ca Granda, Dept Endocrinol, Milan, Italy; [Biondi, Bernadette] Univ Naples Federico II, Dept Clin & Mol Endocrinol & Oncol, Naples, Italy; [Bex, Marie] Katholieke Univ Leuven Hosp, Dept Endocrinol, Leuven, Belgium; [Grossman, Ashley B.] St Bartholomews Hosp, Barts & London Sch Med, Ctr Endocrinol, London, England; [Gruber, Stephen B.] Univ Michigan, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Barontini, Marta] Hosp Ninos Dr Ricardo Gutierrez, Ctr Invest Endocrinol, Buenos Aires, DF, Argentina	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Padua; University of Padua; University of Padua; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Birmingham; University of Birmingham; University of Brescia; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Naples Federico II; KU Leuven; University Hospital Leuven; University of London; Queen Mary University London; University of Michigan System; University of Michigan; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires	Dahia, PLM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	dahia@uthscsa.edu	Robledo, Mercedes/O-2230-2013; Opocher, Giuseppe/F-3950-2014; Vikkula, Miikka/Q-1038-2018; Inglada-Perez, Lucia/Z-3020-2019; MAHER, EAMONN R/A-9507-2008; Toledo, Rodrigo/GQQ-1711-2022; Ricketts, Christopher/AAV-9580-2020; Biondi, Bernadette/AAH-7664-2020; Schiavi, Francesca/AAB-9908-2022; Castellano, Maurizio/C-1096-2011; Toledo, Rodrigo/N-4078-2013; Toledo, Rodrigo/ABH-5248-2020; boaretto, francesca/K-9811-2016; Qin, Yuejuan/F-6801-2010; Cascon, Alberto/G-3160-2014; Iacobone, Maurizio/K-8714-2016; inglada-perez, lucia/H-5378-2015; Toledo, Sergio P. A./S-9291-2018; taschin, elisa/K-3847-2016	Robledo, Mercedes/0000-0001-6256-5902; Opocher, Giuseppe/0000-0002-9845-9623; Vikkula, Miikka/0000-0002-6236-338X; MAHER, EAMONN R/0000-0002-6226-6918; Schiavi, Francesca/0000-0001-8529-4455; Castellano, Maurizio/0000-0002-4569-2659; Toledo, Rodrigo/0000-0003-3070-6795; Toledo, Rodrigo/0000-0003-3070-6795; boaretto, francesca/0000-0003-2015-929X; Cascon, Alberto/0000-0003-2119-891X; Toledo, Sergio P. A./0000-0002-2590-3519; taschin, elisa/0000-0001-9426-4071; ROSSI, GIAN PAOLO/0000-0002-7963-0931; Iacobone, Maurizio/0000-0002-6057-4642; Mannelli, Massimo/0000-0002-8001-9857; INGLADA, LUCIA/0000-0001-9523-2717; Inglada-Perez, Lucia/0000-0001-9814-4368; Persu, Alexandre/0000-0002-4007-9695; Biondi, Bernadette/0000-0001-8360-4464	University of Texas Health Science Center at San Antonio (UTHSCSA); National Cancer Institute (NCI) [P30 CA54174]; National Institute on Aging (NIA) [P30 AG013319, P01AG19316]; Department of Microbiology, UTHSCSA; Fundacao Faculdade de Medicina; Division of Endocrinology; Sao Paulo State Research Foundation (FAPESP) [2009/15386-6]; Cancer Research UK; Belgian Federal Science Policy, network [6/05]; Belgian French Community Ministry [07/12-005]; la Communaute Francaise de Wallonie-Bruxelles et la Lotterie Nationale; FRS-FNRS (Fonds de la Recherche Scientifique), Belgium; NCI [5 P30 CA465920]; Italian University and Research Ministry [2006060473]; Fondazione della Comunita Bresciana; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fondo de Investigaciones Sanitarias [PI 08/080883]; Fundacion Mutua Madrilena [AP2775/2008]; Voelcker Fund; Alex's Lemonade Stand Foundation; Concern Foundation; National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013319, P01AG019316] Funding Source: NIH RePORTER	University of Texas Health Science Center at San Antonio (UTHSCSA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Microbiology, UTHSCSA; Fundacao Faculdade de Medicina; Division of Endocrinology; Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Cancer Research UK(Cancer Research UK); Belgian Federal Science Policy, network(Belgian Federal Science Policy Office); Belgian French Community Ministry; la Communaute Francaise de Wallonie-Bruxelles et la Lotterie Nationale; FRS-FNRS (Fonds de la Recherche Scientifique), Belgium(Fonds de la Recherche Scientifique - FNRS); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Italian University and Research Ministry(Ministry of Education, Universities and Research (MIUR)); Fondazione della Comunita Bresciana; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Voelcker Fund; Alex's Lemonade Stand Foundation; Concern Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Cancer Therapy and Research Center Pathology Core and the Optical Imaging Core are supported by University of Texas Health Science Center at San Antonio (UTHSCSA) and National Cancer Institute (NCI) grant P30 CA54174 (Cancer Therapy and Research Center at UTHSCSA). The Optical Imaging Core is also supported by National Institute on Aging (NIA) grant P30 AG013319 (Nathan Shock Center) and NIA grant P01AG19316. The Nucleic Acids Core Facility receives the support of the Department of Microbiology, UTHSCSA. Funds from the Fundacao Faculdade de Medicina and the Division of Endocrinology provided support for the screening of the Brazilian cohort. Dr R. A. Toledo is supported by a Sao Paulo State Research Foundation (FAPESP grant 2009/15386-6) postdoctoral fellowship. Drs Ricketts and Maher are supported by Cancer Research UK. Dr Vikkula is supported by the Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy, network 6/05; Concerted Research Actions Convention No. 07/12-005 of the Belgian French Community Ministry; la Communaute Francaise de Wallonie-Bruxelles et la Lotterie Nationale. Drs Vikkula and Persu are supported by the FRS-FNRS (Fonds de la Recherche Scientifique), Belgium. Dr Gruber is supported by NCI grant 5 P30 CA465920. Dr Castellano is supported by funds from the Italian University and Research Ministry (grant 2006060473) and by the Fondazione della Comunita Bresciana. Dr S. P. A. Toledo is supported by a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grant. Dr Robledo is supported by Fondo de Investigaciones Sanitarias grant PI 08/080883 and Fundacion Mutua Madrilena (reference AP2775/2008). Dr Dahia is supported by the Voelcker Fund, Alex's Lemonade Stand Foundation, Concern Foundation, and Clinical Translational and Science Awards (National Institutes of Health).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bayley JP, 2010, LANCET ONCOL, V11, P366, DOI 10.1016/S1470-2045(10)70007-3; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Burnichon N, 2009, J CLIN ENDOCR METAB, V94, P2817, DOI 10.1210/jc.2008-2504; Cascon A, 2008, J MED GENET, V45, P233, DOI 10.1136/jmg.2007.054965; Cascon A, 2009, HORM METAB RES, V41, P672, DOI 10.1055/s-0029-1202814; Cascon A, 2009, J CLIN ENDOCR METAB, V94, P1701, DOI 10.1210/jc.2008-2756; Dahia PLM, 2005, CANCER RES, V65, P9651, DOI 10.1158/0008-5472.CAN-05-1427; Gimenez-Roqueplo AP, 2006, CLIN ENDOCRINOL, V65, P699, DOI 10.1111/j.1365-2265.2006.02714.x; Ladroue C, 2008, NEW ENGL J MED, V359, P2685, DOI 10.1056/NEJMoa0806277; Manger WM, 2006, ANN NY ACAD SCI, V1073, P1, DOI 10.1196/annals.1353.001; Mannelli M, 2009, J CLIN ENDOCR METAB, V94, P1541, DOI 10.1210/jc.2008-2419; NEUMANN H, 2009, J CLIN ENDOCR METAB, V94, pA19; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Opocher G, 2003, HORM RES, V59, P56, DOI 10.1159/000067846; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Powers JF, 2000, CELL TISSUE RES, V302, P309, DOI 10.1007/s004410000290; Qin YJ, 2010, NAT GENET, V42, P229, DOI 10.1038/ng.533; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; Ya G, 2009, BIOL PHARM BULL, V32, P882, DOI 10.1248/bpb.32.882; Yeh IT, 2008, HUM GENET, V124, P279, DOI 10.1007/s00439-008-0553-1	22	132	143	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2010	304	23					2611	2619		10.1001/jama.2010.1830	http://dx.doi.org/10.1001/jama.2010.1830			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694MX	21156949	Bronze			2022-12-28	WOS:000285303400024
J	Burney, I; Pemberton, N				Burney, Ian; Pemberton, Neil			Christmas 2010: Whodunit The rise and fall of celebrity pathology	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Burney, Ian; Pemberton, Neil] Univ Manchester, Ctr Hist Sci Technol & Med, Manchester M13 9PL, Lancs, England	University of Manchester	Burney, I (corresponding author), Univ Manchester, Ctr Hist Sci Technol & Med, Manchester M13 9PL, Lancs, England.	ian.burney@manchester.ac.uk						BURNEY I, 2006, POISON VICTORIAN IMA; Burney I, 2000, BODIES EVIDENCE MED; FORAN DR, 2010, J FORENSIC SCI; SIMPSON K, 1969, J FORENSIC SCI SOC, V9, P199, DOI 10.1016/S0015-7368(69)70536-9; 1964, J FORENSIC SCI SOC, V4, P183	5	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 14	2010	341								c6500	10.1136/bmj.c6500	http://dx.doi.org/10.1136/bmj.c6500			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XD	21156736				2022-12-28	WOS:000285552200016
J	Timmerman, D; Ameye, L; Fischerova, D; Epstein, E; Melis, GB; Guerriero, S; Van Holsbeke, C; Savelli, L; Fruscio, R; Lissoni, AA; Testa, AC; Veldman, J; Vergote, I; Van Huffel, S; Bourne, T; Valentin, L				Timmerman, Dirk; Ameye, Lieveke; Fischerova, Daniela; Epstein, Elisabeth; Melis, Gian Benedetto; Guerriero, Stefano; Van Holsbeke, Caroline; Savelli, Luca; Fruscio, Robert; Lissoni, Andrea Alberto; Testa, Antonia Carla; Veldman, Joan; Vergote, Ignace; Van Huffel, Sabine; Bourne, Tom; Valentin, Lil			Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group	BRITISH MEDICAL JOURNAL			English	Article							LOGISTIC-REGRESSION MODELS; TUMOR-ANALYSIS-GROUP; OVARIAN-CANCER; PELVIC MASSES; EXTERNAL VALIDATION; MATHEMATICAL-MODELS; DIAGNOSIS; MULTICENTER; DISCRIMINATION; CARCINOMA	Objectives To prospectively assess the diagnostic performance of simple ultrasound rules to predict benignity/malignancy in an adnexal mass and to test the performance of the risk of malignancy index, two logistic regression models, and subjective assessment of ultrasonic findings by an experienced ultrasound examiner in adnexal masses for which the simple rules yield an inconclusive result. Design Prospective temporal and external validation of simple ultrasound rules to distinguish benign from malignant adnexal masses. The rules comprised five ultrasonic features (including shape, size, solidity, and results of colour Doppler examination) to predict a malignant tumour (M features) and five to predict a benign tumour (B features). If one or more M features were present in the absence of a B feature, the mass was classified as malignant. If one or more B features were present in the absence of an M feature, it was classified as benign. If both M features and B features were present, or if none of the features was present, the simple rules were inconclusive. Setting 19 ultrasound centres in eight countries. Participants 1938 women with an adnexal mass examined with ultrasound by the principal investigator at each centre with a standardised research protocol. Reference standard Histological classification of the excised adnexal mass as benign or malignant. Main outcome measures Diagnostic sensitivity and specificity. Results Of the 1938 patients with an adnexal mass, 1396 (72%) had benign tumours, 373 (19.2%) had primary invasive tumours, 111 (5.7%) had borderline malignant tumours, and 58 (3%) had metastatic tumours in the ovary. The simple rules yielded a conclusive result in 1501 (77%) masses, for which they resulted in a sensitivity of 92% (95% confidence interval 89% to 94%) and a specificity of 96% (94% to 97%). The corresponding sensitivity and specificity of subjective assessment were 91% (88% to 94%) and 96% (94% to 97%). In the 357 masses for which the simple rules yielded an inconclusive result and with available results of CA-125 measurements, the sensitivities were 89% (83% to 93%) for subjective assessment, 50% (42% to 58%) for the risk of malignancy index, 89% (83% to 93%) for logistic regression model 1, and 82% (75% to 87%) for logistic regression model 2; the corresponding specificities were 78% (72% to 83%), 84% (78% to 88%), 44% (38% to 51%), and 48% (42% to 55%). Use of the simple rules as a triage test and subjective assessment for those masses for which the simple rules yielded an inconclusive result gave a sensitivity of 91% (88% to 93%) and a specificity of 93% (91% to 94%), compared with a sensitivity of 90% (88% to 93%) and a specificity of 93% (91% to 94%) when subjective assessment was used in all masses. Conclusions The use of the simple rules has the potential to improve the management of women with adnexal masses. In adnexal masses for which the rules yielded an inconclusive result, subjective assessment of ultrasonic findings by an experienced ultrasound examiner was the most accurate diagnostic test; the risk of malignancy index and the two regression models were not useful.	[Timmerman, Dirk; Veldman, Joan; Vergote, Ignace; Bourne, Tom; Valentin, Lil] Katholieke Univ Leuven, Univ Hosp, Dept Obstet & Gynaecol, B-3000 Louvain, Belgium; [Ameye, Lieveke; Van Huffel, Sabine] Katholieke Univ Leuven, Dept Elect Engn, Louvain, Belgium; [Fischerova, Daniela] Charles Univ Prague, Fac Med 1, Oncogynaecol Ctr, Prague, Czech Republic; [Fischerova, Daniela] Charles Univ Prague, Gen Univ Hosp, Prague, Czech Republic; [Epstein, Elisabeth] Lund Univ, Dept Obstet & Gynaecol, Lund, Sweden; [Melis, Gian Benedetto; Guerriero, Stefano] Univ Cagliari, Osped San Giovanni di Dio, Dept Obstet & Gynaecol, Cagliari, Sardinia, Italy; [Van Holsbeke, Caroline] Genk ZOL, Dept Obstet & Gynaecol, B-3600 Genk, Belgium; [Savelli, Luca] Univ Bologna, Dept Obstet & Gynaecol, Reprod Med Unit, I-40126 Bologna, Italy; [Fruscio, Robert; Lissoni, Andrea Alberto] Univ Milano Bicocca, Osped S Gerardo, Clin Ostetr & Ginecol, Monza, Italy; [Testa, Antonia Carla] Univ Cattolica Sacro Cuore, Ist Clin Ostetr & Ginecol, Rome, Italy; [Bourne, Tom] Univ London Imperial Coll Sci Technol & Med, Queen Charlottes & Chelsea Hosp, Dept Obstet & Gynaecol, London, England; [Valentin, Lil] Lund Univ, Malmo Univ Hosp, Dept Obstet & Gynaecol, Malmo, Sweden	KU Leuven; KU Leuven; Charles University Prague; Charles University Prague; General University Hospital Prague; Lund University; University of Cagliari; East Limburg Hospital; University of Bologna; San Gerardo Hospital; University of Milano-Bicocca; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Imperial College London; Lund University; Skane University Hospital	Timmerman, D (corresponding author), Katholieke Univ Leuven, Univ Hosp, Dept Obstet & Gynaecol, B-3000 Louvain, Belgium.	dirk.timmerman@uzleuven.be	epstein, elisabeth/F-4586-2014; TESTA, Antonia Carla/AAC-2582-2019; Fruscio, Robert/F-8542-2011; Timmerman, Dirk/AAD-2363-2019; Epstein, Elisabeth/F-7076-2011; Bourne, Tom/I-6478-2012; Guerriero, Stefano/AAL-3252-2020; Epstein, Elisabeth/GRO-7235-2022; Fischerova, Daniela/D-2857-2017	epstein, elisabeth/0000-0003-2298-7785; TESTA, Antonia Carla/0000-0003-2217-8726; Fruscio, Robert/0000-0001-5688-2194; Timmerman, Dirk/0000-0002-3707-6645; Bourne, Tom/0000-0003-1421-6059; Guerriero, Stefano/0000-0002-1359-7155; Fischerova, Daniela/0000-0002-7224-3218	Research Council KU Leuven [CoE EF/05/006]; FWO [G.0302.07]; ICCoS; ANMMM; IWT-TBM [070706]; Belgian Federal Science Policy Office [IUAP P6/04]; EU [FP6-2002-IST 508803]; Swedish Medical Research Council [K2001-72X 11605-06A, K2002-72X-11605-07B, K2004-73X-11605-09A, K2006-73X-11605-11-3]; ALF-medel; Landstingsfinansierad Regional Forskning	Research Council KU Leuven(KU Leuven); FWO(FWO); ICCoS; ANMMM; IWT-TBM(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); EU(European Commission); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); ALF-medel; Landstingsfinansierad Regional Forskning	This research was supported by the Research Council KU Leuven: GOA-MANET, CoE EF/05/006 Optimization in Engineering (OPTEC); FWO: G.0302.07 (SVM), research communities (ICCoS, ANMMM); IWT-TBM 070706 (IOTA); Belgian Federal Science Policy Office: IUAP P6/04 (DYSCO); EU: BIOPATTERN (FP6-2002-IST 508803); Swedish Medical Research Council (grants K2001-72X 11605-06A, K2002-72X-11605-07B, K2004-73X-11605-09A, and K2006-73X-11605-11-3); funds administered by Malmo University Hospital; and two Swedish governmental grants (ALF-medel and Landstingsfinansierad Regional Forskning).	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Aslam N, 2000, OBSTET GYNECOL, V96, P75, DOI 10.1016/S0029-7844(00)00835-8; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Ekerhovd E, 2001, AM J OBSTET GYNECOL, V184, P48, DOI 10.1067/mob.2001.108330; Ferrazzi E, 1997, ULTRASOUND OBST GYN, V10, P192, DOI 10.1046/j.1469-0705.1997.10030192.x; Geomini P, 2009, OBSTET GYNECOL, V113, P384, DOI 10.1097/AOG.0b013e318195ad17; GRANBERG S, 1989, GYNECOL ONCOL, V35, P139, DOI 10.1016/0090-8258(89)90031-0; Hayen A, 2010, J CLIN EPIDEMIOL, V63, P883, DOI 10.1016/j.jclinepi.2009.08.024; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS145, DOI 10.1016/S0020-7292(06)60032-5; JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Mol BWJ, 2001, GYNECOL ONCOL, V80, P162, DOI 10.1006/gyno.2000.6052; Moore RG, 2007, J CLIN ONCOL, V25, P4159, DOI 10.1200/JCO.2007.11.9594; Roman LD, 1998, GYNECOL ONCOL, V69, P1, DOI 10.1006/gyno.1998.4996; Timmerman D, 2008, ULTRASOUND OBST GYN, V31, P681, DOI 10.1002/uog.5365; Timmerman D, 2005, J CLIN ONCOL, V23, P8794, DOI 10.1200/JCO.2005.01.7632; Timmerman D, 2004, BEST PRACT RES CL OB, V18, P91, DOI 10.1016/j.bpobgyn.2003.09.009; Timmerman D, 2010, ULTRASOUND OBST GYN, V36, P226, DOI 10.1002/uog.7636; Timmerman D, 2000, ULTRASOUND OBST GYN, V16, P500, DOI 10.1046/j.1469-0705.2000.00287.x; Valentin L, 2006, ULTRASOUND OBST GYN, V27, P438, DOI 10.1002/uog.2707; Valentin L, 2001, ULTRASOUND OBST GYN, V18, P357, DOI 10.1046/j.0960-7692.2001.00500.x; Van Calster B, 2007, JNCI-J NATL CANCER I, V99, P1706, DOI 10.1093/jnci/djm199; Van Holsbeke C, 2007, CLIN CANCER RES, V13, P4440, DOI 10.1158/1078-0432.CCR-06-2958; Vergote I, 2001, LANCET, V357, P176, DOI 10.1016/S0140-6736(00)03590-X	23	208	217	0	16	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2010	341								c6839	10.1136/bmj.c6839	http://dx.doi.org/10.1136/bmj.c6839			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XD	21156740	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000285552200013
J	Xia, LX; Jia, SJ; Huang, SJ; Wang, HL; Zhu, YX; Mu, YJ; Kan, LJ; Zheng, WJ; Wu, D; Li, XM; Sun, QM; Meng, AM; Chen, DH				Xia, Laixin; Jia, Shunji; Huang, Shoujun; Wang, Hailong; Zhu, Yuanxiang; Mu, Yanjun; Kan, Lijuan; Zheng, Wenjing; Wu, Di; Li, Xiaoming; Sun, Qinmiao; Meng, Anming; Chen, Dahua			The Fused/Smurf Complex Controls the Fate of Drosophila Germline Stem Cells by Generating a Gradient BMP Response	CELL			English	Article							BAG-OF-MARBLES; GENE; PROTEIN; NICHE; EXPRESSION; DIVISION; PIWI; DIFFERENTIATION; TRANSCRIPTION; DETERMINES	In the Drosophila ovary, germline stem cells (GSCs) are maintained primarily by bone morphogenetic protein (BMP) ligands produced by the stromal cells of the niche. This signaling represses GSC differentiation by blocking the transcription of the differentiation factor Bam. Remarkably, bam transcription begins only one cell diameter away from the GSC in the daughter cystoblasts (CBs). How this steep gradient of response to BMP signaling is formed has been unclear. Here, we show that Fused (Fu), a serine/threonine kinase that regulates Hedgehog, functions in concert with the E3 ligase Smurf to regulate ubiquitination and proteolysis of the BMP receptor Thickveins in CBs. This regulation generates a steep gradient of BMP activity between GSCs and CBs, allowing for bam expression on CBs and concomitant differentiation. We observed similar roles for Fu during embryonic development in zebrafish and in human cell culture, implying broad conservation of this mechanism.	[Xia, Laixin; Huang, Shoujun; Wang, Hailong; Zhu, Yuanxiang; Mu, Yanjun; Kan, Lijuan; Zheng, Wenjing; Chen, Dahua] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Xia, Laixin; Li, Xiaoming; Sun, Qinmiao; Meng, Anming] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China; [Jia, Shunji; Wu, Di; Meng, Anming] Tsinghua Univ, Coll Life Sci, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Tsinghua University	Chen, DH (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China.	chendh@ioz.ac.cn	Meng, Anming/A-4785-2012; Wenjing, Zheng/H-9766-2013; Zheng, Wenjing/M-7580-2015	Meng, Anming/0000-0001-7228-3431; Xia, Laixin/0000-0003-2735-9518	National Basic Research Program of China [2007CB947502, 2007CB507400]; NSFC [30630042, 30825026, 30830068]	National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC))	We thank Drs. Dennis McKearin, Duojia Pan, Peng Jin, and Zongping Xia for critical readings of the manuscript. This work was supported by grants from the National Basic Research Program of China (2007CB947502 and 2007CB507400 to D.C.) and from the NSFC (#30630042 and 30825026 to D.C. and #30830068 to A.M.).	Casanueva MO, 2004, DEVELOPMENT, V131, P1881, DOI 10.1242/dev.01076; Chen DH, 2005, CURR BIOL, V15, P179, DOI 10.1016/j.cub.2005.01.004; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Chen DS, 2009, DEVELOPMENT, V136, P4133, DOI 10.1242/dev.039032; Claret S, 2007, CURR BIOL, V17, P1326, DOI 10.1016/j.cub.2007.06.059; Cox DN, 2000, DEVELOPMENT, V127, P503; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Haley B, 2008, DEV BIOL, V321, P482, DOI 10.1016/j.ydbio.2008.06.015; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Jia JH, 2003, GENE DEV, V17, P2709, DOI 10.1101/gad.1136603; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jiang XY, 2008, DEV CELL, V14, P494, DOI 10.1016/j.devcel.2008.02.018; King FJ, 2001, MOL CELL, V7, P497, DOI 10.1016/S1097-2765(01)00197-6; Kitisin Krit, 2007, Sci STKE, V2007, pcm1, DOI 10.1126/stke.3992007cm1; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Liang YY, 2003, J BIOL CHEM, V278, P26307, DOI 10.1074/jbc.C300028200; Liu YJ, 2007, GENE DEV, V21, P1949, DOI 10.1101/gad.1557407; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Narbonne-Reveau K, 2006, MECH DEVELOP, V123, P197, DOI 10.1016/j.mod.2006.01.001; Nishikawa SI, 2008, COLD SH Q B, V73, P67, DOI 10.1101/sqb.2008.73.024; Nybakken KE, 2002, J BIOL CHEM, V277, P24638, DOI 10.1074/jbc.M110730200; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; Podos SD, 2001, DEV CELL, V1, P567, DOI 10.1016/S1534-5807(01)00057-0; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Ruel L, 2007, DEVELOPMENT, V134, P3677, DOI 10.1242/dev.011577; SanchezHerrero E, 1996, MECH DEVELOP, V55, P159, DOI 10.1016/0925-4773(96)00498-4; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Spradling AC, 2008, COLD SH Q B, V73, P49, DOI 10.1101/sqb.2008.73.023; Szakmary A, 2005, CURR BIOL, V15, P171, DOI 10.1016/j.cub.2005.01.005; Van Doren M, 1998, CURR BIOL, V8, P243; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wilson CW, 2009, NATURE, V459, P98, DOI 10.1038/nature07883; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680	43	95	100	2	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					978	990		10.1016/j.cell.2010.11.022	http://dx.doi.org/10.1016/j.cell.2010.11.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145463	Bronze			2022-12-28	WOS:000285182600014
J	Kalinka, AT; Varga, KM; Gerrard, DT; Preibisch, S; Corcoran, DL; Jarrells, J; Ohler, U; Bergman, CM; Tomancak, P				Kalinka, Alex T.; Varga, Karolina M.; Gerrard, Dave T.; Preibisch, Stephan; Corcoran, David L.; Jarrells, Julia; Ohler, Uwe; Bergman, Casey M.; Tomancak, Pavel			Gene expression divergence recapitulates the developmental hourglass model	NATURE			English	Article							CONSERVED EMBRYONIC STAGE; PHYLOTYPIC STAGE; EVOLUTION; PATTERNS; VARIABILITY; SEQUENCE; LEVEL	The observation that animal morphology tends to be conserved during the embryonic phylotypic period (a period of maximal similarity between the species within each animal phylum) led to the proposition that embryogenesis diverges more extensively early and late than in the middle, known as the hourglass model(1,2). This pattern of conservation is thought to reflect a major constraint on the evolution of animal body plans(3). Despite a wealth of morphological data confirming that there is often remarkable divergence in the early and late embryos of species from the same phylum(4-7), it is not yet known to what extent gene expression evolution, which has a central role in the elaboration of different animal forms(8,9), underpins the morphological hourglass pattern. Here we address this question using species-specific microarrays designed from six sequenced Drosophila species separated by up to 40 million years. We quantify divergence at different times during embryogenesis, and show that expression is maximally conserved during the arthropod phylotypic period. By fitting different evolutionary models to each gene, we show that at each time point more than 80% of genes fit best to models incorporating stabilizing selection, and that for genes whose evolutionarily optimal expression level is the same across all species, selective constraint is maximized during the phylotypic period. The genes that conform most to the hourglass pattern are involved in key developmental processes. These results indicate that natural selection acts to conserve patterns of gene expression during mid-embryogenesis, and provide a genome-wide insight into the molecular basis of the hourglass pattern of developmental evolution.	[Kalinka, Alex T.; Varga, Karolina M.; Preibisch, Stephan; Jarrells, Julia; Tomancak, Pavel] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Gerrard, Dave T.; Bergman, Casey M.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Corcoran, David L.; Ohler, Uwe] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Max Planck Society; University of Manchester; Duke University	Tomancak, P (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	tomancak@mpi-cbg.de	Bergman, Casey/F-7854-2010; Gerrard, Dave/C-6366-2008; Tomancak, Pavel/C-2109-2009	Bergman, Casey/0000-0002-5462-9854; Tomancak, Pavel/0000-0002-2222-9370; Corcoran, David/0000-0001-7460-9247; Gerrard, Dave/0000-0001-6890-7213; Preibisch, Stephan/0000-0002-0276-494X	Human Frontier Science Program (HFSP) [RGY0084]	Human Frontier Science Program (HFSP)(Human Frontier Science Program)	We thank A. Alexa for providing modified code for his topGO R package, A. Larracuente and T. Sackton for sharing data with us, M. Weber for generating the embryo images for Fig. 2, and Carl Zeiss MicroImaging for providing the SPIM microscope. We also thank N. Barton, T. Bedford, D. Hartl, J. Howard, A. Oates and D. Robertson for providing useful comments and discussion on the manuscript. This work was funded by The Human Frontier Science Program (HFSP) Young Investigator's Grant RGY0084.	Agudelo-Romero P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-92; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Artieri CG, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-26; Bedford T, 2009, P NATL ACAD SCI USA, V106, P1133, DOI 10.1073/pnas.0812009106; Bininda-Emonds ORP, 2003, P ROY SOC B-BIOL SCI, V270, P341, DOI 10.1098/rspb.2002.2242; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cruickshank T, 2008, EVOL DEV, V10, P583, DOI 10.1111/j.1525-142X.2008.00273.x; Darwin C., 1959, WHATS NEW, V67, P2; Davis JC, 2005, J MOL EVOL, V60, P774, DOI 10.1007/s00239-004-0241-2; DUBOULE D, 1994, DEVELOPMENT, P135; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Galis F, 2001, J EXP ZOOL, V291, P195, DOI 10.1002/jez.1069; Garstang W., 1922, Journal of the Linnean Society Zoology, V35, P81; Ge Y, 2003, RESAMPLING BASED MUL; Goldstein B, 1998, CURR BIOL, V8, P157, DOI 10.1016/S0960-9822(98)70062-4; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Hall BK, 1997, TRENDS ECOL EVOL, V12, P461, DOI 10.1016/S0169-5347(97)01222-6; Hansen TF, 1996, EVOLUTION, V50, P1404, DOI 10.1111/j.1558-5646.1996.tb03914.x; Hazkani-Covo E, 2005, J EXP ZOOL PART B, V304B, P150, DOI 10.1002/jez.b.21033; Heger A, 2007, GENOME RES, V17, P1837, DOI 10.1101/gr.6249707; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jonnalagadda S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-267; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Larracuente AM, 2008, TRENDS GENET, V24, P114, DOI 10.1016/j.tig.2007.12.001; Lemos B, 2005, EVOLUTION, V59, P126; Markow TA, 2007, GENETICS, V177, P1269, DOI 10.1534/genetics.107.074112; Nelson CE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r25; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Poe S, 2004, AM NAT, V164, P415, DOI 10.1086/422658; Raff R. A., 1996, SHAPE LIFE GENES DEV; Richardson MK, 1997, ANAT EMBRYOL, V196, P91, DOI 10.1007/s004290050082; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Sander K., 1976, Advances in insect physiology. Volume 12., P125, DOI 10.1016/S0065-2806(08)60255-6; Sander K., 1983, DEV EVOLUTION, P137; Schmidt K, 2004, J EXP ZOOL PART B, V302B, P446, DOI 10.1002/jez.b.21010; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; VONBAER KE, 1928, ENTWICKELUNGSGESCHIC; WRAY GA, 1991, EVOLUTION, V45, P1741, DOI 10.1111/j.1558-5646.1991.tb02684.x; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zhang Y, 2007, NATURE, V450, P233, DOI 10.1038/nature06323	50	264	268	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					811	U102		10.1038/nature09634	http://dx.doi.org/10.1038/nature09634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21150996				2022-12-28	WOS:000285093700043
J	Weston, K; Bush, K; Afshar, F; Rowley, S				Weston, Kelly; Bush, Kate; Afshar, Farid; Rowley, Steven			Christmas 2010: Research Can he fix it? Yes, he can!	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Weston, Kelly] Royal Hampshire Cty Hosp, Winchester SO22 5DG, Hants, England; [Bush, Kate; Rowley, Steven] Royal Bournemouth Hosp, Bournemouth, Dorset, England; [Afshar, Farid] Moorfields Eye Hosp, London, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Weston, K (corresponding author), Royal Hampshire Cty Hosp, Winchester SO22 5DG, Hants, England.	weston.dr@gmail.com						Ezra E, 1996, BRIT J OPHTHALMOL, V80, P350, DOI 10.1136/bjo.80.4.350; RICKER VK, 1970, KLIN MONATSBL AUGENH, V156, P837	2	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 8	2010	341								c6645	10.1136/bmj.c6645	http://dx.doi.org/10.1136/bmj.c6645			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	694ZL	21147747				2022-12-28	WOS:000285340300018
J	Martin, SJ				Martin, Seamus J.			Opening the Cellular Poison Cabinet	SCIENCE			English	Editorial Material							MEMBRANE PERMEABILIZATION; BAX; FAMILY; APOPTOSIS		Trinity Coll Dublin, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland	Trinity College Dublin	Martin, SJ (corresponding author), Trinity Coll Dublin, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland.	martinsj@tcd.ie		Martin, Seamus/0000-0002-8539-3143				Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	9	10	22	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1330	1331		10.1126/science.1199461	http://dx.doi.org/10.1126/science.1199461			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127237				2022-12-28	WOS:000284902100027
J	Drolet, BC; Spalluto, LB; Fischer, SA				Drolet, Brian C.; Spalluto, Lucy B.; Fischer, Staci A.			Residents' Perspectives on ACGME Regulation of Supervision and Duty Hours -- A National Survey.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Drolet, Brian C.] Brown Univ, Warren Alpert Med Sch, Dept Gen Surg & Plast Surg, Providence, RI 02912 USA; [Spalluto, Lucy B.] Brown Univ, Warren Alpert Med Sch, Dept Diagnost Imaging, Providence, RI 02912 USA; [Fischer, Staci A.] Brown Univ, Warren Alpert Med Sch, Dept Med, Providence, RI 02912 USA; [Drolet, Brian C.; Spalluto, Lucy B.; Fischer, Staci A.] Rhode Isl Hosp, Providence, RI USA	Brown University; Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Drolet, BC (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Gen Surg & Plast Surg, Providence, RI 02912 USA.							Antiel RM, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMp1008305; FITZPATRICK S, 1987, J AM STAT ASSOC, V82, P875, DOI 10.2307/2288799; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; Ulmer C, 2009, RESIDENT DUTY HOURS: ENHANCING SLEEP, SUPERVISION, AND SAFETY, P1	4	80	81	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23								10.1056/NEJMp1011413	http://dx.doi.org/10.1056/NEJMp1011413			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	688EP	21121827				2022-12-28	WOS:000284832900005
J	Ray, T				Ray, Tom			Cosmic Rays from Cosmic Birth	SCIENCE			English	Editorial Material							ACCELERATION; JET		Dublin Inst Adv Studies, Dublin 2, Ireland	Dublin Institute for Advanced Studies	Ray, T (corresponding author), Dublin Inst Adv Studies, 31 Fitzwilliam Pl, Dublin 2, Ireland.	tr@cp.dias.ie		Ray, Tom/0000-0002-2110-1068				Carrasco-Gonzalez C, 2010, SCIENCE, V330, P1209, DOI 10.1126/science.1195589; DRURY LO, 1991, MON NOT R ASTRON SOC, V251, P340, DOI 10.1093/mnras/251.2.340; Dulwich F, 2007, MON NOT R ASTRON SOC, V374, P1216, DOI 10.1111/j.1365-2966.2006.11242.x; Garrington ST, 2004, PROC SPIE, V5489, P332, DOI 10.1117/12.553235; Livio M, 1999, PHYS REP, V311, P225, DOI 10.1016/S0370-1573(98)00102-1; Perley R, 2009, P IEEE, V97, P1448, DOI 10.1109/JPROC.2009.2015470; Pudritz R. E., 2007, PROTOSTARS PLANETS, P277; Ray T., 2007, PROTOSTARS PLANETS, P231; RAY TP, 1996, APJ, V468, P103; Reynolds SP, 2008, ANNU REV ASTRON ASTR, V46, P89, DOI 10.1146/annurev.astro.46.060407.145237; Sparks WB, 1996, ASTROPHYS J, V473, P254, DOI 10.1086/178141	12	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2010	330	6008					1184	1185		10.1126/science.1199141	http://dx.doi.org/10.1126/science.1199141			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109656				2022-12-28	WOS:000284613700023
J	Fan, E; Laupacis, A; Pronovost, PJ; Guyatt, GH; Needham, DM				Fan, Eddy; Laupacis, Andreas; Pronovost, Peter J.; Guyatt, Gordon H.; Needham, Dale M.			How to Use an Article About Quality Improvement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE; NONCARDIAC SURGERY; SEVERE SEPSIS; GUIDELINES; SQUIRE; TRIAL; INTERVENTION; PUBLICATION; MORTALITY; STANDARDS	Quality improvement (QI) attempts to change clinician behavior and, through those changes, lead to improved patient outcomes. The methodological quality of studies evaluating the effectiveness of QI interventions is frequently low. Clinicians and others evaluating QI studies should be aware of the risk of bias, should consider whether the investigators measured appropriate outcomes, should be concerned if there has been no replication of the findings, and should consider the likelihood of success of the QI intervention in their practice setting and the costs and possibility of unintended effects of its implementation. This article complements and enhances existing Users' Guides that address the effects of interventions-Therapy, Harm, Clinical Decision Support Systems, and Summarizing the Evidence guides-with an emphasis on issues specific to QI studies. Given the potential for widespread implementation of QI interventions, there is a need for robust study methods in QI research. JAMA. 2010; 304(20): 2279-2287	[Fan, Eddy; Needham, Dale M.] Johns Hopkins Med Inst, Div Pulm & Crit Care Med, Baltimore, MD 21287 USA; [Pronovost, Peter J.] Johns Hopkins Med Inst, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA; [Needham, Dale M.] Johns Hopkins Med Inst, Dept Phys Med & Rehabil, Baltimore, MD 21287 USA; [Fan, Eddy] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Laupacis, Andreas] Univ Toronto, Fac Med, Toronto, ON, Canada; [Laupacis, Andreas] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8S 4L8, Canada; [Guyatt, Gordon H.] McMaster Univ, Dept Biostat, Hamilton, ON L8S 4L8, Canada	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University; McMaster University	Fan, E (corresponding author), Johns Hopkins Med Inst, Div Pulm & Crit Care Med, 1830 E Monument St,5th Floor, Baltimore, MD 21287 USA.	eddy.fan@jhmi.edu			Canadian Institutes of Health Research; National Institutes of Health; Agency for Healthcare Research and Quality	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr Fan is supported by a Fellowship Award from the Canadian Institutes of Health Research. Dr Pronovost is supported by a K24 award from the National Institutes of Health and contracts from the Agency for Healthcare Research and Quality to improve quality of care.	Alexander JA, 2009, MED CARE RES REV, V66, P235, DOI 10.1177/1077558708330424; Auerbach AD, 2007, NEW ENGL J MED, V357, P608, DOI 10.1056/NEJMsb070738; Bailie RS, 2004, MED J AUSTRALIA, V181, P195, DOI 10.5694/j.1326-5377.2004.tb06235.x; Balas EA, 1998, MED CARE, V36, P79, DOI 10.1097/00005650-199801000-00009; Bangalore S, 2008, LANCET, V372, P1962, DOI 10.1016/S0140-6736(08)61560-3; Bardach NS, 2009, CURR OPIN PEDIATR, V21, P777, DOI 10.1097/MOP.0b013e3283329937; Batalden PB, 2007, QUAL SAF HEALTH CARE, V16, P2, DOI 10.1136/qshc.2006.022046; Berwick DM, 2008, JAMA-J AM MED ASSOC, V299, P1182, DOI 10.1001/jama.299.10.1182; BROWN C, 2009, BMJ-BRIT MED J, V337, pA2764; Calhoun AW, 2008, MED CARE, V46, P635, DOI 10.1097/MLR.0b013e3181649412; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Clayton SB, 2006, CRIT CARE MED, V34, P2974, DOI 10.1097/01.CCM.0000248906.10399.CF; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Davidoff F, 2008, QUAL SAF HEALTH CARE, V17, P3, DOI 10.1136/qshc.2008.029066; de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Eccles M, 2003, QUAL SAF HEALTH CARE, V12, P47, DOI 10.1136/qhc.12.1.47; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Ghali WA, 1997, JAMA-J AM MED ASSOC, V277, P379, DOI 10.1001/jama.277.5.379; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Guyatt G., 2008, USERS GUIDES MEDICAL; Guyatt Gordon, 2004, ACP J Club, V140, pA11; HANNAN EL, 1994, JAMA-J AM MED ASSOC, V271, P761, DOI 10.1001/jama.271.10.761; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Holbrook A, 2009, CAN MED ASSOC J, V181, P37, DOI 10.1503/cmaj.081272; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; Jaeschke R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a744; Jamtvedt G, 2006, QUAL SAF HEALTH CARE, V15, P433, DOI 10.1136/qshc.2006.018549; Landefeld C Seth, 2008, BMJ, V336, P1277, DOI 10.1136/bmj.a144; Le May MR, 2008, NEW ENGL J MED, V358, P231, DOI 10.1056/NEJMoa073102; Li LC, 2009, J CLIN EPIDEMIOL, V62, P959, DOI 10.1016/j.jclinepi.2008.10.008; LIPSEY MW, 1993, AM PSYCHOL, V48, P1181, DOI 10.1037/0003-066X.48.12.1181; Lynn J, 2007, ANN INTERN MED, V146, P666, DOI 10.7326/0003-4819-146-9-200705010-00155; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Miller FG, 2008, NEW ENGL J MED, V358, P765, DOI 10.1056/NEJMp0800136; Needham DM, 2009, INT J QUAL HEALTH C, V21, P145, DOI 10.1093/intqhc/mzp005; Ogrinc G, 2008, QUAL SAF HEALTH CARE, V17, P13, DOI 10.1136/qshc.2008.029058; Priestley G, 2004, INTENS CARE MED, V30, P1398, DOI 10.1007/s00134-004-2268-7; Pronovost P, 2006, QUAL SAF HEALTH CARE, V15, P152, DOI 10.1136/qshc.2006.018432; Pronovost PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c309; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; Rubenstein LV, 2008, QUAL SAF HEALTH CARE, V17, P403, DOI 10.1136/qshc.2008.028423; Saint-Martin EC, 1998, QUAL HEALTH CARE, V7, P5, DOI 10.1136/qshc.7.1.5; Solberg LI, 1997, JOINT COMM J QUAL IM, V23, P135, DOI 10.1016/S1070-3241(16)30305-4; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; Thomson RG, 2008, QUAL SAF HEALTH CARE, V17, P10, DOI 10.1136/qshc.2008.029074; Thor J, 2007, QUAL SAF HEALTH CARE, V16, P387, DOI 10.1136/qshc.2006.022194; Treweek S, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-37; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466; Wells KB, 2008, HEALTH SERV RES, V43, P1952, DOI 10.1111/j.1475-6773.2008.00871.x; Zehr KJ, 1998, ANN THORAC SURG, V66, P914, DOI 10.1016/S0003-4975(98)00662-6	56	85	85	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2010	304	20					2279	2287		10.1001/jama.2010.1692	http://dx.doi.org/10.1001/jama.2010.1692			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	684KI	21098772				2022-12-28	WOS:000284548400027
J	Mills, EJ; Rammohan, A; Awofeso, N				Mills, Edward J.; Rammohan, Anu; Awofeso, Niyi			Ageing faster with AIDS in Africa	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; COLLABORATIVE ANALYSIS; INFECTION		[Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6X1, Canada; [Rammohan, Anu] Univ Western Australia, Sch Econ, Perth, WA 6009, Australia; [Awofeso, Niyi] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Awofeso, Niyi] Natl Open Univ Nigeria, Sch Publ Hlth, Lagos, Nigeria	University of Ottawa; University of Western Australia; University of Western Australia	Mills, EJ (corresponding author), Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6X1, Canada.	edward.mills@uottawa.ca	Awofeso, Niyi/J-4705-2019	Rammohan, Anu/0000-0002-9062-4508				Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization ( WHO), 2009, 2009 AIDS EP UPD; Justice AC, 2010, INT J EPIDEMIOL, V39, P146, DOI 10.1093/ije/dyp342; Kautz T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2841; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Negin JC, 2010, B WORLD HEALTH ORGAN, V88, P1847; Negin J, 2010, JAIDS-J ACQ IMM DEF, V55, P239, DOI 10.1097/QAI.0b013e3181e9b3f2; *NIH, 2010, NIH STAT NAT HIV AID; WHO, 2010, DEF OLD ELD PERS	9	29	31	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1131	1133		10.1016/S0140-6736(10)62180-0	http://dx.doi.org/10.1016/S0140-6736(10)62180-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	750IH	21126759				2022-12-28	WOS:000289539300007
J	Spence, JR; Mayhew, CN; Rankin, SA; Kuhar, MF; Vallance, JE; Tolle, K; Hoskins, EE; Kalinichenko, VV; Wells, SI; Zorn, AM; Shroyer, NF; Wells, JM				Spence, Jason R.; Mayhew, Christopher N.; Rankin, Scott A.; Kuhar, Matthew F.; Vallance, Jefferson E.; Tolle, Kathryn; Hoskins, Elizabeth E.; Kalinichenko, Vladimir V.; Wells, Susanne I.; Zorn, Aaron M.; Shroyer, Noah F.; Wells, James M.			Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro	NATURE			English	Article							EFFICIENT DIFFERENTIATION; ENDOCRINE-CELLS; ENDODERM; NEUROGENIN-3; SPECIFICATION; GENERATION; CULTURE; LIVER; FATE	Studies in embryonic development have guided successful efforts to direct the differentiation of human embryonic and induced pluripotent stem cells (PSCs) into specific organ cell types in vitro(1,2). For example, human PSCs have been differentiated into monolayer cultures of liver hepatocytes and pancreatic endocrine cells(3-6) that have therapeutic efficacy in animal models of liver disease(7,8) and diabetes(9), respectively. However, the generation of complex three-dimensional organ tissues in vitro remains a major challenge for translational studies. Here we establish a robust and efficient process to direct the differentiation of human PSCs into intestinal tissue in vitro using a temporal series of growth factor manipulations to mimic embryonic intestinal development(10). This involved activin-induced definitive endoderm formation(11), FGF/Wnt-induced posterior endoderm pattering, hindgut specification and morphogenesis(12-14), and a pro-intestinal culture system(15,16) to promote intestinal growth, morphogenesis and cytodifferentiation. The resulting three-dimensional intestinal 'organoids' consisted of a polarized, columnar epithelium that was patterned into villus-like structures and crypt-like proliferative zones that expressed intestinal stem cell markers(17). The epithelium contained functional enterocytes, as well as goblet, Paneth and enteroendocrine cells. Using this culture system as a model to study human intestinal development, we identified that the combined activity of WNT3A and FGF4 is required for hindgut specification whereas FGF4 alone is sufficient to promote hindgut morphogenesis. Our data indicate that human intestinal stem cells form de novo during development. We also determined that NEUROG3, a pro-endocrine transcription factor that is mutated in enteric anendocrinosis(18), is both necessary and sufficient for human enteroendocrine cell development in vitro. PSC-derived human intestinal tissue should allow for unprecedented studies of human intestinal development and disease.	[Spence, Jason R.; Mayhew, Christopher N.; Rankin, Scott A.; Kuhar, Matthew F.; Tolle, Kathryn; Kalinichenko, Vladimir V.; Zorn, Aaron M.; Shroyer, Noah F.; Wells, James M.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Vallance, Jefferson E.; Shroyer, Noah F.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Hoskins, Elizabeth E.; Wells, Susanne I.] Cincinnati Childrens Hosp Med Ctr, Div Hematol & Oncol, Cincinnati, OH 45229 USA; [Kalinichenko, Vladimir V.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Wells, JM (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	james.wells@cchmc.org	Mayhew, Christopher N/AGB-4929-2022	Vallance, Jefferson/0000-0001-6473-3623; Shroyer, Noah/0000-0002-5934-2852; Mayhew, Chris/0000-0002-7408-1726	Juvenile Diabetes Research Foundation [JDRF-2-2003-530]; NIH [R01GM072915, R01DK080823A1 and S1, R03 DK084167, R01 CA142826, F32 DK83202-01, T32 HD07463];  [P30 DK078392];  [U54 RR025216]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007463] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA142826] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092456, F32DK083202, P30DK078392, K01DK091415, R01DK080823, R03DK084167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072915] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the laboratory, D. Wiginton and C. Wylie for input. We also thank M. Kofron, T. Stefader and R. Lang for assistance with imaging. Vectors and antibodies were from D. Melton (Addgene no. 19410, 19413), S. Yamanaka (17217-17220), C. Baum (OCT4, KLF4, SOX4, MYC lenti), and I. Manabe (KLF5 antibody). This work was supported by the Juvenile Diabetes Research Foundation JDRF-2-2003-530 (J.M.W.) and NIH, R01GM072915 (J.M.W.); R01DK080823A1 and S1 (A.M.Z. and J.M.W.); R03 DK084167 and R01 CA142826 (N.F.S.), F32 DK83202-01 and T32 HD07463 (J.R.S.). We also acknowledge core support for viral vectors, microarrays (supported by P30 DK078392), karyotyping and the Pluripotent Stem Cell Facility (supported by U54 RR025216).	Barbara PD, 2003, CELL MOL LIFE SCI, V60, P1322, DOI 10.1007/s00018-003-2289-3; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Cao L, 2011, DIFFERENTIATION, V81, P1, DOI 10.1016/j.diff.2010.09.182; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dessimoz J, 2006, MECH DEVELOP, V123, P42, DOI 10.1016/j.mod.2005.10.001; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Groneberg DA, 2001, AM J PHYSIOL-GASTR L, V281, pG697, DOI 10.1152/ajpgi.2001.281.3.G697; Haveri H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-9; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Kosinski C, 2010, GASTROENTEROLOGY, V139, P893, DOI 10.1053/j.gastro.2010.06.014; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lambert PF, 2005, METH MOLEC MED, V119, P141; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Lopez-Diaz L, 2007, DEV BIOL, V309, P298, DOI 10.1016/j.ydbio.2007.07.015; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mayhew CN, 2010, CURR OPIN ORGAN TRAN, V15, P54, DOI 10.1097/MOT.0b013e3283337e1c; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Mclin VA, 2009, GASTROENTEROLOGY, V136, P2074, DOI 10.1053/j.gastro.2009.03.001; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Spence JR, 2007, DEV DYNAM, V236, P3218, DOI 10.1002/dvdy.21366; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Torihashi S, 2006, STEM CELLS, V24, P2618, DOI 10.1634/stemcells.2006-0148; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wang JF, 2006, NEW ENGL J MED, V355, P270, DOI 10.1056/NEJMoa054288; Wells JM, 2000, DEVELOPMENT, V127, P1563; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	38	1152	1222	13	249	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					105	U120		10.1038/nature09691	http://dx.doi.org/10.1038/nature09691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21151107	Green Accepted			2022-12-28	WOS:000286886400043
J	Helmink, BA; Tubbs, AT; Dorsett, Y; Bednarski, JJ; Walker, LM; Feng, ZH; Sharma, GG; McKinnon, PJ; Zhang, JR; Bassing, CH; Sleckman, BP				Helmink, Beth A.; Tubbs, Anthony T.; Dorsett, Yair; Bednarski, Jeffrey J.; Walker, Laura M.; Feng, Zhihui; Sharma, Girdhar G.; McKinnon, Peter J.; Zhang, Junran; Bassing, Craig H.; Sleckman, Barry P.			H2AX prevents CtIP-mediated DNA end resection and aberrant repair in G1-phase lymphocytes	NATURE			English	Article							DOUBLE-STRAND BREAKS; V(D)J RECOMBINATION; GENOMIC STABILITY; HISTONE H2AX; MRN COMPLEX; MDC1; NBS1; CHROMATIN; DAMAGE; PROTEINS	DNA double-strand breaks (DSBs) are generated by the recombination activating gene (RAG) endonuclease in all developing lymphocytes as they assemble antigen receptor genes(1). DNA cleavage by RAG occurs only at the G1 phase of the cell cycle and generates two hairpin-sealed DNA (coding) ends that require nucleolytic opening before their repair by classical non-homologous end-joining (NHEJ)(1-3). Although there are several cellular nucleases that could perform this function, only the Artemis nuclease is able to do so efficiently(2,3). Here, in vivo, we show that in murine cells the histone protein H2AX prevents nucleases other than Artemis from processing hairpin-sealed coding ends; in the absence of H2AX, CtIP can efficiently promote the hairpin opening and resection of DNA ends generated by RAG cleavage. This CtIP-mediated resection is inhibited by gamma-H2AX and by MDC-1 (mediator of DNA damage checkpoint 1), which binds to gamma-H2AX in chromatin flanking DNA DSBs. Moreover, the ataxia telangiectasia mutated (ATM) kinase activates antagonistic pathways that modulate this resection. CtIP DNA end resection activity is normally limited to cells at post-replicative stages of the cell cycle, in which it is essential for homology-mediated repair(4,5). In G1-phase lymphocytes, DNA ends that are processed by CtIP are not efficiently joined by classical NHEJ and the joints that do form frequently use micro-homologies and show significant chromosomal deletions. Thus, H2AX preserves the structural integrity of broken DNA ends in G1-phase lymphocytes, thereby preventing these DNA ends from accessing repair pathways that promote genomic instability.	[Helmink, Beth A.; Tubbs, Anthony T.; Dorsett, Yair; Bednarski, Jeffrey J.; Walker, Laura M.; Sleckman, Barry P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Bednarski, Jeffrey J.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Feng, Zhihui; Sharma, Girdhar G.; Zhang, Junran] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63110 USA; [McKinnon, Peter J.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Bassing, Craig H.] Univ Penn, Sch Med,Ctr Childhood Canc Res, Childrens Hosp Philadelphia,Dept Pathol & Lab Med, Abramson Family Canc Res Inst,Div Canc Pathobiol, Philadelphia, PA 19104 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); St Jude Children's Research Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Sleckman, BP (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	sleckman@wustl.edu	Bednarski, Jeff/GLN-6651-2022	Tubbs, Anthony/0000-0002-5605-8231; Helmink, Beth/0000-0002-8206-0351	National Institutes of Health (NIH) [AI074953, AI47829, CA136470, CA125195, CA21765, NS37956, T32 HD007499]; Children's Discovery Institute; NATIONAL CANCER INSTITUTE [P01CA096832, P30CA021765, R01CA136470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074953, R01AI047829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES019779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS037956, R01NS037956] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Oltz and F. Alt for critical review of the manuscript; R. Baer for providing us with the anti-CtIP antibodies; and G. Longmore and Y. Feng for pFLRU, pHR'Delta 8.2R and pCMV-VSVg. This work is supported by National Institutes of Health (NIH) grants AI074953(B. P. S.), AI47829 (B. P. S.), CA136470 (B. P. S. and C. H. B.), CA125195 (C. H. B.), CA21765 (P.J.McK.) and NS37956 (P.J.McK.). J.J.B. is supported by a NIH Ruth L. Kirschstein National Research Service Award (T32 HD007499) and a Children's Discovery Institute Fellows Award. C. H. B. was a Pew Scholar in the Biomedical Sciences program and is a Leukemia and Lymphoma Society Scholar.	Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Deriano L, 2009, MOL CELL, V34, P13, DOI 10.1016/j.molcel.2009.03.009; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Hegedus E, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp539; Helmink BA, 2009, J EXP MED, V206, P669, DOI 10.1084/jem.20081326; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Langer EM, 2008, DEV CELL, V14, P424, DOI 10.1016/j.devcel.2008.01.005; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lieber MR, 2004, DNA REPAIR, V3, P817, DOI 10.1016/j.dnarep.2004.03.015; Lloyd J, 2009, CELL, V139, P100, DOI 10.1016/j.cell.2009.07.043; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lu L, 2008, CELL MOTIL CYTOSKEL, V65, P281, DOI 10.1002/cm.20260; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Savic V, 2009, MOL CELL, V34, P298, DOI 10.1016/j.molcel.2009.04.012; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yin B, 2009, J EXP MED, V206, P2625, DOI 10.1084/jem.20091320; You ZS, 2010, TRENDS CELL BIOL, V20, P402, DOI 10.1016/j.tcb.2010.04.002	33	112	115	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2011	469	7329					245	249		10.1038/nature09585	http://dx.doi.org/10.1038/nature09585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21160476	Green Accepted			2022-12-28	WOS:000286143400045
J	Tamsir, A; Tabor, JJ; Voigt, CA				Tamsir, Alvin; Tabor, Jeffrey J.; Voigt, Christopher A.			Robust multicellular computing using genetically encoded NOR gates and chemical 'wires'	NATURE			English	Article							SYNTHETIC GENE NETWORKS; CIRCUIT; QUORUM; LOGIC; MORPHOGENESIS; SYSTEM; CELLS; MODEL	Computation underlies the organization of cells into higher-order structures, for example during development or the spatial association of bacteria in a biofilm(1-3). Each cell performs a simple computational operation, but when combined with cell-cell communication, intricate patterns emerge. Here we study this process by combining a simple genetic circuit with quorum sensing to produce more complex computations in space. We construct a simple NOR logic gate in Escherichia coli by arranging two tandem promoters that function as inputs to drive the transcription of a repressor. The repressor inactivates a promoter that serves as the output. Individual colonies of E. coli carry the same NOR gate, but the inputs and outputs are wired to different orthogonal quorum-sensing 'sender' and 'receiver' devices(4,5). The quorum molecules form the wires between gates. By arranging the colonies in different spatial configurations, all possible two-input gates are produced, including the difficult XOR and EQUALS functions. The response is strong and robust, with 5- to >300-fold changes between the 'on' and 'off' states. This work helps elucidate the design rules by which simple logic can be harnessed to produce diverse and complex calculations by rewiring communication between cells.	[Tabor, Jeffrey J.; Voigt, Christopher A.] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Tamsir, Alvin] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Voigt, CA (corresponding author), Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.	cavoigt@picasso.ucsf.edu	Tabor, Jeffrey/A-7022-2008	Tabor, Jeffrey/0000-0001-7316-0361	National Science Foundation (NSF) [0943385, CCF-0943385]; Office of Naval Research; Division of Computing and Communication Foundations [0943385] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095765, P50GM081879] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Mulyasasmita and K. Temme for critical discussions. This work was supported by the National Science Foundation (SynBERC, NSF#0943385 and NSF Sandpit CCF-0943385) and the Office of Naval Research.	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Clancy K, 2010, CURR OPIN BIOTECH, V21, P572, DOI 10.1016/j.copbio.2010.07.005; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Ilachinski A., 2001, CELLULAR AUTOMATA DI, V1st, P1; Karig D, 2005, BIOTECHNOL BIOENG, V89, P709, DOI 10.1002/bit.20371; Katz R. H., 1994, CONT LOGIC DESIGN, P141; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Lou CB, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.2; Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Neumann J. V., 1951, GEN LOGICAL THEORY A; Niklas KJ, 2003, AM J BOT, V90, P515, DOI 10.3732/ajb.90.4.515; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; RAJU BS, 1971, INT J CONTROL, V14, P1041, DOI 10.1080/00207177108932113; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Scharle TW., 1965, NOTRE DAME J FORM L, V6, P209, DOI [10.1305/ndjfl/1093958259, DOI 10.1305/NDJFL/1093958259]; Sneppen K, 2005, J MOL BIOL, V346, P399, DOI 10.1016/j.jmb.2004.11.075; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Turing A. M., 1990, B MATH BIOL, V52, P119; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1007/BF02459572; Weber W, 2008, P NATL ACAD SCI USA, V105, P9994, DOI 10.1073/pnas.0800663105; Wolfram S., 2002, NEW KIND SCI, P23; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	31	517	544	5	219	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2011	469	7329					212	215		10.1038/nature09565	http://dx.doi.org/10.1038/nature09565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21150903	Green Accepted			2022-12-28	WOS:000286143400038
J	Moenne-Loccoz, P; Fee, JA				Moenne-Loccoz, Pierre; Fee, James A.			Catalyzing NO to N2O in the Nitrogen Cycle	SCIENCE			English	Editorial Material							NITRIC-OXIDE; CYTOCHROME BA(3); DISPERSAL; EVOLUTION		[Moenne-Loccoz, Pierre] Oregon Hlth & Sci Univ, Inst Environm Hlth, Div Environm & Biomol Syst, Beaverton, OR 97006 USA; [Fee, James A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Oregon Health & Science University; Scripps Research Institute	Moenne-Loccoz, P (corresponding author), Oregon Hlth & Sci Univ, Inst Environm Hlth, Div Environm & Biomol Syst, Beaverton, OR 97006 USA.	ploccoz@ebs.ogi.edu; jafee@scripps.edu		MOENNE-LOCCOZ, PIERRE/0000-0002-7684-7617	NIGMS NIH HHS [R01 GM035342, R01 GM074785] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035342, R01GM074785] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; de Vries S, 2002, BIOCHEM SOC T, V30, P662, DOI 10.1042/bst0300662; Flock U, 2008, J BIOL CHEM, V283, P3839, DOI 10.1074/jbc.M704615200; Hino T, 2010, SCIENCE, V330, P1666, DOI 10.1126/science.1195591; Hunsicker-Wang LM, 2005, ACTA CRYSTALLOGR D, V61, P340, DOI 10.1107/S0907444904033906; Lacis AA, 2010, SCIENCE, V330, P356, DOI 10.1126/science.1190653; Luna VM, 2008, BIOCHEMISTRY-US, V47, P4657, DOI 10.1021/bi800045y; Moenne-Loccoz P, 2007, NAT PROD REP, V24, P610, DOI 10.1039/B604194A; Mosier A, 1998, NUTR CYCL AGROECOSYS, V52, P225, DOI 10.1023/A:1009740530221; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Romeo T, 2006, J BACTERIOL, V188, P7325, DOI 10.1128/JB.01317-06; Stevanin TM, 2007, MICROBES INFECT, V9, P981, DOI 10.1016/j.micinf.2007.04.002; Yeung N, 2009, NATURE, V462, P1079, DOI 10.1038/nature08620	15	27	28	4	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1632	1633		10.1126/science.1200247	http://dx.doi.org/10.1126/science.1200247			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164002	Green Accepted			2022-12-28	WOS:000285390500050
J	Srinivasa, S; Tan, YM; Connolly, A; Hill, AG				Srinivasa, Sanket; Tan, Yu-Mwee; Connolly, Andrew; Hill, Andrew G.			Christmas 2010: History The first 15: New Zealand doctors and rugby	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Srinivasa, Sanket; Tan, Yu-Mwee; Connolly, Andrew; Hill, Andrew G.] Univ Auckland, Middlemore Hosp, S Auckland Clin Sch, Dept Surg, Auckland, New Zealand	University of Auckland	Srinivasa, S (corresponding author), Univ Auckland, Middlemore Hosp, S Auckland Clin Sch, Dept Surg, Auckland, New Zealand.	sanketsri@gmail.com	Hill, Andrew G/H-7278-2019	Hill, Andrew G/0000-0001-8672-6379				Fitzjohn Julie, 2003, N Z Med J, V116, pU626; Wilkinson TJ, 2004, MED EDUC, V38, P1111, DOI 10.1111/j.1365-2929.2004.01962.x	2	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 15	2010	341								c5127	10.1136/bmj.c5127	http://dx.doi.org/10.1136/bmj.c5127			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XJ	21159759				2022-12-28	WOS:000285552800013
J	England, PC; Katz, RF				England, Philip C.; Katz, Richard F.			Global systematics of arc volcano position	NATURE			English	Letter							SUBDUCTION		[England, Philip C.; Katz, Richard F.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	University of Oxford	England, PC (corresponding author), Univ Oxford, Dept Earth Sci, Parks Rd, Oxford OX1 3PR, England.	philip.england@earth.ox.ac.uk	Katz, Richard/D-3364-2009; England, Philip C/A-1920-2010	Katz, Richard/0000-0001-8746-5430; England, Philip C/0000-0002-9024-8901	Natural Environment Research Council [NER/A/S/2001/01067] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		England P, 2004, GEOPHYS J INT, V156, P377, DOI 10.1111/j.1365-246X.2003.02132.x; England PC, 2010, NATURE, V467, P700, DOI 10.1038/nature09417; Gill J., 1981, OROGENIC ANDESITES P; Grove TL, 2009, NATURE, V460, P1044, DOI 10.1038/nature08312; Iwamori H, 1998, EARTH PLANET SC LETT, V160, P65, DOI 10.1016/S0012-821X(98)00080-6; Syracuse EM, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001045; Tatsumi Y., 2005, GSA TODAY, V15, P4, DOI [DOI 10.1130/1052-5173(2005)015[4:TSFHI0]2.0.C0;2, DOI 10.1130/1052-5173(2005)015[4:TSFHIO]2.0.CO;2]; Tatsumi Y., 1995, SUBDUCTION ZONE MAGM; TOVISH A, 1978, GEOPHYS RES LETT, V5, P329, DOI 10.1029/GL005i005p00329; van Keken PE, 2008, PHYS EARTH PLANET IN, V171, P187, DOI 10.1016/j.pepi.2008.04.015	10	6	6	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2010	468	7325					E6	E7		10.1038/nature09154	http://dx.doi.org/10.1038/nature09154			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21150944	Green Submitted			2022-12-28	WOS:000285093700001
J	Waldor, MK; Hotez, PJ; Clemens, JD				Waldor, Matthew K.; Hotez, Peter J.; Clemens, John D.			A National Cholera Vaccine Stockpile - A New Humanitarian and Diplomatic Resource	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Waldor, Matthew K.] Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA; [Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Hotez, Peter J.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Hotez, Peter J.] Sabin Vaccine Inst, Washington, DC USA; [Clemens, John D.] Int Vaccine Inst, Seoul, South Korea	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; George Washington University; International Vaccine Institute	Waldor, MK (corresponding author), Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA.			Waldor, Matthew/0000-0003-1843-7000; Hotez, Peter/0000-0001-8770-1042	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R37 AI042347, R01 AI042347] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042347, R37AI042347] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; CLEMENS JD, 1990, LANCET, V335, P270, DOI 10.1016/0140-6736(90)90080-O; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000346; Lucas MES, 2005, NEW ENGL J MED, V352, P757, DOI 10.1056/NEJMoa043323; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6	5	25	25	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2010	363	24					2279	2282		10.1056/NEJMp1012300	http://dx.doi.org/10.1056/NEJMp1012300			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691PA	21105832	Green Accepted			2022-12-28	WOS:000285092100002
J	Ray, LB				Ray, L. Bryan			Metabolism Is Not Boring INTRODUCTION	SCIENCE			English	Editorial Material																			0	15	15	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1337	1337		10.1126/science.330.6009.1337	http://dx.doi.org/10.1126/science.330.6009.1337			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127242				2022-12-28	WOS:000284902100031
J	Brizendine, K; Wells, JM; Flanders, SA; Saint, S; Centor, RM				Brizendine, Kyle; Wells, J. Michael; Flanders, Scott A.; Saint, Sanjay; Centor, Robert M.			In Search of . . .	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPERCALCEMIA		[Brizendine, Kyle; Wells, J. Michael; Centor, Robert M.] Univ Alabama, Sch Med, Dept Internal Med, Birmingham, AL 35294 USA; [Centor, Robert M.] Huntsville Reg Med Campus, Huntsville, AL USA; [Flanders, Scott A.; Saint, Sanjay] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Saint, Sanjay] Dept Vet Affairs, Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA	University of Alabama System; University of Alabama Birmingham; University of Michigan System; University of Michigan	Centor, RM (corresponding author), Univ Alabama, Sch Med, Dept Internal Med, FOT 720,1530 3rd Ave S, Birmingham, AL 35294 USA.	rcentor@uab.edu	Saint, Sanjay/AAF-5126-2019; Wells, James Michael/ABA-2755-2021					BURT ME, 1980, ARCH SURG-CHICAGO, V115, P704, DOI 10.1001/archsurg.1980.01380060012004; Carroll MF, 2003, AM FAM PHYSICIAN, V67, P1959; Deftos LJ, 2002, ENDOCRIN METAB CLIN, V31, P141, DOI 10.1016/S0889-8529(01)00003-2; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; Li EC, 2003, CLIN THER, V25, P2669, DOI 10.1016/S0149-2918(03)80327-2; Mundy GR, 2008, J AM SOC NEPHROL, V19, P672, DOI 10.1681/ASN.2007090981; Renkema KY, 2008, ANN MED, V40, P82, DOI 10.1080/07853890701689645; SEYMOUR JF, 1993, BLOOD, V82, P1383; Sharma O P, 2000, Curr Opin Pulm Med, V6, P442, DOI 10.1097/00063198-200009000-00010; Shepard MM, 2007, AM J MED SCI, V334, P381, DOI 10.1097/MAJ.0b013e31812f4947; Stewart AF, 2005, NEW ENGL J MED, V352, P373, DOI 10.1056/NEJMcp042806	11	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2249	2254		10.1056/NEJMcps0903034	http://dx.doi.org/10.1056/NEJMcps0903034			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EP	21121838				2022-12-28	WOS:000284832900014
J	Sankaran, VG; Nathan, DG				Sankaran, Vijay G.; Nathan, David G.			Reversing the Hemoglobin Switch.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FETAL-HEMOGLOBIN; BCL11A; EXPRESSION		[Sankaran, Vijay G.] Childrens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Sankaran, VG (corresponding author), Childrens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA.							Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Platt OS, 2008, NEW ENGL J MED, V358, P1362, DOI 10.1056/NEJMct0708272; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	5	33	33	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2258	2260		10.1056/NEJMcibr1010767	http://dx.doi.org/10.1056/NEJMcibr1010767			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EP	21121839				2022-12-28	WOS:000284832900016
J	Voss, JE; Vaney, MC; Duquerroy, S; Vonrhein, C; Girard-Blanc, C; Crublet, E; Thompson, A; Bricogne, G; Rey, FA				Voss, James E.; Vaney, Marie-Christine; Duquerroy, Stephane; Vonrhein, Clemens; Girard-Blanc, Christine; Crublet, Elodie; Thompson, Andrew; Bricogne, Gerard; Rey, Felix A.			Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography	NATURE			English	Article							SEMLIKI-FOREST-VIRUS; MEMBRANE-FUSION; CONFORMATIONAL-CHANGE; SPIKE PROTEIN; ENVELOPE; SURFACE; REPLACEMENT; E1; PH	Chikungunya virus (CHIKV) is an emerging mosquito-borne alphavirus that has caused widespread outbreaks of debilitating human disease in the past five years(1). CHIKV invasion of susceptible cells is mediated by two viral glycoproteins, E1 and E2, which carry the main antigenic determinants and form an icosahedral shell at the virion surface. Glycoprotein E2, derived from furin cleavage of the p62 precursor into E3 and E2, is responsible for receptor binding, and E1 for membrane fusion. In the context of a concerted multidisciplinary effort to understand the biology of CHIKV2, here we report the crystal structures of the precursor p62-E1 heterodimer and of the mature E3-E2-E1 glycoprotein complexes. The resulting atomic models allow the synthesis of a wealth of genetic, biochemical, immunological and electron microscopy data accumulated over the years on alphaviruses in general. This combination yields a detailed picture of the functional architecture of the 25 MDa alphavirus surface glycoprotein shell. Together with the accompanying report on the structure of the Sindbis virus E2-E1 heterodimer at acidic pH (ref. 3), this work also provides new insight into the acid-triggered conformational change on the virus particle and its inbuilt inhibition mechanism in the immature complex.	[Voss, James E.; Vaney, Marie-Christine; Duquerroy, Stephane; Rey, Felix A.] Inst Pasteur, Dept Virol, Unite Virol Struct, F-75724 Paris 15, France; [Voss, James E.; Vaney, Marie-Christine; Duquerroy, Stephane; Rey, Felix A.] CNRS, URA 3015, F-75724 Paris 15, France; [Duquerroy, Stephane] Univ Paris Sud, Fac Orsay, F-91405 Orsay, France; [Vonrhein, Clemens; Bricogne, Gerard] Global Phasing Ltd, Cambridge CB3 0AX, England; [Girard-Blanc, Christine; Crublet, Elodie] Inst Pasteur, Dept Biol Struct & Chim, F-75724 Paris 15, France; [Girard-Blanc, Christine; Crublet, Elodie] CNRS, URA 2185, F-75724 Paris 15, France; [Thompson, Andrew] Synchrotron SOLEIL, F-91192 Gif Sur Yvette, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Global Phasing Limited; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); SOLEIL Synchrotron	Rey, FA (corresponding author), Inst Pasteur, Dept Virol, Unite Virol Struct, 25 Rue Dr Roux, F-75724 Paris 15, France.	rey@pasteur.fr	Rey, Felix/B-6497-2012	Rey, Felix/0000-0002-9953-7988; Duquerroy, Stephane/0000-0003-4386-8013	European Union Research Traning Network; French 'Agence Nationale de la Recherche'; Merck-Serono; Pediatric Dengue Vaccine Initiative; Institut Pasteur [PTR201 CHIKV]	European Union Research Traning Network; French 'Agence Nationale de la Recherche'(French National Research Agency (ANR)); Merck-Serono(Merck & Company); Pediatric Dengue Vaccine Initiative; Institut Pasteur(European Commission)	We thank the CHIKV task force at Institut Pasteur, in particular the group of F. Tangy and the staff of platform PF8 for the CHIKV complementary DNA; A. Haouz of PF6 for crystallogenesis; the staff of synchrotron beamlines PROXIMA 1 at Soleil, ID23-eh2 at the European Synchrotron Radiation Facility and PX-I at the Swiss Light Source; M. Rossmann and Y. Sun for providing the 16 angstrom cryo-EM map of CHIKV virion-like particles and for sharing the coordinates and manuscript of the low pH structure of the SINVE1-E2 heterodimer before publication; and members of the F.A.R. laboratory for help during data collection. J.E.V. was supported by a Marie Curie fellowship through the European Union Research Traning Network program "Intrapath''. This work was funded in part by the French 'Agence Nationale de la Recherche' grant DENtry in the program 'Microbiologie, Infections et Immunite', by Merck-Serono, by the Pediatric Dengue Vaccine Initiative and by the Institut Pasteur program PTR201 CHIKV to F.A.R..	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G., 2010, BUSTER VERSION 2 9; CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FLYNN DC, 1990, J VIROL, V64, P3643, DOI 10.1128/JVI.64.8.3643-3653.1990; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; HALSTEAD SB, 2004, PEDIAT INFECT DIS, P2178; Her Z, 2009, MICROBES INFECT, V11, P1165, DOI 10.1016/j.micinf.2009.09.004; JOHNSON F, 1922, B SCH ORIENT STUDIES, V2, P417; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; KIELIAN M, 1985, J CELL BIOL, V101, P2284, DOI 10.1083/jcb.101.6.2284; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; LOBIGS M, 1990, J VIROL, V64, P4346, DOI 10.1128/JVI.64.9.4346-4355.1990; Mancini EJ, 2000, MOL CELL, V5, P255, DOI 10.1016/S1097-2765(00)80421-9; MARSH M, 1989, ADV VIRUS RES, V36, P107, DOI 10.1016/S0065-3527(08)60583-7; MEYER WJ, 1993, J VIROL, V67, P5117, DOI 10.1128/JVI.67.9.5117-5125.1993; MEYER WJ, 1992, J VIROL, V66, P3504, DOI 10.1128/JVI.66.6.3504-3513.1992; Mukhopadhyay S, 2006, STRUCTURE, V14, P63, DOI 10.1016/j.str.2005.07.025; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Painter J, 2005, ACTA CRYSTALLOGR D, V61, P465, DOI 10.1107/S0907444905001897; Pierro DJ, 2008, J VIROL, V82, P2966, DOI 10.1128/JVI.02060-07; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; Roussel A, 2006, STRUCTURE, V14, P75, DOI 10.1016/j.str.2005.09.014; SALMINEN A, 1992, J CELL BIOL, V116, P349, DOI 10.1083/jcb.116.2.349; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; WAHLBERG JM, 1989, J VIROL, V63, P4991, DOI 10.1128/JVI.63.12.4991-4997.1989; WAHLBERG JM, 1992, J VIROL, V66, P7309, DOI 10.1128/JVI.66.12.7309-7318.1992; Wu SR, 2007, J BIOL CHEM, V282, P6752, DOI 10.1074/jbc.M609125200; ZIEMIECKI A, 1980, J GEN VIROL, V50, P111, DOI 10.1099/0022-1317-50-1-111	44	432	444	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					709	U137		10.1038/nature09555	http://dx.doi.org/10.1038/nature09555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124458				2022-12-28	WOS:000284836700044
J	Gorry, GA				Gorry, G. Anthony			Decisions, Decisions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												tony@rice.edu							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2010	304	21					2339	2340		10.1001/jama.2010.1748	http://dx.doi.org/10.1001/jama.2010.1748			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687FH	21119077				2022-12-28	WOS:000284763900001
J	Zhou, YM; Hu, GP; Wang, DL; Wang, SY; Wang, YJ; Liu, ZG; Hu, JX; Shi, Z; Peng, GY; Liu, SM; Lu, JC; Zheng, JP; Wang, JA; Zhong, NS; Ran, PX				Zhou, Yumin; Hu, Guoping; Wang, Dali; Wang, Shaoyi; Wang, Yujun; Liu, Zhigang; Hu, Jinxin; Shi, Zhe; Peng, Gongyong; Liu, Shengming; Lu, Jiachun; Zheng, Jingping; Wang, Jian; Zhong, Nanshan; Ran, Pixin			Community based integrated intervention for prevention and management of chronic obstructive pulmonary disease (COPD) in Guangdong, China: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LUNG-FUNCTION; SMOKING-CESSATION; CIGARETTE-SMOKING; FEV1/FVC RATIO; DECLINE; PREVALENCE; IMPACT; CARE; BURDEN	Objective To evaluate the effects of a community based integrated intervention for early prevention and management of chronic obstructive pulmonary disease (COPD) in China. Design Cluster randomised controlled trial. Setting Eight healthcare units in two communities. Participants Of 1062 people aged 40-89, 872 (101 with COPD and 771 without COPD) who fulfilled the inclusion and exclusion criteria were allocated to the intervention or the usual care programmes. Intervention Participants randomly assigned to integrated intervention (systematic health education, intensive and individualised intervention, treatment, and rehabilitation) or usual care. Main outcome measures Annual rate of decline in forced expiratory rate in one second (FEV1) before use of bronchodilator. Results Annual rate of decline in FEV1 was significantly lower in the intervention community than the control community, with an adjusted difference of 19 ml/year (95% confidence interval 3 to 36) and 0.9% (0.1% to 1.8%) of predicted values (all P<0.05), as well as a lower annual rate of decline in FEV1/FVC (forced vital capacity) ratio (adjusted difference 0.6% (0.1% to 1.2%) P=0.029). There were also higher rates of smoking cessation (21% v 8%, P<0.004) and lower cumulative death rates from all causes (1% v 3%, P<0.009) in the intervention community than in the control community during the four year follow-up. Improvements in knowledge of COPD and smoking hazards, outdoor air quality, environmental tobacco smoke, and working conditions were also achieved (all P<0.05). The difference in cumulative incidence rate of COPD (both around 4%) and cumulative death rate from COPD (2% v 11%) did not reach significance between the two communities. Conclusions A community based integrated intervention can have a significant impact on the prevention and management of COPD, mainly reflected in the annual rate of decline in FEV1.	[Zhou, Yumin; Hu, Guoping; Hu, Jinxin; Shi, Zhe; Peng, Gongyong; Liu, Shengming; Zheng, Jingping; Wang, Jian; Zhong, Nanshan; Ran, Pixin] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Wang, Dali] Second Hosp Liwan Dist Guangzhou, Guangzhou, Guangdong, Peoples R China; [Wang, Shaoyi; Wang, Yujun; Liu, Zhigang] Bur Environm Protect Guangzhou Municipal, Guangzhou Environm Monitoring Ctr, Bur Environm Protect Liwan Dist, Guangzhou, Guangdong, Peoples R China; [Liu, Shengming] Jinan Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Lu, Jiachun] Guangzhou Med Univ, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China; [Wang, Jian] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Jinan University; Guangzhou Medical University; Johns Hopkins University	Ran, PX (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	nanshan@vip.163.com; pxran@gzhmc.edu.cn	wang, jian/GVS-0711-2022; Peng, Gongyong/K-8470-2017	Ran, Pixin/0000-0001-6651-634X	Chinese Central Government [2001BA703B03(A), B30301]	Chinese Central Government	This study was funded by a grant from the Chinese Central Government key research projects of the 10th National Five-year Development Plan 2001BA703B03(A) and in part by Guangdong Key Research Project grant B30301. The researchers were independent from funders. The study funders had no influence on the study design, collection, analysis, interpretation of data, writing of the report, and the decision to submit the article for publication.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Avol Edward, 2005, NEW ENGL J MED, V352, P1276; Bridevaux PO, 2008, THORAX, V63, P768, DOI 10.1136/thx.2007.093724; BROWNER WS, 1992, WESTERN J MED, V157, P534; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Casas A, 2006, EUR RESPIR J, V28, P123, DOI 10.1183/09031936.06.00063205; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Chan-Yeung M, 2004, INT J TUBERC LUNG D, V8, P2; Decramer M, 2009, LANCET, V374, P1171, DOI 10.1016/S0140-6736(09)61298-8; Garcia-Ayrnerich J, 2007, RESP MED, V101, P1462, DOI 10.1016/j.rmed.2007.01.012; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Gu DF, 2004, AM J PUBLIC HEALTH, V94, P1972, DOI 10.2105/AJPH.94.11.1972; Hansen JE, 2007, CHEST, V131, P349, DOI 10.1378/chest.06-1349; Kanner RE, 2001, AM J RESP CRIT CARE, V164, P358, DOI 10.1164/ajrccm.164.3.2010017; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Omori H, 2005, RESPIROLOGY, V10, P464, DOI 10.1111/j.1440-1843.2005.00727.x; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381, DOI 10.1164/ajrccm.161.2.9901044; Sin DD, 2002, AM J RESP CRIT CARE, V165, P704, DOI 10.1164/ajrccm.165.5.2104055; Swanney MP, 2008, THORAX, V63, P1046, DOI 10.1136/thx.2008.098483; Tabak C, 2001, CLIN EXP ALLERGY, V31, P747, DOI 10.1046/j.1365-2222.2001.01064.x; TAGER IB, 1988, AM REV RESPIR DIS, V138, P837, DOI 10.1164/ajrccm/138.4.837; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Troosters T, 2005, AM J RESP CRIT CARE, V172, P19, DOI 10.1164/rccm.200408-1109SO; Willemse BWM, 2004, EUR RESPIR J, V23, P464, DOI 10.1183/09031936.04.00012704; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Zheng JP, 2002, CHINESE MED J-PEKING, V115, P50; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC; Zhou Y, 2009, EUR RESPIR J, V33, P509, DOI 10.1183/09031936.00084408	34	55	68	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2010	341								c6387	10.1136/bmj.c6387	http://dx.doi.org/10.1136/bmj.c6387			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691OU	21123342	Green Published, hybrid			2022-12-28	WOS:000285091500005
J	Parsons, DW; Li, M; Zhang, XS; Jones, S; Leary, RJ; Lin, JCH; Boca, SM; Carter, H; Samayoa, J; Bettegowda, C; Gallia, GL; Jallo, GI; Binder, ZA; Nikolsky, Y; Hartigan, J; Smith, DR; Gerhard, DS; Fults, DW; VandenBerg, S; Berger, MS; Marie, SKN; Shinjo, SMO; Clara, C; Phillips, PC; Minturn, JE; Biegel, JA; Judkins, AR; Resnick, AC; Storm, PB; Curran, T; He, YP; Rasheed, BA; Friedman, HS; Keir, ST; McLendon, R; Northcott, PA; Taylor, MD; Burger, PC; Riggins, GJ; Karchin, R; Parmigiani, G; Bigner, DD; Yan, H; Papadopoulos, N; Vogelstein, B; Kinzler, KW; Velculescu, VE				Parsons, D. Williams; Li, Meng; Zhang, Xiaosong; Jones, Sian; Leary, Rebecca J.; Lin, Jimmy Cheng-Ho; Boca, Simina M.; Carter, Hannah; Samayoa, Josue; Bettegowda, Chetan; Gallia, Gary L.; Jallo, George I.; Binder, Zev A.; Nikolsky, Yuri; Hartigan, James; Smith, Doug R.; Gerhard, Daniela S.; Fults, Daniel W.; VandenBerg, Scott; Berger, Mitchel S.; Marie, Suely Kazue Nagahashi; Shinjo, Sueli Mieko Oba; Clara, Carlos; Phillips, Peter C.; Minturn, Jane E.; Biegel, Jaclyn A.; Judkins, Alexander R.; Resnick, Adam C.; Storm, Phillip B.; Curran, Tom; He, Yiping; Rasheed, B. Ahmed; Friedman, Henry S.; Keir, Stephen T.; McLendon, Roger; Northcott, Paul A.; Taylor, Michael D.; Burger, Peter C.; Riggins, Gregory J.; Karchin, Rachel; Parmigiani, Giovanni; Bigner, Darell D.; Yan, Hai; Papadopoulos, Nick; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.			The Genetic Landscape of the Childhood Cancer Medulloblastoma	SCIENCE			English	Article							SOMATIC MUTATIONS; HUMAN BREAST; GENOME; AMPLIFICATION; METHYLATION; PROGRESSION; SEQUENCES; COMPLEX; ARID1A; OTX2	Medulloblastoma (MB) is the most common malignant brain tumor of children. To identify the genetic alterations in this tumor type, we searched for copy number alterations using high-density microarrays and sequenced all known protein-coding genes and microRNA genes using Sanger sequencing in a set of 22 MBs. We found that, on average, each tumor had 11 gene alterations, fewer by a factor of 5 to 10 than in the adult solid tumors that have been sequenced to date. In addition to alterations in the Hedgehog and Wnt pathways, our analysis led to the discovery of genes not previously known to be altered in MBs. Most notably, inactivating mutations of the histone-lysine N-methyltransferase genes MLL2 or MLL3 were identified in 16% of MB patients. These results demonstrate key differences between the genetic landscapes of adult and childhood cancers, highlight dysregulation of developmental pathways as an important mechanism underlying MBs, and identify a role for a specific type of histone methylation in human tumorigenesis.	[Parsons, D. Williams; Li, Meng; Zhang, Xiaosong; Jones, Sian; Leary, Rebecca J.; Lin, Jimmy Cheng-Ho; Bettegowda, Chetan; Riggins, Gregory J.; Papadopoulos, Nick; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.] Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [Parsons, D. Williams; Li, Meng; Zhang, Xiaosong; Jones, Sian; Leary, Rebecca J.; Lin, Jimmy Cheng-Ho; Bettegowda, Chetan; Riggins, Gregory J.; Papadopoulos, Nick; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Parsons, D. Williams] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Parsons, D. Williams] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Parsons, D. Williams] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Boca, Simina M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Carter, Hannah; Samayoa, Josue; Karchin, Rachel] Johns Hopkins Med Inst, Dept Biomed Engn, Inst Computat Med, Baltimore, MD 21218 USA; [Bettegowda, Chetan; Gallia, Gary L.; Jallo, George I.; Binder, Zev A.; Riggins, Gregory J.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21231 USA; [Nikolsky, Yuri] GeneGo Inc, St Joseph, MI 49085 USA; [Hartigan, James; Smith, Doug R.] Beckman Coulter Genom Inc, Danvers, MA 01923 USA; [Gerhard, Daniela S.] NCI, Off Canc Genom, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Fults, Daniel W.] Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT 84132 USA; [VandenBerg, Scott] Univ Calif San Diego, Dept Pathol, Div Neuropathol, San Diego, CA 92103 USA; [Berger, Mitchel S.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Marie, Suely Kazue Nagahashi; Shinjo, Sueli Mieko Oba] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, Brazil; [Clara, Carlos] Barretos Canc Hosp, Pio XII Fdn, Sao Paulo, Brazil; [Phillips, Peter C.; Minturn, Jane E.; Biegel, Jaclyn A.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Resnick, Adam C.; Storm, Phillip B.] Childrens Hosp Philadelphia, Div Neurosurg, Philadelphia, PA 19104 USA; [Judkins, Alexander R.; Curran, Tom] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [He, Yiping; Rasheed, B. Ahmed; Friedman, Henry S.; Keir, Stephen T.; McLendon, Roger; Bigner, Darell D.; Yan, Hai] Duke Univ, Med Ctr, Pediat Brain Tumor Fdn Inst, Preston Robert Tisch Brain Tumor Ctr,Dept Pathol, Durham, NC 27710 USA; [He, Yiping; Rasheed, B. Ahmed; Friedman, Henry S.; Keir, Stephen T.; McLendon, Roger; Bigner, Darell D.; Yan, Hai] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Northcott, Paul A.; Taylor, Michael D.] Univ Toronto, Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1L7, Canada; [Burger, Peter C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA; [Parmigiani, Giovanni] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Parmigiani, Giovanni] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Beckman Coulter Inc.; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Utah System of Higher Education; University of Utah; University of California System; University of California San Diego; University of California System; University of California San Francisco; Universidade de Sao Paulo; Hospital de Cancer de Barretos; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Duke University; Duke University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Johns Hopkins University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Vogelstein, B (corresponding author), Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA.	vogelbe@gmail.com; kinzlke@jhmi.edu; velculescu@jhmi.edu	Marie, Suely Kazue Nagahashi/D-1870-2012; Velculescu, Victor/ABF-4846-2020; Northcott, Paul A/N-4022-2018; Karchin, Rachel/A-3385-2010; Boca, Simina/ABE-3747-2020; Curran, Tom/D-7515-2011; Curran, Tom/F-5234-2018; Papadopoulos, Nickolas/K-7272-2012; Jones, Sian/A-5050-2012; Oba-Shinjo, Sueli M./C-4017-2012; Curran, Tom/C-1164-2008; Curran, Thomas/AAE-7631-2019; Carter, Hannah/R-8425-2017	Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Velculescu, Victor/0000-0003-1195-438X; Northcott, Paul A/0000-0002-1220-5252; Boca, Simina/0000-0002-1400-3398; Curran, Tom/0000-0003-1444-7551; Oba-Shinjo, Sueli M./0000-0002-1650-5973; Curran, Tom/0000-0003-1444-7551; Curran, Thomas/0000-0003-1444-7551; Parsons, Donald/0000-0002-8775-3501; Carter, Hannah/0000-0002-1729-2463; Taylor, Michael/0000-0001-7009-3466; Karchin, Rachel/0000-0002-5069-1239	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Virginia and D. K. Ludwig Fund for Cancer Research; Alex's Lemonade Stand Foundation; American Brain Tumor Association; Brain Tumor Research Fund at Johns Hopkins; Hoglund Foundation; Ready or Not Foundation; Children's Brain Tumor Foundation; Pediatric Brain Tumor Foundation Institute; David and Barbara B. Hirschhorn Foundation; American Association for Cancer Research; Johns Hopkins Sommer Scholar Program; NIH [CA121113, CA096832, CA057345, CA118822, CA135877, GM074906-01A1/B7BSCW]; NSF [DBI 0845275]; DOD NDSEG [32 CFR 168a]; NATIONAL CANCER INSTITUTE [R01CA121113, R37CA057345, R01CA057345, R01CA118822, R21CA135877, R01CA108622, P01CA096832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM074906] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Virginia and D. K. Ludwig Fund for Cancer Research; Alex's Lemonade Stand Foundation; American Brain Tumor Association; Brain Tumor Research Fund at Johns Hopkins; Hoglund Foundation; Ready or Not Foundation; Children's Brain Tumor Foundation; Pediatric Brain Tumor Foundation Institute; David and Barbara B. Hirschhorn Foundation; American Association for Cancer Research; Johns Hopkins Sommer Scholar Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); DOD NDSEG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Ptak, N. Silliman, L. Dobbyn, and M. Whalen for technical assistance with sequencing analyses, and M. Ehinger, D. Satterfield, E. Lipp, D. Lister, and M. J. Dougherty for help with sample preparation and data collection. This project has been funded in part by the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government. This work was supported by the Virginia and D. K. Ludwig Fund for Cancer Research, Alex's Lemonade Stand Foundation, the American Brain Tumor Association, the Brain Tumor Research Fund at Johns Hopkins, the Hoglund Foundation, the Ready or Not Foundation, the Children's Brain Tumor Foundation, the Pediatric Brain Tumor Foundation Institute, the David and Barbara B. Hirschhorn Foundation, American Association for Cancer Research Stand Up To Cancer Dream Team Translational Cancer Research Grant, Johns Hopkins Sommer Scholar Program, NIH grants CA121113, CA096832, CA057345, CA118822, CA135877, and GM074906-01A1/B7BSCW, NSF grant DBI 0845275, and DOD NDSEG Fellowship 32 CFR 168a. D. W. P. is a Graham Cancer Research Scholar at Texas Children's Cancer Center. Under licensing agreements between the Johns Hopkins University and Beckman Coulter, B.V., K.W.K., and V.E.V. are entitled to a share of royalties received by the university on sales of products related to research described in this paper. N.P., B.V., K.W.K., and V.E.V are cofounders of Inostics and Personal Genome Diagnostics and are members of their Scientific Advisory Boards. N.P., B.V., K.W.K., and V.E.V. own Inostics and Personal Genome Diagnostics stock, which is subject to certain restrictions under university policy. The terms of these arrangements are managed by Johns Hopkins University in accordance with its conflict-of-interest policies.	Adamson DC, 2010, CANCER RES, V70, P181, DOI 10.1158/0008-5472.CAN-09-2331; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ansari KI, 2010, FEBS J, V277, P1790, DOI 10.1111/j.1742-4658.2010.07606.x; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; BIGNER SH, 1990, CANCER RES, V50, P2347; Boca SM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r112; Boon K, 2005, CANCER RES, V65, P703; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Di CH, 2005, CANCER RES, V65, P919; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Eberhart CG, 2002, CANCER-AM CANCER SOC, V94, P552, DOI 10.1002/cncr.10189; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Giangaspero F., 2007, WHO CLASSIFICATION C; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Northcott PA, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09218; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Polkinghorn WR, 2007, NAT CLIN PRACT ONCOL, V4, P295, DOI 10.1038/ncponc0794; SAYLORS RL, 1991, CANCER RES, V51, P4721; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Soussi T, 2003, HUM MUTAT, V21, P192, DOI 10.1002/humu.10189; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Vermeulen M, 2010, EPIGENOMICS-UK, V2, P395, DOI 10.2217/EPI.10.11; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	43	552	561	1	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					435	439		10.1126/science.1198056	http://dx.doi.org/10.1126/science.1198056			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21163964	Green Accepted			2022-12-28	WOS:000286635900045
J	Huang, B; Babcock, H; Zhuang, XW				Huang, Bo; Babcock, Hazen; Zhuang, Xiaowei			Breaking the Diffraction Barrier: Super-Resolution Imaging of Cells	CELL			English	Article							STED MICROSCOPY REVEALS; FLUORESCENCE MICROSCOPY; STIMULATED-EMISSION; 3-DIMENSIONAL SUPERRESOLUTION; SUBDIFFRACTION RESOLUTION; EXCITATION MICROSCOPY; LIVING CELLS; LOCALIZATION; NANOSCOPY; LIMIT	Anyone who has used a light microscope has wished that its resolution could be a little better. Now, after centuries of gradual improvements, fluorescence microscopy has made a quantum leap in its resolving power due, in large part, to advancements over the past several years in a new area of research called super-resolution fluorescence microscopy. In this Primer, we explain the principles of various super-resolution approaches, such as STED, (S) SIM, and STORM/(F) PALM. Then, we describe recent applications of super-resolution microscopy in cells, which demonstrate how these approaches are beginning to provide new insights into cell biology, microbiology, and neurobiology.	[Huang, Bo] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Huang, Bo] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University		zhuang@chemistry.harvard.edu	uemura, ryu/GPG-3319-2022	Babcock, Hazen/0000-0003-4835-3692	Searle Scholarship; Packard Fellowship; UCSF; Howard Hughes Medical Institute; National Institutes of Health; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096450, R01GM068518] Funding Source: NIH RePORTER	Searle Scholarship; Packard Fellowship(The David & Lucile Packard Foundation); UCSF; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is in part supported by the Searle Scholarship, Packard Fellowship, and the UCSF Program for Breakthrough Biomedical Research (to B. H.) and the Howard Hughes Medical Institute (Collaborative Innovation Award), National Institutes of Health, and the Gatsby Charitable Foundation (to X.Z.). X.Z. is a Howard Hughes Medical Institute investigator.	Abbe E., 1873, ARCH F MIKROSK ANAT, V9, P413, DOI [10.1007/bf02956173, DOI 10.1007/BF02956173, 10.1007/ BF02956173]; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; BETZIG E, 1986, BIOPHYS J, V49, P269, DOI 10.1016/S0006-3495(86)83640-2; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Biteen JS, 2008, NAT METHODS, V5, P947, DOI 10.1038/nmeth.1258; Bretschneider S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.218103; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Dertinger T, 2009, P NATL ACAD SCI USA, V106, P22287, DOI 10.1073/pnas.0907866106; Ding JB, 2009, NEURON, V63, P429, DOI 10.1016/j.neuron.2009.07.011; Donnert G, 2007, BIOPHYS J, V92, pL67, DOI 10.1529/biophysj.107.104497; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Egner A, 2007, BIOPHYS J, V93, P3285, DOI 10.1529/biophysj.107.112201; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Folling J, 2008, CHEMPHYSCHEM, V9, P321, DOI 10.1002/cphc.200700655; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gordon MP, 2004, P NATL ACAD SCI USA, V101, P6462, DOI 10.1073/pnas.0401638101; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; GUSTAFSSON MGL, 1995, P SOC PHOTO-OPT INS, V2412, P147, DOI 10.1117/12.205334; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Harke B, 2008, NANO LETT, V8, P1309, DOI 10.1021/nl073164n; Heintzmann R, 1999, P SOC PHOTO-OPT INS, V3568, P185, DOI 10.1117/12.336833; Heintzmann R, 2002, J OPT SOC AM A, V19, P1599, DOI 10.1364/JOSAA.19.001599; Heintzmann R, 2009, NAT PHOTONICS, V3, P362, DOI 10.1038/nphoton.2009.102; HELL S, 1992, OPT COMMUN, V93, P277, DOI 10.1016/0030-4018(92)90185-T; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kellner RR, 2007, NEUROSCIENCE, V144, P135, DOI 10.1016/j.neuroscience.2006.08.071; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Klar TA, 1999, OPT LETT, V24, P954, DOI 10.1364/OL.24.000954; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]; Lacoste TD, 2000, P NATL ACAD SCI USA, V97, P9461, DOI 10.1073/pnas.170286097; Lagerholm BC, 2006, BIOPHYS J, V91, P3050, DOI 10.1529/biophysj.105.079178; Lee HLD, 2010, J AM CHEM SOC, V132, P15099, DOI 10.1021/ja1044192; LEWIS A, 1984, ULTRAMICROSCOPY, V13, P227, DOI 10.1016/0304-3991(84)90201-8; Lidke KA, 2005, OPT EXPRESS, V13, P7052, DOI 10.1364/OPEX.13.007052; Lord SJ, 2010, ANAL CHEM, V82, P2192, DOI 10.1021/ac9024889; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Matsuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012768; Meyer AC, 2009, NAT NEUROSCI, V12, P444, DOI 10.1038/nn.2293; Moerner WE, 2007, P NATL ACAD SCI USA, V104, P12596, DOI 10.1073/pnas.0610081104; Moneron G, 2010, OPT EXPRESS, V18, P1302, DOI 10.1364/OE.18.001302; Moneron G, 2009, OPT EXPRESS, V17, P14567, DOI 10.1364/OE.17.014567; Nagerl UV, 2008, P NATL ACAD SCI USA, V105, P18982, DOI 10.1073/pnas.0810028105; Neumann Daniel, 2010, PMC Biophys, V3, P4, DOI 10.1186/1757-5036-3-4; Novotny L., 2012, PRINCIPLES NANOOPTIC; Patterson G, 2010, ANNU REV PHYS CHEM, V61, P345, DOI 10.1146/annurev.physchem.012809.103444; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Pertsinidis A, 2010, NATURE, V466, P647, DOI 10.1038/nature09163; POHL DW, 1984, APPL PHYS LETT, V44, P651, DOI 10.1063/1.94865; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Qu XH, 2004, P NATL ACAD SCI USA, V101, P11298, DOI 10.1073/pnas.0402155101; Rittweger E, 2009, NAT PHOTONICS, V3, P144, DOI 10.1038/NPHOTON.2009.2; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schmidt R, 2008, NAT METHODS, V5, P539, DOI 10.1038/nmeth.1214; Schmidt R, 2009, NANO LETT, V9, P2508, DOI 10.1021/nl901398t; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Subach FV, 2010, J AM CHEM SOC, V132, P6481, DOI 10.1021/ja100906g; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Synge EH, 1928, PHILOS MAG, V6, P356; Tang JY, 2010, P NATL ACAD SCI USA, V107, P10068, DOI 10.1073/pnas.1004899107; Testa I, 2010, BIOPHYS J, V99, P2686, DOI 10.1016/j.bpj.2010.08.012; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; van Oijen AM, 1998, CHEM PHYS LETT, V292, P183, DOI 10.1016/S0009-2614(98)00673-3; Vaziri A, 2008, P NATL ACAD SCI USA, V105, P20221, DOI 10.1073/pnas.0810636105; Westphal V, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/12/435; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Willig KI, 2007, NAT METHODS, V4, P915, DOI 10.1038/NMETH1108; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Wombacher R, 2010, NAT METHODS, V7, P717, DOI [10.1038/NMETH.1489, 10.1038/nmeth.1489]; Wu M, 2010, NAT CELL BIOL, V12, P902, DOI 10.1038/ncb2094; Xie XS, 2008, ANNU REV BIOPHYS, V37, P417, DOI 10.1146/annurev.biophys.37.092607.174640; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	90	802	835	24	721	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1047	1058		10.1016/j.cell.2010.12.002	http://dx.doi.org/10.1016/j.cell.2010.12.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21168201	Green Accepted, Bronze			2022-12-28	WOS:000285625400004
J	Thanukos, A; Scotchmoor, JG; Caldwell, R; Lindberg, DR				Thanukos, Anastasia; Scotchmoor, Judith G.; Caldwell, Roy; Lindberg, David R.			Science 101: Building the Foundations for Real Understanding	SCIENCE			English	Editorial Material									[Thanukos, Anastasia; Scotchmoor, Judith G.; Caldwell, Roy; Lindberg, David R.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Caldwell, Roy; Lindberg, David R.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Caldwell, R (corresponding author), Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA.	rlcaldwell@berkeley.edu	Lindberg, David R/D-8138-2011		Howard Hughes Medical Institute [51003439] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bybee R, 2009, J RES SCI TEACH, V46, P865, DOI 10.1002/tea.20333; Lederman N.G., 2007, HDB RES SCI ED, P831, DOI [10.4324/9780203824696, DOI 10.4324/9780203824696]; Mooney C., 2009, UNSCIENTIFIC AM; National Science Board, 2010, SCI ENG IND 2010; ROCKMAN, UNDERSTANDING EVOLUT; STUHLSATZ MAM, 2010, 201008 ER BIOL SCI C	6	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1764	1765		10.1126/science.1186994	http://dx.doi.org/10.1126/science.1186994			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698OS	21127217				2022-12-28	WOS:000285603700028
J	Maiklem, A; Nicol, E				Maiklem, Andrew; Nicol, Ed			A Patient's Journey Heart transplant	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nicol, Ed] Royal Brompton Hosp, Dept Cardiol & Radiol, London SW3 6NP, England	Royal Brompton Hospital	Nicol, E (corresponding author), Royal Brompton Hosp, Dept Cardiol & Radiol, Sydney St, London SW3 6NP, England.	amaiklem@caci.co.uk; cyprusdoc@doctors.org.uk							0	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2010	341								c4918	10.1136/bmj.c4918	http://dx.doi.org/10.1136/bmj.c4918			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XO	21169319				2022-12-28	WOS:000285553300007
J	Virshup, DM; Kaldis, P				Virshup, David M.; Kaldis, Philipp			Enforcing the Greatwall in Mitosis	SCIENCE			English	Editorial Material							XENOPUS EGG EXTRACTS; KINASE; ENTRY; EXIT		[Virshup, David M.] Duke Natl Univ Singapore, Grad Sch Med, Program Canc & Stem Cell Biol, Singapore 169857, Singapore; [Virshup, David M.; Kaldis, Philipp] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Kaldis, Philipp] Inst Mol & Cell Biol, Singapore 138673, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Virshup, DM (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Program Canc & Stem Cell Biol, Singapore 169857, Singapore.	david.virshup@duke-nus.edu.sg	Virshup, David M/C-1449-2009; Kaldis, Philipp/G-2714-2010	Virshup, David M/0000-0001-6976-850X; Kaldis, Philipp/0000-0002-7247-7591				Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; Ferrell JE, 2009, FEBS LETT, V583, P3999, DOI 10.1016/j.febslet.2009.10.068; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Jackson PK, 2006, MOL CELL, V22, P156, DOI 10.1016/j.molcel.2006.04.005; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Vigneron S, 2009, EMBO J, V28, P2786, DOI 10.1038/emboj.2009.228; Voets E, 2010, CELL CYCLE, V9, P3591, DOI 10.4161/cc.9.17.12832; Yu JT, 2006, MOL CELL, V22, P83, DOI 10.1016/j.molcel.2006.02.022; Yu JT, 2004, J CELL BIOL, V164, P487, DOI 10.1083/JCB.200310059	12	12	12	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2010	330	6011					1638	1639		10.1126/science.1199898	http://dx.doi.org/10.1126/science.1199898			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164006				2022-12-28	WOS:000285390500054
J	Johannessen, CM; Boehm, JS; Kim, SY; Thomas, SR; Wardwell, L; Johnson, LA; Emery, CM; Stransky, N; Cogdill, AP; Barretina, J; Caponigro, G; Hieronymus, H; Murray, RR; Salehi-Ashtiani, K; Hill, DE; Vidal, M; Zhao, JJ; Yang, XP; Alkan, O; Kim, S; Harris, JL; Wilson, CJ; Myer, VE; Finan, PM; Root, DE; Roberts, TM; Golub, T; Flaherty, KT; Dummer, R; Weber, BL; Sellers, WR; Schlegel, R; Wargo, JA; Hahn, WC; Garraway, LA				Johannessen, Cory M.; Boehm, Jesse S.; Kim, So Young; Thomas, Sapana R.; Wardwell, Leslie; Johnson, Laura A.; Emery, Caroline M.; Stransky, Nicolas; Cogdill, Alexandria P.; Barretina, Jordi; Caponigro, Giordano; Hieronymus, Haley; Murray, Ryan R.; Salehi-Ashtiani, Kourosh; Hill, David E.; Vidal, Marc; Zhao, Jean J.; Yang, Xiaoping; Alkan, Ozan; Kim, Sungjoon; Harris, Jennifer L.; Wilson, Christopher J.; Myer, Vic E.; Finan, Peter M.; Root, David E.; Roberts, Thomas M.; Golub, Todd; Flaherty, Keith T.; Dummer, Reinhard; Weber, Barbara L.; Sellers, William R.; Schlegel, Robert; Wargo, Jennifer A.; Hahn, William C.; Garraway, Levi A.			COT drives resistance to RAF inhibition through MAP kinase pathway reactivation	NATURE			English	Article							TUMOR PROGRESSION; SIGNALING PATHWAY; BRAF; MUTATIONS; CANCER; CELLS; GENE; TRANSFORMATION; SENSITIVITY; ACTIVATION	Oncogenic mutations in the serine/threonine kinase B-RAF (also known as BRAF) are found in 50-70% of malignant melanomas(1). Pre-clinical studies have demonstrated that the B-RAF(V600E) mutation predicts a dependency on the mitogen-activated protein kinase (MAPK) signalling cascade in melanoma(2-6)-an observation that has been validated by the success of RAF and MEK inhibitors in clinical trials(7-9). However, clinical responses to targeted anticancer therapeutics are frequently confounded by de novo or acquired resistance(10-12). Identification of resistance mechanisms in a manner that elucidates alternative 'druggable' targets may inform effective long-term treatment strategies(13). Here we expressed similar to 600 kinase and kinase-related open reading frames (ORFs) in parallel to interrogate resistance to a selective RAF kinase inhibitor. We identified MAP3K8 (the gene encoding COT/Tpl2) as a MAPK pathway agonist that drives resistance to RAF inhibition in B-RAF(V600E) cell lines. COT activates ERK primarily through MEK-dependent mechanisms that do not require RAF signalling. Moreover, COT expression is associated with de novo resistance in B-RAF(V600E) cultured cell lines and acquired resistance in melanoma cells and tissue obtained from relapsing patients following treatment with MEK or RAF inhibitors. We further identify combinatorial MAPK pathway inhibition or targeting of COT kinase activity as possible therapeutic strategies for reducing MAPK pathway activation in this setting. Together, these results provide new insights into resistance mechanisms involving the MAPK pathway and articulate an integrative approach through which high-throughput functional screens may inform the development of novel therapeutic strategies.	[Johannessen, Cory M.; Boehm, Jesse S.; Kim, So Young; Thomas, Sapana R.; Johnson, Laura A.; Stransky, Nicolas; Barretina, Jordi; Hieronymus, Haley; Yang, Xiaoping; Alkan, Ozan; Root, David E.; Golub, Todd; Hahn, William C.; Garraway, Levi A.] Harvard & Massachusetts Inst Technol, Broad Inst, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Johannessen, Cory M.; Kim, So Young; Thomas, Sapana R.; Wardwell, Leslie; Johnson, Laura A.; Emery, Caroline M.; Barretina, Jordi; Hahn, William C.; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kim, So Young; Murray, Ryan R.; Salehi-Ashtiani, Kourosh; Hill, David E.; Vidal, Marc; Hahn, William C.] Dana Farber Canc Inst, CCSB, Boston, MA 02115 USA; [Cogdill, Alexandria P.; Flaherty, Keith T.; Wargo, Jennifer A.] Massachusetts Gen Hosp, Div Surg Oncol Med Oncol & Dermatol, Boston, MA 02114 USA; [Barretina, Jordi; Golub, Todd; Hahn, William C.; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Caponigro, Giordano; Wilson, Christopher J.; Myer, Vic E.; Finan, Peter M.; Weber, Barbara L.; Sellers, William R.; Schlegel, Robert] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Hieronymus, Haley; Golub, Todd] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Murray, Ryan R.; Salehi-Ashtiani, Kourosh; Hill, David E.; Vidal, Marc; Zhao, Jean J.; Roberts, Thomas M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Murray, Ryan R.; Salehi-Ashtiani, Kourosh; Hill, David E.; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhao, Jean J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Kim, Sungjoon; Harris, Jennifer L.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Novartis; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Novartis; University of Zurich; University Zurich Hospital	Garraway, LA (corresponding author), Harvard & Massachusetts Inst Technol, Broad Inst, Cambridge Ctr 7, Cambridge, MA 02142 USA.	Levi_Garraway@dfci.harvard.edu	Hill, David E/B-6617-2011; Barretina, Jordi/A-7192-2013	Barretina, Jordi/0000-0002-3478-4080; Cogdill, Alexandria/0000-0001-8917-9462; Boehm, Jesse/0000-0002-6795-6336; Wilson, Christopher/0000-0002-9146-522X; Salehi-Ashtiani, Kourosh/0000-0002-6521-5243	NIH [CA134502]; Novartis Institutes for Biomedical Research; Melanoma Research Alliance; Starr Cancer Consortium; US National Cancer Institute [R33 CA128625, RC2 CA148268]; Swiss National Foundation [310040-103671]; Gottfried and Julia Bangerter Rhyner Stiftung; Ellison Foundation; DFCI Strategic Initiative; NATIONAL CANCER INSTITUTE [P50CA093683, R33CA128625, R01CA134502, K08CA115927, RC2CA148268] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Institutes for Biomedical Research; Melanoma Research Alliance; Starr Cancer Consortium; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Gottfried and Julia Bangerter Rhyner Stiftung; Ellison Foundation(Lawrence Ellison Foundation); DFCI Strategic Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Broad Institute/Novartis Cancer Cell Line Encyclopedia (CCLE) for contributing cell line genomic data, expression data and pharmacological cell line sensitivity data; J. Thibault and A. Shipway for CCLE related tissue culture; R. Depinho, G. Dunn, S. Ethier, H. Greulich, A. Henderson, D. Kaplan, R. Levine, C. Miller, H. Piwnica-Worms, H. Suzuki, M. Vigny, D. Vollrath and the Harvard Institute of Proteomics for contributing templates for the kinase collection; J. Du and D. B. Wheeler for assistance with functional testing of kinases; D. A. Barbie for helpful discussions, S. E. Moody and H. W. Cheung for technical assistance, and J. K. Grenier and S. J. Silver for compiling and annotating the list of kinases. This work was supported by the NIH Director's New Innovator Award (L. A. G.), grants from the Novartis Institutes for Biomedical Research (L. A. G.), Melanoma Research Alliance (L. A. G.), Starr Cancer Consortium(L. A. G.) the US National Cancer Institute (R33 CA128625, RC2 CA148268) (W. C. H.), NIH (CA134502) (J.J.Z) the Swiss National Foundation (310040-103671) (R. D.), the Gottfried and Julia Bangerter Rhyner Stiftung (R. D.) the Ellison Foundation (M. V. and CCSB) and institute sponsored research funds from the DFCI Strategic Initiative (M. V. and CCSB).	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Edlundh-Rose E, 2006, MELANOMA RES, V16, P471, DOI 10.1097/01.cmr.0000232300.22032.86; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; George D, 2008, BIOORG MED CHEM LETT, V18, P4952, DOI 10.1016/j.bmcl.2008.08.037; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Hirata K, 2010, BIOL PHARM BULL, V33, P133, DOI 10.1248/bpb.33.133; Hoeflich KP, 2009, CANCER RES, V69, P3042, DOI 10.1158/0008-5472.CAN-08-3563; Infante JR, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.2503; Karreth FA, 2009, MOL CELL, V36, P477, DOI 10.1016/j.molcel.2009.10.017; Lee KM, 2009, CANCER RES, V69, P8043, DOI 10.1158/0008-5472.CAN-09-2316; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Schwartz GK, 2009, J CLIN ONCOL, V27; Seth R, 2009, GUT, V58, P1234, DOI 10.1136/gut.2008.159137; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Tsatsanis C, 1998, ONCOGENE, V17, P2609, DOI 10.1038/sj.onc.1202460; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433	29	1100	1143	0	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					968	U370		10.1038/nature09627	http://dx.doi.org/10.1038/nature09627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21107320	Green Accepted			2022-12-28	WOS:000285344600048
J	Moellering, RC				Moellering, Robert C., Jr.			NDM-1 - A Cause for Worldwide Concern	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RESISTANCE		[Moellering, Robert C., Jr.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Moellering, Robert C., Jr.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Moellering, RC (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Morales G, 2010, CLIN INFECT DIS, V50, P821, DOI 10.1086/650574; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09	5	213	224	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2010	363	25					2377	2379		10.1056/NEJMp1011715	http://dx.doi.org/10.1056/NEJMp1011715			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZK	21158655				2022-12-28	WOS:000285340200001
J	Spanu, PD; Abbott, JC; Amselem, J; Burgis, TA; Soanes, DM; Stuber, K; van Themaat, EVL; Brown, JKM; Butcher, SA; Gurr, SJ; Lebrun, MH; Ridout, CJ; Schulze-Lefert, P; Talbot, NJ; Ahmadinejad, N; Ametz, C; Barton, GR; Benjdia, M; Bidzinski, P; Bindschedler, LV; Both, M; Brewer, MT; Cadle-Davidson, L; Cadle-Davidson, MM; Collemare, J; Cramer, R; Frenkel, O; Godfrey, D; Harriman, J; Hoede, C; King, BC; Klages, S; Kleemann, J; Knoll, D; Koti, PS; Kreplak, J; Lopez-Ruiz, FJ; Lu, XL; Maekawa, T; Mahanil, S; Micali, C; Milgroom, MG; Montana, G; Noir, S; O'Connell, RJ; Oberhaensli, S; Parlange, F; Pedersen, C; Quesneville, H; Reinhardt, R; Rott, M; Sacristan, S; Schmidt, SM; Schon, M; Skamnioti, P; Sommer, H; Stephens, A; Takahara, H; Thordal-Christensen, H; Vigouroux, M; Wessling, R; Wicker, T; Panstruga, R				Spanu, Pietro D.; Abbott, James C.; Amselem, Joelle; Burgis, Timothy A.; Soanes, Darren M.; Stueber, Kurt; van Themaat, Emiel Ver Loren; Brown, James K. M.; Butcher, Sarah A.; Gurr, Sarah J.; Lebrun, Marc-Henri; Ridout, Christopher J.; Schulze-Lefert, Paul; Talbot, Nicholas J.; Ahmadinejad, Nahal; Ametz, Christian; Barton, Geraint R.; Benjdia, Mariam; Bidzinski, Przemyslaw; Bindschedler, Laurence V.; Both, Maike; Brewer, Marin T.; Cadle-Davidson, Lance; Cadle-Davidson, Molly M.; Collemare, Jerome; Cramer, Rainer; Frenkel, Omer; Godfrey, Dale; Harriman, James; Hoede, Claire; King, Brian C.; Klages, Sven; Kleemann, Jochen; Knoll, Daniela; Koti, Prasanna S.; Kreplak, Jonathan; Lopez-Ruiz, Francisco J.; Lu, Xunli; Maekawa, Takaki; Mahanil, Siraprapa; Micali, Cristina; Milgroom, Michael G.; Montana, Giovanni; Noir, Sandra; O'Connell, Richard J.; Oberhaensli, Simone; Parlange, Francis; Pedersen, Carsten; Quesneville, Hadi; Reinhardt, Richard; Rott, Matthias; Sacristan, Soledad; Schmidt, Sarah M.; Schoen, Moritz; Skamnioti, Pari; Sommer, Hans; Stephens, Amber; Takahara, Hiroyuki; Thordal-Christensen, Hans; Vigouroux, Marielle; Wessling, Ralf; Wicker, Thomas; Panstruga, Ralph			Genome Expansion and Gene Loss in Powdery Mildew Fungi Reveal Tradeoffs in Extreme Parasitism	SCIENCE			English	Article							PLANT-PATHOGENS; VIRULENCE; PROTEINS	Powdery mildews are phytopathogens whose growth and reproduction are entirely dependent on living plant cells. The molecular basis of this life-style, obligate biotrophy, remains unknown. We present the genome analysis of barley powdery mildew, Blumeria graminis f.sp. hordei (Blumeria), as well as a comparison with the analysis of two powdery mildews pathogenic on dicotyledonous plants. These genomes display massive retrotransposon proliferation, genome-size expansion, and gene losses. The missing genes encode enzymes of primary and secondary metabolism, carbohydrate-active enzymes, and transporters, probably reflecting their redundancy in an exclusively biotrophic life-style. Among the 248 candidate effectors of pathogenesis identified in the Blumeria genome, very few (less than 10) define a core set conserved in all three mildews, suggesting that most effectors represent species-specific adaptations.	[Spanu, Pietro D.; Abbott, James C.; Burgis, Timothy A.; Butcher, Sarah A.; Ametz, Christian; Barton, Geraint R.; Both, Maike; Montana, Giovanni] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Amselem, Joelle; Collemare, Jerome; Hoede, Claire; Kreplak, Jonathan; Quesneville, Hadi] INRA, Unite Rech Genom Info, F-78026 Versailles, France; [Soanes, Darren M.; Talbot, Nicholas J.] Univ Exeter, Sch Biosci, Exeter, Devon, England; [Stueber, Kurt; van Themaat, Emiel Ver Loren; Schulze-Lefert, Paul; Ahmadinejad, Nahal; Benjdia, Mariam; Bidzinski, Przemyslaw; Kleemann, Jochen; Knoll, Daniela; Koti, Prasanna S.; Lu, Xunli; Maekawa, Takaki; Micali, Cristina; Noir, Sandra; O'Connell, Richard J.; Rott, Matthias; Schmidt, Sarah M.; Schoen, Moritz; Sommer, Hans; Stephens, Amber; Takahara, Hiroyuki; Wessling, Ralf; Panstruga, Ralph] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany; [Brown, James K. M.; Ridout, Christopher J.; Lopez-Ruiz, Francisco J.] John Innes Ctr, Dept Dis & Stress Biol, Norwich, Norfolk, England; [Gurr, Sarah J.; Skamnioti, Pari; Vigouroux, Marielle] Univ Oxford, Dept Plant Sci, Oxford, England; [Bindschedler, Laurence V.; Cramer, Rainer] Univ Reading, Dept Chem, Reading RG6 2AD, Berks, England; [Brewer, Marin T.; Frenkel, Omer; King, Brian C.; Milgroom, Michael G.] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14853 USA; [Cadle-Davidson, Lance; Cadle-Davidson, Molly M.; Harriman, James; Mahanil, Siraprapa] ARS, USDA, Grape Genet Res Unit, Geneva, NY 14853 USA; [Cadle-Davidson, Lance] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Geneva, NY 14456 USA; [Godfrey, Dale; Pedersen, Carsten; Thordal-Christensen, Hans] Univ Copenhagen, Fac Life Sci, Dept Agr & Ecol, Copenhagen, Denmark; [Klages, Sven; Reinhardt, Richard] Max Planck Inst Mol Genet, Berlin, Germany; [Oberhaensli, Simone; Parlange, Francis; Wicker, Thomas] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Sacristan, Soledad] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas UPM INIA, Madrid, Spain; [Sacristan, Soledad] Univ Politecn Madrid, ETSI Agronomos, Madrid, Spain; [Amselem, Joelle; Lebrun, Marc-Henri] INRA, Unite BIOGER CPP, Grignon, France	Imperial College London; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Exeter; Max Planck Society; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Oxford; University of Reading; Cornell University; United States Department of Agriculture (USDA); Cornell University; University of Copenhagen; Max Planck Society; University of Zurich; Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; INRAE	Spanu, PD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	p.spanu@imperial.ac.uk; panstrug@mpiz-koeln.mpg.de	Thordal-Christensen, Hans/F-6281-2014; Wicker, Thomas/Z-1978-2019; Talbot, Nicholas J/I-9584-2014; Montana, Giovanni/H-2598-2013; Talbot, Nicholas J/I-5618-2019; Quesneville, Hadi/AAG-1048-2020; Pedersen, Carsten/F-6797-2014; Spanu, Pietro/P-5859-2019; Ver Loren van Themaat, Emiel/F-2564-2012; Schulze-Lefert, Paul/B-6707-2011; King, Brian/K-2021-2016; Panstruga, Ralph/F-3340-2011; Pedersen, Carsten/L-7266-2013; Stephens, Amber/E-3287-2010; Bindschedler, Laurence/AAD-2936-2020; SACRISTAN, SOLEDAD/H-1062-2015	Thordal-Christensen, Hans/0000-0001-8813-0157; Talbot, Nicholas J/0000-0001-6434-7757; Talbot, Nicholas J/0000-0001-6434-7757; Quesneville, Hadi/0000-0003-3001-4908; Pedersen, Carsten/0000-0002-9520-2232; Spanu, Pietro/0000-0001-8928-6049; King, Brian/0000-0003-3954-5190; Panstruga, Ralph/0000-0002-3756-8957; Pedersen, Carsten/0000-0002-9520-2232; Bindschedler, Laurence/0000-0002-0421-9857; LEBRUN, marc-henri/0000-0003-1562-1902; Kreplak, Jonathan/0000-0001-5563-1932; Collemare, Jerome/0000-0001-8152-6642; Amselem, Joelle/0000-0001-7124-3454; Abbott, James/0000-0001-7701-4249; Benjdia, Mariam/0000-0003-1554-5452; , Thomas/0000-0002-6777-7135; Hoede, Claire/0000-0001-5054-7731; Reinhardt, Richard/0000-0001-9376-2132; Bidzinski, Przemyslaw/0000-0002-6057-2575; Brocke-Ahmadinejad, Nahal/0000-0002-7335-6564; Noir, Sandra/0000-0002-5666-2885; Ridout, Christopher/0000-0001-9287-938X; Cramer, Rainer/0000-0002-8037-2511; SACRISTAN, SOLEDAD/0000-0002-5753-2644	Biotechnology and Biological Sciences Research Council [BB/E0009831/1]; INRA; European Union; Deutsche Forschungsgemeinschaft [SPP1212]; Leverhulme Trust; Max Planck Society; BBSRC [BB/E00282X/1, BB/E002803/1, BB/E000983/1, BB/H001948/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H001948/1, BBS/E/J/00000605, BB/E00282X/1, BB/E002803/1, BB/E000983/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); INRA; European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leverhulme Trust(Leverhulme Trust); Max Planck Society(Max Planck SocietyFoundation CELLEX); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank B. Thomas, T. Carver, and D. Grunewald for providing scanning electron micrographs. This work was supported by funds from the Biotechnology and Biological Sciences Research Council [grant BB/E0009831/1], INRA, the BioExploit European Union Framework 6 project, Deutsche Forschungsgemeinschaft (priority program SPP1212), the Leverhulme Trust, and the Max Planck Society. GenBank project identification numbers are as follows: Blumeria, 28821; E. pisi, 50315; and G. orontii, 50317.	Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Catanzariti AM, 2006, PLANT CELL, V18, P243, DOI 10.1105/tpc.105.035980; Collemare J, 2008, MYCOL RES, V112, P207, DOI 10.1016/j.mycres.2007.08.003; Debuchy R, 2006, MYCOTA, P293, DOI DOI 10.1007/3-540-28135-5_15; Glawe DA, 2008, ANNU REV PHYTOPATHOL, V46, P27, DOI 10.1146/annurev.phyto.46.081407.104740; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Godfrey D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-317; MARSHALL CR, 1994, P NATL ACAD SCI USA, V91, P12283, DOI 10.1073/pnas.91.25.12283; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Mobius N, 2009, CURR OPIN PLANT BIOL, V12, P390, DOI 10.1016/j.pbi.2009.06.004; Panstruga R, 2009, SCIENCE, V324, P748, DOI 10.1126/science.1171652; Sacristan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007463; Takamatsu Susumu, 2004, Mycoscience, V45, P147, DOI 10.1007/s10267-003-0159-3; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625	14	516	555	7	199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1543	1546		10.1126/science.1194573	http://dx.doi.org/10.1126/science.1194573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148392				2022-12-28	WOS:000285153500066
J	Cannuscio, CC				Cannuscio, Carolyn C.			A Perfect Place to Die, Revisited	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												carolyncannu@gmail.com	Cannuscio, Carolyn/A-1123-2007						0	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2010	304	22					2452	2453		10.1001/jama.2010.1766	http://dx.doi.org/10.1001/jama.2010.1766			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691AS	21139101				2022-12-28	WOS:000285053300002
J	Gurumurthy, S; Xie, SZ; Alagesan, B; Kim, J; Yusuf, RZ; Saez, B; Tzatsos, A; Ozsolak, F; Milos, P; Ferrari, F; Park, PJ; Shirihai, OS; Scadden, DT; Bardeesy, N				Gurumurthy, Sushma; Xie, Stephanie Z.; Alagesan, Brinda; Kim, Judith; Yusuf, Rushdia Z.; Saez, Borja; Tzatsos, Alexandros; Ozsolak, Fatih; Milos, Patrice; Ferrari, Francesco; Park, Peter J.; Shirihai, Orian S.; Scadden, David T.; Bardeesy, Nabeel			The Lkb1 metabolic sensor maintains haematopoietic stem cell survival	NATURE			English	Article							PEUTZ-JEGHERS-SYNDROME; GLUCOSE-HOMEOSTASIS; TUMOR SUPPRESSION; IN-VIVO; PATHWAY; KINASE; MICE; APOPTOSIS; SYSTEM; ENERGY	Haematopoietic stem cells (HSCs) can convert between growth states that have marked differences in bioenergetic needs. Although often quiescent in adults, these cells become proliferative upon physiological demand. Balancing HSC energetics in response to nutrient availability and growth state is poorly understood, yet essential for the dynamism of the haematopoietic system. Here we show that the Lkb1 tumour suppressor is critical for the maintenance of energy homeostasis in haematopoietic cells. Lkb1 inactivation in adult mice causes loss of HSC quiescence followed by rapid depletion of all haematopoietic subpopulations. Lkb1-deficient bone marrow cells exhibit mitochondrial defects, alterations in lipid and nucleotide metabolism, and depletion of cellular ATP. The haematopoietic effects are largely independent of Lkb1 regulation of AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling. Instead, these data define a central role for Lkb1 in restricting HSC entry into cell cycle and in broadly maintaining energy homeostasis in haematopoietic cells through a novel metabolic checkpoint.	[Gurumurthy, Sushma; Xie, Stephanie Z.; Alagesan, Brinda; Kim, Judith; Yusuf, Rushdia Z.; Saez, Borja; Tzatsos, Alexandros; Scadden, David T.; Bardeesy, Nabeel] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Gurumurthy, Sushma; Xie, Stephanie Z.; Alagesan, Brinda; Kim, Judith; Yusuf, Rushdia Z.; Saez, Borja; Tzatsos, Alexandros; Scadden, David T.; Bardeesy, Nabeel] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Gurumurthy, Sushma; Xie, Stephanie Z.; Alagesan, Brinda; Kim, Judith; Yusuf, Rushdia Z.; Saez, Borja; Tzatsos, Alexandros; Scadden, David T.; Bardeesy, Nabeel] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Xie, Stephanie Z.; Yusuf, Rushdia Z.; Saez, Borja; Scadden, David T.] Harvard Univ, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Xie, Stephanie Z.; Yusuf, Rushdia Z.; Saez, Borja; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Boston, MA 02115 USA; [Ozsolak, Fatih; Milos, Patrice] Hel BioSci Corp, Cambridge, MA 02139 USA; [Ferrari, Francesco; Park, Peter J.] Childrens Hosp, Ctr Biomed Informat, Boston, MA 02115 USA; [Ferrari, Francesco; Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Ferrari, Francesco; Park, Peter J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Shirihai, Orian S.] Boston Univ, Med Ctr, Mitochondria ARC, Evans Res Ctr,Dept Med, Boston, MA 02118 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Boston University	Bardeesy, N (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.	Scadden.David@MGH.Harvard.edu; Bardeesy.Nabeel@MGH.Harvard.edu	Ferrari, Francesco/H-5007-2012; Saez, Borja/L-7411-2015	Ferrari, Francesco/0000-0002-9811-3753; Saez, Borja/0000-0001-7908-7089; Park, Peter/0000-0001-9378-960X; Shirihai, Orian/0000-0002-9502-2661; Xie, Stephanie/0000-0002-0284-494X	NIH [U01 CA141576-01, DK050234]; Ellison Medical Foundation; Massachusetts Biotechnology Research Council; NATIONAL CANCER INSTITUTE [U01CA141576] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Massachusetts Biotechnology Research Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank the Harvard Stem Cell Institute Flow Cytometry Core and D. Brown and the MGH Electron Microscope Imaging Core for expertise and advice. V. Levy and M. Leisa provided technical assistance in the SeaHorse measurements. D. Van Buren provided advice and assistance in pilot experiments. We thank A. Camacho for mouse colony assistance. We would also like to thank A. Kimmelman, R. Mostoslavsky, M. Vander Heiden, L. Ellisen, W. Kim and M. Ivan for discussions and critical review of the manuscript. We are grateful to S. Morrison and R. DePinho for sharing unpublished data. N.B. would like to acknowledge support from NIH U01 CA141576-01. D.T.S would like to acknowledge support from NIH DK050234 and Ellison Medical Foundation. S.G. was supported by a Massachusetts Biotechnology Research Council Tosteson Fellowship. S.Z.X. was supported by an NIH Ruth L. Kirschstein National Research Service Award.	Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Contreras CM, 2008, CANCER RES, V68, P759, DOI 10.1158/0008-5472.CAN-07-5014; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gurumurthy S, 2008, CANCER RES, V68, P55, DOI 10.1158/0008-5472.CAN-07-3225; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ito K, 2007, J IMMUNOL, V178, P103, DOI 10.4049/jimmunol.178.1.103; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Klimova TA, 2009, FASEB J, V23, P783, DOI 10.1096/fj.08-114256; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Koh HJ, 2010, P NATL ACAD SCI USA, V107, P15541, DOI 10.1073/pnas.1008131107; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Torchia EC, 2007, MOL CELL BIOL, V27, P7918, DOI 10.1128/MCB.00099-07; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09	35	298	313	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					659	U75		10.1038/nature09572	http://dx.doi.org/10.1038/nature09572			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124451	Green Accepted			2022-12-28	WOS:000284836700033
J	Kim, YK; Heo, I; Kim, VN				Kim, Young-Kook; Heo, Inha; Kim, V. Narry			Modifications of Small RNAs and Their Associated Proteins	CELL			English	Review							PIWI-INTERACTING RNAS; EMBRYONIC STEM-CELLS; CAENORHABDITIS-ELEGANS; MICRORNA BIOGENESIS; 3' ADENYLATION; URIDYLATION; MIRNAS; SIRNAS; LIN28; PHOSPHORYLATION	Small regulatory RNAs and their associated proteins are subject to diverse modifications that can impinge on their abundance and function. Some of the modifications are under the influence of cellular signaling, thus contributing to the dynamic regulation of RNA silencing.	[Kim, Young-Kook; Heo, Inha; Kim, V. Narry] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Kim, Young-Kook; Heo, Inha; Kim, V. Narry] Seoul Natl Univ, Ctr Natl Creat Res, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, VN (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	narrykim@snu.ac.kr	Kim, Young-Kook/AAE-8306-2020	Kim, Young-Kook/0000-0001-6434-2235; Kim, Young Kook/0000-0002-6037-8449	National Research Foundation of Korea (NRF) [20100000021, 20100020415]; Ministry of Education, Science and Technology of Korea	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank members of V.N.K.'s laboratory for helpful discussions and comments. This work was supported by the Creative Research Initiatives Program (20100000021) and the National Honor Scientist Program (20100020415) through the National Research Foundation of Korea (NRF) and the BK21 Research Fellowships (I.H.) from the Ministry of Education, Science and Technology of Korea. We apologize to authors whose work has not been covered because of space limitations.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Das SK, 2010, P NATL ACAD SCI USA, V107, P11948, DOI 10.1073/pnas.0914143107; Gy I, 2007, PLANT CELL, V19, P3451, DOI 10.1105/tpc.107.055319; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V139, P28, DOI 10.1016/j.cell.2009.09.013; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Ibrahim F, 2010, P NATL ACAD SCI USA, V107, P3906, DOI 10.1073/pnas.0912632107; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Kamminga LM, 2010, EMBO J, V29, P3688, DOI 10.1038/emboj.2010.233; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kirino Y, 2007, RNA, V13, P1397, DOI 10.1261/rna.659307; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lu SF, 2009, NUCLEIC ACIDS RES, V37, P1878, DOI 10.1093/nar/gkp031; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Ohara T, 2007, NAT STRUCT MOL BIOL, V14, P349, DOI 10.1038/nsmb1220; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Siomi MC, 2010, GENE DEV, V24, P636, DOI 10.1101/gad.1899210; Tang XL, 2010, NUCLEIC ACIDS RES, V38, P6610, DOI 10.1093/nar/gkq547; van Wolfswinkel JC, 2009, CELL, V139, P135, DOI 10.1016/j.cell.2009.09.012; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zeng Y, 2008, BIOCHEM J, V413, P429, DOI 10.1042/BJ20080599	54	134	140	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					703	709		10.1016/j.cell.2010.11.018	http://dx.doi.org/10.1016/j.cell.2010.11.018			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111232	Bronze			2022-12-28	WOS:000284583500013
J	Luk, E; Ranjan, A; FitzGerald, PC; Mizuguchi, G; Huang, Y; Wei, D; Wu, C				Luk, Ed; Ranjan, Anand; FitzGerald, Peter C.; Mizuguchi, Gaku; Huang, Yingzi; Wei, Debbie; Wu, Carl			Stepwise Histone Replacement by SWR1 Requires Dual Activation with Histone H2A.Z and Canonical Nucleosome	CELL			English	Article							VARIANT H2A.Z; CHROMATIN; TRANSCRIPTION; REPLICATION; PROMOTERS; EXCHANGE; COMPLEX; ACETYLATION; STABILITY; DYNAMICS	Histone variant H2A.Z-containing nucleosomes are incorporated at most eukaryotic promoters. This incorporation is mediated by the conserved SWR1 complex, which replaces histone H2A in canonical nucleosomes with H2A.Z in an ATP-dependent manner. Here, we show that promoter-proximal nucleosomes are highly heterogeneous for H2A.Z in Saccharomyces cerevisiae, with substantial representation of nucleosomes containing one, two, or zero H2A.Z molecules. SWR1-catalyzed H2A.Z replacement in vitro occurs in a stepwise and unidirectional fashion, one H2A.Z-H2B dimer at a time, producing heterotypic nucleosomes as intermediates and homotypic H2A.Z nucleosomes as end products. The ATPase activity of SWR1 is specifically stimulated by H2A-containing nucleosomes without ensuing histone H2A eviction. Remarkably, further addition of free H2A.Z-H2B dimer leads to hyperstimulation of ATPase activity, eviction of nucleosomal H2A-H2B, and deposition of H2A.Z-H2B. These results suggest that the combination of H2A-containing nucleosome and free H2A.Z-H2B dimer acting as both effector and substrate for SWR1 governs the specificity and outcome of the replacement reaction.	[Luk, Ed; Ranjan, Anand; Mizuguchi, Gaku; Huang, Yingzi; Wei, Debbie; Wu, Carl] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [FitzGerald, Peter C.] NCI, Genome Anal Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Luk, E (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	luked@mail.nih.gov; carlwu@helix.nih.gov		Luk, Ed/0000-0002-6619-2258	National Cancer Institute; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [ZIABC005263] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W.H. Wu for the yeast strain SWR1-FL htz1 Delta and J. Landry for the yeast strain yJL036. We also thank H. Cam and C. Rubin for advice on microarray techniques, F. Pugh and members of the Wu lab for critical reading of the manuscript, and anonymous reviewers for helpful suggestions. This work was supported by the intramural research program of the National Cancer Institute (C.W.) and by the Leukemia and Lymphoma Society (E.L. and A.R.).	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Altaf M, 2010, J BIOL CHEM, V285, P15966, DOI 10.1074/jbc.M110.117069; Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; Barbaric S, 2007, J BIOL CHEM, V282, P27610, DOI 10.1074/jbc.M700623200; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; CARR AM, 1994, MOL GEN GENET, V245, P628, DOI 10.1007/BF00282226; Chakravarthy S, 2004, COLD SPRING HARB SYM, V69, P227, DOI 10.1101/sqb.2004.69.227; Corpet A, 2009, TRENDS CELL BIOL, V19, P29, DOI 10.1016/j.tcb.2008.10.002; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Gutierrez JL, 2007, EMBO J, V26, P730, DOI 10.1038/sj.emboj.7601524; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Jackson JD, 2000, NUCLEIC ACIDS RES, V28, P3811, DOI 10.1093/nar/28.19.3811; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Smith CL, 2005, MOL CELL BIOL, V25, P5880, DOI 10.1128/MCB.25.14.5880-5892.2005; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; WEST MHP, 1980, BIOCHEMISTRY-US, V19, P3238, DOI 10.1021/bi00555a022; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yoshida T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000910; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zlatanova J, 2008, STRUCTURE, V16, P166, DOI 10.1016/j.str.2007.12.008; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	50	154	158	3	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					725	736		10.1016/j.cell.2010.10.019	http://dx.doi.org/10.1016/j.cell.2010.10.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111233	Green Accepted			2022-12-28	WOS:000284583500015
J	Ozsolak, F; Kapranov, P; Foissac, S; Kim, SW; Fishilevich, E; Monaghan, AP; John, B; Milos, PM				Ozsolak, Fatih; Kapranov, Philipp; Foissac, Sylvain; Kim, Sang Woo; Fishilevich, Elane; Monaghan, A. Paula; John, Bino; Milos, Patrice M.			Comprehensive Polyadenylation Site Maps in Yeast and Human Reveal Pervasive Alternative Polyadenylation	CELL			English	Article							MESSENGER-RNA POLYADENYLATION; NONCODING RNAS; BIDIRECTIONAL PROMOTERS; GENE-EXPRESSION; TRANSCRIPTION; POLY(A); DNA; POLYMERASE; SEQUENCE; CLEAVAGE	The emerging discoveries on the link between polyadenylation and disease states underline the need to fully characterize genome-wide polyadenylation states. Here, we report comprehensive maps of global polyadenylation events inhuman and yeast generated using refinements to the Direct RNA Sequencing technology. This direct approach provides a quantitative view of genome-wide polyadenylation states in a strand-specific manner and requires only attomole RNA quantities. The polyadenylation profiles revealed an abundance of unannotated polyadenylation sites, alternative polyadenylation patterns, and regulatory element-associated poly(A)(+) RNAs. We observed differences in sequence composition surrounding canonical and noncanonical human polyadenylation sites, suggesting novel noncoding RNA-specific polyadenylation mechanisms in humans. Furthermore, we observed the correlation level between sense and antisense transcripts to depend on gene expression levels, supporting the view that overlapping transcription from opposite strands may play a regulatory role. Our data provide a comprehensive view of the polyadenylation state and overlapping transcription.	[Ozsolak, Fatih; Kapranov, Philipp; Milos, Patrice M.] Helicos BioSci Corp, Cambridge, MA 02139 USA; [Foissac, Sylvain] Integromics, Madrid 28760, Spain; [Kim, Sang Woo; Fishilevich, Elane; John, Bino] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Monaghan, A. Paula] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ozsolak, F (corresponding author), Helicos BioSci Corp, Cambridge, MA 02139 USA.	fatihozsolak@gmail.com; pmilos@helicosbio.com		Kim, Sang Woo/0000-0002-3144-4822; Kapranov, Philipp/0000-0003-2647-4856; Foissac, Sylvain/0000-0002-2631-5356	National Human Genome Research Institute [R01-HG005230]; National Institutes of Health [GM079756, MH60774]; American Cancer Society [RSG0905401]; Spanish Ministry of Science and Innovation-FEDER (CDTI) [IDI-20091293]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060774] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Spanish Ministry of Science and Innovation-FEDER (CDTI); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank our Helicos and Integromics colleagues for technical assistance and discussions. This work was supported by the National Human Genome Research Institute (grant R01-HG005230 to F.O. and P.M.M.). B.J. is supported by the National Institutes of Health (grant GM079756) and the American Cancer Society (grant RSG0905401), A.P.M. is supported by the National Institutes of Health (grant MH60774), and S.F. is supported by the Spanish Ministry of Science and Innovation-FEDER (CDTI loan IDI-20091293). F.O., P.K., and P.M.M. are employees of Helicos BioSciences Corporation. S.F. is an employee of Integromics.	Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bennett CL, 2001, IMMUNOGENETICS, V53, P435, DOI 10.1007/s002510100358; BHAT BM, 1987, J VIROL, V61, P3938, DOI 10.1128/JVI.61.12.3938-3945.1987; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; Buratowski S, 2008, SCIENCE, V322, P1804, DOI 10.1126/science.1168805; Chen JJ, 2005, TRENDS GENET, V21, P326, DOI 10.1016/j.tig.2005.04.006; Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Costessi L, 2006, NUCLEIC ACIDS RES, V34, P243, DOI 10.1093/nar/gkj425; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Gehring NH, 2001, NAT GENET, V28, P389, DOI 10.1038/ng578; Graber JH, 2002, NUCLEIC ACIDS RES, V30, P1851, DOI 10.1093/nar/30.8.1851; GUBLER U, 1987, METHOD ENZYMOL, V152, P330; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; HIGGS DR, 1983, NATURE, V306, P398, DOI 10.1038/306398a0; Iseli C, 2002, GENOME RES, V12, P1068, DOI 10.1101/gr.62002; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kapranov P, 2010, NATURE, V466, P642, DOI 10.1038/nature09190; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; Lee J, 2007, PLOS COMPUT BIOL, V3, P721, DOI 10.1371/journal.pcbi.0030067; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Liu DL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-77; Lopez F, 2006, RNA, V12, P1794, DOI 10.1261/rna.136206; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Mahadevan S, 1997, GENE, V190, P69, DOI 10.1016/S0378-1119(96)00708-1; Mamanova L, 2010, NAT METHODS, V7, P130, DOI [10.1038/NMETH.1417, 10.1038/nmeth.1417]; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Mondal N, 2001, NATURE, V413, P435, DOI 10.1038/35096590; MOREIRA A, 1995, EMBO J, V14, P3809, DOI 10.1002/j.1460-2075.1995.tb00050.x; Muro EM, 2008, P NATL ACAD SCI USA, V105, P20286, DOI 10.1073/pnas.0807813105; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; ORKIN SH, 1985, EMBO J, V4, P453, DOI 10.1002/j.1460-2075.1985.tb03650.x; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; QianWu J, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-1-r3, 10.1186/gb-2008-9-5-220]; Rigault C, 2006, BBA-MOL CELL BIOL L, V1761, P1469, DOI 10.1016/j.bbalip.2006.09.014; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Slomovic S, 2010, P NATL ACAD SCI USA, V107, P7407, DOI 10.1073/pnas.0910621107; Slomovic S, 2008, METHOD ENZYMOL, V447, P501, DOI 10.1016/S0076-6879(08)02224-6; SPIEGELMAN S, 1970, NATURE, V227, P1029, DOI 10.1038/2271029a0; SPITZNER JR, 1988, NUCLEIC ACIDS RES, V16, P5533, DOI 10.1093/nar/16.12.5533; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Teixeira A, 2004, NATURE, V432, P526, DOI 10.1038/nature03032; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tian B, 2007, GENOME RES, V17, P156, DOI 10.1101/gr.5532707; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yoon OK, 2010, RNA, V16, P1256, DOI 10.1261/rna.2038810; Zhang HB, 2005, NUCLEIC ACIDS RES, V33, pD116, DOI 10.1093/nar/gki055; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	69	288	301	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					1018	1029		10.1016/j.cell.2010.11.020	http://dx.doi.org/10.1016/j.cell.2010.11.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145465	Green Accepted, Bronze			2022-12-28	WOS:000285182600017
J	de Gonzalez, AB; Hartge, P; Cerhan, JR; Flint, AJ; Hannan, L; MacInnis, RJ; Moore, SC; Tobias, GS; Anton-Culver, H; Freeman, LB; Beeson, WL; Clipp, SL; English, DR; Folsom, AR; Freedman, DM; Giles, G; Hakansson, N; Henderson, KD; Hoffman-Bolton, J; Hoppin, JA; Koenig, KL; Lee, IM; Linet, MS; Park, Y; Pocobelli, G; Schatzkin, A; Sesso, HD; Weiderpass, E; Willcox, BJ; Wolk, A; Zeleniuch-Jacquotte, A; Willett, WC; Thun, MJ				de Gonzalez, Amy Berrington; Hartge, Patricia; Cerhan, James R.; Flint, Alan J.; Hannan, Lindsay; MacInnis, Robert J.; Moore, Steven C.; Tobias, Geoffrey S.; Anton-Culver, Hoda; Freeman, Laura Beane; Beeson, W. Lawrence; Clipp, Sandra L.; English, Dallas R.; Folsom, Aaron R.; Freedman, D. Michal; Giles, Graham; Hakansson, Niclas; Henderson, Katherine D.; Hoffman-Bolton, Judith; Hoppin, Jane A.; Koenig, Karen L.; Lee, I-Min; Linet, Martha S.; Park, Yikyung; Pocobelli, Gaia; Schatzkin, Arthur; Sesso, Howard D.; Weiderpass, Elisabete; Willcox, Bradley J.; Wolk, Alicja; Zeleniuch-Jacquotte, Anne; Willett, Walter C.; Thun, Michael J.			Body-Mass Index and Mortality among 1.46 Million White Adults.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-DOSE ASPIRIN; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; BREAST-CANCER; PREDICTING MORTALITY; PHYSICAL-ACTIVITY; RANDOMIZED-TRIAL; WOMENS HEALTH; BETA-CAROTENE; EARLY MARKER	Background: A high body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) is associated with increased mortality from cardiovascular disease and certain cancers, but the precise relationship between BMI and all-cause mortality remains uncertain. Methods: We used Cox regression to estimate hazard ratios and 95% confidence intervals for an association between BMI and all-cause mortality, adjusting for age, study, physical activity, alcohol consumption, education, and marital status in pooled data from 19 prospective studies encompassing 1.46 million white adults, 19 to 84 years of age (median, 58). Results: The median baseline BMI was 26.2. During a median follow-up period of 10 years (range, 5 to 28), 160,087 deaths were identified. Among healthy participants who never smoked, there was a J-shaped relationship between BMI and all-cause mortality. With a BMI of 22.5 to 24.9 as the reference category, hazard ratios among women were 1.47 (95 percent confidence interval [CI], 1.33 to 1.62) for a BMI of 15.0 to 18.4; 1.14 (95% CI, 1.07 to 1.22) for a BMI of 18.5 to 19.9; 1.00 (95% CI, 0.96 to 1.04) for a BMI of 20.0 to 22.4; 1.13 (95% CI, 1.09 to 1.17) for a BMI of 25.0 to 29.9; 1.44 (95% CI, 1.38 to 1.50) for a BMI of 30.0 to 34.9; 1.88 (95% CI, 1.77 to 2.00) for a BMI of 35.0 to 39.9; and 2.51 (95% CI, 2.30 to 2.73) for a BMI of 40.0 to 49.9. In general, the hazard ratios for the men were similar. Hazard ratios for a BMI below 20.0 were attenuated with longer-term follow-up. Conclusions: In white adults, overweight and obesity (and possibly underweight) are associated with increased all-cause mortality. All-cause mortality is generally lowest with a BMI of 20.0 to 24.9. N Engl J Med 2010;363:2211-9.	[de Gonzalez, Amy Berrington] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Cerhan, James R.] Mayo Clin, Coll Med, Div Epidemiol, Rochester, MN USA; [Flint, Alan J.; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Sesso, Howard D.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Sesso, Howard D.] Brigham & Womens Hosp, Div Aging, Boston, MA 02115 USA; [Lee, I-Min] Harvard Univ, Sch Med, Boston, MA USA; [Hannan, Lindsay; Thun, Michael J.] Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; [MacInnis, Robert J.; English, Dallas R.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Giles, Graham] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [MacInnis, Robert J.] Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Cambridge, England; [Anton-Culver, Hoda] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA; [Beeson, W. Lawrence] Loma Linda Univ, Sch Publ Hlth, Loma Linda, CA 92350 USA; [Henderson, Katherine D.] City Hope Natl Med Ctr, Dept Populat Sci, Duarte, CA 91010 USA; [Clipp, Sandra L.; Hoffman-Bolton, Judith] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Hakansson, Niclas; Wolk, Alicja] Karolinska Inst, Natl Inst Environm Med, Div Nutr Epidemiol, Stockholm, Sweden; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hoppin, Jane A.] Natl Inst Environm Hlth Sci, Epidemiol Branch, Res Triangle Pk, NC USA; [Koenig, Karen L.; Zeleniuch-Jacquotte, Anne] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Pocobelli, Gaia] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Pocobelli, Gaia] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98104 USA; [Weiderpass, Elisabete] Canc Registry Norway, Oslo, Norway; [Weiderpass, Elisabete] Dept Community Med, Tromso, Norway; [Weiderpass, Elisabete] Samfundet Folkhalsan, Helsinki, Finland; [Willcox, Bradley J.] Pacific Hlth Res Inst, Honolulu, HI USA; [Willcox, Bradley J.] Queens Med Ctr, Honolulu, HI USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; American Cancer Society; University of Melbourne; Cancer Council Victoria; Cancer Research UK; University of Cambridge; University of California System; University of California Irvine; Loma Linda University; City of Hope; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Minnesota System; University of Minnesota Twin Cities; Karolinska Institutet; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); New York University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Oslo; Samfundet Folkhalsan; Pacific Health Research & Education Institute; The Queen's Medical Center	de Gonzalez, AB (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Rm 7034,6120 Execut Blvd, Bethesda, MD 20892 USA.	berringtona@mail.nih.gov	Weiderpass, Elisabete/AAP-2747-2021; Håkansson, Niclas/L-7913-2013; Tobias, Geoffrey S/M-4135-2016; Moore, Steven/D-8760-2016; de gonzalez, amy berrington/L-7017-2017; Weiderpass, Elisabete/M-4029-2016; English, Dallas/AAH-5005-2019; Lee, I-Min/ABD-5409-2021; Freeman, Laura E. Beane/C-4468-2015	Weiderpass, Elisabete/0000-0003-2237-0128; Håkansson, Niclas/0000-0001-7673-5554; Tobias, Geoffrey S/0000-0002-2878-8253; Moore, Steven/0000-0002-8169-1661; de gonzalez, amy berrington/0000-0002-7332-8387; Weiderpass, Elisabete/0000-0003-2237-0128; English, Dallas/0000-0001-7828-8188; Freeman, Laura E. Beane/0000-0003-1294-4124; Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303; Hoppin, Jane/0000-0001-8456-0969; Giles, Graham/0000-0003-4946-9099; Cerhan, James/0000-0002-7482-178X; Park, Yikyung/0000-0002-6281-489X; MacInnis, Robert/0000-0002-1627-5047	National Institutes of Health (NIH); Division of Cancer Control and Population Sciences, National Cancer Institute (NCI), NIH; Iovate Health Sciences USA; NATIONAL CANCER INSTITUTE [R01CA077398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049030] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Cancer Control and Population Sciences, National Cancer Institute (NCI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); Iovate Health Sciences USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the Intramural Research Program of the National Institutes of Health (NIH) and the Division of Cancer Control and Population Sciences, National Cancer Institute (NCI), NIH. Details regarding funding for the individual studies are listed in the Supplementary Appendix.; Dr. Sesso reports receiving consulting fees from Iovate Health Sciences USA. No other potential conflict of interest relevant to this article was reported.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Alavanja MCR, 1996, ENVIRON HEALTH PERSP, V104, P362, DOI 10.2307/3432672; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BEESON WL, 1989, CANCER, V64, P570, DOI 10.1002/1097-0142(19890801)64:3<570::AID-CNCR2820640303>3.0.CO;2-4; Bernstein L, 2002, CANCER CAUSE CONTROL, V13, P625, DOI 10.1023/A:1019552126105; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Comstock GW, 1997, CANCER EPIDEM BIOMAR, V6, P907; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; *DEP HLTH HUM SERV, 2006, NAT HLTH NUTR EX SUR; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; FOLSOM AR, 1993, JAMA-J AM MED ASSOC, V269, P1254; FOLSOM AR, 1993, JAMA-J AM MED ASSOC, V269, P483, DOI 10.1001/jama.269.4.483; Freedman DM, 2006, INT J OBESITY, V30, P822, DOI 10.1038/sj.ijo.0803193; Giles G G, 2002, IARC Sci Publ, V156, P69; Hayes RB, 2005, MUTAT RES-FUND MOL M, V592, P147, DOI 10.1016/j.mrfmmm.2005.06.013; Hayes RB, 2000, CONTROL CLIN TRIALS, V21, p349S, DOI 10.1016/S0197-2456(00)00101-X; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; *INT OB TASK FORC, GLOB PREV AD OB; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Manson JE, 2007, J WOMENS HEALTH, V16, P168, DOI 10.1089/jwh.2006.0080; Moore SC, 2008, INT J OBESITY, V32, P730, DOI 10.1038/sj.ijo.0803801; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Orpana HM, 2010, OBESITY, V18, P214, DOI 10.1038/oby.2009.191; Orsini N, 2008, J INTERN MED, V264, P442, DOI 10.1111/j.1365-2796.2008.01985.x; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Pischon T, 2010, NEW ENGL J MED, V362, P2433; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; SAS, 2009, SAS VERS 9 0; SCHAIRER C, 1994, CANCER CAUSE CONTROL, V5, P491, DOI 10.1007/BF01831376; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Stewart ST, 2009, NEW ENGL J MED, V361, P2252, DOI 10.1056/NEJMsa0900459; Takkouche B, 1999, AM J EPIDEMIOL, V150, P206; TONIOLO PG, 1995, JNCI-J NATL CANCER I, V87, P190, DOI 10.1093/jnci/87.3.190; Weiderpass E, 2004, CANCER EPIDEM BIOMAR, V13, P1121; White E, 2004, AM J EPIDEMIOL, V159, P83, DOI 10.1093/aje/kwh010; Whitlock G, 2009, LANCET, V374, P114, DOI 10.1016/S0140-6736(09)61280-0; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2004, LANCET, V363, P902; Wolk A, 2006, JAMA-J AM MED ASSOC, V296, P1371, DOI 10.1001/jama.296.11.1371	44	1525	1557	3	130	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2211	2219		10.1056/NEJMoa1000367	http://dx.doi.org/10.1056/NEJMoa1000367			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EP	21121834	Green Accepted, Bronze			2022-12-28	WOS:000284832900008
J	Landgren, O; Waxman, AJ				Landgren, Ola; Waxman, Adam Justin			Multiple Myeloma Precursor Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNDETERMINED SIGNIFICANCE MGUS; INDEPENDENT RISK-FACTOR; LIGHT-CHAIN RATIO; MONOCLONAL GAMMOPATHY; WHOLE-BODY; IMAGING TECHNIQUES; WORKING GROUP; PROGRESSION; DIAGNOSIS; PREVALENCE	Recent data indicate that multiple myeloma is consistently preceded by the precursor states of monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma. Currently, multiple myeloma is a clinical diagnosis based on manifestations including hypercalcemia, renal failure, anemia, and bone lesions, whereas MGUS and smoldering myeloma are diagnosed based on laboratory abnormalities. Current clinical markers allow for more individualized risk stratification and counseling of these patients. However, there is a dearth of biomarkers and molecular imaging techniques capable of (1) accurately identifying patients with disease biology corresponding with high risk of progression; (2) elucidating the mechanism of transformation to multiple myeloma; and (3) forming a framework for development of targeted therapies. This case presentation and review discusses the current understanding of myeloma precursor disease and future opportunities for improving personalized management of patients with MGUS or smoldering myeloma, as well as the potential for developing early treatment strategies designed to delay and prevent development of multiple myeloma. JAMA. 2010;304(21):2397-2404 www.jama.com	[Landgren, Ola] NCI, NIH, Ctr Canc Res, Med Oncol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Landgren, O (corresponding author), NCI, NIH, Ctr Canc Res, Med Oncol Branch, 900 Rockville Pike,Bldg 10,Room 13N240, Bethesda, MD 20892 USA.	landgreo@mail.nih.gov			National Cancer Institute of the National Institutes of Health	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research for this article was supported by the Intramural Research Program of the National Cancer Institute of the National Institutes of Health.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bauerle T, 2009, RADIOLOGY, V252, P477, DOI 10.1148/radiol.2522081756; Balakumaran A, 2010, EXPERT REV MOL DIAGN, V10, P465, DOI [10.1586/erm.10.31, 10.1586/ERM.10.31]; Barlogie B, 2008, BLOOD, V112, P3122, DOI 10.1182/blood-2008-06-164228; Bartel TB, 2009, BLOOD, V114, P2068, DOI 10.1182/blood-2009-03-213280; Bataille R, 1996, BLOOD, V87, P4762, DOI 10.1182/blood.V87.11.4762.bloodjournal87114762; Bergsagel PL, 2005, BLOOD, V106, P296, DOI 10.1182/blood-2005-01-0034; CATOVSKY D, 1970, BRIT MED J, V3, P438, DOI 10.1136/bmj.3.5720.438; Chiecchio L, 2006, LEUKEMIA, V20, P1610, DOI 10.1038/sj.leu.2404304; Chng WJ, 2007, BEST PRACT RES CL HA, V20, P571, DOI 10.1016/j.beha.2007.08.004; Dimopoulos M, 2009, LEUKEMIA, V23, P1545, DOI 10.1038/leu.2009.89; Dispenzieri A, 2008, BLOOD, V111, P785, DOI 10.1182/blood-2007-08-108357; Dispenzieri A, 2010, LANCET, V375, P1721, DOI 10.1016/S0140-6736(10)60482-5; Fonseca R, 2002, BLOOD, V100, P1417, DOI 10.1182/blood.V100.4.1417.h81602001417_1417_1424; Gleeson TG, 2009, SKELETAL RADIOL, V38, P225, DOI 10.1007/s00256-008-0607-4; Hillengass J, 2010, J CLIN ONCOL, V28, P1606, DOI 10.1200/JCO.2009.25.5356; Hillengass J, 2009, CLIN CANCER RES, V15, P3118, DOI 10.1158/1078-0432.CCR-08-2310; HJORTH M, 1993, EUR J HAEMATOL, V50, P95; Horger M, 2005, EUR J RADIOL, V54, P289, DOI 10.1016/j.ejrad.2004.04.015; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kristinsson SY, 2010, BLOOD, V116, P2651, DOI 10.1182/blood-2010-04-282848; Kristinsson SY, 2010, BLOOD, V115, P4991, DOI 10.1182/blood-2009-11-252072; Kristinsson SY, 2007, J CLIN ONCOL, V25, P1993, DOI 10.1200/JCO.2006.09.0100; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Kyle RA, 2010, LEUKEMIA, V24, P1121, DOI 10.1038/leu.2010.60; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; KYLE RA, 1978, AM J MED, V64, P814, DOI 10.1016/0002-9343(78)90522-3; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Kyle RA, 2006, NEW ENGL J MED, V354, P1362, DOI 10.1056/NEJMoa054494; KYLE RA, 1980, NEW ENGL J MED, V302, P1347, DOI 10.1056/NEJM198006123022405; Kyle RA, 2007, NEW ENGL J MED, V356, P2582, DOI 10.1056/NEJMoa070389; Landgren O, 2007, MAYO CLIN PROC, V82, P1468, DOI 10.4065/82.12.1468; Landgren O, 2010, BLOOD, V116, P1056, DOI 10.1182/blood-2010-01-262394; Landgren O, 2009, BLOOD, V113, P5412, DOI 10.1182/blood-2008-12-194241; Ludwig H, 2010, BLOOD, V115, P4975, DOI 10.1182/blood-2010-04-276345; Mailankody S, 2010, LEUKEMIA LYMPHOMA, V51, P2159, DOI 10.3109/10428194.2010.525725; Mantovani A, 2006, LEUKEMIA, V20, P937, DOI 10.1038/sj.leu.2404229; Mateos MVL-CL, 2009, 51 AM SOC HEM ANN M; Melton LJ, 2004, J BONE MINER RES, V19, P25, DOI 10.1359/JBMR.0301212; Mulligan ME, 2007, SKELETAL RADIOL, V36, P5, DOI 10.1007/s00256-006-0184-3; Musto P, 2008, CANCER-AM CANCER SOC, V113, P1588, DOI 10.1002/cncr.23783; Nau KC, 2008, AM FAM PHYSICIAN, V78, P853; Perez-Persona E, 2007, BLOOD, V110, P2586, DOI 10.1182/blood-2007-05-088443; Politou M, 2004, BRIT J HAEMATOL, V126, P686, DOI 10.1111/j.1365-2141.2004.05092.x; Rajkumar SV, 2007, BLOOD REV, V21, P255, DOI 10.1016/j.blre.2007.01.002; Rajkumar SV, 2005, BLOOD, V106, P812, DOI 10.1182/blood-2005-03-1038; Weiss BM, 2009, BLOOD, V113, P5418, DOI 10.1182/blood-2008-12-195008	48	37	38	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2010	304	21					2397	2404		10.1001/jama.2010.1713	http://dx.doi.org/10.1001/jama.2010.1713			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687FH	21119086	Green Accepted			2022-12-28	WOS:000284763900021
J	Ben-Shem, A; Jenner, L; Yusupova, G; Yusupov, M				Ben-Shem, Adam; Jenner, Lasse; Yusupova, Gulnara; Yusupov, Marat			Crystal Structure of the Eukaryotic Ribosome	SCIENCE			English	Article							TRANSFER-RNA; TRANSLATION INITIATION; MESSENGER-RNA; ANGSTROM RESOLUTION; 70S RIBOSOME; 80S RIBOSOME; E-SITE; SUBUNIT; TRANSLOCATION; MOVEMENT	Crystal structures of prokaryotic ribosomes have described in detail the universally conserved core of the translation mechanism. However, many facets of the translation process in eukaryotes are not shared with prokaryotes. The crystal structure of the yeast 80S ribosome determined at 4.15 angstrom resolution reveals the higher complexity of eukaryotic ribosomes, which are 40% larger than their bacterial counterparts. Our model shows how eukaryote-specific elements considerably expand the network of interactions within the ribosome and provides insights into eukaryote-specific features of protein synthesis. Our crystals capture the ribosome in the ratcheted state, which is essential for translocation of mRNA and transfer RNA (tRNA), and in which the small ribosomal subunit has rotated with respect to the large subunit. We describe the conformational changes in both ribosomal subunits that are involved in ratcheting and their implications in coordination between the two associated subunits and in mRNA and tRNA translocation.	[Ben-Shem, Adam] IGBMC, F-67400 Illkirch Graffenstaden, France; INSERM, U964, F-67400 Illkirch Graffenstaden, France; CNRS, UMR7104, F-67400 Illkirch Graffenstaden, France; Univ Strasbourg, F-67000 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ben-Shem, A (corresponding author), IGBMC, 1 Rue Laurent Fries,BP10142, F-67400 Illkirch Graffenstaden, France.	adam@igbmc.fr; marat@igbmc.fr	Yusupova, Gulnara/E-1877-2014; Yusupov, Marat/I-6126-2013; Jenner, Lasse/H-1584-2017	Yusupov, Marat/0000-0001-5544-0597; Jenner, Lasse/0000-0003-3917-8853; Ben-Shem, Adam/0000-0003-0297-8662	European Molecular Biology Organization; Human Frontier Science Program; French National Research Agency [ANR BLAN07-3_190451, ANR-07-PCVI-0015-01]; European Commission	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); French National Research Agency(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank A. Meskauskas and J. Dinman for providing the strain of S. cerevisiae and for support at the early stages of efforts in development of yeast ribosome purification protocol; A. Urzhumtzev for numerous invaluable crystallographic discussions; and R. Jackson for pointing out to us the possible benefits of glucose depletion in yeast. We gratefully acknowledge help with crystallographic programs from P. Afonine, K. Cowtan, G. Kleywegt, A. Lebedev, S. Panjikar, N. Pannu, R. Read, T. Terwilliger, L. Tong, A. Vagin, C. Vonrhein, and T. Yeates. We thank S. Melnikov and N. Garreau de Loubresse for help during the final stages of this work; M. Iskakova and N. Demeshkina for their participation and encouragement in early stages of this work; the staff of the Structural Biology Department core facility at IGBMC, Strasbourg; and S. Uge for assistance with computer infrastructure; C. Schulze-Briese and the staff at the Swiss Light Source, Switzerland; and A. Thompson and P. Legrand from the Soleil Synchrotron, France, for help with data collection. This work was supported by a European Molecular Biology Organization Long-Term Fellowship (A.B.-S.), Human Frontier Science Program, French National Research Agency grants ANR BLAN07-3_190451 and ANR-07-PCVI-0015-01, and the European Commission SPINE2. Coordinates and structure factors have been deposited with the Protein Data Bank with accession codes 3O2Z, 3O30, 3O58, and 3O5H.	Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; BRETSCHER MS, 1968, NATURE, V218, P675, DOI 10.1038/218675a0; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Halic M, 2005, NAT STRUCT MOL BIOL, V12, P467, DOI 10.1038/nsmb933; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Horan LH, 2007, P NATL ACAD SCI USA, V104, P4881, DOI 10.1073/pnas.0700762104; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; Jenner L, 2010, NAT STRUCT MOL BIOL, V17, P1072, DOI 10.1038/nsmb.1880; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Kaminishi T, 2007, STRUCTURE, V15, P289, DOI 10.1016/j.str.2006.12.008; Korostelev A, 2007, P NATL ACAD SCI USA, V104, P16840, DOI 10.1073/pnas.0707850104; Korostelev A, 2008, CURR OPIN CHEM BIOL, V12, P674, DOI 10.1016/j.cbpa.2008.08.037; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; SPIRIN AS, 1969, COLD SPRING HARB SYM, V34, P197, DOI 10.1101/SQB.1969.034.01.026; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	40	304	371	0	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2010	330	6008					1203	1209		10.1126/science.1194294	http://dx.doi.org/10.1126/science.1194294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109664				2022-12-28	WOS:000284613700031
J	Coggon, D; Palmer, KT				Coggon, David; Palmer, Keith T.			Practice Pointer Assessing fitness for work and writing a "fit note"	BRITISH MEDICAL JOURNAL			English	Editorial Material							INVOLUNTARY JOB LOSS; HOUSEHOLD PANEL SURVEY; LOW-BACK-PAIN; RECOVERY EXPECTATIONS; RETIREMENT SURVEY; HEALTH; UNEMPLOYMENT; EMPLOYMENT; MORTALITY; INTERVENTIONS		[Coggon, David] Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton SO16 6YD, Hants, England	University of Southampton	Coggon, D (corresponding author), Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton SO16 6YD, Hants, England.	dnc@mrc.soton.ac.uk			Medical Research Council [MC_UP_A620_1018, MC_U147585823] Funding Source: Medline; MRC [MC_UP_A620_1018, MC_U147585823] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BANKS MH, 1982, PSYCHOL MED, V12, P789, DOI 10.1017/S0033291700049096; Bartley M, 2004, J EPIDEMIOL COMMUN H, V58, P501, DOI 10.1136/jech.2003.009878; Brenninkmeijer V, 2008, OCCUP MED-OXFORD, V58, P295, DOI 10.1093/occmed/kqn043; Brown J, 2009, J PUBLIC HEALTH-UK, V31, P74, DOI 10.1093/pubmed/fdn098; Clinical Standards Advisory Group, 1994, EP REV EP COST BACK; Cole DC, 2002, CAN MED ASSOC J, V166, P749; Driver and Vehicle Licensing Agency, 2010, GLANC GUID CURR MED; FERRIE JE, 1995, BRIT MED J, V311, P1264, DOI 10.1136/bmj.311.7015.1264; Franche RL, 2005, J OCCUP REHABIL, V15, P607, DOI 10.1007/s10926-005-8038-8; Gallo WT, 2000, J GERONTOL B-PSYCHOL, V55, pS131, DOI 10.1093/geronb/55.3.S131; Gallo WT, 2004, AM J IND MED, V45, P408, DOI 10.1002/ajim.20004; Keefe V, 2002, INT J EPIDEMIOL, V31, P1155, DOI 10.1093/ije/31.6.1155; Krause N, 1998, J OCCUP REHABIL, V8, P113, DOI 10.1023/A:1023015622987; LAHELMA E, 1992, INT J HEALTH SERV, V22, P261, DOI 10.2190/LKDE-1E0K-TANM-HQUY; Martikainen P, 2007, AM J EPIDEMIOL, V165, P1070, DOI 10.1093/aje/kwm057; MORRIS JK, 1994, BMJ-BRIT MED J, V308, P1135, DOI 10.1136/bmj.308.6937.1135; MOSER KA, 1986, LANCET, V1, P365; Nash CE, 2004, J FAM PRACTICE, V53, P706; Nordenmark M, 1999, WORK EMPLOY SOC, V13, P601, DOI 10.1177/09500179922118141; Thomas C, 2005, J EPIDEMIOL COMMUN H, V59, P243, DOI 10.1136/jech.2004.019778; Turner JA, 2006, SPINE, V31, P682, DOI 10.1097/01.brs.0000202762.88787.af; van Oostrom SH, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006955.pub2; Waddell G, 1997, BRIT J GEN PRACT, V47, P647; Waddell G., 2006, IS WORK GOOD YOUR HL; Williams RM, 2007, DISABIL REHABIL, V29, P607, DOI 10.1080/09638280600841513	25	12	12	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 26	2010	341								c6305	10.1136/bmj.c6305	http://dx.doi.org/10.1136/bmj.c6305			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	688EH	21112906	Green Accepted			2022-12-28	WOS:000284832100001
J	Brodribb, TJ; McAdam, SAM				Brodribb, Tim J.; McAdam, Scott A. M.			Passive Origins of Stomatal Control in Vascular Plants	SCIENCE			English	Article							RESPONSES; EVOLUTION; LAND; CO2; TRANSPIRATION; DIVERSITY; CLOSURE; ABA	Carbon and water flow between plants and the atmosphere is regulated by the opening and closing of minute stomatal pores in surfaces of leaves. By changing the aperture of stomata, plants regulate water loss and photosynthetic carbon gain in response to many environmental stimuli, but stomatal movements cannot yet be reliably predicted. We found that the complexity that characterizes stomatal control in seed plants is absent in early-diverging vascular plant lineages. Lycophyte and fern stomata are shown to lack key responses to abscisic acid and epidermal cell turgor, making their behavior highly predictable. These results indicate that a fundamental transition from passive to active metabolic control of plant water balance occurred after the divergence of ferns about 360 million years ago.	[Brodribb, Tim J.; McAdam, Scott A. M.] Univ Tasmania, Sch Plant Sci, Hobart, Tas 7001, Australia	University of Tasmania	Brodribb, TJ (corresponding author), Univ Tasmania, Sch Plant Sci, Private Bag 55, Hobart, Tas 7001, Australia.	timothyb@utas.edu.au	McAdam, Scott/J-7197-2014; Brodribb, Timothy John/C-6797-2013	McAdam, Scott/0000-0002-9625-6750; Brodribb, Timothy John/0000-0002-4964-6107	Australian Research Council [DP0878177, DP0559266]; APA	Australian Research Council(Australian Research Council); APA	We thank K. Mott and G. Jordan for discussion and comments on the manuscript, and J. Ross and N. Davies for assistance with ABA quantification techniques. Supported by Australian Research Council grants DP0878177 and DP0559266 (T.J.B.) and an APA award (S.A.M.M.).	Acharya B, 2009, PLANT MOL BIOL, V69, P451, DOI 10.1007/s11103-008-9427-0; Berry JA, 2010, CURR OPIN PLANT BIOL, V13, P232, DOI 10.1016/j.pbi.2010.04.013; Betts RA, 2007, NATURE, V448, P1037, DOI 10.1038/nature06045; Brodribb TJ, 2009, NEW PHYTOL, V183, P839, DOI 10.1111/j.1469-8137.2009.02844.x; Buckley TN, 2005, NEW PHYTOL, V168, P275, DOI 10.1111/j.1469-8137.2005.01543.x; Buckley TN, 2003, PLANT CELL ENVIRON, V26, P1767, DOI 10.1046/j.1365-3040.2003.01094.x; Cowan I R, 1977, Symp Soc Exp Biol, V31, P471; Darwin, 1898, P R SOC LOND, V190, P531, DOI [10.1098/RSTB.1898.0009, DOI 10.1098/RSPL.1898.0053]; Dewar RC, 2002, PLANT CELL ENVIRON, V25, P1383, DOI 10.1046/j.1365-3040.2002.00909.x; Doi M, 2008, PLANT PHYSIOL, V147, P922, DOI 10.1104/pp.108.118950; Duan BL, 2007, J EXP BOT, V58, P3025, DOI 10.1093/jxb/erm160; Duckett JG, 2009, NEW PHYTOL, V183, P1053, DOI 10.1111/j.1469-8137.2009.02905.x; Edwards D, 1998, J EXP BOT, V49, P255, DOI 10.1093/jexbot/49.suppl_1.255; Edwards D, 2003, PLANT CELL ENVIRON, V26, P57, DOI 10.1046/j.1365-3040.2003.00878.x; Franks PJ, 2007, PLANT PHYSIOL, V143, P78, DOI 10.1104/pp.106.089367; Hartung W, 2010, FUNCT PLANT BIOL, V37, P806, DOI 10.1071/FP10058; HICKOK LG, 1983, CAN J BOT, V61, P888, DOI 10.1139/b83-098; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Lin BL, 2005, J EXP BOT, V56, P2935, DOI 10.1093/jxb/eri290; LLOYD J, 1994, OECOLOGIA, V99, P201, DOI 10.1007/BF00627732; MEIDNER H, 1965, BIOL REV, V40, P483, DOI 10.1111/j.1469-185X.1965.tb00813.x; MITTELHEUSER CJ, 1969, NATURE, V221, P281, DOI 10.1038/221281a0; Mott KA, 2008, PLANT CELL ENVIRON, V31, P1299, DOI 10.1111/j.1365-3040.2008.01845.x; Peterson KM, 2010, PLANT CELL, V22, P296, DOI 10.1105/tpc.109.072777; Pieruschka R, 2010, P NATL ACAD SCI USA, V107, P13372, DOI 10.1073/pnas.0913177107; Raven JA, 2002, NEW PHYTOL, V153, P371, DOI 10.1046/j.0028-646X.2001.00334.x; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; REYNOLDS TL, 1993, J EXP BOT, V44, P1771, DOI 10.1093/jxb/44.12.1771; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Sharpe P. J. H., 1987, STOMATAL FUNCTION, P92; Shope JC, 2008, PLANT CELL ENVIRON, V31, P1290, DOI 10.1111/j.1365-3040.2008.01844.x; TARDIEU F, 1993, PLANT CELL ENVIRON, V16, P341, DOI 10.1111/j.1365-3040.1993.tb00880.x	32	287	298	9	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					582	585		10.1126/science.1197985	http://dx.doi.org/10.1126/science.1197985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21163966				2022-12-28	WOS:000286933600053
J	Hall, MA				Hall, Mark A.			Health Care Reform - What Went Wrong on the Way to the Courthouse	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CONSTITUTIONALITY		Wake Forest Univ, Sch Law, Winston Salem, NC 27109 USA	Wake Forest University	Hall, MA (corresponding author), Wake Forest Univ, Sch Law, Winston Salem, NC 27109 USA.			Hall, Mark A./0000-0001-6277-144X				Balkin JM, 2010, NEW ENGL J MED, V362, P482, DOI 10.1056/NEJMp1000087; Barnett RE, 2001, U CHICAGO LAW REV, V68, P101, DOI 10.2307/1600443; Rosenbaum S, 1999, NEW ENGL J MED, V340, P229, DOI 10.1056/NEJM199901213400312; Rosenbaum S, 2010, NEW ENGL J MED, V363, P1881, DOI 10.1056/NEJMp1010850; Tamanaha Brian Z., 2009, BOSTON COLL LAW REV, V50, p751?52, 757	5	16	16	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					295	297		10.1056/NEJMp1013234	http://dx.doi.org/10.1056/NEJMp1013234			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711LH	21158651				2022-12-28	WOS:000286592600002
J	Wang, K; Diskin, SJ; Zhang, HT; Attiyeh, EF; Winter, C; Hou, CP; Schnepp, RW; Diamond, M; Bosse, K; Mayes, PA; Glessner, J; Kim, C; Frackelton, E; Garris, M; Wang, Q; Glaberson, W; Chiavacci, R; Nguyen, L; Jagannathan, J; Saeki, N; Sasaki, H; Grant, SFA; Iolascon, A; Mosse, YP; Cole, KA; Li, HZ; Devoto, M; McGrady, PW; London, WB; Capasso, M; Rahman, N; Hakonarson, H; Maris, JM				Wang, Kai; Diskin, Sharon J.; Zhang, Haitao; Attiyeh, Edward F.; Winter, Cynthia; Hou, Cuiping; Schnepp, Robert W.; Diamond, Maura; Bosse, Kristopher; Mayes, Patrick A.; Glessner, Joseph; Kim, Cecilia; Frackelton, Edward; Garris, Maria; Wang, Qun; Glaberson, Wendy; Chiavacci, Rosetta; Nguyen, Le; Jagannathan, Jayanti; Saeki, Norihisa; Sasaki, Hiroki; Grant, Struan F. A.; Iolascon, Achille; Mosse, Yael P.; Cole, Kristina A.; Li, Hongzhe; Devoto, Marcella; McGrady, Patrick W.; London, Wendy B.; Capasso, Mario; Rahman, Nazneen; Hakonarson, Hakon; Maris, John M.			Integrative genomics identifies LMO1 as a neuroblastoma oncogene	NATURE			English	Article							COPY NUMBER; CHROMOSOMAL TRANSLOCATIONS; ACTIVATING MUTATIONS; ALK KINASE; GENE; TRANSCRIPTION; CANCER; INTERACTS; TARGET; CELLS	Neuroblastoma is a childhood cancer of the sympathetic nervous system that accounts for approximately 10% of all paediatric oncology deaths(1,2). To identify genetic risk factors for neuroblastoma, we performed a genome-wide association study (GWAS) on 2,251 patients and 6,097 control subjects of European ancestry from four case series. Here we report a significant association within LIM domain only 1 (LMO1) at 11p15.4 (rs110419, combined P = 5.2 x 10(-16), odds ratio of risk allele = 1.34 (95% confidence interval 1.25-1.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P < 0.0001) and survival (P = 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression.	[Wang, Kai; Zhang, Haitao; Hou, Cuiping; Glessner, Joseph; Kim, Cecilia; Frackelton, Edward; Glaberson, Wendy; Chiavacci, Rosetta; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Diskin, Sharon J.; Attiyeh, Edward F.; Winter, Cynthia; Schnepp, Robert W.; Diamond, Maura; Bosse, Kristopher; Mayes, Patrick A.; Garris, Maria; Wang, Qun; Nguyen, Le; Jagannathan, Jayanti; Mosse, Yael P.; Cole, Kristina A.; Maris, John M.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Diskin, Sharon J.; Attiyeh, Edward F.; Winter, Cynthia; Schnepp, Robert W.; Diamond, Maura; Bosse, Kristopher; Mayes, Patrick A.; Garris, Maria; Wang, Qun; Nguyen, Le; Jagannathan, Jayanti; Mosse, Yael P.; Cole, Kristina A.; Maris, John M.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Nguyen, Le; Li, Hongzhe; Devoto, Marcella] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Saeki, Norihisa; Sasaki, Hiroki] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 1040045, Japan; [Nguyen, Le; Grant, Struan F. A.; Mosse, Yael P.; Cole, Kristina A.; Devoto, Marcella; Hakonarson, Hakon; Maris, John M.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Grant, Struan F. A.; Devoto, Marcella; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Iolascon, Achille; Capasso, Mario] CEINGE Biotecnol Avanzate, I-80145 Naples, Italy; [Devoto, Marcella] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [McGrady, Patrick W.] Univ Florida, Dept Stat, Gainesville, FL 32603 USA; [McGrady, Patrick W.] Childrens Oncol Grp, Gainesville, FL 32603 USA; [London, Wendy B.] Dana Farber Childrens Hosp, Ctr Canc, Boston, MA 02115 USA; [London, Wendy B.] Childrens Oncol Grp, Boston, MA 02115 USA; [Iolascon, Achille; Capasso, Mario] Univ Naples Federico 2, Dept Biochem & Med Biotechnol, I-80131 Naples, Italy; [Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; National Cancer Center - Japan; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; CEINGE Biotecnologie Avanzate; Sapienza University Rome; State University System of Florida; University of Florida; Children's Oncology Group (COG); Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Children's Oncology Group (COG); University of Naples Federico II; University of London; Institute of Cancer Research - UK	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	hakonarson@chop.edu; maris@chop.edu	London, Wendy/ABD-4624-2021; Capasso, Mario/D-1617-2014; Iolascon, Achille/A-4461-2014; Cole, Kristina/M-3922-2015; Rahman, Nazneen/B-8890-2012; Devoto, Marcella/AAP-7595-2021; London, Wendy Beth/ABA-8948-2021; Rahman, Nazneen/D-2802-2013	London, Wendy Beth/0000-0003-3571-6538; Rahman, Nazneen/0000-0003-4376-0440; iolascon, achille/0000-0002-9558-0356; Mayes, Patrick/0000-0001-9104-4161; DEVOTO, MARCELLA/0000-0002-4431-5114; Glessner, Joseph/0000-0001-5131-2811; Capasso, Mario/0000-0003-3306-1259; Grant, Struan/0000-0003-2025-5302	National Institutes of Health [R01-CA124709]; Giulio D'Angio Endowed Chair; Alex's Lemonade Stand Foundation; Evan Dunbar Foundation; Rally Foundation; Andrew's Army Foundation; Abramson Family Cancer Research Institute; Howard Hughes Medical Institute; Associazione Oncologia Pediatrica e Neuroblastoma; Cotswold Foundation; Children's Hospital of Philadelphia;  [UL1-RR024134-03]; NATIONAL CANCER INSTITUTE [U10CA098413, U10CA098543, R01CA124709, R00CA151869] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giulio D'Angio Endowed Chair; Alex's Lemonade Stand Foundation; Evan Dunbar Foundation; Rally Foundation; Andrew's Army Foundation; Abramson Family Cancer Research Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Associazione Oncologia Pediatrica e Neuroblastoma; Cotswold Foundation; Children's Hospital of Philadelphia; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We acknowledge the Children's Oncology Group for providing most blood and tumour specimens and clinical and outcome data (U10-CA98543 and U10-CA98413) from neuroblastoma patients. We thank G. P. Tonini for providing neuroblastoma DNA samples in the Italian replication cohort. This work was supported in part by National Institutes of Health grant R01-CA124709 (to J.M.M.), the Giulio D'Angio Endowed Chair (J.M.M.), the Alex's Lemonade Stand Foundation (J.M.M.), the Evan Dunbar Foundation (J.M.M.), the Rally Foundation (J.M.M.), Andrew's Army Foundation (J.M.M.), the Abramson Family Cancer Research Institute (J.M.M.), a Howard Hughes Medical Institute Research Training Fellowship (K. B.), a fellowship from Associazione Oncologia Pediatrica e Neuroblastoma (M. C.), a Research Development Award from the Cotswold Foundation (H. H.), UL1-RR024134-03 (H. H.) and an Institutional Development Award to the Center for Applied Genomics from the Children's Hospital of Philadelphia (H.H.).	Aoyama M, 2005, CANCER RES, V65, P4587, DOI 10.1158/0008-5472.CAN-04-4630; Attiyeh EF, 2009, GENOME RES, V19, P276, DOI 10.1101/gr.075671.107; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; FISCH P, 1992, ONCOGENE, V7, P2389; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Neale Geoffrey A. M., 1997, Leukemia (Basingstoke), V11, P289; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Rabbitts TH, 1998, GENE DEV, V12, P2651, DOI 10.1101/gad.12.17.2651; Rabbitts TH, 1999, CANCER RES, V59, p1794S; Saeki N, 2007, ONCOGENE, V26, P6488, DOI 10.1038/sj.onc.1210475; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sum EYM, 2002, J BIOL CHEM, V277, P7849, DOI 10.1074/jbc.M110603200; Visvader JE, 2001, P NATL ACAD SCI USA, V98, P14452, DOI 10.1073/pnas.251547698; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618	22	216	222	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					216	220		10.1038/nature09609	http://dx.doi.org/10.1038/nature09609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21124317	Green Accepted			2022-12-28	WOS:000286143400039
J	Wipfli, HL; Samet, JM				Wipfli, Heather L.; Samet, Jonathan M.			Second-hand smoke's worldwide disease toll	LANCET			English	Editorial Material									[Wipfli, Heather L.; Samet, Jonathan M.] Univ So Calif, Keck Sch Med USC, Dept Prevent Med, USC Inst Global Hlth, Los Angeles, CA 90089 USA	University of Southern California	Samet, JM (corresponding author), Univ So Calif, Keck Sch Med USC, Dept Prevent Med, USC Inst Global Hlth, Los Angeles, CA 90089 USA.	jsamet@usc.edu						Binns HJ, 2009, PEDIATRICS, V124, P1474, DOI 10.1542/peds.2009-2114; Hawthorne M, 2008, PROTECTING OUR CHILD; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; WHO, 2010, GENDER, WOMEN, AND THE TOBACCO EPIDEMIC, P1; Wipfli H, 2008, AM J PUBLIC HEALTH, V98, P672, DOI 10.2105/AJPH.2007.126631; World Health Organization, 2008, WHO REP GLOB TOB EP; World Health Organization, 2003, WHO FRAM CONV TOB CO; World Health Organization, 2009, WHO REP GLOB TOB EP	9	22	24	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 8	2011	377	9760					101	102		10.1016/S0140-6736(10)61922-8	http://dx.doi.org/10.1016/S0140-6736(10)61922-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	707NH	21112081				2022-12-28	WOS:000286292800005
J	Cisse, M; Halabisky, B; Harris, J; Devidze, N; Dubal, DB; Sun, BG; Orr, A; Lotz, G; Kim, DH; Hamto, P; Ho, K; Yu, GQ; Mucke, L				Cisse, Moustapha; Halabisky, Brian; Harris, Julie; Devidze, Nino; Dubal, Dena B.; Sun, Binggui; Orr, Anna; Lotz, Gregor; Kim, Daniel H.; Hamto, Patricia; Ho, Kaitlyn; Yu, Gui-Qiu; Mucke, Lennart			Reversing EphB2 depletion rescues cognitive functions in Alzheimer model	NATURE			English	Article							AMYLOID-BETA-PROTEIN; DEPENDENT SYNAPTIC PLASTICITY; TRANSGENIC MOUSE MODEL; LONG-TERM POTENTIATION; PRECURSOR PROTEIN; CALCIUM INFLUX; BEHAVIORAL IMPAIRMENTS; CELLULAR PRION; IN-VITRO; DISEASE	Amyloid-beta oligomers may cause cognitive deficits in Alzheimer's disease by impairing neuronal NMDA-type glutamate receptors, whose function is regulated by the receptor tyrosine kinase EphB2. Here we show that amyloid-beta oligomers bind to the fibronectin repeats domain of EphB2 and trigger EphB2 degradation in the proteasome. To determine the pathogenic importance of EphB2 depletions in Alzheimer's disease and related models, we used lentiviral constructs to reduce or increase neuronal expression of EphB2 in memory centres of the mouse brain. In nontransgenic mice, knockdown of EphB2 mediated by short hairpin RNA reduced NMDA receptor currents and impaired long-term potentiation in the dentate gyrus, which are important for memory formation. Increasing EphB2 expression in the dentate gyrus of human amyloid precursor protein transgenic mice reversed deficits in NMDA receptor-dependent long-term potentiation and memory impairments. Thus, depletion of EphB2 is critical in amyloid-beta-induced neuronal dysfunction. Increasing EphB2 levels or function could be beneficial in Alzheimer's disease.	[Cisse, Moustapha; Halabisky, Brian; Harris, Julie; Devidze, Nino; Dubal, Dena B.; Sun, Binggui; Orr, Anna; Lotz, Gregor; Kim, Daniel H.; Hamto, Patricia; Ho, Kaitlyn; Yu, Gui-Qiu; Mucke, Lennart] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Cisse, Moustapha; Halabisky, Brian; Harris, Julie; Dubal, Dena B.; Sun, Binggui; Orr, Anna; Lotz, Gregor; Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Mucke, L (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	lmucke@gladstone.ucsf.edu	Sun, Binggui/J-9028-2016; CISSE, Moustapha/AAM-1022-2021; Dubal, Dena/AAL-2091-2021	Sun, Binggui/0000-0002-0386-6569; CISSE, Moustapha/0000-0003-3890-9183; Lotz, Gregor/0000-0002-0231-5503; Orr, Anna/0000-0002-4036-4277	NIH [AG011385, AG022074, NS041787]; McBean Family Foundation; National Center for Research Resources [RR18928-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011385, R37AG011385, P01AG022074] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McBean Family Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank I. Ethell for the plasmid encoding the Flag-tagged EphB2 receptor; D. J. Selkoe and D. Walsh for CHO-7PA2 cells; S. Finkbeiner for the plasmid encoding the NMDA receptor subunit NR1; J. Palop for comments; H. Solanoy, M. Thwin and X. Wang for technical support; G. Howard and S. Ordway for editorial review; J. Carroll for preparation of graphics; and M. Dela Cruz for administrative assistance. The study was supported by NIH grants AG011385, AG022074 and NS041787 to L.M., a fellowship from the McBean Family Foundation to M. C., and the National Center for Research Resources Grant RR18928-01 to the Gladstone Institutes.	Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Benice TS, 2006, NEUROSCIENCE, V137, P413, DOI 10.1016/j.neuroscience.2005.08.029; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Chen Y, 2008, NEURON GLIA BIOL, V4, P211, DOI 10.1017/S1740925X09990287; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150, DOI 10.1152/jn.1993.69.4.1150; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dere E, 2005, BRAIN RES PROTOC, V16, P10, DOI 10.1016/j.brainresprot.2005.08.001; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Harris JA, 2010, J NEUROSCI, V30, P372, DOI 10.1523/JNEUROSCI.5341-09.2010; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Ikonemevic MD, 1999, EXP NEUROL, V160, P194, DOI 10.1006/exnr.1999.7196; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kurup P, 2010, J NEUROSCI, V30, P5948, DOI 10.1523/JNEUROSCI.0157-10.2010; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li CYT, 2009, SCIENCE, V324, P643, DOI 10.1126/science.1169957; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Simon AM, 2009, J ALZHEIMERS DIS, V17, P773, DOI 10.3233/JAD-2009-1096; Meilandt WJ, 2008, J NEUROSCI, V28, P5007, DOI 10.1523/JNEUROSCI.0590-08.2008; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Nakajima R, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-7; Nguyen PV, 2000, LEARN MEMORY, V7, P170, DOI 10.1101/lm.7.3.170; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Potter MC, 2010, NEUROPSYCHOPHARMACOL, V35, P1734, DOI 10.1038/npp.2010.39; Raber J, 2000, J NEUROSCI, V20, P2064; Raber J, 2002, J NEUROSCI, V22, P5204, DOI 10.1523/JNEUROSCI.22-12-05204.2002; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; ROCKENSTEIN EM, 1995, J BIOL CHEM, V270, P28257; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Scheff SW, 2006, J ALZHEIMERS DIS, V9, P101; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shemer I, 2006, EUR J NEUROSCI, V23, P2035, DOI 10.1111/j.1460-9568.2006.04733.x; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sun BG, 2009, CELL STEM CELL, V5, P624, DOI 10.1016/j.stem.2009.10.003; Sze CI, 2001, J NEUROL SCI, V182, P151, DOI 10.1016/S0022-510X(00)00467-6; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; WAKABAYASHI K, 1994, BRAIN RES, V667, P24, DOI 10.1016/0006-8993(94)91709-4; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wu JQ, 2001, J PHYSIOL-LONDON, V533, P745, DOI 10.1111/j.1469-7793.2001.t01-1-00745.x; Xia ZG, 1996, J NEUROSCI, V16, P5425	50	304	322	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					47	52		10.1038/nature09635	http://dx.doi.org/10.1038/nature09635			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21113149	Green Accepted			2022-12-28	WOS:000285921600028
J	McCamey, DR; Van Tol, J; Morley, GW; Boehme, C				McCamey, D. R.; Van Tol, J.; Morley, G. W.; Boehme, C.			Electronic Spin Storage in an Electrically Readable Nuclear Spin Memory with a Lifetime > 100 Seconds	SCIENCE			English	Article							SINGLE-SHOT READOUT; DOUBLE-RESONANCE; SILICON; RELAXATION	Electron spins are strong candidates with which to implement spintronics because they are both mobile and able to be manipulated. The relatively short lifetimes of electron spins, however, present a problem for the long-term storage of spin information. We demonstrated an ensemble nuclear spin memory in phosphorous-doped silicon, which can be read out electrically and has a lifetime exceeding 100 seconds. The electronic spin information can be mapped onto and stored in the nuclear spin of the phosphorus donors, and the nuclear spins can then be repetitively read out electrically for time periods that exceed the electron spin lifetime. We discuss how this memory can be used in conjunction with other silicon spintronic devices.	[McCamey, D. R.; Boehme, C.] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA; [Van Tol, J.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Morley, G. W.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England; [Morley, G. W.] UCL, Dept Phys & Astron, London WC1H 0AH, England	Utah System of Higher Education; University of Utah; State University System of Florida; Florida State University; University of London; University College London; University of London; University College London	McCamey, DR (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	dane.mccamey@sydney.edu.au	Morley, Gavin W/C-1658-2008; van Tol, Johan/G-4190-2011; McCamey, Dane/A-1206-2011	Morley, Gavin W/0000-0002-8760-6907; van Tol, Johan/0000-0001-6972-2149; McCamey, Dane/0000-0001-7727-6804	National High Magnetic Field Laboratory (NHMFL) [12488]; State of Florida; U.S. Department of Energy; NSF [DMR-0654118, 953225]; Australian Research Council [DP1093526]; Royal Commission; EPSRC; Engineering and Physical Sciences Research Council [EP/H026622/1] Funding Source: researchfish; EPSRC [EP/H026622/1] Funding Source: UKRI	National High Magnetic Field Laboratory (NHMFL); State of Florida; U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Australian Research Council(Australian Research Council); Royal Commission; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported in part by Visiting Scientist Program Grant 12488 from the National High Magnetic Field Laboratory (NHMFL). The NHMFL is funded by the State of Florida, the U.S. Department of Energy, and NSF through Cooperative Agreement DMR-0654118. D. R. M. acknowledges support through an Australian Research Council Postdoctoral Fellowship (DP1093526). G. W. M. acknowledges support from the Royal Commission for the Exhibition of 1851 and the EPSRC COMPASSS grant. C. B. acknowledges support from the NSF CAREER program (grant 953225).	Appelbaum I, 2007, NATURE, V447, P295, DOI 10.1038/nature05803; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; Dash SP, 2009, NATURE, V462, P491, DOI 10.1038/nature08570; FEHER G, 1959, PHYS REV, V114, P1245, DOI 10.1103/PhysRev.114.1245; Fuechsle M, 2010, NAT NANOTECHNOL, V5, P502, DOI [10.1038/NNANO.2010.95, 10.1038/nnano.2010.95]; George RE, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.067601; Jiang L, 2009, SCIENCE, V326, P267, DOI 10.1126/science.1176496; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Ladd TD, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014401; McCamey DR, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2358928; McCamey DR, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.027601; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Morley GW, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.207602; Morley GW, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.220501; Morley GW, 2010, NAT MATER, V9, P725, DOI [10.1038/nmat2828, 10.1038/NMAT2828]; Morley GW, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2937630; Morton JJL, 2008, NATURE, V455, P1085, DOI 10.1038/nature07295; Morton JJL, 2008, J MAGN RESON, V191, P315, DOI 10.1016/j.jmr.2008.01.006; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Sarovar M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.245302; Stich B, 1996, APPL PHYS LETT, V68, P1102, DOI 10.1063/1.115726; Tyryshkin AM, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2204915; Tyryshkin AM, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.193207; van Beveren LHW, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2960356; van Tol J, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1942533; Witzel WM, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.035212; Yusa G, 2005, NATURE, V434, P1001, DOI 10.1038/nature03456	27	76	79	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2010	330	6011					1652	1656		10.1126/science.1197931	http://dx.doi.org/10.1126/science.1197931			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164011				2022-12-28	WOS:000285390500060
J	Irvine, WTM; Vitelli, V; Chaikin, PM				Irvine, William T. M.; Vitelli, Vincenzo; Chaikin, Paul M.			Pleats in crystals on curved surfaces	NATURE			English	Article							GRAIN-BOUNDARY SCARS; ORDER; CRYSTALLOGRAPHY; COLLOIDS; DEFECTS	Hexagons can easily tile a flat surface, but not a curved one. Introducing heptagons and pentagons (defects with topological charge) makes it easier to tile curved surfaces; for example, soccer balls based on the geodesic domes(1) of Buckminster Fuller have exactly 12 pentagons (positive charges). Interacting particles that invariably form hexagonal crystals on a plane exhibit fascinating scarred defect patterns on a sphere(2-4). Here we show that, for more general curved surfaces, curvature may be relaxed by pleats: uncharged lines of dislocations (topological dipoles) that vanish on the surface and play the same role as fabric pleats. We experimentally investigate crystal order on surfaces with spatially varying positive and negative curvature. On cylindrical capillary bridges, stretched to produce negative curvature, we observe a sequence of transitions-consistent with our energetic calculations-from no defects to isolated dislocations, which subsequently proliferate and organize into pleats; finally, scars and isolated heptagons (previously unseen) appear. This fine control of crystal order with curvature will enable explorations of general theories of defects in curved spaces(5-11). From a practical viewpoint, it may be possible to engineer structures with curvature (such as waisted nanotubes and vaulted architecture) and to develop novel methods for soft lithography(12) and directed self-assembly(13).	[Irvine, William T. M.; Chaikin, Paul M.] NYU, Dept Phys, Ctr Soft Matter Res, New York, NY 10003 USA; [Vitelli, Vincenzo] Leiden Univ, Inst Lorentz Theoret Phys, NL-2333 CA Leiden, Netherlands	New York University; Leiden University; Leiden University - Excl LUMC	Irvine, WTM (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.	wtmirvine@uchicago.edu; chaikin@nyu.edu		irvine, william/0000-0002-4925-2060	Rhodia; English Speaking Union; MRSEC [DMR-0820341]; NASA [NNX08AK04G]	Rhodia; English Speaking Union; MRSEC(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	We acknowledge discussions with M. Bowick, A. Grosberg, S. Sacanna and A. M. Turner. W. T. M. I. acknowledges guidance in particle synthesis from A. D. Hollingsworth and M. T. Elsesser. W. T. M. I. acknowledges support from Rhodia and the English Speaking Union. P. M. C. acknowledges support from MRSEC DMR-0820341 and NASA NNX08AK04G. W. T. M. I. and V. V. acknowledge hospitality from Stichting FOM and the Aspen Center for Physics.	[Anonymous], 2007, PRINCIPLES CONDENSED; [Anonymous], 1954, United States of America Patent, Patent No. [2,682,235, 2682235]; ANTL L, 1986, COLLOID SURFACE, V17, P67, DOI 10.1016/0166-6622(86)80187-1; Bausch AR, 2003, SCIENCE, V299, P1716, DOI 10.1126/science.1081160; Bosma G, 2002, J COLLOID INTERF SCI, V245, P292, DOI 10.1006/jcis.2001.7986; Bowick MJ, 2009, ADV PHYS, V58, P449, DOI 10.1080/00018730903043166; Bowick MJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.021602; Bowick MJ, 2000, PHYS REV B, V62, P8738, DOI 10.1103/PhysRevB.62.8738; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; DeVries GA, 2007, SCIENCE, V315, P358, DOI 10.1126/science.1133162; Einert T, 2005, LANGMUIR, V21, P12076, DOI 10.1021/la0517383; Gillette R., 1971, CHEM ENG J, V2, P44, DOI DOI 10.1016/0300-9467(71)87006-5; Giomi L, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.010601; Hexemer A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051604; Hexemer A., 2006, THESIS U CALIFORNIA; Kamien RD, 2002, REV MOD PHYS, V74, P953, DOI 10.1103/RevModPhys.74.953; Langbein D. W., 2002, PARTICULAR WEIGHTLES; Leunissen ME, 2007, P NATL ACAD SCI USA, V104, P2585, DOI 10.1073/pnas.0610589104; Lipowsky P, 2005, NAT MATER, V4, P407, DOI 10.1038/nmat1376; LIPOWSKY P, 2005, DIRECT VISUALIZATION; Modes CD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.235701; Nelson D. R., 2002, DEFECTS GEOMETRY CON; NELSON DR, 1987, J PHYS-PARIS, V48, P1085, DOI 10.1051/jphys:019870048070108500; PerezGarrido A, 1997, PHYS REV B, V56, P3640, DOI 10.1103/PhysRevB.56.3640; Santangelo CD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.017801; Sausset F, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031504; Turner AM, 2010, REV MOD PHYS, V82, P1301, DOI 10.1103/RevModPhys.82.1301; Vitelli V, 2006, P NATL ACAD SCI USA, V103, P12323, DOI 10.1073/pnas.0602755103; Weertman J., 1992, ELEMENTARY DISLOCATI	29	249	251	3	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 16	2010	468	7326					947	951		10.1038/nature09620	http://dx.doi.org/10.1038/nature09620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164482				2022-12-28	WOS:000285344600043
J	Sury, M; Bullock, I; Rabar, S; DeMott, K				Sury, Mike; Bullock, Ian; Rabar, Silvia; DeMott, Kathleen			Guidelines Sedation for diagnostic and therapeutic procedures in children and young people: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sury, Mike] Great Ormond St Hosp Childrens NHS Trust, London WC1N 3JH, England; [Sury, Mike] UCL, Inst Child Hlth, PORTEX Unit Paediat Anaesthesia, London WC1N 1EH, England; [Bullock, Ian; Rabar, Silvia; DeMott, Kathleen] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Royal College of Physicians	Sury, M (corresponding author), Great Ormond St Hosp Childrens NHS Trust, London WC1N 3JH, England.	surym@gosh.nhs.uk						British Medical Association and the Royal Pharmaceutical Society of Great Britain, 2011, BRIT NAT FORM CHILDR; National Institute for Health and Clinical Excellence, 2010, CLIN GUID, V112; Saklad M., 1941, ANESTHESIOLOGY, V2, P281, DOI DOI 10.1097/00000542-194105000-00004	3	35	38	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 16	2010	341								c6819	10.1136/bmj.c6819	http://dx.doi.org/10.1136/bmj.c6819			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XM	21163835				2022-12-28	WOS:000285553100008
J	Wald, HS				Wald, Hedy S.			Lullaby	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												hedy_wald@brown.edu							0	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2010	304	23					2570	2571		10.1001/jama.2010.1794	http://dx.doi.org/10.1001/jama.2010.1794			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694MX	21156939				2022-12-28	WOS:000285303400003
J	Gautel, M; Ehler, E				Gautel, Mathias; Ehler, Elisabeth			Gett'N-WASP Stripes	SCIENCE			English	Editorial Material							FILAMENT LENGTH; MUSCLE; NEBULIN; NUCLEATOR		[Gautel, Mathias] Kings Coll London, British Heart Fdn, Ctr Res Excellence, Div Cardiovasc, London SE1 1UL, England; Kings Coll London, British Heart Fdn, Ctr Res Excellence, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of London; King's College London; University College London; University of London; King's College London; University College London	Gautel, M (corresponding author), Kings Coll London, British Heart Fdn, Ctr Res Excellence, Div Cardiovasc, London SE1 1UL, England.	mathias.gautel@kcl.ac.uk		Ehler, Elisabeth/0000-0001-5646-5964				Bang ML, 2006, J CELL BIOL, V173, P905, DOI 10.1083/jcb.200603119; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; Lange S, 2006, TRENDS CELL BIOL, V16, P11, DOI 10.1016/j.tcb.2005.11.007; Littlefield R, 1998, ANNU REV CELL DEV BI, V14, P487, DOI 10.1146/annurev.cellbio.14.1.487; Pappas CT, 2008, MOL BIOL CELL, V19, P1837, DOI 10.1091/mbc.E07-07-0690; PFUHL M, 1994, EMBO J, V13, P1782, DOI 10.1002/j.1460-2075.1994.tb06446.x; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sanger JW, 2005, J MUSCLE RES CELL M, V26, P343, DOI 10.1007/s10974-005-9016-7; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Takano K, 2010, SCIENCE, V330, P1536, DOI 10.1126/science.1197767; Witt CC, 2006, EMBO J, V25, P3843, DOI 10.1038/sj.emboj.7601242	13	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1491	1492		10.1126/science.1199920	http://dx.doi.org/10.1126/science.1199920			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148382				2022-12-28	WOS:000285153500051
J	McCarthy, MI				McCarthy, Mark I.			GENOMIC MEDICINE Genomics, Type 2 Diabetes, and Obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							COMMON GENETIC-VARIANTS; LARGE-SCALE ASSOCIATION; C-REACTIVE PROTEIN; WIDE ASSOCIATION; FASTING GLUCOSE; FTO GENE; RISK LOCI; SUSCEPTIBILITY LOCI; ORAL SULFONYLUREAS; INSULIN-RESISTANCE		[McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [McCarthy, Mark I.] Univ Oxford, Oxford Natl Inst Hlth Res, Biomed Res Ctr, Oxford OX3 7LJ, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7LJ, England	University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	McCarthy, MI (corresponding author), Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, S Parks Rd, Oxford OX3 7LJ, England.		McCarthy, Mark/M-3763-2015	McCarthy, Mark/0000-0002-4393-0510	Prosidion Pharmaceuticals; Novo Nordisk	Prosidion Pharmaceuticals; Novo Nordisk(Novo Nordisk)	Dr. McCarthy reports receiving consulting fees from Prosidion Pharmaceuticals and lecture fees from Novo Nordisk. No other potential conflict of interest relevant to this article was reported.	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Contopoulos-Ioannidis DG, 2008, SCIENCE, V321, P1298, DOI 10.1126/science.1160622; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Franks PW, 2008, DIABETOLOGIA, V51, P458, DOI 10.1007/s00125-007-0887-6; FRANKS PW, 2008, DIABETOLOGIA, V51, P523; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freathy RM, 2008, DIABETES, V57, P1419, DOI 10.2337/db07-1466; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Hattersley AT, 2005, LANCET, V366, P1315, DOI 10.1016/S0140-6736(05)67531-9; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Larsen LH, 2005, J CLIN ENDOCR METAB, V90, P219, DOI 10.1210/jc.2004-0497; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Luan JA, 2001, INT J EPIDEMIOL, V30, P1035, DOI 10.1093/ije/30.5.1035; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; McCarthy Mark I, 2003, Curr Diab Rep, V3, P159, DOI 10.1007/s11892-003-0040-y; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Meyre D, 2010, DIABETES, V59, P311, DOI 10.2337/db09-0703; Mihaescu R, 2009, GENET MED, V11, P588, DOI 10.1097/GIM.0b013e3181b13a4f; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Orho-Melander M, 2008, DIABETES, V57, P3112, DOI 10.2337/db08-0516; Owen KR, 2010, DIABETES CARE, V33, P1919, DOI 10.2337/dc10-0288; Pearson ER, 2003, LANCET, V362, P1275, DOI 10.1016/S0140-6736(03)14571-0; Pearson ER, 2007, DIABETES, V56, pA18; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Pearson E, 2009, CURR DIABETES REP, V9, P172, DOI 10.1007/s11892-009-0028-3; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Rafiq M, 2008, DIABETES CARE, V31, P204, DOI 10.2337/dc07-1785; Rung J, 2009, NAT GENET, V41, P1156, DOI 10.1038/ng1009-1156c; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V295, pR1360, DOI 10.1152/ajpregu.zh6-6445-corr.2008; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Stumvoll M, 2008, LANCET, V371, P2153, DOI 10.1016/S0140-6736(08)60932-0; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Timpson NJ, 2009, DIABETES, V58, P505, DOI 10.2337/db08-0906; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wareham NJ, 2002, ENDOCRIN METAB CLIN, V31, P553, DOI 10.1016/S0889-8529(02)00007-5; Waterfield T, 2008, PEDIAT HLTH, V2, P517, DOI DOI 10.2217/17455111.2.4.517; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2007, SCIENCE, V317, P1036; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	82	641	661	2	118	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2010	363	24					2339	2350		10.1056/NEJMra0906948	http://dx.doi.org/10.1056/NEJMra0906948			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691PA	21142536				2022-12-28	WOS:000285092100009
J	de Lemos, JA; Drazner, MH; Omland, T; Ayers, CR; Khera, A; Rohatgi, A; Hashim, I; Berry, JD; Das, SR; Morrow, DA; McGuire, DK				de Lemos, James A.; Drazner, Mark H.; Omland, Torbjorn; Ayers, Colby R.; Khera, Amit; Rohatgi, Anand; Hashim, Ibrahim; Berry, Jarett D.; Das, Sandeep R.; Morrow, David A.; McGuire, Darren K.			Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR HYPERTROPHY; MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDES; STABILIZED PATIENTS; PROGNOSTIC VALUE; EARLY-DIAGNOSIS; HEART-DISEASE; I ELEVATION; MECHANISMS; SAMPLE	Context Detectable levels of cardiac troponin T (cTnT) are strongly associated with structural heart disease and increased risk of death and adverse cardiovascular events; however, cTnT is rarely detectable in the general population using standard assays. Objectives To determine the prevalence and determinants of detectable cTnT in the population using a new highly sensitive assay and to assess whether cTnT levels measured with the new assay associate with pathological cardiac phenotypes and subsequent mortality. Design, Setting, and Participants Cardiac troponin T levels were measured using both the standard and the highly sensitive assays in 3546 individuals aged 30 to 65 years enrolled between 2000 and 2002 in the Dallas Heart Study, a multiethnic, population-based cohort study. Mortality follow-up was complete through 2007. Participants were placed into 5 categories based on cTnT levels. Main Outcome Measures Magnetic resonance imaging measurements of cardiac structure and function and mortality through a median of 6.4 (interquartile range, 6.0-6.8) years of follow-up. Results In Dallas County, the prevalence of detectable cTnT (>= 0.003 ng/mL) was 25.0% (95% confidence interval [CI], 22.7%-27.4%) with the highly sensitive assay vs 0.7% (95% CI, 0.3%-1.1%) with the standard assay. Prevalence was 37.1% (95% CI, 33.3%-41.0%) in men vs 12.9% (95% CI, 10.6%-15.2%) in women and 14.0% (95% CI, 11.2%-16.9%) in participants younger than 40 years vs 57.6% (95% CI, 47.0%-68.2%) in those 60 years and older. Prevalence of left ventricular hypertrophy increased from 7.5% (95% CI, 6.4%-8.8%) in the lowest cTnT category (>= 0.003 ng/mL) to 48.1% (95% CI, 36.7%-59.6%) in the highest (>= 0.014 ng/mL) (P<.001); prevalence of left ventricular systolic dysfunction and chronic kidney disease also increased across categories (P<.001 for each). During a median follow-up of 6.4 years, there were 151 total deaths, including 62 cardiovascular disease deaths. All-cause mortality increased from 1.9% (95% CI, 1.5%-2.6%) to 28.4% (95% CI, 21.0%-37.8%) across higher cTnT categories (P<.001). After adjustment for traditional risk factors, C-reactive protein level, chronic kidney disease, and N-terminal pro-brain-type natriuretic peptide level, cTnT category remained independently associated with all-cause mortality (adjusted hazard ratio, 2.8 [95% CI, 1.4-5.2] in the highest category). Adding cTnT categories to the fully adjusted mortality model modestly improved model fit (P=.02) and the integrated discrimination index (0.010 [95% CI, 0.002-0.018]; P=.01). Conclusion In this population-based cohort, cTnT detected with a highly sensitive assay was associated with structural heart disease and subsequent risk for all-cause mortality. JAMA. 2010;304(22):2503-2512 www.jama.com	[de Lemos, James A.; Drazner, Mark H.; Ayers, Colby R.; Khera, Amit; Rohatgi, Anand; Berry, Jarett D.; Das, Sandeep R.; McGuire, Darren K.] Univ Texas SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; [de Lemos, James A.; Drazner, Mark H.; Ayers, Colby R.; Khera, Amit; Rohatgi, Anand; Berry, Jarett D.; Das, Sandeep R.; McGuire, Darren K.] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA; [Hashim, Ibrahim] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Omland, Torbjorn] Aker Univ Hosp, Div Med, Oslo, Norway; [Omland, Torbjorn] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Morrow, David A.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Oslo; University of Oslo; Harvard University; Brigham & Women's Hospital	de Lemos, JA (corresponding author), Univ Texas SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Clin Res Ctr, 5909 Harry Hines Blvd,HA 9-133, Dallas, TX 75390 USA.	james.delemos@utsouthwestern.edu	de Lemos, James/ABD-6669-2021; McGuire, Darren K./AAL-4172-2021		Roche Diagnostics; Biosite/Inverness; Tethys Biomedical; Johnson Johnson; Siemens; AstraZeneca; Pfizer; BMS/sanofi-aventis; Merck/Schering; Abbott Laboratories; Beckman-Coulter; Boerhinger Ingelheim; Instrumentation Laboratories; Menarini; Merck; Sanofi-aventis; Servier; Accumetrics; Amgen; Beckman Coulter; Bristol-Myers Squibb; CV Therapeutics; Daiichi Sankyo Co Ltd; Eli Lilly and Co; GlaxoSmithKline; Integrated Therapeutics; Merck and Co; Merck-Schering Plough Joint Venture; Nanosphere; Novartis Pharmaceuticals; Nuvelo; Ortho-Clinical Diagnostics; Singulex; Tethys Bioscience; Biosite; F. Hoffmann LaRoche/Genentech; Cardiovascular Therapeutics; Novo Nordisk; Daiichi-Sankyo; Mitsubishi Tanabe Pharma; Donald W. Reynolds Foundation; National Institutes of Health (NIH)/NCRR-CR [M01-RR00633]; North and Central Texas Clinical and Translational Science Initiative (NIH) [UL1 RR024982]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000633, UL1RR024982] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL092229] Funding Source: NIH RePORTER	Roche Diagnostics; Biosite/Inverness; Tethys Biomedical; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Siemens(Siemens AG); AstraZeneca(AstraZeneca); Pfizer(Pfizer); BMS/sanofi-aventis(Sanofi-Aventis); Merck/Schering(Merck & Company); Abbott Laboratories(Abbott Laboratories); Beckman-Coulter; Boerhinger Ingelheim; Instrumentation Laboratories; Menarini(Menarini Group); Merck(Merck & Company); Sanofi-aventis(Sanofi-Aventis); Servier(Servier); Accumetrics; Amgen(Amgen); Beckman Coulter; Bristol-Myers Squibb(Bristol-Myers Squibb); CV Therapeutics; Daiichi Sankyo Co Ltd(Daiichi Sankyo Company Limited); Eli Lilly and Co(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Integrated Therapeutics; Merck and Co(Merck & Company); Merck-Schering Plough Joint Venture; Nanosphere; Novartis Pharmaceuticals(Novartis); Nuvelo; Ortho-Clinical Diagnostics; Singulex; Tethys Bioscience; Biosite; F. Hoffmann LaRoche/Genentech(Hoffmann-La RocheRoche HoldingGenentech); Cardiovascular Therapeutics; Novo Nordisk(Novo Nordisk); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Mitsubishi Tanabe Pharma(Mitsubishi Tanabe Pharma Corporation); Donald W. Reynolds Foundation; National Institutes of Health (NIH)/NCRR-CR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); North and Central Texas Clinical and Translational Science Initiative (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr de Lemos reported receiving research grants from Roche Diagnostics and Biosite/Inverness and receiving consulting fees and/or lecture honoraria from Tethys Biomedical, Johnson & Johnson, Roche Diagnostics, Biosite/Inverness, Siemens, AstraZeneca, Pfizer, BMS/sanofi-aventis, and Merck/Schering. Dr Drazner reported receiving consulting fees from Biosite/Inverness and lecture honoraria from GlaxoSmithKline. Dr Omland reported receiving research support and lecture honoraria from Roche Diagnostics and Abbott Laboratories. Dr Morrow reported receiving honoraria for educational presentations from Beckman-Coulter, CV Therapeutics, and Eli Lilly and receiving consulting fees from Beckman-Coulter, Boerhinger Ingelheim, Instrumentation Laboratories, Menarini, Merck, sanofi-aventis, Servier, Roche Diagnostics, Siemens, and AstraZeneca. The TIMI Study Group, which supports Dr Morrow's salary, has received significant research grant support from Accumetrics, Amgen, AstraZeneca, Beckman Coulter, Bristol-Myers Squibb, CV Therapeutics, Daiichi Sankyo Co Ltd, Eli Lilly and Co, GlaxoSmithKline, Integrated Therapeutics, Merck and Co, Merck-Schering Plough Joint Venture, Nanosphere, Novartis Pharmaceuticals, Nuvelo, Ortho-Clinical Diagnostics, Pfizer, Roche Diagnostics, sanofi-aventis, Siemens, and Singulex. Dr McGuire reported receiving grant support from GlaxoSmithKline; receiving consulting fees from Tethys Bioscience, Biosite, F. Hoffmann LaRoche/Genentech, Cardiovascular Therapeutics, AstraZeneca, Novo Nordisk, Daiichi-Sankyo, Mitsubishi Tanabe Pharma, Johnson & Johnson, and sanofi-aventis; and receiving lecture honoraria from Pfizer and Takeda. No other authors reported disclosures.; Grant support for the Dallas Heart Study was provided by the Donald W. Reynolds Foundation and by US Public Health Service General Clinical Research Center grant M01-RR00633 from National Institutes of Health (NIH)/NCRR-CR. This study was supported in part by the North and Central Texas Clinical and Translational Science Initiative (NIH grant UL1 RR024982). Financial and materials support for measurements of cardiac troponin T (cTnT) levels in the present study were provided by Roche Diagnostics (Indianapolis, Indiana). Roche Diagnostics also previously provided materials and support for measurement of levels of cTnT, N-terminal pro-brain-type natriuretic peptide, and C-reactive protein in the Dallas Heart Study. Role of the Sponsor: Roche Diagnostics and the NIH had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.	Abdullah SM, 2005, AM J CARDIOL, V96, P1284, DOI 10.1016/j.amjcard.2005.06.073; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Antolini L, 2005, STAT MED, V24, P3927, DOI 10.1002/sim.2427; Apple FS, 2003, CLIN CHEM, V49, pA61; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Blankenberg S, 2010, CIRCULATION, V121, P2388, DOI 10.1161/CIRCULATIONAHA.109.901413; Colosimo EA, 2002, J STAT COMPUT SIM, V72, P299, DOI 10.1080/00949650212847; Daniels LB, 2008, J AM COLL CARDIOL, V52, P450, DOI 10.1016/j.jacc.2008.04.033; Das SR, 2005, CIRCULATION, V112, P2163, DOI 10.1161/CIRCULATIONAHA.105.555573; de Lemos JA, 2009, AM HEART J, V157, P746, DOI 10.1016/j.ahj.2008.12.017; Drazner MH, 2005, HYPERTENSION, V46, P124, DOI 10.1161/01.HYP.0000169972.96201.8e; Eggers KM, 2008, EUR HEART J, V29, P2252, DOI 10.1093/eurheartj/ehn327; Eggers KM, 2008, AM HEART J, V156, P588, DOI 10.1016/j.ahj.2008.04.022; Eggers KM, 2007, CIRCULATION, V116, P1907, DOI 10.1161/CIRCULATIONAHA.107.708529; Giannitsis E, 2010, CLIN CHEM, V56, P254, DOI 10.1373/clinchem.2009.132654; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Horwich TB, 2003, CIRCULATION, V108, P833, DOI 10.1161/01.CIR.0000084543.79097.34; JONCKHEERE AR, 1967, BRIT J MATH STAT PSY, V20, P163, DOI 10.1111/j.2044-8317.1967.tb00385.x; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Khera A, 2005, J AM COLL CARDIOL, V46, P464, DOI 10.1016/j.jacc.2005.04.051; Konstantinides S, 2002, CIRCULATION, V106, P1263, DOI 10.1161/01.CIR.0000028422.51668.A2; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Lindahl B, 2001, J AM COLL CARDIOL, V38, P979, DOI 10.1016/S0735-1097(01)01501-7; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P2405, DOI 10.1001/jama.286.19.2405; Morrow DA, 2007, CLIN CHEM, V53, P552, DOI 10.1373/clinchem.2006.084194; Morrow DA, 2007, CIRCULATION, V115, P949, DOI 10.1161/CIRCULATIONAHA.106.683110; Morrow DA, 2009, CLIN CHEM, V55, P5, DOI 10.1373/clinchem.2008.117218; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; See R, 2008, ARCH INTERN MED, V168, P1055, DOI 10.1001/archinte.168.10.1055; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wallace TW, 2006, CIRCULATION, V113, P1958, DOI 10.1161/CIRCULATIONAHA.105.609974; Wong GC, 2002, CIRCULATION, V106, P202, DOI 10.1161/01.CIR.0000021921.14653.28; Zethelius B, 2006, CIRCULATION, V113, P1071, DOI 10.1161/CIRCULATIONAHA.105.570762	37	816	831	2	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2010	304	22					2503	2512		10.1001/jama.2010.1768	http://dx.doi.org/10.1001/jama.2010.1768			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691AS	21139111	Green Accepted, Bronze			2022-12-28	WOS:000285053300024
J	Ruta, V; Datta, SR; Vasconcelos, ML; Freeland, J; Looger, LL; Axel, R				Ruta, Vanessa; Datta, Sandeep Robert; Vasconcelos, Maria Luisa; Freeland, Jessica; Looger, Loren L.; Axel, Richard			A dimorphic pheromone circuit in Drosophila from sensory input to descending output	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; MALE COURTSHIP BEHAVIOR; RECEPTOR NEURONS; NEURAL CIRCUITRY; FRUITLESS GENE; MELANOGASTER; REPRESENTATION; AGGRESSION; ORGANIZATION; BRAIN	Drosophila show innate olfactory-driven behaviours that are observed in naive animals without previous learning or experience, suggesting that the neural circuits that mediate these behaviours are genetically programmed. Despite the numerical simplicity of the fly nervous system, features of the anatomical organization of the fly brain often confound the delineation of these circuits. Here we identify a neural circuit responsive to cVA, a pheromone that elicits sexually dimorphic behaviours(1-4). We have combined neural tracing using an improved photoactivatable green fluorescent protein (PA-GFP) with electrophysiology, optical imaging and laser-mediated microlesioning to map this circuit from the activation of sensory neurons in the antennae to the excitation of descending neurons in the ventral nerve cord. This circuit is concise and minimally comprises four neurons, connected by three synapses. Three of these neurons are overtly dimorphic and identify a male-specific neuropil that integrates inputs from multiple sensory systems and sends outputs to the ventral nerve cord. This neural pathway suggests a means by which a single pheromone can elicit different behaviours in the two sexes.	[Ruta, Vanessa; Datta, Sandeep Robert; Vasconcelos, Maria Luisa; Freeland, Jessica; Axel, Richard] Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Ruta, Vanessa; Datta, Sandeep Robert; Vasconcelos, Maria Luisa; Freeland, Jessica; Axel, Richard] Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; [Looger, Loren L.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	ra27@columbia.edu		Ruta, Vanessa/0000-0002-4963-2768; Axel, Richard/0000-0002-3141-4076; Vasconcelos, Maria Luisa/0000-0001-6248-3667; Datta, Sandeep/0000-0002-8068-3862	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; Helen Hay Whitney Foundation; Burroughs Welcome Fund; Howard Hughes Medical Institute	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; Helen Hay Whitney Foundation; Burroughs Welcome Fund(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank T. Jessell, C. Zuker and members of the Axel laboratory for discussion and comments on this manuscript; J. Flores for technical assistance; B. Dickson for reagents; P. Kisloff for assistance in the preparation of this manuscript; and M. Gutierrez and A. Nemes for general laboratory support. This work was funded in part by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative. Further financial support was provided by the Helen Hay Whitney Foundation (V.R. and S.R.D.), the Burroughs Welcome Fund (S.R.D.) and the Howard Hughes Medical Institute (R.A. and L.L.L.).	BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Billeter JC, 2006, CURR BIOL, V16, P1063, DOI 10.1016/j.cub.2006.04.039; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Chan YB, 2007, P NATL ACAD SCI USA, V104, P19577, DOI 10.1073/pnas.0709803104; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dulac C, 2007, CURR OPIN NEUROBIOL, V17, P675, DOI 10.1016/j.conb.2008.01.009; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Ito K, 1998, LEARN MEMORY, V5, P52; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	33	232	235	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					686	U106		10.1038/nature09554	http://dx.doi.org/10.1038/nature09554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124455				2022-12-28	WOS:000284836700039
J	Aaby, P; Martins, CL; Garly, ML; Bale, C; Andersen, A; Rodrigues, A; Ravn, H; Lisse, IM; Benn, CS; Whittle, HC				Aaby, Peter; Martins, Cesario L.; Garly, May-Lill; Bale, Carlito; Andersen, Andreas; Rodrigues, Amabelia; Ravn, Henrik; Lisse, Ida M.; Benn, Christine S.; Whittle, Hilton C.			Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VITAMIN-A SUPPLEMENTATION; FEMALE-MALE MORTALITY; DIPHTHERIA-TETANUS-PERTUSSIS; GUINEA-BISSAU; EDMONSTON-ZAGREB; ROUTINE VACCINATIONS; BCG VACCINE; IMMUNIZATION; TITER; SURVIVAL	Objective To examine in a randomised trial whether a 25% difference in mortality exists between 4.5 months and 3 years of age for children given two standard doses of Edmonston-Zagreb measles vaccines at 4.5 and 9 months of age compared with those given one dose of measles vaccine at 9 months of age (current policy). Design Randomised controlled trial. Setting The Bandim Health Project, Guinea-Bissau, which maintains a health and demographic surveillance system in an urban area. Participants 6648 children aged 4.5 months of age who had received three doses of diphtheria-tetanus-pertussis vaccine at least four weeks before enrolment. A large proportion of the children (80%) had previously taken part in randomised trials of neonatal vitamin A supplementation. Intervention Children were randomised to receive Edmonston-Zagreb measles vaccine at 4.5 and 9 months of age (group A), no vaccine at 4.5 months and Edmonston-Zagreb measles vaccine at 9 months of age (group B), or no vaccine at 4.5 months and Schwarz measles vaccine at 9 months of age (group C). Main outcome measure Mortality rate ratio between 4.5 and 36 months of age for group A compared with groups B and C. Secondary outcomes tested the hypothesis that the beneficial effect was stronger in the 4.5 to 9 months age group, in girls, and in the dry season, but the study was not powered to test whether effects differed significantly between subgroups. Results In the intention to treat analysis of mortality between 4.5 and 36 months of age the mortality rate ratio of children who received two doses of Edmonston-Zagreb vaccine at 4.5 and 9 months of age compared with those who received a single dose of Edmonston-Zagreb vaccine or Schwarz vaccine at 9 months of age was 0.78 (95% confidence interval 0.59 to 1.05). In the analyses of secondary outcomes, the intention to treat mortality rate ratio was 0.67 (0.38 to 1.19) between 4.5 and 9 months and 0.83 (0.83 to 1.16) between 9 and 36 months of age. The effect on mortality between 4.5 and 36 months of age was significant for girls (intention to treat mortality rate ratio 0.64 (0.42 to 0.98)), although this was not significantly different from the effect in boys (0.95 (0.64 to 1.42)) (interaction test, P=0.18). The effect did not differ between the dry season and the rainy season. As neonatal vitamin A supplementation is not WHO policy, the analyses were done separately for the 3402 children who did not receive neonatal vitamin A. In these children, the two dose Edmonston-Zagreb measles vaccine schedule was associated with a significantly lower mortality between 4.5 and 36 months of age (intention to treat mortality rate ratio 0.59 (0.39 to 0.89)). The effect was again significant for girls but not statistically significant from the effect in boys. When measles cases were censored, the intention to treat mortality rate ratio was 0.65 (0.43 to 0.99). Conclusions Although the overall effect did not reach statistical significance, the results may indicate that a two dose schedule with Edmonston-Zagreb measles vaccine given at 4.5 and 9 months of age has beneficial nonspecific effects on children's survival, particularly for girls and for children who have not received neonatal vitamin A. This should be tested in future studies in different locations.	[Aaby, Peter; Martins, Cesario L.; Garly, May-Lill; Bale, Carlito; Andersen, Andreas; Rodrigues, Amabelia; Ravn, Henrik; Benn, Christine S.] Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Aaby, Peter; Garly, May-Lill; Andersen, Andreas; Ravn, Henrik; Benn, Christine S.] Statens Serum Inst, Danish Epidemiol Sci Ctr, Bandim Hlth Project, DK-2300 Copenhagen S, Denmark; [Lisse, Ida M.] Herlev Univ Hosp, Dept Pathol, DK-2730 Herlev, Denmark; [Whittle, Hilton C.] MRC Labs, Fajara, Gambia	Aarhus University; Statens Serum Institut; University of Copenhagen; Herlev & Gentofte Hospital; MRC Laboratory Molecular Biology	Aaby, P (corresponding author), Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau.	p.aaby@bandim.org		Aaby, Peter/0000-0001-8331-1389	Thrasher Foundation; DANIDA; Danish National Research Foundation; Fonden til Laegevidenskabens Fremme; Novo Nordisk Foundation; Medical Research Council [MC_U190074200, MC_U190088487] Funding Source: researchfish; MRC [MC_U190074200, MC_U190088487] Funding Source: UKRI	Thrasher Foundation; DANIDA; Danish National Research Foundation(Danmarks Grundforskningsfond); Fonden til Laegevidenskabens Fremme; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research on the decline in maternal antibodies that inspired this trial was funded by the Thrasher Foundation. This study was mostly funded by DANIDA and the Danish National Research Foundation. The project also received support from Fonden til Laegevidenskabens Fremme and Novo Nordisk Foundation. The Bandim Health Project received support from DANIDA. PA holds a research professorship grant from the Novo Nordisk Foundation. The funding agencies had no role in the study design, data collection, data analysis, data interpretation, or the writing of the report.	AABY P, 1993, BRIT MED J, V307, P1308, DOI 10.1136/bmj.307.6915.1308; AABY P, 1989, PEDIATR INFECT DIS J, V8, P197; Aaby P, 2006, VACCINE, V24, P2764, DOI 10.1016/j.vaccine.2006.01.004; AABY P, 1993, AM J EPIDEMIOL, V138, P746, DOI 10.1093/oxfordjournals.aje.a116912; AABY P, 1988, LANCET, V2, P809; AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; Aaby P, 2003, PEDIATR INFECT DIS J, V22, P798, DOI 10.1097/01.inf.0000083821.33187.b5; Aaby P, 2003, LANCET, V361, P2183, DOI 10.1016/S0140-6736(03)13771-3; Aaby P, 2003, INT J EPIDEMIOL, V32, P106, DOI 10.1093/ije/dyg005; Aaby P, 2002, VACCINE, V21, P120, DOI 10.1016/S0264-410X(02)00430-9; AABY P, 1984, J TROP PEDIATRICS, V30, P164, DOI 10.1093/tropej/30.3.164; Aaby P, 1996, AM J EPIDEMIOL, V143, P1035, DOI 10.1093/oxfordjournals.aje.a008667; AABY P, 1981, LANCET, V2, P93; AABY P, 1994, B WORLD HEALTH ORGAN, V72, P761; AABY P, 1993, J PEDIATR-US, V122, P904, DOI 10.1016/S0022-3476(09)90015-4; Aaby P, 1996, PEDIATR INFECT DIS J, V15, P39, DOI 10.1097/00006454-199601000-00009; AABY P, 1984, J INFECTION, V8, P13, DOI 10.1016/S0163-4453(84)93192-X; AABY P, 1997, PROSPECTIVE COMMUNIT, P276; Aaby P, 2007, PEDIATR INFECT DIS J, V26, P247, DOI 10.1097/01.inf.0000256735.05098.01; Aaby P, 2006, PEDIATR INFECT DIS J, V25, P721, DOI 10.1097/01.inf.0000227829.64686.ae; Aaby P, 2006, VACCINE, V24, P4701, DOI 10.1016/j.vaccine.2006.03.038; Aaby P, 2010, PEDIATR INFECT DIS J, V29, P324, DOI 10.1097/INF.0b013e3181c15367; Aaby P, 2009, LANCET, V373, P1428, DOI 10.1016/S0140-6736(09)60823-0; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P287; [Anonymous], 1992, WKLY EPIDEMIOL REC, V67, P357; Barnard A, 1996, IMMUNOLOGY, V87, P372, DOI 10.1046/j.1365-2567.1996.497560.x; Benn CS, 2009, AM J CLIN NUTR, V90, P629, DOI 10.3945/ajcn.2009.27477; Benn CS, 2008, BMJ-BRIT MED J, V336, P1416, DOI 10.1136/bmj.39542.509444.AE; Benn Christine Stabell, 2010, BMJ, V340, pc1101, DOI 10.1136/bmj.c1101; Benn CS, 2009, VACCINE, V27, P2891, DOI 10.1016/j.vaccine.2009.02.080; Benn CS, 2009, INT J EPIDEMIOL, V38, P304, DOI 10.1093/ije/dyn195; Bennett JV, 1999, PEDIATRICS, V104, P1123, DOI 10.1542/peds.104.5.1123; CLEMENS JD, 1988, AM J EPIDEMIOL, V128, P1330, DOI 10.1093/oxfordjournals.aje.a115086; Cooper WO, 2003, B WORLD HEALTH ORGAN, V81, P821; DULOU AD, 1995, AM J EPIDEMIOL, V142, P643, DOI 10.1093/oxfordjournals.aje.a117688; Expanded Programme on Immunization, 1982, WEEKLY EPIDEMIOL REC, V57, P89; Fischer JE, 2000, J INFECT DIS, V182, P1029, DOI 10.1086/315806; Garly ML, 2008, J PEDIATR-US, V153, P683, DOI 10.1016/j.jpeds.2008.04.069; Garly ML, 1999, INT J EPIDEMIOL, V28, P347, DOI 10.1093/ije/28.2.347; Garly ML, 2001, VACCINE, V19, P1951, DOI 10.1016/S0264-410X(00)00431-X; GRAHAM BS, 1993, J IMMUNOL, V151, P2032; HOLT EA, 1990, PEDIATRICS, V85, P188; HOLT EA, 1993, J INFECT DIS, V168, P1087, DOI 10.1093/infdis/168.5.1087; Knudsen KM, 1996, INT J EPIDEMIOL, V25, P665, DOI 10.1093/ije/25.3.665; KOENIG MA, 1990, B WORLD HEALTH ORGAN, V68, P441; Lindblad EB, 1997, INFECT IMMUN, V65, P623, DOI 10.1128/IAI.65.2.623-629.1997; Martins C, 2009, VACCINE, V27, P5220, DOI 10.1016/j.vaccine.2009.06.076; Martins CL, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a661; Moran TM, 1999, J INFECT DIS, V180, P579, DOI 10.1086/314952; ROTH A, 2010, BMJ-BRIT MED J, V340, pC809; Shann F, 2004, PEDIATR INFECT DIS J, V23, P555, DOI 10.1097/01.inf.0000130155.42392.04; VANBALEN H, 1981, LANCET, V1, P764; Veirum JE, 2005, VACCINE, V23, P1197, DOI 10.1016/j.vaccine.2004.02.053; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; WHITTLE H, 1988, LANCET, V2, P811; WHITTLE HC, 1990, LANCET, V336, P1046, DOI 10.1016/0140-6736(90)92501-8	56	203	205	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2010	341								c6495	10.1136/bmj.c6495	http://dx.doi.org/10.1136/bmj.c6495			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691OG	21118875	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000285090100006
J	Thumbs, A; Borgstein, E				Thumbs, Alexander; Borgstein, Eric			Commentary: managing oesophageal cancer in a resource poor setting-a Malawian example	BMJ-BRITISH MEDICAL JOURNAL			English	Review									[Thumbs, Alexander; Borgstein, Eric] Queen Elizabeth Cent Hosp, Dept Surg, Blantyre, Malawi; [Thumbs, Alexander; Borgstein, Eric] Univ Malawi, Coll Med, Blantyre, Malawi	University of Malawi; University of Malawi		alex_thumbs@hotmail.com						Lagergren J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6280; PARKIN DM, 1993, INT J CANCER, V54, P594, DOI 10.1002/ijc.2910540413; Sammon A, 2009, SQUAMOUS CANC ESOPHA	3	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2010	341								c6723	10.1136/bmj.c6723	http://dx.doi.org/10.1136/bmj.c6723			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EH	21112910				2022-12-28	WOS:000284832100002
J	Manolio, TA; Collins, R				Manolio, Teri A.; Collins, Rory			Enhancing the Feasibility of Large Cohort Studies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ENVIRONMENT; GENES		[Manolio, Teri A.] NHGRI, Off Populat Genom, Bethesda, MD 20892 USA; [Collins, Rory] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Collins, Rory] Univ Oxford, Epidemiol Studies Unit, Oxford, England	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Oxford; University of Oxford	Manolio, TA (corresponding author), NHGRI, Off Populat Genom, Bldg 31,Room 4B-09,31 Ctr Dr,MSC 2154, Bethesda, MD 20892 USA.	manolio@nih.gov			Intramural NIH HHS [Z99 HG999999] Funding Source: Medline; Medical Research Council [MC_U137686857, MC_QA137853] Funding Source: Medline; Medical Research Council [MC_qA137853] Funding Source: researchfish; MRC [MC_U137686857] Funding Source: UKRI	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Doll R, 2005, BRIT J CANCER, V92, P426, DOI 10.1038/sj.bjc.6602359; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; McCarty Catherine A, 2005, Per Med, V2, P49, DOI 10.1517/17410541.2.1.49; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; *UK BIOB, WELC UK BIOB; US Department of Health and Human Services, NAT HLTH INF NETW OV	10	56	60	1	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2010	304	20					2290	2291		10.1001/jama.2010.1686	http://dx.doi.org/10.1001/jama.2010.1686			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KI	21098774	Green Accepted			2022-12-28	WOS:000284548400029
J	Rosenthal, VD				Rosenthal, Victor D.			Health-care-associated infections in developing countries	LANCET			English	Editorial Material							BLOOD-STREAM INFECTION; LENGTH-OF-STAY; CENTRAL VENOUS CATHETER; CONTROL-CONSORTIUM; ATTRIBUTABLE COST; MATCHED ANALYSIS; HOSPITAL STAY; UNITS; MORTALITY; ARGENTINA		Int Nosocomial Infect Control Consortium, RA-1195 Buenos Aires, DF, Argentina		Rosenthal, VD (corresponding author), Int Nosocomial Infect Control Consortium, RA-1195 Buenos Aires, DF, Argentina.	victor_rosenthal@inicc.org	Rosenthal, Victor Daniel/HGD-1892-2022	ROSENTHAL, VICTOR DANIEL/0000-0001-9138-4801				Allegranzi B, 2010, LANCET, DOI S0140-6736(10)61458-4; Barnett AG, 2010, INFECT CONT HOSP EP, V31, P1106, DOI 10.1086/656593; Cuellar LE, 2008, REV PANAM SALUD PUBL, V24, P16, DOI 10.1590/S1020-49892008000700002; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; European Centre for Disease Prevention and Control, 2008, ANN EP REP COMM DIS; Higuera F, 2007, INFECT CONT HOSP EP, V28, P31, DOI 10.1086/510812; Higuera F, 2005, CRIT CARE MED, V33, P2022, DOI 10.1097/01.CCM.0000178190.89663.E5; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Madani Naoufel, 2009, Int Arch Med, V2, P29, DOI 10.1186/1755-7682-2-29; Moreno CA, 2006, INFECT CONT HOSP EP, V27, P349, DOI 10.1086/503341; Rosenthal VD, 2005, AM J INFECT CONTROL, V33, P157, DOI 10.1016/j.ajic.2004.08.008; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P475, DOI 10.1016/j.ajic.2003.03.002; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P291, DOI 10.1067/mic.2003.1; Rosenthal VD, 2008, AM J INFECT CONTROL, V36, P627, DOI [10.1016/j.ajic.2008.10.009, 10.1016/j.ajic.2008.06.003]; Rosenthal VD, 2010, INFECT CONT HOSP EP, V31, P1264, DOI 10.1086/657140; Rosenthal VD, 2010, AM J INFECT CONTROL, V38, P95, DOI 10.1016/j.ajic.2009.12.004; Rosenthal VD, 2009, CLIN INFECT DIS, V49, P1899, DOI 10.1086/648439; Tarricone Rosanna, 2010, Cost Eff Resour Alloc, V8, P8, DOI 10.1186/1478-7547-8-8	18	61	61	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2011	377	9761					186	188		10.1016/S0140-6736(10)62005-3	http://dx.doi.org/10.1016/S0140-6736(10)62005-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	712WG	21146208				2022-12-28	WOS:000286696400007
J	Koksal, M; Jin, YH; Coates, RM; Croteau, R; Christianson, DW				Koeksal, Mustafa; Jin, Yinghua; Coates, Robert M.; Croteau, Rodney; Christianson, David W.			Taxadiene synthase structure and evolution of modular architecture in terpene biosynthesis	NATURE			English	Article							ENT-COPALYL DIPHOSPHATE; CRYSTAL-STRUCTURE; TAXOL BIOSYNTHESIS; COMMITTED STEP; GERANYLGERANYL DIPHOSPHATE; DITERPENE CYCLASE; CYCLIZATION; MECHANISM; CATALYZES; TAXA-4(5),11(12)-DIENE	With more than 55,000 members identified so far in all forms of life, the family of terpene or terpenoid natural products represents the epitome of molecular biodiversity. A well-known and important member of this family is the polycyclic diterpenoid Taxol (paclitaxel), which promotes tubulin polymerization(1) and shows remarkable efficacy in cancer chemotherapy(2). The first committed step of Taxol biosynthesis in the Pacific yew (Taxus brevifolia)(3) is the cyclization of the linear isoprenoid substrate geranylgeranyl diphosphate (GGPP) to form taxa-4(5), 11(12) diene(4), which is catalysed by taxadiene synthase(5). The full-length form of this diterpene cyclase contains 862 residues, but a roughly 80-residue amino-terminal transit sequence is cleaved on maturation in plastids(6). We now report the X-ray crystal structure of a truncation variant lacking the transit sequence and an additional 27 residues at the N terminus, hereafter designated TXS. Specifically, we have determined structures of TXS complexed with 13-aza-13,14-dihydrocopalyl diphosphate (1.82 angstrom resolution) and 2-fluorogeranylgeranyl diphosphate (2.25 angstrom resolution). The TXS structure reveals a modular assembly of three alpha-helical domains. The carboxy-terminal catalytic domain is a class I terpenoid cyclase, which binds and activates substrate GGPP with a three-metal ion cluster. The N-terminal domain and a third 'insertion' domain together adopt the fold of a vestigial class II terpenoid cyclase. A class II cyclase activates the isoprenoid substrate by protonation instead of ionization, and the TXS structure reveals a definitive connection between the two distinct cyclase classes in the evolution of terpenoid biosynthesis.	[Koeksal, Mustafa; Christianson, David W.] Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA; [Jin, Yinghua; Coates, Robert M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Jin, Yinghua] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Croteau, Rodney] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	University of Pennsylvania; University of Illinois System; University of Illinois Urbana-Champaign; University of Colorado System; University of Colorado Boulder; Washington State University	Christianson, DW (corresponding author), Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, 231 S 34th St, Philadelphia, PA 19104 USA.	chris@sas.upenn.edu	jin, Yinghua/T-7461-2019	JIN, YINGHUA/0000-0002-8446-8350	US National Institutes of Health [GM56838, GM13956, CA55254]; University of Illinois; NATIONAL CANCER INSTITUTE [R01CA055254, R37CA055254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056838, R01GM013956] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. MacDermaid and J. Saven for advice and assistance with molecular modelling calculations, and E. Oldfield for helpful comments on the manuscript. We thank the National Synchrotron Light Source at Brookhaven National Laboratory for beamline access. The US National Institutes of Health provided grants GM56838 (D.W.C.), GM13956 (R.M.C.) and CA55254 (R.C.) in support of this research. Y.J. thanks the University of Illinois for support through the John C. Bailar and R. C. Fuson Fellowships.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARBUCK SG, 1995, TAXOL SCI APPL, P379; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao R, 2010, PROTEINS, V78, P2417, DOI 10.1002/prot.22751; Chang TH, 2006, J BIOL CHEM, V281, P14991, DOI 10.1074/jbc.M512886200; Christianson DW, 2008, CURR OPIN CHEM BIOL, V12, P141, DOI 10.1016/j.cbpa.2007.12.008; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao Q, 1996, TETRAHEDRON LETT, V37, P3425, DOI 10.1016/0040-4039(96)00585-0; HEZARI M, 1995, ARCH BIOCHEM BIOPHYS, V322, P437, DOI 10.1006/abbi.1995.1486; Jin QW, 2005, J ORG CHEM, V70, P4667, DOI 10.1021/jo0502091; Jin YH, 2005, J AM CHEM SOC, V127, P7834, DOI 10.1021/ja050592r; Keeling CI, 2010, PLANT PHYSIOL, V152, P1197, DOI 10.1104/pp.109.151456; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Koksal M, 2010, J MOL BIOL, V402, P363, DOI 10.1016/j.jmb.2010.07.009; KOEPP AE, 1995, J BIOL CHEM, V270, P8686, DOI 10.1074/jbc.270.15.8686; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; Lin XY, 1996, BIOCHEMISTRY-US, V35, P2968, DOI 10.1021/bi9526239; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Peters RJ, 2001, J AM CHEM SOC, V123, P8974, DOI 10.1021/ja010670k; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prisic S, 2007, PLANT PHYSIOL, V144, P445, DOI 10.1104/pp.106.095208; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Trapp SC, 2001, GENETICS, V158, P811; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Wendt KU, 1998, STRUCTURE, V6, P127, DOI 10.1016/S0969-2126(98)00015-X; Wendt KU, 2000, ANGEW CHEM INT EDIT, V39, P2812, DOI 10.1002/1521-3773(20000818)39:16<2812::AID-ANIE2812>3.0.CO;2-#; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; Whittington DA, 2002, P NATL ACAD SCI USA, V99, P15375, DOI 10.1073/pnas.232591099; Wildung MR, 1996, J BIOL CHEM, V271, P9201, DOI 10.1074/jbc.271.16.9201; Williams DC, 2000, ARCH BIOCHEM BIOPHYS, V379, P137, DOI 10.1006/abbi.2000.1865; Williams DC, 2000, CHEM BIOL, V7, P969, DOI 10.1016/S1074-5521(00)00046-6	40	200	214	7	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					116	U138		10.1038/nature09628	http://dx.doi.org/10.1038/nature09628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21160477	Green Accepted			2022-12-28	WOS:000285921600043
J	Walton, DA; Ivers, LC				Walton, David A.; Ivers, Louise C.			Responding to Cholera in Post-Earthquake Haiti.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Walton, David A.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; Partners Hlth, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Partners Healthcare System	Walton, DA (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA.		Ivers, Louise C/Q-4164-2018	Ivers, Louise C/0000-0003-2314-9230				*MIN SANT PUBL POP, 2005, ENQ MORT MORB UT SER; Sullivan CA, 2003, NAT RESOUR FORUM, V27, P189, DOI 10.1111/1477-8947.00054; 2010, 101112 WASH CLUSTER	3	61	66	1	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2011	364	1					3	5		10.1056/NEJMp1012997	http://dx.doi.org/10.1056/NEJMp1012997			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702UY	21142690	Bronze			2022-12-28	WOS:000285922600002
J	Gibson, P; Tong, YA; Robinson, G; Thompson, MC; Currle, DS; Eden, C; Kranenburg, TA; Hogg, T; Poppleton, H; Martin, J; Finkelstein, D; Pounds, S; Weiss, A; Patay, Z; Scoggins, M; Ogg, R; Pei, YX; Yang, ZJ; Brun, S; Lee, Y; Zindy, F; Lindsey, JC; Taketo, MM; Boop, FA; Sanford, RA; Gajjar, A; Clifford, SC; Roussel, MF; McKinnon, PJ; Gutmann, DH; Ellison, DW; Wechsler-Reya, R; Gilbertson, RJ				Gibson, Paul; Tong, Yiai; Robinson, Giles; Thompson, Margaret C.; Currle, D. Spencer; Eden, Christopher; Kranenburg, Tanya A.; Hogg, Twala; Poppleton, Helen; Martin, Julie; Finkelstein, David; Pounds, Stanley; Weiss, Aaron; Patay, Zoltan; Scoggins, Matthew; Ogg, Robert; Pei, Yanxin; Yang, Zeng-Jie; Brun, Sonja; Lee, Youngsoo; Zindy, Frederique; Lindsey, Janet C.; Taketo, Makoto M.; Boop, Frederick A.; Sanford, Robert A.; Gajjar, Amar; Clifford, Steven C.; Roussel, Martine F.; McKinnon, Peter J.; Gutmann, David H.; Ellison, David W.; Wechsler-Reya, Robert; Gilbertson, Richard J.			Subtypes of medulloblastoma have distinct developmental origins	NATURE			English	Article							CELL; PROGENITORS; P53; HINDBRAIN; MODEL; MICE	Medulloblastoma encompasses a collection of clinically and molecularly diverse tumour subtypes that together comprise the most common malignant childhood brain tumour(1-4). These tumours are thought to arise within the cerebellum, with approximately 25% originating from granule neuron precursor cells (GNPCs) after aberrant activation of the Sonic Hedgehog pathway (hereafter, SHH subtype)(3-8). The pathological processes that drive heterogeneity among the other medulloblastoma subtypes are not known, hindering the development of much needed new therapies. Here we provide evidence that a discrete subtype of medulloblastoma that contains activating mutations in the WNT pathway effector CTNNB1 (hereafter, WNT subtype) 1,3,4 arises outside the cerebellum from cells of the dorsal brainstem. We found that genes marking human WNT-subtype medulloblastomas are more frequently expressed in the lower rhombic lip (LRL) and embryonic dorsal brainstem than in the upper rhombic lip (URL) and developing cerebellum. Magnetic resonance imaging (MRI) and intra-operative reports showed that human WNT-subtype tumours infiltrate the dorsal brainstem, whereas SHH-subtype tumours are located within the cerebellar hemispheres. Activating mutations in Ctnnb1 had little impact on progenitor cell populations in the cerebellum, but caused the abnormal accumulation of cells on the embryonic dorsal brainstem which included aberrantly proliferating Zic1(+) precursor cells. These lesions persisted in all mutant adult mice; moreover, in 15% of cases in which Tp53 was concurrently deleted, they progressed to form medulloblastomas that recapitulated the anatomy and gene expression profiles of human WNT-subtype medulloblastoma. We provide the first evidence, to our knowledge, that subtypes of medulloblastoma have distinct cellular origins. Our data provide an explanation for the marked molecular and clinical differences between SHH- and WNT-subtype medulloblastomas and have profound implications for future research and treatment of this important childhood cancer.	[Gibson, Paul; Tong, Yiai; Robinson, Giles; Currle, D. Spencer; Eden, Christopher; Kranenburg, Tanya A.; Hogg, Twala; Poppleton, Helen; Martin, Julie; Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Robinson, Giles; Gajjar, Amar; Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Finkelstein, David] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Pounds, Stanley] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Patay, Zoltan; Scoggins, Matthew; Ogg, Robert] St Jude Childrens Res Hosp, Dept Radiol Sci, Memphis, TN 38105 USA; [Lee, Youngsoo; Zindy, Frederique; Roussel, Martine F.; McKinnon, Peter J.] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Boop, Frederick A.; Sanford, Robert A.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA; [Ellison, David W.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Thompson, Margaret C.] Cleveland Clin, Dept Pediat Hematol Oncol, Cleveland, OH 44195 USA; [Weiss, Aaron] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA; [Pei, Yanxin; Yang, Zeng-Jie; Brun, Sonja; Wechsler-Reya, Robert] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Lindsey, Janet C.; Clifford, Steven C.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Cleveland Clinic Foundation; Rutgers State University New Brunswick; Rutgers State University Medical Center; Duke University; Newcastle University - UK; Kyoto University; Washington University (WUSTL)	Gilbertson, RJ (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	Richard.Gilbertson@stjude.org	Gilbertson, Richard James/ABE-1346-2021; Kranenburg, Tanya/F-7138-2012; Patay, Zoltan/N-6994-2018; Robinson, Giles/N-8095-2018; Pounds, Stanley/N-2480-2018	Gilbertson, Richard James/0000-0001-7539-9472; Kranenburg, Tanya/0000-0002-5329-4968; Patay, Zoltan/0000-0003-1479-9864; Robinson, Giles/0000-0001-7441-9486; Lee, Youngsoo/0000-0003-4773-6464; Gutmann, David/0000-0002-3127-5045; Pounds, Stanley/0000-0002-9167-2114; Clifford, Steve/0000-0003-4893-2184	National Institutes of Health [R01CA129541, P01CA96832, P30CA021765]; Collaborative Ependymoma Research Network; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA129541, P30CA021765, P01CA096832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaborative Ependymoma Research Network; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	R.J.G. holds the Howard C. Schott Research Chair from the Malia's Cord Foundation, and is supported by grants from the National Institutes of Health (R01CA129541, P01CA96832 and P30CA021765), the Collaborative Ependymoma Research Network and by the American Lebanese Syrian Associated Charities. We are grateful to A. Chenn, J. Johnson and C. Birchmeier for their gifts of reagents and the staff of the Hartwell Center for Bioinformatics and Biotechnology and ARC at St Jude Children's Research Hospital for technical assistance.	Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Dipietrantonio HJ, 2009, NEUROSCIENCE, V162, P560, DOI 10.1016/j.neuroscience.2009.02.082; Ellison DW, 2005, J CLIN ONCOL, V23, P7951, DOI 10.1200/JCO.2005.01.5479; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Frappart PO, 2009, P NATL ACAD SCI USA, V106, P1880, DOI 10.1073/pnas.0806882106; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hegedus B, 2007, CELL STEM CELL, V1, P443, DOI 10.1016/j.stem.2007.07.008; Huang X, 2010, P NATL ACAD SCI USA, V107, P8422, DOI 10.1073/pnas.0911838107; Ikeda A, 2001, HUM MOL GENET, V10, P1325, DOI 10.1093/hmg/10.12.1325; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Landsberg RL, 2005, NEURON, V48, P933, DOI 10.1016/j.neuron.2005.11.031; Lee Y, 2003, CANCER RES, V63, P5428; Morales D, 2006, J NEUROSCI, V26, P12226, DOI 10.1523/JNEUROSCI.3493-06.2006; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Ray RS, 2009, CURR OPIN CELL BIOL, V21, P741, DOI 10.1016/j.ceb.2009.10.003; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Storm R, 2009, DEVELOPMENT, V136, P295, DOI 10.1242/dev.027193; The WHO, 2020, CLASSIFICATION TUMOU; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Uziel T, 2005, GENE DEV, V19, P2656, DOI 10.1101/gad.1368605; Wetmore C, 2001, CANCER RES, V61, P513; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003	29	538	553	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1095	1099		10.1038/nature09587	http://dx.doi.org/10.1038/nature09587			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21150899	Green Accepted			2022-12-28	WOS:000285553800057
J	Balch, JK; Nepstad, DC; Brando, PM; Alencar, A				Balch, Jennifer K.; Nepstad, Daniel C.; Brando, Paulo M.; Alencar, Ane			Comment on "The Incidence of Fire in Amazonian Forests with Implications for REDD"	SCIENCE			English	Editorial Material							DEFORESTATION; CARBON	Aragao and Shimabukuro (Reports, 4 June 2010, p. 1275) reported that fires increase in agricultural frontiers even as deforestation decreases and concluded that these fires lead to unaccounted carbon emissions under the United Nations climate treaty's tropical deforestation and forest degradation component. Emissions from post-deforestation management activities are, in fact, included in these estimates-but burning of standing forests is not.	[Balch, Jennifer K.; Nepstad, Daniel C.; Brando, Paulo M.; Alencar, Ane] Amazon Environm Res Inst IPAM, BR-71503505 Brasilia, DF, Brazil; [Balch, Jennifer K.] Woods Hole Res Ctr, Woods Hole, MA 02540 USA; [Balch, Jennifer K.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Alencar, Ane] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA	Woods Hole Research Center; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; State University System of Florida; University of Florida	Balch, JK (corresponding author), Amazon Environm Res Inst IPAM, BR-71503505 Brasilia, DF, Brazil.	balch@nceas.ucsb.edu	Brando, Paulo/AAC-9396-2019; Brando, Paulo M/C-4302-2012; /AAX-3684-2020	Brando, Paulo/0000-0001-8952-7025; Brando, Paulo M/0000-0001-8952-7025; /0000-0001-5605-7469				Alencar A, 2006, EARTH INTERACT, V10; Aragao LEOC, 2010, SCIENCE, V328, P1275, DOI 10.1126/science.1186925; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Balch JK, 2008, GLOBAL CHANGE BIOL, V14, P2276, DOI 10.1111/j.1365-2486.2008.01655.x; Barlow Jos, 2006, P225; Fearnside PM, 1997, CLIMATIC CHANGE, V35, P321, DOI 10.1023/A:1005336724350; Hayashi S., 2010, IMAZON B TRANSPARENC; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; Instituto Nacional de Pesquisas Espaciais (INPE), ANN ACC NOAA 15 ACT; Morton DC, 2008, GLOBAL CHANGE BIOL, V14, P2262, DOI 10.1111/j.1365-2486.2008.01652.x; National Institute for Space Research (INPE), MON BRAZ AM FOR SAT; Nepstad D, 2001, FOREST ECOL MANAG, V154, P395, DOI 10.1016/S0378-1127(01)00511-4; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Schroeder W, 2005, EARTH INTERACT, V9; Stickler CM, 2009, GLOBAL CHANGE BIOL, V15, P2803, DOI 10.1111/j.1365-2486.2009.02109.x	16	11	11	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011								10.1126/science.1194032	http://dx.doi.org/10.1126/science.1194032			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164000				2022-12-28	WOS:000285390500045
J	Parker, C; Waters, R; Leighton, C; Hancock, J; Sutton, R; Moorman, AV; Ancliff, P; Morgan, M; Masurekar, A; Goulden, N; Green, N; Revesz, T; Darbyshire, P; Love, S; Saha, V				Parker, Catriona; Waters, Rachel; Leighton, Carly; Hancock, Jeremy; Sutton, Rosemary; Moorman, Anthony V.; Ancliff, Philip; Morgan, Mary; Masurekar, Ashish; Goulden, Nicholas; Green, Nina; Revesz, Tamas; Darbyshire, Philip; Love, Sharon; Saha, Vaskar			Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial	LANCET			English	Article							DOSE ARA-C; CHILDHOOD LEUKEMIA; ACCELERATED APPROVAL; PEDIATRIC-PATIENTS; ONCOLOGY GROUP; RISK; IDARUBICIN; EXPERIENCE; THERAPY; SENSITIVITY	Background Although survival of children with acute lymphoblastic leukaemia has improved greatly in the past two decades, the outcome of those who relapse has remained static. We investigated the outcome of children with acute lymphoblastic leukaemia who relapsed on present therapeutic regimens. Methods This open-label randomised trial was undertaken in 22 centres in the UK and Ireland and nine in Australia and New Zealand. Patients aged 1-18 years with first relapse of acute lymphoblastic leukaemia were stratified into high-risk, intermediate-risk, and standard-risk groups on the basis of duration of first complete remission, site of relapse, and immunophenotype. All patients were allocated to receive either idarubicin or mitoxantrone in induction by stratified concealed randomisation. Neither patients nor those giving interventions were masked. After three blocks of therapy, all high-risk group patients and those from the intermediate group with postinduction high minimal residual disease (>= 10(-4) cells) received an allogenic stem-cell transplant. Standard-risk and intermediate-risk patients with postinduction low minimal residual disease (<10(-4) cells) continued chemotherapy. The primary outcome was progression-free survival and the method of analysis was intention-to-treat. Randomisation was stopped in December, 2007 because of differences in progression-free and overall survival between the two groups. This trial is registered, reference number ISCRTN45724312. Findings Of 239 registered patients, 216 were randomly assigned to either idarubicin (109 analysed) or mitoxantrone (103 analysed). Estimated 3-year progression-free survival was 35.9% (95% CI 25.9-45.9) in the idarubicin group versus 64.6% (54.2-73.2) in the mitoxantrone group (p=0.0004), and 3-year overall survival was 45.2% (34.5-55.3) versus 69.0% (58.5-77.3; p=0.004). Differences in progression-free survival between groups were mainly related to a decrease in disease events (progression, second relapse, disease-related deaths; HR 0.56, 0.34-0.92, p=0.007) rather than an increase in adverse treatment effects (treatment death, second malignancy; HR 0.52, 0.24-1.11). Interpretation As compared with idarubicin, mitoxantrone conferred a significant benefit in progression-free and overall survival in children with relapsed acute lymphobastic leukaemia, a potentially useful clinical finding that warrants further investigation.	[Saha, Vaskar] Christie NHS Fdn Trust, Paediat & Adolescent Oncol Unit, Manchester M20 4BX, Lancs, England; [Parker, Catriona; Leighton, Carly; Masurekar, Ashish; Saha, Vaskar] Univ Manchester, Manchester Acad Hlth Sci Ctr, Cent Manchester Univ Hosp Fdn Trust, Sch Canc & Enabling Sci,Canc Res UK Childrens Can, Manchester, Lancs, England; [Leighton, Carly] Royal Childrens Hosp, Haematol Oncol Dept, Herston, Qld, Australia; [Waters, Rachel; Love, Sharon] Univ Oxford, Ctr Stat Med, Oxford, England; [Hancock, Jeremy] Southmead Hosp, Bristol Genet Lab, Bristol, Avon, England; [Sutton, Rosemary] Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia Med Res, Sydney, NSW, Australia; [Moorman, Anthony V.] Newcastle Univ, No Inst Canc Res, Leukaemia Res Cytogenet Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ancliff, Philip; Goulden, Nicholas] Great Ormond St Hosp Sick Children, London, England; [Morgan, Mary] Southampton Gen Hosp, Child Oncol & Haematol Ctr, Southampton SO9 4XY, Hants, England; [Green, Nina; Revesz, Tamas] Children Youth & Womens Hlth Serv, Dept Clin Haematol Oncol, Adelaide, SA, Australia; [Darbyshire, Philip] Birmingham Childrens Hosp, Dept Haematol, Birmingham, W Midlands, England	Christie NHS Foundation Trust; University of Manchester; Royal Children's Hospital Brisbane; University of Oxford; Southmead Hospital; Children's Cancer Institute; Children's Medical Research Institute - Australia; University of New South Wales Sydney; Newcastle University - UK; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Southampton; University of Birmingham	Saha, V (corresponding author), Christie NHS Fdn Trust, Paediat & Adolescent Oncol Unit, Manchester M20 4BX, Lancs, England.	vaskar.saha@manchester.ac.uk	Moorman, Anthony/G-1468-2014; Love, Seth/E-6545-2012; Sutton, Rosemary/J-3784-2014; Moorman, Anthony/F-5518-2010	Moorman, Anthony/0000-0002-9781-6107; Sutton, Rosemary/0000-0002-0188-6005; Saha, Vaskar/0000-0002-2916-9649; Love, Sharon/0000-0002-6695-5390; Parker, Catriona/0000-0002-3826-2554	Cancer Research UK; Leukaemia and Lymphoma Research; Cancer Council NSW; Sporting Chance Cancer Foundation; Barts; London NHS Trust; University of Leicester NHS Trust; Great Ormond Street Hospital Childrens Charity [V0903] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Leukaemia and Lymphoma Research; Cancer Council NSW(Cancer Council New South Wales); Sporting Chance Cancer Foundation; Barts; London NHS Trust; University of Leicester NHS Trust; Great Ormond Street Hospital Childrens Charity	This study was funded in part by a programme grant from Cancer Research UK (VS); grants from the Leukaemia and Lymphoma Research funded in part the analysis of minimal residual disease (NGo) and the Leukaemia Research Cytogenetics Group (AVM). The Cancer Council NSW and Sporting Chance Cancer Foundation funded analysis of minimal residual disease at CCIA (RS). MRD standardisation and quality control were supported by EuroMRD. The trial was initially sponsored by the Barts and the London NHS Trust (2003-6) and then by the University of Leicester NHS Trust (2006-09). In the UK, assessments of minimal residual disease were done at the UK MRD Network Laboratories (Barts, Bristol, Glasgow, Sheffield). We thank the participating children and their families and the physicians who enrolled their patients into the study. Marita Marshall, Helen Crowne, John Fox, and members of the Cancer Research UK IS team helped to design and run the database. We thank the members of the Data Monitoring Committee-namely, Mike Stevens, Moira Stewart, and Rob Edwards, as well as Tim Eden, Shelchar Krishnan, Louise Chessman, and Anita Lim for their contributions. This paper is dedicated to the memory of Tony Oakhill, who pioneered the management of relapsed acute lymphoblastic leukaemia in the UK.	Cao CY, 2009, CELL MOL IMMUNOL, V6, P469, DOI 10.1038/cmi.2009.59; Chan A, 2005, CLIN EXP IMMUNOL, V139, P152, DOI 10.1111/j.1365-2249.2005.02653.x; Einsiedel HG, 2005, J CLIN ONCOL, V23, P7942, DOI 10.1200/JCO.2005.01.1031; Errington F, 2004, CANCER CHEMOTH PHARM, V53, P155, DOI 10.1007/s00280-003-0701-1; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fleming TR, 2005, HEALTH AFFAIR, V24, P67, DOI 10.1377/hlthaff.24.1.67; Gibson BES, 2005, LEUKEMIA, V19, P2130, DOI 10.1038/sj.leu.2403924; Gray R, 1988, ANN STAT, V16, P1140; Harned TM, 2008, CURR ONCOL REP, V10, P453, DOI 10.1007/s11912-008-0070-3; HENZE G, 1991, BLOOD, V78, P1166; HONGO T, 1991, INT J HEMATOL, V54, P219; Karl S, 2009, J CELL MOL MED, V13, P4239, DOI 10.1111/j.1582-4934.2009.00888.x; Ko RH, 2010, J CLIN ONCOL, V28, P648, DOI 10.1200/JCO.2009.22.2950; Krishnan S, 2010, LEUKEMIA, V24, P450, DOI 10.1038/leu.2009.264; Lawson SE, 2000, BRIT J HAEMATOL, V108, P531; Malempati S, 2007, J CLIN ONCOL, V25, P5800, DOI 10.1200/JCO.2007.10.7508; McCullagh P., 1989, GEN LINEAR MODELS, V(2nd), DOI [10.1007/978-1-4899-3242-6, https://doi.org/10.1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6]; Nachman JB, 1998, NEW ENGL J MED, V338, P1663, DOI 10.1056/NEJM199806043382304; Parker BS, 2004, J BIOL CHEM, V279, P18814, DOI 10.1074/jbc.M400931200; Raetz EA, 2008, J CLIN ONCOL, V26, P3971, DOI 10.1200/JCO.2008.16.1414; REID JM, 1990, CANCER RES, V50, P6525; Roy A, 2005, BRIT J HAEMATOL, V130, P67, DOI 10.1111/j.1365-2141.2005.05572.x; Schrappe M, 2010, LEUKEMIA, V24, P253, DOI 10.1038/leu.2009.276; Seibel NL, 2008, BLOOD, V111, P2548, DOI 10.1182/blood-2007-02-070342; Stam RW, 2003, BLOOD, V101, P1270, DOI 10.1182/blood-2002-05-1600; Susman E, 2004, J NATL CANCER I, V96, P1495, DOI 10.1093/jnci/96.20.1495; Tallen G, 2010, J CLIN ONCOL, V28, P2339, DOI 10.1200/JCO.2009.25.1983; Testi AM, 2002, BRIT J HAEMATOL, V118, P741, DOI 10.1046/j.1365-2141.2002.03706.x; Testi AM, 1997, HAEMATOLOGICA, V82, P664; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; van der Velden VHJ, 2003, LEUKEMIA, V17, P1013, DOI 10.1038/sj.leu.2402922; von Stackelberg A, 2008, BLOOD, V111, P2573, DOI 10.1182/blood-2007-07-102525; WELLS RJ, 1985, J CLIN ONCOL, V3, P998, DOI 10.1200/JCO.1985.3.7.998; 2010, CLIN TRIAL AUTHORISA	34	228	250	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2010	376	9757					2009	2017		10.1016/S0140-6736(10)62002-8	http://dx.doi.org/10.1016/S0140-6736(10)62002-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701GZ	21131038	Green Published			2022-12-28	WOS:000285807700030
J	Kessin, RH				Kessin, Richard H.			Sex and Sacrifice	SCIENCE			English	Editorial Material							DICTYOSTELIUM-DISCOIDEUM		Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University	Kessin, RH (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, 630 W 168th St, New York, NY 10032 USA.	rhk2@columbia.edu						BLASKOVICS JC, 1957, BIOL BULL-US, V113, P58, DOI 10.2307/1538802; Bloomfield G, 2010, SCIENCE, V330, P1533, DOI 10.1126/science.1197423; Flowers JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001013; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; ODAY DH, 1979, CAN J MICROBIOL, V25, P1416, DOI 10.1139/m79-221; Otto GP, 2004, MOL MICROBIOL, V51, P63, DOI 10.1046/j.1365-2958.2003.03826.x; WALLACE MA, 1979, J GEN MICROBIOL, V113, P327, DOI 10.1099/00221287-113-2-327	7	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1487	1488		10.1126/science.1199899	http://dx.doi.org/10.1126/science.1199899			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148379				2022-12-28	WOS:000285153500048
J	Raffaele, S; Farrer, RA; Cano, LM; Studholme, DJ; MacLean, D; Thines, M; Jiang, RHY; Zody, MC; Kunjeti, SG; Donofrio, NM; Meyers, BC; Nusbaum, C; Kamoun, S				Raffaele, Sylvain; Farrer, Rhys A.; Cano, Liliana M.; Studholme, David J.; MacLean, Daniel; Thines, Marco; Jiang, Rays H. Y.; Zody, Michael C.; Kunjeti, Sridhara G.; Donofrio, Nicole M.; Meyers, Blake C.; Nusbaum, Chad; Kamoun, Sophien			Genome Evolution Following Host Jumps in the Irish Potato Famine Pathogen Lineage	SCIENCE			English	Article							PHYTOPHTHORA-INFESTANS; HISTONE METHYLATION; RXLR EFFECTORS; SEQUENCES; DISEASE	Many plant pathogens, including those in the lineage of the Irish potato famine organism Phytophthora infestans, evolve by host jumps followed by specialization. However, how host jumps affect genome evolution remains largely unknown. To determine the patterns of sequence variation in the P. infestans lineage, we resequenced six genomes of four sister species. This revealed uneven evolutionary rates across genomes with genes in repeat-rich regions showing higher rates of structural polymorphisms and positive selection. These loci are enriched in genes induced in planta, implicating host adaptation in genome evolution. Unexpectedly, genes involved in epigenetic processes formed another class of rapidly evolving residents of the gene-sparse regions. These results demonstrate that dynamic repeat-rich genome compartments underpin accelerated gene evolution following host jumps in this pathogen lineage.	[Raffaele, Sylvain; Farrer, Rhys A.; Cano, Liliana M.; Studholme, David J.; MacLean, Daniel; Thines, Marco; Kamoun, Sophien] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Thines, Marco] Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Thines, Marco] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Dept Biol Sci, D-60323 Frankfurt, Germany; [Jiang, Rays H. Y.; Zody, Michael C.; Nusbaum, Chad] Massachusetts Inst Technol & Harvard, Broad Inst, Cambridge, MA 02141 USA; [Kunjeti, Sridhara G.; Donofrio, Nicole M.; Meyers, Blake C.] Univ Delaware, Newark, DE 19716 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Delaware	Kamoun, S (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	sophien.kamoun@tsl.ac.uk	Kamoun, Sophien/B-3529-2009; Raffaele, Sylvain/F-7187-2012; MacLean, Dan/C-7046-2013; Meyers, Blake/B-6535-2012; Kunjeti, Sridhara/AFU-0653-2022; Thines, Marco/H-1685-2011; Cano, Liliana M/O-7041-2016; Raffaele, Sylvain/K-6673-2019; Studholme, David/H-6790-2019	Kamoun, Sophien/0000-0002-0290-0315; Raffaele, Sylvain/0000-0002-2442-9632; MacLean, Dan/0000-0003-1032-0887; Meyers, Blake/0000-0003-3436-6097; Cano, Liliana M/0000-0002-7996-4181; Raffaele, Sylvain/0000-0002-2442-9632; Studholme, David/0000-0002-3010-6637; Kunjeti, Sridhara/0000-0002-6326-2644; Farrer, Rhys/0000-0001-8456-7458	Gatsby Charitable Foundation; Marie-Curie IEF [255104]; National Research Initiative of the U.S. Department of Agriculture [2006-35600-16623]; NSF [EF-0523670]; Ministry of Research, Science and the Arts of Hesse (Germany)	Gatsby Charitable Foundation; Marie-Curie IEF(European Commission); National Research Initiative of the U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF)); Ministry of Research, Science and the Arts of Hesse (Germany)	We thank the Broad Institute Sequencing Platform and J. Pike for sequencing; G. Kessel and V. Vleeshouwers for biomaterial; and D. Weigel, J. Dangl, and J. Ecker for useful comments. This project was funded by the Gatsby Charitable Foundation, Marie-Curie IEF contract 255104, National Research Initiative of the U.S. Department of Agriculture grant 2006-35600-16623, NSF grant EF-0523670, and research funding program LOEWE of the Ministry of Research, Science and the Arts of Hesse (Germany). Sequences are deposited in GenBank under the submission accession numbers SRA02326-2329 and SRA024355 and in the Short Read Archive under study accession numbers ERP000341-344.	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Elango N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000015; Elizondo LI, 2009, CURR GENOMICS, V10, P64, DOI 10.2174/138920209787581271; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kroon LPNM, 2004, FUNGAL GENET BIOL, V41, P766, DOI 10.1016/j.fgb.2004.03.007; Liu ZY, 2005, MOL BIOL EVOL, V22, P659, DOI 10.1093/molbev/msi049; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; van West P, 2008, MICROBIOL-SGM, V154, P1482, DOI 10.1099/mic.0.2007/015545-0; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zeh DW, 2009, BIOESSAYS, V31, P715, DOI 10.1002/bies.200900026; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	20	283	289	2	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2010	330	6010					1540	1543		10.1126/science.1193070	http://dx.doi.org/10.1126/science.1193070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148391				2022-12-28	WOS:000285153500065
J	Weinberger, SE; Pereira, AG; Iobst, WF; Mechaber, AJ; Bronze, MS				Weinberger, Steven E.; Pereira, Anne G.; Iobst, William F.; Mechaber, Alex J.; Bronze, Michael S.		Alliance Acad Internal Med Educ Re	Competency-Based Education and Training in Internal Medicine	ANNALS OF INTERNAL MEDICINE			English	Article							FRAMEWORK; FLEXNER	Recent efforts to improve medical education include adopting a new framework based on 6 broad competencies defined by the Accreditation Council for Graduate Medical Education. In this article, the Alliance for Academic Internal Medicine Education Redesign Task Force II examines the advantages and challenges of a competency-based educational framework for medical residents. Efforts to refine specific competencies by developing detailed milestones are described, and examples of training program initiatives using a competency-based approach are presented. Meeting the challenges of a competency-based framework and supporting these educational innovations require a robust faculty development program. Challenges to competency-based education include teaching and evaluating the competencies related to practice-based learning and improvement and systems-based practice, as well as implementing a flexible time frame to achieve competencies. However, the Alliance for Academic Internal Medicine Education Redesign Task Force II does not favor reducing internal medicine training to less than 36 months as part of competency-based education. Rather, the 36-month time frame should allow for remediation to address deficiencies in achieving competencies and for diverse enrichment experiences in such areas as quality of care and practice improvement for residents who have demonstrated skills in all required competencies.	[Weinberger, Steven E.] Amer Coll Physicians, Philadelphia, PA 19106 USA; [Pereira, Anne G.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Iobst, William F.] Amer Board Internal Med, Philadelphia, PA 19106 USA; [Mechaber, Alex J.] Univ Miami, Miller Sch Med, Miami, FL 33101 USA; [Bronze, Michael S.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73190 USA	American College of Physicians; Hennepin County Medical Center; American Board of Internal Medicine; University of Miami; University of Oklahoma System; University of Oklahoma Health Sciences Center	Weinberger, SE (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	sweinberger@acponline.org						Accreditation Council for Graduate Medical Education, OUTC PROJ; Arora VM, 2008, QUAL SAF HEALTH CARE, V17, P11, DOI 10.1136/qshc.2006.018952; Bordley DR, 2010, AM J MED, V123, P188, DOI 10.1016/j.amjmed.2009.07.029; Bower EA, 2007, J CONTIN EDUC HEALTH, V27, P164, DOI 10.1002/chp.120; Carraccio C, 2004, PEDIATRICS, V113, P252, DOI 10.1542/peds.113.2.252; Carraccio C, 2002, ACAD MED, V77, P361, DOI 10.1097/00001888-200205000-00003; Cooke M, 2010, ED PHYS CALL REFORM; Cordasco KM, 2009, ARE RESIDENCY PROGRA; Duffy FD, 2008, ACAD MED, V83, P893, DOI 10.1097/ACM.0b013e31818509ac; Fitzgibbons JP, 2006, ANN INTERN MED, V144, P920, DOI 10.7326/0003-4819-144-12-200606200-00010; Flexner A., 1910, FLEXNER REPORT; Green Michael L, 2009, J Grad Med Educ, V1, P5, DOI 10.4300/01.01.0003; Hingle Susan, 2009, J Grad Med Educ, V1, P82, DOI 10.4300/01.01.0013; Holmboe ES, 2005, J GEN INTERN MED, V20, P1165, DOI 10.1111/j.1525-1497.2005.0249.x; Institute of Medicine, 2001, CROSS QUAL CHASM; Institute of Medicine, 2003, HLTH PROF ED BRIDG Q; Institute of Medicine, 2008, RES DUT HOURS ENH SL; KELLEY R, 2009, CAN 700 BILLION WAST, P43990; Klass D, 2007, ACAD MED, V82, P529, DOI 10.1097/ACM.0b013e31805557ba; Long DM, 2000, ACAD MED, V75, P1178, DOI 10.1097/00001888-200012000-00009; *MED PAYM ADV COMM, 2009, C MED ED US SUPP LON, P43990; Meyers FJ, 2007, ACAD MED, V82, P1211, DOI 10.1097/ACM.0b013e318159d010; Nahrwold DL, 2005, J CONTIN EDUC HEALTH, V25, P168, DOI 10.1002/chp.25; Ogrinc G, 2003, ACAD MED, V78, P748, DOI 10.1097/00001888-200307000-00019; ROSENBLUM MJ, 2007, ACAD INTERN MED INSI, V5, P18; *ROYAL COLL PHYS S, COMP BAS MED ED SUMM, P43990; Weinberger SE, 2006, ANN INTERN MED, V144, P927, DOI 10.7326/0003-4819-144-12-200606200-00124; Whitcomb ME, 2004, ACAD MED, V79, P493, DOI 10.1097/00001888-200406000-00001; Whitcomb ME, 2009, ACAD MED, V84, P1476, DOI 10.1097/ACM.0b013e3181bb25db; ZETKULIC M, 2009, ASS PROGR DIR INT ME, P43990	30	77	79	2	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 7	2010	153	11					751	756		10.7326/0003-4819-153-11-201012070-00009	http://dx.doi.org/10.7326/0003-4819-153-11-201012070-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	690KN	21135298				2022-12-28	WOS:000285003800007
J	Borys, NJ; Walter, MJ; Huang, J; Talapin, DV; Lupton, JM				Borys, Nicholas J.; Walter, Manfred J.; Huang, Jing; Talapin, Dmitri V.; Lupton, John M.			The Role of Particle Morphology in Interfacial Energy Transfer in CdSe/CdS Heterostructure Nanocrystals	SCIENCE			English	Article							SEMICONDUCTOR NANOCRYSTALS; QUANTUM DOTS; GROWTH	Nanoscale semiconductor heterostructures such as tetrapods can be used to mimic light-harvesting processes. We used single-particle light-harvesting action spectroscopy to probe the impact of particle morphology on energy transfer and carrier relaxation across a heterojunction. The generic form of an action spectrum [in our experiments, photoluminescence excitation (PLE) under absorption in CdS and emission from CdSe in nanocrystal tetrapods, rods, and spheres] was controlled by the physical shape and resulting morphological variation in the quantum confinement parameters of the nanoparticle. A correlation between single-particle PLE and physical shape as determined by scanning electron microscopy was demonstrated. Such an analysis links local structural non-uniformities such as CdS bulbs forming around the CdSe core in CdSe/CdS nanorods to a lower probability of manifesting excitation energy-dependent emission spectra, which in turn is probably related to band alignment and electron delocalization at the heterojunction interface.	[Borys, Nicholas J.; Walter, Manfred J.; Lupton, John M.] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA; [Huang, Jing; Talapin, Dmitri V.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Talapin, Dmitri V.] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA; [Lupton, John M.] Univ Regensburg, Inst Expt Angew Phys, D-93040 Regensburg, Germany	Utah System of Higher Education; University of Utah; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Regensburg	Lupton, JM (corresponding author), Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA.	john.lupton@physik.uni-regensburg.de			NSF [CHE-0748473, DMR-0213745]; U.S. Department of Defense Office of Naval Research [N00014-10-1-0190]	NSF(National Science Foundation (NSF)); U.S. Department of Defense Office of Naval Research(Office of Naval Research)	The authors thank K. van Schooten for technical assistance and R. Polson, M. DeLong, and S. Rupich for help with SEM measurements and are indebted to NSF (grants CHE-0748473 and DMR-0213745) and the U.S. Department of Defense Office of Naval Research (grant N00014-10-1-0190). J.M.L. and D. V. T. are fellows of the David and Lucile Packard Foundation.	Akiyama H, 2003, APPL PHYS LETT, V82, P379, DOI 10.1063/1.1539552; Amirav L, 2010, J PHYS CHEM LETT, V1, P1051, DOI 10.1021/jz100075c; Chen YC, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2956391; Efros AL, 2000, ANNU REV MATER SCI, V30, P475, DOI 10.1146/annurev.matsci.30.1.475; Empedocles SA, 1999, ADV MATER, V11, P1243, DOI 10.1002/(SICI)1521-4095(199910)11:15<1243::AID-ADMA1243>3.0.CO;2-2; Htoon H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.187402; Huynh WU, 2002, SCIENCE, V295, P2425, DOI 10.1126/science.1069156; Ihara T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.126803; Kamat PV, 2008, J PHYS CHEM C, V112, P18737, DOI 10.1021/jp806791s; Manna L, 2003, NAT MATER, V2, P382, DOI 10.1038/nmat902; Mauser C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.153303; Mokari T, 2004, SCIENCE, V304, P1787, DOI 10.1126/science.1097830; Muller J, 2005, NANO LETT, V5, P2044, DOI 10.1021/nl051596x; Neuhauser RG, 2000, PHYS REV LETT, V85, P3301, DOI 10.1103/PhysRevLett.85.3301; Pandey A, 2008, SCIENCE, V322, P929, DOI 10.1126/science.1159832; Pandey A, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2766957; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Peng XG, 1997, J AM CHEM SOC, V119, P7019, DOI 10.1021/ja970754m; Planelles J, 2010, J PHYS CHEM C, V114, P8337, DOI 10.1021/jp102086q; Qu YQ, 2010, NANO LETT, V10, P1941, DOI 10.1021/nl101010m; Saba M, 2009, ADV MATER, V21, P4942, DOI 10.1002/adma.200901482; Sitt A, 2009, NANO LETT, V9, P3470, DOI 10.1021/nl901679q; Smith AM, 2010, ACCOUNTS CHEM RES, V43, P190, DOI 10.1021/ar9001069; Steiner D, 2008, NANO LETT, V8, P2954, DOI 10.1021/nl801848x; Talapin DV, 2007, NANO LETT, V7, P2951, DOI 10.1021/nl072003g; VOSSMEYER T, 1994, J PHYS CHEM-US, V98, P7665, DOI 10.1021/j100082a044; Walter MJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.167401; Yoskovitz E, 2010, NANO LETT, V10, P3068, DOI 10.1021/nl101614s	28	160	161	10	238	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1371	1374		10.1126/science.1198070	http://dx.doi.org/10.1126/science.1198070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127250				2022-12-28	WOS:000284902100040
J	Mudur, G				Mudur, Ganapati			Save the Children BMJ Christmas Appeal Mobile clinics in Delhi	BRITISH MEDICAL JOURNAL			English	Editorial Material												gsmudur@hotmail.com						Agarwal S, 2005, Indian J Public Health, V49, P141	1	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 30	2010	341								c6800	10.1136/bmj.c6800	http://dx.doi.org/10.1136/bmj.c6800			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	691OG	21118876				2022-12-28	WOS:000285090100015
J	Wong, TY; Scott, IU				Wong, Tien Y.; Scott, Ingrid U.			Retinal-Vein Occlusion.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MACULAR EDEMA SECONDARY; CARDIOVASCULAR RISK-FACTORS; ENDOTHELIAL GROWTH-FACTOR; INTRAVITREAL TRIAMCINOLONE; VASCULAR OCCLUSION; STANDARD-CARE; RANIBIZUMAB; MORTALITY; POPULATION; ATHEROSCLEROSIS		[Wong, Tien Y.] Natl Univ Singapore, Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore 168751, Singapore; [Wong, Tien Y.] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Scott, Ingrid U.] Penn State Coll Med, Penn State Hershey Eye Ctr, Hershey, PA USA	National University of Singapore; Singapore National Eye Center; Centre for Eye Research Australia; University of Melbourne; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Wong, TY (corresponding author), Natl Univ Singapore, Singapore Natl Eye Ctr, Singapore Eye Res Inst, 11 3rd Hosp Ave, Singapore 168751, Singapore.	ophwty@nus.edu.sg	Wong, Tien Yin/AAC-9724-2020	Wong, Tien Yin/0000-0002-8448-1264; Scott, Ingrid/0000-0002-3908-7153	Allergan; Novartis; Pfizer; Genentech	Allergan(AbbVieAllergan); Novartis(Novartis); Pfizer(Pfizer); Genentech(Roche HoldingGenentech)	Dr. Wong reports receiving consulting fees from Allergan, Novartis, and Pfizer and speaking fees and grant support from Allergan; and Dr. Scott reports receiving consulting fees from Genentech. No other potential conflict of interest relevant to this article was reported.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; [Anonymous], 1984, AM J OPHTHALMOL, V98, P271; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Brown DM, 2010, OPHTHALMOLOGY, V117, p1124e1; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, p1102e1; Campochiaro PA, 2008, MOL THER, V16, P791, DOI 10.1038/mt.2008.10; Cheung N, 2008, INVEST OPHTH VIS SCI, V49, P4297, DOI 10.1167/iovs.08-1826; Christoffersen N, 2007, OPHTHALMOLOGY, V114, P1186, DOI 10.1016/j.ophtha.2007.01.031; Chua B, 2005, AM J OPHTHALMOL, V139, P181, DOI 10.1016/j.ajo.2004.06.084; Clarkson JC, 1997, ARCH OPHTHALMOL-CHIC, V115, P486; Clarkson JC, 1997, ARCH OPHTHALMOL-CHIC, V115, P1275; CLARKSON JG, 1995, OPHTHALMOLOGY, V102, P1425; CLARKSON JG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1087; CLARKSON JG, 1995, OPHTHALMOLOGY, V102, P1434; Cugati S, 2006, ARCH OPHTHALMOL-CHIC, V124, P726, DOI 10.1001/archopht.124.5.726; Cugati S, 2007, OPHTHALMOLOGY, V114, P520, DOI 10.1016/j.ophtha.2006.06.061; ELMAN MJ, 1990, OPHTHALMOLOGY, V97, P1543; FINKELSTEIN D, 1992, ARCH OPHTHALMOL-CHIC, V110, P1427, DOI 10.1001/archopht.1992.01080220089028; Gillies MC, 2007, NEW ENGL J MED, V356, P748; Greiner K, 1999, AM J OPHTHALMOL, V128, P69, DOI 10.1016/S0002-9394(99)00074-4; Haller JA, 2010, OPHTHALMOLOGY, V117, p1134e3; Hayreh SS, 2005, PROG RETIN EYE RES, V24, P493, DOI 10.1016/j.preteyeres.2004.12.001; HAYREH SS, 1983, OPHTHALMOLOGY, V90, P488; Hayreh SS, 2001, AM J OPHTHALMOL, V131, P61, DOI 10.1016/S0002-9394(00)00709-1; Incorvaia C, 1999, AM J OPHTHALMOL, V128, P247, DOI 10.1016/S0002-9394(99)00069-0; Ip MS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1101, DOI 10.1001/archophthalmol.2009.234; Ip MS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1648; Janssen MCH, 2005, THROMB HAEMOSTASIS, V93, P1021, DOI 10.1160/TH04-11-0768; Jonas JB, 2005, EYE, V19, P65, DOI 10.1038/sj.eye.6701395; Kinge B, 2010, AM J OPHTHALMOL, V150, P310, DOI 10.1016/j.ajo.2010.03.028; Klein R, 2000, Trans Am Ophthalmol Soc, V98, P133; Lahey JM, 2002, OPHTHALMOLOGY, V109, P126, DOI 10.1016/S0161-6420(01)00842-9; Lazo-Langner A, 2010, HAEMATOL-HEMATOL J, V95, P1587, DOI 10.3324/haematol.2010.023614; McAllister IL, 2010, OPHTHALMOLOGY, V117, P954, DOI 10.1016/j.ophtha.2009.10.026; McIntosh RL, 2007, OPHTHALMOLOGY, V114, P835, DOI 10.1016/j.ophtha.2007.01.010; McIntosh RL, 2010, OPHTHALMOLOGY, V117, p1113e15; Mitchell P, 1996, ARCH OPHTHALMOL-CHIC, V114, P1243, DOI 10.1001/archopht.1996.01100140443012; Mohamed Q, 2007, OPHTHALMOLOGY, V114, P507, DOI 10.1016/j.ophtha.2006.11.011; Prager F, 2009, BRIT J OPHTHALMOL, V93, P452, DOI 10.1136/bjo.2008.141085; RATH EZ, 1992, OPHTHALMOLOGY, V99, P509; Rogers S, 2010, OPHTHALMOLOGY, V117, p313e1; Rogers SL, 2010, OPHTHALMOLOGY, V117, p1094e5; ROSENBERG N, 1986, ARCH OPHTHALMOL-CHIC, V104, P34; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rouhani Behnaz, 2010, Retin Cases Brief Rep, V4, P105, DOI 10.1097/ICB.0b013e31819b1a59; *ROYAL COLL OPHTH, 2009, RET VEIN OCCL RVO IN; Scott IU, 2009, ARCH OPHTHALMOL-CHIC, V127, P1115, DOI 10.1001/archophthalmol.2009.233; Scott IU, 2009, ARCH OPHTHALMOL-CHIC, V127, P1655; Spaide RF, 2009, AM J OPHTHALMOL, V147, P298, DOI 10.1016/j.ajo.2008.08.016; Tsaloumas MD, 2000, EYE, V14, P821, DOI 10.1038/eye.2000.230; Wong TY, 2009, AM J OPHTHALMOL, V148, P327, DOI 10.1016/j.ajo.2009.05.012; Wong TY, 2005, OPHTHALMOLOGY, V112, P540, DOI 10.1016/j.ophtha.2004.10.039; Wong TY, 2004, NEW ENGL J MED, V351, P2310, DOI 10.1056/NEJMra032865; Wu L, 2010, RETINA-J RET VIT DIS, V30, P1002, DOI 10.1097/IAE.0b013e3181cea68d	54	159	163	2	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2010	363	22					2135	2144		10.1056/NEJMcp1003934	http://dx.doi.org/10.1056/NEJMcp1003934			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684XE	21105795				2022-12-28	WOS:000284587800008
J	Dragean, CA; Duquesne, L; Theate, I; Ghaye, B; Coche, EE				Dragean, Cristina A.; Duquesne, Louise; Theate, Ivan; Ghaye, Benoit; Coche, Emmanuel E.			Extramedullary haemopoiesis and spinal cord compression	LANCET			English	Editorial Material									[Dragean, Cristina A.; Duquesne, Louise; Ghaye, Benoit; Coche, Emmanuel E.] Clin Univ St Luc, Catholic Univ Louvain, Dept Med Imaging, B-1200 Brussels, Belgium; [Theate, Ivan] Clin Univ St Luc, Catholic Univ Louvain, Dept Pathol, B-1200 Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Coche, EE (corresponding author), Clin Univ St Luc, Catholic Univ Louvain, Dept Med Imaging, Ave Hippocrate 10, B-1200 Brussels, Belgium.	emmanuel.coche@uclouvain.be							0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2011	377	9761					251	251		10.1016/S0140-6736(10)60485-0	http://dx.doi.org/10.1016/S0140-6736(10)60485-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	712WG	21111477	Bronze			2022-12-28	WOS:000286696400032
J	Mochida, S; Maslen, SL; Skehel, M; Hunt, T				Mochida, Satoru; Maslen, Sarah L.; Skehel, Mark; Hunt, Tim			Greatwall Phosphorylates an Inhibitor of Protein Phosphatase 2A That Is Essential for Mitosis	SCIENCE			English	Article							CELL-CYCLE; ALPHA-ENDOSULFINE; XENOPUS; PHOSPHOPROTEINS; EXPRESSION; EXTRACTS; ENTRY; LOOP; EXIT	Entry into mitosis in eukaryotes requires the activity of cyclin-dependent kinase 1 (Cdk1). Cdk1 is opposed by protein phosphatases in two ways: They inhibit activation of Cdk1 by dephosphorylating the protein kinases Wee1 and Myt1 and the protein phosphatase Cdc25 (key regulators of Cdk1), and they also antagonize Cdk1's own phosphorylation of downstream targets. A particular form of protein phosphatase 2A (PP2A) containing a B55 delta subunit (PP2A-B55 delta) is the major protein phosphatase that acts on model CDK substrates in Xenopus egg extracts and has antimitotic activity. The activity of PP2A-B55 delta is high in interphase and low in mitosis, exactly opposite that of Cdk1. We report that inhibition of PP2A-B55 delta results from a small protein, known as alpha-endosulfine (Ensa), that is phosphorylated in mitosis by the protein kinase Greatwall (Gwl). This converts Ensa into a potent and specific inhibitor of PP2A-B55 delta. This pathway represents a previously unknown element in the control of mitosis.	[Mochida, Satoru; Maslen, Sarah L.; Skehel, Mark; Hunt, Tim] Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; [Mochida, Satoru] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto 8600811, Japan	Cancer Research UK; Kumamoto University	Hunt, T (corresponding author), Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	tim.hunt@cancer.org.uk	Hunt, Tim/O-8544-2019	Hunt, Tim/0000-0001-5174-6038	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank H. Mahbubani, J. Kirk, and L. Egbuniwe for care of frogs and other members of the laboratory for advice and reagents, especially J. Gannon for the antibody to doubly phosphorylated Thr<SUP>14</SUP>-Tyr<SUP>15</SUP> of Cdk1 (CP 3.2). S. M. was supported by a fellowship from the Japan Society for the Promotion of Science.	Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; Cohen P, 2006, BIOCHEM J, V393, P1, DOI 10.1042/BJ20051545; Drummond-Barbosa D, 2004, DEV BIOL, V266, P310, DOI 10.1016/j.ydbio.2003.10.028; Dulubova I, 2001, J NEUROCHEM, V77, P229, DOI 10.1046/j.1471-4159.2001.00191.x; GIRAULT JA, 1990, J NEUROSCI, V10, P1124; Goldberg M., COMMUNICATION; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gros L, 2002, DIABETOLOGIA, V45, P703, DOI 10.1007/s00125-002-0794-9; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; Ishii K, 1996, EMBO J, V15, P6629, DOI 10.1002/j.1460-2075.1996.tb01053.x; Kim SY, 2005, MOL CELL BIOL, V25, P10580, DOI 10.1128/MCB.25.23.10580-10590.2005; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Mochida S, 2007, NATURE, V449, P336, DOI 10.1038/nature06121; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Morgan D.O., 2007, CELL CYCLE PRINCIPLE, P297; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Ohsumi Keita, 2006, V322, P445; Pal G, 2008, J CELL BIOL, V180, P931, DOI 10.1083/jcb.200711014; Vigneron S, 2009, EMBO J, V28, P2786, DOI 10.1038/emboj.2009.228; VIRSOLVYVERGINE A, 1992, P NATL ACAD SCI USA, V89, P6629, DOI 10.1073/pnas.89.14.6629; Von Stetina JR, 2008, DEVELOPMENT, V135, P3697, DOI 10.1242/dev.025114; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Yu JT, 2006, MOL CELL, V22, P83, DOI 10.1016/j.molcel.2006.02.022	28	306	317	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1670	1673		10.1126/science.1195689	http://dx.doi.org/10.1126/science.1195689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164013				2022-12-28	WOS:000285390500065
J	Powell, J				Powell, John			Christmas 2010: History Acting on evidence	BRITISH MEDICAL JOURNAL			English	Editorial Material							SPINAL-ANESTHESIA; ADDRESS; DIAGNOSIS		[Powell, John] Univ Warwick, Warwick Med Sch, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England	University of Warwick	Powell, J (corresponding author), Univ Warwick, Warwick Med Sch, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England.	john.powell@warwick.ac.uk		Powell, John/0000-0002-1456-4857				[Anonymous], 1907, BMJ, V2, P24; [Anonymous], 1952, BMJ, V2, P727; [Anonymous], 1931, BMJ, V1, P730; [Anonymous], 1909, BMJ, V2, P44; [Anonymous], 1940, BMJ, V2, P539; Barr J, 1909, BRIT MED J, V1909, P989; British Medical Association, 1909, SECR REM WHAT THEY C; Culpin M, 1919, BRIT MED J, V1919, P501; Culpin M, 1916, BRIT MED J, V1916, P548, DOI 10.1136/bmj.2.2912.548; Culpin M, 1918, BMJ, V1, P425; Dean H P, 1906, Br Med J, V1, P1086; Gowers WR, 1910, BRIT MED J, V1910, P305; Hall A, 1905, BRIT MED J, V1905, P584, DOI 10.1136/bmj.1.2307.584; Head H, 1922, BRIT MED J, V1922, P827; Head H, 1922, BRIT MED J, V1922, P1; Head H, 1919, BMJ-BRIT MED J, V1919, P365, DOI 10.1136/bmj.1.3039.365; Head H, 1922, BMJ, V1, P977; Hewitt F, 1909, BRIT MED J, V2, P1825; Horder T, 1927, BRIT MED J, V1, P699; Keith A, 1931, BRIT MED J, V1, P776; Madden FC, 1912, BRIT MED J, V1912, P345, DOI 10.1136/bmj.2.2694.345; McGavin L, 1909, BRIT MED J, V1909, P1459; Moritz M, 1912, BRIT MED J, V1912, P760, DOI 10.1136/bmj.2.2700.760-a; Richardson WG, 1912, BRIT MED J, V2, P756; Willimott SG, 1934, BRIT MED J, V1934, P1022, DOI 10.1136/bmj.1.3831.1022	25	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 14	2010	341								c5168	10.1136/bmj.c5168	http://dx.doi.org/10.1136/bmj.c5168			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XD	21156733				2022-12-28	WOS:000285552200002
J	Casper, ST				Casper, Stephen T.			Christmas 2010: History "In consequence of enemy action": British medical students in North American medical schools, 1939-45	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Casper, Stephen T.] Clarkson Univ, Humanities & Social Sci, Potsdam, NY 13676 USA	Clarkson University	Casper, ST (corresponding author), Clarkson Univ, Humanities & Social Sci, 8 Clarkson Ave,Box 5750, Potsdam, NY 13676 USA.	scasper@clarkson.edu		Casper, Stephen/0000-0003-2915-8592				ANDREW G, 1943, COMMUNICATION   0311; BUTTEFIELD W, 1943, COMMUNICATION   0103; BUTTERFIELD W, 1944, COMMUNICATION   0709; BUTTERFIELD W, 1942, COMMUNICATION   0825; CADMAN E, COMMUNICATION; Cull Nicholas J., 1996, SELLING WAR BRIT PRO; Dale HH, 1941, BRIT MED J, V1941, P984; Edgerton David, 2006, WARFARE STATE BRITAI; GREGG A, 1941, COMMUNICATION   0311; HILL A, 1941, TIMES           0617, P5; KERFOOT D, 1944, COMMUNICATION   0731; Krige John, 2006, AM HEGEMONY POSTWAR; LAMBERT R, 1945, COMMUNICATION   1126; LAMBERT R, 1945, COMMUNICATION   0831; LAMBERT RA, 1940, COMMUNICATION   0930; LAMBERT RM, COMMUNICATION; LOWENTHAL MM, 1981, J CONTEMP HIST, V16, P413, DOI 10.1177/002200948101600302; NEWTON M, 1944, COMMUNICATION   0724; POND D, 1984, LANCET, V2, P1088; STEELE RW, 1974, J CONTEMP HIST, V9, P195, DOI 10.1177/002200947400900409; 1942, LANCET, V240, P255; 1941, LANCET, P353; 1941, BMJ, V1, P981; 1940, TIMES           1015, P5	24	0	0	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 13	2010	341								c7041	10.1136/bmj.c7041	http://dx.doi.org/10.1136/bmj.c7041			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XA	21149468				2022-12-28	WOS:000285551900001
J	Obi, EE; Weir, C				Obi, Ebube E.; Weir, C.			Christmas 2010: Reading between the Lines A Christmas tree cataract	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Obi, Ebube E.; Weir, C.] Gartnavel Royal Hosp, Glasgow G12 0YN, Scotland	Gartnavel Royal Hospital	Obi, EE (corresponding author), Gartnavel Royal Hosp, Glasgow G12 0YN, Scotland.	e.obi@nhs.net							0	1	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 8	2010	341								c6644	10.1136/bmj.c6644	http://dx.doi.org/10.1136/bmj.c6644			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	694ZL	21147746				2022-12-28	WOS:000285340300001
J	Spence, D				Spence, Des			From the Frontline The problems of controlling controlled drugs	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 8	2010	341								c7040	10.1136/bmj.c7040	http://dx.doi.org/10.1136/bmj.c7040			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	694ZL	21147738				2022-12-28	WOS:000285340300016
J	Lubell, Y				Lubell, Yoel			Cost-effective use of prereferral treatment for severe malaria	LANCET			English	Editorial Material									[Lubell, Yoel] Mahidol Univ, Dept Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10400, Thailand; [Lubell, Yoel] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 9DU, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Lubell, Y (corresponding author), Mahidol Univ, Dept Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10400, Thailand.	yoel@tropmedres.ac		Lubell, Yoel/0000-0002-0237-1070				[Anonymous], 2009, WORLD MAL REP 2009; Day N, 2007, AM J TROP MED HYG, V77, P29; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; Font Fidel, 2002, BMC Int Health Hum Rights, V2, P4, DOI 10.1186/1472-698X-2-4; Gomes MF, 2009, LANCET, V373, P557, DOI 10.1016/S0140-6736(08)61734-1; Simba DO, 2009, TROP MED INT HEALTH, V14, P775, DOI 10.1111/j.1365-3156.2009.02299.x; Snow RW, 2010, LANCET, V376, P1409, DOI 10.1016/S0140-6736(10)61340-2; Tozan Y, 2010, LANCET, DOI S0140-6736(10)61460-2; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340	9	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2010	376	9756					1880	1881		10.1016/S0140-6736(10)61969-1	http://dx.doi.org/10.1016/S0140-6736(10)61969-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	696KH	21122911				2022-12-28	WOS:000285439800007
J	Nakada, D; Saunders, TL; Morrison, SJ				Nakada, Daisuke; Saunders, Thomas L.; Morrison, Sean J.			Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells	NATURE			English	Article							PEUTZ-JEGHERS-SYNDROME; DROSOPHILA LKB1; GENE; KINASE; DEFICIENCY; PATHWAY; MAINTENANCE; MICE; EMBRYOGENESIS; PROGENITORS	Little is known about metabolic regulation in stem cells and how this modulates tissue regeneration or tumour suppression. We studied the Lkb1 tumour suppressor and its substrate AMP-activated protein kinase (AMPK), kinases that coordinate metabolism with cell growth. Deletion of the Lkb1 (also called Stk11) gene in mice caused increased haematopoietic stem cell (HSC) division, rapid HSC depletion and pancytopenia. HSCs depended more acutely on Lkb1 for cell-cycle regulation and survival than many other haematopoietic cells. HSC depletion did not depend on mTOR activation or oxidative stress. Lkb1-deficient HSCs, but not myeloid progenitors, had reduced mitochondrial membrane potential and ATP levels. HSCs deficient for two catalytic alpha-subunits of AMPK (AMPK-deficient HSCs) showed similar changes in mitochondrial function but remained able to reconstitute irradiated mice. Lkb1-deficient HSCs, but not AMPK-deficient HSCs, exhibited defects in centrosomes and mitotic spindles in culture, and became aneuploid. Lkb1 is therefore required for HSC maintenance through AMPK-dependent and AMPK-independent mechanisms, revealing differences in metabolic and cell-cycle regulation between HSCs and some other haematopoietic progenitors.	[Nakada, Daisuke; Morrison, Sean J.] Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Nakada, Daisuke; Saunders, Thomas L.; Morrison, Sean J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329; Saunders, Thom/0000-0003-2015-101X; Nakada, Daisuke/0000-0001-6010-7094	Howard Hughes Medical Institute; University of Michigan (UM) Comprehensive Cancer National Institutes of Health (NIH) [CA46592]; Japan Society for the Promotion of Science; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); University of Michigan (UM) Comprehensive Cancer National Institutes of Health (NIH)(University of Michigan SystemUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Howard Hughes Medical Institute. Flow cytometry was partially supported by the University of Michigan (UM) Comprehensive Cancer National Institutes of Health (NIH) CA46592. D.N. was supported by a postdoctoral fellowship from the Japan Society for the Promotion of Science. We thank A. Prendergast and C. Sifuentes for technical assistance; E. Hughes and the UM Transgenic Animal Model Core for help generating Lkb1<SUP>fl</SUP> mice; D. Adams and M. White for flow cytometry; E. Smith for antibody production; C. Mountford, S. Grove and R. Coolon for mouse colony management; and L. Cantley and C. Thompson for discussions.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Bonaccorsi S, 2007, DEVELOPMENT, V134, P2183, DOI 10.1242/dev.02848; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cao YH, 2010, CELL RES, V20, P99, DOI 10.1038/cr.2009.141; Contreras CM, 2008, CANCER RES, V68, P759, DOI 10.1158/0008-5472.CAN-07-5014; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gurumurthy S, 2008, CANCER RES, V68, P55, DOI 10.1158/0008-5472.CAN-07-3225; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Jishage K, 2002, P NATL ACAD SCI USA, V99, P8903, DOI 10.1073/pnas.122254599; Kiel MJ, 2008, BLOOD, V111, P4413, DOI 10.1182/blood-2007-12-129601; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Pearson HB, 2008, CANCER RES, V68, P2223, DOI 10.1158/0008-5472.CAN-07-5169; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shorning BY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004264; Tamas P, 2010, EUR J IMMUNOL, V40, P242, DOI 10.1002/eji.200939677; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Watts JL, 2000, DEVELOPMENT, V127, P1467; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074	45	374	387	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					653	U69		10.1038/nature09571	http://dx.doi.org/10.1038/nature09571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124450	Green Accepted			2022-12-28	WOS:000284836700032
J	Smith, LK; Manktelow, BN; Draper, ES; Springett, A; Field, DJ				Smith, Lucy K.; Manktelow, Bradley N.; Draper, Elizabeth S.; Springett, Anna; Field, David J.			Nature of socioeconomic inequalities in neonatal mortality: population based study	BRITISH MEDICAL JOURNAL			English	Article							PRETERM BIRTH; CONGENITAL-ANOMALIES; INFANT-MORTALITY; DEPRIVATION; STILLBIRTH; TRENDS; RATES	Objective To investigate time trends in socioeconomic inequalities in cause specific neonatal mortality in order to assess changing patterns in mortality due to different causes, particularly prematurity, and identify key areas of focus for future intervention strategies. Design Retrospective cohort study. Setting England. Participants All neonatal deaths in singleton infants born between 1 January 1997 and 31 December 2007. Main outcome measure Cause specific neonatal mortality per 10 000 births by deprivation tenth (deprivation measured with UK index of multiple deprivation 2004 at super output area level). Results 18 524 neonatal deaths occurred in singleton infants born in the 11 year study period. Neonatal mortality fell between 1997-9 and 2006-7 (from 31.4 to 25.1 per 10 000 live births). The relative deprivation gap (ratio of mortality in the most deprived tenth compared with the least deprived tenth) increased from 2.08 in 1997-9 to 2.68 in 2003-5, before a fall to 2.35 in 2006-7. The most common causes of death were immaturity and congenital anomalies. Mortality due to immaturity before 24 weeks' gestation did not decrease over time and showed the widest relative deprivation gap (2.98 in 1997-9; 4.14 in 2003-5; 3.16 in 2006-7). Mortality rates for all other causes fell over time. For congenital anomalies, immaturity, and accidents and other specific causes, the relative deprivation gap widened between 1997-9 and 2003-5, before a slight fall in 2006-7. For intrapartum events and sudden infant deaths (only 13.5% of deaths) the relative deprivation gap narrowed slightly. Conclusions Almost 80% of the relative deprivation gap in all cause mortality was explained by premature birth and congenital anomalies. To reduce socioeconomic inequalities in mortality, a change in focus is needed to concentrate on these two influential causes of death. Understanding the link between deprivation and preterm birth should be a major research priority to identify interventions to reduce preterm birth.	[Smith, Lucy K.; Manktelow, Bradley N.; Draper, Elizabeth S.; Field, David J.] Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England; [Springett, Anna] Ctr Maternal & Child Enquiries, London NW1 5SD, England	University of Leicester	Smith, LK (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England.	lks1@leicester.ac.uk	Draper, Elizabeth S/I-6304-2018; Draper, Elizabeth/S-6874-2019; Smith, Lucy K/I-6300-2018; Manktelow, Bradley N/G-2794-2011; Smith, Lucy K/S-6593-2019	Draper, Elizabeth S/0000-0001-9340-8176; Draper, Elizabeth/0000-0001-9340-8176; Smith, Lucy K/0000-0001-9470-0793; Manktelow, Bradley N/0000-0002-3264-0323; Smith, Lucy K/0000-0001-9470-0793	Department of Health's National Institute of Health Research (NIHR); UK Department of Health's National Institute of Health Research; National Institute for Health Research [RP-PG-0407-10029] Funding Source: researchfish	Department of Health's National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); UK Department of Health's National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Department of Health's National Institute of Health Research (NIHR) as part of its programme grants for applied research funding scheme. We thank members of the NIHR programme grant team: Chantal Orgeas, Elaine Boyle, and Julie Faulkes (University of Leicester) for helpful advice and comments throughout the study. We also thank Shona Golightly (Centre for Maternal and Child Enquiries) for help with information on neonatal and infant deaths and comments on earlier drafts of the paper.; UK Department of Health's National Institute of Health Research.	DeFranco EA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-316; Department of Health, 2003, TACKL HLTH IN PROGR; Department of Health, 2007, REV HLTH IN INF MORT; Field D, 2009, ARCH DIS CHILD-FETAL, V94, pF253, DOI 10.1136/adc.2008.150433; Field DJ, 2008, BMJ-BRIT MED J, V336, P1221, DOI 10.1136/bmj.39555.670718.BE; Gray R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3754; Guildea ZES, 2001, ARCH DIS CHILD, V84, P307, DOI 10.1136/adc.84.4.307; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Janghorbani M, 2006, J MATERN-FETAL NEO M, V19, P85, DOI 10.1080/14767050500363428; Judge K, 2009, HEALTH SOCIOL REV, V18, P12, DOI 10.5172/hesr.18.1.12; KEELING JW, 1989, ARCH DIS CHILD, V64, P1345, DOI 10.1136/adc.64.10_Spec_No.1345; Lumley T, 2006, UW BIOSTATISTICS WOR; March of Dimes, 2009, WHIT PAP PRET BIRTH; Moser Kath, 2009, Health Stat Q, P78; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Neasham D, 2001, PAEDIATR PERINAT EP, V15, P364, DOI 10.1046/j.1365-3016.2001.0379a.x; Noble M, 2004, INDICES DEPRIVATION; Nuffield Council on Bioethics, 2006, CRIT CAR DEC FET NEO; Oakley Laura, 2009, Health Stat Q, P22; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Rankin J, 2005, ARCH DIS CHILD-FETAL, V90, pF374, DOI 10.1136/adc.2003.047902; Shaw M, 2007, HDB INEQUALITY SOCIO; Smith LK, 2007, ARCH DIS CHILD-FETAL, V92, pF11, DOI 10.1136/adc.2005.090308; Smith LK, 2007, OBSTET GYNECOL, V110, P325, DOI 10.1097/01.AOG.0000270158.57566.2f; Tommiska V, 2007, PEDIATRICS, V119, P29, DOI 10.1542/peds.2006-1472; Vanhaesebrouck P, 2004, PEDIATRICS, V114, P663, DOI 10.1542/peds.2003-0903-L; Vrijheid M, 2000, ARCH DIS CHILD, V82, P349, DOI 10.1136/adc.82.5.349	27	44	47	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 2	2010	341								c6654	10.1136/bmj.c6654	http://dx.doi.org/10.1136/bmj.c6654			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691OW	21127118	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000285091700003
J	Song, JK; Rechkoblit, O; Bestor, TH; Patel, DJ				Song, Jikui; Rechkoblit, Olga; Bestor, Timothy H.; Patel, Dinshaw J.			Structure of DNMT1-DNA Complex Reveals a Role for Autoinhibition in Maintenance DNA Methylation	SCIENCE			English	Article							CXXC DOMAIN; METHYLTRANSFERASE; LEUKEMIA	Maintenance of genomic methylation patterns is mediated primarily by DNA methyltransferase-1 (DNMT1). We have solved structures of mouse and human DNMT1 composed of CXXC, tandem bromo-adjacent homology (BAH1/2), and methyltransferase domains bound to DNA-containing unmethylated CpG sites. The CXXC specifically binds to unmethylated CpG dinucleotide and positions the CXXC-BAH1 linker between the DNA and the active site of DNMT1, preventing de novo methylation. In addition, a loop projecting from BAH2 interacts with the target recognition domain (TRD) of the methyltransferase, stabilizing the TRD in a retracted position and preventing it from inserting into the DNA major groove. Our studies identify an autoinhibitory mechanism, in which unmethylated CpG dinucleotides are occluded from the active site to ensure that only hemimethylated CpG dinucleotides undergo methylation.	[Song, Jikui; Rechkoblit, Olga; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Bestor, Timothy H.] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	Memorial Sloan Kettering Cancer Center; Columbia University	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org		Rechkoblit, Olga/0000-0003-4270-7242	Abby Rockefeller Mauze Trust; Maloris Foundation; NIH; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Abby Rockefeller Mauze Trust; Maloris Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was supported by funds from the Abby Rockefeller Mauze Trust and Maloris Foundation to D.J.P. and from NIH to T.H.B. We thank S. Murakami for technical assistance and Z. Wang and H. Li for their assistance with x-ray data collection and structure determination. We would also like to thank the staff of NE-CAT beamlines at the Advanced Photon Source, Argonne National Laboratory, and the X-29 beamline at the Brookhaven National Laboratory, for access and assistance with data collection. The structures of the complexes have been deposited in the Protein Data Bank (PDB). The accession codes are mDNMT1(650-1602)-DNA complex with bound AdoHcy (3PT6), hDNMT1(646-1600)-DNA complex with bound AdoHcy (3PTA) and mDNMT1(731-1602) with bound AdoHcy (3PT9).	Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Birke M, 2002, NUCLEIC ACIDS RES, V30, P958, DOI 10.1093/nar/30.4.958; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Cierpicki T, 2010, NAT STRUCT MOL BIOL, V17, P62, DOI 10.1038/nsmb.1714; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hou ZG, 2005, P NATL ACAD SCI USA, V102, P8489, DOI 10.1073/pnas.0503525102; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; Pradhan M, 2008, BIOCHEMISTRY-US, V47, P10000, DOI 10.1021/bi8011725; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Zhang ZG, 2002, EMBO J, V21, P4600, DOI 10.1093/emboj/cdf468	17	294	305	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1036	1040		10.1126/science.1195380	http://dx.doi.org/10.1126/science.1195380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21163962	Green Accepted			2022-12-28	WOS:000287699000054
J	Rothwell, PM; Fowkes, FGR; Belch, JFF; Ogawa, H; Warlow, CP; Meade, TW				Rothwell, Peter M.; Fowkes, F. Gerald R.; Belch, Jill F. F.; Ogawa, Hisao; Warlow, Charles P.; Meade, Tom W.			Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials	LANCET			English	Article							LOW-DOSE ASPIRIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; THROMBOSIS PREVENTION TRIAL; COLORECTAL-CANCER; FOLLOW-UP; ISCHEMIC-STROKE; MORTALITY; DISEASE; EVENTS; METAANALYSIS	Background Treatment with daily aspirin for 5 years or longer reduces subsequent risk of colorectal cancer. Several lines of evidence suggest that aspirin might also reduce risk of other cancers, particularly of the gastrointestinal tract, but proof in man is lacking. We studied deaths due to cancer during and after randomised trials of daily aspirin versus control done originally for prevention of vascular events. Methods We used individual patient data from all randomised trials of daily aspirin versus no aspirin with mean duration of scheduled trial treatment of 4 years or longer to determine the effect of allocation to aspirin on risk of cancer death in relation to scheduled duration of trial treatment for gastrointestinal and non-gastrointestinal cancers. In three large UK trials, long-term post-trial follow-up of individual patients was obtained from death certificates and cancer registries. Results In eight eligible trials (25 570 patients, 674 cancer deaths), allocation to aspirin reduced death due to cancer (pooled odds ratio [OR] 0.79, 95% CI 0.68-0.92, p=0.003). On analysis of individual patient data, which were available from seven trials (23 535 patients, 657 cancer deaths), benefit was apparent only after 5 years' follow-up (all cancers, hazard ratio [HR] 0.66, 0.50-0.87; gastrointestinal cancers, 0.46, 0.27-0.77; both p=0.003). The 20-year risk of cancer death (1634 deaths in 12 659 patients in three trials) remained lower in the aspirin groups than in the control groups (all solid cancers, HR 0.80, 0.72-0.88, p<0.0001; gastrointestinal cancers, 0.65, 0.54-0.78, p<0. 0001), and benefit increased (interaction p=0.01) with scheduled duration of trial treatment (>= 7.5 years: all solid cancers, 0.69, 0.54-0.88, p=0.003; gastrointestinal cancers, 0.41, 0.26-0.66, p=0.0001). The latent period before an effect on deaths was about 5 years for oesophageal, pancreatic, brain, and lung cancer, but was more delayed for stomach, colorectal, and prostate cancer. For lung and oesophageal cancer, benefit was confined to adenocarcinomas, and the overall effect on 20-year risk of cancer death was greatest for adenocarcinomas (HR 0.66, 0.56-0.77, p<0.0001). Benefit was unrelated to aspirin dose (75 mg upwards), sex, or smoking, but increased with age the absolute reduction in 20-year risk of cancer death reaching 7.08% (2.42-11.74) at age 65 years and older. Interpretation Daily aspirin reduced deaths due to several common cancers during and after the trials. Benefit increased with duration of treatment and was consistent across the different study populations. These findings have implications for guidelines on use of aspirin and for understanding of carcinogenesis and its susceptibility to drug intervention.	[Rothwell, Peter M.] Univ Oxford, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford, England; [Fowkes, F. Gerald R.] Univ Edinburgh, Ctr Populat Hlth Sci, Wolfson Unit Prevent Peripheral Vasc Dis, Edinburgh, Midlothian, Scotland; [Belch, Jill F. F.] Univ Dundee, Ninewells Hosp & Med Sch, Vasc & Inflammatory Dis Res Unit, Univ Div Med & Therapeut,Inst Cardiovasc Res, Dundee DD1 9SY, Scotland; [Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan; [Warlow, Charles P.] Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland; [Meade, Tom W.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of Oxford; University of Edinburgh; University of Dundee; Kumamoto University; University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine	Rothwell, PM (corresponding author), John Radcliffe Hosp, Univ Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX3 9DU, England.	peter.rothwell@clneuro.ox.ac.uk	Hug, Balthasar L./G-1568-2010; Rothwell, Peter/ABE-5913-2020; Belch, Jill/AAE-9189-2019	Rothwell, Peter/0000-0001-9739-9211; Belch, Jill/0000-0001-8280-6689	Bayer; Sanofi-Aventis/Bristol-Myers Squibb; Astellas; Astellas, AstraZeneca; 17 Banyu; Boehringer Ingelheim; Chugai; Daiichi SanIcyo; Eisai; Guidant Japan; MRC [G9534799, G0701113] Funding Source: UKRI; Medical Research Council [G0701113, G9534799] Funding Source: researchfish	Bayer(Bayer AG); Sanofi-Aventis/Bristol-Myers Squibb(Sanofi-AventisBristol-Myers Squibb); Astellas(Astellas Pharmaceuticals); Astellas, AstraZeneca(Astellas PharmaceuticalsAstraZeneca); 17 Banyu; Boehringer Ingelheim(Boehringer Ingelheim); Chugai; Daiichi SanIcyo(Daiichi Sankyo Company Limited); Eisai(Eisai Co Ltd); Guidant Japan; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was completely independent of any pharmaceutical company or other commercial interest. However, PMR has received honoraria for talks, advisory boards, and clinical trial committees from several pharmaceutical companies with an interest in antiplatelet agents, including AstraZeneca, 15 Bayer, Boehringer Ingelheim, Sanofi-Aventis/Bristol-Myers Squibb, and Servier. FGRF has had research support, honoraria, and travel expenses 16 from Bayer and Sanofi-Aventis/Bristol-Myers Squibb. JFFB has received payment for board membership from Roche Pharmaceuticals and Sanofi-Aventis. HO has received speakers' fees from Astellas, AstraZeneca, 17 Banyu, Bayer, Boehringer Ingelheim, Chugai, Daiichi SanIcyo, Eisai, Guidant Japan. Japan Lifeline, Kowa, Kyowa Halcko Kirin, Novartis, Otsuka, Pfizer, Sanofi-Aventis, Schering-Plough, and Talceda. CPW has received speakers' fees from Bayer for a talk about aspirin. TWM has received an honorarium and travel expenses from Bayer.	Amin R, 2003, NEUROL RES, V25, P370, DOI 10.1179/016164103101201706; Annemans Lieven, 2010, J Med Econ, V13, P418, DOI 10.3111/13696998.2010.499731; [Anonymous], 2010, LANCET, V375, P1665, DOI 10.1016/S0140-6736(10)60718-0; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Bosetti C, 2009, RECENT RESULTS CANC, V181, P231; Brewster DH, 2002, EUR J CANCER, V38, P414, DOI 10.1016/S0959-8049(01)00385-9; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chan FKL, 2005, NEW ENGL J MED, V352, P238, DOI 10.1056/NEJMoa042087; Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; Dannenberg AJ, 2003, PROG EXP TUMOR RES, V37, pVII; Doria-Rose VP, 2009, LUNG CANCER, V63, P295, DOI 10.1016/j.lungcan.2008.05.019; Ederer F, 1999, J CLIN EPIDEMIOL, V52, P447, DOI 10.1016/S0895-4356(99)00016-5; Elwood PC, 2009, LANCET, V373, P1301, DOI 10.1016/S0140-6736(09)60243-9; Farquhar CM, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004143.PUB2; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Fasey N, 2002, BRIT J GEN PRACT, V52, P208; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; FERRIS FL, 1992, JAMA-J AM MED ASSOC, V268, P1292; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Greving JP, 2008, CIRCULATION, V117, P2875, DOI 10.1161/CIRCULATIONAHA.107.735340; HAWKINS MM, 1992, BRIT J CANCER, V66, P408, DOI 10.1038/bjc.1992.279; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q; Lai KC, 2002, NEW ENGL J MED, V346, P2033, DOI 10.1056/NEJMoa012877; Lanas A, 2002, ALIMENT PHARM THER, V16, P779, DOI 10.1046/j.1365-2036.2002.01230.x; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; Maulaz AB, 2005, ARCH NEUROL-CHICAGO, V62, P1217, DOI 10.1001/archneur.62.8.1217; McIlhatton NA, 2007, CANCER RES, V67, P10966, DOI 10.1158/0008-5472.CAN-07-2562; Meade TW, 1998, LANCET, V351, P233; Morgan G, 2009, PUBLIC HEALTH, V123, P787, DOI 10.1016/j.puhe.2009.10.007; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Pollock A M, 1995, Qual Health Care, V4, P184, DOI 10.1136/qshc.4.3.184; Robinson MH, 2000, J MED SCREEN, V7, P97, DOI 10.1136/jms.7.2.97; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Ruschoff J, 1998, P NATL ACAD SCI USA, V95, P11301, DOI 10.1073/pnas.95.19.11301; Serebruany V, 2010, AM J THER, DOI [10.1097/MJT.0b013e3181e9b675, DOI 10.1097/MJT.0B013E3181E9B675]; Sibon I, 2004, NEUROLOGY, V62, P1187, DOI 10.1212/01.WNL.0000118288.04483.02; Sivak-Sears NR, 2004, AM J EPIDEMIOL, V159, P1131, DOI 10.1093/aje/kwh153; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252	44	904	945	2	167	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2011	377	9759					31	41		10.1016/S0140-6736(10)62110-1	http://dx.doi.org/10.1016/S0140-6736(10)62110-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709MQ	21144578				2022-12-28	WOS:000286445200029
J	Suenaga, K; Koshino, M				Suenaga, Kazu; Koshino, Masanori			Atom-by-atom spectroscopy at graphene edge	NATURE			English	Article							ELECTRON-MICROSCOPY; FINE-STRUCTURE; RESOLUTION; VOLTAGE	The properties of many nanoscale devices are sensitive to local atomic configurations, and so elemental identification and electronic state analysis at the scale of individual atoms is becoming increasingly important. For example, graphene is regarded as a promising candidate for future devices, and the electronic properties of nanodevices constructed from this material are in large part governed by the edge structures(1). The atomic configurations at graphene boundaries have been investigated by transmission electron microscopy and scanning tunnelling microscopy(2-4), but the electronic properties of these edge states have not yet been determined with atomic resolution. Whereas simple elemental analysis at the level of single atoms can now be achieved by means of annular dark field imaging(5) or electron energy-loss spectroscopy(6,7), obtaining fine-structure spectroscopic information about individual light atoms such as those of carbon has been hampered by a combination of extremely weak signals and specimen damage by the electron beam. Here we overcome these difficulties to demonstrate site-specific single-atom spectroscopy at a graphene boundary, enabling direct investigation of the electronic and bonding structures of the edge atoms-in particular, discrimination of single-, double- and triple-coordinated carbon atoms is achieved with atomic resolution. By demonstrating how rich chemical information can be obtained from single atoms through energy-loss near-edge fine-structure analysis(8), our results should open the way to exploring the local electronic structures of various nanodevices and individual molecules.	[Suenaga, Kazu; Koshino, Masanori] Natl Inst Adv Ind Sci & Technol, Nanotube Res Ctr, Tsukuba, Ibaraki 3058565, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Suenaga, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Nanotube Res Ctr, AIST Cent 5, Tsukuba, Ibaraki 3058565, Japan.	suenaga-kazu@aist.go.jp	koshino, masanori/M-8237-2018; Suenaga, Kazu/E-2339-2014	koshino, masanori/0000-0002-5474-1475; Suenaga, Kazu/0000-0002-6107-1123	JST	JST(Japan Science & Technology Agency (JST))	This work is partially supported by the JST-CREST programme. We thank C. Jin for discussions and H. Kobayashi for specimen preparations.	Cosgriff EC, 2005, ULTRAMICROSCOPY, V102, P317, DOI 10.1016/j.ultramic.2004.11.001; EGERTON RF, 1996, ELECT ENERGY LOSS SP, P363; GARVIE LAJ, 1994, AM MINERAL, V79, P411; Gass MH, 2008, NAT NANOTECHNOL, V3, P676, DOI 10.1038/nnano.2008.280; Girit CO, 2009, SCIENCE, V323, P1705, DOI 10.1126/science.1166999; Gubbens A, 2010, ULTRAMICROSCOPY, V110, P962, DOI 10.1016/j.ultramic.2010.01.009; JEANGUILLAUME C, 1989, ULTRAMICROSCOPY, V28, P252, DOI 10.1016/0304-3991(89)90304-5; Jiao LY, 2010, NAT NANOTECHNOL, V5, P321, DOI [10.1038/NNANO.2010.54, 10.1038/nnano.2010.54]; KLEIN DJ, 1994, CHEM PHYS LETT, V217, P261, DOI 10.1016/0009-2614(93)E1378-T; Kobayashi Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125415; Koshino M, 2010, ULTRAMICROSCOPY, V110, P1465, DOI 10.1016/j.ultramic.2010.09.003; Krivanek OL, 2010, ULTRAMICROSCOPY, V110, P935, DOI 10.1016/j.ultramic.2010.02.007; Krivanek OL, 2010, NATURE, V464, P571, DOI 10.1038/nature08879; Kusakabe K, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.092406; Liu Z, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.015501; Mizoguchi T, 2000, PHYS REV B, V61, P2180, DOI 10.1103/PhysRevB.61.2180; Pacile D, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2903702; Sasaki T, 2010, J ELECTRON MICROSC, V59, pS7, DOI 10.1093/jmicro/dfq027; Suenaga K, 2000, SCIENCE, V290, P2280, DOI 10.1126/science.290.5500.2280; Suenaga K, 2009, NAT CHEM, V1, P415, DOI [10.1038/NCHEM.282, 10.1038/nchem.282]; Zobelli A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.094104	21	376	379	4	269	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1088	1090		10.1038/nature09664	http://dx.doi.org/10.1038/nature09664			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21160475				2022-12-28	WOS:000285553800055
J	Ivers, LC; Farmer, P; Almazor, CP; Leandre, F				Ivers, Louise C.; Farmer, Paul; Almazor, Charles Patrick; Leandre, Fernet			Five complementary interventions to slow cholera: Haiti	LANCET			English	Editorial Material									[Ivers, Louise C.; Farmer, Paul] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Almazor, Charles Patrick; Leandre, Fernet] Partners Hlth Zanmi Lasante, Port Au Prince, Haiti	Harvard University; Harvard Medical School	Farmer, P (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	paul_farmer@hms.harvard.edu	Ivers, Louise C/Q-4164-2018	Ivers, Louise C/0000-0003-2314-9230				[Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; CDC, 2010, AC WAT DIARRH CHOL H; d'Adestcy AC., 2004, MOVING MOUNTAINS RAC, P93; Dorell C., 2010, Morbidity and Mortality Weekly Report, V59, P1018; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Farmer P, 2003, LANCET, V361, P420, DOI 10.1016/S0140-6736(03)12380-X; Farmer P, 1996, EMERG INFECT DIS, V2, P259, DOI 10.3201/eid0204.960402; FARMER Paul, 1992, AIDS ACCUSATION HAIT; Fraser B, 2010, LANCET, V376, P1813, DOI 10.1016/S0140-6736(10)62151-4; Frew SE, 2009, HEALTH AFFAIR, V28, P1760, DOI 10.1377/hlthaff.28.6.1760; Harris JB, 2010, LANCET, V376, P1961, DOI 10.1016/S0140-6736(10)62172-1; Ivers LC, 2010, CURBING CERVICAL CAN; Lasante Zanmi, 2008, WOCH NAN SOL DEN RIG; Lawrence P.R., 2002, WATER POVERTY INDEX; Legros D, 1999, B WORLD HEALTH ORGAN, V77, P837; Soni A, 2009, HEALTH AFFAIR, V28, P1617, DOI 10.1377/hlthaff.28.6.1617; *UNAIDS WHO, 2005, AIDS EP UPD DEC 2005; Walton DA, 2004, J PUBLIC HEALTH POL, V25, P137, DOI 10.1057/palgrave.jphp.3190013	18	40	41	2	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2010	376	9758					2048	2051		10.1016/S0140-6736(10)62243-X	http://dx.doi.org/10.1016/S0140-6736(10)62243-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702LA	21146206				2022-12-28	WOS:000285895000007
J	Canup, RM				Canup, Robin M.			Origin of Saturn's rings and inner moons by mass removal from a lost Titan-sized satellite	NATURE			English	Article							LATE HEAVY BOMBARDMENT; PLANETARY RINGS; EVOLUTION; VISCOSITY; ACCRETION; GANYMEDE; SYSTEMS; IMPACT; DISK	The origin of Saturn's rings has not been adequately explained. The current rings are more than 90 to 95 per cent water ice(1), which implies that initially they were almost pure ice because they are continually polluted by rocky meteoroids(2). In contrast, a half-rock, half-ice mixture (similar to the composition of many of the satellites in the outer Solar System) would generally be expected. Previous ring origin theories invoke the collisional disruption of a small moon(3,4), or the tidal disruption of a comet during a close passage by Saturn(5). These models are improbable and/or struggle to account for basic properties of the rings, including their icy composition. Saturn has only one large satellite, Titan, whereas Jupiter has four large satellites; additional large satellites probably existed originally but were lost as they spiralled into Saturn(6). Here I report numerical simulations of the tidal removal of mass from a differentiated, Titan-sized satellite as it migrates inward towards Saturn. Planetary tidal forces preferentially strip material from the satellite's outer icy layers, while its rocky core remains intact and is lost to collision with the planet. The result is a pure ice ring much more massive than Saturn's current rings. As the ring evolves, its mass decreases and icy moons are spawned from its outer edge(7) with estimated masses consistent with Saturn's ice-rich moons interior to and including Tethys.	SW Res Inst, Planetary Sci Directorate, Boulder, CO 80302 USA		Canup, RM (corresponding author), SW Res Inst, Planetary Sci Directorate, 1050 Walnut St,Suite 300, Boulder, CO 80302 USA.	robin@boulder.swri.edu		Canup, Robin/0000-0002-2342-3458	NASA	NASA(National Aeronautics & Space Administration (NASA))	I thank W. R. Ward and L. Dones for detailed comments. Support from NASA's Outer Planets Research Program is gratefully acknowledged.	Barr AC, 2010, ICARUS, V209, P858, DOI 10.1016/j.icarus.2010.05.028; Barr AC, 2010, NAT GEOSCI, V3, P164, DOI 10.1038/NGEO746; Benz W, 1999, ICARUS, V142, P5, DOI 10.1006/icar.1999.6204; Canup RM, 2004, ICARUS, V168, P433, DOI 10.1016/j.icarus.2003.09.028; Canup RM, 2002, ASTRON J, V124, P3404, DOI 10.1086/344684; CANUP RM, 2000, P LUNAR PLANET SCI C, V31, P1916; Canup RM, 2006, NATURE, V441, P834, DOI 10.1038/nature04860; Charnoz S, 2010, NATURE, V465, P752, DOI 10.1038/nature09096; Charnoz S, 2009, ICARUS, V199, P413, DOI 10.1016/j.icarus.2008.10.019; Cuzzi JN, 2010, SCIENCE, V327, P1470, DOI 10.1126/science.1179118; Cuzzi JN, 1998, ICARUS, V132, P1, DOI 10.1006/icar.1997.5863; Daisaka H, 2001, ICARUS, V154, P296, DOI 10.1006/icar.2001.6716; DONES L, 1991, ICARUS, V92, P194, DOI 10.1016/0019-1035(91)90045-U; FRIEDSON AJ, 1983, ICARUS, V56, P1, DOI 10.1016/0019-1035(83)90124-0; GOLDREIC.P, 1973, ASTROPHYS J, V183, P1051, DOI 10.1086/152291; GOLDREICH P, 1982, ANNU REV ASTRON ASTR, V20, P249, DOI 10.1146/annurev.aa.20.090182.001341; GOLDREICH P, 1981, ASTROPHYS J, V243, pL75, DOI 10.1086/183446; Haisch KE, 2001, ASTROPHYS J, V553, pL153, DOI 10.1086/320685; Ida S, 1997, NATURE, V389, P353, DOI 10.1038/38669; Jaumann R, 2009, SATURN FROM CASSINI-HUYGENS, P637, DOI 10.1007/978-1-4020-9217-6_20; Marley MS, 2007, ASTROPHYS J, V655, P541, DOI 10.1086/509759; Melosh HJ, 2007, METEORIT PLANET SCI, V42, P2079, DOI 10.1111/j.1945-5100.2007.tb01009.x; Meyer J, 2007, ICARUS, V188, P535, DOI 10.1016/j.icarus.2007.03.001; Robbins SJ, 2010, ICARUS, V206, P431, DOI 10.1016/j.icarus.2009.09.012; Salmon J, 2010, ICARUS, V209, P771, DOI 10.1016/j.icarus.2010.05.030; Sasaki T, 2010, ASTROPHYS J, V714, P1052, DOI 10.1088/0004-637X/714/2/1052; Showman AP, 1997, ICARUS, V129, P367, DOI 10.1006/icar.1997.5778; WARD WR, 1978, P LUNAR PLANET SCI C, V9, P1205; [No title captured]	30	90	91	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 16	2010	468	7326					943	946		10.1038/nature09661	http://dx.doi.org/10.1038/nature09661			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21151108				2022-12-28	WOS:000285344600042
J	Finkelstein, IJ; Visnapuu, ML; Greene, EC				Finkelstein, Ilya J.; Visnapuu, Mari-Liis; Greene, Eric C.			Single-molecule imaging reveals mechanisms of protein disruption by a DNA translocase	NATURE			English	Article							RNA-POLYMERASE; RECBCD ENZYME; REPLICATION FORK; LAC REPRESSOR; TRANSCRIPTION; BINDING; REPLISOME; HELICASE; OPERATOR; MOTOR	In physiological settings, nucleic-acid translocases must act on substrates occupied by other proteins, and an increasingly appreciated role of translocases is to catalyse protein displacement from RNA andDNA(1-4). However, little is known regarding the inevitable collisions that must occur, and the fate of protein obstacles and the mechanisms by which they are evicted from DNA remain unexplored. Here we sought to establish the mechanistic basis for protein displacement from DNA using RecBCD as a model system. Using nanofabricated curtains of DNA and multicolour single-molecule microscopy, we visualized collisions between a model translocase and different DNA-bound proteins in real time. We show that the DNA translocase RecBCD can disrupt core RNA polymerase, holoenzymes, stalled elongation complexes and transcribing RNA polymerases in either head-to-head or head-to-tail orientations, as well as EcoRI(E111Q), lac repressor and even nucleosomes. RecBCD did not pause during collisions and often pushed proteins thousands of base pairs before evicting them from DNA. We conclude that RecBCD overwhelms obstacles through direct transduction of chemomechanical force with no need for specific protein-protein interactions, and that proteins can be removed from DNA through active disruption mechanisms that act on a transition state intermediate as they are pushed from one nonspecific site to the next.	[Greene, Eric C.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Finkelstein, Ilya J.; Visnapuu, Mari-Liis; Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University	Greene, EC (corresponding author), Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA.	ecg2108@columbia.edu			NIH [F32GM80864, GM074739, GM082848]; Columbia University; Nanoscale Science and Engineering Initiative of the National Science Foundation [CHE-0641523]; New York State Office of Science, Technology, and Academic Research; NATIONAL CANCER INSTITUTE [R01CA146940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082848, R01GM074739, F32GM080864] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University; Nanoscale Science and Engineering Initiative of the National Science Foundation(National Science Foundation (NSF)); New York State Office of Science, Technology, and Academic Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Gottesman, R. Gonzalez and members of the Greene laboratory for discussion and assistance throughout this work. We thank P. Modrich for providing an expression construct encoding EcoRI<SUP>E111Q</SUP>, R. Landick and K. Adelmanfor providing RNAP constructs, and J. Gelles for providing plasmids encoding RecBCD. I.J.F. was supported by an NIH Fellowship (F32GM80864). Funding was provided by the National Institutes of Health (GM074739 and GM082848 to E.C.G.). This work was partially supported by the Initiatives in Science and Engineering program through Columbia University, the Nanoscale Science and Engineering Initiative of the National Science Foundation under NSF Award Number CHE-0641523, and by the New York State Office of Science, Technology, and Academic Research. E.C.G is an Early Career Scientist with the Howard Hughes Medical Institute. We apologize to colleagues whose work we were unable to cite owing to length restrictions.	Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; BONNEANDREA C, 1990, NATURE, V343, P719, DOI 10.1038/343719a0; Byrd AK, 2006, NUCLEIC ACIDS RES, V34, P3020, DOI 10.1093/nar/gkl369; EGGLESTON AK, 1995, J BIOL CHEM, V270, P2024, DOI 10.1074/jbc.270.5.2024; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Herbert KM, 2008, ANNU REV BIOCHEM, V77, P149, DOI 10.1146/annurev.biochem.77.073106.100741; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; LIN SY, 1970, NATURE, V228, P1184, DOI 10.1038/2281184a0; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; LIU B, 1994, P NATL ACAD SCI USA, V91, P10660, DOI 10.1073/pnas.91.22.10660; LIU B, 1993, NATURE, V366, P33, DOI 10.1038/366033a0; Marquis KA, 2008, GENE DEV, V22, P1786, DOI 10.1101/gad.1684008; Mollazadeh-Beidokhti L, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031922; Noom MC, 2007, NAT METHODS, V4, P1031, DOI 10.1038/nmeth1126; NUDLER E, 1995, CELL, V81, P351, DOI 10.1016/0092-8674(95)90388-7; PAVCO PA, 1991, NUCLEIC ACIDS RES, V19, P4639, DOI 10.1093/nar/19.17.4639; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; SADLER JR, 1983, P NATL ACAD SCI-BIOL, V80, P6785, DOI 10.1073/pnas.80.22.6785; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Spies M, 2007, CELL, V131, P694, DOI 10.1016/j.cell.2007.09.023; STUDITSKY VM, 1995, CELL, V83, P19, DOI 10.1016/0092-8674(95)90230-9; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; Visnapuu ML, 2009, NAT STRUCT MOL BIOL, V16, P1056, DOI 10.1038/nsmb.1655; Wang YM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048302; WRIGHT DJ, 1989, J BIOL CHEM, V264, P11816	30	125	126	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					983	987		10.1038/nature09561	http://dx.doi.org/10.1038/nature09561			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21107319	Green Accepted			2022-12-28	WOS:000285344600051
J	Rajkumar, SV				Rajkumar, S. Vincent			Zoledronic acid in myeloma: MRC Myeloma IX	LANCET			English	Editorial Material							MULTIPLE-MYELOMA; CLINICAL-PRACTICE; DOUBLE-BLIND; BISPHOSPHONATES; PAMIDRONATE; MECHANISM; TRIAL		Mayo Clin, Div Hematol, Rochester, MN 55905 USA	Mayo Clinic	Rajkumar, SV (corresponding author), Mayo Clin, Div Hematol, Rochester, MN 55905 USA.	rajkumar.vincent@mayo.edu	Rajkumar, S. Vincent/AAV-1834-2021	Rajkumar, S. Vincent/0000-0002-5862-1833				Attal M, 2006, BLOOD, V108, P3289, DOI 10.1182/blood-2006-05-022962; Berenson JR, 1998, J CLIN ONCOL, V16, P593, DOI 10.1200/JCO.1998.16.2.593; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; Guenther A, 2010, INT J CANCER, V126, P239, DOI 10.1002/ijc.24758; Kavanagh KL, 2006, P NATL ACAD SCI USA, V103, P7829, DOI 10.1073/pnas.0601643103; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; Kyle RA, 2007, J CLIN ONCOL, V25, P2464, DOI 10.1200/JCO.2007.12.1269; Lacy MQ, 2006, MAYO CLIN PROC, V81, P1047, DOI 10.4065/81.8.1047; McCloskey EV, 2001, BRIT J HAEMATOL, V113, P1035, DOI 10.1046/j.1365-2141.2001.02851.x; Morgan GJ, 2010, LANCET, V376, P1989, DOI 10.1016/S0140-6736(10)62051-X; Rajkumar SV, 2010, LANCET ONCOL, V11, P29, DOI 10.1016/S1470-2045(09)70284-0; Rosen LS, 2001, CANCER J, V7, P377; Terpos E, 2009, ANN ONCOL, V20, P1303, DOI 10.1093/annonc/mdn796	13	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 11	2010	376	9757					1965	1966		10.1016/S0140-6736(10)62178-2	http://dx.doi.org/10.1016/S0140-6736(10)62178-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701GZ	21131042				2022-12-28	WOS:000285807700005
J	McMichael, AJ; Jones, EY				McMichael, Andrew J.; Jones, E. Yvonne			First-Class Control of HIV-1	SCIENCE			English	Editorial Material							P24 GAG; HLA; ASSOCIATION; PROGRESSION; DISEASE		[McMichael, Andrew J.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OS3 9DS, England; [Jones, E. Yvonne] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	McMichael, AJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OS3 9DS, England.	andrew.mcmichael@ndm.ox.ac.uk; yvonne@strubi.ox.ac.uk	Jones, Yvonne/N-8111-2019; Jones, Yvonne/J-2293-2016	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893	Medical Research Council [MC_U137884177, G9900061, G0900084] Funding Source: Medline; MRC [MC_U137884177, G9900061, G0900084] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Brown WM, 2009, DIABETES OBES METAB, V11, P2, DOI 10.1111/j.1463-1326.2008.00997.x; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Lederberg J, 1999, GENETICS, V153, P1; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Smith KJ, 1996, IMMUNITY, V4, P215, DOI 10.1016/S1074-7613(00)80430-6; Streeck H, 2007, J VIROL, V81, P7725, DOI 10.1128/JVI.00708-07; Turnbull EL, 2006, J IMMUNOL, V176, P6130, DOI 10.4049/jimmunol.176.10.6130	14	21	23	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2010	330	6010					1488	1490		10.1126/science.1200035	http://dx.doi.org/10.1126/science.1200035			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148380				2022-12-28	WOS:000285153500049
J	Groves, J				Groves, J.			CHRISTMAS 2010: THE LIVES OF DOCTORS Bicycle weight and commuting time: randomised trial	BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To determine whether the author's 20.9 lb (9.5 kg) carbon frame bicycle reduced commuting time compared with his 29.75 lb (13.5 kg) steel frame bicycle. Design Randomised trial. Setting Sheffield and Chesterfield, United Kingdom, between mid-January 2010 and mid-July 2010. Participants One consultant in anaesthesia and intensive care. Main outcome measure Total time to complete the 27 mile (43.5 kilometre) journey from Sheffield to Chesterfield Royal Hospital and back. Results The total distance travelled on the steel frame bicycle during the study period was 809 miles (1302 km) and on the carbon frame bicycle was 711 miles (1144 km). The difference in the mean journey time between the steel and carbon bicycles was 00: 00: 32 (hr:min:sec; 95% CI -00:03:34 to 00:02:30; P=0.72). Conclusions A lighter bicycle did not lead to a detectable difference in commuting time. Cyclists may find it more cost effective to reduce their own weight rather than to purchase a lighter bicycle.	Chesterfield Royal Hosp, Dept Anaesthet, Calow, Chesterfield, England		Groves, J (corresponding author), Chesterfield Royal Hosp, Dept Anaesthet, Calow, Chesterfield, England.	jeremy.groves@nhs.net						Armstrong L, 2000, ITS NOT BIKE MY JOUR; Department for Transport, 2009, CYCL WORK SCHEM IMPL; *WIK, BIC PERF	3	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 9	2010	341								c6801	10.1136/bmj.c6801	http://dx.doi.org/10.1136/bmj.c6801			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZU	21148220	hybrid, Green Published			2022-12-28	WOS:000285341200003
J	Feurle, GE; Moos, V; Schinnerling, K; Geelhaar, A; Allers, K; Biagi, F; Blaker, H; Moter, A; Loddenkemper, C; Jansen, A; Schneider, T				Feurle, Gerhard E.; Moos, Verena; Schinnerling, Katina; Geelhaar, Anika; Allers, Kristina; Biagi, Federico; Blaeker, Hendrik; Moter, Annette; Loddenkemper, Christoph; Jansen, Andreas; Schneider, Thomas			The Immune Reconstitution Inflammatory Syndrome in Whipple Disease A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							ANTIRETROVIRAL THERAPY	Background: Whipple disease, which is caused by infection with Tropheryma whipplei, can be treated effectively with antimicrobials. Occasionally, inflammation reappears after initial improvement; this is often interpreted as refractory or recurrent disease. However, polymerase chain reaction for T. whipplei in tissue is sometimes negative during reinflammation, indicating absence of vital bacteria, and this reinflammation does not respond to antimicrobials but does respond to steroids. Objective: To demonstrate that the immune reconstitution inflammatory syndrome (IRIS) occurs in patients treated for Whipple disease. Design: Cohort study. (International Standard Randomised Controlled Trial Number Register registration number: ISRCTN45658456) Setting: 2 academic medical centers in Germany. Methods: 142 patients treated for Whipple disease out of a cohort of 187 were observed for reappearance of inflammatory signs after effective antibiotic therapy. Definitions of IRIS in HIV infection, tuberculosis, and leprosy were adapted for application to Whipple disease. Results: On the basis of study definitions, IRIS was diagnosed in 15 of 142 patients. Symptoms included fever, arthritis, pleurisy, erythema nodosum, inflammatory orbitopathy, small-bowel perforation, and a hypothalamic syndrome. Two patients died. There was a positive correlation with previous immunosuppressive treatment and a negative correlation with previous diarrhea and weight loss. Limitations: The study was observational and thus has inherent weaknesses, such as incomplete and potentially selective data recording. Conclusion: The immune reconstitution inflammatory syndrome was diagnosed in about 10% of patients with Whipple disease in the study cohort; the outcome varied from mild to fatal. Patients who had had previous immunosuppressive therapy were at particular risk. An immune reconstitution syndrome should be considered in patients with Whipple disease in whom inflammatory symptoms recur after effective treatment. Early diagnosis and treatment with steroids may be beneficial; prospective studies are needed.	[Feurle, Gerhard E.] DRK Krankenhaus Neuwied, D-56564 Neuwied, Germany; [Biagi, Federico] Univ Pavia, Dept Internal Med 1, Coeliac Unit, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy; [Blaeker, Hendrik] Heidelberg Univ, Inst Pathol, D-69120 Heidelberg, Germany; [Moter, Annette] Charite, Inst Med Mikrobiol & Hyg, D-10117 Berlin, Germany; Charite, Med Klin 1, D-10117 Berlin, Germany; Charite, Inst Pathol, D-10117 Berlin, Germany; Robert Koch Inst, Abt Infekt Epidemiol, D-1000 Berlin, Germany	IRCCS Fondazione San Matteo; University of Pavia; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute	Moos, V (corresponding author), Charite, Med Klin 1, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany.	verena.moos@charite.de	Biagi, Federico/G-2812-2011	Biagi, Federico/0000-0002-2227-4622; Schneider, Thomas/0000-0003-1125-0518; Moter, Annette/0000-0003-1318-5780; Schinnerling, Katina/0000-0003-2669-9764; Moos, Verena/0000-0002-9558-7291	European Commission [QLG1-CT-2002-01049]; Deutsche Forschungsgemeinschaft [KFO 104, SFB633]	European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	By the 5th Framework Program of the European Commission (grant QLG1-CT-2002-01049) and Deutsche Forschungsgemeinschaft (grants KFO 104 and SFB633).	Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Colebunders R, 2006, INT J TUBERC LUNG D, V10, P946; da Silva SA, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-134; DeArment MC, 2003, J RHEUMATOL, V30, P1347; Durand DV, 1997, MEDICINE, V76, P170, DOI 10.1097/00005792-199705000-00003; Fernandez-Urien I, 2007, GASTROINTEST ENDOSC, V65, P521, DOI 10.1016/j.gie.2006.06.073; FEURLE GE, 1994, DIGEST DIS SCI, V39, P1642, DOI 10.1007/BF02087770; Feurle GE, 2010, GASTROENTEROLOGY, V138, P478, DOI 10.1053/j.gastro.2009.10.041; Fritscher-Ravens A, 2004, ENDOSCOPY, V36, P659, DOI 10.1055/s-2004-814537; Huerva V, 2008, OCUL IMMUNOL INFLAMM, V16, P37, DOI 10.1080/09273940801899756; Lagier JC, 2010, J INFECTION, V60, P79, DOI 10.1016/j.jinf.2009.09.017; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Leone S, 2010, INT J INFECT DIS, V14, pE283, DOI 10.1016/j.ijid.2009.05.016; Lieger O, 2007, J CRANIO MAXILL SURG, V35, P393, DOI 10.1016/j.jcms.2007.03.005; Mancini F, 2009, J CLIN MICROBIOL, V47, P492, DOI 10.1128/JCM.01833-08; Marth T, 2002, GASTROENTEROLOGY, V123, P1468, DOI 10.1053/gast.2002.36583; Martinetti M, 2009, GASTROENTEROLOGY, V136, P2289, DOI 10.1053/j.gastro.2009.01.051; Moos V, 2006, J IMMUNOL, V177, P2015, DOI 10.4049/jimmunol.177.3.2015; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; ORSSAUD C, 1992, J FR OPHTALMOL, V15, P205; Peschard S, 2001, PRESSE MED, V30, P1549; PLAYFORD RJ, 1992, GUT, V33, P132, DOI 10.1136/gut.33.1.132; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; Schaller J, 2009, J AM ACAD DERMATOL, V60, P277, DOI 10.1016/j.jaad.2008.09.024; Schijf LJ, 2008, NETH J MED, V66, P392; Schneider T, 2008, LANCET INFECT DIS, V8, P179, DOI 10.1016/S1473-3099(08)70042-2; Shaw MA, 2001, GENES IMMUN, V2, P196, DOI 10.1038/sj.gene.6363754; vonHerbay A, 1996, VIRCHOWS ARCH, V429, P335; vonHerbay A, 1996, GASTROENTEROLOGY, V110, P1735, DOI 10.1053/gast.1996.v110.pm8964398; Wagner AD, 2008, Z RHEUMATOL, V67, P284, DOI 10.1007/s00393-008-0299-0; Whipple GH, 1907, B JOHNS HOPKINS HOSP, V18, P382	32	66	70	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 7	2010	153	11					710	717		10.7326/0003-4819-153-11-201012070-00004	http://dx.doi.org/10.7326/0003-4819-153-11-201012070-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	690KN	21135294				2022-12-28	WOS:000285003800003
J	Bader, T				Bader, Ted			Liver tests are irrelevant when prescribing statins	LANCET			English	Editorial Material							HEPATOTOXICITY		Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Bader, T (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73104 USA.	tedbader@cox.net						Athyros VG, 2010, LANCET, V376, P1916, DOI 10.1016/S0140-6736(10)61272-X; Bader T, 2008, AM J GASTROENTEROL, V103, P1383, DOI 10.1111/j.1572-0241.2008.01876.x; Bader T, 2010, AM J GASTROENTEROL, V105, P978, DOI 10.1038/ajg.2010.102; Madhoun MF, 2010, DIGEST DIS SCI, V55, P870, DOI 10.1007/s10620-009-1125-5; Rzouq FS, 2010, AM J MED SCI, V340, P89, DOI 10.1097/MAJ.0b013e3181e15da8	5	34	35	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 4	2010	376	9756					1882	1883		10.1016/S0140-6736(10)62142-3	http://dx.doi.org/10.1016/S0140-6736(10)62142-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696KH	21109303				2022-12-28	WOS:000285439800008
J	Bates, M				Bates, Mark			A New Approach to Fluorescence Microscopy	SCIENCE			English	Editorial Material							OPTICAL RECONSTRUCTION MICROSCOPY; LOCALIZATION; PROBES; RESOLUTION; CELLS		Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany	Max Planck Society	Bates, M (corresponding author), Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany.	mbates@ggweg.de						Bates M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108101; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bates M, 2008, CURR OPIN CHEM BIOL, V12, P505, DOI 10.1016/j.cbpa.2008.08.008; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Biteen JS, 2008, NAT METHODS, V5, P947, DOI 10.1038/nmeth.1258; Dempsey GT, 2009, J AM CHEM SOC, V131, P18192, DOI 10.1021/ja904588g; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	17	2	2	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1334	1335		10.1126/science.1200252	http://dx.doi.org/10.1126/science.1200252			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127240	Green Published			2022-12-28	WOS:000284902100030
J	Keasling, JD				Keasling, Jay D.			Manufacturing Molecules Through Metabolic Engineering	SCIENCE			English	Review							ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION MACHINERY; BIOSYNTHETIC PATHWAYS; MICROBIAL-PRODUCTION; GENES; EXPRESSION; DESIGN; GENOME; TERPENOIDS	Metabolic engineering has the potential to produce from simple, readily available, inexpensive starting materials a large number of chemicals that are currently derived from nonrenewable resources or limited natural resources. Microbial production of natural products has been achieved by transferring product-specific enzymes or entire metabolic pathways from rare or genetically intractable organisms to those that can be readily engineered, and production of unnatural specialty chemicals, bulk chemicals, and fuels has been enabled by combining enzymes or pathways from different hosts into a single microorganism and by engineering enzymes to have new function. Whereas existing production routes use well-known, safe, industrial microorganisms, future production schemes may include designer cells that are tailor-made for the desired chemical and production process. In any future, metabolic engineering will soon rival and potentially eclipse synthetic organic chemistry.	[Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Synthet Biol Engn Res Ctr, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Keasling, JD (corresponding author), Joint BioEnergy Inst, 5885 Hollis St, Emeryville, CA 94608 USA.	keasling@berkeley.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088	National Science Foundation [0540879]; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was supported in part by the Synthetic Biology Engineering Research Center, which is funded by National Science Foundation Award No. 0540879 and by the Joint BioEnergy Institute, which is funded by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231.	Alper H, 2007, METAB ENG, V9, P258, DOI 10.1016/j.ymben.2006.12.002; Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; BAILEY JE, 1991, SCIENCE, V252, P1668, DOI 10.1126/science.2047876; Beller HR, 2010, APPL ENVIRON MICROB, V76, P1212, DOI 10.1128/AEM.02312-09; Chang MCY, 2007, NAT CHEM BIOL, V3, P274, DOI 10.1038/nchembio875; Dietrich JA, 2009, ACS CHEM BIOL, V4, P261, DOI 10.1021/cb900006h; Dunlop Mary J, 2010, Syst Synth Biol, V4, P95, DOI 10.1007/s11693-010-9052-5; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P82; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Kizer L, 2008, APPL ENVIRON MICROB, V74, P3229, DOI 10.1128/AEM.02750-07; Leonard E, 2010, P NATL ACAD SCI USA, V107, P13654, DOI 10.1073/pnas.1006138107; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Menzella HG, 2005, NAT BIOTECHNOL, V23, P1171, DOI 10.1038/nbt1128; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; Park JH, 2007, P NATL ACAD SCI USA, V104, P7797, DOI 10.1073/pnas.0702609104; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Prather KLJ, 2008, CURR OPIN BIOTECH, V19, P468, DOI 10.1016/j.copbio.2008.07.009; RENNINGER NS, 2008, Patent No. 200804555; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Siewers V, 2010, BIOTECHNOL BIOENG, V106, P841, DOI 10.1002/bit.22739; Smolke CD, 2000, APPL ENVIRON MICROB, V66, P5399, DOI 10.1128/AEM.66.12.5399-5405.2000; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wisselink HW, 2009, APPL ENVIRON MICROB, V75, P907, DOI 10.1128/AEM.02268-08; Withers ST, 2007, APPL ENVIRON MICROB, V73, P6277, DOI 10.1128/AEM.00861-07; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607; [No title captured]	39	532	564	9	399	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1355	1358		10.1126/science.1193990	http://dx.doi.org/10.1126/science.1193990			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127247				2022-12-28	WOS:000284902100036
J	Kanchanawong, P; Shtengel, G; Pasapera, AM; Ramko, EB; Davidson, MW; Hess, HF; Waterman, CM				Kanchanawong, Pakorn; Shtengel, Gleb; Pasapera, Ana M.; Ramko, Ericka B.; Davidson, Michael W.; Hess, Harald F.; Waterman, Clare M.			Nanoscale architecture of integrin-based cell adhesions	NATURE			English	Article							FOCAL ADHESIONS; ACTIN-FILAMENTS; PROTEIN; FORCE; TALIN; MICROSCOPY; PROBES	Cell adhesions to the extracellular matrix (ECM) are necessary for morphogenesis, immunity and wound healing(1,2). Focal adhesions are multifunctional organelles that mediate cell-ECM adhesion, force transmission, cytoskeletal regulation and signalling(1-3). Focal adhesions consist of a complex network(4) of trans-plasma-membrane integrins and cytoplasmic proteins that form a <200-nm plaque(5,6) linking the ECM to the actin cytoskeleton. The complexity of focal adhesion composition and dynamics implicate an intricate molecular machine(7,8). However, focal adhesion molecular architecture remains unknown. Here we used three-dimensional super-resolution fluorescence microscopy (interferometric photo-activated localization microscopy)(9) to map nanoscale protein organization in focal adhesions. Our results reveal that integrins and actin are vertically separated by a similar to 40-nm focal adhesion core region consisting of multiple protein-specific strata: a membrane-apposed integrin signalling layer containing integrin cytoplasmic tails, focal adhesion kinase and paxillin; an intermediate force-transduction layer containing talin and vinculin; and an uppermost actin-regulatory layer containing zyxin, vasodilator-stimulated phosphoprotein and alpha-actinin. By localizing amino- and carboxyterminally tagged talins, we reveal talin's polarized orientation, indicative of a role in organizing the focal adhesion strata. The composite multilaminar protein architecture provides a molecular blueprint for understanding focal adhesion functions.	[Kanchanawong, Pakorn; Pasapera, Ana M.; Waterman, Clare M.] NHLBI, NIH, Bethesda, MD 20892 USA; [Shtengel, Gleb; Hess, Harald F.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Ramko, Ericka B.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Waterman, CM (corresponding author), NHLBI, NIH, Bethesda, MD 20892 USA.	davidson@magnet.fsu.edu; hessh@janelia.hhmi.org; watermancm@nhlbi.nih.gov	Kanchanawong, Pakorn/M-1315-2017	Kanchanawong, Pakorn/0000-0001-8765-3861; Waterman, Clare/0000-0001-6142-6775	Division of Intramural Research, NHLBI; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005105] Funding Source: NIH RePORTER	Division of Intramural Research, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Lippincott-Schwartz, G. Patterson and M. Parsons for sharing DNA; S. Xie for help with automation software; K. Jaqaman for MATLAB code; and HHMI Janelia Farm Scientific Computing and NIH Helix systems for computing resources. Funding: Division of Intramural Research, NHLBI (P.K., A.M.P. and C.M.W.); Howard Hughes Medical Institute (G.S. and H.F.H.).	AUBIN JE, 1979, J HISTOCHEM CYTOCHEM, V27, P36, DOI 10.1177/27.1.220325; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; CHEN WT, 1982, J CELL BIOL, V95, P205, DOI 10.1083/jcb.95.1.205; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Dulkeith E, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.205424; Franz CM, 2005, J CELL SCI, V118, P5315, DOI 10.1242/jcs.02653; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Hell SW, 2009, NAT PHOTONICS, V3, P381, DOI 10.1038/NPHOTON.2009.112; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LEDBETTER MC, 1963, J CELL BIOL, V19, P239, DOI 10.1083/jcb.19.1.239; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; PALADE GE, 1954, J EXP MED, V100, P641, DOI 10.1084/jem.100.6.641; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Pollard TD, 2009, J BIOL CHEM, V284, P5433, DOI 10.1074/jbc.R800043200; Press W., 1986, NUMERICAL RECIPES; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Wang Yu-li, 2007, Sci STKE, V2007, ppe10; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zamir E, 1999, J CELL SCI, V112, P1655	35	984	1005	8	416	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					580	U262		10.1038/nature09621	http://dx.doi.org/10.1038/nature09621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107430	Green Accepted			2022-12-28	WOS:000284584200046
J	Marinoni, C; Buzzi, A				Marinoni, Christian; Buzzi, Adeline			A geometric measure of dark energy with pairs of galaxies	NATURE			English	Article							COSMOLOGICAL CONSTANT; DATA RELEASE; REAL-SPACE; UNIVERSE; VOIDS	Observations(1,2) indicate that the expansion of the Universe is accelerating, which is attributed to a 'dark energy' component that opposes gravity(3,4). There is a purely geometric test of the expansion of the Universe (the Alcock-Paczynski test), which would provide an independent way of investigating the abundance (Omega(X)) and equation of state (w(X)) of dark energy(5). It is based on an analysis of the geometrical distortions expected from comparing the real-space and redshift-space shape of distant cosmic structures, but it has proved difficult to implement(6-18). Here we report an analysis of the symmetry properties of distant pairs of galaxies from archival data(19,20). This allows us to determine that the Universe is flat. By alternately fixing its spatial geometry at Omega(k) equivalent to 0, and the dark energy equation-of-state parameter at w(X) equivalent to -1, and using the results of baryon acoustic oscillations, we can establish at the 68.3% confidence level that -0.85 > w(X) > - 1.12 and 0.60 < Omega(X) < 0.80.	[Marinoni, Christian; Buzzi, Adeline] Univ Aix Marseille 1, CNRS, UMR 6207, Ctr Phys Theor, F-13288 Marseille 9, France; [Marinoni, Christian] Inst Univ France, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Institut Universitaire de France	Marinoni, C (corresponding author), Univ Aix Marseille 1, CNRS, UMR 6207, Ctr Phys Theor, Campus Luminy,Case 907, F-13288 Marseille 9, France.	marinoni@cpt.univ-mrs.fr			CNRS; Institut Universitaire de France	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Universitaire de France	M. thanks J. Bel, P.-E. Crouzet, M. Davis, L. Guzzo, A. Blanchard, E. Branchini, P. S. Corasaniti, A. Ealet, A. Heavens, O. Le Fevre, L. Moscardini, T. Schucker, P. Taxil and J. M. Virey for discussions. We thank R. Giovanelli, L. Lellouch and P. J. Morrison for reading versions of the manuscript. This paper has greatly benefited from the comments of M. Strauss. C.M. is grateful for support from the Projets Exploratoires Pluridisciplinaires: Physique Theorique et ses Interfaces of the CNRS and from specific project funding of the Institut Universitaire de France.	Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; ALCOCK C, 1979, NATURE, V281, P358, DOI 10.1038/281358a0; Astier P, 2006, ASTRON ASTROPHYS, V447, P31, DOI 10.1051/0004-6361:20054185; Ballinger WE, 1996, MON NOT R ASTRON SOC, V282, P877, DOI 10.1093/mnras/282.3.877; Barkana R, 2006, MON NOT R ASTRON SOC, V372, P259, DOI 10.1111/j.1365-2966.2006.10882.x; Coil AL, 2004, ASTROPHYS J, V609, P525, DOI 10.1086/421337; da Angela J, 2005, MON NOT R ASTRON SOC, V361, P879, DOI 10.1111/j.1365-2966.2005.09212.x; Dunkley J, 2009, ASTROPHYS J SUPPL S, V180, P306, DOI 10.1088/0067-0049/180/2/306; Frieman JA, 2008, ANNU REV ASTRON ASTR, V46, P385, DOI 10.1146/annurev.astro.46.060407.145243; Hui L, 1999, ASTROPHYS J, V511, pL5, DOI 10.1086/311826; Kessler R, 2009, ASTROPHYS J SUPPL S, V185, P32, DOI 10.1088/0067-0049/185/1/32; Kim YR, 2007, MON NOT R ASTRON SOC, V374, P535, DOI 10.1111/j.1365-2966.2006.11168.x; Marinoni C, 1998, ASTROPHYS J, V505, P484, DOI 10.1086/306183; MARINONI C, PHYS REV LETT UNPUB; McDonald P, 2003, ASTROPHYS J, V585, P34, DOI 10.1086/345945; McQuinn M, 2006, ASTROPHYS J, V653, P815, DOI 10.1086/505167; Nusser A, 2005, MON NOT R ASTRON SOC, V364, P743, DOI 10.1111/j.1365-2966.2005.09603.x; Peebles PJE, 2003, REV MOD PHYS, V75, P559, DOI 10.1103/RevModPhys.75.559; Percival WJ, 2010, MON NOT R ASTRON SOC, V401, P2148, DOI 10.1111/j.1365-2966.2009.15812.x; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; PHILLIPPS S, 1994, MON NOT R ASTRON SOC, V269, P1077, DOI 10.1093/mnras/269.4.1077; Popowski PA, 1998, ASTROPHYS J, V498, P11, DOI 10.1086/305528; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; RYDEN BS, 1995, ASTROPHYS J, V452, P25, DOI 10.1086/176277; Ryden BS, 1996, ASTROPHYS J, V470, P160, DOI 10.1086/177857; STRAUSS MA, 1995, PHYS REP, V261, P271, DOI 10.1016/0370-1573(95)00013-7	29	45	46	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					539	541		10.1038/nature09577	http://dx.doi.org/10.1038/nature09577			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107424				2022-12-28	WOS:000284584200036
J	Aiken, LH				Aiken, Linda H.			Nurses for the Future.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EDUCATION		Univ Penn, Sch Nursing, Ctr Hlth Outcomes & Policy Res, Philadelphia, PA 19104 USA	University of Pennsylvania	Aiken, LH (corresponding author), Univ Penn, Sch Nursing, Ctr Hlth Outcomes & Policy Res, Philadelphia, PA 19104 USA.							Aiken LH, 2003, JAMA-J AM MED ASSOC, V290, P1617, DOI 10.1001/jama.290.12.1617; AIKEN LH, 1995, JAMA-J AM MED ASSOC, V273, P1528, DOI 10.1001/jama.273.19.1528; Aiken LH, 2009, HEALTH AFFAIR, V28, pW646, DOI 10.1377/hlthaff.28.4.w646; Institute of Medicine, 2011, FUT NURS LEAD CHANG; Lynaugh JE, 2008, NURS HIST REV, V16, P13, DOI 10.1891/1062-8061.16.13	5	34	35	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2011	364	3					196	198		10.1056/NEJMp1011639	http://dx.doi.org/10.1056/NEJMp1011639			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	708SF	21158647				2022-12-28	WOS:000286383900002
J	Oberg, M; Jaakkola, MS; Woodward, A; Peruga, A; Pruss-Ustun, A				Oberg, Mattias; Jaakkola, Maritta S.; Woodward, Alistair; Peruga, Armando; Pruess-Ustuen, Annette			Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries	LANCET			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; PASSIVE SMOKING; LEGISLATION; CHILDREN; HEALTH; IMPACT	Background Exposure to second-hand smoke is common in many countries but the magnitude of the problem worldwide is poorly described. We aimed to estimate the worldwide exposure to second-hand smoke and its burden of disease in children and adult non-smokers in 2004. Methods The burden of disease from second-hand smoke was estimated as deaths and disability-adjusted life-years (DALYs) for children and adult non-smokers. The calculations were based on disease-specific relative risk estimates and area-specific estimates of the proportion of people exposed to second-hand smoke, by comparative risk assessment methods, with data from 192 countries during 2004. Findings Worldwide, 40% of children, 33% of male non-smokers, and 35% of female non-smokers were exposed to second-hand smoke in 2004. This exposure was estimated to have caused 379 000 deaths from ischaemic heart disease, 165 000 from lower respiratory infections, 36 900 from asthma, and 21 400 from lung cancer. 603 000 deaths were attributable to second-hand smoke in 2004, which was about 1.0% of worldwide mortality. 47% of deaths from second-hand smoke occurred in women, 28% in children, and 26% in men. DALYs lost because of exposure to second-hand smoke amounted to 10.9 million, which was about 0.7% of total worldwide burden of diseases in DALYs in 2004. 61% of DALYs were in children. The largest disease burdens were from lower respiratory infections in children younger than 5 years (5 939 000), ischaemic heart disease in adults (2 836 000), and asthma in adults (1 246 000) and children (651 000). Interpretation These estimates of worldwide burden of disease attributable to second-hand smoke suggest that substantial health gains could be made by extending effective public health and clinical interventions to reduce passive smoking worldwide.	[Pruess-Ustuen, Annette] WHO, Dept Publ Hlth & Environm, CH-1211 Geneva 27, Switzerland; [Oberg, Mattias] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Jaakkola, Maritta S.] Univ Oulu, Resp Med Unit, Ctr Environm & Resp Hlth Res, Oulu, Finland; [Jaakkola, Maritta S.] Univ Oulu, Inst Clin Med, Oulu, Finland; [Woodward, Alistair] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand	World Health Organization; Karolinska Institutet; University of Oulu; University of Oulu; University of Auckland	Pruss-Ustun, A (corresponding author), WHO, Dept Publ Hlth & Environm, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	pruessa@who.int	Peruga, Armando/G-9739-2019	Jaakkola, Maritta S./0000-0003-1373-7784; Oberg, Mattias/0000-0001-5377-530X; Woodward, Alistair/0000-0001-5425-6018	Swedish National Board of Health and Welfare; Bloomberg Philanthropies	Swedish National Board of Health and Welfare; Bloomberg Philanthropies	We thank the Swedish National Board of Health and Welfare and the Bloomberg Philanthropies for their funding support. The authors alone are responsible for the views expressed in this publication, which do not necessarily reflect the decisions or the stated policy of WHO or of its Member States. (C) World Health Organization, 2010.	[Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; California Environmental Protection Agency, 2005, PROP ID ENV TOB SMOK; Centers for Disease Control and Prevention, GLOB YOUTH TOB SURV; Eriksen MP, 2008, ANNU REV PUBL HEALTH, V29, P171, DOI 10.1146/annurev.publhealth.29.020907.090920; ETZEL RA, 1992, PEDIATRICS, V90, P228; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2004, COMP QUANTIFICATION; Fontana L, 2007, G Ital Med Lav Ergon, V29, P484; Gan Q, 2007, TOB CONTROL, V16, P417, DOI 10.1136/tc.2007.021477; Institute of Medicine, 2009, SECONDH SMOK EXP CAR; Intenational Labour Office, 2008, GLOB EMPL TRENDS WOM; International Agency for Research on Cancer, 2009, EV EFF SMOK FREE POL; International Agency for Research on Cancer, 2004, TOB SMOK INV SMOK; Jaakkola MS, 2006, EUR RESPIR J, V28, P397, DOI 10.1183/09031936.06.00001306; Jaakkola MS, 2003, AM J PUBLIC HEALTH, V93, P2055, DOI 10.2105/AJPH.93.12.2055; Jaakkola MS, 1999, ENVIRON HEALTH PERSP, V107, P829, DOI 10.2307/3434561; Li JS, 1999, PEDIATR PULM, V27, P5, DOI 10.1002/(SICI)1099-0496(199901)27:1<5::AID-PPUL3>3.0.CO;2-5; Lightwood JM, 2009, CIRCULATION, V120, P1373, DOI 10.1161/CIRCULATIONAHA.109.870691; Lopez MJ, 2007, TOB CONTROL, V16, P373, DOI 10.1136/tc.2006.019679; McNabola A, 2009, INT J ENV RES PUB HE, V6, P741, DOI 10.3390/ijerph6020741; Menzies D, 2006, JAMA-J AM MED ASSOC, V296, P1742, DOI 10.1001/jama.296.14.1742; Musk AW, 2003, RESPIROLOGY, V8, P286, DOI 10.1046/j.1440-1843.2003.00483.x; Oberg M, GLOBAL ESTI IN PRESS; Pell Jill P, 2008, N Engl J Med, V359, P482, DOI 10.1056/NEJMsa0706740; Pr?ss-?st?n, 2010, 2 HAND SMOKE ASSESSI; SCHONHERR E., 1928, ZEITSCHR KREBSFORSCH, V27, P436, DOI 10.1007/BF02125480; The Gallup Organization, 2009, SURV TOB AN REP; United Nations, 2009, MILL DEV GOALS REP 2; US Department of Health Education and Welfare, 1972, DHEW PUBL; US Surgeon General, 2006, HLTH CONS INV EXP TO; WHO, 2002, RED RISKS PROM HLTH; Wipfli H, 2008, AM J PUBLIC HEALTH, V98, P672, DOI 10.2105/AJPH.2007.126631; Woodward A, 2001, TOB CONTROL, V10, P383, DOI 10.1136/tc.10.4.383; World Health Organization, 2009, WHO FRAM CONV TOB CO; World Health Organization, 1999, INT CONS ENV TOB SMO; World Health Organization, 2009, GLOB BURD DIS 2004 U; World Health Organization, 2009, WHO REP GLOB TOB EP; World Health Organization (WHO), 2009, GUID IMPL WHO FRAM C	38	1138	1182	6	201	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					139	146		10.1016/S0140-6736(10)61388-8	http://dx.doi.org/10.1016/S0140-6736(10)61388-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707NH	21112082				2022-12-28	WOS:000286292800026
J	Nelson, EJ; Nelson, DS; Salam, MA; Sack, DA				Nelson, Eric J.; Nelson, Danielle S.; Salam, Mohammed A.; Sack, David A.			Antibiotics for Both Moderate and Severe Cholera.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nelson, Eric J.] Stanford Univ, Lucile Packard Childrens Hosp, Palo Alto, CA 94304 USA; [Nelson, Danielle S.] Santa Clara Valley Med Ctr, Milpitas, CA USA; [Salam, Mohammed A.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Sack, David A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Lucile Packard Children's Hospital (LPCH); Stanford University; Santa Clara Valley Medical Center; International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Nelson, EJ (corresponding author), Stanford Univ, Lucile Packard Childrens Hosp, Palo Alto, CA 94304 USA.							KHAN MU, 1982, J TROP MED HYG, V85, P27; LINDENBA.J, 1967, B WORLD HEALTH ORGAN, V36, P871; RAHAMAN MM, 1976, ANTIMICROB AGENTS CH, V10, P610, DOI 10.1128/AAC.10.4.610; Saha D, 2006, NEW ENGL J MED, V354, P2452, DOI 10.1056/NEJMoa054493; Weil AA, 2009, CLIN INFECT DIS, V49, P1473, DOI 10.1086/644779	5	64	64	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2011	364	1					5	7		10.1056/NEJMp1013771	http://dx.doi.org/10.1056/NEJMp1013771			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702UY	21142691				2022-12-28	WOS:000285922600003
J	Zaratiegui, M; Vaughn, MW; Irvine, DV; Goto, D; Watt, S; Bahler, J; Arcangioli, B; Martienssen, RA				Zaratiegui, Mikel; Vaughn, Matthew W.; Irvine, Danielle V.; Goto, Derek; Watt, Stephen; Baehler, Juerg; Arcangioli, Benoit; Martienssen, Robert A.			CENP-B preserves genome integrity at replication forks paused by retrotransposon LTR	NATURE			English	Article							FISSION YEAST HOMOLOGS; SCHIZOSACCHAROMYCES-POMBE; DNA-REPLICATION; CHROMOSOME SEGREGATION; FRAGILE SITES; PROTEIN SAP1; RECOMBINATION; CENTROMERE; IDENTIFICATION; PURIFICATION	Centromere-binding protein B (CENP-B) is a widely conserved DNA binding factor associated with heterochromatin and centromeric satellite repeats(1). In fission yeast, CENP-B homologues have been shown to silence long terminal repeat (LTR) retrotransposons by recruiting histone deacetylases(2). However, CENP-B factors also have unexplained roles in DNA replication(3,4). Here we show that a molecular function of CENP-B is to promote replication-fork progression through the LTR. Mutants have increased genomic instability caused by replication-fork blockage that depends on the DNA binding factor switch-activating protein 1 (Sap1), which is directly recruited by the LTR. The loss of Sap1-dependent barrier activity allows the unhindered progression of the replication fork, but results in rearrangements deleterious to the retrotransposon. We conclude that retrotransposons influence replication polarity through recruitment of Sap1 and transposition near replication-fork blocks, whereas CENP-B counteracts this activity and promotes fork stability. Our results may account for the role of LTR in fragile sites, and for the association of CENP-B with pericentromeric heterochromatin and tandem satellite repeats.	[Zaratiegui, Mikel; Vaughn, Matthew W.; Irvine, Danielle V.; Goto, Derek; Martienssen, Robert A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Watt, Stephen; Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Watt, Stephen; Baehler, Juerg] UCL Canc Inst, London WC1E 6BT, England; [Arcangioli, Benoit] Inst Pasteur, Dynam GenomeUnit, CNRS URA2171, Dept Genomes & Genet, F-75015 Paris, France; [Arcangioli, Benoit] Inst Pasteur, Dynam GenomeUnit, CNRS URA2171, Dept Dev Biol, F-75015 Paris, France	Cold Spring Harbor Laboratory; University of London; University College London; University of London; University College London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	Goto, Derek B/B-7053-2009; Bahler, Jurg/B-4572-2009	Bahler, Jurg/0000-0003-4036-1532; Zaratiegui, Mikel/0000-0002-0342-0268; Vaughn, Matthew/0000-0002-1384-4283	National Institutes of Health [RO1GM076396]; Cancer Research UK [C9546/A6517]; Agence Nationale de la Recherche [ANR-06-BLAN-0271]; National Health and Medical Research Council; Spanish Ministry of Education; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Agence Nationale de la Recherche(French National Research Agency (ANR)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Spanish Ministry of Education(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Martienssen laboratory, V. Aranda, E. Mejia-Ramirez and F. Antequera for technical advice and discussions, and R. Allshire, E. Noguchi, M. O'Connell, P. Espenshade and the National BioResource Project (T. Nakamura, Japan) for strains. This work was supported by National Institutes of Health grant RO1GM076396 to R.A.M., Cancer Research UK grant C9546/A6517 to J.B., l'Agence Nationale de la Recherche grant ANR-06-BLAN-0271 to B.A., a National Health and Medical Research Council C.J. Martin Fellowship to D.V.I. and a Postdoctoral Fellowship from the Spanish Ministry of Education to M.Z.	Aguilar-Arnal L, 2008, EMBO J, V27, P1029, DOI 10.1038/emboj.2008.53; ARCANGIOLI B, 1991, EMBO J, V10, P3025, DOI 10.1002/j.1460-2075.1991.tb07853.x; Baum M, 2000, MOL CELL BIOL, V20, P2852, DOI 10.1128/MCB.20.8.2852-2864.2000; Cam HP, 2008, NATURE, V451, P431, DOI 10.1038/nature06499; de Lahondes R, 2003, EUKARYOT CELL, V2, P910, DOI 10.1128/EC.2.5.910-921.2003; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; GHAZVINI M, 1995, MOL CELL BIOL, V15, P4939; Gomez EB, 2008, GENETICS, V179, P757, DOI 10.1534/genetics.107.085779; Guo YB, 2010, GENOME RES, V20, P239, DOI 10.1101/gr.099648.109; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Irelan JT, 2001, GENETICS, V157, P1191; Irvine DV, 2009, GENOME RES, V19, P1077, DOI 10.1101/gr.089318.108; Krings G, 2005, J BIOL CHEM, V280, P39135, DOI 10.1074/jbc.M508996200; KUPIEC M, 1988, GENETICS, V119, P549; Lee JK, 1997, P NATL ACAD SCI USA, V94, P8427, DOI 10.1073/pnas.94.16.8427; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Locovei AM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-27; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; Mejia-Ramirez E, 2005, MOL CELL BIOL, V25, P8755, DOI 10.1128/MCB.25.19.8755-8761.2005; Murakami Y, 1996, P NATL ACAD SCI USA, V93, P502, DOI 10.1073/pnas.93.1.502; Noguchi C, 2007, GENETICS, V175, P553, DOI 10.1534/genetics.106.065334; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Segurado M, 2002, MOL CELL, V10, P907, DOI 10.1016/S1097-2765(02)00684-6; Sehgal A, 2007, PLOS GENET, V3, P1389, DOI 10.1371/journal.pgen.0030131; Szilard RK, 2010, NAT STRUCT MOL BIOL, V17, P299, DOI 10.1038/nsmb.1754; Ton-Hoang B, 2010, CELL, V142, P398, DOI 10.1016/j.cell.2010.06.034; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wong LH, 2004, TRENDS GENET, V20, P611, DOI 10.1016/j.tig.2004.09.011	30	66	67	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					112	115		10.1038/nature09608	http://dx.doi.org/10.1038/nature09608			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21151105	Green Submitted, Green Accepted			2022-12-28	WOS:000285921600042
J	Patel, V; Weiss, HA; Chowdhary, N; Naik, S; Pednekar, S; Chatterjee, S; De Silva, MJ; Bhat, B; Araya, R; King, M; Simon, G; Verdeli, H; Kirkwood, BR				Patel, Vikram; Weiss, Helen A.; Chowdhary, Neerja; Naik, Smita; Pednekar, Sulochana; Chatterjee, Sudipto; De Silva, Mar J.; Bhat, Bhargav; Araya, Ricardo; King, Michael; Simon, Gregory; Verdeli, Helen; Kirkwood, Betty R.			Effectiveness of an intervention led by lay health counsellors for depressive and anxiety disorders in primary care in Goa, India (MANAS): a cluster randomised controlled trial	LANCET			English	Article							COMMON MENTAL-DISORDERS; GROUP INTERPERSONAL PSYCHOTHERAPY; RURAL UGANDA; COMMUNITY; WOMEN; COUNTRIES	Background Depression and anxiety disorders are common mental disorders worldwide. The MANAS trial aimed to test the effectiveness of an intervention led by lay health counsellors in primary care settings to improve outcomes of people with these disorders. Methods In this cluster randomised trial, primary care facilities in Goa, India, were assigned (1:1) by computer-generated randomised sequence to intervention or control (enhanced usual care) groups. All adults who screened positive for common mental disorders were eligible. The collaborative stepped-care intervention offered case management and psychosocial interventions, provided by a trained lay health counsellor, supplemented by antidepressant drugs by the primary care physician and supervision by a mental health specialist. The research assessor was masked. The primary outcome was recovery from common mental disorders as defined by the International Statistical Classification of Diseases and Related Health Problems-10th revision (ICD-10) at 6 months. This study is registered with ClinicalTrials.gov, number NCT00446407. Findings 24 study clusters, with an equal proportion of public and private facilities, were randomised equally between groups. 1160 of 1360 (85%) patients in the intervention group and 1269 of 1436 (88%) in the control group completed the outcome assessment. Patients with ICD-10-confirmed common mental disorders in the intervention group were more likely to have recovered at 6 months than were those in the control group (n=620 [65.0%] vs 553 [52.9%]; risk ratio 1.22, 95% CI 1.00-1.47; risk difference=12.1%, 95% CI 1.6%-22.5%). The intervention had strong evidence of an effect in public facility attenders (369 [65.9%] vs 267 [42.5%], risk ratio 1.55, 95% CI 1.02-2.35) but no evidence for an effect in private facility attenders (251 [64.1%] vs 286 [65.9%], risk ratio 0.95, 0.74-1.22). There were three deaths and four suicide attempts in the collaborative stepped-care group and six deaths and six suicide attempts in the enhanced usual care group. None of the deaths were from suicide. Interpretation A trained lay counsellor-led collaborative care intervention can lead to an improvement in recovery from CMD among patients attending public primary care facilities.	[Patel, Vikram; Chowdhary, Neerja; Naik, Smita; Pednekar, Sulochana; Chatterjee, Sudipto] Sangath Ctr, Alto Porvorim 403521, Goa, India; [Weiss, Helen A.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, MRC, Trop Epidemiol Grp, London WC1, England; [Araya, Ricardo] Univ Bristol, Bristol, Avon, England; [King, Michael] UCL, Sch Med, Dept Psychiat, London W1N 8AA, England; [Simon, Gregory] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; [Verdeli, Helen] Columbia Univ, Teachers Coll, New York, NY 10027 USA	University of London; London School of Hygiene & Tropical Medicine; University of Bristol; University of London; University College London; UCL Medical School; Group Health Cooperative; Columbia University; Columbia University Teachers College	Patel, V (corresponding author), Sangath Ctr, 841-1 Alto Porvorim, Alto Porvorim 403521, Goa, India.	vikram.patel@lshtm.ac.uk	Pednekar, Sulochana/GVS-0184-2022; Araya, Ricardo/S-3144-2019; weiss, helen/ABC-7823-2021; King, Michael B/D-7477-2011	Araya, Ricardo/0000-0002-0420-5148; weiss, helen/0000-0003-3547-7936; King, Michael B/0000-0003-4715-7171; Kirkwood, Betty/0000-0001-5274-6072; Patel, Vikram/0000-0003-1066-8584; Pednekar, Sulochana/0000-0002-4538-4795	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The Wellcome Trust.	Abas M, 2003, HARVARD REV PSYCHIAT, V11, P166, DOI 10.1080/10673220303954; Araya R, 2003, LANCET, V361, P995, DOI 10.1016/S0140-6736(03)12825-5; Bass J, 2006, BRIT J PSYCHIAT, V188, P567, DOI 10.1192/bjp.188.6.567; Bolton P, 2003, JAMA-J AM MED ASSOC, V289, P3117, DOI 10.1001/jama.289.23.3117; Bower P, 2006, BRIT J PSYCHIAT, V189, P484, DOI 10.1192/bjp.bp.106.023655; Brugha R, 1998, HEALTH POLICY PLANN, V13, P107, DOI 10.1093/heapol/13.2.107; Chatterjee S, 2008, WORLD PSYCHIATRY, V7, P39; Cheung YB, 2008, TROP MED INT HEALTH, V13, P247, DOI 10.1111/j.1365-3156.2007.01997.x; Chisholm D, 2000, BRIT J PSYCHIAT, V176, P581, DOI 10.1192/bjp.176.6.581; Cohen A., 2001, WHOMSDMPS011; GOLDBERG DP, 1995, MENTAL ILLNESS GEN H, P323; Hayes RJ, 2009, INTERD STAT, P3; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; Lewin SA, 2005, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD004015.PUB2; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; National Institute for Clinical Excellence, 2004, DEPR MAN DEPR PRIM S; Patel V, 2008, PSYCHOL MED, V38, P221, DOI 10.1017/S0033291707002334; Patel V, 2003, LANCET, V361, P33, DOI 10.1016/S0140-6736(03)12119-8; Patel V, 2003, B WORLD HEALTH ORGAN, V81, P609; Patel V, 2007, TROP MED INT HEALTH, V12, P130, DOI 10.1111/j.1365-3156.2006.01756.x; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000159; Patel VH, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-4; PAYKEL ES, 1992, BRIT MED J, V305, P1198, DOI 10.1136/bmj.305.6863.1198; Pereira B, 2007, J AFFECT DISORDERS, V102, P209, DOI 10.1016/j.jad.2006.09.025; Petersen I, 2000, SOC SCI MED, V51, P321, DOI 10.1016/S0277-9536(99)00456-6; The MANAS program, MAN FAM PHYS COLL ST; USTUN TB, 1995, MENTAL ILLNESS GEN H, P347; Verdeli H, 2003, WORLD PSYCHIAT, V2, P113; Whooley MA, 2000, J GEN INTERN MED, V15, P293, DOI 10.1046/j.1525-1497.2000.04319.x; World Health Organization, 1995, MENT ILLN GEN HLTH C	30	413	413	0	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2010	376	9758					2086	2095		10.1016/S0140-6736(10)61508-5	http://dx.doi.org/10.1016/S0140-6736(10)61508-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702LA	21159375	Green Accepted			2022-12-28	WOS:000285895000026
J	Dutton, PL				Dutton, P. Leslie			Britton Chance (1913-2010)	SCIENCE			English	Biographical-Item									Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania	Dutton, PL (corresponding author), Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	dutton@mail.med.upenn.edu							0	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2010	330	6011					1641	1641		10.1126/science.1200976	http://dx.doi.org/10.1126/science.1200976			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164008				2022-12-28	WOS:000285390500056
J	Kim, BYS; Rutka, JT; Chan, WCW				Kim, Betty Y. S.; Rutka, James T.; Chan, Warren C. W.			Current Concepts: Nanomedicine.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							IN-VIVO; CARBON NANOTUBES; THERMAL THERAPY; QUANTUM DOTS; PHASE-I; NANOPARTICLES; CANCER; DENDRIMERS; TUMORS; ASSAY		[Chan, Warren C. W.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Kim, Betty Y. S.; Chan, Warren C. W.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3G9, Canada; [Chan, Warren C. W.] Univ Toronto, Dept Mat Sci & Engn, Toronto, ON M5S 3G9, Canada; [Chan, Warren C. W.] Univ Toronto, Dept Chem Engn, Toronto, ON M5S 3G9, Canada; [Kim, Betty Y. S.; Rutka, James T.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Rutka, James T.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Chan, WCW (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Inst Biomat & Biomed Engn, 164 Coll St,407, Toronto, ON M5S 3G9, Canada.	warren.chan@utoronto.ca		Kim, Betty Y.S./0000-0001-6890-8355	University of Toronto Department of Surgery; Neurosurgery Research and Education Foundation-American Association of Neurological Surgeons; Natural Sciences and Engineering Research Council of Canada [RGPIN288231-09, NETGP35015-07]; Canadian Institute of Health Research [MOP-74610, RMF-72551, MOP-93532]; Canadian Cancer Society Research Institute; Canadian Foundation for Innovation; Ontario Innovation Trust; Parvus Therapeutics	University of Toronto Department of Surgery; Neurosurgery Research and Education Foundation-American Association of Neurological Surgeons; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; Parvus Therapeutics	Supported by grants from the University of Toronto Department of Surgery Surgeon Scientist Program and Clinical Investigator Program, the Neurosurgery Research and Education Foundation-American Association of Neurological Surgeons (to Dr. Kim), the Natural Sciences and Engineering Research Council of Canada (to Dr. Kim and RGPIN288231-09 and NETGP35015-07 to Dr. Chan), the Canadian Institute of Health Research (MOP-74610, to Dr. Rutka; and RMF-72551 and MOP-93532 to Dr. Chan), the Canadian Cancer Society Research Institute (to Dr. Rutka), and the Canadian Foundation for Innovation and the Ontario Innovation Trust (to Dr. Chan).; Dr. Chan reports receiving grant support from Parvus Therapeutics on behalf of the University of Toronto, cofounding Cytodiagnostics and the Fio Corporation and holding equity in both companies, and having received fees for serving on the Scientific Advisory Board of Sigma-Aldrich Biotechnology in 2008-2009. No other potential conflict of interest relevant to this article was reported.	Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; *BRIT STAND I, 2007, 136 BRIT STAND I; Chattopadhyay PK, 2006, NAT MED, V12, P972, DOI 10.1038/nm1371; *COUNC CAN AC, 2008, SMALL IS DIFF SCI PE; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Enochs WS, 1999, JMRI-J MAGN RESON IM, V9, P228, DOI 10.1002/(SICI)1522-2586(199902)9:2<228::AID-JMRI12>3.3.CO;2-B; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Gharbi N, 2005, NANO LETT, V5, P2578, DOI 10.1021/nl051866b; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Hauck TS, 2010, SMALL, V6, P138, DOI 10.1002/smll.200900626; Heidel JD, 2007, P NATL ACAD SCI USA, V104, P5715, DOI 10.1073/pnas.0701458104; Helms B, 2006, SCIENCE, V313, P929, DOI 10.1126/science.1130639; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Huang XH, 2009, ADV MATER, V21, P4880, DOI 10.1002/adma.200802789; Johannsen M, 2007, INT J HYPERTHER, V23, P315, DOI 10.1080/02656730601175479; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Kim TY, 2004, CLIN CANCER RES, V10, P3708, DOI 10.1158/1078-0432.CCR-03-0655; Lefferts JA, 2009, EXP MOL PATHOL, V87, P105, DOI 10.1016/j.yexmp.2009.06.002; Libutti SK, 2007, J CLIN ONCOL S, V25, p163s; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Liu ZA, 2008, J AM CHEM SOC, V130, P13540, DOI 10.1021/ja806242t; McCarthy TD, 2005, MOL PHARMACEUT, V2, P312, DOI 10.1021/mp050023q; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]; Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; Prencipe G, 2009, J AM CHEM SOC, V131, P4783, DOI 10.1021/ja809086q; Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI [10.1038/nmeth.1248, 10.1038/NMETH.1248]; Schipper ML, 2008, NAT NANOTECHNOL, V3, P216, DOI 10.1038/nnano.2008.68; Sperling RA, 2008, CHEM SOC REV, V37, P1896, DOI 10.1039/b712170a; Suh WH, 2009, NANO TODAY, V4, P27, DOI 10.1016/j.nantod.2008.10.013; Thaxton CS, 2009, P NATL ACAD SCI USA, V106, P18437, DOI 10.1073/pnas.0904719106; Thorek DLJ, 2006, ANN BIOMED ENG, V34, P23, DOI 10.1007/s10439-005-9002-7; Visaria RK, 2006, MOL CANCER THER, V5, P1014, DOI 10.1158/1535-7163.MCT-05-0381; Xia YN, 2009, ANGEW CHEM INT EDIT, V48, P60, DOI 10.1002/anie.200802248	40	778	807	10	146	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2010	363	25					2434	2443		10.1056/NEJMra0912273	http://dx.doi.org/10.1056/NEJMra0912273			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZK	21158659	Green Published			2022-12-28	WOS:000285340200009
J	Wu, JA; Xu, FJ; Lu, L; Lu, M; Miao, LA; Gao, T; Ji, WY; Suo, LD; Liu, DL; Ma, R; Yu, R; Zhangzhu, JZ; Liu, WX; Zeng, Y; Li, XM; Zhang, XC; Pang, XH; Deng, Y				Wu, Jiang; Xu, Fujie; Lu, Li; Lu, Min; Miao, Liang; Gao, Ting; Ji, Wenyan; Suo, Luodan; Liu, Donglei; Ma, Rui; Yu, Rui; Zhangzhu, Jiazi; Liu, Weixiang; Zeng, Yang; Li, Xiaomei; Zhang, Xuechun; Pang, Xinghuo; Deng, Ying			Safety and Effectiveness of a 2009 H1N1 Vaccine in Beijing.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GUILLAIN-BARRE-SYNDROME; INFLUENZA; VIRUS; CHINA	Background: After the first monovalent 2009 pandemic influenza A (H1N1) vaccine became available in September 2009, Chinese officials conducted a mass vaccination program in Beijing. We evaluated the safety and effectiveness of the vaccine. Methods: During a 5-day period in September 2009, a total of 95,244 children and adults received the PANFLU.1 vaccine (Sinovac Biotech), a monovalent split-virion vaccine of 15 microg of hemagglutinin antigen without adjuvant. We assessed adverse events after immunization through an enhanced passive-surveillance system and through active surveillance, using diary cards and telephone interviews. Active surveillance for neurologic diseases was implemented in hospitals citywide. To assess vaccine effectiveness, we compared the rates of reported laboratory-confirmed cases of 2009 H1N1 virus infection in students who received the vaccine with the rates in those who did not receive the vaccine, starting 2 weeks after the mass vaccination. Results: As of December 31, 2009, adverse events were reported by 193 vaccine recipients. Through hospital-based active surveillance, 362 cases of incident neurologic diseases were identified within 10 weeks after the mass vaccination, including 27 cases of the Guillain-Barre syndrome. None of the neurologic conditions occurred among vaccine recipients. From 245 schools, 25,037 students participated in the mass vaccination and 244,091 did not. During the period from October 9 through November 15, 2009, the incidence of confirmed cases of 2009 H1N1 virus infection per 100,000 students was 35.9 (9 of 25,037) among vaccinated students and 281.4 (687 of 244,091) among unvaccinated students. Thus, the estimated vaccine effectiveness was 87.3% (95% confidence interval, 75.4 to 93.4). Conclusions: Among 95,244 children and adults in Beijing, the PANFLU.1 vaccine had a safety profile similar to those of seasonal influenza vaccines and appeared to be effective against confirmed H1N1 virus infection in school-age children. (Funded by the Beijing Municipal Health Bureau.) N Engl J Med 2010;363:2416-23.	[Xu, Fujie] Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA 30333 USA; [Wu, Jiang; Lu, Li; Lu, Min; Miao, Liang; Gao, Ting; Ji, Wenyan; Suo, Luodan; Liu, Donglei; Ma, Rui; Yu, Rui; Zhangzhu, Jiazi; Liu, Weixiang; Zeng, Yang; Li, Xiaomei; Zhang, Xuechun; Pang, Xinghuo; Deng, Ying] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China	Centers for Disease Control & Prevention - USA	Xu, FJ (corresponding author), Ctr Dis Control & Prevent, Div STD Prevent, 1600 Clifton Rd,Mailstop E-02, Atlanta, GA 30333 USA.	fax1@cdc.gov			Beijing Municipal Health Bureau	Beijing Municipal Health Bureau	Supported by the Beijing Municipal Health Bureau.	Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Institute of Medicine, 2003, IMM SAF REV INFL VAC; Khazeni N, 2009, ANN INTERN MED, V151, P840, DOI [10.7326/0000605-200912150-00156, 10.7326/0003-4819-151-12-200912150-00156]; Liang XF, 2010, LANCET, V375, P1694; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; PERRY HD, 1979, ANN OPHTHALMOL, V11, P545; Pfeifer D, 2010, LANCET, V375, P9, DOI 10.1016/S0140-6736(09)62133-4; SAFRANEK TJ, 1991, AM J EPIDEMIOL, V133, P940, DOI 10.1093/oxfordjournals.aje.a115973; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Stone R, 2009, SCIENCE, V325, P1482, DOI 10.1126/science.325_1482; Weycker D, 2005, VACCINE, V23, P1284, DOI 10.1016/j.vaccine.2004.08.044; WHO, 2009, 16 WHO; World Health Organization, 2009, CDC PROT REALT RTPCR	14	94	100	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2010	363	25					2416	2423		10.1056/NEJMoa1006736	http://dx.doi.org/10.1056/NEJMoa1006736			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZK	21158658				2022-12-28	WOS:000285340200007
J	Helffrich, G; Kaneshima, S				Helffrich, George; Kaneshima, Satoshi			Outer-core compositional stratification from observed core wave speed profiles	NATURE			English	Article							FE-FES; PHASE-RELATIONS; HIGH-PRESSURE; TRAVEL-TIMES; EARTHS CORE; P-WAVE; VELOCITY; CONSTRAINTS; RESOLUTION; SYSTEM	Light elements must be present in the nearly pure iron core of the Earth to match the remotely observed properties of the outer and inner cores(1,2). Crystallization of the inner core excludes light elements from the solid, concentrating them in liquid near the inner-core boundary that potentially rises and collects at the top of the core(3), and this may have a seismically observable signal. Here we present array-based observations of seismic waves sensitive to this part of the core whose wave speeds require there to be radial compositional variation in the topmost 300 km of the outer core. The velocity profile significantly departs from that of compression of a homogeneous liquid. Total light-element enrichment is up to five weight per cent at the top of the core if modelled in the Fe-O-S system. The stratification suggests the existence of a subadiabatic temperature gradient at the top of the outer core.	[Helffrich, George] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Kaneshima, Satoshi] Kyushu Univ, Higashi Ku, Fukuoka 8128581, Japan	University of Tokyo; Kyushu University	Helffrich, G (corresponding author), Univ Bristol, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England.	george.helffrich@bris.ac.uk		Helffrich, George/0000-0002-7363-4552	ERI	ERI	This work was supported by an ERI Visiting Professorship to G.H. We thank A. Jackson for comments and O. Lord for experimental references. Data were provided by the ORFEUS Data Center, de Bilt, the Netherlands, the J-Array data centre, ERI, Tokyo, Japan, and by NIED, Tsukuba, Japan.	Alexandrakis C, 2010, PHYS EARTH PLANET IN, V180, P59, DOI 10.1016/j.pepi.2010.02.011; Alfe D, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165118; ANDERSON OL, 1992, REV GEOPHYS, V30, P57, DOI 10.1029/91RG02810; ANDERSON OL, 1993, PHYS CHEM MINER, V19, P369, DOI 10.1007/BF00202974; BINA CR, 1992, ANNU REV EARTH PL SC, V20, P527, DOI 10.1146/annurev.ea.20.050192.002523; BIRCH F, 1952, J GEOPHYS RES, V57, P227, DOI 10.1029/JZ057i002p00227; BOEHLER R, 1993, NATURE, V363, P534, DOI 10.1038/363534a0; BOEHLER R, 1992, EARTH PLANET SC LETT, V111, P217, DOI 10.1016/0012-821X(92)90180-4; BRAGINSKY SI, 1993, J GEOMAGN GEOELECTR, V45, P1517, DOI 10.5636/jgg.45.1517; Buffett BA, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006751; Dobson DP, 2002, PHYS EARTH PLANET IN, V130, P271, DOI 10.1016/S0031-9201(02)00011-0; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Eaton DW, 2006, PHYS EARTH PLANET IN, V155, P104, DOI 10.1016/j.pepi.2005.10.007; FEARN DR, 1981, NATURE, V289, P393, DOI 10.1038/289393a0; FEI YW, 1990, J GEOPHYS RES-SOLID, V95, P6915, DOI 10.1029/JB095iB05p06915; Frost DJ, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006302; GARMANY J, 1979, J GEOPHYS RES, V84, P3615, DOI 10.1029/JB084iB07p03615; GARNERO EJ, 1993, GEOPHYS RES LETT, V20, P2463, DOI 10.1029/93GL02823; GUBBINS D, 1982, GEOPHYS J ROY ASTR S, V68, P241, DOI 10.1111/j.1365-246X.1982.tb06972.x; Helffrich G, 2004, SCIENCE, V306, P2239, DOI 10.1126/science.1101109; HILTY DC, 1952, JOM-J MIN MET MAT S, V4, P1307; KENNETT BLN, 1991, GEOPHYS J INT, V105, P429, DOI 10.1111/j.1365-246X.1991.tb06724.x; KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; Kilburn MR, 1997, EARTH PLANET SC LETT, V152, P139, DOI 10.1016/S0012-821X(97)00125-8; KIND R, 1979, J GEOPHYS-Z GEOPHYS, V45, P373; LAY T, 1990, GEOPHYS RES LETT, V17, P2001, DOI 10.1029/GL017i011p02001; Lister JR, 1998, PHYS EARTH PLANET IN, V105, P5, DOI 10.1016/S0031-9201(97)00082-4; Loper DE, 2000, PHYS EARTH PLANET IN, V117, P179, DOI 10.1016/S0031-9201(99)00096-5; Masters G, 2003, PHYS EARTH PLANET IN, V140, P159, DOI 10.1016/j.pepi.2003.07.008; Masters G., 2000, EARTHS DEEP INTERIOR, V117, P63, DOI DOI 10.1029/GM117P0063; Morard G, 2007, EARTH PLANET SC LETT, V263, P128, DOI 10.1016/j.epsl.2007.09.009; MORELLI A, 1993, GEOPHYS J INT, V112, P178, DOI 10.1111/j.1365-246X.1993.tb01448.x; Ozawa H, 2008, GEOPHYS RES LETT, V35, DOI [10.1029/2007GL032648, 10.1029/2007GL03268]; Rose LA, 2001, ECON GEOL BULL SOC, V96, P145, DOI 10.2113/96.1.145; Rubie DC, 2004, NATURE, V429, P58, DOI 10.1038/nature02473; STEVENSON DJ, 1981, SCIENCE, V214, P611, DOI 10.1126/science.214.4521.611; SVENDSEN B, 1989, PHYS EARTH PLANET IN, V55, P154, DOI 10.1016/0031-9201(89)90241-0; Tanaka S, 2007, EARTH PLANET SC LETT, V259, P486, DOI 10.1016/j.epsl.2007.05.007; USSELMAN TM, 1975, AM J SCI, V275, P278, DOI 10.2475/ajs.275.3.278; Wood BJ, 2006, NATURE, V441, P825, DOI 10.1038/nature04763	40	126	127	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					807	U96		10.1038/nature09636	http://dx.doi.org/10.1038/nature09636			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21150995				2022-12-28	WOS:000285093700042
J	Summers, ZM; Fogarty, HE; Leang, C; Franks, AE; Malvankar, NS; Lovley, DR				Summers, Zarath M.; Fogarty, Heather E.; Leang, Ching; Franks, Ashley E.; Malvankar, Nikhil S.; Lovley, Derek R.			Direct Exchange of Electrons Within Aggregates of an Evolved Syntrophic Coculture of Anaerobic Bacteria	SCIENCE			English	Article							GEOBACTER-SULFURREDUCENS; SP-NOV; REDUCTION; OXIDATION; METHANE; HYDROGEN; ARCHAEA; FE(III); MICROORGANISM; CONSTRAINTS	Microbial consortia that cooperatively exchange electrons play a key role in the anaerobic processing of organic matter. Interspecies hydrogen transfer is a well-documented strategy for electron exchange in dispersed laboratory cultures, but cooperative partners in natural environments often form multispecies aggregates. We found that laboratory evolution of a coculture of Geobacter metallireducens and Geobacter sulfurreducens metabolizing ethanol favored the formation of aggregates that were electrically conductive. Sequencing aggregate DNA revealed selection for a mutation that enhances the production of a c-type cytochrome involved in extracellular electron transfer and accelerates the formation of aggregates. Aggregate formation was also much faster in mutants that were deficient in interspecies hydrogen transfer, further suggesting direct interspecies electron transfer.	[Summers, Zarath M.; Fogarty, Heather E.; Leang, Ching; Franks, Ashley E.; Malvankar, Nikhil S.; Lovley, Derek R.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Malvankar, Nikhil S.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Lovley, DR (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	dlovley@microbio.umass.edu		Franks, Ashley/0000-0003-1664-6060	Office of Science (Office of Biological and Environmental Research), U.S. Department of Energy [DE-FC02-02ER63446, DE-FC-0004485]	Office of Science (Office of Biological and Environmental Research), U.S. Department of Energy(United States Department of Energy (DOE))	We thank P. Brown, C. Barrett, K. Zengler, and Y. Qiu for sequence analysis; L. Raboin for SEM assistance; and K. Rubin for photography assistance. Supported by the Office of Science (Office of Biological and Environmental Research), U.S. Department of Energy, Cooperative Agreement DE-FC02-02ER63446 and Award DE-FC-0004485.	Alperin MJ, 2009, AM J SCI, V309, P869, DOI 10.2475/10.2009.01; BRYANT MP, 1967, ARCH MIKROBIOL, V59, P20, DOI 10.1007/BF00406313; Butler JE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-40; Butler JE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-103; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Coppi MV, 2004, J BACTERIOL, V186, P3022, DOI 10.1128/JB.186.10.3022-3028.2004; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Hillesland KL, 2010, P NATL ACAD SCI USA, V107, P2124, DOI 10.1073/pnas.0908456107; Holmes DE, 2006, ENVIRON MICROBIOL, V8, P1805, DOI 10.1111/j.1462-2920.2006.01065.x; Juarez K, 2009, J MOL MICROB BIOTECH, V16, P146, DOI 10.1159/000115849; Kartal B, 2010, SCIENCE, V328, P702, DOI 10.1126/science.1185941; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Leang C, 2010, APPL ENVIRON MICROB, V76, P4080, DOI 10.1128/AEM.00023-10; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Marx CJ, 2009, SCIENCE, V324, P1150, DOI 10.1126/science.1173088; McInerney MJ, 2009, CURR OPIN BIOTECH, V20, P623, DOI 10.1016/j.copbio.2009.10.001; Mehta T, 2005, APPL ENVIRON MICROB, V71, P8634, DOI 10.1128/AEM.71.12.8634-8641.2005; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Nauhaus K, 2002, ENVIRON MICROBIOL, V4, P296, DOI 10.1046/j.1462-2920.2002.00299.x; Orcutt B, 2008, BIOGEOSCIENCES, V5, P1587, DOI 10.5194/bg-5-1587-2008; OZTURK SS, 1989, BIOTECHNOL BIOENG, V33, P745, DOI 10.1002/bit.260330612; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Reguera G, 2006, APPL ENVIRON MICROB, V72, P7345, DOI 10.1128/AEM.01444-06; Schink B, 2006, PROKARYOTES, V3, P5, DOI DOI 10.1007/0-387-30747-8_1; Schmidt JE, 1996, BIOTECHNOL BIOENG, V49, P229, DOI [10.1002/(SICI)1097-0290(19960205)49:3<229::AID-BIT1>3.0.CO;2-M, 10.1002/(SICI)1097-0290(19960205)49:3&lt;229::AID-BIT1&gt;3.0.CO;2-M]; Sorensen KB, 2001, MICROBIAL ECOL, V42, P1; Stams AJM, 2009, NAT REV MICROBIOL, V7, P568, DOI 10.1038/nrmicro2166	27	609	665	65	800	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1413	1415		10.1126/science.1196526	http://dx.doi.org/10.1126/science.1196526			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127257				2022-12-28	WOS:000284902100052
J	Bazari, H				Bazari, Hasan			BECOMING A PHYSICIAN Gratitude, Memories, and Meaning in Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Internal Med Residency Program, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Bazari, H (corresponding author), Massachusetts Gen Hosp, Internal Med Residency Program, Boston, MA 02114 USA.								0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2187	2189		10.1056/NEJMp1001594	http://dx.doi.org/10.1056/NEJMp1001594			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	688EP	21121831				2022-12-28	WOS:000284832900004
J	Martin, M; Segui, MA; Anton, A; Ruiz, A; Ramos, M; Adrover, E; Aranda, I; Rodriguez-Lescure, A; Grosse, R; Calvo, L; Barnadas, A; Isla, D; del Prado, PM; Borrego, M; Zaluski, J; Arcusa, A; Munoz, M; Vega, JM; Mel, JR; Munarriz, B; Llorca, C; Jara, C; Alba, E; Florian, J; Li, JF; Garcia-Asenjo, JA; Saez, A; Rios, M; Almenar, S; Peiro, G; Lluch, A				Martin, Miguel; Segui, Miguel A.; Anton, Antonio; Ruiz, Amparo; Ramos, Manuel; Adrover, Encarna; Aranda, Ignacio; Rodriguez-Lescure, Alvaro; Grosse, Regina; Calvo, Lourdes; Barnadas, Agusti; Isla, Dolores; Martinez del Prado, Purificacion; Ruiz Borrego, Manuel; Zaluski, Jerzy; Arcusa, Angels; Munoz, Montserrat; Lopez Vega, Jose M.; Mel, Jose R.; Munarriz, Blanca; Llorca, Cristina; Jara, Carlos; Alba, Emilio; Florian, Jesus; Li, Junfang; Lopez Garcia-Asenjo, Jose A.; Saez, Amparo; Jose Rios, Maria; Almenar, Sergio; Peiro, Gloria; Lluch, Ana		GEICAM 9805 Investigators	Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOXORUBICIN PLUS CYCLOPHOSPHAMIDE; CHEMOTHERAPY; PACLITAXEL; THERAPY; TRIAL; FLUOROURACIL; EPIRUBICIN; HIGHLIGHTS; CONSENSUS; REGIMEN	Background: A regimen of docetaxel, doxorubicin, and cyclophosphamide (TAC) is superior to a regimen of fluorouracil, doxorubicin, and cyclophosphamide (FAC) when used as adjuvant therapy in women with node-positive breast cancer. The value of taxanes in the treatment of node-negative disease has not been determined. Methods: We randomly assigned 1060 women with axillary-node-negative breast cancer and at least one high-risk factor for recurrence (according to the 1998 St. Gallen criteria) to treatment with TAC or FAC every 3 weeks for six cycles after surgery. The primary end point was disease-free survival after at least 5 years of follow-up. Secondary end points included overall survival and toxicity. Results: At a median follow-up of 77 months, the proportion of patients alive and disease-free was higher among the 539 women in the TAC group (87.8%) than among the 521 women in the FAC group (81.8%), representing a 32% reduction in the risk of recurrence with TAC (hazard ratio, 0.68; 95% confidence interval [CI], 0.49 to 0.93; P=0.01 by the log-rank test). This benefit was consistent, regardless of hormone-receptor status, menopausal status, or number of high-risk factors. The difference in survival rates (TAC, 95.2%; FAC, 93.5%) was not significant (hazard ratio, 0.76; 95% CI, 0.45 to 1.26); however, the number of events was small (TAC, 26; FAC, 34). Rates of grade 3 or 4 adverse events were 28.2% with TAC and 17.0% with FAC (P<0.001). Toxicity associated with TAC was diminished when primary prophylaxis with granulocyte colony-stimulating factor was provided. Conclusions: As compared with adjuvant FAC, adjuvant TAC improved the rate of disease-free survival among women with high-risk, node-negative breast cancer. (Funded by GEICAM and Sanofi-Aventis; ClinicalTrials.gov number, NCT00121992.) N Engl J Med 2010;363:2200-10.	[Martin, Miguel] Univ Complutense, Hosp Gen Univ Gregorio Maranon, Med Oncol Serv, Madrid 28007, Spain; [Segui, Miguel A.; Saez, Amparo] Corp Sanitaria Parc Tauli, Sabadell, Spain; [Anton, Antonio; Jose Rios, Maria] Hosp Univ Miguel Servet, Zaragoza, Spain; [Isla, Dolores] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain; [Ruiz, Amparo; Almenar, Sergio] Inst Valenciano Oncol, Valencia, Spain; [Munarriz, Blanca] Hosp La Fe, E-46009 Valencia, Spain; [Lluch, Ana] Hosp Clin Valencia, Valencia, Spain; [Ramos, Manuel] Ctr Oncol Galicia, Corunna, Spain; [Calvo, Lourdes] Complejo Hosp Coruna, Corunna, Spain; [Adrover, Encarna; Aranda, Ignacio; Peiro, Gloria] Hosp Gen Univ Alicante, Alicante, Spain; [Rodriguez-Lescure, Alvaro] Hosp Univ Elche, Elche, Spain; [Barnadas, Agusti] Hosp Badalona Germans Trias & Pujol, Badalona, Spain; [Martinez del Prado, Purificacion] Hosp Basurto, Bilbao, Spain; [Ruiz Borrego, Manuel] Hosp Virgen del Rocio, Seville, Spain; [Arcusa, Angels] Consorci Sanit Terrassa, Terrassa, Spain; [Martin, Miguel] Hosp Clin Barcelona, Barcelona, Spain; [Lopez Vega, Jose M.] Hosp Marques de Valdecilla, Santander, Spain; [Mel, Jose R.] Complejo Hosp Xeral Calde, Lugo, Spain; [Llorca, Cristina] Hosp Gen Elda, Elda, Spain; [Jara, Carlos] Fdn Hosp Alcorcon, Alcorcon, Spain; [Alba, Emilio] Hosp Clin Virgen de la Victoria, Malaga, Spain; [Florian, Jesus] Hosp Comarcal de Barbastro, Huesca, Spain; [Lopez Garcia-Asenjo, Jose A.] Hosp Univ Principe de Asturias, Alcala De Henares, Spain; [Grosse, Regina] Martin Luther Univ Klin, Klin & Poliklin Gynakol, Halle, Germany; [Zaluski, Jerzy] Wielkopolskie Ctr Onkol, Poznan, Poland; [Li, Junfang] Sanofi Aventis, Bridgewater, NJ USA	Complutense University of Madrid; General University Gregorio Maranon Hospital; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Miguel Servet University Hospital; Lozano Blesa University Clinical Hospital; Instituto Valenciano De Oncologia; Hospital Universitari i Politecnic La Fe; Complejo Hospitalario Universitario A Coruna; General University Hospital of Alicante; Hospital Germans Trias i Pujol; Basurto Hospital; Virgen del Rocio University Hospital; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Lucus Augusti-Lugo; Alcorcon Foundation University Hospital; Hospital Virgen de la Victoria; Prince of Asturias University Hospital; Martin Luther University Halle Wittenberg; Wielkopolskie Centrum Onkologii; Sanofi-Aventis	Martin, M (corresponding author), Univ Complutense, Hosp Gen Univ Gregorio Maranon, Med Oncol Serv, Dr Esquerdo 46, Madrid 28007, Spain.	mmartin@geicam.org	Lluch, Ana/R-5493-2019; Alba, Emilio/S-1435-2019; Martin, Miguel/V-6589-2019; Muñoz, Montserrat/AAO-9617-2020; Rodríguez-Lescure, Álvaro/AAB-7039-2019; Calvo, Lourdes/M-2352-2014; Adrover, Encarna/AAC-8454-2020; ARANDA, FRANCISCO I/L-5525-2015; MORALES, SERAFIN/L-7216-2019; Martin, Miguel/AAJ-9242-2020; CALVO, LOURDES/F-2329-2015; Anton, Antonio/AAP-6563-2020; Aranda, F. Ignacio/H-5029-2011; Castellà, Eva/K-4140-2017	Lluch, Ana/0000-0003-2766-407X; Alba, Emilio/0000-0002-3364-2603; Muñoz, Montserrat/0000-0001-7772-1437; Rodríguez-Lescure, Álvaro/0000-0002-6823-5290; ARANDA, FRANCISCO I/0000-0003-2338-2286; MORALES, SERAFIN/0000-0001-7445-4193; Martin, Miguel/0000-0001-9237-3231; CALVO, LOURDES/0000-0001-8314-0241; Aranda, F. Ignacio/0000-0003-2338-2286; Adrover, Encarna/0000-0001-8676-8560; Isla, Dolores/0000-0002-2483-198X; SEGUI PALMER, MIQUEL ANGEL/0000-0002-5103-6746	GEICAM; Sanofi-Aventis; Adelphi Communications	GEICAM; Sanofi-Aventis(Sanofi-Aventis); Adelphi Communications	Supported by GEICAM and Sanofi-Aventis; the latter provided funding for molecular studies and for writing support from Helen Jones, Ph.D., of Adelphi Communications.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Allred DC, 1998, MODERN PATHOL, V11, P155; Bria E, 2006, CANCER-AM CANCER SOC, V106, P2337, DOI 10.1002/cncr.21886; De Laurentiis M, 2008, J CLIN ONCOL, V26, P44, DOI 10.1200/JCO.2007.11.3787; Ferguson T, 2007, COCHRANE DB SYST REV, V4; Fisher B, 1997, JNCI-J NATL CANCER I, V89, P1673, DOI 10.1093/jnci/89.22.1673; Fisher B, 2004, JNCI-J NATL CANCER I, V96, P1823, DOI 10.1093/jnci/djh338; Goldhirsch A, 1998, J NATL CANCER I, V90, P1601, DOI 10.1093/jnci/90.21.1601; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; Harlan LC, 2006, J CLIN ONCOL, V24, P872, DOI 10.1200/JCO.2005.03.5840; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Jones, 2007, J CLIN ONCOL, V25, P1819, DOI 10.1200/JCO.2007.11.9602; Jones S, 2009, J CLIN ONCOL, V27, P1177, DOI 10.1200/JCO.2008.18.4028; Jones SE, 2006, J CLIN ONCOL, V24, P5381, DOI 10.1200/JCO.2006.06.5391; Mamounas EP, 2005, J CLIN ONCOL, V23, P3686, DOI 10.1200/JCO.2005.10.517; Martin M, 2006, ANN ONCOL, V17, P1205, DOI 10.1093/annonc/mdl135; Martin M, 2003, ANN ONCOL, V14, P833, DOI 10.1093/annonc/mdg260; Martin M, 2005, NEW ENGL J MED, V352, P2302, DOI 10.1056/NEJMoa043681; Martin M, 2008, JNCI-J NATL CANCER I, V100, P805, DOI 10.1093/jnci/djn151; *NAT COMPR CANC NE, 2010, BREAST CANC, V2; Roche H, 2006, J CLIN ONCOL, V24, P5664, DOI 10.1200/JCO.2006.07.3916; *SEER CANC STAT, 2000, FAST STATS CANC SIT; Sparano JA, 2008, NEW ENGL J MED, V359, P106; Sparano JA, 2009, NEW ENGL J MED, V360, P1685; Sparano JA, 2008, NEW ENGL J MED, V358, P1663, DOI 10.1056/NEJMoa0707056; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775	27	135	139	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2200	2210		10.1056/NEJMoa0910320	http://dx.doi.org/10.1056/NEJMoa0910320			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EP	21121833	Bronze			2022-12-28	WOS:000284832900007
J	Kazilek, C				Kazilek, Charles			Got a Question? "Ask A Biologist"	SCIENCE			English	Editorial Material									Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Kazilek, C (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	ckazilek@asu.edu						*NIH COMM FUND, NEW PATHW DISC	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2010	330	6008					1192	1193		10.1126/science.1186993	http://dx.doi.org/10.1126/science.1186993			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	685FE	21109662				2022-12-28	WOS:000284613700029
J	de Boer, Y				de Boer, Yvo			Copenhagen shows we need caution in Cancun	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 25	2010	468	7323					477	477		10.1038/468477a	http://dx.doi.org/10.1038/468477a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	684WA	21107383	Bronze			2022-12-28	WOS:000284584200006
J	Puthenveedu, MA; Lauffer, B; Temkin, P; Vistein, R; Carlton, P; Thorn, K; Taunton, J; Weiner, OD; Parton, RG; von Zastrow, M				Puthenveedu, Manojkumar A.; Lauffer, Benjamin; Temkin, Paul; Vistein, Rachel; Carlton, Peter; Thorn, Kurt; Taunton, Jack; Weiner, Orion D.; Parton, Robert G.; von Zastrow, Mark			Sequence-Dependent Sorting of Recycling Proteins by Actin-Stabilized Endosomal Microdomains	CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; COUPLED-RECEPTORS; ARP2/3 COMPLEX; DYNAMIC ACTIN; MULTIVESICULAR BODIES; PLASMA-MEMBRANE; CORTACTIN; RESENSITIZATION; CYTOSKELETON; PATHWAY	The functional consequences of signaling receptor endocytosis are determined by the endosomal sorting of receptors between degradation and recycling pathways. How receptors recycle efficiently, in a sequence-dependent manner that is distinct from bulk membrane recycling, is not known. Here, in live cells, we visualize the sorting of a prototypical sequence-dependent recycling receptor, the beta-2 adrenergic receptor, from bulk recycling proteins and the degrading delta-opioid receptor. Our results reveal a remarkable diversity in recycling routes at the level of individual endosomes, and indicate that sequence-dependent recycling is an active process mediated by distinct endosomal subdomains distinct from those mediating bulk recycling. We identify a specialized subset of tubular microdomains on endosomes, stabilized by a highly localized but dynamic actin machinery, that mediate this sorting, and provide evidence that these actin-stabilized domains provide the physical basis for a two-step kinetic and affinity-based model for protein sorting into the sequence-dependent recycling pathway.	[Puthenveedu, Manojkumar A.; Vistein, Rachel] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Lauffer, Benjamin; Temkin, Paul; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Carlton, Peter] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Thorn, Kurt; Weiner, Orion D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Taunton, Jack; von Zastrow, Mark] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Parton, Robert G.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, St Lucia, Qld 4072, Australia	Carnegie Mellon University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Queensland; University of Queensland	Puthenveedu, MA (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	map3@andrew.cmu.edu	Temkin, Paul A/F-9262-2011; Carlton, Peter/AAD-2403-2021; Weiner, Orion D/F-2576-2011; Parton, Robert G/C-5673-2009; Puthenveedu, Manojkumar/A-3795-2016	Carlton, Peter/0000-0002-5320-6024; Weiner, Orion D/0000-0002-1778-6543; Parton, Robert G/0000-0002-7494-5248; Thorn, Kurt/0000-0001-9310-288X; Vistein, Rachel/0000-0002-2172-9947; Puthenveedu, Manojkumar/0000-0002-3177-4231	NIH [DA024698, DA010711, GM084040]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA010711, R00DA024698, K99DA024698] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The majority of the imaging was performed at the Nikon Imaging Center at UCSF. We thank David Drubin, Matt Welch, John Sedat, Aylin Hanyaloglu, Aaron Marley, and James Hislop for essential reagents and valuable help. M.A.P. was supported by a K99/R00 grant DA024698, M.v.Z. by an R37 grant DA010711, and O.D.W. by an RO1 grant GM084040, all from the NIH. J.T. is an investigator of the Howard Hughes Medical Institute.	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Duleh SN, 2010, CYTOSKELETON, V67, P193, DOI 10.1002/cm.20437; DUNN KW, 1992, J CELL BIOL, V117, P301, DOI 10.1083/jcb.117.2.301; FARQUHAR MG, 1983, METHOD ENZYMOL, V98, P1; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Girao H, 2008, FEBS LETT, V582, P2112, DOI 10.1016/j.febslet.2008.04.011; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hanyaloglu AC, 2007, J BIOL CHEM, V282, P3095, DOI 10.1074/jbc.M605398200; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Ikonen E, 1996, MOL BIOL CELL, V7, P961, DOI 10.1091/mbc.7.6.961; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kaksonen M, 2000, J CELL SCI, V113, P4421; Lauffer BEL, 2009, J BIOL CHEM, V284, P2448, DOI 10.1074/jbc.M806370200; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009325; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; PARTON RG, 1991, J CELL BIOL, V113, P261, DOI 10.1083/jcb.113.2.261; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; SCITA G, 2010, TRAFFIC, V7, P1539; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stamnes M, 2002, CURR OPIN CELL BIOL, V14, P428, DOI 10.1016/S0955-0674(02)00349-6; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Yudowski GA, 2006, NAT NEUROSCI, V9, P622, DOI 10.1038/nn1679; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	56	233	235	1	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 24	2010	143	5					761	773		10.1016/j.cell.2010.10.003	http://dx.doi.org/10.1016/j.cell.2010.10.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111236	Green Accepted, Bronze			2022-12-28	WOS:000284583500018
J	Zewail, A				Zewail, Ahmed			Curiouser and curiouser: managing discovery making	NATURE			English	Editorial Material												zewail@caltech.edu		gaber, sarah/0000-0002-5995-7291					0	8	8	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 18	2010	468	7322								10.1038/468347a	http://dx.doi.org/10.1038/468347a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	681KP	21105222	Bronze			2022-12-28	WOS:000284313100004
J	Cox, H; van Cutsem, G				Cox, Helen; van Cutsem, Gilles			Household screening and multidrug-resistant tuberculosis	LANCET			English	Editorial Material									[Cox, Helen] Ctr Populat Hlth, Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3000, Australia; [Cox, Helen; van Cutsem, Gilles] Med San Frontieres, Cape Town, South Africa	Burnet Institute	Cox, H (corresponding author), Ctr Populat Hlth, Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3000, Australia.	hcox@burnet.edu.au	Van Cutsem, Gilles/ABB-1171-2021	Van Cutsem, Gilles/0000-0002-8972-4480; Cox, Helen/0000-0002-6538-7192				[Anonymous], 1999, EPIDEMIOLOGIC BASIS; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Becerra MC, 2011, LANCET, V377, P147, DOI 10.1016/S0140-6736(10)61972-1; Cox H, 2010, S AFR NAT TB C DURB; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; London L, 2009, INT J TUBERC LUNG D, V13, P1200; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Moran-Mendoza O, 2010, INT J TUBERC LUNG D, V14, P1112; World Health Organization (WHO), GUID PROGR MAN DRUG; Xu L, 2008, T ROY SOC TROP MED H, V102, P797, DOI 10.1016/j.trstmh.2008.04.027	11	3	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					103	104		10.1016/S0140-6736(10)61390-6	http://dx.doi.org/10.1016/S0140-6736(10)61390-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	707NH	21145582				2022-12-28	WOS:000286292800006
J	Wang, Z; Chappellaz, J; Park, K; Mak, JE				Wang, Z.; Chappellaz, J.; Park, K.; Mak, J. E.			Large Variations in Southern Hemisphere Biomass Burning During the Last 650 Years	SCIENCE			English	Article							INTERTROPICAL CONVERGENCE ZONE; CARBON-MONOXIDE; ICE-CORE; ATMOSPHERIC CO; 2 MILLENNIA; CLIMATE; 20TH-CENTURY; VARIABILITY; TROPOSPHERE; ANTARCTICA	We present a 650-year Antarctic ice core record of concentration and isotopic ratios (delta C-13 and delta O-18) of atmospheric carbon monoxide. Concentrations decreased by similar to 25% (14 parts per billion by volume) from the mid-1300s to the 1600s then recovered completely by the late 1800s. delta C-13 and delta O-18 decreased by about 2 and 4 per mil (parts per thousand), respectively, from the mid-1300s to the 1600s then increased by about 2.5 and 4 parts per thousand by the late 1800s. These observations and isotope mass balance model results imply that large variations in the degree of biomass burning in the Southern Hemisphere occurred during the last 650 years, with a decrease by about 50% in the 1600s, an increase of about 100% by the late 1800s, and another decrease by about 70% from the late 1800s to present day.	[Wang, Z.; Park, K.; Mak, J. E.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Inst Terr & Planetary Atmospheres, Stony Brook, NY 11794 USA; [Chappellaz, J.] Univ Grenoble, CNRS, LGGE, F-38402 St Martin Dheres, France	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Mak, JE (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Inst Terr & Planetary Atmospheres, Stony Brook, NY 11794 USA.	john.mak@stonybrook.edu	Wang, Zhihui/F-7164-2011; Chappellaz, Jérôme A./A-4872-2011		NSF [OCE0731406]; European Science Foundation (ESF) of the European Commission [ERAS-CT-2003-980409]; Institut National des Sciences de l'Univers (INSU) [ISOTRACE-FP21]; French ANR NEEM [ANR-O7-VULN-09-001]	NSF(National Science Foundation (NSF)); European Science Foundation (ESF) of the European Commission(European Science Foundation (ESF)); Institut National des Sciences de l'Univers (INSU); French ANR NEEM(French National Research Agency (ANR))	We thank C. A. M. Brenninkmeijer for useful help and discussions. South Pole ice core samples were provided by the National Ice Core Laboratory (NICL) and drilled by J. Cole-Dai and colleagues. We greatly thank M. Twickler for ice allocation and thank B. Bencivengo, E. Cravens, and G. Hargreaves for cutting and shipping ice. We thank the drillers (LGGE) and logistics (French polar institute) who made D47 drilling possible. We also thank E. Brook and J. E. Lee from Oregon State University for providing bubble-free ice and M. Montagnat, LGGE, CNRS for providing monocrystalline and polycrystalline bubble-free ice. We also thank L. Emmons for useful help on MOZART-4 simulation and NCAR for providing a supercomputing environment for MOZART-4 simulation. Z.W. strongly thanks P. Martinerie for logistical support in Grenoble. We are grateful to M. Zhang, D. Black, V. Masson-Delmotte, and D. Knopf for their useful comments. We thank A. Matthews from Mt. Sinai High School for providing a walk-in freezer in which to prepare some ice core samples. This work was supported by NSF grant OCE0731406, the European Science Foundation (ESF) EURO-CORES Programme EuroCLIMATE (contract ERAS-CT-2003-980409 of the European Commission, DG Research, FP6), Institut National des Sciences de l'Univers (INSU) project ISOTRACE-FP21, and the French ANR NEEM (ANR-O7-VULN-09-001).	Anderson DM, 2002, SCIENCE, V297, P596, DOI 10.1126/science.1072881; Assonov SS, 2007, ATMOS CHEM PHYS, V7, P295, DOI 10.5194/acp-7-295-2007; Bergamaschi P, 2000, J GEOPHYS RES-ATMOS, V105, P1929, DOI 10.1029/1999JD900819; Brenninkmeijer CAM, 1997, J GEOPHYS RES-ATMOS, V102, P25477, DOI 10.1029/97JD02291; BRENNINKMEIJER CAM, 1993, J GEOPHYS RES-ATMOS, V98, P10595, DOI 10.1029/93JD00587; CRUTZEN PJ, 1991, TELLUS A, V43, P136, DOI 10.1034/j.1600-0870.1991.00012.x; Daniau AL, 2010, QUATERNARY SCI REV, V29, P2918, DOI 10.1016/j.quascirev.2009.11.008; Edwards DP, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006655; Ferretti DF, 2005, SCIENCE, V309, P1714, DOI 10.1126/science.1115193; Gauss M, 2006, ATMOS CHEM PHYS, V6, P575, DOI 10.5194/acp-6-575-2006; Goldewijk KK, 2001, GLOBAL BIOGEOCHEM CY, V15, P417, DOI 10.1029/1999GB001232; Haan D, 1998, TELLUS B, V50, P253, DOI 10.1034/j.1600-0889.1998.t01-2-00004.x; Haan D, 1996, GEOPHYS RES LETT, V23, P2235, DOI 10.1029/96GL02137; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; INMAN RE, 1971, SCIENCE, V172, P1229, DOI 10.1126/science.172.3989.1229; Ito A, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002374; Kato S, 1999, ATMOS ENVIRON, V33, P4357, DOI 10.1016/S1352-2310(99)00243-5; Macfarlane DG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025005; Mann ME, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017814; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Marland G., 2008, TRENDS COMPENDIUM DA; Marlon JR, 2008, NAT GEOSCI, V1, P697, DOI 10.1038/ngeo313; Masson V, 2000, QUATERNARY RES, V54, P348, DOI 10.1006/qres.2000.2172; Mayewski PA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000231; Mischler JA, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003460; Mouillot F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024707; Neukom R, 2010, CLIM DYN, DOI 101007/s00382-010-0793-3; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pyne S.J., 1997, WORLD FIRE CULTURE F; Sachs JP, 2009, NAT GEOSCI, V2, P519, DOI 10.1038/ngeo554; SEILER W, 1974, TELLUS, V26, P116, DOI 10.1111/j.2153-3490.1974.tb01958.x; SEILER W, 1984, TELLUS B, V36, P219, DOI 10.1111/j.1600-0889.1984.tb00244.x; Stager JC, 2009, QUATERNARY RES, V72, P47, DOI 10.1016/j.yqres.2009.04.003; STEVENS CM, 1989, Z NATURFORSCH A, V44, P376, DOI 10.1515/zna-1989-0505; STEVENS CM, 1980, INT J CHEM KINET, V12, P935, DOI 10.1002/kin.550121205; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423, DOI 10.5194/acp-6-3423-2006; Verschuren D, 2000, NATURE, V403, P410, DOI 10.1038/35000179; Wang Z, 2010, ATMOS MEAS TECH, V3, P1307, DOI 10.5194/amt-3-1307-2010	38	97	98	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1663	1666		10.1126/science.1197257	http://dx.doi.org/10.1126/science.1197257			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21127215				2022-12-28	WOS:000285390500063
J	Kelly, B; Whiteley, A; Tallmon, D				Kelly, Brendan; Whiteley, Andrew; Tallmon, David			The Arctic melting pot	NATURE			English	Editorial Material									[Kelly, Brendan] NOAA, Natl Marine Mammal Lab, Juneau, AK 99801 USA; [Whiteley, Andrew] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Tallmon, David] Univ Alaska SE, Fac Biol & Marine Biol, Juneau, AK 99801 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Massachusetts System; University of Massachusetts Amherst; University of Alaska System; University of Alaska Southeastern	Kelly, B (corresponding author), NOAA, Natl Marine Mammal Lab, Juneau, AK 99801 USA.	brendan.kelly@noaa.gov		Whiteley, Andrew/0000-0002-8159-6381					0	74	75	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 16	2010	468	7326					891	891		10.1038/468891a	http://dx.doi.org/10.1038/468891a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164461				2022-12-28	WOS:000285344600019
J	Cohen, D; Carter, P				Cohen, Deborah; Carter, Philip			Diabetes How small changes led to big profits for insulin manufacturers	BRITISH MEDICAL JOURNAL			English	Editorial Material							PEOPLE		[Cohen, Deborah] BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com						[Anonymous], 2010, CONCLUSIONS AVOCAT G; Cameron CG, 2009, CAN MED ASSOC J, V180, P400, DOI 10.1503/cmaj.081180; Cummins E, 2010, HLTH TECHNOL ASSESS, V14; Currie CJ, 2010, DIABETIC MED, V27, P938, DOI 10.1111/j.1464-5491.2010.03040.x; Diabetes Health Intelligence, 2009, PRESCR DIAB ENGL UPD; Diabetes UK, 2010, DIAB UK 2010 KEY STA; Druglibcom, INS GLARG REC CHEM B; Hauber A, 2006, DIABETOLOGIA, V49, P247, DOI 10.1007/s00125-005-0108-0; Holleman F, 2007, DIABETOLOGIA, V50, P1783, DOI 10.1007/s00125-007-0763-4; Home PD, 2010, DIABETES OBES METAB, V12, P772, DOI 10.1111/j.1463-1326.2010.01232.x; IMS Health Midas, 2009, TOP 15 GLOB THER CLA; JORGENSEN S, 1989, BRIT MED J, V299, P415, DOI 10.1136/bmj.299.6696.415; Medicines and Healthcare Products Regulatory Agency, 2004, SAN AV ASHF NURS INC; NICE, 2008, TYP 2 DIAB MAN TYP 2; Novo Nordisk, 2010, NOVO NORDISK NOVO NO; Novo Nordisk, 2010, NOV NORD A S Q4 2009; Pharmaceutical Marketing Society, NHS JOINT WORK IN AC; Presciption Medicines Code of Practice Authority, 2004, COD PRACT REV, P122; Presciption Medicines Code of Practice Authority, 2007, COMPL CAS E LILL VER; Rosenstock J, 2009, DIABETOLOGIA, V52, P1778, DOI 10.1007/s00125-009-1415-7; Sanofi-aventis, 2010, DIAB ONC IR THEM SEM; Sanofi-aventis, 2010, DIAB ROUNDT; Watermeadow Medical, 2007, ED PROGR NOM AW	23	12	12	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 15	2010	341								c7139	10.1136/bmj.c7139	http://dx.doi.org/10.1136/bmj.c7139			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XJ	21159773				2022-12-28	WOS:000285552800006
J	Cranfield, K				Cranfield, Katharine			Christmas 2010: History Teapots: the short and stout physicians' friends	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cranfield, Katharine] Wansbeck Hosp, Ashington, England		Cranfield, K (corresponding author), Wansbeck Hosp, Ashington, England.	kcranfield@doctors.net.uk						[Anonymous], 1947, Br Med J, V2, P619; [Anonymous], 1939, Br Med J, V1, P234; [Anonymous], 1866, BRIT MED J, Vii, P308, DOI [10.1136/bmj.2.298.308, DOI 10.1136/BMJ.2.298.308]; [Anonymous], 1916, BRIT MED J, Vii, P162, DOI [10.1136/bmj.2.2900.162, DOI 10.1136/BMJ.2.2900.162]; [Anonymous], 1929, BRIT MED J, Vi, P583, DOI [10.1136/bmj.1.3559.583, DOI 10.1136/BMJ.1.3559.583]; [Anonymous], 1886, BRIT MED J, Vii, P170, DOI [10.1136/bmj.2.1334.170, DOI 10.1136/BMJ.2.1334.170]; [Anonymous], 1880, BRIT MED J, Vii, P51, DOI [10.1136/bmj.2.1019.51, DOI 10.1136/BMJ.2.1019.51]; [Anonymous], 1904, BRIT MED J, Vi, P1458, DOI [10.1136/bmj.1.2268.1458-a, DOI 10.1136/BMJ.1.2268.1458-A]; [Anonymous], 1869, BRIT MED J, Vi, P427, DOI [10.1136/bmj.1.436.422, DOI 10.1136/BMJ.1.436.422]; Beeton I.M., 1861, BEETONS BOOK HOUSEHO; Edmunds J, 1900, BRIT MED J, V1900, P749, DOI 10.1136/bmj.1.2048.749; Hayes B, 1853, ASS MED J, Vs3-1, P400, DOI [10.1136/bmj.s3-1.18.400, DOI 10.1136/BMJ.S3-1.18.400]; Hutchinson J, 1891, Br Med J, V2, P1247; Mulley GP, 1988, BRIT MED J, V296, P636, DOI [10.1136/bmj.296.6622.636, DOI 10.1136/BMJ.296.6622.636]; Sheffield Medical Society, 1844, PROV MED SURG J S, Vs1-8, P496, DOI [10.1136/bmj.s1-8.32.495, DOI 10.1136/BMJ.S1-8.32.495]; Skevington J, 1852, Prov Med Surg J, V16, P9; Stocken L A, 1941, Br Med J, V2, P448; Wheatcroft J, 1856, ASS MED J S, Vs3-4, P17, DOI [10.1136/bmj.s3-4.157.17-b, DOI 10.1136/BMJ.S3-4.157.17-B]	18	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2010	341								c6738	10.1136/bmj.c6738	http://dx.doi.org/10.1136/bmj.c6738			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XD	21156737				2022-12-28	WOS:000285552200014
J	Huang, JY; Zhong, L; Wang, CM; Sullivan, JP; Xu, W; Zhang, LQ; Mao, SX; Hudak, NS; Liu, XH; Subramanian, A; Fan, HY; Qi, LA; Kushima, A; Li, J				Huang, Jian Yu; Zhong, Li; Wang, Chong Min; Sullivan, John P.; Xu, Wu; Zhang, Li Qiang; Mao, Scott X.; Hudak, Nicholas S.; Liu, Xiao Hua; Subramanian, Arunkumar; Fan, Hongyou; Qi, Liang; Kushima, Akihiro; Li, Ju			In Situ Observation of the Electrochemical Lithiation of a Single SnO2 Nanowire Electrode	SCIENCE			English	Article							SOLID-STATE AMORPHIZATION; RECHARGEABLE LITHIUM BATTERIES; SILICON; DISLOCATIONS; DIFFUSIVITY; CRYSTAL; LICOO2; ALLOYS; LI2O	We report the creation of a nanoscale electrochemical device inside a transmission electron microscope-consisting of a single tin dioxide (SnO2) nanowire anode, an ionic liquid electrolyte, and a bulk lithium cobalt dioxide (LiCoO2) cathode-and the in situ observation of the lithiation of the SnO2 nanowire during electrochemical charging. Upon charging, a reaction front propagated progressively along the nanowire, causing the nanowire to swell, elongate, and spiral. The reaction front is a "Medusa zone" containing a high density of mobile dislocations, which are continuously nucleated and absorbed at the moving front. This dislocation cloud indicates large in-plane misfit stresses and is a structural precursor to electrochemically driven solid-state amorphization. Because lithiation-induced volume expansion, plasticity, and pulverization of electrode materials are the major mechanical effects that plague the performance and lifetime of high-capacity anodes in lithium-ion batteries, our observations provide important mechanistic insight for the design of advanced batteries.	[Huang, Jian Yu; Sullivan, John P.; Hudak, Nicholas S.; Liu, Xiao Hua; Subramanian, Arunkumar] Sandia Natl Labs, Ctr Integrated Nanotechnol, Albuquerque, NM 87185 USA; [Zhong, Li; Zhang, Li Qiang; Mao, Scott X.] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15261 USA; [Wang, Chong Min] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99354 USA; [Xu, Wu] Pacific NW Natl Lab, Energy & Environm Directorate, Richland, WA 99354 USA; [Fan, Hongyou] Sandia Natl Labs, Adv Mat Lab, Albuquerque, NM 87106 USA; [Qi, Liang; Li, Ju] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China; [Qi, Liang; Li, Ju] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Peoples R China; [Qi, Liang; Kushima, Akihiro; Li, Ju] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA	United States Department of Energy (DOE); Sandia National Laboratories; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Sandia National Laboratories; Xi'an Jiaotong University; Xi'an Jiaotong University; University of Pennsylvania	Huang, JY (corresponding author), Sandia Natl Labs, Ctr Integrated Nanotechnol, POB 5800, Albuquerque, NM 87185 USA.	jhuang@sandia.gov; chongmin.wang@pnl.gov; jpsulli@sandia.gov; sxm2@pitt.edu; liju@seas.upenn.edu	Li, Ju/A-2993-2008; Wang, Chongmin/ABE-8457-2020; Huang, Jianyu/AAZ-2474-2020; Liu, Xiaohua/A-8752-2011; Zhang, Liqiang/E-6539-2015; Zhong, Li/I-3714-2014; Huang, Jianyu/C-5183-2008; Kushima, Akihiro/H-2347-2011; Hudak, Nicholas/D-3529-2011; Qi, Liang/A-3851-2010; Sullivan, John P./GXG-0567-2022; Subramanian, Arunkumar/AAT-9350-2021	Li, Ju/0000-0002-7841-8058; Liu, Xiaohua/0000-0002-7300-7145; Zhang, Liqiang/0000-0001-7482-0739; Kushima, Akihiro/0000-0001-5166-4198; Qi, Liang/0000-0002-0201-9333; Huang, Jianyu/0000-0002-8424-5368; Xu, Wu/0000-0002-2685-8684; Zhong, Li/0000-0003-1070-280X	Sandia National Laboratories (SNL); U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES) [DESC0001160]; DOE's National Nuclear Security Administration [DE-AC04-94AL85000]; DOE Office of Science, Offices of Biological and Environmental Research; DOE's Office of Biological and Environmental Research at Pacific Northwest National Laboratory [DE-AC05-76RLO1830]; Honda Research Institute USA; Xi'an Jiaotong University; NSF [CMMI-0728069, DMR-1008104, DMR-0520020]; Air Force Office of Scientific Research [FA9550-08-1-0325]; NSF through the University of Pittsburgh [CMMI0825842, CMMI0928517]; NSF through SNL [CMMI0825842, CMMI0928517]; Chinese Scholarship Council	Sandia National Laboratories (SNL); U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES)(United States Department of Energy (DOE)); DOE's National Nuclear Security Administration(National Nuclear Security Administration); DOE Office of Science, Offices of Biological and Environmental Research(United States Department of Energy (DOE)); DOE's Office of Biological and Environmental Research at Pacific Northwest National Laboratory; Honda Research Institute USA; Xi'an Jiaotong University(Xi'an Jiaotong University); NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF through the University of Pittsburgh; NSF through SNL; Chinese Scholarship Council(China Scholarship Council)	J.Y.H. thanks K. Xu for valuable discussions. Supported by a Laboratory Directed Research and Development (LDRD) project at Sandia National Laboratories (SNL) and by the Science of Precision Multifunctional Nanostructures for Electrical Energy Storage (NEES), an Energy Frontier Research Center funded by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES) under award DESC0001160. This work was performed in part at the Sandia-Los Alamos Center for Integrated Nanotechnologies (CINT), a U.S. DOE, Office of BES user facility. The LDRD supported the development and fabrication of platforms and the development of TEM techniques. The NEES center supported some of the additional platform development and fabrication and materials characterization. CINT supported the TEM capability and the fabrication capabilities that were used for the TEM characterization, and this work represents the efforts of several CINT users, primarily those with affiliation external to SNL. SNL is a multiprogram laboratory operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin company, for the DOE's National Nuclear Security Administration under contract DE-AC04-94AL85000. The work of C. M. W. and W. X. was supported by the DOE Office of Science, Offices of Biological and Environmental Research, and was conducted in the Environmental Molecular Sciences Laboratory, a national scientific user facility sponsored by DOE's Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory, which is operated by Battelle for the DOE under contract DE-AC05-76RLO1830. L. Q., A. K., and J.L. were supported by Honda Research Institute USA, Xi'an Jiaotong University, NSF grants CMMI-0728069, DMR-1008104, and DMR-0520020, and Air Force Office of Scientific Research grant FA9550-08-1-0325. S. X. M., L.Z., and L.Q.Z. were supported by NSF grants CMMI0825842 and CMMI0928517 through the University of Pittsburgh and SNL. L.Q.Z. thanks the Chinese Scholarship Council for financial support and Z. Ye's encouragement from Zhejiang University.	BAKKER H, 1995, PROG MATER SCI, V39, P159, DOI 10.1016/0079-6425(95)00001-1; Bhandakkar TK, 2010, INT J SOLIDS STRUCT, V47, P1424, DOI 10.1016/j.ijsolstr.2010.02.001; Brazier A, 2008, CHEM MATER, V20, P2352, DOI 10.1021/cm7033933; Chan CK, 2008, NAT NANOTECHNOL, V3, P31, DOI 10.1038/nnano.2007.411; Courtney IA, 1997, J ELECTROCHEM SOC, V144, P2045, DOI 10.1149/1.1837740; Curtright AE, 2004, INT J NANOTECHNOL, V1, P226, DOI 10.1504/IJNT.2004.003726; FECHT HJ, 1992, NATURE, V356, P133, DOI 10.1038/356133a0; Gabrisch H, 2002, ELECTROCHEM SOLID ST, V5, pA111, DOI 10.1149/1.1472257; Habasaki J, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.144207; Huang JY, 1999, PHIL MAG LETT, V79, P305, DOI 10.1080/095008399177147; Huang JY, 2004, PHIL MAG LETT, V84, P183, DOI 10.1080/09500830310001657353; Kang B, 2009, NATURE, V458, P190, DOI 10.1038/nature07853; Khachaturyan A. G., 1983, THEORY STRUCTURAL TR; Kim H, 2008, NANO LETT, V8, P3688, DOI 10.1021/nl801853x; Ko YD, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455701; Kostarelos K, 2010, NANOMEDICINE-UK, V5, P341, DOI 10.2217/NNM.10.19; Lai W, 2010, ADV MATER, V22, pE139, DOI 10.1002/adma.200903650; Legros M, 2008, SCIENCE, V319, P1646, DOI 10.1126/science.1151771; Limthongkul P, 2003, ACTA MATER, V51, P1103, DOI 10.1016/S1359-6454(02)00514-1; LIU DR, 1986, PHILOS MAG B, V53, pL123; Magasinski A, 2010, NAT MATER, V9, P353, DOI [10.1038/nmat2725, 10.1038/NMAT2725]; Mughrabi H, 2006, PHILOS MAG, V86, P4037, DOI 10.1080/14786430500509054; Nam KT, 2006, SCIENCE, V312, P885, DOI 10.1126/science.1122716; Oda T, 2009, J NUCL MATER, V386-88, P1087, DOI 10.1016/j.jnucmat.2008.12.294; OHNO H, 1983, J NUCL MATER, V118, P242, DOI 10.1016/0022-3115(83)90231-3; Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1188, DOI 10.1149/1.1837571; Park MS, 2007, ANGEW CHEM INT EDIT, V46, P750, DOI 10.1002/anie.200603309; Shao-Horn Y, 2003, NAT MATER, V2, P464, DOI 10.1038/nmat922; Suryanarayana C, 2001, PROG MATER SCI, V46, P1, DOI 10.1016/S0079-6425(99)00010-9; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Wang YM, 2007, P NATL ACAD SCI USA, V104, P11155, DOI 10.1073/pnas.0702344104; Wang ZL, 2006, SCIENCE, V312, P242, DOI 10.1126/science.1124005; WOLF D, 1990, J MATER RES, V5, P286, DOI 10.1557/JMR.1990.0286; Zhu T, 2010, PROG MATER SCI, V55, P710, DOI 10.1016/j.pmatsci.2010.04.001	34	1253	1294	29	1735	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1515	1520		10.1126/science.1195628	http://dx.doi.org/10.1126/science.1195628			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148385				2022-12-28	WOS:000285153500058
J	Kim, KP; Weiner, BM; Zhang, LR; Jordan, A; Dekker, J; Kleckner, N				Kim, Keun P.; Weiner, Beth M.; Zhang, Liangran; Jordan, Amy; Dekker, Job; Kleckner, Nancy			Sister Cohesion and Structural Axis Components Mediate Homolog Bias of Meiotic Recombination	CELL			English	Article							DOUBLE-STRAND BREAK; SYNAPTONEMAL COMPLEX-FORMATION; CHROMATID COHESION; CHIASMA FORMATION; CROSSING-OVER; MEK1 KINASE; MEIOSIS; ORGANIZATION; TRANSITION; CROSSOVER	Meiotic double-strand break (DSB)-initiated recombination must occur between homologous maternal and paternal chromosomes ("homolog bias"), even though sister chromatids are present. Through physical recombination analyses, we show that sister cohesion, normally mediated by meiotic cohesin Rec8, promotes "sister bias"; that meiosis-specific axis components Red1/Mek1kinase counteract this effect, thereby satisfying an essential precondition for homolog bias; and that other components, probably recombinosome-related, directly ensure homolog partner selection. Later, Rec8 acts positively to ensure maintenance of bias. These complexities mirror opposing dictates for global sister cohesion versus local separation and differentiation of sisters at recombination sites. Our findings support DSB formation within axis-tethered recombinosomes containing both sisters and ensuing programmed sequential release of "first" and "second" DSB ends. First-end release would create a homology-searching "tentacle." Rec8 and Red1/Mek1 also independently license recombinational progression and abundantly localize to different domains. These domains could comprise complementary environments that integrate inputs from DSB repair and mitotic chromosome morphogenesis into the complete meiotic program.	[Kim, Keun P.; Weiner, Beth M.; Zhang, Liangran; Jordan, Amy; Dekker, Job; Kleckner, Nancy] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Dekker, Job] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01655 USA; [Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA	Harvard University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu		Kim, Keun/0000-0002-5973-8259; zhang, liangran/0000-0002-8550-6742	National Institutes of Health [GM-044794]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Kleckner laboratory members and many other colleagues for helpful comments, A. Amon for Tet repressor/operator and pREC8-MCD1 strains, and N. Hollingsworth for mek1as. Research was supported by National Institutes of Health Grant GM-044794 to N.K.	Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2008, P NATL ACAD SCI USA, V105, P3327, DOI 10.1073/pnas.0711864105; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Bzymek M, 2010, NATURE, V464, P937, DOI 10.1038/nature08868; Callender TL, 2010, GENETICS, V185, P771, DOI 10.1534/genetics.110.117523; Cha R.S., 2000, GENE DEV, V14, P493; Covo S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001006; Diaz-Martinez LA, 2008, J CELL SCI, V121, P2107, DOI 10.1242/jcs.029132; Eijpe M, 2003, J CELL BIOL, V160, P657, DOI 10.1083/jcb.200212080; Goldfarb T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000520; Heidinger-Pauli JM, 2010, CURR BIOL, V20, P957, DOI 10.1016/j.cub.2010.04.018; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N., 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Jones GH, 2006, CELL, V126, P246, DOI 10.1016/j.cell.2006.07.010; Joshi N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000557; Kee K, 2004, EMBO J, V23, P1815, DOI 10.1038/sj.emboj.7600184; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kugou K, 2009, MOL BIOL CELL, V20, P3064, DOI 10.1091/mbc.E08-12-1223; Lao JP, 2008, MOL CELL, V29, P517, DOI 10.1016/j.molcel.2007.12.014; Lao JP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000519; Latypov V, 2010, MOL CELL BIOL, V30, P1570, DOI 10.1128/MCB.00919-09; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Malone RE, 2004, EUKARYOT CELL, V3, P598, DOI 10.1128/EC.3.3.598-609.2004; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Niu H., 2005, MOL BIOL CELL, V16, P5804; Niu H, 2007, MOL CELL BIOL, V27, P5456, DOI 10.1128/MCB.00416-07; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Penkner AM, 2005, CELL, V120, P789, DOI 10.1016/j.cell.2005.01.017; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Sanchez-Moran E., 2007, GENE DEV, V21, P2220; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Sheridan S., 2006, GENE DEV, V20, P1685; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; Storlazzi A, 2008, GENE DEV, V22, P796, DOI 10.1101/gad.459308; Storlazzi A, 2010, CELL, V141, P94, DOI 10.1016/j.cell.2010.02.041; Terentyev Y, 2010, NUCLEIC ACIDS RES, V38, P4349, DOI 10.1093/nar/gkq137; Thompson DA, 1999, GENETICS, V153, P621; Wu HY, 2010, CURR BIOL, V20, P1707, DOI 10.1016/j.cub.2010.09.016; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	48	170	171	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					924	937		10.1016/j.cell.2010.11.015	http://dx.doi.org/10.1016/j.cell.2010.11.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145459	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000285182600010
J	Kurlan, R				Kurlan, Roger			Tourette's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; OBSESSIVE-COMPULSIVE DISORDER; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; DEEP BRAIN-STIMULATION; TIC DISORDERS; DOUBLE-BLIND; CHILDREN; CLONIDINE; TRANSMISSION	A 9-year-old boy has a 3-year history of hyperactive behavior, distractibility, and inattention. He is starting to fall behind in school. During the past year, he has had frequent eye blinking and throat clearing. How should he be evaluated and treated?	Overlook Hosp, Movement Disorders Program, Atlantic Neurosci Inst, Summit, NJ USA	Atlantic Health System	Kurlan, R (corresponding author), Overlook Hosp, Movement Disorders Program, Atlantic Neurosci Inst, Summit, NJ USA.				Boehringer Ingelheim; Biovail; Michael J. Fox Foundation; Kyowa; Neurologix	Boehringer Ingelheim(Boehringer Ingelheim); Biovail; Michael J. Fox Foundation; Kyowa; Neurologix	Dr. Kurlan reports receiving consulting fees from Boehringer Ingelheim and Biovail and grant support from the Michael J. Fox Foundation, Kyowa, and Neurologix. No other potential conflict of interest relevant to this article was reported.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Albin RL, 2009, NEUROLOGY, V72, P1390, DOI 10.1212/WNL.0b013e3181a187dd; Allen AJ, 2005, NEUROLOGY, V65, P1941, DOI 10.1212/01.wnl.0000188869.58300.a7; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; American Psychiatric Association, 2000, DIAGN STAT MAN PSYCH; COMINGS DE, 1984, J AM ACAD CHILD PSY, V23, P138, DOI 10.1097/00004583-198403000-00004; Dion Y, 2002, J CLIN PSYCHOPHARM, V22, P31, DOI 10.1097/00004714-200202000-00006; Du YS, 2008, AUST NZ J PSYCHIAT, V42, P807, DOI 10.1080/00048670802277222; Ercan-Sencicek AG, 2010, NEW ENGL J MED, V362, P1901, DOI 10.1056/NEJMoa0907006; Freeman RD, 2009, DEV MED CHILD NEUROL, V51, P218, DOI 10.1111/j.1469-8749.2008.03135.x; GOETZ CG, 1987, ANN NEUROL, V21, P307, DOI 10.1002/ana.410210313; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; GOYETTE CH, 1978, J ABNORM CHILD PSYCH, V6, P221, DOI 10.1007/BF00919127; Jankovic J, 2010, J NEUROL NEUROSUR PS, V81, P70, DOI 10.1136/jnnp.2009.185348; Jankovic J, 2001, NEW ENGL J MED, V345, P1184, DOI 10.1056/NEJMra010032; Jenike MA, 2004, NEW ENGL J MED, V350, P259, DOI 10.1056/NEJMcp031002; Kenney CJ, 2007, J PEDIATR NEUROL, V5, P9; KOVACS M, 1999, CHILD DEPRESSION INV; KURLAN R, 1994, ARCH NEUROL-CHICAGO, V51, P1145, DOI 10.1001/archneur.1994.00540230083017; Kurlan R, 1999, NEUROLOGY, V52, P874; Kurlan R, 2002, NEUROLOGY, V58, P527; KURLAN R, 1994, NEUROLOGY, V44, P2336, DOI 10.1212/WNL.44.12.2336; Kurlan R, 2008, PEDIATRICS, V121, P1188, DOI 10.1542/peds.2007-2657; Kwak CH, 2000, ARCH NEUROL-CHICAGO, V57, P1190, DOI 10.1001/archneur.57.8.1190; Leckman JF, 1998, PEDIATRICS, V102, P14, DOI 10.1542/peds.102.1.14; LECKMAN JF, 1991, ARCH GEN PSYCHIAT, V48, P324, DOI 10.1001/archpsyc.1991.01810280040006; LECKMAN JF, 1993, AM J PSYCHIAT, V150, P98; Maciunas RJ, 2007, J NEUROSURG, V107, P1004, DOI 10.3171/JNS-07/11/1004; Meyer P, 1999, NEUROLOGY, V53, P371, DOI 10.1212/WNL.53.2.371; Moriarty J, 1997, NEUROLOGY, V49, P410, DOI 10.1212/WNL.49.2.410; Palumbo Donna, 2007, Neuropsychiatr Dis Treat, V3, P687; PAULS DL, 1986, ARCH GEN PSYCHIAT, V43, P1180; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; Piacentini J, 2010, JAMA-J AM MED ASSOC, V303, P1929, DOI 10.1001/jama.2010.607; Porta M, 2008, CLIN DRUG INVEST, V28, P443, DOI 10.2165/00044011-200828070-00006; PRINGSHEIM T, 2009, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD006996.PUB2; Rappley MD, 2005, NEW ENGL J MED, V352, P165, DOI 10.1056/NEJMcp032387; Ringman JM, 2000, J CHILD NEUROL, V15, P394, DOI 10.1177/088307380001500608; Robertson MM, 2008, J PSYCHOSOM RES, V65, P461, DOI 10.1016/j.jpsychores.2008.03.006; Sallee FR, 1997, AM J PSYCHIAT, V154, P1057; Scahill L, 2003, NEUROLOGY, V60, P1130, DOI 10.1212/01.WNL.0000055434.39968.67; Scahill L, 2001, AM J PSYCHIAT, V158, P1067, DOI 10.1176/appi.ajp.158.7.1067; Scahill Lawrence, 2006, NeuroRx, V3, P192, DOI 10.1007/BF03207049; Scharf JM, 2010, NEUROLOGY, V74, P1564, DOI 10.1212/WNL.0b013e3181e24161; Servello D, 2008, J NEUROL NEUROSUR PS, V79, P136, DOI 10.1136/jnnp.2006.104067; Simpson DM, 2008, NEUROLOGY, V70, P1699, DOI 10.1212/01.wnl.0000311389.26145.95; SINGER HS, 1991, MEDICINE, V70, P15, DOI 10.1097/00005792-199101000-00002; Sundaram SK, 2010, NEUROLOGY, V74, P1583, DOI 10.1212/WNL.0b013e3181e0f147; Walkup JT, 1996, AM J HUM GENET, V59, P684	49	58	70	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2010	363	24					2332	2338		10.1056/NEJMcp1007805	http://dx.doi.org/10.1056/NEJMcp1007805			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691PA	21142535				2022-12-28	WOS:000285092100008
J	Newman, M				Newman, Melanie			Research Ethics The rules of retraction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												melanienewman@tbij.com						Corbyn Z., 2009, TIMES HIGHER ED 0820; *INT COMM MED J ED, CORR RETR EXPR CONC; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; LIU SV, 2005, LOGICAL BIOL, V5, P235; Martin A, 2008, J AM ACAD CHILD PSY, V47, P119, DOI 10.1097/chi.0b013e31815d6dba; *MHRA, 2008, MHRA INV GLAX SER; Nissen SE, 2010, JAMA-J AM MED ASSOC, V303, P1194, DOI 10.1001/jama.2010.333; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; Sox HC, 2006, ANN INTERN MED, V144, P609, DOI 10.7326/0003-4819-144-8-200604180-00123; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008	10	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2010	341								c6985	10.1136/bmj.c6985	http://dx.doi.org/10.1136/bmj.c6985			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	694YK	21138994				2022-12-28	WOS:000285337600023
J	Dyer, C				Dyer, Clare			Briefing The Bribery Act: what it means for you	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Dyer, C (corresponding author), BMJ, London WC1H 9JR, England.	ClareDyer@aol.com						*ATT GEN OFF, 2010, ATT GEN WORLD BRIB C; BOSELY S, 2006, GUARDIAN        0214; *FIELD FISH WAT, 2010, BEW BRIB ACT 2010 IT; Prescription Medicines Code of Practice Authority, ABPI COD PRACT PHARM; *TRANSP INT, AD PROC GUID UK BRIB	5	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 6	2010	341								c6996	10.1136/bmj.c6996	http://dx.doi.org/10.1136/bmj.c6996			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	694YC	21135013				2022-12-28	WOS:000285336800008
J	Fagerstrom, K; Gilljam, H; Metcalfe, M; Tonstad, S; Messig, M				Fagerstrom, Karl; Gilljam, Hans; Metcalfe, Michael; Tonstad, Serena; Messig, Michael			Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RECEPTOR PARTIAL AGONIST; SUSTAINED-RELEASE BUPROPION; SMOKING-CESSATION; NICOTINE INTAKE; EFFICACY; PREDICTORS; SNUFF	Objective To assess the efficacy and safety of varenicline (a licensed cigarette smoking cessation aid) in helping users of smokeless tobacco to quit. Design Double blind, placebo controlled, parallel group, multicentre, randomised controlled trial. Setting Medical clinics (mostly primary care) in Norway and Sweden. Participants Men and women aged >= 18 who used smokeless tobacco at least eight times a day, with no abstinence period over three months within one year before screening, who wanted to quit all tobacco use. Participants were excluded if they used any other form of tobacco (except smokeless tobacco) or medication to stop smoking within three months of screening or had any pre-existing medical or psychiatric condition. Interventions Varenicline 1 mg twice daily (titrated during the first week) or placebo for 12 weeks, with 14 weeks' follow-up after treatment. Main outcome measures The primary end point was the four week continuous abstinence rate at the end of treatment (weeks 9-12) confirmed with cotinine concentration. A secondary end point was continuous abstinence rate for weeks 9-26. Safety and tolerability were also evaluated. Results 431 participants (213 varenicline; 218 placebo) were randomised and received at least one dose of study drug. Participants' demographics and baseline use of smokeless tobacco were similar (89% (189) and 90% (196), respectively, were men; mean age in both groups was 43.9; participants used smokeless tobacco products about 15 times a day, and about 80% first used smokeless tobacco within 30 minutes after awakening). Continuous abstinence rate at week 9-12 was higher in the varenicline group than the placebo group (59% (125) v 39% (85); relative risk 1.60, 95% confidence interval 1.32 to 1.87, P<0.001; risk difference 20%; number needed to treat 5). The advantage of varenicline over placebo persisted through 14 weeks of follow-up (continuous abstinence rate at week 9-26 was 45% (95) v 34% (73); relative risk 1.42, 1.08 to 1.79, P=0.012; risk difference 11%; number needed to treat 9). The most common adverse events in the varenicline group compared with the placebo group were nausea (35% (74) v 6% (14)), fatigue (10% (22) v 7% (15)), headache (10% (22) v 9% (20)), and sleep disorder (10% (22) v 7% (15)). Few adverse events led to discontinuation of treatment (9% (19) and 4% (9), respectively), and serious adverse events occurred in two (1%) and three (1%) participants, respectively. Conclusion Varenicline can help people to give up smokeless tobacco and has an acceptable safety profile. The response rate in the placebo group in this study was high, suggesting a population less resistant to treatment than smokers.	[Fagerstrom, Karl] Fagerstrom Consulting AB, Smokers Informat Ctr, S-25452 Helsingborg, Sweden; [Gilljam, Hans] Karolinska Inst, Dept Publ Hlth Sci, S-10462 Stockholm, Sweden; [Metcalfe, Michael] Pfizer, Tadworth KT20 7NS, Surrey, England; [Tonstad, Serena] Oslo Univ Hosp, Ulleval Dept Prevent Cardiol, Oslo, Norway; [Messig, Michael] Pfizer, New York, NY 10017 USA	Karolinska Institutet; Pfizer; University of Oslo; Pfizer	Fagerstrom, K (corresponding author), Fagerstrom Consulting AB, Smokers Informat Ctr, Berga Alle 1, S-25452 Helsingborg, Sweden.	Karl.fagerstrom@swipnet.se			Pfizer	Pfizer(Pfizer)	This work was supported by Pfizer. KF, HG, and ST did not receive any financial support with respect to the writing or development of this manuscript.	*AM CANC SOC, 2009, SMOK TOB QUIT; BENOWITZ NL, 1987, CLIN PHARMACOL THER, V41, P467, DOI 10.1038/clpt.1987.58; Cahill K, 2008, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD006103.PUB3; Carr AB, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005084.pub2; *CDCP, 2006, SMOK TOB US NAT YOUT; *CDCP, 1993, MMWR-MORBID MORTAL W, V42, P263; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Eaton Danice K., 2008, Morbidity and Mortality Weekly Report, V57, P1; EBBERT JO, 2007, COCHRANE DB SYST REV, V4; Ebbert JO, 2009, NICOTINE TOB RES, V11, P1415, DOI 10.1093/ntr/ntp154; Faessel HM, 2006, J CLIN PHARMACOL, V46, P1439, DOI 10.1177/0091270006292624; Ferguson JA, 2003, ADDICT BEHAV, V28, P1203, DOI 10.1016/S0306-4603(02)00260-5; Fiore MC, 2008, CLIN PRACTICE GUIDEL; Gilljam H, 2003, ADDICTION, V98, P1183, DOI 10.1046/j.1360-0443.2003.00379.x; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; GRITZ ER, 1981, CLIN PHARMACOL THER, V30, P201, DOI 10.1038/clpt.1981.149; Harris KJ, 2004, PREV MED, V38, P498, DOI 10.1016/j.ypmed.2003.12.008; HOLM H, 1992, PSYCHOPHARMACOLOGY, V108, P507, DOI 10.1007/BF02247429; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Lund Karl Erik, 2008, Tidsskr Nor Laegeforen, V128, P1808; *MIN HLTH SOC AFF, 2008, RES NAT HLTH INT SUR; Nakamura M, 2007, CLIN THER, V29, P1040, DOI 10.1016/j.clinthera.2007.06.012; Rigotti NA, 2010, CIRCULATION, V121, P221, DOI 10.1161/CIRCULATIONAHA.109.869008; Rollema H, 2007, NEUROPHARMACOLOGY, V52, P985, DOI 10.1016/j.neuropharm.2006.10.016; Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), 2008, SCI OP HLTH EFF SMOK; Tonstad S, 2010, DRUG SAFETY, V33, P289, DOI 10.2165/11319180-000000000-00000; Tsai ST, 2007, CLIN THER, V29, P1027, DOI 10.1016/j.clinthera.2007.06.011	27	47	50	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 6	2010	341								c6549	10.1136/bmj.c6549	http://dx.doi.org/10.1136/bmj.c6549			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694YC	21134997	Green Published, hybrid			2022-12-28	WOS:000285336800001
J	Li, XY; Ko, HG; Chen, T; Descalzi, G; Koga, K; Wang, HS; Kim, SS; Shang, YZ; Kwak, C; Park, SW; Shim, J; Lee, K; Collingridge, GL; Kaang, BK; Zhuo, M				Li, Xiang-Yao; Ko, Hyoung-Gon; Chen, Tao; Descalzi, Giannina; Koga, Kohei; Wang, Hansen; Kim, Susan S.; Shang, Yuze; Kwak, Chuljung; Park, Soo-Won; Shim, Jaehoon; Lee, Kyungmin; Collingridge, Graham L.; Kaang, Bong-Kiun; Zhuo, Min			Alleviating Neuropathic Pain Hypersensitivity by Inhibiting PKM zeta in the Anterior Cingulate Cortex	SCIENCE			English	Article							KINASE M-ZETA; STIMULATED ADENYLYL CYCLASES; LONG-TERM POTENTIATION; IN-VIVO EXPERIENCE; SYNAPTIC-TRANSMISSION; MOLECULAR-BIOLOGY; MEMORY STORAGE; PROTEIN; MAINTENANCE; SENSITIZATION	Synaptic plasticity is a key mechanism for chronic pain. It occurs at different levels of the central nervous system, including spinal cord and cortex. Studies have mainly focused on signaling proteins that trigger these plastic changes, whereas few have addressed the maintenance of plastic changes related to chronic pain. We found that protein kinase M zeta (PKM zeta) maintains pain-induced persistent changes in the mouse anterior cingulate cortex (ACC). Peripheral nerve injury caused activation of PKM zeta in the ACC, and inhibiting PKM zeta by a selective inhibitor, zeta-pseudosubstrate inhibitory peptide (ZIP), erased synaptic potentiation. Microinjection of ZIP into the ACC blocked behavioral sensitization. These results suggest that PKM zeta in the ACC acts to maintain neuropathic pain. PKM zeta could thus be a new therapeutic target for treating chronic pain.	[Li, Xiang-Yao; Chen, Tao; Shim, Jaehoon; Collingridge, Graham L.; Kaang, Bong-Kiun; Zhuo, Min] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul 151747, South Korea; [Li, Xiang-Yao; Chen, Tao; Descalzi, Giannina; Koga, Kohei; Wang, Hansen; Kim, Susan S.; Shang, Yuze; Zhuo, Min] Univ Toronto, Ctr Study Pain, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Ko, Hyoung-Gon; Kwak, Chuljung; Park, Soo-Won; Shim, Jaehoon; Lee, Kyungmin; Kaang, Bong-Kiun] Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Natl Creat Res Initiat,Ctr Nat Sci, Seoul 151747, South Korea; [Lee, Kyungmin] Kyungpook Natl Univ, Sch Med, Dept Anat, Taegu 700422, South Korea; [Collingridge, Graham L.] Univ Bristol, Sch Physiol & Pharmacol, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	Seoul National University (SNU); University of Toronto; Seoul National University (SNU); Kyungpook National University; University of Bristol	Kaang, BK (corresponding author), Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul 151747, South Korea.	kaang@snu.ac.kr; min.zhuo@utoronto.ca	Lee, Kyungmin/AAH-9165-2020; Collingridge, Graham L/C-4605-2015; wang, hansen/I-2510-2019; Zhuo, Min/A-2072-2008; Li, xiang-Yao/B-7622-2011; collingridge, graham/AAI-8362-2020; Lee, Kyungmin/ABC-5624-2020	Collingridge, Graham L/0000-0002-9572-5359; wang, hansen/0000-0003-4414-3372; Zhuo, Min/0000-0001-9062-3241; Li, xiang-Yao/0000-0002-4793-0550; Lee, Kyungmin/0000-0002-5425-4212; Descalzi, Giannina/0000-0003-3734-394X; Park, Soowon/0000-0002-3348-940X; Ko, Hyoung-Gon/0000-0002-7730-6986	EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health; Canada Research Chair; NeuroCanada; Canadian Institute for Health Research [CIHR66975, CIHR84256]; Ministry of Education, Science and Technology in Korea through National Research Foundation [R32-10142]; Fragile X Research Foundation of Canada; Korean Ministry of Science and Technology, Korea; BK21 fellowship, Korea; MRC (UK); MRC [G0601813] Funding Source: UKRI; Medical Research Council [G0601813] Funding Source: researchfish	EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NeuroCanada; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Ministry of Education, Science and Technology in Korea through National Research Foundation; Fragile X Research Foundation of Canada; Korean Ministry of Science and Technology, Korea; BK21 fellowship, Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health, Canada Research Chair, NeuroCanada, and Canadian Institute for Health Research operating grants (CIHR66975 and CIHR84256) (M.Z.). M.Z., B.-K.K., and G. L. C. are also supported by the World-Class University (WCU) program of the Ministry of Education, Science and Technology in Korea through National Research Foundation (R32-10142). X.-Y.L., T. C., and H. W. are supported by postdoctoral fellowships from Fragile X Research Foundation of Canada. B.-K.K. is supported by the National Creative Research Initiative Program of the Korean Ministry of Science and Technology, Korea. H.-G. K. and C. K. are supported by a BK21 fellowship, Korea. G. L. C. receives support from the MRC (UK).	Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Bliss TVP, 2006, SCIENCE, V313, P1058, DOI 10.1126/science.1132538; Clem RL, 2008, SCIENCE, V319, P101, DOI 10.1126/science.1143808; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelly MT, 2007, J NEUROSCI, V27, P3439, DOI 10.1523/JNEUROSCI.5612-06.2007; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Liauw J, 2005, J NEUROPHYSIOL, V94, P878, DOI 10.1152/jn.01205.2004; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Naik MU, 2000, J COMP NEUROL, V426, P243, DOI 10.1002/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Sacktor TC, 2008, PROG BRAIN RES, V169, P27, DOI 10.1016/S0079-6123(07)00002-7; Shema R, 2009, LEARN MEMORY, V16, P122, DOI 10.1101/lm.1183309; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Vadakkan KI, 2005, J PAIN, V6, P747, DOI 10.1016/j.jpain.2005.07.005; Wei F, 1999, J NEUROSCI, V19, P9346; Wei F, 2002, NEURON, V36, P713, DOI 10.1016/S0896-6273(02)01019-X; Wu LJ, 2005, J NEUROPHYSIOL, V94, P1805, DOI 10.1152/jn.00091.2005; Xu H, 2008, J NEUROSCI, V28, P7445, DOI 10.1523/JNEUROSCI.1812-08.2008; Zhuo M, 2008, TRENDS NEUROSCI, V31, P199, DOI 10.1016/j.tins.2008.01.003	28	297	314	0	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1400	1404		10.1126/science.1191792	http://dx.doi.org/10.1126/science.1191792			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127255				2022-12-28	WOS:000284902100048
J	Reynolds, T; Kong, ML				Reynolds, Toby; Kong, Ming-Li			Medical Education Shifting the learning curve	BRITISH MEDICAL JOURNAL			English	Editorial Material							SIMULATION; RESIDENTS		[Reynolds, Toby; Kong, Ming-Li] Royal London Hosp, London E1 2ES, England	Barts Health NHS Trust; Royal London Hospital	Reynolds, T (corresponding author), Royal London Hosp, London E1 2ES, England.	toby.reynolds@gmail.com						ABRAHAMSON S, 1969, J MED EDUC, V44, P515; Bristol Medical Simulation Center, WORLD SIM CTR DAT; Donaldson L, 2009, ANN REPORT CHIEF MED; Johnson D, 2001, BRIT MED J, V322, P563, DOI 10.1136/bmj.322.7285.563; Kneebone R, 2010, MED TEACH, V32, P65, DOI 10.3109/01421590903419749; Kory PD, 2007, CHEST, V132, P1927, DOI 10.1378/chest.07-1554; Wayne DB, 2008, CHEST, V133, P56, DOI 10.1378/chest.07-0131; World Health Organization, 2009, WHO PAT SAF CURR GUI	8	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 2	2010	341								c6260	10.1136/bmj.c6260	http://dx.doi.org/10.1136/bmj.c6260			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	691OW	21127119				2022-12-28	WOS:000285091700013
J	Carrasco-Gonzalez, C; Rodriguez, LF; Anglada, G; Marti, J; Torrelles, JM; Osorio, M				Carrasco-Gonzalez, Carlos; Rodriguez, Luis F.; Anglada, Guillem; Marti, Josep; Torrelles, Jose M.; Osorio, Mayra			A Magnetized Jet from a Massive Protostar	SCIENCE			English	Article							LARGE PROPER MOTIONS; ASTROPHYSICAL JETS; YOUNG STARS; RELATIVISTIC JETS; RADIO JETS; FIELDS; DISKS; FLOWS; POLARIZATION; OUTFLOWS	Synchrotron emission is commonly found in relativistic jets from active galactic nuclei (AGNs) and microquasars, but so far its presence in jets from young stellar objects (YSOs) has not been proved. Here, we present evidence of polarized synchrotron emission arising from the jet of a YSO. The apparent magnetic field, with strength of similar to 0.2 milligauss, is parallel to the jet axis, and the polarization degree increases toward the jet edges, as expected for a confining helical magnetic field configuration. These characteristics are similar to those found in AGN jets, hinting at a common origin of all astrophysical jets.	[Carrasco-Gonzalez, Carlos; Anglada, Guillem; Osorio, Mayra] CSIC, Inst Astrofis Andalucia, E-18008 Granada, Spain; [Carrasco-Gonzalez, Carlos; Rodriguez, Luis F.] Univ Nacl Autonoma Mexico, Ctr Radioastron & Astrofis, Morelia 58089, Michoacan, Mexico; [Marti, Josep] Univ Jaen, EPSJ, Dept Fis, Jaen 23071, Spain; [Torrelles, Jose M.] Univ Barcelona, Inst Ciencias Espacio CSIC IEEC UB, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Universidad Nacional Autonoma de Mexico; Universidad de Jaen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona	Carrasco-Gonzalez, C (corresponding author), CSIC, Inst Astrofis Andalucia, Camino Bajo Huetor 50, E-18008 Granada, Spain.	charly@iaa.es	Martí, Josep/Y-6538-2019; Torrelles, Jose Maria/ABF-5543-2020; Rodriguez, Luis/U-9365-2019; Torrelles, Jose Maria/ABD-8181-2020	Marti, Josep/0000-0001-5302-0660; Torrelles, Jose Maria/0000-0002-6896-6085; Anglada, Guillem/0000-0002-7506-5429; Carrasco-Gonzalez, Carlos/0000-0003-2862-5363	Ministerio de Ciencia e Innovacion (Spain) [AYA2008-06189-C03, AYA2007-68034-C03-02]; Fondo Europeo de Desarrollo Regional (FEDER); Junta de Andalucia (Spain); Direccion General de Asuntos del Personal Academico; UNAM; Consejo Nacional de Ciencia y Technologia, Mexico	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission); Direccion General de Asuntos del Personal Academico; UNAM(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Technologia, Mexico	National Radio Astronomy Observatory is a facility of the NSF, operated under cooperative agreement by Associated Universities, Incorporated. We acknowledge I. Agudo, A. Alberdi, and J. L. Gomez for useful comments. G. A., C. C.-G., J. M., M.O., and J. M. T. acknowledge support from Ministerio de Ciencia e Innovacion (Spain) grants AYA2008-06189-C03 and AYA2007-68034-C03-02 [co-funded with Fondo Europeo de Desarrollo Regional (FEDER) funds] and from Junta de Andalucia (Spain). L. F. R. acknowledges the support of Direccion General de Asuntos del Personal Academico, UNAM, and Consejo Nacional de Ciencia y Technologia, Mexico.	Beck R, 2005, ASTRON NACHR, V326, P414, DOI 10.1002/asna.200510366; BELL AR, 1978, MON NOT R ASTRON SOC, V182, P147, DOI 10.1093/mnras/182.2.147; BLANDFORD RD, 1982, MON NOT R ASTRON SOC, V199, P883, DOI 10.1093/mnras/199.4.883; Bosch-Ramon V, 2010, ASTRON ASTROPHYS, V511, DOI 10.1051/0004-6361/200913488; BRIDLE AH, 1984, ANNU REV ASTRON ASTR, V22, P319, DOI 10.1146/annurev.aa.22.090184.001535; Cabrit S., 2007, IAU S, V243, P203, DOI DOI 10.1017/S1743921307009568; Chrysostomou A, 2007, NATURE, V450, P71, DOI 10.1038/nature06220; Curran RL, 2007, MON NOT R ASTRON SOC, V382, P699, DOI 10.1111/j.1365-2966.2007.12399.x; Dal Pino EMD, 2005, AIP CONF PROC, V784, P183, DOI 10.1063/1.2077183; DEYOUNG DS, 1991, SCIENCE, V252, P389, DOI 10.1126/science.252.5004.389; Ferreira J, 1997, ASTRON ASTROPHYS, V319, P340; Garay G, 1996, ASTROPHYS J, V459, P193, DOI 10.1086/176882; Girart JM, 2002, REV MEX ASTRON ASTR, V38, P169; Girart JM, 2006, SCIENCE, V313, P812, DOI 10.1126/science.1129093; Gomez JL, 2008, ASTROPHYS J LETT, V681, pL69, DOI 10.1086/590388; Livio M, 1997, ASTR SOC P, V121, P845, DOI 10.1017/S0252921100044298; Lizano S, 2009, REV MEX AST ASTR, V36, P149; Lyutikov M, 2005, MON NOT R ASTRON SOC, V360, P869, DOI 10.1111/j.1365-2966.2005.08954.x; MARTI J, 1995, ASTROPHYS J, V449, P184, DOI 10.1086/176044; MARTI J, 1993, ASTROPHYS J, V416, P208, DOI 10.1086/173227; McKinney JC, 2009, MON NOT R ASTRON SOC, V394, pL126, DOI 10.1111/j.1745-3933.2009.00625.x; Mirabel IF, 1999, ANNU REV ASTRON ASTR, V37, P409, DOI 10.1146/annurev.astro.37.1.409; MORSE JA, 1993, ASTROPHYS J, V410, P764, DOI 10.1086/172793; Pacholczyk A. G., 1970, RADIO ASTROPHYSICS; Patel NA, 2005, NATURE, V437, P109, DOI 10.1038/nature04011; Pech G, 2010, ASTROPHYS J, V712, P1403, DOI 10.1088/0004-637X/712/2/1403; Pudritz R. E., 2007, PROTOSTARS PLANETS, P277; PUDRITZ RE, 1983, ASTROPHYS J, V274, P677, DOI 10.1086/161481; Ray TP, 2009, REV MEX AST ASTR, V36, P179; Ray TP, 1997, NATURE, V385, P415, DOI 10.1038/385415a0; Reipurth B, 2001, ANNU REV ASTRON ASTR, V39, P403, DOI 10.1146/annurev.astro.39.1.403; Rodriguez LF, 2005, ASTROPHYS J, V626, P953, DOI 10.1086/430268; RODRIGUEZ LF, 1989, ASTROPHYS J, V346, pL85, DOI 10.1086/185585; RODRIGUEZ LF, 1980, ASTROPHYS J, V235, P845, DOI 10.1086/157687; SCHALLER G, 1992, ASTRON ASTROPHYS SUP, V96, P269; SHU F, 1994, ASTROPHYS J, V429, P781, DOI 10.1086/174363; Vlemmings WHT, 2010, MON NOT R ASTRON SOC, V404, P134, DOI 10.1111/j.1365-2966.2010.16297.x; Wilner DJ, 1999, ASTROPHYS J, V513, P775, DOI 10.1086/306907	38	129	129	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2010	330	6008					1209	1212		10.1126/science.1195589	http://dx.doi.org/10.1126/science.1195589			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109665	Green Submitted			2022-12-28	WOS:000284613700032
J	Heuer, AH; Jia, CL; Lagerlof, KPD				Heuer, A. H.; Jia, C. L.; Lagerloef, K. P. D.			The Core Structure of Basal Dislocations in Deformed Sapphire (alpha-Al2O3)	SCIENCE			English	Article							SLIP	The atomic structure of dislocation cores is decisive for the understanding of plasticity in crystalline solids. The core structure of dislocations in sapphire introduced by high-temperature plastic deformation has been investigated with the use of the negative spherical-aberration imaging technique. The ability of this technique to discriminate oxygen columns from aluminum (Al) columns, combined with reproduction of subtle contrast features by image simulation, leads to a markedly detailed atomic model of the dislocation cores. The partial dislocations are Al-terminated, with electrical neutrality being achieved because half of the Al columns are missing. These partials also undergo core spreading, which results in random occupancy of both tetrahedrally and octahedrally coordinated sites, though Al in tetrahedral coordination never occurs in a perfect crystal. Unusual dislocation core structures may be present in other technologically important nonmetallic solids.	[Heuer, A. H.; Lagerloef, K. P. D.] Case Western Reserve Univ, Dept Mat Sci & Engn, Cleveland, OH 44106 USA; [Jia, C. L.] Forschungszentrum Julich GmbH, Inst Solid State Res, D-52425 Julich, Germany; [Jia, C. L.] Forschungszentrum Julich GmbH, Ernst Ruska Ctr Microscopy & Spect Electrons ER C, D-52425 Julich, Germany	Case Western Reserve University; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich	Heuer, AH (corresponding author), Case Western Reserve Univ, Dept Mat Sci & Engn, Cleveland, OH 44106 USA.	heuer@case.edu						BildeSorensen JB, 1996, ACTA MATER, V44, P2145, DOI 10.1016/1359-6454(95)00264-2; ESHELBY JD, 1951, PHILOS MAG, V42, P1401; Jhon MH, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.214101; Jia CL, 2008, NAT MATER, V7, P57, DOI 10.1038/nmat2080; Jia CL, 2003, SCIENCE, V299, P870, DOI 10.1126/science.1079121; KRONBERG ML, 1957, ACTA METALL MATER, V5, P507, DOI 10.1016/0001-6160(57)90090-1; Lagerlof K, 2009, PHILOS MAG, V89, P489, DOI 10.1080/14786430802672691; LAGERLOF KDP, 1984, ACTA METALL MATER, V32, P97, DOI 10.1016/0001-6160(84)90206-2; Marinopoulos AG, 2001, PHIL MAG LETT, V81, P329, DOI 10.1080/09500830110039984; PHILLIPS DS, 1982, PHILOS MAG A, V45, P1371; Shibata N, 2007, SCIENCE, V316, P82, DOI 10.1126/science.1136155; Watchman Jr. J. N., 1954, J AM CERAM SOC, V37, P291; Williams DB, 2009, SPRINGER, P407, DOI DOI 10.1295/KOBUNSHI.43.94	13	35	36	6	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2010	330	6008					1227	1231		10.1126/science.1192319	http://dx.doi.org/10.1126/science.1192319			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109669				2022-12-28	WOS:000284613700037
J	Greene, JA; Kesselheim, AS				Greene, Jeremy A.; Kesselheim, Aaron S.			Pharmaceutical Marketing and the New Social Media.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Greene, Jeremy A.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Greene, JA (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				ARNST CA, 2009, BUSINESSWEEK    1119; Greene JA, 2010, AM J PUBLIC HEALTH, V100, P793, DOI 10.2105/AJPH.2009.181255; Jones S., 2009, GENERATIONS ONLINE 2	3	48	50	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2010	363	22					2087	2089		10.1056/NEJMp1004986	http://dx.doi.org/10.1056/NEJMp1004986			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	684XE	21105789				2022-12-28	WOS:000284587800003
J	Marshall, M; McLoughlin, V				Marshall, Martin; McLoughlin, Vin			How do patients use information on health providers?	BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSUMERS		[Marshall, Martin; McLoughlin, Vin] Hlth Fdn, London WC2E 9RA, England		Marshall, M (corresponding author), Hlth Fdn, London WC2E 9RA, England.	martin.marshall@health.org.uk						[Anonymous], 2007, INFLUENCE PSYCHOL PE; BURGESS S, 2010, 09222 U BRIST CTR MA; *CAR QUAL COMM, INF HEALTHC SERV OV; Cialdini R. B., 1993, INFLUENCE SCI PRACTI; *CONS PART, WHER WE STAND HLTH; Department of Health, 2009, OP FRAM NHS ENGL 201; Devlin N., 2010, GETTING MOST OUT PRO; Dixon A., 2010, PATIENT CHOICE PATIE; EdgmanLevitan S, 1996, HEALTH AFFAIR, V15, P42, DOI 10.1377/hlthaff.15.4.42; Grand JL, 2007, OTHER INVISIBLE HAND: DELIVERING PUBLIC SERVICES THROUGH CHOICE AND COMPETITION, P1; *LIB DEM, WHAT WE STAND HLTH; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; *NHS CHOIC, EAS READ PAG; Rogers A., 1999, DEMANDING PATIENTS A; Shekelle P, 2008, DOES PUBLIC RELEASE; *SOC CARD SURG GRE, NAT AD CARD SURG DAT; Vaiana ME, 2002, MED CARE RES REV, V59, P3, DOI 10.1177/1077558702059001001	17	19	19	3	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 25	2010	341								c5272	10.1136/bmj.c5272	http://dx.doi.org/10.1136/bmj.c5272			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	688ED	21109576				2022-12-28	WOS:000284831700005
J	Creton, S; Jentsch, S				Creton, Sandrine; Jentsch, Stefan			SnapShot: The SUMO System	CELL			English	Editorial Material							UBIQUITIN		[Creton, Sandrine; Jentsch, Stefan] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society	Creton, S (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.							Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591	6	34	37	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 24	2010	143	5					848	U329		10.1016/j.cell.2010.11.026	http://dx.doi.org/10.1016/j.cell.2010.11.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111242	Bronze			2022-12-28	WOS:000284583500025
J	Hart, GW; Copeland, RJ				Hart, Gerald W.; Copeland, Ronald J.			Glycomics Hits the Big Time	CELL			English	Article							MASS-SPECTROMETRY; PROTEIN GLYCOSYLATION; FUNCTIONAL GLYCOMICS; DISEASE; PHOSPHORYLATION; MICROARRAYS; ANNOTATION; SPECTRA; BINDING; MICE	Cells run on carbohydrates. Glycans, sequences of carbohydrates conjugated to proteins and lipids, are arguably the most abundant and structurally diverse class of molecules in nature. Recent advances in glycomics reveal the scope and scale of their functional roles and their impact on human disease.	[Hart, Gerald W.; Copeland, Ronald J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu		Hart, Gerald/0000-0001-7812-4351	NIH [R01CA42486, R01 DK61671, R24 DK084949]; NATIONAL CANCER INSTITUTE [R01CA042486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK084949, P30DK079637, R33DK071280, R01DK061671] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Chad Slawson for helpful suggestions. Original research in the author's laboratory was supported by NIH grants R01CA42486, R01 DK61671, and R24 DK084949.	An HJ, 2009, CURR OPIN CHEM BIOL, V13, P421, DOI 10.1016/j.cbpa.2009.07.022; Aoki-Kinoshita KF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000075; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Bertozzi C.R., 2009, ESSENTIALS GLYCOBIOL; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chang JS, 2010, BLOOD, V116, P1779, DOI 10.1182/blood-2009-12-260513; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; Endo T, 2010, J BIOCHEM, V147, P9, DOI 10.1093/jb/mvp193; Goldberg D, 2005, PROTEOMICS, V5, P865, DOI 10.1002/pmic.200401071; Gupta G, 2010, OMICS, V14, P419, DOI 10.1089/omi.2009.0150; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hsu KL, 2006, NAT CHEM BIOL, V2, P153, DOI 10.1038/nchembio767; Krishnamoorthy L, 2009, ACS CHEM BIOL, V4, P715, DOI 10.1021/cb900103n; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Laremore TN, 2010, METHOD ENZYMOL, V478, P79, DOI 10.1016/S0076-6879(10)78003-4; Ly M, 2010, OMICS, V14, P389, DOI 10.1089/omi.2009.0123; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; North SJ, 2010, METHOD ENZYMOL, V478, P27, DOI 10.1016/S0076-6879(10)78002-2; Packer NH, 2008, PROTEOMICS, V8, P8, DOI 10.1002/pmic.200700917; Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785; Raman R, 2006, GLYCOBIOLOGY, V16, p82R, DOI 10.1093/glycob/cwj080; Reid GE, 2002, ANAL CHEM, V74, P577, DOI 10.1021/ac015618l; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Schachter H, 2009, BBA-MOL BASIS DIS, V1792, P925, DOI 10.1016/j.bbadis.2008.11.002; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; SWIEDLER SJ, 1985, J BIOL CHEM, V260, P4046; Taniguchi N, 2008, MOL CELL PROTEOMICS, V7, P626; Taylor AD, 2009, GENOME MED, V1, DOI 10.1186/gm57; Tian Y, 2009, J PROTEOME RES, V8, P1657, DOI 10.1021/pr800952h; Vanderschaeghe D, 2010, BIOL CHEM, V391, P149, DOI 10.1515/bc.2010.031; Varki A., 2009, ESSENTIALS GLYCOBIOL; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Zaia J, 2010, OMICS, V14, P401, DOI 10.1089/omi.2009.0146; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	40	499	519	8	181	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 24	2010	143	5					672	676		10.1016/j.cell.2010.11.008	http://dx.doi.org/10.1016/j.cell.2010.11.008			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111227	Bronze, Green Accepted			2022-12-28	WOS:000284583500008
J	Wolfe-Simon, F; Blum, JS; Kulp, TR; Gordon, GW; Hoeft, SE; Pett-Ridge, J; Stolz, JF; Webb, SM; Weber, PK; Davies, PCW; Anbar, AD; Oremland, RS				Wolfe-Simon, Felisa; Blum, Jodi Switzer; Kulp, Thomas R.; Gordon, Gwyneth W.; Hoeft, Shelley E.; Pett-Ridge, Jennifer; Stolz, John F.; Webb, Samuel M.; Weber, Peter K.; Davies, Paul C. W.; Anbar, Ariel D.; Oremland, Ronald S.			A Bacterium That Can Grow by Using Arsenic Instead of Phosphorus	SCIENCE			English	Article							MARINE	Life is mostly composed of the elements carbon, hydrogen, nitrogen, oxygen, sulfur, and phosphorus. Although these six elements make up nucleic acids, proteins, and lipids and thus the bulk of living matter, it is theoretically possible that some other elements in the periodic table could serve the same functions. Here, we describe a bacterium, strain GFAJ-1 of the Halomonadaceae, isolated from Mono Lake, California, that is able to substitute arsenic for phosphorus to sustain its growth. Our data show evidence for arsenate in macromolecules that normally contain phosphate, most notably nucleic acids and proteins. Exchange of one of the major bio-elements may have profound evolutionary and geochemical importance.	[Wolfe-Simon, Felisa; Davies, Paul C. W.; Anbar, Ariel D.] NASA, Astrobiol Inst, Washington, DC 20546 USA; [Wolfe-Simon, Felisa; Blum, Jodi Switzer; Kulp, Thomas R.; Hoeft, Shelley E.; Oremland, Ronald S.] US Geol Survey, Menlo Pk, CA 94025 USA; [Gordon, Gwyneth W.; Anbar, Ariel D.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Pett-Ridge, Jennifer; Weber, Peter K.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Stolz, John F.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Webb, Samuel M.] Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Davies, Paul C. W.] Arizona State Univ, BEYOND Ctr Fundamental Concepts Sci, Tempe, AZ 85287 USA; [Anbar, Ariel D.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	National Aeronautics & Space Administration (NASA); United States Department of the Interior; United States Geological Survey; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Duquesne University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Wolfe-Simon, F (corresponding author), NASA, Astrobiol Inst, Washington, DC 20546 USA.	felisawolfesimon@gmail.com	, Jennifer Pett RIdge/AFF-7780-2022; Weber, Peter Kilian/AAP-9517-2020; , Jennifer Pett RIdge/AAE-9934-2022; Webb, Samuel M/D-4778-2009	Weber, Peter Kilian/0000-0001-6022-6050; Webb, Samuel M/0000-0003-1188-0464; Webb, Eric/0000-0003-4085-7730; Pett-Ridge, Jennifer/0000-0002-4439-2398	DOE Office of Basic Energy Sciences, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; DOE at Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; DOE OBER [SCW1039]; NASA Exobiology; NASA; NASA Astrobiology Institute at the U.S. Geological Survey, Menlo Park, CA	DOE Office of Basic Energy Sciences, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE at Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); DOE OBER(United States Department of Energy (DOE)); NASA Exobiology(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); NASA Astrobiology Institute at the U.S. Geological Survey, Menlo Park, CA	The authors thank S. Benner, W. Hastings, I. L. ten Kate, A. Pohorille, B. Rosen, D. Schulze-Makuch, and R. Shapiro for stimulating discussions. We thank G. King, A. Oren, and L. Young for constructive criticisms of earlier drafts of this manuscript and S. Baesman, M. Dudash, and L. Miller for technical assistance. Cultures of GFAJ-1 were submitted to the American Type Culture Collection and Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ) culture collections on 21 March 2011 and will be available from these sources within several months. Until then, samples of GFAJ-1 are available to the community from the Oremland lab upon completion of a materials transfer agreement, which is required by the U.S. Geological Survey for the transfer of bacterial cultures. Sequence data are deposited with GenBank (accession HQ449183). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a division of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Basic Energy Sciences, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program. NanoSIMS analyses were performed under the auspices of the DOE at Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. J.P.R. and P.K.W. were supported in part by the DOE OBER Genomic Sciences program SCW1039. R.S.O. and J.F.S. were supported by NASA Exobiology. F.W.S. acknowledges support from the NASA Postdoctoral Program, NASA Astrobiology/Exobiology, and the NASA Astrobiology Institute while in residence at the U.S. Geological Survey, Menlo Park, CA. The authors declare no conflicts of interest.	BAER CD, 1981, INORG CHEM, V20, P905, DOI 10.1021/ic50217a052; Berg J.M., 2007, BIOCHEMISTRY-US, V6th ed.; Blum JS, 1998, ARCH MICROBIOL, V171, P19, DOI 10.1007/s002030050673; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; HOLBROOK SR, 1985, ACTA CRYSTALLOGR B, V41, P255, DOI 10.1107/S0108768185002087; Jameson G. B., 2007, BIOL INORGANIC CHEM, P354; Lane TW, 2000, P NATL ACAD SCI USA, V97, P4627, DOI 10.1073/pnas.090091397; LIDE D.R., 2010, J AM CHEM SOC, DOI [DOI 10.1021/acs.est.8b00586, DOI 10.1021/JA906434C]; Makino W, 2003, FUNCT ECOL, V17, P121, DOI 10.1046/j.1365-2435.2003.00712.x; MANDELSTAM J, 1960, BACTERIOL REV, V24, P289, DOI 10.1128/MMBR.24.3.289-308.1960; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Oremland RS, 2004, FEMS MICROBIOL ECOL, V48, P15, DOI 10.1016/j.femsec.2003.12.016; Pickering IJ, 2000, PLANT PHYSIOL, V122, P1171, DOI 10.1104/pp.122.4.1171; Quillaguaman J, 2006, ENZYME MICROB TECH, V38, P148, DOI 10.1016/j.enzmictec.2005.05.013; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Smith PG, 2005, ENVIRON SCI TECHNOL, V39, P248, DOI 10.1021/es049358b; Takeuchi M, 2007, J BIOTECHNOL, V127, P434, DOI 10.1016/j.jbiotec.2006.07.018; Wolfe-Simon F, 2009, INT J ASTROBIOL, V8, P69, DOI 10.1017/S1473550408004394	18	303	312	8	418	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2011	332	6034					1163	1166		10.1126/science.1197258	http://dx.doi.org/10.1126/science.1197258			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21127214	Green Submitted			2022-12-28	WOS:000291205200038
J	Sato, T; van Es, JH; Snippert, HJ; Stange, DE; Vries, RG; van den Born, M; Barker, N; Shroyer, NF; van de Wetering, M; Clevers, H				Sato, Toshiro; van Es, Johan H.; Snippert, Hugo J.; Stange, Daniel E.; Vries, Robert G.; van den Born, Maaike; Barker, Nick; Shroyer, Noah F.; van de Wetering, Marc; Clevers, Hans			Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts	NATURE			English	Article							BETA-CATENIN; ADULT-MOUSE; EPITHELIUM; DIFFERENTIATION; GENE; EXPRESSION; CANCER; MATH1; COLON; SOX9	Homeostasis of self-renewing small intestinal crypts results from neutral competition between Lgr5 stem cells, which are small cycling cells located at crypt bottoms(1,2). Lgr5 stem cells are interspersed between terminally differentiated Paneth cells that are known to produce bactericidal products such as lysozyme and cryptdins/defensins(3). Single Lgr5-expressing stem cells can be cultured to form long-lived, self-organizing crypt-villus organoids in the absence of non-epithelial niche cells(4). Here we find a close physical association of Lgr5 stem cells with Paneth cells in mice, both in vivo and in vitro. CD24(+) Paneth cells express EGF, TGF-alpha, Wnt3 and the Notch ligand Dll4, all essential signals for stem-cell maintenance in culture. Co-culturing of sorted stem cells with Paneth cells markedly improves organoid formation. This Paneth cell requirement can be substituted by a pulse of exogenous Wnt. Genetic removal of Paneth cells in vivo results in the concomitant loss of Lgr5 stem cells. In colon crypts, CD24(+) cells residing between Lgr5 stem cells may represent the Paneth cell equivalents. We conclude that Lgr5 stem cells compete for essential niche signals provided by a specialized daughter cell, the Paneth cell.	[Sato, Toshiro; van Es, Johan H.; Snippert, Hugo J.; Stange, Daniel E.; Vries, Robert G.; van den Born, Maaike; Barker, Nick; van de Wetering, Marc; Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Sato, Toshiro; van Es, Johan H.; Snippert, Hugo J.; Stange, Daniel E.; Vries, Robert G.; van den Born, Maaike; Barker, Nick; van de Wetering, Marc; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Shroyer, Noah F.] Cincinnati Childrens Hosp, Div Gastroenterol, Med Ctr, MLC 2010, Cincinnati, OH 45229 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Cincinnati Children's Hospital Medical Center	Clevers, H (corresponding author), KNAW, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	van+Es, Johan/ABD-5411-2021; Stange, Daniel E/O-1837-2015; Barker, Nick/AAS-2774-2020; Barker, Nick/A-5535-2011; Barker, Nick/AAE-9833-2021; Sato, Toshiro/J-3522-2014	Stange, Daniel E/0000-0003-4246-2230; Barker, Nick/0000-0003-3566-4475; Sato, Toshiro/0000-0001-8353-8137; Shroyer, Noah/0000-0002-5934-2852	NATIONAL CANCER INSTITUTE [R01CA142826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK084167] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA142826, R01 CA142826-01] Funding Source: Medline; NIDDK NIH HHS [R03 DK084167-01, R03 DK084167] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTMANN GG, 1983, AM J ANAT, V167, P95, DOI 10.1002/aja.1001670109; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; BJERKNES M, 1981, AM J ANAT, V160, P77, DOI 10.1002/aja.1001600107; Bjerknes M, 2010, DEV BIOL, V345, P49, DOI 10.1016/j.ydbio.2010.06.021; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; POULSEN SS, 1986, HISTOCHEMISTRY, V85, P389, DOI 10.1007/BF00982668; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173	29	1618	1692	17	410	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					415	+		10.1038/nature09637	http://dx.doi.org/10.1038/nature09637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21113151	Green Accepted			2022-12-28	WOS:000286385600056
J	Kar-Purkayastha, I				Kar-Purkayastha, Ishani			An epidemic of loneliness	LANCET			English	Editorial Material									Hlth Protect Agcy, London SW1W 9SZ, England	Health Protection Agency	Kar-Purkayastha, I (corresponding author), Hlth Protect Agcy, London SW1W 9SZ, England.	ishanik@doctors.org.uk							0	11	11	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 18	2010	376	9758					2114	2115		10.1016/S0140-6736(10)62190-3	http://dx.doi.org/10.1016/S0140-6736(10)62190-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702LA	21167590				2022-12-28	WOS:000285895000029
J	Akavia, UD; Litvin, O; Kim, J; Sanchez-Garcia, F; Kotliar, D; Causton, HC; Pochanard, P; Mozes, E; Garraway, LA; Pe'er, D				Akavia, Uri David; Litvin, Oren; Kim, Jessica; Sanchez-Garcia, Felix; Kotliar, Dylan; Causton, Helen C.; Pochanard, Panisa; Mozes, Eyal; Garraway, Levi A.; Pe'er, Dana			An Integrated Approach to Uncover Drivers of Cancer	CELL			English	Article							GENE-EXPRESSION; MELANOMA; MITF; IDENTIFICATION; TRANSFORMATION; INTERFERENCE; REGULATORS; NETWORKS; MODULES; PROTEIN	Systematic characterization of cancer genomes has revealed a staggering number of diverse aberrations that differ among individuals, such that the functional importance and physiological impact of most tumor genetic alterations remain poorly defined. We developed a computational framework that integrates chromosomal copy number and gene expression data for detecting aberrations that promote cancer progression. We demonstrate the utility of this framework using a melanoma data set. Our analysis correctly identified known drivers of melanoma and predicted multiple tumor dependencies. Two dependencies, TBC1D16 and RAB27A, confirmed empirically, suggest that abnormal regulation of protein trafficking contributes to proliferation in melanoma. Together, these results demonstrate the ability of integrative Bayesian approaches to identify candidate drivers with biological, and possibly therapeutic, importance in cancer.	[Akavia, Uri David; Litvin, Oren; Sanchez-Garcia, Felix; Kotliar, Dylan; Causton, Helen C.; Mozes, Eyal; Pe'er, Dana] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Akavia, Uri David; Litvin, Oren; Pe'er, Dana] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Kim, Jessica; Pochanard, Panisa; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kim, Jessica; Pochanard, Panisa; Garraway, Levi A.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Columbia University; Columbia University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Pe'er, D (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	dpeer@biology.columbia.edu	Lin, Jessica J/U-3020-2019; Akavia, Uri David/P-8437-2019	Pe'er, Dana/0000-0002-9259-8817; Causton, Helen/0000-0003-4630-6569	National Institutes of Health Roadmap Initiative; NIH [1-DP2-OD002414-01]; National Centers for Biomedical Computing [1U54CA121852-01A1]; Burroughs Wellcome Fund; Packard Fellowship for Science and Engineering; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002414] Funding Source: NIH RePORTER	National Institutes of Health Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centers for Biomedical Computing; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Fellowship for Science and Engineering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors will like to thank Nir Hacohen, Antonio Iavarone, Daphne Koller, Liz Miller, Itsik Pe'er, Suzanne Pfeffer, Neal Rosen, and Olga Troyanskaya for valuable comments. This research was supported by the National Institutes of Health Roadmap Initiative, NIH Director's New Innovator Award Program through grant number 1-DP2-OD002414-01, and National Centers for Biomedical Computing Grant 1U54CA121852-01A1. D.P. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and Packard Fellowship for Science and Engineering.	Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chiaverini C, 2008, J BIOL CHEM, V283, P12635, DOI 10.1074/jbc.M800130200; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Fischer T, 2010, J CLIN ONCOL, V28, P4339, DOI 10.1200/JCO.2010.28.9678; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Johansson P, 2007, PIGM CELL RES, V20, P216, DOI 10.1111/j.1600-0749.2007.00375.x; Jordens I., 2006, CELL RES, V19, P412; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Sanchez-Garcia F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-189; Satijn DPE, 1997, MOL CELL BIOL, V17, P6076, DOI 10.1128/MCB.17.10.6076; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taub N, 2007, MOL BIOL CELL, V18, P4698, DOI 10.1091/mbc.E07-02-0098; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wang L., 2009, CANCER SCI, V100, P1801; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Ying HQ, 2010, P NATL ACAD SCI USA, V107, P6912, DOI 10.1073/pnas.0914930107; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061	42	350	357	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					1005	1017		10.1016/j.cell.2010.11.013	http://dx.doi.org/10.1016/j.cell.2010.11.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21129771	Green Accepted, Bronze			2022-12-28	WOS:000285182600016
J	Hadders, MA; Williams, RL				Hadders, Michael A.; Williams, Roger L.			Kinases Charging to the Membrane	CELL			English	Editorial Material							DOMAINS	Being at the right place and time is as fundamental to biology as it is to academic careers. In this issue, Moravcevic and colleagues (2010) survey membrane-interacting proteins in yeast and discover a new membrane-targeting module, the kinase associated-1 domain KA1, which ensures that proteins are active at the correct place and time.	[Hadders, Michael A.; Williams, Roger L.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Hadders, MA (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	mhadders@mrc-lmb.cam.ac.uk; rlw@mrc-lmb.cam.ac.uk		Williams, Roger/0000-0001-7754-4207	Medical Research Council [MC_U105184308] Funding Source: Medline; MRC [MC_U105184308] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Goransson O, 2006, J CELL SCI, V119, P4059, DOI 10.1242/jcs.03097; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Marx A, 2010, FASEB J, V24, P1637, DOI 10.1096/fj.09-148064; Moravcevic K, 2010, CELL, V143, P966, DOI 10.1016/j.cell.2010.11.028; Tochio N, 2006, PROTEIN SCI, V15, P2534, DOI 10.1110/ps.062391106; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	8	5	5	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 10	2010	143	6					865	867		10.1016/j.cell.2010.11.044	http://dx.doi.org/10.1016/j.cell.2010.11.044			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145452	Bronze			2022-12-28	WOS:000285182600003
J	VijayRaghavan, K; Bate, M				VijayRaghavan, K.; Bate, Michael			Veronica Rodrigues (1953-2010)	SCIENCE			English	Biographical-Item									[VijayRaghavan, K.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Bate, Michael] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Cambridge	VijayRaghavan, K (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	vijay@ncbs.res.in							0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1493	1493		10.1126/science.1200787	http://dx.doi.org/10.1126/science.1200787			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148383				2022-12-28	WOS:000285153500052
J	Rudd, RE				Rudd, Rima E.			Improving Americans' Health Literacy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Rudd, RE (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							Agency for Healthcare Research and Quality (AHRQ), 2010, AHRQ PUBL; BERKMAN ND, 2004, 87 AG HEALTHC RES QU, P1; Harper W, 2007, AM J HEALTH BEHAV, V31, pS111; Office of Disease Prevention and Health Promotion U.S. Department of Health and Human Services, 2010, NAT ACT PLAN IMPR HL; Rudd RE, 2007, AM J HEALTH BEHAV, V31, pS8	5	74	76	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2010	363	24					2283	2285		10.1056/NEJMp1008755	http://dx.doi.org/10.1056/NEJMp1008755			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	691PA	21142532				2022-12-28	WOS:000285092100003
J	McFall, M; Saxon, AJ; Malte, CA; Chow, B; Bailey, S; Baker, DG; Beckham, JC; Boardman, KD; Carmody, TP; Joseph, AM; Smith, MW; Shih, MC; Lu, Y; Holodniy, M; Lavori, PW				McFall, Miles; Saxon, Andrew J.; Malte, Carol A.; Chow, Bruce; Bailey, Sara; Baker, Dewleen G.; Beckham, Jean C.; Boardman, Kathy D.; Carmody, Timothy P.; Joseph, Anne M.; Smith, Mark W.; Shih, Mei-Chiung; Lu, Ying; Holodniy, Mark; Lavori, Philip W.		CSP 519 Study Team	Integrating Tobacco Cessation Into Mental Health Care for Posttraumatic Stress Disorder A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SMOKING-CESSATION; MAJOR DEPRESSION; PSYCHIATRIC-DISORDERS; CLINICAL-TRIALS; VETERANS; SMOKERS; DEPENDENCE; INTERVENTIONS; PREVALENCE; ABSTINENCE	Context Most smokers with mental illness do not receive tobacco cessation treatment. Objective To determine whether integrating smoking cessation treatment into mental health care for veterans with posttraumatic stress disorder (PTSD) improves long-term smoking abstinence rates. Design, Setting, and Patients A randomized controlled trial of 943 smokers with military-related PTSD who were recruited from outpatient PTSD clinics at 10 Veterans Affairs medical centers and followed up for 18 to 48 months between November 2004 and July 2009. Intervention Smoking cessation treatment integrated within mental health care for PTSD delivered by mental health clinicians (integrated care [IC]) vs referral to Veterans Affairs smoking cessation clinics (SCC). Patients received smoking cessation treatment within 3 months of study enrollment. Main Outcome Measures Smoking outcomes included 12-month bioverified prolonged abstinence (primary outcome) and 7- and 30-day point prevalence abstinence assessed at 3-month intervals. Amount of smoking cessation medications and counseling sessions delivered were tested as mediators of outcome. Posttraumatic stress disorder and depression were repeatedly assessed using the PTSD Checklist and Patient Health Questionnaire 9, respectively, to determine if IC participation or quitting smoking worsened psychiatric status. Results Integrated care was better than SCC on prolonged abstinence (8.9% vs 4.5%; adjusted odds ratio, 2.26; 95% confidence interval [CI], 1.30-3.91; P=.004). Differences between IC vs SCC were largest at 6 months for 7-day point prevalence abstinence (78/472 [16.5%] vs 34/471 [7.2%], P<.001) and remained significant at 18 months (86/472 [18.2%] vs 51/471 [10.8%], P<.001). Number of counseling sessions received and days of cessation medication used explained 39.1% of the treatment effect. Between baseline and 18 months, psychiatric status did not differ between treatment conditions. Posttraumatic stress disorder symptoms for quitters and nonquitters improved. Nonquitters worsened slightly on the Patient Health Questionnaire 9 relative to quitters (differences ranged between 0.4 and 2.1, P=.03), whose scores did not change over time. Conclusion Among smokers with military-related PTSD, integrating smoking cessation treatment into mental health care compared with referral to specialized cessation treatment resulted in greater prolonged abstinence.	[McFall, Miles; Saxon, Andrew J.] Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; [McFall, Miles; Saxon, Andrew J.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Malte, Carol A.] Vet Affairs Puget Sound Hlth Care Syst, Ctr Excellence Subst Abuse Treatment & Educ, Washington, DC USA; [Chow, Bruce; Shih, Mei-Chiung; Lu, Ying; Holodniy, Mark] Vet Affairs Palo Alto Hlth Care Syst, Vet Affairs Cooperat Studies Program, Palo Alto, CA USA; [Bailey, Sara] Baylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USA; [Bailey, Sara] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Baker, Dewleen G.] Vet Affairs Healthcare Syst, Vet Affairs Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Baker, Dewleen G.] Univ Calif San Diego, San Diego, CA 92103 USA; [Beckham, Jean C.] Duke Univ, Med Ctr, Durham Vet Affairs Med Ctr, Vet Affairs Midatlantic Reg Mental Illness Res Ed, Durham, NC USA; [Beckham, Jean C.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Boardman, Kathy D.] Clin Res Pharm Coordinating Ctr, Vet Affairs Cooperat Studies Program, Albuquerque, NM USA; [Carmody, Timothy P.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Carmody, Timothy P.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Joseph, Anne M.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Smith, Mark W.] Dept Vet Affairs, Hlth Econ Resource Ctr, Menlo Pk, CA USA; [Shih, Mei-Chiung; Lu, Ying; Lavori, Philip W.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Palo Alto, CA 94304 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	McFall, M (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, 1660 S Columbian Way,S-116 MHC, Seattle, WA 98108 USA.	miles.mcfall@va.gov	Schnoor, Jerald L/B-1951-2008; Smith, Mark W/G-1522-2012; Baker, Dewleen/O-4957-2019	Smith, Mark W/0000-0002-4582-9088; Baker, Dewleen/0000-0002-1736-9838; Joseph, Anne/0000-0002-3440-2679; Hays, J Taylor/0000-0002-6110-3121; Holodniy, Mark/0000-0002-6655-7982	US Department of Veterans Affairs [CSP 519]; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER	US Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the US Department of Veterans Affairs Cooperative Studies Program (CSP 519).	Acosta MC, 2004, NICOTINE TOB RES, V6, P615, DOI 10.1080/14622200410001727867; Aubin HJ, 2009, CURR MED RES OPIN, V25, P519, DOI 10.1185/03007990802707600 ; Beckham JC, 1997, ADDICT BEHAV, V22, P637, DOI 10.1016/S0306-4603(96)00071-8; Boscarino JA, 2006, ANN EPIDEMIOL, V16, P248, DOI 10.1016/j.annepidem.2005.03.009; Brown RA, 2001, J CONSULT CLIN PSYCH, V69, P471, DOI 10.1037/0022-006X.69.3.471; Cleary M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001088.pub2; Collins SE, 2009, DRUG ALCOHOL DEPEN, V105, P164, DOI 10.1016/j.drugalcdep.2009.05.023; Cook JW, 2007, J TRAUMA STRESS, V20, P989, DOI 10.1002/jts.20275; Deykin EY, 2001, PSYCHOSOM MED, V63, P835, DOI 10.1097/00006842-200109000-00018; Drake RE, 2008, J SUBST ABUSE TREAT, V34, P123, DOI 10.1016/j.jsat.2007.01.011; Feldner MT, 2007, ADDICT BEHAV, V32, P214, DOI 10.1016/j.addbeh.2006.03.032; Fiore MC, 2008, TREATING TOBACCO USE; Fu SS, 2007, NICOTINE TOB RES, V9, P1071, DOI 10.1080/14622200701488418; George TP, 2000, AM J PSYCHIAT, V157, P1835, DOI 10.1176/appi.ajp.157.11.1835; Glassman AH, 2001, LANCET, V357, P1929, DOI 10.1016/S0140-6736(00)05064-9; Goldman R, 2004, NATL ASS VA AMBULATO, V15, P6; Hall SM, 2006, AM J PUBLIC HEALTH, V96, P1808, DOI 10.2105/AJPH.2005.080382; Hall SM, 2009, ANNU REV CLIN PSYCHO, V5, P409, DOI 10.1146/annurev.clinpsy.032408.153614; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Himelhoch S, 2003, AM J PSYCHIAT, V160, P2228, DOI 10.1176/appi.ajp.160.12.2228; Hughes JR, 2003, NICOTINE TOB RES, V5, P13, DOI 10.1080/1462220031000070552; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Killen JD, 2003, ADDICT BEHAV, V28, P461, DOI 10.1016/S0306-4603(01)00266-0; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; MacKinnon D.P., 2012, INTRO STAT MEDIATION; MacPherson L, 2010, J CONSULT CLIN PSYCH, V78, P55, DOI 10.1037/a0017939; McFall M, 2005, AM J PSYCHIAT, V162, P1311, DOI 10.1176/appi.ajp.162.7.1311; McFall M, 2007, CLIN TRIALS, V4, P178, DOI 10.1177/1740774507076923; Piper ME, 2010, J CONSULT CLIN PSYCH, V78, P13, DOI 10.1037/a0018065; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Prochaska JJ, 2004, J CONSULT CLIN PSYCH, V72, P1144, DOI 10.1037/0022-006X.72.6.1144; Prochaska JJ, 2008, AM J PUBLIC HEALTH, V98, P446, DOI 10.2105/AJPH.2006.101147; Schnurr PP, 2003, ARCH GEN PSYCHIAT, V60, P481, DOI 10.1001/archpsyc.60.5.481; Sherman SE, 2006, AM J HEALTH PROMOT, V20, P313, DOI 10.4278/0890-1171-20.5.313; Sherman SE, 2006, MIL MED, V171, P80, DOI 10.7205/MILMED.171.1.80; Sherman SE, 2005, AM J MED QUAL, V20, P33, DOI 10.1177/1062860604273776; Substance Abuse and Mental Health Services Administration, RES 2007 NAT SURV DR; Thorndike AN, 2007, AM J PUBLIC HEALTH, V97, P1878, DOI 10.2105/AJPH.2006.092577; Tiet QQ, 2007, ALCOHOL CLIN EXP RES, V31, P513, DOI 10.1111/j.1530-0277.2007.00336.x; Tsoh JY, 2000, AM J PSYCHIAT, V157, P368, DOI 10.1176/appi.ajp.157.3.368; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Weathers F, 1993, ANN CONVENTION INT S; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Weinberger AH, 2010, DRUG ALCOHOL DEPEN, V108, P7, DOI 10.1016/j.drugalcdep.2009.11.004; Ziedonis D, 2008, NICOTINE TOB RES, V10, P1691, DOI 10.1080/14622200802443569	47	165	165	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2010	304	22					2485	2493		10.1001/jama.2010.1769	http://dx.doi.org/10.1001/jama.2010.1769			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	691AS	21139110	Green Accepted, Bronze			2022-12-28	WOS:000285053300022
J	Attaran, A				Attaran, Amir			Spying at the UN: why America should be punished	LANCET			English	Editorial Material									[Attaran, Amir] Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada; [Attaran, Amir] Univ Ottawa, Fac Med, Ottawa, ON K1N 6N5, Canada	University of Ottawa; University of Ottawa	Attaran, A (corresponding author), Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada.							Office of the President, 2009, FED REGISTER, V74, P4683; UN General Assembly, 1946, CONV PRIV IMM UN; 2009, REPORTING COLLECTION	3	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 4	2010	376	9756					1885	1885		10.1016/S0140-6736(10)62188-5	http://dx.doi.org/10.1016/S0140-6736(10)62188-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	696KH	21130276				2022-12-28	WOS:000285439800010
J	Li, L; Jose, J; Xiang, Y; Kuhn, RJ; Rossmann, MG				Li, Long; Jose, Joyce; Xiang, Ye; Kuhn, Richard J.; Rossmann, Michael G.			Structural changes of envelope proteins during alphavirus fusion	NATURE			English	Article							SEMLIKI-FOREST-VIRUS; PH-DEPENDENT FUSION; CLASS-II VIRUS; SINDBIS VIRUS; CONFORMATIONAL-CHANGE; DYNAMIC ENVELOPE; MEMBRANE-FUSION; GLYCOPROTEIN; PRECURSOR; E3	Alphaviruses are enveloped RNA viruses that have a diameter of about 700 angstrom and can be lethal human pathogens(1). Entry of virus into host cells by endocytosis is controlled by two envelope glycoproteins, E1 and E2. The E2-E1 heterodimers form 80 trimeric spikes on the icosahedral virus surface(1,2), 60 with quasi-three-fold symmetry and 20 coincident with the icosahedral three-fold axes arranged with T 54 quasi-symmetry. The E1 glycoprotein has a hydrophobic fusion loop at one end and is responsible for membrane fusion(3,4). The E2 protein is responsible for receptor binding(5,6) and protects the fusion loop at neutral pH. The lower pH in the endosome induces the virions to undergo an irreversible conformational change in which E2 and E1 dissociate and E1 forms homotrimers, triggering fusion of the viral membrane with the endosomal membrane and then releasing the viral genome into the cytoplasm(3,4). Here we report the structure of an alphavirus spike, crystallized at low pH, representing an intermediate in the fusion process and clarifying the maturation process. The trimer of E2-E1 in the crystal structure is similar to the spikes in the neutral pH virus except that the E2 middle region is disordered, exposing the fusion loop. The amino-and carboxy-terminal domains of E2 each form immunoglobulin-like folds, consistent with the receptor attachment properties of E2.	[Li, Long; Jose, Joyce; Xiang, Ye; Kuhn, Richard J.; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	mr@purdue.edu	Li, Long/F-8892-2010; Kuhn, Richard/AAR-2722-2021	Kuhn, Richard/0000-0003-4148-1026; Xiang, Ye/0000-0003-0230-9522	NIH [P01 AI055672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055672] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to thank S. Sun, A. Aksyuk and T. Edwards for discussions. We are also grateful to S. Kelly for help in the preparation of the manuscript. We thank F. Rey for sharing the coordinates of Chikungunya virus E2-E1 to help interpret the Sindbis virus cryo-EM density of the E2 domain B. We would like to thank the staff at the Advanced Photon Source, Argonne National Laboratory, GM/CA sector for their help in data collection. The work was supported by NIH grant P01 AI055672 to R.J.K. and M.G.R.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DUBUISSON J, 1993, J VIROL, V67, P3363, DOI 10.1128/JVI.67.6.3363-3374.1993; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferlenghi I, 1998, J MOL BIOL, V283, P71, DOI 10.1006/jmbi.1998.2066; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; GRIFFIN DE, 1995, SEMIN VIROL, V6, P249, DOI 10.1006/smvy.1995.0030; HEIDNER HW, 1994, J VIROL, V68, P2683, DOI 10.1128/JVI.68.4.2683-2692.1994; KIELIAN M, 1995, ADV VIRUS RES, V45, P113, DOI 10.1016/S0065-3527(08)60059-7; Kleywegt GJ, 1997, ACTA CRYSTALLOGR D, V53, P179, DOI 10.1107/S0907444996012279; Lehr RV, 2000, PROTEIN EXPRES PURIF, V19, P362, DOI 10.1006/prep.2000.1258; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEYER WJ, 1993, J VIROL, V67, P5117, DOI 10.1128/JVI.67.9.5117-5125.1993; Mukhopadhyay S, 2006, STRUCTURE, V14, P63, DOI 10.1016/j.str.2005.07.025; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen KE, 1996, J VIROL, V70, P2757, DOI 10.1128/JVI.70.5.2757-2763.1996; Paredes AM, 1998, J VIROL, V72, P1534, DOI 10.1128/JVI.72.2.1534-1541.1998; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Sharff AJ, 2000, ACTA CRYSTALLOGR D, V56, P785, DOI 10.1107/S090744490000370X; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smit JM, 1999, J VIROL, V73, P8476, DOI 10.1128/JVI.73.10.8476-8484.1999; STRAUSS EG, 1991, J VIROL, V65, P4654, DOI 10.1128/JVI.65.9.4654-4664.1991; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; VONBONSDORFF CH, 1975, J VIROL, V16, P141, DOI 10.1128/JVI.16.1.141-145.1975; WAHLBERG JM, 1989, J VIROL, V63, P4991, DOI 10.1128/JVI.63.12.4991-4997.1989; WAHLBERG JM, 1992, J CELL BIOL, V116, P339, DOI 10.1083/jcb.116.2.339; WHITE J, 1980, J CELL BIOL, V87, P264, DOI 10.1083/jcb.87.1.264; WHITE J, 1980, P NATL ACAD SCI-BIOL, V77, P3273, DOI 10.1073/pnas.77.6.3273; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu SR, 2008, J BIOL CHEM, V283, P26452, DOI 10.1074/jbc.M801470200; Wu SR, 2007, J BIOL CHEM, V282, P6752, DOI 10.1074/jbc.M609125200; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zhang W, 2005, VIROLOGY, V332, P511, DOI 10.1016/j.virol.2004.11.043; Zhang W, 2002, J VIROL, V76, P11645, DOI 10.1128/JVI.76.22.11645-11658.2002; Zhang XY, 2004, VIROLOGY, V327, P287, DOI 10.1016/j.virol.2004.06.037; ZIEMIECKI A, 1978, J MOL BIOL, V122, P259, DOI 10.1016/0022-2836(78)90189-4; ZIEMIECKI A, 1980, J GEN VIROL, V50, P111, DOI 10.1099/0022-1317-50-1-111	45	220	225	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					705	U131		10.1038/nature09546	http://dx.doi.org/10.1038/nature09546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124457	Green Accepted			2022-12-28	WOS:000284836700043
J	Seitzinger, S				Seitzinger, Sybil			A sustainable planet needs scientists to think ahead	NATURE			English	Editorial Material									Int Geosphere Biosphere Programme, Stockholm, Sweden		Seitzinger, S (corresponding author), Int Geosphere Biosphere Programme, Stockholm, Sweden.	Sybil.seitzinger@igbp.kva.se							0	4	4	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 2	2010	468	7324					601	601		10.1038/468601a	http://dx.doi.org/10.1038/468601a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	688GB	21124410	Bronze			2022-12-28	WOS:000284836700004
J	Shapira, P; Wang, J				Shapira, Philip; Wang, Jue			Follow the money	NATURE			English	Editorial Material							NANOTECHNOLOGY		[Shapira, Philip] Univ Manchester, Manchester M15 9PL, Lancs, England; [Shapira, Philip] Georgia Inst Technol, Atlanta, GA 30332 USA; [Wang, Jue] Florida Int Univ, Miami, FL 33199 USA	University of Manchester; University System of Georgia; Georgia Institute of Technology; State University System of Florida; Florida International University	Shapira, P (corresponding author), Univ Manchester, Manchester M15 9PL, Lancs, England.	pshapira@gmail.com	Wang, Jue/P-6168-2014	Wang, Jue/0000-0002-3401-713X; Shapira, Philip/0000-0003-2488-5985				*LUX RES, 2010, IR NAN COMM FRAM 201; Porter AL, 2008, J NANOPART RES, V10, P715, DOI 10.1007/s11051-007-9266-y; SARGANT JF, 2008, NANOTECHNOLOGY US CO; Shapira P, 2009, ASIAN BUS MANAG, V8, P461, DOI 10.1057/abm.2009.15; Youtie J, 2008, J NANOPART RES, V10, P981, DOI 10.1007/s11051-008-9360-9	5	77	80	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 2	2010	468	7324					627	628		10.1038/468627a	http://dx.doi.org/10.1038/468627a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	688GB	21124430	Bronze			2022-12-28	WOS:000284836700014
J	Pitman, RK				Pitman, Roger K.			A Recent VA Rules Change and the Traumatic Event Requirement in PTSD	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Pitman, Roger K.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Pitman, Roger K.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Pitman, RK (corresponding author), MGH E, Massachusetts Gen Hosp, 120 2nd Ave, Charlestown, MA 02129 USA.	roger_pitman@hms.harvard.edu						American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; DAO J, 2010, NEW YORK TIMES  1220, pA1; First M.B., 2004, DSM 4 TR GUIDEBOOK; SATEL S, 2010, WALL STREET J   0717, pW3; SHINSEKI E, 2010, US TODAY        0712, pA9; US Department of Veterans Affairs, 2010, FED REGISTER, P39843; WEATHERS FA, 2009, PRACTICE GUIDELINES, P23	8	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2010	304	21					2409	2410		10.1001/jama.2010.1739	http://dx.doi.org/10.1001/jama.2010.1739			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687FH	21119089				2022-12-28	WOS:000284763900024
J	Hennigan, T				Hennigan, Tom			Brazil Economic success threatens aspirations of Brazil's public health system	BRITISH MEDICAL JOURNAL			English	Editorial Material												hennigantom@gmail.com						Macinko J, 2006, J EPIDEMIOL COMMUN H, V60, P13, DOI 10.1136/jech.2005.038323	1	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 29	2010	341								c5453	10.1136/bmj.c5453	http://dx.doi.org/10.1136/bmj.c5453			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	691NT	21115588				2022-12-28	WOS:000285088800002
J	Culler, SJ; Hoff, KG; Smolke, CD				Culler, Stephanie J.; Hoff, Kevin G.; Smolke, Christina D.			Reprogramming Cellular Behavior with RNA Controllers Responsive to Endogenous Proteins	SCIENCE			English	Article							KAPPA-B; EXPRESSION; SELECTION; ACTIVATION; EVOLUTION; MICRORNA; APTAMER	Synthetic genetic devices that interface with native cellular pathways can be used to change natural networks to implement new forms of control and behavior. The engineering of gene networks has been limited by an inability to interface with native components. We describe a class of RNA control devices that overcome these limitations by coupling increased abundance of particular proteins to targeted gene expression events through the regulation of alternative RNA splicing. We engineered RNA devices that detect signaling through the nuclear factor kappa B and Wnt signaling pathways in human cells and rewire these pathways to produce new behaviors, thereby linking disease markers to noninvasive sensing and reprogrammed cellular fates. Our work provides a genetic platform that can build programmable sensing-actuation devices enabling autonomous control over cellular behavior.	[Culler, Stephanie J.; Hoff, Kevin G.; Smolke, Christina D.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Smolke, Christina D.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	California Institute of Technology; Stanford University	Smolke, CD (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd,MC 210-41, Pasadena, CA 91125 USA.	csmolke@stanford.edu	Taylor, Graham/A-4027-2012		Caltech Joseph Jacobs Institute for Molecular Engineering for Medicine; NIH; U.S. Department of Defense; Alfred P. Sloan Foundation; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091298] Funding Source: NIH RePORTER	Caltech Joseph Jacobs Institute for Molecular Engineering for Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Hertel for providing the pHis-BIVT-MS2-RSp55 construct, M. Jensen for providing pCD19t-Tk-T2A-IL15op_epHIV7, L. J. Maher for providing pGAD24, and B. Stewart for laboratory assistance. This work was supported by the Caltech Joseph Jacobs Institute for Molecular Engineering for Medicine (grant to C. D. S.), the NIH (fellowship to K. G. H., grant to C. D. S.), the U.S. Department of Defense (grant to C. D. S.), the Alfred P. Sloan Foundation (fellowship to C. D. S.), and the Bill and Melinda Gates Foundation (grant to C. D. S.). The authors have filed for a patent related to this work.	Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Beltinger C, 1999, P NATL ACAD SCI USA, V96, P8699, DOI 10.1073/pnas.96.15.8699; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; CAREY J, 1983, BIOCHEMISTRY-US, V22, P4723, DOI 10.1021/bi00289a017; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Chan R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj028; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Culler SJ, 2010, NUCLEIC ACIDS RES, V38, P5152, DOI 10.1093/nar/gkq248; Davidson EA, 2007, NAT CHEM BIOL, V3, P23, DOI 10.1038/nchembio846; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Hellweg CE, 2006, ANN NY ACAD SCI, V1091, P191, DOI 10.1196/annals.1378.066; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kim DS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-23; Lee HK, 2007, CANCER RES, V67, P9315, DOI 10.1158/0008-5472.CAN-07-1128; Lifang Yang, 2008, J Exp Clin Cancer Res, V27, P42, DOI 10.1186/1756-9966-27-42; Link KH, 2009, GENE THER, V16, P1189, DOI 10.1038/gt.2009.81; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mi J, 2006, NUCLEIC ACIDS RES, V34, P3577, DOI 10.1093/nar/gkl482; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Song Y, 2006, INT J GYNECOL CANCER, V16, P156, DOI 10.1111/j.1525-1438.2006.00470.x; Suess B, 2008, RNA BIOL, V5, P24, DOI 10.4161/rna.5.1.5955; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Villemaire J, 2003, J BIOL CHEM, V278, P50031, DOI 10.1074/jbc.M308897200; Weber W, 2009, CHEM BIOL, V16, P287, DOI 10.1016/j.chembiol.2009.02.005; Win MN, 2009, CHEM BIOL, V16, P298, DOI 10.1016/j.chembiol.2009.02.011; Wurster SE, 2008, RNA, V14, P1037, DOI 10.1261/rna.878908	30	206	218	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1251	1255		10.1126/science.1192128	http://dx.doi.org/10.1126/science.1192128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109673	Green Accepted			2022-12-28	WOS:000284613700044
J	Akiyoshi, B; Sarangapani, KK; Powers, AF; Nelson, CR; Reichow, SL; Arellano-Santoyo, H; Gonen, T; Ranish, JA; Asbury, CL; Biggins, S				Akiyoshi, Bungo; Sarangapani, Krishna K.; Powers, Andrew F.; Nelson, Christian R.; Reichow, Steve L.; Arellano-Santoyo, Hugo; Gonen, Tamir; Ranish, Jeffrey A.; Asbury, Charles L.; Biggins, Sue			Tension directly stabilizes reconstituted kinetochore-microtubule attachments	NATURE			English	Article							SINGLE KINESIN MOLECULES; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MITOTIC SPINDLE; PROTEIN-KINASE; CATCH BONDS; AURORA B; COMPLEX; MITOSIS; FORCE	Kinetochores are macromolecular machines that couple chromosomes to dynamic microtubule tips during cell division, thereby generating force to segregate the chromosomes(1,2). Accurate segregation depends on selective stabilization of correct 'bi-oriented' kinetochore-microtubule attachments, which come under tension as the result of opposing forces exerted by microtubules(3). Tension is thought to stabilize these bi-oriented attachments indirectly, by suppressing the destabilizing activity of a kinase, Aurora B-4,B-5. However, a complete mechanistic understanding of the role of tension requires reconstitution of kinetochore-microtubule attachments for biochemical and biophysical analyses in vitro. Here we show that native kinetochore particles retaining the majority of kinetochore proteins can be purified from budding yeast and used to reconstitute dynamic microtubule attachments. Individual kinetochore particles maintain load-bearing associations with assembling and disassembling ends of single microtubules for >30 min, providing a close match to the persistent coupling seen in vivo between budding yeast kinetochores and single microtubules(6). Moreover, tension increases the lifetimes of the reconstituted attachments directly, through a catch bond-like mechanism that does not require Aurora B7-10. On the basis of these findings, we propose that tension selectively stabilizes proper kinetochore-microtubule attachments in vivo through a combination of direct mechanical stabilization and tension-dependent phosphoregulation.	[Akiyoshi, Bungo; Nelson, Christian R.; Arellano-Santoyo, Hugo; Biggins, Sue] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Akiyoshi, Bungo; Arellano-Santoyo, Hugo] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Sarangapani, Krishna K.; Powers, Andrew F.; Arellano-Santoyo, Hugo; Asbury, Charles L.] Univ Washington, Dept Physiol Biophys, Seattle, WA 98195 USA; [Reichow, Steve L.; Gonen, Tamir] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Gonen, Tamir] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Ranish, Jeffrey A.] Inst Syst Biol, Seattle, WA 98103 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Institute for Systems Biology (ISB)	Biggins, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	casbury@u.washington.edu; sbiggins@fhcrc.org		Reichow, Steve/0000-0001-5276-7690; Akiyoshi, Bungo/0000-0001-6010-394X; Biggins, Susan/0000-0002-4499-6319	NSF IGERT [DGE-0504573]; NIH [T32GM07270, T32HL007312, GM078069, GM064386]; NCI Cancer Center [CA015704]; NIGMS [PM50 GM076547, R01GM79373]; Searle Scholar Award [06-L-111]; Packard Fellowship for Science and Engineering [2006-30521]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064386, R01GM079373, P50GM076547, T32GM007270, R01GM078069] Funding Source: NIH RePORTER	NSF IGERT(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Searle Scholar Award; Packard Fellowship for Science and Engineering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Desai for antibodies, and J. Kilmartin, G. Barnes, D. Pellman, R. Tsien and the Yeast Resource Center for strains and plasmids. We also thank M. Press for constructing the Cse4-GFP strain, M. Yuan at the ISB for help, and the Seattle Mitosis Club for comments. We are grateful to T. Davis, W. Thomas, B. Zagotta, T. Tsukiyama, J. Stumpff, F. Rieke, S. Gordon and the Biggins lab for comments on the manuscript. This work was supported by an NSF IGERT fellowship (DGE-0504573) and NIH traineeship (T32GM07270) to A.F.P., an NIH Cardiovascular Pathology traineeship (T32HL007312) to K.K.S., a Beckman Young Investigator grant to S.B., NIH grants (GM078069 and GM064386) to S.B., an NCI Cancer Center Support grant (CA015704) and an NIGMS grant (PM50 GM076547/Center for Systems Biology) to J.A.R., a Searle Scholar Award (06-L-111) to C.L.A., a Packard Fellowship for Science and Engineering (2006-30521) to C.L.A. and an NIGMS grant (R01GM79373) to C.L.A. S.B. is a Scholar of the Leukemia and Lymphoma Society and T.G. is a Howard Hughes Medical Institute Early Career Scientist.	Akiyoshi B, 2009, GENE DEV, V23, P2887, DOI 10.1101/gad.1865909; Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Enquist-Newman M, 2001, MOL BIOL CELL, V12, P2601, DOI 10.1091/mbc.12.9.2601; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; Franck AD, 2010, METHODS, V51, P242, DOI 10.1016/j.ymeth.2010.01.020; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Gestaut DR, 2010, METHOD CELL BIOL, V95, P641, DOI 10.1016/S0091-679X(10)95032-2; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Kitamura E, 2007, GENE DEV, V21, P3319, DOI 10.1101/gad.449407; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maresca TJ, 2010, J CELL SCI, V123, P825, DOI 10.1242/jcs.064790; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Nekrasov VS, 2003, MOL BIOL CELL, V14, P4931, DOI 10.1091/mbc.E03-06-0419; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; NICKLAS RB, 1988, ANNU REV BIOPHYS BIO, V17, P431, DOI 10.1146/annurev.bb.17.060188.002243; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rose MD., 1990, METHODS YEAST GENETI; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; SIKORSKI RS, 1989, GENETICS, V122, P19; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804; Tien JF, 2010, J CELL BIOL, V189, P713, DOI 10.1083/jcb.200910142; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601	39	304	307	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					576	U255		10.1038/nature09594	http://dx.doi.org/10.1038/nature09594			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107429	Green Accepted, Green Submitted			2022-12-28	WOS:000284584200045
J	Kidd, JM; Graves, T; Newman, TL; Fulton, R; Hayden, HS; Malig, M; Kallicki, J; Kaul, R; Wilson, RK; Eichler, EE				Kidd, Jeffrey M.; Graves, Tina; Newman, Tera L.; Fulton, Robert; Hayden, Hillary S.; Malig, Maika; Kallicki, Joelle; Kaul, Rajinder; Wilson, Richard K.; Eichler, Evan E.			A Human Genome Structural Variation Sequencing Resource Reveals Insights into Mutational Mechanisms	CELL			English	Article							DOUBLE-STRAND BREAKS; COPY-NUMBER; L1 RETROTRANSPOSITION; RECOMBINATION; REPEATS; IDENTIFICATION; DELETIONS; COMMON; TRANSDUCTION; POLYMORPHISM	Understanding the prevailing mutational mechanisms responsible for human genome structural variation requires uniformity in the discovery of allelic variants and precision in terms of breakpoint delineation. We develop a resource based on capillary end sequencing of 13.8 million fosmid clones from 17 human genomes and characterize the complete sequence of 1054 large structural variants corresponding to 589 deletions, 384 insertions, and 81 inversions. We analyze the 2081 breakpoint junctions and infer potential mechanism of origin. Three mechanisms account for the bulk of germline structural variation: microhomology-mediated processes involving short (2-20 bp) stretches of sequence (28%), nonallelic homologous recombination (22%), and L1 retrotransposition (19%). The high quality and long-range continuity of the sequence reveals more complex mutational mechanisms, including repeat-mediated inversions and gene conversion, that are most often missed by other methods, such as comparative genomic hybridization, single nucleotide polymorphism microarrays, and next-generation sequencing.	[Kidd, Jeffrey M.; Newman, Tera L.; Hayden, Hillary S.; Malig, Maika; Kaul, Rajinder; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Graves, Tina; Fulton, Robert; Kallicki, Joelle; Wilson, Richard K.] Washington Univ, Genome Sequencing Ctr, Sch Med, St Louis, MO 63108 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Washington University (WUSTL); Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Wilson, Richard K./AAF-4139-2019	Wilson, Richard K./0000-0002-1992-1358; Kaul, Rajinder/0000-0002-7895-9284; Kidd, Jeffrey/0000-0002-9631-1465	National Science Foundation; National Institutes of Health [HG004120]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG004120] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank D. Smith and the staff at Agencourt Biosciences for library production, E. Kirkness and staff of the J. Craig Venter Institute for end-sequence data from the JVCI library, and L. Chen for computational assistance in the mapping of end-sequence data. We thank S. Girirajan, J. Moran, and C. Payen for thoughtful discussion; T. Brown for manuscript preparation assistance; and members of the University of Washington and Washington University Genome Centers for assistance with data generation. J.M.K. is supported by a National Science Foundation Graduate Research Fellowship. This work was supported by the National Institutes of Health Grant HG004120 to E.E.E., who is an investigator of the Howard Hughes Medical Institute. E.E.E is on the scientific advisory board for Pacific Biosciences. T.L.N. is an employee and founder of iGenix Inc.	Abe H, 2009, HEPATOL RES, V39, P1159, DOI 10.1111/j.1872-034X.2009.00566.x; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; An P, 2009, J INFECT DIS, V200, P1054, DOI 10.1086/605644; Antonacci F, 2010, NAT GENET, V42, P745, DOI 10.1038/ng.643; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bekpen C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000403; Bennett EA, 2008, GENOME RES, V18, P1875, DOI 10.1101/gr.081737.108; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Buard J, 2000, AM J HUM GENET, V67, P333, DOI 10.1086/303015; Chiaromonte F, 2002, Pac Symp Biocomput, P115; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; Han K, 2007, PLOS GENET, V3, P1939, DOI 10.1371/journal.pgen.0030184; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; Jiang ZS, 2008, GENOME RES, V18, P1362, DOI 10.1101/gr.078477.108; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Kidd JM, 2010, NAT METHODS, V7, P365, DOI 10.1038/NMETH.1451; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lagerstedt K, 1997, HUM MOL GENET, V6, P627, DOI 10.1093/hmg/6.4.627; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reiter LT, 1997, HUM MOL GENET, V6, P1595, DOI 10.1093/hmg/6.9.1595; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Smit A, 1996, REPEATMASKER OPEN 30; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Szak ST, 2002, GENOME BIOL, V3; Tristem M, 2000, J VIROL, V74, P3715, DOI 10.1128/JVI.74.8.3715-3730.2000; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Visser R, 2005, AM J HUM GENET, V76, P52, DOI 10.1086/426950; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Witherspoon DJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-410	62	187	191	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					837	847		10.1016/j.cell.2010.10.027	http://dx.doi.org/10.1016/j.cell.2010.10.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111241	Green Accepted, Bronze			2022-12-28	WOS:000284583500024
J	Ganten, D; Haines, A; Souhami, R				Ganten, Detlev; Haines, Andy; Souhami, Robert			Health co-benefits of policies to tackle climate change	LANCET			English	Editorial Material							STRATEGIES		[Ganten, Detlev] German Natl Acad Sci Leopoldina, D-06108 Halle, Germany; [Haines, Andy] London Sch Hyg & Trop Med, London WC1, England; [Souhami, Robert] Acad Med Sci, London, England	University of London; London School of Hygiene & Tropical Medicine	Ganten, D (corresponding author), German Natl Acad Sci Leopoldina, D-06108 Halle, Germany.	detlev.ganten@charite.de		Haines, Andy/0000-0002-8053-4605				*AC MED SCI, 2009, MIT CLIM CHANG IMPR; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; Gill M, 2009, LANCET, V374, P1953, DOI 10.1016/S0140-6736(09)61830-4; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; *INT MED PAN, 2010, STAT HLTH COB POL TA; Markandya A, 2009, LANCET, V374, P2006, DOI 10.1016/S0140-6736(09)61715-3; NHS Sustainable Development Unit, 2008, NHS ENGL CARB EM CAR; Smith KR, 2009, LANCET, V374, P2091, DOI 10.1016/S0140-6736(09)61716-5; Stern N., 2007, EC CLIMATE CHANGE; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1	11	28	28	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2010	376	9755					1802	1804		10.1016/S0140-6736(10)62139-3	http://dx.doi.org/10.1016/S0140-6736(10)62139-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	696KG	21111893				2022-12-28	WOS:000285439700005
J	Lee, TH				Lee, Thomas H.			Putting the Value Framework to Work.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		Partners Healthcare Syst, Boston, MA USA	Partners Healthcare System	Lee, TH (corresponding author), Partners Healthcare Syst, Boston, MA USA.							Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Gawande A., 2009, CHECKLIST MANIFESTO; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Wasserman J, 2010, STROKE, V41, pE345	4	60	60	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2010	363	26					2481	2483		10.1056/NEJMp1013111	http://dx.doi.org/10.1056/NEJMp1013111			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697YL	21142527				2022-12-28	WOS:000285555600002
J	Buffett, BA				Buffett, Bruce A.			Tidal dissipation and the strength of the Earth's internal magnetic field	NATURE			English	Article							ROTATING SPHERICAL-SHELL; SHEAR LAYERS; TORSIONAL OSCILLATIONS; CORE; NUTATION; CONSTRAINTS; PRECESSION; CONVECTION; GEODYNAMO; DYNAMICS	Magnetic fields at the Earth's surface represent only a fraction of the field inside the core(1). The strength and structure of the internal field are poorly known(2-5), yet the details are important for our understanding of the geodynamo. Here I obtain an indirect estimate for the field strength from measurements of tidal dissipation. Tidally driven flow in the Earth's liquid core develops internal shear layers, which distort the internal magnetic field and generate electric currents. Ohmic losses damp the tidal motions and produce detectable signatures in the Earth's nutations. Previously reported evidence of anomalous dissipation in nutations(3,6) can be explained with a core-averaged field of 2.5 mT, eliminating the need for high fluid viscosity(6) or a stronger magnetic field at the inner-core boundary(3). Estimates for the internal field constrain the power required for the geodynamo(7,8).	Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Buffett, BA (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	bbuffett@berkeley.edu						Aubert J, 2009, GEOPHYS J INT, V179, P1414, DOI 10.1111/j.1365-246X.2009.04361.x; Buffett BA, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000056; Buffett BA, 2009, GEOPHYS J INT, V177, P878, DOI 10.1111/j.1365-246X.2009.04129.x; Christensen UR, 2006, GEOPHYS J INT, V166, P97, DOI 10.1111/j.1365-246X.2006.03009.x; Christensen UR, 2004, NATURE, V429, P169, DOI 10.1038/nature02508; de Wijs GA, 1998, NATURE, V392, P805, DOI 10.1038/33905; Desai SD, 1995, J GEOPHYS RES-OCEANS, V100, P25205, DOI 10.1029/95JC02258; Dobson DP, 2002, PHYS EARTH PLANET IN, V130, P271, DOI 10.1016/S0031-9201(02)00011-0; Gillet N, 2010, NATURE, V465, P74, DOI 10.1038/nature09010; HOLLERBACH R, 1995, J FLUID MECH, V298, P327, DOI 10.1017/S0022112095003338; Jackson A, 2009, GEOPHYS J INT, V177, P367, DOI 10.1111/j.1365-246X.2008.04008.x; KERSWELL RR, 1995, J FLUID MECH, V298, P311, DOI 10.1017/S0022112095003326; Koot L, 2010, GEOPHYS J INT, V182, P1279, DOI 10.1111/j.1365-246X.2010.04711.x; Kuang WJ, 1999, J COMPUT PHYS, V153, P51, DOI 10.1006/jcph.1999.6274; MATHEWS PM, 1991, J GEOPHYS RES-SOLID, V96, P8219, DOI 10.1029/90JB01955; Mathews PM, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000390; Poincare H., 1910, B ASTRON, V27, P321; Rieutord M, 1997, J FLUID MECH, V341, P77, DOI 10.1017/S0022112097005491; SAAD Y, 1986, SIAM J SCI STAT COMP, V7, P856, DOI 10.1137/0907058; Sovers OJ, 1998, REV MOD PHYS, V70, P1393, DOI 10.1103/RevModPhys.70.1393; Starchenko SV, 2002, ICARUS, V157, P426, DOI 10.1006/icar.2002.6842; Tilgner A, 1999, PHYS REV E, V59, P1789, DOI 10.1103/PhysRevE.59.1789; Tilgner A, 2007, TREATISE GEOPHYS, V8, P207, DOI DOI 10.1016/B978-044452748-6.00129-2; WAHR JM, 1986, GEOPHYS J ROY ASTRON, V64, P633; WALTON IC, 1975, PROC R SOC LON SER-A, V344, P101, DOI 10.1098/rspa.1975.0092; Zatman S, 1997, NATURE, V388, P760, DOI 10.1038/41987	26	53	54	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 16	2010	468	7326					952	U345		10.1038/nature09643	http://dx.doi.org/10.1038/nature09643			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164483				2022-12-28	WOS:000285344600044
J	Sam, AH; Beynon, HLC				Sam, Amir H.; Beynon, Huw L. C.			Wound Botulism.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sam, Amir H.] Hammersmith Hosp, London, England; [Beynon, Huw L. C.] Royal Free Hosp, London NW3 2QG, England	Imperial College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Sam, AH (corresponding author), Hammersmith Hosp, London, England.	amir_h_sam@hotmail.com			National Institute for Health Research [ACF-2006-21-011] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))			0	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2010	363	25					2444	2444		10.1056/NEJMicm1003352	http://dx.doi.org/10.1056/NEJMicm1003352			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZK	21158660				2022-12-28	WOS:000285340200010
J	Tsai, WW; Wang, ZX; Yiu, TT; Akdemir, KC; Xia, WY; Winter, S; Tsai, CY; Shi, XB; Schwarzer, D; Plunkett, W; Aronow, B; Gozani, O; Fischle, W; Hung, MC; Patel, DJ; Barton, MC				Tsai, Wen-Wei; Wang, Zhanxin; Yiu, Teresa T.; Akdemir, Kadir C.; Xia, Weiya; Winter, Stefan; Tsai, Cheng-Yu; Shi, Xiaobing; Schwarzer, Dirk; Plunkett, William; Aronow, Bruce; Gozani, Or; Fischle, Wolfgang; Hung, Mien-Chie; Patel, Dinshaw J.; Barton, Michelle Craig			TRIM24 links a non-canonical histone signature to breast cancer	NATURE			English	Article							GENE-EXPRESSION; PHD FINGER; NUCLEAR RECEPTORS; BINDING MODULES; CHROMATIN REGULATION; COACTIVATOR HTIF1; TRANSCRIPTION; ESTROGEN; COMPLEX; ALPHA	Recognition of modified histone species by distinct structural domains within 'reader' proteins plays a critical role in the regulation of gene expression. Readers that simultaneously recognize histones with multiple marks allow transduction of complex chromatin modification patterns into specific biological outcomes. Here we report that chromatin regulator tripartite motif-containing 24 (TRIM24) functions in humans as a reader of dual histone marks by means of tandem plant homeodomain (PHD) and bromodomain (Bromo) regions. The three-dimensional structure of the PHD-Bromo region of TRIM24 revealed a single functional unit for combinatorial recognition of unmodified H3K4 (that is, histone H3 unmodified at lysine 4, H3K4me0) and acetylated H3K23 (histone H3 acetylated at lysine 23, H3K23ac) within the same histone tail. TRIM24 binds chromatin and oestrogen receptor to activate oestrogen-dependent genes associated with cellular proliferation and tumour development. Aberrant expression of TRIM24 negatively correlates with survival of breast cancer patients. The PHD-Bromo of TRIM24 provides a structural rationale for chromatin activation through a non-canonical histone signature, establishing a new route by which chromatin readers may influence cancer pathogenesis.	[Wang, Zhanxin; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Tsai, Wen-Wei; Yiu, Teresa T.; Shi, Xiaobing; Barton, Michelle Craig] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Program Genes & Dev, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Yiu, Teresa T.; Akdemir, Kadir C.; Shi, Xiaobing; Barton, Michelle Craig] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA; [Yiu, Teresa T.; Akdemir, Kadir C.; Shi, Xiaobing; Barton, Michelle Craig] Univ Texas MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Houston, TX 77030 USA; [Xia, Weiya; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Akdemir, Kadir C.] Univ Texas MD Anderson Canc Ctr, Dept Biostat & Bioinformat, Houston, TX 77030 USA; [Winter, Stefan; Fischle, Wolfgang] Max Planck Inst Biophys Chem, Lab Chromatin Biochem, D-37077 Gottingen, Germany; [Tsai, Cheng-Yu; Plunkett, William] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Schwarzer, Dirk] Leibniz Inst Mol Pharmakol FMP, Dept Chem Biol Prot Chem, D-13125 Berlin, Germany; [Aronow, Bruce] Cincinnati Childrens Hosp Med Ctr, Computat Med Ctr, Cincinnati, OH 45229 USA; [Gozani, Or] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Hung, Mien-Chie] China Med Univ & Hosp, Grad Inst Canc Biol, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ & Hosp, Ctr Mol Med, Taichung 404, Taiwan	Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Max Planck Society; University of Texas System; UTMD Anderson Cancer Center; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Cincinnati Children's Hospital Medical Center; Stanford University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org; mbarton@mdanderson.org	Wang, Zhanxin/A-7967-2012; Gozani, Or P/I-6157-2013; Hung, Mien-Chie/ABD-5911-2021; Aronow, Bruce J/F-8438-2012	Hung, Mien-Chie/0000-0003-4317-4740; Shi, Xiaobing/0000-0001-5242-8189; Schwarzer, Dirk/0000-0002-7477-3319; Barton, Michelle/0000-0002-4042-1374; Gozani, Or/0000-0002-1365-4463; Tsai, Cheng-Yu/0000-0002-6351-1858	National Institutes of Health (NIH) [GM081627, U54 RR025216, P30DK078392-01, GM079641]; George and Cynthia Mitchell Foundation; China Medical University and Hospital; MDACC; Starr Foundation; Leukemia and Lymphoma Society; Max Planck Society; NCI Cancer Center; Sowell-Huggins Foundation; EMBO; Center for Cancer Epigenetics;  [T32 HD07325]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007325] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079641, P01GM081627] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George and Cynthia Mitchell Foundation; China Medical University and Hospital(China Medical University); MDACC; Starr Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Max Planck Society(Max Planck Society); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sowell-Huggins Foundation; EMBO(European Molecular Biology Organization (EMBO)); Center for Cancer Epigenetics; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the National Institutes of Health (NIH GM081627) and the George and Cynthia Mitchell Foundation (to M. C. B.), from NIH (U54 RR025216 and P30DK078392-01) to B. A., from NIH (GM079641) to O.G., from the Sister Institution Fund of China Medical University and Hospital and MDACC to M.-C. H., from the Starr Foundation and the Leukemia and Lymphoma Society to D.J.P., from the Max Planck Society to W. F., and from the NCI Cancer Center (Support Grant) to the UT MD Anderson Cancer Center. W.-W.T. was supported in part by the Sowell-Huggins Foundation; S. W. by a long-term EMBO fellowship; T.T.Y. by T32 HD07325; and K. C. A. by the Center for Cancer Epigenetics. We thank J. Song, D. C. Jamison, A. Dose, Z. Coban and Y. Wei for technical support and assistance. We are grateful to S. Stratton, M. Lee, M. Bedford, G. Lozano, S. Dent, A. Nardulli and members of our laboratories for advice, reagents and discussions.	Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Belloni E, 2005, GENE CHROMOSOME CANC, V42, P320, DOI 10.1002/gcc.20144; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Boney-Montoya J, 2010, MOL ENDOCRINOL, V24, P346, DOI 10.1210/me.2009-0429; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cheskis BJ, 2007, J CELL PHYSIOL, V213, P610, DOI 10.1002/jcp.21253; ECKERT RL, 1982, J BIOL CHEM, V257, P8840; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Jacobs SA, 2004, METHOD ENZYMOL, V376, P131; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Katzenellenbogen BS, 1996, BIOL REPROD, V54, P287, DOI 10.1095/biolreprod54.2.287; Klugbauer S, 1999, ONCOGENE, V18, P4388, DOI 10.1038/sj.onc.1202824; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Stavropoulos P, 2006, NAT STRUCT MOL BIOL, V13, P626, DOI 10.1038/nsmb1113; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thenot S, 1997, J BIOL CHEM, V272, P12062, DOI 10.1074/jbc.272.18.12062; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; Tsai WW, 2008, MOL CELL BIOL, V28, P5139, DOI 10.1128/MCB.00287-08; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang ZX, 2010, CELL, V141, P1183, DOI 10.1016/j.cell.2010.05.016; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Xia WY, 2004, CLIN CANCER RES, V10, P3815, DOI 10.1158/1078-0432.CCR-03-0527; Yanagisawa J, 2002, MOL CELL, V9, P553, DOI 10.1016/S1097-2765(02)00478-1; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong S, 1999, NAT GENET, V23, P287, DOI 10.1038/15463; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057	54	295	301	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					927	U320		10.1038/nature09542	http://dx.doi.org/10.1038/nature09542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164480	Green Accepted, Green Published			2022-12-28	WOS:000285344600039
J	Watanabe, A; Choe, S; Chaptal, V; Rosenberg, JM; Wright, EM; Grabe, M; Abramson, J				Watanabe, Akira; Choe, Seungho; Chaptal, Vincent; Rosenberg, John M.; Wright, Ernest M.; Grabe, Michael; Abramson, Jeff			The mechanism of sodium and substrate release from the binding pocket of vSGLT	NATURE			English	Article							AMINO-ACID ANTIPORTER; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; TRANSPORTER; COTRANSPORTER; MODEL; RESOLUTION; SOFTWARE; INSIGHTS; HOMOLOG	Membrane co-transport proteins that use a five-helix inverted repeat motif have recently emerged as one of the largest structural classes of secondary active transporters(1,2). However, despite many structural advances there is no clear evidence of how ion and substrate transport are coupled. Here we report a comprehensive study of the sodium/galactose transporter from Vibrio parahaemolyticus (vSGLT), consisting of molecular dynamics simulations, biochemical characterization and a new crystal structure of the inward-open conformation at a resolution of 2.7 angstrom. Our data show that sodium exit causes a reorientation of transmembrane helix 1 that opens an inner gate required for substrate exit, and also triggers minor rigid-body movements in two sets of transmembrane helical bundles. This cascade of events, initiated by sodium release, ensures proper timing of ion and substrate release. Once set in motion, these molecular changes weaken substrate binding to the transporter and allow galactose readily to enter the intracellular space. Additionally, we identify an allosteric pathway between the sodium-binding sites, the unwound portion of transmembrane helix 1 and the substrate-binding site that is essential in the coupling of co-transport.	[Watanabe, Akira; Chaptal, Vincent; Wright, Ernest M.; Abramson, Jeff] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Choe, Seungho; Rosenberg, John M.; Grabe, Michael] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Rosenberg, John M.; Grabe, Michael] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA	University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Abramson, J (corresponding author), Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA.	mdgrabe@pitt.edu; jabramson@mednet.ucla.edu	Choe, Seungho/B-1877-2008	Choe, Seungho/0000-0003-2291-747X; chaptal, vincent/0000-0003-2603-0294	NIH [GM078844, RGY0069, DK19567]; Human Frontier Science Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078844] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Vondriska and K. Philipson as well as members of the Abramson, Wright and Grabe labs for useful discussions and for reading the manuscript. We would also like to thank S. Faham for contributions at the early stages of this work, S. Iwata for advance release of the Mhp1 coordinates (Protein Data Bank ID, 2X79), and R. Roskies for assistance with the computations. Simulations were carried out through a TeraGrid grant at the Pittsburgh Supercomputing Center and the Texas Advanced Computing Center. This work was supported by NIH grants GM078844 (J.A.), RGY0069 (J.A.) and DK19567 (E.M.W.), and a grant from the Human Frontier Science Program (J.A.). M.G. is an Alfred P. Sloan Research Fellow.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; DeLano W.L., 2002, PYMOL MOL VIEWER; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Isaji M, 2007, CURR OPIN INVEST DR, V8, P285; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Joosten RP, 2009, ACTA CRYSTALLOGR D, V65, P176, DOI 10.1107/S0907444908037591; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Lomize AL, 2006, PROTEIN SCI, V15, P1318, DOI 10.1110/ps.062126106; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Quick M, 2001, J BIOL CHEM, V276, P1728, DOI 10.1074/jbc.M005521200; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200; Turk E, 2006, BIOCHEMISTRY-US, V45, P1470, DOI 10.1021/bi052160z; Veenstra M, 2004, BIOCHEMISTRY-US, V43, P3620, DOI 10.1021/bi0357210; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	39	147	148	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					988	U162		10.1038/nature09580	http://dx.doi.org/10.1038/nature09580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21131949	Green Accepted			2022-12-28	WOS:000285344600052
J	Brooks, N				Brooks, Nicholas			Is coronary artery bypass grafting the treatment of choice for diabetic patients with multivessel disease? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERVENTION; RESTENOSIS; MELLITUS; OUTCOMES		[Brooks, Nicholas] Wythenshawe Hosp, Manchester M23 9LT, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Brooks, N (corresponding author), Wythenshawe Hosp, Manchester M23 9LT, England.	Nicholas.Brooks@uhsm.nhs.uk						Banning AP, 2010, J AM COLL CARDIOL, V55, P1067, DOI 10.1016/j.jacc.2009.09.057; Barsness GW, 1997, CIRCULATION, V96, P2551, DOI 10.1161/01.CIR.96.8.2551; Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Hong SJ, 2006, HEART, V92, P1119, DOI 10.1136/hrt.2005.075960; Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014; Lee MS, 2010, AM J CARDIOL, V105, P1540, DOI 10.1016/j.amjcard.2010.01.009; Mathew V, 2004, CIRCULATION, V109, P476, DOI 10.1161/01.CIR.0000109693.64957.20; TIKALINOS TA, 2009, LANCET, V373, P911	11	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2010	341								c6961	10.1136/bmj.c6961	http://dx.doi.org/10.1136/bmj.c6961			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XA	21149466				2022-12-28	WOS:000285551900007
J	Ferrara, F				Ferrara, Felicetto			Treatment of older patients with acute myeloid leukaemia	LANCET			English	Editorial Material							ACUTE MYELOGENOUS LEUKEMIA; ADULTS; DIAGNOSIS; DECISION; SURVIVAL; AML; AGE		[Ferrara, Felicetto] Cardarelli Hosp, Div Haematol, I-80128 Naples, Italy; [Ferrara, Felicetto] Cardarelli Hosp, Stem Cell Transplantat Unit, I-80128 Naples, Italy	Antonio Cardarelli Hospital; Antonio Cardarelli Hospital	Ferrara, F (corresponding author), Cardarelli Hosp, Div Haematol, I-80128 Naples, Italy.	felicettoferrara@katamail.com						Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Estey E, 2009, BEST PRACT RES CL HA, V22, P529, DOI 10.1016/j.beha.2009.08.007; Ferrara F, 2004, LANCET ONCOL, V5, P443, DOI 10.1016/S1470-2045(04)01512-8; Ferrara F, 2008, CRIT REV ONCOL HEMAT, V66, P181, DOI 10.1016/j.critrevonc.2007.09.008; Juliusson G, 2009, BLOOD, V113, P4179, DOI 10.1182/blood-2008-07-172007; Kantarjian H, 2010, BLOOD, V116, P4422, DOI 10.1182/blood-2010-03-276485; Klepin HD, 2009, ONCOLOGIST, V14, P222, DOI 10.1634/theoncologist.2008-0224; Krug U, 2010, LANCET, V376, P2000, DOI 10.1016/S0140-6736(10)62105-8; Sekeres MA, 2004, LEUKEMIA, V18, P809, DOI 10.1038/sj.leu.2403289; Sekeres MA, 2009, BLOOD, V113, P28, DOI 10.1182/blood-2008-05-157065; Shipley JL, 2009, EXP HEMATOL, V37, P649, DOI 10.1016/j.exphem.2009.04.002; Wheatley K, 2009, BRIT J HAEMATOL, V145, P598, DOI 10.1111/j.1365-2141.2009.07663.x	12	9	10	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 11	2010	376	9757					1967	1968		10.1016/S0140-6736(10)62104-6	http://dx.doi.org/10.1016/S0140-6736(10)62104-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701GZ	21131041				2022-12-28	WOS:000285807700006
J	Dodds, PN				Dodds, Peter N.			Genome Evolution in Plant Pathogens	SCIENCE			English	Editorial Material							CELLS; TRANSLOCATION; EFFECTORS; DELIVERY; PROTEINS; ENTRY		CSIRO, Div Plant Ind, Canberra, ACT 2614, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Dodds, PN (corresponding author), CSIRO, Div Plant Ind, Canberra, ACT 2614, Australia.	peter.dodds@csiro.au	Biology, Transformational/D-5787-2011; Dodds, Peter/D-1181-2009	Dodds, Peter/0000-0003-0620-5923	NIGMS NIH HHS [R01 GM074265-01A2] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074265] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Khang CH, 2010, PLANT CELL, V22, P1388, DOI 10.1105/tpc.109.069666; Panstruga R, 2009, SCIENCE, V324, P748, DOI 10.1126/science.1171652; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; Schirawski J, 2010, SCIENCE, V330, P1546, DOI 10.1126/science.1195330; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Voegele RT, 2003, NEW PHYTOL, V159, P93, DOI 10.1046/j.1469-8137.2003.00761.x; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203	13	24	26	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1486	1487		10.1126/science.1200245	http://dx.doi.org/10.1126/science.1200245			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148378	Green Accepted			2022-12-28	WOS:000285153500047
J	Shaw, Q				Shaw, Quentin			Christmas 2010: Primary Care Reflections of Father Christmas's GP	BRITISH MEDICAL JOURNAL			English	Editorial Material									Stirchley Med Ctr, Telford TF3 1FB, Shrops, England		Shaw, Q (corresponding author), Stirchley Med Ctr, Telford TF3 1FB, Shrops, England.	quentin.shaw@nhs.net						*GEN MED COUNC, CONF RESP CRIT PRESS; Grills NJ, 2009, BMJ, V339; Pine KJ, 2007, J DEV BEHAV PEDIATR, V28, P456, DOI 10.1097/DBP.0b013e31815eddff; Trinkaus J, 2008, PSYCHOL REP, V103, P691, DOI 10.2466/PR0.103.3.691-694; WorkSafe Victoria, 2020, WORK RELATED VIOLENC	5	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 10	2010	341								c6782	10.1136/bmj.c6782	http://dx.doi.org/10.1136/bmj.c6782			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	695AE	21148618				2022-12-28	WOS:000285342200005
J	Brenner, H; Tao, S; Haug, U				Brenner, Hermann; Tao, Sha; Haug, Ulrike			Low-Dose Aspirin Use and Performance of Immunochemical Fecal Occult Blood Tests	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COLORECTAL ADENOMA DETECTION; CARDIOVASCULAR-DISEASE; OUTPATIENT COLONOSCOPY; AMERICAN-COLLEGE; TASK-FORCE; CANCER; RISK; POPULATION; PREVENTION	Context Immunochemical fecal occult blood tests (iFOBTs) are potentially promising tools for colorectal cancer screening. Low-dose aspirin use, which increases the likelihood of gastrointestinal bleeding, is common in the target population for colorectal cancer screening. Objective To assess the association of low-dose aspirin use with the performance of 2 quantitative iFOBTs in a large sample of patients undergoing colorectal cancer screening. Design, Setting, and Participants Diagnostic study conducted from 2005 through 2009 at internal medicine and gastroenterology practices in southern Germany including 1979 patients (mean age, 62.1 years): 233 regular users of low-dose aspirin (167 men, 67 women) and 1746 who never used low-dose aspirin (809 men, 937 women). Main Outcome Measures Sensitivity, specificity, positive and negative predictive values, and area under receiver operating characteristic (ROC) curves in detecting advanced colorectal neoplasms (colorectal cancer or advanced adenoma) with 2 quantitative iFOBTs. Results Advanced neoplasms were found in 24 users (10.3%) and 181 nonusers (10.4%) of low-dose aspirin. At the cut point recommended by the manufacturer, sensitivities of the 2 tests were 70.8% (95% confidence interval [CI], 48.9%-87.4%) for users compared with 35.9% (95% CI, 28.9%-43.4%) for nonusers and 58.3% (95% CI, 36.6%-77.9%) for users compared with 32.0% (95% CI, 25.3%-39.4%) for nonusers (P=.001 and P=.01, respectively). Specificities were 85.7% (95% CI, 80.2%-90.1%) for users compared with 89.2% (95% CI, 87.6%-90.7%) for nonusers and 85.7% (95% CI, 80.2%-90.1%) for users compared with 91.1% (95% CI, 89.5%-92.4%) for nonusers (P=.13 and P=.01, respectively). The areas under the ROC curve were 0.79 (95% CI, 0.68-0.90) for users compared with 0.67 (95% CI, 0.62-0.71) for nonusers and 0.73 (95% CI, 0.62-0.85) for users compared with 0.65 (95% CI, 0.61-0.69) for nonusers (P=.05 and P=.17, respectively). Among men, who composed the majority of low-dose aspirin users, the areas under the ROC curve were 0.87 (95% CI, 0.76-0.98) for users compared with 0.68 (95% CI, 0.63-0.74) for nonusers and 0.81 (95% CI, 0.68-0.93) for users compared with 0.67 (95% CI, 0.61-0.72) for nonusers (P=.003 and P=.04, respectively). Conclusion For 2 iFOBTs, use of low-dose aspirin compared with no aspirin was associated with a markedly higher sensitivity for detecting advanced colorectal neoplasms, with only a slightly lower specificity. JAMA. 2010;304(22):2513-2520 www.jama.com	[Brenner, Hermann; Tao, Sha; Haug, Ulrike] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Brenner, H (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	h.brenner@dkfz.de	Brenner, Hermann/B-4627-2017; Brenner, Hermann/ABE-6383-2020	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Haug, Ulrike/0000-0002-1886-2923	Eiken Chemical; German Research Foundation (Deutsche Forschungsgemeinschaft) [Graduiertenkolleg 793]; German Federal Ministry of Education and Research [O1ESO72]	Eiken Chemical; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Dr Brenner reported that the German Cancer Research Center received a grant from Eiken Chemical to evaluate an immunochemical fecal occult blood test (iFOBT) that was not included in this analysis. Dr Brenner also reported that a patent application was filed at the European Patent Office for the combination of low-dose aspirin use and iFOBTs in early detection of colorectal neoplasms. No other disclosures were reported.; This study was supported in part by the German Research Foundation (Deutsche Forschungsgemeinschaft) within the framework of a PhD program (Graduiertenkolleg 793) and by a grant from the German Federal Ministry of Education and Research (No. O1ESO72). The test kits were provided free of charge by the manufacturer.	Berger JS, 2008, AM J MED, V121, P43, DOI 10.1016/j.amjmed.2007.10.002; Brenner H, 2007, GUT, V56, P1585, DOI 10.1136/gut.2007.122739; Brenner H, 2010, AM J GASTROENTEROL, V105, P2457, DOI 10.1038/ajg.2010.301; Brenner H, 2010, INT J CANCER, V127, P1643, DOI 10.1002/ijc.25154; Campbell CL, 2007, JAMA-J AM MED ASSOC, V297, P2018, DOI 10.1001/jama.297.18.2018; Ell C, 2007, Z Gastroenterol, V45, P1191, DOI 10.1055/s-2007-963632; FLEMING JL, 1987, MAYO CLIN PROC, V62, P159, DOI 10.1016/S0025-6196(12)62437-9; Greenberg PD, 1996, AM J MED, V100, P598, DOI 10.1016/S0002-9343(96)00009-5; Haug U, 2010, AM J GASTROENTEROL, V105, P682, DOI 10.1038/ajg.2009.668; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Hundt S, 2009, ANN INTERN MED, V150, P162, DOI 10.7326/0003-4819-150-3-200902030-00005; Kahi CJ, 2004, AM J MED, V117, P837, DOI 10.1016/j.amjmed.2004.05.028; LANAS A, 1992, GASTROENTEROLOGY, V103, P862, DOI 10.1016/0016-5085(92)90018-T; Levi Z, 2009, AM J GASTROENTEROL, V104, P933, DOI 10.1038/ajg.2009.14; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Levin TR, 2009, AM J GASTROENTEROL, V104, P939, DOI 10.1038/ajg.2009.18; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; McCarthy DM, 2010, DIGEST DIS SCI, V55, P1503, DOI 10.1007/s10620-010-1247-9; Nakama H, 1998, HEPATO-GASTROENTEROL, V45, P752; Rabeneck L, 2008, GASTROENTEROLOGY, V135, P1899, DOI 10.1053/j.gastro.2008.08.058; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Sawhney MS, 2010, DIGEST DIS SCI, V55, P1637, DOI 10.1007/s10620-010-1150-4; Stock C, 2010, ENDOSCOPY, V42, P546, DOI 10.1055/s-0029-1244127; Strul H, 2006, AM J GASTROENTEROL, V101, P255, DOI 10.1111/j.1572-0241.2006.00430.x; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Wolff T, 2009, ANN INTERN MED, V150, P405, DOI 10.7326/0003-4819-150-6-200903170-00009; RIDASCREEN HAEMOGLOB	28	103	104	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2010	304	22					2513	2520		10.1001/jama.2010.1773	http://dx.doi.org/10.1001/jama.2010.1773			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691AS	21139112				2022-12-28	WOS:000285053300025
J	Bandyopadhyay, S; Mehta, M; Kuo, D; Sung, MK; Chuang, R; Jaehnig, EJ; Bodenmiller, B; Licon, K; Copeland, W; Shales, M; Fiedler, D; Dutkowski, J; Guenole, A; van Attikum, H; Shokat, KM; Kolodner, RD; Huh, WK; Aebersold, R; Keogh, MC; Krogan, NJ; Ideker, T				Bandyopadhyay, Sourav; Mehta, Monika; Kuo, Dwight; Sung, Min-Kyung; Chuang, Ryan; Jaehnig, Eric J.; Bodenmiller, Bernd; Licon, Katherine; Copeland, Wilbert; Shales, Michael; Fiedler, Dorothea; Dutkowski, Janusz; Guenole, Aude; van Attikum, Haico; Shokat, Kevan M.; Kolodner, Richard D.; Huh, Won-Ki; Aebersold, Ruedi; Keogh, Michael-Christopher; Krogan, Nevan J.; Ideker, Trey			Rewiring of Genetic Networks in Response to DNA Damage	SCIENCE			English	Article							H2A VARIANT HTZ1; SACCHAROMYCES-CEREVISIAE; YEAST; PATHWAYS; FAMILY; MAPS; CELL	Although cellular behaviors are dynamic, the networks that govern these behaviors have been mapped primarily as static snapshots. Using an approach called differential epistasis mapping, we have discovered widespread changes in genetic interaction among yeast kinases, phosphatases, and transcription factors as the cell responds to DNA damage. Differential interactions uncover many gene functions that go undetected in static conditions. They are very effective at identifying DNA repair pathways, highlighting new damage-dependent roles for the Slt2 kinase, Pph3 phosphatase, and histone variant Htz1. The data also reveal that protein complexes are generally stable in response to perturbation, but the functional relations between these complexes are substantially reorganized. Differential networks chart a new type of genetic landscape that is invaluable for mapping cellular responses to stimuli.	[Mehta, Monika; Keogh, Michael-Christopher] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Bandyopadhyay, Sourav; Licon, Katherine; Dutkowski, Janusz; Kolodner, Richard D.; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kuo, Dwight; Chuang, Ryan; Copeland, Wilbert; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Sung, Min-Kyung; Huh, Won-Ki] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Sung, Min-Kyung; Huh, Won-Ki] Seoul Natl Univ, Inst Microbiol, Res Ctr Funct Cellul, Seoul 151742, South Korea; [Jaehnig, Eric J.; Kolodner, Richard D.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Jaehnig, Eric J.; Kolodner, Richard D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Bodenmiller, Bernd; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Shales, Michael; Fiedler, Dorothea; Shokat, Kevan M.; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Fiedler, Dorothea; Shokat, Kevan M.] Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Guenole, Aude; van Attikum, Haico] Leiden Univ, Med Ctr, Dept Toxicogenet, Leiden, Netherlands; [Kolodner, Richard D.; Ideker, Trey] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Diego; University of California System; University of California San Diego; Seoul National University (SNU); Seoul National University (SNU); Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California San Diego	Keogh, MC (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA.	michael.keogh@einstein.yu.edu; krogan@cmp.ucsf.edu; tideker@ucsd.edu	van Attikum, Haico/A-4596-2010; jaehnig, eric/CCF-3596-2022; Califano, Andrea/F-7239-2012; Huh, Won-Ki/AAQ-6767-2021	Van Attikum, Haico/0000-0001-8590-0240; Ideker, Trey/0000-0002-1708-8454; Jaehnig, Eric/0000-0001-9618-6011; Mehta, Monika/0000-0003-3928-3733	NIH [R01-ES14811, R01-GM084279]; 21C Frontier Functional Proteomics Project [FPR08A1-060]; SystemsX.ch; Swiss National Science Foundation; NCI [P30CA013330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026017, R01GM026017, R01GM084448, R01GM084279, P50GM081879] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 21C Frontier Functional Proteomics Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); SystemsX.ch; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank S. Collins, H. Hombauer, A. Desai, S. Gasser, X. Shen, and S. Choi for helpful discussions and strains. This work was funded by NIH grants R01-ES14811 and R01-GM084279. Additionally, W-K. H. and M-K. S. were funded by the 21C Frontier Functional Proteomics Project (FPR08A1-060), R. A. and B. B. were supported by SystemsX.ch and the Swiss National Science Foundation, and M-C. K. was supported by the NCI (P30CA013330). N.J.K. is a Keck Young Investigator Fellow and a Searle Fellow. T.I. is a David and Lucille Packard Fellow. R. D. K. is a paid consultant to On-Q-ity.	Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065; Begley TJ, 2002, MOL CANCER RES, V1, P103; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; CAI MJ, 1990, CELL, V61, P437, DOI 10.1016/0092-8674(90)90525-J; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0027-5107(74)90176-6; Heideker J, 2007, CELL CYCLE, V6, P3058, DOI 10.4161/cc.6.24.5100; Jaimovich A, 2010, BIOINFORMATICS, V26, pi228, DOI 10.1093/bioinformatics/btq197; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948	22	334	337	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1385	1389		10.1126/science.1195618	http://dx.doi.org/10.1126/science.1195618			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127252	Green Accepted			2022-12-28	WOS:000284902100044
J	Rabinowitz, JD; White, E				Rabinowitz, Joshua D.; White, Eileen			Autophagy and Metabolism	SCIENCE			English	Review							BETA-CELL MASS; INSULIN-RESISTANCE; KEY ROLE; MICE; STARVATION; DEGRADATION; DEFICIENT; PROMOTES; PROTEIN; P62	Autophagy is a process of self-cannibalization. Cells capture their own cytoplasm and organelles and consume them in lysosomes. The resulting breakdown products are inputs to cellular metabolism, through which they are used to generate energy and to build new proteins and membranes. Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however-cancer cells exploit it to survive in nutrient-poor tumors.	[Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Carl Icahn Lab 241, Princeton, NJ 08544 USA; [Rabinowitz, Joshua D.; White, Eileen] Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [White, Eileen] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [White, Eileen] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA	Princeton University; Princeton University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Rabinowitz, JD (corresponding author), Princeton Univ, Dept Chem, Washington Rd, Princeton, NJ 08544 USA.	joshr@genomics.princeton.edu; whiteei@umdnj.edu	Rabinowitz, Joshua/GPP-4019-2022; White, Eileen/ABD-6745-2021	Rabinowitz, Joshua/0000-0002-1247-4727; White, Eileen/0000-0003-2961-3065	NATIONAL CANCER INSTITUTE [R01CA130893, R37CA053370, RC1CA147961] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA053370-19, RC1 CA147961, RC1 CA147961-02, R01 CA130893, R01 CA130893-03, R37 CA053370] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kanamori H, 2009, AM J PATHOL, V174, P1705, DOI 10.2353/ajpath.2009.080875; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuma A, 2010, SEMIN CELL DEV BIOL, V21, P683, DOI 10.1016/j.semcdb.2010.03.002; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Oku M, 2010, FEBS J, V277, P3289, DOI 10.1111/j.1742-4658.2010.07741.x; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	37	1400	1498	9	313	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1344	1348		10.1126/science.1193497	http://dx.doi.org/10.1126/science.1193497			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127245	Green Accepted			2022-12-28	WOS:000284902100034
J	Lagergren, J; Lagergren, P				Lagergren, Jesper; Lagergren, Pernilla			Oesophageal cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HELICOBACTER-PYLORI INFECTION; BARRETTS-ESOPHAGUS; SURGICAL-TREATMENT; UNITED-STATES; ADENOCARCINOMA; SURGERY; SURVIVAL; CHEMORADIOTHERAPY; CHEMOTHERAPY; MANAGEMENT		[Lagergren, Jesper; Lagergren, Pernilla] Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointest Res, SE-17176 Stockholm, Sweden; [Lagergren, Jesper] Kings Coll London, Div Canc Studies, London, England	Karolinska Institutet; University of London; King's College London	Lagergren, J (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointest Res, SE-17176 Stockholm, Sweden.	jesper.lagergren@ki.se		Lagergren, Pernilla/0000-0002-4634-0233; Lagergren, Jesper/0000-0002-5143-5448	Swedish Research Council; Swedish Cancer Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	JL and PL are funded by the Swedish Research Council and the Swedish Cancer Society.	Abnet CC, 2009, BRIT J CANCER, V100, P551, DOI 10.1038/sj.bjc.6604880; Anderson LA, 2008, GUT, V57, P734, DOI 10.1136/gut.2007.132662; Bollschweiler E, 2001, CANCER, V92, P549, DOI 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L; Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; Djarv T, 2008, BRIT J SURG, V95, P1121, DOI 10.1002/bjs.6293; Galvani CA, 2008, SURG ENDOSC, V22, P188, DOI 10.1007/s00464-007-9441-3; Gebski V, 2007, LANCET ONCOL, V8, P226, DOI 10.1016/S1470-2045(07)70039-6; Gemmill EH, 2007, BRIT J SURG, V94, P1461, DOI 10.1002/bjs.6015; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Heath EI, 2007, J NATL CANCER I, V99, P545, DOI 10.1093/jnci/djk112; Jankowski J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4551; Kadri SR, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4372; Kelly S, 2001, GUT, V49, P534, DOI 10.1136/gut.49.4.534; Lagarde SM, 2010, ANN THORAC SURG, V89, P1319, DOI 10.1016/j.athoracsur.2009.09.062; Lagergren J, 2000, JAMA-J AM MED ASSOC, V284, P961, DOI 10.1001/jama.284.8.961; Lagergren J, 2010, GASTROENTEROLOGY, V138, P1297, DOI 10.1053/j.gastro.2010.01.004; Lordick F, 2007, LANCET ONCOL, V8, P797, DOI 10.1016/S1470-2045(07)70244-9; McElholm AR, 2010, GASTROENTEROLOGY, V139, P204, DOI 10.1053/j.gastro.2010.04.014; McNair AGK, 2008, EUR J CANCER, V44, P2623, DOI 10.1016/j.ejca.2008.08.009; Meyers BF, 2007, J THORAC CARDIOV SUR, V133, P738, DOI 10.1016/j.jtcvs.2006.09.079; Morgan MA, 2009, BRIT J SURG, V96, P1300, DOI 10.1002/bjs.6705; *MRC OES CANC WORK, 2002, SCIENCE, V359, P1727; Nguyen DM, 2009, CLIN GASTROENTEROL H, V7, P1299, DOI 10.1016/j.cgh.2009.06.001; Prasad GA, 2009, GASTROENTEROLOGY, V137, P815, DOI 10.1053/j.gastro.2009.05.059; Pring C, 2010, SURG ENDOSC, V24, P1195, DOI 10.1007/s00464-009-0736-4; Rees JR, 2010, COCHRANE DB SYST REV, V1; Rittegard M, 2009, ANN SURG, V249, P256, DOI 10.1097/SLA.0b013e318194d1a5; Rokkas T, 2007, CLIN GASTROENTEROL H, V5, P1413, DOI 10.1016/j.cgh.2007.08.010; Rouvelas I, 2005, LANCET ONCOL, V6, P864, DOI 10.1016/S1470-2045(05)70347-8; Rubenstein JH, 2008, GASTROINTEST ENDOSC, V68, P849, DOI 10.1016/j.gie.2008.02.062; Shaheen NJ, 2009, NEW ENGL J MED, V360, P2277, DOI 10.1056/NEJMoa0808145; Sreedharan A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005048.pub2; Stephens MR, 2006, DIS ESOPHAGUS, V19, P164, DOI 10.1111/j.1442-2050.2006.00559.x; Stitzenberg KB, 2009, J CLIN ONCOL, V27, P4671, DOI 10.1200/JCO.2008.20.1715; Sundelof M, 2002, INT J CANCER, V99, P751, DOI 10.1002/ijc.10420; Verschuur EML, 2009, BRIT J CANCER, V100, P70, DOI 10.1038/sj.bjc.6604811; Zhai RH, 2010, J CLIN ONCOL, V28, P2445, DOI 10.1200/JCO.2009.26.2790	37	80	83	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2010	341								c6280	10.1136/bmj.c6280	http://dx.doi.org/10.1136/bmj.c6280			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EH	21112905				2022-12-28	WOS:000284832100009
J	Smith, FA; Boyer, AG; Brown, JH; Costa, DP; Dayan, T; Ernest, SKM; Evans, AR; Fortelius, M; Gittleman, JL; Hamilton, MJ; Harding, LE; Lintulaakso, K; Lyons, SK; McCain, C; Okie, JG; Saarinen, JJ; Sibly, RM; Stephens, PR; Theodor, J; Uhen, MD				Smith, Felisa A.; Boyer, Alison G.; Brown, James H.; Costa, Daniel P.; Dayan, Tamar; Ernest, S. K. Morgan; Evans, Alistair R.; Fortelius, Mikael; Gittleman, John L.; Hamilton, Marcus J.; Harding, Larisa E.; Lintulaakso, Kari; Lyons, S. Kathleen; McCain, Christy; Okie, Jordan G.; Saarinen, Juha J.; Sibly, Richard M.; Stephens, Patrick R.; Theodor, Jessica; Uhen, Mark D.			The Evolution of Maximum Body Size of Terrestrial Mammals	SCIENCE			English	Article							DIVERSIFICATION; VEGETATION; DINOSAURS; DYNAMICS	The extinction of dinosaurs at the Cretaceous/Paleogene (K/Pg) boundary was the seminal event that opened the door for the subsequent diversification of terrestrial mammals. Our compilation of maximum body size at the ordinal level by sub-epoch shows a near-exponential increase after the K/Pg. On each continent, the maximum size of mammals leveled off after 40 million years ago and thereafter remained approximately constant. There was remarkable congruence in the rate, trajectory, and upper limit across continents, orders, and trophic guilds, despite differences in geological and climatic history, turnover of lineages, and ecological variation. Our analysis suggests that although the primary driver for the evolution of giant mammals was diversification to fill ecological niches, environmental temperature and land area may have ultimately constrained the maximum size achieved.	[Smith, Felisa A.; Brown, James H.; Hamilton, Marcus J.; Okie, Jordan G.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Boyer, Alison G.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Costa, Daniel P.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Dayan, Tamar] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Ernest, S. K. Morgan] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Ernest, S. K. Morgan] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Evans, Alistair R.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Fortelius, Mikael; Lintulaakso, Kari; Saarinen, Juha J.] Univ Helsinki, Dept Geosci & Geog, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Gittleman, John L.; Stephens, Patrick R.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Harding, Larisa E.] Umea Univ, Dept Ecol & Environm Sci, SE-90187 Umea, Sweden; [Lyons, S. Kathleen] MRC 121, Smithsonian Inst, Washington, DC 20013 USA; [McCain, Christy] Univ Colorado, CU Nat Hist Museum, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Sibly, Richard M.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Theodor, Jessica] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Uhen, Mark D.] George Mason Univ, Dept Atmospher Ocean & Earth Sci, Fairfax, VA 22030 USA	University of New Mexico; Yale University; University of California System; University of California Santa Cruz; Tel Aviv University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Monash University; University of Helsinki; University System of Georgia; University of Georgia; Umea University; Smithsonian Institution; University of Colorado System; University of Colorado Boulder; University of Reading; University of Calgary; George Mason University	Smith, FA (corresponding author), Univ New Mexico, Dept Biol, MSC03 2020, Albuquerque, NM 87131 USA.	fasmith@unm.edu	Opazo, Luis-Felipe/G-9586-2011; Smith, Felisa/ABE-6160-2021; Uhen, Mark D/AAZ-3158-2020; Ernest, S.K. Morgan/O-2532-2015; Evans, Alistair R/D-4239-2011; Ernest, Morgan/A-4355-2008; Lintulaakso, Kari/N-7775-2013; Costa, Daniel/E-2616-2013	Smith, Felisa/0000-0001-6262-436X; Uhen, Mark D/0000-0002-2689-0801; Ernest, S.K. Morgan/0000-0002-6026-8530; Evans, Alistair R/0000-0002-4078-4693; Ernest, Morgan/0000-0002-6026-8530; Lyons, S. Kathleen/0000-0001-5112-2508; Sibly, Richard/0000-0001-6828-3543; Theodor, Jessica/0000-0002-5159-7041; Fortelius, Mikael/0000-0002-4851-783X; Lintulaakso, Kari/0000-0001-9627-8821; Costa, Daniel/0000-0002-0233-5782	Integrating Macroecological Pattern and Process across Scales (IMPPS) NSF Research Coordination Network (NSF) [DEB-0541625]	Integrating Macroecological Pattern and Process across Scales (IMPPS) NSF Research Coordination Network (NSF)(National Science Foundation (NSF))	This project was supported by the Integrating Macroecological Pattern and Process across Scales (IMPPS) NSF Research Coordination Network (NSF grant DEB-0541625 to F. A. S., S. K. M. E., and S. K. L.). This is IMPPS publication no. 11.	Alexander RM, 1998, PALAEONTOLOGY, V41, P1231; Alroy J, 1999, SYST BIOL, V48, P107, DOI 10.1080/106351599260472; Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; Clauss M, 2003, OECOLOGIA, V136, P14, DOI 10.1007/s00442-003-1254-z; Crompton A. W., 1980, COMP PHYSL PRIMITIVE, P1; GOULD SJ, 1988, J PALEONTOL, V62, P319, DOI 10.1017/S0022336000059126; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; GUNNELL GF, 1995, PALAEOGEOGR PALAEOCL, V115, P265, DOI 10.1016/0031-0182(94)00115-O; GUNNELL GF, 1998, EVOLUTION TERTIARY M, V1, P91; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; JANIS CM, 1993, ANNU REV ECOL SYST, V24, P467, DOI 10.1146/annurev.es.24.110193.002343; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Marquet PA, 1998, EVOL ECOL, V12, P127, DOI 10.1023/A:1006567227154; MCSHEA DW, 1994, EVOLUTION, V48, P1747, DOI 10.1111/j.1558-5646.1994.tb02211.x; Payne JL, 2009, P NATL ACAD SCI USA, V106, P24, DOI 10.1073/pnas.0806314106; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Rensch B., 1959, EVOLUTION SPECIES LE; Retallack GJ, 2001, J GEOL, V109, P407, DOI 10.1086/320791; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Tappan H., 1974, TOPICS MOL OXYGEN RE, P81; Trammer J, 2005, EVOLUTION, V59, P941; Trites AW, 1998, CAN J ZOOL, V76, P886, DOI 10.1139/cjz-76-5-886; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; WOLFE JA, 1986, NATURE, V324, P148, DOI 10.1038/324148a0; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	29	188	190	3	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1216	1219		10.1126/science.1194830	http://dx.doi.org/10.1126/science.1194830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109666				2022-12-28	WOS:000284613700034
J	Landrigan, CP; Parry, GJ; Bones, CB; Hackbarth, AD; Goldmann, DA; Sharek, PJ				Landrigan, Christopher P.; Parry, Gareth J.; Bones, Catherine B.; Hackbarth, Andrew D.; Goldmann, Donald A.; Sharek, Paul J.			Temporal Trends in Rates of Patient Harm Resulting from Medical Care.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHYSICIAN ORDER ENTRY; ADVERSE DRUG EVENTS; HOSPITALIZED-PATIENTS; WORK HOURS; SAFETY; INTERVENTION; ERRORS; SYSTEM	Background: In the 10 years since publication of the Institute of Medicine's report To Err Is Human, extensive efforts have been undertaken to improve patient safety. The success of these efforts remains unclear. Methods: We conducted a retrospective study of a stratified random sample of 10 hospitals in North Carolina. A total of 100 admissions per quarter from January 2002 through December 2007 were reviewed in random order by teams of nurse reviewers both within the hospitals (internal reviewers) and outside the hospitals (external reviewers) with the use of the Institute for Healthcare Improvement's Global Trigger Tool for Measuring Adverse Events. Suspected harms that were identified on initial review were evaluated by two independent physician reviewers. We evaluated changes in the rates of harm, using a random-effects Poisson regression model with adjustment for hospital-level clustering, demographic characteristics of patients, hospital service, and high-risk conditions. Results: Among 2341 admissions, internal reviewers identified 588 harms (25.1 harms per 100 admissions; 95% confidence interval [CI], 21.4 to 24.9). Multivariate analyses of harms identified by internal reviewers showed no significant changes in the overall rate of harms per 1000 patient-days (reduction factor, 0.99 per year; 95% CI, 0.94 to 1.04; P=0.61) or the rate of preventable harms. There was a reduction in preventable harms identified by external reviewers that did not reach statistical significance (reduction factor, 0.92; 95% CI, 0.85 to 1.00; P=0.06), with no significant change in the overall rate of harms (reduction factor, 0.98; 95% CI, 0.93 to 1.04; P=0.47). Conclusions: In a study of 10 North Carolina hospitals, we found that harms remain common, with little evidence of widespread improvement. Further efforts are needed to translate effective safety interventions into routine practice and to monitor health care safety over time. (Funded by the Rx Foundation.) N Engl J Med 2010;363:2124-34.	[Landrigan, Christopher P.] Brigham & Womens Hosp, Dept Med, Div Sleep Med, Boston, MA 02115 USA; [Landrigan, Christopher P.] Harvard Univ, Sch Med, Boston, MA USA; [Landrigan, Christopher P.; Parry, Gareth J.] Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA 02115 USA; [Goldmann, Donald A.] Childrens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Parry, Gareth J.; Bones, Catherine B.; Hackbarth, Andrew D.; Goldmann, Donald A.] Inst Healthcare Improvement, Cambridge, MA USA; [Hackbarth, Andrew D.] Pardee RAND Grad Sch, Santa Monica, CA USA; [Sharek, Paul J.] Lucile Packard Childrens Hosp, Dept Pediat, Div Gen Pediat, Stanford, CA USA; [Sharek, Paul J.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Institute for Healthcare Improvement; RAND Corporation; Pardee RAND Graduate School; Lucile Packard Children's Hospital (LPCH); Stanford University	Landrigan, CP (corresponding author), Brigham & Womens Hosp, Dept Med, Div Sleep Med, 221 Longwood Ave, Boston, MA 02115 USA.	clandrigan@partners.org	Parry, Gareth/CAF-6975-2022	Landrigan, Christopher/0000-0001-8386-4100	Rx Foundation	Rx Foundation	Supported by a grant from the Rx Foundation.	Agency for Healthcare Research and Quality, MED ERR PAT SAF; [Anonymous], JOURN HIST JOINT COM; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Bates DW, 1999, J AM MED INFORM ASSN, V6, P313, DOI 10.1136/jamia.1999.00660313; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1013; Classen DC, 2008, J PATIENT SAF, V4, P169, DOI [DOI 10.1097/PTS.0B013E318183A475, 10.1097/pts.0b013e318183a475]; CULLEN DJ, 1995, JOINT COMM J QUAL IM, V21, P541, DOI 10.1016/S1070-3241(16)30180-8; Griffin FA, 2007, GLOBAL TRIGGER TOOL; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Institute for Healthcare Improvement, 2006, NETW WORKS 100000 LI; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Landrigan CP, 2006, JAMA-J AM MED ASSOC, V296, P1063, DOI 10.1001/jama.296.9.1063; Landrigan CP, 2005, PEDIATR CLIN N AM, V52, P979, DOI 10.1016/j.pcl.2005.05.001; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Longo DR, 2006, JAMA-J AM MED ASSOC, V295, P164; Longo DR, 2005, JAMA-J AM MED ASSOC, V294, P2858, DOI 10.1001/jama.294.22.2858; McCannon CJ, 2007, JT COMM J QUAL PATIE, V33, P477, DOI 10.1016/S1553-7250(07)33051-1; *NCC MERP, NCC MERP IND CAT MED; North Carolina Center for Hospital Quality and Patient Safety, AB US; Office of the Inspector General, 2010, OEI060800221 DEP HLT; Page A., 2004, KEEPING PATIENTS SAF; PJ Sharek, 2010, HLTH SERV RES   0816; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2007, NEW ENGL J MED, V356, P1268; Resar RK, 2003, QUAL SAF HEALTH CARE, V12, pII39, DOI 10.1136/qhc.12.suppl_2.ii39; Rogers AE, 2004, HEALTH AFFAIR, V23, P202, DOI 10.1377/hlthaff.23.4.202; Sari ABA, 2007, BMJ-BRIT MED J, V334, P79, DOI 10.1136/bmj.39031.507153.AE; Sharek PJ, 2008, PEDIATRICS, V122, pE861, DOI 10.1542/peds.2008-1011; Sharek PJ, 2006, PEDIATRICS, V118, P1332, DOI 10.1542/peds.2006-0565; Shojania KG, 2002, JAMA-J AM MED ASSOC, V288, P508, DOI 10.1001/jama.288.4.508; Thomas EJ, 2000, INT J QUAL HEALTH C, V12, P371, DOI 10.1093/intqhc/12.5.371; Ulmer C, 2009, RESIDENT DUTY HOURS: ENHANCING SLEEP, SUPERVISION, AND SAFETY, P1; Vincent C, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2426	39	724	746	1	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2010	363	22					2124	2134		10.1056/NEJMsa1004404	http://dx.doi.org/10.1056/NEJMsa1004404			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	684XE	21105794				2022-12-28	WOS:000284587800007
J	Pasternak, B; Hviid, A				Pasternak, Bjorn; Hviid, Anders			Use of Proton-Pump Inhibitors in Early Pregnancy and the Risk of Birth Defects.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEROTONIN-REUPTAKE INHIBITORS; SAFETY; REGISTRATION; OMEPRAZOLE; MALFORMATIONS; REGISTER; COHORT	Background: Symptoms of gastroesophageal reflux are common in pregnancy, but there are limited data on the risk of birth defects associated with exposure to proton-pump inhibitors (PPIs) in early pregnancy. Methods: We conducted a cohort study to assess the association between exposure to PPIs during pregnancy and the risk of major birth defects among all infants born alive in Denmark between January 1996 and September 2008. We linked data from nationwide registries, including individual-level information on exposure to PPIs (prescriptions), birth defects, and potential confounders. Major birth defects, diagnosed within the first year of life, were categorized according to the standardized classification scheme of the European surveillance of congenital anomalies (EUROCAT). Our primary analyses assessed the use of PPIs from 4 weeks before conception through 12 weeks of gestation and from 0 through 12 weeks of gestation (first trimester). Results: Among 840,968 live births, 5082 involved exposure to PPIs between 4 weeks before conception and the end of the first trimester of pregnancy. There were 174 major birth defects in infants whose mothers had been exposed to PPIs during this period (3.4%), as compared with 21,811 in the group whose mothers had not been exposed (2.6%) (adjusted prevalence odds ratio, 1.23; 95% confidence interval [CI], 1.05 to 1.44). In analyses limited to exposure during the first trimester, there were 118 major birth defects among 3651 infants exposed to PPIs (3.2%), and the adjusted prevalence odds ratio was 1.10 (95% CI, 0.91 to 1.34). The risk of birth defects was not significantly increased in secondary analyses of exposure to individual PPIs during the first trimester or in analyses limited to the offspring of women who had filled PPI prescriptions and received enough doses to have a theoretical chance of first-trimester exposure. Conclusions: In this large cohort, exposure to PPIs during the first trimester of pregnancy was not associated with a significantly increased risk of major birth defects. (Funded by the Danish Medical Research Council and the Lundbeck Foundation.) N Engl J Med 2010;363:2114-23.	[Pasternak, Bjorn; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Pasternak, B (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	bjp@ssi.dk	Hug, Balthasar L./G-1568-2010; Hviid, Anders/AAH-4319-2020; Pasternak, Bjorn/H-5739-2012	Hviid, Anders/0000-0002-7509-9127; Pasternak, Bjorn/0000-0002-2097-8466	Danish Medical Research Council; Lundbeck Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	Supported by the Danish Medical Research Council and the Lundbeck Foundation.	Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2008, PRIL; [Anonymous], 2002, DAT DANM STAT; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Dehlink E, 2009, CLIN EXP ALLERGY, V39, P246, DOI 10.1111/j.1365-2222.2008.03125.x; Diav-Citrin O, 2005, ALIMENT PHARM THER, V21, P269, DOI 10.1111/j.1365-2036.2005.02306.x; EKMAN L, 1985, SCAND J GASTROENTERO, V20, P53, DOI 10.3109/00365528509095819; Gill SK, 2009, AM J GASTROENTEROL, V104, P1541, DOI 10.1038/ajg.2009.122; Jepsen P, 2006, INT J RISK SAF MED, V18, P77; Jorgensen Finn Stener, 2003, Ugeskr Laeger, V165, P4409; Kahrilas PJ, 2008, NEW ENGL J MED, V359, P1700, DOI 10.1056/NEJMcp0804684; Kallen B, 1998, BRIT J OBSTET GYNAEC, V105, P877, DOI 10.1111/j.1471-0528.1998.tb10233.x; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; Lalkin A, 1998, AM J OBSTET GYNECOL, V179, P727, DOI 10.1016/S0002-9378(98)70072-9; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Matok I, 2009, ARCH DIS CHILD, V94, pe1; Matok I, 2009, NEW ENGL J MED, V360, P2528, DOI 10.1056/NEJMoa0807154; Mitchell AA, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P501; Nava-Ocampo AA, 2006, CAN FAM PHYSICIAN, V52, P853; Nielsen GL, 1999, ALIMENT PHARM THERAP, V13, P1085; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Pedersen CB, 2006, DAN MED BULL, V53, P441; Rey E, 2007, AM J GASTROENTEROL, V102, P2395, DOI 10.1111/j.1572-0241.2007.01452.x; Richter JE, 2005, ALIMENT PHARM THER, V22, P749, DOI 10.1111/j.1365-2036.2005.02654.x; Ruigomez A, 1999, AM J EPIDEMIOL, V150, P476	28	86	101	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2010	363	22					2114	2123		10.1056/NEJMoa1002689	http://dx.doi.org/10.1056/NEJMoa1002689			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684XE	21105793				2022-12-28	WOS:000284587800006
J	Demontis, F; Perrimon, N				Demontis, Fabio; Perrimon, Norbert			FOXO/4E-BP Signaling in Drosophila Muscles Regulates Organism-wide Proteostasis during Aging	CELL			English	Article							FOXO TRANSCRIPTION FACTORS; EXTENDS LIFE-SPAN; PROTEIN-DEGRADATION; AUTOPHAGY; ELEGANS; DISEASE; CELLS; BODY; ACTIVATION; PATHWAYS	The progressive loss of muscle strength during aging is a common degenerative event of unclear pathogenesis. Although muscle functional decline precedes age-related changes in other tissues, its contribution to systemic aging is unknown. Here, we show that muscle aging is characterized in Drosophila by the progressive accumulation of protein aggregates that associate with impaired muscle function. The transcription factor FOXO and its target 4E-BP remove damaged proteins at least in part via the autophagy/lysosome system, whereas foxo mutants have dysfunctional proteostasis. Both FOXO and 4E-BP delay muscle functional decay and extend life span. Moreover, FOXO/4E-BP signaling in muscles decreases feeding behavior and the release of insulin from producing cells, which in turn delays the age-related accumulation of protein aggregates in other tissues. These findings reveal an organism-wide regulation of proteostasis in response to muscle aging and a key role of FOXO/4E-BP signaling in the coordination of organismal and tissue aging.	[Demontis, Fabio; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Demontis, F (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	fdemontis@genetics.med.harvard.edu; perrimon@receptor.med.harvard.edu		Demontis, Fabio/0000-0002-8698-9555; Perrimon, Norbert/0000-0001-7542-472X	NIH [1P01CA120964-01A1]; Paul F. Glenn Labs for the Molecular Biology of Aging; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088718] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul F. Glenn Labs for the Molecular Biology of Aging; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Andreas Brech, Didier Contamine, Ernst Hafen, Pierre Leopold, Susan Lindquist, Ioannis Nezis, Amita Sehgal, Marc Tatar, Robert Tjian, John Tower, the DRSC/TRiP, and members of the Perrimon lab for fly stocks, reagents, and advice. We thank Maria Ericsson for assistance with electron microscopy, Christians Villalta for embryo injection, and Chris Bakal, Rami Rahal, and Jonathan Zirin for critically reading the manuscript. This work was supported by the NIH (1P01CA120964-01A1) and a Pilot Project Grant from the Paul F. Glenn Labs for the Molecular Biology of Aging. F.D. is an Ellison Medical Foundation/AFAR postdoctoral fellow. N.P. is an investigator of the Howard Hughes Medical Institute.	Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Augustin H, 2009, BBA-GEN SUBJECTS, V1790, P1084, DOI 10.1016/j.bbagen.2009.06.011; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Boyle PA, 2009, ARCH NEUROL-CHICAGO, V66, P1339, DOI 10.1001/archneurol.2009.240; Broughton SJ, 2010, AGING CELL, V9, P336, DOI 10.1111/j.1474-9726.2010.00558.x; Chen H, 2005, NEUROLOGY, V64, P664, DOI 10.1212/01.WNL.0000151960.28687.93; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Demontis F, 2009, DEVELOPMENT, V136, P983, DOI 10.1242/dev.027466; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Garigan D, 2002, GENETICS, V161, P1101; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; Grefte S, 2007, STEM CELLS DEV, V16, P857, DOI 10.1089/scd.2007.0058; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Nair KS, 2005, AM J CLIN NUTR, V81, P953; Needham M, 2008, NEUROMUSCULAR DISORD, V18, P6, DOI 10.1016/j.nmd.2007.11.001; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Plata-Salaman CR, 1998, NEWS PHYSIOL SCI, V13, P298; Rhodenizer D, 2008, EXP GERONTOL, V43, P739, DOI 10.1016/j.exger.2008.04.011; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Tower J, 2009, TRENDS ENDOCRIN MET, V20, P216, DOI 10.1016/j.tem.2008.12.005; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wessells RJ, 2004, NAT GENET, V36, P1275, DOI 10.1038/ng1476; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zheng A, 2005, P NATL ACAD SCI USA, V102, P12083, DOI 10.1073/pnas.0503374102; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	49	430	441	2	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					813	825		10.1016/j.cell.2010.10.007	http://dx.doi.org/10.1016/j.cell.2010.10.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111239	Green Accepted, Bronze			2022-12-28	WOS:000284583500022
J	Ikeda, F; Crosetto, N; Dikic, I				Ikeda, Fumiyo; Crosetto, Nicola; Dikic, Ivan			What Determines the Specificity and Outcomes of Ubiquitin Signaling?	CELL			English	Article							POLYUBIQUITIN CHAINS; STRUCTURAL BASIS; BINDING DOMAINS; RECOGNITION; PROTEASOME; DEGRADATION; ACTIVATION; PROTEINS; COMPLEX; LIGASE	Ubiquitin signals and ubiquitin-binding domains are implicated in almost every cellular process, but how is their functionality achieved in cells? We assess recent advances in monitoring the dynamics and specificity of ubiquitin networks in vivo and discuss challenges ahead.	[Ikeda, Fumiyo; Crosetto, Nicola; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, D-60590 Frankfurt, Germany; [Ikeda, Fumiyo; Crosetto, Nicola; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Main, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Dikic, I (corresponding author), Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	ivan.dikic@biochem2.de	Ikeda, Fumiyo/AAD-3770-2020; Dikic, Ivan/O-4650-2015	Ikeda, Fumiyo/0000-0003-0407-2768; Dikic, Ivan/0000-0001-8156-9511				Bianchi K, 2009, MOL CELL, V36, P736, DOI 10.1016/j.molcel.2009.11.029; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirkpatrick DS, 2005, PROTEOMICS, V5, P2104, DOI 10.1002/pmic.200401089; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Sato Y, 2009, EMBO J, V28, P3903, DOI 10.1038/emboj.2009.345; Shabek N, 2009, P NATL ACAD SCI USA, V106, P11907, DOI 10.1073/pnas.0905746106; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/NCHEMBIO.426, 10.1038/nchembio.426]; Wang HP, 2008, P NATL ACAD SCI USA, V105, P20197, DOI 10.1073/pnas.0810461105; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wickliffe K, 2009, CHEM REV, V109, P1537, DOI 10.1021/cr800414e; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010; Zhao SK, 2010, P NATL ACAD SCI USA, V107, P7704, DOI 10.1073/pnas.0908764107	42	125	131	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					677	681		10.1016/j.cell.2010.10.026	http://dx.doi.org/10.1016/j.cell.2010.10.026			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111228	Bronze			2022-12-28	WOS:000284583500009
J	Michel, JB; Shen, YK; Aiden, AP; Veres, A; Gray, MK; Pickett, JP; Hoiberg, D; Clancy, D; Norvig, P; Orwant, J; Pinker, S; Nowak, MA; Aiden, EL				Michel, Jean-Baptiste; Shen, Yuan Kui; Aiden, Aviva Presser; Veres, Adrian; Gray, Matthew K.; Pickett, Joseph P.; Hoiberg, Dale; Clancy, Dan; Norvig, Peter; Orwant, Jon; Pinker, Steven; Nowak, Martin A.; Aiden, Erez Lieberman		Google Books Team	Quantitative Analysis of Culture Using Millions of Digitized Books	SCIENCE			English	Article								We constructed a corpus of digitized texts containing about 4% of all books ever printed. Analysis of this corpus enables us to investigate cultural trends quantitatively. We survey the vast terrain of 'culturomics,' focusing on linguistic and cultural phenomena that were reflected in the English language between 1800 and 2000. We show how this approach can provide insights about fields as diverse as lexicography, the evolution of grammar, collective memory, the adoption of technology, the pursuit of fame, censorship, and historical epidemiology. Culturomics extends the boundaries of rigorous quantitative inquiry to a wide array of new phenomena spanning the social sciences and the humanities.	[Michel, Jean-Baptiste; Nowak, Martin A.; Aiden, Erez Lieberman] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Michel, Jean-Baptiste; Shen, Yuan Kui; Aiden, Aviva Presser; Veres, Adrian; Aiden, Erez Lieberman] Harvard Univ, Cultural Observ, Cambridge, MA 02138 USA; [Michel, Jean-Baptiste] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Michel, Jean-Baptiste] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Michel, Jean-Baptiste; Pinker, Steven] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Shen, Yuan Kui; Aiden, Aviva Presser; Veres, Adrian; Aiden, Erez Lieberman] Harvard Univ, Lab Large, Cambridge, MA 02138 USA; [Shen, Yuan Kui] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Veres, Adrian] Harvard Univ, Cambridge, MA 02138 USA; [Gray, Matthew K.; Clancy, Dan; Norvig, Peter; Orwant, Jon; Google Books Team] Google, Mountain View, CA 94043 USA; [Pickett, Joseph P.] Houghton Mifflin Harcourt, Boston, MA 02116 USA; [Hoiberg, Dale] Encyclopaedia Britannica, Chicago, IL 60654 USA; [Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Nowak, Martin A.; Aiden, Erez Lieberman] Harvard Univ, Dept Math, Cambridge, MA 02138 USA; [Aiden, Erez Lieberman] Harvard Univ, Broad Inst Harvard & MIT, Cambridge, MA 02138 USA; [Aiden, Erez Lieberman] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Aiden, Erez Lieberman] Harvard Univ, Harvard Soc Fellows, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Google Incorporated; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University	Michel, JB (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	jb.michel@gmail.com; erez@erez.com	Aiden, Erez Lieberman/A-2908-2010; Michel, Jean-Baptiste/AAH-9336-2020; Norvig, Peter/ABF-7770-2021; Pinker, Steven/GPX-7942-2022; Nowak, Martin A/A-6977-2008	Veres, Adrian/0000-0002-3849-3475	Foundational Questions in Evolutionary Biology Prize Fellowship; Harvard Medical School; NIH [HD 18381, R01GM078986]; Harvard Society of Fellows; Fannie and John Hertz Foundation; National Defense Science and Engineering Graduate Fellowship; NSF; National Space Biomedical Research Institute; National Human Genome Research Institute [T32 HG002295]; Google Research Award; Templeton Foundation; Bill and Melinda Gates Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018381] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER	Foundational Questions in Evolutionary Biology Prize Fellowship; Harvard Medical School; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Society of Fellows; Fannie and John Hertz Foundation; National Defense Science and Engineering Graduate Fellowship; NSF(National Science Foundation (NSF)); National Space Biomedical Research Institute; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Google Research Award(Google Incorporated); Templeton Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.-B.M. was supported by the Foundational Questions in Evolutionary Biology Prize Fellowship and the Systems Biology Program (Harvard Medical School). Y.K.S. was supported by internships at Google. S. P. acknowledges support from NIH grant HD 18381. E. L. A. was supported by the Harvard Society of Fellows, the Fannie and John Hertz Foundation Graduate Fellowship, a National Defense Science and Engineering Graduate Fellowship, an NSF Graduate Fellowship, the National Space Biomedical Research Institute, and National Human Genome Research Institute grant T32 HG002295. This work was supported by a Google Research Award. The Program for Evolutionary Dynamics acknowledges support from the Templeton Foundation, NIH grant R01GM078986, and the Bill and Melinda Gates Foundation. Some of the methods described in this paper are covered by U. S. patents 7463772 and 7508978. We are grateful to D. Bloomberg, A. Popat, M. McCormick, T. Mitchison, U. Alon, S. Shieber, E. Lander, R. Nagpal, J. Fruchter, J. Guldi, J. Cauz, C. Cole, P. Bordalo, N. Christakis, C. Rosenberg, M. Liberman, J. Scheidlower, B. Zimmer, R. Darnton, and A. Spector for discussions; to C.-M. Hetrea and K. Sen for assistance with Encyclopaedia Britannica's database; to S. Eismann, W. Tress, and the City of Berlin Web site (berlin.de) for assistance in documenting victims of Nazi censorship; to C. Lazell and G. T. Fournier for assistance with annotation; to M. Lopez for assistance with Fig. 1; to G. Elbaz and W. Gilbert for reviewing an early draft; and to Google's library partners and every author who has ever picked up a pen, for books.	Algeo J., 1991, 50 YEARS NEW WORDS D; [Anonymous], 1958, B AM MATH SOC; Babcock Gove P., 1993, WEBSTERS 3 NEW INT D; Barron S., 1991, DEGENERATE ARTFATE A; Barry John, 2004, THE GREAT INFLUENZA; Braudy Leo., 1997, FRENZY RENOWN FAME I; Bybee J, 2006, LANGUAGE, V82, P711, DOI 10.1353/lan.2006.0186; CAVALLI-SFORZA L.L, 1981, CULTURAL TRANSMISSIO; Ebbinghaus H., 1987, MEMORY CONTRIBUTION; GREGORIAN V, 1984, CENSORSHIP 500 YEARS; Halbwachs M., 1992, COLLECTIVE MEMORY; HOIBERG D, 2002, ENCY BRITANNICA; Kroch A., 1989, J LANGUAGE VARIATION, V1, P199, DOI [DOI 10.1017/S0954394500000168, 10.1017/S0954394500000168]; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lieberman E, 2007, NATURE, V449, P713, DOI 10.1038/nature06137; Lieberson S, 2008, SOCIOL METHODOL, V38, P1; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Niyogi P, 2006, CURR STUD LINGUIST, V43, P1; Pickett J.P., 2000, AM HERITAGE DICT ENG; Pinker S., 1999, WORDS RULES; READ AW, 1933, AM SPEECH, V8, P10; SAUDER G, 1985, BUCHERVERBRENNUNG 10; *SCRIPT, DIG SCRIPT; Simpson J.A., 1993, OXFORD ENGLISH DICT; SPERBER D, 1985, MAN, V20, P73, DOI 10.2307/2802222; Tre&beta;, 2003, WIDER UNDEUTSCHEN GE; Wilson E.O, 1998, CONSILIENCE; Zipf GK, 1935, PSYCHOBIOLOGY LANGUA	28	1368	1398	20	436	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2011	331	6014					176	182		10.1126/science.1199644	http://dx.doi.org/10.1126/science.1199644			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21163965	Green Accepted			2022-12-28	WOS:000286433100032
J	Henter, JI; Palmkvist-Kaijser, K; Holzgraefe, B; Bryceson, YT; Palmer, K				Henter, Jan-Inge; Palmkvist-Kaijser, Kajsa; Holzgraefe, Bernhard; Bryceson, Yenan T.; Palmer, Kenneth			Cytotoxic therapy for severe swine flu A/H1N1	LANCET			English	Editorial Material							HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; INFLUENZA		[Henter, Jan-Inge; Palmkvist-Kaijser, Kajsa] Karolinska Inst, Karolinska Univ Hosp Solna, Childhood Canc Res Unit, Dept Womens & Childrens Hlth, SE-17176 Stockholm, Sweden; [Holzgraefe, Bernhard; Palmer, Kenneth] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Physiol & Pharmacol,ECMO Ctr Karolinska, Sect Anesthesiol & Intens Care Med, SE-17176 Stockholm, Sweden; [Bryceson, Yenan T.] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med, Ctr Infect Med, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Henter, JI (corresponding author), Karolinska Inst, Karolinska Univ Hosp Solna, Childhood Canc Res Unit, Dept Womens & Childrens Hlth, C6 05, SE-17176 Stockholm, Sweden.	jan-inge.henter@ki.se	Bryceson, Yenan T/D-2121-2018	Bryceson, Yenan T/0000-0002-7783-9934; Holzgraefe, Bernhard/0000-0002-5654-7764; Henter, Jan-Inge/0000-0002-0629-2126				Harms PW, 2010, AM J CLIN PATHOL, V134, P27, DOI 10.1309/AJCP35KOZSAVNQZW; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Henter JI, 2002, BLOOD, V100, P2367, DOI 10.1182/blood-2002-01-0172; Henter JI, 2006, LANCET, V367, P870, DOI 10.1016/S0140-6736(06)68232-9; Strauss R, 2004, CRIT CARE MED, V32, P1316, DOI 10.1097/01.CCM.0000127779.24232.15	5	32	35	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 18	2010	376	9758					2116	2116		10.1016/S0140-6736(10)61345-1	http://dx.doi.org/10.1016/S0140-6736(10)61345-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702LA	21168053				2022-12-28	WOS:000285895000030
J	Ghosh, S; Bachilo, SM; Simonette, RA; Beckingham, KM; Weisman, RB				Ghosh, Saunab; Bachilo, Sergei M.; Simonette, Rebecca A.; Beckingham, Kathleen M.; Weisman, R. Bruce			Oxygen Doping Modifies Near-Infrared Band Gaps in Fluorescent Single-Walled Carbon Nanotubes	SCIENCE			English	Article							STONE-WALES DEFECTS; OZONE ADSORPTION; OXIDATION; FUNCTIONALIZATION; PURIFICATION; OZONOLYSIS; MOBILITY; OZONIDES; C60O	Controlled chemical modifications of single-walled carbon nanotubes (SWCNTs) that tune their useful properties have been sought for multiple applications. We found that beneficial optical changes in SWCNTs resulted from introducing low concentrations of oxygen atoms. Stable covalently oxygen-doped nanotubes were prepared by exposure to ozone and then light. Treated samples showed distinct, structure-specific near-infrared fluorescence at wavelengths 10 to 15% longer than displayed by pristine semiconducting SWCNTs. Dopant sites harvest light energy absorbed in undoped nanotube regions by trapping mobile excitons. The oxygen-doped SWCNTs are much easier to detect and image than pristine SWCNTs because they give stronger near-infrared emission and do not absorb at the shifted emission wavelength.	[Ghosh, Saunab; Bachilo, Sergei M.; Weisman, R. Bruce] Rice Univ, Dept Chem, Houston, TX 77005 USA; [Ghosh, Saunab; Bachilo, Sergei M.; Simonette, Rebecca A.; Beckingham, Kathleen M.; Weisman, R. Bruce] Rice Univ, RE Smalley Inst Nanoscale Sci & Technol, Houston, TX 77005 USA; [Simonette, Rebecca A.; Beckingham, Kathleen M.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA	Rice University; Rice University; Rice University	Weisman, RB (corresponding author), Rice Univ, Dept Chem, POB 1892, Houston, TX 77005 USA.	weisman@rice.edu	Ghosh, Saunab/DYO-7073-2022; Bachilo, Sergei/ABC-4606-2020	Bachilo, Sergei/0000-0001-5236-1383; Weisman, R. Bruce/0000-0001-8546-9980	NSF [CHE-0809020]; Welch Foundation [C-0807, C-1119]; NASA [NNX09AH43G]	NSF(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NASA(National Aeronautics & Space Administration (NASA))	Supported by NSF grant CHE-0809020, Welch Foundation grants C-0807 and C-1119, and NASA grant NNX09AH43G. We thank J. K. Johnson for unpublished computational results, and C. Farach-Carson and D. Carson for providing the cultured cell line.	Akdim B, 2007, CHEM PHYS LETT, V445, P281, DOI 10.1016/j.cplett.2007.08.001; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Banerjee S, 2005, ADV MATER, V17, P17, DOI 10.1002/adma.200401340; Banerjee S, 2002, J PHYS CHEM B, V106, P12144, DOI 10.1021/jp026304k; Cai LT, 2002, CHEM MATER, V14, P4235, DOI 10.1021/cm020273o; Chen ZY, 2006, J PHYS CHEM B, V110, P11624, DOI 10.1021/jp057494c; Cognet L, 2007, SCIENCE, V316, P1465, DOI 10.1126/science.1141316; Ghosh S, 2010, NAT NANOTECHNOL, V5, P443, DOI [10.1038/NNANO.2010.68, 10.1038/nnano.2010.68]; Harutyunyan H, 2009, NANO LETT, V9, P2010, DOI 10.1021/nl9002798; Heymann D, 2002, J AM CHEM SOC, V124, P6317, DOI 10.1021/ja012488p; Heymann D, 2000, J AM CHEM SOC, V122, P11473, DOI 10.1021/ja0025651; Heymann D, 2006, CR CHIM, V9, P1107, DOI 10.1016/j.crci.2006.02.003; Hirsch A, 2005, TOP CURR CHEM, V245, P193; Kiowski O, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.237402; Li MH, 2008, CARBON, V46, P466, DOI 10.1016/j.carbon.2007.12.012; Lu X, 2002, J PHYS CHEM B, V106, P2136, DOI 10.1021/jp015537t; Luer L, 2009, NAT PHYS, V5, P54, DOI [10.1038/nphys1149, 10.1038/NPHYS1149]; Mawhinney DB, 2000, J AM CHEM SOC, V122, P2383, DOI 10.1021/ja994094s; Murakami Y, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195407; Ogrin D, 2006, J AM CHEM SOC, V128, P11322, DOI 10.1021/ja061680u; Perebeinos V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257402; Picozzi S, 2004, J CHEM PHYS, V120, P7147, DOI 10.1063/1.1669381; Qin SH, 2004, MACROMOLECULES, V37, P3965, DOI 10.1021/ma049681z; Reich S., 2004, CARBON NANOTUBES BAS; Siitonen AJ, 2010, J PHYS CHEM LETT, V1, P2189, DOI 10.1021/jz100749c; Siitonen AJ, 2010, NANO LETT, V10, P1595, DOI 10.1021/nl9039845; Simmons JM, 2006, J PHYS CHEM B, V110, P7113, DOI 10.1021/jp0548422; Torrens ON, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.157401; Tsvaygboym K., 2007, THESIS RICE U; Weisman RB, 2001, J AM CHEM SOC, V123, P9720, DOI 10.1021/ja016267v; Yim WL, 2009, J PHYS CHEM C, V113, P17636, DOI 10.1021/jp908089c	31	272	277	4	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1656	1659		10.1126/science.1196382	http://dx.doi.org/10.1126/science.1196382			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21109631				2022-12-28	WOS:000285390500061
J	Wang, R; Chadalavada, K; Wilshire, J; Kowalik, U; Hovinga, KE; Geber, A; Fligelman, B; Leversha, M; Brennan, C; Tabar, V				Wang, Rong; Chadalavada, Kalyani; Wilshire, Jennifer; Kowalik, Urszula; Hovinga, Koos E.; Geber, Adam; Fligelman, Boris; Leversha, Margaret; Brennan, Cameron; Tabar, Viviane			Glioblastoma stem-like cells give rise to tumour endothelium	NATURE			English	Article							NERVOUS-SYSTEM; RECURRENT GLIOBLASTOMA; IN-VIVO; ANGIOGENESIS; EGFR; IDENTIFICATION; RECRUITMENT; INHIBITION; PATHWAYS; MARKER	Glioblastoma (GBM) is among the most aggressive of human cancers(1). A key feature of GBMs is the extensive network of abnormal vasculature characterized by glomeruloid structures and endothelial hyperplasia(2). Yet the mechanisms of angiogenesis and the origin of tumour endothelial cells remain poorly defined(3-5). Here we demonstrate that a subpopulation of endothelial cells within glioblastomas harbour the same somatic mutations identified within tumour cells, such as amplification of EGFR and chromosome 7. We additionally demonstrate that the stem-cell-like CD133(+) fraction includes a subset of vascular endothelial-cadherin (CD144)-expressing cells that show characteristics of endothelial progenitors capable of maturation into endothelial cells. Extensive in vitro and in vivo lineage analyses, including single cell clonal studies, further show that a subpopulation of the CD133(+) stem-like cell fraction is multipotent and capable of differentiation along tumour and endothelial lineages, possibly via an intermediate CD133(+)/CD144(+) progenitor cell. The findings are supported by genetic studies of specific exons selected from The Cancer Genome Atlas(6), quantitative FISH and comparative genomic hybridization data that demonstrate identical genomic profiles in the CD133(+) tumour cells, their endothelial progenitor derivatives and mature endothelium. Exposure to the clinical anti-angiogenesis agent bevacizumab(7) or to a gamma-secretase inhibitor(8) as well as knockdown shRNA studies demonstrate that blocking VEGF or silencing VEGFR2 inhibits the maturation of tumour endothelial progenitors into endothelium but not the differentiation of CD133(+) cells into endothelial progenitors, whereas c-secretase inhibition or NOTCH1 silencing blocks the transition into endothelial progenitors. These data may provide new perspectives on the mechanisms of failure of anti-angiogenesis inhibitors currently in use. The lineage plasticity and capacity to generate tumour vasculature of the putative cancer stem cells within glioblastoma are novel findings that provide new insight into the biology of gliomas and the definition of cancer stemness, as well as the mechanisms of tumour neo-angiogenesis.	[Wang, Rong; Kowalik, Urszula; Hovinga, Koos E.; Geber, Adam; Fligelman, Boris; Brennan, Cameron; Tabar, Viviane] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Wang, Rong; Tabar, Viviane] Mem Sloan Kettering Canc Ctr, Ctr Stem Cell Biol, New York, NY 10065 USA; [Wang, Rong; Brennan, Cameron; Tabar, Viviane] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10065 USA; [Hovinga, Koos E.] Univ Amsterdam, Acad Med Ctr, Neurosurg Ctr Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Brennan, Cameron] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Amsterdam; Academic Medical Center Amsterdam; Memorial Sloan Kettering Cancer Center	Tabar, V (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA.	tabarv@mskcc.org	Brennan, Cameron/R-7082-2019	Brennan, Cameron/0000-0003-4064-8891; Geber, Adam/0000-0003-3022-0525	New York State Stem Cell Science Fund (NYSTEM); NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	New York State Stem Cell Science Fund (NYSTEM); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank J. Imai, H. Xu, G. Lee, M. Tomishima and L. Studer for critical reading of the manuscript, P. Gutin for assistance with tissue acquisition and discussions, B. Weksler for the brain endothelial cell line (hCMEC), S. Jhanwar for the clinical cytogenetics data and M. Sadelain and E. Papapetrou for the lentiviral vectors. Funding was provided in part through a grant from the New York State Stem Cell Science Fund (NYSTEM).	Akino T, 2009, AM J PATHOL, V175, P2657, DOI 10.2353/ajpath.2009.090202; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Beaty RM, 2007, J NEURO-ONCOL, V81, P241, DOI 10.1007/s11060-006-9227-9; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; El Hallani S, 2010, BRAIN, V133, P973, DOI 10.1093/brain/awq044; Franco-Hernandez C, 2007, INT J ONCOL, V30, P209; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Hendrix MJC, 2002, CANCER RES, V62, P665; Hovinga KE, 2010, STEM CELLS, V28, P1019, DOI 10.1002/stem.429; Iwamoto FM, 2009, NEUROLOGY, V73, P1200, DOI 10.1212/WNL.0b013e3181bc0184; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Laib AM, 2009, NAT PROTOC, V4, P1202, DOI 10.1038/nprot.2009.96; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shmelkov SV, 2005, INT J BIOCHEM CELL B, V37, P715, DOI 10.1016/j.biocel.2004.08.010; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; VOYTA JC, 1984, J CELL BIOL, V99, pA81; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604	31	865	914	1	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					829	U128		10.1038/nature09624	http://dx.doi.org/10.1038/nature09624			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21102433				2022-12-28	WOS:000285093700047
J	Kelen, GD; Catlett, CL				Kelen, Gabor D.; Catlett, Christina L.			Violence in the Health Care Setting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kelen, Gabor D.] Johns Hopkins Univ, Sch Med, Johns Hopkins Inst, Johns Hopkins Off Crit Event Preparedness & Respo, Baltimore, MD 21204 USA; Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21204 USA	Johns Hopkins University; Johns Hopkins University	Kelen, GD (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Inst, Johns Hopkins Off Crit Event Preparedness & Respo, 1830 E Monument St,Ste 600, Baltimore, MD 21204 USA.	gkelen@jhmi.edu		Kelen, Gabor/0000-0002-3236-8286				[Anonymous], NIOSH PUBL; *BUR LAB STAT, 1997, OCC HOM SEL CHAR; *CDCP, US GOV OCC VIOL; Centers for Disease Control and Prevention National Institute for Occupational Safety and Health (NIOSH), 2006, NIOSH PUBL, V2009-117; Gerberich SG, 2004, OCCUP ENVIRON MED, V61, P495, DOI 10.1136/oem.2003.007294; *NATIONMASTER, ASS PER CAP MOST REC; QUICK B, 2009, J BROADCASTING E MAR; Rankins RG, 1999, ANN EMERG MED, V33, P676, DOI 10.1016/S0196-0644(99)70197-6; The Joint Commission, 2010, PREV VIOL HLTH CAR S; *UN, INT HOM RAT PER 1000	10	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2010	304	22					2530	2531		10.1001/jama.2010.1795	http://dx.doi.org/10.1001/jama.2010.1795			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691AS	21139115				2022-12-28	WOS:000285053300028
J	Vispute, TP; Zhang, HY; Sanna, A; Xiao, R; Huber, GW				Vispute, Tushar P.; Zhang, Huiyan; Sanna, Aimaro; Xiao, Rui; Huber, George W.			Renewable Chemical Commodity Feedstocks from Integrated Catalytic Processing of Pyrolysis Oils	SCIENCE			English	Article							BIO-OIL; LIQUID-FUEL; BIOMASS; HYDROCARBONS; CONVERSION; ZEOLITE; AROMATIZATION; ALKYLATION; AROMATICS; ETHYLENE	Fast pyrolysis of lignocellulosic biomass produces a renewable liquid fuel called pyrolysis oil that is the cheapest liquid fuel produced from biomass today. Here we show that pyrolysis oils can be converted into industrial commodity chemical feedstocks using an integrated catalytic approach that combines hydroprocessing with zeolite catalysis. The hydroprocessing increases the intrinsic hydrogen content of the pyrolysis oil, producing polyols and alcohols. The zeolite catalyst then converts these hydrogenated products into light olefins and aromatic hydrocarbons in a yield as much as three times higher than that produced with the pure pyrolysis oil. The yield of aromatic hydrocarbons and light olefins from the biomass conversion over zeolite is proportional to the intrinsic amount of hydrogen added to the biomass feedstock during hydroprocessing. The total product yield can be adjusted depending on market values of the chemical feedstocks and the relative prices of the hydrogen and biomass.	[Vispute, Tushar P.; Zhang, Huiyan; Sanna, Aimaro; Huber, George W.] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA; [Zhang, Huiyan; Xiao, Rui] Southeast Univ, Sch Energy & Environm, Nanjing 210096, Peoples R China; [Sanna, Aimaro] Univ Nottingham, Dept Chem & Environm Engn, Energy & Sustainabil Res Div, Nottingham NG7 2RD, England	University of Massachusetts System; University of Massachusetts Amherst; Southeast University - China; University of Nottingham	Vispute, TP (corresponding author), Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.		Zhang, Huiyan/A-8640-2011; Huber, George/D-2569-2018; Huber, George/Y-2473-2019	Huber, George/0000-0002-7838-6893; Zhang, Huiyan/0000-0002-4818-7156	U.S. Department of Energy Office of Energy Efficiency and Renewable Energy [DE-FG36-08GO18212]; Defense Advanced Research Projects Agency (DARPA) through the Defense Science Office [HR0011-09-C-0075]; National Basic Research Program of China (973 Program) [2010CB732206]; National Natural Science Foundation of China [51076031]	U.S. Department of Energy Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); Defense Advanced Research Projects Agency (DARPA) through the Defense Science Office(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the U.S. Department of Energy Office of Energy Efficiency and Renewable Energy, under grant DE-FG36-08GO18212; and by the Defense Advanced Research Projects Agency (DARPA) through the Defense Science Office Agreement HR0011-09-C-0075) (Approved for Public Release, Distribution Unlimited); the National Basic Research Program of China (973 Program, grant no. 2010CB732206); and the National Natural Science Foundation of China (grant no. 51076031). The views, opinions, and/or findings contained in this article/presentation are those of the author/presenter and should not be interpreted as representing the official views or policies, either expressed or implied, of the DARPA or the Department of Defense. We thank A. Javaid for the microfiltration of bio-oil, Y. Cheng for help with zeolite upgrading experiments, and the National Renewable Energy Laboratory and P. H. Steele from the Forest Products Department at Mississippi State University for providing us with bio-oil samples. The University of Massachusetts has filed a patent based on the methods presented here. G. W. H. has a financial interest in Anellotech, a privately held company focused on producing renewable petrochemicals from biomass.	ADJAYE JD, 1995, FUEL PROCESS TECHNOL, V45, P161, DOI 10.1016/0378-3820(95)00034-5; ADJAYE JD, 1995, FUEL PROCESS TECHNOL, V45, P185, DOI 10.1016/0378-3820(95)00040-E; Agrawal R, 2007, P NATL ACAD SCI USA, V104, P4828, DOI 10.1073/pnas.0609921104; Anex R. P., 2009, DIV FUEL CHEM, V54, P704; [Anonymous], ICIS PRIC REP; Bartholomew CH, 2006, FUNDAMENTALS OF INDUSTRIAL CATALYTIC PROCESSES, 2ND EDITION, P1, DOI 10.1002/9780471730071; Bayerbach R, 2009, J ANAL APPL PYROL, V85, P98, DOI 10.1016/j.jaap.2008.10.021; Carlson TR, 2008, CHEMSUSCHEM, V1, P397, DOI 10.1002/cssc.200800018; Carlson TR, 2011, ENERG ENVIRON SCI, V4, P145, DOI 10.1039/c0ee00341g; CHEN NY, 1986, CHEMTECH, V16, P506; Chornet, 2001, [No title captured], Patent No. [6172272B1, 6172272, 6,172,272 ]; Choudhary VR, 2001, MICROPOR MESOPOR MAT, V47, P253, DOI 10.1016/S1387-1811(01)00385-7; Cortright RD, 2002, NATURE, V418, P964, DOI 10.1038/nature01009; Crossley S, 2010, SCIENCE, V327, P68, DOI 10.1126/science.1180769; Czernik S, 2004, ENERG FUEL, V18, P590, DOI 10.1021/ef034067u; Degnan TF, 2001, APPL CATAL A-GEN, V221, P283, DOI 10.1016/S0926-860X(01)00807-9; Elliott DC, 2007, ENERG FUEL, V21, P1792, DOI 10.1021/ef070044u; Gayubo AG, 2004, IND ENG CHEM RES, V43, P2610, DOI 10.1021/ie030791o; GUISNET M, 1992, APPL CATAL A-GEN, V89, P1, DOI 10.1016/0926-860X(92)80075-N; Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d; Huber GW, 2004, ANGEW CHEM INT EDIT, V43, P1549, DOI 10.1002/anie.200353050; Huber GW, 2003, SCIENCE, V300, P2075, DOI 10.1126/science.1085597; Klass DL., 1998, BIOMASS RENEWABLE EN; Kunkes EL, 2008, SCIENCE, V322, P417, DOI 10.1126/science.1159210; Lappin G., 1989, ALPHA OLEFINS APPL H; Li N, 2010, J CATAL, V270, P48, DOI 10.1016/j.jcat.2009.12.006; Marker T. L., 2005, DEFG3605GO15085 UOP; Miller JE, 1999, FUEL, V78, P1363, DOI 10.1016/S0016-2361(99)00072-1; Milne T, 1997, DEV THERMOCHEMICAL B, P409, DOI DOI 10.1007/978-94-009-1559-6_32; Mohan D, 2006, ENERG FUEL, V20, P848, DOI 10.1021/ef0502397; National Research Council and National Academy of Engineering, 2004, HYDR EC OPP COSTS BA; Oasmaa A, 1999, ENERG FUEL, V13, P914, DOI 10.1021/ef980272b; Olcay H, 2010, CHEMCATCHEM, V2, P1420, DOI 10.1002/cctc.201000134; Padro C, 1999, NRELTP57027079, DOI 10.2172/12212; Perego C, 2002, CATAL TODAY, V73, P3, DOI 10.1016/S0920-5861(01)00511-9; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Shabtai J. S., 1999, [No title captured], Patent No. [US 5959167 A, 5959167, US 5959167]; SZMANT H, 1989, ORGANIC BUILDING BLO; Vispute TP, 2009, GREEN CHEM, V11, P1433, DOI 10.1039/b912522c; Wright MM, 2010, FUEL, V89, pS11, DOI 10.1016/j.fuel.2010.07.029; Zhao C, 2010, CHEM COMMUN, V46, P412, DOI 10.1039/b916822b; Zhao C, 2009, ANGEW CHEM INT EDIT, V48, P3987, DOI 10.1002/anie.200900404	42	850	888	31	879	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1222	1227		10.1126/science.1194218	http://dx.doi.org/10.1126/science.1194218			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109668				2022-12-28	WOS:000284613700036
J	Chen, ZC; Borek, D; Padrick, SB; Gomez, TS; Metlagel, Z; Ismail, AM; Umetani, J; Billadeau, DD; Otwinowski, Z; Rosen, MK				Chen, Zhucheng; Borek, Dominika; Padrick, Shae B.; Gomez, Timothy S.; Metlagel, Zoltan; Ismail, Ayman M.; Umetani, Junko; Billadeau, Daniel D.; Otwinowski, Zbyszek; Rosen, Michael K.			Structure and control of the actin regulatory WAVE complex	NATURE			English	Article							WASP/SCAR PROTEINS; TYROSINE KINASE; CELL-MIGRATION; WASP FAMILY; PHOSPHORYLATION; ACTIVATION; MEMBRANE; MODEL; RAC1; INTEGRATION	Members of the Wiskott-Aldrich syndrome protein (WASP) family control cytoskeletal dynamics by promoting actin filament nucleation with the Arp2/3 complex. The WASP relative WAVE regulates lamellipodia formation within a 400-kilodalton, hetero-pentameric WAVE regulatory complex (WRC). The WRC is inactive towards the Arp2/3 complex, but can be stimulated by the Rac GTPase, kinases and phosphatidylinositols. Here we report the 2.3-angstrom crystal structure of the WRC and complementary mechanistic analyses. The structure shows that the activity-bearing VCA motif of WAVE is sequestered by a combination of intramolecular and intermolecular contacts within the WRC. Rac and kinases appear to destabilize a WRC element that is necessary for VCA sequestration, suggesting the way in which these signals stimulate WRC activity towards the Arp2/3 complex. The spatial proximity of the Rac binding site and the large basic surface of the WRC suggests how the GTPase and phospholipids could cooperatively recruit the complex to membranes.	[Chen, Zhucheng; Borek, Dominika; Padrick, Shae B.; Metlagel, Zoltan; Ismail, Ayman M.; Umetani, Junko; Otwinowski, Zbyszek; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chen, Zhucheng; Padrick, Shae B.; Metlagel, Zoltan; Ismail, Ayman M.; Umetani, Junko; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Gomez, Timothy S.; Billadeau, Daniel D.] Mayo Clin, Coll Med, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Mayo Clinic	Rosen, MK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	michael.rosen@utsouthwestern.edu	Otwinowski, Zbyszek/F-3665-2011; Borek, Dominika M/D-2943-2011	Borek, Dominika M/0000-0002-4321-6253; Otwinowski, Zbyszek/0000-0003-3640-8545; Padrick, Shae/0000-0002-6916-6194	Cancer Research Institute; NIH [1F32-GM06917902, R01-AI065474, R01-GM053163, R01-GM056322]; Allergic Diseases Training grant [AI07047]; Welch Foundation [I-1544]; Howard Hughes Medical Institute; US DOE [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007047, R01AI065474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053163, R01GM056322] Funding Source: NIH RePORTER	Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allergic Diseases Training grant; Welch Foundation(The Welch Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Chen for providing samples of full-length WRC and VCA polypeptide for electron microscopy and some biochemical analyses, C. Pak for helping with the total internal reflection fluorescence experiment, D. Tomchick and C. Brautigam for technical assistance and N. Grishin for assistance with sequence analysis and discussion. Research was supported by fellowships from the Cancer Research Institute and the NIH (1F32-GM06917902) to Z.C. and S.B.P., respectively, an Allergic Diseases Training grant (AI07047) to T.S.G., grants from the NIH to D.D.B. (R01-AI065474), Z.O. (R01-GM053163) and M.K.R. (R01-GM056322), a grant from the Welch Foundation to M.K.R. (I-1544) and the Howard Hughes Medical Institute. D.D.B. is a Leukemia and Lymphoma Society Scholar. Use of the Argonne National Laboratory Structural Biology Center beamlines at the Advanced Photon Source was supported by the US DOE under contract DE-AC02-06CH11357.	Ardern H, 2006, CELL MOTIL CYTOSKEL, V63, P6, DOI 10.1002/cm.20101; Borek D, 2007, J SYNCHROTRON RADIAT, V14, P24, DOI 10.1107/S0909049506046589; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ismail AM, 2009, NAT STRUCT MOL BIOL, V16, P561, DOI 10.1038/nsmb.1587; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakao S, 2008, J CELL BIOL, V182, P395, DOI 10.1083/jcb.200802069; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Nowicki ST, 2007, J DEV BEHAV PEDIATR, V28, P133, DOI 10.1097/01.DBP.0000267563.18952.c9; Oikawa T, 2004, NAT CELL BIOL, V6, P420, DOI 10.1038/ncb1125; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Pollitt AY, 2009, J CELL SCI, V122, P2575, DOI 10.1242/jcs.023879; Ryu JR, 2009, MOL CELL BIOL, V29, P1735, DOI 10.1128/MCB.01483-08; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Stovold CF, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-11; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Stuart JR, 2006, J BIOL CHEM, V281, P31290, DOI 10.1074/jbc.M602389200; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Vartiainen MK, 2004, CURR OPIN CELL BIOL, V16, P174, DOI 10.1016/j.ceb.2004.02.004; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	50	309	322	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					533	U207		10.1038/nature09623	http://dx.doi.org/10.1038/nature09623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107423	Green Accepted			2022-12-28	WOS:000284584200035
J	Buse, JB; Bergenstal, RM; Glass, LC; Heilmann, CR; Lewis, MS; Kwan, AYM; Hoogwerf, BJ; Rosenstock, J				Buse, John B.; Bergenstal, Richard M.; Glass, Leonard C.; Heilmann, Cory R.; Lewis, Michelle S.; Kwan, Anita Y. M.; Hoogwerf, Byron J.; Rosenstock, Julio			Use of Twice-Daily Exenatide in Basal Insulin-Treated Patients With Type 2 Diabetes A Randomized, Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							TO-TARGET TRIAL; GLUCOSE-LOWERING DRUGS; GLYCEMIC CONTROL; ORAL-THERAPY; COMBINATION THERAPY; NAIVE PEOPLE; NPH INSULIN; OPEN-LABEL; ADD-ON; GLARGINE	Background: Insulin replacement in diabetes often requires prandial intervention to reach hemoglobin A(1c) (HbA(1c)) targets. Objective: To test whether twice-daily exenatide injections reduce HbA(1c) levels more than placebo in people receiving insulin glargine. Design: Parallel, randomized, placebo-controlled trial, blocked and stratified by HbA(1c) level at site, performed from October 2008 to January 2010. Participants, investigators, and personnel conducting the study were masked to treatment assignments. (ClinicalTrials.gov registration number: NCT00765817) Setting: 59 centers in 5 countries. Patients: Adults with type 2 diabetes and an HbA(1c) level of 7.1% to 10.5% who were receiving insulin glargine alone or in combination with metformin or pioglitazone (or both agents). Intervention: Assignment by a centralized, computer-generated, random-sequence interactive voice-response system to exenatide, 10 mu g twice daily, or placebo for 30 weeks. Measurements: The primary outcome was change in HbA(1c) level. Secondary outcomes included the percentage of participants with HbA(1c) values of 7.0% or less and 6.5% or less, 7-point self-monitored glucose profiles, body weight, waist circumference, insulin dose, hypoglycemia, and adverse events. Results: 112 of 138 exenatide recipients and 101 of 123 placebo recipients completed the study. The HbA(1c) level decreased by 1.74% with exenatide and 1.04% with placebo (between-group difference, -0.69% [95% CI, -0.93% to -0.46%]; P < 0.001). Weight decreased by 1.8 kg with exenatide and increased by 1.0 kg with placebo (between-group difference, -2.7 kg [CI, -3.7 to -1.7]). Average increases in insulin dosage with exenatide and placebo were 13 U/d and 20 U/d. The estimated rate of minor hypoglycemia was similar between groups. Thirteen exenatide recipients and 1 placebo recipient discontinued the study because of adverse events (P < 0.010); rates of nausea (41% vs. 8%), diarrhea (18% vs. 8%), vomiting (18% vs. 4%), headache (14% vs. 4%), and constipation (10% vs. 2%) were higher with exenatide than with placebo. Limitations: The study was of short duration. There were slight imbalances between groups at baseline in terms of sex, use of concomitant glucose-lowering medications, and HbA(1c) levels, and more exenatide recipients than placebo recipients withdrew because of adverse events. Conclusion: Adding twice-daily exenatide injections improved glycemic control without increased hypoglycemia or weight gain in participants with uncontrolled type 2 diabetes who were receiving insulin glargine treatment. Adverse events of exenatide included nausea, diarrhea, vomiting, headache, and constipation. Primary Funding Source: Alliance of Eli Lilly and Company and Amylin Pharmaceuticals. Ann Intern Med. 2011;154:103-112.	[Buse, John B.] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; Int Diabet Ctr Pk Nicollet, Minneapolis, MN USA; Eli Lilly & Co, Indianapolis, IN 46285 USA; Lilly USA, Indianapolis, IN USA; Dallas Diabet & Endocrine Ctr Med City, Dallas, TX USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; International Diabetes Center; Eli Lilly; Lilly USA LLC; Diabetes & Endocrine Center	Buse, JB (corresponding author), Univ N Carolina, Sch Med, CB 7172,Burnett Womack 8027, Chapel Hill, NC 27599 USA.	jbuse@med.unc.edu	Buse, John Bernard/J-9742-2019	Buse, John Bernard/0000-0002-9723-3876	Alliance of Eli Lilly and Company; Amylin Pharmaceuticals	Alliance of Eli Lilly and Company; Amylin Pharmaceuticals(Bristol-Myers Squibb)	By the Alliance of Eli Lilly and Company and Amylin Pharmaceuticals.r Dr. Buse: Grant (money to institution): Eli Lilly and Company; Consulting fee or honorarium (money to institution): Eli Lilly and Company; Support for travel to meetings for the study or otherwise: Eli Lilly and Company; Support for travel to meetings for the study or otherwise (money to institution): Eli Lilly and Company; Support in kind such as writing, provision of medicines or equipment, or administrative support: Eli Lilly and Company. Dr. Bergenstal: Grant (money to institution): Eli Lilly and Company. Dr. Glass: Employment: Eli Lilly and Company; Stock/stock options: Eli Lilly and Company. Dr. Heilmann: Employment: Eli Lilly and Company; Stock/stock options: Eli Lilly and Company; Travel/accommodations/meeting expenses unrelated to activities listed: Eli Lilly and Company. Dr. Lewis: Employment: Eli Lilly and Company. Ms. Kwan: Employment: Lilly USA. Dr. Hoogwerf: Employment: Eli Lilly and Company; Stock/stock options: Eli Lilly and Company. Dr. Rosenstock: Grant (money to institution): Eli Lilly and Company; Consultancy: Pfizer, Roche, sanofi-aventis, Novo Nordisk, Eli Lilly and Company, MannKind, GlaxoSmithKline, Takeda, Daiichi Sankyo, Forest, Johnson & Johnson, Novartis, Boehringer Ingelheim, Amylin; Grants/grants pending (money to institution): Merck & Co., Pfizer, sanofi-aventis, Novo Nordisk, Roche, Bristol-Myers Squibb, Eli Lilly and Company, Forest, GlaxoSmithKline, Takeda, Novartis, AstraZeneca, Amylin, Johnson & Johnson, Daiichi Sankyo, MannKind, Boehringer Ingelheim. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M10-1795.	Abraira C, 1998, DIABETES CARE, V21, P574, DOI 10.2337/diacare.21.4.574; [Anonymous], 1997, JAMA-J AM MED ASSOC, V277, P925; Arnolds S, 2010, DIABETES CARE   0331; Bergenstal RM, 2008, DIABETES CARE, V31, P1305, DOI 10.2337/dc07-2137; Bunck MC, 2009, DIABETES CARE, V32, P762, DOI 10.2337/dc08-1797; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Buse John B, 2003, Diabetes Technol Ther, V5, P355, DOI 10.1089/152091503765691839; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Davies M, 2005, DIABETES CARE, V28, P1282, DOI 10.2337/diacare.28.6.1282; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Dodd AH, 2009, CURR MED RES OPIN, V25, P1605, DOI 10.1185/03007990902973300; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Dungan KM, 2006, DIABETES CARE, V29, P1214, DOI 10.2337/dc06-1910; Gill A, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-6; Hermansen K, 2006, DIABETES CARE, V29, P1269, DOI 10.2337/dc05-1365; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392; Holman RR, 2009, NEW ENGL J MED, V361, P1736, DOI 10.1056/NEJMoa0905479; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Kolterman OG, 2003, J CLIN ENDOCR METAB, V88, P3082, DOI 10.1210/jc.2002-021545; Koro CE, 2004, DIABETES CARE, V27, P17, DOI 10.2337/diacare.27.1.17; Lankisch MR, 2008, DIABETES OBES METAB, V10, P1178, DOI 10.1111/j.1463-1326.2008.00967.x; Lipkovich I, 2005, PHARM STAT, V4, P267, DOI 10.1002/pst.188; McGill JRB, 2004, DIABETES CARE, V27, P1859, DOI 10.2337/diacare.27.8.1859; Molenberghs G., 2007, MISSING DATA CLIN ST; Moretto TJ, 2008, CLIN THER, V30, P1448, DOI 10.1016/j.clinthera.2008.08.006; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nayak UA, 2010, QJM-INT J MED, V103, P687, DOI 10.1093/qjmed/hcq112; Norris SL, 2009, DIABETIC MED, V26, P837, DOI 10.1111/j.1464-5491.2009.02790.x; Raskin P, 2005, DIABETES CARE, V28, P2811, DOI 10.2337/diacare.28.11.2811; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; Rosenstock J, 2008, DIABETOLOGIA, V51, P408, DOI 10.1007/s00125-007-0911-x; Rosenstock J, 2007, DIABETES CARE, V30, P2972, DOI 10.2337/dc07-1592; Sheffield Catherine A, 2008, Endocr Pract, V14, P285; Stettler C, 2008, DIABETES CARE, V31, P1534, DOI 10.2337/dc08-0385; Tzefos M, 2010, ANN PHARMACOTHER, V44, P1294, DOI 10.1345/aph.1P047; Yki-Jarvinen H, 2006, DIABETOLOGIA, V49, P442, DOI 10.1007/s00125-005-0132-0; Yki-Jarvinen H, 2001, DIABETES CARE, V24, P758, DOI 10.2337/diacare.24.4.758; Yki-Jarvinen H, 2007, DIABETES CARE, V30, P1364, DOI 10.2337/dc06-1357; Yoon NM, 2009, CLIN THER, V31, P1511, DOI 10.1016/j.clinthera.2009.07.021; Zinman B, 2007, ANN INTERN MED, V146, P477, DOI 10.7326/0003-4819-146-7-200704030-00003	41	404	426	1	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2					103	+		10.7326/0003-4819-154-2-201101180-00300	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-00300			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706MW	21138825				2022-12-28	WOS:000286223500004
J	Mizuno, H; Higashida, C; Yuan, YF; Ishizaki, T; Narumiya, S; Watanabe, N				Mizuno, Hiroaki; Higashida, Chiharu; Yuan, Yunfeng; Ishizaki, Toshimasa; Narumiya, Shuh; Watanabe, Naoki			Rotational Movement of the Formin mDia1 Along the Double Helical Strand of an Actin Filament	SCIENCE			English	Article							ADP-ACTIN; ATP-ACTIN; MECHANISM; DYNAMICS; POLYMERIZATION; NUCLEATION; PROFILIN; TWIST	Formin homology proteins (formins) elongate actin filaments (F-actin) by continuously associating with filament tips, potentially harnessing actin-generated pushing forces. During this processive elongation, formins are predicted to rotate along the axis of the double helical F-actin structure (referred to here as helical rotation), although this has not yet been definitively shown. We demonstrated helical rotation of the formin mDia1 by single-molecule fluorescence polarization (FLP). FLP of labeled F-actin, both elongating and depolymerizing from immobilized mDia1, oscillated with a periodicity corresponding to that of the F-actin long-pitch helix, and this was not altered by actin-bound nucleotides or the actin-binding protein profilin. Thus, helical rotation is an intrinsic property of formins. To harness pushing forces from growing F-actin, formins must be anchored flexibly to cell structures.	[Mizuno, Hiroaki; Watanabe, Naoki] Tohoku Univ, Grad Sch Life Sci, Lab Single Mol Cell Biol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Higashida, Chiharu; Yuan, Yunfeng; Ishizaki, Toshimasa; Narumiya, Shuh] Kyoto Univ, Fac Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan	Tohoku University; Kyoto University	Watanabe, N (corresponding author), Tohoku Univ, Grad Sch Life Sci, Lab Single Mol Cell Biol, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	nwatanabe@m.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Uehara Memorial Foundation; Human Frontier Science Program	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Human Frontier Science Program(Human Frontier Science Program)	We thank H. Honda for rabbit muscle acetone powder and T. M. Watanabe for customizing the G-track software. This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and grants from the Uehara Memorial Foundation (N.W.) and the Human Frontier Science Program (N.W.).	Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Bubb MR, 2003, J BIOL CHEM, V278, P24629, DOI 10.1074/jbc.M302796200; Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Fujiwara I, 2007, P NATL ACAD SCI USA, V104, P8827, DOI 10.1073/pnas.0702510104; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Higashida C, 2008, J CELL SCI, V121, P3403, DOI 10.1242/jcs.030940; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2009, NATURE, V457, P389, DOI 10.1038/457389a; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Orlova A, 2004, P NATL ACAD SCI USA, V101, P17664, DOI 10.1073/pnas.0407525102; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; POLLARD TD, 1992, J BIOL CHEM, V267, P20339; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Romero S, 2007, J BIOL CHEM, V282, P8435, DOI 10.1074/jbc.M609886200; Sase I, 1997, P NATL ACAD SCI USA, V94, P5646, DOI 10.1073/pnas.94.11.5646; Shemesh T, 2005, J CELL BIOL, V170, P889, DOI 10.1083/jcb.200504156; Tsuda Y, 1996, P NATL ACAD SCI USA, V93, P12937, DOI 10.1073/pnas.93.23.12937; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Watanabe N, 2010, P JPN ACAD B-PHYS, V86, P62, DOI 10.2183/pjab.86.62	27	80	81	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					80	83		10.1126/science.1197692	http://dx.doi.org/10.1126/science.1197692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21148346				2022-12-28	WOS:000285974000040
J	Teolis, BD; Jones, GH; Miles, PF; Tokar, RL; Magee, BA; Waite, JH; Roussos, E; Young, DT; Crary, FJ; Coates, AJ; Johnson, RE; Tseng, WL; Baragiola, RA				Teolis, B. D.; Jones, G. H.; Miles, P. F.; Tokar, R. L.; Magee, B. A.; Waite, J. H.; Roussos, E.; Young, D. T.; Crary, F. J.; Coates, A. J.; Johnson, R. E.; Tseng, W-L; Baragiola, R. A.			Cassini Finds an Oxygen-Carbon Dioxide Atmosphere at Saturn's Icy Moon Rhea	SCIENCE			English	Article							CONDENSED O-2; SATELLITES; OZONE; EUROPA	The flyby measurements of the Cassini spacecraft at Saturn's moon Rhea reveal a tenuous oxygen (O-2)-carbon dioxide (CO2) atmosphere. The atmosphere appears to be sustained by chemical decomposition of the surface water ice under irradiation from Saturn's magnetospheric plasma. This in situ detection of an oxidizing atmosphere is consistent with remote observations of other icy bodies, such as Jupiter's moons Europa and Ganymede, and suggestive of a reservoir of radiolytic O-2 locked within Rhea's ice. The presence of CO2 suggests radiolysis reactions between surface oxidants and organics or sputtering and/or outgassing of CO2 endogenic to Rhea's ice. Observations of outflowing positive and negative ions give evidence for pickup ionization as a major atmospheric loss mechanism.	[Teolis, B. D.; Miles, P. F.; Magee, B. A.; Waite, J. H.; Young, D. T.; Crary, F. J.] SW Res Inst, Space Sci & Engn Div, San Antonio, TX 78238 USA; [Jones, G. H.; Coates, A. J.] Univ Coll London, Mullard Space Sci Lab, Dept Space & Climate Phys, Dorking RH5 6NT, Surrey, England; [Jones, G. H.; Coates, A. J.] UCL Birkbeck, Ctr Planetary Sci, London WC1E 6BT, England; [Tokar, R. L.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Roussos, E.] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; [Johnson, R. E.; Tseng, W-L; Baragiola, R. A.] Univ Virginia, Dept Mat Sci & Engn, Charlottesville, VA 22903 USA	Southwest Research Institute; University of London; University College London; University of London; Birkbeck University London; University College London; United States Department of Energy (DOE); Los Alamos National Laboratory; Max Planck Society; University of Virginia	Teolis, BD (corresponding author), SW Res Inst, Space Sci & Engn Div, 6220 Culebra Rd, San Antonio, TX 78238 USA.	ben.teolis@swri.org	Roussos, Elias/H-2249-2011; Coates, Andrew/C-2396-2008; Jones, Geraint H./C-1682-2008	Coates, Andrew/0000-0002-6185-3125; Jones, Geraint H./0000-0002-5859-1136; Roussos, Elias/0000-0002-5699-0678	NASA under SwRI [1283095]; Jet Propulsion Laboratory under SwRI [1356497]; UK Science and Technology Facilities Council; NSF [AST0807830]; Science and Technology Facilities Council [PP/E001173/1, ST/H00260X/1, PP/D005213/1] Funding Source: researchfish; UK Space Agency [PP/D00084X/1, ST/I002642/1] Funding Source: researchfish; STFC [PP/E001173/1, PP/D005213/1, ST/H00260X/1] Funding Source: UKRI	NASA under SwRI; Jet Propulsion Laboratory under SwRI; UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NSF(National Science Foundation (NSF)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank E. Roussos, D. Mitchell, and the Cassini MIMI team for providing the MIMI data used in figs. S1 and S4 and N. G. Petrik, A. G. Kavetsky, and G. A. Kimmel at Pacific Northwest National Laboratory, Richland, Washington, USA, for contributing the O<INF>2</INF> electron-stimulated desorption measurements in fig. S9. The INMS and CAPS teams acknowledge support from NASA and the Jet Propulsion Laboratory under SwRI subcontracts 1283095 and 1356497, respectively. G.H.J. and A.J.C. acknowledge support for CAPS-ELS operations and analysis by the United Kingdom Space Agency, and G.H.J. was supported by a UK Science and Technology Facilities Council Advanced Fellowship. B.D.T. and R.A.B. acknowledge support by the NSF Astronomy and Astrophysics Program through grant AST0807830.	Carlson RW, 1999, SCIENCE, V283, P820, DOI 10.1126/science.283.5403.820; Clark RN, 2008, ICARUS, V193, P372, DOI 10.1016/j.icarus.2007.08.035; Coates AJ, 2010, ICARUS, V206, P618, DOI 10.1016/j.icarus.2009.07.013; Cruikshank DP, 2010, ICARUS, V206, P561, DOI 10.1016/j.icarus.2009.07.012; Cruikshank DP, 2005, ICARUS, V175, P268, DOI 10.1016/j.icarus.2004.09.003; Glein CR, 2008, ICARUS, V197, P157, DOI 10.1016/j.icarus.2008.03.021; Hall DT, 1998, ASTROPHYS J, V499, P475, DOI 10.1086/305604; Jones GH, 2008, SCIENCE, V319, P1380, DOI 10.1126/science.1151524; Khurana KK, 2008, ICARUS, V193, P465, DOI 10.1016/j.icarus.2007.08.005; Noll KS, 1997, NATURE, V388, P45, DOI 10.1038/40348; Noll KS, 1996, SCIENCE, V273, P341, DOI 10.1126/science.273.5273.341; Saur J, 2005, ASTROPHYS J, V620, pL115, DOI 10.1086/428665; Spencer J, 1998, ICARUS, V136, P349, DOI 10.1006/icar.1998.6024; Spencer JR, 2002, ASTRON J, V124, P3400, DOI 10.1086/344307; SPENCER JR, 1995, J GEOPHYS RES-PLANET, V100, P19049, DOI 10.1029/95JE01503; Stephan K., 2009, 40 LUN PLAN SCI C LU; Sunshine JM, 2009, SCIENCE, V326, P565, DOI 10.1126/science.1179788; Teolis BD, 2006, ASTROPHYS J, V644, pL141, DOI 10.1086/505743; Teolis BD, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3091998; Tseng WL, 2010, ICARUS, V206, P382, DOI 10.1016/j.icarus.2009.05.019; Waite JH, 2004, SPACE SCI REV, V114, P113, DOI 10.1007/s11214-004-1408-2; Wilson RJ, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014679; Young DT, 2004, SPACE SCI REV, V114, P1, DOI 10.1007/s11214-004-1406-4	23	110	110	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1813	1815		10.1126/science.1198366	http://dx.doi.org/10.1126/science.1198366			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21109635				2022-12-28	WOS:000285603700038
J	Van Overwalle, G				Van Overwalle, Geertrui			Turning Patent Swords into Shares	SCIENCE			English	Editorial Material							INTELLECTUAL PROPERTY; LIABILITY RULES; UNCERTAINTY; INNOVATION; GENETICS; SOCIETY; RIGHTS; VIEW		[Van Overwalle, Geertrui] Univ Louvain, Ctr Intellectual Property Rights, B-3000 Louvain, Belgium; [Van Overwalle, Geertrui] Tilburg Univ, Tilburg Inst Law Technol & Soc, NL-5000 LE Tilburg, Netherlands	Tilburg University	Van Overwalle, G (corresponding author), Univ Louvain, Ctr Intellectual Property Rights, B-3000 Louvain, Belgium.	geertrui.vanoverwalle@law.kuleuven.be						AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Barton JH, 2006, NAT BIOTECHNOL, V24, P939, DOI 10.1038/nbt0806-939; Burk Daniel L., 2009, PATENT CRISIS COURTS; CALABRESI G, 1972, HARVARD LAW REV, V85, P1089, DOI 10.2307/1340059; Caulfield T, 2006, NAT BIOTECHNOL, V24, P1352, DOI 10.1038/nbt1106-1352; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; Drahos Peter, 1996, PHILOS INTELLECTUAL; Gold ER, 2010, GENET MED, V12, pS39, DOI 10.1097/GIM.0b013e3181d72661; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; HOLMAN CH, 2008, BIOTECH BRIEF, V5, P1; Hopkins MM, 2007, NAT BIOTECHNOL, V25, P185, DOI 10.1038/nbt0207-185; Huys I, 2009, NAT BIOTECHNOL, V27, P903, DOI 10.1038/nbt1009-903; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Merges RP, 1996, CALIF LAW REV, V84, P1293, DOI 10.2307/3480996; MERGES RP, 2001, EXPANDING BOUNDARIES, P123; RAI K, 2003, LAW CONTEMP PROBL, V66, P289; Reichman JH, 2000, VANDERBILT LAW REV, V53, P1743; *SACGHS, 2010, REV DRAFT REP GE PAT; Shapiro C, 2001, INNOV POLICY EC, V1, P119, DOI DOI 10.1086/ipe.1.25056143; Van Overwalle G, 2006, NAT REV GENET, V7, P143, DOI 10.1038/nrg1765; VanOverwalle G, 2009, CAM INTELLECT PROP, P1, DOI 10.1017/CBO9780511581182; Walsh JP, 2005, SCIENCE, V309, P2002, DOI 10.1126/science.1115813; 2010, GENET MED S, V12, pS1	23	27	27	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2010	330	6011					1630	1631		10.1126/science.1189592	http://dx.doi.org/10.1126/science.1189592			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	695RO	21164001				2022-12-28	WOS:000285390500049
J	Nazarian, R; Shi, HB; Wang, Q; Kong, XJ; Koya, RC; Lee, H; Chen, ZG; Lee, MK; Attar, N; Sazegar, H; Chodon, T; Nelson, SF; McArthur, G; Sosman, JA; Ribas, A; Lo, RS				Nazarian, Ramin; Shi, Hubing; Wang, Qi; Kong, Xiangju; Koya, Richard C.; Lee, Hane; Chen, Zugen; Lee, Mi-Kyung; Attar, Narsis; Sazegar, Hooman; Chodon, Thinle; Nelson, Stanley F.; McArthur, Grant; Sosman, Jeffrey A.; Ribas, Antoni; Lo, Roger S.			Melanomas acquire resistance toB-RAF(V600E) inhibition by RTK or N-RAS upregulation	NATURE			English	Article							BRAF; MUTATIONS; KINASE; SENSITIVITY; PATHWAY; CRAF; MEK	Activating B-RAF(V600E) (also known as BRAF) kinase mutations occur in similar to 7% of human malignancies and similar to 60% of melanomas(1). Early clinical experience with a novel class I RAF-selective inhibitor, PLX4032, demonstrated an unprecedented 80% anti-tumour response rate among patients with B-RAF(V600E)-positive melanomas, but acquired drug resistance frequently develops after initial responses(2). Hypotheses for mechanisms of acquired resistance to B-RAF inhibition include secondary mutations in B-RAF(V600E), MAPK reactivation, and activation of alternative survival pathways(3-5). Here we show that acquired resistance to PLX4032 develops by mutually exclusive PDGFR beta (also known as PDGFRB) upregulation or N-RAS (also known as NRAS) mutations but not through secondary mutations in B-RAF(V600E). We used PLX4032-resistant sub-lines artificially derived from B-RAF(V600E)-positive melanoma cell lines and validated key findings in PLX4032-resistant tumours and tumour-matched, short-term cultures from clinical trial patients. Induction of PDGFR beta RNA, protein and tyrosine phosphorylation emerged as a dominant feature of acquired PLX4032 resistance in a subset of melanoma sub-lines, patient-derived biopsies and short-term cultures. PDGFR beta-upregulated tumour cells have low activated RAS levels and, when treated with PLX4032, do not reactivate the MAPK pathway significantly. In another subset, high levels of activated N-RAS resulting from mutations lead to significant MAPK pathway reactivation upon PLX4032 treatment. Knockdown of PDGFR beta or N-RAS reduced growth of the respective PLX4032-resistant subsets. Overexpression of PDGFR beta or N-RAS(Q61K) conferred PLX4032 resistance to PLX4032-sensitive parental cell lines. Importantly, MAPK reactivation predicts MEK inhibitor sensitivity. Thus, melanomas escape B-RAF(V600E) targeting not through secondary B-RAF(V600E) mutations but via receptor tyrosine kinase (RTK)-mediated activation of alternative survival pathway(s) or activated RAS-mediated reactivation of the MAPK pathway, suggesting additional therapeutic strategies.	[Nazarian, Ramin; Shi, Hubing; Wang, Qi; Kong, Xiangju; Lee, Mi-Kyung; Lo, Roger S.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Nazarian, Ramin; Shi, Hubing; Wang, Qi; Kong, Xiangju; Koya, Richard C.; Lee, Hane; Chen, Zugen; Lee, Mi-Kyung; Attar, Narsis; Sazegar, Hooman; Chodon, Thinle; Nelson, Stanley F.; Ribas, Antoni; Lo, Roger S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Koya, Richard C.; Ribas, Antoni] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Surg, Div Surg Oncol, Los Angeles, CA 90095 USA; [Lee, Hane; Chen, Zugen; Nelson, Stanley F.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Human Genet, Los Angeles, CA 90095 USA; [Attar, Narsis; Sazegar, Hooman; Chodon, Thinle; Ribas, Antoni] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Nelson, Stanley F.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Pediat, Los Angeles, CA 90095 USA; [McArthur, Grant] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; [Sosman, Jeffrey A.] Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN 37232 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Peter Maccallum Cancer Center; Vanderbilt University	Lo, RS (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Dermatol, 52-121 CHS, Los Angeles, CA 90095 USA.	rlo@mednet.ucla.edu	Nelson, Stanley F/D-4771-2009; Shi, Hubing/B-8445-2014	Nelson, Stanley F/0000-0002-2082-3114; Shi, Hubing/0000-0002-2926-3440; Wang, Qi/0000-0002-6420-1720; McArthur, Grant/0000-0001-8908-6071	Dermatology Foundation; Burroughs Wellcome Fund; STOP CANCER Foundation; Margaret E. Early Medical Trust; Ian Copeland Memorial Melanoma Fund; V Foundation for Cancer Research; Melanoma Research Foundation; American Skin Association; Caltech-UCLA Joint Center for Translational Medicine; Wesley Coyle Memorial Fund; Melanoma Research Alliance; T32 Tumor Immunology Training Grant; California Institute for Regenerative Medicine (CIRM); Jonsson Cancer Center Foundation (JCCF); NATIONAL CANCER INSTITUTE [K22CA151638, K24CA097588] Funding Source: NIH RePORTER	Dermatology Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); STOP CANCER Foundation; Margaret E. Early Medical Trust; Ian Copeland Memorial Melanoma Fund; V Foundation for Cancer Research; Melanoma Research Foundation; American Skin Association; Caltech-UCLA Joint Center for Translational Medicine; Wesley Coyle Memorial Fund; Melanoma Research Alliance; T32 Tumor Immunology Training Grant; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Jonsson Cancer Center Foundation (JCCF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to G. Bollag and P. Lin (Plexxikon) for providing PLX4032, J.S. Economou for biopsies, B. Comin-Anduix for FACS assistance, S. Mok for assistance with virus production, C. Ng for tissue acquisition and culture establishment, R. Huang for patient tissue processing, N. Doan for immunohistochemistry, P. Mischel for discussion, B. Chmielowski for coordinated patient care, T. L. Toy for technical help with library generation for deep sequencing, and B. Harry for help with analysis of deep sequence data. R. S. L. acknowledges funding from the following: Dermatology Foundation, Burroughs Wellcome Fund, STOP CANCER Foundation, Margaret E. Early Medical Trust, Ian Copeland Memorial Melanoma Fund, V Foundation for Cancer Research, Melanoma Research Foundation, American Skin Association, Caltech-UCLA Joint Center for Translational Medicine, Wesley Coyle Memorial Fund, and Melanoma Research Alliance. R. N. is supported by a post-doctoral fellowship from the T32 Tumor Immunology Training Grant (S. Dubinett). A. R. is supported by the California Institute for Regenerative Medicine (CIRM), the Jonsson Cancer Center Foundation (JCCF), and Caltech-UCLA Joint Center for Translational Medicine. Array and sequence work were performed within the Jonsson Comprehensive Cancer Center Gene Expression Shared Resource. Patient-informed consent was obtained for the research performed in this study. We would like to thank all the patients that participated in this study.	Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Packer LM, 2009, PIGM CELL MELANOMA R, V22, P785, DOI 10.1111/j.1755-148X.2009.00618.x; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Smith G, 2010, BRIT J CANCER, V102, P693, DOI 10.1038/sj.bjc.6605534; Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Whittaker S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000758; Wu EX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003794	18	1628	1692	3	226	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					973	U377		10.1038/nature09626	http://dx.doi.org/10.1038/nature09626			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21107323	Green Accepted			2022-12-28	WOS:000285344600049
J	Bollyky, TJ; Gostin, LO				Bollyky, Thomas J.; Gostin, Lawrence O.			The United States' Engagement in Global Tobacco Control Proposals for Comprehensive Funding and Strategies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bollyky, Thomas J.] Ctr Global Dev, Washington, DC 20036 USA; [Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA	Georgetown University	Bollyky, TJ (corresponding author), Ctr Global Dev, 1800 Massachusetts Ave NW, Washington, DC 20036 USA.	tbollyky@cgdev.org		Gostin, Lawrence/0000-0001-5286-4044				BOLLYKY TJ, RATIFICATION FUTURE; Frieden TR, 2007, LANCET, V369, P1758, DOI 10.1016/S0140-6736(07)60782-X; *INT CTR TRAD SUST, TOB CO FIL CLAIM AG; Mahgoub A., 2010, CASH DELIVERY NEW AP; Mitchell AD, 2010, ASIAN J WTO INT HEAL, V5, P399; *UN EC SOC COUNC, E201055 WHO UN EC SO; *WHO, 2010, 3 WHO NCDNET INT ADV, P5; WHO, PART WHO FRAM CONV T; World Health Organisation, REP GLOB TOB EP 2009; 2008, LANCET, V372, P345	10	9	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2010	304	23					2637	2638		10.1001/jama.2010.1842	http://dx.doi.org/10.1001/jama.2010.1842			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694MX	21156952				2022-12-28	WOS:000285303400027
J	Friedman, EA; Adashi, EY				Friedman, Eric A.; Adashi, Eli Y.			The Right to Health as the Unheralded Narrative of Health Care Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Adashi, Eli Y.] Brown Univ, Providence, RI 02906 USA; [Friedman, Eric A.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Friedman, Eric A.] Phys Human Rights, Washington, DC USA	Brown University; Georgetown University	Adashi, EY (corresponding author), Brown Univ, 272 George St, Providence, RI 02906 USA.	eli_adashi@brown.edu						*AM RHET ONL SPEEC, 2008, DEM NAT CONV AUG 25; *HIGH COMM HUM RIG, 1993, WORLD C HUM RIGHTS 1; Kinney ED, 2004, CORNELL INT LAW J, V37, P285; Kunz JosefL., 1949, AM J INT LAW, V43, P316; *OPP AG, HUM RIGHTS US OP RES; SOHN L, 1982, AM U LAW REV, V13, P1; *U MINN HUM RIGHTS, CIRCL RIGHTS EC SOC; *UN EC SOC COUNC, SUBST ISS AR IMPL IN; *UN HIGH COMM HUM, TREAT BOD DAT	9	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2010	304	23					2639	2640		10.1001/jama.2010.1845	http://dx.doi.org/10.1001/jama.2010.1845			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	694MX	21156953				2022-12-28	WOS:000285303400028
J	Suri, P; Rainville, J; Kalichman, L; Katz, JN				Suri, Pradeep; Rainville, James; Kalichman, Leonid; Katz, Jeffrey N.			Does This Older Adult With Lower Extremity Pain Have the Clinical Syndrome of Lumbar Spinal Stenosis?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIAGNOSIS SUPPORT TOOL; LEG PAIN; BACK; CLASSIFICATION; PREVALENCE; MANAGEMENT	Context The clinical syndrome of lumbar spinal stenosis (LSS) is a common diagnosis in older adults presenting with lower extremity pain. Objective To systematically review the accuracy of the clinical examination for the diagnosis of the clinical syndrome of LSS. Data Sources MEDLINE, EMBASE, and CINAHL searches of articles published from January 1966 to September 2010. Study Selection Studies were included if they contained adequate data on the accuracy of the history and physical examination for diagnosing the clinical syndrome of LSS, using a reference standard of expert opinion with radiographic or anatomic confirmation. Data Extraction Two authors independently reviewed each study to determine eligibility, extract data, and appraise levels of evidence. Data Synthesis Four studies evaluating 741 patients were identified. Among patients with lower extremity pain, the likelihood of the clinical syndrome of LSS was increased for individuals older than 70 years (likelihood ratio [LR], 2.0; 95% confidence interval [CI], 1.6-2.5), and was decreased for those younger than 60 years (LR, 0.40; 95% CI, 0.29-0.57). The most useful symptoms for increasing the likelihood of the clinical syndrome of LSS were having no pain when seated (LR, 7.4; 95% CI, 1.9-30), improvement of symptoms when bending forward (LR, 6.4; 95% CI, 4.1-9.9), the presence of bilateral buttock or leg pain (LR, 6.3; 95% CI, 3.1-13), and neurogenic claudication (LR, 3.7; 95% CI, 2.9-4.8). Absence of neurogenic claudication (LR, 0.23; 95% CI, 0.17-0.31) decreased the likelihood of the diagnosis. A wide-based gait (LR, 13; 95% CI, 1.9-95) and abnormal Romberg test result (LR, 4.2; 95% CI, 1.4-13) increased the likelihood of the clinical syndrome of LSS. A score of 7 or higher on a diagnostic support tool including history and examination findings increased the likelihood of the clinical syndrome of LSS (LR, 3.3; 95% CI, 2.7-4.0), while a score lower than 7 made the diagnosis much less likely (LR, 0.10; 95% CI, 0.06-0.16). Conclusions The diagnosis of the clinical syndrome of LSS requires the appropriate clinical picture and radiographic findings. Absence of pain when seated and improvement of symptoms when bending forward are the most useful individual findings. Combinations of findings are most useful for identifying patients who are unlikely to have the diagnosis. JAMA. 2010; 304(23): 2628-2636	[Suri, Pradeep] Spaulding Rehabil Hosp, Boston, MA 02114 USA; [Suri, Pradeep; Rainville, James] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Katz, Jeffrey N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Katz, Jeffrey N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Orthoped Surg,Div Rheumatol Immunol & Allerg, Boston, MA 02115 USA; [Suri, Pradeep] VA Boston Healthcare Syst, Boston, MA USA; [Suri, Pradeep; Rainville, James; Kalichman, Leonid] New England Baptist Hosp, Boston, MA USA; [Kalichman, Leonid] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Phys Therapy, IL-84105 Beer Sheva, Israel	Harvard University; Spaulding Rehabilitation Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; New England Baptist Hospital; Ben Gurion University	Suri, P (corresponding author), Spaulding Rehabil Hosp, Room 753,125 Nashua St, Boston, MA 02114 USA.	psuri@partners.org	Kalichman, Leonid/C-6266-2008; Kalichman, Leonid/Q-7547-2019; Suri, Pradeep/AAH-9572-2020	Kalichman, Leonid/0000-0003-2987-4396; Kalichman, Leonid/0000-0003-2987-4396; 	National Institutes of Health [K12 HD 01097]; Rehabilitation Medicine Scientist Training Program (RMSTP) [K12 HD 01097]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [K24 AR 02124, P60 AR 47782]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR002123, P60AR047782] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rehabilitation Medicine Scientist Training Program (RMSTP); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Dr Suri is funded by grant K12 HD 01097 from the National Institutes of Health and the Rehabilitation Medicine Scientist Training Program (RMSTP). Dr Katz is also funded in part by grants K24 AR 02124 and P60 AR 47782 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases.	Alvarez JA, 1998, AM FAM PHYSICIAN, V57, P1825; AMUNDSEN T, 1995, SPINE, V20, P1178, DOI 10.1097/00007632-199505150-00013; Birkmeyer NJO, 2002, SPINE, V27, P1361, DOI 10.1097/00007632-200206150-00020; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; Djurasovic M, 2010, ORTHOP CLIN N AM, V41, P183, DOI 10.1016/j.ocl.2009.12.003; Fardon DF, 2001, SPINE, V26, P461, DOI 10.1097/00007632-200103010-00007; Genevay S, 2010, SPINE, V35, P803, DOI 10.1097/BRS.0b013e3181bc9454; Genevay S, 2010, BEST PRACT RES CL RH, V24, P253, DOI 10.1016/j.berh.2009.11.001; Haig Andrew J, 2002, Spine J, V2, P372, DOI 10.1016/S1529-9430(02)00201-2; Haig AJ, 2010, JAMA-J AM MED ASSOC, V303, P71, DOI 10.1001/jama.2009.1946; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Hicks GE, 2008, ARTHRIT RHEUM-ARTHR, V59, P1306, DOI 10.1002/art.24006; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; Kalichman L, 2009, SPINE J, V9, P545, DOI 10.1016/j.spinee.2009.03.005; Kato Y, 2009, J ORTHOP SCI, V14, P711, DOI 10.1007/s00776-009-1391-2; Katz JN, 2008, NEW ENGL J MED, V358, P818, DOI 10.1056/NEJMcp0708097; KATZ JN, 1991, ARTHRITIS RHEUM-US, V34, P1228, DOI 10.1002/art.1780341004; KATZ JN, 1995, ARTHRITIS RHEUM, V38, P1236, DOI 10.1002/art.1780380910; Khan NA, 2006, JAMA-J AM MED ASSOC, V295, P536, DOI 10.1001/jama.295.5.536; KIRKALDY-WILLIS W H, 1978, Spine, V3, P319, DOI 10.1097/00007632-197812000-00004; Konno S, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-102; Konno S, 2007, EUR SPINE J, V16, P1951, DOI 10.1007/s00586-007-0402-2; Ljunggren AE, 1991, NEURO-ORTHOPEDICS, V11, P91; Lurie JD, 2008, SPINE, V33, P1605, DOI 10.1097/BRS.0b013e3181791af3; Malmivaara A, 2007, SPINE, V32, P1, DOI 10.1097/01.brs.0000251014.81875.6d; Patel N, 2002, J NEUROL NEUROSUR PS, V73, pI42; PINKSY LE, 2000, EVIDENCE BASED CLIN, P165; Siebert E, 2009, NAT REV NEUROL, V5, P392, DOI 10.1038/nrneurol.2009.90; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Simon RW, 2007, BRIT MED J, V334, P746, DOI 10.1136/bmj.39036.624306.68; Sugioka T, 2008, FAM PRACT, V25, P237, DOI 10.1093/fampra/cmn031; Tong HC, 2006, J BACK MUSCULOSKELET, V19, P67, DOI 10.3233/BMR-2006-192-305; Truumees Eeric, 2005, Instr Course Lect, V54, P287; Verbiest H, 1980, Neurosurg Rev, V3, P75, DOI 10.1007/BF01644422; Vogt MT, 2006, SPINE, V31, P1445, DOI 10.1097/01.brs.0000219875.19688.a6; Weinstein JN, 2008, NEW ENGL J MED, V358, P794, DOI 10.1056/NEJMoa0707136; White C, 2007, NEW ENGL J MED, V356, P1241, DOI 10.1056/NEJMcp064483; Yamashita K, 2007, SPINE, V32, P980, DOI 10.1097/01.brs.0000261031.10091.f5; Yukawa Y, 2002, J BONE JOINT SURG AM, V84A, P1954, DOI 10.2106/00004623-200211000-00008	41	127	129	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2010	304	23					2628	2636		10.1001/jama.2010.1833	http://dx.doi.org/10.1001/jama.2010.1833			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694MX	21156951	Green Accepted			2022-12-28	WOS:000285303400026
J	Prinz, WA				Prinz, William A.			Lipid Trafficking sans Vesicles: Where, Why, How?	CELL			English	Article							OXYSTEROL-BINDING PROTEIN; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; GLYCOSPHINGOLIPID SYNTHESIS; NONVESICULAR TRAFFICKING; SACCHAROMYCES-CEREVISIAE; INTRACELLULAR-TRANSPORT; GOLGI-APPARATUS; STEROL TRANSFER; CHOLESTEROL	Eukaryotic cells possess a remarkable diversity of lipids, which distribute among cellular membranes by well-characterized vesicle trafficking pathways. However, transport of lipids by alternate, or "nonvesicular," routes is also critical for lipid synthesis, metabolism, and proper membrane partitioning. In the past few years, considerable progress has been made in characterizing the mechanisms of nonvesicular lipid transport and how it may go awry in particular diseases, but many fundamental questions remain for this rising field.	NIDDKD, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Prinz, WA (corresponding author), NIDDKD, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA.	williamp@intra.niddk.nih.gov			National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060004] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	I thank Ted Steck, Jim Hurley, and Tim Schulz for reading the manuscript. This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases.	Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Choi JY, 2006, BIOCHEM SOC T, V34, P404, DOI 10.1042/BST0340404; D'Angelo G, 2008, CURR OPIN CELL BIOL, V20, P360, DOI 10.1016/j.ceb.2008.03.013; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; Funato K, 2001, J CELL BIOL, V155, P949, DOI 10.1083/jcb.200105033; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; HECHTBERGER P, 1995, FEBS LETT, V367, P201, DOI 10.1016/0014-5793(95)00567-S; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Kallen CB, 1998, J BIOL CHEM, V273, P26285, DOI 10.1074/jbc.273.41.26285; KAPLAN MR, 1985, J CELL BIOL, V101, P441, DOI 10.1083/jcb.101.2.441; KAPLAN MR, 1985, J CELL BIOL, V101, P446, DOI 10.1083/jcb.101.2.446; Kok JW, 1998, BIOCHEM J, V333, P779, DOI 10.1042/bj3330779; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Levine TP, 2001, MOL BIOL CELL, V12, P1633, DOI 10.1091/mbc.12.6.1633; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Maxfield FR, 2006, BIOCHEM SOC T, V34, P335, DOI 10.1042/BST0340335; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Prinz WA, 2007, PROG LIPID RES, V46, P297, DOI 10.1016/j.plipres.2007.06.002; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Raychaudhuri S, 2008, P NATL ACAD SCI USA, V105, P15785, DOI 10.1073/pnas.0808321105; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; SLEIGHT RG, 1983, J BIOL CHEM, V258, P9050; Steck TL, 2002, BIOPHYS J, V83, P2118, DOI 10.1016/S0006-3495(02)73972-6; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; Voelker DR, 2009, ANNU REV BIOCHEM, V78, P827, DOI 10.1146/annurev.biochem.78.081307.112144; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; WARNOCK DE, 1994, P NATL ACAD SCI USA, V91, P2708, DOI 10.1073/pnas.91.7.2708; WATTENBERG BW, 1990, J CELL BIOL, V111, P421, DOI 10.1083/jcb.111.2.421; Yamaji T, 2008, IUBMB LIFE, V60, P511, DOI 10.1002/iub.83	39	84	84	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 10	2010	143	6					870	874		10.1016/j.cell.2010.11.031	http://dx.doi.org/10.1016/j.cell.2010.11.031			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145454	Green Accepted, Bronze			2022-12-28	WOS:000285182600005
J	Ricci-Vitiani, L; Pallini, R; Biffoni, M; Todaro, M; Invernici, G; Cenci, T; Maira, G; Parati, EA; Stassi, G; Larocca, LM; De Maria, R				Ricci-Vitiani, Lucia; Pallini, Roberto; Biffoni, Mauro; Todaro, Matilde; Invernici, Gloria; Cenci, Tonia; Maira, Giulio; Parati, Eugenio Agostino; Stassi, Giorgio; Larocca, Luigi Maria; De Maria, Ruggero			Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells	NATURE			English	Article							VASCULOGENIC MIMICRY; IN-VIVO; CANCER; IDENTIFICATION; ANGIOGENESIS; RESISTANCE; MECHANISMS; MELANOMA; NICHE	Glioblastoma is a highly angiogenetic malignancy, the neoformed vessels of which are thought to arise by sprouting of pre-existing brain capillaries. The recent demonstration that a population of glioblastoma stem-like cells (GSCs) maintains glioblastomas(1,2) indicates that the progeny of these cells may not be confined to the neural lineage(3). Normal neural stem cells are able to differentiate into functional endothelial cells(4). The connection between neural stem cells and the endothelial compartment seems to be critical in glioblastoma, where cancer stem cells closely interact with the vascular niche and promote angiogenesis through the release of vascular endothelial growth factor (VEGF) and stromal-derived factor 1 (refs 5-9). Here we show that a variable number (range 20-90%, mean 60.7%) of endothelial cells in glioblastoma carry the same genomic alteration as tumour cells, indicating that a significant portion of the vascular endothelium has a neoplastic origin. The vascular endothelium contained a subset of tumorigenic cells that produced highly vascularized anaplastic tumours with areas of vasculogenic mimicry in immunocompromised mice. In vitro culture of GSCs in endothelial conditions generated progeny with phenotypic and functional features of endothelial cells. Likewise, orthotopic or subcutaneous injection of GSCs in immunocompromised mice produced tumour xenografts, the vessels of which were primarily composed of human endothelial cells. Selective targeting of endothelial cells generated by GSCs in mouse xenografts resulted in tumour reduction and degeneration, indicating the functional relevance of the GSC-derived endothelial vessels. These findings describe a new mechanism for tumour vasculogenesis and may explain the presence of cancer-derived endothelial-like cells in several malignancies.	[Ricci-Vitiani, Lucia; Biffoni, Mauro; De Maria, Ruggero] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Pallini, Roberto; Maira, Giulio] Univ Cattolica Sacro Cuore, Dept Neurosurg, I-00168 Rome, Italy; [Todaro, Matilde; Stassi, Giorgio] Univ Palermo, Dept Surg & Oncol Sci, I-90127 Palermo, Italy; [Invernici, Gloria; Parati, Eugenio Agostino] Neurol Inst Carlo Besta, Fdn IRCCS, UO Cerebrovasc Dis Cellular Neurobiol Lab, I-20133 Milan, Italy; [Cenci, Tonia; Larocca, Luigi Maria] Univ Cattolica Sacro Cuore, Inst Pathol, I-00168 Rome, Italy; [Stassi, Giorgio] Carattere Sci Fdn Salvatore Maugeri, Ist Ricovero & Cura, I-27100 Pavia, Italy; [De Maria, Ruggero] Mediterranean Inst Oncol, I-95029 Catania, Italy	Istituto Superiore di Sanita (ISS); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Palermo; IRCCS Istituto Neurologico Besta; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Mediterranean Institute of Oncology	De Maria, R (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	pallini@rm.unicatt.it; demaria@iss.it	Ricci Vitiani, Lucia/J-8320-2016; PALLINI, Roberto/AAA-3747-2019; todaro, matilde/AAC-1003-2022; Cenci, Tonia/K-1010-2016; Pallini, Roberto/AAA-3760-2019; Parati, Eugenio Agostino/AAN-5893-2021; Stassi, Giorgio/AAC-1175-2022; Larocca, Luigi M/A-1577-2008; Cenci, Tonia/AAC-1372-2019; Biffoni, Mauro/J-8318-2016; Larocca, Luigi Maria/M-9590-2019; Parati, Eugenio A/G-8765-2011; De Maria, Ruggero/S-6385-2019	Ricci Vitiani, Lucia/0000-0001-7336-5615; PALLINI, Roberto/0000-0002-4611-8827; todaro, matilde/0000-0001-8686-8043; Cenci, Tonia/0000-0003-2838-8433; Parati, Eugenio Agostino/0000-0001-5020-6523; Larocca, Luigi M/0000-0003-1739-4758; Cenci, Tonia/0000-0002-6272-4587; Biffoni, Mauro/0000-0002-1304-9060; Larocca, Luigi Maria/0000-0003-1739-4758; De Maria, Ruggero/0000-0003-2255-0583	Associazione Italiana per la Ricerca sul Cancro	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	We thank L. Naldini for providing the lentiviral vectors and S. Forte for gene array data elaboration. This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro.	Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; De Palma M, 2003, HUM GENE THER, V14, P1193, DOI 10.1089/104303403322168028; Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Folkins C, 2009, CANCER RES, V69, P7243, DOI 10.1158/0008-5472.CAN-09-0167; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Pallini R, 2008, CLIN CANCER RES, V14, P8205, DOI 10.1158/1078-0432.CCR-08-0644; Pezzolo A, 2007, J CLIN ONCOL, V25, P376, DOI 10.1200/JCO.2006.09.0696; Ricci-Vitiani L, 2008, CELL DEATH DIFFER, V15, P1491, DOI 10.1038/cdd.2008.72; Ricci-Vitiani L, 2004, J EXP MED, V200, P1257, DOI 10.1084/jem.20040921; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Streubel B, 2004, NEW ENGL J MED, V351, P250, DOI 10.1056/NEJMoa033153; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604	23	931	978	6	192	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					824	U121		10.1038/nature09557	http://dx.doi.org/10.1038/nature09557			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21102434				2022-12-28	WOS:000285093700046
J	Kind, AJH; Bartels, C; Mell, MW; Mullahy, J; Smith, M				Kind, Amy J. H.; Bartels, Christie; Mell, Matthew W.; Mullahy, John; Smith, Maureen			For-Profit Hospital Status and Rehospitalizations at Different Hospitals: An Analysis of Medicare Data	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY-CARE PHYSICIANS; CONFIDENCE-INTERVALS; INSURANCE STATUS; PATIENT SAFETY; VOLUME; MORTALITY; QUALITY; MARKET; RISK; OPPORTUNITIES	Background: About one quarter of rehospitalized Medicare patients are admitted to hospitals different from their original hospital. The extent to which this practice is related to for-profit hospital status and affects payments and mortality is unknown. Objective: To describe and examine predictors of and payments for rehospitalization at a different hospital among Medicare patients rehospitalized within 30 days at for-profit and nonprofit or public hospitals. Design: Cohort study of patients discharged and rehospitalized from January 2005 to November 2006. Setting: Medicare fee-for-service hospitals throughout the United States. Participants: A 5% random national sample of Medicare patients with acute care rehospitalizations within 30 days of discharge (n = 74 564). Measurements: 30-day rehospitalizations at different hospitals and total payments or mortality over the subsequent 30 days. Multivariate logistic and quantile regression models included index hospital for-profit status, discharge counts, geographic region, rural-urban commuting area, and teaching status; patient socio-demographic characteristics, disability status, and comorbid conditions; and a measure of risk adjustment. Results: 16 622 patients (22%) in the sample were rehospitalized at a different hospital. Factors associated with increased risk for rehospitalization at a different hospital included index hospitalization at a for-profit, major medical school-affiliated, or low-volume hospital and having a Medicare-defined disability. Compared with patients rehospitalized at the same hospital, patients rehospitalized at different hospitals had higher adjusted 30-day total payments (median additional cost, $1308 per patient; P < 0.001) but no statistically significant differences in 30-day mortality, regardless of index hospital for-profit status. Limitation: The database lacked detailed clinical information about patients and did not include information about specific provider practice motivations or the role of patient choice in hospitalization venues. Conclusion: Rehospitalizations at different hospitals are common among Medicare patients, are more likely among those initially hospitalized at a for-profit hospital, and are related to increased overall payments without improved mortality.	[Kind, Amy J. H.] William S Middleton Vet Affairs Hosp, Geriatr Res Educ & Clin Ctr, Madison, WI 53705 USA; [Bartels, Christie; Smith, Maureen] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Mell, Matthew W.] Stanford Univ, Stanford, CA 94305 USA; [Mullahy, John] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53726 USA	Geriatric Research Education & Clinical Center; University of Wisconsin System; University of Wisconsin Madison; Stanford University; University of Wisconsin System; University of Wisconsin Madison	Kind, AJH (corresponding author), William S Middleton Vet Affairs Hosp, Geriatr Res Educ & Clin Ctr, 2500 Overlook Terrace, Madison, WI 53705 USA.	ajk@medicine.wisc.edu	Bartels, Christie Michels/ABG-4072-2020	Bartels, Christie Michels/0000-0001-6523-0374; Kind, Amy/0000-0002-7183-610X	University of Wisconsin (UW) Hartford Center of Excellence in Geriatrics; UW Health Innovation Program; National Center for Research Resources, National Institutes of Health through UW-Madison [1KL2RR025012-01, 1UL1RR025011]; UW Institute for Clinical and Translational Research; National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025012, UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG034551] Funding Source: NIH RePORTER	University of Wisconsin (UW) Hartford Center of Excellence in Geriatrics; UW Health Innovation Program; National Center for Research Resources, National Institutes of Health through UW-Madison(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UW Institute for Clinical and Translational Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the University of Wisconsin (UW) Hartford Center of Excellence in Geriatrics; the UW Health Innovation Program; a KL-2 grant from the National Center for Research Resources, National Institutes of Health (1KL2RR025012-01) through the Institutional Clinical and Translational Science Award (UW-Madison) program (1UL1RR025011 to Dr. Kind); and the Community-Academic Partnerships core of the UW Institute for Clinical and Translational Research.; University of Wisconsin Hartford Center of Excellence in Geriatrics, National Institutes of Health.	[Anonymous], 2009, CLIN CLASS SOFTW CCS; Archdeacon MT, 2007, J BONE JOINT SURG AM, V89A, P2625, DOI 10.2106/JBJS.F.01499; Berman L, 2010, J PEDIATR SURG, V45, P38, DOI 10.1016/j.jpedsurg.2009.10.006; Bhalla R, 2010, ANN INTERN MED, V152, P114, DOI 10.7326/0003-4819-152-2-201001190-00185; Billingsley KG, 2007, ARCH SURG-CHICAGO, V142, P23, DOI 10.1001/archsurg.142.1.23; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Casalino LP, 2003, HEALTH AFFAIR, V22, P56, DOI 10.1377/hlthaff.22.6.56; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Cram P, 2008, MED CARE, V46, P467, DOI 10.1097/MLR.0b013e31816c43d9; Duggan M, 2002, RAND J ECON, V33, P433, DOI 10.2307/3087466; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Elixhauser A, 2003, HEALTH AFFAIR, V22, P167, DOI 10.1377/hlthaff.22.2.167; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Goldsmith J, 2003, HEALTH AFFAIR, V22, P44, DOI 10.1377/hlthaff.22.4.44; Greene W, 1997, ECONOMETRIC ANAL; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kessler DP, 2002, RAND J ECON, V33, P488, DOI 10.2307/3087469; Kind AJH, 2007, J AM GERIATR SOC, V55, P365, DOI 10.1111/j.1532-5415.2007.01091.x; Kind AJH, 2010, ARCH PHYS MED REHAB, V91, P189, DOI 10.1016/j.apmr.2009.10.015; Kleinman LC, 2009, HEALTH SERV RES, V44, P288, DOI 10.1111/j.1475-6773.2008.00900.x; Kolstad JT, 2009, MED CARE RES REV, V66, p28S, DOI 10.1177/1077558708325887; Koval KJ, 2006, J BONE JOINT SURG AM, V88A, P2124, DOI 10.2106/JBJS.F.00245; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; LUFT HS, 1990, JAMA-J AM MED ASSOC, V263, P2899, DOI 10.1001/jama.263.21.2899; *MED PAYM ADV COMM, 2009, C IMPR  INC MED PROG; Medicare Payment Advisory Commission, 2008, C REF DEL SYST WASH; Medicare Payment Advisory Commission, 2007, C PROM GREAT EFF MED; Mukamel DB, 2007, MED CARE, V45, P1227, DOI 10.1097/MLR.0b013e31812f56bb; Nathens AB, 2001, J TRAUMA, V50, P776, DOI 10.1097/00005373-200105000-00002; PETERSON ED, 1994, ANN INTERN MED, V121, P919, DOI 10.7326/0003-4819-121-12-199412150-00003; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Sharma G, 2009, JAMA-J AM MED ASSOC, V301, P1671, DOI 10.1001/jama.2009.517; Sosa JA, 1998, ANN SURG, V228, P429, DOI 10.1097/00000658-199809000-00016; Trzeciak S, 2003, EMERG MED J, V20, P402, DOI 10.1136/emj.20.5.402; Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (full printed version), 2003, UN TREATM CONFR RAC; United States Department of Agriculture (USDA) Economic Research Service, 2005, MEAS RUR RUR URB COM; *WA STAT DEP HLTH, 2010, 4 TIER CONS RUCA SYS; Weiss SJ, 2004, ACAD EMERG MED, V11, P38, DOI 10.1197/S1069-6563(03)00583-9; Yuan Z, 2000, MED CARE, V38, P231, DOI 10.1097/00005650-200002000-00012	44	55	55	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 7	2010	153	11					718	727		10.7326/0003-4819-153-11-201012070-00005	http://dx.doi.org/10.7326/0003-4819-153-11-201012070-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	690KN	21135295	Green Accepted			2022-12-28	WOS:000285003800004
J	Athyros, VG; Tziomalos, K; Gossios, TD; Griva, T; Anagnostis, P; Kargiotis, K; Pagourelias, ED; Theocharidou, E; Karagiannis, A; Mikhailidis, DP				Athyros, Vasilios G.; Tziomalos, Konstantinos; Gossios, Thomas D.; Griva, Theodora; Anagnostis, Panagiotis; Kargiotis, Konstantinos; Pagourelias, Efstathios D.; Theocharidou, Eleni; Karagiannis, Asterios; Mikhailidis, Dimitri P.		GREACE Study Collaborative Grp	Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis	LANCET			English	Article							NONALCOHOLIC FATTY LIVER; GAMMA-GLUTAMYL-TRANSFERASE; URIC-ACID LEVELS; SUBGROUP ANALYSIS; METABOLIC SYNDROME; FOLLOW-UP; UNTREATED DYSLIPIDEMIA; RENAL-FUNCTION; TRANSAMINASE; CHOLESTEROL	Background Long-term statin treatment reduces the frequency of cardiovascular events, but safety and efficacy in patients with abnormal liver tests is unclear. We assessed whether statin therapy is safe and effective for these patients through post-hoc analysis of the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) study population. Methods GREACE was a prospective, intention-to-treat study that randomly assigned by a computer-generated randomisation list 1600 patients with coronary heart disease (aged <75 years, with serum concentrations of LDL cholesterol >2.6 mmol/L and triglycerides <4.5 mmol/L) at the Hippokration University Hospital, Thessaloniki, Greece to receive statin or usual care, which could include statins. The primary outcome of our post-hoc analysis was risk reduction for first recurrent cardiovascular event in patients treated with a statin who had moderately abnormal liver tests (defined as serum alanine aminotransferase or aspartate aminotransferase concentrations of less than three times the upper limit of normal) compared with patients with abnormal liver tests who did not receive a statin. This risk reduction was compared with that for patients treated (or not) with statin and normal liver tests. Findings Of 437 patients with moderately abnormal liver tests at baseline, which were possibly associated with nonalcoholic fatty liver disease, 227 who were treated with a statin (mainly atorvastatin 24 mg per day) had substantial improvement in liver tests (p<0.0001) whereas 210 not treated with a statin had further increases of liver enzyme concentrations. Cardiovascular events occurred in 22 (10%) of 227 patients with abnormal liver tests who received statin (3.2 events per 100 patient-years) and 63 (30%) of 210 patients with abnormal liver tests who did not receive statin (10.0 events per 100 patient-years; 68% relative risk reduction, p<0.0001). This cardiovascular disease benefit was greater (p=0.0074) than it was in patients with normal liver tests (90 [14%] events in 653 patients receiving a statin [4.6 per 100 patient-years] vs 117 [23%] in 510 patients not receiving a statin [7.6 per 100 patient-years]; 39% relative risk reduction, p<0.0001). Seven (<1%) of 880 participants who received a statin discontinued statin treatment because of liver-related adverse effects (transaminase concentrations more than three-times the upper limit of normal). Interpretation Stalin treatment is safe and can improve liver tests and reduce cardiovascular morbidity in patients with mild-to-moderately abnormal liver tests that are potentially attributable to non-alcoholic fatty liver disease.	[Mikhailidis, Dimitri P.] UCL, Sch Med, Dept Clin Biochem, Vasc Prevent Clin, London NW3 2QG, England; [Athyros, Vasilios G.; Griva, Theodora; Kargiotis, Konstantinos; Theocharidou, Eleni; Karagiannis, Asterios] Aristotle Univ Thessaloniki, Hippokrat Hosp, Sch Med, Propedeut Dept Internal Med 2, GR-54006 Thessaloniki, Greece; [Tziomalos, Konstantinos] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Sch Med, Propedeut Dept Internal Med 1, GR-54006 Thessaloniki, Greece; [Gossios, Thomas D.; Pagourelias, Efstathios D.] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Sch Med, Cardiol Clin 1, GR-54006 Thessaloniki, Greece; [Anagnostis, Panagiotis] Hippokrateion Hosp, Endocrinol Clin, Thessaloniki, Greece	University of London; University College London; UCL Medical School; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Ahepa University Hospital; Aristotle University of Thessaloniki; Ahepa University Hospital	Mikhailidis, DP (corresponding author), UCL, Sch Med, Dept Clin Biochem, Vasc Prevent Clin, Royal Free Hosp Campus,Pond St, London NW3 2QG, England.	mikhailidis@aol.com	Mikhailidis, Dimitri P/A-1869-2013; Christaki, Eirini/E-5514-2013; Pagourelias, Efstathios D/J-6573-2013; Pagourelias, Efstathios/AAN-8392-2020; Athyros, V.G./H-5328-2019; Gossios, Thomas/AAG-9203-2020; Anagnostis, Panagiotis/S-4803-2019; Gossios, Thomas/AAO-6178-2020	Mikhailidis, Dimitri P/0000-0002-9566-2263; Christaki, Eirini/0000-0002-8152-6367; Pagourelias, Efstathios/0000-0003-0189-8353; Athyros, V.G./0000-0002-0882-8676; Gossios, Thomas/0000-0001-6260-9813; Theocharidou, Eleni/0000-0001-8136-3927	Cardiology Society of North Greece; Hellenic (Greek) Atherosclerosis Society	Cardiology Society of North Greece; Hellenic (Greek) Atherosclerosis Society	We thank the members of the GREACE Study Collaborative Group for providing patient data. TDG is supported by a grant from the Cardiology Society of North Greece. TG and KK are supported by a grant from the Hellenic (Greek) Atherosclerosis Society. Some of the authors have attended conferences, given lectures and participated in advisory boards or trials sponsored by various pharmaceutical companies.	Adibi P, 2007, LIVER INT, V27, P895, DOI 10.1111/j.1478-3231.2007.01545.x; *AM GASTR ASS, 2002, GASTROENTEROLOGY, V123, P1702, DOI DOI 10.1053/GAST.2002.36569; Anfossi G, 2004, NUTR METAB CARDIOVAS, V14, P215, DOI 10.1016/S0939-4753(04)80008-5; Arnaud C, 2005, ARTERIOSCL THROM VAS, V25, P1231, DOI 10.1161/01.ATV.0000163840.63685.0c; Athyros VG, 2007, NEPHROL DIAL TRANSPL, V22, P118, DOI 10.1093/ndt/gfl538; Athyros VG, 2006, CURR MED RES OPIN, V22, P873, DOI 10.1185/030079906X104696; Athyros VG, 2009, CURR PHARM DESIGN, V15, P479, DOI 10.2174/138161209787315729; Athyros VG, 2002, CURR MED RES OPIN, V18, P220, DOI 10.1185/030079902125000787; Athyros VG, 2003, ANGIOLOGY, V54, P679, DOI 10.1177/000331970305400607; Athyros VG, 2004, J CLIN PATHOL, V57, P728, DOI 10.1136/jcp.2003.012989; Athyros VG, 2004, AM J KIDNEY DIS, V43, P589, DOI 10.1053/j.ajkd.2003.12.023; Calderon RM, 2010, MAYO CLIN PROC, V85, P349, DOI 10.4065/mcp.2009.0365; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5; Dale KM, 2007, AM J MED, V120, P706, DOI 10.1016/j.amjmed.2006.07.033; Ekstedt M, 2007, J HEPATOL, V47, P135, DOI 10.1016/j.jhep.2007.02.013; Emdin M, 2009, INT J CARDIOL, V136, P80, DOI 10.1016/j.ijcard.2008.04.030; Hatzitolios Apostolos, 2004, Indian J Gastroenterol, V23, P131; Kimura Y, 2010, J GASTROENTEROL, V45, P750, DOI 10.1007/s00535-010-0203-y; Lewis JH, 2007, HEPATOLOGY, V46, P1453, DOI 10.1002/hep.21848; Mangaloglu L, 2002, METABOLISM, V51, P409, DOI 10.1053/meta.2002.30954; Mannuicci E, 2007, NUTR METAB CARDIOVAS, V17, P719, DOI 10.1016/j.numecd.2006.09.003; Martin-Castillo A, 2010, BIOMED PHARMACOTHER, V64, P275, DOI 10.1016/j.biopha.2009.06.003; Newman C, 2006, AM J CARDIOL, V97, P61, DOI 10.1016/j.amjcard.2005.07.108; Paolicchi A, 2006, ATHEROSCLEROSIS, V186, P80, DOI 10.1016/j.atherosclerosis.2005.07.012; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Ramesh S, 2005, J HEPATOL, V42, pS2, DOI 10.1016/j.jhep.2004.11.022; Riley P, 2009, CARDIOVASC THER, V27, P216, DOI 10.1111/j.1755-5922.2009.00088.x; Rodriguez-Hernandez H, 2008, EUR J GASTROEN HEPAT, V20, P399, DOI 10.1097/MEG.0b013e3282f448af; Soderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314; 2001, JAMA, V285, P2486	30	497	529	0	41	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 4	2010	376	9756					1916	1922		10.1016/S0140-6736(10)61272-X	http://dx.doi.org/10.1016/S0140-6736(10)61272-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696KH	21109302				2022-12-28	WOS:000285439800033
J	Connaughton, M; Rivett, JG				Connaughton, Mark; Rivett, John G.			Easily Missed? Infective endocarditis	BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL PRESENTATION; DIAGNOSIS		[Connaughton, Mark] St Marys Hosp, Cardiol Dept, Newport PO30 5TG, Wight, England; [Rivett, John G.] Martins Oak Surg, Battle TN33 0EA, England		Connaughton, M (corresponding author), St Marys Hosp, Cardiol Dept, Newport PO30 5TG, Wight, England.	mark.connaughton@iow.nhs.uk						Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Dodds GA, 1996, AM J CARDIOL, V77, P403, DOI 10.1016/S0002-9149(97)89372-1; Gouriet F, 2006, CLIN VACCINE IMMUNOL, V13, P301, DOI 10.1128/CVI.13.2.301.2006; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hill EE, 2006, CLIN MICROBIOL INFEC, V12, P5, DOI 10.1111/j.1469-0691.2005.01289.x; Hill EE, 2007, MAYO CLIN PROC, V82, P1165, DOI 10.4065/82.10.1165; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Netzer ROM, 2002, HEART, V88, P61, DOI 10.1136/heart.88.1.61; Rozich JD, 2003, J AM SOC ECHOCARDIOG, V16, P97, DOI 10.1067/mje.2003.36; San Martin J, 2010, J HEART VALVE DIS, V19, P131; Verhagen DWM, 2006, J ANTIMICROB CHEMOTH, V57, P819, DOI 10.1093/jac/dkl087	11	5	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 1	2010	341								c6596	10.1136/bmj.c6596	http://dx.doi.org/10.1136/bmj.c6596			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691OU	21123344				2022-12-28	WOS:000285091500014
J	Barlowe, C				Barlowe, Charles			ER Sheets Get Roughed Up	CELL			English	Editorial Material							ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; MICROTUBULES		Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Barlowe, C (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA.	charles.barlowe@dartmouth.edu			NIGMS NIH HHS [R01 GM052549] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052549] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Klopfenstein DR, 2001, J CELL BIOL, V153, P1287, DOI 10.1083/jcb.153.6.1287; Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168; Nikonov AV, 2007, J CELL SCI, V120, P2248, DOI 10.1242/jcs.008979; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047	8	6	6	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 24	2010	143	5					665	666		10.1016/j.cell.2010.11.011	http://dx.doi.org/10.1016/j.cell.2010.11.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111224	Bronze			2022-12-28	WOS:000284583500005
J	Clague, MJ; Urbe, S				Clague, Michael J.; Urbe, Sylvie			Ubiquitin: Same Molecule, Different Degradation Pathways	CELL			English	Review							ENDOLYSOSOMAL DEGRADATION; PROTEASOME ACTIVITY; CHAINS; AUTOPHAGY; LIGASE; RECOGNITION; P62/SQSTM1; COMPLEX; SIGNAL	Ubiquitin is a common demoninator in the targeting of substrates to all three major protein degradation pathways in mammalian cells: the proteasome, the lysosome, and the autophagosome. The factors that direct a substrate toward a particular route of degradation likely include ubiquitin chain length and linkage type, which may favor interaction with particular receptors or confer differential susceptibility to deubiquitinase activities associated with each pathway.	[Clague, Michael J.; Urbe, Sylvie] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Clague, MJ (corresponding author), Univ Liverpool, Inst Translat Med, Crown St, Liverpool L69 3BX, Merseyside, England.	clague@liv.ac.uk; urbe@liv.ac.uk	Urbe, Sylvie/S-1433-2018; Clague, Michael J/A-7199-2008	Urbe, Sylvie/0000-0003-4735-9814; Clague, Michael J/0000-0003-3355-9479	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Carter S, 2004, J BIOL CHEM, V279, P52835, DOI 10.1074/jbc.M407769200; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Geetha T, 2008, TRAFFIC, V9, P1146, DOI 10.1111/j.1600-0854.2008.00751.x; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gorbea C, 2010, J BIOL CHEM, V285, P31616, DOI 10.1074/jbc.M110.154120; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Jacobson AD, 2009, J BIOL CHEM, V284, P35485, DOI 10.1074/jbc.M109.052928; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kraft C, 2008, AUTOPHAGY, V4, P838, DOI 10.4161/auto.6603; Kristensen AR, 2008, MOL CELL PROTEOMICS, V7, P2419, DOI 10.1074/mcp.M800184-MCP200; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	25	338	352	4	73	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 24	2010	143	5					682	685		10.1016/j.cell.2010.11.012	http://dx.doi.org/10.1016/j.cell.2010.11.012			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111229	Bronze			2022-12-28	WOS:000284583500010
J	Antos, JR				Antos, Joseph R.			Reforming Health Care Reform in the 112th Congress.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Amer Enterprise Inst Publ Policy Res, Washington, DC USA	American Enterprise Institute for Public Policy Research	Antos, JR (corresponding author), Amer Enterprise Inst Publ Policy Res, Washington, DC USA.							ADAMY J, 2010, WALL STREET J   1001; STREETER S, 2008, RL30343 CRS; STREETER S, 2007, 97684 CRS	3	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2011	364	1					1	3		10.1056/NEJMp1012299	http://dx.doi.org/10.1056/NEJMp1012299			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702UY	21142530				2022-12-28	WOS:000285922600001
J	Famulski, JK; Trivedi, N; Howell, D; Yang, YA; Tong, YA; Gilbertson, R; Solecki, DJ				Famulski, Jakub K.; Trivedi, Niraj; Howell, Danielle; Yang, Yuan; Tong, Yiai; Gilbertson, Richard; Solecki, David J.			Siah Regulation of Pard3A Controls Neuronal Cell Adhesion During Germinal Zone Exit	SCIENCE			English	Article							ASYMMETRIC DIVISION; GRANULE CELLS; MIGRATION; NEOCORTEX; BRAIN; CENTROSOME; POLARITY; MODE	The brain's circuitry is established by directed migration and synaptogenesis of neurons during development. Although neurons mature and migrate in specific patterns, little is known about how neurons exit their germinal zone niche. We found that cerebellar granule neuron germinal zone exit is regulated by proteasomal degradation of Pard3A by the Seven in Absentia homolog (Siah) E3 ubiquitin ligase. Pard3A gain of function and Siah loss of function induce precocious radial migration. Time-lapse imaging using a probe to measure neuronal cell contact reveals that Pard3A promotes adhesive interactions needed for germinal zone exit by recruiting the epithelial tight junction adhesion molecule C to the neuronal cell surface. Our findings define a Siah-Pard3A signaling pathway that controls adhesion-dependent exit of neuronal progenitors or immature neurons from a germinal zone niche.	[Famulski, Jakub K.; Trivedi, Niraj; Howell, Danielle; Yang, Yuan; Tong, Yiai; Gilbertson, Richard; Solecki, David J.] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Solecki, DJ (corresponding author), St Jude Childrens Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	david.solecki@stjude.org	Gilbertson, Richard James/ABE-1346-2021; Solecki, David/N-8080-2018	Gilbertson, Richard James/0000-0001-7539-9472; 	American Lebanese Syrian Associated Charities (ALSAC); National Cancer Institute Cancer Center; March of Dimes Basil O'Connor Starter Scholar Research Award; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA129541, P01CA096832] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); March of Dimes Basil O'Connor Starter Scholar Research Award(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to J. Morgan, M. Dyer, M. Roussel, and N. Ayad for critically reading the manuscript; A. Sawa, S. Zakharenko, and B. Schulman for insightful discussions; S. Connell, R. Baird, and K. Kilborn (Intelligent Imaging Innovations) for timely data analysis advice and support; G. Chan for providing space for some of the revision experiments; and S. Naron for excellent editorial assistance. G. Miesenbock and Memorial Sloan-Kettering Cancer Center provided the pHluorin reporter, A. Miyawaki provided Venus, F. Polleux provided pCIG2, M. Aurrand-Lions provided anti-JAM-C antiserum, I. Dikic provided the hemagglutinin-ubiquitin (HA-Ubq) construct, and A. Sawa shared Siah reagents. Supported by American Lebanese Syrian Associated Charities (ALSAC, D.J.S.), a National Cancer Institute Cancer Center Support Grant (D.J.S.), and a March of Dimes Basil O'Connor Starter Scholar Research Award (D.J.S.).	Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; FISHELL G, 1991, DEVELOPMENT, V113, P755; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; House CM, 2006, STRUCTURE, V14, P695, DOI 10.1016/j.str.2005.12.013; House CM, 2009, CANCER RES, V69, P8835, DOI 10.1158/0008-5472.CAN-09-1676; Karakuzu O, 2009, DEVELOPMENT, V136, P943, DOI 10.1242/dev.029363; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001; Metin C, 2008, J NEUROSCI, V28, P11746, DOI 10.1523/JNEUROSCI.3860-08.2008; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Polleux F, 2002, DEVELOPMENT, V129, P3147; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rakic P, 1985, CELL CONTACT ADHESIO, P67; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; RYDER EF, 1994, NEURON, V12, P1011, DOI 10.1016/0896-6273(94)90310-7; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Solecki DJ, 2006, GENE DEV, V20, P2639, DOI 10.1101/gad.1462506; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030	29	69	70	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1834	1838		10.1126/science.1198480	http://dx.doi.org/10.1126/science.1198480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21109632	Green Accepted			2022-12-28	WOS:000285603700044
J	Gallo, CM; Wang, JT; Motegi, F; Seydoux, G				Gallo, Christopher M.; Wang, Jennifer T.; Motegi, Fumio; Seydoux, Geraldine			Cytoplasmic Partitioning of P Granule Components Is Not Required to Specify the Germline in C. elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; ASYMMETRY; PROTEINS	Asymmetric segregation of P granules during the first four divisions of the Caenorhabditis elegans embryo is a classic example of cytoplasmic partitioning of germline determinants. It is thought that asymmetric partitioning of P granule components during mitosis is essential to distinguish germline from soma. We have identified a mutant (pptr-1) in which P granules become unstable during mitosis and P granule proteins and RNAs are distributed equally to somatic and germline blastomeres. Despite symmetric partitioning of P granule components, pptr-1 mutants segregate a germline that uniquely expresses P granules during postembryonic development. pptr-1 mutants are fertile, except at high temperatures. Hence, asymmetric partitioning of maternal P granules is not essential to specify germ cell fate. Instead, it may serve to protect the nascent germline from stress.	[Gallo, Christopher M.; Wang, Jennifer T.; Motegi, Fumio; Seydoux, Geraldine] Johns Hopkins Sch Med, Ctr Cell Dynam, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine	Seydoux, G (corresponding author), Johns Hopkins Sch Med, Ctr Cell Dynam, Howard Hughes Med Inst, Dept Mol Biol & Genet, 725 N Wolfe St,PCTB 706, Baltimore, MD 21205 USA.	gseydoux@jhmi.edu	SEYDOUX, Geraldine/AAA-2005-2020	Wang, Jennifer/0000-0002-8506-5182; Seydoux, Geraldine/0000-0001-8257-0493	NIH [GM080042, HD007276, HD037047]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080042] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. H. Kim, S. Strome, E. Voronina, K. Kemphues, K. Bennett, and C. Eckmann for reagents and advice. We also obtained reagents from the National Bioresource Project for the Nematode (Japan), the Caenorhabditis Genetics Center, and the Developmental Studies Hybridoma Bank (USA). This work was supported by NIH grants GM080042 to C. M. G., HD007276 to J.T.W., and HD037047 to G. S. G. S. is a Howard Hughes Medical Institute investigator. Plasmids are supplied under a Materials Transfer Agreement from the Howard Hughes Medical Institute.	Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Chuma S, 2009, MOL CELL ENDOCRINOL, V306, P17, DOI 10.1016/j.mce.2008.11.009; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Daniels BR, 2009, J CELL BIOL, V184, P473, DOI 10.1083/jcb.200809077; Gonczy Pierre, 2005, WormBook, P1; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kawasaki L, 2004, GENETICS, V167, P645, DOI 10.1534/genetics.103.023093; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Munro E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003400; Nakamura A, 2008, DEVELOPMENT, V135, P3817, DOI 10.1242/dev.022434; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Spike C, 2008, GENETICS, V178, P1973, DOI 10.1534/genetics.107.083469; Strome Susan, 2005, WormBook, P1, DOI 10.1895/wormbook.1.9.1; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; Updike D, 2010, J ANDROL, V31, P53, DOI 10.2164/jandrol.109.008292; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022	20	95	98	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1685	1689		10.1126/science.1193697	http://dx.doi.org/10.1126/science.1193697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21127218	Green Accepted			2022-12-28	WOS:000285390500069
J	Krug, U; Rollig, C; Koschmieder, A; Heinecke, A; Sauerland, MC; Schaich, M; Thiede, C; Kramer, M; Braess, J; Spiekermann, K; Haferlach, T; Haferlach, C; Koschmieder, S; Rohde, C; Serve, H; Wormann, B; Hiddemann, W; Ehninger, G; Berdel, WE; Buchner, T; Muller-Tidow, C				Krug, Utz; Roellig, Christoph; Koschmieder, Anja; Heinecke, Achim; Sauerland, Maria Cristina; Schaich, Markus; Thiede, Christian; Kramer, Michael; Braess, Jan; Spiekermann, Karsten; Haferlach, Torsten; Haferlach, Claudia; Koschmieder, Steffen; Rohde, Christian; Serve, Hubert; Woermann, Bernhard; Hiddemann, Wolfgang; Ehninger, Gerhard; Berdel, Wolfgang E.; Buechner, Thomas; Mueller-Tidow, Carsten		German Acute Myeloid Leukaemia Coo	Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes	LANCET			English	Article							MICRORNA-EXPRESSION SIGNATURES; RISK MYELODYSPLASTIC SYNDROME; STEM-CELL TRANSPLANTATION; ELDERLY-PATIENTS; INDUCTION CHEMOTHERAPY; FAVORABLE PROGNOSIS; DOSE CYTARABINE; NPM1 MUTATIONS; SURVIVAL; CANCER	Background About 50% of patients (age >= 60 years) who have acute myeloid leukaemia and are otherwise medically healthy (ie, able to undergo intensive chemotherapy) achieve a complete remission (CR) after intensive chemotherapy, but with a substantially increased risk of early death (ED) compared with younger patients. We verified the association of standard clinical and laboratory variables with CR and ED and developed a web-based application for risk assessment of intensive chemotherapy in these patients. Methods Multivariate regression analysis was used to develop risk scores with or without knowledge of the cytogenetic and molecular risk profiles for a cohort of 1406 patients (aged >= 60 years) with acute myeloid leukaemia, but otherwise medically healthy, who were treated with two courses of intensive induction chemotherapy (tioguanine, standard-dose cytarabine, and daunorubicin followed by high-dose cytarabine and mitoxantrone; or with high-dose cytarabine and mitoxantrone in the first and second induction courses) in the German Acute Myeloid Leukaemia Cooperative Group 1999 study. Risk prediction was validated in an independent cohort of 801 patients (aged >60 years) with acute myeloid leukaemia who were given two courses of cytarabine and daunorubicin in the Acute Myeloid Leukaemia 1996 study. Findings Body temperature, age, de-novo leukaemia versus leukaemia secondary to cytotoxic treatment or an antecedent haematological disease, haemoglobin, platelet count, fibrinogen, and serum concentration of lactate dehydrogenase were significantly associated with CR or ED. The probability of CR with knowledge of cytogenetic and molecular risk (score 1) was from 12% to 91%, and without knowledge (score 2) from 21% to 80%. The predicted risk of ED was from 6% to 69% for score 1 and from 7% to 63% for score 2. The predictive power of the risk scores was confirmed in the independent patient cohort (CR score 1, from 10% to 91%; CR score 2, from 16% to 80%; ED score 1, from 6% to 69%; and ED score 2, from 7% to 61%). Interpretation The scores for acute myeloid leukaemia can be used to predict the probability of CR and the risk of ED in older patients with acute myeloid leukaemia, but otherwise medically healthy, for whom intensive induction chemotherapy is planned. This information can help physicians with difficult decisions for treatment of these patients.	[Koschmieder, Anja; Koschmieder, Steffen; Rohde, Christian; Berdel, Wolfgang E.; Buechner, Thomas; Mueller-Tidow, Carsten] Univ Munster, Dept Med Haematol & Oncol A, Munster, Germany; [Roellig, Christoph; Schaich, Markus; Thiede, Christian; Kramer, Michael; Ehninger, Gerhard] Tech Univ Dresden, Dept Med 1, Dresden, Germany; [Heinecke, Achim; Sauerland, Maria Cristina] Univ Munster, Inst Biostat & Clin Res, Munster, Germany; [Braess, Jan; Spiekermann, Karsten; Hiddemann, Wolfgang] Univ Munich, Dept Internal Med 3, Munich, Germany; [Haferlach, Torsten; Haferlach, Claudia] Munich Leukaemia Lab, Munich, Germany; [Serve, Hubert] Goethe Univ Frankfurt, Dept Med, Frankfurt, Germany; [Woermann, Bernhard] Municipal Hosp, Dept Haematol & Oncol, Braunschweig, Germany	University of Munster; Technische Universitat Dresden; University of Munster; University of Munich; MLL Munich Leukemia Laboratory; Goethe University Frankfurt	Krug, U (corresponding author), Univ Hosp Munster, Dept Med A, Albert Schweitzer Str 33, D-48149 Munster, Germany.	utz.krug@ukmuenster.de	Müller-Tidow, Carsten/O-7207-2018; Müller-Tidow, Carsten CMT/B-5257-2014; Sauerland, Maria Cristina/A-4154-2014; Gramatzki, Martin/A-9533-2010	Müller-Tidow, Carsten/0000-0002-7166-5232; Serve, Hubert/0000-0001-8472-5516; Koschmieder, Steffen/0000-0002-1011-8171; Kramer, Michael/0000-0002-0251-2726; Thiede, Christian/0000-0003-1241-2048	Amgen; Celgene; Bundesministerium fur Bildung und Forschung; Novartis; Bayer; Ambit; Bristol-Myers Sqibb; Mundipharma; Deutsche Forschungsgemeinschaft [Mu-1328/8-1]; Deutsche Krebshilfe; Sander-Foundation; Aicuris; Leverkusen; Deutsche Krebshilfe [70-2839-Bu4]	Amgen(Amgen); Celgene(Bristol-Myers SquibbCelgene Corporation); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Novartis(Novartis); Bayer(Bayer AG); Ambit; Bristol-Myers Sqibb; Mundipharma; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Sander-Foundation; Aicuris; Leverkusen; Deutsche Krebshilfe(Deutsche Krebshilfe)	UK has received expenses for travel, accommodation, and meetings from Amgen and Celgene. CT has received grants from Bundesministerium fur Bildung und Forschung; payment for lectures, including service on speakers' bureaus, from Novartis; payment for diagnostic services from Novartis and Ambit; and expenses for travel, accommodations, and meetings from Novartis, Bayer, and Ambit. TH has received payment for lectures including service on speakers' bureaus from Novartis, Bristol-Myers Sqibb, and Celgene; and has part ownership in Munich Leukemia Laboratory. CH has part ownership in Munich Leukemia Laboratory. SK has received grants from Novartis; and expenses for travel, accommodations, and meetings from Mundipharma, Novartis, and Bristol-Myers Sqibb. WEB has received grants from Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe, and Sander-Foundation; payment for lectures, including service on speakers' bureaus, and development of educational presentations from Molecular and Targeted Therapy of Cancer; and expenses for travel, accommodations, and meetings from Amgen. CMT has received grants from Bundesministerium fur Bildung und Forschung; payment for lectures, including service on speakers' bureaus, from Novartis and Celgene; payment for manuscript preparation from Celgene; and expenses for travel, accommodations, and meetings from Celgene, Amgen, Novartis, and Bayer. GE has received payment for board membership from Rhon Klinikum; payment for consultancy from Aicuris, Leverkusen; and grants from Deutsche Forschungsgemeinschaft; payments for lectures, including service on speakers' bureaus, from Update Conference; has stock or stock options in Rhon Klinikum; and has received expenses for travel, accommodations, and meetings from Novartis. The other authors declare that they have no conflicts of interest.; This work was supported by a grant from the Deutsche Krebshilfe (70-2839-Bu4 to TB) and by a grant from the Deutsche Forschungsgemeinschaft (Mu-1328/8-1 to CMT and TB).	Anderson JE, 2002, BLOOD, V100, P3869, DOI 10.1182/blood-2001-12-0354; Appelbaum FR, 2006, BLOOD, V107, P3481, DOI 10.1182/blood-2005-09-3724; Becker H, 2010, J CLIN ONCOL, V28, P596, DOI 10.1200/JCO.2009.25.1496; Bertz H, 2003, J CLIN ONCOL, V21, P1480, DOI 10.1200/JCO.2003.09.110; Breccia M, 2009, HEMATOL ONCOL, V27, P148, DOI 10.1002/hon.889; Buchner T, 2006, J CLIN ONCOL, V24, P2480, DOI 10.1200/JCO.2005.04.5013; Buchner T, 2009, J CLIN ONCOL, V27, P61, DOI 10.1200/JCO.2007.15.4245; Burnett AK, 2007, CANCER, V109, P1114, DOI 10.1002/cncr.22496; Cashen AF, 2010, J CLIN ONCOL, V28, P556, DOI 10.1200/JCO.2009.23.9178; COMINGS DE, 1973, EXP CELL RES, V77, P469, DOI 10.1016/0014-4827(73)90601-0; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Etienne A, 2007, CANCER, V109, P1376, DOI 10.1002/cncr.22537; Fenaux P, 2010, J CLIN ONCOL, V28, P562, DOI 10.1200/JCO.2009.23.8329; Giles FJ, 2007, BRIT J HAEMATOL, V136, P624, DOI 10.1111/j.1365-2141.2006.06476.x; Goldstone AH, 2002, BLOOD, V100, p88A; Goldstone AH, 2001, BLOOD, V98, P1302, DOI 10.1182/blood.V98.5.1302; Grimwade D, 2001, BLOOD, V98, P1312, DOI 10.1182/blood.V98.5.1312; Itzykson R, 2011, BLOOD, V117, P403, DOI 10.1182/blood-2010-06-289280; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1090, DOI 10.1002/cncr.21723; Kantarjian H, 2010, BLOOD, V116, P4422, DOI 10.1182/blood-2010-03-276485; Kern W, 2003, BLOOD, V101, P64, DOI 10.1182/blood-2002-02-0532; LOWENBERG B, 1989, J CLIN ONCOL, V7, P1268; Lowenberg B, 2009, NEW ENGL J MED, V361, P1235, DOI 10.1056/NEJMoa0901409; Ohtake S, 2011, BLOOD, V117, P2358, DOI 10.1182/blood-2010-03-273243; Rollig C, 2010, BLOOD, V116, P971, DOI 10.1182/blood-2010-01-267302; Rollig C, 2009, BLOOD, V114, P139, DOI 10.1182/blood.V114.22.329.329; Rowe JM, 2004, BLOOD, V103, P479, DOI 10.1182/blood-2003-05-1686; Schnittger S, 2005, BLOOD, V106, p68A, DOI 10.1182/blood.V106.11.223.223; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Sekeres MA, 2009, BLOOD, V113, P28, DOI 10.1182/blood-2008-05-157065; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Walter RB, 2010, J CLIN ONCOL, V28, P1766, DOI 10.1200/JCO.2009.25.1066; Whitman SP, 2010, BLOOD, V116, P3622, DOI 10.1182/blood-2010-05-283648	34	216	226	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2010	376	9757					2000	2008		10.1016/S0140-6736(10)62105-8	http://dx.doi.org/10.1016/S0140-6736(10)62105-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701GZ	21131036				2022-12-28	WOS:000285807700029
J	Schrappe, M				Schrappe, Martin			Mitoxantrone in first-relapse paediatric ALL: the ALL R3 trial	LANCET			English	Editorial Material							ACUTE LYMPHOBLASTIC-LEUKEMIA; MINIMAL RESIDUAL DISEASE; THERAPY		Univ Med Ctr Schleswig Holstein, Ctr Paediat, D-24105 Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Schrappe, M (corresponding author), Univ Med Ctr Schleswig Holstein, Ctr Paediat, Campus Kiel, D-24105 Kiel, Germany.	m.schrappe@pediatrics.uni-kiel.de	Schrappe, Martin/ABA-6144-2020					Bader P, 2009, J CLIN ONCOL, V27, P377, DOI 10.1200/JCO.2008.17.6065; Bruggemann M, 2010, LEUKEMIA, V24, P521, DOI 10.1038/leu.2009.268; Gaynon PS, 2005, BRIT J HAEMATOL, V131, P579, DOI 10.1111/j.1365-2141.2005.05773.x; Moricke A, 2008, BLOOD, V111, P4477, DOI 10.1182/blood-2007-09-112920; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Parker C, 2010, LANCET, V376, P2009, DOI 10.1016/S0140-6736(10)62002-8; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; REITER A, 1994, BLOOD, V84, P3122, DOI 10.1182/blood.V84.9.3122.3122; Sallan S E, 1990, Haematol Blood Transfus, V33, P459; Schrappe M, 2010, LEUKEMIA, V24, P253, DOI 10.1038/leu.2009.276; Tallen G, 2010, J CLIN ONCOL, V28, P2339, DOI 10.1200/JCO.2009.25.1983; van der Velden VHJ, 2003, LEUKEMIA, V17, P1013, DOI 10.1038/sj.leu.2402922; van Dongen JJM, 1998, LANCET, V352, P1731, DOI 10.1016/S0140-6736(98)04058-6	13	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2010	376	9757					1968	1970		10.1016/S0140-6736(10)62194-0	http://dx.doi.org/10.1016/S0140-6736(10)62194-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701GZ	21131040				2022-12-28	WOS:000285807700007
J	Bottke, WF; Walker, RJ; Day, JMD; Nesvorny, D; Elkins-Tanton, L				Bottke, William F.; Walker, Richard J.; Day, James M. D.; Nesvorny, David; Elkins-Tanton, Linda			Stochastic Late Accretion to Earth, the Moon, and Mars	SCIENCE			English	Article							SIDEROPHILE ELEMENT SYSTEMATICS; CORE FORMATION; OSMIUM ISOTOPE; ASTEROID BELT; MANTLE; ORIGIN; DIFFERENTIATION; CONSTRAINTS; METEORITES; SILICATE	Core formation should have stripped the terrestrial, lunar, and martian mantles of highly siderophile elements (HSEs). Instead, each world has disparate, yet elevated HSE abundances. Late accretion may offer a solution, provided that >= 0.5% Earth masses of broadly chondritic planetesimals reach Earth's mantle and that similar to 10 and similar to 1200 times less mass goes to Mars and the Moon, respectively. We show that leftover planetesimal populations dominated by massive projectiles can explain these additions, with our inferred size distribution matching those derived from the inner asteroid belt, ancient martian impact basins, and planetary accretion models. The largest late terrestrial impactors, at 2500 to 3000 kilometers in diameter, potentially modified Earth's obliquity by similar to 10 degrees, whereas those for the Moon, at similar to 250 to 300 kilometers, may have delivered water to its mantle.	[Bottke, William F.; Nesvorny, David] SW Res Inst, Boulder, CO 80302 USA; [Bottke, William F.; Nesvorny, David] NASA, Lunar Sci Inst, Boulder, CO 80302 USA; [Walker, Richard J.; Day, James M. D.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Day, James M. D.] Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA 92093 USA; [Elkins-Tanton, Linda] MIT, Cambridge, MA 02139 USA	National Aeronautics & Space Administration (NASA); University System of Maryland; University of Maryland College Park; University of California System; University of California San Diego; Scripps Institution of Oceanography; Massachusetts Institute of Technology (MIT)	Bottke, WF (corresponding author), SW Res Inst, 1050 Walnut St,Suite 400, Boulder, CO 80302 USA.	bottke@boulder.swri.edu	Day, James/A-5099-2010; Walker, Richard/K-6869-2016; Elkins-Tanton, Linda/C-5508-2008	Day, James/0000-0001-9520-3465; Walker, Richard/0000-0003-0348-2407; Elkins-Tanton, Linda/0000-0003-4008-1098	NASA's Lunar Science Institute [NNA09DB33A]; NASA [NNG04GJ49A]; Direct For Mathematical & Physical Scien [0747154] Funding Source: National Science Foundation	NASA's Lunar Science Institute; NASA(National Aeronautics & Space Administration (NASA)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank A. Barr, R. Canup, R. Citron, L. Dones, H. Levison, J. Jones, H. Nekvasil, A. Morbidelli, D. Minton, S. Mojzsis, G. J. Taylor, and D. Vokouhlicky for many useful discussions and two anonymous reviewers for constructive reviews. W.F.B's and D.N.'s participation was supported by NASA's Lunar Science Institute through a grant to the Center for Lunar Origin and Evolution at the Southwest Research Institute in Boulder, Colorado. R.J.W.'s and J.M.D.D.'s work was supported by NASA's Lunar Science Institute through contract NNA09DB33A to the Center for Lunar Science and Exploration at the Lunar and Planetary Institute in Houston, Texas, and the NASA Astrobiology Program through grant NNG04GJ49A to the Goddard Center for Astrobiology in Greenbelt, Maryland.	Artemieva NA, 2008, SOLAR SYST RES+, V42, P329, DOI 10.1134/S0038094608040059; Asphaug E, 2010, CHEM ERDE-GEOCHEM, V70, P199, DOI 10.1016/j.chemer.2010.01.004; Becker H, 2006, GEOCHIM COSMOCHIM AC, V70, P4528, DOI 10.1016/j.gca.2006.06.004; Bennett VC, 2002, GEOCHIM COSMOCHIM AC, V66, P2615, DOI 10.1016/S0016-7037(02)00862-1; Borg LE, 2003, METEORIT PLANET SCI, V38, P1713, DOI 10.1111/j.1945-5100.2003.tb00011.x; BORISOV A, 1994, GEOCHIM COSMOCHIM AC, V58, P705, DOI 10.1016/0016-7037(94)90500-2; Bottke WF, 2002, ICARUS, V156, P399, DOI 10.1006/icar.2001.6788; Bottke WF, 2006, NATURE, V439, P821, DOI 10.1038/nature04536; Bottke WF, 2007, ICARUS, V190, P203, DOI 10.1016/j.icarus.2007.02.010; Brandon AD, 2000, GEOCHIM COSMOCHIM AC, V64, P4083, DOI 10.1016/S0016-7037(00)00482-8; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; Chou CL, 1978, P LUNAR PLANET SCI, V9, P219; Cuzzi JN, 2010, ICARUS, V208, P518, DOI 10.1016/j.icarus.2010.03.005; Dahl TW, 2010, EARTH PLANET SC LETT, V295, P177, DOI 10.1016/j.epsl.2010.03.038; Day JMD, 2010, EARTH PLANET SC LETT, V289, P595, DOI 10.1016/j.epsl.2009.12.001; FARINELLA P, 1992, ICARUS, V97, P111, DOI 10.1016/0019-1035(92)90060-K; Frey HV, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002449; Halliday AN, 2005, TREATISE GEOCHEM, V1, P509; HOLSAPPLE KA, 1993, ANNU REV EARTH PL SC, V21, P333, DOI 10.1146/annurev.ea.21.050193.002001; Johansen A, 2007, NATURE, V448, P1022, DOI 10.1038/nature06086; JONES JH, 1986, NATURE, V323, P470, DOI 10.1038/323470a0; Jones JH, 2003, CHEM GEOL, V196, P21, DOI 10.1016/S0009-2541(02)00404-7; Maier WD, 2009, NATURE, V460, P620, DOI 10.1038/nature08205; Marinova MM, 2008, NATURE, V453, P1216, DOI 10.1038/nature07070; McCubbin FM, 2010, P NATL ACAD SCI USA, V107, P11223, DOI 10.1073/pnas.1006677107; Nesvorny D, 2010, ASTROPHYS J, V713, P816, DOI 10.1088/0004-637X/713/2/816; Puchtel IS, 2008, GEOCHIM COSMOCHIM AC, V72, P3022, DOI 10.1016/j.gca.2008.04.006; Robert F, 2003, SPACE SCI REV, V106, P87, DOI 10.1023/A:1024629402715; Rubie DC, 2004, NATURE, V429, P58, DOI 10.1038/nature02473; Rubie DC, 2003, EARTH PLANET SC LETT, V205, P239, DOI 10.1016/S0012-821X(02)01044-0; Sharp ZD, 2010, SCIENCE, V329, P1050, DOI 10.1126/science.1192606; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Walker RJ, 2009, CHEM ERDE-GEOCHEM, V69, P101, DOI 10.1016/j.chemer.2008.10.001; Walker RJ, 2004, EARTH PLANET SC LETT, V224, P399, DOI 10.1016/j.epsl.2004.05.036; Ward WR, 2000, NATURE, V403, P741, DOI 10.1038/35001516; Warren PH, 2005, TREATISE GEOCHEM, V1, P559	39	159	161	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1527	1530		10.1126/science.1196874	http://dx.doi.org/10.1126/science.1196874			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148387				2022-12-28	WOS:000285153500061
J	Hirose, H; Asano, Y; Obara, K; Kimura, T; Matsuzawa, T; Tanaka, S; Maeda, T				Hirose, Hitoshi; Asano, Youichi; Obara, Kazushige; Kimura, Takeshi; Matsuzawa, Takanori; Tanaka, Sachiko; Maeda, Takuto			Slow Earthquakes Linked Along Dip in the Nankai Subduction Zone	SCIENCE			English	Article							SOUTHWEST JAPAN; SLIP EVENTS; BUNGO CHANNEL; TREMOR		[Hirose, Hitoshi; Asano, Youichi; Obara, Kazushige; Kimura, Takeshi; Matsuzawa, Takanori; Tanaka, Sachiko] Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 3050006, Japan; [Obara, Kazushige; Maeda, Takuto] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Maeda, Takuto] Univ Tokyo, Interfac Initiat Informat Studies, Ctr Integrated Disaster Informat, Bunkyo Ku, Tokyo 1130032, Japan	National Research Institute for Earth Science & Disaster Resilience; University of Tokyo; University of Tokyo	Hirose, H (corresponding author), Natl Res Inst Earth Sci & Disaster Prevent, 3-1 Tennodai, Tsukuba, Ibaraki 3050006, Japan.	hirose@bosai.go.jp	Matsuzawa, Takanori/C-1907-2018; Hirose, Hitoshi/AAF-8903-2020; Maeda, Takuto/E-5332-2013	Matsuzawa, Takanori/0000-0003-0440-251X; Hirose, Hitoshi/0000-0001-5527-3733; Maeda, Takuto/0000-0002-8861-4597				Hirose H, 2005, EARTH PLANETS SPACE, V57, P961, DOI 10.1186/BF03351875; Hirose H, 1999, GEOPHYS RES LETT, V26, P3237, DOI 10.1029/1999GL010999; Ito Y, 2007, SCIENCE, V315, P503, DOI 10.1126/science.1134454; Obara K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020848; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Obara K, 2005, EARTH PLANETS SPACE, V57, P321, DOI 10.1186/BF03352570; Obara K, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043679; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Sagiya T, 1999, J GEOPHYS RES-SOL EA, V104, P1111, DOI 10.1029/98JB02644	9	81	82	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1502	1502		10.1126/science.1197102	http://dx.doi.org/10.1126/science.1197102			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148384				2022-12-28	WOS:000285153500054
J	Frenk, J; Chen, L; Bhutta, ZA; Cohen, J; Crisp, N; Evans, T; Fineberg, H; Garcia, P; Ke, Y; Kelley, P; Kistnasamy, B; Meleis, A; Naylor, D; Pablos-Mendez, A; Reddy, S; Scrimshaw, S; Sepulveda, J; Serwadda, D; Zurayk, H				Frenk, Julio; Chen, Lincoln; Bhutta, Zulfiqar A.; Cohen, Jordan; Crisp, Nigel; Evans, Timothy; Fineberg, Harvey; Garcia, Patricia; Ke, Yang; Kelley, Patrick; Kistnasamy, Barry; Meleis, Afaf; Naylor, David; Pablos-Mendez, Ariel; Reddy, Srinath; Scrimshaw, Susan; Sepulveda, Jaime; Serwadda, David; Zurayk, Huda			Health professionals for a new century: transforming education to strengthen health systems in an interdependent world	LANCET			English	Review							MEDICAL-EDUCATION; PUBLIC-HEALTH; HUMAN-RESOURCES; GLOBAL HEALTH; REFORM; WORKFORCE; COUNTRIES; SCHOOL; SOUTH; CARE		[Frenk, Julio] Harvard Univ, Sch Publ Hlth, Off Dean, Boston, MA 02115 USA; [Chen, Lincoln] China Med Board, Cambridge, MA 02138 USA; [Bhutta, Zulfiqar A.] Aga Khan Univ, Karachi, Pakistan; [Cohen, Jordan] George Washington Univ, Med Ctr, Washington, DC 20037 USA; [Evans, Timothy] James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Fineberg, Harvey; Kelley, Patrick] US Inst Med, Washington, DC USA; [Garcia, Patricia] Univ Peruana Cayetano Heredia, Sch Publ Hlth, Lima, Peru; [Ke, Yang] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Kistnasamy, Barry] Natl Hlth Lab Serv, Johannesburg, South Africa; [Meleis, Afaf] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Naylor, David] Univ Toronto, Toronto, ON, Canada; [Pablos-Mendez, Ariel] Rockefeller Fdn, New York, NY USA; [Reddy, Srinath] Publ Hlth Fdn India, New Delhi, India; [Scrimshaw, Susan] Sage Coll, Troy, MI USA; [Sepulveda, Jaime] Bill & Melinda Gates Fdn, Seattle, WA USA; [Serwadda, David] Makarere Univ, Sch Publ Hlth, Kampala, Uganda; [Zurayk, Huda] Amer Univ Beirut, Fac Hlth Sci, Ctr Res Populat & Hlth, Beirut, Lebanon	Harvard University; Harvard T.H. Chan School of Public Health; Aga Khan University; George Washington University; Universidad Peruana Cayetano Heredia; Peking University; National Health Laboratory Service; University of Pennsylvania; University of Toronto; Public Health Foundation of India; Bill & Melinda Gates Foundation; Makerere University; American University of Beirut	Frenk, J (corresponding author), Harvard Univ, Sch Publ Hlth, Off Dean, Kresge Bldg,Room 1005,677 Huntington Ave, Boston, MA 02115 USA.	jfrenk@hsph.harvard.edu; lchen@cmbfound.org	Dharamsi, Shafik/H-3165-2011	Reddy, K Srinath/0000-0003-3416-3548; Crisp, Nigel/0000-0002-9452-095X	Bill & Melinda Gates Foundation; Rockefeller Foundation; China Medical Board	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Rockefeller Foundation; China Medical Board	The work of the Commission was supported by funding from the Bill & Melinda Gates Foundation, the Rockefeller Foundation, and the China Medical Board. The commissioners are pleased to acknowledge the contribution of the research team, consisting of Catherine M Michaud, Ananda S Bandyopadhyay, Chenhui Liu, Ruvandhi Nathavitharana, Stanislava Nikolova, Sonali Vaid, and Leans S Wen. They also thank two independent reviewers, Anita Berlin and Kenji Shibuya, for their valuable commentaries on the submitted manuscript.	Accorsi S, 2010, T ROY SOC TROP MED H, V104, P336, DOI 10.1016/j.trstmh.2009.12.009; Adams O., 2004, HUM RESOUR HEALTH, V2, P1; AHMED SM, 2007, AS PAC ACT ALL HUM R; Aiken LH, 2004, HEALTH AFFAIR, V23, P69, DOI 10.1377/hlthaff.23.3.69; *AM ASS COLL NURS, 1996, ESS MAST ED ADV PRAC; *AM ASS COLL NURS, 2010, ACAD MED, V85, pS1; Amin Z, 2010, ACAD MED, V85, P333, DOI 10.1097/ACM.0b013e3181c874cb; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Anand S, 2008, LANCET, V372, P1774, DOI 10.1016/S0140-6736(08)61363-X; Anderson LM, 2003, AM J PREV MED, V24, P68, DOI 10.1016/S0749-3797(02)00657-8; [Anonymous], JAPAN HLTH SYSTEM RE; [Anonymous], 2000, LEARNING TRANSFORMAT; [Anonymous], 2004, HUM RES HLTH OV CRIS; [Anonymous], 1998, CHINESE MAT MED CHEM; *ASS FAC MED CANF, 2010, FUT MED ED CAN FMEC; Azizi F, 1997, MED EDUC, V31, P159, DOI 10.1111/j.1365-2923.1997.tb02559.x; BACH S, 2007, INT MIGRATION HLTH W; Bakeera SK, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-25; Benner P., 2010, ED NURSES CALL RADIC, V15; Berlinguer Giovanni, 2001, CHALLENGING INEQUITI, P35; BHUTTA Z, 2010, GLOB EXP COMM HLTH W; BHUTTA ZA, 2008, B WHO B, V86; Blades DS, 2000, BRIT J GEN PRACT, V50, P483; Blumenthal D S, 1994, J Rural Health, V10, P109, DOI 10.1111/j.1748-0361.1994.tb00217.x; Boelen C, 2009, MED EDUC, V43, P887, DOI 10.1111/j.1365-2923.2009.03413.x; Bonner, 1996, BECOMING PHYS MED ED; Cruz ERB, 2008, MEDICC REV, V10, P35, DOI 10.37757/MR2008.V10.N4.8; Bostridge M, 2008, F NIGHTINGALE MAKING; Brenna T, 2003, J AM COLL SURGEONS, V196, P115; Buchan J, 2002, B WORLD HEALTH ORGAN, V80, P575; Bullock Mary Brown, 1980, AM TRANSPLANT ROCKEF; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Calabretta N, 2002, J MED LIBR ASSOC, V90, P32; Carson S, 2009, OPEN LEARN, V24, P23, DOI 10.1080/02680510802627787; Chanda R, 2002, B WORLD HEALTH ORGAN, V80, P158; Chatterjee P, 2010, LANCET, V375, P1679, DOI 10.1016/S0140-6736(10)60720-9; CHEN CC, 1989, MED RURAL CHINA; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Chen LC, 2006, LANCET, V367, P1800, DOI 10.1016/S0140-6736(06)68783-7; Chen LC, 2005, NEW ENGL J MED, V353, P1850, DOI 10.1056/NEJMe058188; Chen LC, 2010, B WORLD HEALTH ORGAN, V88, P323, DOI 10.2471/BLT.10.078477; Cherian M, 2010, B WORLD HEALTH ORGAN, V88, P637, DOI 10.2471/BLT.09.072371; Cohen JJ, 2007, JAMA-J AM MED ASSOC, V298, P670, DOI 10.1001/jama.298.6.670; *COMM STUD NURS ED, 1923, NURS NURS ED US; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Cooke M, 2010, ED PHYS CALL REFORM; Cooke M, 2006, NEW ENGL J MED, V355, P1339, DOI 10.1056/NEJMra055445; CORBETT MA, 1981, J NURSE-MIDWIFERY, V26, P33, DOI 10.1016/0091-2182(81)90085-9; CRISP N, 2010, TURNING WORLD UPSIDE, P201; CRISP N, 2010, TURNING WORLD UPSIDE, P114; Crisp Nigel., 2010, TURNING WORLD UPSIDE; DOVLO D, 1999, HUMAN RESOURCES HLTH, V3, P40; Dzau VJ, 2010, LANCET, V375, P949, DOI 10.1016/S0140-6736(09)61082-5; Eckhert NL, 2010, ACAD MED, V85, P622, DOI 10.1097/ACM.0b013e3181d2aee1; Epstein RM, 2002, JAMA-J AM MED ASSOC, V287, P226, DOI 10.1001/jama.287.2.226; Evans T., 2001, CHALLENGING INEQUITI; Filliozat Jean, 1964, CLASSICAL DOCTRINE I; Flexner A., 1910, MED ED US CANADA REP; Flexner A, 1912, MEDICAL ED EUROPE RE, V6; Fosdick RB, 1952, STORY ROCKEFELLER FD; Freidson E., 1988, PROFESSION MED STUDY; Freire P., 1970, PEDAGOGY OPPRESSED 1; Frenk J, 2003, LANCET, V362, P1667, DOI 10.1016/S0140-6736(03)14803-9; FRENK J, 2009, DE BARM GLOB HLTH LE; Frenk J., 1993, CHANGING MED PROFESS, P25; Frenk J, 2009, LANCET, V374, P170, DOI 10.1016/S0140-6736(09)60693-0; Frenk J, 2008, J PUBLIC HEALTH POL, V29, P449, DOI 10.1057/jphp.2008.35; Fried LP, 2010, LANCET, V375, P535, DOI 10.1016/S0140-6736(10)60203-6; Garcia PJ, 2009, J PUBLIC HEALTH POL, V30, P250, DOI 10.1057/jphp.2009.6; Gebbie K, 2003, WHO WILL KEEP THE PUBLIC HEALTHY?, P27; GHUMAN BS, 2010, TRIBUNE CHANDIG 0525; Gies WJ, 1926, DENT ED US CANADA RE; *GLOB HLTH WORKF A, 2008, SCAL UP SAV LIV; *GLOB HLTH WORKF A, 2010, COMM HLTH WORK KEY M; Government of India, 1946, REP HLTH SURV DEV CO; GRUPPEN LD, 2010, COMPETENCY BASED ED; HAFFERTY FW, 1993, CHANGING MED PROFESS; Hagopian Amy, 2004, Hum Resour Health, V2, P17, DOI 10.1186/1478-4491-2-17; Haidet P, 2002, ACAD MED, V77, P40, DOI 10.1097/00001888-200201000-00009; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; HANSEN F, 2008, REVOLUTION HEALTHCAR; HARDEN RM, 1988, MED TEACH, V10, P19, DOI 10.3109/01421598809019321; Harden RM, 1999, MED TEACH, V21, P553, DOI 10.1080/01421599978960; Hauer KE, 2008, JAMA-J AM MED ASSOC, V300, P1154, DOI 10.1001/jama.300.10.1154; Herrick DM, 2007, MED TOURISM GLOBAL C; Horowitz Michael D, 2007, MedGenMed, V9, P33; Horton R, 2005, LANCET, V366, P1514, DOI 10.1016/S0140-6736(05)67454-5; Horton R, 2000, LANCET, V355, P2231, DOI 10.1016/S0140-6736(00)02414-4; Horton R, 2009, LANCET, V373, P784, DOI 10.1016/S0140-6736(09)60100-8; HUNT P, 2007, AHRC428 OFF UN HIGH; *I MED, 2009, GLOB ISS WAT SAN HLT; Iiyoshi T., 2008, OPENING UP ED; Institute of Medicine, 2009, INT MED HLTH PUBL SU; Institute of Medicine, 2003, HLTH PROF ED BRIDG Q; Institute of Medicine, 2010, FUT NURS LEAD CHANG; Institute of Medicine, 2002, FUT PUBL HLTH 21 CEN; *INT I MED ED, 2010, GLOB MIN STAND; Irvine D, 2006, MED EDUC, V40, P202, DOI 10.1111/j.1365-2929.2006.02397.x; *J MAC JR FDN, 2008, REV MED SCH ED MISS; Jarman H, 2010, HEALTH POLICY, V94, P158, DOI 10.1016/j.healthpol.2009.09.007; Kanchanaraksa S, 2009, OPEN LEARN, V24, P39, DOI 10.1080/02680510802627811; Kark S. L., 1981, PRACTICE COMMUNITY O; KE Y, 2010, 2 M COMM ED HLTH PRO; Keehan S, 2008, HEALTH AFFAIR, V27, pW145, DOI 10.1377/hlthaff.27.2.w145; KELLER H, 1918, LIBERATOR, P13; Kent A, 2007, MED TEACH, V29, P906, DOI 10.1080/01421590701832122; Kline DS, 2003, J NURS SCHOLARSHIP, V35, P107, DOI 10.1111/j.1547-5069.2003.00107.x; Koplan JP, 2009, LANCET, V373, P1993, DOI 10.1016/S0140-6736(09)60332-9; Kurdak H, 2008, MED TEACH, V30, P768, DOI 10.1080/01421590802232834; Kwong JC, 2002, CAN MED ASSOC J, V166, P1023; Lam TP, 2009, ACAD MED, V84, P1313, DOI 10.1097/ACM.0b013e3181b18189; Lee MY, 2008, MED TEACH, V30, P159, DOI 10.1080/01421590701881665; Levinson W, 2010, HEALTH AFFAIR, V29, P1310, DOI 10.1377/hlthaff.2009.0450; Lionis C, 2010, FAM PRACT, V27, P48, DOI 10.1093/fampra/cmp078; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; LUBANPLOZZA B, 1995, PATIENT EDUC COUNS, V26, P257, DOI 10.1016/0738-3991(95)00756-P; Markos L, 2003, J TRANSFORMATIVE ED, V1, P3, DOI DOI 10.1177/1541344603252099; MASEEH J, 2010, MEDIA SCAN      0604; MENAND L, 2010, MARKETPLACE IDEAS RE, P101; MERSON M, 2009, HLTH SYSTEMS STRENGT; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Mokwena K, 2007, B WORLD HEALTH ORGAN, V85, P949, DOI 10.2471/BLT.07.044552; Mudur G, 2005, BRIT MED J, V330, P920, DOI 10.1136/bmj.330.7497.920-a; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Mullan Fitzhugh, 2005, HEALERS ABROAD AM RE; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P717; National Health Service (UK), 2007, ROL DOCT CONS STAT; Naylor CD, 2006, CLIN MED, V6, P488, DOI 10.7861/clinmedicine.6-5-488; *NCFMEA, 2010, NCFMEA M TRANS UNPUB; Neville AJ, 2009, MED PRIN PRACT, V18, P1, DOI 10.1159/000163038; Nightingale F., 1859, NOTES NURSING WHAT I; *OECD, 2005, POL BRIEF EL TERT ED; OECD, 2007, GIV KNOWL FREE EM OP; Pablos-Mendez A, 2005, B WORLD HEALTH ORGAN, V83, P723; PALSDOTTIR B, 2010, TRANSFORMING MED ED; Pang T, 2002, BMJ-BRIT MED J, V324, P499, DOI 10.1136/bmj.324.7336.499; Papa FJ, 1999, ACAD MED, V74, P154, DOI 10.1097/00001888-199902000-00015; Patel V, 2003, BRIT MED J, V327, P926, DOI 10.1136/bmj.327.7420.926; PICKERING G, 1978, QUEST EXCELLENCE MED; Porter R., 1997, GREATEST BENEFIT MAN; Prime Minister's Commission on the Future of Nursing and Midwifery, 2010, FRONT LIN CAR FUT NU; *PUBL HLTH FDN IND, 2008, INT C NEW DIR PUBL H; Reichenbach L., 2007, EXPLORING GENDER DIM; ROSENBERG CE, 2007, OUR PRESENT COMPALIN; Royal College of Physicians, 2005, DOCT SOC MED PROF CH; Ruiz JG, 2006, ACAD MED, V81, P207, DOI 10.1097/00001888-200603000-00002; Schwarz MR, 2007, MED TEACH, V29, P699, DOI 10.1080/01421590701749821; SEIPP C, 1963, HLTH CARE COMMUNITY; Sen A., 2010, IDEA JUSTICE, DOI DOI 10.2307/J.CTVJNRV7N; SEPULVEDA J, 2007, PEPFAR IMPLEMENTATIO; Shanafelt TD, 2009, ARCH INTERN MED, V169, P990, DOI 10.1001/archinternmed.2009.70; Shirey MR, 2006, NURS EDUC, V31, P95, DOI 10.1097/00006223-200605000-00002; Shomaker TS, 2010, ACAD MED, V85, P363, DOI 10.1097/ACM.0b013e3181c865b8; Siantz MLD, 2007, J TRANSCULT NURS, V18, p86S, DOI 10.1177/1043659606296465; Smolinski M.S., 2005, MICROBIAL THREATS HL; Southall D, 2010, LANCET, V376, P498, DOI 10.1016/S0140-6736(10)61157-9; Starr P, 1982, SOCIAL TRANSFORMATIO; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Swick HM, 2000, ACAD MED, V75, P612, DOI 10.1097/00001888-200006000-00010; UK General Medical Council, 2009, TOM DOCT OUTC STAND; Upvall MJ, 2004, INT J NURS ED SCHOLA, V1; *US GOV ACC OFF, 2009, GRAD MED ED TRENDS T; VALBERG LS, 1994, CAN MED ASSOC J, V151, P1581; Wartman SA, 2009, LANCET, V374, P1402, DOI 10.1016/S0140-6736(09)61594-4; Welch WH., 1916, I HYGIENE BEING REPO; WELLMAN C, 1912, NEW ORL MED SURG J, V64, P893; Whitcomb ME, 2009, ACAD MED, V84, P1476, DOI 10.1097/ACM.0b013e3181bb25db; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; *WHO, 2006, WORLD HLTH REP WORK, P46; *WHO DIV DEV HUM R, 1995, DEF MEAS SOC ACC MED; *WHO WFME STRAT PA, 2004, TECHN M SCHAEFF COP; Woollard RF, 2006, MED EDUC, V40, P301, DOI 10.1111/j.1365-2929.2006.02416.x; WOOLLARD RF, 2010, SOCIAL ACCOUNTABILIT; World Health Organization, 2010, WHO GLOB COD PRACT I; World Health Organization, 2006, WORLD HLTH REP WORK; *WTO, 2010, HLTH SOC SERV; Wyon J. B., 1971, KHANNA STUDY POPULAT; Xu D, 2010, LANCET, V375, P1502, DOI 10.1016/S0140-6736(10)60241-3; Yach D, 2005, SCIENCE, V307, P317, DOI 10.1126/science.307.5708.317; Zhang DQ, 2008, LANCET, V372, P1865, DOI 10.1016/S0140-6736(08)61355-0	181	2253	2300	22	459	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2010	376	9756					1923	1958		10.1016/S0140-6736(10)61854-5	http://dx.doi.org/10.1016/S0140-6736(10)61854-5			36	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	696KH	21112623	Green Published, Green Submitted			2022-12-28	WOS:000285439800034
J	McTighe, SM; Cowell, RA; Winters, BD; Bussey, TJ; Saksida, LM				McTighe, Stephanie M.; Cowell, Rosemary A.; Winters, Boyer D.; Bussey, Timothy J.; Saksida, Lisa M.			Paradoxical False Memory for Objects After Brain Damage	SCIENCE			English	Article							SHORT-TERM-MEMORY; RECOGNITION MEMORY; AMNESIC PATIENTS; PERIRHINAL CORTEX; ANIMAL-MODEL; RETROACTIVE INTERFERENCE; CONSOLIDATION; RETRIEVAL; LESIONS; IMPAIRMENT	Poor memory after brain damage is usually considered to be a result of information being lost or rendered inaccessible. It is assumed that such memory impairment must be due to the incorrect interpretation of previously encountered information as being novel. In object recognition memory experiments with rats, we found that memory impairment can take the opposite form: a tendency to treat novel experiences as familiar. This impairment could be rescued with the use of a visual-restriction procedure that reduces interference. Such a pattern of data can be explained in terms of a recent representational-hierarchical view of cognition.	[McTighe, Stephanie M.; Bussey, Timothy J.; Saksida, Lisa M.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [McTighe, Stephanie M.; Bussey, Timothy J.; Saksida, Lisa M.] Univ Cambridge, MRC, Cambridge CB2 3EB, England; [McTighe, Stephanie M.; Bussey, Timothy J.; Saksida, Lisa M.] Univ Cambridge, Wellcome Trust Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; [Cowell, Rosemary A.] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; [Winters, Boyer D.] Univ Guelph, Dept Psychol, Guelph, ON N1G 2W1, Canada	University of Cambridge; University of Cambridge; University of Cambridge; University of California System; University of California San Diego; University of Guelph	Saksida, LM (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	lms42@cam.ac.uk	Cowell, Rosemary/K-2366-2012; Bussey, Timothy J/M-2758-2016; Saksida, Lisa M/M-2753-2016	Bussey, Timothy J/0000-0001-7518-4041; Saksida, Lisa M/0000-0002-8416-8171	BBSRC; MRC at the University of Cambridge; Clinical Neuroscience Institute	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC at the University of Cambridge; Clinical Neuroscience Institute	Supported by a grant from the BBSRC (L. M. S., T.J.B., B. D. W.), and a 3-year MRC-funded Ph.D. studentship at the University of Cambridge, MRC/Wellcome Trust Behavioral and Clinical Neuroscience Institute (S.M.M.).	ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P5637, DOI 10.1073/pnas.91.12.5637; BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; Bartko SJ, 2010, NEUROPSYCHOLOGIA, V48, P2987, DOI 10.1016/j.neuropsychologia.2010.06.007; Bussey TJ, 2007, HIPPOCAMPUS, V17, P898, DOI 10.1002/hipo.20320; Bussey TJ, 1999, J NEUROSCI, V19, P495, DOI 10.1523/JNEUROSCI.19-01-00495.1999; Clark RE, 2010, NEUROPSYCHOLOGIA, V48, P2234, DOI 10.1016/j.neuropsychologia.2010.02.004; Cowan N, 2004, BRAIN, V127, P825, DOI 10.1093/brain/awh107; Cowell RA, 2006, J NEUROSCI, V26, P12186, DOI 10.1523/JNEUROSCI.2818-06.2006; Della Sala S, 2005, MEMORY, V13, P435, DOI 10.1080/09658210344000387; Dewar M, 2009, NEUROPSYCHOLOGY, V23, P627, DOI 10.1037/a0015568; Dewar MT, 2007, CORTEX, V43, P616, DOI 10.1016/S0010-9452(08)70492-1; Ennaceur A, 1996, BEHAV BRAIN RES, V80, P9, DOI 10.1016/0166-4328(96)00006-X; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; MUMBY DG, 1994, BEHAV NEUROSCI, V108, P11, DOI 10.1037/0735-7044.108.1.11; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; Murray EA, 2007, ANNU REV NEUROSCI, V30, P99, DOI 10.1146/annurev.neuro.29.051605.113046; Saksida LM, 2010, NEUROPSYCHOLOGIA, V48, P2370, DOI 10.1016/j.neuropsychologia.2010.02.026; Saksida LM, 2009, SCIENCE, V325, P40, DOI 10.1126/science.1177156; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; WARRINGT.EK, 1970, NATURE, V228, P628, DOI 10.1038/228628a0; WARRINGTON EK, 1974, NEUROPSYCHOLOGIA, V12, P419, DOI 10.1016/0028-3932(74)90072-4; WARRINGTON EK, 1978, NEUROPSYCHOLOGIA, V16, P169, DOI 10.1016/0028-3932(78)90104-5; Winters BD, 2005, J NEUROSCI, V25, P52, DOI 10.1523/JNEUROSCI.3827-04.2005; Winters BD, 2010, NEUROPSYCHOLOGIA, V48, P2251, DOI 10.1016/j.neuropsychologia.2010.01.023; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555	25	100	100	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1408	1410		10.1126/science.1194780	http://dx.doi.org/10.1126/science.1194780			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127256				2022-12-28	WOS:000284902100050
J	Xu, M; Futaba, DN; Yamada, T; Yumura, M; Hata, K				Xu, Ming; Futaba, Don N.; Yamada, Takeo; Yumura, Motoo; Hata, Kenji			Carbon Nanotubes with Temperature-Invariant Viscoelasticity from-196 degrees to 1000 degrees C	SCIENCE			English	Article							ARRAYS	Viscoelasticity describes the ability of a material to possess both elasticity and viscosity. Viscoelastic materials, such as rubbers, possess a limited operational temperature range (for example, for silicone rubber it is -55 degrees to 300 degrees C), above which the material breaks down and below which the material undergoes a glass transition and hardens. We created a viscoelastic material composed from a random network of long interconnected carbon nanotubes that exhibited an operational temperature range from -196 degrees to 1000 degrees C. The storage and loss moduli, frequency stability, reversible deformation level, and fatigue resistance were invariant from -140 degrees to 600 degrees C. We interpret that the thermal stability stems from energy dissipation through the zipping and unzipping of carbon nanotubes at contacts.	[Xu, Ming; Futaba, Don N.; Yamada, Takeo; Yumura, Motoo; Hata, Kenji] Natl Inst Adv Ind Sci & Technol, Technol Res Assoc Single Wall Carbon Nanotubes, Tsukuba, Ibaraki 3058565, Japan; [Xu, Ming; Futaba, Don N.; Yamada, Takeo; Yumura, Motoo; Hata, Kenji] Natl Inst Adv Ind Sci & Technol, Nanotube Res Ctr, Tsukuba, Ibaraki 3058565, Japan; [Hata, Kenji] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST)	Futaba, DN (corresponding author), Natl Inst Adv Ind Sci & Technol, Technol Res Assoc Single Wall Carbon Nanotubes, Tsukuba, Ibaraki 3058565, Japan.	d-futaba@aist.go.jp; kenji-hata@aist.go.jp	Xu, Ming/A-1523-2012; Yamada, Takeo/D-3938-2009; Futaba, Don N./C-8294-2009; Yumura, Motoo/L-5191-2018	Yamada, Takeo/0000-0001-6439-1942; Futaba, Don N./0000-0002-7083-2772; Yumura, Motoo/0000-0003-3278-2652	TASC	TASC	We acknowledge partial funding by TASC. M. X. acknowledges technical consultations from Y. Hayamizu, A. Izadi-Najafabadi, and Y. Seki.	Bhushan B, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.165428; Cao AY, 2005, SCIENCE, V310, P1307, DOI 10.1126/science.1118957; Chen B, 2003, APPL PHYS LETT, V83, P3570, DOI 10.1063/1.1623013; Gui XC, 2010, ADV MATER, V22, P617, DOI 10.1002/adma.200902986; Hata K, 2004, SCIENCE, V306, P1362, DOI 10.1126/science.1104962; Lakes R, 2009, VISCOELASTIC MATERIALS, P1, DOI 10.1017/CBO9780511626722; Lenaz G., 1997, BIOELECTROCHEMISTRY; Osswald S, 2005, CHEM PHYS LETT, V402, P422, DOI 10.1016/j.cplett.2004.12.066; Pathak S, 2009, CARBON, V47, P1969, DOI 10.1016/j.carbon.2009.03.042; Qu LT, 2008, SCIENCE, V322, P238, DOI 10.1126/science.1159503; Suhr J, 2007, NAT NANOTECHNOL, V2, P417, DOI 10.1038/nnano.2007.186; Thostenson ET, 2005, COMPOS SCI TECHNOL, V65, P491, DOI 10.1016/j.compscitech.2004.11.003; Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276; Zhang Q, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/31/315401	14	283	296	16	339	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1364	1368		10.1126/science.1194865	http://dx.doi.org/10.1126/science.1194865			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127248				2022-12-28	WOS:000284902100038
J	Parker, CV; Aynajian, P; Neto, EHD; Pushp, A; Ono, S; Wen, JS; Xu, ZJ; Gu, GD; Yazdani, A				Parker, Colin V.; Aynajian, Pegor; da Silva Neto, Eduardo H.; Pushp, Aakash; Ono, Shimpei; Wen, Jinsheng; Xu, Zhijun; Gu, Genda; Yazdani, Ali			Fluctuating stripes at the onset of the pseudogap in the high-T-c superconductor Bi2Sr2CaCu2O8+x	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; QUASI-PARTICLE INTERFERENCE; SYMMETRY-BREAKING; MOTT INSULATOR; ATOMIC-SCALE; STATES; PHASE	Doped Mott insulators have a strong propensity to form patterns of holes and spins often referred to as stripes(1-5). In copper oxides, doping also gives rise to the pseudogap state(6), which can be transformed into a high-temperature superconducting state with sufficient doping or by reducing the temperature. A long-standing issue has been the interplay between the pseudogap, which is generic to all hole-doped copper oxide superconductors, and stripes, whose static form occurs in only one family of copper oxides over a narrow range of the phase diagram(2,7). Here we report observations of the spatial reorganization of electronic states with the onset of the pseudogap state in the high-temperature superconductor Bi2Sr2CaCu2O8+x, using spectroscopic mapping with a scanning tunnelling microscope. We find that the onset of the pseudogap phase coincides with the appearance of electronic patterns that have the predicted characteristics of fluctuating stripes(8). As expected, the stripe patterns are strongest when the hole concentration in the CuO2 planes is close to 1/8 (per copper atom)(2-5,8). Although they demonstrate that the fluctuating stripes emerge with the onset of the pseudogap state and occur over a large part of the phase diagram, our experiments indicate that the stripes are a consequence of pseudogap behaviour rather than its cause.	[Parker, Colin V.; Aynajian, Pegor; da Silva Neto, Eduardo H.; Pushp, Aakash; Yazdani, Ali] Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA; [Parker, Colin V.; Aynajian, Pegor; da Silva Neto, Eduardo H.; Pushp, Aakash; Yazdani, Ali] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Ono, Shimpei] Cent Res Inst Elect Power Ind, Tokyo 2018511, Japan; [Wen, Jinsheng; Xu, Zhijun; Gu, Genda] Brookhaven Natl Lab, Upton, NY 11973 USA	Princeton University; Princeton University; Central Research Institute of Electric Power Industry - Japan; United States Department of Energy (DOE); Brookhaven National Laboratory	Yazdani, A (corresponding author), Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA.	yazdani@princeton.edu	Parker, Colin/AAK-6766-2021; Wen, Jinsheng/F-4209-2010; xu, zhijun/A-3264-2013; Pushp, Aakash/G-6626-2011; Ono, Shimpei/D-2918-2017	Wen, Jinsheng/0000-0001-5864-1466; xu, zhijun/0000-0001-7486-2015; Aynajian, Pegor/0000-0002-0123-527X; Yazdani, Ali/0000-0003-4996-8904; XU, ZHIJUN/0000-0002-4960-3801; da Silva Neto, Eduardo/0000-0001-6902-6100; Parker, Colin/0000-0001-6902-4471; Ono, Shimpei/0000-0003-1514-8879	DOE-BES; NSF-DMR; NSF-MRSEC through the Princeton Centre for Complex Materials; W. M. Keck Foundation	DOE-BES(United States Department of Energy (DOE)); NSF-DMR(National Science Foundation (NSF)); NSF-MRSEC through the Princeton Centre for Complex Materials; W. M. Keck Foundation(W.M. Keck Foundation)	We acknowledge discussions with P. W. Anderson, D. Huse, S. Kivelson, E. Fradkin, N. P. Ong and A. Pasupathy. This work was primarily supported by grant from the DOE-BES. The instrumentation and infrastructure at the Princeton Nanoscale Microscopy Laboratory are also supported by grants from the NSF-DMR, the NSF-MRSEC programme, through the Princeton Centre for Complex Materials, and the W. M. Keck Foundation.	Abbamonte P, 2005, NAT PHYS, V1, P155, DOI 10.1038/nphys178; Chatterjee U, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.107006; COLEMAN RV, 1993, METHODS EXPT PHYSICS, V27, P349; Dan WL, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.134504; Daou R, 2010, NATURE, V463, P519, DOI 10.1038/nature08716; Fang A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.214514; Gomes KK, 2007, NATURE, V447, P569, DOI 10.1038/nature05881; Hackl A, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.045102; Hanaguri T, 2007, NAT PHYS, V3, P865, DOI 10.1038/nphys753; Hashimoto M, 2010, NAT PHYS, V6, P414, DOI 10.1038/NPHYS1632; Hoffman JE, 2002, SCIENCE, V297, P1148, DOI 10.1126/science.1072640; Howald C, 2003, P NATL ACAD SCI USA, V100, P9705, DOI 10.1073/pnas.1233768100; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kohsaka Y, 2008, NATURE, V454, P1072, DOI 10.1038/nature07243; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Lawler MJ, 2010, NATURE, V466, P347, DOI 10.1038/nature09169; Lee J, 2009, SCIENCE, V325, P1099, DOI 10.1126/science.1176369; Li L, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.054510; McElroy K, 2003, NATURE, V422, P592, DOI 10.1038/nature01496; Robertson JA, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.134507; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Vershinin M, 2004, SCIENCE, V303, P1995, DOI 10.1126/science.1093384; Vojta M, 2009, ADV PHYS, V58, P699, DOI 10.1080/00018730903122242; White SR, 1998, PHYS REV LETT, V80, P1272, DOI 10.1103/PhysRevLett.80.1272; Wise WD, 2008, NAT PHYS, V4, P696, DOI 10.1038/nphys1021; Wise WD, 2009, NAT PHYS, V5, P213, DOI 10.1038/NPHYS1197; Xu GY, 2009, NAT PHYS, V5, P642, DOI 10.1038/NPHYS1360; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391	31	191	192	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					677	680		10.1038/nature09597	http://dx.doi.org/10.1038/nature09597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124453	Green Submitted			2022-12-28	WOS:000284836700037
J	Pietrzynski, G; Thompson, IB; Gieren, W; Graczyk, D; Bono, G; Udalski, A; Soszynski, I; Minniti, D; Pilecki, B				Pietrzynski, G.; Thompson, I. B.; Gieren, W.; Graczyk, D.; Bono, G.; Udalski, A.; Soszynski, I.; Minniti, D.; Pilecki, B.			The dynamical mass of a classical Cepheid variable star in an eclipsing binary system	NATURE			English	Article							LARGE-MAGELLANIC-CLOUD; GRAVITATIONAL LENSING EXPERIMENT.; OGLE-III CATALOG; PULSATION; PARAMETERS; COMPANION; CURVES; MODELS; LIGHT	Stellar pulsation theory provides a means of determining the masses of pulsating classical Cepheid supergiants-it is the pulsation that causes their luminosity to vary. Such pulsational masses are found to be smaller than the masses derived from stellar evolution theory: this is the Cepheid mass discrepancy problem(1,2), for which a solution is missing(3-5). An independent, accurate dynamical mass determination for a classical Cepheid variable star (as opposed to type-II Cepheids, low-mass stars with a very different evolutionary history) in a binary system is needed in order to determine which is correct. The accuracy of previous efforts to establish a dynamical Cepheid mass from Galactic single-lined non-eclipsing binaries was typically about 15-30% (refs 6, 7), which is not good enough to resolve the mass discrepancy problem. In spite of many observational efforts(8,9), no firm detection of a classical Cepheid in an eclipsing double-lined binary has hitherto been reported. Here we report the discovery of a classical Cepheid in a well detached, double-lined eclipsing binary in the Large Magellanic Cloud. We determine the mass to a precision of 1% and show that it agrees with its pulsation mass, providing strong evidence that pulsation theory correctly and precisely predicts the masses of classical Cepheids.	[Pietrzynski, G.; Gieren, W.; Graczyk, D.; Pilecki, B.] Univ Concepcion, Dept Astron, Concepcion, Chile; [Pietrzynski, G.; Udalski, A.; Soszynski, I.; Pilecki, B.] Uniwersytetu Warszawskiego, Obserwatorium Astron, PL-00478 Warsaw, Poland; [Thompson, I. B.] Carnegie Observ, Pasadena, CA USA; [Bono, G.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Bono, G.] Osserv Astron Roma, INAF, I-00040 Monte Porzio Catone, Italy; [Minniti, D.] Pontificia Univ Catolica Chile, Dept Astron & Astrofis, Santiago 22, Chile	Universidad de Concepcion; University of Warsaw; Carnegie Institution for Science; University of Rome Tor Vergata; Istituto Nazionale Astrofisica (INAF); Pontificia Universidad Catolica de Chile	Pietrzynski, G (corresponding author), Univ Concepcion, Dept Astron, Casilla 160-C, Concepcion, Chile.	pietrzyn@astrouw.edu.pl	Minniti, Dante/AAD-7251-2021	Soszynski, Igor/0000-0002-7777-0842; Udalski, Andrzej/0000-0001-5207-5619; Pietrzynski, Grzegorz/0000-0002-9443-4138; Pilecki, Bogumil/0000-0003-3861-8124; Minniti, Dante/0000-0002-7064-099X	Chilean Center for Astrophysics FONDAP; BASAL Centro de Astrofisica y Tecnologias Afines (CATA); NSF; Polish Ministry of Science; Foundation for Polish Science (FOCUS, TEAM); GEMINI-CONICYT; European Research Council	Chilean Center for Astrophysics FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); BASAL Centro de Astrofisica y Tecnologias Afines (CATA)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); NSF(National Science Foundation (NSF)); Polish Ministry of Science(Ministry of Science and Higher Education, Poland); Foundation for Polish Science (FOCUS, TEAM)(Foundation for Polish Science); GEMINI-CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Chilean Center for Astrophysics FONDAP, the BASAL Centro de Astrofisica y Tecnologias Afines (CATA), NSF, the Polish Ministry of Science, the Foundation for Polish Science (FOCUS, TEAM), and the GEMINI-CONICYT Fund. The OGLE project has received funding from the European Research Council ('Advanced Grants'). We thank the staff astronomers at Las Campanas and ESO La Silla who provided support in the data acquisition. We also thank D. Queloz, S. Udry and C. Lovis for their help in reducing and analysing the radial-velocity data obtained with the HARPS instrument.	Alcock C, 2002, ASTROPHYS J, V573, P338, DOI 10.1086/340560; Bono G, 2000, ASTROPHYS J, V529, P293, DOI 10.1086/308263; Bono G, 2001, ASTROPHYS J, V563, P319, DOI 10.1086/323834; CHRISTY RF, 1968, Q J ROY ASTRON SOC, V9, P13; COX AN, 1980, ANNU REV ASTRON ASTR, V18, P15, DOI 10.1146/annurev.aa.18.090180.000311; Evans NR, 2008, ASTRON J, V136, P1137, DOI 10.1088/0004-6256/136/3/1137; Evans NR, 2009, AIP CONF PROC, V1170, P69, DOI 10.1063/1.3246577; GIEREN WP, 1989, ASTRON ASTROPHYS, V225, P381; Gieren WP, 1998, ASTROPHYS J, V496, P17, DOI 10.1086/305374; Keller SC, 2008, ASTROPHYS J, V677, P483, DOI 10.1086/529366; Lepischak D, 2004, ASTROPHYS J, V611, P1100, DOI 10.1086/422188; Luck RE, 1998, ASTRON J, V115, P605, DOI 10.1086/300227; Neilson HR, 2008, ASTROPHYS J, V684, P569, DOI 10.1086/588650; Soszynski I, 2008, ACTA ASTRONOM, V58, P163; Soszynski I, 2008, ACTA ASTRONOM, V58, P293; STOBIE RS, 1969, MON NOT R ASTRON SOC, V144, P511, DOI 10.1093/mnras/144.4.511; Udalski A, 1999, ACTA ASTRONOM, V49, P223; Van Hamme W, 2007, ASTROPHYS J, V661, P1129, DOI 10.1086/517870; WILSON RE, 1971, ASTROPHYS J, V166, P605, DOI 10.1086/150986	19	91	91	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 25	2010	468	7323					542	544		10.1038/nature09598	http://dx.doi.org/10.1038/nature09598			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107425	Green Submitted			2022-12-28	WOS:000284584200037
J	Arbabi, EM; Kelly, RJ; Carrim, ZI				Arbabi, Esmaeil M.; Kelly, Ross J.; Carrim, Zia I.			10 Minute Consultation Chalazion	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Arbabi, Esmaeil M.; Carrim, Zia I.] Hull & E Yorkshire Eye Hosp, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Kelly, Ross J.] Spencer St Surg, Carlisle, PA USA		Arbabi, EM (corresponding author), Hull & E Yorkshire Eye Hosp, Kingston Upon Hull HU3 2JZ, N Humberside, England.	esarbabi@gmail.com							0	8	8	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2010	341								c4044	10.1136/bmj.c4044	http://dx.doi.org/10.1136/bmj.c4044			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640DQ	21155069	Green Published			2022-12-28	WOS:000281028800004
J	Lee, DH; Gupta, JA				Lee, D. H.; Gupta, J. A.			Tunable Field Control Over the Binding Energy of Single Dopants by a Charged Vacancy in GaAs	SCIENCE			English	Article							ATOM; SURFACE; MN	Local manipulation of electric fields at the atomic scale may enable new methods for quantum transport and creates new opportunities for field control of ferromagnetism and spin-based quantum information processing in semiconductors. We used a scanning tunneling microscope to position charged arsenic (As) vacancies in the gallium arsenide 110 [GaAs(110)] surface with atomic precision, thereby tuning the local electrostatic field experienced by single manganese (Mn) acceptors. The effects of this field are quantified by measuring the shift of an acceptor state within the band gap of GaAs. Experiments with varying tip-induced band-bending conditions suggest a large binding energy for surface-layer Mn, which is reduced by direct Coulomb repulsion when the As vacancy is moved nearby.	[Lee, D. H.; Gupta, J. A.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Gupta, JA (corresponding author), Ohio State Univ, Dept Phys, 174 W 18th Ave, Columbus, OH 43210 USA.	gupta.208@osu.edu	Gupta, Jay/AGK-0162-2022	Gupta, Jay/0000-0002-3908-7719	Arnold and Mabel Beckman Foundation; Center for Emergent Materials at Ohio State University, an NSF Materials Research Science and Engineering Center [DMR-0820414]	Arnold and Mabel Beckman Foundation; Center for Emergent Materials at Ohio State University, an NSF Materials Research Science and Engineering Center	We thank D. R. Daughton and X. H. Qiu for help with the STM construction and A. J. Heinrich, S. Loth, M. E. Flatte, and A. H. MacDonald for helpful discussions. We are grateful for support from the Arnold and Mabel Beckman Foundation and the Center for Emergent Materials at Ohio State University, an NSF Materials Research Science and Engineering Center (DMR-0820414).	Celebi CC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.086404; Coey JMD, 2008, MRS BULL, V33, P1053, DOI 10.1557/mrs2008.225; Ebert P, 1999, SURF SCI REP, V33, P121, DOI 10.1016/S0167-5729(98)00011-9; Feenstra RM, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.125316; Garleff JK, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.035303; Garleff JK, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075313; Jancu JM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.196801; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Kitchen D, 2007, J APPL PHYS, V101, DOI 10.1063/1.2694511; Kitchen D, 2006, NATURE, V442, P436, DOI 10.1038/nature04971; Lansbergen GP, 2008, NAT PHYS, V4, P656, DOI 10.1038/nphys994; Lengel G, 1996, PHYS REV LETT, V76, P4725, DOI 10.1103/PhysRevLett.76.4725; Linnarsson M, 1997, PHYS REV B, V55, P6938, DOI 10.1103/PhysRevB.55.6938; Loth S, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.235318; Loth S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.066403; Loth S, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115344; Marczinowski F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.157202; Marczinowski F, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115318; Matsui T, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.165405; MICHAELSON HB, 1977, J APPL PHYS, V48, P4729, DOI 10.1063/1.323539; Peercy PS, 2000, NATURE, V406, P1023, DOI 10.1038/35023223; Piva PG, 2005, NATURE, V435, P658, DOI 10.1038/nature03563; Richardella A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.045318; ROBINSON PD, 1958, P PHYS SOC LOND, V71, P828, DOI 10.1088/0370-1328/71/5/313; Shinada T, 2005, NATURE, V437, P1128, DOI 10.1038/nature04086; Strandberg TO, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.024425; Tang JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.106803; Tang JM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.047201; Teichmann K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.076103; WANG J, 1993, PHYS REV B, V47, P10326, DOI 10.1103/PhysRevB.47.10326; Yakunin AM, 2007, NAT MATER, V6, P512, DOI 10.1038/nmat1936; Yakunin AM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.216806; Yang JJ, 2008, NAT NANOTECHNOL, V3, P429, DOI 10.1038/nnano.2008.160	33	66	67	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1807	1810		10.1126/science.1197434	http://dx.doi.org/10.1126/science.1197434			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21148345				2022-12-28	WOS:000285603700036
J	Costache, MV; Valenzuela, SO				Costache, Marius V.; Valenzuela, Sergio O.			Experimental Spin Ratchet	SCIENCE			English	Article							COULOMB-BLOCKADE; BROWNIAN MOTORS; TRANSPORT	Spintronics relies on the ability to transport and use the spin properties of an electron rather than its charge. We describe a spin ratchet at the single-electron level that produces spin currents with no net bias or charge transport. Our device is based on the ground-state energetics of a single-electron transistor comprising a superconducting island connected to normal leads via tunnel barriers with different resistances that break spatial symmetry. We demonstrate spin transport and quantify the spin ratchet efficiency by using ferromagnetic leads with known spin polarization. Our results are modeled theoretically and provide a robust route to the generation and manipulation of pure spin currents.	[Costache, Marius V.; Valenzuela, Sergio O.] Ctr Invest Nanociencia & Nanotecnol CIN2, Inst Catala Nanotecnol, E-08193 Barcelona, Spain; [Valenzuela, Sergio O.] ICREA, E-08010 Barcelona, Spain; [Valenzuela, Sergio O.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Barcelona Institute of Science & Technology; Catalan Institute of Nanoscience & Nanotechnology (ICN2); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-ICN - Centro de Investigacion en Nanociencia y Nanotecnologia (CIN2); ICREA; Harvard University	Valenzuela, SO (corresponding author), Ctr Invest Nanociencia & Nanotecnol CIN2, Inst Catala Nanotecnol, Campus Univ Autonoma Barcelona, E-08193 Barcelona, Spain.	SOV@icrea.cat	Valenzuela, Sergio/A-1169-2007; Costache, Marius Vasile/AAQ-3947-2021	Valenzuela, Sergio/0000-0002-4632-8891; Costache, Marius Vasile/0000-0001-7432-6175	Spanish Ministerio de Ciencia e Innovacion [MAT2010-18065, FIS2009-06671-E]; ICREA Funding Source: Custom	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); ICREA(ICREA)	We gratefully acknowledge discussions with and support from M. Tinkham and thank I. Zutic and Y. Tserkovnyak for discussions and W. D. Oliver, P. Gambardella, and A. Bachtold for a critical reading of the manuscript. This research was supported in part by the Spanish Ministerio de Ciencia e Innovacion (MAT2010-18065, FIS2009-06671-E). Samples were made at the Center for Nanoscale Systems, Harvard University.	AVERIN DV, 1992, PHYS REV LETT, V69, P1993, DOI 10.1103/PhysRevLett.69.1993; Awschalom DD, 2002, NANOSCI TECHNOL, P147; Bena C, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.037901; Cadden-Zimansky P, 2009, NAT PHYS, V5, P393, DOI 10.1038/NPHYS1252; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Ferguson AJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.086602; Flatte ME, 2008, NAT PHYS, V4, P587, DOI 10.1038/nphys1047; Hanggi P, 2009, REV MOD PHYS, V81, P387, DOI 10.1103/RevModPhys.81.387; Hanggi P, 2005, ANN PHYS-BERLIN, V14, P51, DOI 10.1002/andp.200410121; HEKKING FWJ, 1993, PHYS REV LETT, V70, P4138, DOI 10.1103/PhysRevLett.70.4138; Herrmann LG, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.026801; Hofstetter L, 2009, NATURE, V461, P960, DOI 10.1038/nature08432; Linke H, 1999, SCIENCE, V286, P2314, DOI 10.1126/science.286.5448.2314; Reimann P, 2002, PHYS REP, V361, P57, DOI 10.1016/S0370-1573(01)00081-3; Saraga DS, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.166803; Scheid M, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/17001; Scheid M, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/401; Schon G., 1998, QUANTUM TRANSPORT DI; Smirnov S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.230601; Song AM, 1998, PHYS REV LETT, V80, P3831, DOI 10.1103/PhysRevLett.80.3831; TUOMINEN MT, 1992, PHYS REV LETT, V69, P1997, DOI 10.1103/PhysRevLett.69.1997; Valenzuela SO, 2009, INT J MOD PHYS B, V23, P2413, DOI 10.1142/S021797920905290X; Valenzuela SO, 2006, NATURE, V442, P176, DOI 10.1038/nature04937; Villegas JE, 2003, SCIENCE, V302, P1188, DOI 10.1126/science.1090390; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	26	45	48	3	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1645	1648		10.1126/science.1196228	http://dx.doi.org/10.1126/science.1196228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164009	Green Submitted			2022-12-28	WOS:000285390500058
J	Hansen, CS; Faerch, LH; Kristensen, PL				Hansen, Christian Stevns; Faerch, Louise Holmsgaard; Kristensen, Peter Lommer			CHRISTMAS 2010: RESEARCH Testing the validity of the Danish urban myth that alcohol can be absorbed through feet: open labelled self experimental study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To determine the validity of the Danish urban myth that it is possible to get drunk by submerging feet in alcohol. Design Open labelled, self experimental study, with no control group. Setting Office of a Danish hospital. Participants Three adults, median age 32 (range 31-35), free of chronic skin and liver disease and non-dependent on alcohol and psychoactive drugs. Main outcome measures The primary end point was the concentration of plasma ethanol (detection limit 2.2 mmol/L (10 mg/100 mL)), measured every 30 minutes for three hours while feet were submerged in a washing-up bowl containing the contents of three 700 mL bottles of vodka. The secondary outcome was self assessment of intoxication related symptoms (self confidence, urge to speak, and number of spontaneous hugs), scored on a scale of 0 to 10. Results Plasma ethanol concentrations were below the detection limit of 2.2 mmol/L (10 mg/100 mL) throughout the experiment. No significant changes were observed in the intoxication related symptoms, although self confidence and urge to speak increased slightly at the start of the study, probably due to the setup. Conclusion Our results suggest that feet are impenetrable to the alcohol component of vodka. We therefore conclude that the Danish urban myth of being able to get drunk by submerging feet in alcoholic beverages is just that; a myth. The implications of the study are many though.	[Hansen, Christian Stevns; Faerch, Louise Holmsgaard; Kristensen, Peter Lommer] Hillerod Hosp, Dept Cardiol & Endocrinol, Endocrinol Sect, DK-3400 Hillerod, Denmark	University of Copenhagen	Kristensen, PL (corresponding author), Hillerod Hosp, Dept Cardiol & Endocrinol, Endocrinol Sect, Dyrehavevej 29, DK-3400 Hillerod, Denmark.	pelk@hih.regionh.dk	Kristensen, Peter L/B-4218-2009; Kristensen, Peter/V-5630-2019	Kristensen, Peter/0000-0001-5431-824X; Hansen, Christian Stevns/0000-0002-5782-3476	Department of Clinical Biochemistry, Hillerod Hospital	Department of Clinical Biochemistry, Hillerod Hospital	The measurement of ethanol concentrations was funded by the Department of Clinical Biochemistry, Hillerod Hospital.	Miller MA, 2006, AM J EMERG MED, V24, P815, DOI 10.1016/j.ajem.2006.05.006; Saghir SA, 2010, INT J TOXICOL, V29, P268, DOI 10.1177/1091581810366604; Yu CY, 2009, APPL ERGON, V40, P767, DOI 10.1016/j.apergo.2008.08.004	3	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2010	341								c6812	10.1136/bmj.c6812	http://dx.doi.org/10.1136/bmj.c6812			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XD	21156749	Green Published, hybrid			2022-12-28	WOS:000285552200015
J	Domazet-Loso, T; Tautz, D				Domazet-Loso, Tomislav; Tautz, Diethard			A phylogenetically based transcriptome age index mirrors ontogenetic divergence patterns	NATURE			English	Article							CONSERVED EMBRYONIC STAGE; DROSOPHILA-MELANOGASTER; PHYLOTYPIC STAGE; GENE-EXPRESSION; DEVELOPMENTAL HOURGLASS; ZEBRAFISH DEVELOPMENT; LIFE-CYCLE; EVOLUTION; VERTEBRATES; HISTORY	Parallels between phylogeny and ontogeny have been discussed for almost two centuries, and a number of theories have been proposed to explain such patterns(1). Especially elusive is the phylotypic stage, a phase during development where species within a phylum are particularly similar to each other(2-6). Although this has formerly been interpreted as a recapitulation of phylogeny(1), it is now thought to reflect an ontogenetic progression phase(2), where strong constraints on developmental regulation and gene interactions exist(2,3). Several studies have shown that genes expressed during this stage evolve at a slower rate, but it has so far not been possible to derive an unequivocal molecular signature associated with this stage(7-15). Here we use a combination of phylostratigraphy(16) and stage-specific gene expression data to generate a cumulative index that reflects the evolutionary age of the transcriptome at given ontogenetic stages. Using zebrafish ontogeny and adult development as a model, we find that the phylotypic stage does indeed express the oldest transcriptome set and that younger sets are expressed during early and late development, thus faithfully mirroring the hourglass model of morphological divergence(2,3). Reproductively active animals show the youngest transcriptome, with major differences between males and females. Notably, ageing animals express increasingly older genes. Comparisons with similar data sets from flies and nematodes show that this pattern occurs across phyla. Our results indicate that an old transcriptome marks the phylotypic phase and that phylogenetic differences at other ontogenetic stages correlate with the expression of newly evolved genes.	[Domazet-Loso, Tomislav; Tautz, Diethard] Max Planck Inst Evolut Biol, D-24306 Plon, Germany; [Domazet-Loso, Tomislav] Rudjer Boskovic Inst, Div Mol Biol, Lab Evolutionary Genet, Zagreb 10002, Croatia	Max Planck Society; Rudjer Boskovic Institute	Domazet-Loso, T (corresponding author), Max Planck Inst Evolut Biol, August Thienemannstr 2, D-24306 Plon, Germany.	tdomazet@irb.hr	Tautz, Diethard/H-8436-2014; Tautz, Diethard/D-4304-2011	Tautz, Diethard/0000-0002-0460-5344; 	Adris Foundation [49]; Max-Planck Society	Adris Foundation; Max-Planck Society(Max Planck Society)	We thank B. Walderich for providing zebrafish, A. Nolte, E. Blohm-Sievers, B. Kleinhenz, L. Turner and J. Bryk for laboratory support, R. Bakaric has provided the phylostratigraphic map of C. elegans, and M. Domazet-Loso and V. Dunjko have helped with statistics. L. Boell, F. Chang and A. Pozhitkov have made suggestions on the manuscript. This work was supported by Unity Through Knowledge Fund (grant No. 49), Adris Foundation and funds of the Max-Planck Society. Computational resources were provided by CSTMB and RBI (Phylostrat Cluster).	Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Artieri CG, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-42; Bininda-Emonds ORP, 2003, P ROY SOC B-BIOL SCI, V270, P341, DOI 10.1098/rspb.2002.2242; Comte A, 2010, EVOL DEV, V12, P144, DOI 10.1111/j.1525-142X.2010.00400.x; Cruickshank T, 2008, EVOL DEV, V10, P583, DOI 10.1111/j.1525-142X.2008.00273.x; Davis JC, 2005, J MOL EVOL, V60, P774, DOI 10.1007/s00239-004-0241-2; Domazet-Loso T, 2003, GENOME RES, V13, P2213, DOI 10.1101/gr.1311003; Domazet-Loso T, 2008, MOL BIOL EVOL, V25, P2699, DOI 10.1093/molbev/msn214; Domazet-Loso T, 2007, TRENDS GENET, V23, P533, DOI 10.1016/j.tig.2007.08.014; Domazet-Loso T, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-66; DUBOULE D, 1994, DEVELOPMENT, P135; Efron B., 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Flatt T, 2006, INTEGR COMP BIOL, V46, P777, DOI 10.1093/icb/icl034; Gould S. J., 1977, ONTOGENY PHYLOGENY; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Hall BK, 1997, TRENDS ECOL EVOL, V12, P461, DOI 10.1016/S0169-5347(97)01222-6; Hanada K, 2007, MOL BIOL EVOL, V24, P2235, DOI 10.1093/molbev/msm152; Hazkani-Covo E, 2005, J EXP ZOOL PART B, V304B, P150, DOI 10.1002/jez.b.21033; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Irie N, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-1; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koutsos AC, 2007, P NATL ACAD SCI USA, V104, P11304, DOI 10.1073/pnas.0703988104; Levine MT, 2006, P NATL ACAD SCI USA, V103, P9935, DOI 10.1073/pnas.0509809103; Leys SP, 2005, INTEGR COMP BIOL, V45, P342, DOI 10.1093/icb/45.2.342; Nolte AW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-59; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Raff R. A., 1996, SHAPE LIFE GENES DEV; Richardson MK, 1997, ANAT EMBRYOL, V196, P91, DOI 10.1007/s004290050082; Roux J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000311; Sander K., 1983, DEV EVOLUTION, P137; Yassin A, 2010, EVOL DEV, V12, P288, DOI 10.1111/j.1525-142X.2010.00414.x	32	249	254	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2010	468	7325					815	U107		10.1038/nature09632	http://dx.doi.org/10.1038/nature09632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21150997				2022-12-28	WOS:000285093700044
J	Eley, KA; Watt-Smith, SR				Eley, Karen A.; Watt-Smith, Stephen R.			Christmas 2010: Surgery The IKEA pencil: a surprising find in the NHS	BRITISH MEDICAL JOURNAL			English	Editorial Material							BONE PENCIL		[Eley, Karen A.] Univ Oxford, Nuffield Dept Surg Sci, Oxford OX1 2JD, England; [Watt-Smith, Stephen R.] Oxford Radcliffe Hosp NHS Trust, Dept Oral & Maxillofacial Surg, Oxford OX3 9DU, England	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Eley, KA (corresponding author), Univ Oxford, Nuffield Dept Surg Sci, Oxford OX1 2JD, England.	karen.a.eley@gmail.com		Eley, Karen/0000-0003-2970-8662				*FAC, 2010, IKEA PENC STEAL APPR; Frazee TA, 1998, J ORAL MAXIL SURG, V56, P101, DOI 10.1016/S0278-2391(98)90926-0; HUSAMI T, 1988, PLAST RECONSTR SURG, V82, P1100, DOI 10.1097/00006534-198812000-00040; OHRI P, 2010, CHAIR RECREATED 500; ZINS JE, 1987, PLAST RECONSTR SURG, V80, P453, DOI 10.1097/00006534-198709000-00023	5	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 9	2010	341								c6595	10.1136/bmj.c6595	http://dx.doi.org/10.1136/bmj.c6595			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZU	21148219				2022-12-28	WOS:000285341200012
J	Giuliari, G				Giuliari, GianPaolo			Intravitreal Triamcinolone for Diabetic Macular Edema	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Giuliari, G (corresponding author), Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada.								0	4	4	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2010	363	24					2351	2351		10.1056/NEJMicm1003140	http://dx.doi.org/10.1056/NEJMicm1003140			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691PA	21142537				2022-12-28	WOS:000285092100010
J	Arie, S				Arie, Sophie			Conflict and Rape After war, what next?	BRITISH MEDICAL JOURNAL			English	Editorial Material												ariesophie@yahoo.co.uk						*AMN INT, 2009, BOSN HERZ WHOS JUST; UNFPA (United Nations Fund for Population Activities), 2010, STAT WORLD POP	2	0	0	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2010	341								c6910	10.1136/bmj.c6910	http://dx.doi.org/10.1136/bmj.c6910			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	694YK	21138998				2022-12-28	WOS:000285337600001
J	Marchitto, TM; Muscheler, R; Ortiz, JD; Carriquiry, JD; van Geen, A				Marchitto, Thomas M.; Muscheler, Raimund; Ortiz, Joseph D.; Carriquiry, Jose D.; van Geen, Alexander			Dynamical Response of the Tropical Pacific Ocean to Solar Forcing During the Early Holocene	SCIENCE			English	Article							NORTH-ATLANTIC CLIMATE; EL-NINO; CALIFORNIA CURRENT; MIDHOLOCENE; EVOLUTION; MONSOON; OSCILLATION; VARIABILITY; SEDIMENTS; SYSTEM	We present a high-resolution magnesium/calcium proxy record of Holocene sea surface temperature (SST) from off the west coast of Baja California Sur, Mexico, a region where interannual SST variability is dominated today by the influence of the El Nino-Southern Oscillation (ENSO). Temperatures were lowest during the early to middle Holocene, consistent with documented eastern equatorial Pacific cooling and numerical model simulations of orbital forcing into a La Nina-like state at that time. The early Holocene SSTs were also characterized by millennial-scale fluctuations that correlate with cosmogenic nuclide proxies of solar variability, with inferred solar minima corresponding to El Nino-like (warm) conditions, in apparent agreement with the theoretical "ocean dynamical thermostat" response of ENSO to exogenous radiative forcing.	[Marchitto, Thomas M.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Marchitto, Thomas M.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Muscheler, Raimund] Lund Univ, Dept Earth & Ecosyst Sci, S-22362 Lund, Sweden; [Ortiz, Joseph D.] Kent State Univ, Dept Geol, Kent, OH 44242 USA; [Carriquiry, Jose D.] Univ Autonoma Baja California, Dept Environm Geosci, Ensenada 22830, Baja California, Mexico; [van Geen, Alexander] Columbia Univ, Lamont Doherty Geol Observ, Palisades, NY 10964 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Lund University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Universidad Autonoma de Baja California; Columbia University	Marchitto, TM (corresponding author), Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA.	tom.marchitto@colorado.edu	CARRIQUIRY, JOSE D/R-9190-2017; Ortiz, Joseph/E-1144-2011	Ortiz, Joseph/0000-0002-6583-3850; Muscheler, Raimund/0000-0003-2772-3631	NSF [OCE-0214221, OCE-0214646]; Knut and Alice Wallenberg Foundation	NSF(National Science Foundation (NSF)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	We thank P. Cappa, D. Lopez, D. Weller, and C. Wolak for laboratory assistance. This manuscript was improved by comments from B. Fox-Kemper and S. Lehman. This work was supported by collaborative NSF grants OCE-0214221 and OCE-0214646. R. M. is supported by the Royal Swedish Academy of Sciences through a grant financed by the Knut and Alice Wallenberg Foundation. Data are available at the NOAA National Climatic Data Center for Paleoclimatology.	Alley RB, 1997, GEOLOGY, V25, P483, DOI 10.1130/0091-7613(1997)025<0483:HCIAPW>2.3.CO;2; Asmerom Y, 2007, GEOLOGY, V35, P1, DOI 10.1130/G22865A.1; Barron JA, 2007, PALAEOGEOGR PALAEOCL, V248, P313, DOI 10.1016/j.palaeo.2006.12.009; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; Bush ABG, 1999, GEOPHYS RES LETT, V26, P99, DOI 10.1029/1998GL900261; Clement AC, 2000, PALEOCEANOGRAPHY, V15, P731, DOI 10.1029/1999PA000466; Clement AC, 1996, J CLIMATE, V9, P2190, DOI 10.1175/1520-0442(1996)009<2190:AODT>2.0.CO;2; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; Cook ER, 2007, EARTH-SCI REV, V81, P93, DOI 10.1016/j.earscirev.2006.12.002; Durazo R, 2002, PROG OCEANOGR, V54, P7, DOI 10.1016/S0079-6611(02)00041-1; Emile-Geay J, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001304; Finkel RC, 1997, J GEOPHYS RES-OCEANS, V102, P26699, DOI 10.1029/97JC01282; Herbert TD, 2001, SCIENCE, V293, P71, DOI 10.1126/science.1059209; Koutavas A, 2006, GEOLOGY, V34, P993, DOI 10.1130/G22810A.1; Koutavas A, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001593; Lean J, 2000, GEOPHYS RES LETT, V27, P2425, DOI 10.1029/2000GL000043; Leduc G, 2010, QUATERNARY SCI REV, V29, P989, DOI 10.1016/j.quascirev.2010.01.004; Liu ZY, 2000, GEOPHYS RES LETT, V27, P2265, DOI 10.1029/2000GL011452; Mann ME, 2005, J CLIMATE, V18, P447, DOI 10.1175/JCLI-3276.1; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Meehl GA, 2009, SCIENCE, V325, P1114, DOI 10.1126/science.1172872; Morrill C, 2003, HOLOCENE, V13, P465, DOI 10.1191/0959683603hl639ft; Neff U, 2001, NATURE, V411, P290, DOI 10.1038/35077048; Otto-Bliesner BL, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018553; Reimer PJ, 2004, RADIOCARBON, V46, pV; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Sautter LR, 1991, PALEOCEANOGRAPHY, V6, P307, DOI 10.1029/91PA00385; Schwing FB, 2002, PROG OCEANOGR, V54, P459, DOI 10.1016/S0079-6611(02)00064-2; SCHWING FB, 1996, NOAATMNMFSSWSFC231; Stott L, 2004, NATURE, V431, P56, DOI 10.1038/nature02903; van Geen A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000911; Vecchi G. A., 2008, EOS T AM GEOPHYS UN, V89, P81, DOI DOI 10.1029/2008EO090002; Vonmoos M, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011500; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Webster PJ, 1998, J GEOPHYS RES-OCEANS, V103, P14451, DOI 10.1029/97JC02719	35	110	113	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1378	1381		10.1126/science.1194887	http://dx.doi.org/10.1126/science.1194887			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127251				2022-12-28	WOS:000284902100042
J	Fuchs, VR				Fuchs, Victor R.			Government Payment for Health Care -- Causes and Consequences.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Stanford, CA 94305 USA	Stanford University	Fuchs, VR (corresponding author), Stanford Univ, Stanford, CA 94305 USA.							Johnson Samuel, 1775, JOURNEY W ISLANDS SC; Stigler George, 1975, CITIZEN STATE ESSAYS, P140; Tocqueville Alexis de, 1840, DEMOCRACY AM, V2	3	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2181	2183		10.1056/NEJMp1011362	http://dx.doi.org/10.1056/NEJMp1011362			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	688EP	21121829				2022-12-28	WOS:000284832900001
J	Devos, DP; Reynaud, EG				Devos, Damien P.; Reynaud, Emmanuel G.			Intermediate Steps	SCIENCE			English	Editorial Material							COMPARATIVE GENOMICS; BUDDING BACTERIA; RIBOSOMAL-RNA; CELL-WALL; EUKARYOTES; MEMBRANE; ARCHAEA; ORIGIN; VERRUCOMICROBIA; PLANCTOMYCES		[Devos, Damien P.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Reynaud, Emmanuel G.] UCD Sci Ctr, Sch Biol & Environm Sci, Dublin 4, Ireland	European Molecular Biology Laboratory (EMBL)	Devos, DP (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	devos@embl.de; emmanuel.reynaud@ucd.ie	Reynaud, Emamnuel/H-2928-2019; devos, damien/ABH-5348-2020	Reynaud, Emamnuel/0000-0003-1502-661X; Devos, Damien/0000-0002-9453-4753				Aravind L, 2006, CURR OPIN STRUC BIOL, V16, P409, DOI 10.1016/j.sbi.2006.04.006; Bauer M, 2004, J MOL EVOL, V59, P571, DOI 10.1007/s00239-004-2643-6; Chistoserdova L, 2004, MOL BIOL EVOL, V21, P1234, DOI 10.1093/molbev/msh113; Dacks JB, 2001, CELL, V107, P419, DOI 10.1016/S0092-8674(01)00584-0; Damste JSS, 2002, NATURE, V419, P708, DOI 10.1038/nature01128; de Duve C, 2007, NAT REV GENET, V8, P395, DOI 10.1038/nrg2071; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; FERST JA, 1991, P NATL ACAD SCI USA, V88, P8184; Forterre P, 2011, RES MICROBIOL, V162, P77, DOI 10.1016/j.resmic.2010.10.005; Fuerst JA, 1998, FEMS MICROBIOL LETT, V166, P29, DOI 10.1111/j.1574-6968.1998.tb13179.x; Gribaldo S, 2010, NAT REV MICROBIOL, V8, P743, DOI 10.1038/nrmicro2426; HACKSTADT T, 1991, P NATL ACAD SCI USA, V88, P3937, DOI 10.1073/pnas.88.9.3937; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; KERGER BD, 1988, ARCH MICROBIOL, V149, P255, DOI 10.1007/BF00422014; KONIG E, 1984, ARCH MICROBIOL, V138, P200, DOI 10.1007/BF00402120; Lee KC, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-4; Lee KC, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-5; Lonhienne TGA, 2010, P NATL ACAD SCI USA, V107, P12883, DOI 10.1073/pnas.1001085107; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Pearson A, 2003, P NATL ACAD SCI USA, V100, P15352, DOI 10.1073/pnas.2536559100; Pereto J, 2004, TRENDS BIOCHEM SCI, V29, P469, DOI 10.1016/j.tibs.2004.07.002; Pilhofer M, 2008, J BACTERIOL, V190, P3192, DOI 10.1128/JB.01797-07; Pilhofer M, 2007, MOL BIOL EVOL, V24, P1439, DOI 10.1093/molbev/msm069; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; SANCHEZAMAT A, 1990, APPL ENVIRON MICROB, V56, P2717; Santarella-Mellwig R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000281; Wachtershauser G, 2003, MOL MICROBIOL, V47, P13, DOI 10.1046/j.1365-2958.2003.03267.x; Wagner M, 2006, CURR OPIN BIOTECH, V17, P241, DOI 10.1016/j.copbio.2006.05.005; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Yee B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-37	30	60	60	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2010	330	6008					1187	1188		10.1126/science.1196720	http://dx.doi.org/10.1126/science.1196720			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109658				2022-12-28	WOS:000284613700025
J	Higley, MJ; Strittmatter, SM				Higley, Michael J.; Strittmatter, Stephen M.			Lynx for Braking Plasticity	SCIENCE			English	Editorial Material							OCULAR-DOMINANCE PLASTICITY; NOGO RECEPTOR; VISUAL-CORTEX; AXONAL REGENERATION; RECOVERY; ACETYLCHOLINE; GROWTH; MYELIN; PIRB; CNS		[Higley, Michael J.] Yale Univ, Sch Med, Dept Neurol, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06536 USA; Yale Univ, Sch Med, Dept Neurobiol, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06536 USA	Yale University; Yale University	Higley, MJ (corresponding author), Yale Univ, Sch Med, Dept Neurol, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06536 USA.	michael.higley@yale.edu; stephen.strittmatter@yale.edu	Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033020] Funding Source: NIH RePORTER; NINDS NIH HHS [R37 NS033020-19, R37 NS033020] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Ramanathan D, 2009, J NEUROSCI, V29, P5992, DOI 10.1523/JNEUROSCI.0230-09.2009; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Wang XX, 2006, ANN NEUROL, V60, P540, DOI 10.1002/ana.20953	16	5	5	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2010	330	6008					1189	1190		10.1126/science.1198983	http://dx.doi.org/10.1126/science.1198983			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109660	Green Accepted			2022-12-28	WOS:000284613700027
J	Matyas, F; Sreenivasan, V; Marbach, F; Wacongne, C; Barsy, B; Mateo, C; Aronoff, R; Petersen, CCH				Matyas, Ferenc; Sreenivasan, Varun; Marbach, Fred; Wacongne, Catherine; Barsy, Boglarka; Mateo, Celine; Aronoff, Rachel; Petersen, Carl C. H.			Motor Control by Sensory Cortex	SCIENCE			English	Article							WHISKER MOVEMENTS; BEHAVING MICE; BARREL CORTEX; CORTICAL-NEURONS; TRANSGENIC MICE; CEREBRAL-CORTEX; RAT; STIMULATION; CHANNELRHODOPSIN-2; MICROSTIMULATION	Classical studies of mammalian movement control define a prominent role for the primary motor cortex. Investigating the mouse whisker system, we found an additional and equally direct pathway for cortical motor control driven by the primary somatosensory cortex. Whereas activity in primary motor cortex directly evokes exploratory whisker protraction, primary somatosensory cortex directly drives whisker retraction, providing a rapid negative feedback signal for sensorimotor integration. Motor control by sensory cortex suggests the need to reevaluate the functional organization of cortical maps.	[Matyas, Ferenc; Sreenivasan, Varun; Marbach, Fred; Wacongne, Catherine; Barsy, Boglarka; Mateo, Celine; Aronoff, Rachel; Petersen, Carl C. H.] Ecole Polytech Fed Lausanne, Fac Life Sci, Brain Mind Inst, Lab Sensory Proc, CH-1015 Lausanne, Switzerland; [Matyas, Ferenc] Hungarian Acad Sci, Inst Expt Med, Lab Thalamus Res, H-1450 Budapest, Hungary; [Wacongne, Catherine] INSERM, U992, Cognit Neuroimaging Unit, F-91191 Gif Sur Yvette, France; [Barsy, Boglarka] Hungarian Acad Sci, Inst Expt Med, H-1450 Budapest, Hungary	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Petersen, CCH (corresponding author), Ecole Polytech Fed Lausanne, Fac Life Sci, Brain Mind Inst, Lab Sensory Proc, CH-1015 Lausanne, Switzerland.	carl.petersen@epfl.ch	Petersen, Carl/M-5123-2017; Mateo, Celine/V-4619-2019	Petersen, Carl/0000-0003-3344-4495; Sreenivasan, Varun/0000-0003-0559-9713; Aronoff, Rachel/0000-0001-5813-2899	Swiss National Science Foundation; Human Frontiers in Science Program; SystemsX.ch; European Molecular Biology Organization	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontiers in Science Program(Human Frontier Science Program); SystemsX.ch; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	We thank H. Bokor and L. Acsady for advice on brainstem anatomy and lesions and K. Svoboda (Addgene plasmid 20071) and C. Luscher (virus) for AAV-ChR2. This work was funded by grants from the Swiss National Science Foundation (C. C. H. P.), Human Frontiers in Science Program (C. C. H. P.), SystemsX.ch (C. C. H. P.), and a European Molecular Biology Organization long-term fellowship (F. Matyas).	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Aronoff R, 2010, EUR J NEUROSCI, V31, P2221, DOI 10.1111/j.1460-9568.2010.07264.x; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Brecht M, 2007, CURR OPIN NEUROBIOL, V17, P408, DOI 10.1016/j.conb.2007.07.008; COULTER JD, 1977, BRAIN RES, V129, P335, DOI 10.1016/0006-8993(77)90012-9; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Haiss F, 2005, J NEUROSCI, V25, P1579, DOI 10.1523/JNEUROSCI.3760-04.2005; Hattox AM, 2002, J COMP NEUROL, V442, P266, DOI 10.1002/cne.10089; Herfst LJ, 2008, J NEUROPHYSIOL, V99, P2821, DOI 10.1152/jn.01014.2007; Hill DN, 2008, J NEUROSCI, V28, P3438, DOI 10.1523/JNEUROSCI.5008-07.2008; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; JACQUIN MF, 1990, J NEUROPHYSIOL, V64, P3, DOI 10.1152/jn.1990.64.1.3; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pinganaud G, 1999, J COMP NEUROL, V415, P91, DOI 10.1002/(SICI)1096-9861(19991206)415:1<91::AID-CNE7>3.0.CO;2-A; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Seidemann E, 2002, SCIENCE, V295, P862, DOI 10.1126/science.1066641; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; WELKER WI, 1957, J NEUROPHYSIOL, V20, P347, DOI 10.1152/jn.1957.20.4.347; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	32	258	261	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1240	1243		10.1126/science.1195797	http://dx.doi.org/10.1126/science.1195797			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109671				2022-12-28	WOS:000284613700041
J	Simancas, R; Dari, D; Velamazan, N; Navarro, MT; Cantin, A; Jorda, JL; Sastre, G; Corma, A; Rey, F				Simancas, Raquel; Dari, Djamal; Velamazan, Noemi; Navarro, Maria T.; Cantin, Angel; Jorda, Jose L.; Sastre, German; Corma, Avelino; Rey, Fernando			Modular Organic Structure-Directing Agents for the Synthesis of Zeolites	SCIENCE			English	Article							HIGH-SILICA ZEOLITE; CRYSTAL-STRUCTURE; FRAMEWORK; BOGGSITE; CATIONS; PORES	Organic structure-directing agents (OSDAs) are used to guide the formation of particular types of pores and channels during the synthesis of zeolites. We report that the use of highly versatile OSDAs based on phosphazenes has been successfully introduced for the synthesis of zeolites. This approach has made possible the synthesis of the elusive boggsite zeolite, which is formed by 10- and 12-ring intersecting channels. This topology and these pore dimensions present interesting opportunities for catalysis in reactions of industrial relevance.	[Simancas, Raquel; Dari, Djamal; Velamazan, Noemi; Navarro, Maria T.; Cantin, Angel; Jorda, Jose L.; Sastre, German; Corma, Avelino; Rey, Fernando] Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Valencia 46022, Spain; [Dari, Djamal] Univ Oran Es Senia, Lab Chim Mat, Oran 1524, Algeria	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ); Universite d'Oran	Corma, A (corresponding author), Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Ave de los Naranjos S-N, Valencia 46022, Spain.	acorma@itq.upv.es	Sastre, German/C-1265-2011; Simancas, Raquel/AAB-4181-2022; Jorda, Jose L./D-1334-2009; CANOS, AVELINO CORMA/A-3040-2013; Rey, Fernando/C-6778-2011; NAVARRO VILLALBA, M.TERESA/I-4141-2015; Cantin, Angel/I-4282-2015	Sastre, German/0000-0003-0496-6331; Simancas, Raquel/0000-0001-7093-2338; Jorda, Jose L./0000-0002-0304-5680; CANOS, AVELINO CORMA/0000-0002-2232-3527; Rey, Fernando/0000-0003-3227-5669; NAVARRO VILLALBA, M.TERESA/0000-0001-5012-8414; Cantin, Angel/0000-0002-3219-1919	Spanish government [MAT2009-14528-C02-01, PLE2009-0054]; Generalitat Valenciana; UPV; CSIC; Junta para la Ampliacion de Estudios	Spanish government(Spanish GovernmentEuropean Commission); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); UPV; CSIC; Junta para la Ampliacion de Estudios	The authors thank the Spanish government (projects MAT2009-14528-C02-01, PLE2009-0054, and CONSOLIDER INGENIO 2010) and Generalitat Valenciana (Project Prometeo) for financial support. R. S. and N.V. thank UPV and CSIC for Programa de Formacion de Personal Investigador and Junta para la Ampliacion de Estudios predoctoral fellowships, respectively. Further details on the crystal structure may be obtained from the Fachinformationszentrum Karlsruhe, D-76344 Eggenstein-Leopoldshafen, Germany [fax: (+49) 7247-808-666; e-mail: crysdata@fiz-Karlruhe.de], on quoting the depository number CDS-422193.	Archer RH, 2010, MICROPOR MESOPOR MAT, V130, P255, DOI 10.1016/j.micromeso.2009.11.018; Baerlocher C., 2007, ATLAS ZEOLITE FRAMEW; Burton AW, 2005, CURR OPIN COLLOID IN, V10, P211, DOI 10.1016/j.cocis.2005.08.005; Castaneda R, 2003, J AM CHEM SOC, V125, P7820, DOI 10.1021/ja035534p; CHEN CY, 2001, STUD SURF SCI CATAL, V135, P1710; Corma A, 1998, MICROPOR MESOPOR MAT, V21, P487, DOI 10.1016/S1387-1811(98)00115-2; Corma A, 2003, NAT MATER, V2, P493, DOI 10.1038/nmat921; Corma A, 2010, P NATL ACAD SCI USA, V107, P13997, DOI 10.1073/pnas.1003009107; Corma A, 2008, J AM CHEM SOC, V130, P16482, DOI 10.1021/ja806903c; Dorset DL, 2006, J PHYS CHEM B, V110, P2045, DOI 10.1021/jp0565352; Dorset DL, 2008, CHEM MATER, V20, P5325, DOI 10.1021/cm801126t; Dorset DL, 2006, J AM CHEM SOC, V128, P8862, DOI 10.1021/ja061206o; Elomari S, 2009, MICROPOR MESOPOR MAT, V118, P325, DOI 10.1016/j.micromeso.2008.09.011; Fild C, 2000, PHYS CHEM CHEM PHYS, V2, P3091, DOI 10.1039/b002134m; GALLI E, 1995, EUR J MINERAL, V7, P1029; HOWARD DG, 1990, AM MINERAL, V75, P1200; Jackowski A, 2009, J AM CHEM SOC, V131, P1092, DOI 10.1021/ja806978f; Jiang JX, 2010, ANGEW CHEM INT EDIT, V49, P3120, DOI 10.1002/anie.200904016; Josien L, 2003, CHEM-EUR J, V9, P856, DOI 10.1002/chem.200390095; Koller H, 2005, MICROPOR MESOPOR MAT, V79, P215, DOI 10.1016/j.micromeso.2004.10.035; LOBO RF, 1995, J INCLUS PHENOM MOL, V21, P47; LOBO RF, 1995, J AM CHEM SOC, V117, P3764; LOBO RF, 1993, SCIENCE, V262, P1543, DOI 10.1126/science.262.5139.1543; PLUTH JJ, 1990, AM MINERAL, V75, P501; Schwesinger R, 1996, LIEBIGS ANN-RECL, P1055; SHANNON MD, 1991, NATURE, V353, P417, DOI 10.1038/353417a0; Sun JL, 2009, NATURE, V458, P1154, DOI 10.1038/nature07957; Zones S. I., 1990, U. S. Patent, Patent No. 491006; ZONES SI, 1992, J AM CHEM SOC, V114, P4195, DOI 10.1021/ja00037a023	29	106	109	5	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1219	1222		10.1126/science.1196240	http://dx.doi.org/10.1126/science.1196240			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109667				2022-12-28	WOS:000284613700035
J	Powell, K				Powell, Kendall			Research funding: Making the cut	NATURE			English	News Item																			0	21	21	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					383	385		10.1038/467383a	http://dx.doi.org/10.1038/467383a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20864969	Bronze			2022-12-28	WOS:000282090200008
J	Kaplan, K				Kaplan, Karen			EMPLOYMENT TRENDS Drawn to academia	NATURE			English	Editorial Material																			0	27	27	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1135	1135		10.1038/nj7327-1135a	http://dx.doi.org/10.1038/nj7327-1135a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21157983	Bronze			2022-12-28	WOS:000285553800067
